PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Eckhoff, J; Dohmen, RJ				Eckhoff, Julia; Dohmen, R. Juergen			In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protein degradation; Saccharomyces cerevisiae; small ubiquitin-like modifier (SUMO); sumoylation	CELL-CYCLE PROGRESSION; SUMOYLATED PROTEINS; SACCHAROMYCES-CEREVISIAE; GLOBAL ANALYSIS; ISOPEPTIDASE; IDENTIFICATION; SMT4; CONJUGATION; PROTEOME; ENCODES	Background: Modification of proteins with small ubiquitin-related modifier has many important functions in cell biology. Results: Substrate-attached SUMO chains are processed by the yeast enzymes Ulp1 and Ulp2 via different mechanisms. Conclusion: Ulp2 recognizes chains with three or more SUMO units and releases single SUMO molecules from their distal ends. Significance: Ulp2 controls the dynamic length range of cellular SUMO chains. Sumoylation is a post-translational modification essential in most eukaryotes that regulates stability, localization, activity, or interaction of a multitude of proteins. It is a reversible process wherein counteracting ligases and proteases, respectively, mediate the conjugation and deconjugation of SUMO molecules to/from target proteins. Apart from attachment of single SUMO moieties to targets, formation of poly-SUMO chains occurs by the attachment of additional SUMO molecules to lysine residues in the N-terminal extensions of SUMO. In Saccharomyces cerevisiae there are apparently only two SUMO(Smt3)-specific proteases: Ulp1 and Ulp2. Ulp2 has been shown to be important for the control of poly-SUMO conjugates in cells and to dismantle SUMO chains in vitro, but the mechanism by which it acts remains to be elucidated. Applying an in vitro approach, we found that Ulp2 acts sequentially rather than stochastically, processing substrate-linked poly-SUMO chains from their distal ends down to two linked SUMO moieties. Furthermore, three linked SUMO units turned out to be the minimum length of a substrate-linked chain required for efficient binding to and processing by Ulp2. Our data suggest that Ulp2 disassembles SUMO chains by removing one SUMO moiety at a time from their ends (exo mechanism). Apparently, Ulp2 recognizes surfaces at or near the N terminus of the distal SUMO moiety, as attachments to this end significantly reduce cleavage efficiency. Our studies suggest that Ulp2 controls the dynamic range of SUMO chain lengths by trimming them from the distal ends.	[Eckhoff, Julia; Dohmen, R. Juergen] Univ Cologne, Inst Genet, Bioctr, D-50674 Cologne, Germany	University of Cologne	Dohmen, RJ (corresponding author), Univ Cologne, Inst Genet, Bioctr, Zulpicher Str 47a, D-50674 Cologne, Germany.	j.dohmen@uni-koeln.de	Dohmen, R. Jürgen/AAD-6649-2022	Dohmen, R. Jürgen/0000-0002-5756-6780	North Rhine-Westphalia International Graduate School in Development, Health and Disease	North Rhine-Westphalia International Graduate School in Development, Health and Disease	Supported by a pre-doctoral fellowship from the North Rhine-Westphalia International Graduate School in Development, Health and Disease.	Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Baek SH, 1997, J BIOL CHEM, V272, P25560, DOI 10.1074/jbc.272.41.25560; Bekes M, 2011, J BIOL CHEM, V286, P10238, DOI 10.1074/jbc.M110.205153; Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Bylebyl GR, 2003, J BIOL CHEM, V278, P44113, DOI 10.1074/jbc.M308357200; Da Silva-Ferrada E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01690; Da Silva-Ferrada E, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/875148; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fox Jeffrey D, 2003, Methods Mol Biol, V205, P99; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Hickey CM, 2012, NAT REV MOL CELL BIO, V13, P755, DOI 10.1038/nrm3478; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hunter T, 2009, ERNST SCHERING FOUND, V1, P1, DOI 10.1007/2789_2008_098; Hutchins AP, 2013, MOL BIOL EVOL, V30, P1172, DOI 10.1093/molbev/mst022; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kim JH, 2009, BBA-MOL BASIS DIS, V1792, P155, DOI 10.1016/j.bbadis.2008.12.008; Kim KI, 2000, J BIOL CHEM, V275, P14102, DOI 10.1074/jbc.275.19.14102; Klug H, 2013, MOL CELL, V50, P625, DOI 10.1016/j.molcel.2013.03.027; Kolli N, 2010, BIOCHEM J, V430, P335, DOI 10.1042/BJ20100504; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Kroetz MB, 2009, MOL BIOL CELL, V20, P2196, DOI 10.1091/mbc.E08-10-1090; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Lima CD, 2008, J BIOL CHEM, V283, P32045, DOI 10.1074/jbc.M805655200; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Mukhopadhyay D, 2007, TRENDS BIOCHEM SCI, V32, P286, DOI 10.1016/j.tibs.2007.05.002; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Mullen JR, 2010, MOL CELL BIOL, V30, P3737, DOI 10.1128/MCB.01649-09; Nayak A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0422-2; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Schimmel J, 2014, MOL CELL, V53, P1053, DOI 10.1016/j.molcel.2014.02.001; Schou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100692; Schwartz DC, 2007, MOL CELL BIOL, V27, P6948, DOI 10.1128/MCB.00774-07; Schwienhorst I, 2000, MOL GEN GENET, V263, P771, DOI 10.1007/s004380000254; Shen LN, 2009, BIOCHEM J, V421, P223, DOI 10.1042/BJ20090246; Shin EJ, 2012, EMBO REP, V13, P339, DOI 10.1038/embor.2012.3; Srikumar T, 2013, J CELL BIOL, V201, P145, DOI 10.1083/jcb.201210019; Sriramachandran AM, 2014, BBA-MOL CELL RES, V1843, P75, DOI 10.1016/j.bbamcr.2013.08.022; Stingele J, 2014, CELL, V158, P327, DOI 10.1016/j.cell.2014.04.053; Strunnikov AV, 2001, GENETICS, V158, P95; Su D, 2010, MOL CELL BIOL, V30, P3734, DOI 10.1128/MCB.00673-10; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Vertegaal ACO, 2010, BIOCHEM SOC T, V38, P46, DOI 10.1042/BST0380046; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2006, J PROTEOME RES, V5, P761, DOI 10.1021/pr050451o; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	66	15	15	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12268	12281		10.1074/jbc.M114.622217	http://dx.doi.org/10.1074/jbc.M114.622217			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25833950	hybrid, Green Published			2022-12-26	WOS:000354388600037
J	Fayle, TM; Scholtz, O; Dumbrell, AJ; Russell, S; Segar, ST; Eggleton, P				Fayle, Tom M.; Scholtz, Olivia; Dumbrell, Alex J.; Russell, Stephen; Segar, Simon T.; Eggleton, Paul			Detection of Mitochondrial COII DNA Sequences in Ant Guts as a Method for Assessing Termite Predation by Ants	PLOS ONE			English	Article							FOETENS FAB HYMENOPTERA; BEHAVIORAL INTERACTIONS; FORMICIDAE; ISOPTERA; BIODIVERSITY; DIVERSITY; CLASSIFICATION; RECRUITMENT; DISTURBANCE; PHYLOGENY	Termites and ants contribute more to animal biomass in tropical rain forests than any other single group and perform vital ecosystem functions. Although ants prey on termites, at the community level the linkage between these groups is poorly understood. Thus, assessing the distribution and specificity of ant termitophagy is of considerable interest. We describe an approach for quantifying ant-termite food webs by sequencing termite DNA (cytochrome c oxidase subunit II, COII) from ant guts and apply this to a soil-dwelling ant community from tropical rain forest in Gabon. We extracted DNA from 215 ants from 15 species. Of these, 17.2 % of individuals had termite DNA in their guts, with BLAST analysis confirming the identity of 34.1 % of these termites to family level or better. Although ant species varied in detection of termite DNA, ranging from 63% (5/7; Camponotus sp. 1) to 0% (0/7; Ponera sp. 1), there was no evidence (with small sample sizes) for heterogeneity in termite consumption across ant taxa, and no evidence for species-specific ant-termite predation. In all three ant species with identifiable termite DNA in multiple individuals, multiple termite species were represented. Furthermore, the two termite species that were detected on multiple occasions in ant guts were in both cases found in multiple ant species, suggesting that anttermite food webs are not strongly compartmentalised. However, two ant species were found to consume only Anoplotermes-group termites, indicating possible predatory specialisation at a higher taxonomic level. Using a laboratory feeding test, we were able to detect termite COII sequences in ant guts up to 2 h after feeding, indicating that our method only detects recent feeding events. Our data provide tentative support for the hypothesis that unspecialised termite predation by ants is widespread and highlight the use of molecular approaches for future studies of ant-termite food webs.	[Fayle, Tom M.; Segar, Simon T.] Univ South Bohemia, Czech Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budejovice 37005, Czech Republic; [Fayle, Tom M.; Segar, Simon T.] Univ South Bohemia, Fac Sci, Ceske Budejovice 37005, Czech Republic; [Fayle, Tom M.] Univ London Imperial Coll Sci Technol & Med, Forest Ecol & Conservat Grp, Ascot SL5 7PY, Berks, England; [Fayle, Tom M.] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu 88400, Sabah, Malaysia; [Scholtz, Olivia] Wildlife Conservat Soc, Global Conservat Program, Bronx, NY 10460 USA; [Dumbrell, Alex J.] Univ Essex, Sch Biol Sci, Colchester CO4 3SQ, Essex, England; [Russell, Stephen] Nat Hist Museum, Dept Facil Sci, London SW6 5BD, England; [Eggleton, Paul] Nat Hist Museum, Dept Life Sci, London SW6 5BD, England	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; University of South Bohemia Ceske Budejovice; Imperial College London; Universiti Malaysia Sabah; Wildlife Conservation Society; University of Essex; Natural History Museum London; Natural History Museum London	Fayle, TM (corresponding author), Univ South Bohemia, Czech Acad Sci, Ctr Biol, Inst Entomol, Branisovska 31, Ceske Budejovice 37005, Czech Republic.	tmfayle@gmail.com	Fayle, Tom Maurice/A-2721-2009; Segar, Simon/K-6783-2015; Eggleton, Paul/A-3155-2015	Fayle, Tom Maurice/0000-0002-1667-1189; Eggleton, Paul/0000-0002-1420-7518	UK Natural Environment Research Council [NE/H011307/1]; project "Biodiversity of Forest Ecosystems" [CZ.1.07/2.3.00/20.0064]; state budget of the Czech Republic; Czech Science Foundation [14-32302S]; Yayasan Sime Darby (TMF); University of South Bohemia Postdoc project [CZ.1.07/2.3.00/30.0006]; European Social Fund; Natural Environment Research Council [NE/H011307/1] Funding Source: researchfish; NERC [NE/H011307/1] Funding Source: UKRI	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); project "Biodiversity of Forest Ecosystems"; state budget of the Czech Republic; Czech Science Foundation(Grant Agency of the Czech Republic); Yayasan Sime Darby (TMF); University of South Bohemia Postdoc project; European Social Fund(European Social Fund (ESF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding provided by a UK Natural Environment Research Council small grant (NE/H011307/1), the project "Biodiversity of Forest Ecosystems" CZ.1.07/2.3.00/20.0064 co-financed by the European Social Fund and the state budget of the Czech Republic, a Czech Science Foundation Standard Grant (14-32302S), Yayasan Sime Darby (TMF) and a University of South Bohemia Postdoc project CZ.1.07/2.3.00/30.0006 co-financed by the European Social Fund and the state budget of the Czech Republic (STS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Benson DA, 2005, NUCLEIC ACIDS RES, V33, pD34, DOI 10.1093/nar/gki063; Bolton B, 2008, ZOOTAXA, P1; Buczkowski G, 2007, INSECT SOC, V54, P219, DOI 10.1007/s00040-007-0933-x; Buczkowski G, 2008, J INSECT BEHAV, V21, P296, DOI 10.1007/s10905-008-9127-2; Cameron SL, 2007, GENOME, V50, P188, DOI 10.1139/G06-148; Cerda X., 2011, PREDATION HYMENOPTER, P39; Crist TO, 2009, MYRMECOL NEWS, V12, P3; DEJEAN A, 1985, INSECT SOC, V32, P23, DOI 10.1007/BF02233224; Dejean A, 2007, J APPL ENTOMOL, V131, P625, DOI 10.1111/j.1439-0418.2007.01223.x; DEJEAN A, 1993, J ETHOL, V11, P43, DOI 10.1007/BF02350005; Dejean A, 1999, SOCIOBIOLOGY, V34, P555; Dejean A, 1996, INSECT SOC, V43, P87, DOI 10.1007/BF01253959; DeSouza O, 2009, B ENTOMOL RES, V99, P603, DOI 10.1017/S000748530900666X; Donovan SE, 2001, ECOL ENTOMOL, V26, P356, DOI 10.1046/j.1365-2311.2001.00342.x; Dormann C.F., 2008, R NEWS, V8, P8; Eggleton P, 2002, AGR ECOSYST ENVIRON, V90, P189, DOI 10.1016/S0167-8809(01)00206-7; Eggleton P, 1996, PHILOS T R SOC B, V351, P51, DOI 10.1098/rstb.1996.0004; Ellwood MDF, 2002, BIOTROPICA, V34, P575, DOI 10.1111/j.1744-7429.2002.tb00576.x; FITTKAU E J, 1973, Biotropica, V5, P2, DOI 10.2307/2989676; Folgarait PJ, 1998, BIODIVERS CONSERV, V7, P1221, DOI 10.1023/A:1008891901953; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Holldobler B., 1990, pi; Hrcek J, 2011, MOL ECOL RESOUR, V11, P786, DOI 10.1111/j.1755-0998.2011.03016.x; Inward DJG, 2007, MOL PHYLOGENET EVOL, V44, P953, DOI 10.1016/j.ympev.2007.05.014; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; LaPolla JS, 2010, SYST ENTOMOL, V35, P118, DOI 10.1111/j.1365-3113.2009.00492.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawton JH, 1996, BIODIVERS CONSERV, V5, P261, DOI 10.1007/BF00055835; LEDOUX ANDRE, 1952, ANN SCI NAT ZOOL 11E SE R, V14, P231; Leponce M, 1999, INSECT SOC, V46, P126, DOI 10.1007/s000400050122; Pequeno PACL, 2012, SOCIOBIOLOGY, V59, P893; LONGHURST C, 1978, ANIM BEHAV, V26, P1213, DOI 10.1016/0003-3472(78)90111-2; LONGHURST C, 1978, OECOLOGIA, V32, P101, DOI 10.1007/BF00344694; LONGHURST C, 1979, OECOLOGIA, V38, P83, DOI 10.1007/BF00347826; LONGHURST C, 1979, J CHEM ECOL, V5, P703, DOI 10.1007/BF00986555; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Morris RJ, 2004, NATURE, V428, P310, DOI 10.1038/nature02394; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pompanon F, 2012, MOL ECOL, V21, P1931, DOI 10.1111/j.1365-294X.2011.05403.x; PRESTWICH GD, 1984, ANNU REV ENTOMOL, V29, P201, DOI 10.1146/annurev.en.29.010184.001221; Quinet Y, 2005, J INSECT BEHAV, V18, P1, DOI 10.1007/s10905-005-9343-y; Rougerie R, 2011, MOL ECOL, V20, P179, DOI 10.1111/j.1365-294X.2010.04918.x; Schatz B, 1999, SOCIOBIOLOGY, V34, P569; Scholtz O, 2010, THESIS; Scholtz OI, 2008, ZOOL J LINN SOC-LOND, V153, P631, DOI 10.1111/j.1096-3642.2008.00396.x; Schoning C, 2007, BIOTROPICA, V39, P663, DOI 10.1111/j.1744-7429.2007.00296.x; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; TRANIELLO JFA, 1981, P NATL ACAD SCI-BIOL, V78, P1976, DOI 10.1073/pnas.78.3.1976; WENT FW, 1972, BIOSCIENCE, V22, P82, DOI 10.2307/1296037	53	8	8	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122533	10.1371/journal.pone.0122533	http://dx.doi.org/10.1371/journal.pone.0122533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853549	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000352478400070
J	Kenty, JHR; Melton, DA				Kenty, Jennifer H. R.; Melton, Douglas A.			Testing Pancreatic Islet Function at the Single Cell Level by Calcium Influx with Associated Marker Expression	PLOS ONE			English	Article							BETA-CELL; INSULIN-SECRETION; CYTOPLASMIC CA2+; IDENTIFIED ALPHA; INTACT ISLETS; DELTA-CELLS; OSCILLATIONS; EXOCYTOSIS; LANGERHANS; PATTERNS	Studying the response of islet cells to glucose stimulation is important for understanding cell function in healthy and disease states. Most functional assays are performed on whole islets or cell populations, resulting in averaged observations and loss of information at the single cell level. We demonstrate methods to examine calcium fluxing in individual cells of intact islets in response to multiple glucose challenges. Wild-type mouse islets predominantly contained cells that responded to three (out of three) sequential high glucose challenges, whereas cells of diabetic islets (db/db or NOD) responded less frequently or not at all. Imaged islets were also immunostained for endocrine markers to associate the calcium flux profile of individual cells with gene expression. Wild-type mouse islet cells that robustly fluxed calcium expressed beta cell markers (INS/NKX6.1), whereas islet cells that inversely fluxed at low glucose expressed alpha cell markers (GCG). Diabetic mouse islets showed a higher proportion of dysfunctional beta cells that responded poorly to glucose challenges. Most of the failed calcium influx responses in beta cells were observed in the second and third high glucose challenges, emphasizing the importance of multiple sequential glucose challenges for assessing the full function of islet cells. Human islet cells were also assessed and showed functional alpha and beta cells. This approach to analyze islet responses to multiple glucose challenges in correlation with gene expression assays expands the understanding of beta cell function and the diseased state.	[Kenty, Jennifer H. R.; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Sánchez-Margalet, Victor/AAB-9986-2021; Young, Richard A/F-6495-2012	Sánchez-Margalet, Victor/0000-0001-8638-8680; Young, Richard A/0000-0001-8855-8647	Helmsley Charitable Trust [2015PG-T1044]; JPB Foundation [135]; National Institues of Health (NIH) [1RC4DK090781-01]; Vanderbilt-University/NIH [U01DK072473]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473, RC4DK090781] Funding Source: NIH RePORTER	Helmsley Charitable Trust; JPB Foundation; National Institues of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-University/NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Helmsley Charitable Trust (2015PG-T1044), http://helmsleytrust.org/, to JHRK; JPB Foundation (135), http://jpbfoundation.org/, to JHRK; National Institues of Health (NIH) (1RC4DK090781-01), https://www.hhmi.org/, to JHRK; and Vanderbilt-University/NIH (U01DK072473), to JHRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada N, 1998, DIABETES, V47, P751, DOI 10.2337/diabetes.47.5.751; Blum B, 2012, NAT BIOTECHNOL, V30, P261, DOI 10.1038/nbt.2141; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GILON P, 1993, J BIOL CHEM, V268, P22265; Hamming KSC, 2010, DIABETES, V59, P1686, DOI 10.2337/db09-0630; Henquin J C, 1997, Jpn J Physiol, V47 Suppl 1, pS9; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hodson DJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1612; Hrvatin S, 2014, PLOS ONE, V10, P1371; Kjems LL, 2002, DIABETES, V51, pS177, DOI 10.2337/diabetes.51.2007.S177; Le Marchand SJ, 2010, JBC, P1; Le Marchand SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047084; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Liang XD, 2011, WORLD J GASTROENTERO, V17, P2812, DOI 10.3748/wjg.v17.i23.2812; MARCHETTI P, 1994, DIABETES, V43, P827, DOI 10.2337/diabetes.43.6.827; Merrins MJ, 2010, BIOPHYS J, V99, P76, DOI 10.1016/j.bpj.2010.04.012; Mohammed JS, 2008, THE ROYAL SOCIETY OF, V9, P97; Moser T, 1997, J NEUROSCI, V17, P2314; Nadal A, 1999, J PHYSIOL-LONDON, V517, P85, DOI 10.1111/j.1469-7793.1999.0085z.x; Nunemaker CS, 2005, DIABETES, V54, P3517, DOI 10.2337/diabetes.54.12.3517; Quesada I, 1999, DIABETES, V48, P2390, DOI 10.2337/diabetes.48.12.2390; Quesada I, 2006, DIABETES, V55, P2463, DOI 10.2337/db06-0272; Rupnik M, 2009, ACTA PHYSIOL, V195, P123, DOI 10.1111/j.1748-1716.2008.01927.x; Rutter GA, 2013, MOL ENDOCRINOL, V27, P1984, DOI 10.1210/me.2013-1278; Sanchez-Cardenas C, 2010, NEUROENDOCRINOLOGY, V91, P239, DOI 10.1159/000274493; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; Sedej S, 2005, J PHYSIOL-LONDON, V567, P799, DOI 10.1113/jphysiol.2005.090381; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Stozer A, 2013, PLOS ONE, V9, P1, DOI [10.1371/journal.pcbi.1002923, DOI 10.1371/JOURNAL.PCBI.1002923]; Stozer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054638; Sweet IR, 2006, DIABETES, V55, P3509, DOI 10.2337/db06-0400; Taylor BL, 2013, CELL REP, V4, P1262, DOI 10.1016/j.celrep.2013.08.010; Wang RN, 1999, J ENDOCRINOL, V163, P181, DOI 10.1677/joe.0.1630181; Westerlund J, 1997, J CLIN INVEST, V100, P2547, DOI 10.1172/JCI119797	36	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122044	10.1371/journal.pone.0122044	http://dx.doi.org/10.1371/journal.pone.0122044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853429	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400059
J	Shi, YY; He, XH; Zhu, GG; Tu, HL; Liu, ZC; Li, WH; Han, S; Yin, J; Peng, BW; Liu, WH				Shi, Yingying; He, Xiaohua; Zhu, Guoguo; Tu, Huilin; Liu, Zhongchun; Li, Wenhua; Han, Song; Yin, Jun; Peng, Biwen; Liu, Wanhong			Coxsackievirus A16 Elicits Incomplete Autophagy Involving the mTOR and ERK Pathways	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HERPES-SIMPLEX-VIRUS; CELL-DEATH; PROTEIN; ACTIVATION; REPLICATION; INHIBITION; INDUCTION; MECHANISM; APOPTOSIS	Autophagy is an important homeostatic process for the degradation of cytosolic proteins and organelles and has been reported to play an important role in cellular responses to pathogens and virus replication. However, the role of autophagy in Coxsackievirus A16 (CA16) infection and pathogenesis remains unknown. Here, we demonstrated that CA16 infection enhanced autophagosome formation, resulting in increased extracellular virus production. Moreover, expression of CA16 nonstructural proteins 2C and 3C was sufficient to trigger autophagosome accumulation by blocking the fusion of autophagosomes with lyso-somes. Interestingly, we found that Immunity-related GTPase family M (IRGM) was crucial for the activation of CA16 infection-induced autophagy; in turn, reducing IRGM expression suppressed autophagy. Expression of viral protein 2C enhanced IRGM promoter activation, thereby increasing IRGM expression and inducing autophagy. CA16 infection inhibited Akt/mTOR signaling and activated extracellular signal-regulated kinase (ERK) signaling, both of which are necessary for autophagy induction. In summary, CA16 can use autophagy to enhance its own replication. These results raise the possibility of targeting the autophagic pathway for the treatment of hand, foot, and mouth disease (HFMD).	[Shi, Yingying; He, Xiaohua; Zhu, Guoguo; Tu, Huilin; Han, Song; Yin, Jun; Peng, Biwen; Liu, Wanhong] Wuhan Univ, Sch Basic Med Sci, Pathogen Organism & Infect Dis Res Inst, Wuhan 430071, Peoples R China; [Shi, Yingying; Liu, Wanhong] Hubei Prov Key Lab Allergy & Immunol, Wuhan 430071, Peoples R China; [He, Xiaohua; Peng, Biwen] Wuhan Univ, Sch Basic Med Sci, Hubei Prov Key Lab Developmentally Originated Dis, Wuhan 430072, Peoples R China; [Zhu, Guoguo] Wuhan Gen Hosp Guangzhou Command, Emergency Dept, Intens Care Unit, Wuhan 430071, Peoples R China; [Liu, Zhongchun] Wuhan Univ, Renmin Hosp, Inst Neuropsychiat, Wuhan 430060, Peoples R China; [Li, Wenhua] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Wuhan University	Liu, WH (corresponding author), Wuhan Univ, Sch Basic Med Sci, Pathogen Organism & Infect Dis Res Inst, Wuhan 430071, Peoples R China.	liuwanhong@whu.edu.cn		/0000-0002-5599-6779	National Natural Sciences Foundation of China [81171577, 81371790, 81371422, 81171127]; Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China [2014ZX10001003]; Fundamental Research Funds for the Central Universities of China; Translational Medical Research Fund of the Wuhan University School of Medicine	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Translational Medical Research Fund of the Wuhan University School of Medicine	This work was supported by the National Natural Sciences Foundation of China (No. 81171577, 81371790, 81371422 and 81171127), Major AIDS and Viral Hepatitis and Other Major Infectious Disease Prevention and Control project of China (2014ZX10001003), the Fundamental Research Funds for the Central Universities of China, and the Translational Medical Research Fund of the Wuhan University School of Medicine.	Alexander DE, 2007, J VIROL, V81, P12128, DOI 10.1128/JVI.01356-07; Bekpen C, 2010, SEMIN IMMUNOPATHOL, V32, P437, DOI 10.1007/s00281-010-0224-x; BIENZ K, 1987, VIROLOGY, V160, P220, DOI 10.1016/0042-6822(87)90063-8; Brabec-Zaruba M, 2007, J VIROL, V81, P10815, DOI 10.1128/JVI.00143-07; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; CHEN XQ, 2013, PLOS NEGLECT TROP D, V7, P82861, DOI DOI 10.1371/JOURNAL.PONE.0082861; DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2; Datan E, 2014, VIROLOGY, V452, P175, DOI 10.1016/j.virol.2014.01.008; Deegan S, 2014, BIOCH BIOPHYS RES CO; Ding BB, 2014, CELL HOST MICROBE, V15, P564, DOI 10.1016/j.chom.2014.04.004; English L, 2009, NAT IMMUNOL, V10, P480, DOI 10.1038/ni.1720; Gregoire IP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002422; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Hou L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-156; Huang J, 2014, MOL CELL BIOCH; Hung CH, 2014, J VIROL, V88, P12133, DOI 10.1128/JVI.02033-14; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kuyumcu-Martinez NM, 2004, MOL CELL BIOL, V24, P1779, DOI 10.1128/MCB.24.4.1779-1790.2004; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Liang QM, 2013, J VIROL, V87, P12499, DOI 10.1128/JVI.01898-13; Liu YJ, 2014, VIRUS GENES, V48, P260, DOI 10.1007/s11262-014-1035-2; Lussignol M, 2013, J VIROL, V87, P859, DOI 10.1128/JVI.01158-12; Mao QY, 2014, HUM VACC IMMUNOTHER, V10, P360, DOI 10.4161/hv.27087; Martinez-Lopez N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3799; Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12; McFarlane S, 2011, J VIROL, V85, P4212, DOI 10.1128/JVI.02435-10; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; RODRIGUEZ PL, 1995, J BIOL CHEM, V270, P10105, DOI 10.1074/jbc.270.17.10105; RODRIGUEZ PL, 1993, J BIOL CHEM, V268, P8105; Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14; Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073; Singh SB, 2010, NAT CELL BIOL, V12, P1154, DOI 10.1038/ncb2119; Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Sun MX, 2012, AUTOPHAGY, V8, P1434, DOI 10.4161/auto.21159; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Surviladze Z, 2013, J VIROL, V87, P2508, DOI 10.1128/JVI.02319-12; Svensson L, 1999, J VIROL METHODS, V80, P17, DOI 10.1016/S0166-0934(99)00018-X; Tang SW, 2013, J VIROL, V87, P1699, DOI 10.1128/JVI.02147-12; Tanida I, 2011, ANTIOXID REDOX SIGN, V14, P2201, DOI 10.1089/ars.2010.3482; Teterina NL, 1997, J VIROL, V71, P8962, DOI 10.1128/JVI.71.12.8962-8972.1997; Wang CL, 2012, J VIROL, V86, P9964, DOI 10.1128/JVI.00914-12; Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954; Wei W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094746; Weidman MK, 2001, VIROLOGY, V291, P260, DOI 10.1006/viro.2001.1215; Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08; Zhou Z, 2009, AUTOPHAGY, V5, P321, DOI 10.4161/auto.5.3.7406; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12; Zhu GG, 2013, BIOCHEM BIOPH RES CO, V441, P856, DOI 10.1016/j.bbrc.2013.10.142	54	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122109	10.1371/journal.pone.0122109	http://dx.doi.org/10.1371/journal.pone.0122109			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853521	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400060
J	Demeter, F; Shackelford, L; Westaway, K; Duringer, P; Bacon, AM; Ponche, JL; Wu, XJ; Sayavongkhamdy, T; Zhao, JX; Barnes, L; Boyon, M; Sichanthongtip, P; Senegas, F; Karpoff, AM; Patole-Edoumba, E; Coppens, Y; Braga, J				Demeter, Fabrice; Shackelford, Laura; Westaway, Kira; Duringer, Philippe; Bacon, Anne-Marie; Ponche, Jean-Luc; Wu, Xiujie; Sayavongkhamdy, Thongsa; Zhao, Jian-Xin; Barnes, Lani; Boyon, Marc; Sichanthongtip, Phonephanh; Senegas, Frank; Karpoff, Anne-Marie; Patole-Edoumba, Elise; Coppens, Yves; Braga, Jose			Early Modern Humans and Morphological Variation in Southeast Asia: Fossil Evidence from Tam Pa Ling, Laos	PLOS ONE			English	Article							HUMAN REMAINS; HOMINID SITE; HOMO; MIDDLE; MANDIBLES; GUANGXI; SUPPORT; CAVE	Little is known about the timing of modern human emergence and occupation in Eastern Eurasia. However a rapid migration out of Africa into Southeast Asia by at least 60 ka is supported by archaeological, paleogenetic and paleoanthropological data. Recent discoveries in Laos, a modern human cranium (TPL1) from Tam Pa Ling's cave, provided the first evidence for the presence of early modern humans in mainland Southeast Asia by 63-46 ka. In the current study, a complete human mandible representing a second individual, TPL 2, is described using discrete traits and geometric morphometrics with an emphasis on determining its population affinity. The TPL2 mandible has a chin and other discrete traits consistent with early modern humans, but it retains a robust lateral corpus and internal corporal morphology typical of archaic humans across the Old World. The mosaic morphology of TPL2 and the fully modern human morphology of TPL1 suggest that a large range of morphological variation was present in early modern human populations residing in the eastern Eurasia by MIS 3.	[Demeter, Fabrice] Musee Homme Paris, Dept Homme Nat Soc, Unite Mixte Rech 7206, Unite Sci Museum 104,Museum Natl Hist Nat, Paris, France; [Demeter, Fabrice] Univ Paris 06, Chaire Sorbonne Univ FaciLe, Inst Calcul & Simulat, Paris, France; [Shackelford, Laura] Univ Illinois, Dept Anthropol, Urbana, IL USA; [Westaway, Kira; Barnes, Lani] Macquarie Univ, Dept Geog & Environm, Sydney, NSW 2109, Australia; [Duringer, Philippe; Boyon, Marc; Karpoff, Anne-Marie] Univ Strasbourg, Ecole Observ Sci Terre, CNRS, Unite Mixte Rech 7516,Inst Phys Globe Strasbourg, Strasbourg, France; [Bacon, Anne-Marie; Senegas, Frank] CNRS, Unite Propre Rech 2147, Paris, France; [Wu, Xiujie] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing, Peoples R China; [Sayavongkhamdy, Thongsa; Sichanthongtip, Phonephanh] Minist Informat & Culture, Dept Natl Heritage, Viangchan, Laos; [Zhao, Jian-Xin] Univ Queensland, Sch Earth Sci, Brisbane, Qld, Australia; [Ponche, Jean-Luc] Univ Strasbourg, Inst Chim & Proc Energie Environm & Sante, CNRS, Unite Mixte Rech 7515, Strasbourg, France; [Ponche, Jean-Luc] Ecole & Observ Sci Terre, Unite Mixte Rech 7516 & 7362, Strasbourg, France; [Patole-Edoumba, Elise] Museum Hist Nat Rochelle, La Rochelle, France; [Coppens, Yves] Coll France, F-75231 Paris, France; [Braga, Jose] Univ Toulouse 3, Unite Mixte Rech Anthropobiol & Imagerie Anat 528, CNRS, F-31062 Toulouse, France; [Braga, Jose] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Braga, Jose] Univ Witwatersrand, Kromdraai Res Project, Johannesburg, South Africa	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Illinois System; University of Illinois Urbana-Champaign; Macquarie University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University of Queensland; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Witwatersrand; University of Witwatersrand	Demeter, F (corresponding author), Musee Homme Paris, Dept Homme Nat Soc, Unite Mixte Rech 7206, Unite Sci Museum 104,Museum Natl Hist Nat, Paris, France.	demeter@mnhn.fr; llshacke@illinois.edu	Zhao, Jian-xin/A-5938-2008	Zhao, Jian-xin/0000-0002-2413-6178; Westaway, Kira/0000-0001-5315-778X	Australian Research Council (ARC) Discovery Grant [DP1093049]; LIEF [LE100100094]; French Ministry of Foreign Affair; Ministry of Culture and Information of LAO PDR; University of Illinois at Urbana-Champaign, USA; CNRS [UPR2147]; MNHN, Paris [UMR7206]; CNRS/IPGS Strasbourg [UMR7516]	Australian Research Council (ARC) Discovery Grant(Australian Research Council); LIEF; French Ministry of Foreign Affair; Ministry of Culture and Information of LAO PDR; University of Illinois at Urbana-Champaign, USA; CNRS(Centre National de la Recherche Scientifique (CNRS)); MNHN, Paris; CNRS/IPGS Strasbourg	The chronological aspects of this research were funded by Australian Research Council (ARC) Discovery Grant DP1093049 and LIEF Grant LE100100094. This work is supported by the French Ministry of Foreign Affair, the Ministry of Culture and Information of LAO PDR and the University of Illinois at Urbana-Champaign, USA, the UPR2147 (CNRS), the UMR7206 (MNHN, Paris), the UMR7516 (CNRS/IPGS Strasbourg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker G, 2007, J HUM EVOL, V52, P243, DOI 10.1016/j.jhevol.2006.08.011; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brauer G, 2008, EVOL ANTHROPOL, V17, P22, DOI 10.1002/evan.20157; Brauer G, 1988, ANTHROPOLOGIE, P160; Brown P, 2009, J HUM EVOL, V57, P571, DOI 10.1016/j.jhevol.2009.06.002; Chang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7037; DAY MH, 1969, NATURE, V222, P1135, DOI 10.1038/2221135a0; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; Demeter F, 2012, P NATL ACAD SCI USA, V109, P14375, DOI 10.1073/pnas.1208104109; Dobson SD, 2002, J HUM EVOL, V43, P67, DOI 10.1006/jhev.2002.0563; Fromaget J., 1936, CR Acad Sci Paris, V203, P738; Fromaget J, 1940, RECENTES DECOUVERTES, P51; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; [高斌 GAO Bin], 2007, [暨南大学学报. 自然科学与医学版, Journal of Jinan University], V28, P308; Jia L, 1959, PALEOVERTEBRATA PALE, V1, P16; Jidoi K, 2000, ANTHROPOL SCI, V108, P345, DOI 10.1537/ase.108.345; Kennedy KAR, 1999, EVOL ANTHROPOL, V8, P165, DOI 10.1002/(SICI)1520-6505(1999)8:5<165::AID-EVAN5>3.0.CO;2-0; KENNEDY KAR, 1987, AM J PHYS ANTHROPOL, V72, P441, DOI 10.1002/ajpa.1330720405; Lague MR, 2008, J ANAT, V213, P670, DOI 10.1111/j.1469-7580.2008.00989.x; Lebel S, 2002, J HUM EVOL, V43, P659, DOI 10.1006/jhev.2002.0598; Liu W, 2010, P NATL ACAD SCI USA, V107, P19201, DOI 10.1073/pnas.1014386107; Lumley M. A, 1982, HOMO ERECTUS PLACE H, P814; Mitteroecker P, 2011, EVOL BIOL, V38, P100, DOI 10.1007/s11692-011-9109-8; MOLNAR S, 1971, AM J PHYS ANTHROPOL, V34, P175, DOI 10.1002/ajpa.1330340204; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Nicholson E, 2006, AM J PHYS ANTHROPOL, V131, P368, DOI 10.1002/ajpa.20425; Pierret A, 2012, P NATL ACAD SCI USA, V109, pE3523, DOI 10.1073/pnas.1216774109; Quam RM, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P405; Reyes-Centeno H, 2014, P NATL ACAD SCI USA, V111, P7248, DOI 10.1073/pnas.1323666111; Rightmire P, 1990, EVOLUTION HOMO ERECT; Rosas A, 2001, AM J PHYS ANTHROPOL, V114, P74, DOI 10.1002/1096-8644(200101)114:1<74::AID-AJPA1007>3.3.CO;2-L; ROSAS A, 1995, J HUM EVOL, V28, P533, DOI 10.1006/jhev.1995.1041; Mijares AS, 2010, J HUM EVOL, V59, P123, DOI 10.1016/j.jhevol.2010.04.008; Shang H, 2010, EARLY MODERN HUMAN T; Shang H, 2007, P NATL ACAD SCI USA, V104, P6573, DOI 10.1073/pnas.0702169104; Shen GJ, 2002, J HUM EVOL, V43, P817, DOI 10.1006/jhev.2002.0601; Shen GJ, 2007, J ARCHAEOL SCI, V34, P2109, DOI 10.1016/j.jas.2007.02.008; Stefan VH, 1998, J HUM EVOL, V34, P443, DOI 10.1006/jhev.1997.0210; Trinkaus E, 2014, LIFE DEATH PESTERA C; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Viterbo KMA, 2012, AM J PHYS ANTHROPOL, V147, P294; Walker MJ, 2010, AM J PHYS ANTHROPOL, V142, P261, DOI 10.1002/ajpa.21223; Weidenreich F., 1936, Palaeontologia Sinica, VD7, P1; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Woo J, 1959, SCI REC, V3, P165; WOO J. K., 1959, VERTEBR PALASIAT [CHINA], V3, P109; WOO JU-KANG, 1958, VERTEBR PALASIAT [CHINA], V2, P208; Woo RK, 1959, VERTEBRAT PALASIATIC, V3, P176; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Yuan S.X., 1986, ACTA ANTHROPOL SIN, V5, P179	52	38	38	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121193	10.1371/journal.pone.0121193	http://dx.doi.org/10.1371/journal.pone.0121193			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849125	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800048
J	Girihagama, L; Nof, D; Hancock, C				Girihagama, Lakshika; Nof, Doron; Hancock, Cathrine			Bubble-Induced Cave Collapse	PLOS ONE			English	Article							VELOCITY; LIMESTONE; STRENGTH	Conventional wisdom among cave divers is that submerged caves in aquifers, such as in Florida or the Yucatan, are unstable due to their ever-growing size from limestone dissolution in water. Cave divers occasionally noted partial cave collapses occurring while they were in the cave, attributing this to their unintentional (and frowned upon) physical contact with the cave walls or the aforementioned "natural" instability of the cave. Here, we suggest that these cave collapses do not necessarily result from cave instability or contacts with walls, but rather from divers bubbles rising to the ceiling and reducing the buoyancy acting on isolated ceiling rocks. Using familiar theories for the strength of flat and arched (un-cracked) beams, we first show that the flat ceiling of a submerged limestone cave can have a horizontal expanse of 63 meters. This is much broader than that of most submerged Florida caves (similar to 10 m). Similarly, we show that an arched cave roof can have a still larger expanse of 240 meters, again implying that Florida caves are structurally stable. Using familiar bubble dynamics, fluid dynamics of bubble-induced flows, and accustomed diving practices, we show that a group of 1-3 divers submerged below a loosely connected ceiling rock will quickly trigger it to fall causing a "collapse". We then present a set of qualitative laboratory experiments illustrating such a collapse in a circular laboratory cave (i.e., a cave with a circular cross section), with concave and convex ceilings. In these experiments, a metal ball represented the rock (attached to the cave ceiling with a magnet), and the bubbles were produced using a syringe located at the cave floor.	[Girihagama, Lakshika; Nof, Doron; Hancock, Cathrine] Florida State Univ, Inst Geophys Fluid Dynam, Tallahassee, FL 32306 USA; [Nof, Doron] Florida State Univ, Dept Earth Ocean & Atmospher Sci Dept, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Girihagama, L (corresponding author), Florida State Univ, Inst Geophys Fluid Dynam, Tallahassee, FL 32306 USA.	lng09@my.fsu.edu			AGS Grant [1032403]; LANL/IGPP Grant [1815]; NSF [OCE-0752225, OCE-9911342, OCE-0545204, OCE-0241036]; BSF [2006296]; NASA [NNX07AL97G]	AGS Grant; LANL/IGPP Grant; NSF(National Science Foundation (NSF)); BSF(US-Israel Binational Science Foundation); NASA(National Aeronautics & Space Administration (NASA))	This work was supported by an AGS Grant (1032403), LANL/IGPP Grant (1815), NSF (OCE-0752225, OCE-9911342, OCE-0545204, and OCE-0241036), BSF (2006296), and NASA (NNX07AL97G). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1953, EXPT INVESTIGATION D; Bagde MN, 2005, INT J ROCK MECH MIN, V42, P237, DOI 10.1016/j.ijrmms.2004.08.008; BATCHELOR GK, 1987, J FLUID MECH, V184, P399, DOI 10.1017/S0022112087002945; Batchelor GK, 1967, INTRO FLUID DYNAMICS, P475; Baykasoglu A, 2008, EXPERT SYST APPL, V35, P111, DOI 10.1016/j.eswa.2007.06.006; Bozzano G, 2001, COMPUT CHEM ENG, V25, P571, DOI 10.1016/S0098-1354(01)00636-6; Geschwindner LF, 1999, STRUCTURAL STEEL DES, P41; Hibbeler RC, 1997, STRUCTURAL ANAL; Iannacchione AT, 1998, 17TH INTERNATIONAL CONFERENCE ON GROUND CONTROL IN MINING, PROCEEDINGS, P102; Joseph DD, 2003, J FLUID MECH, V488, P213, DOI 10.1017/S0022112003004968; Kenyon KE, 2011, PHYS ESSAYS, V24; Nof D, 2012, J FORENSIC SCI, V57, P932, DOI 10.1111/j.1556-4029.2011.02038.x; Nof D, 2010, SAFETY SCI, V48, P607, DOI 10.1016/j.ssci.2010.01.010; Tahir M, 2011, J HIMAL EARTH SCI, V44, P45; Zheng L, 2000, J HYDRAUL ENG-ASCE, V126, P852, DOI 10.1061/(ASCE)0733-9429(2000)126:11(852)	15	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122349	10.1371/journal.pone.0122349	http://dx.doi.org/10.1371/journal.pone.0122349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849088	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800120
J	Kim, HJ; Kim, MK; Lee, MJ; Won, HJ; Choi, SS; Kim, ES				Kim, Hye-Jin; Kim, Min-Kyung; Lee, Mi-Jin; Won, Hyung-Jin; Choi, Si-Sun; Kim, Eung-Soo			Post-PKS Tailoring Steps of a Disaccharide-Containing Polyene NPP in Pseudonocardia autotrophica	PLOS ONE			English	Article							POLYKETIDE SYNTHASE; CONJUGAL TRANSFER; ESCHERICHIA-COLI; AMPHOTERICIN-B; BIOSYNTHESIS; DERIVATIVES; NYSTATIN; CLONING; GLYCOSYLTRANSFERASES; MACROLIDES	A novel polyene compound NPP identified in a rare actinomycetes, Pseudonocardia autotrophica KCTC9441, was shown to contain an aglycone identical to nystatin but to harbor a unique di-sugar moiety, mycosaminyl-(alpha 1-4)-N-acetyl-glucosamine, which led to higher solubility and reduced hemolytic activity. Although the nppDI was proved to be responsible for the transfer of first polyene sugar, mycosamine in NPP biosynthesis, the gene responsible for the second sugar extending glycosyltransferase (GT) as well as NPP post-PKS tailoring mechanism remained unknown. Here, we identified a NPP-specific second sugar extending GT gene named nppY, located at the edge of the NPP biosynthetic gene cluster. Targeted nppY gene deletion and its complementation proved that nppY is indeed responsible for the transfer of second sugar, N-acetyl-glucosamine in NPP biosynthesis. Site-directed mutagenesis on nppY also revealed several amino acid residues critical for NppY GT function. Moreover, a combination of deletions and complementations of two GT genes (nppDI and nppY) and one P450 hydroxylase gene (nppL) involved in the NPP post-PKS biosynthesis revealed that NPP aglycone is sequentially modified by the two different GTs encoded by nppDI and nppY, respectively, followed by the nppL-driven regio-specific hydroxylation at the NPP C10 position. These results set the stage for the biotechnological application of sugar diversification for the biosynthesis of novel polyene compounds in actinomycetes.	[Kim, Hye-Jin; Kim, Min-Kyung; Lee, Mi-Jin; Won, Hyung-Jin; Choi, Si-Sun; Kim, Eung-Soo] Inha Univ, Dept Biol Engn, Inchon, South Korea	Inha University	Kim, ES (corresponding author), Inha Univ, Dept Biol Engn, Inchon, South Korea.	eungsoo@inha.ac.kr			Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ011296]	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea	This work was supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ011296), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baginski M, 2009, CURR DRUG METAB, V10, P459, DOI 10.2174/138920009788898019; Baginski M, 2006, CHEM REC, V6, P320, DOI 10.1002/tcr.20096; Barke J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-109; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Brautaset T, 2011, APPL ENVIRON MICROB, V77, P6636, DOI 10.1128/AEM.05780-11; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Bruheim P, 2004, ANTIMICROB AGENTS CH, V48, P4120, DOI 10.1128/AAC.48.11.4120-4129.2004; Butts A, 2012, PLOS PATHOG, P8; Byrne B, 2003, CHEM BIOL, V10, P1215, DOI 10.1016/j.chembiol.2003.12.001; Caffrey P, 2001, CHEM BIOL, V8, P713, DOI 10.1016/S1074-5521(01)00046-1; Carmody M, 2005, J BIOL CHEM, V280, P34420, DOI 10.1074/jbc.M506689200; Choi SU, 2004, ARCH MICROBIOL, V181, P294, DOI 10.1007/s00203-004-0654-8; De Poire E, 2013, APPL ENVIRON MICROB, V79, P6156, DOI 10.1128/AEM.02197-13; Ellepola ANB, 2000, CRIT REV ORAL BIOL M, V11, P172, DOI 10.1177/10454411000110020301; Hansen SF, 2010, MOL BIOSYST, V6, P1773, DOI 10.1039/c000238k; Hopwood DA, 1997, CHEM REV, V97, P2465, DOI 10.1021/cr960034i; Kim BG, 2009, J IND MICROBIOL BIOT, V36, P1425, DOI 10.1007/s10295-009-0629-5; Kim HJ, 2014, J MICROBIOL BIOTECHN, V25, P143; Lai Chih-Cheng, 2008, Journal of Infection and Chemotherapy, V14, P77, DOI 10.1007/s10156-007-0595-7; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Lee MJ, 2012, APPL MICROBIOL BIOT, V95, P157, DOI 10.1007/s00253-012-3955-x; Luzhetskyy A, 2008, CURR TOP MED CHEM, V8, P680, DOI 10.2174/156802608784221514; Luzhetskyy A, 2007, APPL MICROBIOL BIOT, V75, P1367, DOI 10.1007/s00253-007-0950-8; MACNEIL DJ, 1992, GENE, V111, P61, DOI 10.1016/0378-1119(92)90603-M; Mulichak AM, 2014, BIOCHEMISTRY-US, V43, P5170; Murphy B, 2010, ORG BIOMOL CHEM, V8, P3758, DOI 10.1039/b922074g; Nosanchuk Joshua D, 2006, Recent Pat Antiinfect Drug Discov, V1, P75, DOI 10.2174/157489106775244109; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Power P, 2008, CHEM BIOL, V15, P78, DOI 10.1016/j.chembiol.2007.11.008; Samaranayake LP, 2009, PERIODONTOL 2000, V49, P39, DOI 10.1111/j.1600-0757.2008.00291.x; Sekurova O, 1999, FEMS MICROBIOL LETT, V177, P297, DOI 10.1111/j.1574-6968.1999.tb13746.x; Stephens N, 2013, BIOSCI BIOTECH BIOCH, V77, P880, DOI 10.1271/bbb.120961; Thibodeaux CJ, 2007, NATURE, V446, P1008, DOI 10.1038/nature05814; Volokhan O, 2006, APPL ENVIRON MICROB, V72, P2514, DOI 10.1128/AEM.72.4.2514-2519.2006; Wakiec R, 2007, MYCOSES, V50, P109, DOI [10.1111/j.1439-0507.2006.01327.x, 10.1111/j.0933-7407.2006.01327.x]; WeymouthWilson AC, 1997, NAT PROD REP, V14, P99, DOI 10.1039/np9971400099; Williams David, 2011, J Oral Microbiol, V3, DOI 10.3402/jom.v3i0.5771; Zotchev SB, 2003, CURR MED CHEM, V10, P211, DOI 10.2174/0929867033368448	38	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123270	10.1371/journal.pone.0123270	http://dx.doi.org/10.1371/journal.pone.0123270			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849545	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800220
J	Knight, GM; Dodd, PJ; Grant, AD; Fielding, KL; Churchyard, GJ; White, RG				Knight, Gwenan M.; Dodd, Peter J.; Grant, Alison D.; Fielding, Katherine L.; Churchyard, Gavin J.; White, Richard G.			Tuberculosis Prevention in South Africa	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; RANDOMIZED TRIAL; TRANSMISSION; INFECTION; DIAGNOSIS; RISK	Background South Africa has one of the highest per capita rates of tuberculosis (TB) incidence in the world. In 2012, the South African government produced a National Strategic Plan (NSP) to control the spread of TB with the ambitious aim of zero new TB infections and deaths by 2032, and a halving of the 2012 rates by 2016. Methods We used a transmission model to investigate whether the NSP targets could be reached if immediate scale up of control methods had happened in 2014. We explored the potential impact of four intervention portfolios; 1) "NSP" represents the NSP strategy, 2) "WHO" investigates increasing antiretroviral therapy eligibility, 3) "Novel Strategies" considers new isoniazid preventive therapy strategies and HIV "Universal Test and Treat" and 4) "Optimised" contains the most effective interventions. Findings We find that even with this scale-up, the NSP targets are unlikely to be achieved. The portfolio that achieved the greatest impact was "Optimised", followed closely by "NSP". The "WHO" and "Novel Strategies" had little impact on TB incidence by 2050. Of the individual interventions explored, the most effective were active case finding and reductions in pretreatment loss to follow up which would have a large impact on TB burden. Conclusion Use of existing control strategies has the potential to have a large impact on TB disease burden in South Africa. However, our results suggest that the South African TB targets are unlikely to be reached without new technologies. Despite this, TB incidence could be dramatically reduced by finding and starting more TB cases on treatment.	[Knight, Gwenan M.; White, Richard G.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England; [Knight, Gwenan M.; Grant, Alison D.; Fielding, Katherine L.; Churchyard, Gavin J.; White, Richard G.] London Sch Hyg & Trop Med, TB Ctr, London WC1, England; [Dodd, Peter J.] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England; [Churchyard, Gavin J.] Aurum Inst, Johannesburg, South Africa; [Churchyard, Gavin J.] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa	University of London; London School of Hygiene & Tropical Medicine; University of Sheffield; University of Witwatersrand	Knight, GM (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, TB Modelling Grp, London WC1, England.	gwen.knight@lshtm.ac.uk	Knight, Gwen/AAF-1176-2020; Knight, Gwen/AGE-2703-2022; White, Richard G/D-5407-2009	White, Richard G/0000-0003-4410-6635; Knight, Gwenan/0000-0002-7263-9896; Dodd, Pete/0000-0001-5825-9347; Churchyard, Gavin/0000-0002-4269-3699	CDC/PEPFAR via the Aurum Institute [U2GPS0008111]; Medical Research Council (UK) [MR/J005088/1]; Bill and Melinda Gates Foundation [21675 / OPP1084276, 19790.01]; MRC [MR/J005088/1] Funding Source: UKRI; Medical Research Council [MR/J005088/1, MR/K012126/1] Funding Source: researchfish; National Institute for Health Research [PHCS/03/01] Funding Source: researchfish	CDC/PEPFAR via the Aurum Institute; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was funded by CDC/PEPFAR via the Aurum Institute (U2GPS0008111). RGW is also funded by the Medical Research Council (UK) (MR/J005088/1), the Bill and Melinda Gates Foundation (TB Modelling and Analysis Consortium: Grants 21675 / OPP1084276 and Consortium to Respond Effectively to the AIDS/TB Epidemic: 19790.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akolo C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000171.pub3; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; [Anonymous], 2011, MILL DEV GOALS REP; [Anonymous], 2013, GLOB TUB CONTR; [Anonymous], 2011, GUID INT TUB CAS FIN; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Behr MA, 1999, LANCET, V353, P444, DOI 10.1016/S0140-6736(98)03406-0; Botha E, 2008, INT J TUBERC LUNG D, V12, P936; Churchyard G, 2014, EFFECT XPERT MTB RIF; Churchyard GJ, 2014, SAMJ S AFR MED J, V104, P244, DOI [10.7196/samj.7689, 10.7196/SAMJ.7689]; Churchyard GJ, 2014, NEW ENGL J MED, V370, P301, DOI [10.1056/NEJMoa1214289, 10.1056/NEJMc1402073]; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dodd PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075466; Dodd PJ, MYCOBACTERI IN PRESS; Dye C, 2013, ANNU REV PUBL HEALTH, V34, P271, DOI 10.1146/annurev-publhealth-031912-114431; Eaton JW, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001245; Fielding KL, 2014, XPERT 1 LINE TB TEST; Houben RMGJ, 2014, P NATL ACAD SCI US; KOPANOFF DE, 1978, AM REV RESPIR DIS, V117, P991; Nash D, 2011, AIDS, V25, P1523, DOI 10.1097/QAD.0b013e32834811b2; Pretorius C, 2014, AIDS, V28, pS25, DOI 10.1097/QAD.0000000000000085; Samandari T, 2011, LANCET, V377, P1588, DOI 10.1016/S0140-6736(11)60204-3; SANAC, 2012, YEAR 1 KEY NSP THEM; South African National AIDS Commission (SANAC), 2012, GLOB AIDS RESP PROGR; South African National AIDS Council (SANAC), 2012, NAT STRAT PLAN HIV S; South African National AIDS Council (SANAC), 2010, NAT HIV COUNS TEST C; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; Tostmann A, 2008, CLIN INFECT DIS, V47, P1135, DOI 10.1086/591974; [UN DEPARTMENT OF ECONOMIC AND SOCIAL AFFAIRS P. D.], 2011, WORLD POP PROSP 2010; UNAIDS, 2021, AIDSINFO; Vynnycky E, 1997, INT J TUBERC LUNG D, V1, P389; WHO, 2013, TB DAT; WHO, 2012, GLOB TUB CONTR; World Health Organization, SYST SCREEN ACT TUB; Zelner JL, 2014, AM J RESP CRIT CARE	36	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122514	10.1371/journal.pone.0122514	http://dx.doi.org/10.1371/journal.pone.0122514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849558	gold, Green Published, Green Accepted			2022-12-26	WOS:000352477800137
J	Otten, C; De Benedetti, S; Gaballah, A; Buhl, H; Klockner, A; Brauner, J; Sahl, HG; Henrichfreise, B				Otten, Christian; De Benedetti, Stefania; Gaballah, Ahmed; Buehl, Henrike; Kloeckner, Anna; Brauner, Jarryd; Sahl, Hans-Georg; Henrichfreise, Beate			Co-Solvents as Stabilizing Agents during Heterologous Overexpression in Escherichia coli - Application to Chlamydial Penicillin-Binding Protein 6	PLOS ONE			English	Article							RECOMBINANT PROTEINS; PEPTIDOGLYCAN; PNEUMONIAE; AGGREGATION; EXPRESSION; WALL	Heterologous overexpression of foreign proteins in Escherichia coli often leads to insoluble aggregates of misfolded inactive proteins, so-called inclusion bodies. To solve this problem use of chaperones or in vitro refolding procedures are the means of choice. These methods are time consuming and cost intensive, due to additional purification steps to get rid of the chaperons or the process of refolding itself. We describe an easy to use lab-scale method to avoid formation of inclusion bodies. The method systematically combines use of co-solvents, usually applied for in vitro stabilization of biologicals in biopharmaceutical formulation, and periplasmic expression and can be completed in one week using standard equipment in any life science laboratory. Demonstrating the unique power of our method, we overproduced and purified for the first time an active chlamydial penicillin-binding protein, demonstrated its function as penicillin sensitive DD-carboxypeptidase and took a major leap towards understanding the "chlamydial anomaly."	[Otten, Christian; De Benedetti, Stefania; Gaballah, Ahmed; Buehl, Henrike; Kloeckner, Anna; Brauner, Jarryd; Sahl, Hans-Georg; Henrichfreise, Beate] Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany	University of Bonn	Otten, C (corresponding author), Univ Bonn, Inst Pharmaceut Microbiol, Bonn, Germany.	cfotten@uni-bonn.de; bhenrich@uni-bonn.de	Gaballah, Ahmed/AFL-6554-2022	Gaballah, Ahmed/0000-0002-9038-6597; Klockner, Anna/0000-0001-9372-4144	Jurgen Manchot foundation; German Academic Exchange Service (DAAD); NRW International Graduate Research School Biotech-Pharma	Jurgen Manchot foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NRW International Graduate Research School Biotech-Pharma	CO and HB received a PhD fellowship from the Jurgen Manchot foundation. AG and SDB obtained a fellowship from the German Academic Exchange Service (DAAD) and from the NRW International Graduate Research School Biotech-Pharma, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth S, 2000, APPL ENVIRON MICROB, V66, P1572, DOI 10.1128/AEM.66.4.1572-1579.2000; BOWDEN GA, 1990, J BIOL CHEM, V265, P16760; Choi JH, 2004, APPL MICROBIOL BIOT, V64, P625, DOI 10.1007/s00253-004-1559-9; Clarke TB, 2009, BIOCHEMISTRY-US, V48, P2675, DOI 10.1021/bi801993x; Ghosh AS, 2008, TRENDS MICROBIOL, V16, P309, DOI 10.1016/j.tim.2008.04.006; Ghuysen JM, 1999, ANTIMICROB AGENTS CH, V43, P2339, DOI 10.1128/AAC.43.10.2339; Grieshaber S, 2002, CELL MICROBIOL, V4, P273, DOI 10.1046/j.1462-5822.2002.00191.x; Jantos CA, 1997, J CLIN MICROBIOL, V35, P620, DOI 10.1128/JCM.35.3.620-623.1997; Klockner A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5201; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumarasiri M, 2014, PROTEINS, V82, P1348, DOI 10.1002/prot.24501; Lee JC, 2000, CURR OPIN BIOTECH, V11, P81, DOI 10.1016/S0958-1669(99)00058-0; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lloyd AJ, 2008, J BIOL CHEM, V283, P6402, DOI 10.1074/jbc.M708105200; Mac TT, 2008, J BIOL CHEM, V283, P824, DOI 10.1074/jbc.M707863200; Manning MC, 2010, PHARM RES-DORDR, V27, P544, DOI 10.1007/s11095-009-0045-6; Margreiter Gerd, 2008, Biotechnology Journal, V3, P1245, DOI 10.1002/biot.200800072; McCoy AJ, 2006, TRENDS MICROBIOL, V14, P70, DOI 10.1016/j.tim.2005.12.004; Nelson DE, 2000, J BACTERIOL, V182, P1714, DOI 10.1128/JB.182.6.1714-1721.2000; Nishihara K, 2000, APPL ENVIRON MICROB, V66, P884, DOI 10.1128/AEM.66.3.884-889.2000; Oliva M, 2003, PROTEINS, V53, P88, DOI 10.1002/prot.10450; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pilhofer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3856; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ramon A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00056; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; Timasheff SN, 1998, ADV PROTEIN CHEM, V51, P355; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4	31	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122110	10.1371/journal.pone.0122110	http://dx.doi.org/10.1371/journal.pone.0122110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849314	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800098
J	Terblanche, W; Wilson, T				Terblanche, Wilma; Wilson, Tom			An Evaluation of Nearly-Extinct Cohort Methods for Estimating the Very Elderly Populations of Australia and New Zealand	PLOS ONE			English	Article							MORTALITY; AGES	The rapid growth of very elderly populations requires accurate population estimates up to the highest ages. However, it is recognised that estimates derived from census counts are often unreliable. Methods that make use of death data have not previously been evaluated for Australia and New Zealand. The aim was to evaluate a number of nearly-extinct cohort methods for producing very elderly population estimates by age and sex for Australia and New Zealand. The accuracy of official estimates was also assessed. Variants of three nearly-extinct cohort methods, the Survivor Ratio method, the Das Gupta method and a new method explicitly allowing for falling mortality over time, were evaluated by retrospective application over the period 1976-1996. Estimates by sex and single years of age were compared against numbers derived from the extinct cohort method. Errors were measured by the Weighted Mean Absolute Percentage Error. It is confirmed that for Australian females the Survivor Ratio method constrained to official estimates for ages 90+ performed well. However, for Australian males and both sexes in New Zealand, more accurate estimates were obtained by constraining the Survivor Ratio method to official estimates for ages 85+. Official estimates in Australia proved reasonably accurate for ages 90+ but at 100+ they varied significantly in accuracy from year to year. Estimates produced by Statistics New Zealand in aggregate for ages 90+ proved very accurate. We recommend the use of the Survivor Ratio method constrained to official estimates for ages 85+ to create very elderly population estimates for Australia and New Zealand.	[Terblanche, Wilma] Univ Queensland, Sch Geog Planning & Environm Management, Queensland Ctr Populat Res, Brisbane, Qld, Australia; [Wilson, Tom] New Farm, Adv Demog Modelling, Brisbane, Qld, Australia	University of Queensland	Terblanche, W (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Queensland Ctr Populat Res, Brisbane, Qld, Australia.	w.terblanche@uq.edu.au		Wilson, Tom/0000-0001-8812-7556	University of Queensland	University of Queensland(University of Queensland)	The first author was in receipt of a scholarship from the University of Queensland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2014, EL DAT CUST DEATH DA; ABS (Australian Bureau of Statistics), 2013, AUSTR DEM STAT; Andreev KF, 2004, DEMOGR RES, V11, P235; Andreev KF, 1999, THESIS U SO DENMARK; Australian Institute of Health and Welfare (AIHW), 2007, OLD AUSTR GLANC; Bourbeau R, 2000, DEMOGR RES, V2, P1, DOI DOI 10.4054/DEMRES.2000.2.3; COALE A J, 1990, Genus, V46, P1; COALE AJ, 1986, POP STUD-J DEMOG, V40, P389, DOI 10.1080/0032472031000142316; Coale AJ, 1990, ASIAN PACIFIC POPULA, V4, P1; Das Gupta P., 1990, RECONSTRUCTION AGE D; DEPOID F, 1973, POPULATION, V28, P755, DOI 10.2307/1531256; Hill ME, 2000, DEMOGRAPHY, V37, P175, DOI 10.2307/2648119; Jdanov DA, 2005, WP2005010 MPIDR; Jdanov DA, 2008, WP200813 MPIDR; KANNISTO V, 1988, POP STUD-J DEMOG, V42, P389, DOI 10.1080/0032472031000143546; KANNISTO V, 1994, POPUL DEV REV, V20, P793, DOI 10.2307/2137662; Kannisto V, 1994, MONOGRAPHS POPULATIO, V1, DOI [10.1097/CCM.0b013e31825fec26, DOI 10.1097/CCM.0B013E31825FEC26]; Khawaja M., 2010, NZ POPULATION REV, V36, P117; Mesle F, 2002, POPULATION, V57, P603, DOI 10.2307/1534798; ONS, 2012, QUAL METH INF POP ES; Preston SH, 1999, POP STUD-J DEMOG, V53, P165, DOI 10.1080/00324720308075; Siegel J. S., 2002, APPL DEMOGRAPHY APPL; Statistics New Zealand, 2013, NAT POP EST 30 JUN 2; Statistics New Zealand, 2012, NAT POP PROJ 2011 BA; Terblanche W, 2014, J POPUL AGEING, V7, P301, DOI 10.1007/s12062-014-9107-6; THATCHER AR, 1992, POP STUD-J DEMOG, V46, P411, DOI 10.1080/0032472031000146426; Thatcher AR., 2002, DEMOGR RES, V6, P1, DOI [10.4054/DemRes.2002.6.1, DOI 10.4054/DEMRES.2002.6.1]; Thatcher R, 1999, Popul Trends, P5; Vincent P, 1951, POPULATION, V6, P181, DOI 10.2307/1524149; Wilmoth JR, 2007, METHODS PROTOCOL HUM; Wilson T, 2012, NZ POPULATION REV, V38, P95; Wilson T, 2004, DEMOGR RES, V11, P195	32	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123692	10.1371/journal.pone.0123692	http://dx.doi.org/10.1371/journal.pone.0123692			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849096	gold, Green Published			2022-12-26	WOS:000352477800252
J	Kayser, BD; Goran, MI; Bouret, SG				Kayser, Brandon D.; Goran, Michael I.; Bouret, Sebastien G.			Perinatal Overnutrition Exacerbates Adipose Tissue Inflammation Caused by High-Fat Feeding in C57BL/6J Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE; VISCERAL FAT; OBESITY; MACROPHAGES; SENSITIVITY; METABOLISM; MECHANISMS; CHILDHOOD; SIZE; DIET	Obesity causes white adipose tissue (WAT) inflammation and insulin resistance in some, but not all individuals. Here, we used a mouse model of early postnatal overfeeding to determine the role of neonatal nutrition in lifelong WAT inflammation and metabolic dysfunction. C57BL/6J mice were reared in small litters of 3 (SL) or normal litters of 7 pups (NL) and fed either regular chow or a 60% high fat diet (HFD) from 5 to 17 weeks. At weaning, SL mice did not develop WAT inflammation despite increased fat mass, although there was an up-regulation of WAT Arg1 and Tlr4 expression. On HFD, adult SL mice had greater inguinal fat mass compared to NL mice, however both groups showed similar increases in visceral fat depots and adipocyte hypertrophy. Despite the similar levels of visceral adiposity, SL-HFD mice displayed greater impairments in glucose homeostasis and more pronounced hepatic steatosis compared to NL-HFD mice. In addition, WAT from SL mice fed a HFD displayed greater crown-like structure formation, increased M1 macrophages, and higher cytokine gene expression. Together, these data suggest that early postnatal overnutrition may be a critical determinant of fatty liver and insulin resistance in obese adults by programming the inflammatory capacity of adipose tissue.	[Kayser, Brandon D.] Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Human & Evolutionary Biol Program, Los Angeles, CA 90089 USA; [Kayser, Brandon D.; Goran, Michael I.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Childhood Obes Res Ctr, Los Angeles, CA 90033 USA; [Bouret, Sebastien G.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dev Neurosci Program, Los Angeles, CA USA	University of Southern California; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Goran, MI (corresponding author), Univ So Calif, Dornsife Coll Letters Arts & Sci, Dept Biol Sci, Human & Evolutionary Biol Program, Los Angeles, CA 90089 USA.	goran@usc.edu	Bouret, Sebastien/AAG-7120-2021	Bouret, Sebastien/0000-0002-4174-9769	Dr. Robert C. and Veronica Atkins endowed chair funds; National Institutes of Health [R01DK84142, P01ES022845]; United States Environment Protection Agency [RD83544101]; EU [266408]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022845] Funding Source: NIH RePORTER	Dr. Robert C. and Veronica Atkins endowed chair funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Environment Protection Agency; EU(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the Dr. Robert C. and Veronica Atkins endowed chair funds (to M.I.G.), the National Institutes of Health (Grants R01DK84142, P01ES022845 to S.G.B.), the United States Environment Protection Agency (Grant RD83544101 to SGB), and the EU FP7 integrated project (grant agreement no. 266408, "Full4Health", to SGB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2013, FAST FACTS DAT STAT; [Anonymous], 2014, R LANG ENV STAT COMP; Aouadi M, 2013, P NATL ACAD SCI USA, V110, P8278, DOI 10.1073/pnas.1300492110; AUBERT R, 1980, J NUTR, V110, P649, DOI 10.1093/jn/110.4.649; BARKER DJP, 1986, LANCET, V1, P1077; Boullu-Ciocca S, 2008, DIABETES, V57, P669, DOI 10.2337/db07-1316; Brochu M, 2001, J CLIN ENDOCR METAB, V86, P1020, DOI 10.1210/jc.86.3.1020; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Ferrannini E, 1997, J CLIN INVEST, V100, P1166, DOI 10.1172/JCI119628; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Glavas MM, 2010, ENDOCRINOLOGY, V151, P1598, DOI 10.1210/en.2009-1295; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Habbout A, 2013, J NUTR, V143, P553, DOI 10.3945/jn.112.172825; HIRSCH J, 1968, J LIPID RES, V9, P110; HOLM S, 1979, SCAND J STAT, V6, P65; Huang RC, 2011, DIABETES CARE, V34, P1019, DOI 10.2337/dc10-1809; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kenny SJ, 1995, DIABETES AM, P47; Kloting N, 2010, AM J PHYSL ENDOCRINO; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Liu ZG, 2013, J ENDOCRINOL, V219, P131, DOI 10.1530/JOE-13-0111; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; PAIK MC, 1988, COMMUN STAT SIMULAT, V17, P1155, DOI 10.1080/03610918808812718; Parkes AS, 1926, ANN APPL BIOL, V13, P374, DOI 10.1111/j.1744-7348.1926.tb04284.x; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plagemann A, 2004, J PERINAT MED, V32, P297, DOI 10.1515/JPM.2004.055; Rodrigues AL, 2011, J NUTR BIOCHEM, V22, P109, DOI 10.1016/j.jnutbio.2009.11.013; Roseboom T, 2006, EARLY HUM DEV, V82, P485, DOI 10.1016/j.earlhumdev.2006.07.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sell H, 2006, ENDOCRINOLOGY, V147, P2458, DOI 10.1210/en.2005-0969; Senn JJ, 2002, DIABETES, V51, P3391, DOI 10.2337/diabetes.51.12.3391; Shi H, 2004, J BIOL CHEM, V279, P34733, DOI 10.1074/jbc.M403886200; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sun B, 2012, DIABETES, V61, P2833, DOI 10.2337/db11-0957; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Vogt M, 2014, CELL; Wang Y, 2006, INT J PEDIATR OBES, V1, P11, DOI 10.1080/17477160600586747; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	49	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121954	10.1371/journal.pone.0121954	http://dx.doi.org/10.1371/journal.pone.0121954			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835281	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000070
J	Watt, C; Abuya, T; Warren, CE; Obare, F; Kanya, L; Bellows, B				Watt, Claire; Abuya, Timothy; Warren, Charlotte E.; Obare, Francis; Kanya, Lucy; Bellows, Ben			Can Reproductive Health Voucher Programs Improve Quality of Postnatal Care? A Quasi-Experimental Evaluation of Kenya's Safe Motherhood Voucher Scheme	PLOS ONE			English	Article							OF-CARE; INTERVENTION; NEWBORN	This study tests the group-level causal relationship between the expansion of Kenya's Safe Motherhood voucher program and changes in quality of postnatal care (PNC) provided at voucher-contracted facilities. We compare facilities accredited since program inception in 2006 (phase I) and facilities accredited since 2010-2011 (phase II) relative to comparable non-voucher facilities. PNC quality is assessed using observed clinical content processes, as well as client-reported outcome measures. Two-tailed unpaired t-tests are used to identify differences in mean process quality scores and client-reported outcome measures, comparing changes between intervention and comparison groups at the 2010 and 2012 data collection periods. Difference-in-differences analysis is used to estimate the reproductive health (RH) voucher program's causal effect on quality of care by exploiting group-level differences between voucher-accredited and non-accredited facilities in 2010 and 2012. Participation in the voucher scheme since 2006 significantly improves overall quality of postnatal care by 39% (p=0.02), where quality is defined as the observable processes or components of service provision that occur during a PNC consultation. Program participation since phase I is estimated to improve the quality of observed maternal postnatal care by 86% (p=0.02), with the largest quality improvements in counseling on family planning methods (IRR 5.0; p=0.01) and return to fertility (IRR 2.6; p=0.01). Despite improvements in maternal aspects of PNC, we find a high proportion of mothers who seek PNC are not being checked by any provider after delivery. Additional strategies will be necessary to standardize provision of packaged postnatal interventions to both mother and newborn. This study addresses an important gap in the existing RH literature by using a strong evaluation design to assess RH voucher program effectiveness on quality improvement.	[Watt, Claire] Jacaranda Hlth, Nairobi, Kenya; [Abuya, Timothy; Obare, Francis; Kanya, Lucy; Bellows, Ben] Populat Council, Nairobi, Kenya; [Warren, Charlotte E.] Populat Council, Washington, DC USA	Population Council	Watt, C (corresponding author), Jacaranda Hlth, Nairobi, Kenya.	cew690@mail.harvard.edu	Abuya, Timothy/AAH-5479-2020	Rothschild, Claire/0000-0002-2419-9881; Bellows, Ben/0000-0001-9205-6623	Bill & Melinda Gates Foundation [51761]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding for the Reproductive Health Voucher Program Evaluation was provided by the Bill & Melinda Gates Foundation (http://www.gatesfoundation.org/). Project Title: Evaluation of voucher and accreditation interventions for improving business models applied to reproductive health service delivery systems (Grant Number 51761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuya T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-540; Ahmed S, 2011, HEALTH POLICY PLANN, V26, P25, DOI 10.1093/heapol/czq015; Anderson ML, 2008, J AM STAT ASSOC, V103, P1481, DOI 10.1198/016214508000000841; Bellows B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-667; Bellows N., 2012, VOUCHERS REPROD HLTH; Bellows NM, 2011, TROP MED INT HEALTH, V16, P84, DOI 10.1111/j.1365-3156.2010.02667.x; Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bhatia M. R., 2007, Journal of International Development, V19, P975, DOI 10.1002/jid.1361; Bhutta ZA, 2011, SYSTEMATIC REV HUMAN; Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; BRUCE J, 1990, STUD FAMILY PLANN, V21, P61, DOI 10.2307/1966669; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gabrysch S, 2012, TROP MED INT HEALTH, V17, P2, DOI 10.1111/j.1365-3156.2011.02851.x; Hatt L., 2010, EC EVALUATION DEMAND; Hodgins S, 2014, GLOB HEALTH-SCI PRAC, V2, P173, DOI 10.9745/GHSP-D-13-00176; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kanya L, 2014, HEALTH POLICY PLANN, V29, pI4, DOI 10.1093/heapol/czt079; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Lawn J, 2009, STATE WORLDS CHILDRE; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Meuwissen LE, 2006, INT J QUAL HEALTH C, V18, P35, DOI 10.1093/intqhc/mzi073; Meuwissen LE, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-204; Meuwissen LE, 2006, TROP MED INT HEALTH, V11, P889, DOI 10.1111/j.1365-3156.2006.01632.x; Morgan L., 2011, MORE CHOICES WOMEN V; Obare F, 2013, LANCET, V2013, P381, DOI [10.1016/S0140-6736(13)61354-9, DOI 10.1016/S0140-6736(13)61354-9]; Obare F, 2013, HEALTH POLICY PLANN, V28, P165, DOI 10.1093/heapol/czs033; Rogo KO, 2006, DISEASE AND MORTALITY IN SUB-SAHARAN AFRICA, 2ND EDITION, P223; Ross JA, 2001, INT FAM PLAN PERSPEC, V27, P20, DOI 10.2307/2673801; Sandiford P, 2005, GUIDE COMPETITIVE VO; Warren C, 2006, POSTNATAL CARE OPPOR, P79; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; World Health Organization, 2014, WHO REC POSTN CAR MO; Zwane AP, 2011, P NATL ACAD SCI USA, V108, P1821, DOI 10.1073/pnas.1000776108	35	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122828	10.1371/journal.pone.0122828	http://dx.doi.org/10.1371/journal.pone.0122828			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835713	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352139000114
J	Cozar, A; Sanz-Martin, M; Marti, E; Gonzalez-Gordillo, JI; Ubeda, B; Galvez, JA; Irigoien, X; Duarte, CM				Cozar, Andres; Sanz-Martin, Marina; Marti, Elisa; Gonzalez-Gordillo, J. Ignacio; Ubeda, Barbara; Galvez, Jose A.; Irigoien, Xabier; Duarte, Carlos M.			Plastic Accumulation in the Mediterranean Sea	PLOS ONE			English	Article							MARINE DEBRIS; FLOATING DEBRIS; SURFACE; MICROPLASTICS; ENVIRONMENT; ABUNDANCE; CHEMICALS; FISH	Concentrations of floating plastic were measured throughout the Mediterranean Sea to assess whether this basin can be regarded as a great accumulation region of plastic debris. We found that the average density of plastic (1 item per 4 m(2)), as well as its frequency of occurrence (100% of the sites sampled), are comparable to the accumulation zones described for the five subtropical ocean gyres. Plastic debris in the Mediterranean surface waters was dominated by millimeter-sized fragments, but showed a higher proportion of large plastic objects than that present in oceanic gyres, reflecting the closer connection with pollution sources. The accumulation of floating plastic in the Mediterranean Sea (between 1,000 and 3,000 tons) is likely related to the high human pressure together with the hydrodynamics of this semi-enclosed basin, with outflow mainly occurring through a deep water layer. Given the biological richness and concentration of economic activities in the Mediterranean Sea, the affects of plastic pollution on marine and human life are expected to be particularly frequent in this plastic accumulation region.	[Cozar, Andres; Marti, Elisa; Gonzalez-Gordillo, J. Ignacio; Ubeda, Barbara; Galvez, Jose A.] Univ Cadiz, Fac Ciencias Mar & Ambient, Dept Biol, E-11510 Puerto Real, Spain; [Sanz-Martin, Marina; Duarte, Carlos M.] CSIC UIB, IMEDEA, Inst Mediterraneo Estudios Avanzados, Dept Global Change Res, Esporles 07190, Spain; [Sanz-Martin, Marina] Univ Barcelona, Fac Geol, Dept Geol Dinam Geofis & Paleontol, E-08028 Barcelona, Spain; [Irigoien, Xabier; Duarte, Carlos M.] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal 239556900, Saudi Arabia	Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Barcelona; University of Barcelona; King Abdullah University of Science & Technology	Cozar, A (corresponding author), Univ Cadiz, Fac Ciencias Mar & Ambient, Dept Biol, Campus Excelencia Int Mar, E-11510 Puerto Real, Spain.	andres.cozar@uca.es	Iturraspe, Juan Ignacio/AAT-9984-2020; Ubeda, Barbara/AAT-6839-2020; Marti, Elisa/AAA-1559-2020; Irigoien, Xabier/B-8171-2009; Duarte, Carlos M/A-7670-2013; Galvez, Jose Angel/AAN-4367-2020; Cozar, Andres/G-2141-2016; Duarte Quesada, Carlos Manuel/ABD-6208-2021	Iturraspe, Juan Ignacio/0000-0003-2859-3939; Irigoien, Xabier/0000-0002-5411-6741; Duarte, Carlos M/0000-0002-1213-1361; Galvez, Jose Angel/0000-0001-6203-5186; Cozar, Andres/0000-0003-1370-9935; Sanz-Martin, Marina/0000-0002-9777-5894; Ubeda Sanchez, Barbara/0000-0001-8165-2091	EU; Spanish Ministry of Economy and Competitiveness through project MedSeA (EU) [FP7-2010-265103]; Spanish Ministry of Education, Culture and Sport [PRX14/00743]; Spanish Ministry of Economy and Competitiveness through project ESTRESX [CTM2012-32603]; Spanish Ministry of Economy and Competitiveness through project MEGAN [CTM2013-49048-C2-1-R]	EU(European Commission); Spanish Ministry of Economy and Competitiveness through project MedSeA (EU); Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Economy and Competitiveness through project ESTRESX; Spanish Ministry of Economy and Competitiveness through project MEGAN	The present study was funded by the EU's Framework Programme 7 and the Spanish Ministry of Economy and Competitiveness through projects MedSeA (EU contract number FP7-2010-265103), ESTRESX (ref. CTM2012-32603) and MEGAN (ref. CTM2013-49048-C2-1-R). Andres Cozar is grateful for the funding of a "Salvador de Madariaga" stay to continue the study of the plastic pollution in the Mediterranean Sea (Spanish Ministry of Education, Culture and Sport, ref. PRX14/00743). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliani S, 2003, MAR POLLUT BULL, V46, P1142, DOI 10.1016/S0025-326X(03)00192-9; Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; [Anonymous], NAT AGGR GEOSP DAT P; Association of Plastic Manufacturers, 2011, PLAST FACTS 2011 ANA; Beranger K, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005648; Bianchi CN, 2000, MAR POLLUT BULL, V40, P367, DOI 10.1016/S0025-326X(00)00027-8; Campani T, 2013, MAR POLLUT BULL, V74, P225, DOI 10.1016/j.marpolbul.2013.06.053; Codina-Garcia M, 2013, MAR POLLUT BULL, V77, P220, DOI 10.1016/j.marpolbul.2013.10.002; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; de Lucia GA, 2014, MAR ENVIRON RES, V100, P10, DOI 10.1016/j.marenvres.2014.03.017; de Stephanis R, 2013, MAR POLLUT BULL, V69, P206, DOI 10.1016/j.marpolbul.2013.01.033; Doyle MJ, 2011, MAR ENVIRON RES, V71, P41, DOI 10.1016/j.marenvres.2010.10.001; Engler RE, 2012, ENVIRON SCI TECHNOL, V46, P12302, DOI 10.1021/es3027105; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V68, P71, DOI 10.1016/j.marpolbul.2012.12.021; Foekema EM, 2013, ENVIRON SCI TECHNOL, V47, P8818, DOI 10.1021/es400931b; Fossi MC, 2014, MAR ENVIRON RES, V100, P17, DOI 10.1016/j.marenvres.2014.02.002; GALGANI F, 1995, MAR POLLUT BULL, V30, P713, DOI 10.1016/0025-326X(95)00055-R; Gassel M, 2013, MAR POLLUT BULL, V73, P231, DOI 10.1016/j.marpolbul.2013.05.014; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Goldstein MC, 2012, BIOL LETTERS, V8, P817, DOI 10.1098/rsbl.2012.0298; Gregory MR, 2009, PHILOS T R SOC B, V364, P2013, DOI 10.1098/rstb.2008.0265; Kukulka T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051116; LACOMBE H, 1981, OCEANOL ACTA, V4, P247; Law KL, 2014, ENVIRON SCI TECHNOL, V48, P4732, DOI 10.1021/es4053076; Law KL, 2010, SCIENCE, V329, P1185, DOI 10.1126/science.1192321; Lebreton LCM, 2012, MAR POLLUT BULL, V64, P653, DOI 10.1016/j.marpolbul.2011.10.027; Lechner A, 2014, ENVIRON POLLUT, V188, P177, DOI 10.1016/j.envpol.2014.02.006; Leggett C., 2014, ASSESSING EC BENEFIT; Maximenko N, 2012, MAR POLLUT BULL, V65, P51, DOI 10.1016/j.marpolbul.2011.04.016; MCCOY FW, 1988, MAR POLLUT BULL, V19, P25, DOI 10.1016/0025-326X(88)90749-7; MORRIS RJ, 1980, MAR POLLUT BULL, V11, P125, DOI 10.1016/0025-326X(80)90073-9; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; Pham CK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095839; Poulain PM, 2013, OCEANOGRAPHY, V26, P38, DOI 10.5670/oceanog.2013.03; Reisser J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080466; Rochman C.M., 2014, SCI TOTAL ENV; Ryan PG, 2013, MAR POLLUT BULL, V69, P128, DOI 10.1016/j.marpolbul.2013.01.016; Soto-Navarro J, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2010JC006302; SUARIA G, 2014, MAR POLLUT BULL, P8061; Suaria G, 2014, MAR POLLUT B; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2004, SCIENCE, V304, P838, DOI 10.1126/science.1094559; Topcu E.N., 2010, RAPP COMM INT MER M, V39, P804; UNEP, 2009, MARINE LITTER A GLOB; UNEP/MAP-Plan Bleu, 2009, STAT ENV DEV MED; United Nations Environment Programme/Mediterranean Action Plan (UNEP/MAP), 2011, ASS STAT MAR LITT ME; Van Cauwenberghe L, 2014, ENVIRON POLLUT, V193, P65, DOI 10.1016/j.envpol.2014.06.010; van Sebille E, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044040; Zhou P, 2011, MAR POLLUT BULL, V62, P1998, DOI 10.1016/j.marpolbul.2011.06.018	50	413	423	8	237	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121762	10.1371/journal.pone.0121762	http://dx.doi.org/10.1371/journal.pone.0121762			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831129	Green Published, gold			2022-12-26	WOS:000352135600083
J	Kim, BS; Serebreni, L; Fallica, J; Hamdan, O; Wang, L; Johnston, L; Kolb, T; Damarla, M; Damico, R; Hassoun, PM				Kim, Bo S.; Serebreni, Leonid; Fallica, Jonathan; Hamdan, Omar; Wang, Lan; Johnston, Laura; Kolb, Todd; Damarla, Mahendra; Damico, Rachel; Hassoun, Paul M.			Cyclin-Dependent Kinase Five Mediates Activation of Lung Xanthine Oxidoreductase in Response to Hypoxia	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; BRONCHOALVEOLAR LAVAGE FLUID; OXIDASE ACTIVITY; OXIDATIVE STRESS; CDK5; PHOSPHORYLATION; BRAIN; DEHYDROGENASE; INHIBITION; APOPTOSIS	Background Xanthine oxidoreductase (XOR) is involved in oxidative metabolism of purines and is a source of reactive oxygen species (ROS). As such, XOR has been implicated in oxidantmediated injury in multiple cardiopulmonary diseases. XOR enzyme activity is regulated, in part, via a phosphorylation-dependent, post-translational mechanism, although the kinase (s) responsible for such hyperactivation are unknown. Methods and Results Using an in silico approach, we identified a cyclin-dependent kinase 5 (CDK5) consensus motif adjacent to the XOR flavin adenine dinucleotide (FAD) binding domain. CDK5 is a proline- directed serine/threonine kinase historically linked to neural development and injury. We tested the hypothesis that CDK5 and its activators are mediators of hypoxia-induced hyperactivation of XOR in pulmonary microvascular endothelial cells (EC) and the intact murine lung. Using complementary molecular and pharmacologic approaches, we demonstrated that hypoxia significantly increased CDK5 activity in EC. This was coincident with increased expression of the CDK5 activators, cyclin-dependent kinase 5 activator 1 (CDK5r1 or p35/p25), and decreased expression of the CDK5 inhibitory peptide, p10. Expression of p35/p25 was necessary for XOR hyperactivation. Further, CDK5 physically associated with XOR and was necessary and sufficient for XOR phosphorylation and hyperactivation both in vitro and in vivo. XOR hyperactivation required the target threonine (T222) within the CDK5-consensus motif. Conclusions and Significance These results indicate that p35/CDK5-mediated phosphorylation of T222 is required for hypoxia-induced XOR hyperactivation in the lung. Recognizing the contribution of XOR to oxidative injury in cardiopulmonary disease, these observations identify p35/CDK5 as novel regulators of XOR and potential modifiers of ROS-mediated injury.	[Kim, Bo S.; Serebreni, Leonid; Hamdan, Omar; Wang, Lan; Johnston, Laura; Kolb, Todd; Damarla, Mahendra; Damico, Rachel; Hassoun, Paul M.] Johns Hopkins Univ, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA; [Fallica, Jonathan; Damico, Rachel] Johns Hopkins Univ, Sch Publ Hlth, Environm Hlth Sci, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University	Hassoun, PM (corresponding author), Johns Hopkins Univ, Div Pulm & Crit Care Med, Dept Med, Baltimore, MD 21224 USA.	phassoun1@jhmi.edu	Kolb, Todd/ABD-8204-2020		National Institute of Health [NIH/NHLBI 5R01HL049441-17, K08HL088320, F32HL097588]; Flight attendants medical research institute [072129, 110627]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097588, K08HL088320, R01HL049441] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight attendants medical research institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding provided by National Institute of Health: NIH/NHLBI 5R01HL049441-17 (PMH). Role: study design, data analysis, preparation of manuscript. http://grants.nih.gov/grants/oer.htm. National Institute of Health: K08HL088320 (RD). Role: study design, data analysis, preparation of manuscript. National Institute of Health: F32HL097588 (BSK). Role: study design, data analysis, data collection, manuscript prep. Flight attendants medical research institute: 072129 (BSK) and 110627 (RD). Role: study design, data analysis, manuscript prep. http://www.famri.org/core/.	Abdulnour REE, 2006, AM J PHYSIOL-LUNG C, V291, pL345, DOI 10.1152/ajplung.00453.2005; BECKMAN JS, 1989, FREE RADICAL BIO MED, V6, P607, DOI 10.1016/0891-5849(89)90068-3; Boueiz A, 2008, AM J PHYSIOL-LUNG C, V294, pL830, DOI 10.1152/ajplung.00007.2008; Cai XH, 1997, NEUROSCI RES, V28, P355, DOI 10.1016/S0168-0102(97)00063-1; Damico RL, 2008, AM J RESP CELL MOL, V39, P77, DOI 10.1165/rcmb.2007-0248OC; Girgis RE, 2003, AM J PHYSIOL-HEART C, V285, pH938, DOI 10.1152/ajpheart.01097.2002; Green SL, 1997, NEUROCHEM INT, V31, P617, DOI 10.1016/S0197-0186(97)00012-0; Harrison R, 2002, FREE RADICAL BIO MED, V33, P774, DOI 10.1016/S0891-5849(02)00956-5; Heunks LMA, 1999, AM J PHYSIOL-REG I, V277, pR1697, DOI 10.1152/ajpregu.1999.277.6.R1697; HOSHINO T, 1988, TRANSPLANTATION, V45, P284, DOI 10.1097/00007890-198802000-00006; Kayyali US, 2001, J BIOL CHEM, V276, P14359, DOI 10.1074/jbc.M010100200; Kim BS, 2013, FREE RADICAL BIO MED, V60, P336, DOI 10.1016/j.freeradbiomed.2013.01.023; LEW J, 1992, J BIOL CHEM, V267, P13383; Liebl J, 2011, CELL SIGNAL, V23, P1698, DOI 10.1016/j.cellsig.2011.06.020; Madamanchi NR, 2005, J THROMB HAEMOST, V3, P254, DOI 10.1111/j.1538-7836.2004.01085.x; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; Minhas KM, 2006, CIRC RES, V98, P271, DOI 10.1161/01.RES.0000200181.59551.71; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Page S, 1998, BBA-GEN SUBJECTS, V1381, P191, DOI 10.1016/S0304-4165(98)00028-2; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pinamonti S, 1998, FREE RADICAL BIO MED, V25, P771, DOI 10.1016/S0891-5849(98)00128-2; Pinamonti S, 1996, FREE RADICAL BIO MED, V21, P147, DOI 10.1016/0891-5849(96)00030-5; Poss WB, 1996, AM J PHYSIOL-LUNG C, V270, pL941, DOI 10.1152/ajplung.1996.270.6.L941; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Sharma MR, 2004, J CELL BIOCHEM, V91, P398, DOI 10.1002/jcb.10762; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103	27	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0124189	10.1371/journal.pone.0124189	http://dx.doi.org/10.1371/journal.pone.0124189			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831123	Green Published, gold, Green Submitted			2022-12-26	WOS:000352135600153
J	Petherick, KJ; Conway, OJL; Mpamhanga, C; Osborne, SA; Kamal, A; Saxty, B; Ganley, IG				Petherick, Katy J.; Conway, Owen J. L.; Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara; Ganley, Ian G.			Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy (vol 290, pg 11376, 2015)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction														Ganley, Ian/0000-0003-1481-9407; Conway, Owen/0000-0002-0640-1038	Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: Medline; MRC [MC_UU_12016/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Petherick KJ, 2015, J BIOL CHEM, V290, P28726, DOI [10.1074/jbc.C114.627778, 10.1074/jbc.A114.627778]	1	207	217	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 27	2015	290	48					28726	28726		10.1074/jbc.A114.627778	http://dx.doi.org/10.1074/jbc.A114.627778			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CX5SH	25833948	Green Published, hybrid			2022-12-26	WOS:000365762300015
J	Korasick, DA; Chatterjee, S; Tonelli, M; Dashti, H; Lee, SG; Westfall, CS; Fulton, DB; Andreotti, AH; Amarasinghe, GK; Strader, LC; Jez, JM				Korasick, David A.; Chatterjee, Srirupa; Tonelli, Marco; Dashti, Hesam; Lee, Soon Goo; Westfall, Corey S.; Fulton, D. Bruce; Andreotti, Amy H.; Amarasinghe, Gaya K.; Strader, Lucia C.; Jez, Joseph M.			Defining a Two-pronged Structural Model for PB1 (Phox/Bem1p) Domain Interaction in Plant Auxin Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; AUX/IAA PROTEINS; MUTATIONAL ANALYSIS; NMR; BINDING; BIOSYNTHESIS; SPECTROSCOPY; SPECIFICITY; PERCEPTION; ASSIGNMENT	Phox/Bem1p (PB1) domains are universal structural modules that use surfaces of different charge for protein-protein association. In plants, PB1-mediated interactions of auxin response factors (ARF) and auxin/indole 3-acetic acid inducible proteins regulate transcriptional events modulated by the phytohormone auxin. Here we investigate the thermodynamic and structural basis for Arabidopsis thaliana ARF7 PB1 domain self-interaction. Isothermal titration calorimetry and NMR experiments indicate that key residues on both the basic and acidic faces of the PB1 domain contribute to and organize coordinately to stabilize protein-protein interactions. Calorimetric analysis of ARF7PB1 site-directed mutants defines a two-pronged electrostatic interaction. The canonical PB1 interaction between a lysine and a cluster of acidic residues provides one prong with an arginine and a second cluster of acidic residues defining the other prong. Evolutionary conservation of this core recognition feature and other co-varying interface sequences allows for versatile PB1-mediated interactions in auxin signaling.	[Korasick, David A.; Lee, Soon Goo; Westfall, Corey S.; Strader, Lucia C.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Chatterjee, Srirupa; Amarasinghe, Gaya K.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Tonelli, Marco; Dashti, Hesam] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Fulton, D. Bruce; Andreotti, Amy H.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Washington University (WUSTL); Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; Iowa State University	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Regan, Clinton/E-6250-2012	Strader, Lucia/0000-0002-7600-7204; Korasick, David/0000-0002-6337-2085; Lee, Soon Goo/0000-0002-1541-8587	National Institutes of Health (NIGMS) [P41GM103399]; University of Wisconsin-Madison; National Institutes of Health [P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, S10RR029220]; National Science Foundation [DMB-8415048, OIA-9977486, BIR-9214394]; United States Department of Agriculture; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR008438, S10RR002781, S10RR023438, S10RR025062, S10RR029220, P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103399, R00GM089987] Funding Source: NIH RePORTER	National Institutes of Health (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Wisconsin-Madison; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work made use of the National Magnetic Resonance Facility at Madison, which is supported by National Institutes of Health Grant P41GM103399 (NIGMS; old number: P41RR002301). Equipment was purchased with funds from the University of Wisconsin-Madison, National Institutes of Health Grants P41GM103399, S10RR02781, S10RR08438, S10RR023438, S10RR025062, and S10RR029220, National Science Foundation Grants DMB-8415048, OIA-9977486, and BIR-9214394, and by the United States Department of Agriculture.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Christian F, 2014, BBA-MOL CELL RES, V1843, P2765, DOI 10.1016/j.bbamcr.2014.07.021; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Enders TA, 2015, AM J BOT, V102, P180, DOI 10.3732/ajb.1400285; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Guilfoyle TJ, 2015, PLANT CELL, V27, P33, DOI 10.1105/tpc.114.132753; Guilfoyle TJ, 2012, PLANT SCI, V190, P82, DOI 10.1016/j.plantsci.2012.04.003; Han M, 2014, P NATL ACAD SCI USA, V111, P18613, DOI 10.1073/pnas.1419525112; Hyberts SG, 2012, J BIOMOL NMR, V52, P315, DOI 10.1007/s10858-012-9611-z; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim J, 1997, P NATL ACAD SCI USA, V94, P11786, DOI 10.1073/pnas.94.22.11786; Korasick DA, 2014, P NATL ACAD SCI USA, V111, P5427, DOI 10.1073/pnas.1400074111; Korasick DA, 2013, J EXP BOT, V64, P2541, DOI 10.1093/jxb/ert080; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lavenus J, 2013, TRENDS PLANT SCI, V18, P455, DOI 10.1016/j.tplants.2013.04.006; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Nanao MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4617; Ni J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085358; Pearce KH, 1996, BIOCHEMISTRY-US, V35, P10300, DOI 10.1021/bi960513b; Piya S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00744; Prabhu NV, 2005, ANNU REV PHYS CHEM, V56, P521, DOI 10.1146/annurev.physchem.56.092503.141202; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Teale WD, 2006, NAT REV MOL CELL BIO, V7, P847, DOI 10.1038/nrm2020; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vanneste S, 2009, CELL, V136, P1005, DOI 10.1016/j.cell.2009.03.001; Wang RH, 2014, CURR OPIN PLANT BIOL, V21, P51, DOI 10.1016/j.pbi.2014.06.006; Wells JA, 1996, ANNU REV BIOCHEM, V65, P609, DOI 10.1146/annurev.bi.65.070196.003141; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	39	25	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12868	12878		10.1074/jbc.M115.648253	http://dx.doi.org/10.1074/jbc.M115.648253			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839233	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000354569000037
J	Ahronheim, SR; McGillivray, D; Barbic, S; Barbic, D; Klam, S; Brisebois, P; Lambrinakos-Raymond, K; Nemeth, J				Ahronheim, Sara R.; McGillivray, David; Barbic, Skye; Barbic, David; Klam, Stephanie; Brisebois, Paul; Lambrinakos-Raymond, Kristen; Nemeth, Joe			Expectant Parents' Understanding of the Implications and Management of Fever in the Neonate	PLOS ONE			English	Article							CHILDHOOD FEVER; EMERGENCY; PERCEPTIONS; PATTERNS; INFANTS	Objective We estimated the extent to which Canadian expectant parents would seek medical care in a febrile neonate (age 30 days or less). We also evaluated expectant parents' knowledge of signs and symptoms of fever in a neonate, and explored the actions Canadian expectant parents would take to optimize the health of their child. Methods We conducted a cross-sectional survey of a sample of expectant parents from a large urban center in Canada. We recruited participants from waiting rooms in an obstetrical ultrasound clinic located in an urban tertiary care hospital in Montreal, Canada. We asked participants nine questions about fever in neonates including if, and how, they would seek care for their neonate if they suspected he/she were febrile. Results Among the 355 respondents, (response rate 87%) we found that 75% of parents reported that they would take their febrile neonate for immediate medical assessment, with nearly one fifth of the sample reporting that they would not seek medical care. We found no significant associations between the choice to seek medical care and expectant parents socio-demographic characteristics. Conclusions Despite universal access to high quality health care in Canada, our study highlights concerning gaps in the knowledge of the care of the febrile infant in one fifth of expectant parents. Physicians and health providers should strive to provide early education to expectant parents about how to recognize signs of fever in the neonate and how best to seek medical care. This may improve neonatal health outcomes in Canada.	[Ahronheim, Sara R.] McGill Univ, Jewish Gen Hosp, Dept Emergency Med, Montreal, PQ H3T 1E2, Canada; [Ahronheim, Sara R.; McGillivray, David] McGill Univ, Ctr Hosp, Montreal Childrens Hosp, Div Pediat Emergency Med, Montreal, PQ, Canada; [Barbic, Skye] Univ British Columbia, St Pauls Hosp, Dept Psychiat, Vancouver, BC V5Z 1M9, Canada; [Barbic, David] Univ British Columbia, St Pauls Hosp, Dept Emergency Med, Vancouver, BC V5Z 1M9, Canada; [Klam, Stephanie] McGill Univ, Jewish Gen Hosp, Dept Obstet & Gynecol, Montreal, PQ H3T 1E2, Canada; [Brisebois, Paul; Lambrinakos-Raymond, Kristen] McGill Univ, Montreal, PQ, Canada; [Nemeth, Joe] McGill Univ, Ctr Hlth, Montreal Gen Hosp, Div Emergency Med, Montreal, PQ, Canada	McGill University; McGill University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; McGill University; McGill University	Ahronheim, SR (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Emergency Med, Montreal, PQ H3T 1E2, Canada.	sara.ahronheim@mcgill.ca	Barbic, Skye/AAW-4044-2020	Barbic, Skye/0000-0002-7076-2452				Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; Alpern ER, 2010, TXB PEDIAT EMERGENCY, P266; Bertille N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083469; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Cohee LMS, 2010, CLIN PEDIATR, V49, P221, DOI 10.1177/0009922809336209; Conference Board of Canada, 2014, INFANT MORTALITY; Crocetti M, 2009, CLIN PEDIATR, V48, P183, DOI 10.1177/0009922808324949; Dongre AR, 2009, INDIAN J PEDIATR, V76, P691, DOI 10.1007/s12098-009-0106-1; Goldman RD, 2009, PEDIATRICS, V124, P439, DOI 10.1542/peds.2007-3736; Institut National de la Statistique des Etudes Economique (INSEE), 2008, REPARTITION DES IMMI; Jain S, 2014, PEDIATRICS, V133, P187, DOI 10.1542/peds.2013-1820; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2004, LANCET, V364, P399, DOI 10.1016/S0140-6736(04)16783-4; Marx J, 2013, ROSENS EMERGENCY MED, P476, DOI [10.1111/j.1553-2712.2011.01011.x, DOI 10.1111/J.1553-2712.2011.01011.X]; Niehues T, 2013, DTSCH ARZTEBL INT, V110, P764, DOI 10.3238/arztebl.2013.0764; Oestergaard MZ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001080; Organisation for Economic Co-operation and Development, 2014, OECD FACTBOOK 2014 E; Perry AM, 2013, PEDIATR EMERG CARE, V29, P58, DOI 10.1097/PEC.0b013e31827b540e; Rupe A, 2010, CLIN PEDIATR, V49, P172, DOI 10.1177/0009922809336208; Sandberg J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097253; Schorr CA, 2014, TRENDS MOL MED, V20, P192, DOI 10.1016/j.molmed.2014.02.001; Schweich PJ, 1998, PEDIATR EMERG CARE, V14, P89, DOI 10.1097/00006565-199804000-00001; Seow VK, 2007, AM J EMERG MED, V25, P1004, DOI 10.1016/j.ajem.2007.03.001; Statistics Canada, 2009, CANADIAN VITAL STATI; Taveras EM, 2004, PEDIATR EMERG CARE, V20, P579, DOI 10.1097/01.pec.0000139739.46591.dd; Thaver D, 2009, PEDIATR INFECT DIS J, V28, pS3, DOI 10.1097/INF.0b013e3181958755; Thompson-Robinson Melva, 2006, J Cult Divers, V13, P97; Walsh A, 2006, J ADV NURS, V54, P217, DOI 10.1111/j.1365-2648.2006.03802.x; Yarden-Bilavsky H, 2014, ACTA PAEDIATR, V103, P379, DOI 10.1111/apa.12560; Zupran J, 2005, PERINATAL MORTALITY; Zyoud SH, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-66	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120959	10.1371/journal.pone.0120959	http://dx.doi.org/10.1371/journal.pone.0120959			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853510	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400024
J	Inui, Y; Shimizu-kaya, U; Okubo, T; Yamsaki, E; Itioka, T				Inui, Yoko; Shimizu-kaya, Usun; Okubo, Tadahiro; Yamsaki, Eri; Itioka, Takao			Various Chemical Strategies to Deceive Ants in Three Arhopala Species (Lepidoptera: Lycaenidae) Exploiting Macaranga Myrmecophytes	PLOS ONE			English	Article							CUTICULAR HYDROCARBONS; PERCEPTUAL SIMILARITY; NESTMATE RECOGNITION; SOCIAL PARASITE; CREMATOGASTER; HYMENOPTERA; ASSOCIATION; BUTTERFLIES; DIVERSITY; SYMBIOSIS	Macaranga myrmecophytes (ant-plants) are generally well protected from herbivore attacks by their symbiotic ants (plant-ants). However, larvae of Arhopala (Lepidoptera: Lycaenidae) species survive and develop on specific Macaranga ant-plant species without being attacked by the plant-ants of their host species. We hypothesized that Arhopala larvae chemically mimic or camouflage themselves with the ants on their host plant so that the larvae are accepted by the plant-ant species of their host. Chemical analyses of cuticular hydrocarbons showed that chemical congruency varied among Arhopala species; A. dajagaka matched well the host plant-ants, A. amphimuta did not match, and unexpectedly, A. zylda lacked hydrocarbons. Behaviorally, the larvae and dummies coated with cuticular chemicals of A. dajagaka were well attended by the plant-ants, especially by those of the host. A. amphimuta was often attacked by all plant-ants except for the host plant-ants toward the larvae, and those of A. zylda were ignored by all plant-ants. Our results suggested that conspicuous variations exist in the chemical strategies used by the myrmecophilous butterflies that allow them to avoid ant attack and be accepted by the plant-ant colonies.	[Inui, Yoko] Osaka Kyoiku Univ, Dept Arts & Sci, Osaka 543, Japan; [Shimizu-kaya, Usun; Okubo, Tadahiro; Itioka, Takao] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Yamsaki, Eri] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan	Osaka University of Education; Kyoto University; Kyoto University	Inui, Y (corresponding author), Osaka Kyoiku Univ, Dept Arts & Sci, Osaka 543, Japan.	inui@cc.osaka-kyoiku.ac.jp	Yamasaki, Eri/L-6541-2016	Yamasaki, Eri/0000-0002-8858-2839	Ministry of Education, Culture, Sports, Science and Technology, Japan [21255004, 23770022]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was financially supported by Grant-in-Aid to TI (no. 21255004) and to YI (no. 23770022, URL: http://kaken.nii.ac.jp/p?q5=23770022) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akino T, 1999, P ROY SOC B-BIOL SCI, V266, P1419, DOI 10.1098/rspb.1999.0796; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; Akino T, 2006, APPL ENTOMOL ZOOL, V41, P667, DOI 10.1303/aez.2006.667; Axen AH, 1996, ANIM BEHAV, V52, P321, DOI 10.1006/anbe.1996.0178; Blomquist GJ, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P1, DOI 10.1017/CBO9780511711909; BONAVITACOUGOURDAN A, 1987, J ENTOMOL SCI, V22, P1; Bos N, 2013, J EXP BIOL, V216, P3314, DOI 10.1242/jeb.087007; Bos N, 2012, J INSECT PHYSIOL, V58, P138, DOI 10.1016/j.jinsphys.2011.10.010; BUCKNER JS, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P227; Cvacka J, 2006, J CHEM ECOL, V32, P409, DOI 10.1007/s10886-005-9008-5; DETTNER K, 1994, ANNU REV ENTOMOL, V39, P129, DOI 10.1146/annurev.en.39.010194.001021; Fiala B, 1999, BIOL J LINN SOC, V66, P305, DOI 10.1006/bijl.1998.0279; FIALA B, 1989, OECOLOGIA, V79, P463, DOI 10.1007/BF00378662; FIALA B, 1994, OECOLOGIA, V97, P186, DOI 10.1007/BF00323148; FIEDLER K, 1989, J NAT HIST, V23, P833, DOI 10.1080/00222938900770441; Fiedler K, 1996, EXPERIENTIA, V52, P14, DOI 10.1007/BF01922410; GRUNSHAW JP, 1990, J CHEM ECOL, V16, P2835, DOI 10.1007/BF00979477; Guerrieri FJ, 2009, P ROY SOC B-BIOL SCI, V276, P2461, DOI 10.1098/rspb.2008.1860; Heckroth HP, 1998, J TROP ECOL, V14, P427, DOI 10.1017/S0266467498000327; HENNING SF, 1983, J ENTOMOL SOC S AFR, V46, P341; Hojo MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086054; Hojo MK, 2009, P ROY SOC B-BIOL SCI, V276, P551, DOI 10.1098/rspb.2008.1064; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Inui Y, 2007, J CHEM ECOL, V33, P2054, DOI 10.1007/s10886-007-9369-z; Itino T, 2001, ECOL RES, V16, P787, DOI 10.1046/j.1440-1703.2001.00442.x; Itioka T, 2000, BIOTROPICA, V32, P318, DOI 10.1111/j.1744-7429.2000.tb00475.x; Jeral JM, 1997, PHYSIOL ENTOMOL, V22, P207, DOI 10.1111/j.1365-3032.1997.tb01160.x; Lenoir A, 2001, ANNU REV ENTOMOL, V46, P573, DOI 10.1146/annurev.ento.46.1.573; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Lorenzi MC, 2002, PARASITOLOGY, V125, P507, DOI 10.1017/S003118200200238X; MASCHWITZ U, 1984, OECOLOGIA, V64, P78, DOI 10.1007/BF00377547; Nash DR, 2008, SCIENCE, V319, P88, DOI 10.1126/science.1149180; Nomura M, 2000, ECOL RES, V15, P1, DOI 10.1046/j.1440-1703.2000.00318.x; Nomura M, 2011, PLANT ECOL, V212, P143, DOI 10.1007/s11258-010-9810-1; Okubo Tadahiro, 2009, Transactions of the Lepidopterological Society of Japan, V60, P37; Pierce NE, 2002, ANNU REV ENTOMOL, V47, P733, DOI 10.1146/annurev.ento.47.091201.145257; Shimizu-kaya U, 2013, J NAT HIST, V47, P2707, DOI 10.1080/00222933.2013.791943; Shimizu-kaya U, 2013, ENTOMOL NEWS, V123, P63, DOI 10.3157/021.123.0115; Ueda S, 2008, P ROY SOC B-BIOL SCI, V275, P2319, DOI 10.1098/rspb.2008.0573; Ueda S, 2012, ECOL RES, V27, P437, DOI 10.1007/s11284-011-0915-3; van Zweden JS, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P222, DOI 10.1017/CBO9780511711909.012; Vander Meer Robert K., 1998, P79	42	7	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120652	10.1371/journal.pone.0120652	http://dx.doi.org/10.1371/journal.pone.0120652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853675	Green Submitted, gold, Green Published			2022-12-26	WOS:000352478400017
J	Bagley, JC; Alda, F; Breitman, MF; Bermingham, E; van den Berghe, EP; Johnson, JB				Bagley, Justin C.; Alda, Fernando; Florencia Breitman, M.; Bermingham, Eldredge; van den Berghe, Eric P.; Johnson, Jerald B.			Assessing Species Boundaries Using Multilocus Species Delimitation in a Morphologically Conserved Group of Neotropical Freshwater Fishes, the Poecilia sphenops Species Complex (Poeciliidae)	PLOS ONE			English	Article							HAPLOTYPE RECONSTRUCTION; PISCES-POECILIIDAE; CRYPTIC DIVERSITY; COMPUTER-PROGRAM; COALESCENT; PHYLOGENY; DIVERSIFICATION; BIOGEOGRAPHY; SYSTEMATICS; TELEOSTEI	Accurately delimiting species is fundamentally important for understanding species diversity and distributions and devising effective strategies to conserve biodiversity. However, species delimitation is problematic in many taxa, including 'non-adaptive radiations' containing morphologically cryptic lineages. Fortunately, coalescent-based species delimitation methods hold promise for objectively estimating species limits in such radiations, using multilocus genetic data. Using coalescent-based approaches, we delimit species and infer evolutionary relationships in a morphologically conserved group of Central American freshwater fishes, the Poecilia sphenops species complex. Phylogenetic analyses of multiple genetic markers (sequences of two mitochondrial DNA genes and five nuclear loci) from 10/15 species and genetic lineages recognized in the group support the P. sphenops species complex as monophyletic with respect to outgroups, with eight mitochondrial 'major-lineages' diverged by >= 2% pairwise genetic distances. From general mixed Yule-coalescent models, we discovered (conservatively) 10 species within our concatenated mitochondrial DNA dataset, 9 of which were strongly supported by subsequent multilocus Bayesian species delimitation and species tree analyses. Results suggested species-level diversity is underestimated or overestimated by at least similar to 15% in different lineages in the complex. Nonparametric statistics and coalescent simulations indicate genealogical discordance among our gene tree results has mainly derived from interspecific hybridization in the nuclear genome. However, mitochondrial DNA show little evidence for introgression, and our species delimitation results appear robust to effects of this process. Overall, our findings support the utility of combining multiple lines of genetic evidence and broad phylogeographical sampling to discover and validate species using coalescent-based methods. Our study also highlights the importance of testing for hybridization versus incomplete lineage sorting, which aids inference of not only species limits but also evolutionary processes influencing genetic diversity.	[Bagley, Justin C.; Florencia Breitman, M.; Johnson, Jerald B.] Brigham Young Univ, Evolutionary Ecol Labs, Dept Biol, Provo, UT 84602 USA; [Alda, Fernando; Bermingham, Eldredge] Smithsonian Trop Res Inst, Balboa, Panama; [Florencia Breitman, M.] Consejo Nacl Invest Cient & Tecn, Ctr Nacl Patagon CENPAT, Puerto Madryn, Chubut, Argentina; [van den Berghe, Eric P.] Zamorano Univ, Dept Ambiente & Desarrollo, Ctr Zamorano Biodiversidad, Tegucigalpa, Honduras; [Johnson, Jerald B.] Brigham Young Univ, Monte L Bean Life Sci Museum, Provo, UT 84602 USA	Brigham Young University; Smithsonian Institution; Smithsonian Tropical Research Institute; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Brigham Young University	Bagley, JC (corresponding author), Brigham Young Univ, Evolutionary Ecol Labs, Dept Biol, Provo, UT 84602 USA.	justin.bagley@byu.edu	Johnson, Jerald/AAN-5574-2020; Bagley, Justin/D-3982-2011; Alda, Fernando/C-5646-2011; Bagley, Justin C./N-9654-2019; Breitman, Maria Florencia/AAP-5104-2020; Breitman, Maria/I-8004-2014	Bagley, Justin/0000-0001-6737-8380; Alda, Fernando/0000-0002-6858-9566; Bagley, Justin C./0000-0001-6737-8380; Breitman, Maria/0000-0001-6964-841X	Brigham Young University (BYU) Mentoring Environment Grant; U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant [DEB-1210883]; BYU Graduate Studies Graduate Research Fellowship; NSF PIRE Grant [OISE PIRE-0530267]	Brigham Young University (BYU) Mentoring Environment Grant; U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant(National Science Foundation (NSF)); BYU Graduate Studies Graduate Research Fellowship; NSF PIRE Grant(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was supported by a Brigham Young University (BYU) Mentoring Environment Grant to JBJ and a U.S. National Science Foundation (NSF) Doctoral Dissertation Improvement Grant (DEB-1210883) to JBJ and JCB. JCB received stipend support from a BYU Graduate Studies Graduate Research Fellowship award, and an NSF PIRE Grant (OISE PIRE-0530267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Agapow PM, 2005, CONSERV BIOL SER, V8, P57; Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Alda F, 2013, MOL PHYLOGENET EVOL, V66, P1011, DOI 10.1016/j.ympev.2012.12.012; Alpirez Quesada O, 1971, ESTUDIO SISTEMITICO; Bacon CD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-23; Bagley JC, 2014, BIOL REV, V89, P767, DOI 10.1111/brv.12076; Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219; Barraclough TG, 2001, TRENDS ECOL EVOL, V16, P391, DOI 10.1016/S0169-5347(01)02161-9; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bouckaert R, 2014, PLOS COMPUTATIONAL B; Breden F, 1999, MOL PHYLOGENET EVOL, V12, P95, DOI 10.1006/mpev.1998.0600; Burridge CP, 2008, MOL BIOL EVOL, V25, P624, DOI 10.1093/molbev/msm271; Bussing, 1998, FRESHWATER FISHES CO; Camargo A, 2012, EVOLUTION, V66, P2834, DOI 10.1111/j.1558-5646.2012.01640.x; Camargo A, 2012, SYST BIOL, V61, P272, DOI 10.1093/sysbio/syr105; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chan KMA, 2005, EVOLUTION, V59, P720; Chow S, 1998, FISHERIES SCI, V64, P397, DOI 10.2331/fishsci.64.397; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coyne J.A., 2004, SPECIATION; Cronquist A, 1978, BIOSYSTEMATICS AGR, P3; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Degnan JH, 2009, TRENDS ECOL EVOL, V24, P332, DOI 10.1016/j.tree.2009.01.009; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Fowler H. W., 1943, Notulae Naturae Philadelphia, V117, P1; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; GITTENBERGER E, 1991, BIOL J LINN SOC, V43, P263, DOI 10.1111/j.1095-8312.1991.tb00598.x; GREENFIELD DW, 1990, COPEIA, P449; Hamilton A, 2001, MOL PHYLOGENET EVOL, V19, P277, DOI 10.1006/mpev.2000.0919; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; HUBBS CARL L., 1933, THE AQUARIUM, V1, P263; Hubbs CL, 1926, MISCELLANEOUS PUBLIC, V16, P1; HUDSON RR, 1987, GENETICS, V116, P153; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Jockusch EL, 2002, BIOL J LINN SOC, V76, P361, DOI 10.1046/j.1095-8312.2002.d01-6.x; Joly S, 2012, MOL ECOL RESOUR, V12, P179, DOI 10.1111/j.1755-0998.2011.03065.x; Joly S, 2009, AM NAT, V174, pE54, DOI 10.1086/600082; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Leache AD, 2009, P NATL ACAD SCI USA, V106, P12418, DOI 10.1073/pnas.0906380106; Lee JB, 2009, MOL ECOL, V18, P4088, DOI 10.1111/j.1365-294X.2009.04339.x; Li CH, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-44; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lomolino M, 2012, BIOGEOGRAPHY; Lucinda Paulo Henrique Franco, 2005, Neotrop. ichthyol., V3, P1, DOI 10.1590/S1679-62252005000100001; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Matamoros WA, 2012, REV FISH BIOL FISHER, V22, P351, DOI 10.1007/s11160-011-9232-8; Mayden R. L., 1997, V54, P381; Mayr E., 1942, P1; MENZEL BW, 1973, COPEIA, P225; Miller R.R., 1975, Occasional Papers of the Museum of Zoology University of Michigan, VNo. 672, P1; Miller R. R, 2005, FRESHWATER FISHES ME; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; MISHLER BD, 1982, SYST ZOOL, V31, P491, DOI 10.2307/2413371; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Morando M, 2003, SYST BIOL, V52, P159, DOI 10.1080/10635150390192717; Myers EA, 2013, MOL ECOL, V22, P5418, DOI 10.1111/mec.12478; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Niemiller ML, 2012, EVOLUTION, V66, P846, DOI 10.1111/j.1558-5646.2011.01480.x; Nosil P, 2009, TRENDS ECOL EVOL, V24, P145, DOI 10.1016/j.tree.2008.10.011; O'Meara BC, 2010, SYST BIOL, V59, P59, DOI 10.1093/sysbio/syp077; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Palacios M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071069; Pascual R, 1981, 8 C GEOL ARG ACT 3, P746; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Poeser FN, 1998, ITAL J ZOOL, V65, P145, DOI 10.1080/11250009809386806; Poeser FN, 2003, AMAZON RIVER AMAZON, V1801; Poeser FN, 2011, COPEIA, P418, DOI 10.1643/CI-09-111; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ptacek MB, 1998, J FISH BIOL, V53, P64, DOI 10.1006/jfbi.1998.0807; Quattro JM, 1999, COPEIA, P191, DOI 10.2307/1447401; Rambaut A, 2013, TRACER V 1 5; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; RIVAS L R, 1978, Northeast Gulf Science, V2, P98; Rosen D. E., 1963, Bulletin of the American Museum of Natural History, V126, P1; Ruane S, 2014, SYST BIOL, V63, P231, DOI 10.1093/sysbio/syt099; Satler JD, 2013, SYST BIOL, V62, P805, DOI 10.1093/sysbio/syt041; SCHULTZ RJ, 1971, COPEIA, P282; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Smith BT, 2013, MOL ECOL, V22, P483, DOI 10.1111/mec.12118; Smith SA, 2005, J BIOGEOGR, V32, P1835, DOI 10.1111/j.1365-2699.2005.01317.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tobler M, 2011, EVOLUTION, V65, P2213, DOI 10.1111/j.1558-5646.2011.01298.x; Unmack PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038433; Vogler AP, 2007, J ZOOL SYST EVOL RES, V45, P1, DOI 10.1111/j.1439-0469.2006.00384.x; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wakeley J., 2008, COALESCENT THEORY IN; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waters JM, 1999, MOL PHYLOGENET EVOL, V11, P1, DOI 10.1006/mpev.1998.0554; Welton LJ, 2013, MOL ECOL, V22, P3495, DOI 10.1111/mec.12324; Willis SC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-96; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zhang C, 2011, SYST BIOL, V60, P747, DOI 10.1093/sysbio/syr071; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499; Zwickl D. J, 2006, GENETIC ALGORITHM AP	109	44	44	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121139	10.1371/journal.pone.0121139	http://dx.doi.org/10.1371/journal.pone.0121139			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849959	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800045
J	Biedron, R; Konopinski, MK; Marcinkiewicz, J; Jozefowski, S				Biedron, Rafal; Konopinski, Maciej K.; Marcinkiewicz, Janusz; Jozefowski, Szczepan			Oxidation by Neutrophils-Derived HOCl Increases Immunogenicity of Proteins by Converting Them into Ligands of Several Endocytic Receptors Involved in Antigen Uptake by Dendritic Cells and Macrophages	PLOS ONE			English	Article							LOW-DENSITY LIPOPROTEINS; A SCAVENGER RECEPTORS; CYSTEINE-RICH DOMAIN; MANNOSE RECEPTOR; HYPOCHLOROUS ACID; IMMUNE-RESPONSE; SR-BI; MYELOPEROXIDASE; RECOGNITION; CD36	The initiation of adaptive immune responses to protein antigens has to be preceded by their uptake by antigen presenting cells and intracellular proteolytic processing. Paradoxically, endocytic receptors involved in antigen uptake do not bind the majority of proteins, which may be the main reason why purified proteins stimulate at most weak immune responses. A shared feature of different types of adjuvants, capable of boosting immunogenicity of protein vaccines, is their ability to induce acute inflammation, characterized by early influx of activated neutrophils. Neutrophils are also rapidly recruited to sites of tissue injury or infection. These cells are the source of potent oxidants, including hypochlorous acid (HOCl), causing oxidation of proteins present in inflammatory foci. We demonstrate that oxidation of proteins by endogenous, neutrophils-derived HOCl increases their immunogenicity. Upon oxidation, different, randomly chosen simple proteins (yeast alcohol dehydrogenase, human and bovine serum albumin) and glycoproteins (human apo-transferrin, ovalbumin) gain the ability to bind with high affinity to several endocytic receptors on antigen presenting cells, which seems to be the major mechanism of their increased immunogenicity. The mannose receptor (CD206), scavenger receptors A (CD204) and CD36 were responsible for the uptake and presentation of HOCl-modified proteins by murine dendritic cells and macrophages. Other scavenger receptors, SREC-I and LOX-1, as well as RAGE were also able to bind HOCl-modified proteins, but they did not contribute significantly to these ligands uptake by dendritic cells because they were either not expressed or exhibited preference for more heavily oxidised proteins. Our results indicate that oxidation by neutrophils-derived HOCl may be a physiological mechanism of conferring immunogenicity on proteins which in their native forms do not bind to endocytic receptors. This mechanism might enable the immune system to detect infections caused by pathogens not recognized by pattern recognition receptors.	[Biedron, Rafal; Marcinkiewicz, Janusz; Jozefowski, Szczepan] Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland; [Konopinski, Maciej K.] Polish Acad Sci, Inst Nat Conservat, Krakow, Poland	Jagiellonian University; Collegium Medicum Jagiellonian University; Polish Academy of Sciences	Jozefowski, S (corresponding author), Jagiellonian Univ, Coll Med, Dept Immunol, Krakow, Poland.	szczepan.jozefowski@uj.edu.pl	Biedron, Rafal/AAN-9034-2020; Konopiński, Maciej/G-9982-2011	Konopiński, Maciej/0000-0003-0893-0846	National Science Centre, Poland [NN 401 042139]	National Science Centre, Poland(National Science Centre, Poland)	The study was financed by a grant from the National Science Centre, Poland (grant no. NN 401 042139). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/547179; Becker M, 2006, EUR J IMMUNOL, V36, P950, DOI 10.1002/eji.200535660; Boonstra A, 2003, J EXP MED, V197, P101, DOI 10.1084/jem.20021908; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Chiang CLL, 2006, CANCER IMMUNOL IMMUN, V55, P1384, DOI 10.1007/s00262-006-0127-9; Chiang CLL, 2013, CLIN CANCER RES, V19, P4801, DOI 10.1158/1078-0432.CCR-13-1185; Chieppa M, 2003, J IMMUNOL, V171, P4552, DOI 10.4049/jimmunol.171.9.4552; Cotena A, 2004, J IMMUNOL, V173, P6427, DOI 10.4049/jimmunol.173.10.6427; Dagenais TR, 2009, J IMMUNOL, V183, P3344, DOI 10.4049/jimmunol.0802005; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; DIMENT S, 1987, J LEUKOCYTE BIOL, V42, P485, DOI 10.1002/jlb.42.5.485; Emara M, 2011, J BIOL CHEM, V286, P13033, DOI 10.1074/jbc.M111.220657; Fiete DJ, 1998, P NATL ACAD SCI USA, V95, P2089, DOI 10.1073/pnas.95.5.2089; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gerber CE, 1996, EUR J CLIN CHEM CLIN, V34, P901; Geurts N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027131; HABERLAND ME, 1984, J BIOL CHEM, V259, P1305; Harvey BP, 2014, MOL IMMUNOL, V58, P56, DOI 10.1016/j.molimm.2013.10.013; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; Hazen SL, 1997, J CLIN INVEST, V99, P2075, DOI 10.1172/JCI119379; He LZ, 2007, J IMMUNOL, V178, P6259, DOI 10.4049/jimmunol.178.10.6259; Hjelm F, 2006, SCAND J IMMUNOL, V64, P177, DOI 10.1111/j.1365-3083.2006.01818.x; Huang HB, 2013, CLIN VACCINE IMMUNOL, V20, P1585, DOI 10.1128/CVI.00463-13; Ilchmann A, 2010, J ALLERGY CLIN IMMUN, V125, P175, DOI 10.1016/j.jaci.2009.08.013; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Jacobson LS, 2013, J BIOL CHEM, V288, P7481, DOI 10.1074/jbc.M112.400655; JANSEN RW, 1991, J BIOL CHEM, V266, P3343; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Jozefowski S, 2005, IMMUNOLOGY, V116, P418, DOI 10.1111/j.1365-2567.2005.02241.x; Jozefowski S, 2005, J IMMUNOL, V175, P8032, DOI 10.4049/jimmunol.175.12.8032; Jozefowski S, 2004, J LEUKOCYTE BIOL, V76, P1066, DOI 10.1189/jlb.0504270; Jozefowski S, 2014, INNATE IMMUN-LONDON, V20, P826, DOI 10.1177/1753425913510960; Jozefowski S, 2012, POSTEP HIG MED DOSW, V66, P104, DOI 10.5604/17322693.984079; Jozefowski S, 2011, MICROB PATHOGENESIS, V50, P350, DOI 10.1016/j.micpath.2011.03.001; Jozefowski S, 2010, INFLAMM RES, V59, P277, DOI 10.1007/s00011-009-0096-5; Jutras I, 2008, MOL CELL PROTEOMICS, V7, P697, DOI 10.1074/mcp.M700267-MCP200; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004; Leteux C, 2000, J EXP MED, V191, P1117, DOI 10.1084/jem.191.7.1117; Leung S, 2013, CELL IMMUNOL, V282, P79, DOI 10.1016/j.cellimm.2012.12.006; Lysko PG, 1999, J PHARMACOL EXP THER, V289, P1277; Mac-Daniel L, 2014, J IMMUNOL, V193, P1246, DOI 10.4049/jimmunol.1302669; MARCINKIEWICZ J, 1991, INT J BIOCHEM, V23, P1393, DOI 10.1016/0020-711X(91)90280-Z; Marsche G, 2001, FASEB J, V15, P1095, DOI 10.1096/fj.00-0532fje; Marsche G, 2003, J BIOL CHEM, V278, P47562, DOI 10.1074/jbc.M308428200; Marsche G, 2007, FASEB J, V21, P3075, DOI 10.1096/fj.07-8316com; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Mukundan L, 2005, J IMMUNOL, V174, P1081, DOI 10.4049/jimmunol.174.2.1081; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Odobasic D, 2013, BLOOD, V121, P4195, DOI 10.1182/blood-2012-09-456483; Paveley RA, 2011, INT J PARASITOL, V41, P1335, DOI 10.1016/j.ijpara.2011.08.005; Peiser L, 2006, INFECT IMMUN, V74, P5191, DOI 10.1128/IAI.00124-06; Platt CD, 2010, P NATL ACAD SCI USA, V107, P4287, DOI 10.1073/pnas.0910609107; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Poole JA, 2015, J IMMUNOTOXICOL, V12, P64, DOI 10.3109/1547691X.2014.882449; Prokopowicz Z, 2012, ARCH IMMUNOL THER EX, V60, P43, DOI 10.1007/s00005-011-0156-8; Prokopowicz ZM, 2010, J IMMUNOL, V184, P824, DOI 10.4049/jimmunol.0902606; Rzepecka J, 2009, MOL IMMUNOL, V46, P1109, DOI 10.1016/j.molimm.2008.10.032; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SNIDER DP, 1990, J EXP MED, V171, P1957, DOI 10.1084/jem.171.6.1957; Tagliani E, 2008, J IMMUNOL, V180, P3201, DOI 10.4049/jimmunol.180.5.3201; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; Terrazas CA, 2013, FASEB J, V27, P4547, DOI 10.1096/fj.13-228932; Turley SJ, 2000, SCIENCE, V288, P522, DOI 10.1126/science.288.5465.522; Valencia JV, 2004, ANAL BIOCHEM, V324, P68, DOI 10.1016/j.ab.2003.09.013; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Westman E, 2004, SCAND J IMMUNOL, V59, P458, DOI 10.1111/j.0300-9475.2004.01428.x; WINTERBOURN CC, 1985, BIOCHIM BIOPHYS ACTA, V840, P204, DOI 10.1016/0304-4165(85)90120-5; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x; Yi HF, 2012, J MOL MED, V90, P413, DOI 10.1007/s00109-011-0828-1; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345; Zhao Y, 2014, MUCOSAL IMMUNOL, V7, P440, DOI 10.1038/mi.2013.63	81	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123293	10.1371/journal.pone.0123293	http://dx.doi.org/10.1371/journal.pone.0123293			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849867	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800222
J	Mannava, AG; Tolwinski, NS				Mannava, Anirudh G.; Tolwinski, Nicholas S.			Membrane Bound GSK-3 Activates Wnt Signaling through Disheveled and Arrow	PLOS ONE			English	Article							POLARITY GENE ARMADILLO; ADENOMATOUS POLYPOSIS-COLI; TUMOR-SUPPRESSOR PROTEIN; BETA-CATENIN; DROSOPHILA HOMOLOG; WINGLESS SIGNAL; AXIN; PHOSPHORYLATION; INHIBITION; EXPRESSION	Wnt ligands and their downstream pathway components coordinate many developmental and cellular processes. In adults, they regulate tissue homeostasis through regulation of stem cells. Mechanistically, signal transduction through this pathway is complicated by pathway components having both positive and negative roles in signal propagation. Here we examine the positive role of GSK-3/Zw3 in promoting signal transduction at the plasma membrane. We find that targeting GSK-3 to the plasma membrane activates signaling in Drosophila embryos. This activation requires the presence of the co-receptor Arrow-LRP5/6 and the pathway activating protein Disheveled. Our results provide genetic evidence for evolutionarily conserved, separable roles for GSK-3 at the membrane and in the cytosol, and are consistent with a model where the complex cycles from cytosol to membrane in order to promote signaling at the membrane and to prevent it in the cytosol.	[Tolwinski, Nicholas S.] Natl Univ Singapore, Yale NUS Coll, Singapore 117599, Singapore; Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Med, Dept Biol Sci, Singapore 117599, Singapore	National University of Singapore; Yale NUS College; National University of Singapore	Tolwinski, NS (corresponding author), Natl Univ Singapore, Yale NUS Coll, 14 Med Dr,Level 10 South,10-02M, Singapore 117599, Singapore.	nicholas.tolwinski@yale-nus.edu.sg	Tolwinski, Nicholas/Q-5782-2019	Tolwinski, Nicholas/0000-0002-8507-2737; GAUTAM, ANIRUDH/0000-0002-1724-9625	Academic Research Fund (AcRF) of the Ministry of Education, Singapore [MOE2014-T2-2-039]	Academic Research Fund (AcRF) of the Ministry of Education, Singapore	This work was supported by an Academic Research Fund (AcRF) grant (MOE2014-T2-2-039) of the Ministry of Education, Singapore to N. Tolwinski. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; CHOU TB, 1992, GENETICS, V131, P643; Chou TB, 1996, GENETICS, V144, P1673; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cliffe A, 2003, CURR BIOL, V13, P960, DOI 10.1016/S0960-9822(03)00370-1; Colosimo PF, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000009; Colosimo PF, 2010, DEV DYNAM, V239, P115, DOI 10.1002/dvdy.21963; Cruciat CM, 2014, CURR OPIN CELL BIOL, V31, P46, DOI 10.1016/j.ceb.2014.08.003; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; DOUGAN S, 1992, NATURE, V360, P347, DOI 10.1038/360347a0; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Kaplan NA, 2009, GENETICS, V183, P897, DOI 10.1534/genetics.109.108878; Kim SE, 2013, SCIENCE, V340, P867, DOI 10.1126/science.1232389; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Muller HAJ, 1996, J CELL BIOL, V134, P149, DOI 10.1083/jcb.134.1.149; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; PEIFER M, 1994, DEVELOPMENT, V120, P369; PEIFER M, 1994, DEV BIOL, V166, P543, DOI 10.1006/dbio.1994.1336; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; PERRIMON N, 1987, DEV BIOL, V119, P587, DOI 10.1016/0012-1606(87)90061-3; Qian LH, 2011, P NATL ACAD SCI USA, V108, P8692, DOI 10.1073/pnas.1100328108; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; Roberts DM, 2012, MOL BIOL CELL, V23, P2041, DOI 10.1091/mbc.E11-11-0965; Schlessinger K, 2009, GENE DEV, V23, P265, DOI 10.1101/gad.1760809; Schwarz-Romond T, 2005, J CELL SCI; SIEGFRIED E, 1992, CELL, V71, P1167, DOI 10.1016/S0092-8674(05)80065-0; SIEGFRIED E, 1990, NATURE, V345, P825, DOI 10.1038/345825a0; SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Tacchelly-Benites O, 2013, BIOESSAYS, V35, P1063, DOI 10.1002/bies.201300101; Takacs CM, 2008, SCIENCE, V319, P333, DOI 10.1126/science.1151232; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tolwinski NS, 2009, GENETICS, V181, P1169, DOI 10.1534/genetics.108.098236; Tolwinski NS, 2004, PLOS BIOL, V2, P486, DOI 10.1371/journal.pbio.0020095; Tolwinski NS, 2004, TRENDS GENET, V20, P177, DOI 10.1016/j.tig.2004.02.003; Tolwinski NS, 2003, DEV CELL, V4, P407, DOI 10.1016/S1534-5807(03)00063-7; Tolwinski NS, 2001, DEVELOPMENT, V128, P2107; van Amerongen R, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.135re9; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Willert K, 1999, GENE DEV, V13, P1768, DOI 10.1101/gad.13.14.1768; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Zecca M, 1996, CELL, V87, P833, DOI 10.1016/S0092-8674(00)81991-1; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	57	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121879	10.1371/journal.pone.0121879	http://dx.doi.org/10.1371/journal.pone.0121879			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848770	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800082
J	Mazzone, P; Scudiero, I; Ferravante, A; Paolucci, M; D'Andrea, LE; Varricchio, E; Telesio, G; De Maio, C; Pizzulo, M; Zotti, T; Reale, C; Vito, P; Stilo, R				Mazzone, Pellegrino; Scudiero, Ivan; Ferravante, Angela; Paolucci, Marina; D'Andrea, Luca E.; Varricchio, Ettore; Telesio, Gianluca; De Maio, Chiara; Pizzulo, Maddalena; Zotti, Tiziana; Reale, Carla; Vito, Pasquale; Stilo, Romania			Functional Characterization of Zebrafish (Danio rerio) Bcl10	PLOS ONE			English	Article							NF-KAPPA-B; CASPASE RECRUITMENT DOMAIN; CONTAINING PROTEIN; CARMA PROTEINS; MALT LYMPHOMA; FAMILY MEMBER; ACTIVATION; REGULATOR; PATHWAY; GENE	The complexes formed by BCL10, MALT1 and specific members of the family of CARMA proteins (CBM complex), have recently focused much attention because they represent a central hub regulating activation of the transcription factor NF-kappa B following various cellular stimulations. In this manuscript, we report the functional characterization of a Danio rerio 241 amino acids polypeptide ortholog of the Caspase recruiting domain (CARD)-containing protein BCL10. Biochemical studies show that zebrafish Bcl10 (zBcl10) dimerizes and binds to components of the CBM complex. Fluorescence microscopy observations demonstrate that zBcl10 forms cytoplasmic filaments similar to that formed by human BCL10 (hBCL10). Functionally, in human cells zBcl10 is more effective in activating NF-kappa B compared to hBCL10, possibly due to the lack of carboxy-terminal inhibitory serine residues present in the human protein. Also, depletion experiments carried out through expression of short hairpin RNAs targeting hBCL10 indicate that zBcl10 can functionally replace the human protein. Finally, we show that the zebrafish cell line PAC2 is suitable to carry out reporter assays for monitoring the activation state of NF-kappa B transcription factor. In conclusion, this work shows that zebrafish may excellently serve as a model organism to study complex and intricate signal transduction pathways, such as those that control NF-kappa B activation.	[Mazzone, Pellegrino; Scudiero, Ivan; Ferravante, Angela; D'Andrea, Luca E.; De Maio, Chiara; Pizzulo, Maddalena; Reale, Carla; Vito, Pasquale] Biogem, Ariano Irpino, AV, Italy; [Paolucci, Marina; Varricchio, Ettore; Zotti, Tiziana; Vito, Pasquale; Stilo, Romania] Univ Sannio, Dipartimento Sci & Tecnol, Benevento, Italy; [Telesio, Gianluca] Univ Naples Federico II, Naples, Italy	University of Sannio; University of Naples Federico II	Vito, P (corresponding author), Biogem, Via Camporeale, Ariano Irpino, AV, Italy.	vito@unisannio.it	Varricchio, Ettore/GQZ-1929-2022; Mazzone, Pellegrino/AAC-6576-2020; Reale, Carla/AAB-7939-2020; vito, pasquale/ABF-5505-2020; Zotti, Tiziana/AAV-6768-2021	Varricchio, Ettore/0000-0001-6241-7096; Mazzone, Pellegrino/0000-0002-6217-1505; Reale, Carla/0000-0001-7682-4784; Zotti, Tiziana/0000-0003-4753-116X; Paolucci, Marina/0000-0002-1784-3843; ferravante, angela/0000-0002-4932-3877; vito, pasquale/0000-0002-5721-7716; scudiero, ivan/0000-0001-5559-5548	Qatar National Research Fund (a member of Qatar Foundation) [NPRP 7-466-3-119]	Qatar National Research Fund (a member of Qatar Foundation)	Part of this work was made possible by the NPRP grant NPRP 7-466-3-119 from the Qatar National Research Fund (a member of Qatar Foundation). The statements made herein are solely the responsibility of the authors. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Bidere N, 2009, NATURE, V458, P92, DOI 10.1038/nature07613; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; Chang MX, 2010, DEV COMP IMMUNOL, V34, P1, DOI 10.1016/j.dci.2009.08.002; Costanzo A, 1999, J BIOL CHEM, V274, P20127, DOI 10.1074/jbc.274.29.20127; D' Andrea EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116062; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Eitelhuber AC, 2011, EMBO J, V30, P594, DOI 10.1038/emboj.2010.331; Follo C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021908; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Guiet C, 2002, CELL DEATH DIFFER, V9, P138, DOI 10.1038/sj/cdd/4400947; Guiet C, 2000, J CELL BIOL, V148, P1131, DOI 10.1083/jcb.148.6.1131; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Koseki T, 1999, J BIOL CHEM, V274, P9955, DOI 10.1074/jbc.274.15.9955; Laing KJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-42; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042775; Marasco D, 2009, BIOCHEM J, V422, P553, DOI 10.1042/BJ20090055; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Palkowitsch L, 2011, J BIOL CHEM, V286, P7522, DOI 10.1074/jbc.M110.155895; Park Y, 2013, P NATL ACAD SCI USA, V110, P9433, DOI 10.1073/pnas.1221925110; Paul S, 2014, SCI SIGNAL, V7, DOI [10.1126/scisignal.2005032, DOI 10.1126/SCISIGNAL.2005032]; Qiao Q, 2013, MOL CELL, V51, P766, DOI 10.1016/j.molcel.2013.08.032; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sakamoto T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085762; Scudiero I, 2014, J CELL PHYSIOL, V229, P990, DOI 10.1002/jcp.24543; Scudiero I, 2012, J BIOL CHEM, V287, P6053, DOI 10.1074/jbc.M111.300137; Scudiero I, 2011, J CELL PHYSIOL, V226, P3121, DOI 10.1002/jcp.22667; Srinivasula SM, 1999, J BIOL CHEM, V274, P17946, DOI 10.1074/jbc.274.25.17946; Stein C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r251; Stilo R, 2004, J BIOL CHEM, V279, P34323, DOI 10.1074/jbc.M402244200; Stilo R, 2008, J CELL SCI, V121, P1165, DOI 10.1242/jcs.021105; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thome M, 1999, J BIOL CHEM, V274, P9962, DOI 10.1074/jbc.274.15.9962; Thome M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003004; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vessichelli M, 2012, J BIOL CHEM, V287, P13722, DOI 10.1074/jbc.M111.304436; Vito P, 2014, IMMUNOL LETT, V160, P102, DOI 10.1016/j.imlet.2014.02.002; Wang L, 2001, J BIOL CHEM, V276, P21405, DOI 10.1074/jbc.M102488200; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Willis TG, 1999, CELL, V96, P35, DOI 10.1016/S0092-8674(00)80957-5; Yan MH, 1999, J BIOL CHEM, V274, P10287, DOI 10.1074/jbc.274.15.10287; Yoneda T, 2000, J BIOL CHEM, V275, P11114, DOI 10.1074/jbc.275.15.11114; Zhang QG, 1999, NAT GENET, V22, P63, DOI 10.1038/8767; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273; Zotti T, 2014, MOL IMMUNOL, V58, P27, DOI 10.1016/j.molimm.2013.10.015; Zotti T, 2011, J BIOL CHEM, V286, P22924, DOI 10.1074/jbc.M110.215426	48	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122365	10.1371/journal.pone.0122365	http://dx.doi.org/10.1371/journal.pone.0122365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849213	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800121
J	Sidik, SM; Salsman, J; Dellaire, G; Rohde, JR				Sidik, Saima M.; Salsman, Jayme; Dellaire, Graham; Rohde, John R.			Shigella Infection Interferes with SUMOylation and Increases PML-NB Number	PLOS ONE			English	Article							NUCLEAR-BODIES; DNA-DAMAGE; EFFECTOR OSPG; PROTEIN; UBIQUITIN; SECRETION; BODY; SUMO; MECHANISMS; EXPRESSION	Shigellosis is a severe diarrheal disease that affects hundreds of thousands of individuals resulting in significant morbidity and mortality worldwide. Shigellosis is caused by Shigella spp., a gram-negative bacterium that uses a Type 3 Secretion System (T3SS) to deliver effector proteins into the cytosol of infected human cells. Shigella infection triggers multiple signaling programs that result in a robust host transcriptional response that includes the induction of multiple proinflammatory cytokines. PML nuclear bodies (PML-NBs) are dynamic subnuclear structures that coordinate immune signaling programs and have a demonstrated role in controlling viral infection. We show that PML-NB number increases upon Shigella infection. We examined the effects of Shigella infection on SUMOylation and found that upon Shigella infection the localization of SUMOylated proteins is altered and the level of SUMOylated proteins decreases. Although Shigella infection does not alter the abundance of SUMO activating enzymes SAE1 or SAE2, it dramatically decreases the level of the SUMO conjugating enzyme Ubc9. All Shigella-induced alterations to the SUMOylation system are dependent upon a T3SS. Thus, we demonstrate that Shigella uses one or more T3SS effectors to influence both PML-NB number and the SUMOylation machinery in human cells.	[Sidik, Saima M.; Rohde, John R.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Salsman, Jayme; Dellaire, Graham] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada; [Dellaire, Graham] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Dellaire, Graham] Beatrice Hunter Canc Res Inst, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Rohde, JR (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.	John.Rohde@Dal.Ca	Dellaire, Graham/L-9948-2014	Dellaire, Graham/0000-0002-3466-6316	Natural Sciences and Engineering Research Council [RGPIN 386297]; Canadian Institutes of Health Research [MOP-102594, MOP-84260]; Beatrice Hunter Cancer Research Institute; Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Beatrice Hunter Cancer Research Institute; Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR(Canadian Institutes of Health Research (CIHR))	Natural Sciences and Engineering Research Council: RGPIN 386297 Canadian Institutes of Health Research: MOP-102594 and MOP-84260 SS was an Alexander Graham Bell Canada Graduate Scholar, GD is a Senior Scientist of the Beatrice Hunter Cancer Research Institute (BHCRI), JS was supported by a trainee award from the Beatrice Hunter Cancer Research Institute with funds provided the Terry Fox Foundation as part of a Strategic Health Research Training Program in Cancer Research at CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; ALLAOUI A, 1993, MOL MICROBIOL, V7, P59, DOI 10.1111/j.1365-2958.1993.tb01097.x; Ashida H, 2014, NAT REV MICROBIOL, V12, P399, DOI 10.1038/nrmicro3259; Behrends C, 2011, NAT STRUCT MOL BIOL, V18, P520, DOI 10.1038/nsmb.2066; Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013; Beyer AR, 2015, CELL MICROBIOL, V17, P504, DOI 10.1111/cmi.12380; Bloch DB, 1999, MOL CELL BIOL, V19, P4423; Bourdeau V, 2009, FRONT BIOSCI-LANDMRK, V14, P475, DOI 10.2741/3256; Brouwer AK, 2009, MOL BIOL CELL, V20, P4804, DOI 10.1091/mbc.E09-04-0309; Dellaire G, 2006, J CELL SCI, V119, P1034, DOI 10.1242/jcs.02817; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; Dellaire G, 2006, J CELL BIOL, V175, P55, DOI 10.1083/jcb.200604009; Dunphy PS, 2014, INFECT IMMUN, V82, P4154, DOI 10.1128/IAI.01984-14; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Eskiw CH, 2002, BIOCHEM CELL BIOL, V80, P301, DOI 10.1139/O02-079; Everett RD, 2005, J VIROL, V79, P5078, DOI 10.1128/JVI.79.8.5078-5089.2005; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Everett RD, 2006, J VIROL, V80, P7995, DOI 10.1128/JVI.00734-06; Everett RD, 2013, NAT REV MICROBIOL, V11, P400, DOI 10.1038/nrmicro3015; Fritah S, 2014, EMBO REP, V15, P965, DOI 10.15252/embr.201338386; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gomes R, 2010, VIROLOGY, V396, P256, DOI 10.1016/j.virol.2009.10.005; Huibregtse J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004255; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Jehl SP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002809; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kubori T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001216; LABIGNEROUSSEL AF, 1984, INFECT IMMUN, V46, P251, DOI 10.1128/IAI.46.1.251-259.1984; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Li HT, 2007, SCIENCE, V315, P1000, DOI 10.1126/science.1138960; Lunardi Andrea, 2011, Genes Cancer, V2, P10, DOI 10.1177/1947601911402682; Maarifi G, 2014, CYTOKINE GROWTH F R, V25, P551, DOI 10.1016/j.cytogfr.2014.04.008; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Onodera NT, 2012, J BACTERIOL, V194, P3022, DOI 10.1128/JB.00393-12; Parsot C, 2009, CURR OPIN MICROBIOL, V12, P110, DOI 10.1016/j.mib.2008.12.002; Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056; Perry JJP, 2008, TRENDS BIOCHEM SCI, V33, P201, DOI 10.1016/j.tibs.2008.02.001; Pinder Jordan B., 2013, Frontiers in Genetics, V4, P45, DOI 10.3389/fgene.2013.00045; Pruneda JN, 2014, EMBO J, V33, P437, DOI 10.1002/embj.201386386; Ribet D, 2010, NATURE, V464, P1192, DOI 10.1038/nature08963; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Rohde JR, 2007, CELL HOST MICROBE, V1, P77, DOI 10.1016/j.chom.2007.02.002; Sahin U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5187; Salsman J, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000100; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sidik S, 2014, G3-GENES GENOM GENET, V4, P2493, DOI 10.1534/g3.114.014381; Sivachandran N, 2012, J VIROL, V86, P6146, DOI 10.1128/JVI.00013-12; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Tavalai N, 2011, VIRUS RES, V157, P128, DOI 10.1016/j.virusres.2010.10.002; Ulrich HD, 2014, NAT STRUCT MOL BIOL, V21, P317, DOI 10.1038/nsmb.2805; Van Damme E, 2010, INT J BIOL SCI, V6, P51, DOI 10.7150/ijbs.6.51; Way SS, 1998, INFECT IMMUN, V66, P1342, DOI 10.1128/IAI.66.4.1342-1348.1998	57	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122585	10.1371/journal.pone.0122585	http://dx.doi.org/10.1371/journal.pone.0122585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848798	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800142
J	Zhang, DJ; Zheng, XY; Xi, ZY; Bourtzis, K; Gilles, JRL				Zhang, Dongjing; Zheng, Xiaoying; Xi, Zhiyong; Bourtzis, Kostas; Gilles, Jeremie R. L.			Combining the Sterile Insect Technique with the Incompatible Insect Technique: I-Impact of Wolbachia Infection on the Fitness of Triple- and Double-Infected Strains of Aedes albopictus	PLOS ONE			English	Article							INDUCED CYTOPLASMIC INCOMPATIBILITY; DIPTERA-CULICIDAE; DROSOPHILA; POPULATIONS; MOSQUITOS; VECTOR; ERADICATION; SYMBIOSIS; DENSITY	The mosquito species Aedes albopictus is a major vector of the human diseases dengue and chikungunya. Due to the lack of efficient and sustainable methods to control this mosquito species, there is an increasing interest in developing and applying the sterile insect technique (SIT) and the incompatible insect technique (IIT), separately or in combination, as population suppression approaches. Ae. albopictus is naturally double-infected with two Wolbachia strains, wAlbA and wAlbB. A new triple Wolbachia-infected strain (i.e., a strain infected with wAlbA, wAlbB, and wPip), known as HC and expressing strong cytoplasmic incompatibility (CI) in appropriate matings, was recently developed. In the present study, we compared several fitness traits of three Ae. albopictus strains (triple-infected, double-infected and uninfected), all of which were of the same genetic background ("Guangzhou City, China") and were reared under the same conditions. Investigation of egg-hatching rate, survival of pupae and adults, sex ratio, duration of larval stages (development time from L-1 to pupation), time to emergence (development time from L1 to adult emergence), wing length, female fecundity and adult longevity indicated that the presence of Wolbachia had only a minimal effect on host fitness. Based on this evidence, the HC strain is currently under consideration for mass rearing and application in a combined SIT-IIT strategy to control natural populations of Ae. albopictus in mainland China.	[Zhang, Dongjing; Bourtzis, Kostas; Gilles, Jeremie R. L.] Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria; [Zhang, Dongjing; Zheng, Xiaoying; Xi, Zhiyong] Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou, Guangdong, Peoples R China; [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Sun Yat Sen University; Michigan State University	Gilles, JRL (corresponding author), Joint FAO IAEA Div Nucl Tech Food & Agr, Insect Pest Control Lab, Vienna, Austria.	J.Gilles@iaea.org	Xi, Zhiyong/AAD-7936-2022	Xi, Zhiyong/0000-0001-7786-012X; Zheng, Xiaoying/0000-0001-6264-8433	Key Project of Chinese Ministry of Education [311030]; Guangdong Innovative Research Team Program [2011S009]; Scientific and Technological Leading Talents of Guangzhou Development District [2013L-P116]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Key Project of Chinese Ministry of Education(Ministry of Education, China); Guangdong Innovative Research Team Program; Scientific and Technological Leading Talents of Guangzhou Development District; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation	Research in Prof. Zhiyong Xi's laboratory was supported by the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x; ARUNACHALAM N, 1985, J MED ENTOMOL, V22, P648, DOI 10.1093/jmedent/22.6.648; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192; Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108; Bourtzis K., 2007, P125, DOI 10.1007/978-1-4020-6059-5_11; Bourtzis K, 1996, GENETICS, V144, P1063; Bourtzis K, 2003, CONT T ENT, P217; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; BOYLE L, 1993, SCIENCE, V260, P1796, DOI 10.1126/science.8511587; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Calvitti M, 2009, MED VET ENTOMOL, V23, P132, DOI 10.1111/j.1365-2915.2008.00791.x; Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254; Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140; Chen L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002030; Dobson SL, 2004, EVOLUTION, V58, P2156, DOI 10.1111/j.0014-3820.2004.tb01594.x; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 2001, J MED ENTOMOL, V38, P844, DOI 10.1603/0022-2585-38.6.844; Dobson SL, 2001, J MED ENTOMOL, V38, P382, DOI 10.1603/0022-2585-38.3.382; EDWARDS C. A., 1970, Critical Revs environml Control, V1, P7; Fu YQ, 2010, APPL ENVIRON MICROB, V76, P5887, DOI 10.1128/AEM.00218-10; Gilles JRL, 2011, J MED ENTOMOL, V48, P296, DOI 10.1603/ME09209; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; HOFFMANN AA, 1990, GENETICS, V126, P933; Hosokawa T, 2010, P NATL ACAD SCI USA, V107, P769, DOI 10.1073/pnas.0911476107; Ioannidis Panagiotis, 2007, Entomological Research, V37, P125, DOI 10.1111/j.1748-5967.2007.00102.x; Islam MS, 2006, J MED ENTOMOL, V43, P689, DOI 10.1603/0022-2585(2006)43[689:WEOAAD]2.0.CO;2; Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79; KNIPLING EF, 1960, SCI AM, V203, P54, DOI 10.1038/scientificamerican1060-54; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; Pannebakker BA, 2007, P NATL ACAD SCI USA, V104, P213, DOI 10.1073/pnas.0607845104; Puggioli A, 2013, J MED ENTOMOL, V50, P819, DOI 10.1603/ME13011; RITTER L, 1995, PERSISTANT ORGANIC P; Ritter L, 1995, INT PROGRAMME CHEM S, V65, P66; Sarakatsanou A, 2011, J APPL ENTOMOL, V135, P554, DOI 10.1111/j.1439-0418.2011.01610.x; Saridaki A, 2010, CURR OPIN MICROBIOL, V13, P67, DOI 10.1016/j.mib.2009.11.005; Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025; Stouthamer R, 1999, ANNU REV MICROBIOL, V53, P71, DOI 10.1146/annurev.micro.53.1.71; Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Zabalou S, 2004, P NATL ACAD SCI USA, V101, P15042, DOI 10.1073/pnas.0403853101; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x	51	95	101	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121126	10.1371/journal.pone.0121126	http://dx.doi.org/10.1371/journal.pone.0121126			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849812	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800044
J	Cesbron, Y; Shaheen, U; Free, P; Levy, R				Cesbron, Yann; Shaheen, Umbreen; Free, Paul; Levy, Raphael			TAT and HA2 Facilitate Cellular Uptake of Gold Nanoparticles but Do Not Lead to Cytosolic Localisation	PLOS ONE			English	Article							PEPTIDES; PROTEIN; DELIVERY; CELLS; SIZE; PENETRATION; TRAFFICKING; ABSORPTION; EFFICIENCY; MICROSCOPY	The methods currently available to deliver functional labels and drugs to the cell cytosol are inefficient and this constitutes a major obstacle to cell biology (delivery of sensors and imaging probes) and therapy (drug access to the cell internal machinery). As cell membranes are impermeable to most molecular cargos, viral peptides have been used to bolster their internalisation through endocytosis and help their release to the cytosol by bursting the endosomal vesicles. However, conflicting results have been reported on the extent of the cytosolic delivery achieved. To evaluate their potential, we used gold nanoparticles as model cargos and systematically assessed how the functionalisation of their surface by either or both of the viral peptides TAT and HA2 influenced their intracellular delivery. We evaluated the number of gold nanoparticles present in cells after internalisation using photothermal microscopy and their subcellular localisation by electron microscopy. While their uptake increased when the TAT and/or HA2 viral peptides were present on their surface, we did not observe a significant cytosolic delivery of the gold nanoparticles.	[Cesbron, Yann] Univ Liverpool, Dept Chem, Liverpool L69 3BX, Merseyside, England; [Cesbron, Yann; Shaheen, Umbreen; Free, Paul; Levy, Raphael] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Cesbron, Yann] CNRS, Inst Genet & Dev Rennes, UMR 6290, Rennes, France; [Cesbron, Yann] Univ Rennes 1, Univ Europeenne Bretagne Struct Fed Rech Biosit, Rennes, France; [Free, Paul] ASTAR, Inst Mat Res & Engn, Singapore, Singapore	University of Liverpool; University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Materials Research & Engineering (IMRE)	Levy, R (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	rapha@liverpool.ac.uk	Free, Paul/AAW-7885-2021; Levy, Raphael/D-1474-2009; Cesbron, Yann/A-6485-2010	Free, Paul/0000-0002-6231-6989; Levy, Raphael/0000-0001-5728-0531; Cesbron, Yann/0000-0002-6953-1913	Engineering and Physical Sciences Research Council; Higher Education Commission of Pakistan; Biotechnology and Biological Sciences Research Council (David Phillips Fellowship) [BB/D020638/1]; Medical Research Council [MR/K015931/1]; BBSRC [BB/D020638/1] Funding Source: UKRI; MRC [MR/K015931/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D020638/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Higher Education Commission of Pakistan(Higher Education Commission of Pakistan); Biotechnology and Biological Sciences Research Council (David Phillips Fellowship)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	YC thanks the Engineering and Physical Sciences Research Council for the award of a Liverpool University Doctoral Training Grant studentship. US thanks the Higher Education Commission of Pakistan for a PhD scholarship. RL thanks the Biotechnology and Biological Sciences Research Council (David Phillips Fellowship BB/D020638/1) and the Medical Research Council (MR/K015931/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts Bruce, 2009, Science, V324, P463, DOI 10.1126/science.324_463a; Arnida, 2010, J APPL TOXICOL, V30, P212, DOI 10.1002/jat.1486; Bechara C, 2013, FEBS LETT, V587, P1693, DOI 10.1016/j.febslet.2013.04.031; Berciaud S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.045424; Berciaud S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.257402; Berciaud S, 2005, NANO LETT, V5, P515, DOI 10.1021/nl050062t; Berciaud S, 2007, NANO LETT, V7, P1203, DOI 10.1021/nl062933k; Berciaud S, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.077402; Berry CC, 2007, IEEE T NANOBIOSCI, V6, P262, DOI 10.1109/TNB.2007.908973; Bogart LK, 2014, ACS NANO, V8, P3107, DOI 10.1021/nn500962q; Bogart LK, 2012, ACS NANO, V6, P5961, DOI 10.1021/nn300868z; Brandenberger C, 2010, SMALL, V6, P1669, DOI 10.1002/smll.201000528; Cesbron Y, 2014, INTRACELLULAR DELIVE; Cesbron Y, 2014, CCALNN PEG MONOLAYER; Cesbron Y, 2012, SMALL, V8, P3714, DOI 10.1002/smll.201001465; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Chou LYT, 2011, CHEM SOC REV, V40, P233, DOI 10.1039/c0cs00003e; Conde J, 2012, ACS NANO, V6, P8316, DOI 10.1021/nn3030223; Cross KJ, 2009, PROTEIN PEPTIDE LETT, V16, P766, DOI 10.2174/092986609788681715; de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+; Dokka S, 2000, ADV DRUG DELIVER REV, V44, P35, DOI 10.1016/S0169-409X(00)00082-X; Ehrenberg MS, 2009, BIOMATERIALS, V30, P603, DOI 10.1016/j.biomaterials.2008.09.050; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; FRENS G, 1973, NATURE-PHYS SCI, V241, P20, DOI 10.1038/physci241020a0; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Gilleron J, 2013, NAT BIOTECHNOL, V31, P638, DOI 10.1038/nbt.2612; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HARFORD CG, 1957, J BIOPHYS BIOCHEM CY, V3, P749, DOI 10.1083/jcb.3.5.749; Hirose H, 2012, MOL THER, V20, P984, DOI 10.1038/mt.2011.313; Iversen TG, 2011, NANO TODAY, V6, P176, DOI 10.1016/j.nantod.2011.02.003; Josephson L, 1999, BIOCONJUGATE CHEM, V10, P186, DOI 10.1021/bc980125h; Kaplan IM, 2005, J CONTROL RELEASE, V107, P571, DOI 10.1016/j.jconrel.2004.10.018; Kimling J, 2006, J PHYS CHEM B, V110, P15700, DOI 10.1021/jp061667w; Krpetic Z, 2011, ACS NANO, V5, P5195, DOI 10.1021/nn201369k; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lasne D, 2006, BIOPHYS J, V91, P4598, DOI 10.1529/biophysj.106.089771; Lee YJ, 2011, BBA-GEN SUBJECTS, V1810, P752, DOI 10.1016/j.bbagen.2011.05.013; Levy R, 2006, CHEMBIOCHEM, V7, P592, DOI 10.1002/cbic.200500457; Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269; Levy R, 2010, NANO REV EXP, V1, DOI 10.3402/nano.v1i0.4889; Liou JS, 2012, PEPTIDES, V37, P273, DOI 10.1016/j.peptides.2012.07.019; Liu XL, 2013, INT J PHARMACEUT, V448, P159, DOI 10.1016/j.ijpharm.2013.03.033; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Nativo P, 2008, ACS NANO, V2, P1639, DOI 10.1021/nn800330a; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Pujals S, 2009, CHEMBIOCHEM, V10, P1025, DOI 10.1002/cbic.200800843; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Santra S, 2004, CHEM COMMUN, P2810, DOI 10.1039/b411916a; Santra S, 2005, CHEM COMMUN, P3144, DOI 10.1039/b503234b; See V, 2009, ACS NANO, V3, P2461, DOI 10.1021/nn9006994; Shaheen U, 2014, EFFECT PEG INTRACELL; Shaheen U, 2014, INFLUENCE PROPORTION; Shaheen U, 2014, ORIENTATION HA2 PEPT; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Stirling J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108482; Sugita T, 2007, BIOCHEM BIOPH RES CO, V363, P1027, DOI 10.1016/j.bbrc.2007.09.077; Todorova N, 2014, NANO LETT, V14, P5229, DOI 10.1021/nl5021848; Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Xia HM, 2012, INT J PHARMACEUT, V436, P840, DOI 10.1016/j.ijpharm.2012.07.029; Yguerabide J, 1998, ANAL BIOCHEM, V262, P137, DOI 10.1006/abio.1998.2759; Yin P, 2010, MAT SCI ENG C-MATER, V30, P1260, DOI 10.1016/j.msec.2010.07.006; Yu M, 2012, SMALL, V8, P3720, DOI 10.1002/smll.201202322; Zhang Y, 2008, CURR OPIN BIOTECH, V19, P506, DOI 10.1016/j.copbio.2008.07.005	70	20	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121683	10.1371/journal.pone.0121683	http://dx.doi.org/10.1371/journal.pone.0121683			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836335	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000056
J	Jacobsen, E; Dart, AJ; Mondori, T; Horadogoda, N; Jeffcott, LB; Little, CB; Smith, MM				Jacobsen, Else; Dart, Andrew J.; Mondori, Takamitsu; Horadogoda, Neil; Jeffcott, Leo B.; Little, Christopher B.; Smith, Margaret M.			Focal Experimental Injury Leads to Widespread Gene Expression and Histologic Changes in Equine Flexor Tendons	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; MESSENGER-RNA; ANIMAL-MODELS; EXTRACELLULAR-MATRIX; PATELLAR TENDON; ELITE FOOTBALL; TENDINITIS; METALLOPROTEINASES; TENDINOSIS; AGGRECAN	It is not known how extensively a localised flexor tendon injury affects the entire tendon. This study examined the extent of and relationship between histopathologic and gene expression changes in equine superficial digital flexor tendon after a surgical injury. One forelimb tendon was hemi-transected in six horses, and in three other horses, one tendon underwent a sham operation. After euthanasia at six weeks, transected and control (sham and non-operated contralateral) tendons were regionally sampled (medial and lateral halves each divided into six 3cm regions) for histologic (scoring and immunohistochemistry) and gene expression (real time PCR) analysis of extracellular matrix changes. The histopathology score was significantly higher in transected tendons compared to control tendons in all regions except for the most distal (P <= 0.03) with no differences between overstressed (medial) and stress-deprived (lateral) tendon halves. Proteoglycan scores were increased by transection in all but the most proximal region (P < 0.02), with increased immunostaining for aggrecan, biglycan and versican. After correcting for location within the tendon, gene expression for aggrecan, versican, biglycan, lumican, collagen types I, II and III, MMP14 and TIMP1 was increased in transected tendons compared with control tendons (P < 0.02) and decreased for ADAMTS4, MMP3 and TIMP3 (P < 0.001). Aggrecan, biglycan, fibromodulin, and collagen types I and III expression positively correlated with all histopathology scores (P < 0.001), whereas lumican, ADAMTS4 and MMP14 expression positively correlated only with collagen fiber malalignment (P < 0.001). In summary, histologic and associated gene expression changes were significant and widespread six weeks after injury to the equine SDFT, suggesting rapid and active development of tendinopathy throughout the entire length of the tendon. These extensive changes distant to the focal injury may contribute to poor functional outcomes and re-injury in clinical cases. Our data suggest that successful treatments of focal injuries will need to address pathology in the entire tendon, and that better methods to monitor the development and resolution of tendinopathy are required.	[Jacobsen, Else; Dart, Andrew J.; Horadogoda, Neil; Jeffcott, Leo B.] Univ Sydney, Univ Vet Teaching Hosp, Res & Clin Training Unit, Camden, NSW, Australia; [Mondori, Takamitsu; Little, Christopher B.; Smith, Margaret M.] Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia	University of Sydney; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Smith, MM (corresponding author), Univ Sydney, Royal N Shore Hosp, Raymond Purves Bone & Joint Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia.	mobsmith@sydney.edu.au	Dart, A. J./K-7113-2017; Smith, Margaret/E-9633-2010; Jeffcott, Leo/S-8887-2017; little, christopher/A-9280-2015	Dart, A. J./0000-0002-9102-8003; Smith, Margaret/0000-0002-2020-0056; Jacobson, Else/0000-0001-7524-7655; Jeffcott, Leo/0000-0002-2855-6946; little, christopher/0000-0002-0353-7634	Australian Orthopaedic Association; Hillcrest Foundation; National Health and Medical Research Council of Australia [570922]	Australian Orthopaedic Association; Hillcrest Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was partially funded by grants from the Australian Orthopaedic Association (www.aoa.org.au) and the Hillcrest Foundation (https://www.bankofamerica.com/philanthropic/foundation.go?fnId=89). MMS was funded by the National Health and Medical Research Council of Australia (Project #570922; www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; Alfredson H, 2003, J ORTHOPAED RES, V21, P970, DOI 10.1016/S0736-0266(03)00107-4; Archambault JM, 2007, J ORTHOP RES, V25, P617, DOI 10.1002/jor.20347; Attia M, 2014, BRIT J SPORT MED, V48, P469, DOI 10.1136/bjsports-2013-092633; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Bey MJ, 2012, J SHOULDER ELB SURG, V21, P149, DOI 10.1016/j.jse.2011.10.023; Burssens A, 2013, KNEE SURG SPORT TR A, V21, P1459, DOI 10.1007/s00167-012-2203-3; Bustin Stephen A, 2004, J Biomol Tech, V15, P155; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Corps AN, 2004, RHEUMATOLOGY, V43, P969, DOI 10.1093/rheumatology/keh222; Corps AN, 2008, MATRIX BIOL, V27, P393, DOI 10.1016/j.matbio.2008.02.002; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Crevier-Denoix N, 2005, J BIOMECH, V38, P2212, DOI 10.1016/j.jbiomech.2004.09.026; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dakin SG, 2014, VET IMMUNOL IMMUNOP, V158, P121, DOI 10.1016/j.vetimm.2014.01.007; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Demehri S, 2014, J COMPUT ASSIST TOMO, V38, P299, DOI 10.1097/RCT.0b013e3182aa72bf; Docking SI, 2012, VET J, V194, P338, DOI 10.1016/j.tvjl.2012.04.024; Donaldson Peter R, 2012, Clin J Sport Med, V22, P169, DOI 10.1097/JSM.0b013e31824c2b2c; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dy CJ, 2012, J HAND SURG-AM, V37A, P919, DOI 10.1016/j.jhsa.2012.02.003; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; Hagglund M, 2006, BRIT J SPORT MED, V40, P767, DOI 10.1136/bjsm.2006.026609; Hosaka YZ, 2010, TISSUE CELL, V42, P9, DOI 10.1016/j.tice.2009.06.002; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Jelinsky SA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-86; John T, 2010, J ORTHOP RES, V28, P1071, DOI 10.1002/jor.21079; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Lake SP, 2008, DISABIL REHABIL, V30, P1530, DOI 10.1080/09638280701785460; Leigh DR, 2008, J ORTHOP RES, V26, P1306, DOI 10.1002/jor.20650; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Longo UG, 2011, SPORTS MED ARTHROSC, V19, P184, DOI 10.1097/JSA.0b013e318205470e; Lui PPY, 2011, SCAND J MED SCI SPOR, V21, P3, DOI 10.1111/j.1600-0838.2010.01164.x; Lui PPY, 2012, J ORTHOP RES, V30, P37, DOI 10.1002/jor.21495; Lundin AC, 2014, SCAND J MED SCI SPOR, V24, P363, DOI 10.1111/j.1600-0838.2012.01514.x; Mazzocca AD, 2013, ARTHROSCOPY, V29, P972, DOI 10.1016/j.arthro.2013.02.002; Nilsson-Helander K, 2010, AM J SPORT MED, V38, P2186, DOI 10.1177/0363546510376052; O'Meara B, 2010, EQUINE VET J, V42, P322, DOI 10.1111/j.2042-3306.2009.00021.x; Oikawa Masa-aki, 2002, Journal of Equine Science, V13, P41, DOI 10.1294/jes.13.41; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Patterson-Kane JC, 2009, VET J, V181, P79, DOI 10.1016/j.tvjl.2008.02.009; Peffers MJ, 2014, J BIOL CHEM, V289, P25867, DOI 10.1074/jbc.M114.566554; Petersen J, 2010, SCAND J MED SCI SPOR, V20, P588, DOI 10.1111/j.1600-0838.2009.00995.x; Rand T, 1998, INVEST RADIOL, V33, P433, DOI 10.1097/00004424-199808000-00002; Reardon RJM, 2013, VET J, V195, P325, DOI 10.1016/j.tvjl.2012.06.033; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 2005, SCAND J MED SCI SPOR, V15, P241, DOI 10.1111/j.1600-0838.2005.00456.x; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Schramme M, 2010, VET COMP ORTHOPAED, V23, P231, DOI 10.3415/VCOT-09-10-0106; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Sivaguru M, 2014, METHODS, V66, P256, DOI 10.1016/j.ymeth.2013.07.016; Slager R F, 1977, Am J Sports Med, V5, P37, DOI 10.1177/036354657700500201; Smith MM, 2008, ARTHRITIS RHEUM-US, V58, P1055, DOI 10.1002/art.23388; Sobhani S, 2013, SCAND J MED SCI SPOR, V23, P669, DOI 10.1111/j.1600-0838.2012.01509.x; Stanton H, 2011, BBA-MOL BASIS DIS, V1812, P1616, DOI 10.1016/j.bbadis.2011.08.009; Sztrolovics R, 2002, BIOCHEM J, V362, P465, DOI 10.1042/0264-6021:3620465; Tallon C, 2001, MED SCI SPORT EXER, V33, P1983, DOI 10.1097/00005768-200112000-00002; Thornton GM, 2011, J MUSCULOSKEL NEURON, V11, P94; van Hamel SE, 2014, EQUINE VET J, V46, P300, DOI 10.1111/evj.12129; Voleti PB, 2012, ANNU REV BIOMED ENG, V14, P47, DOI 10.1146/annurev-bioeng-071811-150122; Warden SJ, 2007, BRIT J SPORT MED, V41, P232, DOI 10.1136/bjsm.2006.032342; Watanabe T, 2012, J ANAT, V220, P156, DOI 10.1111/j.1469-7580.2011.01456.x; WATKINS JP, 1985, AM J VET RES, V46, P2091; Watts AE, 2012, EQUINE VET J, V44, P576, DOI 10.1111/j.2042-3306.2011.00471.x; Wilkins R, 2012, AM J SPORT MED, V40, P2154, DOI 10.1177/0363546512453293; Williams RB, 2001, EQUINE VET J, V33, P478, DOI 10.2746/042516401776254808; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	71	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122220	10.1371/journal.pone.0122220	http://dx.doi.org/10.1371/journal.pone.0122220			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837713	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000086
J	Nicholson, J; Azim, S; Rebecchi, MJ; Galbavy, W; Feng, T; Reinsel, R; Rizwan, S; Fowler, CJ; Benveniste, H; Kaczocha, M				Nicholson, James; Azim, Syed; Rebecchi, Mario J.; Galbavy, William; Feng, Tian; Reinsel, Ruth; Rizwan, Sabeen; Fowler, Christopher J.; Benveniste, Helene; Kaczocha, Martin			Leptin Levels Are Negatively Correlated with 2-Arachidonoylglycerol in the Cerebrospinal Fluid of Patients with Osteoarthritis	PLOS ONE			English	Article							CIRCULATING ENDOCANNABINOID LEVELS; CARDIOMETABOLIC RISK-FACTORS; ANANDAMIDE LEVELS; CANNABINOID RECEPTOR; SERUM LEPTIN; SYSTEM; DIET; ACTIVATION; ADIPOSE; OBESITY	` Background There is compelling evidence in humans that peripheral endocannabinoid signaling is disrupted in obesity. However, little is known about the corresponding central signaling. Here, we have investigated the relationship between gender, leptin, body mass index (BMI) and levels of the endocannabinoids anandamide (AEA) and 2-arachidonoylglycerol (2-AG) in the serum and cerebrospinal fluid (CSF) of primarily overweight to obese patients with osteoarthritis. Methodology/Principal Findings Patients (20 females, 15 males, age range 44-78 years, BMI range 24-42) undergoing total knee arthroplasty for end-stage osteoarthritis were recruited for the study. Endocannabinoids were quantified by liquid chromatography - mass spectrometry. AEA and 2-AG levels in the serum and CSF did not correlate with either age or BMI. However, 2-AG levels in the CSF, but not serum, correlated negatively with CSF leptin levels (Spearman's. -0.48, P=0.0076, n=30). No such correlations were observed for AEA and leptin. Conclusions/Significance In the patient sample investigated, there is a negative association between 2-AG and leptin levels in the CSF. This is consistent with pre-clinical studies in animals, demonstrating that leptin controls the levels of hypothalamic endocannabinoids that regulate feeding behavior.	[Nicholson, James] SUNY Stony Brook, Dept Orthoped Surg, Stony Brook, NY 11794 USA; [Azim, Syed; Rebecchi, Mario J.; Galbavy, William; Reinsel, Ruth; Rizwan, Sabeen; Benveniste, Helene; Kaczocha, Martin] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Feng, Tian] SUNY Stony Brook, Dept Appl Math & Stat, Stony Brook, NY 11794 USA; [Fowler, Christopher J.] Umea Univ, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Kaczocha, Martin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Umea University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Benveniste, H (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.	Helene.Benveniste@Stonybrookmedicine.edu; Martin.Kaczocha@Stonybrook.edu	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874; Galbavy, William/0000-0003-0948-9538; Kaczocha, Martin/0000-0002-2527-1398	Department of Anesthesiology; National Institutes of Health [DA035923, DA035949]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035949, R01DA035923] Funding Source: NIH RePORTER	Department of Anesthesiology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Department of Anesthesiology and National Institutes of Health grants DA035923 and DA035949. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulnour J, 2014, OBESITY, V22, P211, DOI 10.1002/oby.20498; Annuzzi G, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-43; Artmann A, 2008, BBA-MOL CELL BIOL L, V1781, P200, DOI 10.1016/j.bbalip.2008.01.006; Azim S, 2015, PAIN, V156, P341, DOI 10.1097/01.j.pain.0000460315.80981.59; Banni S, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-7; Bennetzen MF, 2011, INT J OBESITY, V35, P1377, DOI 10.1038/ijo.2011.8; Boden G, 1996, J CLIN ENDOCR METAB, V81, P3419, DOI 10.1210/jc.81.9.3419; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Buettner C, 2008, NAT MED, V14, P667, DOI 10.1038/nm1775; Cable JC, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-129; Cardinal P, 2014, MOL METAB, V3, P705, DOI 10.1016/j.molmet.2014.07.004; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Cote M, 2007, INT J OBESITY, V31, P692, DOI 10.1038/sj.ijo.0803539; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; de Chiara V, 2013, NEUROSCIENCE, V250, P232, DOI 10.1016/j.neuroscience.2013.06.069; De Vry J, 2004, EUR J PHARMACOL, V483, P55, DOI 10.1016/j.ejphar.2003.10.012; Di Filippo M, 2008, J NEUROL NEUROSUR PS, V79, P1224, DOI 10.1136/jnnp.2007.139071; Di Marzo V, 2009, DIABETOLOGIA, V52, P213, DOI 10.1007/s00125-008-1178-6; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; DiPatrizio NV, 2012, TRENDS NEUROSCI, V35, P403, DOI 10.1016/j.tins.2012.04.006; Dube JJ, 2007, AM J PHYSIOL-REG I, V293, pR642, DOI 10.1152/ajpregu.00133.2007; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Fernandez-Aranda F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104534; Fujioka K, 1999, JAMA-J AM MED ASSOC, V282, P1517, DOI 10.1001/jama.282.16.1517; Gatta-Cherifi B, 2012, INT J OBESITY, V36, P880, DOI 10.1038/ijo.2011.165; Giuffrida A, 2004, NEUROPSYCHOPHARMACOL, V29, P2108, DOI 10.1038/sj.npp.1300558; Hagan MM, 1999, J CLIN ENDOCR METAB, V84, P3579, DOI 10.1210/jc.84.10.3579; Hanlon EC, 2015, J CLIN ENDOCR METAB, V100, P220, DOI 10.1210/jc.2014-3455; Hauer D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062741; Hickey MS, 1996, BIOCHEM MOL MED, V59, P1, DOI 10.1006/bmme.1996.0056; Hill MN, 2013, PSYCHONEUROENDOCRINO, V38, P2952, DOI 10.1016/j.psyneuen.2013.08.004; Ho WSV, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-32; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Jumpertz R, 2011, J CLIN ENDOCR METAB, V96, P787, DOI 10.1210/jc.2010-2028; Kaczocha M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094200; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kloke JD, 2012, R J, V4, P57, DOI 10.32614/rj-2012-014; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; Koethe D, 2009, J NEURAL TRANSM, V116, P301, DOI 10.1007/s00702-008-0169-6; Koppel J, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-2; Kunos G, 2008, J BIOL CHEM, V283, P33021, DOI 10.1074/jbc.R800012200; Lehmann R., 1977, BIOMETRICAL J, V19, P229; Leweke FM, 2007, SCHIZOPHR RES, V94, P29, DOI 10.1016/j.schres.2007.04.025; Liu J, 2012, GASTROENTEROLOGY, V142, P1218, DOI 10.1053/j.gastro.2012.01.032; Maccarrone M, 2001, J IMMUNOL, V166, P7183, DOI 10.4049/jimmunol.166.12.7183; Martins CJM, 2014, HORM METAB RES, V46, P529, DOI 10.1055/s-0034-1375653; Massa F, 2010, J NEUROSCI, V30, P6273, DOI 10.1523/JNEUROSCI.2648-09.2010; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Monteleone P, 2005, NEUROPSYCHOPHARMACOL, V30, P1216, DOI 10.1038/sj.npp.1300695; Morgan CJA, 2013, BRIT J PSYCHIAT, V202, P381, DOI 10.1192/bjp.bp.112.121178; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2005, FEBS LETT, V579, P295, DOI 10.1016/j.febslet.2004.11.024; Pisani A, 2005, ANN NEUROL, V57, P777, DOI 10.1002/ana.20462; Pisani V, 2010, MOVEMENT DISORD, V25, P920, DOI 10.1002/mds.23014; Quarta C, 2011, TRENDS MOL MED, V17, P518, DOI 10.1016/j.molmed.2011.05.002; Quercioli A, 2013, EUR HEART J, V34, P2063, DOI 10.1093/eurheartj/eht085; Rojo ML, 2013, LIFE SCI, V92, P757, DOI 10.1016/j.lfs.2013.02.002; Romigi A, 2010, EPILEPSIA, V51, P768, DOI 10.1111/j.1528-1167.2009.02334.x; Sainz N, 2015, METABOLISM, V64, P35, DOI 10.1016/j.metabol.2014.10.015; Sarchielli P, 2007, NEUROPSYCHOPHARMACOL, V32, P1384, DOI 10.1038/sj.npp.1301246; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; Sipe JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008792; Tam J, 2012, CELL METAB, V16, P167, DOI 10.1016/j.cmet.2012.07.002; Team R.C, R LANG ENV STAT COMP; Van Gaal LF, 2008, EUR HEART J, V29, P1761, DOI 10.1093/eurheartj/ehn076; Watanabe T, 2009, J BIOL CHEM, V284, P1803, DOI 10.1074/jbc.M807120200; Wong A, 2014, J LIPID RES, V55, P1902, DOI 10.1194/jlr.M048694	69	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123132	10.1371/journal.pone.0123132	http://dx.doi.org/10.1371/journal.pone.0123132			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835291	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000130
J	Plewnia, C; Schroeder, PA; Kunze, R; Faehling, F; Wolkenstein, L				Plewnia, Christian; Schroeder, Philipp A.; Kunze, Roland; Faehling, Florian; Wolkenstein, Larissa			Keep Calm and Carry On: Improved Frustration Tolerance and Processing Speed by Transcranial Direct Current Stimulation (tDCS)	PLOS ONE			English	Article							SERIAL ADDITION TEST; COGNITIVE CONTROL; PREFRONTAL CORTEX; WORKING-MEMORY; DEPRESSED-PATIENTS; NEGATIVE AFFECT; NEURAL MECHANISMS; PERFORMANCE; TASK; INTERFERENCE	Cognitive control (CC) of attention is a major prerequisite for effective information processing. Emotional distractors can bias and impair goal-directed deployment of attentional resources. Frustration-induced negative affect and cognition can act as internal distractors with negative impact on task performance. Consolidation of CC may thus support task-oriented behavior under challenging conditions. Recently, transcranial direct current stimulation (tDCS) has been put forward as an effective tool to modulate CC. Particularly, anodal, activity enhancing tDCS to the left dorsolateral prefrontal cortex (dlPFC) can increase insufficient CC in depression as indicated by a reduction of attentional biases induced by emotionally salient stimuli. With this study, we provide first evidence that, compared to sham stimulation, tDCS to the left dlPFC enhances processing speed measured by an adaptive version of the Paced Auditory Serial Addition Task (PASAT) that is typically thwarted by frustration. Notably, despite an even larger amount of error-related negative feedback, the task-induced upset was suppressed in the group receiving anodal tDCS. Moreover, inhibition of task-related negative affect was correlated with performance gains, suggesting a close link between enhanced processing speed and consolidation of CC by tDCS. Together, these data provide first evidence that activity enhancing anodal tDCS to the left dlPFC can support focused cognitive processing particularly when challenged by frustration-induced negative affect.	[Plewnia, Christian; Schroeder, Philipp A.; Kunze, Roland; Faehling, Florian] Univ Tubingen, Dept Psychiat & Psychotherapy Neurophysiol & Inte, D-72076 Tubingen, Germany; [Plewnia, Christian] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Wolkenstein, Larissa] Univ Tubingen, Dept Psychol Clin Psychol & Psychotherapy, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Plewnia, C (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy Neurophysiol & Inte, Calwerstr 14, D-72076 Tubingen, Germany.	christian.plewnia@uni-tuebingen.de	Schroeder, Philipp/E-5148-2018	Schroeder, Philipp/0000-0002-9941-6086; Plewnia, Christian/0000-0003-3852-9906	GCBS research consortium - German Federal Ministry of Education and Research [FKZ 01EE1403D]; University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg ) [2013-217]	GCBS research consortium - German Federal Ministry of Education and Research; University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg )	This work was supported by the GCBS research consortium (FKZ 01EE1403D) funded by the German Federal Ministry of Education and Research. Christian Plewnia and Florian Faehling received a grant from the University of Tubingen Faculty of Medicine (IZKF-Promotionskolleg 2013-217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Andrews SC, 2011, BRAIN STIMUL, V4, P84, DOI 10.1016/j.brs.2010.06.004; Anticevic A, 2010, COGN AFFECT BEHAV NE, V10, P159, DOI 10.3758/CABN.10.2.159; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brunoni AR, 2014, J AFFECT DISORDERS, V162, P43, DOI 10.1016/j.jad.2014.03.026; Calkins Amanda W, 2015, Behav Cogn Psychother, V43, P578, DOI 10.1017/S1352465814000046; Carver C, 2014, INT HDB EMOTIONS ED; Clark DA, 2010, TRENDS COGN SCI, V14, P418, DOI 10.1016/j.tics.2010.06.007; Clarke PJF, 2014, BIOL PSYCHIAT, V76, P946, DOI 10.1016/j.biopsych.2014.03.003; Clemens B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095984; Crawford JR, 2004, BRIT J CLIN PSYCHOL, V43, P245, DOI 10.1348/0144665031752934; Davidson RJ, 2003, AM J PSYCHIAT, V160, P64, DOI 10.1176/appi.ajp.160.1.64; Dayan E, 2013, NAT NEUROSCI, V16, P838, DOI 10.1038/nn.3422; DEARY IJ, 1991, PERS INDIV DIFFER, V12, P983, DOI 10.1016/0191-8869(91)90027-9; Disner SG, 2011, NAT REV NEUROSCI, V12, P467, DOI 10.1038/nrn3027; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Elliott R, 1997, PSYCHOL MED, V27, P931, DOI 10.1017/S0033291797005187; Eysenck MW, 2007, EMOTION, V7, P336, DOI 10.1037/1528-3542.7.2.336; Filmer HL, 2014, TRENDS NEUROSCI, V37, P742, DOI 10.1016/j.tins.2014.08.003; Foland-Ross LC, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00489; Fregni F, 2005, EXP BRAIN RES, V166, P23, DOI 10.1007/s00221-005-2334-6; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Gemar M C, 1996, Depression, V4, P81, DOI 10.1002/(SICI)1522-7162(1996)4:2<81::AID-DEPR8>3.0.CO;2-I; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Gotlib IH, 2010, ANNU REV CLIN PSYCHO, V6, P285, DOI 10.1146/annurev.clinpsy.121208.131305; Gronwall D.M.A., 1974, PSYCHOL EFFECTS CONC, V128, P501, DOI 10.1192/S000712500010443X; Herz DM, 2014, J NEUROSCI, V34, P3210, DOI 10.1523/JNEUROSCI.4081-13.2014; Hester R, 2005, MEM COGNITION, V33, P221, DOI 10.3758/BF03195311; Holdwick DJ, 1999, ARCH CLIN NEUROPSYCH, V14, P273, DOI 10.1016/S0887-6177(98)00021-3; INGRAM RE, 1987, J PERS SOC PSYCHOL, V53, P734, DOI 10.1037/0022-3514.53.4.734; Jones NP, 2010, COGN AFFECT BEHAV NE, V10, P129, DOI 10.3758/CABN.10.1.129; Kanske P, 2011, CEREB CORTEX, V21, P1379, DOI 10.1093/cercor/bhq216; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Koechlin E, 2003, SCIENCE, V302, P1181, DOI 10.1126/science.1088545; Kouneiher F, 2009, NAT NEUROSCI, V12, P939, DOI 10.1038/nn.2321; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kuo MF, 2012, CLIN EEG NEUROSCI, V43, P192, DOI 10.1177/1550059412444975; Lazeron RHC, 2003, J NEUROL SCI, V213, P29, DOI 10.1016/S0022-510X(03)00144-8; Lejuez C. W., 2003, BEHAV THERAPIST, DOI DOI 10.1002/DA.20091; Mathews A, 2005, ANNU REV CLIN PSYCHO, V1, P167, DOI 10.1146/annurev.clinpsy.1.102803.143916; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miller EK, 2000, NAT REV NEUROSCI, V1, P59, DOI 10.1038/35036228; Moriya J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034244, 10.1371/journal.pone.0047221]; Nejad AB, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00666; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Oatley K, 2014, TRENDS COGN SCI, V18, P134, DOI 10.1016/j.tics.2013.12.004; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Oei NYL, 2012, SOC COGN AFFECT NEUR, V7, P403, DOI 10.1093/scan/nsr024; Okada G, 2003, NEUROPSYCHOBIOLOGY, V47, P21, DOI 10.1159/000068871; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Plewnia C, 2013, CORTEX, V49, P1801, DOI 10.1016/j.cortex.2012.11.002; Priori A, 2003, CLIN NEUROPHYSIOL, V114, P589, DOI 10.1016/S1388-2457(02)00437-6; Priori A, 2008, CEREB CORTEX, V18, P451, DOI 10.1093/cercor/bhm088; Rock PL, 2014, PSYCHOL MED, V44, P2029, DOI 10.1017/S0033291713002535; Roiser JP, 2012, NEUROPSYCHOPHARMACOL, V37, P117, DOI 10.1038/npp.2011.183; Schweizer S, 2013, J NEUROSCI, V33, P5301, DOI 10.1523/JNEUROSCI.2593-12.2013; Segrave RA, 2014, BRAIN STIMUL, V7, P325, DOI 10.1016/j.brs.2013.12.008; Siegle GJ, 2007, COGNITIVE THER RES, V31, P235, DOI 10.1007/s10608-006-9118-6; Siegle GJ, 2007, BIOL PSYCHIAT, V61, P198, DOI 10.1016/j.biopsych.2006.05.048; Staal M. A., 2004, 212824 NASA; Subramaniam K, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00452; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Vanderhasselt MA, 2015, PROG NEURO-PSYCHOPH, V57, P93, DOI 10.1016/j.pnpbp.2014.09.015; Vanderhasselt MA, 2013, NEUROPSYCHOLOGIA, V51, P2581, DOI 10.1016/j.neuropsychologia.2013.08.011; Vanderhasselt MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062219; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wells A., 1995, ATTENTION EMOTION CL; Wessa M, 2013, SOC COGN AFFECT NEUR, V8, P305, DOI 10.1093/scan/nsr098; Wolkenstein L, 2014, CORTEX, V59, P103, DOI 10.1016/j.cortex.2014.07.011; Wolkenstein L, 2013, BIOL PSYCHIAT, V73, P646, DOI 10.1016/j.biopsych.2012.10.010; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	75	39	40	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122578	10.1371/journal.pone.0122578	http://dx.doi.org/10.1371/journal.pone.0122578			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837520	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000102
J	Shin, E; Lee, H; Yoo, SA; Chong, SC				Shin, Eunsam; Lee, Hunjae; Yoo, Sang-Ah; Chong, Sang Chul			Training Improves the Capacity of Visual Working Memory When It Is Adaptive, Individualized, and Targeted	PLOS ONE			English	Article							SHORT-TERM-MEMORY; STORAGE CAPACITY; INFORMATION; MECHANISMS; EXPERTISE; OBJECTS; FILTER; ADULTS; TASK	The current study investigated whether training improves the capacity of visual working memory using individualized adaptive training methods. Two groups of participants were trained for two targeted processes, filtering and consolidation. Before and after the training, the participants, including those with no training, performed a lateralized change detection task in which one side of the visual display had to be selected and the other side ignored. Across ten-day training sessions, the participants performed two modified versions of the lateralized change detection task. The number of distractors and duration of the consolidation period were adjusted individually to increase the task difficulty of the filtering and consolidation training, respectively. Results showed that the degree of improvement shown during the training was positively correlated with the increase in memory capacity, and training-induced benefits were most evident for larger set sizes in the filtering training group. These results suggest that visual working memory training is effective, especially when it is adaptive, individualized, and targeted.	[Shin, Eunsam] Yonsei Univ, Ctr Cognit Sci, Seoul 120749, South Korea; [Lee, Hunjae; Yoo, Sang-Ah; Chong, Sang Chul] Yonsei Univ, Grad Program Cognit Sci, Seoul 120749, South Korea; [Chong, Sang Chul] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea	Yonsei University; Yonsei University; Yonsei University	Chong, SC (corresponding author), Yonsei Univ, Grad Program Cognit Sci, Seoul 120749, South Korea.	scchong@yonsei.ac.kr		Chong, Sang Chul/0000-0002-1901-4715; Yoo, Sang-Ah/0000-0002-6797-2846	National Research Foundation of Korea - Korean Government (MEST) [20110025005]	National Research Foundation of Korea - Korean Government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of KoreaKorean Government)	This work was supported by a grant from the National Research Foundation of Korea funded by the Korean Government (MEST, No. 20110025005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Arend AM, 2012, NEUROPSYCHOLOGIA, V50, P2379, DOI 10.1016/j.neuropsychologia.2012.06.007; Bays PM, 2008, SCIENCE, V321, P851, DOI 10.1126/science.1158023; Berry AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011537; Chen DY, 2006, VIS COGN, V14, P37, DOI 10.1080/13506280544000282; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; Curby KM, 2009, J EXP PSYCHOL HUMAN, V35, P94, DOI 10.1037/0096-1523.35.1.94; GEGENFURTNER KR, 1993, J EXP PSYCHOL HUMAN, V19, P845, DOI 10.1037/0096-1523.19.4.845; Jost K, 2011, CEREB CORTEX, V21, P1147, DOI 10.1093/cercor/bhq185; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Lee EY, 2010, BRAIN, V133, P2677, DOI 10.1093/brain/awq197; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Luck SJ, 1997, NATURE, V390, P279, DOI 10.1038/36846; Moore CD, 2006, J NEUROSCI, V26, P11187, DOI 10.1523/JNEUROSCI.1873-06.2006; Morrison AB, 2011, PSYCHON B REV, V18, P46, DOI 10.3758/s13423-010-0034-0; Olesen PJ, 2004, NAT NEUROSCI, V7, P75, DOI 10.1038/nn1165; Olson IR, 2005, J EXP PSYCHOL HUMAN, V31, P889, DOI 10.1037/0096-1523.31.5.889; Olson IR, 2004, MEM COGNITION, V32, P1326, DOI 10.3758/BF03206323; PASHLER H, 1988, PERCEPT PSYCHOPHYS, V44, P369, DOI 10.3758/BF03210419; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Rouder JN, 2011, PSYCHON B REV, V18, P682, DOI 10.3758/s13423-011-0088-7; Sorensen TA, 2012, ACTA PSYCHOL, V140, P158, DOI 10.1016/j.actpsy.2012.04.004; Stout DM, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00058; Vogel EK, 2006, J EXP PSYCHOL HUMAN, V32, P1436, DOI 10.1037/0096-1523.32.6.1436; Vogel EK, 2005, NATURE, V438, P500, DOI 10.1038/nature04171; Vogel EK, 2004, NATURE, V428, P748, DOI 10.1038/nature02447; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860; Zimmer HD, 2012, BRAIN RES, V1466, P44, DOI 10.1016/j.brainres.2012.05.019	29	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121702	10.1371/journal.pone.0121702	http://dx.doi.org/10.1371/journal.pone.0121702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25836651	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000057
J	Werncke, T; Ringe, KI; von Falck, C; Kruschewski, M; Wacker, F; Meyer, BC				Werncke, Thomas; Ringe, Kristina Imeen; von Falck, Christian; Kruschewski, Martin; Wacker, Frank; Meyer, Bernhard Christian			Diagnostic Confidence of Run-Off CT-Angiography as the Primary Diagnostic Imaging Modality in Patients Presenting with Acute or Chronic Peripheral Arterial Disease	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; CRITICAL LIMB ISCHEMIA; OCCLUSIVE DISEASE; MDCT ANGIOGRAPHY; PERFORMANCE; ACCURACY; TRIAL; AORTA	Objectives To investigate the reliability of CT-angiography of the lower extremities (run-off CTA) to derive a treatment decision in patients with acute and chronic peripheral artery disease (PAD). Materials and Methods 314 patients referred for run-off CTA were includ-ed in this retrospective study. First, diagnostic confidence of run-off CTA to derive a treat-ment decision was assessed in an interdisciplinary vascular conference using a 2 point scale (sufficient or not sufficient diagnostic confidence) and compared with the image quality eval-uated by two readers in consensus in four different levels (abdominopelvic, thigh, calf, foot arteries). Second, reliability of treatment decision was verified in all patients undergoing re-vascularization therapy. Results Diagnostic confidence of run-off CTA to derive a treatment deci-sion was sufficient in all patients with acute and in 97% of patients (215/221) with chronic PAD, whereas the rate of run-off CTA with non-diagnostic image quality was considerably higher in the calf and foot level (acute vs. chronic; calf: 28% vs. 17%; foot: 52% vs. 20%). Reliability of treatment decision was superior for patients with chronic (123/133 = 92%) than for patients with acute PAD (64/78 = 82%, P = 0.02). Conclusion Run-off CTA is a reliable imaging modality for primary diag-nostic work-up of patients with acute and chronic PAD.	[Werncke, Thomas; Kruschewski, Martin; Meyer, Bernhard Christian] Charite, Radiol Klin, D-13353 Berlin, Germany; [Ringe, Kristina Imeen; von Falck, Christian; Wacker, Frank] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School	Werncke, T (corresponding author), Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany.	Werncke.Thomas@mh-hannover.de	Meyer, Bernhard/AAH-3329-2019; Werncke, Thomas/AFV-2471-2022; von Falck, Christian/AAO-2108-2020	Meyer, Bernhard/0000-0001-6486-7955; 	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) [02NUK008D]; German Research Foundation project "Open Access Publication"	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Research Foundation project "Open Access Publication"	This study was in part supported by the German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) through the grant 02NUK008D (http://www.helmholtzmuenchen.de/iss/forschung/arbeitsgruppen/experimentelle-radiooekologie/projekte/kompetenzverbund-strahlenforschung-kvsf/index.html). The publication of this study is supported by the German Research Foundation project "Open Access Publication." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There were no further current funding sources for this study.	Adriaensen MEAPM, 2004, RADIOLOGY, V233, P385, DOI 10.1148/radiol.2331031595; Albrecht T, 2007, AM J ROENTGENOL, V189, P702, DOI 10.2214/AJR.07.2333; Biswas D, 2009, J BONE JOINT SURG AM, V91A, P1882, DOI 10.2106/JBJS.H.01199; Bradbury AW, 2010, J VASC SURG, V51, p18S, DOI 10.1016/j.jvs.2010.01.074; Callum K, 2000, BRIT MED J, V320, P764, DOI 10.1136/bmj.320.7237.764; Duan YH, 2013, AM J ROENTGENOL, V201, pW906, DOI 10.2214/AJR.12.10209; European Society of Urogenital Radiology, 2014, ESUR GUID CONTR MED; Fotiadis N, 2011, CLIN RADIOL, V66, P945, DOI 10.1016/j.crad.2011.04.015; Fujihara M, 2015, CATHETER CARDIO INTE, V85, P870, DOI 10.1002/ccd.25722; Iezzi R, 2012, RADIOLOGY, V263, P287, DOI 10.1148/radiol.11110700; Jens S, 2013, EUR RADIOL, V23, P3104, DOI 10.1007/s00330-013-2933-8; Laswed T, 2008, EUR RADIOL, V18, P263, DOI 10.1007/s00330-007-0749-0; Menke J, 2010, ANN INTERN MED, V153, P325, DOI 10.7326/0003-4819-153-5-201009070-00007; Met R, 2009, JAMA-J AM MED ASSOC, V301, P415, DOI 10.1001/jama.301.4.415; Meyer BC, 2008, EUR RADIOL, V18, P1546, DOI 10.1007/s00330-008-0914-0; Meyer BC, 2010, EUR RADIOL, V20, P497, DOI 10.1007/s00330-009-1555-7; Napoli A, 2011, RADIOLOGY, V261, P976, DOI 10.1148/radiol.11103564; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Ouwendijk R, 2008, AM J ROENTGENOL, V190, P1349, DOI 10.2214/AJR.07.3359; Pollak AW, 2012, CIRC-CARDIOVASC IMAG, V5, P797, DOI 10.1161/CIRCIMAGING.111.970814; Qi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099112; Sandhu GS, 2012, AM J ROENTGENOL, V198, P686, DOI 10.2214/AJR.11.7065; Schernthaner R, 2008, EUR RADIOL, V18, P665, DOI 10.1007/s00330-007-0822-8; Schernthaner R, 2009, AM J ROENTGENOL, V192, P1416, DOI 10.2214/AJR.08.1078; Siriapisith T, 2010, J CARDIOVASC COMPUT, V4, P173, DOI 10.1016/j.jcct.2010.03.011; Sommer WH, 2010, EUR RADIOL, V20, P2876, DOI 10.1007/s00330-010-1861-0; Valentin Jack, 2007, Annals of the ICRP, V37, P3; Werncke T, 2013, EUR RADIOL, V23, P2482, DOI 10.1007/s00330-013-2865-3; Werncke T, 2012, INVEST RADIOL, V47, P530, DOI 10.1097/RLI.0b013e31825cc629	29	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119900	10.1371/journal.pone.0119900	http://dx.doi.org/10.1371/journal.pone.0119900			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835948	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000015
J	Tanaka, H; Goto, H; Inoko, A; Makihara, H; Enomoto, A; Horimoto, K; Matsuyama, M; Kurita, K; Izawa, I; Inagaki, M				Tanaka, Hiroki; Goto, Hidemasa; Inoko, Akihito; Makihara, Hiroyuki; Enomoto, Atsushi; Horimoto, Katsuhisa; Matsuyama, Makoto; Kurita, Kenichi; Izawa, Ichiro; Inagaki, Masaki			Cytokinetic Failure-induced Tetraploidy Develops into Aneuploidy, Triggering Skin Aging in Phosphovimentin-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; INTERMEDIATE-FILAMENT PROTEINS; ONCOGENE-INDUCED SENESCENCE; RHO-ASSOCIATED KINASE; VIMENTIN PHOSPHORYLATION; CELL-CYCLE; POLYPLOIDY; BUBR1; SEGREGATION; ROLES	Tetraploidy, a state in which cells have doubled chromosomal sets, is observed in similar to 20% of solid tumors and is considered to frequently precede aneuploidy in carcinogenesis. Tetraploidy is also detected during terminal differentiation and represents a hallmark of aging. Most tetraploid cultured cells are arrested by p53 stabilization. However, the fate of tetraploid cells in vivo remains largely unknown. Here, we analyze the ability to repair wounds in the skin of phosphovimentin-deficient (VIMSA/SA) mice. Early into wound healing, subcutaneous fibroblasts failed to undergo cytokinesis, resulting in binucleate tetraploidy. Accordingly, the mRNA level of p21 (a p53-responsive gene) was elevated in a VIMSA/SA-specific manner. Disappearance of tetraploidy coincided with an increase in aneuploidy. Thereafter, senescence-related markers were significantly elevated in VIMSA/SA mice. Because our tetraploidy-prone mouse model also exhibited subcutaneous fat loss at the age of 14 months, another premature aging phenotype, our data suggest that following cytokinetic failure, a subset of tetraploid cells enters a new cell cycle and develops into aneuploid cells in vivo, which promote premature aging.	[Tanaka, Hiroki; Goto, Hidemasa; Inoko, Akihito; Makihara, Hiroyuki; Matsuyama, Makoto; Izawa, Ichiro; Inagaki, Masaki] Aichi Canc Ctr, Res Inst, Div Biochem, Nagoya, Aichi 4648681, Japan; [Goto, Hidemasa; Inagaki, Masaki] Nagoya Univ, Grad Sch Med, Dept Cellular Oncol, Nagoya, Aichi 4668550, Japan; [Enomoto, Atsushi] Nagoya Univ, Grad Sch Med, Dept Pathol, Nagoya, Aichi 4668550, Japan; [Makihara, Hiroyuki; Kurita, Kenichi] Aichi Gakuin Univ, Sch Dent, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 4668550, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Mol Profiling Res Ctr Drug Discovery, Tokyo 1350064, Japan	Aichi Cancer Center; Nagoya University; Nagoya University; Aichi Gakuin University; National Institute of Advanced Industrial Science & Technology (AIST)	Inagaki, M (corresponding author), Aichi Canc Ctr, Res Inst, Div Biochem, Chikusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	minagaki@aichi-cc.jp	Enomoto, Atsushi/I-7272-2014; Inagaki, Masaki/B-9920-2016	Enomoto, Atsushi/0000-0002-9206-6116; Goto, Hidemasa/0000-0002-6796-4467; TANAKA, HIROKI/0000-0003-3469-6555; Matsuyama, Makoto/0000-0003-2606-059X; Inoko, Akihito/0000-0002-6739-2948	Japan Society for the Promotion of Science; Ministry of Education, Science, Technology, Sports and Culture of Japan; Takeda Science Foundation; Grants-in-Aid for Scientific Research [15K08324, 26670650] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Science, Technology, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and from the Ministry of Education, Science, Technology, Sports and Culture of Japan and by a research grant from the Takeda Science Foundation.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Baker DJ, 2008, NAT CELL BIOL, V10, P825, DOI 10.1038/ncb1744; Baker DJ, 2013, CELL REP, V3, P1164, DOI 10.1016/j.celrep.2013.03.028; Baker DJ, 2013, NAT CELL BIOL, V15, P96, DOI 10.1038/ncb2643; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Behrens A, 2014, NAT CELL BIOL, V16, P201, DOI 10.1038/ncb2928; Bornheim R, 2008, J CELL SCI, V121, P3737, DOI 10.1242/jcs.030312; CHOU YH, 1991, J BIOL CHEM, V266, P7325; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Coulombe PA, 2001, J CELL SCI, V114, P4345; Coulombe PA, 2003, J INVEST DERMATOL, V121, P219, DOI 10.1046/j.1523-1747.2003.12387.x; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Da Q, 2014, BLOOD, V123, P2715, DOI 10.1182/blood-2013-10-530428; Davoli T, 2012, CANCER CELL, V21, P765, DOI 10.1016/j.ccr.2012.03.044; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; dos Santos G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7574; Eckes B, 1998, J CELL SCI, V111, P1897; Eckes B, 2000, J CELL SCI, V113, P2455; Enomoto M, 2009, J BIOL CHEM, V284, P34223, DOI 10.1074/jbc.C109.051540; ERIKSSON J E, 1992, Current Opinion in Cell Biology, V4, P99, DOI 10.1016/0955-0674(92)90065-K; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Ganem NJ, 2014, CELL, V158, P833, DOI 10.1016/j.cell.2014.06.029; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Goto H, 2003, J BIOL CHEM, V278, P8526, DOI 10.1074/jbc.M210892200; Goto H, 2014, IUBMB LIFE, V66, P195, DOI 10.1002/iub.1260; Guidotti JE, 2003, J BIOL CHEM, V278, P19095, DOI 10.1074/jbc.M300982200; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanselmann RG, 2001, MED HYPOTHESES, V56, P58, DOI 10.1054/mehy.2000.1111; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Inagaki M, 1996, BIOESSAYS, V18, P481, DOI 10.1002/bies.950180610; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kasahara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2879; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita-Kikuta E, 2007, MOL CELL PROTEOMICS, V6, P356, DOI 10.1074/mcp.T600044-MCP200; Kroemer G, 2010, NAT REV MOL CELL BIO, V11, P539, DOI 10.1038/nrm2924; Kuffer C, 2013, CHROMOSOMA, V122, P305, DOI 10.1007/s00412-013-0414-0; KUSUBATA M, 1992, J BIOL CHEM, V267, P20937; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Li P, 2012, MOL BIOL CELL, V23, P1582, DOI 10.1091/mbc.E11-10-0883; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Matsuyama M, 2013, J BIOL CHEM, V288, P35626, DOI 10.1074/jbc.M113.514737; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Mor-Vaknin N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01045; Mosieniak G, 2010, CURR PHARM DESIGN, V16, P734, DOI 10.2174/138161210790883714; Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440; Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; O'Connell CB, 1999, J CELL BIOL, V144, P305, DOI 10.1083/jcb.144.2.305; PARRY D A D, 1992, Current Opinion in Cell Biology, V4, P94, DOI 10.1016/0955-0674(92)90064-J; Puschmann TB, 2013, GLIA, V61, P432, DOI 10.1002/glia.22446; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Ricke RM, 2013, J CELL BIOL, V201, P11, DOI 10.1083/jcb.201301061; Rogel MR, 2011, FASEB J, V25, P3873, DOI 10.1096/fj.10-170795; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Song SH, 2009, J CLIN INVEST, V119, P1837, DOI 10.1172/JCI38277; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; TSUJIMURA K, 1994, J BIOL CHEM, V269, P31097; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Yang D, 2007, AGING CELL, V6, P257, DOI 10.1111/j.1474-9726.2007.00274.x; Yasui Y, 1998, J CELL BIOL, V143, P1249, DOI 10.1083/jcb.143.5.1249; Yasui Y, 2001, ONCOGENE, V20, P2868, DOI 10.1038/sj.onc.1204407; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	73	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					12984	12998		10.1074/jbc.M114.633891	http://dx.doi.org/10.1074/jbc.M114.633891			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847236	hybrid, Green Published			2022-12-26	WOS:000354975700002
J	Merceron, R; Awama, AM; Montserret, R; Marcillat, O; Gouet, P				Merceron, Romain; Awama, Ayman M.; Montserret, Roland; Marcillat, Olivier; Gouet, Patrice			The Substrate-free and -bound Crystal Structures of the Duplicated Taurocyamine Kinase from the Human Parasite Schistosoma mansoni	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCLE CREATINE-KINASE; SMALL-ANGLE SCATTERING; STATE ANALOG COMPLEX; PROTEIN SECONDARY STRUCTURE; 2-DOMAIN ARGININE KINASE; X-RAY-SCATTERING; PHOSPHAGEN KINASE; GENE DUPLICATION; GUANIDINO KINASE; LIGAND-BINDING	The taurocyamine kinase from the blood fluke Schistosoma mansoni (SmTK) belongs to the phosphagen kinase (PK) family and catalyzes the reversible Mg2+-dependent transfer of a phosphoryl group between ATP and taurocyamine. SmTK is derived from gene duplication, as are all known trematode TKs. Our crystallographic study of SmTK reveals the first atomic structure of both a TK and a PK with a bilobal structure. The two unliganded lobes present a canonical open conformation and interact via their respective C-and N-terminal domains at a helix-mediated interface. This spatial arrangement differs from that observed in true dimeric PKs, in which both N-terminal domains make contact. Our structures of SmTK complexed with taurocyamine or L-arginine compounds explain the mechanism by which an arginine residue of the phosphagen specificity loop is crucial for substrate specificity. An SmTK crystal was soaked with the dead end transition state analog (TSA) components taurocyamine-NO32--MgADP. One SmTK monomer was observed with two bound TSAs and an asymmetric conformation, with the first lobe semiclosed and the second closed. However, isothermal titration calorimetry and enzyme kinetics experiments showed that the two lobes function independently. A small angle x-ray scattering model of SmTK-TSA in solution with two closed active sites was generated.	[Merceron, Romain; Montserret, Roland; Gouet, Patrice] Univ Lyon 1, CNRS, UMR 5086, Inst Biol & Chim Prot,BMSSI IBCP, F-69367 Lyon 07, France; [Awama, Ayman M.; Marcillat, Olivier] Univ Lyon 1, CNRS, UMR 5246, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Marcillat, O (corresponding author), Univ Lyon 1, CNRS, UMR 5246, Inst Chim & Biochim Mol & Supramol, F-69622 Villeurbanne, France.	olivier.marcillat@univ-lyon1.fr; p.gouet@ibcp.fr		gouet, patrice/0000-0001-9485-6157	European Community [283570]	European Community(European Commission)	The crystallization work in the study benefited from the IBCP/UMS 3444/US8 crystallogenesis facilities of SFR Biosciences. This work was supported by the European Community's Seventh Framework Program (FP7/2007-2013) under Grant Agreement 283570 (BioStruct-X).	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Awama AM, 2008, ACTA CRYSTALLOGR F, V64, P854, DOI 10.1107/S1744309108025979; Awama AM, 2007, ARCH BIOCHEM BIOPHYS, V458, P158, DOI 10.1016/j.abb.2006.09.001; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; Borders CL, 2002, BIOCHEMISTRY-US, V41, P6995, DOI 10.1021/bi020105+; Bush DJ, 2011, J BIOL CHEM, V286, P9338, DOI 10.1074/jbc.M110.202796; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clark SA, 2012, BIOCHEM BIOPH RES CO, V427, P212, DOI 10.1016/j.bbrc.2012.09.053; Compaan DM, 2003, J EXP BIOL, V206, P1545, DOI 10.1242/jeb.00299; Davulcu O, 2009, STRUCTURE, V17, P1356, DOI 10.1016/j.str.2009.08.014; DEGANI C, 1980, J BIOL CHEM, V255, P8221; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Forstner M, 1996, J MOL STRUCT, V383, P217, DOI 10.1016/S0022-2860(96)09289-7; Forstner M, 1999, FEBS LETT, V461, P111, DOI 10.1016/S0014-5793(99)01431-3; Forstner M, 1998, BIOPHYS J, V75, P1016, DOI 10.1016/S0006-3495(98)77590-3; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; Gaffney JP, 2012, BBA-GEN SUBJECTS, V1820, P212, DOI 10.1016/j.bbagen.2011.09.014; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hoffman GG, 2008, FEBS J, V275, P646, DOI 10.1111/j.1742-4658.2007.06226.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jarilla BR, 2010, KOREAN J PARASITOL, V48, P281, DOI 10.3347/kjp.2010.48.4.281; Jarilla BR, 2009, FEBS LETT, V583, P2218, DOI 10.1016/j.febslet.2009.05.049; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Londergan CH, 2015, BIOCHEMISTRY-US, V54, P83, DOI 10.1021/bi5008063; Lopez-Zavala AA, 2013, J BIOENERG BIOMEMBR, V45, P511, DOI 10.1007/s10863-013-9521-0; MARCILLAT O, 1987, BIOCHIM BIOPHYS ACTA, V890, P233, DOI 10.1016/0005-2728(87)90024-7; Mazon H, 2003, BIOCHEMISTRY-US, V42, P13596, DOI 10.1021/bi035208m; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; MORRISON JF, 1958, BIOCHEM J, V68, P447, DOI 10.1042/bj0680447; Mylonas E, 2007, J APPL CRYSTALLOGR, V40, pS245, DOI 10.1107/S002188980700252X; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; PRICE NC, 1976, BIOCHIM BIOPHYS ACTA, V445, P364, DOI 10.1016/0005-2744(76)90090-5; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; Rao JK, 1998, FEBS LETT, V439, P133; Riviere G, 2012, FEBS J, V279, P2863, DOI 10.1111/j.1742-4658.2012.08667.x; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; SHOEMAKER CB, 1994, MOL BIOCHEM PARASIT, V68, P319, DOI 10.1016/0166-6851(94)90177-5; STEIN LD, 1990, J BIOL CHEM, V265, P6582; Suzuki T, 1998, BBA-PROTEIN STRUCT M, V1388, P253, DOI 10.1016/S0167-4838(98)00167-8; Suzuki T, 1997, BBA-PROTEIN STRUCT M, V1343, P152, DOI 10.1016/S0167-4838(97)00128-3; Suzuki T, 2002, INT J BIOCHEM CELL B, V34, P1221, DOI 10.1016/S1357-2725(02)00050-X; Suzuki T, 2013, INT J BIOL MACROMOL, V57, P273, DOI 10.1016/j.ijbiomac.2013.02.023; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tisi D, 2001, ACTA CRYSTALLOGR D, V57, P187, DOI 10.1107/S0907444900015614; Tokuhiro S, 2014, MOL BIOCHEM PARASIT, V194, P56, DOI 10.1016/j.molbiopara.2014.04.010; Tokuhiro S, 2013, MOL BIOCHEM PARASIT, V188, P91, DOI 10.1016/j.molbiopara.2013.04.001; Uda K, 2008, COMP BIOCHEM PHYS B, V151, P176, DOI 10.1016/j.cbpb.2008.06.012; VIAL C, 1986, ARCH BIOCHEM BIOPHYS, V251, P558, DOI 10.1016/0003-9861(86)90364-4; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wu XA, 2010, FASEB J, V24, P242, DOI 10.1096/fj.09-140194; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Xiao JY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002548; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	73	8	8	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12951	12963		10.1074/jbc.M114.628909	http://dx.doi.org/10.1074/jbc.M114.628909			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837252	hybrid, Green Published			2022-12-26	WOS:000354569000044
J	Guo, KF; Lu, JX; Huang, Y; Wu, M; Zhang, L; Yu, HY; Zhang, ML; Bao, YQ; He, JC; Chen, HB; Jia, WP				Guo, Kaifeng; Lu, Junxi; Huang, Yan; Wu, Mian; Zhang, Lei; Yu, Haoyong; Zhang, Mingliang; Bao, Yuqian; He, John Cijiang; Chen, Haibing; Jia, Weiping			Protective Role of PGC-1 alpha in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling	PLOS ONE			English	Article							GAMMA COACTIVATOR 1-ALPHA; MESANGIAL CELLS; TRANSCRIPTIONAL COACTIVATOR; OXIDATIVE STRESS; POTENTIAL ROLE; FISSION; PROTEIN; PGC-1; DYSFUNCTION; KIDNEY	The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1 alpha in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1 alpha-overexpressing plasmid (pcDNA3-PGC-1 alpha) for 48 h. In the diabetic rats, decreased PGC-1 alpha expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1 alpha, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1 alpha. These data suggest that PGC-1 alpha may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN.	[Guo, Kaifeng; Lu, Junxi; Huang, Yan; Wu, Mian; Zhang, Lei; Yu, Haoyong; Zhang, Mingliang; Bao, Yuqian; Chen, Haibing; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab,Shanghai Key Lab Diabet M, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [He, John Cijiang] Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY 10029 USA; [He, John Cijiang] Icahn Sch Med Mt Sinai, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Shanghai Jiao Tong University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	He, JC (corresponding author), Icahn Sch Med Mt Sinai, Div Nephrol, Dept Med, New York, NY 10029 USA.	cijiang.he@mssm.edu; chenhb@sjtu.edu.cn; wpjia@sjtu.edu.cn			Major State Basic Research Development Program of China (973 program) [2012CB517700]; National Natural Science Foundation of China [81070649]; Plan for New hundred people of Shanghai Jiao Tong University; EFSD/CDS/Lilly Programme; Shanghai Pujiang Program [14PJD025]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan for New hundred people of Shanghai Jiao Tong University; EFSD/CDS/Lilly Programme; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by the Major State Basic Research Development Program of China (973 program) #2012CB517700, grants from the National Natural Science Foundation of China #81070649, the Plan for New hundred people of Shanghai Jiao Tong University, the EFSD/CDS/Lilly Programme for Collaborative Research between China and Europe, and the Shanghai Pujiang Program #14PJD025 (to H Chen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AYO SH, 1990, AM J PATHOL, V136, P1339; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Benani A, 2007, DIABETES, V56, P152, DOI 10.2337/db06-0440; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; De Vos KJ, 2005, CURR BIOL, V15, P678, DOI 10.1016/j.cub.2005.02.064; Ferrari LF, 2011, J NEUROSCI, V31, P11404, DOI 10.1523/JNEUROSCI.2223-11.2011; Ferree A, 2012, ADV EXP MED BIOL, V748, P13, DOI 10.1007/978-1-4614-3573-0_2; Floyd R A, 1986, Free Radic Res Commun, V1, P163, DOI 10.3109/10715768609083148; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Friederich M, 2008, BBA-BIOENERGETICS, V1777, P935, DOI 10.1016/j.bbabio.2008.03.030; Gemma C, 2009, OBESITY, V17, P1032, DOI 10.1038/oby.2008.605; Hwang I, 2012, DIABETES, V61, P728, DOI 10.2337/db11-0584; Jeninga EH, 2010, ONCOGENE, V29, P4617, DOI 10.1038/onc.2010.206; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kim MY, 2013, DIABETOLOGIA, V56, P204, DOI 10.1007/s00125-012-2747-2; Kiritoshi S, 2003, DIABETES, V52, P2570, DOI 10.2337/diabetes.52.10.2570; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V288, pC1440, DOI 10.1152/ajpcell.00607.2004; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nordquist L, 2007, CURR DIABETES REV, V3, P53, DOI 10.2174/157339907779802120; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Ribel-Madsen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051302; Rube DA, 2004, MOL CELL BIOCHEM, V256, P331, DOI 10.1023/B:MCBI.0000009879.01256.f6; Ruggiero C, 2011, AM J PHYSIOL-ENDOC M, V300, pE1047, DOI 10.1152/ajpendo.00666.2010; Sarin M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.201; Sawada N, 2014, CELL METAB, V19, P246, DOI 10.1016/j.cmet.2013.12.014; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Shenouda SM, 2011, CIRCULATION, V124, P444, DOI 10.1161/CIRCULATIONAHA.110.014506; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tanaka A, 2008, MOL CELL, V29, P409, DOI 10.1016/j.molcel.2008.02.005; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yano N, 2009, BIOCHEM J, V423, P129, DOI 10.1042/BJ20082277; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2008, CARDIOVASC RES, V79, P341, DOI 10.1093/cvr/cvn104; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Zhang PX, 2005, FEBS LETT, V579, P1446, DOI 10.1016/j.febslet.2005.01.046; Zheng Z, 2010, DIABETES, V59, P2315, DOI 10.2337/db10-0638; Zhu LY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004182	43	68	77	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0125176	10.1371/journal.pone.0125176	http://dx.doi.org/10.1371/journal.pone.0125176			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853493	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400150
J	Pefura-Yone, EW; Kengne, AP; Balkissou, AD; Boulleys-Nana, JR; Efe-De-Melingui, NR; Ndjeutcheu-Moualeu, PI; Mbele-Onana, CL; Kenmegne-Noumsi, EC; Kolontchang-Yomi, BL; Theubo-Kamgang, BJ; Ebouki, ER; Djuikam-Kamga, CK; Magne-Fotso, CG; Amougou, F; Mboumtou, L; Ngo-Yonga, M; Petchou-Talla, EL; Afane-Ze, E; Kuaban, C				Pefura-Yone, Eric Walter; Kengne, Andre Pascal; Balkissou, Adamou Dodo; Boulleys-Nana, Julie Raicha; Efe-de-Melingui, Nelly Rachel; Ndjeutcheu-Moualeu, Patricia Ingrid; Mbele-Onana, Charles Lebon; Kenmegne-Noumsi, Elvira Christelle; Kolontchang-Yomi, Barbara Linda; Theubo-Kamgang, Boris Judicael; Ebouki, Emilienne Regine; Djuikam-Kamga, Chrystelle Karen; Magne-Fotso, Christiane Gaelle; Amougou, Francine; Mboumtou, Liliane; Ngo-Yonga, Martine; Petchou-Talla, Elsie Linda; Afane-Ze, Emmanuel; Kuaban, Christopher		RGRDC	Prevalence of Asthma and Allergic Rhinitis among Adults in Yaounde, Cameroon	PLOS ONE			English	Article							QUALITY-OF-LIFE; RURAL AREA; POPULATION; DIAGNOSIS; SYMPTOMS; DISEASES; BURDEN; WHEEZE; IMPACT; URBAN	Background Population-based estimates of asthma and allergic rhinitis in sub-Saharan African adults are lacking. We assessed the prevalence and determinants of asthma and allergic rhinitis in urban adult Cameroonians. Methods A community-based survey was conducted from December 2013 to April 2014 among adults aged 19 years and above (N = 2,304, 57.3% women), selected through multilevel stratified random sampling across all districts of Yaounde (Capital city). Internationally validated questionnaires were used to investigate the presence of allergic diseases. Logistic regressions were employed to investigate the determinants of allergic conditions. Results Prevalence rates were 2.7% (95% CI: 2.1-3.4) for asthma-ever, 6.9% (5.9-7.9) for lifetime wheezing, 2.9% (92.2-3.6) for current wheezing and 11.4%(10.1-12.7) for self-reported lifetime allergic rhinitis; while 240 (10.4%) participants reported current symptoms of allergic rhinitis, and 125 (5.4%) had allergic rhino-conjunctivitis. The prevalence of current asthma medication use and self-reported asthma attack was 0.8 (0.4-1.2) and 1 (0.6-1.4) respectively. Multivariable adjusted determinants of current wheezing were signs of atopic eczema [2.91 (1.09-7.74)] and signs of allergic rhinitis [3.24 (1.83-5.71)]. Age group 31-40 years [0.27(0.09-0.78), p = 0.016] was an independent protective factor for wheezing. Determinants of current rhinitis symptoms were active smoking [2.20 (1.37-3.54), p<0.001], signs of atopic eczema [2.84 (1.48-5.46)] and current wheezing [3.02 (1.70-5.39)]. Conclusion Prevalence rates for asthma and allergic rhinitis among adults in this population were at the lower tails of those reported in other regions of the world. Beside the classical interrelation between allergic diseases found in this study, active smoking was an independent determinant of allergic rhinitis symptoms. Nationwide surveys are needed to investigate regional variations.	[Pefura-Yone, Eric Walter; Afane-Ze, Emmanuel; Kuaban, Christopher] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon; [Pefura-Yone, Eric Walter; Afane-Ze, Emmanuel] Yaounde Jamot Hosp, Serv Pneumol, Yaounde, Cameroon; [Kengne, Andre Pascal] South African Med Res Council, Cape Town, South Africa; [Kengne, Andre Pascal] Univ Cape Town, ZA-7925 Cape Town, South Africa; [Balkissou, Adamou Dodo] Biyemassi Dist Hosp, Yaounde, Cameroon; [Boulleys-Nana, Julie Raicha; Efe-de-Melingui, Nelly Rachel; Ndjeutcheu-Moualeu, Patricia Ingrid; Mbele-Onana, Charles Lebon; Kenmegne-Noumsi, Elvira Christelle; Kolontchang-Yomi, Barbara Linda; Theubo-Kamgang, Boris Judicael; Ebouki, Emilienne Regine; Djuikam-Kamga, Chrystelle Karen; Magne-Fotso, Christiane Gaelle; Amougou, Francine; Mboumtou, Liliane; Ngo-Yonga, Martine; Petchou-Talla, Elsie Linda] Inst Super Technol Med, Yaounde, Cameroon; [Kuaban, Christopher] Univ Bamenda, Fac Heath Sci, Bamenda, Cameroon	University of Yaounde I; South African Medical Research Council; University of Cape Town	Pefura-Yone, EW (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Subspecialties, Yaounde, Cameroon.	pefura2002@yahoo.fr	Kengne, Andre Pascal/ABB-3696-2020	Kengne, Andre Pascal/0000-0002-5183-131X				Adams G, 2004, J CLIN EPIDEMIOL, V57, P785, DOI 10.1016/j.jclinepi.2003.12.013; Adeloye D, 2013, CROAT MED J, V54, P519, DOI 10.3325/cmj.2013.54.519; Amberbir A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022551; Anandan C, 2010, ALLERGY, V65, P152, DOI 10.1111/j.1398-9995.2009.02244.x; Arif AA, 2003, EUR RESPIR J, V21, P827, DOI 10.1183/09031936.03.00054103a; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bauchau V, 2004, EUR RESPIR J, V24, P758, DOI 10.1183/09031936.04.00013904; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Braback L, 2005, EUR RESPIR J, V26, P1064, DOI 10.1183/09031936.05.00022105; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Bureau Central des Recensements et des Etudes de Population, 2010, RAPP PRES RES DEF; Bureau Central des Recensements et des Etudes de Population, 2010, POP CHIFFR; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Cameroon's National Institute of Statistics, POP CAM STAT STRUCT; Canova C, 2013, EUR RESPIR J, V42, P935, DOI 10.1183/09031936.00097412; Chinn S, 2004, THORAX, V59, P646, DOI 10.1136/thx.2004.021642; Custovic A, 1998, ALLERGY, V53, P115, DOI 10.1111/j.1398-9995.1998.tb05011.x; de Marco R, 2012, EUR RESPIR J, V39, P883, DOI 10.1183/09031936.00061611; Desalu O O, 2009, Afr J Med Med Sci, V38, P149; Desalu OO, 2009, J INVEST ALLERG CLIN, V19, P474; Ehrlich RI, 2005, THORAX, V60, P895, DOI 10.1136/thx.2004.030932; El Felkih L, 2014, REV FR ALLERGOL, V54, P107, DOI 10.1016/j.reval.2014.01.033; Erhabor GE, 2006, J ASTHMA, V43, P161, DOI 10.1080/02770900500499046; Janson C, 2001, EUR RESPIR J, V18, P598, DOI 10.1183/09031936.01.00205801; Leynaert B, 2000, AM J RESP CRIT CARE, V162, P1391, DOI 10.1164/ajrccm.162.4.9912033; Liu AH, 2007, PAEDIATR PERINAT EP, V21, P2, DOI 10.1111/j.1365-3016.2007.00878.x; Meltzer Eli O, 2012, Allergy Asthma Proc, V33 Suppl 1, pS113, DOI 10.2500/aap.2012.33.3603; Mugusi F, 2004, TROP DOCT, V34, P209, DOI 10.1177/004947550403400408; Musafiri S, 2011, RESP MED, V105, P1596, DOI 10.1016/j.rmed.2011.06.013; Nyembue TD, 2012, INT FORUM ALLERGY RH, V2, P285, DOI 10.1002/alr.21017; Organisation Mondiale de la Sante, 1986, JEUN SANT DEF SOC; Ozdoganoglu T, 2012, THER ADV RESPIR DIS, V6, P11, DOI 10.1177/1753465811431975; Pefura-Yone EW, 2015, J ASTHMA, V52, P571, DOI 10.3109/02770903.2014.995306; Pefura-Yone EW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004062; Piau JP, 2010, INT J TUBERC LUNG D, V14, P506; Rutkowski K, 2014, POSTEP DERM ALERGOL, V31, P77, DOI 10.5114/pdia.2014.40936; Saulyte J, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001611; Schoenwetter WF, 2004, CURR MED RES OPIN, V20, P305, DOI 10.1185/030079903125003053; Song WJ, 2014, ASIA PAC ALLERGY, V4, P3, DOI [10.5415/apallergy.2014.4.1.3, 10.5415/apallergy.2014.4.2.75]; Sonomjamts M, 2014, ASIA PAC ALLERGY, V4, P25, DOI 10.5415/apallergy.2014.4.1.25; Woodward M., 2005, CHAPMEN HALL CRC TEX, V849; World Health Organization, 1997, OB PREV MAN GLOB EP, DOI [10.2147/IJNRD.S78310, DOI 10.2147/IJNRD.S78310]; Zhang Y, 2014, ALLERGY ASTHMA IMMUN, V6, P105, DOI 10.4168/aair.2014.6.2.105; Zhu Hong, 2007, Beijing Da Xue Xue Bao Yi Xue Ban, V39, P494	45	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123099	10.1371/journal.pone.0123099	http://dx.doi.org/10.1371/journal.pone.0123099			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853516	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400096
J	Shim, J; Son, HJ; Kim, Y; Kim, KH; Kim, JT; Moon, H; Kim, MJ; Misaka, T; Rhyu, MR				Shim, Jaewon; Son, Hee Jin; Kim, Yiseul; Kim, Ki Hwa; Kim, Jung Tae; Moon, Hana; Kim, Min Jung; Misaka, Takumi; Rhyu, Mee-Ra			Modulation of Sweet Taste by Umami Compounds via Sweet Taste Receptor Subunit hT1R2	PLOS ONE			English	Article							TRANSMEMBRANE DOMAIN; BITTER; MECHANISM	Although the five basic taste qualities-sweet, sour, bitter, salty and umami-can be recognized by the respective gustatory system, interactions between these taste qualities are often experienced when food is consumed. Specifically, the umami taste has been investigated in terms of whether it enhances or reduces the other taste modalities. These studies, however, are based on individual perception and not on a molecular level. In this study we investigated umami-sweet taste interactions using umami compounds including monosodium glutamate (MSG), 5'-mononucleotides and glutamyl-dipeptides, glutamate-glutamate (Glu-Glu) and glutamate-aspartic acid (Glu-Asp), in human sweet taste receptor hT1R2/hT1R3-expressing cells. The sensitivity of sucrose to hT1R2/hT1R3 was significantly attenuated by MSG and umami active peptides but not by umami active nucleotides. Inhibition of sweet receptor activation by MSG and glutamyl peptides is obvious when sweet receptors are activated by sweeteners that target the extracellular domain (ECD) of T1R2, such as sucrose and acesulfame K, but not by cyclamate, which interact with the T1R3 transmembrane domain (TMD). Application of umami compounds with lactisole, inhibitory drugs that target T1R3, exerted a more severe inhibitory effect. The inhibition was also observed with F778A sweet receptor mutant, which have the defect in function of T1R3 TMD. These results suggest that umami peptides affect sweet taste receptors and this interaction prevents sweet receptor agonists from binding to the T1R2 ECD in an allosteric manner, not to the T1R3. This is the first report to define the interaction between umami and sweet taste receptors.	[Shim, Jaewon; Son, Hee Jin; Kim, Yiseul; Kim, Ki Hwa; Kim, Jung Tae; Moon, Hana; Kim, Min Jung; Rhyu, Mee-Ra] Korea Food Res Inst, Div Creat Food Sci Hlth, Songnam, Gyeonggi Do, South Korea; [Misaka, Takumi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan	Korea Food Research Institute (KFRI); University of Tokyo	Rhyu, MR (corresponding author), Korea Food Res Inst, Div Creat Food Sci Hlth, Songnam, Gyeonggi Do, South Korea.	mrrhyu@kfri.re.kr		Misaka, Takumi/0000-0002-9547-5767; Shim, Jaewon/0000-0003-4818-7057	Korea Food Research Institute [E0131201, E0143043494]	Korea Food Research Institute	This study was supported by Korea Food Research Institute (E0131201, E0143043494). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assadi-Porter FM, 2010, J MOL BIOL, V398, P584, DOI 10.1016/j.jmb.2010.03.017; Breslin PAS, 1996, TRENDS FOOD SCI TECH, V7, P390, DOI 10.1016/S0924-2244(96)10039-X; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chu B, 2014, CURR BIOL, V24, P1978, DOI 10.1016/j.cub.2014.07.020; Cui M, 2006, CURR PHARM DESIGN, V12, P4591, DOI 10.2174/138161206779010350; Cygankiewicz AI, 2014, CRIT REV FOOD SCI, V54, P771, DOI 10.1080/10408398.2011.606929; Fujiwara S, 2012, FOOD CHEM, V130, P561, DOI 10.1016/j.foodchem.2011.07.073; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Imada T, 2010, BIOCHEM BIOPH RES CO, V397, P220, DOI 10.1016/j.bbrc.2010.05.088; Jiang PH, 2005, J BIOL CHEM, V280, P34296, DOI 10.1074/jbc.M505255200; Keast SJR, 2003, FOOD QUAL PREFER, V14, P111, DOI 10.1016/S0950-3293(02)00110-6; KEMP SE, 1994, J FOOD SCI, V59, P682, DOI 10.1111/j.1365-2621.1994.tb05592.x; Kim MJ, 2015, BIOCHEM BIOPH RES CO, V456, P586, DOI 10.1016/j.bbrc.2014.11.114; Kniazeff J, 2011, PHARMACOL THERAPEUT, V130, P9, DOI 10.1016/j.pharmthera.2011.01.006; Li XD, 2009, AM J CLIN NUTR, V90, p733S, DOI 10.3945/ajcn.2009.27462G; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Liu B, 2011, J NEUROSCI, V31, P11070, DOI 10.1523/JNEUROSCI.0791-11.2011; Lyall V, 1999, AM J PHYSIOL-CELL PH, V277, pC800, DOI 10.1152/ajpcell.1999.277.4.C800; Masuda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035380; Nie Y, 2005, CURR BIOL, V15, P1948, DOI 10.1016/j.cub.2005.09.037; Pin JP, 2003, PHARMACOL THERAPEUT, V98, P325, DOI 10.1016/S0163-7258(03)00038-X; Sako N, 2003, CHEM SENSES, V28, P261, DOI 10.1093/chemse/28.3.261; Sakurai T, 2009, J AGR FOOD CHEM, V57, P2508, DOI 10.1021/jf8040148; Temussi PA, 2009, TRENDS BIOCHEM SCI, V34, P296, DOI 10.1016/j.tibs.2009.02.005; Tokita K, 2012, J NEUROPHYSIOL, V108, P2179, DOI 10.1152/jn.00465.2012; Winnig M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-22; Woskow M. H., 1969, FOOD TECHNOLOGY, V23, P32; Xu H, 2004, P NATL ACAD SCI USA, V101, P14258, DOI 10.1073/pnas.0404384101	28	17	20	5	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124030	10.1371/journal.pone.0124030	http://dx.doi.org/10.1371/journal.pone.0124030			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853419	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400131
J	Chekmarev, SF				Chekmarev, Sergei F.			Protein Folding as a Complex Reaction: A Two-Component Potential for the Driving Force of Folding and Its Variation with Folding Scenario	PLOS ONE			English	Article							BETA-SHEET MINIPROTEIN; FREE-ENERGY SURFACES; SYMMETRICAL PROTEIN; B-DOMAIN; PATHWAYS; STATE; STABILIZATION; OPTIMIZATION; PERSPECTIVE; LANDSCAPE	The Helmholtz decomposition of the vector field of probability fluxes in a two-dimensional space of collective variables makes it possible to introduce a potential for the driving force of protein folding [Chekmarev, J. Chem. Phys. 139 (2013) 145103]. The potential has two components: one component (Phi) is responsible for the source and sink of the folding flow, which represent, respectively, the unfolded and native state of the protein, and the other (psi) accounts for the flow vorticity inherently generated at the periphery of the flow field and provides the canalization of the flow between the source and sink. Both components obey Poisson's equations with the corresponding source/sink terms. In the present paper, we consider how the shape of the potential changes depending on the scenario of protein folding. To mimic protein folding dynamics projected onto a two-dimensional space of collective variables, the two-dimensional Muller and Brown potential is employed. Three characteristic scenarios are considered: a single pathway from the unfolded to the native state without intermediates, two parallel pathways without intermediates, and a single pathway with an off-pathway intermediate. To determine the probability fluxes, the hydrodynamic description of the folding reaction is used, in which the first-passage folding is viewed as a steady flow of the representative points of the protein from the unfolded to the native state. We show that despite the possible complexity of the folding process, the Phi-component is simple and universal in shape. The psi-component is more complex and reveals characteristic features of the process of folding. The present approach is potentially applicable to other complex reactions, for which the transition from the reactant to the product can be described in a space of two (collective) variables.	[Chekmarev, Sergei F.] Russian Acad Sci, Inst Thermophys, Novosibirsk 630090, Russia; [Chekmarev, Sergei F.] Novosibirsk State Univ, Dept Phys, Novosibirsk 630090, Russia	Russian Academy of Sciences; S.S. Kutateladze Institute of Thermophysics, Siberian Division of the Russian Academy of Sciences; Novosibirsk State University	Chekmarev, SF (corresponding author), Russian Acad Sci, Inst Thermophys, Novosibirsk 630090, Russia.	chekmarev@itp.nsc.ru	Chekmarev, Sergei F/N-4255-2017	Chekmarev, Sergei F/0000-0002-5603-8193	Russian Science Foundation [14-14-00325]	Russian Science Foundation(Russian Science Foundation (RSF))	This work was supported by the Russian Science Foundation, grant No. 14-14-00325; http://www.rscf.ru/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen NH, 2006, J AM CHEM SOC, V128, P6101, DOI 10.1021/ja054971w; BISWAS R, 1986, PHYS REV B, V34, P895, DOI 10.1103/PhysRevB.34.895; BOCZKO EM, 1995, SCIENCE, V269, P393, DOI 10.1126/science.7618103; Caflisch A, 2006, CURR OPIN STRUC BIOL, V16, P71, DOI 10.1016/j.sbi.2006.01.002; Chekmarev SF, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.018107; Chekmarev SF, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4824133; Chekmarev SF, 2005, J PHYS CHEM B, V109, P5312, DOI 10.1021/jp047012h; Dagan S, 2013, P NATL ACAD SCI USA, V110, P10628, DOI 10.1073/pnas.1302284110; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dill KA, 2012, SCIENCE, V338, P1042, DOI 10.1126/science.1219021; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; DORR FW, 1970, SIAM REV, V12, P248, DOI 10.1137/1012045; Eyink GL, 1996, J STAT PHYS, V83, P385, DOI 10.1007/BF02183738; Forst, 1973, THEORY UNIMOLECULAR; GRAHAM R, 1977, Z PHYS B CON MAT, V26, P397, DOI 10.1007/BF01570750; Itoh K, 2006, P NATL ACAD SCI USA, V103, P7298, DOI 10.1073/pnas.0510324103; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Jas GS, 2012, J PHYS CHEM B, V116, P6598, DOI 10.1021/jp211645s; Kalgin IV, 2014, J PHYS CHEM B, V118, P4287, DOI 10.1021/jp412729r; Kalgin IV, 2013, J PHYS CHEM B, V117, P6092, DOI 10.1021/jp401742y; Kalgin IV, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.011920; Kalgin IV, 2009, J PHYS CHEM B, V113, P12759, DOI 10.1021/jp903325z; Krivov SV, 2004, P NATL ACAD SCI USA, V101, P14766, DOI 10.1073/pnas.0406234101; Landau L.D., 1987, PHYS TODAY; Lange OF, 2008, PROTEINS, V70, P1294, DOI 10.1002/prot.21618; Leventhal C, 1969, MOSSBAUER SPECTROSCO, P22; Levy RM, 2013, PROTEIN SCI, V22, P1459, DOI 10.1002/pro.2335; McLeish TCB, 2005, BIOPHYS J, V88, P172, DOI 10.1529/biophysj.103.036616; MULLER K, 1979, THEOR CHIM ACTA, V53, P75, DOI 10.1007/BF00547608; MUNOZ V, 1994, BIOCHEMISTRY-US, V33, P5858, DOI 10.1021/bi00185a025; Olender R, 1996, J CHEM PHYS, V105, P9299, DOI 10.1063/1.472727; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Otzen DE, 1999, P NATL ACAD SCI USA, V96, P11746, DOI 10.1073/pnas.96.21.11746; Palyanov AY, 2007, J PHYS CHEM B, V111, P2675, DOI 10.1021/jp067027a; Rimratchada S, 2014, BIOPHYS J, V106, P1729, DOI 10.1016/j.bpj.2014.01.051; Sato S, 2007, J MOL BIOL, V372, P254, DOI 10.1016/j.jmb.2007.06.043; Shea JE, 2001, ANNU REV PHYS CHEM, V52, P499, DOI 10.1146/annurev.physchem.52.1.499; Sobolev SL., 1989, PARTIAL DIFFERENTIAL; Socci ND, 1998, PROTEINS, V32, P136, DOI 10.1002/(SICI)1097-0134(19980801)32:2<136::AID-PROT2>3.3.CO;2-5; TOMITA K, 1974, PROG THEOR PHYS, V51, P1731, DOI 10.1143/PTP.51.1731; VanKampen N. G., 1992, STOCHASTIC PROCESSES, V1; Wales D., 2003, ENERGY LANDSCAPES AP; Wang J, 1996, PHYS REV LETT, V76, P4861, DOI 10.1103/PhysRevLett.76.4861; Weber H. J., 2004, ESSENTIAL MATH METHO; WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783; Zheng WW, 2011, J PHYS CHEM B, V115, P13065, DOI 10.1021/jp2076935; 2010, ANNU REV PHYS CHEM, V61, P391, DOI DOI 10.1146/ANNUREV.PHYSCHEM.040808.090412	48	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121640	10.1371/journal.pone.0121640	http://dx.doi.org/10.1371/journal.pone.0121640			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848943	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800071
J	Ghosh, S; Lasko, P				Ghosh, Sanjay; Lasko, Paul			Loss-of-Function Analysis Reveals Distinct Requirements of the Translation Initiation Factors eIF4E, eIF4E-3, eIF4G and eIF4G2 in Drosophila Spermatogenesis	PLOS ONE			English	Article							MEIOTIC CELL-CYCLE; SPERMATID DIFFERENTIATION; DON-JUAN; MELANOGASTER SPERMATOGENESIS; POSTMEIOTIC TRANSCRIPTION; GENE-EXPRESSION; CDC25 HOMOLOG; GERM-CELLS; MECHANISMS; PROTEINS	In eukaryotes, post-transcriptional regulation of gene expression has a key role in many cellular and developmental processes. Spermatogenesis involves a complex developmental program that includes changes in cell cycle dynamics and dramatic cellular remodeling. Translational control is critical for spermatogenesis in Drosophila as many mRNAs synthesized in the spermatocytes are translated only much later during spermatid differentiation. Testes-specific translation initiation factors eIF4E-3 and eIF4G2 are essential specifically for male fertility. However, details of their roles during different stages of spermatogenesis are unknown, and the role of canonical translation initiation factors in spermatogenesis remains unexplored. In this study, we addressed the functional role of eIF4E-1, eIF4E-3, eIF4G and eIF4G2 in testes development and formation of mature sperm. Using the UAS-Gal4 system and RNA interference, we systematically knocked down these four genes in different stages of germ cell development, and in the somatic cells. Our results show that eIF4E-1 function in early germ cells and the surrounding somatic cells is critical for spermatogenesis. Both eIF4E-1 and eIF4E-3 are required in spermatocytes for chromosome condensation and cytokinesis during the meiotic stages. Interestingly, we find that eIF4G knockdown did not affect male fertility while eIF4G2 has distinct functions during spermatogenesis; it is required in early germ cells for proper meiotic divisions and spermatid elongation while its abrogation in spermatocytes caused meiotic arrest. Double knockdown of eIF4G and eIF4G2 shows that these proteins act redundantly during the early stages of spermatogenesis. Taken together, our analysis reveals spatio-temporal roles of the canonical and testes-specific translation initiation factors in coordinating developmental programs during spermatogenesis.	[Ghosh, Sanjay; Lasko, Paul] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Ghosh, S (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford, England.	sanjay.ghosh@mcgill.ca; paul.lasko@mcgill.ca	Lasko, Paul/C-6761-2014	Lasko, Paul/0000-0002-4037-3501; Ghosh, Sanjay/0000-0002-8833-9468	CIHR [IOP-107945]	CIHR(Canadian Institutes of Health Research (CIHR))	Funding was provided by CIHR grant IOP-107945 to PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Amiri A, 2001, DEVELOPMENT, V128, P3899; Baker CC, 2007, DEVELOPMENT, V134, P2863, DOI 10.1242/dev.003764; Barreau C, 2008, DEVELOPMENT, V135, P1897, DOI 10.1242/dev.021949; BRAND AH, 1993, DEVELOPMENT, V118, P401; CENCI G, 1994, J CELL SCI, V107, P3521; Eun SH, 2014, SCIENCE, V343, P1513, DOI 10.1126/science.1246514; Franklin-Dumont TM, 2007, DEVELOPMENT, V134, P2851, DOI 10.1242/dev.003517; FULLER MT, 1993, DEV DROSOPHILA MELAN, V1, P71; GONCZY P, 1994, CELL, V77, P1015, DOI 10.1016/0092-8674(94)90441-3; Gonczy P, 1997, DEVELOPMENT, V124, P4361; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Hempel LU, 2006, DEV DYNAM, V235, P1053, DOI 10.1002/dvdy.20698; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hernandez G, 2005, MECH DEVELOP, V122, P529, DOI 10.1016/j.mod.2004.11.011; Hernandez G, 2012, DEVELOPMENT, V139, P3211, DOI 10.1242/dev.073122; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Kibanov MV, 2013, ANAL BIOCHEM, V436, P55, DOI 10.1016/j.ab.2013.01.009; Kong J, 2012, NAT REV GENET, V13, P383, DOI 10.1038/nrg3184; Lachance PED, 2002, MOL CELL BIOL, V22, P1656, DOI 10.1128/MCB.22.6.1656-1663.2002; LANTZ V, 1992, DEVELOPMENT, V115, P75; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li MA, 2003, NAT CELL BIOL, V5, P994, DOI 10.1038/ncb1058; Lin TY, 1996, DEVELOPMENT, V122, P1331; LINDSLEY DL, 1980, GENETICS BIOL DROSOP, P00225, DOI DOI 10.1111/J.1601-5223.1952.TB02915.X; Ni JQ, 2011, NAT METHODS, V8, P405, DOI [10.1038/NMETH.1592, 10.1038/nmeth.1592]; OLIVIERI G, 1965, MUTAT RES, V2, P366, DOI 10.1016/0027-5107(65)90072-2; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Robalino J, 2004, J BIOL CHEM, V279, P10532, DOI 10.1074/jbc.M313688200; Santel A, 1997, MECH DEVELOP, V64, P19, DOI 10.1016/S0925-4773(97)00031-2; Santel A, 1998, J CELL SCI, V111, P3299; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SIGRIST S, 1995, MECH DEVELOP, V53, P247, DOI 10.1016/0925-4773(95)00441-3; Sitaram P, 2014, JOVE-J VIS EXP, DOI 10.3791/51058; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song AR, 2010, J CELL SCI, V123, P2228, DOI 10.1242/jcs.063107; STERN B, 1993, DEVELOPMENT, V117, P219; Tettweiler G, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/960420; Toledano H, 2012, NAT PROTOC, V7, P1808, DOI 10.1038/nprot.2012.105; Vibranovski MD, 2010, GENETICS, V186, P431, DOI 10.1534/genetics.110.118919; Vibranovski MD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000731; White-Cooper H, 1998, DEVELOPMENT, V125, P125; White-Cooper Helen, 2012, Spermatogenesis, V2, P11; White-Cooper H, 2010, REPRODUCTION, V139, P11, DOI 10.1530/REP-09-0083; WHITECOOPER H, 1993, J CELL SCI, V106, P1035; Xu SW, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003079	47	23	23	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122519	10.1371/journal.pone.0122519	http://dx.doi.org/10.1371/journal.pone.0122519			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849588	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800138
J	Lin, CY; Huang, FP; Ling, YS; Liang, HJ; Lee, SH; Hu, MY; Tsao, PN				Lin, Ching-Yu; Huang, Feng-Peng; Ling, Yee Soon; Liang, Hao-Jan; Lee, Sheng-Han; Hu, Mei-Yun; Tsao, Po-Nien			Use of Nuclear Magnetic Resonance-Based Metabolomics to Characterize the Biochemical Effects of Naphthalene on Various Organs of Tolerant Mice	PLOS ONE			English	Article							CLARA CELL CYTOTOXICITY; CYTOCHROME-P-450 ACTIVITY; GLUTATHIONE DEPLETION; RESPIRATORY-TRACT; EARLY EVENTS; TOXICITY; METABOLISM; NMR; LACTATE; EXPOSURES	Naphthalene, the most common polycyclic aromatic hydrocarbon, causes airway epithelium injury in mice. Repeated exposure of mice to naphthalene induces airway epithelia that are resistant to further injury. Previous studies revealed that alterations in bioactivation enzymes and increased levels of gamma-glutamylcysteine synthase in the bronchioles protect tolerant mice from naphthalene and its reactive metabolites. In our current study, tolerance was induced in male ICR mice using a total of 7 daily intraperitoneal injections of naphthalene (200 mg/kg). Both naphthalene-tolerant and non-tolerantmice were challenged with a dose of 300 mg/kg naphthalene on day 8 to investigate metabolite differences. The lungs, liver, and kidneys were collected for histopathology 24 h after the challenge dose. Bronchial alveolar lavage fluid (BALF) and both hydrophilic and hydrophobic extracts from each organ were analyzed using nuclear magnetic resonance (NMR)-based metabolomics. The histological results showed no observable injuries to the airway epithelium of naphthalene-tolerant mice when compared with the control. In contrast, airway injuries were observed in mice given a single challenge dose (injury mice). The metabolomics analysis revealed that the energy metabolism in the lungs of tolerant and injury mice was significantly perturbed. However, antioxidant metabolites, such as glutathione and succinate, were significantly increased in the lungs of tolerant mice, suggesting a role for these compounds in the protection of organs from naphthalene-induced electrophilic metabolites and free radicals. Damage to the airway cellular membrane, as shown by histopathological results and increased acetone in the BALF and perturbation of hydrophobic lung extracts, including cholesterol, phosphorylcholine-containing lipids, and fatty acyl chains, were observed in injury mice. Consistent with our histopathological results, fewer metabolic effects were observed in the liver and kidney of mice after naphthalene treatments. In conclusion, NMR-based metabolomics reveals possible mechanisms of naphthalene tolerance and naphthalene-induced toxicity in the respiratory system of mice.	[Lin, Ching-Yu; Huang, Feng-Peng; Ling, Yee Soon; Liang, Hao-Jan; Lee, Sheng-Han] Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 100, Taiwan; [Hu, Mei-Yun; Tsao, Po-Nien] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 100, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lin, CY (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Environm Hlth, Taipei 100, Taiwan.	chingyulin@ntu.edu.tw	Ling, Yee_Soon/H-6815-2016	Ling, Yee_Soon/0000-0002-1042-7820; LIN, CHING-YU/0000-0002-7144-0383; TSAO, PO-NIEN/0000-0002-6114-1769	Ministry of Science and Technology [MST 99-2314-B-002-127-MY3, MST 102-2628-B-002 -048 -MY3]; National Health Research Institutes [NHRI-EX100-9915EC, NHRI-EX101-9915EC]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan)	Funding was provided by the Ministry of Science and Technology (http://www.most.gov.tw/) (MST 99-2314-B-002-127-MY3 and MST 102-2628-B-002 -048 -MY3) and National Health Research Institutes (http://www.nhri.org.tw/) (NHRI-EX100-9915EC and NHRI-EX101-9915EC) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye EO, 1999, CANCER RES, V59, P80; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Bellomo R, 2002, CRIT CARE, V6, P322; BESSMAN SP, 1985, ANNU REV BIOCHEM, V54, P831, DOI 10.1146/annurev.bi.54.070185.004151; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOYD MR, 1981, TOXICOLOGY, V19, P85, DOI 10.1016/0300-483X(81)90091-3; Buckpitt A, 2002, DRUG METAB REV, V34, P791, DOI 10.1081/DMR-120015694; BUCKPITT A, 1995, MOL PHARMACOL, V47, P74; Chen WX, 2011, MAGN RESON MED, V66, P1531, DOI 10.1002/mrm.22957; CHO M, 1995, DRUG METAB REV, V27, P369, DOI 10.3109/03602539509029830; DEVEREUX TR, 1989, PHARMACOL THERAPEUT, V41, P243, DOI 10.1016/0163-7258(89)90109-5; Fonville JM, 2010, ANAL CHEM, V82, P1811, DOI 10.1021/ac902443k; Groussard C, 2000, J APPL PHYSIOL, V89, P169, DOI 10.1152/jappl.2000.89.1.169; Gudkov SV, 2006, RADIAT RES, V165, P538, DOI 10.1667/RR3552.1; Hong JH, 2014, J APPL TOXICOL, V34, P1379, DOI 10.1002/jat.2970; Hu JZ, 2008, TOXICOL MECH METHOD, V18, P385, DOI 10.1080/15376510701611032; Jia CR, 2010, INT J ENV RES PUB HE, V7, P2903, DOI 10.3390/ijerph7072903; Jurkowitz MS, 1998, J NEUROCHEM, V71, P535; Lakritz J, 1996, J PHARMACOL EXP THER, V278, P1408; Lankadurai BP, 2013, ENVIRON REV, V21, P180, DOI 10.1139/er-2013-0011; Lin CY, 2007, METABOLOMICS, V3, P55, DOI 10.1007/s11306-006-0043-1; Lin CY, 2006, PROTEOMICS, V6, P972, DOI 10.1002/pmic.200500170; Lin CY, 2005, CHEM RES TOXICOL, V18, P802, DOI 10.1021/tx049746r; Ling YS, 2014, MOL BIOSYST, V10, P1918, DOI 10.1039/c4mb00090k; Ludwig C, 2010, PHYTOCHEM ANALYSIS, V21, P22, DOI 10.1002/pca.1186; Messner KR, 2002, J BIOL CHEM, V277, P42563, DOI 10.1074/jbc.M204958200; Miekisch W, 2004, CLIN CHIM ACTA, V347, P25, DOI 10.1016/j.cccn.2004.04.023; Mitchell AE, 2000, ARCH TOXICOL, V74, P215, DOI 10.1007/s002040000120; NAKANISHI T, 1989, P NATL ACAD SCI USA, V86, P6002, DOI 10.1073/pnas.86.15.6002; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; OBRIEN KAF, 1989, TOXICOL APPL PHARM, V99, P487, DOI 10.1016/0041-008X(89)90156-7; Oostendorp M, 2006, CLIN CHEM, V52, P1395, DOI 10.1373/clinchem.2006.069112; Phimister AJ, 2004, TOXICOL SCI, V82, P268, DOI 10.1093/toxsci/kfh258; Phypers B, 2006, BJA EDUC, V6, P128, DOI 10.1093/bjaceaccp/mkl018; PLOPPER CG, 1987, EXP LUNG RES, V13, P59, DOI 10.3109/01902148709064309; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; PLOPPER CG, 1992, LAB INVEST, V67, P553; Plopper CG, 2001, AM J RESP CELL MOL, V24, P272, DOI 10.1165/ajrcmb.24.3.4247; Preuss R, 2003, INT ARCH OCC ENV HEA, V76, P556, DOI 10.1007/s00420-003-0458-1; Robinson MS, 2008, ANN OCCUP HYG, V52, P497, DOI 10.1093/annhyg/men027; Sehirli O, 2008, ECOTOX ENVIRON SAFE, V71, P301, DOI 10.1016/j.ecoenv.2007.08.023; Stohs SJ, 2002, TOXICOLOGY, V180, P97, DOI 10.1016/S0300-483X(02)00384-0; Van Winkle LS, 1999, AM J RESP CELL MOL, V21, P44, DOI 10.1165/ajrcmb.21.1.3630; Viant Mark R., 2008, V410, P137; Viant MR, 2003, BIOCHEM BIOPH RES CO, V310, P943, DOI 10.1016/j.bbrc.2003.09.092; West JAA, 2000, J PHARMACOL EXP THER, V294, P516; West JAA, 2001, TOXICOL APPL PHARM, V173, P114, DOI 10.1006/taap.2001.9151; West JAA, 2003, TOXICOL SCI, V75, P161, DOI 10.1093/toxsci/kfg156; West JAA, 2002, AM J PATHOL, V160, P1115, DOI 10.1016/S0002-9440(10)64932-2; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Zira A, 2013, TOXICOLOGY, V303, P115, DOI 10.1016/j.tox.2012.10.015	52	8	8	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120429	10.1371/journal.pone.0120429	http://dx.doi.org/10.1371/journal.pone.0120429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849086	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800024
J	Liong, S; Lappas, M				Liong, Stella; Lappas, Martha			Endoplasmic Reticulum Stress Is Increased in Adipose Tissue of Women with Gestational Diabetes	PLOS ONE			English	Article							UNFOLDED-PROTEIN RESPONSE; POLYCYSTIC-OVARY-SYNDROME; ER STRESS; INFLAMMASOME ACTIVATION; INSULIN-RESISTANCE; SKELETAL-MUSCLE; P2X(7) RECEPTOR; HUMAN PLACENTA; OBESITY; MELLITUS	Maternal obesity and gestational diabetes mellitus (GDM) are two increasingly common and important obstetric complications that are associated with severe long-term health risks to mothers and babies. IL-1 beta, which is increased in obese and GDM pregnancies, plays an important role in the pathophysiology of these two pregnancy complications. In non-pregnant tissues, endoplasmic (ER) stress is increased in diabetes and can induce IL-1 beta via inflammasome activation. The aim of this study was to determine whether ER stress is increased in omental adipose tissue of women with GDM, and if ER stress can also upregulate inflammasome-dependent secretion of IL-1 beta. ER stress markers IRE1 alpha, GRP78 and XBP-1s were significantly increased in adipose tissue of obese compared to lean pregnant women. ER stress was also increased in adipose tissue of women with GDM compared to BMI-matched normal glucose tolerant (NGT) women. Thapsigargin, an ER stress activator, induced upregulated secretion of mature IL-1 alpha and IL-1 beta in human omental adipose tissue explants primed with bacterial endotoxin LPS, the viral dsRNA analogue poly(I:C) or the pro-inflammatory cytokine TNF-alpha. Inhibition of capase-1 with Ac-YVAD-CHO resulted in decreased IL-1 alpha and IL-1 beta secretion, whereas inhibition of pannexin-1 with carbenoxolone suppressed IL-1 beta secretion only. Treatment with anti-diabetic drugs metformin and glibenclamide also reduced IL-1 alpha and IL-1 beta secretion in infection and cytokine-primed adipose tissue. In conclusion, this study has demonstrated ER stress to activate the inflammasome in pregnant adipose tissue. Therefore, increased ER stress may contribute towards the pathophysiology of obesity in pregnancy and GDM.	[Liong, Stella; Lappas, Martha] Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia; [Liong, Stella; Lappas, Martha] Mercy Hosp Women, Mercy Perinatal Res Ctr, Heidelberg, Vic, Australia	University of Melbourne	Lappas, M (corresponding author), Univ Melbourne, Dept Obstet & Gynaecol, Obstet Nutr & Endocrinol Grp, Heidelberg, Vic, Australia.	mlappas@unimelb.edu.au	Liong, Stella/AAQ-5308-2021	Liong, Stella/0000-0001-6131-858X	Career Development Fellowship by the National Health and Medical Research Council (NHMRC) [1047025]; Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust (DART)	Career Development Fellowship by the National Health and Medical Research Council (NHMRC); Medical Research Foundation for Women and Babies; Diabetes Australia Research Trust (DART)	Associate Professor Martha Lappas is supported by a Career Development Fellowship by the National Health and Medical Research Council (NHMRC; grant no. 1047025). This work was funded by grants from the Medical Research Foundation for Women and Babies and Diabetes Australia Research Trust (DART). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Khalifah R, 2012, J CLIN NEONATOL, V1, P29, DOI 10.4103/2249-4847.92241; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; Basu S, 2011, OBESITY, V19, P476, DOI 10.1038/oby.2010.215; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BOYD AE, 1988, DIABETES, V37, P847, DOI 10.2337/diabetes.37.7.847; Buchanan TA, 2005, J CLIN INVEST, V115, P485, DOI 10.1172/JCI200524531; Choi AMK, 2011, NAT IMMUNOL, V12, P379, DOI 10.1038/ni.2028; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Dhurandhar NV, 1997, OBES RES, V5, P464, DOI 10.1002/j.1550-8528.1997.tb00672.x; ELLIOTT BD, 1991, AM J OBSTET GYNECOL, V165, P807, DOI 10.1016/0002-9378(91)90421-M; Fang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072344; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Giannarelli R, 2003, DIABETES METAB, V29, pS28; Hata N, 2008, CLIN OPHTHALMOL, V2, P743; He JY, 2006, MOL ENDOCRINOL, V20, P114, DOI 10.1210/me.2005-0107; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kewcharoenwong C, 2013, SCI REP-UK, V3, DOI 10.1038/srep03363; Kim S, 2013, INNATE IMMUNITY; Kim S, 2013, INNATE IMMUN; Lain KY, 2007, CLIN OBSTET GYNECOL, V50, P938, DOI 10.1097/GRF.0b013e31815a5494; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lappas M, 2005, J ENDOCRINOL, V186, P457, DOI 10.1677/joe.1.06227; Lappas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115854; Lappas M, 2014, J ENDOCRINOL, V222, P99, DOI 10.1530/JOE-14-0179; Lappas M, 2014, METABOLISM, V63, P860, DOI 10.1016/j.metabol.2014.03.007; Lappas M, 2014, MOL CELL ENDOCRINOL, V382, P74, DOI 10.1016/j.mce.2013.09.011; Lautatzis ME, 2013, METABOLISM, V62, P1522, DOI 10.1016/j.metabol.2013.06.006; Lee HM, 2013, DIABETES, V62, P194, DOI 10.2337/db12-0420; MAIER JAM, 1990, SCIENCE, V249, P1570, DOI 10.1126/science.2218499; Mitanchez D, 2010, DIABETES METAB, V36, P617, DOI 10.1016/j.diabet.2010.11.013; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Osborn O, 2008, SWISS MED WKLY, V138, P665, DOI /aop/smw-aop12276; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pelegrin P, 2008, DRUG NEWS PERSPECT, V21, P424, DOI 10.1358/dnp.2008.21.8.1265800; Perkins JM, 2007, CLIN DIABETES, V25, P57; Rosa JS, 2008, PEDIATR DIABETES, V9, P9, DOI 10.1111/j.1399-5448.2007.00243.x; Rosenn B, 2008, J MATERN-FETAL NEO M, V21, P159, DOI 10.1080/14767050801929455; Rowan JA, 2011, DIABETES CARE, V34, P2279, DOI 10.2337/dc11-0660; Sage AT, 2012, OBESITY, V20, P748, DOI 10.1038/oby.2011.144; Shen XH, 2004, J CHEM NEUROANAT, V28, P79, DOI 10.1016/j.jchemneu.2004.02.006; SOBEL DO, 1992, DIABETES, V41, P515, DOI 10.2337/diabetes.41.4.515; Tertti K, 2014, ACTA DIABETOL; Um JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029524; Vanky E, 2005, FERTIL STERIL, V83, P1575, DOI 10.1016/j.fertnstert.2004.11.051; Vassiliadis S, 1999, MEDIAT INFLAMM, V8, P85, DOI 10.1080/09629359990577; Yazdi AS, 2013, ANN RHEUM DIS, V72, P96, DOI 10.1136/annrheumdis-2012-202252; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zeng YC, 2014, ADV MED SCI-POLAND, V59, P95, DOI 10.1016/j.advms.2014.03.001	52	37	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122633	10.1371/journal.pone.0122633	http://dx.doi.org/10.1371/journal.pone.0122633			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849717	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800151
J	Lyons, R; Stiller, J; Powell, J; Rusu, A; Manners, JM; Kazan, K				Lyons, Rebecca; Stiller, Jiri; Powell, Jonathan; Rusu, Anca; Manners, John M.; Kazan, Kemal			Fusarium oxysporum Triggers Tissue-Specific Transcriptional Reprogramming in Arabidopsis thaliana	PLOS ONE			English	Article							APOPLASTIC OXIDATIVE BURST; PLANT DEFENSE RESPONSES; MANNOSE-BINDING-LECTIN; DISEASE-RESISTANCE; SALICYLIC-ACID; ABSCISIC-ACID; GENE-EXPRESSION; FACTOR-2 ARF2; ROOT; AUXIN	Some of the most devastating agricultural diseases are caused by root-infecting pathogens, yet the majority of studies on these interactions to date have focused on the host responses of aerial tissues rather than those belowground. Fusarium oxysporum is a root-infecting pathogen that causes wilt disease on several plant species including Arabidopsis thaliana. To investigate and compare transcriptional changes triggered by F. oxysporum in different Arabidopsis tissues, we infected soil-grown plants with F. oxysporum and subjected root and leaf tissue harvested at early and late timepoints to RNA-seq analyses. At least half of the genes induced or repressed by F. oxysporum showed tissue-specific regulation. Regulators of auxin and ABA signalling, mannose binding lectins and peroxidases showed strong differential expression in root tissue. We demonstrate that ARF2 and PRX33, two genes regulated in the roots, promote susceptibility to F. oxysporum. In the leaves, defensins and genes associated with the response to auxin, cold and senescence were strongly regulated while jasmonate biosynthesis and signalling genes were induced throughout the plant.	[Lyons, Rebecca; Stiller, Jiri; Powell, Jonathan; Rusu, Anca; Kazan, Kemal] CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld, Australia; [Manners, John M.] CSIRO Agr Flagship, Black Mt Labs, Brisbane, Qld, Australia; [Kazan, Kemal] Univ Queensland, Queensland Alliance Agr & Food Innovat, Brisbane, Qld 4067, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Lyons, R (corresponding author), CSIRO Agr Flagship, Queensland Biosci Precinct, Brisbane, Qld, Australia.	rebeccalyons23@hotmail.com	Kazan, Kemal/B-8032-2008; Stiller, Jiri/E-1564-2012; Manners, John M/A-4922-2008	Kazan, Kemal/0000-0002-5169-8934; Powell, Jonathan/0000-0002-6222-8030	CSIRO OCE (Office of the Chief Executive)	CSIRO OCE (Office of the Chief Executive)	This work was partially funded by the CSIRO OCE (Office of the Chief Executive) postdoctoral fellowship to RL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adio AM, 2011, PLANT CELL, V23, P3303, DOI 10.1105/tpc.111.088989; Ali MA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-47; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Araujo JH, 2010, J AGR FOOD CHEM, V58, P4090, DOI 10.1021/jf903254b; Asai S, 2009, MOL PLANT MICROBE IN, V22, P619, DOI 10.1094/MPMI-22-6-0619; Balmer D, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00256; Balmer D, 2013, PLANT J, V74, P213, DOI 10.1111/tpj.12114; Barre A, 2001, BIOCHIMIE, V83, P645, DOI 10.1016/S0300-9084(01)01315-3; Baudry A, 2010, PLANT CELL, V22, P606, DOI 10.1105/tpc.109.072843; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen YC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05584; Chilley PM, 2006, PLANT CELL, V18, P3058, DOI 10.1105/tpc.106.040790; Cole SJ, 2014, MOL PLANT PATHOL, V15, P589, DOI 10.1111/mpp.12117; Cox KD, 2006, PLANTA, V224, P1373, DOI 10.1007/s00425-006-0322-0; Czymmek KJ, 2007, FUNGAL GENET BIOL, V44, P1011, DOI 10.1016/j.fgb.2007.01.012; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; De Coninck B, 2015, TRENDS PLANT SCI, V20, P91, DOI 10.1016/j.tplants.2014.09.007; Diener AC, 2005, GENETICS, V171, P305, DOI 10.1534/genetics.105.042218; Dong X, 2014, WORLD J MICROB BIOT, V30, P1399, DOI 10.1007/s11274-013-1564-1; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Edgar CI, 2006, AUSTRALAS PLANT PATH, V35, P581, DOI 10.1071/AP06060; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furutani M, 2011, DEVELOPMENT, V138, P2069, DOI 10.1242/dev.057745; Guidarelli M, 2014, MOL PLANT PATHOL, V15, P832, DOI 10.1111/mpp.12143; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hu YR, 2013, PLANT CELL, V25, P2907, DOI 10.1105/tpc.113.112631; Hwang IS, 2011, PLANT PHYSIOL, V155, P447, DOI 10.1104/pp.110.164848; Jin J, 2011, PLANT SIGNAL BEHAV, V6, P1778, DOI 10.4161/psb.6.11.17684; Jing HC, 2008, PLANT BIOLOGY, V10, P85, DOI 10.1111/j.1438-8677.2008.00087.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kazan K, 2009, TRENDS PLANT SCI, V14, P373, DOI 10.1016/j.tplants.2009.04.005; Kidd BN, 2011, MOL PLANT MICROBE IN, V24, P733, DOI 10.1094/MPMI-08-10-0194; Kiirika LM, 2012, PLANT PHYSIOL, V159, P501, DOI 10.1104/pp.112.193706; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Korves TM, 2003, PLANT PHYSIOL, V133, P339, DOI 10.1104/pp.103.027094; Lee SH, 2015, J INTEGR PLANT BIOL, V57, P562, DOI 10.1111/jipb.12276; Lev-Yadun S, 2009, LIFES COLORFUL SOLUT, P22; Lim CW, 2014, PLANT CELL PHYSIOL, V55, P1691, DOI 10.1093/pcp/pcu100; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu PP, 2010, MOL PLANT MICROBE IN, V23, P82, DOI 10.1094/MPMI-23-1-0082; LOHMAN KN, 1994, PHYSIOL PLANTARUM, V92, P322, DOI 10.1111/j.1399-3054.1994.tb05343.x; Lyons R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02866; Mammarella ND, 2015, PHYTOCHEMISTRY, V112, P110, DOI 10.1016/j.phytochem.2014.07.010; Manzano C, 2014, PLANT PHYSIOL, V165, P1105, DOI 10.1104/pp.114.238873; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Miyakawa T, 2014, PLANT PHYSIOL, V166, P766, DOI 10.1104/pp.114.242636; Morkunas I, 2014, ACTA PHYSIOL PLANT, V36, P1607, DOI 10.1007/s11738-014-1559-z; Mueller-Roeber B, 2014, J PLANT GROWTH REGUL, V33, P21, DOI 10.1007/s00344-013-9398-5; Nekrasov V, 2009, EMBO J, V28, P3428, DOI 10.1038/emboj.2009.262; O'Brien JA, 2012, PLANT PHYSIOL, V158, P2013, DOI 10.1104/pp.111.190140; Okushima Y, 2005, PLANT J, V43, P29, DOI 10.1111/j.1365-313X.2005.02426.x; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Pantelides IS, 2013, PLANT PATHOL, V62, P1302, DOI 10.1111/ppa.12042; Passardi F, 2006, PLANTA, V223, P965, DOI 10.1007/s00425-005-0153-4; Plancot B, 2013, PLANT PHYSIOL, V163, P1584, DOI 10.1104/pp.113.222356; Ranjan A, 2015, 3 BIOTECH, V5, P585, DOI 10.1007/s13205-014-0257-2; Reitz MU, 2012, PLANT PHYSIOL, V160, P349, DOI 10.1104/pp.112.201319; Robert-Seilaniantz A, 2011, PLANT J, V67, P218, DOI 10.1111/j.1365-313X.2011.04591.x; Rogg LE, 2001, PLANT CELL, V13, P465, DOI 10.1105/tpc.13.3.465; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; Seo E, 2009, PLANT CELL, V21, P3185, DOI 10.1105/tpc.108.063883; Seo S, 2012, PLANT CELL PHYSIOL, V53, P1432, DOI 10.1093/pcp/pcs085; Stotz HU, 2011, PLANT CELL PHYSIOL, V52, P1941, DOI 10.1093/pcp/pcr127; Sun XW, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1486; Tauzin AS, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00293; Thatcher LF, 2012, PLANT PHYSIOL, V160, P407, DOI 10.1104/pp.112.199067; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; Thatcher LF, 2009, PLANT J, V58, P927, DOI 10.1111/j.1365-313X.2009.03831.x; Tiwari SB, 2001, PLANT CELL, V13, P2809, DOI 10.1105/tpc.13.12.2809; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tytgat TO, 2013, MOL ECOL, V22, P6179, DOI [10.1111/mec.12555, DOI 10.1111/MEC.12555]; Vaten A, 2011, DEV CELL, V21, P1144, DOI 10.1016/j.devcel.2011.10.006; Wang HX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078484; Wang XC, 2001, PLANT J, V25, P651, DOI 10.1046/j.1365-313x.2001.00999.x; Wang Z, 2009, MOL PLANT, V2, P323, DOI 10.1093/mp/ssn078; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhu AH, 2012, GENE, V10, P259	89	58	63	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121902	10.1371/journal.pone.0121902	http://dx.doi.org/10.1371/journal.pone.0121902			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849296	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800085
J	Tadeu, AMB; Lin, S; Hou, L; Chung, LS; Zhong, M; Zhao, HY; Horsley, V				Tadeu, Ana Mafalda Baptista; Lin, Samantha; Hou, Lin; Chung, Lisa; Zhong, Mei; Zhao, Hongyu; Horsley, Valerie			Transcriptional Profiling of Ectoderm Specification to Keratinocyte Fate in Human Embryonic Stem Cells	PLOS ONE			English	Article							LARGE GENE LISTS; EPIDERMAL DIFFERENTIATION; TERMINAL DIFFERENTIATION; SKIN DEVELOPMENT; HOMEOBOX GENE; EPITHELIAL DIFFERENTIATION; EPIDERMOLYSIS-BULLOSA; FOLLICLE DEVELOPMENT; SIGNALING PATHWAYS; AP-2 FACTORS	In recent years, several studies have shed light into the processes that regulate epidermal specification and homeostasis. We previously showed that a broad-spectrum gamma-secretase inhibitor DAPT promoted early keratinocyte specification in human embryonic stem cells triggered to undergo ectoderm specification. Here, we show that DAPT accelerates human embryonic stem cell differentiation and induces expression of the ectoderm protein AP2. Furthermore, we utilize RNA sequencing to identify several candidate regulators of ectoderm specification including those involved in epithelial and epidermal development in human embryonic stem cells. Genes associated with transcriptional regulation and growth factor activity are significantly enriched upon DAPT treatment during specification of human embryonic stem cells to the ectoderm lineage. The human ectoderm cell signature identified in this study contains several genes expressed in ectodermal and epithelial tissues. Importantly, these genes are also associated with skin disorders and ectodermal defects, providing a platform for understanding the biology of human epidermal keratinocyte development under diseased and homeostatic conditions.	[Tadeu, Ana Mafalda Baptista; Lin, Samantha; Horsley, Valerie] Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06511 USA; [Hou, Lin; Chung, Lisa; Zhao, Hongyu] Yale Univ, Yale Sch Publ Hlth, Dept Biostat, New Haven, CT 06520 USA; [Zhong, Mei] Yale Univ, Yale Stem Cell Ctr, Genom Facil, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Horsley, V (corresponding author), Yale Univ, Dept Mol Cell & Dev Biol, New Haven, CT 06511 USA.	valerie.horsley@yale.edu			State of CT Stem Cell Fund [12-SCB-YALE-01]; NIH [AR060295]; Clinical and Translational Science Award from the National Center for Research Resources, National Institutes of Health [UL1 RR024139]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060295] Funding Source: NIH RePORTER	State of CT Stem Cell Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award from the National Center for Research Resources, National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded by the State of CT Stem Cell Fund (12-SCB-YALE-01) to V. H. A. T. was a Fundacao para a Ciencia e Tecnologia postdoctoral fellow. V. H. is a Pew Scholar in Biomedical Research and is funded by the NIH (AR060295). L.C. and L.H. were supported in part by the Clinical and Translational Science Award UL1 RR024139 from the National Center for Research Resources, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberdam D, 2007, CELL CYCLE, V6, P291, DOI 10.4161/cc.6.3.3800; Aberdam E, 2008, STEM CELLS, V26, P440, DOI 10.1634/stemcells.2007-0588; Ashery-Padan R, 2000, GENE DEV, V14, P2701, DOI 10.1101/gad.184000; Bilousova Ganna, 2013, Methods Mol Biol, V961, P337, DOI 10.1007/978-1-62703-227-8_22; Bilousova G, 2011, J INVEST DERMATOL, V131, P857, DOI 10.1038/jid.2010.364; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Cai JL, 2006, STEM CELLS, V24, P516, DOI 10.1634/stemcells.2005-0143; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coletta RD, 2008, CANCER RES, V68, P2204, DOI 10.1158/0008-5472.CAN-07-3141; DELLAMBRA E, 1995, J CELL SCI, V108, P3569; Di Costanzo A, 2009, CELL CYCLE, V8, P1185, DOI 10.4161/cc.8.8.8202; El-Hashash AHK, 2011, DEVELOPMENT, V138, P1395, DOI 10.1242/dev.058479; El-Hashash AHK, 2011, DEV BIOL, V350, P112, DOI 10.1016/j.ydbio.2010.11.022; FANG WJ, 1992, J BIOL CHEM, V267, P25889; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; Finch JL, 1999, INT J CANCER, V80, P533, DOI 10.1002/(SICI)1097-0215(19990209)80:4<533::AID-IJC9>3.0.CO;2-5; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Georgakopoulos A, 2006, EMBO J, V25, P1242, DOI 10.1038/sj.emboj.7601031; Gordon K, 2013, J INVEST DERMATOL, V133, P712, DOI 10.1038/jid.2012.391; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Guttormsen J, 2008, DEV BIOL, V317, P187, DOI 10.1016/j.ydbio.2008.02.017; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hwang J, 2008, DEVELOPMENT, V135, P3149, DOI 10.1242/dev.022202; Ingraham CR, 2006, NAT GENET, V38, P1335, DOI 10.1038/ng1903; Inoue E, 2009, J CELL BIOL, V185, P551, DOI 10.1083/jcb.200809151; Itoh M, 2011, P NATL ACAD SCI USA, V108, P8797, DOI 10.1073/pnas.1100332108; Janes SM, 2004, J CELL SCI, V117, P4157, DOI 10.1242/jcs.01302; Ji L, 2006, TISSUE ENG, V12, P665, DOI 10.1089/ten.2006.12.665; Kaplan N, 2012, INVEST OPHTH VIS SCI, V53, P936, DOI 10.1167/iovs.11-8685; Koch PJ, 2004, J INVEST DERMATOL, V123, pX, DOI 10.1111/j.0022-202X.2004.23495.x; Koster MI, 2007, ANNU REV CELL DEV BI, V23, P93, DOI 10.1146/annurev.cellbio.23.090506.123357; Koster MI, 2010, J INVEST DERMATOL, V130, P2352, DOI 10.1038/jid.2010.119; Koster MI, 2006, DEV BIOL, V289, P253, DOI 10.1016/j.ydbio.2005.10.041; Laugel-Haushalter Virginie, 2013, BMC Res Notes, V6, P113, DOI 10.1186/1756-0500-6-113; Laurikkala J, 2006, DEVELOPMENT, V133, P1553, DOI 10.1242/dev.02325; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; LEFFERS H, 1993, J MOL BIOL, V231, P982, DOI 10.1006/jmbi.1993.1346; Lin S, 2012, SEMIN CELL DEV BIOL, V23, P92, DOI 10.1016/j.semcdb.2011.10.017; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; Litterst C, 2007, J BIOL CHEM, V282, P16155, DOI 10.1074/jbc.M611449200; Luo T, 2002, DEV BIOL, V245, P136, DOI 10.1006/dbio.2002.0621; McDade SS, 2012, NUCLEIC ACIDS RES, V40, P7190, DOI 10.1093/nar/gks389; Medawar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003441; Metallo CM, 2008, STEM CELLS, V26, P372, DOI 10.1634/stemcells.2007-0501; Metallo CM, 2010, METHODS MOL BIOL, V585, P83, DOI 10.1007/978-1-60761-380-0_7; Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nagarajan P, 2008, CRIT REV EUKAR GENE, V18, P57; Nakagawa N, 2012, J DERMATOL SCI, V65, P196, DOI 10.1016/j.jdermsci.2011.12.011; Olsburgh J, 2003, J PATHOL, V199, P41, DOI 10.1002/path.1252; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Radoja N, 2007, DEVELOPMENT, V134, P13, DOI 10.1242/dev.02703; Richardson L, 2014, NUCLEIC ACIDS RES, V42, pD835, DOI 10.1093/nar/gkt1155; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; RIDDLE RD, 1995, CELL, V83, P631, DOI 10.1016/0092-8674(95)90103-5; Sander G, 2000, J INVEST DERMATOL, V115, P753, DOI 10.1046/j.1523-1747.2000.00122.x; Shalom-Feuerstein R, 2013, P NATL ACAD SCI USA, V110, P2152, DOI 10.1073/pnas.1201753109; Short K, 2007, IUBMB LIFE, V59, P427, DOI 10.1080/15216540701510581; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Tadeu AMB, 2013, DEVELOPMENT, V140, P3777, DOI 10.1242/dev.093948; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tolar J, 2013, J INVEST DERMATOL, V133, P562, DOI 10.1038/jid.2012.278; Tolar J, 2011, J INVEST DERMATOL, V131, P848, DOI 10.1038/jid.2010.346; Tomita T, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-2; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; TSENG H, 1992, P NATL ACAD SCI USA, V89, P10311, DOI 10.1073/pnas.89.21.10311; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Wang Z, 2012, CELL STEM CELL, V10, P440, DOI 10.1016/j.stem.2012.02.016; WATT FM, 1983, J INVEST DERMATOL, V81, pS100, DOI 10.1111/1523-1747.ep12540786; White BEP, 2014, CELL ADHES MIGR, V8, P327, DOI 10.4161/19336918.2014.970012; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	81	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122493	10.1371/journal.pone.0122493	http://dx.doi.org/10.1371/journal.pone.0122493			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849374	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800135
J	Tisa, F; Davoody, M; Raman, AAA; Daud, WMAW				Tisa, Farhana; Davoody, Meysam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan			Degradation and Mineralization of Phenol Compounds with Goethite Catalyst and Mineralization Prediction Using Artificial Intelligence	PLOS ONE			English	Article							NEURAL-NETWORKS; HYDROGEN-PEROXIDE; FENTON; OXIDATION; DECOLORIZATION; KINETICS; DECOMPOSITION; SIMULATION; MODEL; H2O2	The efficiency of phenol degradation via Fenton reaction using mixture of heterogeneous goethite catalyst with homogeneous ferrous ion was analyzed as a function of three independent variables, initial concentration of phenol (60 to 100 mg /L), weight ratio of initial concentration of phenol to that of H2O2 (1: 6 to 1: 14) and, weight ratio of initial concentration of goethite catalyst to that of H2O2 (1:0.3 to 1:0.7). More than 90 % of phenol removal and more than 40% of TOC removal were achieved within 60 minutes of reaction. Two separate models were developed using artificial neural networks to predict degradation percentage by a combination of Fe3+ and Fe2+ catalyst. Five operational parameters were employed as inputs while phenol degradation and TOC removal were considered as outputs of the developed models. Satisfactory agreement was observed between testing data and the predicted values (R-Phenol(2) = 0.9214 and (RTOC)-T-2 = 0.9082).	[Tisa, Farhana; Davoody, Meysam; Raman, Abdul Aziz Abdul; Daud, Wan Mohd Ashri Wan] Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Raman, AAA (corresponding author), Univ Malaya, Fac Engn, Dept Chem Engn, Kuala Lumpur 50603, Malaysia.	azizraman@um.edu.my	ABDUL RAMAN, ABDUL AZIZ/B-8094-2010; DAUD, WAN MOHD ASHRI WAN/C-1022-2010; Davoody, Meysam/N-6409-2015	ABDUL RAMAN, ABDUL AZIZ/0000-0001-7586-1903; Davoody, Meysam/0000-0002-2089-3331	Ministry of Higher Education of Malaysia and University of Malaya [HIR-MOHE-D000038-16001]	Ministry of Higher Education of Malaysia and University of Malaya	The authors thank the University of Malaya High Impact Research Grant (HIR-MOHE-D000038-16001) from the Ministry of Higher Education of Malaysia and University of Malaya for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleboyeh A, 2008, DYES PIGMENTS, V77, P288, DOI 10.1016/j.dyepig.2007.05.014; Babuponnusami A, 2011, CLEAN-SOIL AIR WATER, V39, P142, DOI 10.1002/clen.201000072; Bach A, 2010, DESALINATION, V264, P188, DOI 10.1016/j.desal.2010.04.011; Bayat M, 2012, J IND ENG CHEM, V18, P957, DOI 10.1016/j.jiec.2011.09.004; Chamjangali MA, 2007, J MOL GRAPH MODEL, V26, P360, DOI 10.1016/j.jmgm.2007.01.005; Chiang WYK, 2006, DECIS SUPPORT SYST, V41, P514, DOI 10.1016/j.dss.2004.08.016; Choi JS, 2006, CATAL TODAY, V111, P280, DOI 10.1016/j.cattod.2005.10.037; Chou SS, 2001, ENVIRON SCI TECHNOL, V35, P1247, DOI 10.1021/es001129b; Cinar S, 2004, ADV ENVIRON RES, V8, P477, DOI 10.1016/S1093-0191(02)00146-6; Daneshvar N, 2006, J HAZARD MATER, V137, P1788, DOI 10.1016/j.jhazmat.2006.05.042; Duran A, 2006, APPL CATAL B-ENVIRON, V65, P127, DOI 10.1016/j.apcatb.2006.01.004; Dutta S, 2010, J PETROL SCI ENG, V72, P93, DOI 10.1016/j.petrol.2010.03.007; Dutta S, 2010, EXPERT SYST APPL, V37, P8634, DOI 10.1016/j.eswa.2010.06.090; Elmolla ES, 2010, J HAZARD MATER, V179, P127, DOI 10.1016/j.jhazmat.2010.02.068; Garson G.D., 1991, AI EXPERT, V6, P46; Gevrey M, 2003, ECOL MODEL, V160, P249, DOI 10.1016/S0304-3800(02)00257-0; Gob S, 1999, CHEM ENG PROCESS, V38, P373, DOI 10.1016/S0255-2701(99)00028-8; Graupe D., 2007, PRINCIPLES ARTIFICIA; Guimaraes IR, 2008, APPL CATAL A-GEN, V347, P89, DOI 10.1016/j.apcata.2008.06.001; Hamed MM, 2004, ENVIRON MODELL SOFTW, V19, P919, DOI 10.1016/j.envsoft.2003.10.005; Hanbay D, 2008, EXPERT SYST APPL, V34, P1038, DOI 10.1016/j.eswa.2006.10.030; Hassan H, 2011, CHEM ENG J, V171, P912, DOI 10.1016/j.cej.2011.04.040; Huang CP, 2008, APPL CATAL A-GEN, V346, P140, DOI 10.1016/j.apcata.2008.05.017; Huang CP, 2009, APPL CATAL A-GEN, V357, P135, DOI 10.1016/j.apcata.2008.12.043; Hush DR, 1993, IEEE SIGNAL PROC MAG, V10, P8, DOI 10.1109/79.180705; Hussain MA, 2002, J FOOD ENG, V51, P239, DOI 10.1016/S0260-8774(01)00063-2; Jorjani E, 2008, FUEL, V87, P2727, DOI 10.1016/j.fuel.2008.01.029; Kasiri MB, 2008, ENVIRON SCI TECHNOL, V42, P7970, DOI 10.1021/es801372q; Kavitha V, 2004, CHEMOSPHERE, V55, P1235, DOI 10.1016/j.chemosphere.2003.12.022; Lek S, 1999, ECOL MODEL, V120, P65, DOI 10.1016/S0304-3800(99)00092-7; Lu MC, 2000, CHEMOSPHERE, V40, P125, DOI 10.1016/S0045-6535(99)00213-1; Maren AJ, 1990, HDB NEURAL COMPUTING, DOI [10.1016/c2013-0-11292-5, DOI 10.1016/C2013-0-11292-5]; Martinez F, 2007, IND ENG CHEM RES, V46, P4396, DOI 10.1021/ie070165h; Meng YB, 2008, ECOTOX ENVIRON SAFE, V71, P172, DOI 10.1016/j.ecoenv.2007.06.011; Monteagudo JM, 2010, CHEM ENG J, V162, P702, DOI 10.1016/j.cej.2010.06.029; de la Plata GBO, 2012, J PHOTOCH PHOTOBIO A, V233, P53, DOI 10.1016/j.jphotochem.2012.02.023; Pareek VK, 2003, CHEM ENG SCI, V58, P859, DOI 10.1016/S0009-2509(02)00617-6; Pontes RFF, 2010, J HAZARD MATER, V176, P402, DOI 10.1016/j.jhazmat.2009.11.044; Saien J, 2012, DESALIN WATER TREAT, V40, P174, DOI 10.5004/dwt.2012.2847; Salari D, 2005, J HAZARD MATER, V125, P205, DOI 10.1016/j.jhazmat.2005.05.030; Shojaeefard MH, 2013, ADV MATER SCI ENG, V2013, DOI 10.1155/2013/574914; Toma FL, 2004, J PHOTOCH PHOTOBIO A, V165, P91, DOI 10.1016/j.jphotochem.2004.03.004; Wen CH, 1998, ENG APPL ARTIF INTEL, V11, P685, DOI 10.1016/S0952-1976(98)00036-0; Wu JJ, 2006, CATAL COMMUN, V7, P901, DOI 10.1016/j.catcom.2006.03.015; Xu LJ, 2011, J HAZARD MATER, V186, P256, DOI 10.1016/j.jhazmat.2010.10.116; Zazo JA, 2005, ENVIRON SCI TECHNOL, V39, P9295, DOI 10.1021/es050452h; Zhang JB, 2008, CHEMOSPHERE, V73, P1524, DOI 10.1016/j.chemosphere.2008.05.050; ZINDER B, 1986, GEOCHIM COSMOCHIM AC, V50, P1861, DOI 10.1016/0016-7037(86)90244-9	48	1	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119933	10.1371/journal.pone.0119933	http://dx.doi.org/10.1371/journal.pone.0119933			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849556	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800017
J	Wasserman, JK; Nicholas, G; Yaworski, R; Wasserman, AM; Woulfe, JM; Jansen, GH; Chakraborty, S; Nguyen, TB				Wasserman, Jason K.; Nicholas, Garth; Yaworski, Rebecca; Wasserman, Anne-Marie; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.			Radiological and Pathological Features Associated with IDH1-R132H Mutation Status and Early Mortality in Newly Diagnosed Anaplastic Astrocytic Tumours	PLOS ONE			English	Article							IDH2 MUTATIONS; 2-HYDROXYGLUTARATE; SURVIVAL; GLIOBLASTOMA; TEMOZOLOMIDE; METHYLATION; GLIOMAS; CELL	Background Glioblastoma can occur either de novo or by the transformation of a low grade tumour; the majority of which harbor a mutation in isocitrate dehydrogenase (IDH1). Anaplastic tumours are high-grade gliomas that may represent the final step in the evolution of a secondary glioblastoma or the initial presentation of an early primary glioblastoma. We sought to determine whether pathological and/or radiological variables exist that can reliably distinguish IDH1-R132H-positive from IDH1-R132H-negative tumours and to identify variables associated with early mortality. Methods Patients diagnosed with anaplastic astrocytic tumours were included. Magnetic resonance imaging was performed and immunohistochemistry was used to identify tumours with the IDH1-R132H mutation. Survival was assessed 12 months after diagnosis. Variables associated with IDH1-R132H status were identified by univariate and ROC analysis. Results 37 gliomas were studied; 18 were positive for the IDH1-R132H mutation. No tumours demonstrated a combined loss of chromosomes 1p/19q. Patients with IDH1-R132H-positive tumours were less likely to die within 12 months of diagnosis (17% vs. 47%; p = 0.046), more likely to have tumours located in the frontal lobe (55% vs. 16%; p = 0.015), and have a higher minimum apparent diffusion coefficient (1.115 x 10(-3) mm(2)/sec vs. 0.838 x 10(-3) mm(2)/sec; p = 0.016), however, these variables demonstrated only moderate strength for predicting the IDH1-R132H mutation status (AUC = 0.735 and 0.711, respectively). The Ki-67 index was significantly lower in IDH1-R132H-positive tumours (0.13 vs. 0.21; p = 0.034). An increased risk of death was associated with contrast-enhancement >= 5 cm(3) in patients with IDH1-R132H-positive tumours while edema >= 1 cm beyond the tumour margin and <5 mitoses/mm(2) were associated with an increased risk of death in patients with IDH1-R132H-negative tumours. Conclusions IDH1-R132H-positive and -negative anaplastic tumours demonstrate unique features. Factors associated with early mortality are also dependent on IDH1-R132H status and can be used to identify patients at high risk for death.	[Wasserman, Jason K.; Yaworski, Rebecca; Woulfe, John M.; Jansen, Gerard H.; Nguyen, Thanh B.] Dept Anat Pathol, Div Lab Med, Ottawa, ON, Canada; [Nicholas, Garth; Wasserman, Anne-Marie] Ottawa Hosp, Ctr Canc, Ottawa, ON, Canada; [Chakraborty, Santanu] Dept Med Imaging, Div Neuroimaging, Ottawa, ON, Canada; [Wasserman, Jason K.; Nicholas, Garth; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.] Univ Ottawa, Ottawa, ON, Canada; [Wasserman, Jason K.; Nicholas, Garth; Woulfe, John M.; Jansen, Gerard H.; Chakraborty, Santanu; Nguyen, Thanh B.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Nguyen, TB (corresponding author), Dept Anat Pathol, Div Lab Med, Ottawa, ON, Canada.	thnguyen@toh.on.ca		Chakraborty, Santanu/0000-0002-2975-2260				Beiko J, 2014, NEURO-ONCOLOGY, V16, P81, DOI 10.1093/neuonc/not159; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Carrillo JA, 2012, AM J NEURORADIOL, V33, P1349, DOI 10.3174/ajnr.A2950; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Faguer R, 2014, NEURO CHIRURGIE; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hartmann C, 2009, ACTA NEUROPATHOL, V118, P469, DOI 10.1007/s00401-009-0561-9; Jiang HH, 2013, NEURO-ONCOLOGY, V15, P775, DOI 10.1093/neuonc/not027; Jiang HH, 2013, J NEURO-ONCOL, V111, P367, DOI 10.1007/s11060-012-1026-x; Kitis O, 2005, EUR J RADIOL, V55, P393, DOI 10.1016/j.ejrad.2005.02.004; Lai A, 2011, J CLIN ONCOL, V29, P4482, DOI 10.1200/JCO.2010.33.8715; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2014, BRAIN PATHOL, V24, P429, DOI 10.1111/bpa.12171; Metellus P, 2010, ACTA NEUROPATHOL, V120, P719, DOI 10.1007/s00401-010-0777-8; Minniti G, 2014, J NEURO-ONCOL, V118, P377, DOI 10.1007/s11060-014-1443-0; Murakami R, 2009, RADIOLOGY, V251, P838, DOI 10.1148/radiol.2513080899; Norden AD, 2008, LANCET NEUROL, V7, P1152, DOI 10.1016/S1474-4422(08)70260-6; Ohgaki H, 2013, CLIN CANCER RES, V19, P764, DOI 10.1158/1078-0432.CCR-12-3002; Ozawa T, 2014, CANCER CELL, V26, P288, DOI 10.1016/j.ccr.2014.06.005; Pope WB, 2012, J NEURO-ONCOL, V107, P197, DOI 10.1007/s11060-011-0737-8; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Shi JL, 2014, NEUROL SCI, V35, P839, DOI 10.1007/s10072-013-1607-2; Shibahara I, 2012, INT J CLIN ONCOL, V17, P551, DOI 10.1007/s10147-011-0323-2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; van den Bent MJ, 2013, J NEURO-ONCOL, V112, P173, DOI 10.1007/s11060-013-1056-z; Wang JB, 2014, ONCOL LETT, V7, P651, DOI 10.3892/ol.2014.1806; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wick W, 2009, J CLIN ONCOL, V27, P5874, DOI 10.1200/JCO.2009.23.6497; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	31	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123890	10.1371/journal.pone.0123890	http://dx.doi.org/10.1371/journal.pone.0123890			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849605	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800258
J	Xu, ZX; Wang, YY; Li, HZ				Xu, Zuxin; Wang, Yiyao; Li, Huaizheng			Stoichiometric Determination of Nitrate Fate in Agricultural Ecosystems during Rainfall Events	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; GROWTH EFFICIENCY; NITROGEN; STREAM; DENITRIFICATION; GROUNDWATER; TRANSFORMATION; REMOVAL	Ecologists have found a close relationship between the concentrations of nitrate (NO3-) and dissolved organic carbon (DOC) in ecosystems. However, it is difficult to determine the NO3- fate exactly because of the low coefficient in the constructed relationship. In the present paper, a negative power-function equation (r(2) = 0.87) was developed by using 411 NO3- data points and DOC: NO3- ratios from several agricultural ecosystems during different rainfall events. Our analysis of the stoichiometric method reveals several observations. First, the NO3- concentration demonstrated the largest changes when the DOC: NO3- ratio increased from 1 to 10. Second, the biodegradability of DOC was an important factor in controlling the NO3- concentration of agricultural ecosystems. Third, sediment was important not only as a denitrification site, but also as a major source of DOC for the overlying water. Fourth, a high DOC concentration was able to maintain a low NO3- concentration in the groundwater. In conclusion, this new stoichiometric method can be used for the accurate estimation and analysis of NO3- concentrations in ecosystems.	[Xu, Zuxin; Wang, Yiyao; Li, Huaizheng] Tongji Univ, Inst Water Environm Rehabil, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China	Tongji University	Wang, YY (corresponding author), Tongji Univ, Inst Water Environm Rehabil, Coll Environm Sci & Engn, Shanghai 200092, Peoples R China.	wyy1042@aliyun.com			Ministry of Science and Technology of the RRC [2012BAJ21B06-04]	Ministry of Science and Technology of the RRC	This study is part of the Twelfth Five-year Country Program founded by the Ministry of Science and Technology of the RRC (2012BAJ21B06-04). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitkenhead JA, 2000, GLOBAL BIOGEOCHEM CY, V14, P127, DOI 10.1029/1999GB900083; Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Arango CP, 2007, FRESHWATER BIOL, V52, P1210, DOI 10.1111/j.1365-2427.2007.01758.x; Battin TJ, 2000, LIMNOL OCEANOGR, V45, P1308, DOI 10.4319/lo.2000.45.6.1308; Burgin AJ, 2007, FRONT ECOL ENVIRON, V5, P89, DOI 10.1890/1540-9295(2007)5[89:HWOTRO]2.0.CO;2; Buss S.R., 2005, USING SCI CREATE BET; Donner SD, 2008, P NATL ACAD SCI USA, V105, P4513, DOI 10.1073/pnas.0708300105; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Fan AM, 1996, REGUL TOXICOL PHARM, V23, P35, DOI 10.1006/rtph.1996.0006; Findlay S, 1996, J N AM BENTHOL SOC, V15, P35, DOI 10.2307/1467431; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Goodale CL, 2005, ECOSYSTEMS, V8, P334, DOI 10.1007/s10021-003-0162-8; Hill AR, 2000, BIOGEOCHEMISTRY, V51, P193, DOI 10.1023/A:1006476514038; Howarth RW, 1996, BIOGEOCHEMISTRY, V35, P75, DOI 10.1007/BF02179825; Inwood SE, 2005, J N AM BENTHOL SOC, V24, P227, DOI 10.1899/04-032.1; Johnson LT, 2012, ECOSYSTEMS, V15, P1027, DOI 10.1007/s10021-012-9563-x; Konohira E, 2005, ECOL RES, V20, P359, DOI 10.1007/s11284-005-0051-z; Lapworth DJ, 2008, SCI TOTAL ENVIRON, V390, P241, DOI 10.1016/j.scitotenv.2007.09.043; Mason C F., 2002, BIOL FRESHWATER POLL; Mehler WT, 2010, CHEMOSPHERE, V78, P814, DOI 10.1016/j.chemosphere.2009.11.052; Mulholland PJ, 2008, NATURE, V452, P202, DOI 10.1038/nature06686; Pasten-Zapata E, 2014, SCI TOTAL ENVIRON, V470, P855, DOI 10.1016/j.scitotenv.2013.10.043; QUALLS RG, 1992, SOIL SCI SOC AM J, V56, P578, DOI 10.2136/sssaj1992.03615995005600020038x; Ram ASP, 2003, MICROBIAL ECOL, V45, P88, DOI 10.1007/s00248-002-3005-9; REDFIELD AC, 1958, AM SCI, V46, P205; SEPA, 2002, METH WAT AN; Smil V, 1999, GLOBAL BIOGEOCHEM CY, V13, P647, DOI 10.1029/1999GB900015; Sobczak WV, 2002, ECOLOGY, V83, P3194, DOI 10.1890/0012-9658(2002)083[3194:VIBODO]2.0.CO;2; Sobczak WV, 2003, BIOGEOCHEMISTRY, V62, P309, DOI 10.1023/A:1021192631423; Stadler S, 2012, WATER SA, V38, P213, DOI 10.4314/wsa.v38i2.6; Stelzer RS, 2011, BIOGEOCHEMISTRY, V103, P91, DOI 10.1007/s10533-010-9449-y; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Ward BB, 2013, SCIENCE, V341, P352, DOI 10.1126/science.1240314; Zarnetske JP, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001356	36	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122484	10.1371/journal.pone.0122484	http://dx.doi.org/10.1371/journal.pone.0122484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849210	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800133
J	Ziegler, A; Schock-Kusch, D; Bopp, D; Dounia, S; Radle, M; Stahl, U				Ziegler, Andreas; Schock-Kusch, Daniel; Bopp, Dominik; Dounia, Sandra; Raedle, Matthias; Stahl, Ulf			Single Bacteria Movement Tracking by Online Microscopy - A Proof of Concept Study	PLOS ONE			English	Article							MULTIPARAMETER FLOW-CYTOMETRY; ESCHERICHIA-COLI W3110; PHYSIOLOGICAL-STATE; BACILLUS-SUBTILIS; CELL-DENSITY; FED-BATCH; MOTILITY; FERMENTATIONS; SURFACE	In this technical report we demonstrate a low-cost online unit allowing movement tracking of flagellated bacteria on a single-cell level during fermentation processes. The system's ability to distinguish different metabolic states (viability) of bacteria by movement velocity was investigated. A flow-through cuvette with automatically adjustable layer thickness was developed. The cuvette can be used with most commercially available laboratory microscopes equipped with 40x amplification and a digital camera. In addition, an automated sample preparation unit and a software module was developed measuring size, moved distance, and speed of bacteria. In a proof of principle study the movement velocities of Bacillus amyloliquefaciens FZB42 during three batch fermentation processes were investigated. In this process the bacteria went through different metabolic states, vegetative growth, diauxic shift, vegetative growth after diauxic shift, and sporulation. It was shown that the movement velocities during the different metabolic states significantly differ from each other. Therefore, the described setup has the potential to be used as a bacteria viability monitoring tool. In contrast to some other techniques, such as electro-optical techniques, this method can even be used in turbid production media.	[Ziegler, Andreas; Schock-Kusch, Daniel; Bopp, Dominik; Raedle, Matthias] Mannheim Univ Appl Sci, Inst Proc Control & Innovat Energy Convers, Mannheim, Germany; [Dounia, Sandra; Stahl, Ulf] Berlin Univ Technol, Dept Appl & Mol Microbiol, Berlin, Germany; [Dounia, Sandra; Stahl, Ulf] Res & Teaching Inst Brewing Berlin, Res Inst Special Microbiol, Berlin, Germany	Technical University of Berlin	Ziegler, A (corresponding author), Mannheim Univ Appl Sci, Inst Proc Control & Innovat Energy Convers, Mannheim, Germany.	a.ziegler@hs-mannheim.de			Federal Ministry for Economic Affairs and Energy [HS-Mannheim: KF 2035730UL1, TU Berlin: KF 2503705UL1]	Federal Ministry for Economic Affairs and Energy	The study was funded by the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag (URL: http://www.aif.de/innovationsfoerderung/zim-kooperationen.html, Grant Numbers: HS-Mannheim: KF 2035730UL1 TU Berlin: KF 2503705UL1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Absi NR, 2003, CYTOM PART A, V51A, P87, DOI 10.1002/cyto.a.10016; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Broger T, 2011, J BIOTECHNOL, V154, P240, DOI 10.1016/j.jbiotec.2011.05.003; Brognaux A, 2013, J IND MICROBIOL BIOT, V40, P679, DOI 10.1007/s10295-013-1271-9; Davey HM, 2011, APPL ENVIRON MICROB, V77, P5571, DOI 10.1128/AEM.00744-11; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Grossart HP, 2001, AQUAT MICROB ECOL, V25, P247, DOI 10.3354/ame025247; Hammes F, 2012, CYTOM PART A, V81A, P508, DOI 10.1002/cyto.a.22048; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; Herwig H, 2008, STROMUNGSMECHANIK EI, P163; Hewitt CJ, 1999, BIOTECHNOL BIOENG, V63, P705, DOI 10.1002/(SICI)1097-0290(19990620)63:6<705::AID-BIT8>3.0.CO;2-M; Hewitt CJ, 1999, J BIOTECHNOL, V75, P251, DOI 10.1016/S0168-1656(99)00168-6; Hewitt CJ, 2001, CYTOMETRY, V44, P179, DOI 10.1002/1097-0320(20010701)44:3<179::AID-CYTO1110>3.0.CO;2-D; Hopfner T, 2010, BIOPROC BIOSYST ENG, V33, P247, DOI 10.1007/s00449-009-0319-8; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; J. R. POSTGATE, 1969, Methods in microbiology. Vol. 1, P611, DOI 10.1016/S0580-9517(08)70149-1; Junne S, 2008, BIOTECHNOL BIOENG, V99, P862, DOI 10.1002/bit.21639; Junne S, 2010, J IND MICROBIOL BIOT, V37, P935, DOI 10.1007/s10295-010-0742-5; Karim QN, 1998, J CLIN PATHOL, V51, P623, DOI 10.1136/jcp.51.8.623; Krebs B, 1998, Z PFLANZENK PFLANZEN, V105, P181; Kudo S, 2005, FEMS MICROBIOL LETT, V242, P221, DOI 10.1016/j.femsle.2004.11.007; Lourenco ND, 2012, ANAL BIOANAL CHEM, V404, P1211, DOI 10.1007/s00216-012-6073-9; MACNAB RM, 1977, J MOL BIOL, V112, P1, DOI 10.1016/S0022-2836(77)80153-8; Mendelson NH, 1999, J BACTERIOL, V181, P600, DOI 10.1128/JB.181.2.600-609.1999; Muller S, 2010, FEMS MICROBIOL REV, V404, P1618; Ping LY, 2012, SCI CHINA LIFE SCI, V55, P202, DOI 10.1007/s11427-012-4298-7; PRIEST FG, 1987, INT J SYST BACTERIOL, V37, P69, DOI 10.1099/00207713-37-1-69; Rudolph G, 2009, ADV BIOCHEM ENG BIOT, V116, P125, DOI 10.1007/10_2009_12; Sonnleitner B, 2013, ADV BIOCHEM ENG BIOT, V132, P1, DOI 10.1007/10_2012_173; STOCKER BAD, 1959, J GEN MICROBIOL, V20, P670, DOI 10.1099/00221287-20-3-670; Stoylov SP, 2009, BIOELECTROCHEMISTRY, V75, P50, DOI 10.1016/j.bioelechem.2009.02.001; Surek D, 2007, ANGEWANDTE STROMUNGS, P71; Vater SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087765; Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474, DOI 10.1128/AEM.63.9.3474-3479.1997	35	1	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122531	10.1371/journal.pone.0122531	http://dx.doi.org/10.1371/journal.pone.0122531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849813	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800140
J	Ventham, NT; Gardner, RA; Kennedy, NA; Shubhakar, A; Kalla, R; Nimmo, ER; Fernandes, DL; Satsangi, J; Spencer, DIR				Ventham, Nicholas T.; Gardner, Richard A.; Kennedy, Nicholas A.; Shubhakar, Archana; Kalla, Rahul; Nimmo, Elaine R.; Fernandes, Daryl L.; Satsangi, Jack; Spencer, Daniel I. R.		IBD-BIOM Consortium	Changes to Serum Sample Tube and Processing Methodology Does Not Cause Inter-Individual Variation in Automated Whole Serum N-Glycan Profiling in Health and Disease	PLOS ONE			English	Article							BLOOD COLLECTION TUBES; THERAPEUTIC DRUGS; GLYCOSYLATION; COMMON; PERFORMANCE; ABSORPTION; STABILITY; ARTHRITIS; GEL	Introduction Serum N-glycans have been identified as putative biomarkers for numerous diseases. The impact of different serum sample tubes and processing methods on N-glycan analysis has received relatively little attention. This study aimed to determine the effect of different sample tubes and processing methods on the whole serum N-glycan profile in both health and disease. A secondary objective was to describe a robot automated N-glycan release, labeling and cleanup process for use in a biomarker discovery system. Methods 25 patients with active and quiescent inflammatory bowel disease and controls had three different serum sample tubes taken at the same draw. Two different processing methods were used for three types of tube ( with and without gel-separation medium). Samples were randomised and processed in a blinded fashion. Whole serum N-glycan release, 2-aminobenzamide labeling and cleanup was automated using a Hamilton Microlab STARlet Liquid Handling robot. Samples were analysed using a hydrophilic interaction liquid chromatography/ethylene bridged hybrid(BEH) column on an ultra-high performance liquid chromatography instrument. Data were analysed quantitatively by pairwise correlation and hierarchical clustering using the area under each chromatogram peak. Qualitatively, a blinded assessor attempted to match chromatograms to each individual. Results There was small intra-individual variation in serum N-glycan profiles from samples collected using different sample processing methods. Intra-individual correlation coefficients were between 0.99 and 1. Unsupervised hierarchical clustering and principal coordinate analyses accurately matched samples from the same individual. Qualitative analysis demonstrated good chromatogram overlay and a blinded assessor was able to accurately match individuals based on chromatogram profile, regardless of disease status. Conclusions The three different serum sample tubes processed using the described methods cause minimal inter-individual variation in serum whole N-glycan profile when processed using an automated workstream. This has important implications for N-glycan biomarker discovery studies using different serum processing standard operating procedures.	[Ventham, Nicholas T.; Kennedy, Nicholas A.; Kalla, Rahul; Nimmo, Elaine R.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Ctr Genet & Mol Med, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Gardner, Richard A.; Shubhakar, Archana; Fernandes, Daryl L.; Spencer, Daniel I. R.] Ludger Ltd, Culham Sci Ctr, Oxford OX14 3EB, Oxon, England	University of Edinburgh; Culham Science Centre; UK Atomic Energy Authority	Spencer, DIR (corresponding author), Ludger Ltd, Culham Sci Ctr, Oxford OX14 3EB, Oxon, England.	Daniel.Spencer@ludger.com	Kalla, Rahul/M-2694-2019; Kennedy, Nicholas Alexander/AET-5648-2022	Kalla, Rahul/0000-0002-3276-6751; Kennedy, Nicholas Alexander/0000-0003-4368-1961; Boyapati, Ray/0000-0001-9683-8411	Wellcome Trust [WT097943MA]; European Commission FP7 grant: European Commission IBD-BIOM [305479]; European Commission FP7 grant: European Commission HighGlycan [278535]; European Commission FP7 grant: European Commission IBD-CHARACTER [2858546]; Ludger Ltd.; MRC [G0800675, G0600329, G0800759] Funding Source: UKRI; Medical Research Council [G0800675, G0800759, G0600329, 1202121] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/137, ETM/75] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); European Commission FP7 grant: European Commission IBD-BIOM; European Commission FP7 grant: European Commission HighGlycan; European Commission FP7 grant: European Commission IBD-CHARACTER; Ludger Ltd.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	The study has been funded by the following European Commission FP7 grants: European Commission IBD-BIOM (contract # 305479); HighGlycan (contract # 278535); IBD-CHARACTER (contract # 2858546). NAK is funded by the Wellcome Trust (grant number WT097943MA). Ludger Ltd. provided support in the form of salaries for authors AG, AS, DF and DS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section	Bowen RAR, 2010, CLIN BIOCHEM, V43, P4, DOI 10.1016/j.clinbiochem.2009.10.001; Chen CY, 2009, J PROTEOME RES, V8, P463, DOI 10.1021/pr800656e; Collins ES, 2013, RHEUMATOLOGY, V52, P1572, DOI 10.1093/rheumatology/ket189; Cuhadar S, 2012, BIOCHEM MEDICA, V22, P202; Dasgupta A, 2000, THER DRUG MONIT, V22, P427, DOI 10.1097/00007691-200008000-00011; DASGUPTA A, 1994, AM J CLIN PATHOL, V101, P456; Drake SK, 2004, CLIN CHEM, V50, P2398, DOI 10.1373/clinchem.2004.040303; Ercan A, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3756; Ercan A, 2010, ARTHRITIS RHEUM-US, V62, P2239, DOI 10.1002/art.27533; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Gornik O, 2008, DIS MARKERS, V25, P267, DOI 10.1155/2008/493289; Guile GR, 1996, ANAL BIOCHEM, V240, P210, DOI 10.1006/abio.1996.0351; Hanson B.A., 2014, CHEMOSPEC EXPLORATOR; Harvey DJ, 2008, ANAL BIOCHEM, V376, P44, DOI 10.1016/j.ab.2008.01.025; Herrmann E., 2013, LOKERN KERNEL REGRES; Hsieh SY, 2006, PROTEOMICS, V6, P3189, DOI 10.1002/pmic.200500535; Huffman JE, 2014, MOL CELL PROTEOMICS, V13, P1598, DOI 10.1074/mcp.M113.037465; Knezevic A, 2009, J PROTEOME RES, V8, P694, DOI 10.1021/pr800737u; Miyahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074861; Novokmet M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04347; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; Reiding KR, 2014, ANAL CHEM, V86, P5784, DOI 10.1021/ac500335t; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Sharratt CL, 2009, INT J CLIN PRACT, V63, P1259, DOI 10.1111/j.1742-1241.2008.01981.x; Shi RZ, 2012, CLIN BIOCHEM, V45, P1706, DOI 10.1016/j.clinbiochem.2012.08.008; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Zolg JW, 2004, MOL CELL PROTEOMICS, V3, P345, DOI 10.1074/mcp.M400007-MCP200	29	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0123028	10.1371/journal.pone.0123028	http://dx.doi.org/10.1371/journal.pone.0123028			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831126	Green Published, gold			2022-12-26	WOS:000352135600133
J	Abdelmagid, SM; Sondag, GR; Moussa, FM; Belcher, JY; Yu, B; Stinnett, H; Novak, K; Mbimba, T; Khol, M; Hankenson, KD; Malcuit, C; Safadi, FF				Abdelmagid, Samir M.; Sondag, Gregory R.; Moussa, Fouad M.; Belcher, Joyce Y.; Yu, Bing; Stinnett, Hilary; Novak, Kimberly; Mbimba, Thomas; Khol, Matthew; Hankenson, Kurt D.; Malcuit, Christopher; Safadi, Fayez F.			Mutation in Osteoactivin Promotes Receptor Activator of NF kappa B Ligand (RANKL)-mediated Osteoclast Differentiation and Survival but Inhibits Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT ACID-PHOSPHATASE; GLYCOGEN-SYNTHASE KINASE-3-BETA; COLONY-STIMULATING FACTOR; OSTEOBLAST DIFFERENTIATION; TRANSMEMBRANE PROTEIN; KINASE-ACTIVITY; BONE-FORMATION; FAMILY-MEMBER; BCL-2 FAMILY; DC-STAMP	We previously reported on the importance of osteoactivin (OA/Gpnmb) in osteogenesis. In this study, we examined the role of OA in osteoclastogenesis, using mice with a nonsense mutation in the Gpnmb gene (D2J) and wild-type controls (D2J/Gpnmb(+)). In these D2J mice, micro-computed tomography and histomorphometric analyses revealed increased cortical thickness, whereas total porosity and eroded surface were significantly reduced in D2J mice compared with wildtype controls, and these results were corroborated by lower serum levels of CTX-1. Contrary to these observations and counterintuitively, temporal gene expression analyses supported up-regulated osteoclastogenesis in D2J mice and increased osteoclast differentiation rates ex vivo, marked by increased number and size. The finding that MAPK was activated in early differentiating and mature D2J osteoclasts and that survival of D2J osteoclasts was enhanced and mediated by activation of the AKT-GSK3 beta pathway supports this observation. Furthermore, this was abrogated by the addition of recombinant OA to cultures, which restored osteoclastogenesis to wild-type levels. Moreover, mix and match co-cultures demonstrated an induction of osteoclastogenesis in D2J osteoblasts co-cultured with osteoclasts of D2J or wild-type. Last, in functional osteo-assays, we show that bone resorption activity of D2J osteoclasts is dramatically reduced, and these osteoclasts present an abnormal ruffled border over the bone surface. Collectively, these data support a model whereby OA/Gpnmb acts as a negative regulator of osteoclast differentiation and survival but not function by inhibiting the ERK/AKT signaling pathways.	[Abdelmagid, Samir M.; Sondag, Gregory R.; Moussa, Fouad M.; Yu, Bing; Stinnett, Hilary; Novak, Kimberly; Mbimba, Thomas; Khol, Matthew; Safadi, Fayez F.] Northeast Ohio Med Univ, Dept Anat & Neurobiol, Coll Med, Rootstown, OH 44272 USA; [Sondag, Gregory R.; Moussa, Fouad M.; Malcuit, Christopher; Safadi, Fayez F.] Kent State Univ, Sch Biomed Sci, Kent, OH 44240 USA; [Malcuit, Christopher] Kent State Univ, Dept Biol Sci, Kent, OH 44240 USA; [Belcher, Joyce Y.] Temple Univ, Sch Med, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA; [Hankenson, Kurt D.] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA	Northeast Ohio Medical University (NEOMED); University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania	Safadi, FF (corresponding author), NE Ohio Med Univ, Dept Anat & Neurobiol, 4209 State Rt 44, Rootstown, OH 44224 USA.	fayez.safadi@neomed.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020; Safadi, Fayez/AAU-8699-2021	Hankenson, Kurt/0000-0001-6361-143X; 	National Institutes of Health, NIAMS [R01AR048892]; Ohio State Department of Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048892] Funding Source: NIH RePORTER	National Institutes of Health, NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Ohio State Department of Development; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health, NIAMS, Grant R01AR048892. This work was also supported by a grant from the Ohio State Department of Development.	Abdelmagid SM, 2008, EXP CELL RES, V314, P2334, DOI 10.1016/j.yexcr.2008.02.006; Abdelmagid SM, 2007, J CELL PHYSIOL, V210, P26, DOI 10.1002/jcp.20841; Abdelmagid SM, 2014, AM J PATHOL, V184, P697, DOI 10.1016/j.ajpath.2013.11.031; Abdelmagid SM, 2010, J CELL BIOCHEM, V111, P295, DOI 10.1002/jcb.22702; Akiyama T, 2003, EMBO J, V22, P6653, DOI 10.1093/emboj/cdg635; Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-1; Arosarena OA, 2011, J CELL PHYSIOL, V226, P2943, DOI 10.1002/jcp.22639; Bain SD, 2005, TOP BON BIO, V2, P58; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Bateman JP, 2012, J PERIODONTAL RES, V47, P243, DOI 10.1111/j.1600-0765.2011.01428.x; Berson JF, 2001, MOL BIOL CELL, V12, P3451, DOI 10.1091/mbc.12.11.3451; Borah B, 2010, J BONE MINER RES, V25, P41, DOI 10.1359/jbmr.090711; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Crockett JC, 2011, OSTEOPOROSIS INT, V22, P1, DOI 10.1007/s00198-010-1272-8; Cross DAE, 2001, J NEUROCHEM, V77, P94, DOI 10.1046/j.1471-4159.2001.00251.x; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Dobbins DE, 2002, J BONE MINER RES, V17, P1761, DOI 10.1359/jbmr.2002.17.10.1761; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; ERIKSEN EF, 1993, BONE, V14, P443, DOI 10.1016/8756-3282(93)90177-C; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Gingery A, 2003, J CELL BIOCHEM, V89, P165, DOI 10.1002/jcb.10503; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Hayashi H, 2008, FEBS LETT, V582, P3243, DOI 10.1016/j.febslet.2008.08.023; He YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024780; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Janckila AJ, 2007, AM J CLIN PATHOL, V127, P556, DOI 10.1309/DGEA9BE2VE5VCFYH; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kanzaki H, 2001, J DENT RES, V80, P887, DOI 10.1177/00220345010800030801; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Kukita T, 1996, HISTOL HISTOPATHOL, V11, P821; Kwon OH, 2005, BIOCHEM BIOPH RES CO, V335, P437, DOI 10.1016/j.bbrc.2005.07.092; Lassus J, 1998, CLIN ORTHOP RELAT R, P7; Lau KHW, 2003, J BONE MINER RES, V18, P1897, DOI 10.1359/jbmr.2003.18.10.1897; Lee SP, 2001, J BIOL CHEM, V276, P29826, DOI 10.1074/jbc.M101822200; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Lemaire V, 2004, J THEOR BIOL, V229, P293, DOI 10.1016/j.jtbi.2004.03.023; Li XT, 2002, ENDOCRINOLOGY, V143, P3105, DOI 10.1210/en.143.8.3105; Loftus SK, 2009, PIGM CELL MELANOMA R, V22, P99, DOI 10.1111/j.1755-148X.2008.00518.x; Lotinun S, 2013, J CLIN INVEST, V123, P666, DOI 10.1172/JCI64840; Margolis DS, 2008, CALCIFIED TISSUE INT, V82, P66, DOI 10.1007/s00223-007-9098-x; MILLER SC, 1982, CALCIFIED TISSUE INT, V34, P422, DOI 10.1007/BF02411278; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; MIYAUCHI A, 1993, OSTEOPOROSIS INT, V3, pS132; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; MOUTIER R, 1980, PATHOL RES PRACT, V168, P65, DOI 10.1016/S0344-0338(80)80207-X; Neutzsky-Wulff AV, 2010, DEV BIOL, V344, P1001, DOI 10.1016/j.ydbio.2010.06.018; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Owen TA, 2003, CRIT REV EUKAR GENE, V13, P205; Partington GA, 2004, BONE, V34, P237, DOI 10.1016/j.bone.2003.11.010; PHILIPPART C, 1989, J ORAL PATHOL MED, V18, P163, DOI 10.1111/j.1600-0714.1989.tb00755.x; Pogoda P, 2005, OSTEOPOROSIS INT, V16, pS18, DOI 10.1007/s00198-004-1787-y; Popoff SN, 1996, MOL MED TODAY, V2, P349, DOI 10.1016/1357-4310(96)81801-6; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Quinn JMW, 1998, ENDOCRINOLOGY, V139, P4424, DOI 10.1210/endo.139.10.6331; RAISZ LG, 1981, METAB BONE DIS RELAT, V3, P117, DOI 10.1016/0221-8747(81)90029-1; Raynaud CM, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/658356; Ripoll VM, 2008, GENE, V413, P32, DOI 10.1016/j.gene.2008.01.014; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Safadi FF, 2002, J CELL BIOCHEM, V84, P12, DOI 10.1002/jcb.1259; Sheng MHC, 2008, FEBS LETT, V582, P1451, DOI 10.1016/j.febslet.2008.03.030; Sheng MHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035280; Shih MS, 2009, BONE PATHOLOGY, SECOND EDITION, P129, DOI 10.1007/978-1-59745-347-9_8; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Singh M, 2010, CRIT REV EUKAR GENE, V20, P341, DOI 10.1615/CritRevEukarGeneExpr.v20.i4.50; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Sun Y, 2005, J BIOL CHEM, V280, P32356, DOI 10.1074/jbc.M414213200; Takahashi N, 1999, BIOCHEM BIOPH RES CO, V256, P449, DOI 10.1006/bbrc.1999.0252; Tondravi MM, 1997, NATURE, V386, P81, DOI 10.1038/386081a0; Tsurukai T, 2000, J BONE MINER METAB, V18, P177, DOI 10.1007/s007740070018; Turque N, 1996, EMBO J, V15, P3338, DOI 10.1002/j.1460-2075.1996.tb00699.x; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Watcharasit P, 2002, P NATL ACAD SCI USA, V99, P7951, DOI 10.1073/pnas.122062299; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; Wong BR, 1999, MOL CELL, V4, P1041, DOI 10.1016/S1097-2765(00)80232-4; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9; Yam LT, 2003, J BONE MINER RES, V18, P1894, DOI 10.1359/jbmr.2003.18.10.1894; Zhao HB, 2001, J BIOL CHEM, V276, P39295, DOI 10.1074/jbc.M010999200	84	25	26	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2015	290	33					20128	20146		10.1074/jbc.M114.624270	http://dx.doi.org/10.1074/jbc.M114.624270			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CP1AT	25837253	Green Published, hybrid			2022-12-26	WOS:000359608900016
J	Beyriere, F; Sommer, ME; Szczepek, M; Bartl, FJ; Hofmann, KP; Heck, M; Ritter, E				Beyriere, Florent; Sommer, Martha E.; Szczepek, Michal; Bartl, Franz J.; Hofmann, Klaus Peter; Heck, Martin; Ritter, Eglof			Formation and Decay of the Arrestin center dot Rhodopsin Complex in Native Disc Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFORM INFRARED-SPECTROSCOPY; PROTEIN-COUPLED RECEPTOR; METARHODOPSIN-II; CRYSTAL-STRUCTURE; PHOSPHORYLATION SITES; MONOMERIC RHODOPSIN; SECONDARY STRUCTURE; FTIR SPECTROSCOPY; VISUAL ARRESTIN; SIGNALING STATE	In the G protein-coupled receptor rhodopsin, light-induced cis/trans isomerization of the retinal ligand triggers a series of distinct receptor states culminating in the active Metarhodopsin II (Meta II) state, which binds and activates the G protein transducin (G(t)). Long before Meta II decays into the aporeceptor opsin and free all-trans-retinal, its signaling is quenched by receptor phosphorylation and binding of the protein arrestin-1, which blocks further access of G(t) to Meta II. Although recent crystal structures of arrestin indicate how it might look in a pre-complex with the phosphorylated receptor, the transition into the high affinity complex is not understood. Here we applied Fourier transform infrared spectroscopy to monitor the interaction of arrestin-1 and phosphorylated rhodopsin in native disc membranes. By isolating the unique infrared signature of arrestin binding, we directly observed the structural alterations in both reaction partners. In the high affinity complex, rhodopsin adopts a structure similar to G(t)-bound Meta II. In arrestin, a modest loss of beta-sheet structure indicates an increase in flexibility but is inconsistent with a large scale structural change. During Meta II decay, the arrestin-rhodopsin stoichiometry shifts from 1:1 to 1:2. Arrestin stabilizes half of the receptor population in a specific Meta II protein conformation, whereas the other half decays to inactive opsin. Altogether these results illustrate the distinct binding modes used by arrestin to interact with different functional forms of the receptor.	[Beyriere, Florent; Sommer, Martha E.; Szczepek, Michal; Bartl, Franz J.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Bartl, Franz J.; Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat BPI, D-10115 Berlin, Germany; [Ritter, Eglof] Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Humboldt University of Berlin	Ritter, E (corresponding author), Humboldt Univ, Inst Biol, Expt Biophys, D-10115 Berlin, Germany.	eglof.ritter@hu-berlin.de		Sommer, Martha E./0000-0003-0493-8584	Deutsche Forschungsgemeinschaft [SFB 740, SO1037/1-2]; European Research Council; German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [05K13KH1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Collaborative Research Grant SFB 740 (to K. P. H. and M. H.) and Grant SO1037/1-2 (to M. E. S.), European Research Council Advanced Grant "Towards Understanding the Structure and Dynamics of Receptor Protein" (TUDOR) (to K. P. H.), and German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) Grant 05K13KH1 (to Peter Hegemann).	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Allin C, 2001, P NATL ACAD SCI USA, V98, P7754, DOI 10.1073/pnas.131549798; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BANDEKAR J, 1979, P NATL ACAD SCI USA, V76, P774, DOI 10.1073/pnas.76.2.774; Bartl F, 2000, FEBS LETT, V473, P259, DOI 10.1016/S0014-5793(00)01544-1; Bartl FJ, 2001, J BIOL CHEM, V276, P30161, DOI 10.1074/jbc.M101506200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Cooper E A, 1995, Pharm Biotechnol, V7, P101; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; Elgeti M, 2013, J AM CHEM SOC, V135, P12305, DOI 10.1021/ja405133k; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Elgeti M, 2008, Z PHYS CHEM, V222, P1117, DOI 10.1524/zpch.2008.5392; FAHMY K, 1993, P NATL ACAD SCI USA, V90, P10206, DOI 10.1073/pnas.90.21.10206; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gibson SK, 1998, BIOCHEMISTRY-US, V37, P11393, DOI 10.1021/bi980933w; GOORMAGHTIGH E, 1990, EUR J BIOCHEM, V193, P409, DOI 10.1111/j.1432-1033.1990.tb19354.x; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich VV, 2011, PROG RETIN EYE RES, V30, P405, DOI 10.1016/j.preteyeres.2011.07.002; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; HENRY ER, 1992, METHOD ENZYMOL, V210, P129; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Kim M, 2012, P NATL ACAD SCI USA, V109, P18407, DOI 10.1073/pnas.1216304109; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Klahn M, 2004, J PHYS CHEM A, V108, P6186, DOI 10.1021/jp048617g; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; KRIMM S, 1962, J MOL BIOL, V4, P528; Lefkowitz RJ, 2013, PROG MOL BIOL TRANSL, V118, P3, DOI 10.1016/B978-0-12-394440-5.00001-2; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; Maurice P, 2011, ADV PHARMACOL, V62, P349, DOI 10.1016/B978-0-12-385952-5.00001-4; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Ritter E, 2007, J BIOL CHEM, V282, P10720, DOI 10.1074/jbc.M610658200; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Schroder K, 2002, J BIOL CHEM, V277, P43987, DOI 10.1074/jbc.M206211200; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; Siebert F, 1995, ISRAEL J CHEM, V35, P309; SMITH WC, 1994, J BIOL CHEM, V269, P15407; Sommer ME, 2006, VISION RES, V46, P4532, DOI 10.1016/j.visres.2006.08.031; Sommer Martha E, 2014, Handb Exp Pharmacol, V219, P101, DOI 10.1007/978-3-642-41199-1_5; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2011, J BIOL CHEM, V286, P7359, DOI 10.1074/jbc.M110.204941; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vedantham G, 2000, ANAL BIOCHEM, V285, P33, DOI 10.1006/abio.2000.4744; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Vogel R, 2003, BIOCHEMISTRY-US, V42, P9863, DOI 10.1021/bi034684+; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Vogel R, 2007, J MOL BIOL, V366, P1580, DOI 10.1016/j.jmb.2006.12.019; Ye SX, 2010, NATURE, V464, P1386, DOI 10.1038/nature08948; Zhang LR, 1997, J BIOL CHEM, V272, P14762, DOI 10.1074/jbc.272.23.14762; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	56	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12919	12928		10.1074/jbc.M114.620898	http://dx.doi.org/10.1074/jbc.M114.620898			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847250	Green Published, hybrid			2022-12-26	WOS:000354569000041
J	Ballester, R; Huertas, F; Yuste, FJ; Llorens, F; Sanabria, D				Ballester, Rafael; Huertas, Florentino; Javier Yuste, Francisco; Llorens, Francesc; Sanabria, Daniel			The Relationship between Regular Sports Participation and Vigilance in Male and Female Adolescents	PLOS ONE			English	Article							SHUTTLE RUN TEST; SOCCER PLAYERS; PHYSICAL-FITNESS; AEROBIC FITNESS; NEUROCOGNITIVE FUNCTION; TASK-PERFORMANCE; OLDER-ADULTS; CHILDREN; EXPERTISE; EXERCISE	The present study investigated the relationship between regular sport participation (soccer) and vigilance performance. Two groups of male and female adolescents differentiated in terms of their sport participation (athletes, n = 39, and non-athletes, n = 36) took part in the study. In one session, participants performed the Leger Multi-stage fitness test to estimate their aerobic fitness level. In the other session, participants completed the Psychomotor Vigilance Task (PVT) to evaluate their vigilance performance. Perceived arousal prior to the task and motivation toward the task were also measured in the PVT session. The results revealed that athletes had better cardiovascular fitness and showed better performance in the PVT. However, correlation analyses did not show any significant relationship between cardiovascular fitness and performance in the PVT. Athletes showed larger scores in motivation and perceived arousal measures with respect to non-athletes, although, once again, these variables were not correlated with PVT performance. Gender differences were observed only in the Leger test, with males showing greater fitness level than females. The major outcome of this research points to a positive relationship between regular sport participation and vigilance during adolescence. This relationship did not seem to be influenced by gender, perceived arousal, motivation toward the task or cardiovascular fitness. We discuss our results in terms of the different hypotheses put forward in the literature to explain the relationship between physical activity and cognitive functioning.	[Ballester, Rafael; Huertas, Florentino; Javier Yuste, Francisco; Llorens, Francesc] Univ Catolica Valencia San Vicente Martir, Dept Phys Act & Sport Sci, Valencia, Spain; [Sanabria, Daniel] Univ Granada, Mind Brain & Behav Res Ctr, Granada, Spain; [Sanabria, Daniel] Univ Granada, Dept Expt Psychol, Granada, Spain	Universidad Catolica de Valencia San Vicente Martir; University of Granada; University of Granada	Ballester, R (corresponding author), Univ Catolica Valencia San Vicente Martir, Dept Phys Act & Sport Sci, Valencia, Spain.	rafael.ballester@ucv.es	Olmedo, Florentino Huertas/I-8787-2013; Sanabria, Daniel/C-3409-2012; Llorens, Francesc/AAY-1464-2020; Ballester, Rafael/R-4245-2016	Olmedo, Florentino Huertas/0000-0002-1518-8582; Sanabria, Daniel/0000-0002-4164-7607; Ballester, Rafael/0000-0002-1602-6809; Llorens, Francesc/0000-0003-3313-709X	Spanish Ministerio de Educacion y Cultura [FPU13-05605]; Junta de Andalucia Proyecto de Excelencia [SEJ-6414]; Ministerio de Economia y Competitividad [PSI2013-46385]	Spanish Ministerio de Educacion y Cultura(German Research Foundation (DFG)); Junta de Andalucia Proyecto de Excelencia(Junta de Andalucia); Ministerio de Economia y Competitividad(Spanish Government)	This research was supported by a Spanish Ministerio de Educacion y Cultura (https://sede.educacion.gob.es) predoctoral grant (FPU13-05605) to the first author, and project research grants: Junta de Andalucia Proyecto de Excelencia SEJ-6414 (http://www.juntadeandalucia.es) and Ministerio de Economia y Competitividad PSI2013-46385 (http://www.mineco.gob.es) to DS and FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Beijamini F, 2008, BRAZ J MED BIOL RES, V41, P734, DOI 10.1590/S0100-879X2008000800016; Blatter K, 2006, BEHAV BRAIN RES, V168, P312, DOI 10.1016/j.bbr.2005.11.018; Bonnefond A, 2011, BRAIN COGNITION, V77, P464, DOI 10.1016/j.bandc.2011.08.010; Chaddock L, 2011, J INT NEUROPSYCH SOC, V17, P975, DOI 10.1017/S1355617711000567; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Davies DR, 1982, PSYCHOL VIGILANCE; Drummond SPA, 2005, SLEEP, V28, P1059; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Etnier JL, 2006, BRAIN RES REV, V52, P119, DOI 10.1016/j.brainresrev.2006.01.002; Gunzelmann G, 2010, COGNITIVE FATIGUE MU, P83; Hainsworth R., 1998, CLIN GUIDE CARDIAC A, P3, DOI [10.1007/978-94-017-1057-2_1, DOI 10.1007/978-94-017-1057-2_1]; Hammami MA, 2013, J SPORT SCI, V31, P589, DOI 10.1080/02640414.2012.746721; Haugen T, 2014, SCAND J PUBLIC HEALT, V42, P67, DOI 10.1177/1403494813504502; Huttermann S, 2015, COGNITION EMOTION, V29, P471, DOI 10.1080/02699931.2014.920767; JENNINGS JR, 1976, PSYCHOPHYSIOLOGY, V13, P277; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Krustrup P, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01108.x; LEGER LA, 1982, EUR J APPL PHYSIOL O, V49, P1, DOI 10.1007/BF00428958; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; Luque-Casado A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056935; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; Matthews G, 1999, PERS INDIV DIFFER, V26, P583, DOI 10.1016/S0191-8869(98)00158-5; MONK TH, 1989, PSYCHIAT RES, V27, P89, DOI 10.1016/0165-1781(89)90013-9; North T C, 1990, Exerc Sport Sci Rev, V18, P379; Pesce C, 2001, J PSYCHOPHYSIOL, V15, P256, DOI 10.1027//0269-8803.15.4.256; Pesce C, 2007, J SPORT SCI, V25, P1259, DOI 10.1080/02640410601040085; Pontifex MB, 2012, NEUROPSYCHOLOGY, V26, P407, DOI 10.1037/a0028795; Reilly T, 2005, J SPORT SCI, V23, P561, DOI 10.1080/02640410400021245; Robertson IH, 1997, NEUROPSYCHOLOGIA, V35, P747, DOI 10.1016/S0028-3932(97)00015-8; Sibley BA, 2003, PEDIATR EXERC SCI, V15, P243, DOI 10.1123/pes.15.3.243; Singh TP, 2008, MED SCI SPORT EXER, V40, P601, DOI 10.1249/MSS.0b013e3181621ec4; Smiley-Oyen AL, 2008, ANN BEHAV MED, V36, P280, DOI 10.1007/s12160-008-9064-5; Steinmayr R, 2010, LEARN INDIVID DIFFER, V20, P14, DOI 10.1016/j.lindif.2009.10.009; Tomkinson GR, 2003, SPORTS MED, V33, P285, DOI 10.2165/00007256-200333040-00003; Trautmann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032279; Vanttinen T, 2010, PERCEPT MOTOR SKILL, V110, P675, DOI 10.2466/PMS.110.3.675-692; Vanttinen T, 2011, J STRENGTH COND RES, V25, P3342, DOI 10.1519/JSC.0b013e318236d0c2; Venker CC, 2007, SLEEP BREATH, V11, P217, DOI 10.1007/s11325-007-0103-4; Verburgh L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091254; Vestberg T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034731; Voss MW, 2011, J APPL PHYSIOL, V111, P1505, DOI 10.1152/japplphysiol.00210.2011; Voss MW, 2010, APPL COGNITIVE PSYCH, V24, P812, DOI 10.1002/acp.1588; Ward P, 2003, J SPORT EXERCISE PSY, V25, P93, DOI 10.1123/jsep.25.1.93; Warm JS, 2008, HUM FACTORS, V50, P433, DOI 10.1518/001872008X312152; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Wilson A, 2010, BEHAV RES METHODS, V42, P754, DOI 10.3758/BRM.42.3.754	47	22	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123898	10.1371/journal.pone.0123898	http://dx.doi.org/10.1371/journal.pone.0123898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849873	Green Published, gold			2022-12-26	WOS:000352477800260
J	Burke, JJ; Chen, JP				Burke, John J.; Chen, Junping			Enhancement of Reproductive Heat Tolerance in Plants	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; HIGH-TEMPERATURE STRESS; SHOCK-PROTEIN; IN-VITRO; CARBON-DIOXIDE; GENETIC-TRANSFORMATION; TISSUE-SPECIFICITY; COMBINING ABILITY; TOMATO GENOTYPES; TOBACCO POLLEN	Comparison of average crop yields with reported record yields has shown that major crops exhibit annual average yields three-to seven-fold lower than record yields because of unfavorable environments. The current study investigated the enhancement of pollen heat tolerance through expressing an Arabidopsis thaliana heat shock protein 101 (AtHSP101) that is not normally expressed in pollen but reported to play a crucial role in vegetative thermotolerance. The AtHSP101 construct under the control of the constitutive ocs/mas 'superpromoter' was transformed into cotton Coker 312 and tobacco SRI lines via Agrobacterium mediated transformation. Thermotolerance of pollen was evaluated by in vitro pollen germination studies. Comparing with those of wild type and transgenic null lines, pollen from AtHSP101 transgenic tobacco and cotton lines exhibited significantly higher germination rate and much greater pollen tube elongation under elevated temperatures or after a heat exposure. In addition, significant increases in boll set and seed numbers were also observed in transgenic cotton lines exposed to elevated day and night temperatures in both greenhouse and field studies. The results of this study suggest that enhancing heat tolerance of reproductive tissues in plant holds promise in the development of crops with improved yield production and yield sustainability in unfavorable environments.	[Burke, John J.; Chen, Junping] USDA ARS, Cropping Syst Res Lab, Lubbock, TX 79401 USA	United States Department of Agriculture (USDA)	Burke, JJ (corresponding author), USDA ARS, Cropping Syst Res Lab, 3810 4th St, Lubbock, TX 79401 USA.	john.burke@ars.usda.gov			United States Department of Agriculture, Agricultural Research Service, Base Funding	United States Department of Agriculture, Agricultural Research Service, Base Funding	This work was supported by United States Department of Agriculture, Agricultural Research Service, Base Funding.	ABDULBAKI AA, 1995, HORTSCIENCE, V30, P115, DOI 10.21273/HORTSCI.30.1.115; BANDYOPADHYAY RS, 1989, J BIOL CHEM, V264, P19399; BAYLEY C, 1992, THEOR APPL GENET, V83, P645, DOI 10.1007/BF00226910; Bokszczanin KL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00315; Boston RS, 1996, PLANT MOL BIOL, V32, P191, DOI 10.1007/BF00039383; BOUCHEZ D, 1989, EMBO J, V8, P4197, DOI 10.1002/j.1460-2075.1989.tb08605.x; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Brown P.W., 1997, SERIES U ARIZONA, V108, P91; Burke JJ, 2004, AGRON J, V96, P359, DOI 10.2134/agronj2004.0359; Burke JJ, 2005, United States Department of Agriculture patents, Patent No. [US 6,939,676 B2, 6939676]; Chaturvedi P, 2013, J PROTEOME RES, V12, P4892, DOI 10.1021/pr400197p; COOPER P, 1984, PLANT PHYSIOL, V75, P431, DOI 10.1104/pp.75.2.431; DANE F, 1991, J AM SOC HORTIC SCI, V116, P906, DOI 10.21273/JASHS.116.5.906; De Storme N, 2014, PLANT CELL ENVIRON, V37, P1, DOI 10.1111/pce.12142; DUPUIS I, 1990, PLANT PHYSIOL, V94, P665, DOI 10.1104/pp.94.2.665; Fisher W. D., 1975, P 27 COTT IMPR C, P85; FRALEY RT, 1986, CRC CR REV PLANT SCI, V4, P1, DOI 10.1080/07352688609382217; FROVA C, 1994, MOL GEN GENET, V245, P424, DOI 10.1007/BF00302254; Gagliardi D, 1995, PLANT MOL BIOL, V29, P841, DOI 10.1007/BF00041173; Goswami C. L., 1980, Cotton Development, V9, P15; Guinn G., 1984, Crop physiology. Advancing frontiers, P177; HALTERLEIN AJ, 1980, J AM SOC HORTIC SCI, V105, P12; Harsant J, 2013, J EXP BOT, V64, P2971, DOI 10.1093/jxb/ert142; HERRERO MP, 1980, CROP SCI, V20, P796, DOI 10.2135/cropsci1980.0011183X002000060030x; Hong SW, 2000, P NATL ACAD SCI USA, V97, P4392, DOI 10.1073/pnas.97.8.4392; HOPF N, 1992, PLANT MOL BIOL, V19, P623, DOI 10.1007/BF00026788; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Kakani VG, 2005, ANN BOT-LONDON, V96, P59, DOI 10.1093/aob/mci149; Kakani VG, 2002, PLANT CELL ENVIRON, V25, P1651, DOI 10.1046/j.1365-3040.2002.00943.x; KANDASAMY MK, 1989, PROTOPLASMA, V153, P104, DOI 10.1007/BF01322470; KONCZ C, 1983, EMBO J, V2, P1597, DOI 10.1002/j.1460-2075.1983.tb01630.x; Lee U, 2005, PLANT CELL, V17, P559, DOI 10.1105/tpc.104.027540; Magnard JL, 1996, PLANT PHYSIOL, V111, P1085, DOI 10.1104/pp.111.4.1085; Mandhu Bajaj, 1992, Angiosperm pollen and ovules., P349; MEYER VG, 1969, CROP SCI, V9, P237, DOI 10.2135/cropsci1969.0011183X000900020039x; MITCHELL JC, 1988, J PLANT PHYSIOL, V133, P625, DOI 10.1016/S0176-1617(88)80019-1; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; OTTEN LABM, 1978, BIOCHIM BIOPHYS ACTA, V527, P497, DOI 10.1016/0005-2744(78)90363-7; Pan SQ, 2000, PLANT CELL, V12, P125, DOI 10.1105/tpc.12.1.125; Percy RG, 2006, CROP SCI, V46, P1828, DOI 10.2135/cropsci2005.12-0483; Pettigrew WT, 2008, CROP SCI, V48, P278, DOI 10.2135/cropsci2007.05.0261; Prasad PVV, 2006, AGR FOREST METEOROL, V139, P237, DOI 10.1016/j.agrformet.2006.07.003; Queitsch C, 2000, PLANT CELL, V12, P479, DOI 10.1105/tpc.12.4.479; RAO GU, 1992, ANN BOT-LONDON, V69, P193, DOI 10.1093/oxfordjournals.aob.a088329; REDDY KR, 1992, AGRON J, V84, P237, DOI 10.2134/agronj1992.00021962008400020022x; Reddy KR, 1999, AGRON J, V91, P851, DOI 10.2134/agronj1999.915851x; REDDY KR, 1995, AGR ECOSYST ENVIRON, V54, P17, DOI 10.1016/0167-8809(95)00593-H; REDDY KR, 1992, AGRON J, V84, P26, DOI 10.2134/agronj1992.00021962008400010006x; RODRIGUEZGARAY B, 1988, CROP SCI, V28, P857, DOI 10.2135/cropsci1988.0011183X002800050030x; Sakata T, 2000, J PLANT RES, V113, P395, DOI 10.1007/PL00013947; SARVELLA P, 1966, CROP SCI, V6, P361, DOI 10.2135/cropsci1966.0011183X000600040020x; SCHOPER JB, 1987, CROP SCI, V27, P27, DOI 10.2135/cropsci1987.0011183X002700010007x; SHIVANNA KR, 1991, SEX PLANT REPROD, V4, P104; Snider JL, 2009, PHYSIOL PLANTARUM, V137, P125, DOI 10.1111/j.1399-3054.2009.01266.x; VELTEN J, 1984, EMBO J, V3, P2723, DOI 10.1002/j.1460-2075.1984.tb02202.x; VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981; Volkov RA, 2005, PLANT MOL BIOL, V57, P487, DOI 10.1007/s11103-005-0339-y; Walker-Peach C, 1984, AGROBACTERIUM MEDIAT; WEAVER ML, 1989, HORTSCIENCE, V24, P493; Xin ZG, 2003, BIOTECHNIQUES, V34, P820, DOI 10.2144/03344rr04; Young TE, 2001, PLANT PHYSIOL, V127, P777, DOI 10.1104/pp.010160	61	44	51	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122933	10.1371/journal.pone.0122933	http://dx.doi.org/10.1371/journal.pone.0122933			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849955	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800177
J	Grubbs, KJ; Scott, JJ; Budsberg, KJ; Read, H; Balser, TC; Currie, CR				Grubbs, Kirk J.; Scott, Jarrod J.; Budsberg, Kevin J.; Read, Harry; Balser, Teri C.; Currie, Cameron R.			Unique Honey Bee (Apis mellifera) Hive Component-Based Communities as Detected by a Hybrid of Phospholipid Fatty-Acid and Fatty-Acid Methyl Ester Analyses	PLOS ONE			English	Article							MICROBIAL COMMUNITY; SOIL; DIVERSITY; BACTERIA; BIOMASS; POLLEN; LARVAE; GUT; LIPOPOLYSACCHARIDES; RECLASSIFICATION	Microbial communities (microbiomes) are associated with almost all metazoans, including the honey bee Apis mellifera. Honey bees are social insects, maintaining complex hive systems composed of a variety of integral components including bees, comb, propolis, honey, and stored pollen. Given that the different components within hives can be physically separated and are nutritionally variable, we hypothesize that unique microbial communities may occur within the different microenvironments of honey bee colonies. To explore this hypothesis and to provide further insights into the microbiome of honey bees, we use a hybrid of fatty acid methyl ester (FAME) and phospholipid-derived fatty acid (PLFA) analysis to produce broad, lipid-based microbial community profiles of stored pollen, adults, pupae, honey, empty comb, and propolis for 11 honey bee hives. Averaging component lipid profiles by hive, we show that, in decreasing order, lipid markers representing fungi, Gram-negative bacteria, and Gram-positive bacteria have the highest relative abundances within honey bee colonies. Our lipid profiles reveal the presence of viable microbial communities in each of the six hive components sampled, with overall microbial community richness varying from lowest to highest in honey, comb, pupae, pollen, adults and propolis, respectively. Finally, microbial community lipid profiles were more similar when compared by component than by hive, location, or sampling year. Specifically, we found that individual hive components typically exhibited several dominant lipids and that these dominant lipids differ between components. Principal component and two-way clustering analyses both support significant grouping of lipids by hive component. Our findings indicate that in addition to the microbial communities present in individual workers, honey bee hives have resident microbial communities associated with different colony components.	[Grubbs, Kirk J.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Scott, Jarrod J.] Bigelow Lab Ocean Sci, East Boothbay, ME USA; [Budsberg, Kevin J.; Read, Harry; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Balser, Teri C.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL USA	University of North Carolina; University of North Carolina Chapel Hill; Bigelow Laboratory for Ocean Sciences; University of Wisconsin System; University of Wisconsin Madison; State University System of Florida; University of Florida	Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	Currie@bact.wisc.edu		Scott, Jarrod/0000-0001-9863-1318	National Institute of Food and Agriculture, United States Department of Agriculture [WISO1321]; National Science Foundation [MCB-0702025]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Institute of Food and Agriculture, United States Department of Agriculture, under ID number WISO1321, and National Science Foundation grant MCB-0702025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Anderson KE, 2011, INSECT SOC, V58, P431, DOI 10.1007/s00040-011-0194-6; Ashiralieva A, 2006, APIDOLOGIE, V37, P411, DOI 10.1051/apido:2006028; Babendreier D, 2007, FEMS MICROBIOL ECOL, V59, P600, DOI 10.1111/j.1574-6941.2006.00249.x; BAILEY L, 1983, J APPL BACTERIOL, V55, P65, DOI 10.1111/j.1365-2672.1983.tb02648.x; Bardgett RD, 1996, BIOL FERT SOILS, V22, P261, DOI 10.1007/BF00382522; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bull ID, 2000, NATURE, V405, P175, DOI 10.1038/35012061; Burdock GA, 1998, FOOD CHEM TOXICOL, V36, P347, DOI 10.1016/S0278-6915(97)00145-2; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Colwell R.K., 2006, ESTIMATES STAT ESTIM; Cornman RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043562; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Engel P, 2012, P NATL ACAD SCI USA, V109, P11002, DOI 10.1073/pnas.1202970109; Foote H., 1957, AM BEE J, V97, P476; Fritze H, 2000, EUR J SOIL SCI, V51, P565, DOI 10.1046/j.1365-2389.2000.00346.x; GILLIAM M, 1987, J INVERTEBR PATHOL, V49, P70, DOI 10.1016/0022-2011(87)90127-3; GILLIAM M, 1979, APIDOLOGIE, V10, P43, DOI 10.1051/apido:19790106; GILLIAM M, 1989, APIDOLOGIE, V20, P53, DOI 10.1051/apido:19890106; Gilliam M, 1997, FEMS MICROBIOL LETT, V155, P1; Gilliam M, 1979, MICROBIOLOGY POLLEN; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Heyndrickx M, 1996, INT J SYST BACTERIOL, V46, P270, DOI 10.1099/00207713-46-1-270; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jeyaprakash A, 2003, J INVERTEBR PATHOL, V84, P96, DOI 10.1016/j.jip.2003.08.007; Kaur A, 2005, CURR SCI INDIA, V89, P1103; Keith-Roach MJ, 2002, BIOGEOCHEMISTRY, V60, P77, DOI 10.1023/A:1016553225977; Kujumgiev A, 1999, J ETHNOPHARMACOL, V64, P235, DOI 10.1016/S0378-8741(98)00131-7; Lee FJ, 2014, ENVIRON MICROBIOL, pn/a; Martinson VG, 2012, APPL ENVIRON MICROB, V78, P2830, DOI 10.1128/AEM.07810-11; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Mattila HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032962; Mentzer JL, 2006, PLANT SOIL, V284, P85, DOI 10.1007/s11104-006-0032-1; Midi I, 2001, SHERLOCK MICROBIAL I; MILLIGAN GW, 1980, PSYCHOMETRIKA, V45, P325, DOI 10.1007/BF02293907; Mohr KI, 2006, ENVIRON MICROBIOL, V8, P258, DOI 10.1111/j.1462-2920.2005.00893.x; Moran NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036393; Olofsson TC, 2008, CURR MICROBIOL, V57, P356, DOI 10.1007/s00284-008-9202-0; Oravecz O, 2004, FOLIA MICROBIOL, V49, P83, DOI 10.1007/BF02931652; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Ruby E, 2004, SCIENCE, V303, P1305, DOI 10.1126/science.1094662; RUIZARGUESO T, 1975, APPL MICROBIOL, V30, P893, DOI 10.1128/AEM.30.6.893-896.1975; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Scott JJ, 2010, PLOS ONE, V5; Simone-Finstrom MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034601; STANDIFER LN, 1980, APIDOLOGIE, V11, P163, DOI 10.1051/apido:19800206; TOLLEFSON TS, 1983, SOIL BIOL BIOCHEM, V15, P145, DOI 10.1016/0038-0717(83)90095-0; VESTAL JR, 1989, BIOSCIENCE, V39, P535, DOI 10.2307/1310976; Wahdan HAL, 1998, INFECTION, V26, P30; Waldrop MP, 2000, SOIL BIOL BIOCHEM, V32, P1837, DOI 10.1016/S0038-0717(00)00157-7; White D, 1983, ANAL MICROORGANISMS; Winston M. L. L., 1991, BIOL HONEY BEE; Zak DR, 2003, ECOLOGY, V84, P2042, DOI 10.1890/02-0433; ZELLES L, 1992, SOIL BIOL BIOCHEM, V24, P317, DOI 10.1016/0038-0717(92)90191-Y; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533	56	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121697	10.1371/journal.pone.0121697	http://dx.doi.org/10.1371/journal.pone.0121697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849080	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800072
J	Kekkonen, M; Mutanen, M; Kaila, L; Nieminen, M; Hebert, PDN				Kekkonen, Mari; Mutanen, Marko; Kaila, Lauri; Nieminen, Marko; Hebert, Paul D. N.			Delineating Species with DNA Barcodes: A Case of Taxon Dependent Method Performance in Moths	PLOS ONE			English	Article							INTEGRATIVE APPROACH; MOLECULAR PHYLOGENY; DELIMITATION METHOD; DIVERSITY; LEPIDOPTERA; MODEL; COLEOPTERA; INSIGHTS; CLASSIFICATION; MYGALOMORPHAE	The accelerating loss of biodiversity has created a need for more effective ways to discover species. Novel algorithmic approaches for analyzing sequence data combined with rapidly expanding DNA barcode libraries provide a potential solution. While several analytical methods are available for the delineation of operational taxonomic units (OTUs), few studies have compared their performance. This study compares the performance of one morphology- based and four DNA-based (BIN, parsimony networks, ABGD, GMYC) methods on two groups of gelechioid moths. It examines 92 species of Finnish Gelechiinae and 103 species of Australian Elachistinae which were delineated by traditional taxonomy. The results reveal a striking difference in performance between the two taxa with all four DNA-based methods. OTU counts in the Elachistinae showed a wider range and a relatively low (ca. 65%) OTU match with reference species while OTU counts were more congruent and performance was higher (ca. 90%) in the Gelechiinae. Performance rose when only monophyletic species were compared, but the taxon-dependence remained. None of the DNA-based methods produced a correct match with non-monophyletic species, but singletons were handled well. A simulated test of morphospecies-grouping performed very poorly in revealing taxon diversity in these small, dull-colored moths. Despite the strong performance of analyses based on DNA barcodes, species delineated using single-locus mtDNA data are best viewed as OTUs that require validation by subsequent integrative taxonomic work.	[Kekkonen, Mari; Kaila, Lauri] Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland; [Kekkonen, Mari; Hebert, Paul D. N.] Univ Guelph, Biodivers Inst Ontario, Guelph, ON N1G 2W1, Canada; [Mutanen, Marko] Univ Oulu, Dept Genet & Physiol, Oulu, Finland; [Nieminen, Marko] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland	University of Helsinki; University of Guelph; University of Oulu; University of Helsinki	Kekkonen, M (corresponding author), Univ Helsinki, Finnish Museum Nat Hist, Zool Unit, Helsinki, Finland.	kekkonen@uoguelph.ca	Kekkonen, Mari/I-7352-2017; Hebert, Paul DN/C-4161-2013	Kekkonen, Mari/0000-0001-7906-1698; Hebert, Paul DN/0000-0002-3081-6700; Kaila, Lauri/0000-0003-0277-1872	Research Foundation of the University of Helsinki; Finnish Concordia Fund; Ella and Georg Ehrnrooth Foundation; Academy of Finland [1110906]; HOK-Elanto; government of Canada; Ontario Genomics Institute	Research Foundation of the University of Helsinki; Finnish Concordia Fund; Ella and Georg Ehrnrooth Foundation; Academy of Finland(Academy of Finland); HOK-Elanto; government of Canada(CGIAR); Ontario Genomics Institute	This work was supported by the Research Foundation of the University of Helsinki (MK) (http:// www.helsinki.fi/tiedesaatio/english/), Finnish Concordia Fund (MK) (https://www.konkordia-liitto.com/index. html), Ella and Georg Ehrnrooth Foundation (MK, MN) (http://www.ellageorg.fi/en/about), Academy of Finland LK (project 1110906) (http:// www.aka.fi/en-GB/A/), HOK-Elanto LK (http://www.hok-elanto.fi/in-brief/), and the government of Canada through Genome Canada and the Ontario Genomics Institute in support of the International Barcode of Life project PDNH (http://www.genomecanada.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; [Anonymous], 2010, MICROLEPIDOPT EUROPE, DOI [10.1163/9789004260986, DOI 10.1163/9789004260986]; Ardila NE, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-246; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Barco A, 2013, ZOOL J LINN SOC-LOND, V169, P389, DOI 10.1111/zoj.12069; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barrett CF, 2011, MOL ECOL, V20, P2771, DOI 10.1111/j.1365-294X.2011.05124.x; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Brewer MS, 2012, MOL PHYLOGENET EVOL, V64, P232, DOI 10.1016/j.ympev.2012.04.003; Brown SDJ, 2012, MOL ECOL RESOUR, V12, P562, DOI 10.1111/j.1755-0998.2011.03108.x; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Condamine FL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-82; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; DeWaard Jeremy R., 2008, V410, P275; Dinca V, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1329; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, PACKAGE SPLITS SPECI; Farris J.S., 1981, Advances in Cladistics, V1, P3; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gernhard T, 2008, J MATH BIOL, V57, P713, DOI 10.1007/s00285-008-0186-y; Glez-Pena D, 2010, NUCLEIC ACIDS RES, V38, pW14, DOI 10.1093/nar/gkq321; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Hausmann A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084518; Hebert PDN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068535; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heikkila Maria, 2014, Cladistics, V30, P563, DOI 10.1111/cla.12064; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hendrixson BE, 2013, MOL PHYLOGENET EVOL, V66, P327, DOI 10.1016/j.ympev.2012.10.004; Hodges R.W., 1998, LEPIDOPTERA MOTHS BU, VIV, P131, DOI DOI 10.1515/9783110804744.131; Huemer Peter, 1999, Microlepidoptera of Europe, V3, P1; Huemer P, 2012, ZOOTAXA, P1; Huemer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115774; Huemer P, 2011, ZOOTAXA, P1; Huemer P, 2013, ZOOTAXA, V 3746, P69, DOI 10.11646/zootaxa.3746.1.3; Jorger KM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-245; Jones M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019259; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kaila L, 2006, ZOOTAXA, P1; Kaila L, 2011, MONOGR AUST LEPIDOPT, V11, P1; Kaila L, 2011, MOL PHYLOGENET EVOL, V61, P801, DOI 10.1016/j.ympev.2011.08.016; Kekkonen M, 2014, MOL ECOL RESOUR, V14, P706, DOI 10.1111/1755-0998.12233; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kingman J., 1982, STOCH PROC APPL, V13, P235, DOI [DOI 10.1016/0304-4149(82)90011-4, 10.1016/0304-4149(82)90011-4]; Kullberg J., 2002, SAHLBERGIA, V6, P45; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Landry JF, 2013, ZOOKEYS, P43, DOI 10.3897/zookeys.327.5831; MICHENER CD, 1957, EVOLUTION, V11, P130, DOI 10.2307/2406046; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Mutanen M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02901; Mutanen M, 2015, MOL ECOL RESOUR, V15, P967, DOI 10.1111/1755-0998.12361; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Pantaleoni RA, 2012, B INSECTOL, V65, P139; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paz A, 2012, J BIOSCIENCES, V37, P887, DOI 10.1007/s12038-012-9255-x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Pons J, 2011, MOL PHYLOGENET EVOL, V59, P251, DOI 10.1016/j.ympev.2011.02.013; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Prevot V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060736; Prockow M, 2013, ZOOL J LINN SOC-LOND, V169, P124, DOI 10.1111/zoj.12048; Puillandre N, 2012, MOL ECOL, V21, P2671, DOI 10.1111/j.1365-294X.2012.05559.x; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2007, TRACER V1 4; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ratnasingham S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066213; Ceccarelli FS, 2012, MOL PHYLOGENET EVOL, V62, P485, DOI 10.1016/j.ympev.2011.10.018; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sauer J, 2012, CLADISTICS, V28, P300, DOI 10.1111/j.1096-0031.2011.00382.x; Seehausen Ole, 2009, P155; Sipek P, 2011, SYST ENTOMOL, V36, P628, DOI 10.1111/j.1365-3113.2011.00582.x; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Sites JW, 2003, TRENDS ECOL EVOL, V18, P462, DOI 10.1016/S0169-5347(03)00184-8; Tanzler R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028832; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TEMPLETON AR, 1992, GENETICS, V132, P619; Vahtera V, 2006, CLADISTICS, V22, P222, DOI 10.1111/j.1096-0031.2006.00099.x; Weigand AM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-18; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	94	89	92	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122481	10.1371/journal.pone.0122481	http://dx.doi.org/10.1371/journal.pone.0122481			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849083	Green Published, gold			2022-12-26	WOS:000352477800132
J	Wang, HJ; Si, QJ; Shan, ZL; Guo, YT; Lin, K; Zhao, XN; Wang, YT				Wang, Hai-Jun; Si, Quan-Jin; Shan, Zhao-Liang; Guo, Yu-Tao; Lin, Kun; Zhao, Xiao-Ning; Wang, Yu-Tang			Effects of Body Mass Index on Risks for Ischemic Stroke, Thromboembolism, and Mortality in Chinese Atrial Fibrillation Patients: A Single-Center Experience	PLOS ONE			English	Article							GENDER-DIFFERENCES; PREDICTING STROKE; OBESITY; OUTCOMES	Background Obesity is considered to be related to recurrence of atrial fibrillation (AF), left atrial thrombus formation, and atrial remodeling. However, whether obesity is an independent risk factor for stroke and other thromboembolic events is still controversial. Objective This study aimed to investigate the effects of body mass index (BMI) on the risks of stroke, thromboembolism, and mortality in AF patients. Methods Patients who were diagnosed with nonvalvular AF were included in this observational, retrospective study. The study population was stratified by BMI at baseline. The Cox proportional hazard model was adopted to calculate adjusted hazard ratios of risk factors for adverse clinical events (stroke, thromboembolism, and mortality). Results A total of 1286 AF patients (males, 78.30%; mean age, 74.50 years; 94.48% paroxysmal AF) were followed up for a median of 2.1 years (IQR: 1.5-2.9 years). Overall, 159 patients died. A total of 84 strokes and 35 thromboembolic events occurred. Multivariate analysis showed that overweight (25.0 <= BMI<30.0 kg/m(2)) and age >= 75 years were independent risk factors for ischemic stroke (both P<0.01). Obesity (BMI >= 30.0 kg/m(2)), age >= 75 years, persistent/permanent AF, and prior thromboembolism were independent risk factors for thromboembolism (all P<0.05). Underweight (BMI <18.5 kg/m(2)), age >= 75 years, prior ischemic stroke/transient ischemic attack, renal dysfunction, and heart failure were independent risk factors for all-cause deaths (all P<0.05). Conclusions Overweight or obesity may be a risk factor of ischemic stroke and thromboembolism in AF patients. Excessive low weight is significantly associated with increased all-cause mortality.	[Wang, Hai-Jun; Guo, Yu-Tao; Zhao, Xiao-Ning; Wang, Yu-Tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China; [Si, Quan-Jin] Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Healthcare Dept 2, Sanya, Peoples R China; [Shan, Zhao-Liang; Lin, Kun] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Si, QJ (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hainan Branch, Healthcare Dept 2, Sanya, Peoples R China.	quanjin2004@sohu.com; wangyutang2014@163.com			Science and Technology Innovation Fund of Chinese PLA General Hospital [14KMM14]	Science and Technology Innovation Fund of Chinese PLA General Hospital	This work was supported by the Science and Technology Innovation Fund of Chinese PLA General Hospital (14KMM14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed HS, 2013, HEART RHYTHM, V10, P90, DOI 10.1016/j.hrthm.2012.08.043; Azarbal F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001127; Badheka AO, 2010, AM J MED, V123, P646, DOI 10.1016/j.amjmed.2009.11.026; Banerjee A, 2013, INT J CARDIOL, V167, P2682, DOI 10.1016/j.ijcard.2012.06.118; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Chilukuri K, 2010, J CARDIOVASC ELECTR, V21, P521, DOI 10.1111/j.1540-8167.2009.01653.x; Di Angelantonio E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4986; Disertori M, 2013, BMC CARDIOVASC DISOR, V13, DOI 10.1186/1471-2261-13-28; Dublin S, 2006, ARCH INTERN MED, V166, P2322, DOI 10.1001/archinte.166.21.2322; Facila L, 2013, WORLD J CARDIOL, V5, P124, DOI 10.4330/wjc.v5.i5.124; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Guglin M, 2011, AM J CARDIOL, V107, P579, DOI 10.1016/j.amjcard.2010.10.018; Karasoy D, 2013, EUROPACE, V15, P781, DOI 10.1093/europace/eus422; Letsas KP, 2009, EUROPACE, V11, P158, DOI 10.1093/europace/eun309; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Naderi S, 2014, ETHNIC DIS, V24, P144; Nakagawa K, 2011, AM J CARDIOL, V107, P912, DOI 10.1016/j.amjcard.2010.10.074; Novo G, 2008, INT ANGIOL, V27, P433; Overvad TF, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2012.11.024; Poli D, 2013, THROMB RES, V131, P12, DOI 10.1016/j.thromres.2012.10.009; Reas DL, BMC PUBLIC HLTH, V30, P267; Rosito GA, 2004, THROMB HAEMOSTASIS, V91, P683, DOI 10.1160/TH03-01-0014; Sasahara E, 2012, J CARDIOL, V60, P484, DOI 10.1016/j.jjcc.2012.09.001; Schnabel RB, 2009, AM J CARDIOL, V104, P92, DOI 10.1016/j.amjcard.2009.02.053; Shen AYJ, 2008, CNS DRUGS, V22, P815, DOI 10.2165/00023210-200822100-00003; Shen AYJ, 2010, J NATL MED ASSOC, V102, P906; Singer DE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000250; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tang RB, 2009, AM J CARDIOL, V104, P1699, DOI 10.1016/j.amjcard.2009.07.054; Tsadok MA, 2012, JAMA-J AM MED ASSOC, V307, P1952, DOI 10.1001/jama.2012.3490; Tsang TSM, 2008, EUR HEART J, V29, P2227, DOI 10.1093/eurheartj/ehn324; Wang J, 2014, INT J CARDIOL, V176, P1356, DOI 10.1016/j.ijcard.2014.07.264; Yazdan-Ashoori P, 2011, INT J CARDIOL, V146, P131, DOI 10.1016/j.ijcard.2010.10.104	34	22	21	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123516	10.1371/journal.pone.0123516	http://dx.doi.org/10.1371/journal.pone.0123516			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848965	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800239
J	Zhang, YY; George, J; Li, Y; Olufade, R; Zhao, XY				Zhang, Yuanyuan; George, Jasmine; Li, Yun; Olufade, Rebecca; Zhao, Xueying			Matrix Metalloproteinase-9 Expression Is Enhanced in Renal Parietal Epithelial Cells of Zucker Diabetic Fatty Rats and Is Induced by Albumin in In Vitro Primary Parietal Cell Culture	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY INJURY; MURINE MODEL; NEPHROPATHY; MMP-9; PODOCYTOPENIA; SUPPRESSION; MODULATION; PODOCYTES; MIGRATION	As a subfamily of matrix metalloproteinases (MMPs), gelatinases including MMP-2 and MMP-9 play an important role in remodeling and homeostasis of the extracellular matrix. However, conflicting results have been reported regarding their expression level and activity in the diabetic kidney. This study investigated whether and how MMP-9 expression and activity were changed in glomerular epithelial cells upon albumin overload. In situ zymography, immunostaining and Western blot for renal MMP gelatinolytic activity and MMP-9 protein expression were performed in Zucker lean and Zucker diabetic rats. Confocal microscopy revealed a focal increase in gelatinase activity and MMP-9 protein in the glomeruli of diabetic rats. Increased glomerular MMP-9 staining was mainly observed in hyperplastic parietal epithelial cells (PECs) expressing claudin-1 in the diabetic kidneys. Interestingly, increased parietal MMP-9 was often accompanied by decreased staining for podocyte markers (nephrin and podocalyxin) in the sclerotic area of affected glomeruli in diabetic rats. Additionally, urinary excretion of podocyte marker proteins was significantly increased in association with the levels of MMP-9 and albumin in the urine of diabetic animals. To evaluate the direct effect of albumin on expression and activity of MMP-9, primary cultured rat glomerular PECs were incubated with rat serum albumin (0.25 - 1 mg/ml) for 24 - 48 hrs. MMP-9 mRNA levels were significantly increased following albumin treatment. Meanwhile, albumin administration resulted in a dose-dependent increase in MMP-9 protein and activity in culture supernatants of PECs. Moreover, albumin activated p44/42 mitogen-activated protein kinase (MAPK) in PECs. Inhibition of p44/42 MAPK suppressed albumin-induced MMP-9 secretion from glomerular PECs. Taken together, we have demonstrated that an up-regulation of MMP-9 in activated parietal epithelium is associated with a loss of adjacent podocytes in progressive diabetic nephropathy. Albumin overload may induce MMP-9 expression and secretion by PECs via the activation of p44/42 MAPK pathway.	[Zhang, Yuanyuan; George, Jasmine; Li, Yun; Olufade, Rebecca; Zhao, Xueying] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Morehouse School of Medicine	Zhao, XY (corresponding author), Morehouse Sch Med, Dept Physiol, 720 Westview Dr Sw, Atlanta, GA 30310 USA.	xzhao@msm.edu	zhang, yuanyuan/GYA-4428-2022	George, Jasmine/0000-0002-6999-5099	National Institutes of Health [SDK096441, NIH/NCRR G12-RR03034, NIH/NCRR U54RR026137]; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026137, G12RR003034] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health SDK096441, NIH/NCRR G12-RR03034 and U54RR026137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja TS, 2003, NEPHRON CLIN PRACT, V95, pC100, DOI 10.1159/000074323; Antonio RC, 2014, MOL CELL BIOCHEM, V386, P99, DOI 10.1007/s11010-013-1848-7; Bai YL, 2006, CELL PHYSIOL BIOCHEM, V17, P57, DOI 10.1159/000091464; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Caron A, 2005, CAN J PHYSIOL PHARM, V83, P287, DOI 10.1139/Y05-011; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; Fang Z, 2009, J HUAZHONG U SCI-MED, V29, P710, DOI 10.1007/s11596-009-0607-1; Kawata N, 2006, UROLOGY, V68, P523, DOI 10.1016/j.urology.2006.03.063; Kothari P, 2014, J IMMUNOL, V192, P349, DOI 10.4049/jimmunol.1301906; Kuroda Tadahide, 2004, Clin Exp Nephrol, V8, P206; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Li YJ, 2008, AM J PATHOL, V172, P299, DOI 10.2353/ajpath.2008.070057; Liu SY, 2006, MOL CELL BIOCHEM, V284, P9, DOI 10.1007/s11010-005-9005-6; McLennan SV, 2002, DIABETOLOGIA, V45, P268, DOI 10.1007/s00125-001-0730-4; Mikami S, 2015, INT J CANCER, V136, P1504, DOI 10.1002/ijc.29137; Morigi M, 2002, J AM SOC NEPHROL, V13, P1179; Ohse T, 2009, AM J PHYSIOL-RENAL, V297, pF1566, DOI 10.1152/ajprenal.00214.2009; Ohse T, 2009, KIDNEY INT, V76, P1225, DOI 10.1038/ki.2009.386; Ohtomo S, 2008, KIDNEY INT, V74, P768, DOI 10.1038/ki.2008.302; Orgaz JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5255; Ralay R. H., 2011, J NEUROTRAUM, V28, P1757, DOI DOI 10.1089/NEU.2011.1799; Ranaivo HR, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-68; Shankland SJ, 2013, CURR OPIN NEPHROL HY, V22, P302, DOI 10.1097/MNH.0b013e32835fefd4; Smeets B, 2011, J AM SOC NEPHROL, V22, P1262, DOI 10.1681/ASN.2010090970; Smeets B, 2009, J AM SOC NEPHROL, V20, P2604, DOI 10.1681/ASN.2009010122; Strutz F, 2002, KIDNEY INT, V61, P1714, DOI 10.1046/j.1523-1755.2002.00333.x; Suzuki T, 2009, AM J PATHOL, V174, P1675, DOI 10.2353/ajpath.2009.080789; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Venkatareddy M, 2014, J AM SOC NEPHROL, V25, P1118, DOI 10.1681/ASN.2013080859; WATANABE K, 1990, NEPHRON, V56, P405, DOI 10.1159/000186184; Weil EJ, 2012, KIDNEY INT, V82, P1010, DOI 10.1038/ki.2012.234; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Whitney JL, 2013, BIOL SEX DIFFER, V4, DOI 10.1186/2042-6410-4-12; Wong CY, 2008, PATHOLOGY, V40, P52, DOI 10.1080/00313020701716367; Yang CQ, 2014, CELL PHYSIOL BIOCHEM, V34, P266, DOI 10.1159/000362997; Yang JW, 2002, J CLIN INVEST, V110, P1525, DOI 10.1172/JC1200216219; Yao XM, 2010, J ENDOCRINOL INVEST, V33, P292, DOI [10.1007/BF03346588, 10.3275/6558]; Yao XM, 2009, DIABETES OBES METAB, V11, P519, DOI 10.1111/j.1463-1326.2008.00990.x; Yaoita E, 2001, CELL TISSUE RES, V304, P339; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zhao Hong, 2013, World J Nephrol, V2, P84, DOI 10.5527/wjn.v2.i3.84; Zhao XY, 2011, AM J NEPHROL, V34, P268, DOI 10.1159/000330187	42	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123276	10.1371/journal.pone.0123276	http://dx.doi.org/10.1371/journal.pone.0123276			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849723	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800221
J	Gowrishankar, K; Gunatilake, D; Gallagher, SJ; Tiffen, J; Rizos, H; Hersey, P				Gowrishankar, Kavitha; Gunatilake, Dilini; Gallagher, Stuart J.; Tiffen, Jessamy; Rizos, Helen; Hersey, Peter			Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-kappa B	PLOS ONE			English	Article							UP-REGULATION; TUMOR-SUPPRESSOR; B7-H1 EXPRESSION; BRAF INHIBITION; APOPTOSIS; INFLAMMATION; KINASE; SAFETY; GAMMA; TRANSCRIPTION	Monoclonal antibodies against immune checkpoint blockade have proven to be a major success in the treatment of melanoma. The programmed death receptor-1 ligand-1 (PD-L1) expression on melanoma cells is believed to have an inhibitory effect on T cell responses and to be an important escape mechanism from immune attack. Previous studies have shown that PD-L1 can be expressed constitutively or can be induced by IFN-gamma secreted by infiltrating lymphocytes. In the present study we have investigated the mechanism underlying these two modes of PD-L1 expression in melanoma cells including cells that had acquired resistance to the BRAF inhibitor vemurafenib. PD-L1 expression was examined by flow cytometry and immunoblotting. Specific inhibitors and siRNA knockdown approaches were used to examine the roles of the RAF/MEK, PI3K, NF-kappa B, STAT3 and AP1/c-Jun pathways. IFN-gamma inducible expression of PD-L1 was dependent on NF-kappa B as shown by inhibition with BMS-345541, an inhibitor of I kappa B and the BET protein inhibitor I-BET151, as well as by siRNA knockdown of NF-kappa B subunits. We were unable to implicate the BRAF/MEK pathway as major regulators in PD-L1 expression on vemurafenib resistant cells. Similarly the PI3K/AKT pathway and the transcription factors STAT3 and c-Jun had only minor roles in IFN-gamma induced expression of PD-L1. The mechanism underlying constitutive expression remains unresolved. We suggest these results have significance in selection of treatments that can be used in combination with monoclonal antibodies against PD1, to enhance their effectiveness and to reduce inhibitory effects melanoma cells have against cytotoxic T cell activity.	[Gowrishankar, Kavitha; Gunatilake, Dilini; Gallagher, Stuart J.; Tiffen, Jessamy; Hersey, Peter] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Melanoma Res, Sydney, NSW 2006, Australia; [Rizos, Helen] Macquarie Univ, Fac Med & Hlth Sci, Sydney, NSW 2109, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Macquarie University	Hersey, P (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Melanoma Res, Sydney, NSW 2006, Australia.	peter.hersey@sydney.edu.au	Rizos, Helen/AAE-5010-2020; Gallagher, Stuart/S-6718-2019	Rizos, Helen/0000-0002-2094-9198; Gallagher, Stuart/0000-0003-2651-9671	Australian National Health and Medical Research Council (NHMRC) [633004]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	The study was supported by the program grant 633004 from the Australian National Health and Medical Research Council (NHMRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Atefi M, 2014, CLIN CANCER RES, V20, P3446, DOI 10.1158/1078-0432.CCR-13-2797; Azuma K, 2014, ANN ONCOLOGY OFFICIA; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Chen J, 2012, CANCER IMMUNOL IMMUN, V61, P101, DOI 10.1007/s00262-011-1094-3; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Franco AV, 2001, J IMMUNOL, V166, P5337, DOI 10.4049/jimmunol.166.9.5337; Gallagher SJ, 2014, J INVEST DERMATOL; Gallagher SJ, 2014, PIGMENT CELL MELANOM; Gowrishankar K, 2012, J INVEST DERMATOL, V132, P1850, DOI 10.1038/jid.2012.63; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hamid O, 2013, EXPERT OPIN BIOL TH, V13, P847, DOI 10.1517/14712598.2013.770836; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; He XH, 2005, ACTA PHARMACOL SIN, V26, P462, DOI 10.1111/j.1745-7254.2005.00086.x; Huang G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061602; Irvine M, 2010, CELL CYCLE, V9, P829, DOI 10.4161/cc.9.4.10785; Jiang XF, 2013, CLIN CANCER RES, V19, P598, DOI 10.1158/1078-0432.CCR-12-2731; Kamphorst AO, 2013, CURR OPIN IMMUNOL, V25, P381, DOI 10.1016/j.coi.2013.03.003; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Lai F, 2012, MELANOMA RES, V22, P244, DOI 10.1097/CMR.0b013e328353eff2; Lee SJ, 2006, FEBS LETT, V580, P755, DOI 10.1016/j.febslet.2005.12.093; Lee SK, 2005, J DERMATOL SCI, V40, P95, DOI 10.1016/j.jdermsci.2005.06.008; Li N, 2011, CANCER CELL, V19, P429, DOI 10.1016/j.ccr.2011.03.018; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Mijatov BSK, 2012, PIGM CELL MELANOMA R, V25, P875; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Parsa AT, 2007, NAT MED, V13, P84, DOI 10.1038/nm1517; Perkins ND, 2012, NAT REV CANCER, V12, P121, DOI 10.1038/nrc3204; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Smale ST, 2012, IMMUNOL REV, V246, P193, DOI 10.1111/j.1600-065X.2011.01091.x; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Taube JM, 2014, CLIN CANC RES; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2013, J CLIN ONCOL, V31; Ueda Y, 2006, PIGM CELL RES, V19, P112, DOI 10.1111/j.1600-0749.2006.00304.x; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Yang JM, 2006, CLIN CANCER RES, V12, P950, DOI 10.1158/1078-0432.CCR-05-1220; Zhang XD, 1999, CANCER RES, V59, P2747	43	157	170	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123410	10.1371/journal.pone.0123410	http://dx.doi.org/10.1371/journal.pone.0123410			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844720	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700021
J	Jian, WS; Wu, MS; Shi, HL; Wang, LT; Zhang, L; Luo, SQ				Jian, Wushuai; Wu, Mingshu; Shi, Hongli; Wang, Liting; Zhang, Lu; Luo, Shuqian			Signs Analysis and Clinical Assessment: Phase-Contrast Computed Tomography of Human Breast Tumours	PLOS ONE			English	Article							SYNCHROTRON-RADIATION; HIGH-RESOLUTION; MAMMOGRAPHY; CANCER; RADIOLOGY; CT; VISUALIZATION; CARCINOMA; SPECIMENS	Purpose To analyse the diagnostic signs present in slices of human breast tumour specimens using synchrotron radiation phase-contrast imaging computed tomography (PCI-CT) for the first time and assess the feasibility of this technique for clinical applications. Materials and Methods The ethics committee of our university and relevant clinical hospital approved this prospective study, and written informed consent was obtained from all patients. PCI-CT of human breast tumour specimens with synchrotron radiation was performed at the Shanghai Synchrotron Radiation Facility (SSRF). A total of 14 specimens of early-stage carcinomas and 8 specimens of adenomas were enrolled. Based on raw data reconstruction, the diagnostic signs present in the slices were analysed and correlated with histopathology. We proposed a criterion for clinical diagnosis according to the evaluated signs and the Breast Imaging Reporting and Data System (BI-RADS) for reference. The criterion was then assessed by clinicians in a double-blind method. Finally, descriptive statistics were evaluated, depending on the assessment results. Results The 14 carcinoma specimens and 8 adenoma specimens were diagnosed as malignant and benign tumours, respectively. The total coincidence rate was 100%. Conclusion Our study results demonstrate that the X-ray diagnostic signs observed in the specimen slices and the criterion used for clinical diagnosis were accurate and reliable. The criterion based on signs analysis can be used to differentiate early-stage benign or malignant tumours. As a promising imaging method, PCI-CT can serve as a possible and feasible supplement to BI-RADS in the future.	[Jian, Wushuai; Wu, Mingshu; Shi, Hongli; Wang, Liting; Zhang, Lu; Luo, Shuqian] Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China	Capital Medical University	Luo, SQ (corresponding author), Capital Med Univ, Sch Biomed Engn, Beijing, Peoples R China.	sqluo@ieee.org			National Natural Science Foundation of China [60532090, 61227802, 30770593]; 7th Framework Programme of the European Community [PIRSES-GA-2009-269124]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 7th Framework Programme of the European Community	This work was supported by the National Natural Science Foundation of China (Grant Numbers 60532090, 61227802 and 30770593) and was partly supported by the 7th Framework Programme of the European Community (Grant Agreement Number: PIRSES-GA-2009-269124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACR, 2003, ACR BI RADS MRI BREA; Arfelli F, 1998, PHYS MED BIOL, V43, P2845, DOI 10.1088/0031-9155/43/10/013; Arfelli F, 2000, RADIOLOGY, V215, P286, DOI 10.1148/radiology.215.1.r00ap10286; Benson JR, 2012, FUTURE ONCOL, V8, P697, DOI [10.2217/fon.12.61, 10.2217/FON.12.61]; Bravin A, 2007, PHYS MED BIOL, V52, P2197, DOI 10.1088/0031-9155/52/8/011; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; BURATTINI E, 1995, RADIOLOGY, V195, P239, DOI 10.1148/radiology.195.1.7892478; Burattini E, 1992, Radiol Med, V84, P181; Castelli E, 2011, RADIOLOGY, V259, P684, DOI 10.1148/radiol.11100745; Chen RC, 2012, J SYNCHROTRON RADIAT, V19, P836, DOI 10.1107/S0909049512029731; Curado MP, 2011, SALUD PUBLICA MEXICO, V53, P372; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Fernandez M, 2005, PHYS MED BIOL, V50, P2991, DOI 10.1088/0031-9155/50/13/002; Fiedler S, 2004, PHYS MED BIOL, V49, P175, DOI 10.1088/0031-9155/49/2/001; Fitzgerald R, 2000, PHYS TODAY, V53, P23, DOI 10.1063/1.1292471; Gao DC, 1998, RADIOGRAPHICS, V18, P1257, DOI 10.1148/radiographics.18.5.9747618; Karellas A, 2008, MED PHYS, V35, P4878, DOI 10.1118/1.2986144; Keyrilainen J, 2005, EUR J RADIOL, V53, P226, DOI 10.1016/j.ejrad.2004.03.015; Keyrilainen J, 2010, ACTA RADIOL, V51, P866, DOI 10.3109/02841851.2010.504742; Kilburn-Toppin F, 2013, CLIN ONCOL-UK, V25, P93, DOI 10.1016/j.clon.2012.10.002; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Liberman L, 2002, RADIOL CLIN N AM, V40, P409, DOI 10.1016/S0033-8389(01)00017-3; Margaritondo G, 2003, EUR RADIOL, V13, P2633, DOI 10.1007/s00330-003-2073-7; Morimoto T, 2009, BREAST CANCER-TOKYO, V16, P2, DOI 10.1007/s12282-008-0077-5; Olivo A, 2009, APPL RADIAT ISOTOPES, V67, P1033, DOI 10.1016/j.apradiso.2009.01.075; Pisano ED, 2000, RADIOLOGY, V214, P895, DOI 10.1148/radiology.214.3.r00mr26895; Quai E, 2013, RADIOL MED, V118, P89, DOI 10.1007/s11547-012-0847-1; Schmidt MM, 2011, CLIN OBSTET GYNECOL, V54, P103, DOI 10.1097/GRF.0b013e31820800c2; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sledge George W Jr, 2004, Clin Breast Cancer, V5, P11; Smetherman DH, 2013, SURG CLIN N AM, V93, P309, DOI 10.1016/j.suc.2013.01.004; Smith JA, 2004, ANN ONCOL, V15, pI18, DOI 10.1093/annonc/mdh653; Sztrokay A, 2012, PHYS MED BIOL, V57, P2931, DOI 10.1088/0031-9155/57/10/2931; Sztrokay A, 2013, EUR RADIOL, V23, P381, DOI 10.1007/s00330-012-2592-1; Tao Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039936; Vanel D, 2007, EUR J RADIOL, V61, P183, DOI 10.1016/j.ejrad.2006.08.030; Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Williams IM, 2008, EUR J RADIOL, V68, pS73, DOI 10.1016/j.ejrad.2008.04.042; Wise J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3780; Xi Y, 2012, J SYNCHROTRON RADIAT, V19, P821, DOI 10.1107/S0909049512029354; Zhang L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017400; Zhang L, 2011, EUR J RADIOL, V80, P158, DOI 10.1016/j.ejrad.2010.08.019; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109; Zhou SA, 2008, PHYS MEDICA, V24, P129, DOI 10.1016/j.ejmp.2008.05.006	44	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0124143	10.1371/journal.pone.0124143	http://dx.doi.org/10.1371/journal.pone.0124143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844722	gold, Green Published, Green Submitted			2022-12-26	WOS:000352475700025
J	Bolsheva, NL; Zelenin, AV; Nosova, IV; Amosova, AV; Samatadze, TE; Yurkevich, OY; Melnikova, NV; Zelenina, DA; Volkov, AA; Muravenko, OV				Bolsheva, Nadezhda L.; Zelenin, Alexander V.; Nosova, Inna V.; Amosova, Alexandra V.; Samatadze, Tatiana E.; Yurkevich, Olga Yu.; Melnikova, Nataliya V.; Zelenina, Daria A.; Volkov, Alexander A.; Muravenko, Olga V.			The Diversity of Karyotypes and Genomes within Section Syllinum of the Genus Linum (Linaceae) Revealed by Molecular Cytogenetic Markers and RAPD Analysis	PLOS ONE			English	Article							B-CHROMOSOME; PATTERNS; ADENOLINUM; ORIGIN; GENES; PCR	The wide variation in chromosome number found in species of the genus Linum (2n = 16, 18, 20, 26, 28, 30, 32, 36, 42, 72, 84) indicates that chromosomal mutations have played an important role in the speciation of this taxon. To contribute to a better understanding of the genetic diversity and species relationships in this genus, comparative studies of karyotypes and genomes of species within section Syllinum Griseb. (2n = 26, 28) were carried out. Elongated with 9-aminoacridine chromosomes of 10 species of section Syllinum were investigated by C-and DAPI/.-banding, CMA and Ag-NOR-staining, FISH with probes of rDNA and of telomere repeats. RAPD analysis was also performed. All the chromosome pairs in karyotypes of the studied species were identified. Chromosome DAPI/C-banding patterns of 28-chromosomal species were highly similar. Two of the species differed from the others in chromosomal location of rDNA sites. B chromosomes were revealed in all the 28-chromosomal species. Chromosomes of Linum nodiflorum L. (2n = 26) and the 28-chromosomal species were similar in DAPI/C-banding pattern and localization of several rDNA sites, but they differed in chromosomal size and number. The karyotype of L. nodiflorum was characterized by an intercalary site of telomere repeat, one additional 26S rDNA site and also by the absence of B chromosomes. Structural similarities between different chromosome pairs in karyotypes of the studied species were found indicating their tetraploid origin. RAPD analysis did not distinguish the species except L. nodiflorum. The species of section Syllinum probably originated from a common tetraploid ancestor. The 28-chromosomal species were closely related, but L. nodiflorum diverged significantly from the rest of the species probably due to chromosomal rearrangements occurring during evolution.	[Bolsheva, Nadezhda L.; Zelenin, Alexander V.; Nosova, Inna V.; Amosova, Alexandra V.; Samatadze, Tatiana E.; Yurkevich, Olga Yu.; Melnikova, Nataliya V.; Muravenko, Olga V.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia; [Zelenina, Daria A.; Volkov, Alexander A.] Russian Fed Res Inst Fisheries & Oceanog, Moscow, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Research lnstitute of Fisheries & Oceanography	Bolsheva, NL (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	nlbolsheva@mail.ru	Tatiana, Samatadze/AAD-4816-2019; Zelenina, Daria/AAK-2025-2021; Melnikova, Nataliya V./E-5894-2014; Yurkevich, Olga Yu./CAF-7659-2022; Volkov, Alexander A/C-8405-2014; Yurkevich, Olga Yu./CAI-2654-2022; Muravenko, Olga/A-3889-2017	Tatiana, Samatadze/0000-0002-1012-3560; Melnikova, Nataliya V./0000-0001-8083-3018; Yurkevich, Olga Yu./0000-0003-4124-2367; Volkov, Alexander A/0000-0002-4305-8726; Yurkevich, Olga Yu./0000-0003-4124-2367; Muravenko, Olga/0000-0003-3150-8598	Russian Foundation of Basic Research [13-04-01770, 14-08-01167, 15-04-08519]	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR))	The Russian Foundation of Basic Research (https://kias.rfbr.ru/) grant N 13-04-01770 AZ; grant N 14-08-01167 OM; grant N 15-04-08519 NB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolkhovskikh Z., 1969, CHROMOSOME NUMBERS F; CHENNAVEERAIAH MS, 1983, CYTOLOGIA, V48, P833, DOI 10.1508/cytologia.48.833; COX AV, 1993, ANN BOT-LONDON, V72, P239, DOI 10.1006/anbo.1993.1104; Dhar MK, 2002, CHROMOSOMA, V111, P332, DOI 10.1007/s00412-002-0214-4; Fu YB, 2010, GENET RESOUR CROP EV, V57, P667, DOI 10.1007/s10722-009-9502-7; GILL KS, 1967, CROP SCI, V7, P623, DOI 10.2135/cropsci1967.0011183X000700060021x; Goldblatt P., 1979, INDEX PLANT CHROMOSO; Guerra M, 2000, GENET MOL BIOL, V23, P1029, DOI 10.1590/S1415-47572000000400049; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; JAMILENA M, 1994, J CELL SCI, V107, P703; Jones N, 2003, TRENDS PLANT SCI, V8, P417, DOI 10.1016/S1360-1385(03)00187-0; JONES RN, 1975, INT REV CYTOL, V40, P1, DOI 10.1016/S0074-7696(08)60951-1; Jones RN, 1995, NEW PHYTOL, V131, P411, DOI 10.1111/j.1469-8137.1995.tb03079.x; Kutuzova SN, 1999, T BOT GENET SEL, V156, P29; Leach CR, 2005, GENETICS, V171, P269, DOI 10.1534/genetics.105.043273; McDill J, 2009, SYST BOT, V34, P386, DOI 10.1600/036364409788606244; McDill JR, 2011, BOT J LINN SOC, V165, P64, DOI 10.1111/j.1095-8339.2010.01096.x; Melnikova NV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/231589; Muravenko O V, 2010, Genetika, V46, P1339; Muravenko OV, 2009, RUSS J GENET+, V45, P1338, DOI 10.1134/S1022795409110088; Muravenko OV, 2009, GENETICA, V135, P245, DOI 10.1007/s10709-008-9273-7; Muravenko OV, 2003, CYTOM PART A, V51A, P52, DOI 10.1002/cyto.a.10002; Nosova IV, 2005, BIOL MEMBRANY, V22, P244; Nosova IV, 2008, COT ZHURN RUSSIA, V91, P138; Optasyuk OM, 2010, UKR BOT ZH, V67, P405; Phitos D, 1988, BOT CHRON, V8, P45; Rachinskaia O A, 2011, Genetika, V47, P65; Ray C, 1944, AM J BOT, V31, P241, DOI 10.2307/2437613; Saleem M, 2005, NAT PROD REP, V22, P696, DOI 10.1039/b514045p; Schmidt TJ, 2010, PHYTOCHEMISTRY, V71, P1714, DOI 10.1016/j.phytochem.2010.06.015; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; [Светлова А.А. Svetlova A.], 2009, [Новости систематики высших растений, Novitates Systematicae Plantarum Vascularium, Novosti sistematiki vysshikh rastenii], P99; Velasco L, 2000, PLANT SYST EVOL, V221, P77, DOI 10.1007/BF01086382; Vromans J., 2006, THESIS WAGENINGEN U; Webb D.A., 1968, FLORA EUROPEA, V2, P206; Yurkevich OY, 2013, GENET RESOUR CROP EV, V60, P661, DOI 10.1007/s10722-012-9865-z; Zelenina DA, 2006, RUSS J GENET+, V42, P563, DOI 10.1134/S1022795406050140	37	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122015	10.1371/journal.pone.0122015	http://dx.doi.org/10.1371/journal.pone.0122015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835524	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000073
J	Dahlin, LB; Guner, N; Larsson, HE; Speidel, T				Dahlin, Lars B.; Guner, Nuray; Larsson, Helena Elding; Speidel, Toni			Vibrotactile Perception in Finger Pulps and in the Sole of the Foot in Healthy Subjects among Children or Adolescents	PLOS ONE			English	Article							VIBRATORY PERCEPTION; DETECTION THRESHOLDS; SENSE; NEUROPATHY; HAND; AGE; TEMPERATURE; SENSIBILITY; SENSITIVITY; STIMULI	Aims To evaluate vibrotactile perception at different frequencies in fingers and in foot in healthy girls and boys. Methods Vibration perception thresholds (VPTs) were measured in 283 healthy (8-20 years), consecutively included, girls (n= 146) and boys (n= 137); i.e., 269 children after excluding those with diseases or disorders possibly affecting the nervous system. Thresholds were measured in finger pulps of index and little fingers (seven frequencies; 8-500 Hz) and at first and fifth metatarsal head and at heel in the sole of the foot (six frequencies; 8-250 Hz;) using Multi Frequency Tactilometry. Results VPTs, divided in six groups by age and gender (i.e., 8-10 years, 11-15 years and 16-20 years), at all three sites in the sole increased with higher frequencies, but without gender differences. Thresholds at 64 and 125 Hz were generally higher at heel compared to metatarsal heads. VPTs in finger pulps of index and little fingers, with no finger differences, had a different pattern with increasing thresholds with frequency, but with lower thresholds at 64 and 125 Hz. Thresholds at lower frequencies were higher in finger pulps, while at higher frequencies VPTs were lower in finger pulps than in the sole of the foot; thus, vibration perception in the sole was better than perception in finger pulps at lower frequencies and opposite at higher frequencies. VPTs were higher among adolescents than in younger children in the foot, while thresholds were lower in the finger pulps among adolescents, particularly in index finger. Thresholds in finger pulps of index and little fingers, particularly at higher frequencies, correlated with each other, which the three sites in the sole also did. Conclusions VPTs in fingers and in feet are different as related to frequency in healthy girls and boys. Multi Frequency Tactilometry is a future valuable method to detect neuropathy in children and adolescents.	[Dahlin, Lars B.] Lund Univ, Skane Univ Hosp, Dept Translat Med Hand Surg, Malmo, Sweden; [Guner, Nuray] Skane Univ Hosp, Reg Skane Competence Ctr, Lund, Sweden; [Larsson, Helena Elding] Skane Univ Hosp, Dept Clin Sci Malmo Paediat Endocrinol, Malmo, Sweden; [Speidel, Toni] PID AB, Malmo, Sweden	Lund University; Skane University Hospital; Lund University; Skane University Hospital; Lund University; Skane University Hospital	Dahlin, LB (corresponding author), Lund Univ, Skane Univ Hosp, Dept Translat Med Hand Surg, Malmo, Sweden.	Lars.Dahlin@med.lu.se		Elding Larsson, Helena/0000-0003-3306-1742	Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane; University Hospital Malmo, Sweden	Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane; University Hospital Malmo, Sweden	The project was supported by grants from the Swedish Research Council (Medicine), Diabetesforeningen Malmo med omnejd, Region Skane and Funds from the University Hospital Malmo, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaberg ML, 2008, J DIABETES COMPLICAT, V22, P83, DOI 10.1016/j.jdiacomp.2007.06.009; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Blankenburg M, 2012, DIABETIC MED, V29, P1425, DOI 10.1111/j.1464-5491.2012.03685.x; Booya F, 2005, BMC NEUROL, V5, DOI 10.1186/1471-2377-5-24; Cederlund RI, 2009, J DIABETES COMPLICAT, V23, P32, DOI 10.1016/j.jdiacomp.2007.09.002; Chemnitz A, 2013, J BONE JOINT SURG AM, V95A, P329, DOI 10.2106/JBJS.L.00074; Dahlin LB, 2008, DIABETIC MED, V25, P543, DOI 10.1111/j.1464-5491.2008.02433.x; Dahlin LB, 2011, DIABETIC MED, V28, P1045, DOI 10.1111/j.1464-5491.2011.03328.x; Gardner E.P., 2000, PRINCIPLES NEURAL SC, P411; GESCHEIDER GA, 1994, SOMATOSENS MOT RES, V11, P345, DOI 10.3109/08990229409028878; Hilz MJ, 1998, J NEUROL SCI, V159, P219, DOI 10.1016/S0022-510X(98)00177-4; Inami K, 2005, J ORTHOP SCI, V10, P291, DOI 10.1007/s00776-005-0897-5; Karvestedt L, 2009, DIABETES CARE, V32, P317, DOI 10.2337/dc08-1250; LAMOTTE RH, 1975, J NEUROPHYSIOL, V38, P539, DOI 10.1152/jn.1975.38.3.539; Louraki M, 2012, DIABETES METAB, V38, P281, DOI 10.1016/j.diabet.2012.02.006; Louraki M, 2013, PRIM CARE DIABETES; LUNDBORG G, 1992, SCAND J PLAST RECONS, V26, P275, DOI 10.3109/02844319209015271; Lundborg GN, 2010, DIABETIC MED, V27, P823, DOI 10.1111/j.1464-5491.2010.03014.x; LUNDSTROM R, 1992, INT ARCH OCC ENV HEA, V64, P201, DOI 10.1007/BF00380910; LUNDSTROM RJ, 1986, SCAND J WORK ENV HEA, V12, P413, DOI 10.5271/sjweh.2121; MEH D, 1995, J NEUROL SCI, V134, P136, DOI 10.1016/0022-510X(95)00230-9; Meier PM, 2001, MUSCLE NERVE, V24, P1339, DOI 10.1002/mus.1153; MOUNTCASTLE VB, 1972, J NEUROPHYSIOL, V35, P122, DOI 10.1152/jn.1972.35.1.122; Nelander J, 2012, DIABETIC MED, V29, pe449, DOI 10.1111/dme.12024; O'Brien JC, 2008, J MOTOR BEHAV, V40, P43, DOI 10.3200/JMBR.40.1.43-61; OLSEN BS, 1994, DIABETIC MED, V11, P888, DOI 10.1111/j.1464-5491.1994.tb00374.x; Schlee G, 2012, RES DEV DISABIL, V33, P1957, DOI 10.1016/j.ridd.2012.05.020; Schlee G, 2009, CLIN NEUROPHYSIOL, V120, P1548, DOI 10.1016/j.clinph.2009.06.010; Stromberg T, 1998, SCAND J WORK ENV HEA, V24, P495, DOI 10.5271/sjweh.374; Thomsen NOB, 2011, DIABETIC MED, V28, P1401, DOI 10.1111/j.1464-5491.2011.03308.x; Thomsen NOB, 2009, DIABETIC MED, V26, P1120, DOI 10.1111/j.1464-5491.2009.02823.x; Thrainsdottir S, 2009, ACTA NEUROL SCAND, V120, P38, DOI 10.1111/j.1600-0404.2008.01118.x; VERRILLO RT, 1980, J GERONTOL, V35, P185, DOI 10.1093/geronj/35.2.185; Verrillo RT, 2003, SOMATOSENS MOT RES, V20, P133, DOI 10.1080/089902203100105163; Wikland KA, 2002, ACTA PAEDIATR, V91, P739, DOI 10.1080/08035250213216; Williams CM, 2012, J CHILD NEUROL, V27, P1017, DOI 10.1177/0883073811432748	36	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119753	10.1371/journal.pone.0119753	http://dx.doi.org/10.1371/journal.pone.0119753			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835710	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000014
J	Musoke, D; Miiro, G; Karani, G; Morris, K; Kasasa, S; Ndejjo, R; Nakiyingi-Miiro, J; Guwatudde, D; Musoke, MB				Musoke, David; Miiro, George; Karani, George; Morris, Keith; Kasasa, Simon; Ndejjo, Rawlance; Nakiyingi-Miiro, Jessica; Guwatudde, David; Musoke, Miph Boses			Promising Perceptions, Divergent Practices and Barriers to Integrated Malaria Prevention in Wakiso District, Uganda: A Mixed Methods Study	PLOS ONE			English	Article							INSECTICIDE-TREATED NETS; PERSONAL-PROTECTION; VECTOR CONTROL; INTERVENTIONS; ACHIEVEMENTS; COMMUNITIES; CHALLENGES; AFRICA; KENYA	Background The World Health Organization recommends use of multiple approaches to control malaria. The integrated approach to malaria prevention advocates the use of several malaria prevention methods in a holistic manner. This study assessed perceptions and practices on integrated malaria prevention in Wakiso district, Uganda. Methods A clustered cross-sectional survey was conducted among 727 households from 29 villages using both quantitative and qualitative methods. Assessment was done on awareness of various malaria prevention methods, potential for use of the methods in a holistic manner, and reasons for dislike of certain methods. Households were classified as using integrated malaria prevention if they used at least two methods. Logistic regression was used to test for factors associated with the use of integrated malaria prevention while adjusting for clustering within villages. Results Participants knew of the various malaria prevention methods in the integrated approach including use of insecticide treated nets (97.5%), removing mosquito breeding sites (89.1%), clearing overgrown vegetation near houses (97.9%), and closing windows and doors early in the evenings (96.4%). If trained, most participants (68.6%) would use all the suggested malaria prevention methods of the integrated approach. Among those who would not use all methods, the main reasons given were there being too many (70.2%) and cost (32.0%). Only 33.0% households were using the integrated approach to prevent malaria. Use of integrated malaria prevention by households was associated with reading newspapers (AOR 0.34; 95% CI 0.22 -0.53) and ownership of a motorcycle/car (AOR 1.75; 95% CI 1.03 - 2.98). Conclusion Although knowledge of malaria prevention methods was high and perceptions on the integrated approach promising, practices on integrated malaria prevention was relatively low. The use of the integrated approach can be improved by promoting use of multiple malaria prevention methods through various communication channels such as mass media.	[Musoke, David; Ndejjo, Rawlance] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda; [Miiro, George] Uganda Virus Res Inst, Entebbe, Uganda; [Karani, George; Morris, Keith] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff, S Glam, Wales; [Kasasa, Simon; Guwatudde, David] Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda; [Nakiyingi-Miiro, Jessica] Uganda Virus Res Inst, MRC, Entebbe, Uganda; [Musoke, Miph Boses] Nkumba Univ, Sch Sci, Entebbe, Uganda	Makerere University; Uganda Virus Research Institute; Cardiff Metropolitan University; Cardiff University; Makerere University; Uganda Virus Research Institute	Musoke, D (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Publ Hlth, Dept Dis Control & Environm Hlth, Kampala, Uganda.	dmusoke@musph.ac.ug		Musoke, David/0000-0003-3262-3918; Ndejjo, Rawlance/0000-0001-9263-557X	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust [087540]; TDR; Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank; WHO	Training Health Researchers into Vocational Excellence (THRiVE) in East Africa - Wellcome Trust; TDR; Special Programme for Research and Training in Tropical Diseases; UNICEF; UNDP; World Bank(The World Bank India); WHO(World Health Organization)	The work was supported by Training Health Researchers into Vocational Excellence (THRiVE) in East Africa, grant number 087540, funded by Wellcome Trust. This investigation also received financial support from TDR, the Special Programme for Research and Training in Tropical Diseases, co-sponsored by UNICEF, UNDP, the World Bank and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjah ESO, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-123; [Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 2013, J ENV HLTH RES; Babu BV, 2007, ANN TROP MED PARASIT, V101, P601, DOI 10.1179/136485907X193897; Berthelemy JC, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-200; Centers for Disease Control and Prevention, 2008, AN MOS; De Allegri M, 2013, INT J HEALTH PLAN M, V28, P102, DOI 10.1002/hpm.2116; Debboun M, 2013, MED VET ENTOMOL, V27, P1, DOI 10.1111/j.1365-2915.2012.01020.x; Fernando SD, 2008, T ROY SOC TROP MED H, V102, P1081, DOI 10.1016/j.trstmh.2008.06.007; Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fullman N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-62; Hamel MJ, 2011, AM J TROP MED HYG, V85, P1080, DOI 10.4269/ajtmh.2011.10-0684; Hlongwana KW, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-118; Hwang J, 2007, PLOS ONE, V5; Ingstad B, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-15; Kish L, 1965, SURVEY SAMPLING; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Knox Stephanie A, 2004, BMC Med Res Methodol, V4, P30, DOI 10.1186/1471-2288-4-30; Musoke D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-327; Ng'ang'a PN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-146; Onwujekwe O, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-315; Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2; Ruberto I, 2014, J VECTOR DIS, V51, P119; Sharma S K, 2001, Indian J Public Health, V45, P93; SHOUSHA A. T., 1948, BULL WORLD HEALTH ORGAN, V1, P309; Soper FL, 1943, ANOPHELES GAMBIAE BR; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; Walker K, 2007, MED VET ENTOMOL, V21, P2, DOI 10.1111/j.1365-2915.2007.00674.x; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2004, WHOCDSCPEPVC200410; Yeka A, 2012, ACTA TROP, V121, P184, DOI 10.1016/j.actatropica.2011.03.004	32	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122699	10.1371/journal.pone.0122699	http://dx.doi.org/10.1371/journal.pone.0122699			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837978	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000107
J	Simpfendorfer, KR; Strugnell, RA; Brodnicki, TC; Wijburg, OLC				Simpfendorfer, Kim R.; Strugnell, Richard A.; Brodnicki, Thomas C.; Wijburg, Odilia L. C.			Increased Autoimmune Diabetes in pIgR-Deficient NOD Mice Is Due to a "Hitchhiking" Interval that Refines the Genetic Effect of Idd5.4	PLOS ONE			English	Article							INBRED MOUSE STRAINS; SECRETORY ANTIBODIES; CONGENIC MICE; INTESTINAL MICROBIOTA; MUCOSAL IMMUNITY; PD-1 PATHWAY; MODEL; LOCI; EXPRESSION; HOMEOSTASIS	Selective breeding to introduce a gene mutation from one mouse strain onto the genetic background of another strain invariably produces "hitchhiking"(i. e. flanking) genomic intervals, which may independently affect a disease trait of interest. To investigate a role for the polymeric Ig receptor in autoimmune diabetes, a congenic nonobese diabetic (NOD) mouse strain was generated that harbors a Pigr null allele derived from C57BL/6 (B6) mice. These pIgR-deficient NOD mice exhibited increased serum IgA along with an increased diabetes incidence. However, the Pigr null allele was encompassed by a relatively large "hitchhiking"genomic interval that was derived from B6 mice and overlaps Idd5.4, a susceptibility locus for autoimmune diabetes. Additional congenic NOD mouse strains, harboring smaller B6derived intervals, confirmed Idd5.4 independently of the other three known susceptibility loci on chromosome 1, and further localized Idd5.4 to an interval proximal to Pigr. Moreover, these congenic NOD mice showed that B6 mice harbor a more diabetogenic allele than NOD mice for this locus. The smallest B6-derived interval encompassing the Pigr null allele may, however, confer a small degree of protection against diabetes, but this protection appears to be dependent on the absence of the diabetogenic B6 allele for Idd5.4. This study provides another example of the potential hidden effects of "hitchhiking"genomic intervals and how such intervals can be used to localize disease susceptibility loci.	[Simpfendorfer, Kim R.; Strugnell, Richard A.; Wijburg, Odilia L. C.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Strugnell, Richard A.; Wijburg, Odilia L. C.] Univ Melbourne, Australian Bacterial Pathogenesis Program, Parkville, Vic 3052, Australia; [Brodnicki, Thomas C.] St Vincents Inst Med Res, Immunol & Diabet Unit, Fitzroy, Vic 3065, Australia	University of Melbourne; University of Melbourne; St. Vincent's Institute of Medical Research	Wijburg, OLC (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	odilia@unimelb.edu.au	Simpfendorfer, Kim R/AAG-1940-2019	Simpfendorfer, Kim R/0000-0002-1906-2899; Strugnell, Richard/0000-0003-0614-5641	NHMRC [400011]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by the NHMRC (grant ID 400011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726; Armstrong NJ, 2006, MAMM GENOME, V17, P273, DOI 10.1007/s00335-005-0123-y; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Brodnicki TC, 2003, DIABETES, V52, P218, DOI 10.2337/diabetes.52.1.218; Chen YG, 2014, DIABETES, V63, P68, DOI 10.2337/db13-0192; de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Fife BT, 2011, ANN NY ACAD SCI, V1217, P45, DOI 10.1111/j.1749-6632.2010.05919.x; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; GHOSH S, 1993, NAT GENET, V4, P404, DOI 10.1038/ng0893-404; Gorrell RJ, 2013, INFECT IMMUN, V81, P3880, DOI 10.1128/IAI.01424-12; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hollis-Moffatt JE, 2005, DIABETES, V54, P2820, DOI 10.2337/diabetes.54.9.2820; Hunter K, 2007, J IMMUNOL, V179, P8341, DOI 10.4049/jimmunol.179.12.8341; Irie J, 2008, J IMMUNOL, V180, P1071, DOI 10.4049/jimmunol.180.2.1071; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kanagawa O, 2000, J IMMUNOL, V164, P3919, DOI 10.4049/jimmunol.164.7.3919; Lamhamedi-Cherradi SE, 2001, DIABETES, V50, P2874, DOI 10.2337/diabetes.50.12.2874; Leiter EH, 2002, DIABETOLOGIA, V45, P296, DOI 10.1007/s00125-001-0743-z; Lin XT, 2013, J IMMUNOL, V190, P3109, DOI 10.4049/jimmunol.1203422; Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Morgan MAJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0071974, 10.1371/journal.pone.0056738, 10.1371/journal.pone.0069936]; Morin J, 2006, MAMM GENOME, V17, P1105, DOI 10.1007/s00335-006-0076-9; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Ridgway WM, 2007, NAT IMMUNOL, V8, P669, DOI 10.1038/ni0707-669; Ridgway WM, 2008, ADV IMMUNOL, V100, P151, DOI 10.1016/S0065-2776(08)00806-7; Rogier EW, 2014, P NATL ACAD SCI USA, V111, P3074, DOI 10.1073/pnas.1315792111; Rogner UC, 2003, NAT REV IMMUNOL, V3, P243, DOI 10.1038/nri1031; Sait LC, 2007, INT IMMUNOL, V19, P257, DOI 10.1093/intimm/dxl142; Uren TK, 2003, J IMMUNOL, V170, P2531, DOI 10.4049/jimmunol.170.5.2531; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang J, 2005, P NATL ACAD SCI USA, V102, P11823, DOI 10.1073/pnas.0505497102; Wang N, 2014, IMMUNOGENETICS, V66, P501, DOI 10.1007/s00251-014-0782-5; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Wicker LS, 2004, J IMMUNOL, V173, P164, DOI 10.4049/jimmunol.173.1.164; Wijburg OLC, 2006, J EXP MED, V203, P21, DOI 10.1084/jem.20052093; Yurkovetskiy L, 2013, IMMUNITY, V39, P400, DOI 10.1016/j.immuni.2013.08.013	41	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121979	10.1371/journal.pone.0121979	http://dx.doi.org/10.1371/journal.pone.0121979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835383	Green Published, gold			2022-12-26	WOS:000352139000071
J	Di, CX; Lin, XL; Zhang, YJ; Zhong, WW; Yuan, YF; Zhou, T; Liu, JL; Xia, ZW				Di, Caixia; Lin, Xiaoliang; Zhang, Yanjie; Zhong, Wenwei; Yuan, Yufan; Zhou, Tong; Liu, Junling; Xia, Zhenwei			Basophil-associated OX40 Ligand Participates in the Initiation of Th2 Responses during Airway Inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS INDUCE; MAST-CELL; MURINE MODEL; T-CELLS; IN-VIVO; EXPRESSION; ASTHMA; IMMUNITY; DIFFERENTIATION; PROTEASES	Asthma is characterized by increased airway submucosal infiltration of T helper (Th) cells and myeloid cells that co-conspire to sustain a chronic inflammation. While recent studies have demonstrated that the myeloid basophils promote Th2 cells in response to various types of allergens, the underlying mechanisms are poorly understood. Here, we found for the first time that in a mouse model of allergic asthma basophils highly expressed OX40 ligand (OX40L) after activation. Interestingly, blockade of OX40-OX40L interaction suppressed basophils-primed Th2 cell differentiation in vitro and ameliorated ovalbumin (OVA)-induced allergic eosinophilic inflammation mediated by Th2 activation. In accordance, the adoptive transfer of basophils derived from mediastinal lymph nodes (MLN) of OVA-immunized mice triggered a robust Th2 response and eosinophilic inflammation in wild-type mice but largely muted in OX40(-/-) mice and mice receiving OX40L-blocked basophils. Taken together, our results reveal a critical role of OX40L presented by the activated basophils to initiate Th2 responses in an allergic asthma model, implicating OX40-OX40L signaling as a potential therapeutic target in the treatment of allergic airway inflammation.	[Di, Caixia; Lin, Xiaoliang; Zhang, Yanjie; Yuan, Yufan; Zhou, Tong; Xia, Zhenwei] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Pediat, Shanghai 200025, Peoples R China; [Zhong, Wenwei] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Pediat, Shanghai 200127, Peoples R China; [Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Xia, ZW (corresponding author), Ruijin Hosp, Dept Pediat, Ruijin 2nd Rd 197, Shanghai 200025, Peoples R China.	xzw63@hotmail.com			National Natural Science Foundation of China [81470217, 81270084, 81070022]; Shanghai Municipal Science and Technology Commission Foundation [13XD1402800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Science and Technology Commission Foundation	This work was supported by grants from the National Natural Science Foundation of China (81470217, 81270084, and 81070022) and the Shanghai Municipal Science and Technology Commission Foundation (13XD1402800).	Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Burgess JK, 2004, J ALLERGY CLIN IMMUN, V113, P683, DOI 10.1016/j.jaci.2003.12.311; Croft M, 2013, NAT REV DRUG DISCOV, V12, P147, DOI 10.1038/nrd3930; Croft M, 2012, TRENDS IMMUNOL, V33, P144, DOI 10.1016/j.it.2011.10.004; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Gopisetty A, 2013, J IMMUNOL, V190, P5516, DOI 10.4049/jimmunol.1202298; Gramaglia I, 1998, J IMMUNOL, V161, P6510; Hamid Q, 2009, ANNU REV PHYSIOL, V71, P489, DOI 10.1146/annurev.physiol.010908.163200; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Hoshino A, 2003, EUR J IMMUNOL, V33, P861, DOI 10.1002/eji.200323455; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Karasuyama H, 2011, ANNU REV IMMUNOL, V29, P45, DOI 10.1146/annurev-immunol-031210-101257; Kawamata S, 1998, J BIOL CHEM, V273, P5808, DOI 10.1074/jbc.273.10.5808; Kim MS, 2013, ALLERGY ASTHMA IMMUN, V5, P197, DOI 10.4168/aair.2013.5.4.197; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Lloyd CM, 2010, NAT REV IMMUNOL, V10, P838, DOI 10.1038/nri2870; Lutzelschwab C, 1998, EUR J IMMUNOL, V28, P1022, DOI 10.1002/(SICI)1521-4141(199803)28:03<1022::AID-IMMU1022>3.0.CO;2-1; Metcalf D, 2013, P NATL ACAD SCI USA, V110, P9031, DOI 10.1073/pnas.1307711110; Morimoto S, 2000, J IMMUNOL, V164, P4097, DOI 10.4049/jimmunol.164.8.4097; Murata K, 2000, J EXP MED, V191, P365, DOI 10.1084/jem.191.2.365; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Rogers PR, 2001, IMMUNITY, V15, P445, DOI 10.1016/S1074-7613(01)00191-1; Salek-Ardakani S, 2008, J IMMUNOL, V181, P7969, DOI 10.4049/jimmunol.181.11.7969; Siddiqui S, 2010, CHEST, V137, P797, DOI 10.1378/chest.09-1839; Siracusa MC, 2013, J ALLERGY CLIN IMMUN, V132, P789, DOI 10.1016/j.jaci.2013.07.046; Siracusa MC, 2011, NATURE, V477, P229, DOI 10.1038/nature10329; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; Tanaka H, 2000, J EXP MED, V192, P405, DOI 10.1084/jem.192.3.405; Tang H, 2010, NAT IMMUNOL, V11, P608, DOI 10.1038/ni.1883; Ugajin T, 2009, J LEUKOCYTE BIOL, V86, P1417, DOI 10.1189/jlb.0609400; van Beek AA, 2013, INT ARCH ALLERGY IMM, V160, P7, DOI 10.1159/000341633; Wakahara K, 2013, ALLERGY, V68, P180, DOI 10.1111/all.12072; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Weinberg AD, 1999, J IMMUNOL, V162, P1818; Wynn TA, 2009, NAT IMMUNOL, V10, P679, DOI 10.1038/ni0709-679; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737; Zhang JY, 2013, EUR J IMMUNOL, V43, P1953, DOI 10.1002/eji.201243097; Zhang YJ, 2013, J BIOL CHEM, V288, P34612, DOI 10.1074/jbc.M113.494369; Zhong WW, 2014, IMMUNOLOGY, V142, P202, DOI 10.1111/imm.12240; Zingoni A, 2004, J IMMUNOL, V173, P3716, DOI 10.4049/jimmunol.173.6.3716	46	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12523	12536		10.1074/jbc.M115.642637	http://dx.doi.org/10.1074/jbc.M115.642637			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839234	hybrid, Green Published			2022-12-26	WOS:000354569000009
J	Lee, C; Hong, S; Lee, MH; Koo, HS				Lee, Changrim; Hong, Seokbong; Lee, Min Hye; Koo, Hyeon-Sook			A PHF8 Homolog in C. elegans Promotes DNA Repair via Homologous Recombination	PLOS ONE			English	Article							CROSS-LINK REPAIR; FANCONI-ANEMIA; HISTONE DEMETHYLASES; FOCI; H3K4	PHF8 is a JmjC domain-containing histone demethylase, defects in which are associated with X-linked mental retardation. In this study, we examined the roles of two PHF8 homologs, JMJD-1.1 and JMJD-1.2, in the model organism C. elegans in response to DNA damage. A deletion mutation in either of the genes led to hypersensitivity to interstrand DNA crosslinks (ICLs), while only mutation of jmjd-1.1 resulted in hypersensitivity to double-strand DNA breaks (DSBs). In response to ICLs, JMJD-1.1 did not affect the focus formation of FCD-2, a homolog of FANCD2, a key protein in the Fanconi anemia pathway. However, the dynamic behavior of RPA-1 and RAD-51 was affected by the mutation: the accumulations of both proteins at ICLs appeared normal, but their subsequent disappearance was retarded, suggesting that later steps of homologous recombination were defective. Similar changes in the dynamic behavior of RPA-1 and RAD-51 were seen in response to DSBs, supporting a role of JMJD-1.1 in homologous recombination. Such a role was also supported by our finding that the hypersensitivity of jmjd-1.1 worms to ICLs was rescued by knockdown of lig-4, a homolog of Ligase 4 active in nonhomologous end-joining. The hypersensitivity of jmjd-1.1 worms to ICLs was increased by rad-54 knockdown, suggesting that JMJD-1.1 acts in parallel with RAD-54 in modulating chromatin structure. Indeed, the level of histone H3 Lys9 tri-methylation, a marker of heterochromatin, was higher in jmjd-1.1 cells than in wild-type cells. We conclude that the histone demethylase JMJD-1.1 influences homologous recombination either by relaxing heterochromatin structure or by indirectly regulating the expression of multiple genes affecting DNA repair.	[Lee, Changrim; Hong, Seokbong; Lee, Min Hye; Koo, Hyeon-Sook] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea	Yonsei University	Koo, HS (corresponding author), Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea.	kooh@yonsei.ac.kr		Hong, Seokbong/0000-0002-7428-8065; Koo, Hyeon-Sook/0000-0002-5712-3875	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [20110023645]	National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. 20110023645) to HSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Agarwal S, 2011, J CELL BIOL, V192, P735, DOI 10.1083/jcb.201011025; Ayoub N, 2003, MOL CELL BIOL, V23, P4356, DOI 10.1128/MCB.23.12.4356-4370.2003; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Braun S, 2011, CELL, V144, P41, DOI 10.1016/j.cell.2010.11.051; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chiolo I, 2011, CELL, V144, P732, DOI 10.1016/j.cell.2011.02.012; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Deans AJ, 2011, NAT REV CANCER, V11, P467, DOI 10.1038/nrc3088; Godthelp BC, 2002, ONCOGENE, V21, P5002, DOI 10.1038/sj.onc.1205656; Gospodinov A, 2013, DNA REPAIR, V12, P800, DOI 10.1016/j.dnarep.2013.07.006; Hoffmann I, 2012, MOL ONCOL, V6, P683, DOI 10.1016/j.molonc.2012.07.004; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Katz DJ, 2009, CELL, V137, P308, DOI 10.1016/j.cell.2009.02.015; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; Lee KY, 2007, BIOCHEM BIOPH RES CO, V352, P479, DOI 10.1016/j.bbrc.2006.11.039; Lee KY, 2010, DNA REPAIR, V9, P374, DOI 10.1016/j.dnarep.2009.12.018; Li F, 2008, CELL, V135, P272, DOI 10.1016/j.cell.2008.08.036; Lin HQ, 2010, CELL RES, V20, P899, DOI 10.1038/cr.2010.84; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Mallette FA, 2012, EMBO J, V31, P1865, DOI 10.1038/emboj.2012.47; Nottke AC, 2011, P NATL ACAD SCI USA, V108, P12805, DOI 10.1073/pnas.1102298108; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pedersen MT, 2010, TRENDS CELL BIOL, V20, P662, DOI 10.1016/j.tcb.2010.08.011; Ryu JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064028; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Wakeman TP, 2012, EMBO J, V31, P2169, DOI 10.1038/emboj.2012.50; Watanabe S, 2013, NAT STRUCT MOL BIOL, V20, P1425, DOI 10.1038/nsmb.2702; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028	32	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123865	10.1371/journal.pone.0123865	http://dx.doi.org/10.1371/journal.pone.0123865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853498	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400123
J	White, SB; Chen, J; Gordon, AC; Harris, KR; Nicolai, JR; West, DL; Larson, AC				White, Sarah B.; Chen, Jeane; Gordon, Andrew C.; Harris, Kathleen R.; Nicolai, Jodi R.; West, Derek L.; Larson, Andrew C.			Percutaneous Ultrasound Guided Implantation of VX2 for Creation of a Rabbit Hepatic Tumor Model	PLOS ONE			English	Article							LIVER-TUMOR; ANIMAL-MODEL; CHEMOEMBOLIZATION; CANCER; CARCINOMA; ABLATION; TRANSPLANTATION; EMBOLIZATION; INOCULATION; HEPATECTOMY	Creation of a VX2 tumor model has traditionally required a laparotomy and surgical implantation of tumor fragments. Open surgical procedures are invasive and require long procedure times and recovery that can result in post-operative morbidity and mortality. The purpose of this study is to report the results of a percutaneous ultrasound guided method for creation of a VX2 model in rabbit livers. A total of 27 New Zealand white rabbits underwent a percutaneous ultrasound guided approach, where a VX2 tumor fragment was implanted in the liver. Magnetic resonance imaging was used to assess for tumor growth and necropsy was performed to determine rates of tract seeding and metastatic disease. Ultrasound guided tumor implantation was successful in all 27 rabbits. One rabbit died 2 days following the implantation procedure. Two rabbits had no tumors seen on follow-up imaging. Therefore, tumor development was seen in 24/26 (92%) rabbits. During the follow-up period, tract seeding was seen in 8% of rabbits and 38% had extra-hepatic metastatic disease. Therefore, percutaneous ultrasound guided tumor implantation safely provides reliable tumor growth for establishing hepatic VX2 tumors in a rabbit model with decreased rates of tract seeding, compared to previously reported methods.	[White, Sarah B.] Med Coll Wisconsin, Dept Radiol, Div Intervent Radiol, Milwaukee, WI 53226 USA; [White, Sarah B.; Chen, Jeane; Gordon, Andrew C.; Harris, Kathleen R.; Nicolai, Jodi R.; West, Derek L.; Larson, Andrew C.] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA; [Chen, Jeane] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA; [Gordon, Andrew C.; Larson, Andrew C.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [West, Derek L.] Univ Texas Houston, Sch Med, Dept Diagnost & Intervent Imaging, Houston, TX USA; [Larson, Andrew C.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Medical College of Wisconsin; Northwestern University; Northwestern University; Northwestern University; University of Texas System; University of Texas Health Science Center Houston; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	White, SB (corresponding author), Med Coll Wisconsin, Dept Radiol, Div Intervent Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA.	sbwhite@mcw.edu			 [NIH 5 R25 CA 132822-03]; NATIONAL CANCER INSTITUTE [R01CA159178, R01CA196967, R01CA181658, R25CA132822, P30CA060553] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by SBW: NIH 5 R25 CA 132822-03, http://grants.nih.gov/grants/guide/pa-files/PAR-14-076.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKOWITZ DM, 1975, J NATL CANCER I, V54, P233, DOI 10.1093/jnci/54.1.233; BURGENER FA, 1979, INVEST RADIOL, V14, P410, DOI 10.1097/00004424-197909000-00005; Chen JH, 2004, LAB ANIM-UK, V38, P79, DOI 10.1258/00236770460734434; FRANK JA, 1987, J NEUROSURG, V67, P106, DOI 10.3171/jns.1987.67.1.0106; Geschwind JFH, 2000, J VASC INTERV RADIOL, V11, P1245, DOI 10.1016/S1051-0443(07)61299-8; Guo Y, 2012, INVEST RADIOL, V47, P116, DOI 10.1097/RLI.0b013e31822e57cc; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hurst EW, 1933, J EXP MED, V58, P607, DOI 10.1084/jem.58.5.607; Jiang Xiong-ying, 2013, Zhonghua Yi Xue Za Zhi, V93, P3139; Larson AC, 2006, J MAGN RESON IMAGING, V24, P242, DOI 10.1002/jmri.20623; Lee JM, 2003, EUR RADIOL, V13, P1324, DOI 10.1007/s00330-002-1658-x; Lee KH, 2009, J SURG RES, V155, P94, DOI 10.1016/j.jss.2008.08.036; Lin WY, 2002, J VET MED SCI, V64, P649, DOI 10.1292/jvms.64.649; Liu JY, 2013, ONCOL LETT, V6, P1550, DOI 10.3892/ol.2013.1618; Luo W, 2010, J ULTRAS MED, V29, P51, DOI 10.7863/jum.2010.29.1.51; Okuma T, 2006, J NUCL MED, V47, P1351; Oshiro H, 2014, MED MOL MORPHOL, V27, P27; Parvinian A, 2014, DIAGN INTERV RADIOL, V20, P335, DOI 10.5152/dir.2014.13415; Qian T, 2014, MAGN RESON IMAGING, V32, P1052, DOI 10.1016/j.mri.2014.05.011; Rashidi B, 2001, INT J CANCER, V91, P231, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1042>3.3.CO;2-O; Rhee TK, 2007, J VASC INTERV RADIOL, V18, P411, DOI 10.1016/j.jvir.2007.01.013; Tanaka T, 2014, J VASC INTERV RADIOL, V25, P1037, DOI 10.1016/j.jvir.2014.04.005; THORSTENSEN O, 1994, INVEST RADIOL, V29, P469; Virmani S, 2008, J VASC INTERV RADIOL, V19, P931, DOI 10.1016/j.jvir.2008.02.019; Vossen JA, 2008, CLIN EXP METASTAS, V25, P811, DOI 10.1007/s10585-008-9195-x; Weichert JP, 2000, RADIOLOGY, V216, P865, DOI 10.1148/radiology.216.3.r00se43865; Zhang YD, 2014, TECHNOLOGIES, V2, DOI 10.3390/technologies2040164	28	19	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123888	10.1371/journal.pone.0123888	http://dx.doi.org/10.1371/journal.pone.0123888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853660	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400125
J	Wikenros, C; Sand, H; Bergstrom, R; Liberg, O; Chapron, G				Wikenros, Camilla; Sand, Hakan; Bergstrom, Roger; Liberg, Olof; Chapron, Guillaume			Response of Moose Hunters to Predation following Wolf Return in Sweden	PLOS ONE			English	Article							CANIS-LUPUS PREDATION; ALCES-ALCES; POPULATION-DYNAMICS; KILL RATES; YELLOWSTONE ELK; NORTH-AMERICAN; BODY CONDITION; WOLVES; HARVEST; DEER	Background Predation and hunter harvest constitute the main mortality factors affecting the size and dynamics of many exploited populations. The re-colonization by wolves (Canis lupus) of the Scandinavian Peninsula may therefore substantially reduce hunter harvest of moose (Alces alces), the main prey of wolves. Methodology/Principal findings We examined possible effects of wolf presence on hunter harvest in areas where we had data before and after wolf establishment (n = 25), and in additional areas that had been continuously exposed to wolf predation during at least ten years (n = 43). There was a general reduction in the total number of moose harvested (n = 31,827) during the ten year study period in all areas irrespective of presence of wolves or not. However, the reduction in hunter harvest was stronger within wolf territories compared to control areas without wolves. The reduction in harvest was larger in small (500-800 km(2)) compared to large (1,200-1,800 km(2)) wolf territories. In areas with newly established wolf territories moose management appeared to be adaptive with regard to both managers (hunting quotas) and to hunters (actual harvest). In these areas an instant reduction in moose harvest over-compensated the estimated number of moose killed annually by wolves and the composition of the hunted animals changed towards a lower proportion of adult females. Conclusions/Significance We show that the re-colonization of wolves may result in an almost instant functional response by another large predator-humans-that reduced the potential for a direct numerical effect on the density of wolves' main prey, the moose. Because most of the worlds' habitat that will be available for future colonization by large predators are likely to be strongly influenced by humans, human behavioural responses may constitute a key trait that govern the impact of large predators on their prey.	[Wikenros, Camilla; Sand, Hakan; Liberg, Olof; Chapron, Guillaume] Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden; [Bergstrom, Roger] Forestry Res Inst Sweden, Uppsala, Sweden	Swedish University of Agricultural Sciences; Skogforsk	Wikenros, C (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Grimso Wildlife Res Stn, Riddarhyttan, Sweden.	camilla.wikenros@slu.se			Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; WWF Sweden; Olle Foundation; Carl Tryggers Foundation; Swedish Carnivore Association; Signhild Engkvists Foundation	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Swedish Environmental Protection Agency; Swedish Association for Hunting and Wildlife Management; WWF Sweden; Olle Foundation; Carl Tryggers Foundation; Swedish Carnivore Association; Signhild Engkvists Foundation	The study was funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS), Swedish Environmental Protection Agency, Swedish Association for Hunting and Wildlife Management, WWF Sweden, Olle and Signhild Engkvists Foundations, Carl Tryggers Foundation, and the Swedish Carnivore Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R, 2007, WILDLIFE BIOL, V13, P467, DOI 10.2981/0909-6396(2007)13[467:SOELLL]2.0.CO;2; [Anonymous], 2006, RES FRAN INV AV BJOM; Ballard WB, 2001, WILDLIFE SOC B, V29, P99; Boertje RD, 2010, J WILDLIFE MANAGE, V74, P917, DOI 10.2193/2009-261; Boman M, 2011, ENVIRON RESOUR ECON, V50, P515, DOI 10.1007/s10640-011-9480-z; Caswell, 2000, MATRIX POPULATION MO; Coulson T, 2005, J ANIM ECOL, V74, P789, DOI 10.1111/j.1365-2656.2005.00975.x; Coulson T, 2004, ECOLOGY, V85, P411, DOI 10.1890/03-0009; DelGiudice GD, 2009, RECOVERY OF GRAY WOLVES IN THE GREAT LAKES REGION OF THE UNITED STATES, P155, DOI 10.1007/978-0-387-85952-1_10; Eberhardt LL, 2003, ECOL APPL, V13, P776, DOI 10.1890/1051-0761(2003)013[0776:ATIOWO]2.0.CO;2; Ericsson G, 1999, WILDLIFE BIOL, V5, P177, DOI 10.2981/wlb.1999.022; Esseen Per-Anders, 1997, Ecological Bulletins, V46, P16; Evans SB, 2006, J WILDLIFE MANAGE, V70, P1372, DOI 10.2193/0022-541X(2006)70[1372:SOAFEI]2.0.CO;2; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Fryxell JM, 2010, SCIENCE, V328, P903, DOI 10.1126/science.1185802; Fuller Todd K., 2003, P161; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GASAWAY WC, 1992, WILDLIFE MONOGR, P1; GINSBERG JR, 1994, CONSERV BIOL, V8, P157, DOI 10.1046/j.1523-1739.1994.08010157.x; Gundersen H, 2008, EUR J WILDLIFE RES, V54, P335, DOI 10.1007/s10344-007-0155-6; Hayes RD, 2000, CAN J ZOOL, V78, P60, DOI 10.1139/cjz-78-1-60; Hayes RD, 2000, CAN J ZOOL, V78, P36, DOI 10.1139/cjz-78-1-36; Hebblewhite M, 2013, POPUL ECOL, V55, P511, DOI 10.1007/s10144-013-0384-3; Jonzen N, 2013, ECOL MODEL, V265, P140, DOI 10.1016/j.ecolmodel.2013.05.017; Lavsund Sten, 2003, Alces, V39, P109; Liberg Olof, 2010, P37; Mattisson J, 2013, OECOLOGIA, V173, P813, DOI 10.1007/s00442-013-2668-x; McCullough DR, 2001, J WILDLIFE MANAGE, V65, P46, DOI 10.2307/3803276; Mech LD, 2012, BIOL CONSERV, V150, P143, DOI 10.1016/j.biocon.2012.03.003; Mech LD, 2000, J WILDLIFE MANAGE, V64, P129, DOI 10.2307/3802982; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Nilsen EB, 2005, J APPL ECOL, V42, P389, DOI 10.1111/j.1365-2664.2005.01018.x; Nilsen EB, 2006, EUR J WILDLIFE RES, V52, P153, DOI 10.1007/s10344-005-0023-1; Olsson O, 1997, WILDLIFE BIOL, V3, P13, DOI 10.2981/wlb.1997.003; Pole A, 2003, P R SOC LOND B S, V270, P57; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ronnegard L, 2008, WILDLIFE BIOL, V14, P358, DOI 10.2981/0909-6396(2008)14[358:EOFMUT]2.0.CO;2; Saether BE, 2004, WILDLIFE BIOL, V10, P51, DOI 10.2981/wlb.2004.009; Saether BE, 2007, ECOGRAPHY, V30, P417, DOI 10.1111/j.2007.0906-7590.05006.x; Sand H, 2005, WILDLIFE SOC B, V33, P914, DOI 10.2193/0091-7648(2005)33[914:UGTAGC]2.0.CO;2; Sand H, 2012, CAN J ZOOL, V90, P403, DOI 10.1139/Z2012-007; Sand H, 2008, OECOLOGIA, V156, P53, DOI 10.1007/s00442-008-0969-2; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Sand H, 2012, OIKOS, V121, P1454, DOI 10.1111/j.1600-0706.2012.20082.x; Seiler A, 2004, WILDLIFE BIOL, V10, P225, DOI 10.2981/wlb.2004.028; Smith DW, 2004, J WILDLIFE MANAGE, V68, P153, DOI 10.2193/0022-541X(2004)068[0153:WPSAEO]2.0.CO;2; Solberg EJ, 2000, WILDLIFE BIOL, V6, P41, DOI 10.2981/wlb.2000.036; Solberg EJ, 1999, J ANIM ECOL, V68, P186, DOI 10.1046/j.1365-2656.1999.00275.x; Solberg EJ, 2006, MOOSE NORWAY ANAL MA, P125; Storaas T, 2001, ALCES-N AM MOOSE CON, V37, P97; Swenson JE, 2007, J WILDLIFE MANAGE, V71, P1993, DOI 10.2193/2006-308; Ueno M, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00083.1; Varley N, 2006, ECOL MODEL, V193, P315, DOI 10.1016/j.ecolmodel.2005.09.001; Vucetich JA, 2005, OIKOS, V111, P259, DOI 10.1111/j.0030-1299.2005.14180.x; Vucetich JA, 2002, ECOLOGY, V83, P3003; Wabakken P, 2001, CAN J ZOOL, V79, P710, DOI 10.1139/cjz-79-4-710; Wabakken P, 2008, WOLF SCANDINAVIA STA, V6; White PJ, 2005, WILDLIFE SOC B, V33, P942, DOI 10.2193/0091-7648(2005)33[942:NYEAWR]2.0.CO;2; White PJ, 2005, BIOL CONSERV, V125, P141, DOI 10.1016/j.biocon.2005.01.048; Wikenros C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077373; Zimmermann B., 2014, THESIS HEDMARK U COL	61	25	25	0	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119957	10.1371/journal.pone.0119957	http://dx.doi.org/10.1371/journal.pone.0119957			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853570	Green Published, gold, Green Accepted			2022-12-26	WOS:000352478400007
J	Alsahafi, N; Debbeche, O; Sodroski, J; Finzi, A				Alsahafi, Nirmin; Debbeche, Olfa; Sodroski, Joseph; Finzi, Andres			Effects of the I559P gp41 Change on the Conformation and Function of the Human Immunodeficiency Virus (HIV-1) Membrane Envelope Glycoprotein Trimer	PLOS ONE			English	Article							GP120 INNER DOMAIN; INTERMOLECULAR DISULFIDE BOND; TYPE-1 GP41; DEPENDENT EPITOPE; ATOMIC-STRUCTURE; STRUCTURAL BASIS; CD4-BOUND STATE; RECEPTOR; FUSION; NEUTRALIZATION	The mature human immunodeficiency virus (HIV-1) envelope glycoprotein (Env) trimer is produced by proteolytic cleavage of a precursor and consists of three gp120 exterior and three gp41 transmembrane subunits. The metastable Env complex is induced to undergo conformational changes required for virus entry by the binding of gp120 to the receptors, CD4 and CCR5/CXCR4. An isoleucine-to-proline change (I559P) in the gp41 ectodomain has been used to stabilize soluble forms of HIV-1 Env trimers for structural characterization and for use as immunogens. In the native membrane-anchored HIV-1(BG505) Env, the I559P change modestly decreased proteolytic maturation, increased the non-covalent association of gp120 with the Env trimer, and resulted in an Env conformation distinctly different from that of the wild-type HIV-1(BG505) Env. Compared with the wild-type Env, the I559P Env was recognized inefficiently by polyclonal sera from HIV-1-infected individuals, by several gp41-directed antibodies, by some antibodies against the CD4-binding site of gp120, and by antibodies that preferentially recognize the CD4-bound Env. Some of the gp120-associated antigenic differences between the wild-type HIV-1(BG505) Env and the I559P mutant were compensated by the SOS disulfide bond between gp120 and gp41, which has been used to stabilize cleaved soluble Env trimers. Nonetheless, regardless of the presence of the SOS changes, Envs with proline 559 were recognized less efficiently than Envs with isoleucine 559 by the VRC01 neutralizing antibody, which binds the CD4-binding site of gp120, and the PGT151 neutralizing antibody, which binds a hybrid gp120-gp41 epitope. The I559P change completely eliminated the ability of the HIV-1(BG505) Env to mediate cell-cell fusion and virus entry, and abolished the capacity of the SOS Env to support virus infection in the presence of a reducing agent. These results suggest that differences exist between the quaternary structures of functional Env spikes and I559P Envs.	[Alsahafi, Nirmin; Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Alsahafi, Nirmin; Debbeche, Olfa; Finzi, Andres] Univ Montreal, Ctr Hosp, Ctr Rech, Montreal, PQ H2X 0A9, Canada; [Debbeche, Olfa; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada; [Sodroski, Joseph] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Sodroski, Joseph] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	McGill University; Universite de Montreal; Universite de Montreal; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	joseph_sodroski@dfci.harvard.edu; andres.finzi@umontreal.ca		Finzi, Andres/0000-0002-4992-5288	National Institutes of Health [AI24755, AI100645]; Canada Foundation [29866]; CIHR operating grants [119334, 134117]; FRQS Establishment of Young Scientist grant [26702]; Canada Research Chair on Retroviral Entry [950-229930]; King Abdullah scholarship for higher education from the Saudi Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024755, R37AI024755, UM1AI100645, R01AI093256] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Foundation; CIHR operating grants(Canadian Institutes of Health Research (CIHR)); FRQS Establishment of Young Scientist grant; Canada Research Chair on Retroviral Entry; King Abdullah scholarship for higher education from the Saudi Government; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (AI24755 and AI100645) and by the late William F. McCarty-Cooper to JS and by a Canada Foundation for Innovation Program Leader grant #29866, by CIHR operating grants #119334 and #134117, by a FRQS Establishment of Young Scientist grant #26702 to AF. AF is the recipient of a Canada Research Chair on Retroviral Entry #950-229930. NA is the recipient of a King Abdullah scholarship for higher education from the Saudi Government.	Abrahamyan LG, 2005, J VIROL, V79, P106, DOI 10.1128/JVI.79.1.106-115.2005; Abrahamyan LG, 2003, J VIROL, V77, P5829, DOI 10.1128/JVI.77.10.5829-5836.2003; Acharya P, 2014, J VIROL, V88, P12895, DOI 10.1128/JVI.02194-14; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; ALLAN JS, 1985, SCIENCE, V228, P1091, DOI 10.1126/science.2986290; [Anonymous], SCIENCE; Bartesaghi A, 2013, NAT STRUCT MOL BIOL, V20, P1352, DOI 10.1038/nsmb.2711; Binley JM, 2003, J VIROL, V77, P5678, DOI 10.1128/JVI.77.10.5678-5684.2003; Binley JM, 2000, J VIROL, V74, P627, DOI 10.1128/JVI.74.2.627-643.2000; Blattner C, 2014, IMMUNITY, V40, P669, DOI 10.1016/j.immuni.2014.04.008; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chakrabarti BK, 2011, AIDS RES HUM RETROV, V27, P877, DOI 10.1089/AID.2010.0281; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Choe H, 1996, CELL, V85, P1135, DOI 10.1016/S0092-8674(00)81313-6; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Desormeaux A, 2013, J VIROL, V87, P2549, DOI 10.1128/JVI.03104-12; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Do Kwon Y, 2012, P NATL ACAD SCI USA, V109, P5663, DOI 10.1073/pnas.1112391109; Doores KJ, 2010, J VIROL, V84, P10690, DOI 10.1128/JVI.01110-10; Doranz BJ, 1996, CELL, V85, P1149, DOI 10.1016/S0092-8674(00)81314-8; Doria-Rose NA, 2014, NATURE; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; EARL PL, 1994, J VIROL, V68, P3015, DOI 10.1128/JVI.68.5.3015-3026.1994; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Furuta RA, 1998, NAT STRUCT BIOL, V5, P276, DOI 10.1038/nsb0498-276; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Haim H, 2013, CELL HOST MICROBE, V14, P547, DOI 10.1016/j.chom.2013.10.006; Haim H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002101; Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360; He Y, 2003, J VIROL, V77, P1666, DOI 10.1128/JVI.77.3.1666-1671.2003; Huang J, 2014, NATURE; Julien JP, 2013, SCIENCE, V342, P1477, DOI 10.1126/science.1245625; Julien JP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003342; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kassa A, 2009, J VIROL; Kassa A, 2009, J VIROL, V83, P8364, DOI 10.1128/JVI.00594-09; Kesavardhana S, 2014, J VIROL, V88, P9590, DOI 10.1128/JVI.00494-14; Klasse PJ, 2013, J VIROL, V87, P9873, DOI 10.1128/JVI.01226-13; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Kong L, 2013, NAT STRUCT MOL BIOL, V20, P796, DOI 10.1038/nsmb.2594; Korber B., 1998, HUMAN RETROVIRUSES A; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; Kovacs JM, 2012, P NATL ACAD SCI USA, V109, P12111, DOI 10.1073/pnas.1204533109; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Lu M, 2001, J VIROL, V75, P11146, DOI 10.1128/JVI.75.22.11146-11156.2001; Mao Y, 2013, PROC NATL ACAD SCI U; Mao Y, 2012, NAT STRUCT MOL BIOL; Mo HM, 2004, VIROLOGY, V329, P319, DOI 10.1016/j.virol.2004.08.025; Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109; Murin CD, 2014, J VIROL, V88, P10177, DOI 10.1128/JVI.01229-14; Pancera M, 2014, NATURE; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; RHO HM, 1981, VIROLOGY, V112, P355, DOI 10.1016/0042-6822(81)90642-5; ROBEY WG, 1985, SCIENCE, V228, P593, DOI 10.1126/science.2984774; Rossmann MG, 2001, J STRUCT BIOL, V136, P190, DOI 10.1006/jsbi.2002.4435; Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618; Sanders RW, 2000, J VIROL, V74, P5091, DOI 10.1128/JVI.74.11.5091-5100.2000; Sanders RW, 2004, AIDS RES HUM RETROV, V20, P742, DOI 10.1089/0889222041524544; Sanders RW, 2002, J VIROL, V76, P8875, DOI 10.1128/JVI.76.17.8875-8889.2002; Schulke N, 2002, J VIROL, V76, P7760, DOI 10.1128/JVI.76.15.7760-7776.2002; Sen J, 2010, BIOCHEMISTRY-US, V49, P5057, DOI 10.1021/bi1005267; Si ZH, 2004, P NATL ACAD SCI USA, V101, P5036, DOI 10.1073/pnas.0307953101; Sok D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008104; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; THALI M, 1993, J VIROL, V67, P3978, DOI 10.1128/JVI.67.7.3978-3988.1993; Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Veillette M, 2014, JOVE-J VIS EXP, DOI 10.3791/51995; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Weng YK, 1998, J VIROL, V72, P9676, DOI 10.1128/JVI.72.12.9676-9682.1998; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wu SR, 2010, P NATL ACAD SCI USA, V107, P18844, DOI 10.1073/pnas.1007227107; Wu XL, 2006, J VIROL, V80, P835, DOI 10.1128/JVI.80.2.835-844.2006; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Yang XZ, 2000, J VIROL, V74, P4746, DOI 10.1128/JVI.74.10.4746-4754.2000; Yang XZ, 2003, VIROLOGY, V313, P117, DOI 10.1016/S0042-6822(03)00273-3; Yang XZ, 2000, J VIROL, V74, P5716, DOI 10.1128/JVI.74.12.5716-5725.2000; Zhang CWH, 2001, J BIOL CHEM, V276, P39577, DOI 10.1074/jbc.M107147200; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	93	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122111	10.1371/journal.pone.0122111	http://dx.doi.org/10.1371/journal.pone.0122111			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849367	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800099
J	Bang, C; Cheng, J				Bang, Chi; Cheng, Jun			Dynamic Interplay of Spectrosome and Centrosome Organelles in Asymmetric Stem Cell Divisions	PLOS ONE			English	Article							DROSOPHILA FUSOME; SELF-RENEWAL; ORIENTATION; ACTIVATION; MECHANISMS; PROTEINS	Stem cells have remarkable self-renewal ability and differentiation potency, which are critical for tissue repair and tissue homeostasis. Recently it has been found, in many systems (e.g. gut, neurons, and hematopoietic stem cells), that the self-renewal and differentiation balance is maintained when the stem cells divide asymmetrically. Drosophila male germline stem cells (GSCs), one of the best characterized model systems with well-defined stem cell niches, were reported to divide asymmetrically, where centrosome plays an important role. Utilizing time-lapse live cell imaging, customized tracking, and image processing programs, we found that most acentrosomal GSCs have the spectrosomes reposition from the basal end (wild type) to the apical end close to hub-GSC interface (acentrosomal GSCs). In addition, these apically positioned spectrosomes were mostly stationary while the basally positioned spectrosomes were mobile. For acentrosomal GSCs, their mitotic spindles were still highly oriented and divided asymmetrically with longer mitosis duration, resulting in asymmetric divisions. Moreover, when the spectrosome was knocked out, the centrosomes velocity decreased and centrosomes located closer to hub-GSC interface. We propose that in male GSCs, the spectrosome recruited to the apical end plays a complimentary role in ensuring proper spindle orientation when centrosome function is compromised.	[Bang, Chi; Cheng, Jun] Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Cheng, J (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60612 USA.	juncheng@uic.edu			Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust	The work was partly funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Brunet A, 2007, NATURE, V449, P288, DOI 10.1038/449288a; Cheng J, 2009, CURRENT PROTOCOLS ST; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng W, 1997, DEV BIOL, V189, P79, DOI 10.1006/dbio.1997.8669; Dubielecka PM, 2003, CELL MOL BIOL LETT, V8, P221; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Inaba M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012473; Januschke J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1245; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lighthouse DV, 2008, DEV BIOL, V317, P59, DOI 10.1016/j.ydbio.2008.02.009; LIN HF, 1995, DEV GENET, V16, P6, DOI 10.1002/dvg.1020160104; LIN HF, 1994, DEVELOPMENT, V120, P947; Liu Wei, 2008, V450, P61, DOI 10.1007/978-1-60327-214-8_4; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pariser H, 2005, P NATL ACAD SCI USA, V102, P12407, DOI 10.1073/pnas.0505901102; Petrella LN, 2007, DEVELOPMENT, V134, P703, DOI 10.1242/dev.02766; Riparbelli MG, 2011, DEV BIOL, V349, P427, DOI 10.1016/j.ydbio.2010.10.021; Snapp EL, 2004, MOL BIOL CELL, V15, P4512, DOI 10.1091/mbc.E04-06-0475; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yuan HB, 2012, DEV BIOL, V361, P57, DOI 10.1016/j.ydbio.2011.10.010	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123294	10.1371/journal.pone.0123294	http://dx.doi.org/10.1371/journal.pone.0123294			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849996	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800223
J	Maestre-Reyna, M; Liu, WC; Jeng, WY; Lee, CC; Hsu, CA; Wen, TN; Wang, AHJ; Shyur, LF				Maestre-Reyna, Manuel; Liu, Wei-Chun; Jeng, Wen-Yih; Lee, Cheng-Chung; Hsu, Chih-An; Wen, Tuan-Nan; Wang, Andrew H. -J.; Shyur, Lie-Fen			Structural and Functional Roles of Glycosylation in Fungal Laccase from Lentinus sp.	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; BIOCHEMICAL-CHARACTERIZATION; FORCE-FIELD; SOFTWARE; VALIDATION; COMPONENT; ACCURACY; YEAST	Laccases are multi-copper oxidases that catalyze the oxidation of various organic and inorganic compounds by reducing O-2 to water. Here we report the crystal structure at 1.8 angstrom resolution of a native laccase (designated nLcc4) isolated from a white-rot fungus Lentinus sp. nLcc4 is composed of three cupredoxin-like domains D1-D3 each folded into a Greek key beta-barrel topology. T1 and T2/T3 copper binding sites and three N-glycosylated sites at Asn(75), Asn(238), and Asn(458) were elucidated. Initial rate kinetic analysis revealed that the k(cat), K-m, and k(cat)/K-m of nLcc4 with substrate ABTS were 3,382 s(-1), 65.0 +/- 6.5 mu M, and 52 s(-1) mu M-1, respectively; and the values with lignosulfonic acid determined using isothermal titration calorimetry were 0.234 s(-1), 56.7 +/- 3.2 mu M, and 0.004 s(-1) mu M-1, respectively. Endo H-deglycosylated nLcc4 (dLcc4), with only one GlcNAc residue remaining at each of the three N-glycosylation sites in the enzyme, exhibited similar kinetic efficiency and thermal stability to that of nLcc4. The isolated Lcc4 gene contains an open reading frame of 1563 bp with a deduced polypeptide of 521 amino acid residues including a predicted signaling peptide of 21 residues at the N-terminus. Recombinant wild-type Lcc4 and mutant enzymes N75D, N238D and N458D were expressed in Pichia pastoris cells to evaluate the effect on enzyme activity by single glycosylation site deficiency. The mutant enzymes secreted in the cultural media of P. pastoris cells were observed to maintain only 4-50% of the activity of the wildtype laccase. Molecular dynamics simulations analyses of various states of (de-) glycosylation in nLcc support the kinetic results and suggest that the local H-bond networks between the domain connecting loop D2-D3 and the glycan moieties play a crucial role in the laccase activity. This study provides new insights into the role of glycosylation in the structure and function of a Basidiomycete fungal laccase.	[Maestre-Reyna, Manuel; Hsu, Chih-An; Wang, Andrew H. -J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Liu, Wei-Chun; Lee, Cheng-Chung; Wang, Andrew H. -J.; Shyur, Lie-Fen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Jeng, Wen-Yih] Natl Cheng Kung Univ, Ctr Biosci & Biotechnol, Tainan 70101, Taiwan; [Jeng, Wen-Yih; Lee, Cheng-Chung; Wang, Andrew H. -J.] Acad Sinica, Core Facil Prot Struct Anal, Taipei 115, Taiwan; [Wen, Tuan-Nan] Acad Sinica, Inst Plant & Microbial Biol, Taipei 115, Taiwan; [Wang, Andrew H. -J.] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Shyur, Lie-Fen] Kaohsiung Med Univ, PhD Program Translat Med, Kaohsiung, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Cheng Kung University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Taipei Medical University; Kaohsiung Medical University	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw; lfshyur@ccvax.sinica.edu.tw			Ministry of Science and Technology, Taiwan, R.O.C. [NSC 102-2628-B-001-002-MY3, NSC 100-3111-Y-001-006, NSC 99-3113-B-001-001]	Ministry of Science and Technology, Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	This work was supported by grants from Ministry of Science and Technology (NSC 102-2628-B-001-002-MY3, NSC 100-3111-Y-001-006, and NSC 99-3113-B-001-001), Taiwan, R.O.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berends E, 2009, TRENDS MICROBIOL, V17, P439, DOI 10.1016/j.tim.2009.07.002; Bertrand T, 2002, BIOCHEMISTRY-US, V41, P7325, DOI 10.1021/bi0201318; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Chen SC, 2012, PROTEIN ENG DES SEL, V25, P761, DOI 10.1093/protein/gzs082; Christensen NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061985; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Fadda E, 2010, DRUG DISCOV TODAY, V15, P596, DOI 10.1016/j.drudis.2010.06.001; Ferraroni M, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-60; Garg N, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-75; Giardina P, 2010, CELL MOL LIFE SCI, V67, P369, DOI 10.1007/s00018-009-0169-1; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Hsu CA, 2012, ENVIRON SCI TECHNOL, V46, P5109, DOI 10.1021/es2047014; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiiskinen LL, 2002, APPL MICROBIOL BIOT, V59, P198, DOI 10.1007/s00253-002-1012-x; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li X, 2007, BIOCHEM BIOPH RES CO, V354, P21, DOI 10.1016/j.bbrc.2006.12.116; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikolasch A, 2009, APPL MICROBIOL BIOT, V82, P605, DOI 10.1007/s00253-009-1869-z; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Morozova V, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1136, DOI 10.1134/S0006297907100112; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peters MB, 2010, J CHEM THEORY COMPUT, V6, P2935, DOI 10.1021/ct1002626; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodgers CJ, 2010, TRENDS BIOTECHNOL, V28, P63, DOI 10.1016/j.tibtech.2009.11.001; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sapay Nicolas, 2013, Methods Mol Biol, V924, P469, DOI 10.1007/978-1-62703-017-5_18; Sedlak E, 2008, P NATL ACAD SCI USA, V105, P19258, DOI 10.1073/pnas.0806431105; Sirim D, 2011, DATABASE; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Vite-Vallejo O, 2009, ENZYME MICROB TECH, V45, P233, DOI 10.1016/j.enzmictec.2009.05.007; Volkova N, 2012, ENZYME MICROB TECH, V50, P233, DOI 10.1016/j.enzmictec.2012.01.005; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	48	51	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120601	10.1371/journal.pone.0120601	http://dx.doi.org/10.1371/journal.pone.0120601			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849464	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800028
J	Malyshev, A; Goz, R; LoTurco, JJ; Volgushev, M				Malyshev, Aleksey; Goz, Roman; LoTurco, Joseph J.; Volgushev, Maxim			Advantages and Limitations of the Use of Optogenetic Approach in Studying Fast-Scale Spike Encoding	PLOS ONE			English	Article							DYNAMICAL RESPONSE PROPERTIES; NEURONS IN-VIVO; NEOCORTICAL NEURONS; CORTICAL-NEURONS; PYRAMIDAL NEURONS; SYNAPTIC PLASTICITY; NEURAL ACTIVITY; OPTICAL CONTROL; EXCITATION; ENSEMBLES	Understanding single-neuron computations and encoding performed by spike-generation mechanisms of cortical neurons is one of the central challenges for cell electrophysiology and computational neuroscience. An established paradigm to study spike encoding in controlled conditions in vitro uses intracellular injection of a mixture of signals with fluctuating currents that mimic in vivo-like background activity. However this technique has two serious limitations: it uses current injection, while synaptic activation leads to changes of conductance, and current injection is technically most feasible in the soma, while the vast majority of synaptic inputs are located on the dendrites. Recent progress in optogenetics provides an opportunity to circumvent these limitations. Transgenic expression of light-activated ionic channels, such as Channelrhodopsin2 (ChR2), allows induction of controlled conductance changes even in thin distant dendrites. Here we show that photostimulation provides a useful extension of the tools to study neuronal encoding, but it has its own limitations. Optically induced fluctuating currents have a low cutoff (similar to 70Hz), thus limiting the dynamic range of frequency response of cortical neurons. This leads to severe underestimation of the ability of neurons to phase-lock their firing to high frequency components of the input. This limitation could be worked around by using short (2 ms) light stimuli which produce membrane potential responses resembling EPSPs by their fast onset and prolonged decay kinetics. We show that combining application of short light stimuli to different parts of dendritic tree for mimicking distant EPSCs with somatic injection of fluctuating current that mimics fluctuations of membrane potential in vivo, allowed us to study fast encoding of artificial EPSPs photoinduced at different distances from the soma. We conclude that dendritic photostimulation of ChR2 with short light pulses provides a powerful tool to investigate population encoding of simulated synaptic potentials generated in dendrites at different distances from the soma.	[Malyshev, Aleksey; Volgushev, Maxim] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Malyshev, Aleksey; Volgushev, Maxim] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Goz, Roman; LoTurco, Joseph J.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA	University of Connecticut; Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; University of Connecticut	Volgushev, M (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	maxim.volgushev@uconn.edu	Volgushev, Maxim/AAO-6793-2020; Malyshev, Alexey/P-2775-2015; Malyshev, Aleksey/R-8471-2018	Volgushev, Maxim/0000-0002-8080-1136; Malyshev, Aleksey/0000-0002-4633-7691	National Institutes of Health [R01MH087631]; Startup funds from the University of Connecticut; Russian Science Foundation [14-25-00072]; Russian Foundation for Basic Research [15-04-06286, 13-04-40332]; Humboldt Research Award from the Alexander von Humboldt-Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087631] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Startup funds from the University of Connecticut; Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Humboldt Research Award from the Alexander von Humboldt-Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the grant R01MH087631 from the National Institutes of Health and Startup funds from the University of Connecticut to MV; grants #14-25-00072 from the Russian Science Foundation and #15-04-06286 and #13-04-40332 from the Russian Foundation for Basic Research to AM. MV was partially supported by Humboldt Research Award from the Alexander von Humboldt-Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azouz R, 2000, P NATL ACAD SCI USA, V97, P8110, DOI 10.1073/pnas.130200797; Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153; Boucsein C, 2009, J NEUROSCI, V29, P1006, DOI 10.1523/JNEUROSCI.3424-08.2009; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Destexhe A, 2003, NAT REV NEUROSCI, V4, P739, DOI 10.1038/nrn1198; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Higgs MH, 2009, J NEUROSCI, V29, P1285, DOI 10.1523/JNEUROSCI.3728-08.2009; Ilin V, 2013, J NEUROSCI, V33, P2281, DOI 10.1523/JNEUROSCI.0771-12.2013; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kondgen H, 2008, CEREB CORTEX, V18, P2086, DOI 10.1093/cercor/bhm235; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Letzkus JJ, 2006, J NEUROSCI, V26, P10420, DOI 10.1523/JNEUROSCI.2650-06.2006; Maher BJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034053; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Malyshev A, 2013, EUR J NEUROSCI, V38, P3181, DOI 10.1111/ejn.12338; Marino J, 2005, NAT NEUROSCI, V8, P194, DOI 10.1038/nn1391; Miura K, 2007, J NEUROSCI, V27, P13802, DOI 10.1523/JNEUROSCI.2452-07.2007; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Oviedo HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033831; Ramos RL, 2006, CEREB CORTEX, V16, P1323, DOI 10.1093/cercor/bhj074; Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8; Silberberg G, 2004, J NEUROPHYSIOL, V91, P704, DOI 10.1152/jn.00415.2003; Sjostrom PJ, 2006, NEURON, V51, P227, DOI 10.1016/j.neuron.2006.06.017; Tchumatchenko T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00184; Tchumatchenko T, 2011, J NEUROSCI, V31, P12171, DOI 10.1523/JNEUROSCI.2182-11.2011; Volgushev M, 2003, EUR J NEUROSCI, V17, P1768, DOI 10.1046/j.1460-9568.2003.02609.x; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Zhang F, 2006, NAT METHODS, V3, P785, DOI 10.1038/nmeth936; Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988	32	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122286	10.1371/journal.pone.0122286	http://dx.doi.org/10.1371/journal.pone.0122286			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850004	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800116
J	Shen, EY; Jiang, Y; Mao, WJ; Futai, K; Hock, H; Akbarian, S				Shen, Erica Y.; Jiang, Yan; Mao, Wenjie; Futai, Kensuke; Hock, Hanno; Akbarian, Schahram			Cognition and Mood-Related Behaviors in L3mbtl1 Null Mutant Mice	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; HISTONE METHYLATION; OPEN-FIELD; EPIGENETIC MECHANISMS; MOUSE MODEL; DEPRESSION; PROTEIN; EXPRESSION; DISORDER; STRESS	Alterations in histone lysine methylation and epigenetic regulators of gene expression could play a role in the neurobiology and treatment of patients diagnosed with mood spectrum disorder, including depression and anxiety. Mutations and altered expression of various lysine methyltransferases (KMTs) and demethylases (KDMs) have been linked to changes in motivational and emotional behaviors in preclinical model systems. However, it is not known whether regulators operating downstream of histone lysine methylation could affect mood-related behavior. Malignant Brain Tumor (MBT) domain 'chromatin reader' proteins bind to methylated histone lysine residues and associate with chromatin remodeling complexes to facilitate or repress gene expression. MBT proteins, including the founding member, L3mbtl1, maintain high levels of expression in neurons of the mature brain. Here, we exposed L3mbtl1 null mutant mice to a wide range of tests exploring cognition and mood-relevant behaviors at baseline and in the context of social isolation, as a stressor to elicit depression- related behavior in susceptible mice. L3mbtl1 loss-of-function was associated with significant decreases in depression and and anxiety in some of the behavioral paradigms. This was not associated with a more generalized neurological dysfunction because cognition and memory remained unaltered in comparison to controls. These findings warrant further investigations on the role of MBT chromatin reader proteins in the context of emotional and affective behaviors.	[Shen, Erica Y.; Jiang, Yan; Akbarian, Schahram] Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA; [Mao, Wenjie; Futai, Kensuke] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Worcester, MA 01604 USA; [Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Icahn School of Medicine at Mount Sinai; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Akbarian, S (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, Dept Psychiat, New York, NY 10029 USA.	schahram.akbarian@mssm.edu			National Institutes of Health [R01MH086509, P50MH096890]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086509, P50MH096890] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health grants R01MH086509 and P50MH096890. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Valles A, 2014, BIOL PSYCHIAT, V76, P57, DOI 10.1016/j.biopsych.2013.09.014; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bonasio R, 2010, SEMIN CELL DEV BIOL, V21, P221, DOI 10.1016/j.semcdb.2009.09.010; Burman MA, 2014, J NEUROSCI METH, V222, P111, DOI 10.1016/j.jneumeth.2013.11.005; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Castro J, 2014, P NATL ACAD SCI USA, V111, P9941, DOI 10.1073/pnas.1311685111; Chaudhury S, 2014, P NATL ACAD SCI USA, V111, P11834, DOI 10.1073/pnas.1411618111; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Cheung I, 2010, P NATL ACAD SCI USA, V107, P8824, DOI 10.1073/pnas.1001702107; Chotiwat C, 2006, HORM BEHAV, V50, P489, DOI 10.1016/j.yhbeh.2006.06.007; Chourbaji S, 2005, BEHAV BRAIN RES, V164, P100, DOI 10.1016/j.bbr.2005.06.003; Cruceanu C, 2013, INT J NEUROPSYCHOPH, V16, P289, DOI 10.1017/S1461145712000363; Desai RI, 2005, PHARMACOL BIOCHEM BE, V81, P843, DOI 10.1016/j.pbb.2005.06.006; Ernst C, 2009, MOL PSYCHIATR, V14, P830, DOI 10.1038/mp.2009.35; Francis TC, 2015, BIOL PSYCHIAT, V77, P212, DOI 10.1016/j.biopsych.2014.07.021; Goto T, 2014, BEHAV BRAIN RES, V270, P339, DOI 10.1016/j.bbr.2014.05.040; Gurvich N, 2010, P NATL ACAD SCI USA, V107, P22552, DOI 10.1073/pnas.1017092108; Haghighi F, 2014, DIALOGUES CLIN NEURO, V16, P430; Heredia L, 2014, J PHARMACOL TOX MET, V69, P108, DOI 10.1016/j.vascn.2013.12.005; Hoya-Arias R, 2011, STEM CELLS DEV, V20, P1889, DOI 10.1089/scd.2010.0437; Hunter RG, 2009, P NATL ACAD SCI USA, V106, P20912, DOI 10.1073/pnas.0911143106; Ishikawa J, 2014, BEHAV BRAIN RES, V264, P197, DOI 10.1016/j.bbr.2014.02.007; Jakobsson J, 2008, NEURON, V60, P818, DOI 10.1016/j.neuron.2008.09.036; Jiang Y, 2010, J NEUROSCI, V30, P7152, DOI 10.1523/JNEUROSCI.1314-10.2010; Kormos V, 2013, NEUROPEPTIDES, V47, P401, DOI 10.1016/j.npep.2013.10.014; Krishnan V, 2010, AM J PSYCHIAT, V167, P1305, DOI 10.1176/appi.ajp.2009.10030434; Kulesskaya N, 2014, PHYSIOL BEHAV, V133, P30, DOI 10.1016/j.physbeh.2014.05.006; Lang PJ, 2009, ANXIETY STRESS COPIN, V22, P5, DOI 10.1080/10615800802478247; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Mahgoub M, 2013, NEUROTHERAPEUTICS, V10, P734, DOI 10.1007/s13311-013-0213-6; Martin AL, 2010, BEHAV BRAIN RES, V207, P196, DOI 10.1016/j.bbr.2009.10.006; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Mellios N, 2014, P NATL ACAD SCI USA, V111, P9947, DOI 10.1073/pnas.1309426111; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Neumann ID, 2011, PROG NEURO-PSYCHOPH, V35, P1357, DOI 10.1016/j.pnpbp.2010.11.028; Oh G, 2015, BIOL PSYCHIAT, V77, P246, DOI 10.1016/j.biopsych.2014.06.016; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Peter CJ, 2011, TRENDS MOL MED, V17, P372, DOI 10.1016/j.molmed.2011.02.003; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prusevich P, 2014, ACS CHEM BIOL, V9, P1284, DOI 10.1021/cb500018s; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Qin JZ, 2012, CELL STEM CELL, V11, P319, DOI 10.1016/j.stem.2012.06.002; Qin JZ, 2010, J BIOL CHEM, V285, P27767, DOI 10.1074/jbc.M110.115410; Qureshi IA, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0506; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Roybal K, 2007, P NATL ACAD SCI USA, V104, P6406, DOI 10.1073/pnas.0609625104; Sabunciyan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034451; Schaefer A, 2009, NEURON, V64, P678, DOI 10.1016/j.neuron.2009.11.019; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Takata A, 2014, NEURON, V82, P773, DOI 10.1016/j.neuron.2014.04.043; TAKEUCHI H, 2014, FRONT PSYCHOL, V5, P56173, DOI DOI 10.3389/FNSYS.2014.00200; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Turecki G, 2014, NAT REV NEUROSCI, V15, P802, DOI 10.1038/nrn3839; Vialou V, 2013, ANNU REV PHARMACOL, V53, P59, DOI 10.1146/annurev-pharmtox-010611-134540; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009	60	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121252	10.1371/journal.pone.0121252	http://dx.doi.org/10.1371/journal.pone.0121252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849281	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800049
J	Li, RP; Liu, XP; Sidabras, JW; Paulson, ES; Jesmanowicz, A; Nencka, AS; Hudetz, AG; Hyde, JS				Li, Rupeng; Liu, Xiping; Sidabras, Jason W.; Paulson, Eric S.; Jesmanowicz, Andrzej; Nencka, Andrew S.; Hudetz, Anthony G.; Hyde, James S.			Restoring Susceptibility Induced MRI Signal Loss in Rat Brain at 9.4 T: A Step towards Whole Brain Functional Connectivity Imaging	PLOS ONE			English	Article							FOREPAW STIMULATION; AMYGDALOID NUCLEUS; HUMAN CONNECTOME; INSULAR CORTEX; FMRI; FEAR; PROJECTIONS; RESPONSES; MODEL; MOUSE	The aural cavity magnetic susceptibility artifact leads to significant echo planar imaging (EPI) signal dropout in rat deep brain that limits acquisition of functional connectivity fcMRI data. In this study, we provide a method that recovers much of the EPI signal in deep brain. Needle puncture introduction of a liquid-phase fluorocarbon into the middle ear allows acquisition of rat fcMRI data without signal dropout. We demonstrate that with seeds chosen from previously unavailable areas, including the amygdala and the insular cortex, we are able to acquire large scale networks, including the limbic system. This tool allows EPI-based neuroscience and pharmaceutical research in rat brain using fcMRI that was previously not feasible.	[Li, Rupeng; Sidabras, Jason W.; Jesmanowicz, Andrzej; Nencka, Andrew S.; Hyde, James S.] Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA; [Liu, Xiping] Med Coll Wisconsin, Dept Dermatol, Milwaukee, WI 53226 USA; [Paulson, Eric S.] Med Coll Wisconsin, Dept Radiat Oncol, Milwaukee, WI 53226 USA; [Hudetz, Anthony G.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Hyde, JS (corresponding author), Med Coll Wisconsin, Dept Biophys, Milwaukee, WI 53226 USA.	jshyde@mcw.edu		Sidabras, Jason/0000-0002-4537-7501	National Institutes of Health (NIH) [R01 EB000215]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000215] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grant R01 EB000215 from the National Institutes of Health, which was received by J.S.H. The National Institutes of Health (NIH) website can be accessed here: http://grants.nih.gov/grants/oer.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak JM, 2010, NEUROIMAGE, V51, P704, DOI 10.1016/j.neuroimage.2010.02.083; Barch DM, 2013, NEUROIMAGE, V80, P169, DOI 10.1016/j.neuroimage.2013.05.033; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Bota M, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00002; Brooks JCW, 2005, NEUROIMAGE, V27, P201, DOI 10.1016/j.neuroimage.2005.03.041; Brydges NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054197; Chen Y, 2013, MAGN RESON MED, V69, P1326, DOI 10.1002/mrm.24366; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; de Graaf RA, 2003, MAGNET RESON MED, V49, P409, DOI 10.1002/mrm.10404; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hettinger PC, 2011, J NEUROSCI METH, V200, P106, DOI 10.1016/j.jneumeth.2011.06.018; Hyde JS, 2014, BRAIN CONNECT, V4, P470, DOI 10.1089/brain.2014.0281; Juchem C, 2013, J MAGN RESON, V236, P95, DOI 10.1016/j.jmr.2013.08.015; Juchem C, 2010, J MAGN RESON, V204, P281, DOI 10.1016/j.jmr.2010.03.008; Komlosh ME, 2008, MAGN RESON MED, V59, P803, DOI 10.1002/mrm.21528; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LEDOUX JE, 1988, J NEUROSCI, V8, P2517; Lu HB, 2003, MAGNET RESON MED, V50, P1215, DOI 10.1002/mrm.10655; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Mahankali S, 2000, MAGNET RESON MED, V43, P155, DOI 10.1002/(SICI)1522-2594(200001)43:1<155::AID-MRM20>3.0.CO;2-5; Malinverno G, 1996, FOOD CHEM TOXICOL, V34, P639, DOI 10.1016/0278-6915(96)00023-3; Mandeville JB, 2004, MAGNET RESON MED, V52, P1272, DOI 10.1002/mrm.20278; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Marota JJA, 2000, NEUROIMAGE, V11, P13, DOI 10.1006/nimg.1999.0520; Matsuura S, 2002, J UROLOGY, V168, P2035, DOI 10.1016/S0022-5347(05)64290-5; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Moussa MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044428; Niuwenhuys R, HUMAN CENTRAL NERVOU; Oh SW, 2014, NATURE, V508, P207, DOI 10.1038/nature13186; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Peyron C, 1998, NEUROSCIENCE, V82, P443; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Quirk GJ, 2003, J NEUROSCI, V23, P8800, DOI 10.1523/jneurosci.23-25-08800.2003; RICARDO JA, 1978, BRAIN RES, V153, P1, DOI 10.1016/0006-8993(78)91125-3; RUBENS AB, 1985, NEUROLOGY, V35, P1019, DOI 10.1212/WNL.35.7.1019; SAPER CB, 1982, J COMP NEUROL, V210, P163, DOI 10.1002/cne.902100207; Sugar Jorgen, 2011, Front Neuroinform, V5, P7, DOI 10.3389/fninf.2011.00007; Tai CF, 2009, J NEUROPHYSIOL, V102, P2719, DOI 10.1152/jn.00700.2009; Tyszka JM, 2011, J NEUROSCI, V31, P15154, DOI 10.1523/JNEUROSCI.1453-11.2011; Van Essen DC, 2012, NEUROIMAGE, V62, P1299, DOI 10.1016/j.neuroimage.2012.01.032; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; YASUI Y, 1991, J COMP NEUROL, V303, P355, DOI 10.1002/cne.903030303; Zuo XN, 2012, CEREB CORTEX, V22, P1862, DOI 10.1093/cercor/bhr269	52	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0119450	10.1371/journal.pone.0119450	http://dx.doi.org/10.1371/journal.pone.0119450			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844644	Green Submitted, gold, Green Published			2022-12-26	WOS:000352475700001
J	Franco, PG; Pasquini, JM; Silvestroff, L				Franco, Paula G.; Pasquini, Juana M.; Silvestroff, Lucas			Optimizing Culture Medium Composition to Improve Oligodendrocyte Progenitor Cell Yields In Vitro from Subventricular Zone-Derived Neural Progenitor Cell Neurospheres	PLOS ONE			English	Article							WHITE-MATTER; STEM-CELLS; GLIAL PROGENITORS; ADULT-RAT; PDGF-AA; PRECURSOR; GENERATION; EXPRESSION; RECEPTOR; LINEAGE	Neural Stem and Progenitor Cells (NSC/NPC) are gathering tangible recognition for their uses in cell therapy and cell replacement therapies for human disease, as well as a model system to continue research on overall neural developmental processes in vitro. The Subventricular Zone is one of the largest NSC/NPC niches in the developing mammalian Central Nervous System, and persists through to adulthood. Oligodendrocyte progenitor cell (OPC) enriched cultures are usefull tools for in vitro studies as well as for cell replacement therapies for treating demyelination diseases. We used Subventricular Zone-derived NSC/NPC primary cultures from newborn mice and compared the effects of different growth factor combinations on cell proliferation and OPC yield. The Platelet Derived Growth Factor-AA and BB homodimers had a positive and significant impact on OPC generation. Furthermore, heparin addition to the culture media contributed to further increase overall culture yields. The OPC generated by this protocol were able to mature into Myelin Basic Protein-expressing cells and to interact with neurons in an in vitro co-culture system. As a whole, we describe an optimized in vitro method for increasing OPC.	[Silvestroff, Lucas] Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, RA-1053 Buenos Aires, DF, Argentina; Ciudad Autonoma Buenos Aires, UBA CONICET, Inst Quim & Fisicoquim Biol Profesor Alejandro C, Buenos Aires, DF, Argentina	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Silvestroff, L (corresponding author), Univ Buenos Aires, Dept Quim Biol, Fac Farm & Bioquim, RA-1053 Buenos Aires, DF, Argentina.	lsilver81@yhoo.com.ar		Franco, Paula/0000-0002-0551-791X	Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 1767, PIP 0711]; Agencia Nacionasl de Promocion Cientifica y Tecnologica [Prestamo BID PICT 2011-2040, Prestamo BID PICT 2008-0791]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacionasl de Promocion Cientifica y Tecnologica	This work was supported by PIP 1767-Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/) (PGF); PIP 0711-Consejo Nacional de Investigaciones Cientificas y Tecnicas (http://www.conicet.gov.ar/) (PGF); Prestamo BID PICT 2011-2040-Agencia Nacionasl de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) (PGF); and Prestamo BID PICT 2008-0791)-Agencia Nacionasl de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) (JMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre A, 2004, J NEUROSCI, V24, P10530, DOI 10.1523/JNEUROSCI.3572-04.2004; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Azim K, 2012, GLIA, V60, P1977, DOI 10.1002/glia.22413; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Belachew S, 2001, DEV NEUROSCI-BASEL, V23, P287, DOI 10.1159/000048712; Bilican B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002863; Broughton SK, 2007, J NEUROCHEM, V100, P628, DOI 10.1111/j.1471-4159.2006.04171.x; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Caldwell MA, 2004, EXP NEUROL, V188, P408, DOI 10.1016/j.expneurol.2004.05.007; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; Cohen RI, 1999, J EXP BIOL, V202, P461; Colello R J, 2001, Curr Protoc Neurosci, VChapter 3, DOI 10.1002/0471142301.ns0312s03; Coles-Takabe BLK, 2008, STEM CELLS, V26, P2938, DOI 10.1634/stemcells.2008-0558; Demoulin JB, 2014, CYTOKINE GROWTH F R, V25, P273, DOI 10.1016/j.cytogfr.2014.03.003; Diers-Fenger M, 2001, GLIA, V34, P213, DOI 10.1002/glia.1055; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Erlandsson A, 2006, CANCER RES, V66, P8042, DOI 10.1158/0008-5472.CAN-06-0900; Furusho M, 2011, J NEUROSCI, V31, P5055, DOI 10.1523/JNEUROSCI.4800-10.2011; Gallagher S, 2000, CURR PROTOC CELL BIO; GARD AL, 1993, DEV BIOL, V159, P618, DOI 10.1006/dbio.1993.1269; Gardner A, 2012, NAT PROTOC, V7, P1774, DOI 10.1038/nprot.2012.100; Gil-Perotin S, 2013, ANAT REC, V296, P1435, DOI 10.1002/ar.22746; Grade S, 2013, INT J DEV NEUROSCI, V31, P692, DOI 10.1016/j.ijdevneu.2013.01.004; GRINSPAN JB, 1990, ANN NY ACAD SCI, V605, P71, DOI 10.1111/j.1749-6632.1990.tb42382.x; He YT, 2009, NEUROSCI RES, V65, P272, DOI 10.1016/j.neures.2009.07.011; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Hill RA, 2014, GLIA, V62, P1195, DOI 10.1002/glia.22664; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu JG, 2004, J NEUROSCI RES, V78, P637, DOI 10.1002/jnr.20317; Hu JG, 2012, INT J MOL MED, V30, P1113, DOI 10.3892/ijmm.2012.1110; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; KELLY JD, 1991, J BIOL CHEM, V266, P8987; Kessaris N, 2004, DEVELOPMENT, V131, P1289, DOI 10.1242/dev.01027; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Lachapelle F, 2002, MOL CELL NEUROSCI, V20, P390, DOI 10.1006/mcne.2002.1124; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Masae N, 2006, DEV BIOL, V297, P262, DOI 10.1016/j.ydbio.2006.05.017; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Mirzadeh Z, 2010, J VIS EXP, P39; Moore L, 2014, ASN NEURO, V6, DOI [10.1042/AN20140004, DOI 10.1042/AN20140004]; Moors M, 2009, ENVIRON HEALTH PERSP, V117, P1131, DOI 10.1289/ehp.0800207; Nakatsuji Y, 2001, J NEUROSCI RES, V66, P487, DOI 10.1002/jnr.1240; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Niu JQ, 2012, J NEUROSCI METH, V209, P241, DOI 10.1016/j.jneumeth.2012.05.032; Pedraza CE, 2008, GLIA, V56, P1339, DOI 10.1002/glia.20702; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Silvestroff L, 2013, ASN NEURO, V5, P43, DOI 10.1042/AN20120075; Silvestroff L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033937; Sim FJ, 2011, NAT BIOTECHNOL, V29, P934, DOI 10.1038/nbt.1972; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Wang J, 2013, STEM CELLS DEV, V22, P2121, DOI 10.1089/scd.2013.0003; Woodruff RH, 2004, MOL CELL NEUROSCI, V25, P252, DOI 10.1016/j.mcn.2003.10.014; Xu SY, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/803930; Yang ZS, 2005, J NEUROSCI METH, V149, P50, DOI 10.1016/j.jneumeth.2005.05.003; Yuan XQ, 2002, J NEUROSCI RES, V70, P529, DOI 10.1002/jnr.10368; Zhang SC, 1998, J NEUROCYTOL, V27, P475, DOI 10.1023/A:1006953023845; Zhu XQ, 2011, DEVELOPMENT, V138, P745, DOI 10.1242/dev.047951	72	8	9	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121774	10.1371/journal.pone.0121774	http://dx.doi.org/10.1371/journal.pone.0121774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837625	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000063
J	Fristedt, R; Martins, NF; Strenkert, D; Clarke, CA; Suchoszek, M; Thiele, W; Schottler, MA; Merchant, SS				Fristedt, Rikard; Martins, Nadia Figueira; Strenkert, Daniela; Clarke, Cornelia A.; Suchoszek, Monika; Thiele, Wolfram; Schoettler, Mark Aurel; Merchant, Sabeeha S.			The Thylakoid Membrane Protein CGL160 Supports CF1CF0 ATP Synthase Accumulation in Arabidopsis thaliana	PLOS ONE			English	Article							PHOTOSYNTHETIC ELECTRON-TRANSPORT; COUPLING FACTOR; PHOTOSYSTEM-I; NUCLEAR GENE; BETA-SUBUNIT; COMPLEX; MITOCHONDRIAL; PLASTOCYANIN; PHOSPHORYLATION; IDENTIFICATION	The biogenesis of the major thylakoid protein complexes of the photosynthetic apparatus requires auxiliary proteins supporting individual assembly steps. Here, we identify a plant lineage specific gene, CGL160, whose homolog, atp1, co-occurs with ATP synthase subunits in an operon-like arrangement in many cyanobacteria. Arabidopsis thaliana T-DNA insertion mutants, which no longer accumulate the nucleus-encoded CGL160 protein, accumulate less than 25% of wild-type levels of the chloroplast ATP synthase. Severe cosmetic or growth phenotypes result under either short day or fluctuating light growth conditions, respectively, but this is ameliorated under long day constant light growth conditions where the growth, ATP synthase activity and photosynthetic electron transport of the mutants are less affected. Accumulation of other photosynthetic complexes is largely unaffected in cgl160 mutants, suggesting that CGL160 is a specific assembly or stability factor for the CF1CF0 complex. CGL160 is not found in the mature assembled complex but it does interact specifically with subunits of ATP synthase, predominantly those in the extrinsic CF1 sub-complex. We suggest therefore that it may facilitate the assembly of CF1 into the holocomplex.	[Fristedt, Rikard; Strenkert, Daniela; Clarke, Cornelia A.; Merchant, Sabeeha S.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Martins, Nadia Figueira; Suchoszek, Monika; Thiele, Wolfram; Schoettler, Mark Aurel] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Fristedt, Rikard; Merchant, Sabeeha S.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA USA	University of California System; University of California Los Angeles; Max Planck Society; University of California System; University of California Los Angeles	Merchant, SS (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	merchant@chem.ucla.edu		Schottler, Mark Aurel/0000-0003-3210-0260; Strenkert, Daniela/0000-0002-3420-1332	U.S. Department of Energy [DE-FC02-02ER63421]; WennerGren Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); WennerGren Foundation	This work was supported by grants from the U.S. Department of Energy (Cooperative Agreement DE-FC02-02ER63421 to David Eisenberg at UCLA), and by a postdoctoral fellowship from the WennerGren Foundation (to R.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; ACKERMAN SH, 1990, J BIOL CHEM, V265, P9952; ANDERSON JM, 1992, PHOTOSYNTH RES, V34, P341, DOI 10.1007/BF00029810; Armbruster U, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6439; Avenson TJ, 2005, PLANT CELL ENVIRON, V28, P97, DOI 10.1111/j.1365-3040.2005.01294.x; Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Benz M, 2009, MOL PLANT, V2, P1410, DOI 10.1093/mp/ssp095; Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498; Carraretto L, 2013, SCIENCE, V342, P114, DOI 10.1126/science.1242113; Chateigner-Boutin AL, 2008, PLANT J, V56, P590, DOI 10.1111/j.1365-313X.2008.03634.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cramer WA, 2006, BBA-BIOENERGETICS, V1757, P339, DOI 10.1016/j.bbabio.2006.04.020; Cruz JA, 2001, BIOCHEMISTRY-US, V40, P1226, DOI 10.1021/bi0018741; Daum B, 2010, PLANT CELL, V22, P1299, DOI 10.1105/tpc.109.071431; del Riego G, 2006, PHOTOSYNTH RES, V89, P11, DOI 10.1007/s11120-006-9078-4; Fristedt R, 2009, BIOCHEMISTRY-US, V48, P499, DOI 10.1021/bi8016334; Fristedt R, 2014, J BIOL CHEM, V289, P30657, DOI 10.1074/jbc.M114.587758; Fristedt R, 2014, PLANT PHYSIOL, V164, P201, DOI 10.1104/pp.113.228338; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Grossman AR, 2010, PHOTOSYNTH RES, V106, P3, DOI 10.1007/s11120-010-9555-7; Hansson M, 2007, J BIOL CHEM, V282, P16214, DOI 10.1074/jbc.M605833200; Hope AB, 2000, BBA-BIOENERGETICS, V1456, P5, DOI 10.1016/S0005-2728(99)00101-2; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Jansson S, 1996, PLANT PHYSIOL, V112, P409, DOI 10.1104/pp.112.1.409; Junge W, 2009, NATURE, V459, P364, DOI 10.1038/nature08145; Karpowicz SJ, 2011, J BIOL CHEM, V286, P21427, DOI 10.1074/jbc.M111.233734; Kirchhoff H, 2002, BIOCHEMISTRY-US, V41, P4872, DOI 10.1021/bi011650y; Kramer DM, 1999, PHOTOSYNTH RES, V60, P151, DOI 10.1023/A:1006212014787; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; LEONG TY, 1984, PHOTOSYNTH RES, V5, P117, DOI 10.1007/BF00028525; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyska D, 2013, PLANTA, V237, P413, DOI 10.1007/s00425-012-1752-5; MERCHANT S, 1983, EUR J BIOCHEM, V137, P373, DOI 10.1111/j.1432-1033.1983.tb07838.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; MILLER KR, 1976, J CELL BIOL, V68, P30, DOI 10.1083/jcb.68.1.30; Mulo P, 2008, PHOTOSYNTH RES, V98, P489, DOI 10.1007/s11120-008-9320-3; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nickelsen J, 2013, ANNU REV PLANT BIOL, V64, P609, DOI 10.1146/annurev-arplant-050312-120124; Osman C, 2007, MOL BIOL CELL, V18, P627, DOI 10.1091/mbc.E06-09-0839; Ozaki Y, 2008, BIOCHEM BIOPH RES CO, V367, P663, DOI 10.1016/j.bbrc.2007.12.170; Paul MF, 2000, J BIOL CHEM, V275, P29238, DOI 10.1074/jbc.M004546200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivier C, 2001, EMBO J, V20, P1765, DOI 10.1093/emboj/20.7.1765; RODERMEL SR, 1988, CELL, V55, P673, DOI 10.1016/0092-8674(88)90226-7; Rott M, 2011, PLANT CELL, V23, P304, DOI 10.1105/tpc.110.079111; Ruhle T, 2014, PLANT PHYSIOL, V165, P207, DOI 10.1104/pp.114.237883; Schottler MA, 2007, BIOCHEM J, V403, P251, DOI 10.1042/BJ20061573; Schottler MA, 2014, FRONT PLANT SCI, V5, DOI [10.3389/fpls.2014.00188, 10.3389/fpsyg.2014.00808]; Schottler MA, 2011, J PLANT PHYSIOL, V168, P1452, DOI 10.1016/j.jplph.2010.12.009; Schottler MA, 2004, PLANT PHYSIOL, V136, P4265, DOI 10.1104/pp.104.052324; Schottler MA, 2014, J EXP BOT; SELMANREIMER S, 1981, BIOCHEMISTRY-US, V20, P5476, DOI 10.1021/bi00522a020; SHARKEY TD, 1989, PLANT PHYSIOL, V91, P679, DOI 10.1104/pp.91.2.679; Shih PM, P NATL ACAD SCI US; Suzuki T, P NATL ACAD SCI US; Takizawa K, 2007, BBA-BIOENERGETICS, V1767, P1233, DOI 10.1016/j.bbabio.2007.07.006; Vollmar M, 2009, J BIOL CHEM, V284, P18228, DOI 10.1074/jbc.M109.006916; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yamori W, 2011, PLANT PHYSIOL, V155, P956, DOI 10.1104/pp.110.168435; Zeng XM, 2008, MOL BIOL CELL, V19, P1366, DOI 10.1091/mbc.E07-08-0746	62	22	25	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121658	10.1371/journal.pone.0121658	http://dx.doi.org/10.1371/journal.pone.0121658			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835989	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000055
J	Janjua, NZ; Mahmood, B; Bhatti, JA; Khan, MI				Janjua, Naveed Zafar; Mahmood, Bushra; Bhatti, Junaid A.; Khan, M. Imran			Association of Household and Community Socioeconomic Position and Urbanicity with Underweight and Overweight among Women in Pakistan	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; CHILD UNDERNUTRITION; GLOBAL BURDEN; RISK-FACTORS; OBESITY; POPULATION; NUTRITION; OVERNUTRITION; COUNTRIES; URBANIZATION	Background Similar to other developing countries, Pakistan is going through a rapid nutrition transition where shift from underweight to overweight and obesity is occurring. In this paper, we report on the relationship of household socioeconomic position (SEP), community SEP and urbanicity with under- and over-weight categories of BMI among Pakistani women. Methods We analyzed data on 4,767 women ages 15-49 years enrolled in a nationally representative Pakistan Demographic Health Survey (PDHS) conducted in 2012-13 that employed a multistage, stratified cluster sampling design. We assessed the association of urbanicity, household and community SEP derived from household assets and utilities, with categories of body mass index (BMI) using multinomial regression analysis where normal weight (BMI 18.6-22.5) was the reference category. Results Thirteen percent of women were underweight (BMI <18.5), 15% pre-overweight (BMI: 22.6-24.9), 25% overweight (BMI: 25.0-29.9) and 14% were obese (BMI >= 30). Pre-overweight, overweight and obesity among women increased across household wealth quintiles (HWQs) in a graded fashion whereas there was no significant difference in underweight by household wealth. Women in urban areas were more likely to be obese. There was a pronounced increase in adjusted odds ratios (aORs) for overweight/obesity across HWQs within urban areas compared to rural areas. There was a steeper gradient in aORs for obesity from 1st to 5th HWQs in high income communities compared to the middle-and low income communities. In community-level analyses, communities in urban areas were more likely to have higher levels of obesity while in rural areas, especially in Sindh, more communities were more likely to have a higher level of underweight. Conclusion A shift to higher overweight and obesity than underweight in Pakistan is associated with high household and community wealth as well as living in urban areas. Clustering of obesity and underweight in distinct communities afford opportunity for tailored intervention programs.	[Janjua, Naveed Zafar] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Janjua, Naveed Zafar; Mahmood, Bushra] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Bhatti, Junaid A.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Bhatti, Junaid A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Bhatti, Junaid A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Khan, M. Imran] Sabin Vaccine Inst, Washington, DC USA	University of British Columbia; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto	Janjua, NZ (corresponding author), British Columbia Ctr Dis Control, Vancouver, BC, Canada.	Naveed.Janjua@bccdc.ca	Zafar, Naveed/A-2712-2008	Zafar, Naveed/0000-0001-5681-719X				Ahmed T, 2012, ANN NUTR METAB, V61, P8, DOI 10.1159/000345165; Allender S, 2008, J URBAN HEALTH, V85, P938, DOI 10.1007/s11524-008-9325-4; Aloia CR, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-4; [Anonymous], 2005, PAK COUNTR GEND ASS; [Anonymous], 2009, BANGL DEM HLTH SURV, P1; [Anonymous], 2011, NUTR NAT DEV PAK INT; [Anonymous], 2007, NAT FAM HLTH SURV NF, P1; [Anonymous], 2013, BANGL DEM HLTH SURV, P1; [Anonymous], 2013, PAK DEM HLTH SURV 20, P1; Arambepola C, 2008, TROP MED INT HEALTH, V13, P448, DOI 10.1111/j.1365-3156.2008.02021.x; Ayesha Khan, 1999, Reproductive Health Matters, V7, P39; Balarajan Y, 2009, J NUTR, V139, P2139, DOI 10.3945/jn.109.112029; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Corsi DJ, 2011, J NUTR, V141, P631, DOI 10.3945/jn.110.131599; Dahly DL, 2010, J NUTR, V140, P366, DOI 10.3945/jn.109.114207; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; DURKIN MS, 1994, SOC SCI MED, V38, P1289, DOI 10.1016/0277-9536(94)90192-9; Feeney G, 2003, POPUL DEV REV, V29, P483, DOI 10.1111/j.1728-4457.2003.00483.x; Fernald LCH, 2008, J NUTR, V138, P2250, DOI 10.3945/jn.108.090506; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Gersh BJ, 2010, EUR HEART J, V31, P642, DOI 10.1093/eurheartj/ehq030; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hilmers A, 2012, AM J PUBLIC HEALTH, V102, P1644, DOI 10.2105/AJPH.2012.300865; Holsten JE, 2009, PUBLIC HEALTH NUTR, V12, P397, DOI 10.1017/S1368980008002267; Jalil HH, 2010, PAKISTAN DEV REV, V49; Janjua NZ, 2011, AM J EPIDEMIOL, V173, pS116; Janjua NZ, 2011, ANN EPIDEMIOL, V21, P884, DOI 10.1016/j.annepidem.2011.08.006; Khan A, 2014, PAKISTAN EC SURVEY 2, P145; Larson NI, 2009, AM J PREV MED, V36, P74, DOI 10.1016/j.amepre.2008.09.025; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mumtaz Z, 2005, SOC SCI MED, V60, P1751, DOI 10.1016/j.socscimed.2004.08.019; Naseer M, 2013, J PHYS ACT HEALTH, V10, P1039, DOI 10.1123/jpah.10.7.1039; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Pappas G, 2001, AM J PUBLIC HEALTH, V91, P93, DOI 10.2105/AJPH.91.1.93; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Raza Q, 2013, OBESITY FACTS, V6, P523, DOI 10.1159/000357176; Samir Nafisa, 2011, BMC Res Notes, V4, P174, DOI 10.1186/1756-0500-4-174; Shafique S, 2007, INT J EPIDEMIOL, V36, P449, DOI 10.1093/ije/dyl306; Shera AS, 2010, PRIM CARE DIABETES, V4, P79, DOI 10.1016/j.pcd.2010.01.003; Song YM, 2006, INT J EPIDEMIOL, V35, P112, DOI 10.1093/ije/dyi227; Subramanian SV, 2007, J EPIDEMIOL COMMUN H, V61, P802, DOI 10.1136/jech.2006.053801; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Thang NM, 2004, EUR J CLIN NUTR, V58, P145, DOI 10.1038/sj.ejcn.1601761; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Zahid N, 2011, J OBES, V2011, DOI 10.1155/2011/163749; Zhai FY, 2007, ASIA PAC J CLIN NUTR, V16, P374	52	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122314	10.1371/journal.pone.0122314	http://dx.doi.org/10.1371/journal.pone.0122314			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835540	gold, Green Submitted, Green Published			2022-12-26	WOS:000352139000093
J	Mestres, G; Espanol, M; Xia, W; Persson, C; Ginebra, MP; Ott, MK				Mestres, Gemma; Espanol, Montserrat; Xia, Wei; Persson, Cecilia; Ginebra, Maria-Pau; Ott, Marjam Karlsson			Inflammatory Response to Nano- and Microstructured Hydroxyapatite	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; IN-VITRO; CELL RESPONSE; TRICALCIUM PHOSPHATE; PARTICLE-SIZE; BONE-MARROW; MACROPHAGES; BIOMATERIALS; TOPOGRAPHY; ACTIVATION	The proliferation and activation of leukocytes upon contact with a biomaterial play a crucial role in the degree of inflammatory response, which may then determine the clinical failure or success of an implanted biomaterial. The aim of this study was to evaluate whether nano-and microstructured biomimetic hydroxyapatite substrates can influence the growth and activation of macrophage-like cells. Hydroxyapatite substrates with different crystal morphologies consisting of an entangled network of plate-like and needle-like crystals were evaluated. Macrophage proliferation was evaluated on the material surface (direct contact) and also in extracts i.e. media modified by the material (indirect contact). Additionally, the effect of supplementing the extracts with calcium ions and/or proteins was investigated. Macrophage activation on the substrates was evaluated by quantifying the release of reactive oxygen species and by morphological observations. The results showed that differences in the substrate's microstructure play a major role in the activation of macrophages as there was a higher release of reactive oxygen species after culturing the macrophages on plate-like crystals substrates compared to the almost non-existent release on needle-like substrates. However, the difference in macrophage proliferation was ascribed to different ionic exchanges and protein adsorption/retention from the substrates rather than to the texture of materials.	[Mestres, Gemma; Xia, Wei; Persson, Cecilia; Ott, Marjam Karlsson] Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden; [Espanol, Montserrat; Ginebra, Maria-Pau] Tech Univ Catalonia, Dept Mat Sci & Met, Biomat Biomech & Tissue Engn, Barcelona, Spain	Uppsala University; Universitat Politecnica de Catalunya	Ott, MK (corresponding author), Uppsala Univ, Dept Engn Sci, Div Appl Mat Sci, Mat Med, Uppsala, Sweden.	marjam.ott@angstrom.uu.se	Ginebra, Maria-Pau/J-8149-2017; Espanol, Montserrat/J-8293-2017; Persson, Cecilia/E-9326-2013; Mestres, Gemma/E-3791-2016	Ginebra, Maria-Pau/0000-0002-4700-5621; Persson, Cecilia/0000-0001-6663-6536; Mestres, Gemma/0000-0001-7462-4236	Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth [GROWTH 291795]; Lars Hiertas Minne Foundation [FO2013-0337]; STINT [IG2011-2047]; Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning; Spanish Government [MAT2012-38438-003-01]; EU through European Regional Development Funds; prize "ICREA Academia'' for excellence in research - Generalitat de Catalunya	Marie Curie Actions FP7-PEOPLE-COFUND via the VINNOVA programme Mobility for Growth; Lars Hiertas Minne Foundation; STINT; Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning; Spanish Government(Spanish GovernmentEuropean Commission); EU through European Regional Development Funds; prize "ICREA Academia'' for excellence in research - Generalitat de Catalunya(ICREA)	This work was funded by Marie Curie Actions FP7-PEOPLE-2011-COFUND (GROWTH 291795) via the VINNOVA programme Mobility for Growth, Lars Hiertas Minne Foundation (FO2013-0337 project), STINT (IG2011-2047 project), and Ollie och Elof Ericssons Stifelse for Vetenskaplig Forskning. The authors acknowledge the Spanish Government for financial support through project MAT2012-38438-003-01, co-funded by the EU through European Regional Development Funds. Support for the research of MPG was received through the prize "ICREA Academia'' for excellence in research, funded by the Generalitat de Catalunya. Part of this work was performed at the BioMat facility/Science for Life Laboratory at Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2009, TOXICOL IN VITRO, V23, P520, DOI 10.1016/j.tiv.2009.01.005; Ambrozova G, 2010, EUR J NUTR, V49, P133, DOI 10.1007/s00394-009-0057-3; Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; Barradas AMC, 2011, EUR CELLS MATER, V21, P407, DOI 10.22203/eCM.v021a31; Bieback K, 2009, STEM CELLS, V27, P2331, DOI 10.1002/stem.139; BLINKS JR, 1982, PROG BIOPHYS MOL BIO, V40, P1, DOI 10.1016/0079-6107(82)90011-6; Bota PCS, 2010, J BIOMED MATER RES A, V95A, P649, DOI 10.1002/jbm.a.32893; Chen ZT, 2014, BIOMATERIALS, V35, P1507, DOI 10.1016/j.biomaterials.2013.11.014; COLLART MA, 1991, MOL CELL BIOL, V11, P2826, DOI 10.1128/MCB.11.5.2826; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101; Ekstrom K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075227; Engel E, 2008, TISSUE ENG PT A, V14, P1341, DOI 10.1089/ten.tea.2007.0287; Espanol M, 2009, ACTA BIOMATER, V5, P2752, DOI 10.1016/j.actbio.2009.03.011; Espanol M, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0037-7; FARLEY JR, 1994, J BONE MINER RES, V9, P497; Franz S, 2011, BIOMATERIALS, V32, P6692, DOI 10.1016/j.biomaterials.2011.05.078; Ginebra MP, 2004, BIOMATERIALS, V25, P3453, DOI 10.1016/j.biomaterials.2003.10.049; Grandjean-Laquerriere A, 2004, BIOMATERIALS, V25, P5921, DOI 10.1016/j.biomaterials.2004.02.003; Gustavsson J, 2012, J MATER SCI-MATER M, V23, P2509, DOI 10.1007/s10856-012-4705-4; Gustavsson J, 2011, ACTA BIOMATER, V7, P4242, DOI 10.1016/j.actbio.2011.07.016; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KAIBUCHI K, 1985, J BIOL CHEM, V260, P1366; Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9; Laquerriere P, 2003, BIOMATERIALS, V24, P2739, DOI 10.1016/S0142-9612(03)00089-9; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Lim JY, 2005, J R SOC INTERFACE, V2, P97, DOI 10.1098/rsif.2004.0019; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Mestres G, 2012, ACTA BIOMATER, V8, P1169, DOI 10.1016/j.actbio.2011.11.021; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; Muller KH, 2014, BIOMATERIALS, V35, P1074, DOI 10.1016/j.biomaterials.2013.10.041; Nadra I, 2008, ATHEROSCLEROSIS, V196, P98, DOI 10.1016/j.atherosclerosis.2007.02.005; Omar OM, 2011, BIOMATERIALS, V32, P8190, DOI 10.1016/j.biomaterials.2011.07.055; Paula NE, 2008, BIOMATERIALS, V29, P4056, DOI 10.1016/j.biomaterials.2008.07.010; Pirraco RP, 2013, J TISSUE ENG REGEN M, V7, P392, DOI 10.1002/term.535; Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075; Rey C, 2007, MAT SCI ENG C-BIO S, V27, P198, DOI 10.1016/j.msec.2006.05.015; Samavedi S, 2013, ACTA BIOMATER, V9, P8037, DOI 10.1016/j.actbio.2013.06.014; Shie MY, 2011, ACTA BIOMATER, V7, P2604, DOI 10.1016/j.actbio.2011.02.023; Thomsen P, 2001, CURR OPIN SOLID ST M, V5, P163, DOI 10.1016/S1359-0286(01)00004-3; Tidwell CD, 1997, LANGMUIR, V13, P3404, DOI 10.1021/la9604341; Velard F, 2013, ACTA BIOMATER, V9, P4956, DOI 10.1016/j.actbio.2012.09.035; Webster TJ, 2000, J BIOMED MATER RES, V51, P475, DOI 10.1002/1097-4636(20000905)51:3<475::AID-JBM23>3.3.CO;2-0; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Xing SM, 2002, MICROSC RES TECHNIQ, V57, P523, DOI 10.1002/jemt.10106; Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390	47	35	36	2	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120381	10.1371/journal.pone.0120381	http://dx.doi.org/10.1371/journal.pone.0120381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837264	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000020
J	Wendt, ER; Ferry, H; Greaves, DR; Keshav, S				Wendt, Emily R.; Ferry, Helen; Greaves, David R.; Keshav, Satish			Ratiometric Analysis of Fura Red by Flow Cytometry: A Technique for Monitoring Intracellular Calcium Flux in Primary Cell Subsets	PLOS ONE			English	Article							INFLAMMATORY PROTEIN 3-ALPHA; CC-CHEMOKINE RECEPTOR; HUMAN DENDRITIC CELLS; T-CELLS; EXPRESSION; RESPONSIVENESS; IMMUNITY; FLUO-3; BLOOD	Calcium flux is a rapid and sensitive measure of cell activation whose utility could be enhanced with better techniques for data extraction. We describe a technique to monitor calcium flux by flow cytometry, measuring Fura Red calcium dye by ratiometric analysis. This technique has several advantages: 1) using a single calcium dye provides an additional channel for surface marker characterization, 2) allows robust detection of calcium flux by minority cell populations within a heterogeneous population of primary T cells and monocytes 3) can measure total calcium flux and additionally, the proportion of responding cells, 4) can be applied to studying the effects of drug treatment, simultaneously stimulating and monitoring untreated and drug treated cells. Using chemokine receptor activation as an example, we highlight the utility of this assay, demonstrating that only cells expressing a specific chemokine receptor are activated by cognate chemokine ligand. Furthermore, we describe a technique for simultaneously stimulating and monitoring calcium flux in vehicle and drug treated cells, demonstrating the effects of the G alpha i inhibitor, pertussis toxin (PTX), on chemokine stimulated calcium flux. The described real time calcium flux assay provides a robust platform for characterizing cell activation within primary cells, and offers a more accurate technique for studying the effect of drug treatment on receptor activation in a heterogeneous population of primary cells.	[Wendt, Emily R.; Ferry, Helen; Keshav, Satish] Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford, England; [Greaves, David R.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford, England	University of Oxford; University of Oxford	Keshav, S (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Div Expt Med, Translat Gastroenterol Unit, Oxford, England.	satish.keshav@ndm.ox.ac.uk		Greaves, David/0000-0003-2856-9410; Keshav, Satish/0000-0003-0508-8665	Oxford Biomedical Research Centre - United Kingdom National Institutes for Health Research [A93081]; ChemoCentryx, Inc., Mountain View, California, United States of America; MRC [G0200231] Funding Source: UKRI; British Heart Foundation [RG/10/15/28578] Funding Source: researchfish; Medical Research Council [G0200231] Funding Source: researchfish	Oxford Biomedical Research Centre - United Kingdom National Institutes for Health Research; ChemoCentryx, Inc., Mountain View, California, United States of America; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Oxford Biomedical Research Centre (http://oxfordbrc.nihr.ac.uk/), funded by the United Kingdom National Institutes for Health Research (grant number A93081, awarded to SK) and an unrestricted grant from ChemoCentryx, Inc., Mountain View, California, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; CHARO IF, 1994, P NATL ACAD SCI USA, V91, P2752, DOI 10.1073/pnas.91.7.2752; Dustin LB, 2000, CLIN APPL IMMUNOL RE, V1, P5, DOI DOI 10.1016/S1529-1049(00)00002-7; Fernandez EJ, 2002, ANNU REV PHARMACOL, V42, P469, DOI 10.1146/annurev.pharmtox.42.091901.115838; Greaves DR, 1997, J EXP MED, V186, P837, DOI 10.1084/jem.186.6.837; Gronski MA, 2009, CELL DEATH DIFFER, V16, P1323, DOI 10.1038/cdd.2009.55; June Carl H, 2004, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0505s64; Liao F, 1999, J IMMUNOL, V162, P186; Lohr C, 2003, CELL CALCIUM, V34, P295, DOI 10.1016/S0143-4160(03)00105-2; Luster AD, 1998, NEW ENGL J MED, V338, P436, DOI 10.1056/NEJM199802123380706; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Proudfoot A E, 2001, Curr Protoc Pharmacol, VChapter 12, DOI 10.1002/0471141755.ph1204s14; Rabin RL, 1999, J IMMUNOL, V162, P3840; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Sozzani S, 1997, J IMMUNOL, V159, P1993; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Zhang HH, 2010, J IMMUNOL, V185, P6646, DOI 10.4049/jimmunol.0904156; ZIEGLERHEITBROCK HWL, 1993, EUR J IMMUNOL, V23, P2053, DOI 10.1002/eji.1830230902; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	25	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119532	10.1371/journal.pone.0119532	http://dx.doi.org/10.1371/journal.pone.0119532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835294	Green Published, gold			2022-12-26	WOS:000352139000010
J	Fan, ZY; Chen, C; Pang, XY; Yu, Z; Qi, Y; Chen, XY; Liang, HH; Fang, XL; Sha, XY				Fan, Zhuoyang; Chen, Cheng; Pang, Xiaoying; Yu, Zhou; Qi, Yang; Chen, Xinyi; Liang, Huihui; Fang, Xiaoling; Sha, Xianyi			Adding Vitamin E-TPGS to the Formulation of Genexol-PM: Specially Mixed Micelles Improve Drug-Loading Ability and Cytotoxicity against Multidrug-Resistant Tumors Significantly	PLOS ONE			English	Article							CELL LUNG-CANCER; PHASE-II; COPOLYMER MICELLES; CREMOPHOR-FREE; IN-VITRO; PACLITAXEL; DELIVERY; GLYCOPROTEIN; PHARMACOKINETICS; BIODISTRIBUTION	Genexol-PM, produced by Samyang Company (Korea) is an excellent preparation of paclitaxel (PTX) for clinical cancer treatment. However, it cannot resolve the issue of multidrug resistance (MDR)-a significant problem in the administration of PTX to cancer patients. To increase the efficacy of Genexol-PM against MDR tumors, a mixed micelle capable of serving as a vehicle for PTX was developed, and two substances were chosen as carrier materials: 1) Polyethylene glycol-polylactic acid (PEG-PLA), the original vehicle of Genexol-PM. 2) Vitamin E-TPGS, an inhibitor of P-glycoprotein (P-gp). P-gp has been proven to be the main cause of MDR. In vitro evaluation indicated that the mixed micelle was an ideal PTX delivery system for the treatment of MDR tumors; the mixed micelle also showed a significantly better drug-loading coefficient than Genexol-PM.	[Fan, Zhuoyang; Chen, Cheng; Pang, Xiaoying; Yu, Zhou; Qi, Yang; Chen, Xinyi; Liang, Huihui; Fang, Xiaoling; Sha, Xianyi] Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ & PLA,Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China	Fudan University	Sha, XY (corresponding author), Fudan Univ, Sch Pharm, Dept Pharmaceut, Minist Educ & PLA,Key Lab Smart Drug Delivery, Lane 826,Zhangheng Rd, Shanghai 201203, Peoples R China.	shaxy@fudan.edu.cn			National Natural Science Foundation of China [81273459]; National Basic Research Program of China [2013CB932500]; National Science and Technology Major Project [2012ZX09304004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); National Science and Technology Major Project	This research was supported by the National Natural Science Foundation of China (81273459), National Basic Research Program of China (2013CB932500) and National Science and Technology Major Project (2012ZX09304004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger W, 2005, J CANCER RES CLIN, V131, P355, DOI 10.1007/s00432-004-0653-9; BJORNEBOE A, 1990, J NUTR, V120, P233, DOI 10.1093/jn/120.3.233; Chang G, 2003, FEBS LETT, V555, P102, DOI 10.1016/S0014-5793(03)01085-8; Chen LC, 2013, INT J NANOMED, V8, P73, DOI 10.2147/IJN.S38221; Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r; Collnot EM, 2010, MOL PHARMACEUT, V7, P642, DOI 10.1021/mp900191s; Filipits M, 2004, DRUG DISCOV TODAY, V1, P229, DOI DOI 10.1016/J.DDMEC.2004.10.001; GAISFORD S, 1995, J CHEM SOC CHEM COMM, P1843, DOI 10.1039/c39950001843; Gaisford S, 1997, LANGMUIR, V13, P2606, DOI 10.1021/la962033r; Han LM, 2006, ACTA PHARMACOL SIN, V27, P747, DOI 10.1111/j.1745-7254.2006.00340.x; Hugger ED, 2002, J PHARM SCI-US, V91, P1991, DOI 10.1002/jps.10176; Johnson BM, 2002, AAPS PHARMSCI, V4; Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9; Kang HK, 2005, MOL CANCER THER, V4, P1358, DOI 10.1158/1535-7163.MCT-05-0139; Kataoka K, 2001, ADV DRUG DELIVER REV, V47, P113, DOI 10.1016/S0169-409X(00)00124-1; Kim SC, 2001, J CONTROL RELEASE, V72, P191, DOI 10.1016/S0168-3659(01)00275-9; Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7; Kim TY, 2004, CLIN CANCER RES, V10, P3708, DOI 10.1158/1078-0432.CCR-03-0655; Lee E, 2006, ARCH PHARM RES, V29, P1018, DOI 10.1007/BF02969286; Lee JL, 2012, INVEST NEW DRUG, V30, P1984, DOI 10.1007/s10637-011-9757-7; Letchford K, 2007, EUR J PHARM BIOPHARM, V65, P259, DOI 10.1016/j.ejpb.2006.11.009; Mayer LD, 2001, CANCER METAST REV, V20, P87, DOI 10.1023/A:1013108524062; McLeod AD, 1998, J PHARM SCI, V8, P704; Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4; Postma TJ, 2000, ANN ONCOL, V11, P409, DOI 10.1023/A:1008376123066; Prados MD, 1996, J CLIN ONCOL, V14, P2316, DOI 10.1200/JCO.1996.14.8.2316; Qiu LY, 2006, PHARM RES-DORDR, V23, P1, DOI 10.1007/s11095-005-9046-2; ROFSTAD EK, 1986, CELL TISSUE KINET, V19, P205, DOI 10.1111/j.1365-2184.1986.tb00731.x; ROWINSKY EK, 1995, NEW ENGL J MED, V332, P1004, DOI 10.1056/NEJM199504133321507; Santini MT, 1999, PATHOBIOLOGY, V67, P148, DOI 10.1159/000028065; Saxena V, 2012, INT J NANOMED, V7, P713, DOI 10.2147/IJN.S28745; Singla AK, 2002, INT J PHARMACEUT, V235, P179, DOI 10.1016/S0378-5173(01)00986-3; Varma MVS, 2005, EUR J PHARM SCI, V25, P445, DOI 10.1016/j.ejps.2005.04.003; Wang YZ, 2008, ARCH PHARM RES, V31, P530, DOI 10.1007/s12272-001-1189-2; Wang YZ, 2007, INT J PHARM, V337, P63, DOI 10.1016/j.ijpharm.2006.12.033; WEISS RB, 1990, J CLIN ONCOL, V8, P1263, DOI 10.1200/JCO.1990.8.7.1263; Yamazaki T, 2000, CANCER LETT, V149, P153, DOI 10.1016/S0304-3835(99)00355-9; Zhang XC, 1996, INT J PHARM, V132, P195, DOI 10.1016/0378-5173(95)04386-1	38	33	34	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120129	10.1371/journal.pone.0120129	http://dx.doi.org/10.1371/journal.pone.0120129			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831130	Green Published, Green Submitted, gold			2022-12-26	WOS:000352135600023
J	Mishra, RK; Wei, CY; Hresko, RC; Bajpai, R; Heitmeier, M; Matulis, SM; Nooka, AK; Rosen, ST; Hruz, PW; Schiltz, GE; Shanmugam, M				Mishra, Rama K.; Wei, Changyong; Hresko, Richard C.; Bajpai, Richa; Heitmeier, Monique; Matulis, Shannon M.; Nooka, Ajay K.; Rosen, Steven T.; Hruz, Paul W.; Schiltz, Gary E.; Shanmugam, Mala			In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER; MULTIPLE-MYELOMA; STRUCTURE VALIDATION; INSULIN; GLUT4; DAPAGLIFLOZIN; RITONAVIR; RESISTANCE; MOLPROBITY; MECHANISM	Tumor cells rely on elevated glucose consumption and metabolism for survival and proliferation. Glucose transporters mediating glucose entry are key proximal rate-limiting checkpoints. Unlike GLUT1 that is highly expressed in cancer and more ubiquitously expressed in normal tissues, GLUT4 exhibits more limited normal expression profiles. We have previously determined that insulin-responsive GLUT4 is constitutively localized on the plasma membrane of myeloma cells. Consequently, suppression of GLUT4 or inhibition of glucose transport with the HIV protease inhibitor ritonavir elicited growth arrest and/or apoptosis in multiple myeloma. GLUT4 inhibition also caused sensitization to metformin in multiple myeloma and chronic lymphocytic leukemia and a number of solid tumors suggesting the broader therapeutic utility of targeting GLUT4. This study sought to identify selective inhibitors of GLUT4 to develop a more potent cancer chemotherapeutic with fewer potential off-target effects. Recently, the crystal structure of GLUT1 in an inward open conformation was reported. Although this is an important achievement, a full understanding of the structural biology of facilitative glucose transport remains elusive. To date, there is no three-dimensional structure for GLUT4. We have generated a homology model for GLUT4 that we utilized to screen for drug-like compounds from a library of 18 million compounds. Despite 68% homology between GLUT1 and GLUT4, our virtual screen identified two potent compounds that were shown to target GLUT4 preferentially over GLUT1 and block glucose transport. Our results strongly bolster the utility of developing GLUT4-selective inhibitors as anti-cancer therapeutics.	[Mishra, Rama K.; Schiltz, Gary E.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Evanston, IL 60208 USA; [Hresko, Richard C.; Heitmeier, Monique; Hruz, Paul W.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Rosen, Steven T.] City Hope Natl Med Ctr, Duarte, CA 91010 USA; [Wei, Changyong; Bajpai, Richa; Matulis, Shannon M.; Nooka, Ajay K.; Shanmugam, Mala] Emory Univ, Dept Hematol & Med Oncol, Sch Med, Atlanta, GA 30322 USA	Northwestern University; Washington University (WUSTL); City of Hope; Emory University	Shanmugam, M (corresponding author), Emory Univ, Winship Canc Inst, 1365C Clifton Rd NE,Ste C4002, Atlanta, GA 30322 USA.	mala.shan@emory.edu	Bajpai, Richa/H-6404-2019; Shanmugam, Mala/M-6491-2019	Shanmugam, Mala/0000-0002-4415-8083; Hruz, Paul/0000-0002-1478-3355; Rosen, Steven/0000-0002-8818-7724	American Cancer Society [RSG-11-254-01-CSM]; Richard Silverman-Center for Molecular Innovation and Drug Discovery; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health from the NCI [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Richard Silverman-Center for Molecular Innovation and Drug Discovery; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Research Scholar Grant RSG-11-254-01-CSM (to M. S.) and a research award from the Richard Silverman-Center for Molecular Innovation and Drug Discovery (to M. S.). Part of this work was performed by the Northwestern University Medicinal and Synthetic Chemistry Core (ChemCore) at the Center for Molecular Innovation and Drug Discovery, which is funded by the Chicago Biomedical Consortium with support from The Searle Funds at The Chicago Community Trust. This work was supported in part by National Institutes of Health Grant P30 CA060553 from the NCI (to the Robert H. Lurie Comprehensive Cancer Center).	Adekola KUA, 2015, LEUKEMIA LYMPHOMA, V56, P450, DOI 10.3109/10428194.2014.922180; [Anonymous], 2011, GLID VERS 5 7; Baell JB, 2013, J CHEM INF MODEL, V53, P39, DOI 10.1021/ci300461a; Bartel TB, 2009, BLOOD, V114, P2068, DOI 10.1182/blood-2009-03-213280; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bredella MA, 2005, AM J ROENTGENOL, V184, P1199, DOI 10.2214/ajr.184.4.01841199; Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9; Castellani M, 2010, CLIN NUCL MED, V35, P1, DOI 10.1097/RLU.0b013e3181c3619c; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; Dalva-Aydemir S, 2015, CLIN CANCER RES, V21, P1161, DOI 10.1158/1078-0432.CCR-14-1088; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Deng D, 2014, NATURE, V510, P121, DOI 10.1038/nature13306; Durie BGM, 2002, J NUCL MED, V43, P1457; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Han SP, 2008, DIABETES, V57, P1723, DOI 10.2337/db07-1472; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; Hertel J, 2004, J BIOL CHEM, V279, P55147, DOI 10.1074/jbc.M410826200; Hresko RC, 2014, J BIOL CHEM, V289, P16100, DOI 10.1074/jbc.M113.528430; Hresko RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025237; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Ji LN, 2014, CLIN THER, V36, P84, DOI 10.1016/j.clinthera.2013.11.002; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Lemieux MJ, 2005, J ELECTRON MICROSC, V54, pI43, DOI 10.1093/jmicro/dfi017; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Manolescu AR, 2007, PHYSIOLOGY, V22, P234, DOI 10.1152/physiol.00011.2007; Maratou E, 2007, EUR J CLIN INVEST, V37, P282, DOI 10.1111/j.1365-2362.2007.01786.x; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; McBrayer SK, 2012, BLOOD, V119, P4686, DOI 10.1182/blood-2011-09-377846; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Munshi Nikhil C, 2008, Hematology Am Soc Hematol Educ Program, P297, DOI 10.1182/asheducation-2008.1.297; Murata H, 2000, J BIOL CHEM, V275, P20251, DOI 10.1074/jbc.C000228200; OKA Y, 1990, NATURE, V345, P550, DOI 10.1038/345550a0; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; PIPER RC, 1991, AM J PHYSIOL, V260, pC570, DOI 10.1152/ajpcell.1991.260.3.C570; Ptaszynska A, 2014, DRUG SAFETY, V37, P815, DOI 10.1007/s40264-014-0213-4; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Rodriguez-Enriquez S, 2009, J CELL PHYSIOL, V221, P552, DOI 10.1002/jcp.21885; Schrodinger, 2013, MAESTR VERS 9 6 PRIM; TORDJMAN KM, 1989, P NATL ACAD SCI USA, V86, P7761, DOI 10.1073/pnas.86.20.7761; Tripos, 2011, SYBYL X VERS 1 3; Vyas AK, 2010, J BIOL CHEM, V285, P36395, DOI 10.1074/jbc.M110.176321; WRIGHT EM, 1994, J EXP BIOL, V196, P197; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Xu RH, 2005, LEUKEMIA, V19, P2153, DOI 10.1038/sj.leu.2403968; Yang XP, 2014, EUR J CLIN PHARMACOL, V70, P1149, DOI 10.1007/s00228-014-1730-x; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187	51	48	51	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14441	14453		10.1074/jbc.M114.628826	http://dx.doi.org/10.1074/jbc.M114.628826			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847249	hybrid, Green Published			2022-12-26	WOS:000355754600015
J	Xia, P; Hu, XY; Wang, J; Hu, BB; Xu, QL; Zhou, ZJ; Lou, M				Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin; Zhou, Zhi-Jie; Lou, Min			Risk Factors for Subdural Haematoma in Patients with Spontaneous Intracranial Hypotension	PLOS ONE			English	Article							CEREBROSPINAL-FLUID LEAKS; EPIDURAL BLOOD PATCH; RANDOMIZED CLINICAL-TRIALS; ORTHOSTATIC HEADACHE; BRAIN; METAANALYSIS; MANAGEMENT; THERAPY; ADULTS	Subdural haematoma (SDH) is a potentially life-threatening complication in patients with spontaneous intracranial hypotension (SIH). In serious cases, SIH patients who present with SDHs develop neurological deficits, a decreased level of consciousness, or cerebral herniation, and may even require an urgent neurosurgical drainage. Despite numerous publications on SDHs, few report its potential risk factors in patients with SIH. In this study, we retrospectively investigated 93 consecutive SIH patients and divided them into an SDH group (n = 25) and a non-SDH (NSDH) group (n = 68). The clinical and radiographic characteristics of these 93 patients were analyzed, and then univariate analysis and further multiple logistic regression analysis were performed to identify the potential risk factors for the development of SDHs. The univariate analysis showed that advanced age, male gender, longer clinical course, dural enhancement, and the venous distension sign were associated with the development of SDHs. However, multivariate analysis only included the latter three factors. Our study reveals important radiological manifestations for predicting the development of SDHs in patients with SIH.	[Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Neurol, Hangzhou 310016, Zhejiang, Peoples R China; [Xia, Ping; Hu, Xing-Yue; Wang, Jin; Hu, Bei-Bei; Xu, Qing-Lin; Zhou, Zhi-Jie] Zhejiang Univ, Sir Run Run Shaw Inst Clin Med, Hangzhou 310016, Zhejiang, Peoples R China; [Zhou, Zhi-Jie] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Orthopaed Surg, Hangzhou 310016, Zhejiang, Peoples R China; [Lou, Min] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurol, Hangzhou 310009, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Zhou, ZJ (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Neurol, 3 East Qingchun Rd, Hangzhou 310016, Zhejiang, Peoples R China.	zzj-0708@163.com; louminhz@163.com			National Natural Science Fund of China [81301587]; Natural Science Fund of Zhejiang Province [LQ13H060002]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); Natural Science Fund of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	The study was sponsored by the National Natural Science Fund of China (81301587), and the Natural Science Fund of Zhejiang Province (LQ13H060002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanese A, 2005, J NEUROSURG, V102, P1130, DOI 10.3171/jns.2005.102.6.1130; Almenawer SA, 2014, ANN SURG, V259, P449, DOI 10.1097/SLA.0000000000000255; Aspegren OP, 2013, CLIN NEUROL NEUROSUR, V115, P981, DOI 10.1016/j.clineuro.2012.10.008; Beck J, 2014, J NEUROSURG, P1; Brightbill TC, 2000, HEADACHE, V40, P292, DOI 10.1046/j.1526-4610.2000.00043.x; Chen HH, 2008, J CHIN MED ASSOC, V71, P147, DOI 10.1016/S1726-4901(08)70007-8; Chu E, 2013, J MED IMAG RADIAT ON, V57, P455, DOI 10.1111/1754-9485.12072; Chung SJ, 2006, NEUROLOGY, V67, P1088, DOI 10.1212/01.wnl.0000237338.44702.61; Connolly BJ, 2014, STROKE, V45, P1672, DOI 10.1161/STROKEAHA.114.005430; Connolly BJ, 2013, J STROKE CEREBROVASC, V22, P444, DOI 10.1016/j.jstrokecerebrovasdis.2013.01.007; de Noronha RJ, 2003, J NEUROL NEUROSUR PS, V74, P752, DOI 10.1136/jnnp.74.6.752; Duray MC, 2013, ACTA NEUROL BELG, V113, P537, DOI 10.1007/s13760-013-0252-0; Farb RI, 2007, AM J NEURORADIOL, V28, P1489, DOI 10.3174/ajnr.A0621; Ferrante E, 2010, EUR J NEUROL, V17, P715, DOI 10.1111/j.1468-1331.2009.02913.x; Forghani R, 2008, NEURORADIOLOGY, V50, P1025, DOI 10.1007/s00234-008-0445-z; Garcia-Morales I, 2001, CEPHALALGIA, V21, P703, DOI 10.1046/j.1468-2982.2001.00226.x; Hashizume K, 2013, CLIN NEUROL NEUROSUR, V115, P1403, DOI 10.1016/j.clineuro.2013.01.022; Jiang Yun, 2014, Zhejiang Da Xue Xue Bao Yi Xue Ban, V43, P83; Kanat A, 2010, J NEUROSURG SCI, V54, P99; Kuramae T, 2011, NEUROL MED-CHIR, V51, P518, DOI 10.2176/nmc.51.518; Lai TH, 2007, CEPHALALGIA, V27, P133, DOI 10.1111/j.1468-2982.2006.01249.x; Lindvall P, 2009, J CLIN NEUROSCI, V16, P1287, DOI 10.1016/j.jocn.2009.01.001; Loya JJ, 2012, J NEUROSURG, V117, P615, DOI 10.3171/2012.4.JNS112030; Murakami M, 2000, NEUROL MED-CHIR, V40, P484, DOI 10.2176/nmc.40.484; Nakajima Hiroshi, 1996, Neurologia Medico-Chirurgica, V36, P647, DOI 10.2176/nmc.36.647; Paldino Michael, 2003, Neurosurg Focus, V15, pECP2; Quinones-Hinojosa Alfredo, 2003, Neurosurg Focus, V15, pE3; REICH JB, 1993, ANN NEUROL, V33, P159, DOI 10.1002/ana.410330205; Sato Y, 1997, CEPHALALGIA, V17, P42, DOI 10.1046/j.1468-2982.1997.1701042.x; Sato Y, 1998, CEPHALALGIA, V18, P60, DOI 10.1046/j.1468-2982.1998.1801060.x; Schievink WI, 2008, CEPHALALGIA, V28, DOI 10.1111/j.1468-2982.2008.01776.x; Schievink WI, 2006, JAMA-J AM MED ASSOC, V295, P2286, DOI 10.1001/jama.295.19.2286; Schievink WI, 2005, J NEUROSURG, V103, P608, DOI 10.3171/jns.2005.103.4.0608; Schievink WI, 2010, J NEUROSURG, V112, P295, DOI 10.3171/2008.10.JNS08428; Sim YW, 2012, J KOREAN NEUROSURG S, V52, P234, DOI 10.3340/jkns.2012.52.3.234; Thomke F, 1999, NERVENARZT, V70, P909, DOI 10.1007/s001150050595; Wang J, 2014, CHINESE MED J-PEKING, V127, P2063, DOI 10.3760/cma.j.issn.0366-6999.20132966; [王谨 WANG Jin], 2009, [中华神经科杂志, Chinese Journal of Neurology], V42, P319; Xia P, 2011, NEUROSURG QUART, V21, P185, DOI 10.1097/WNQ.0b013e31821264d5; Yang AIL, 2012, BRAIN INJURY, V26, P1731, DOI 10.3109/02699052.2012.698364	40	11	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123616	10.1371/journal.pone.0123616	http://dx.doi.org/10.1371/journal.pone.0123616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853681	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400108
J	Hu, SJ; Parker, J; Wright, JT				Hu, Shijia; Parker, Joel; Wright, John Timothy			Towards Unraveling the Human Tooth Transcriptome: The Dentome	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL INTERACTIONS; GENE-EXPRESSION; MAMMALIAN TOOTH; MICRODISSECTION; MICROARRAY; COMPLEX; CELLS; GERM; MORPHOGENESIS; ORGANIZATION	The goal of the study was to characterize the transcriptome profiles of human ameloblasts and odontoblasts, evaluate molecular pathways and advance our knowledge of the human "dentome". Laser capture microdissection was used to isolate odontoblasts and ameloblasts from human tooth buds (15-20week gestational age) from 4 fetuses. RNA was examined using Agilent 41k whole genome arrays at 2 different stages of enamel formation, presecretory and secretory. Probe detection was considered against the array negative control to control for background noise. Differential expression was examined using Significance Analysis of Microarrays (SAM) 4.0 between different cell types and developmental stages with a false discovery rate of 20%. Pathway analysis was conducted using Ingenuity Pathway Analysis software. We found that during primary tooth formation, odontoblasts expressed 14,802 genes, presecretory ameloblasts 15,179 genes and secretory ameloblasts 14,526 genes. Genes known to be active during tooth development for each cell type (eg COL1A1, AMELX) were shown to be expressed by our approach. Exploring further into the list of differentially expressed genes between the motile odontoblasts and non-motile presecretory ameloblasts we found several genes of interest that could be involved in cell movement (FN1, LUM, ASTN1). Furthermore, our analysis indicated that the Phospholipase C and ERK5 pathways, that are important for cell movement, were activated in the motile odontoblasts. In addition our pathway analysis identified WNT3A and TGFB1 as important upstream contributors. Recent studies implicate these genes in the development of Schimke immuno-osseous dysplasia. The utility of laser capture microdissection can be a valuable tool in the examination of specific tissues or cell populations present in human tooth buds. Advancing our knowledge of the human dentome and related molecular pathways provides new insights into the complex mechanisms regulating odontogenesis and biomineralization. This knowledge could prove useful in future studies of odontogenic related pathologies.	[Hu, Shijia; Wright, John Timothy] Univ N Carolina, Pediat Dent, Chapel Hill, NC 27514 USA; [Hu, Shijia] Univ N Carolina, Oral Biol Curriculum, Chapel Hill, NC USA; [Parker, Joel] Univ N Carolina, Canc Genet, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hu, SJ (corresponding author), Univ N Carolina, Pediat Dent, Chapel Hill, NC 27514 USA.	Shijia_Hu@unc.edu	Wright, John Timothy/AAX-5755-2020; Parker, Joel/AAG-1108-2019	Hu, Shijia/0000-0001-6136-9926	National Institute of Dental and Craniofacial Research [DE016079]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016079] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/), grant number: DE016079 for JTW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Bartlett JD, 2013, J DENT RES, V92, P10, DOI 10.1177/0022034512463397; Bergendal B, 2011, AM J MED GENET A, V155A, P1616, DOI 10.1002/ajmg.a.34045; Bunney TD, 2010, NAT REV CANCER, V10, P342, DOI 10.1038/nrc2842; Chokechanachaisakul U, 2012, MICROSC RES TECHNIQ, V75, P1341, DOI 10.1002/jemt.22072; Cobourne MT, 2001, J DENT RES, V80, P1974, DOI 10.1177/00220345010800110501; Couve E, 2013, J DENT RES, V92, P765, DOI 10.1177/0022034513495874; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Dassule HR, 1998, DEV BIOL, V202, P215, DOI 10.1006/dbio.1998.8992; DeCarlo K, 2011, METHODS MOL BIOL, V755, P1, DOI 10.1007/978-1-61779-163-5_1; Deutsch D, 1995, CONNECT TISSUE RES, V32, P97, DOI 10.3109/03008209509013710; Ganter B, 2008, PHARMACOGENOMICS, V9, P35, DOI 10.2217/14622416.9.1.35; Gorlov IP, 2007, CANCER RES, V67, P8406, DOI 10.1158/0008-5472.CAN-06-4784; Guan X, 2013, J DENT RES, V92, P1123, DOI 10.1177/0022034513506581; Hayashi Y, 2010, J PERIODONTAL RES, V45, P618, DOI 10.1111/j.1600-0765.2010.01276.x; Heikinheimo K, 2002, J DENT RES, V81, P525, DOI 10.1177/154405910208100805; Howard C, 2010, J ENDODONT, V36, P1963, DOI 10.1016/j.joen.2010.08.046; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008; Kim KM, 2012, ARCH ORAL BIOL, V57, P1100, DOI 10.1016/j.archoralbio.2012.02.019; Kolsch V, 2008, J CELL SCI, V121, P551, DOI 10.1242/jcs.023333; Landin Maria A. dos Santos Silva, 2012, Frontiers in Genetics, V3, P139, DOI 10.3389/fgene.2012.00139; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lin DH, 2007, DEV DYNAM, V236, P1307, DOI 10.1002/dvdy.21127; Liu F, 2010, J DENT RES, V89, P318, DOI 10.1177/0022034510363373; Matheson S, 2005, J PERIODONTAL RES, V40, P312, DOI 10.1111/j.1600-0765.2005.00800.x; Morimoto M, 2012, J DENT RES, V91, pS29, DOI 10.1177/0022034512450299; Nieminen P, 1998, EUR J ORAL SCI, V106, P7, DOI 10.1111/j.1600-0722.1998.tb02146.x; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Pillas D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000856; Pispa J, 1999, DEV BIOL, V216, P521, DOI 10.1006/dbio.1999.9514; QVIST V, 1975, SCAND J DENT RES, V83, P54; Radwanska A, 2008, LIFE SCI, V83, P651, DOI 10.1016/j.lfs.2008.09.008; Rufini A, 2011, BIOCHEM PHARMACOL, V82, P1256, DOI 10.1016/j.bcp.2011.07.068; Salmon CR, 2012, DIAGN MOL PATHOL, V21, P120, DOI 10.1097/PDM.0b013e31823e9395; Schoner K, 2013, PRENATAL DIAG, V33, P75, DOI 10.1002/pd.4012; Shtutman M, 2011, P NATL ACAD SCI USA, V108, P12449, DOI 10.1073/pnas.1103842108; Simmer JP, 2012, INT J ORAL SCI, V4, P129, DOI 10.1038/ijos.2012.59; Sorkin BC, 2000, J HISTOCHEM CYTOCHEM, V48, P397, DOI 10.1177/002215540004800309; Sun JX, 2012, INT J ORAL SCI, V4, P7, DOI 10.1038/ijos.2012.15; Thesleff I, 2001, Adv Dent Res, V15, P14; Tranasi M, 2009, J ENDODONT, V35, P1211, DOI 10.1016/j.joen.2009.05.026; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; Wilson PM, 2010, J NEUROSCI, V30, P8529, DOI 10.1523/JNEUROSCI.0032-10.2010	45	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124801	10.1371/journal.pone.0124801	http://dx.doi.org/10.1371/journal.pone.0124801			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849153	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800276
J	Mendivil, CO; Koziel, H; Brain, JD				Mendivil, Carlos O.; Koziel, Henry; Brain, Joseph D.			Metabolic Hormones, Apolipoproteins, Adipokines, and Cytokines in the Alveolar Lining Fluid of Healthy Adults: Compartmentalization and Physiological Correlates	PLOS ONE			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; ADIPONECTIN; BARRIER; UREA; PERMEABILITY; TRANSPORT; INSULIN; LEPTIN; ALPHA	Objectives Our current understanding of hormone regulation in lung parenchyma is quite limited. We aimed to quantify a diverse array of biologically relevant protein mediators in alveolar lining fluid (ALF), compared to serum concentrations, and explore factors associated with protein compartmentalization on either side of the air-blood barrier. Research Design and Methods Participants were 24 healthy adult non-smoker volunteers without respiratory symptoms or significant medical conditions, with normal lung exams and office spirometry. Cell-free bronchoalveolar lavage fluid and serum were analyzed for 24 proteins (including enteric and metabolic hormones, apolipoproteins, adipokines, and cytokines) using a highly sensitive multiplex ELISA. Measurements were normalized to ALF concentrations. The ALF: serum concentration ratios were examined in relation to measures of protein size, hydrophobicity, charge, and to participant clinical and spirometric values. Results ALF measurements from 24 individuals detected 19 proteins, including adiponectin, adipsin, apoA-I, apoA-II, apoB, apoC-II, apoC-III, apoE, C-reactive protein, ghrelin, glucose-dependent insulinotropic peptide (GIP), glucagon-like peptide-1 (GLP-1), glucagon, insulin, leptin, monocyte chemoattractant protein-1, plasminogen activator inhibitor-1, resistin, and visfatin. C-peptide and serpin E1 were not detected in ALF for any individual, and IL-6, IL-10, and TNF-alpha were not detected in either ALF or serum for any individual. In general, ALF levels were similar or lower in concentration for most proteins compared to serum. However, ghrelin, resistin, insulin, visfatin and GLP-1 had ALF concentrations significantly higher compared to serum. Importantly, elevated ALF: serum ratios of ghrelin, visfatin and resistin correlated with protein net charge and isoelectric point, but not with molecular weight or hydrophobicity. Conclusions Biologically relevant enteric and metabolic hormones, apolipoproteins, adipokines, and cytokines can be detected in the ALF of healthy individuals. For the proteins measured, charge may influence trafficking and compartmentalization to the alveolar airspace more than molecular weight or hydrophobicity. These data may have implications for homeostasis and drug delivery to the lung.	[Mendivil, Carlos O.] Univ Los Andes, Sch Med, Bogota, Colombia; [Mendivil, Carlos O.] Hosp Univ Fdn Santa Fe Bogota, Endocrinol Sect, Bogota, Colombia; [Koziel, Henry] Beth Israel Deaconess Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA; [Koziel, Henry] Harvard Univ, Sch Med, Boston, MA USA; [Brain, Joseph D.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA	Universidad de los Andes (Colombia); Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Brain, JD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Mol & Integrat Physiol Sci Program, Boston, MA 02115 USA.	brain@hsph.harvard.edu		Mendivil, Carlos O/0000-0001-5546-4206				Assad NA, 2012, BIOCHIMIE, V94, P2180, DOI 10.1016/j.biochi.2012.03.006; Bartlett JA, 2013, AM J PHYSIOL-LUNG C, V305, P1256, DOI 10.1152/ajplung.00056.2013; Bernotiene E, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2004; Bhattacharya J, 2013, ANNU REV PHYSIOL, V75, P593, DOI 10.1146/annurev-physiol-030212-183756; Brain JD, 2007, DIABETES TECHNOL THE, V9, pS4, DOI 10.1089/dia.2007.0228; BYRON PR, 1993, AEROSOL SCI TECH, V18, P223, DOI 10.1080/02786829308959599; CONHAIM RL, 1988, J APPL PHYSIOL, V64, P1134, DOI 10.1152/jappl.1988.64.3.1134; FENG NH, 1992, J APPL PHYSIOL, V72, P1081, DOI 10.1152/jappl.1992.72.3.1081; Foster MW, 2013, J PROTEOME RES, V12, P2194, DOI 10.1021/pr400066g; Garcia-Verdugo I, 2010, BIOCHIMIE, V92, P1608, DOI 10.1016/j.biochi.2010.05.010; Haslam PL, 1999, EUR RESPIR J, V14, P245, DOI 10.1034/j.1399-3003.1999.14b01.x; HOLTER JF, 1986, J CLIN INVEST, V78, P1513, DOI 10.1172/JCI112743; Kolka CM, 2012, PHYSIOLOGY, V27, P237, DOI 10.1152/physiol.00012.2012; Koziel H, 1998, J CLIN INVEST, V102, P1332, DOI 10.1172/JCI560; Kwan R, 2010, J ELECTR COMPUT ENG, V2010, DOI [10.1097/TA.0b013e3181bb9878, 10.1155/2010/273486]; MARCY TW, 1987, AM REV RESPIR DIS, V135, P1276; Marino MT, 2010, CLIN PHARMACOL THER, V88, P243, DOI 10.1038/clpt.2010.85; Matej R, 2014, EXP THER MED, V8, P533, DOI 10.3892/etm.2014.1776; Mendivil CO, 2012, DIABETES TECHNOL THE, V14, P50, DOI 10.1089/dia.2011.0148; Merrill WW, 1999, EUR RESPIR REV, V9, P70; NIEDERMAN MS, 1984, AM REV RESPIR DIS, V129, P943; Patton JS, 2007, NAT REV DRUG DISCOV, V6, P67, DOI 10.1038/nrd2153; RENNARD SI, 1986, J APPL PHYSIOL, V60, P532, DOI 10.1152/jappl.1986.60.2.532; SCHNEEBE.EE, 1968, J CELL BIOL, V37, P781, DOI 10.1083/jcb.37.3.781; Summer R, 2009, AM J PHYSIOL-LUNG C, V297, pL432, DOI 10.1152/ajplung.90599.2008; SUTINEN S, 1995, RESP MED, V89, P85, DOI 10.1016/0954-6111(95)90189-2; Teirila L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102624; THEODORE J, 1975, AM J PHYSIOL, V229, P989, DOI 10.1152/ajplegacy.1975.229.4.989; Vara E, 2001, AM J RESP CRIT CARE, V163, P840, DOI 10.1164/ajrccm.163.4.9912132; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; WARD C, 1992, AM REV RESPIR DIS, V146, P444, DOI 10.1164/ajrccm/146.2.444; West JB, 1999, ANNU REV PHYSIOL, V61, P543, DOI 10.1146/annurev.physiol.61.1.543; Xu SQ, 2008, ARTERIOSCL THROM VAS, V28, P899, DOI 10.1161/ATVBAHA.108.163634	33	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123344	10.1371/journal.pone.0123344	http://dx.doi.org/10.1371/journal.pone.0123344			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848795	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800226
J	Onuma, Y; Higuchi, K; Aiki, Y; Shu, YJ; Asada, M; Asashima, M; Suzuki, M; Imamura, T; Ito, Y				Onuma, Yasuko; Higuchi, Kumiko; Aiki, Yasuhiko; Shu, Yujing; Asada, Masahiro; Asashima, Makoto; Suzuki, Masashi; Imamura, Toru; Ito, Yuzuru			A Stable Chimeric Fibroblast Growth Factor (FGF) Can Successfully Replace Basic FGF in Human Pluripotent Stem Cell Culture	PLOS ONE			English	Article							SELF-RENEWAL; LINES; MAINTENANCE; RECEPTORS	Fibroblast growth factors (FGFs) are essential for maintaining self-renewal in human embryonic stem cells and induced pluripotent stem cells. Recombinant basic FGF (bFGF or FGF2) is conventionally used to culture pluripotent stem cells; however, because of the instability of bFGF, repeated addition of fresh bFGF into the culture medium is required in order to maintain its concentration. In this study, we demonstrate that a heat-stable chimeric variant of FGF, termed FGFC, can be successfully used for maintaining human pluripotent stem cells. FGFC is a chimeric protein composed of human FGF1 and FGF2 domains that exhibits higher thermal stability and protease resistance than do both FGF1 and FGF2. Both human embryonic stem cells and induced pluripotent stem cells were maintained in ordinary culture medium containing FGFC instead of FGF2. Comparison of cells grown in FGFC with those grown in conventional FGF2 media showed no significant differences in terms of the expression of pluripotency markers, global gene expression, karyotype, or differentiation potential in the three germ lineages. We therefore propose that FGFC may be an effective alternative to FGF2, for maintenance of human pluripotent stem cells.	[Onuma, Yasuko; Higuchi, Kumiko; Aiki, Yasuhiko; Shu, Yujing; Asashima, Makoto; Suzuki, Masashi; Ito, Yuzuru] Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Asada, Masahiro; Suzuki, Masashi; Imamura, Toru] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Signaling Mol Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Suzuki, Masashi] Ibaraki Univ, Grad Sch Sci & Engn, Mito, Ibaraki 3108512, Japan; [Imamura, Toru] Tokyo Univ Technol, Sch Biosci & Biotechnol, Cell Regulat Lab, Tokyo 1920982, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Ibaraki University; Tokyo University of Technology	Ito, Y (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Stem Cell Engn, Tsukuba Cent 4,1-1-1 Higashi, Tsukuba, Ibaraki 3058562, Japan.	yuzu-itou@aist.go.jp	Suzuki, Masashi/M-1696-2018; Asashima, Makoto/O-8389-2018; ASADA, MASAHIRO/M-4086-2018; Onuma, Yasuko/L-7083-2018; Ito, Yuzuru/M-1085-2018	Suzuki, Masashi/0000-0002-7218-0923; Asashima, Makoto/0000-0002-0012-026X; ASADA, MASAHIRO/0000-0001-6092-2080; Onuma, Yasuko/0000-0002-9330-194X; Ito, Yuzuru/0000-0001-7923-865X	NCHHSTP CDC HHS [UA1 PS000063] Funding Source: Medline	NCHHSTP CDC HHS		Avery S, 2006, STEM CELLS DEV, V15, P729, DOI 10.1089/scd.2006.15.729; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Ding VMY, 2010, J CELL PHYSIOL, V225, P417, DOI 10.1002/jcp.22214; Dvorak P, 2005, FOLIA HISTOCHEM CYTO, V43, P203; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289; Makino H, 2009, EXP CELL RES, V315, P2727, DOI 10.1016/j.yexcr.2009.06.016; Motomura K, 2008, BBA-GEN SUBJECTS, V1780, P1432, DOI 10.1016/j.bbagen.2008.08.001; Nagata S, 2009, GENES CELLS, V14, P1395, DOI 10.1111/j.1365-2443.2009.01356.x; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nishino K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013017; Onuma Y, 2013, BIOCHEM BIOPH RES CO, V431, P524, DOI 10.1016/j.bbrc.2013.01.025; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tateno H, 2009, GLYCOBIOLOGY, V19, P527, DOI 10.1093/glycob/cwp016; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211	22	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118931	10.1371/journal.pone.0118931	http://dx.doi.org/10.1371/journal.pone.0118931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850016	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800009
J	Koehler, NKU; Stransky, E; Meyer, M; Gaertner, S; Shing, M; Schnaldt, M; Celej, MS; Jovin, TM; Leyhe, T; Laske, C; Batra, A; Buchkremer, G; Fallgatter, AJ; Wernet, D; Richartz-Salzburger, E				Koehler, Niklas K. U.; Stransky, Elke; Meyer, Mirjam; Gaertner, Susanne; Shing, Mona; Schnaldt, Martina; Celej, Maria S.; Jovin, Thomas M.; Leyhe, Thomas; Laske, Christoph; Batra, Anil; Buchkremer, Gerhard; Fallgatter, Andreas J.; Wernet, Dorothee; Richartz-Salzburger, Elke			Alpha-Synuclein Levels in Blood Plasma Decline with Healthy Aging	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKERS; PARKINSONS-DISEASE; LEWY BODIES; PROTEIN-DEGRADATION; ALZHEIMERS-DISEASE; DEMENTIA; MICE; TAU; FIBRILLIZATION; MITOCHONDRIA	There is unequivocal evidence that alpha-synuclein plays a pivotal pathophysiological role in neurodegenerative diseases, and in particular in synucleinopathies. These disorders present with a variable extent of cognitive impairment and alpha-synuclein is being explored as a biomarker in CSF, blood serum and plasma. Considering key events of aging that include proteostasis, alpha-synuclein may not only be useful as a marker for differential diagnosis but also for aging per se. To explore this hypothesis, we developed a highly specific ELISA to measure alpha-synuclein. In healthy males plasma alpha-synuclein levels correlated strongly with age, revealing much lower concentrations in older (avg. 58.1 years) compared to younger (avg. 27.6 years) individuals. This difference between the age groups was enhanced after acidification of the plasmas (p<0.0001), possibly reflecting a decrease of alpha-synuclein-antibody complexes or chaperone activity in older individuals. Our results support the concept that alpha-synuclein homeostasis may be impaired early on, possibly due to disturbance of the proteostasis network, a key component of healthy aging. Thus, alpha-synuclein may be a novel biomarker of aging, a factor that should be considered when analyzing its presence in biological specimens.	[Koehler, Niklas K. U.; Stransky, Elke; Meyer, Mirjam; Gaertner, Susanne; Shing, Mona; Leyhe, Thomas; Laske, Christoph; Batra, Anil; Buchkremer, Gerhard; Fallgatter, Andreas J.; Richartz-Salzburger, Elke] Univ Tubingen, Dept Psychiat & Psychotherapy, D-72076 Tubingen, Germany; [Koehler, Niklas K. U.; Laske, Christoph] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany; [Schnaldt, Martina; Wernet, Dorothee] Zentrum Klin Transfus Med, D-72076 Tubingen, Germany; [Leyhe, Thomas] Psychiat Univ Hosp, Ctr Old Age Psychiat, CH-4012 Basel, Switzerland; [Celej, Maria S.; Jovin, Thomas M.] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37077 Gottingen, Germany; [Celej, Maria S.] Natl Univ Cordoba, Sch Chem Sci, Dept Biol Chem, CIQUIBIC,CONICET, Cordoba, Argentina	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Koehler, NKU (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Calwerstr 14, D-72076 Tubingen, Germany.	niklaskoehler@yahoo.com	Celej, Maria Soledad/N-5709-2019; Demchuk, Andrew M/E-1103-2012	Celej, Maria Soledad/0000-0002-7831-9244; Demchuk, Andrew M/0000-0002-4930-7789	Eberhard-Karls-University Tubingen; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tubingen University	Eberhard-Karls-University Tubingen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tubingen University	The authors acknowledge support by internal funds from the Eberhard-Karls-University Tubingen and support by Deutsche Forschungsgemeinschaft, Open Access Publishing Fund of Tubingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Baba M, 1998, AM J PATHOL, V152, P879; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Ben-Zvi A, 2009, P NATL ACAD SCI USA, V106, P14914, DOI 10.1073/pnas.0902882106; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Bonsch D, 2005, ALCOHOL CLIN EXP RES, V29, P763, DOI 10.1097/01.ALC.0000164360.43907.24; Borghi R, 2000, NEUROSCI LETT, V287, P65, DOI 10.1016/S0304-3940(00)01153-8; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brighina L, 2010, NEUROBIOL AGING, V31, P884, DOI 10.1016/j.neurobiolaging.2008.06.010; Chahine Lama M, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS99, DOI 10.1016/S1353-8020(13)70025-7; Clayton DF, 1999, J NEUROSCI RES, V58, P120, DOI 10.1002/(SICI)1097-4547(19991001)58:1<120::AID-JNR12>3.3.CO;2-5; Colom-Cadena M, 2013, J NEUROPATH EXP NEUR, V72, P1203, DOI 10.1097/NEN.0000000000000018; Costanzo M, 2013, BIOCHEM J, V452, P1, DOI 10.1042/BJ20121898; Darvin K, 2013, J GERONTOL A; David DC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000450; del Campo M, 2012, BIOMARK MED, V6, P419, DOI [10.2217/bmm.12.46, 10.2217/BMM.12.46]; Dimant H, 2012, NEUROSCIENTIST, V18, P589, DOI 10.1177/1073858412441372; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; Ebrahimi-Fakhari D, 2012, ACTA NEUROPATHOL, V124, P153, DOI 10.1007/s00401-012-1004-6; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Eller M, 2011, CLIN CHEM LAB MED, V49, P403, DOI 10.1515/CCLM.2011.077; Eriksen JL, 2005, TRENDS MOL MED, V11, P91, DOI 10.1016/j.molmed.2005.01.001; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; Giasson BI, 2003, NEUROMOL MED, V4, P49, DOI 10.1385/NMM:4:1-2:49; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Gorostidi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052312; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hashimoto M, 1997, BIOCHEM BIOPH RES CO, V237, P611, DOI 10.1006/bbrc.1997.6978; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Irwin DJ, 2013, NAT REV NEUROSCI, V14, P626, DOI 10.1038/nrn3549; Jellinger KA, 2012, J CELL MOL MED, V16, P1166, DOI 10.1111/j.1582-4934.2011.01507.x; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kasten M, 2013, MOVEMENT DISORD, V28, P697, DOI 10.1002/mds.25499; Kasuga Kensaku, 2012, Int J Alzheimers Dis, V2012, P437025, DOI 10.1155/2012/437025; Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040504; Kim TD, 2000, BIOCHEMISTRY-US, V39, P14839, DOI 10.1021/bi001441y; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Kokhan VS, 2012, BEHAV BRAIN RES, V231, P226, DOI 10.1016/j.bbr.2012.03.026; Kotzbauer PT, 2001, J MOL NEUROSCI, V17, P225, DOI 10.1385/JMN:17:2:225; Labbadia John, 2014, F1000Prime Rep, V6, P7, DOI 10.12703/P6-7; Larson ME, 2012, J NEUROSCI, V32, P10253, DOI 10.1523/JNEUROSCI.0581-12.2012; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee HC, 2012, ADV EXP MED BIOL, V942, P311, DOI 10.1007/978-94-007-2869-1_14; Li QY, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-21; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Malek N, 2014, ACTA NEUROL SCAND, V130, P59, DOI 10.1111/ane.12247; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; Mash DC, 2008, DRUG ALCOHOL DEPEN, V94, P246, DOI 10.1016/j.drugalcdep.2007.09.020; Mata IF, 2010, ARCH NEUROL-CHICAGO, V67, P1350, DOI 10.1001/archneurol.2010.279; Michell AW, 2005, NEUROSCI LETT, V381, P294, DOI 10.1016/j.neulet.2005.02.030; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; O'Nuallain B, 2010, J CLIN IMMUNOL, V30, pS37, DOI 10.1007/s10875-010-9413-6; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Richartz-Salzburger E, 2010, NERVENARZT, V81, P837, DOI 10.1007/s00115-009-2918-7; Rott R, 2013, CNS NEUROL DISORD-DR; Schapira AHV, 2013, CURR OPIN NEUROL, V26, P395, DOI 10.1097/WCO.0b013e3283633741; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; SCHULZ R, 1988, J GERONTOL, V43, pP113, DOI 10.1093/geronj/43.5.P113; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Simm A, 2008, BIOL CHEM, V389, P257, DOI 10.1515/BC.2008.034; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stenh C, 2005, ANN NEUROL, V58, P147, DOI 10.1002/ana.20524; Sun ZF, 2013, MOVEMENT DISORD; Tanaka H, 2008, J PHYSIOL-LONDON, V586, P55, DOI 10.1113/jphysiol.2007.141879; Tinsley RB, 2010, J NEUROSCI RES, V88, P2693, DOI 10.1002/jnr.22417; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Ulusoy A, 2013, MOL NEUROBIOL, V47, P484, DOI 10.1007/s12035-012-8329-y; van Geel WJA, 2008, J NEUROSCI METH, V168, P182, DOI 10.1016/j.jneumeth.2007.09.021; Fjorback AW, 2007, SCAND J CLIN LAB INV, V67, P431, DOI 10.1080/00365510601161497; Yung RL, 2008, AUTOIMMUNITY, V41, P329, DOI 10.1080/08916930802024889	80	29	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123444	10.1371/journal.pone.0123444	http://dx.doi.org/10.1371/journal.pone.0123444			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844871	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700022
J	McAdams, RM; McPherson, RJ; Beyer, RP; Bammler, TK; Farin, FM; Juul, SE				McAdams, Ryan M.; McPherson, Ronald J.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Juul, Sandra E.			Dose-Dependent Effects of Morphine Exposure on mRNA and microRNA (miR) Expression in Hippocampus of Stressed Neonatal Mice	PLOS ONE			English	Article							MU-OPIOID RECEPTOR; OXIDATIVE STRESS; CELLS; BRAIN; STEM; DIFFERENTIATION; INFLAMMATION; CYTOKINES; MOLECULE; DENSITY	Morphine is used to sedate critically ill infants to treat painful or stressful conditions associated with intensive care. Whether neonatal morphine exposure affects microRNA (miR) expression and thereby alters mRNA regulation is unknown. We tested the hypothesis that repeated morphine treatment in stress-exposed neonatal mice alters hippocampal mRNA and miR expression. C57BL/6 male mice were treated from postnatal day (P) 5 to P9 with morphine sulfate at 2 or 5 mg/kg ip twice daily and then exposed to stress consisting of hypoxia (100% N-2 1 min and 100% O-2 5 min) followed by 2h maternal separation. Control mice were untreated and dam-reared. mRNA and miR expression profiling was performed on hippocampal tissues at P9. Overall, 2 and 5 mg/kg morphine treatment altered expression of a total of 150 transcripts (>1.5 fold change, P<0.05) from which 100 unique mRNAs were recognized (21 genes were up- and 79 genes were down-regulated), and 5 mg/kg morphine affected 63 mRNAs exclusively. The most upregulated mRNAs were fidgetin, arginine vasopressin, and resistin-like alpha, and the most down-regulated were defensin beta 11, aquaporin 1, calmodulin-like 4, chloride intracellular channel 6, and claudin 2. Gene Set Enrichment Analysis revealed that morphine treatment affected pathways related to cell cycle, membrane function, signaling, metabolism, cell death, transcriptional regulation, and immune response. Morphine decreased expression of miR-204-5p, miR-455-3p, miR-448-5p, and miR-574-3p. Nine morphine-responsive mRNAs that are involved in neurodevelopment, neurotransmission, and inflammation are predicted targets of the aforementioned differentially expressed miRs. These data establish that morphine produces dose-dependent changes in both hippocampal mRNA and miR expression in stressed neonatal mice. If permanent, morphine-mediated neuroepigenetic effects may affect long-term hippocampal function, and this provides a mechanism for the neonatal morphine-related impairment of adult learning.	[McAdams, Ryan M.; McPherson, Ronald J.; Juul, Sandra E.] Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McAdams, RM (corresponding author), Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA.	mcadams@uw.edu			Seattle Children's Hospital Academic Enrichment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER	Seattle Children's Hospital Academic Enrichment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by a local award from the Seattle Children's Hospital Academic Enrichment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham CR, 2012, FUTURE MED CHEM, V4, P1671, DOI [10.4155/fmc.12.134, 10.4155/FMC.12.134]; Adkins P, 2001, J IMMUNOL, V166, P918, DOI 10.4049/jimmunol.166.2.918; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Anand KJS, 2007, J PERINATOL, V27, pS4, DOI 10.1038/sj.jp.7211712; Barca-Mayo O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00013; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baumgart E, 1996, P NATL ACAD SCI USA, V93, P13748, DOI 10.1073/pnas.93.24.13748; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Boasen JF, 2009, NEONATOLOGY, V95, P230, DOI 10.1159/000165379; Borck G, 2008, HUM MUTAT, V29, P966, DOI 10.1002/humu.20531; Brown JN, 2012, MOL CELL PROTEOMICS, V11, P605, DOI 10.1074/mcp.M111.016121; Cacciagli P, 2014, EUR J HUM GENET, V22, P363, DOI 10.1038/ejhg.2013.135; Chavez-Valdez R, 2013, J PERINATOL, V33, P374, DOI 10.1038/jp.2012.124; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Cioni JM, 2013, CURR BIOL, V23, P850, DOI 10.1016/j.cub.2013.04.007; Cornwell WD, 2013, J NEUROIMMUNOL, V265, P43, DOI 10.1016/j.jneuroim.2013.09.013; Dave RS, 2010, J CELL BIOCHEM, V110, P834, DOI 10.1002/jcb.22592; Decaro MH, 2011, EARLY HUM DEV, V87, pS19, DOI 10.1016/j.earlhumdev.2011.01.005; Dorum G, 2009, STAT APPL GENET MOL, V8, DOI 10.2202/1544-6115.1418; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Filipczak-Bryniarska I, 2012, PHARMACOL REP, V64, P1200, DOI 10.1016/S1734-1140(12)70916-7; Fiore R, 2011, PROG MOL BIOL TRANSL, V102, P47, DOI 10.1016/B978-0-12-415795-8.00004-0; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghafari S, 2011, FOLIA NEUROPATHOL, V49, P328; GOODMAN RR, 1980, P NATL ACAD SCI-BIOL, V77, P6239, DOI 10.1073/pnas.77.10.6239; Hays SL, 2012, BEHAV BRAIN RES, V227, P7, DOI 10.1016/j.bbr.2011.10.033; He Ying, 2012, Frontiers in Genetics, V3, P110, DOI 10.3389/fgene.2012.00110; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Heimfarth L, 2013, METAB BRAIN DIS, V28, P429, DOI 10.1007/s11011-013-9379-1; Ji F, 2013, J GENET GENOMICS, V40, P61, DOI 10.1016/j.jgg.2012.12.008; Juul SE, 2011, PEDIATR RES, V69, P285, DOI 10.1203/PDR.0b013e31820bd165; Kahn L, 2005, EUR J NEUROSCI, V21, P493, DOI 10.1111/j.1460-9568.2005.03883.x; Kurokawa D, 2014, DEV BIOL, V387, P203, DOI 10.1016/j.ydbio.2014.01.011; Leviton A, 2005, ANN NEUROL, V58, P821, DOI 10.1002/ana.20662; Li YJ, 2013, NEUROSCI LETT, V545, P17, DOI 10.1016/j.neulet.2013.04.008; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Loohuis NFMO, 2012, CELL MOL LIFE SCI, V69, P89, DOI 10.1007/s00018-011-0788-1; Sanchez-Simon FM, 2010, MOL PHARMACOL, V78, P935, DOI 10.1124/mol.110.066837; Majewski IJ, 2010, BLOOD, V116, P731, DOI 10.1182/blood-2009-12-260760; McNeill E, 2012, NEURON, V75, P363, DOI 10.1016/j.neuron.2012.07.005; McPherson RJ, 2007, NEONATOLOGY, V92, P33, DOI 10.1159/000100084; McPherson RJ, 2009, PEDIATR RES, V66, P278, DOI 10.1203/PDR.0b013e3181b1bd1b; Messmer D, 2006, MOL MED, V12, P284, DOI 10.2119/2006-00043.Messmer; Milner TA, 2013, SYNAPSE, V67, P757, DOI 10.1002/syn.21683; Mizota T, 2013, J ANESTH, V27, P80, DOI 10.1007/s00540-012-1472-9; Moghadam Paanteha K, 2013, Front Endocrinol (Lausanne), V4, P124, DOI 10.3389/fendo.2013.00124; Okuse K, 2007, INT J BIOCHEM CELL B, V39, P490, DOI 10.1016/j.biocel.2006.11.016; Peng XH, 2000, J LEUKOCYTE BIOL, V68, P723; Rodriguez Raquel E., 2012, Frontiers in Genetics, V3, P223, DOI 10.3389/fgene.2012.00223; Roy S, 2004, J NEUROIMMUNOL, V147, P78, DOI 10.1016/j.jneuroim.2003.10.016; Roy S, 2001, SURGERY, V130, P304, DOI 10.1067/msy.2001.116033; Roy S, 2011, J NEUROIMMUNE PHARM, V6, P442, DOI 10.1007/s11481-011-9292-5; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shao D, 2009, MOL CELL NEUROSCI, V42, P219, DOI 10.1016/j.mcn.2009.07.003; Shiozaki M, 2008, NEUROSCIENCE, V152, P924, DOI 10.1016/j.neuroscience.2008.01.032; Simeone A, 2011, MOL NEUROBIOL, V43, P107, DOI 10.1007/s12035-010-8148-y; Slamberova R, 2003, HIPPOCAMPUS, V13, P461, DOI 10.1002/hipo.10076; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sudhof TC, 2013, NAT MED, V19, P1227, DOI 10.1038/nm.3338; Tapocik JD, 2013, ADDICT BIOL, V18, P480, DOI 10.1111/j.1369-1600.2012.00470.x; Tripathi PP, 2014, NEUROSCIENCE, V261, P173, DOI 10.1016/j.neuroscience.2013.12.045; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vien TN, 2009, NEONATOLOGY, V96, P235, DOI 10.1159/000220763; White R, 2012, FILM QUART, V65, P4, DOI 10.1525/FQ.2012.65.3.04; Williams WM, 2012, SCI WORLD J, DOI 10.1100/2012/905785; Wood Emily J., 2012, Frontiers in Genetics, V3, P241, DOI 10.3389/fgene.2012.00241; Wu QF, 2013, FASEB J, V27, P522, DOI 10.1096/fj.12-213439; Zaits MN, 2014, MOL PSYCHIATR, V19, P848, DOI 10.1038/mp.2013.93; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848; Zheng K, 2012, NEUROSCIENTIST, V18, P114, DOI 10.1177/1073858411398322	75	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123047	10.1371/journal.pone.0123047	http://dx.doi.org/10.1371/journal.pone.0123047			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844808	Green Published, Green Submitted, gold			2022-12-26	WOS:000352475700018
J	Siegl, D; Midura, EF; Annecke, T; Conzen, P; Caldwell, CC; Tschoep, J				Siegl, Daniel; Midura, Emily F.; Annecke, Thorsten; Conzen, Peter; Caldwell, Charles C.; Tschoep, Johannes			The Effect of Ghrelin upon the Early Immune Response in Lean and Obese Mice during Sepsis	PLOS ONE			English	Article							MURINE MODEL; CECAL LIGATION; PROTECTS MICE; PLASMA LEPTIN; ORGAN INJURY; MORTALITY; ACTIVATION; CYTOKINES; HYPOTHERMIA; EXPRESSION	Introduction It is well established that obesity-related hormones can have modulatory effects associated with the immune response. Ghrelin, a hormone mainly derived from endocrine cells of the gastric mucosa, regulates appetite, energy expenditure and body weight counteracting leptin, a hormone mainly derived from adipocytes. Additionally, receptors of both have been detected on immune cells and demonstrated an immune regulatory function during sepsis. Methods In the present study, the effect of peripheral ghrelin administration on early immune response and survival was investigated with lean mice and mice with diet-induced obesity using cecal ligation and puncture to induce sepsis. Results In the obese group, we found that ghrelin treatment improved survival, ameliorated hypothermia, and increased hyperleptinemia as compared to the lean controls. We also observed that ghrelin treatment divergently regulated serum IL-1 beta and TNF-alpha concentrations in both lean and obese septic mice. Ghrelin treatment initially decreased but later resulted in increased bacteriaemia in lean mice while having no impact upon obese mice. Similarly, ghrelin treatment increased early neutrophil oxidative burst while causing a decrease 48 hours after sepsis inducement. Conclusion In conclusion, as the immune response to sepsis temporally changes, ghrelin treatment differentially mediates this response. Specifically, we observed that ghrelin conferred protective effects during the early phase of sepsis, but during the later phase deteriorated immune response and outcome. These adverse effects were more pronounced upon lean mice as compared to obese mice.	[Siegl, Daniel] Univ Munich, Walter Brendel Ctr Expt Med, Munich, Germany; [Conzen, Peter; Tschoep, Johannes] Univ Hosp Munich LMU, Dept Anaesthesiol, Munich, Germany; [Midura, Emily F.; Caldwell, Charles C.] Univ Cincinnati, Coll Med, Dept Surg, Div Res, Cincinnati, OH USA; [Annecke, Thorsten] Univ Hosp Cologne, Dept Anaesthesiol & Intens Care Med, Cologne, Germany	University of Munich; University of Munich; University System of Ohio; University of Cincinnati; University of Cologne	Tschoep, J (corresponding author), Univ Hosp Munich LMU, Dept Anaesthesiol, Munich, Germany.	Johannes.Tschoep@med.uni-muenchen.de	Annecke, Thorsten/AAG-3909-2020	Annecke, Thorsten/0000-0002-2496-4432; Midura, Emily/0000-0002-7659-316X; Caldwell, Charles/0000-0003-1692-4550	Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany; Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany; Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program - Ludwig-Maximilians-University, Munich, Germany	Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany; Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany; Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program - Ludwig-Maximilians-University, Munich, Germany	The study was supported by an intramural grant of the Department of Anesthesiology, Ludwig-Maximilians-University Munich, Munich, Germany and by the Gesellschaft fur medizinische Forschung und Weiterbildung e.V., Munich, Germany (to JT) and by the Metiphys (Munich Excellence Training Initiative for Physician Scientists) Program awarded by Ludwig-Maximilians-University, Munich, Germany (to DS). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami S, 1997, AM J PHYSIOL-HEART C, V272, pH2219, DOI 10.1152/ajpheart.1997.272.5.H2219; Bornstein SR, 1998, J CLIN ENDOCR METAB, V83, P280, DOI 10.1210/jc.83.1.280; Chang L, 2003, ACTA PHARMACOL SIN, V24, P45; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; Disse E, 2011, PHYSIOL BEHAV, V102, P481, DOI 10.1016/j.physbeh.2010.12.006; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jaeschke Roman Z, 2008, Pol Arch Med Wewn, V118, P92; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kuperman EF, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-377; Lawrence CB, 2002, ENDOCRINOLOGY, V143, P155, DOI 10.1210/en.143.1.155; Lee HM, 2002, ENDOCRINOLOGY, V143, P185, DOI 10.1210/en.143.1.185; Lin LG, 2012, METHOD ENZYMOL, V514, P355, DOI 10.1016/B978-0-12-381272-8.00022-2; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; Marik PE, 2000, INTENS CARE MED, V26, P716, DOI 10.1007/s001340051237; Martignoni A, 2008, SHOCK, V29, P591, DOI 10.1097/SHK.0b013e318157f427; Maruna P, 2005, EUR SURG RES, V37, P354, DOI 10.1159/000090336; Medina E, 2010, METHODS MOL BIOL, V602, P411, DOI 10.1007/978-1-60761-058-8_23; Misra A, 2008, J CLIN ENDOCR METAB, V93, pS9, DOI 10.1210/jc.2008-1595; Murphey ED, 2004, SHOCK, V21, P415, DOI 10.1097/00024382-200405000-00004; Nieman DC, 1999, J AM DIET ASSOC, V99, P294, DOI 10.1016/S0002-8223(99)00077-2; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Peng ZY, 2012, INT IMMUNOPHARMACOL, V13, P440, DOI 10.1016/j.intimp.2012.04.006; PRUITT JH, 1995, SHOCK, V3, P235, DOI 10.1097/00024382-199504000-00001; Rajan D, 2012, SURGERY, V151, P37, DOI 10.1016/j.surg.2011.06.027; Remick DG, 2002, SHOCK, V17, P463, DOI 10.1097/00024382-200206000-00004; Robertson CM, 2006, MICROBES INFECT, V8, P1382, DOI 10.1016/j.micinf.2005.12.016; Scumpia PO, 2005, CRIT CARE MED, V33, pS468, DOI 10.1097/01.CCM.0000186268.53799.67; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Tschoep J, 2008, J LEUKOCYTE BIOL, V83, P581, DOI 10.1189/jlb.0707507; Tschoep Johannes, 2010, Endocrine Metabolic & Immune Disorders-Drug Targets, V10, P336; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Wang LX, 2006, AM J PHYSIOL-GASTR L, V291, pG611, DOI 10.1152/ajpgi.00533.2005; Wang W, 2009, AM J PHYSIOL-RENAL, V297, pF1032, DOI 10.1152/ajprenal.00044.2009; Waseern T, 2008, SURGERY, V143, P334, DOI 10.1016/j.surg.2007.09.039; Wiedmer P, 2011, PHYSIOL BEHAV, V105, P43, DOI 10.1016/j.physbeh.2011.03.027; Wu R, 2007, AM J RESP CRIT CARE, V176, P805, DOI 10.1164/rccm.200604-511OC; Wu RQ, 2007, ANN SURG, V245, P480, DOI 10.1097/01.sla.0000251614.42290.ed; Wu RQ, 2004, AM J PHYSIOL-HEART C, V287, pH1296, DOI 10.1152/ajpheart.00852.2003; Xia Q, 2004, REGUL PEPTIDES, V122, P173, DOI 10.1016/j.regpep.2004.06.016; Yilmaz Z, 2008, CRIT CARE MED, V36, P828, DOI 10.1097/01.CCM.0B013E3181611F5AA	46	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122211	10.1371/journal.pone.0122211	http://dx.doi.org/10.1371/journal.pone.0122211			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844479	Green Published, Green Submitted, gold			2022-12-26	WOS:000352475700012
J	Ahlin, C; Stupica, D; Strle, F; Lusa, L				Ahlin, Crt; Stupica, Dasa; Strle, Franc; Lusa, Lara			medplot: A Web Application for Dynamic Summary and Analysis of Longitudinal Medical Data Based on R	PLOS ONE			English	Article							FALSE DISCOVERY RATE; REGRESSION; SEPARATION	In biomedical studies the patients are often evaluated numerous times and a large number of variables are recorded at each time-point. Data entry and manipulation of longitudinal data can be performed using spreadsheet programs, which usually include some data plotting and analysis capabilities and are straightforward to use, but are not designed for the analyses of complex longitudinal data. Specialized statistical software offers more flexibility and capabilities, but first time users with biomedical background often find its use difficult. We developed medplot, an interactive web application that simplifies the exploration and analysis of longitudinal data. The application can be used to summarize, visualize and analyze data by researchers that are not familiar with statistical programs and whose knowledge of statistics is limited. The summary tools produce publication-ready tables and graphs. The analysis tools include features that are seldom available in spreadsheet software, such as correction for multiple testing, repeated measurement analyses and flexible non-linear modeling of the association of the numerical variables with the outcome. medplot is freely available and open source, it has an intuitive graphical user interface (GUI), it is accessible via the Internet and can be used within a web browser, without the need for installing and maintaining programs locally on the user's computer. This paper describes the application and gives detailed examples describing how to use the application on real data from a clinical study including patients with early Lyme borreliosis.	[Ahlin, Crt] Univ Ljubljana, Stat Programme, Ljubljana, Slovenia; [Stupica, Dasa; Strle, Franc] Univ Med Ctr Ljubljana, Dept Infect Dis, Ljubljana, Slovenia; [Lusa, Lara] Univ Ljubljana, Inst Biostat & Med Informat, Ljubljana 61000, Slovenia	University of Ljubljana; University Medical Centre Ljubljana; University of Ljubljana	Lusa, L (corresponding author), Univ Ljubljana, Inst Biostat & Med Informat, Ljubljana 61000, Slovenia.	lara.lusa@mf.uni-lj.si	Lusa, Lara/C-6692-2015	Lusa, Lara/0000-0002-8981-2421	European Union; European Social Fund; Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development; Slovenian Research Agency [P3-0296]	European Union(European Commission); European Social Fund(European Social Fund (ESF)); Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development; Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This article is partly a result of doctoral research done by one of the authors, Crt Ahlin, which was in part financed by the European Union, European Social Fund and the Republic of Slovenia, Ministry for Education, Science and Sport in the framework of the Operational programme for human resources development for the period 2007 - 2013. Franc Strle obtained grant from the Slovenian Research Agency (grant P3-0296). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Browner W., 2013, DESIGNING CLIN RES, V4th, ppp65; Carro A, 2010, NUCLEIC ACIDS RES, V38, pW182, DOI 10.1093/nar/gkq441; Chang W, 2015, SHINY WEB APPL FRAME; Diaz-Uriarte R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000737; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Heinze G, 2002, STAT MED, V21, P2409, DOI 10.1002/sim.1047; Heinze G, 2010, STAT MED, V29, P770, DOI 10.1002/sim.3794; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Ogrinc K, 2013, CLIN INFECT DIS, V57, P501, DOI 10.1093/cid/cit317; Petchey O. L., 2009, B BRIT ECOL SOC, V20, P55; R Core Team, 2021, R LANGUAGE ENV STAT; Sinha AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031690; Strle F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082132; Stupica D, 2011, VECTOR-BORNE ZOONOT, V11, P883, DOI 10.1089/vbz.2010.0018; Swihart BJ, 2010, EPIDEMIOLOGY, V21, P621, DOI 10.1097/EDE.0b013e3181e5b06a; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Wickham H, GGPLOT2 ELEGANT GRAP; Xie YH, 2014, IMPLEMENTING REPROD, P3	23	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121760	10.1371/journal.pone.0121760	http://dx.doi.org/10.1371/journal.pone.0121760			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837352	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000060
J	Nygren, J; Shad, N; Kvarnheden, A; Westerbergh, A				Nygren, Jim; Shad, Nadeem; Kvarnheden, Anders; Westerbergh, Anna			Variation in Susceptibility to Wheat dwarf virus among Wild and Domesticated Wheat	PLOS ONE			English	Article							A-GENOME DONOR; NUCLEOTIDE DIVERSITY; GENETIC DIVERSITY; PLANT-RESISTANCE; POLYPLOID WHEAT; HOST-RANGE; B-GENOME; TRITICUM; AEGILOPS; ORIGIN	We investigated the variation in plant response in host-pathogen interactions between wild (Aegilops spp., Triticum spp.) and domesticated wheat (Triticum spp.) and Wheat dwarf virus (WDV). The distribution of WDV and its wild host species overlaps in Western Asia in the Fertile Crescent, suggesting a coevolutionary relationship. Bread wheat originates from a natural hybridization between wild emmer wheat (carrying the A and B genomes) and the wild D genome donor Aegilops tauschii, followed by polyploidization and domestication. We studied whether the strong selection during these evolutionary processes, leading to genetic bottlenecks, may have resulted in a loss of resistance in domesticated wheat. In addition, we investigated whether putative fluctuations in intensity of selection imposed on the hostpathogen interactions have resulted in a variation in susceptibility to WDV. To test our hypotheses we evaluated eighteen wild and domesticated wheat taxa, directly or indirectly involved in wheat evolution, for traits associated with WDV disease such as leaf chlorosis, different growth traits and WDV content. The plants were exposed to viruliferous leafhoppers (Psammotettix alienus) in a greenhouse trial and evaluated at two time points. We found three different plant response patterns: i) continuous reduction in growth over time, ii) weak response at an early stage of plant development but a much stronger response at a later stage, and iii) remission of symptoms over time. Variation in susceptibility may be explained by differences in the intensity of natural selection, shaping the coevolutionary interaction between WDV and the wild relatives. However, genetic bottlenecks during wheat evolution have not had a strong impact on WDV resistance. Further, this study indicates that the variation in susceptibility may be associated with the genome type and that the ancestor Ae. tauschii may be useful as genetic resource for the improvement of WDV resistance in wheat.	[Nygren, Jim; Shad, Nadeem; Kvarnheden, Anders; Westerbergh, Anna] Swedish Univ Agr Sci, Linnean Ctr Plant Biol Uppsala, Uppsala BioCtr, Dept Plant Biol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Westerbergh, A (corresponding author), Univ Punjab, Fac Life Sci, Inst Agr Sci, Lahore, Pakistan.	anna.westerbergh@slu.se			Swedish Research Council Formas; Royal Swedish Academy of Agriculture and Forestry; Higher Education Commission, Pakistan through University of the Punjab	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Royal Swedish Academy of Agriculture and Forestry; Higher Education Commission, Pakistan through University of the Punjab	This study has been funded by the Swedish Research Council Formas and the Royal Swedish Academy of Agriculture and Forestry. NS was supported by the Higher Education Commission, Pakistan through University of the Punjab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adderley S, 2014, GENE, V533, P142, DOI 10.1016/j.gene.2013.09.103; Baum BR, 2004, GENET RESOUR CROP EV, V51, P183, DOI 10.1023/B:GRES.0000020861.96294.f4; Behjatnia SAA, 2011, AUSTRALAS PLANT PATH, V40, P12, DOI 10.1007/s13313-010-0008-8; Benkovics AH, 2010, PLANT PATHOL, V59, P1144, DOI 10.1111/j.1365-3059.2010.02318.x; Berger S, 2007, J EXP BOT, V58, P4019, DOI 10.1093/jxb/erm298; Bisnieks M, 2005, Z PFLANZENK PFLANZEN, V112, P521; BOULTON MI, 1991, VIROLOGY, V181, P312, DOI 10.1016/0042-6822(91)90497-Y; BOULTON MI, 1991, VIROLOGY, V183, P114, DOI 10.1016/0042-6822(91)90124-T; BOULTON RE, 1980, ANN APPL BIOL, V94, P69, DOI 10.1111/j.1744-7348.1980.tb03897.x; Brenchley R, 2012, NATURE, V491, P705, DOI 10.1038/nature11650; Brown JKM, 2011, ANNU REV PHYTOPATHOL, V49, P345, DOI 10.1146/annurev-phyto-072910-095301; Brown JK, 2005, PHYTOPATHOLOGY, V95, P1217, DOI 10.1094/PHYTO-95-1217; Carrillo-Tripp J, 2007, PHYTOPATHOLOGY, V97, P51, DOI 10.1094/PHYTO-97-0051; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; CLARK MF, 1977, J GEN VIROL, V34, P475, DOI 10.1099/0022-1317-34-3-475; Culver JN, 2007, ANNU REV PHYTOPATHOL, V45, P221, DOI 10.1146/annurev.phyto.45.062806.094422; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; DVORAK J, 1993, GENOME, V36, P21, DOI 10.1139/g93-004; Dvorak J, 2012, J HERED, V103, P426, DOI 10.1093/jhered/esr152; Ekzayez AM, 2011, PLANT DIS, V95, P76, DOI 10.1094/PDIS-09-10-0628; Fargette D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000125; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Hagen C, 2008, PHYTOPATHOLOGY, V98, P1029, DOI 10.1094/PHYTO-98-9-1029; Hall MD, 2009, EUPHYTICA, V169, P169, DOI 10.1007/s10681-009-9910-y; HAMMER K, 1980, Kulturpflanze, V28, P33; Hanley-Bowdoin L, 2013, NAT REV MICROBIOL, V11, P777, DOI 10.1038/nrmicro3117; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Heun M, 1997, SCIENCE, V278, P1312, DOI 10.1126/science.278.5341.1312; Hohn T, 2011, BBA-GENE REGUL MECH, V1809, P588, DOI 10.1016/j.bbagrm.2011.06.002; Jay F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002035; Kanyuka K, 2004, PLANT PATHOL, V53, P154, DOI 10.1111/j.0032-0862.2004.01000.x; Karagoz Alptekin, 2006, Turkish Journal of Agriculture and Forestry, V30, P387; Kilian B, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: CEREALS, P1, DOI 10.1007/978-3-642-14228-4_1; Koh EJ, 2012, PROTOPLASMA, V249, P687, DOI 10.1007/s00709-011-0312-3; Koklu G, 2004, PHYTOPROTECTION, V85, P19, DOI 10.7202/008902ar; Koklu G, 2007, VIRUS GENES, V34, P359, DOI 10.1007/s11262-006-0029-0; Kvarnheden A, 2002, ARCH VIROL, V147, P205, DOI 10.1007/s705-002-8313-x; Laine AL, 2004, J ECOL, V92, P990, DOI 10.1111/j.0022-0477.2004.00925.x; Laine AL, 2011, J ECOL, V99, P96, DOI 10.1111/j.1365-2745.2010.01738.x; Laine AL, 2009, J EXP BOT, V60, P2957, DOI 10.1093/jxb/erp168; Lemoine R, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00272; Li WL, 2012, PLANT CELL REP, V31, P905, DOI 10.1007/s00299-011-1211-y; Lindblad M, 2004, CROP PROT, V23, P229, DOI 10.1016/j.cropro.2003.08.011; Lindblad M, 2002, AGR ECOSYST ENVIRON, V92, P115, DOI 10.1016/S0167-8809(01)00302-4; LINDSTEN K, 1991, ACTA PHYTOPATHOL HUN, V26, P175; LINDSTEN K, 1970, Statens Vaxtskyddsanstalt Meddelanden, V14, P285; Lindsten K., 1980, P 3 C VIR DIS GRAM E, P27; Liu Y, 2014, VIRUS RES, V190, P34, DOI 10.1016/j.virusres.2014.06.014; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Mochizuki T, 2014, VIROLOGY, V456, P292, DOI 10.1016/j.virol.2014.04.010; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Ozkan H, 2002, MOL BIOL EVOL, V19, P1797, DOI 10.1093/oxfordjournals.molbev.a004002; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Peng JHH, 2011, MOL BREEDING, V28, P281, DOI 10.1007/s11032-011-9608-4; Persson T, 2007, ACTA AGR SCAND B-S P, V57, P10, DOI 10.1080/09064710500487895; Petersen G, 2006, MOL PHYLOGENET EVOL, V39, P70, DOI 10.1016/j.ympev.2006.01.023; Raja P, 2008, J VIROL, V82, P8997, DOI 10.1128/JVI.00719-08; Ramsell JNE, 2008, PLANT PATHOL, V57, P834, DOI 10.1111/j.1365-3059.2008.01862.x; Rodriguez-Negrete EA, 2009, J VIROL, V83, P1332, DOI 10.1128/JVI.01474-08; Sakuma S, 2011, PLANT CELL PHYSIOL, V52, P738, DOI 10.1093/pcp/pcr025; Salse J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-555; Schneider A, 2008, EUPHYTICA, V163, P1, DOI 10.1007/s10681-007-9624-y; Sirlova Lenka, 2005, Plant Protection Science, V41, P1; Smith NA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002022; Strange RN, 2005, ANNU REV PHYTOPATHOL, V43, P83, DOI 10.1146/annurev.phyto.43.113004.133839; Stukenbrock EH, 2008, ANNU REV PHYTOPATHOL, V46, P75, DOI 10.1146/annurev.phyto.010708.154114; Thompson J. N., 2005, INTERSPEC INTERACT; Tsuda S, 2007, PHYTOPATHOLOGY, V97, P412, DOI 10.1094/PHYTO-97-4-0412; Vacke J., 2001, Czech Journal of Genetics and Plant Breeding, V37, P50; Vacke J., 2000, Czech Journal of Genetics and Plant Breeding, V36, P1; Vacke J., 1972, Vedecke Prace Vyzkumnych Ustavu Rostlinne Vyroby v Praze-Ruzyni, V17, P151; VACKE J, 1961, BIOL PLANTARUM, V3, P228, DOI 10.1007/BF02933566; Vacke J, 1964, P 5 C CZECH PLANT VI, P331; Van Slageren M.W., 1994, ICARDA WAGENINGEN AG; Vuorinen AL, 2011, PLANT SCI, V181, P355, DOI 10.1016/j.plantsci.2011.06.008; WAINES JG, 1992, HEREDITAS, V116, P207, DOI 10.1111/j.1601-5223.1992.tb00143.x; Wang YJ, 2014, PHYTOPATHOLOGY, V104, P897, DOI 10.1094/PHYTO-09-13-0251-R; Wang YQ, 2014, J GEN VIROL, V95, P2082, DOI 10.1099/vir.0.064246-0; Ward E, 2005, NEW PHYTOL, V165, P875, DOI 10.1111/j.1469-8137.2004.01291.x; Wu BL, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-335; Yazdkhasti E., 2012, THESIS SWEDISH U AGR; Zaharieva M, 2001, EUPHYTICA, V119, P33, DOI 10.1023/A:1017500728227; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	87	19	20	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121580	10.1371/journal.pone.0121580	http://dx.doi.org/10.1371/journal.pone.0121580			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837893	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000048
J	Zhang, LQ; Polyansky, A; Buck, M				Zhang, Liqun; Polyansky, Anton; Buck, Matthias			Modeling Transmembrane Domain Dimers/Trimers of Plexin Receptors: Implications for Mechanisms of Signal Transmission across the Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; GTPASE BINDING DOMAIN; HELIX ASSOCIATION; LIPID-BILAYERS; EGF RECEPTOR; PROTEINS; DIMERS; PREDICTION; PROGRAM; RND1	Single-pass transmembrane (TM) receptors transmit signals across lipid bilayers by helix association or by configurational changes within preformed dimers. The structure determination for such TM regions is challenging and has mostly been accomplished by NMR spectroscopy. Recently, the computational prediction of TM dimer structures is becoming recognized for providing models, including alternate conformational states, which are important for receptor regulation. Here we pursued a strategy to predict helix oligomers that is based on packing considerations (using the PREDDIMER webserver) and is followed by a refinement of structures, utilizing microsecond all-atom molecular dynamics simulations. We applied this method to plexin TM receptors, a family of 9 human proteins, involved in the regulation of cell guidance and motility. The predicted models show that, overall, the preferences identified by PREDDIMER are preserved in the unrestrained simulations and that TM structures are likely to be diverse across the plexin family. Plexin-B1 and -B3 TM helices are regular and tend to associate, whereas plexin-A1, -A2, -A3, -A4, -C1 and -D1 contain sequence elements, such as poly-Glycine or aromatic residues that distort helix conformation and association. Plexin-B2 does not form stable dimers due to the presence of TM prolines. No experimental structural information on the TM region is available for these proteins, except for plexin-C1 dimeric and plexin-B1 -trimeric structures inferred from X-ray crystal structures of the intracellular regions. Plexin-B1 TM trimers utilize Ser and Thr sidechains for interhelical contacts. We also modeled the juxtamembrane (JM) region of plexin-C1 and plexin-B1 and show that it synergizes with the TM structures. The structure and dynamics of the JM region and TM-JM junction provide determinants for the distance and distribution of the intracellular domains, and for their binding partners relative to the membrane. The structures suggest experimental tests and will be useful for the interpretation of future studies.	[Zhang, Liqun; Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Polyansky, Anton] Univ Vienna, Dept Struct & Computat Biol, Max F Perutz Labs, AT-1030 Vienna, Austria; [Polyansky, Anton] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Neurosci, Case Comprehens Canc Ctr,Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Case Comprehens Canc Ctr,Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; University of Vienna; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Case Western Reserve University; Case Western Reserve University	Buck, M (corresponding author), Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, 10900 Euclid Ave, Cleveland, OH 44106 USA.	Matthias.Buck@case.edu	Buck, Matthias/B-2106-2017; Zhang, Li/GWM-7501-2022; Polyansky, Anton A/J-2145-2018	Buck, Matthias/0000-0002-2958-0403; Polyansky, Anton A/0000-0002-1011-2706	NIH [1R01GM112491, R21EY022839]; Russian Scientific Foundation [14-1400871];  [NIH T32DK007470]; Russian Science Foundation [14-14-00871] Funding Source: Russian Science Foundation; NATIONAL EYE INSTITUTE [R21EY022839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112491, R01GM092851, RC2GM093307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Scientific Foundation(Russian Science Foundation (RSF)); ; Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by grants to M.B. (partially by NIH 1R01GM112491, then R21EY022839 which were preceded by R01GM092851) and a postdoctoral fellowship to L.Z. (NIH T32DK007470). A.A.P. expresses his gratitude to the Russian Scientific Foundation (grant 14-1400871) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aci-Seche S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097779; Adamian L, 2005, PROTEINS, V59, P496, DOI 10.1002/prot.20456; [Anonymous], PYM MOL GRAPH SYST V; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Azzarelli R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4405; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bell CH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001134; Bocharov EV, 2010, CELL ADHES MIGR, V4, P284, DOI 10.4161/cam.4.2.11930; Bocharov EV, 2010, BIOPHYS J, V98, P881, DOI 10.1016/j.bpj.2009.11.008; Braun R, 2004, BIOPHYS J, V87, P754, DOI 10.1529/biophysj.104.040279; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bu LT, 2007, BIOPHYS J, V92, P854, DOI 10.1529/biophysj.106.095216; Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019; Cymer F, 2010, CELL ADHES MIGR, V4, P299, DOI 10.4161/cam.4.2.11191; Dror RO, 2009, IEEE ENG MED BIO, P2340, DOI 10.1109/IEMBS.2009.5335057; Garman EF, 2014, SCIENCE, V343, P1102, DOI 10.1126/science.1247829; Hendrickson WA, 2005, Q REV BIOPHYS, V38, P321, DOI 10.1017/S0033583506004136; Hota PK, 2009, PROTEIN SCI, V18, P1060, DOI 10.1002/pro.116; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Im W, 2012, BBA-BIOMEMBRANES, V1818, P252, DOI 10.1016/j.bbamem.2011.07.048; Jang H, 2006, BIOPHYS J, V91, P2848, DOI 10.1529/biophysj.106.084046; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Koldso H, 2014, MARK LIPID CLUSTERIN, DOI [10.1371/journal.pcbi.1003911, DOI 10.1371/JOURNAL.PCBI.1003911]; Kordyukova LV, 2011, BBA-BIOMEMBRANES, V1808, P1843, DOI 10.1016/j.bbamem.2011.03.005; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Li PC, 2014, J COMPUT CHEM, V35, P300, DOI 10.1002/jcc.23494; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Polyansky AA, 2012, J AM CHEM SOC, V134, P14390, DOI 10.1021/ja303483k; Reddy T, 2014, BIOCHEMISTRY-US, V53, P323, DOI 10.1021/bi401576k; Roney KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024795; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sawma P, 2014, J MOL BIOL, DOI [10.1016/jmb.2014.10.007, DOI 10.1016/JMB.2014.10.007]; Sayadi M, 2010, BIOPHYS J, V98, P805, DOI 10.1016/j.bpj.2009.11.015; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Stansfeld PJ, 2011, STRUCTURE, V19, P1562, DOI 10.1016/j.str.2011.10.002; Tong Y, 2008, STRUCTURE, V16, P246, DOI 10.1016/j.str.2007.12.012; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Tong YF, 2009, J BIOL CHEM, V284, P35962, DOI 10.1074/jbc.M109.056275; Torres J, 2003, TRENDS BIOCHEM SCI, V28, P137, DOI 10.1016/S0968-0004(03)00026-4; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Wang H, 2011, J BIOL CHEM, V286, P26093, DOI 10.1074/jbc.M110.197053; Wang YX, 2013, ELIFE, V2, DOI 10.7554/eLife.01279; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Zerbetto M, 2013, J PHYS CHEM B, V117, P174, DOI 10.1021/jp310142f; Zhang JM, 2009, BIOPHYS J, V96, P4418, DOI 10.1016/j.bpj.2009.03.008; Zhang LQ, 2013, PROTEINS, V81, P365, DOI 10.1002/prot.24192; Ziomkiewicz I, 2013, CYTOM PART A, V83, P794, DOI 10.1002/cyto.a.22311	54	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121513	10.1371/journal.pone.0121513	http://dx.doi.org/10.1371/journal.pone.0121513			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837709	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000046
J	Kesh, K; Subramanian, L; Ghosh, N; Gupta, V; Gupta, A; Bhattacharya, S; Mahapatra, NR; Swarnakar, S				Kesh, Kousik; Subramanian, Lakshmi; Ghosh, Nillu; Gupta, Vinayak; Gupta, Arnab; Bhattacharya, Samir; Mahapatra, Nitish R.; Swarnakar, Snehasikta			Association of MMP7-181A -> G Promoter Polymorphism with Gastric Cancer Risk INFLUENCE OF NICOTINE IN DIFFERENTIAL ALLELE-SPECIFIC TRANSCRIPTION VIA INCREASED PHOSPHORYLATION OF cAMP-RESPONSE ELEMENT-BINDING PROTEIN (CREB)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; SQUAMOUS-CELL CARCINOMA; MATRIX METALLOPROTEINASE-7; EXPRESSION; TOBACCO; SUSCEPTIBILITY; ACTIVATION; MATRILYSIN; INVASION; PROTEIN	Elevated expression of matrix metalloproteinase7 (MMP7) has been demonstrated to play a pivotal role in cancer invasion. The - 181A -> G(rs11568818) polymorphism in the MMP7 promoter modulates gene expression and possibly affects cancer progression. Here, we evaluated the impact of - 181A -> G polymorphism on MMP7 promoter activity and its association with gastric cancer risk in eastern Indian case-control cohorts (n = 520). The GG genotype as compared with the AA genotype was predisposed (p = 0.02; odds ratio = 1.9, 95% confidence interval = 1.1-3.3) to gastric cancer risk. Stratification analysis showed that tobacco addiction enhanced gastric cancer risk in GG subjects when compared with AA subjects (p = 0.03, odds ratio = 2.46, and 95% confidence interval = 1.07-5.68). Meta-analysis revealed that tobacco enhanced the risk for cancer more markedly in AG and GG carriers. Activity and expression of MMP7 were significantly higher in GG than in AA carriers. In support, MMP7 promoter-reporter assays showed greater transcriptional activity toward A to G transition under basal/nicotine-induced/cAMP-response element-binding protein (CREB) overexpressed conditions in gastric adenocarcinoma cells. Moreover, nicotine (a major component of tobacco) treatment significantly up-regulated MMP7 expression due to enhanced CREB phosphorylation followed by its nuclear translocation in gastric adenocarcinoma cells. Furthermore, chromatin immunoprecipitation experiments revealed higher binding of phosphorylated CREB with the -181G than the -181A allele. Altogether, specific binding of phosphorylated CREB to the G allele-carrying promoter enhances MMP7 gene expression that is further augmented by nicotine due to increased CREB phosphorylation and thereby increases the risk for gastric cancer.	[Kesh, Kousik; Ghosh, Nillu; Swarnakar, Snehasikta] Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India; [Subramanian, Lakshmi; Gupta, Vinayak; Mahapatra, Nitish R.] Indian Inst Technol Madras, Dept Biotechnol, Bhupat & Jyoti Mehta Sch Biosci, Madras 600036, Tamil Nadu, India; [Gupta, Arnab; Bhattacharya, Samir] Saroj Gupta Canc Ctr & Res Inst, Kolkata 700104, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Swarnakar, S (corresponding author), Indian Inst Chem Biol, Drug Dev Diagnost & Biotechnol Div, 4 Raja SC Mullick Rd, Kolkata 700032, India.	snehasiktas@hotmail.com	Kesh, Kousik/AAR-9458-2021; Mahapatra, Nitish R/D-4123-2014	Mahapatra, Nitish R/0000-0002-0695-3510; Gupta, Dr. Vinayak/0000-0003-1001-9269	Council of Scientific and Industrial Research, India [BSC 0111, BSC 0119]; Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by Grants BSC 0111 and BSC 0119 from Council of Scientific and Industrial Research, India.r Recipients of Senior Research Fellowship from Council of Scientific and Industrial Research, India.	Al-Wadei MH, 2012, CARCINOGENESIS, V33, P1745, DOI 10.1093/carcin/bgs229; Chuang HC, 2008, MODERN PATHOL, V21, P1444, DOI 10.1038/modpathol.2008.99; Dey S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088040; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Elkington P, 2011, J CLIN INVEST, V121, P1827, DOI 10.1172/JCI45666; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Ghilardi G, 2003, CLIN CHEM, V49, P1940, DOI 10.1373/clinchem.2003.018911; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gueorguiev VD, 2006, J BIOL CHEM, V281, P10188, DOI 10.1074/jbc.M513806200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He ZH, 2011, J BIOL CHEM, V286, P7279, DOI 10.1074/jbc.M110.178780; Honda M, 1996, GUT, V39, P444, DOI 10.1136/gut.39.3.444; Hughes S, 2007, CLIN CANCER RES, V13, P6673, DOI 10.1158/1078-0432.CCR-07-0884; Ii M, 2006, EXP BIOL MED, V231, P20; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jensen Kendal, 2012, Transl Gastrointest Cancer, V1, P81; Jormsjo S, 2001, ARTERIOSCL THROM VAS, V21, P1834, DOI 10.1161/hq1101.098229; Kubben FJJM, 2006, BRIT J CANCER, V95, P744, DOI 10.1038/sj.bjc.6603307; Langers AMJ, 2011, WORLD J GASTRO ONCOL, V3, P79, DOI 10.4251/wjgo.v3.i6.79; Li ZZ, 2015, MOL CELL BIOCHEM, V399, P49, DOI 10.1007/s11010-014-2231-z; Lien YC, 2011, ANN SURG ONCOL, V18, P2671, DOI 10.1245/s10434-011-1598-2; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Malik MA, 2011, SAUDI J GASTROENTERO, V17, P301, DOI 10.4103/1319-3767.84480; Malik MA, 2011, ASIAN PAC J CANCER P, V12, P73; Maurel J, 2007, INT J CANCER, V121, P1066, DOI 10.1002/ijc.22799; Mishra A, 2011, BIOCHIMIE, V93, P854, DOI 10.1016/j.biochi.2011.02.007; Nagini S, 2012, WORLD J GASTRO ONCOL, V4, P156, DOI 10.4251/wjgo.v4.i7.156; Nakayama H, 2001, J NEUROCHEM, V79, P489, DOI 10.1046/j.1471-4159.2001.00602.x; Oh DY, 2009, CANCER RES TREAT, V41, P59, DOI 10.4143/crt.2009.41.2.59; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Perera FP, 1997, SCIENCE, V278, P1068, DOI 10.1126/science.278.5340.1068; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Richards TJ, 2012, AM J PHYSIOL-LUNG C, V302, pL746, DOI 10.1152/ajplung.00319.2011; Roman J, 2005, AM J PHYSIOL-LUNG C, V288, pL975, DOI 10.1152/ajplung.00003.2004; Rudra DS, 2013, J PINEAL RES, V54, P398, DOI 10.1111/jpi.12034; Sarkissian G, 2008, CLIN CHEM, V54, P574, DOI 10.1373/clinchem.2007.090837; Schuller HM, 1999, CANCER RES, V59, P4510; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Shi M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-269; Shin VY, 2010, CANCER LETT, V292, P237, DOI 10.1016/j.canlet.2009.12.011; Singh H, 2008, GYNECOL ONCOL, V110, P71, DOI 10.1016/j.ygyno.2008.03.007; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Sonawane PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016661; Srivastava P, 2010, DIS MARKERS, V29, P37, DOI [10.3233/DMA-2010-0724, 10.1155/2010/149651]; Swarnakar S, 2005, J BIOL CHEM, V280, P9409, DOI 10.1074/jbc.M413398200; Szarvas T, 2011, PATHOL ONCOL RES, V17, P325, DOI 10.1007/s12253-010-9320-4; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; Tredaniel J, 1997, INT J CANCER, V72, P565, DOI 10.1002/(SICI)1097-0215(19970807)72:4<565::AID-IJC3>3.0.CO;2-O; Vairaktaris E, 2007, ANTICANCER RES, V27, P2493; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; Wang FQ, 2006, CANCER LETT, V236, P292, DOI 10.1016/j.canlet.2005.05.042; Wang FQ, 2005, INT J CANCER, V114, P19, DOI 10.1002/ijc.20697; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Yeh YC, 2010, DIGEST DIS SCI, V55, P1649, DOI 10.1007/s10620-009-0926-x; Yi YC, 2010, CLIN CHEM LAB MED, V48, P337, DOI 10.1515/CCLM.2010.082; Zhang JH, 2005, CARCINOGENESIS, V26, P1748, DOI 10.1093/carcin/bgi144	57	25	27	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14391	14406		10.1074/jbc.M114.630129	http://dx.doi.org/10.1074/jbc.M114.630129			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847246	hybrid, Green Published			2022-12-26	WOS:000355754600011
J	Gordeev, EG; Ananikov, VP				Gordeev, Evgeniy G.; Ananikov, Valentine P.			Computational Study of a Model System of Enzyme-Mediated [4+2] Cycloaddition Reaction	PLOS ONE			English	Article							DIELS-ALDER REACTION; GAUSSIAN-BASIS SETS; CORRELATED MOLECULAR CALCULATIONS; DENSITY-FUNCTIONAL THEORY; MAIN-GROUP THERMOCHEMISTRY; AB-INITIO; NONCOVALENT INTERACTIONS; PERICYCLIC-REACTIONS; ACTIVATION BARRIERS; REACTION ENERGETICS	A possible mechanistic pathway related to an enzyme-catalyzed [4+2] cycloaddition reaction was studied by theoretical calculations at density functional (B3LYP, O3LYP, M062X) and semiempirical levels (PM6-DH2, PM6) performed on a model system. The calculations were carried out for the key [4+2] cycloaddition step considering enzyme-catalyzed biosynthesis of Spinosyn A in a model reaction, where a reliable example of a biological Diels-Alder reaction was reported experimentally. In the present study it was demonstrated that the [4+2] cycloaddition reaction may benefit from moving along the energetically balanced reaction coordinate, which enabled the catalytic rate enhancement of the [4+2] cycloaddition pathway involving a single transition state. Modeling of such a system with coordination of three amino acids indicated a reliable decrease of activation energy by similar to 18.0 kcal/mol as compared to a non-catalytic transformation.	[Gordeev, Evgeniy G.; Ananikov, Valentine P.] Russian Acad Sci, Zelinsky Inst Organ Chem, Moscow, Russia	Russian Academy of Sciences; Zelinsky Institute of Organic Chemistry	Ananikov, VP (corresponding author), Russian Acad Sci, Zelinsky Inst Organ Chem, Leninsky Prospekt 47, Moscow, Russia.	val@ioc.ac.ru	Ananikov, Valentine/AHC-8917-2022; Gordeev, Evgeniy G./AAE-2462-2022	Gordeev, Evgeniy G./0000-0002-0545-5720; Ananikov, Valentine/0000-0002-6447-557X	Russian Foundation for Basic Research [14-03-31752]; Russian Science Foundation (RSF) [14-50-00126]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation (RSF)(Russian Science Foundation (RSF))	EGG acknowledges support from Russian Foundation for Basic Research (grant: 14-03-31752), VPA acknowledges support from Russian Science Foundation (RSF grant 14-50-00126). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananikov VP, 2011, CHEM SCI, V2, P2332, DOI 10.1039/c1sc00380a; Ananikov VP, 2003, J PHYS ORG CHEM, V16, P253, DOI 10.1002/poc.613; Ananikov VP, 2001, J PHYS ORG CHEM, V14, P109, DOI 10.1002/1099-1395(200102)14:2<109::AID-POC344>3.0.CO;2-J; Anastas P. T., 1998, GREEN CHEM THEORY PR; Appukkuttan P, 2010, CHEM SOC REV, V39, P1467, DOI 10.1039/b815717k; Auclair K, 2000, J AM CHEM SOC, V122, P11519, DOI 10.1021/ja003216+; Balcells D, 2007, NEW J CHEM, V31, P333, DOI 10.1039/b615528f; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Bokach NA, 2010, RUSS CHEM REV+, V79, P89, DOI 10.1070/RC2010v079n02ABEH004083; Cohen AJ, 2001, MOL PHYS, V99, P607, DOI 10.1080/00268970010023435; Coxon JM, 1999, SYNLETT, P1681; Dinadayalane TC, 2002, J PHYS CHEM A, V106, P1627, DOI 10.1021/jp013910r; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; El-Sayed I, 2003, EUR J ORG CHEM, V2003, P813, DOI 10.1002/ejoc.200390123; Ess DH, 2005, J PHYS CHEM A, V109, P9542, DOI 10.1021/jp052504v; Fringuelli F., 2002, DIELS ALDER REACTION; Frisch M.J., 2016, GAUSSIAN 16 REV C 01; Gayatri G, 2011, INDIAN J CHEM A, V50, P1579; Goerigk L, 2010, J CHEM THEORY COMPUT, V6, P107, DOI 10.1021/ct900489g; Goldstein E, 1996, J AM CHEM SOC, V118, P6036, DOI 10.1021/ja9601494; GONZALEZ C, 1990, J PHYS CHEM-US, V94, P5523, DOI 10.1021/j100377a021; GONZALEZ C, 1989, J CHEM PHYS, V90, P2154, DOI 10.1063/1.456010; Grimme S, 2011, WIRES COMPUT MOL SCI, V1, P211, DOI 10.1002/wcms.30; Guner V, 2003, J PHYS CHEM A, V107, P11445, DOI 10.1021/jp035501w; Guner VA, 2004, J PHYS CHEM A, V108, P2959, DOI 10.1021/jp0369286; Hess BA, 2012, ORG BIOMOL CHEM, V10, P7503, DOI 10.1039/c2ob25827g; Hratchian HP, 2005, J CHEM THEORY COMPUT, V1, P61, DOI 10.1021/ct0499783; Hratchian HP, 2004, J CHEM PHYS, V120, P9918, DOI 10.1063/1.1724823; Isiorho EA, 2014, BIOCHEMISTRY-US, V53, P4292, DOI 10.1021/bi5003629; Isiorho EA, 2012, BIOCHEMISTRY-US, V51, P1213, DOI 10.1021/bi201860q; Ivachtchenko AV, 2010, RUSS CHEM REV+, V79, P787, DOI 10.1070/RC2010v079n09ABEH004086; Johnson ER, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3021474; Jones GO, 2006, J PHYS CHEM A, V110, P1216, DOI 10.1021/jp052055z; Kamp MW, 2008, NAT PROD REP, V25, P1001, DOI [10.1039/b600517a, DOI 10.1039/B600517A]; Kasahara K, 2010, CHEMBIOCHEM, V11, P1245, DOI 10.1002/cbic.201000173; Kelly WL, 2011, NATURE, V473, P35, DOI 10.1038/473035a; Kelly WL, 2008, ORG BIOMOL CHEM, V6, P4483, DOI 10.1039/b814552k; Kim HJ, 2012, CURR OPIN CHEM BIOL, V16, P124, DOI 10.1016/j.cbpa.2011.12.017; Kim HJ, 2011, NATURE, V473, P109, DOI 10.1038/nature09981; Kim RR, 2010, J AM CHEM SOC, V132, P2983, DOI 10.1021/ja908395r; Kobayashi S., 2001, CYCLOADDITION REACTI; Korth M, 2010, J CHEM THEORY COMPUT, V6, P3808, DOI 10.1021/ct100408b; Korth M, 2010, J CHEM THEORY COMPUT, V6, P344, DOI 10.1021/ct900541n; Korth M, 2009, J CHEM THEORY COMPUT, V5, P993, DOI 10.1021/ct800511q; Lassila JK, 2010, CURR OPIN CHEM BIOL, V14, P676, DOI 10.1016/j.cbpa.2010.08.010; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lei YL, 2011, PROTEIN SCI, V20, P1566, DOI 10.1002/pro.685; Linder M, 2011, J CHEM INF MODEL, V51, P1906, DOI 10.1021/ci200177d; MCLEAN AD, 1980, J CHEM PHYS, V72, P5639, DOI 10.1063/1.438980; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Oikawa H, 2004, NAT PROD REP, V21, P321, DOI 10.1039/b305068h; Prathyusha V, 2012, J ORG CHEM, V77, P5371, DOI 10.1021/jo300812q; Qiao KJ, 2011, METAB ENG, V13, P723, DOI 10.1016/j.ymben.2011.09.008; Razzak M, 2011, NAT CHEM BIOL, V7, P865, DOI [10.1038/NCHEMBIO.709, 10.1038/nchembio.709]; Riley KE, 2011, WIRES COMPUT MOL SCI, V1, P3, DOI 10.1002/wcms.8; Ringe D, 2008, SCIENCE, V320, P1428, DOI 10.1126/science.1159747; Riplinger C, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4821834; Riplinger C, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4773581; Sheldon RA, 2000, PURE APPL CHEM, V72, P1233, DOI 10.1351/pac200072071233; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stewart James J. P., STEWART COMPUTATIONA; Stocking EM, 2003, ANGEW CHEM INT EDIT, V42, P3078, DOI 10.1002/anie.200200534; Taber DF, 1984, INTRAMOLECULAR DIELS, V18; Takao K, 2005, CHEM REV, V105, P4779, DOI 10.1021/cr040632u; Tantillo DJ, 2010, ORG LETT, V12, P1164, DOI 10.1021/ol9028435; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Townsend CA, 2011, CHEMBIOCHEM, V12, P2267, DOI 10.1002/cbic.201100431; TROST BM, 1995, ANGEW CHEM INT EDIT, V34, P259, DOI 10.1002/anie.199502591; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Watanabe K, 2000, J BIOL CHEM, V275, P38393, DOI 10.1074/jbc.M003119200; Wessig P, 2008, CHEM REV, V108, P2051, DOI 10.1021/cr0783986; WOON DE, 1993, J CHEM PHYS, V98, P1358, DOI 10.1063/1.464303; WOON DE, 1994, J CHEM PHYS, V100, P2975, DOI 10.1063/1.466439; Zhao Y, 2008, J CHEM THEORY COMPUT, V4, P1849, DOI 10.1021/ct800246v; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zhao Y, 2011, J CHEM THEORY COMPUT, V7, P669, DOI 10.1021/ct1006604; Zhao Y, 2011, CHEM PHYS LETT, V502, P1, DOI 10.1016/j.cplett.2010.11.060	82	17	18	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119984	10.1371/journal.pone.0119984	http://dx.doi.org/10.1371/journal.pone.0119984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853669	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400008
J	Michael, N; Lowel, S; Bischof, HJ				Michael, Neethu; Loewel, Siegrid; Bischof, Hans-Joachim			Features of the Retinotopic Representation in the Visual Wulst of a Laterally Eyed Bird, the Zebra Finch (Taeniopygia guttata)	PLOS ONE			English	Article							RECEPTIVE-FIELD PROPERTIES; PIGEON COLUMBA-LIVIA; CASTANOTIS-GOULD; STRIATE CORTEX; OPTIC TECTUM; BINOCULAR INTEGRATION; EVOKED-RESPONSES; NUCLEUS ROTUNDUS; SINGLE NEURONS; GANGLION-CELLS	The visual wulst of the zebra finch comprises at least two retinotopic maps of the contralateral eye. As yet, it is not known how much of the visual field is represented in the wulst neuronal maps, how the organization of the maps is related to the retinal architecture, and how information from the ipsilateral eye is involved in the activation of the wulst. Here, we have used auto-fluorescent flavoprotein imaging and classical anatomical methods to investigate such characteristics of the most posterior map of the multiple retinotopic representations. We found that the visual wulst can be activated by visual stimuli from a large part of the visual field of the contralateral eye. Horizontally, the visual field representation extended from -5 degrees beyond the beak tip up to +125 degrees laterally. Vertically, a small strip from -10 degrees below to about +25 degrees above the horizon activated the visual wulst. Although retinal ganglion cells had a much higher density around the fovea and along a strip extending from the fovea towards the beak tip, these areas were not overrepresented in the wulst map. The wulst area activated from the foveal region of the ipsilateral eye, overlapped substantially with the middle of the three contralaterally activated regions in the visual wulst, and partially with the other two. Visual wulst activity evoked by stimulation of the frontal visual field was stronger with contralateral than with binocular stimulation. This confirms earlier electrophysiological studies indicating an inhibitory influence of the activation of the ipsilateral eye on wulst activity elicited by stimulating the contralateral eye. The lack of a foveal overrepresentation suggests that identification of objects may not be the primary task of the zebra finch visual wulst. Instead, this brain area may be involved in the processing of visual information necessary for spatial orientation.	[Michael, Neethu; Loewel, Siegrid] Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany; [Bischof, Hans-Joachim] Univ Bielefeld, Verhaltensforsch, D-33615 Bielefeld, Germany; [Michael, Neethu] Gottingen Grad Sch Neurosci Biophys & Mol Biosci, Gottingen, Germany	University of Gottingen; University of Bielefeld	Michael, N (corresponding author), Univ Gottingen, Dept Syst Neurosci, Johann Friedrich Blumenbach Inst Zool & Anthropol, D-37073 Gottingen, Germany.	nmichae@gwdg.de			Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF) [01GQ0810]; Deutsche Forschungsgemeinschaft (DFG) [BI 245/21-1, LO 442/8-1, LO 442/8-2]; Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant) [GSC 226/2]	Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant)	This study was funded by grants from the Federal Ministry of Education and Research (Bundesministerium fur Bilding und Forschung, BMBF, http://www.bmbf.de/)-grant number 01GQ0810 (S.L), the Deutsche Forschungsgemeinschaft (DFG) (http://www.dfg.de/index.jsp)-grant numbers BI 245/21-1, LO 442/8-1 and LO 442/8-2, Gottingen Graduate School for Neurosciences, Biophysics and Molecular Biosciences (DFG Grant GSC 226/2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN JM, 1976, SCIENCE, V191, P572, DOI 10.1126/science.814619; [Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; BAGNOLI P, 1980, ARCH ITAL BIOL, V118, P72; Beckmann R, 1982, VISNEUROSCI, V10, P237; BILGE M, 1971, Q J EXP PHYSIOL CMS, V56, P242, DOI 10.1113/expphysiol.1971.sp002125; BISCHOF HJ, 1990, CELL TISSUE RES, V262, P307, DOI 10.1007/BF00309886; Bischof HJ, 1997, EUR J MORPHOL, V35, P246, DOI 10.1076/ejom.35.4.246.13080; BISCHOF HJ, 1981, BRAIN RES BULL, V7, P435, DOI 10.1016/0361-9230(81)90042-3; BISCHOF HJ, 1988, J COMP PHYSIOL A, V163, P329, DOI 10.1007/BF00604008; Bowmaker James K., 2012, P441; BOWMAKER JK, 1977, VISION RES, V17, P1129, DOI 10.1016/0042-6989(77)90147-X; BOWMAKER JK, 1977, VISION RES, V17, P17, DOI 10.1016/0042-6989(77)90195-X; BREDENKOTTER M, 1990, VISUAL NEUROSCI, V5, P155, DOI 10.1017/S0952523800000201; BREDENKOTTER M, 1990, BRAIN RES, V515, P343, DOI 10.1016/0006-8993(90)90620-Q; Budzynski CA, 2002, EUR J NEUROSCI, V15, P197, DOI 10.1046/j.0953-816x.2001.01833.x; CLARKE PGH, 1976, Q J EXP PHYSIOL CMS, V61, P351, DOI 10.1113/expphysiol.1976.sp002366; CLARKE R, 1968, Journal of the Royal Microscopical Society, V88, P189; Dennisenko G, 1881, ARCH MIKROSK ANAT, P733; Duijni M., 1959, Archives Neerlandaises de Zoologie, V13, P128; ENGELAGE J, 1988, EXP BRAIN RES, V70, P79; FITE KV, 1975, BRAIN BEHAV EVOLUT, V12, P97, DOI 10.1159/000124142; GALIFRET Y, 1968, Z ZELLFORSCH MIK ANA, V86, P535, DOI 10.1007/BF00324864; GANDAL CHARLES P., 1956, JOUR AMER VET MED ASSOC, V128, P332; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Gunturkun O, 1999, BEHAV BRAIN RES, V98, P193, DOI 10.1016/S0166-4328(98)00084-9; Gunturkun Onur, 1993, P115; Hellmann B, 2001, J COMP NEUROL, V429, P94, DOI 10.1002/1096-9861(20000101)429:1<94::AID-CNE8>3.0.CO;2-5; Heyers D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000937; Howarth M, 2014, CURR BIOL, V24, P1241, DOI 10.1016/j.cub.2014.04.014; INZUNZA O, 1991, ANAT REC, V229, P271, DOI 10.1002/ar.1092290214; Iwaniuk AN, 2008, J COMP PHYSIOL A, V194, P267, DOI 10.1007/s00359-007-0304-0; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KARTEN HJ, 1973, J COMP NEUROL, V150, P253, DOI 10.1002/cne.901500303; Keary N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038697; Keary N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011912; Kirmse W, 1990, ZOOL JB PHYSL, P217; Li BW, 2003, J NEUROPHYSIOL, V90, P204, DOI 10.1152/jn.00954.2002; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; LOWEL S, 1987, J COMP NEUROL, V255, P401, DOI 10.1002/cne.902550307; Martin GR, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0040; MARTINOYA C, 1984, NEUROSCI LETT, V45, P335, DOI 10.1016/0304-3940(84)90248-9; Mathews GVT Bird Navigation, 1955, CAMBRIDGE MONOGRAPHS, V3; Medina L, 2000, TRENDS NEUROSCI, V23, P1, DOI 10.1016/S0166-2236(99)01486-1; Meyer D.B., 1977, VISUAL SYSTEM VERTEB, V5, P550; MICELI D, 1987, J HIRNFORSCH, V28, P45; Michael N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085225; MORONEY MK, 1987, J COMP PHYSIOL A, V160, P137, DOI 10.1007/BF00609721; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Nair G, 2011, DOC OPHTHALMOL, V122, P163, DOI 10.1007/s10633-011-9271-4; Nakamura A, 1998, NEUROIMAGE, V7, P377, DOI 10.1006/nimg.1998.0332; NALBACH HO, 1990, VISION RES, V30, P529, DOI 10.1016/0042-6989(90)90065-S; Ng BSW, 2010, J NEUROSCI, V30, P6713, DOI 10.1523/JNEUROSCI.4078-09.2010; Nieder A, 2000, J NEUROPHYSIOL, V83, P2967, DOI 10.1152/jn.2000.83.5.2967; NIXDORF BE, 1982, BRAIN RES, V248, P9, DOI 10.1016/0006-8993(82)91142-8; Nixdorf-Bergweiler BE., 2007, STEREOTAXIC ATLAS BR; Orban GA, 1984, NEURAL OPERATIONS VI; PEARSON R, 1972, AVIAN BRAIN; PETTIGREW JD, 1976, SCIENCE, V193, P675, DOI 10.1126/science.948741; Rasband W., 2006, IMAGEJ; REMY M, 1991, J COMP NEUROL, V305, P57, DOI 10.1002/cne.903050107; Rosa MGP, 1997, J NEUROPHYSIOL, V77, P3193, DOI 10.1152/jn.1997.77.6.3193; Schmidt A, 2001, BRAIN RES, V923, P20, DOI 10.1016/S0006-8993(01)03192-4; Scholl B, 2013, J NEUROPHYSIOL, V109, P3013, DOI 10.1152/jn.01021.2012; SENGPIEL F, 1995, NEUROREPORT, V6, P2235, DOI 10.1097/00001756-199511000-00032; Shibuki K, 2003, J PHYSIOL-LONDON, V549, P919, DOI 10.1113/jphysiol.2003.040709; Shimizu Toru, 2012, P473; Sillman A.J., 1973, P349; STONE J, 1965, J COMP NEUROL, V124, P337, DOI 10.1002/cne.901240305; Tohmi M, 2006, J NEUROSCI, V26, P11775, DOI 10.1523/JNEUROSCI.1643-06.2006; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; TUSA RJ, 1978, J COMP NEUROL, V177, P213, DOI 10.1002/cne.901770204; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1979, ANNU REV NEUROSCI, V2, P227, DOI 10.1146/annurev.ne.02.030179.001303; Voogd J, 2004, J COMP NEUROL, V470, P107, DOI 10.1002/cne.11022; Voss J, 2003, J COMP PHYSIOL A, V189, P545, DOI 10.1007/s00359-003-0430-2; Voss J, 2009, J EXP BIOL, V212, P1568, DOI 10.1242/jeb.024950; Walls GL, 1942, VERTEBRATE EYE; WANG YC, 1993, VISUAL NEUROSCI, V10, P21, DOI 10.1017/S0952523800003199; WASSLE H, 1989, NATURE, V341, P643, DOI 10.1038/341643a0; Watanabe S, 2011, BEHAV BRAIN RES, V222, P51, DOI 10.1016/j.bbr.2011.03.035; WILSON P, 1980, BRAIN RES, V188, P333, DOI 10.1016/0006-8993(80)90035-9; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	82	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124917	10.1371/journal.pone.0124917	http://dx.doi.org/10.1371/journal.pone.0124917			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853253	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400148
J	Nagao, S; Ueda, M; Osuka, H; Komori, H; Kamikubo, H; Kataoka, M; Higuchi, Y; Hirota, S				Nagao, Satoshi; Ueda, Mariko; Osuka, Hisao; Komori, Hirofumi; Kamikubo, Hironari; Kataoka, Mikio; Higuchi, Yoshiki; Hirota, Shun			Domain-Swapped Dimer of Pseudomonas aeruginosa Cytochrome c(551): Structural Insights into Domain Swapping of Cytochrome c Family Proteins	PLOS ONE			English	Article							ACID SIDE-CHAIN; HYDROGENOBACTER-THERMOPHILUS; FERRICYTOCHROME-C; OLIGOMER FORMATION; FOLDING MECHANISM; CRYSTAL-STRUCTURE; AMYLOID FORMATION; ALPHA-HELIX; STATE; HEME	Cytochrome c (cyt c) family proteins, such as horse cyt c, Pseudomonas aeruginosa cytochrome c(551) (PA cyt c(551)), and Hydrogenobacter thermophilus cytochrome c(552) (HT cyt c(552)), have been used as model proteins to study the relationship between the protein structure and folding process. We have shown in the past that horse cyt c forms oligomers by domain swapping its C-terminal helix, perturbing the Met-heme coordination significantly compared to the monomer. HT cyt c(552) forms dimers by domain swapping the region containing the N-terminal alpha-helix and heme, where the heme axial His and Met ligands belong to different protomers. Herein, we show that PA cyt c(551) also forms domain-swapped dimers by swapping the region containing the N-terminal a-helix and heme. The secondary structures of the M61A mutant of PA cyt c(551) were perturbed slightly and its oligomer formation ability decreased compared to that of the wild-type protein, showing that the stability of the protein secondary structures is important for domain swapping. The hinge loop of domain swapping for cyt c family proteins corresponded to the unstable region specified by hydrogen exchange NMR measurements for the monomer, although the swapping region differed among proteins. These results show that the unstable loop region has a tendency to become a hinge loop in domain-swapped proteins.	[Nagao, Satoshi; Ueda, Mariko; Osuka, Hisao; Kamikubo, Hironari; Kataoka, Mikio; Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Osuka, Hisao; Higuchi, Yoshiki] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Ako, Hyogo 6781297, Japan; [Komori, Hirofumi] Kagawa Univ, Fac Educ, Takamatsu, Kagawa 7608522, Japan; [Komori, Hirofumi; Higuchi, Yoshiki] RIKEN, SPring Ctr 8, Sayo, Hyogo 6795148, Japan	Nara Institute of Science & Technology; University of Hyogo; Kagawa University; RIKEN	Hirota, S (corresponding author), Nara Inst Sci & Technol, Grad Sch Mat Sci, 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	hirota@ms.naist.jp	Kataoka, Mikio/H-4402-2011; Hirota, Shun/AAD-2651-2021	Hirota, Shun/0000-0003-3227-8376; Nagao, Satoshi/0000-0003-1674-7697; Higuchi, Yoshiki/0000-0001-8284-5709	JSPS [26288080, 24750163]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by Grants-in-Aid for Young Scientists (B) (No. 24750163 (S.N.)) and for Scientific Research (B) (No. 26288080 (S.H.)) from JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Banci L, 1997, BIOCHEMISTRY-US, V36, P9867, DOI 10.1021/bi970724w; Battistuzzi G, 1997, BIOCHEMISTRY-US, V36, P16247, DOI 10.1021/bi971535g; BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127; BERRY EA, 1987, ANAL BIOCHEM, V161, P1, DOI 10.1016/0003-2697(87)90643-9; BERTRAND P, 1995, BIOCHEMISTRY-US, V34, P11071, DOI 10.1021/bi00035a012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUSHNELL GW, 1990, J MOL BIOL, V214, P585, DOI 10.1016/0022-2836(90)90200-6; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Daggett V, 2003, TRENDS BIOCHEM SCI, V28, P18, DOI 10.1016/S0968-0004(02)00012-9; Das P, 2011, P NATL ACAD SCI USA, V108, P10514, DOI 10.1073/pnas.1019152108; Dehouck Y, 2003, J MOL BIOL, V330, P1215, DOI 10.1016/S0022-2836(03)00614-4; Deshpande MS, 2014, BIOCHEMISTRY-US, V53, P4696, DOI 10.1021/bi500497s; DICKERSON RE, 1971, J BIOL CHEM, V246, P1511; Ding F, 2006, STRUCTURE, V14, P5, DOI 10.1016/j.str.2005.09.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FISHER WR, 1973, J BIOL CHEM, V248, P3188; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Gianni S, 2003, J MOL BIOL, V330, P1145, DOI 10.1016/S0022-2836(03)00689-2; Gianni S, 2001, J MOL BIOL, V309, P1177, DOI 10.1006/jmbi.2001.4728; Hafner-Bratkovic I, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.213926; Hasegawa J, 1999, J BIOL CHEM, V274, P37533, DOI 10.1074/jbc.274.53.37533; Hayashi Y, 2012, BIOCHEMISTRY-US, V51, P8608, DOI 10.1021/bi3011303; Hirota S, 2010, P NATL ACAD SCI USA, V107, P12854, DOI 10.1073/pnas.1001839107; HONG XL, 1989, FEBS LETT, V246, P105, DOI 10.1016/0014-5793(89)80262-5; Huang YQ, 2012, PROTEINS, V80, P1610, DOI 10.1002/prot.24055; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu C, 2011, NAT STRUCT MOL BIOL, V18, P49, DOI 10.1038/nsmb.1948; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Liu YS, 1998, P NATL ACAD SCI USA, V95, P3437, DOI 10.1073/pnas.95.7.3437; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; Maity H, 2005, P NATL ACAD SCI USA, V102, P4741, DOI 10.1073/pnas.0501043102; MATSUURA Y, 1982, J MOL BIOL, V156, P389, DOI 10.1016/0022-2836(82)90335-7; Mauk AG, 1997, J BIOL INORG CHEM, V2, P119, DOI 10.1007/s007750050115; Michel LV, 2008, J BIOL INORG CHEM, V13, P837, DOI 10.1007/s00775-008-0370-y; Michel LV, 2007, BIOCHEMISTRY-US, V46, P11753, DOI 10.1021/bi701177j; Munoz V, 1997, BIOPOLYMERS, V41, P495, DOI 10.1002/(SICI)1097-0282(19970415)41:5<495::AID-BIP2>3.3.CO;2-6; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nugraheni AD, 2013, J BIOL INORG CHEM, V18, P383, DOI 10.1007/s00775-013-0982-8; Oikawa K, 2005, J BIOL CHEM, V280, P5527, DOI 10.1074/jbc.M412392200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parui PP, 2013, BIOCHEMISTRY-US, V52, P8732, DOI 10.1021/bi400986g; Lopez-Alonso JP, 2010, J AM CHEM SOC, V132, P1621, DOI 10.1021/ja9081638; Ptitsyn OB, 1998, J MOL BIOL, V278, P655, DOI 10.1006/jmbi.1997.1620; Russell BS, 2003, J BIOL INORG CHEM, V8, P156, DOI 10.1007/s00775-002-0401-z; Russell BS, 2000, P NATL ACAD SCI USA, V97, P8312, DOI 10.1073/pnas.150239397; Schlunegger MP, 1997, ADV PROTEIN CHEM, V50, P61, DOI 10.1016/S0065-3233(08)60319-8; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Takayama SJ, 2005, BIOCHEMISTRY-US, V44, P5488, DOI 10.1021/bi047498s; TANIGUCHI VT, 1980, PURE APPL CHEM, V52, P2275, DOI 10.1351/pac198052102275; Travaglini-Allocatelli C, 1999, J MOL BIOL, V289, P1459, DOI 10.1006/jmbi.1999.2852; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2004, TRENDS BIOCHEM SCI, V29, P535, DOI 10.1016/j.tibs.2004.08.004; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE CJA, 1992, J BIOL CHEM, V267, P3852; Wang ZH, 2011, ORG BIOMOL CHEM, V9, P4766, DOI 10.1039/c1ob05552f; Yamamoto Y, 2002, J AM CHEM SOC, V124, P11574, DOI 10.1021/ja025597s; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yang SC, 2005, J MOL BIOL, V352, P202, DOI 10.1016/j.jmb.2005.06.062; Zegers I, 1999, P NATL ACAD SCI USA, V96, P818, DOI 10.1073/pnas.96.3.818	60	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123653	10.1371/journal.pone.0123653	http://dx.doi.org/10.1371/journal.pone.0123653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853415	Green Published, gold			2022-12-26	WOS:000352478400113
J	Choudhury, GR; Winters, A; Rich, RM; Ryou, MG; Gryczynski, Z; Yuan, F; Yang, SH; Liu, R				Choudhury, Gourav Roy; Winters, Ali; Rich, Ryan M.; Ryou, Myoung-Gwi; Gryczynski, Zygmunt; Yuan, Fang; Yang, Shao-Hua; Liu, Ran			Methylene Blue Protects Astrocytes against Glucose Oxygen Deprivation by Improving Cellular Respiration	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; GLYCOGEN-METABOLISM; STROKE; DAMAGE; NEURODEGENERATION; PATHOPHYSIOLOGY; DYSFUNCTION; MECHANISMS; TRANSIENT; NEURONS	Astrocytes outnumber neurons and serve many metabolic and trophic functions in the mammalian brain. Preserving astrocytes is critical for normal brain function as well as for protecting the brain against various insults. Our previous studies have indicated that methylene blue (MB) functions as an alternative electron carrier and enhances brain metabolism. In addition, MB has been shown to be protective against neurodegeneration and brain injury. In the current study, we investigated the protective role of MB in astrocytes. Cell viability assays showed that MB treatment significantly protected primary astrocytes from oxygenglucose deprivation (OGD) & reoxygenation induced cell death. We also studied the effect of MB on cellular oxygen and glucose metabolism in primary astrocytes following OGD-reoxygenation injury. MB treatment significantly increased cellular oxygen consumption, glucose uptake and ATP production in primary astrocytes. In conclusion our study demonstrated that MB protects astrocytes against OGD-reoxygenation injury by improving astrocyte cellular respiration.	[Choudhury, Gourav Roy; Winters, Ali; Ryou, Myoung-Gwi; Yang, Shao-Hua; Liu, Ran] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA; [Rich, Ryan M.; Gryczynski, Zygmunt] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Immunol, Ft Worth, TX USA; [Yuan, Fang; Yang, Shao-Hua] Capital Med Univ, Beijing Tiantan Hosp, Beijing Neurosurg Inst, Dept Neurosurg, Beijing, Peoples R China	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; Beijing Neurosurgical Institute; Capital Medical University	Yang, SH (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	shaohua.yang@unthsc.edu; ran.liu@unthsc.edu	Choudhury, Gourav Roy/L-7707-2016	Choudhury, Gourav Roy/0000-0001-8664-7638; Liu, Ran/0000-0002-3882-0616	National Institutes of Health [NS054651, NS088596, NS087209]; AHA [SDG16960084]; National Natural Science Foundation of China [81228009]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087209, R01NS088596, R01NS054651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants NS054651, NS088596, NS087209, AHA SDG16960084, and National Natural Science Foundation of China Grant 81228009.	Amaro S, 2011, STROKE, V42, P1495, DOI 10.1161/STROKEAHA.111.615039; Aronowski J, 1997, J CEREBR BLOOD F MET, V17, P1048, DOI 10.1097/00004647-199710000-00006; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Benarroch EE, 2010, NEUROLOGY, V74, P919, DOI 10.1212/WNL.0b013e3181d3e44b; Brown AM, 2005, J NEUROSCI RES, V79, P74, DOI 10.1002/jnr.20335; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Chan PH, 1996, STROKE, V27, P1124, DOI 10.1161/01.STR.27.6.1124; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Crack PJ, 2005, FREE RADICAL BIO MED, V38, P1433, DOI 10.1016/j.freeradbiomed.2005.01.019; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Diener HC, 2008, STROKE, V39, P1751, DOI 10.1161/STROKEAHA.107.503334; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Fried R. FLW., 1974, IMETHODS ENZYMATIC A, P644; Haberg A, 2006, NEUROCHEM INT, V48, P531, DOI 10.1016/j.neuint.2005.12.025; HEISS WD, 1992, J CEREBR BLOOD F MET, V12, P193, DOI 10.1038/jcbfm.1992.29; Huang YZ, 2004, CELL, V118, P665, DOI 10.1016/j.cell.2004.09.004; Ji J, 2002, J BIOMED OPT, V7, P404, DOI 10.1117/1.1483082; Kapogiannis D, 2011, LANCET NEUROL, V10, P187, DOI 10.1016/S1474-4422(10)70277-5; Lin AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046585; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Mergenthaler P, 2004, METAB BRAIN DIS, V19, P151, DOI 10.1023/B:MEBR.0000043966.46964.e6; Metea MR, 2006, J NEUROSCI, V26, P2862, DOI 10.1523/JNEUROSCI.4048-05.2006; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nehlig A, 2004, J CEREBR BLOOD F MET, V24, P1004, DOI 10.1097/01.WCB.0000128533.84196.D8; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Oz M, 2009, BIOCHEM PHARMACOL, V78, P927, DOI 10.1016/j.bcp.2009.04.034; Pascual JM, 2007, ARCH NEUROL-CHICAGO, V64, P507, DOI 10.1001/archneur.64.4.noc60165; Petzold GC, 2011, NEURON, V71, P782, DOI 10.1016/j.neuron.2011.08.009; Poteet E, 2013, J BIOL CHEM, V288, P9153, DOI 10.1074/jbc.M112.440354; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; REHNCRONA S, 1981, J CEREBR BLOOD F MET, V1, P297, DOI 10.1038/jcbfm.1981.34; Rodriguez P, 2014, BRAIN RES; Roy Choudhury G, 2014, BRAIN RES; SAKAMOTO A, 1991, BRAIN RES, V554, P186, DOI 10.1016/0006-8993(91)90187-Z; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Scheindlin S, 2008, MOL INTERV, V8, P268, DOI 10.1124/mi.8.6.1; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Shen Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079833; Sims NR, 2010, BBA-MOL BASIS DIS, V1802, P80, DOI 10.1016/j.bbadis.2009.09.003; Stack C, 2014, HUM MOL GENET; SWANSON RA, 1992, CAN J PHYSIOL PHARM, V70, pS138, DOI 10.1139/y92-255; Thoren AE, 2006, J NEUROCHEM, V97, P968, DOI 10.1111/j.1471-4159.2006.03778.x; Watts LT, 2014, J NEUROTRAUM; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Zhang XA, 2006, NEUROTOX RES, V9, P47, DOI 10.1007/BF03033307	48	20	21	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123096	10.1371/journal.pone.0123096	http://dx.doi.org/10.1371/journal.pone.0123096			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848957	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800203
J	Zhang, CK; Zhai, SM; Wu, L; Bai, YH; Jia, JB; Zhang, Y; Zhang, B; Yan, B				Zhang, Chengke; Zhai, Shumei; Wu, Ling; Bai, Yuhong; Jia, Jianbo; Zhang, Yi; Zhang, Bin; Yan, Bing			Induction of Size-Dependent Breakdown of Blood-Milk Barrier in Lactating Mice by TiO2 Nanoparticles	PLOS ONE			English	Article							TITANIUM-DIOXIDE NANOPARTICLES; WALLED CARBON NANOTUBES; OXIDATIVE STRESS; PHYSIOLOGICAL SIGNIFICANCE; GOLD NANOPARTICLES; ACUTE TOXICITY; SURFACE; PARTICLES; ACCUMULATION; LACTOFERRIN	This study aims to investigate the potential nanotoxic effects of TiO2 nanoparticles (TNPs) to dams and pups during lactation period. TiO2 nanoparticles are accumulated in mammary glands of lactating mice after i.v. administration. This accumulation of TiO2 NP likely causes a ROS-induced disruption of tight junction of the blood-milk barrier as indicated by the loss of tight junction proteins and the shedding of alveolar epithelial cells. Compared to larger TNPs (50 nm), smaller ones (8 nm) exhibit a higher accumulation in mammary glands and are more potent in causing perturbations to blood-milk barrier. An alarming finding is that the smaller TNPs (8 nm) are transferred from dams to pups through breastfeeding, likely through the disrupted blood-milk barrier. However, during the lactation period, the nutrient quality of milk from dams and the early developmental landmarks of the pups are not affected by above perturbations.	[Zhang, Chengke; Zhai, Shumei; Wu, Ling; Bai, Yuhong; Jia, Jianbo; Zhang, Yi; Zhang, Bin; Yan, Bing] Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China	Shandong University	Yan, B (corresponding author), Shandong Univ, Sch Chem & Chem Engn, Jinan 250100, Peoples R China.	drbingyan@yahoo.com	Zhang, Bin/H-4942-2014	Zhang, Bin/0000-0002-1529-6356; Jia, Jianbo/0000-0002-1703-6734; Wu, Ling/0000-0002-5786-4315	National Natural Science Foundation of China [21137002]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB14030401]; Natural Science Foundation of Shandong Province [ZR2014BM026]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by National Natural Science Foundation of China (grant numbers: 21137002 to BY) (http://www.nsfc.gov.cn), the Strategic Priority Research Program of the Chinese Academy of Sciences (grant numbers: XDB14030401 to BY) (http://www.cas.cn) and the Natural Science Foundation of Shandong Province (grant numbers: ZR2014BM026 to ZSM) (http://www.sdnsf.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JW, 1999, AM J CLIN NUTR, V70, P525; Bai YH, 2010, NAT NANOTECHNOL, V5, P683, DOI [10.1038/NNANO.2010.153, 10.1038/nnano.2010.153]; Bonazzi M, 2011, J CELL BIOL, V195, P348, DOI 10.1083/jcb.201106011; Burgoyne RD, 1998, J MAMMARY GLAND BIOL, V3, P275, DOI 10.1023/A:1018763427108; Burton JL, 2003, VET CLIN N AM-FOOD A, V19, P1, DOI 10.1016/S0749-0720(02)00073-7; Chen HH, 2012, CHEM REV, V112, P5919, DOI 10.1021/cr3002092; Chen JY, 2009, J APPL TOXICOL, V29, P330, DOI 10.1002/jat.1414; Chen XX, 2013, SMALL, V9, P1765, DOI 10.1002/smll.201201506; Cho WS, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-9; D'Alessandro A, 2010, J PROTEOME RES, V9, P3339, DOI 10.1021/pr100123f; Deng XY, 2009, CARBON, V47, P1421, DOI 10.1016/j.carbon.2008.12.032; DePeters EJ, 2009, J MAMMARY GLAND BIOL, V14, P397, DOI 10.1007/s10911-009-9158-0; Dewey KG, 1998, AM J CLIN NUTR, V67, P10, DOI 10.1093/ajcn/67.1.10; Duan YM, 2010, BIOMATERIALS, V31, P894, DOI 10.1016/j.biomaterials.2009.10.003; Gao XY, 2011, BIOL TRACE ELEM RES, V143, P1616, DOI 10.1007/s12011-011-8990-4; Gosens I, 2014, NANOTOXICOLOGY, V8, P643, DOI 10.3109/17435390.2013.815814; He B, 2013, BIOMATERIALS, V34, P6082, DOI 10.1016/j.biomaterials.2013.04.053; Hougaard KS, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-16; Jacoby WA, 1998, ENVIRON SCI TECHNOL, V32, P2650, DOI 10.1021/es980036f; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Labbok MH, 2004, NAT REV IMMUNOL, V4, P565, DOI 10.1038/nri1393; Li WQ, 2013, SMALL, V9, P1708, DOI 10.1002/smll.201201079; Liu Huiting, 2010, Toxicological and Environmental Chemistry, V92, P175, DOI 10.1080/02772240902732530; Lonnerdal B, 2003, AM J CLIN NUTR, V77, p1537S; Lonnerdal B, 2003, NUTR REV, V61, P295, DOI 10.1301/nr.2003.sept.295-305; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lykkesfeldt J, 2007, VET J, V173, P502, DOI 10.1016/j.tvjl.2006.06.005; Ma LL, 2010, BIOMATERIALS, V31, P99, DOI 10.1016/j.biomaterials.2009.09.028; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Mohammadipour A, 2016, TOXICOL IND HEALTH, V32, P221, DOI 10.1177/0748233713498440; Mutlu EA, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-19; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Pietroiusti A, 2011, ACS NANO, V5, P4624, DOI 10.1021/nn200372g; Project on Emerging Nanotechnologies, 2014, CONSUMER PRODUCTS IN; Rao R, 2008, FRONT BIOSCI-LANDMRK, V13, P7210, DOI 10.2741/3223; Schilling K, 2010, PHOTOCH PHOTOBIO SCI, V9, P495, DOI 10.1039/b9pp00180h; Seo JW, 2007, SMALL, V3, P850, DOI 10.1002/smll.200600488; Sordillo LM, 2009, VET IMMUNOL IMMUNOP, V128, P104, DOI 10.1016/j.vetimm.2008.10.305; STELWAGEN K, 1994, J DAIRY SCI, V77, P426, DOI 10.3168/jds.S0022-0302(94)76969-1; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Su GX, 2012, J PHYS CHEM C, V116, P4993, DOI 10.1021/jp211041m; Sumner SCJ, 2010, J APPL TOXICOL, V30, P354, DOI 10.1002/jat.1503; Tian X, 2013, SMALL, V9, P2432, DOI 10.1002/smll.201300817; Valenti P, 2005, CELL MOL LIFE SCI, V62, P2576, DOI 10.1007/s00018-005-5372-0; Wang JX, 2007, TOXICOL LETT, V168, P176, DOI 10.1016/j.toxlet.2006.12.001; Wang JX, 2008, TOXICOLOGY, V254, P82, DOI 10.1016/j.tox.2008.09.014; Wang T, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-35; Ward PP, 2005, CELL MOL LIFE SCI, V62, P2540, DOI 10.1007/s00018-005-5369-8; WHEELER TT, 1995, EXP CELL RES, V217, P346, DOI 10.1006/excr.1995.1096; WILLIAMSON DH, 1995, P NUTR SOC, V54, P165, DOI 10.1079/PNS19950046; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Xie GP, 2011, TOXICOL LETT, V205, P55, DOI 10.1016/j.toxlet.2011.04.034; Yamashita K, 2011, NAT NANOTECHNOL, V6, P321, DOI [10.1038/nnano.2011.41, 10.1038/NNANO.2011.41]; Yang ST, 2008, TOXICOL LETT, V181, P182, DOI 10.1016/j.toxlet.2008.07.020; Ye D, 2013, NANOSCALE, V5, P11153, DOI 10.1039/c3nr02905k; Yeo MK, 2012, MOL CELL TOXICOL, V8, P317, DOI 10.1007/s13273-012-0039-z; Yoshida S, 2010, FERTIL STERIL, V93, P1695, DOI 10.1016/j.fertnstert.2009.03.094; Zhang CK, 2013, CURR PHARM DESIGN, V19, P6667; Zhang LL, 2011, TOXICOL LETT, V207, P73, DOI 10.1016/j.toxlet.2011.08.001; Zhu HY, 2004, J AM CHEM SOC, V126, P8380, DOI 10.1021/ja048204t; Zhu HY, 2005, J AM CHEM SOC, V127, P6730, DOI 10.1021/ja044689+	62	39	41	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122591	10.1371/journal.pone.0122591	http://dx.doi.org/10.1371/journal.pone.0122591			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849145	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800144
J	Choong, E; Guo, J; Persson, A; Virding, S; Johansson, I; Mkrtchian, S; Ingelman-Sundberg, M				Choong, Eva; Guo, Jia; Persson, Anna; Virding, Susanne; Johansson, Inger; Mkrtchian, Souren; Ingelman-Sundberg, Magnus			Developmental Regulation and Induction of Cytochrome P450 2W1, an Enzyme Expressed in Colon Tumors	PLOS ONE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; GENE-EXPRESSION; LINOLEIC-ACID; CYP2W1; CELLS; PROTEIN; CYP1B1; MOUSE; DIFFERENTIATION	Cytochrome P450 2W1 (CYP2W1) is expressed predominantly in colorectal and also in hepatic tumors, whereas the levels are insignificant in the corresponding normal human adult tissues. CYP2W1 has been proposed as an attractive target for colorectal cancer (CRC) therapy by exploiting its ability to activate duocarmycin prodrugs to cytotoxic metabolites. However, its endogenous function, regulation and developmental pattern of expression remain unexplored. Here we report the CYP2W1 developmental expression in the murine and human gastrointestinal tissues. The gene expression in the colon and small intestine commence at early stages of embryonic life and is completely silenced shortly after the birth. Immunohistochemical analysis of human fetal colon revealed that CYP2W1 expression is restricted to the crypt cells. The silencing of CYP2W1 after birth correlates with the increased methylation of CpG-rich regions in both murine and human CYP2W1 genes. Analysis of CYP2W1 expression in the colon adenocarcinoma cell line HCC2998 revealed that the gene expression can be induced by e.g. the antitumor agent imatinib, linoleic acid and its derivatives. The imatinib mediated induction of CYP2W1 suggests an adjuvant therapy to treatment with duocarmycins that thus would involve induction of tumor CYP2W1 levels followed by the CYP2W1 activated duocarmycin prodrugs. Taken together these data strongly support further exploration of CYP2W1 as a specific drug target in CRC.	[Choong, Eva; Guo, Jia; Persson, Anna; Virding, Susanne; Johansson, Inger; Mkrtchian, Souren; Ingelman-Sundberg, Magnus] Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden	Karolinska Institutet	Ingelman-Sundberg, M (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Pharmacogenet Sect, Stockholm, Sweden.	magnus.ingelman-sundberg@ki.se	Choong, Eva/F-1570-2019; Ingelman-Sundberg, Magnus/ABD-9302-2021	Choong, Eva/0000-0001-6776-4978; Mkrtchian, Souren/0000-0001-9801-2736	Swiss National Research Foundation [139821, 145578]; Swedish Cancer Society; Swedish Research Council; Karolinska Institutet	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet)	This work was supported by grants from the Swiss National Research Foundation (projects no: 139821, 145578) and by grants from the Swedish Cancer Society, the Swedish Research Council, the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-187; Aung PP, 2006, ONCOGENE, V25, P2546, DOI 10.1038/sj.onc.1209279; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Bazzi R, 2009, TOXICOL APPL PHARM, V237, P102, DOI 10.1016/j.taap.2009.02.015; Benjamin S, 2013, J ZHEJIANG UNIV-SC B, V14, P115, DOI 10.1631/jzus.B1200175; Bianco C, 2005, CURR TOP DEV BIOL, V67, P85, DOI 10.1016/S0070-2153(05)67003-2; Butura A, 2004, BIOCHEM PHARMACOL, V67, P1249, DOI 10.1016/j.bcp.2003.10.033; Carriere V, 2001, TOXICOL IN VITRO, V15, P373, DOI 10.1016/S0887-2333(01)00039-X; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Choudhary D, 2007, DRUG METAB DISPOS, V35, P987, DOI 10.1124/dmd.106.014282; Cui JH, 2014, CURR MED CHEM, V21, P519, DOI 10.2174/09298673113206660277; Davies RJ, 2005, NAT REV CANCER, V5, P199, DOI 10.1038/nrc1569; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Finn RD, 2009, BIOCHEM J, V417, P43, DOI 10.1042/BJ20080740; Fraczek J, 2012, INVEST NEW DRUG, V30, P1715, DOI 10.1007/s10637-011-9659-8; Gao F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-716; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; Hammarstrom S, 1999, SEMIN CANCER BIOL, V9, P67, DOI 10.1006/scbi.1998.0119; Hendrix MJC, 2007, NAT REV CANCER, V7, P246, DOI 10.1038/nrc2108; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hu M, 2005, CANCER RES, V65, P8715, DOI 10.1158/0008-5472.CAN-05-0700; Ioannidis P, 2003, ANTICANCER RES, V23, P2179; Jjingo D, 2012, ONCOTARGET, V3, P462, DOI 10.18632/oncotarget.497; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Kulis M, 2013, BBA-GENE REGUL MECH, V1829, P1161, DOI 10.1016/j.bbagrm.2013.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lurje G, 2007, CLIN COLORECTAL CANC, V6, P683, DOI 10.3816/CCC.2007.n.037; Murray GI, 1997, CANCER RES, V57, P3026; Murray MJ, 1999, SEMIN REPROD ENDOCR, V17, P275, DOI 10.1055/s-2007-1016235; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Pierre AS, 2013, BBA-MOL CELL BIOL L, V1831, P759, DOI 10.1016/j.bbalip.2013.01.005; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Rochat B, 2008, BIOPHARM DRUG DISPOS, V29, P103, DOI 10.1002/bdd.598; Sargsyan E, 2002, J BIOL CHEM, V277, P17009, DOI 10.1074/jbc.M200539200; Sivertsson L, 2010, DRUG METAB DISPOS, V38, P995, DOI 10.1124/dmd.110.032367; Spelt L, 2012, EJSO-EUR J SURG ONC, V38, P16, DOI 10.1016/j.ejso.2011.10.013; STARZYNSKA T, 1992, BRIT J CANCER, V66, P867, DOI 10.1038/bjc.1992.375; Stenstedt K, 2014, ACTA ONCOL, V53, P885, DOI 10.3109/0284186X.2014.887224; Stenstedt K, 2013, PHARMACOGENOMICS, V14, P1615, DOI 10.2217/pgs.13.136; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Tan BS, 2011, MOL CANCER THER, V10, P1982, DOI 10.1158/1535-7163.MCT-11-0391; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238; Wang JH, 2013, CHEM PHYS LIPIDS, V175, P27, DOI 10.1016/j.chemphyslip.2013.07.009; Wang K, 2012, CHEM RES TOXICOL; Wu ZL, 2006, MOL PHARMACOL, V69, P2007, DOI 10.1124/mol.106.023648; Xiao Y, 2012, J LIPID RES; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Zhang K, 2014, TUMOR BIOL, V35, P7669, DOI 10.1007/s13277-014-2023-9	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122820	10.1371/journal.pone.0122820	http://dx.doi.org/10.1371/journal.pone.0122820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844926	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700015
J	Camargo, JF; Bhimji, A; Kumar, D; Kaul, R; Pavan, R; Schuh, A; Seftel, M; Lipton, JH; Gupta, V; Humar, A; Husain, S				Camargo, Jose F.; Bhimji, Alyajahan; Kumar, Deepali; Kaul, Rupert; Pavan, Rhea; Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas; Humar, Atul; Husain, Shahid			Impaired T Cell Responsiveness to Interleukin-6 in Hematological Patients with Invasive Aspergillosis	PLOS ONE			English	Article							STEM-CELL; TRANSPLANT RECIPIENTS; SINGLE-CELL; FUNGAL-INFECTIONS; FLOW-CYTOMETRY; THERAPY; PTX3; EPIDEMIOLOGY; DEFICIENCY	Invasive mold infections (IMI) are among the most devastating complications following chemotherapy and hematopoietic stem cell transplantation (HSCT), with high mortality rates. Yet, the molecular basis for human susceptibility to invasive aspergillosis (IA) and mucormycosis remain poorly understood. Herein, we aimed to characterize the immune profile of individuals with hematological malignancies (n = 18) who developed IMI during the course of chemotherapy or HSCT, and compared it to that of hematological patients who had no evidence of invasive fungal infection (n = 16). First, we measured the expression of the pattern recognition receptors pentraxin 3, dectin-1, and Toll-like receptors (TLR) 2 and 4 in peripheral blood of chemotherapy and HSCT recipients with IMI. Compared to hematological controls, individuals with IA and mucormycosis had defective expression of dectin-1; in addition, patients with mucormycosis had decreased TLR2 and increased TLR4 expression. Since fungal recognition via dectin-1 favors T helper 17 responses and the latter are highly dependent on activation of the signal transducer and activator of transcription (STAT) 3, we next used phospho-flow cytometry to measure the phosphorylation of the transcription factors STAT1 and STAT3 in response to interferon-gamma (IFN-gamma) and interleukin (IL)-6, respectively. While IFN-gamma/STAT1 signaling was similar between groups, naive T cells from patients with IA, but not those with mucormycosis, exhibited reduced responsiveness to IL-6 as measured by STAT3 phosphorylation. Furthermore, IL-6 increased Aspergillus-induced IL-17 production in culture supernatants from healthy and hematological controls but not in patients with IA. Altogether, these observations suggest an important role for dectin-1 and the IL-6/STAT3 pathway in protective immunity against Aspergillus.	[Camargo, Jose F.; Bhimji, Alyajahan; Kumar, Deepali; Pavan, Rhea; Humar, Atul; Husain, Shahid] Univ Toronto, Univ Hlth Network, Multiorgan Transplant Program, Transplant Infect Dis, Toronto, ON, Canada; [Camargo, Jose F.; Kumar, Deepali; Kaul, Rupert; Pavan, Rhea; Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas; Humar, Atul; Husain, Shahid] Univ Hlth Network, Dept Med, Toronto, ON, Canada; [Bhimji, Alyajahan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kaul, Rupert] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada; [Schuh, Andre; Seftel, Matthew; Lipton, Jeffrey H.; Gupta, Vikas] Univ Hlth Network, Div Med Oncol & Hematol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Husain, S (corresponding author), Univ Toronto, Univ Hlth Network, Multiorgan Transplant Program, Transplant Infect Dis, Toronto, ON, Canada.	Shahid.Husain@uhn.ca	Seftel, Matthew/L-9607-2019	Gupta, Vikas/0000-0002-1419-8607; Husain, Shahid/0000-0002-9216-5229; Kaul, Rupert/0000-0002-1586-4093				Bellocchio S, 2005, J ANTIMICROB CHEMOTH, V55, P214, DOI 10.1093/jac/dkh542; Biagi E, 2008, J PEDIAT HEMATOL ONC, V30, P881, DOI 10.1097/MPH.0b013e318180bc1d; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Camargo JF, 2014, CLIN INFECT DIS, V59, P569, DOI 10.1093/cid/ciu337; Cenci E, 2001, J INFECT DIS, V184, P610, DOI 10.1086/322793; Chamilos G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012955; Chandesris MO, 2012, MEDICINE, V91, pE1, DOI 10.1097/MD.0b013e31825f95b9; Cunha C, 2014, NEW ENGL J MED, V370, P421, DOI 10.1056/NEJMoa1211161; Cunha C, 2010, BLOOD, V116, P5394, DOI 10.1182/blood-2010-04-279307; De Pauw B, 2008, CLIN INFECT DIS, V46, P1813, DOI 10.1086/588660; Dohner H, 2013, HAEMATOLOGICA, V98, P233, DOI 10.3324/haematol.2012.072264; Huang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021671; Irish JM, 2004, CELL, V118, P217, DOI 10.1016/j.cell.2004.06.028; Jaillon S, 2007, J EXP MED, V204, P793, DOI 10.1084/jem.20061301; Jenq RR, 2010, NAT REV CANCER, V10, P213, DOI 10.1038/nrc2804; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Lee AW, 2008, J VIROL, V82, P3702, DOI 10.1128/JVI.01582-07; Marr KA, 2002, BLOOD, V100, P4358, DOI 10.1182/blood-2002-05-1496; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Muranski P, 2013, BLOOD, V121, P2402, DOI 10.1182/blood-2012-09-378653; Neofytos D, 2009, CLIN INFECT DIS, V48, P265, DOI 10.1086/595846; Potenza L, 2011, BLOOD, V118, P5416, DOI 10.1182/blood-2011-07-366526; Rivera A, 2011, J EXP MED, V208, P369, DOI 10.1084/jem.20100906; Roilides E, 2012, CLIN INFECT DIS, V54, pS61, DOI 10.1093/cid/cir869; Sainz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032273; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Vinh DC, 2010, J ALLERGY CLIN IMMUN, V125, P1389, DOI 10.1016/j.jaci.2010.01.047	31	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123171	10.1371/journal.pone.0123171	http://dx.doi.org/10.1371/journal.pone.0123171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835547	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000133
J	Cheng, YQ; Liu, JF; Zhang, HD; Wang, J; Zhao, YX; Geng, WT				Cheng, Yunqing; Liu, Jianfeng; Zhang, Huidi; Wang, Ju; Zhao, Yixin; Geng, Wanting			Transcriptome Analysis and Gene Expression Profiling of Abortive and Developing Ovules during Fruit Development in Hazelnut	PLOS ONE			English	Article							REPRODUCTIVE GROWTH; CORYLUS	Background A high ratio of blank fruit in hazelnut (Corylus heterophylla Fisch) is a very common phenomenon that causes serious yield losses in northeast China. The development of blank fruit in the Corylus genus is known to be associated with embryo abortion. However, little is known about the molecular mechanisms responsible for embryo abortion during the nut development stage. Genomic information for C. heterophylla Fisch is not available; therefore, data related to transcriptome and gene expression profiling of developing and abortive ovules are needed. Methodology/Principal Findings In this study, de novo transcriptome sequencing and RNA-seq analysis were conducted using short-read sequencing technology (Illumina HiSeq 2000). The results of the transcriptome assembly analysis revealed genetic information that was associated with the fruit development stage. Two digital gene expression libraries were constructed, one for a full (normally developing) ovule and one for an empty (abortive) ovule. Transcriptome sequencing and assembly results revealed 55,353 unigenes, including 18,751 clusters and 36,602 singletons. These results were annotated using the public databases NR, NT, Swiss-Prot, KEGG, COG, and GO. Using digital gene expression profiling, gene expression differences in developing and abortive ovules were identified. A total of 1,637 and 715 unigenes were significantly upregulated and downregulated, respectively, in abortive ovules, compared with developing ovules. Quantitative real-time polymerase chain reaction analysis was used in order to verify the differential expression of some genes. Conclusions/Significance The transcriptome and digital gene expression profiling data of normally developing and abortive ovules in hazelnut provide exhaustive information that will improve our understanding of the molecular mechanisms of abortive ovule formation in hazelnut.	[Cheng, Yunqing; Liu, Jianfeng; Zhang, Huidi; Wang, Ju; Zhao, Yixin; Geng, Wanting] Jilin Normal Univ, Coll Life Sci, Siping 136000, Jilin Province, Peoples R China	Jilin Normal University	Liu, JF (corresponding author), Jilin Normal Univ, Coll Life Sci, Siping 136000, Jilin Province, Peoples R China.	jianfengliu1976@163.com			National Natural Science Foundation of China [31370683, 31070610]; China Scholarship Council Project [201208220004]; Science and Technology Project of Jilin Province [20130102052JC, 20140101145JC]; Scientific Items of Jilin Provincial Department of Education [2013202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council Project(China Scholarship Council); Science and Technology Project of Jilin Province; Scientific Items of Jilin Provincial Department of Education	The funders include the National Natural Science Foundation of China (31370683 and 31070610), China Scholarship Council Project (201208220004), Science and Technology Project of Jilin Province (20130102052JC and 20140101145JC), and Scientific Items of Jilin Provincial Department of Education (2013202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JS, 2006, J AGR FOOD CHEM, V54, P449, DOI 10.1021/jf052133f; Benjamini Y, 2001, ANN STAT, V29, P1165; Beyhan N, 2007, SCI HORTIC-AMSTERDAM, V113, P208, DOI 10.1016/j.scienta.2007.02.007; Cheng YQ, 2013, PLANT MOL BIOL REP, V31, P607, DOI 10.1007/s11105-012-0533-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Erdogan V, 2000, J AM SOC HORTIC SCI, V125, P489, DOI 10.21273/JASHS.125.4.489; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hossain MA, 2010, PLANT MOL BIOL, V72, P557, DOI 10.1007/s11103-009-9592-9; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Liu JF, 2013, SCI HORTIC-AMSTERDAM, V150, P348, DOI 10.1016/j.scienta.2012.12.001; Liu JF, 2012, SCI HORTIC-AMSTERDAM, V136, P128, DOI 10.1016/j.scienta.2012.01.008; Ma H, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-152; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Olsen KM, 2013, ANNU REV PLANT BIOL, V64, P47, DOI 10.1146/annurev-arplant-050312-120048; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rowley ER, 2012, CROP SCI, V52, P2679, DOI 10.2135/cropsci2012.02.0065; Savage GP, 1997, J AM OIL CHEM SOC, V74, P755, DOI 10.1007/s11746-997-0214-x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029	22	18	23	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122072	10.1371/journal.pone.0122072	http://dx.doi.org/10.1371/journal.pone.0122072			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836368	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000077
J	Herrero, L; Valcarcel, L; da Silva, CA; Albert, N; Diez-Noguera, A; Cambras, T; Serra, D				Herrero, Laura; Valcarcel, Lorea; Andressa da Silva, Crhistiane; Albert, Nerea; Diez-Noguera, Antoni; Cambras, Trinitat; Serra, Dolors			Altered Circadian Rhythm and Metabolic Gene Profile in Rats Subjected to Advanced Light Phase Shifts	PLOS ONE			English	Article							MOTOR-ACTIVITY RHYTHM; ADIPOSE-TISSUE; PPAR-ALPHA; CLOCK; DISRUPTION	The circadian clock regulates metabolic homeostasis and its disruption predisposes to obesity and other metabolic diseases. However, the effect of phase shifts on metabolism is not completely understood. We examined whether alterations in the circadian rhythm caused by phase shifts induce metabolic changes in crucial genes that would predispose to obesity. Three-month-old rats were maintained on a standard diet under lighting conditions with chronic phase shifts consisting of advances, delays or advances plus delays. Serum leptin, insulin and glucose levels decreased only in rats subjected to advances. The expression of the clock gene Bmal 1 increased in the hypothalamus, white adipose tissue (WAT), brown adipose tissue (BAT) and liver of the advanced group compared to control rats. The advanced group showed an increase in hypothalamic AgRP and NPY mRNA, and their lipid metabolism gene profile was altered in liver, WAT and BAT. WAT showed an increase in inflammation and ER stress and brown adipocytes suffered a brown-to-white transformation and decreased UCP-1 expression. Our results indicate that chronic phase advances lead to significant changes in neuropeptides, lipid metabolism, inflammation and ER stress gene profile in metabolically relevant tissues such as the hypothalamus, liver, WAT and BAT. This highlights a link between alteration of the circadian rhythm and metabolism at the transcriptional level.	[Herrero, Laura; Valcarcel, Lorea; Serra, Dolors] Univ Barcelona, Fac Farm, Dept Biochem & Mol Biol, IBUB, E-08028 Barcelona, Spain; [Herrero, Laura; Valcarcel, Lorea; Serra, Dolors] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obes & Nutr CIBE, Madrid, Spain; [Andressa da Silva, Crhistiane; Albert, Nerea; Diez-Noguera, Antoni; Cambras, Trinitat] Univ Barcelona, Fac Farm, Dept Physiol, E-08028 Barcelona, Spain; [Andressa da Silva, Crhistiane] Univ Fed Rio Grande do Norte, Dept Fisiol, Lab Neurobiol & Ritimicidade Biol, BR-59072970 Natal, RN, Brazil	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Barcelona; Universidade Federal do Rio Grande do Norte	Cambras, T (corresponding author), Univ Barcelona, Fac Farm, Dept Physiol, E-08028 Barcelona, Spain.	cambras@ub.edu; dserra@ub.edu	Valcarcel, Lorea/F-6747-2017; Serra, Dolors/L-3657-2014; Cambras, Trinitat/S-3881-2019; Herrero, Laura/D-4011-2014; Silva, Crhistiane/K-6479-2013	Valcarcel, Lorea/0000-0002-7309-9924; Serra, Dolors/0000-0002-4936-4206; Cambras, Trinitat/0000-0002-9009-4690; Herrero, Laura/0000-0003-4244-4673; Silva, Crhistiane/0000-0003-2637-162X; ALBERT COLOMER, NEREA/0000-0001-8893-1317	Spanish Ministry of Economy and Competitiveness [BFU2008-00199, SAF2013-45887-R, SAF2011-30520-C02-01]; Generalitat de Catalunya [2014SGR-465]; Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III [CB06/03/0026]; European Foundation for the Study of Diabetes (EFSD)/Lilly; European Foundation for the Study of Diabetes (EFSD)/Janssen; L'Oreal-UNESCO; Ministerio de Educacion y Ciencia [BFU2008-00199]; CAPES [BEX 4970/10-1]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Foundation for the Study of Diabetes (EFSD)/Lilly(Eli Lilly); European Foundation for the Study of Diabetes (EFSD)/Janssen; L'Oreal-UNESCO(L'Oreal Group); Ministerio de Educacion y Ciencia(Spanish Government); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by the Spanish Ministry of Economy and Competitiveness (Grant BFU2008-00199 to TC and AD, Grant SAF2013-45887-R to LH and Grant SAF2011-30520-C02-01 to DS), Generalitat de Catalunya (2014SGR-465 to DS), Centro de Investigacion Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN), Instituto de Salud Carlos III (Grant CB06/03/0026 to DS), European Foundation for the Study of Diabetes (EFSD)/Lilly and European Foundation for the Study of Diabetes (EFSD)/Janssen (research fellowships to LH), L'Oreal-UNESCO (research fellowship to LH) and by the Ministerio de Educacion y Ciencia (BFU2008-00199). CAS was Bolsista da CAPES - Proc. no BEX 4970/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert N, 2013, BEHAV BRAIN RES, V252, P347, DOI 10.1016/j.bbr.2013.06.025; Albrecht U, 2012, NEURON, V74, P246, DOI 10.1016/j.neuron.2012.04.006; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Cai DS, 2013, TRENDS ENDOCRIN MET, V24, P40, DOI 10.1016/j.tem.2012.11.003; Campuzano A, 1998, PHYSIOL BEHAV, V63, P171, DOI 10.1016/S0031-9384(97)00416-2; Caton PW, 2011, DIABETES OBES METAB, V13, P1097, DOI 10.1111/j.1463-1326.2011.01466.x; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2008, NEUROBIOL AGING, V29, P471, DOI 10.1016/j.neurobiolaging.2006.10.018; Froy O, 2010, ENDOCR REV, V31, P1, DOI 10.1210/er.2009-0014; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hondares E, 2011, J BIOL CHEM, V286, P12983, DOI 10.1074/jbc.M110.215889; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Husse J, 2012, PLOS ONE, V7, DOI [10.1371/ journal. pone. 0052983, DOI 10.1371/J0URNAL.P0NE.0052983]; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Karatsoreos IN, 2011, P NATL ACAD SCI USA, V108, P1657, DOI 10.1073/pnas.1018375108; Kennaway DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065255; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lancha A, 2012, NUTR RES REV, V25, P223, DOI 10.1017/S0954422412000145; Li SM, 2009, J APPL PHYSIOL, V107, P1959, DOI 10.1152/japplphysiol.00467.2009; Lucas RJ, 2012, PROG BRAIN RES, V199, P1, DOI 10.1016/B978-0-444-59427-3.00001-0; Lundasen T, 2007, BIOCHEM BIOPH RES CO, V360, P437, DOI 10.1016/j.bbrc.2007.06.068; Madrid JA, 1998, AM J PHYSIOL-REG I, V275, pR372, DOI 10.1152/ajpregu.1998.275.2.R372; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Martin ASG, 2006, AM J CLIN NUTR, V83, p461S, DOI 10.1093/ajcn/83.2.461s; Mazzoccoli G, 2012, CHRONOBIOL INT, V29, P227, DOI 10.3109/07420528.2012.658127; Pan XY, 2010, CELL METAB, V12, P174, DOI 10.1016/j.cmet.2010.05.014; Ribas F, 2014, BIOCHEM J, V463, P191, DOI 10.1042/BJ20140403; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Salgado-Delgado RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060052; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Summa KC, 2014, ADV NUTR, V5, p312S, DOI 10.3945/an.113.005132; Szantoova K, 2011, MOL CELL BIOCHEM, V348, P53, DOI 10.1007/s11010-010-0636-x; Varcoe TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053800; Zafrir B, 2013, HORM METAB RES, V45, P774, DOI 10.1055/s-0033-1348264	37	24	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122570	10.1371/journal.pone.0122570	http://dx.doi.org/10.1371/journal.pone.0122570			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837425	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000101
J	Ten Brink, AF; Nijboer, TCW; Bergsma, DP; Barton, JJS; Van der Stigchel, S				Ten Brink, Antonia F.; Nijboer, Tanja C. W.; Bergsma, Douwe P.; Barton, Jason J. S.; Van der Stigchel, Stefan			Lack of Multisensory Integration in Hemianopia: No Influence of Visual Stimuli on Aurally Guided Saccades to the Blind Hemifield	PLOS ONE			English	Article							PRIMATE SUPERIOR COLLICULUS; EYE-MOVEMENT TRAJECTORIES; SOMATOSENSORY CONVERGENCE; AUDIOVISUAL STIMULATION; TELL US; VISION; DISTRACTORS; ENHANCEMENT; CAPTURE; TARGET	In patients with visual hemifield defects residual visual functions may be present, a phenomenon called blindsight. The superior colliculus (SC) is part of the spared pathway that is considered to be responsible for this phenomenon. Given that the SC processes input from different modalities and is involved in the programming of saccadic eye movements, the aim of the present study was to examine whether multimodal integration can modulate oculomotor competition in the damaged hemifield. We conducted two experiments with eight patients who had visual field defects due to lesions that affected the retinogeniculate pathway but spared the retinotectal direct SC pathway. They had to make saccades to an auditory target that was presented alone or in combination with a visual stimulus. The visual stimulus could either be spatially coincident with the auditory target (possibly enhancing the auditory target signal), or spatially disparate to the auditory target (possibly competing with the auditory tar-get signal). For each patient we compared the saccade endpoint deviation in these two bi-modal conditions with the endpoint deviation in the unimodal condition (auditory target alone). In all seven hemianopic patients, saccade accuracy was affected only by visual stimuli in the intact, but not in the blind visual field. In one patient with a more limited quadrantano-pia, a facilitation effect of the spatially coincident visual stimulus was observed. We conclude that our results show that multisensory integration is infrequent in the blind field of patients with hemianopia.	[Ten Brink, Antonia F.; Nijboer, Tanja C. W.; Van der Stigchel, Stefan] Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Brain Ctr, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Ten Brink, Antonia F.; Nijboer, Tanja C. W.] Rehabil Ctr Hoogstr, Utrecht, Netherlands; [Bergsma, Douwe P.] Radboud Univ Nijmegen Med Ctr, Dept Cognit Neurosci, Nijmegen, Netherlands; [Barton, Jason J. S.] Univ British Columbia, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada; [Barton, Jason J. S.] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; University of British Columbia; University of British Columbia	Ten Brink, AF (corresponding author), Univ Utrecht, Helmholtz Inst, Expt Psychol, Utrecht, Netherlands.	t.t.brink@dehoogstraat.nl	Ten Brink, Antonia/AAM-9341-2020; Barton, Jason JS/A-6362-2012	Ten Brink, Antonia/0000-0001-7634-0819; 	Netherlands Organization for Scientific Research [451-09-019, 451-10-013]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was funded by two grants from the Netherlands Organization for Scientific Research: (http://www.nwo.nl/), Grant Nos. 451-09-019 (to S.V.d.S.) and 451-10-013 (to T.C.W.N.). This organization had no other role in the conduct of the research or preparation of the article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasio TJ, 2000, NEURAL COMPUT, V12, P1165, DOI 10.1162/089976600300015547; Azzopardi P, 1998, CONSCIOUS COGN, V7, P292, DOI 10.1006/ccog.1998.0358; Barton Jason J S, 2011, Handb Clin Neurol, V102, P223, DOI 10.1016/B978-0-444-52903-9.00015-7; Bell AH, 2005, J NEUROPHYSIOL, V93, P3659, DOI 10.1152/jn.01214.2004; Bolognini N, 2005, BRAIN, V128, P2830, DOI 10.1093/brain/awh656; Bolognini N, 2005, EXP BRAIN RES, V160, P273, DOI 10.1007/s00221-004-2005-z; Carey DP, 2008, NEUROPSYCHOLOGIA, V46, P3053, DOI 10.1016/j.neuropsychologia.2008.06.015; Colonius H, 2001, PERCEPT PSYCHOPHYS, V63, P126, DOI 10.3758/BF03200508; CORBETTA M, 1990, BRAIN, V113, P603, DOI 10.1093/brain/113.3.603; COREN S, 1972, PERCEPT MOTOR SKILL, V34, P499, DOI 10.2466/pms.1972.34.2.499; Corneil BD, 2002, J NEUROPHYSIOL, V88, P438, DOI 10.1152/jn.2002.88.1.438; Corneil BD, 1996, J NEUROSCI, V16, P8193; Cowey A, 2004, Q J EXP PSYCHOL-A, V57, P577, DOI 10.1080/02724980343000882; Danckert J, 2005, NEUROSCI BIOBEHAV R, V29, P1035, DOI 10.1016/j.neubiorev.2005.02.001; DORRIS MC, 1995, J NEUROPHYSIOL, V73, P2558, DOI 10.1152/jn.1995.73.6.2558; Doyle MC, 2002, EXP BRAIN RES, V142, P116, DOI 10.1007/s00221-001-0919-2; EDWARDS SB, 1979, J COMP NEUROL, V184, P309, DOI 10.1002/cne.901840207; ENGELKEN EJ, 1989, AVIAT SPACE ENVIR MD, V60, P762; Fayel A, 2014, EXP BRAIN RES, V232, P903, DOI 10.1007/s00221-013-3803-y; FENDRICH R, 1992, SCIENCE, V258, P1489, DOI 10.1126/science.1439839; FINDLAY JM, 1982, VISION RES, V22, P1033, DOI 10.1016/0042-6989(82)90040-2; Frassinetti F, 2005, J COGNITIVE NEUROSCI, V17, P1442, DOI 10.1162/0898929054985446; FRENS MA, 1995, EXP BRAIN RES, V107, P103, DOI 10.1007/BF00228022; FRENS MA, 1995, PERCEPT PSYCHOPHYS, V57, P802, DOI 10.3758/BF03206796; Klemen J, 2012, NEUROSCI BIOBEHAV R, V36, P111, DOI 10.1016/j.neubiorev.2011.04.015; Ladavas E, 2008, ANN NY ACAD SCI, V1124, P98, DOI 10.1196/annals.1440.008; Leh SE, 2006, BRAIN, V129, P1822, DOI 10.1093/brain/awl111; Leo F, 2008, BRAIN, V131, P855, DOI 10.1093/brain/awn003; Leopold DA, 2012, ANNU REV NEUROSCI, V35, P91, DOI 10.1146/annurev-neuro-062111-150356; Lewald J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031603; MARZI CA, 1986, NEUROPSYCHOLOGIA, V24, P749, DOI 10.1016/0028-3932(86)90074-6; MEREDITH MA, 1992, EXP BRAIN RES, V88, P181, DOI 10.1007/BF02259139; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Overgaard M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0209; Overgaard M, 2011, EXP BRAIN RES, V209, P473, DOI 10.1007/s00221-011-2578-2; Passamonti C, 2009, NEUROPSYCHOLOGIA, V47, P546, DOI 10.1016/j.neuropsychologia.2008.10.008; PERROTT DR, 1991, HUM FACTORS, V33, P389, DOI 10.1177/001872089103300402; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; RAFAL R, 1990, SCIENCE, V250, P118, DOI 10.1126/science.2218503; SASLOW MG, 1967, J OPT SOC AM, V57, P1030, DOI 10.1364/JOSA.57.001030; Sparks D L, 1989, Rev Oculomot Res, V3, P213; SPARKS DL, 1986, PHYSIOL REV, V66, P118, DOI 10.1152/physrev.1986.66.1.118; Stanford T. R., 2004, CROSSMODAL SPACE CRO, P25; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; Stein BE., 1993, MERGING SENSES; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Ten Brink AF, 2014, EXP BRAIN RES, V232, P1357, DOI 10.1007/s00221-014-3854-8; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Van der Stigchel S, 2010, BRAIN COGNITION, V74, P66, DOI 10.1016/j.bandc.2010.06.006; Van der Stigchel S, 2008, J COGNITIVE NEUROSCI, V20, P2025, DOI 10.1162/jocn.2008.20145; Van der Stigchel S, 2006, NEUROSCI BIOBEHAV R, V30, P666, DOI 10.1016/j.neubiorev.2005.12.001; Van der Stigchel S, 2011, J EYE MOVEMENT RES, V4; Van der Stigchel S, 2010, CONSCIOUS COGN, V19, P186, DOI 10.1016/j.concog.2009.11.003; Walker R, 2000, P ROY SOC B-BIOL SCI, V267, P431, DOI 10.1098/rspb.2000.1018; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	57	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122054	10.1371/journal.pone.0122054	http://dx.doi.org/10.1371/journal.pone.0122054			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835952	Green Published, gold			2022-12-26	WOS:000352139000075
J	Zerrouki, H; Rizzati, V; Bernis, C; Negre-Salvayre, A; Sarrette, JP; Cousty, S				Zerrouki, Hayat; Rizzati, Virginie; Bernis, Corinne; Negre-Salvayre, Anne; Sarrette, Jean Philippe; Cousty, Sarah			Escherichia coli Morphological Changes and Lipid A Removal Induced by Reduced Pressure Nitrogen Afterglow Exposure	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ATMOSPHERIC-PRESSURE; NONCULTURABLE STATE; PLASMA; STERILIZATION; SURVIVAL; ROLES; ASSAY; HEAT; DRY	Lipid A is a major hydrophobic component of lipopolysaccharides (endotoxin) present in the membrane of most Gram-negative bacteria, and the major responsible for the bioactivity and toxicity of the endotoxin. Previous studies have demonstrated that the late afterglow region of flowing post-discharges at reduced pressure (1-20 Torr) can be used for the sterilization of surfaces and of the reusable medical instrumentation. In the present paper, we show that the antibacterial activity of a pure nitrogen afterglow can essentially be attributed to the large concentrations of nitrogen atoms present in the treatment area and not to the UV radiation of the afterglow. In parallel, the time variation of the inactivation efficiency quantified by the log reduction of the initial Escherichia coli (E. coli) population is correlated with morphologic changes observed on the bacteria by scanning electron microscopy (SEM) for increasing afterglow exposure times. The effect of the afterglow exposure is also studied on pure lipid A and on lipid A extracted from exposed E. coli bacteria. We report that more than 60% of lipid A (pure or bacteria-extracted) are lost with the used operating conditions (nitrogen flow Q(N2) = 1 standard liter per minute (slpm), pressure p = 5 Torr, microwave injected power P-MW = 200 W, exposure time: 40 minutes). The afterglow exposure also results in a reduction of the lipid A proinflammatory activity, assessed by the net decrease of the redox-sensitive NF kappa B transcription factor nuclear translocation in murine aortic endothelial cells stimulated with control vs afterglow-treated (pure and extracted) lipid A. Altogether these results point out the ability of reduced pressure nitrogen afterglows to neutralize the cytotoxic components in Gram-negative bacteria.	[Zerrouki, Hayat; Sarrette, Jean Philippe] Univ Toulouse, Lab Plasma & Convers Energie, LAPLACE, UPS,INPT, F-31062 Toulouse, France; [Zerrouki, Hayat; Sarrette, Jean Philippe] CNRS, LAPLACE, F-31062 Toulouse, France; [Rizzati, Virginie; Bernis, Corinne; Negre-Salvayre, Anne] Univ Toulouse, INSERM, UMR 1048, F-31062 Toulouse, France; [Cousty, Sarah] Univ Toulouse, Ctr Hosp, UPS, Fac Chirurg Dent Toulouse, F-31062 Toulouse, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Sarrette, JP (corresponding author), Univ Toulouse, Lab Plasma & Convers Energie, LAPLACE, UPS,INPT, Bat 3R2, F-31062 Toulouse, France.	jean-philippe.sarrette@laplace.univ-tlse.fr	Cousty, Sarah/AGZ-6395-2022	Cousty, Sarah/0000-0003-4077-2796; Sarrette, Jean Philippe/0000-0001-7735-0576; Bernis, Corinne/0000-0002-2335-187X; Negre-Salvayre, Anne/0000-0003-2136-5706	french ANR program through the grant "PLASMAVIV" [ANR 2010 BLAN 0950 01]	french ANR program through the grant "PLASMAVIV"(French National Research Agency (ANR))	The work was supported by the french ANR program through the grant "PLASMAVIV", ANR 2010 BLAN 0950 01.	Abreu MT, 2004, J PEDIATR-US, V144, P421, DOI 10.1016/j.jpeds.2004.01.057; Alfa MJ, 1999, AM J INFECT CONTROL, V27, P392, DOI 10.1016/S0196-6553(99)70004-0; Auge N, 2002, ARTERIOSCLER THROMB, V22; Baxter RL, 2006, J HOSP INFECT, V63, P439, DOI 10.1016/j.jhin.2006.03.011; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; Boudam MK, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/29/295202; BYRD JJ, 1991, APPL ENVIRON MICROB, V57, P875, DOI 10.1128/AEM.57.3.875-878.1991; Colwell RR, 1996, WORLD J MICROB BIOT, V12, P28, DOI 10.1007/BF00327795; DesCoteaux J G, 1995, AORN J, V62, P23, DOI 10.1016/S0001-2092(06)63680-6; Dinarello CA, 2000, CHEST, V118, P503, DOI 10.1378/chest.118.2.503; Dolezalova E, 2015, BIOELECTROCHEMISTRY, V103, P7, DOI 10.1016/j.bioelechem.2014.08.018; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Kutasi K, 2007, J PHYS D APPL PHYS, V40, P5612, DOI 10.1088/0022-3727/40/18/017; Lerouge S., 2000, PLASMAS POLYM, V5, P31, DOI [10.1023/A:1009504209276, DOI 10.1023/A:1009504209276]; LINDBERG C, 1991, J PHOTOCH PHOTOBIO B, V11, P69, DOI 10.1016/1011-1344(91)80269-N; Lipscomb IP, 2006, J CLIN MICROBIOL, V44, P3728, DOI 10.1128/JCM.01280-06; Miller DM, 2001, ANAESTHESIA, V56, P1069, DOI 10.1046/j.1365-2044.2001.02277.x; Moesby L, 2005, EUR J PHARM SCI, V26, P318, DOI 10.1016/j.ejps.2005.07.003; Moisan M, 2013, EUR PHYS J-APPL PHYS, V63, DOI 10.1051/epjap/2013120510; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKATA T, 1993, J PARENT SCI TECHN, V47, P258; Oliver JD, 2010, FEMS MICROBIOL REV, V34, P415, DOI 10.1111/j.1574-6976.2009.00200.x; Philip N, 2002, IEEE T PLASMA SCI, V30, P1429, DOI 10.1109/TPS.2002.804203; Pintassilgo CD, 2003, P 16 INT S PLASM CHE; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rossi F, 2006, PLASMA PROCESS POLYM, V3, P431, DOI 10.1002/ppap.200600011; ROTH WG, 1988, APPL ENVIRON MICROB, V54, P3142, DOI 10.1128/AEM.54.12.3142-3146.1988; Sifuentes-Osornio J, 2001, GAC MED MEX, V137, P191; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Vasselle A, 2006, 421 OPEPS; Villeger S, 2008, EUR PHYS J-APPL PHYS, V42, P25, DOI 10.1051/epjap:2007177; Wang HW, 2010, J MICROBIOL METH, V82, P330, DOI 10.1016/j.mimet.2010.06.014; Williams David, 2003, Med Device Technol, V14, P10; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6; Zerrouki H, 2013, CONTRIB PLASM PHYS, V53, P599, DOI 10.1002/ctpp.201300008	35	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0116083	10.1371/journal.pone.0116083	http://dx.doi.org/10.1371/journal.pone.0116083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837580	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000002
J	Zhang, JJ; Ren, A; Chen, H; Zhao, MW; Shi, L; Chen, MJ; Wang, H; Feng, ZY				Zhang, Jinjing; Ren, Ang; Chen, Hui; Zhao, Mingwen; Shi, Liang; Chen, Mingjie; Wang, Hong; Feng, Zhiyong			Transcriptome Analysis and Its Application in Identifying Genes Associated with Fruiting Body Development in Basidiomycete Hypsizygus marmoreus	PLOS ONE			English	Article							EDIBLE MUSHROOM; NADPH OXIDASE; SIGNAL-TRANSDUCTION; AGARICUS-BISPORUS; LENTINULA-EDODES; GROWTH; LIGHT; EXPRESSION; PHOTORECEPTOR; MYCELIUM	To elucidate the mechanisms of fruit body development in H. marmoreus, a total of 43609521 high-quality RNA-seq reads were obtained from four developmental stages, including the mycelial knot (H-M), mycelial pigmentation (H-V), primordium (H-P) and fruiting body (H-F) stages. These reads were assembled to obtain 40568 unigenes with an average length of 1074 bp. A total of 26800 (66.06%) unigenes were annotated and analyzed with the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and Eukaryotic Orthologous Group (KOG) databases. Differentially expressed genes (DEGs) from the four transcriptomes were analyzed. The KEGG enrichment analysis revealed that the mycelium pigmentation stage was associated with the MAPK, cAMP, and blue light signal transduction pathways. In addition, expression of the two-component system members changed with the transition from H-M to H-V, suggesting that light affected the expression of genes related to fruit body initiation in Hypsizygus marmoreus. During the transition from H-V to H-P, stress signals associated with MAPK, cAMP and ROS signals might be the most important inducers. Our data suggested that nitrogen starvation might be one of the most important factors in promoting fruit body maturation, and nitrogen metabolism and mTOR signaling pathway were associated with this process. In addition, 30 genes of interest were analyzed by quantitative real-time PCR to verify their expression profiles at the four developmental stages. This study advances our understanding of the molecular mechanism of fruiting body development in Hypsizygus marmoreus by identifying a wealth of new genes that may play important roles in mushroom morphogenesis.	[Zhang, Jinjing; Ren, Ang; Zhao, Mingwen; Shi, Liang; Feng, Zhiyong] Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China; [Zhang, Jinjing; Chen, Hui; Chen, Mingjie; Wang, Hong; Feng, Zhiyong] Shanghai Acad Agr Sci, Natl Res Ctr Edible Fungi Biotechnol & Engn, Key Lab Appl Mycol Resources & Utilizat,Inst Edib, Minist Agr,Shanghai Key Lab Agr Genet & Breeding, Shanghai, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Shanghai Academy of Agricultural Sciences	Feng, ZY (corresponding author), Nanjing Agr Univ, Coll Life Sci, Key Lab Microbiol Engn Agr Environm, Minist Agr, Nanjing, Jiangsu, Peoples R China.	feng_zy@yahoo.com	Gulliver, Aaron/K-7925-2012; Zhao, Ming-Wen/AAS-1510-2020	Gulliver, Aaron/0000-0001-9919-0323; zhao, mingwen/0000-0002-9413-1743	National Natural Science Foundation of China [31401932]; Key Scientific Research Project of Shanghai [11391901003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Scientific Research Project of Shanghai	This work was supported by the National Natural Science Foundation of China (Project No. 31401932) and the Key Scientific Research Project of Shanghai (Project No. 11391901003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akavia Eden, 2006, International Journal of Medicinal Mushrooms, V8, P361, DOI 10.1615/IntJMedMushr.v8.i4.70; Aleksandrova EA, 1998, MICROBIOLOGY+, V67, P535; Bidartondo MI, 2001, NEW PHYTOL, V151, P543, DOI 10.1046/j.1469-8137.2001.00180.x; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cheng CK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-195; Chum WWY, 2008, MYCOL RES, V112, P950, DOI 10.1016/j.mycres.2008.01.028; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Groot PWJ, 1998, MYCOL RES, V102, P1297, DOI 10.1017/S0953756298007266; Eastwood DC, 2013, FUNGAL GENET BIOL, V55, P54, DOI 10.1016/j.fgb.2013.01.001; Etxebeste O, 2009, MOL MICROBIOL, V73, P775, DOI 10.1111/j.1365-2958.2009.06804.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hsu KH, 2011, INT J MED MUSHROOMS, V13, P513, DOI 10.1615/IntJMedMushr.v13.i6.30; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Jang MJ, 2013, MYCOBIOLOGY, V41, P63, DOI 10.5941/MYCO.2013.41.1.63; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katherine PD, 2000, PLANT CELL, V11, P2045; Krieg RC, 2005, J BIOCHEM BIOPH METH, V65, P13, DOI 10.1016/j.jbbm.2005.08.005; Kues U., 2004, Fungi in human and animal health, P431; Kues U, 2000, MICROBIOL MOL BIOL R, V64, P316, DOI 10.1128/MMBR.64.2.316-353.2000; Kues U, 2000, APPL MICROBIOL BIOT, V54, P141, DOI 10.1007/s002530000396; Kuratani M, 2010, FUNGAL GENET BIOL, V47, P152, DOI 10.1016/j.fgb.2009.10.006; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lara-Ortiz T, 2003, MOL MICROBIOL, V50, P1241, DOI 10.1046/j.1365-2958.2003.03800.x; LEATHAM GF, 1987, T BRIT MYCOL SOC, V88, P9, DOI 10.1016/S0007-1536(87)80180-8; Lee CY, 2012, FEMS MICROBIOL LETT, V327, P54, DOI 10.1111/j.1574-6968.2011.02458.x; Lee YL, 2009, LWT-FOOD SCI TECHNOL, V42, P594, DOI 10.1016/j.lwt.2008.09.003; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li P, 2013, GENE, V532, P63, DOI 10.1016/j.gene.2013.09.014; Lilleskov EA, 2002, ECOLOGY, V83, P104, DOI 10.1890/0012-9658(2002)083[0104:BEFCCO]2.0.CO;2; Malagnac F, 2004, FUNGAL GENET BIOL, V41, P982, DOI 10.1016/j.fgb.2004.07.008; Masloff S, 1999, GENETICS, V152, P191; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mu DS, 2014, ENVIRON MICROBIOL, V16, P1709, DOI 10.1111/1462-2920.12326; Muraguchi H, 2000, FUNGAL GENET BIOL, V29, P49, DOI 10.1006/fgbi.2000.1184; Nakazawa T, 2011, FUNGAL GENET BIOL, V48, P519, DOI 10.1016/j.fgb.2011.01.010; Palmer GE, 2006, FEMS MICROBIOL LETT, V262, P1, DOI 10.1111/j.1574-6968.2006.00341.x; Park G, 2008, EUKARYOT CELL, V7, P2113, DOI 10.1128/EC.00466-07; Park HY, 1999, CELL MOL BIOL, V45, P919; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sanchez-Ferrer A., 1995, BIOCHIM BIOPHYS ACTA, V1, P1247; Sano H, 2007, BIOSCI BIOTECH BIOCH, V71, P2206, DOI 10.1271/bbb.70170; Sano H, 2009, FUNGAL GENET BIOL, V46, P333, DOI 10.1016/j.fgb.2009.01.001; Stamets P, 1993, GROWING GOURMET MED, V103, P242; Takemoto D, 2006, PLANT CELL, V18, P2807, DOI 10.1105/tpc.106.046169; Tang LH, 2013, APPL MICROBIOL BIOT, V97, P4977, DOI 10.1007/s00253-013-4832-y; Terashima K, 2005, GENETICS, V171, P101, DOI 10.1534/genetics.104.040048; Umar MH, 1998, MYCOL RES, V102, P719, DOI 10.1017/S0953756297005893; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083517; Weijn A, 2013, FUNGAL GENET BIOL, V55, P42, DOI 10.1016/j.fgb.2012.10.004; WESSELS JGH, 1993, NEW PHYTOL, V123, P397, DOI 10.1111/j.1469-8137.1993.tb03751.x; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu JR, 2000, FUNGAL GENET BIOL, V31, P137, DOI 10.1006/fgbi.2000.1237; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040; Yu GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044031; Zhang H, 2014, FOOD CHEM, V147, P189, DOI 10.1016/j.foodchem.2013.09.118; Zhang JJ, 2014, MICROBIOL RES, V169, P741, DOI 10.1016/j.micres.2014.01.004	59	51	66	7	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123025	10.1371/journal.pone.0123025	http://dx.doi.org/10.1371/journal.pone.0123025			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837428	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000121
J	Gilder, AS; Jones, KA; Hu, JJ; Wang, L; Chen, CC; Carter, BS; Gonias, SL				Gilder, Andrew S.; Jones, Karra A.; Hu, Jingjing; Wang, Lei; Chen, Clark C.; Carter, Bob S.; Gonias, Steven L.			Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; EGF RECEPTOR; MUTANT EGFR; PROGNOSTIC VALUE; CLEAVED FORMS; IN-VIVO; UPAR; HETEROGENEITY; SURVIVAL; CANCER	Genomic heterogeneity is characteristic of glioblastoma (GBM). In many GBMs, the EGF receptor gene (EGFR) is amplified and may be truncated to generate a constitutively active form of the receptor called EGFRvIII. EGFR gene amplification and EGFRvIII are associated with GBM progression, even when only a small fraction of the tumor cells express EGFRvIII. In this study, we show that EGFRvIII-positive GBM cells express significantly increased levels of cellular urokinase receptor (uPAR) and release increased amounts of soluble uPAR (suPAR). When mice were xenografted with human EGFRvIII-expressing GBM cells, tumor-derived suPAR was detected in the plasma, and the level was significantly increased compared with that detected in plasma samples from control mice xenografted with EGFRvIII-negative GBM cells. suPAR also was increased in plasma from patients with EGFRvIII-positive GBMs. Purified suPAR was biologically active when added to cultures of EGFRvIII-negative GBM cells, activating cell signaling and promoting cell migration and invasion. suPAR did not significantly stimulate cell signaling or migration of EGFRvIII-positive cells, probably because cell signaling was already substantially activated in these cells. The activities of suPAR were replicated by conditioned medium (CM) from EGFRvIII-positive GBM cells. When the CM was preincubated with uPAR-neutralizing antibody or when uPAR gene expression was silenced in cells used to prepare CM, the activity of the CM was significantly attenuated. These results suggest that suPAR may function as an important paracrine signaling factor in EGFRvIII-positive GBMs, inducing an aggressive phenotype in tumor cells that are EGFRvIII-negative.	[Gilder, Andrew S.; Jones, Karra A.; Hu, Jingjing; Wang, Lei; Gonias, Steven L.] Univ Calif San Diego, Div Neurosurg, Dept Pathol, La Jolla, CA 92093 USA; [Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Div Neurosurg, Dept Surg, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	sgonias@ucsd.edu	Jones, Karra A/GXM-8805-2022; Regan, Clinton/E-6250-2012; Carter, Bob/AAB-4868-2021	Jones, Karra A/0000-0002-8819-8992; Carter, Bob/0000-0002-3586-1324; Gilder, Andrew/0000-0002-3938-4086	National Institutes of Health [R01 CA169096, 2P01CA069246-15A, UH2TR000931]; Doris Duke Charitable Foundation Clinical Scientist Development Award; Sontag Foundation Distinguished Scientist Award; Burroughs Wellcome Fund Career Awards for Medical Scientists; Kimmel Scholar award; American Brain Tumor Association; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; NATIONAL CANCER INSTITUTE [R01CA169096, P01CA069246] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000931] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); Sontag Foundation Distinguished Scientist Award; Burroughs Wellcome Fund Career Awards for Medical Scientists; Kimmel Scholar award; American Brain Tumor Association; Accelerated Brain Cancer Cure; William Guy Forbeck Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA169096 (to S. L. G.) and 2P01CA069246-15A and UH2TR000931 (to B. S. C.).; Supported by the Doris Duke Charitable Foundation Clinical Scientist Development Award, the Sontag Foundation Distinguished Scientist Award, the Burroughs Wellcome Fund Career Awards for Medical Scientists, the Kimmel Scholar award, a Discovery Grant from the American Brain Tumor Association, a grant from Accelerated Brain Cancer Cure, and the William Guy Forbeck Research Foundation.	Almasi CE, 2011, PROSTATE, V71, P899, DOI 10.1002/pros.21306; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bruntz RC, 2014, J BIOL CHEM, V289, P600, DOI 10.1074/jbc.M113.532978; Chumbalkar V, 2011, J PROTEOME RES, V10, P1343, DOI 10.1021/pr101075e; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Edsfeldt A, 2012, STROKE, V43, P3305, DOI 10.1161/STROKEAHA.112.664094; EKSTRAND AJ, 1994, ONCOGENE, V9, P2313; Francis JM, 2014, CANCER DISCOV, V4, P956, DOI 10.1158/2159-8290.CD-13-0879; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Gonias SL, 2011, CURR PHARM DESIGN, V17, P1962; Harada K, 1998, CANCER RES, V58, P4694; Henic E, 2008, CLIN CANCER RES, V14, P5785, DOI 10.1158/1078-0432.CCR-08-0096; Holst-Hansen C, 1999, BRIT J CANCER, V81, P203, DOI 10.1038/sj.bjc.6690678; Hu J, 2015, ONCOGENE, V34, P4078, DOI 10.1038/onc.2014.336; Hu JJ, 2011, P NATL ACAD SCI USA, V108, P15984, DOI 10.1073/pnas.1113416108; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Inda MD, 2010, GENE DEV, V24, P1731, DOI 10.1101/gad.1890510; Jing JX, 2012, J CLIN LAB ANAL, V26, P16, DOI 10.1002/jcla.20499; Jo M, 2007, ONCOGENE, V26, P2585, DOI 10.1038/sj.onc.1210066; Jo MJ, 2005, J BIOL CHEM, V280, P17449, DOI 10.1074/jbc.M413141200; Jo MJ, 2003, J BIOL CHEM, V278, P46692, DOI 10.1074/jbc.M308808200; Koga T, 2011, CLIN EXP RHEUMATOL, V29, P811; Langkilde A, 2011, CANCER EPIDEM BIOMAR, V20, P609, DOI 10.1158/1055-9965.EPI-10-1009; LIBERMANN TA, 1984, CANCER RES, V44, P753; LIBERMANN TA, 1985, NATURE, V313, P144, DOI 10.1038/313144a0; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Lomholt AF, 2010, ACTA ONCOL, V49, P805, DOI 10.3109/0284186X.2010.491086; MANDRIOTA SJ, 1995, J BIOL CHEM, V270, P9709, DOI 10.1074/jbc.270.17.9709; Mazzieri R, 2006, MOL BIOL CELL, V17, P367, DOI 10.1091/mbc.E05-07-0635; Montuori N, 2002, J BIOL CHEM, V277, P46932, DOI 10.1074/jbc.M207494200; Montuori N, 2009, FRONT BIOSCI-LANDMRK, V14, P2494, DOI 10.2741/3392; Mukasa A, 2010, P NATL ACAD SCI USA, V107, P2616, DOI 10.1073/pnas.0914356107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; PLESNER T, 1994, AM J CLIN PATHOL, V102, P835, DOI 10.1093/ajcp/102.6.835; PYKE C, 1993, FEBS LETT, V326, P69, DOI 10.1016/0014-5793(93)81763-P; Rao JS, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.19; Reidy MA, 1996, CIRC RES, V78, P405, DOI 10.1161/01.RES.78.3.405; Resnati M, 2002, P NATL ACAD SCI USA, V99, P1359, DOI 10.1073/pnas.022652999; Rigolin GM, 2003, BRIT J HAEMATOL, V120, P953, DOI 10.1046/j.1365-2141.2003.04176.x; Riisbro R, 2002, CLIN CANCER RES, V8, P1132; Salkeni MA, 2013, J NEURO-ONCOL, V115, P27, DOI 10.1007/s11060-013-1209-0; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Savva A, 2011, J INFECTION, V63, P344, DOI 10.1016/j.jinf.2011.07.016; Selleri C, 2005, BLOOD, V105, P2198, DOI 10.1182/blood-2004-06-2424; Shariat SF, 2007, J CLIN ONCOL, V25, P349, DOI 10.1200/JCO.2006.05.6853; Shetty S, 1996, AM J RESP CELL MOL, V15, P78, DOI 10.1165/ajrcmb.15.1.8679225; Shinojima N, 2003, CANCER RES, V63, P6962; Sidenius N, 2000, FEBS LETT, V475, P52, DOI 10.1016/S0014-5793(00)01624-0; Sidenius N, 2000, BLOOD, V96, P4091; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Solberg H, 2001, J HISTOCHEM CYTOCHEM, V49, P237, DOI 10.1177/002215540104900211; Tarui T, 2001, J BIOL CHEM, V276, P3983, DOI 10.1074/jbc.M008220200; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Wykosky J, 2015, CANCER RES, V75, P394, DOI 10.1158/0008-5472.CAN-14-2004; Zimmermann HW, 2012, LIVER INT, V32, P500, DOI 10.1111/j.1478-3231.2011.02665.x	60	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2015	290	24					14798	14809		10.1074/jbc.M115.637488	http://dx.doi.org/10.1074/jbc.M115.637488			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CK4FK	25837250	Green Published, hybrid			2022-12-26	WOS:000356177300001
J	Andreassen, OA; Desikan, RS; Wang, Y; Thompson, WK; Schork, AJ; Zuber, V; Doncheva, NT; Ellinghaus, E; Albrecht, M; Mattingsdal, M; Franke, A; Lie, BA; Mills, I; Aukrust, P; McEvoy, LK; Djurovic, S; Karlsen, TH; Dale, AM				Andreassen, Ole A.; Desikan, Rahul S.; Wang, Yunpeng; Thompson, Wesley K.; Schork, Andrew J.; Zuber, Verena; Doncheva, Nadezhda T.; Ellinghaus, Eva; Albrecht, Mario; Mattingsdal, Morten; Franke, Andre; Lie, Benedicte A.; Mills, Ian; Aukrust, Pal; McEvoy, Linda K.; Djurovic, Srdjan; Karlsen, Tom H.; Dale, Anders M.			Abundant Genetic Overlap between Blood Lipids and Immune-Mediated Diseases Indicates Shared Molecular Genetic Mechanisms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RHEUMATOID-ARTHRITIS; CROHN DISEASE; PUBLIC-HEALTH; IDENTIFIES 7; RISK LOCUS; ATHEROSCLEROSIS; INFLAMMATION; METABOLISM	Epidemiological studies suggest a relationship between blood lipids and immune-mediated diseases, but the nature of these associations is not well understood. We used genome-wide association studies (GWAS) to investigate shared single nucleotide polymorphisms (SNPs) between blood lipids and immune-mediated diseases. We analyzed data from GWAS (n similar to 200,000 individuals), applying new False Discovery Rate (FDR) methods, to investigate genetic overlap between blood lipid levels [triglycerides (TG), low density lipoproteins (LDL), high density lipoproteins (HDL)] and a selection of archetypal immune-mediated diseases (Crohn's disease, ulcerative colitis, rheumatoid arthritis, type 1 diabetes, celiac disease, psoriasis and sarcoidosis). We found significant polygenic pleiotropy between the blood lipids and all the investigated immune-mediated diseases. We discovered several shared risk loci between the immune-mediated diseases and TG (n = 88), LDL (n = 87) and HDL (n = 52). Three-way analyses differentiated the pattern of pleiotropy among the immune-mediated diseases. The new pleiotropic loci increased the number of functional gene network nodes representing blood lipid loci by 40%. Pathway analyses implicated several novel shared mechanisms for immune pathogenesis and lipid biology, including glycosphingolipid synthesis (e.g. FUT2) and intestinal host-microbe interactions (e.g. ATG16L1). We demonstrate a shared genetic basis for blood lipids and immune-mediated diseases independent of environmental factors. Our findings provide novel mechanistic insights into dyslipidemia and immune-mediated diseases and may have implications for therapeutic trials involving lipid-lowering and anti-inflammatory agents.	[Andreassen, Ole A.; Wang, Yunpeng; Zuber, Verena; Mattingsdal, Morten; Djurovic, Srdjan] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0407 Oslo, Norway; [Andreassen, Ole A.; Wang, Yunpeng; Zuber, Verena; Mattingsdal, Morten; Djurovic, Srdjan] Oslo Univ Hosp, Div Mental Hlth & Addict, N-0407 Oslo, Norway; [Desikan, Rahul S.; Wang, Yunpeng; Schork, Andrew J.; McEvoy, Linda K.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Schork, Andrew J.] Univ Calif San Diego, Cognit Sci Grad Program, La Jolla, CA 92093 USA; [Zuber, Verena; Mills, Ian] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA; [Zuber, Verena; Mills, Ian] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med Norway, N-0407 Oslo, Norway; [Doncheva, Nadezhda T.; Albrecht, Mario] Oslo Univ Hosp, N-0407 Oslo, Norway; [Ellinghaus, Eva; Franke, Andre] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Albrecht, Mario] Univ Kiel, Inst Clin Mol Biol, D-24118 Kiel, Germany; [Albrecht, Mario] Univ Med Greifswald, Inst Biometr & Med Informat, Dept Bioinformat, D-17475 Greifswald, Germany; [Albrecht, Mario; Lie, Benedicte A.] Graz Univ Technol, Inst Knowledge Discovery, A-8010 Graz, Austria; [Mattingsdal, Morten] BioTechMed Graz, A-8010 Graz, Austria; [Aukrust, Pal; Djurovic, Srdjan] Sorlandet Hosp, N-3000 Kristiansand, Norway; [Mills, Ian] Univ Oslo, Dept Med Genet, N-0407 Oslo, Norway; [Mills, Ian] Oslo Univ Hosp, Inst Canc Res, Dept Canc Prevent, N-0407 Oslo, Norway; [Karlsen, Tom H.] Oslo Univ Hosp, Dept Urol, N-0407 Oslo, Norway; [Aukrust, Pal] Oslo Univ Hosp, Rikshosp, KG Jebsen Inflammat Res Ctr, Internal Med Res Inst,Div Canc Med Surg & Transpl, N-0407 Oslo, Norway; [Karlsen, Tom H.] Oslo Univ Hosp, Sect Clin Immunol & Infect Dis, N-0407 Oslo, Norway; [Karlsen, Tom H.] Univ Bergen, Inst Med, Div Gastroenterol, N-5000 Bergen, Norway; [Dale, Anders M.] Oslo Univ Hosp, Rikshosp, Norwegian PSC Res Ctr, Dept Transplantat Med,Div Canc Med Surg & Transpl, N-0407 Oslo, Norway; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of Oslo; University of Oslo; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; Max Planck Society; University of Kiel; Greifswald Medical School; Graz University of Technology; University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Bergen; University of Oslo; National Hospital Norway; University of California System; University of California San Diego	Andreassen, OA (corresponding author), Univ Oslo, Inst Clin Med, KG Jebsen Ctr Psychosis Res, NORMENT, N-0407 Oslo, Norway.	o.a.andreassen@medisin.uio.no; amdale@ucsd.edu	Mattingsdal, Morten/Q-9367-2016; Mills, Ian/AAK-9292-2020; Franke, Andre/B-2151-2010; Andreassen, Ole A./AAY-7531-2020; Wang, Yunpeng/W-8871-2018; Albrecht, Mario/B-6694-2008; Ellinghaus, Eva/E-6490-2012	Mattingsdal, Morten/0000-0003-4440-0324; Mills, Ian/0000-0001-5347-5083; Franke, Andre/0000-0003-1530-5811; Wang, Yunpeng/0000-0001-9831-1090; Albrecht, Mario/0000-0002-3103-9624; Ellinghaus, Eva/0000-0003-2914-3382; Djurovic, Srdjan/0000-0002-8140-8061; Doncheva, Nadezhda T./0000-0002-8806-6850; Zuber, Verena/0000-0001-9827-1877	Research Council of Norway; South-East Norway Regional Health Authority; KG Jebsen Foundation, NIH; German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104400] Funding Source: NIH RePORTER	Research Council of Norway(Research Council of Norway); South-East Norway Regional Health Authority; KG Jebsen Foundation, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by the Research Council of Norway, the South-East Norway Regional Health Authority, KG Jebsen Foundation, NIH, the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN). OAA and AMD had full access to all the data in the study and had final responsibility for the decision to submit for publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andreassen OA, 2015, MOL PSYCHIATR, V20, P207, DOI 10.1038/mp.2013.195; Andreassen OA, 2014, INT J EPIDEMIOL, V43, P1205, DOI 10.1093/ije/dyu090; Andreassen OA, 2014, HYPERTENSION, V63, P819, DOI 10.1161/HYPERTENSIONAHA.113.02077; Andreassen OA, 2014, SCHIZOPHRENIA BULL, V40, P13, DOI 10.1093/schbul/sbt168; Andreassen OA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003455; Andreassen OA, 2013, AM J HUM GENET, V92, P197, DOI 10.1016/j.ajhg.2013.01.001; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bartoloni E, 2011, ARTHRIT CARE RES, V63, P178, DOI 10.1002/acr.20322; Biyyani RSRS, 2010, J CLIN LIPIDOL, V4, P478, DOI 10.1016/j.jacl.2010.08.021; Bowie RV, 2012, AM J PHYSIOL-GASTR L, V302, pG781, DOI 10.1152/ajpgi.00002.2011; Chodick G, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000336; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Ellinghaus D, 2012, AM J HUM GENET, V90, P636, DOI 10.1016/j.ajhg.2012.02.020; Fischer A, 2012, AM J RESP CRIT CARE, V186, P877, DOI 10.1164/rccm.201204-0708OC; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Garces SP, 2008, ANN RHEUM DIS, V67, P895, DOI 10.1136/ard.2007.078287; Hahn BH, 2007, J AUTOIMMUN, V28, P69, DOI 10.1016/j.jaut.2007.02.004; Hofmann S, 2013, EUR RESPIR J, V41, P888, DOI 10.1183/09031936.00033812; Jamnitski A, 2013, ANN RHEUM DIS, V72, P467, DOI 10.1136/annrheumdis-2011-201194corr1; Jenkins DJA, 2005, METABOLISM, V54, P103, DOI 10.1016/j.metabol.2004.07.019; Kaddurah-Daouk R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025482; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Liu JZ, 2013, NAT GENET, V45, P670, DOI 10.1038/ng.2616; Martinelli N, 2009, J NUTRIGENET NUTRIGE, V2, P129, DOI 10.1159/000238177; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mineo C, 2012, CIRC RES, V111, P1079, DOI 10.1161/CIRCRESAHA.111.258673; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Nisar A, 2012, JCPSP-J COLL PHYSICI, V22, P235, DOI 04.2012/JCPSP.235239; Norata GD, 2012, ATHEROSCLEROSIS, V220, P11, DOI 10.1016/j.atherosclerosis.2011.06.045; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pietrzak A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/535612; Piquer BR, 2006, METABOLISM, V55, P980, DOI 10.1016/j.metabol.2006.03.006; Radaelli T, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.04.019; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Salazar A, 1998, ATHEROSCLEROSIS, V136, P133, DOI 10.1016/S0021-9150(97)00198-6; Schlicker A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-302; Schlicker A, 2010, NUCLEIC ACIDS RES, V38, pD244, DOI 10.1093/nar/gkp979; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith GD, 2005, LANCET, V366, P1484, DOI 10.1016/S0140-6736(05)67601-5; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Toms TE, 2011, ANN RHEUM DIS, V70, P1025, DOI 10.1136/ard.2010.144634; van Halm VP, 2007, ANN RHEUM DIS, V66, P184, DOI 10.1136/ard.2006.051672; Verges B, 2009, DIABETES METAB, V35, P353, DOI 10.1016/j.diabet.2009.04.004; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Wei D, 2010, DIABETES, V59, P471, DOI 10.2337/db09-0284; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; Williams HRT, 2012, DIGEST DIS SCI, V57, P2157, DOI 10.1007/s10620-012-2127-2; Zambon AC, 2012, BIOINFORMATICS, V28, P2209, DOI 10.1093/bioinformatics/bts366	63	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123057	10.1371/journal.pone.0123057	http://dx.doi.org/10.1371/journal.pone.0123057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853426	Green Published, gold			2022-12-26	WOS:000352478400095
J	Bernarde, C; Keravec, M; Mounier, J; Gouriou, S; Rault, G; Ferec, C; Barbier, G; Hery-Arnaud, G				Bernarde, Cedric; Keravec, Marlene; Mounier, Jerome; Gouriou, Stephanie; Rault, Gilles; Ferec, Claude; Barbier, Georges; Hery-Arnaud, Genevieve			Impact of the CFTR-Potentiator Ivacaftor on Airway Microbiota in Cystic Fibrosis Patients Carrying A G551D Mutation	PLOS ONE			English	Article							IN-VITRO; DIVERSITY; BACTERIA; COMMUNITIES; INFECTIONS; SPUTUM	Background Airway microbiota composition has been clearly correlated with many pulmonary diseases, and notably with cystic fibrosis (CF), an autosomal genetic disorder caused by mutation in the CF transmembrane conductance regulator (CFTR). Recently, a new molecule, ivacaftor, has been shown to re-establish the functionality of the G551D-mutated CFTR, allowing significant improvement in lung function. Objective and Methods The purpose of this study was to follow the evolution of the airway microbiota in CF patients treated with ivacaftor, using quantitative PCR and pyrosequencing of 16S rRNA amplicons, in order to identify quantitative and qualitative changes in bacterial communities. Three G551D children were followed up longitudinally over a mean period of more than one year covering several months before and after initiation of ivacaftor treatment. Results 129 operational taxonomy units (OTUs), representing 64 genera, were identified. There was no significant difference in total bacterial load before and after treatment. Comparison of global community composition found no significant changes in microbiota. Two OTUs, however, showed contrasting dynamics: after initiation of ivacaftor, the relative abundance of the anaerobe Porphyromonas 1 increased (p<0.01) and that of Streptococcus 1 (S. mitis group) decreased (p<0.05), possibly in relation to the anti-Gram-positive properties of ivacaftor. The anaerobe Prevotella 2 correlated positively with the pulmonary function test FEV-1 (r=0.73, p<0.05). The study confirmed the presumed positive role of anaerobes in lung function. Conclusion Several airway microbiota components, notably anaerobes (obligate or facultative anaerobes), could be valuable biomarkers of lung function improvement under ivacaftor, and could shed light on the pathophysiology of lung disease in CF patients.	[Bernarde, Cedric; Keravec, Marlene; Mounier, Jerome; Gouriou, Stephanie; Barbier, Georges; Hery-Arnaud, Genevieve] Univ Brest, EA 3882, Lab Univ Biodivers & Ecol Microbienne, Brest, France; [Rault, Gilles] CRCM Mixte, Ctr Perharidy, Roscoff, France; [Ferec, Claude] INSERM, UMR1078, Brest, France; [Hery-Arnaud, Genevieve] CHRU Brest, Dept Bacteriol Virol Hyg & Parasitol Mycol, Brest, France; [Ferec, Claude] CHRU Brest, Genet Mol Lab, Brest, France; [Ferec, Claude] Univ Brest, Fac Med & Sci Sante, Brest, France; [Ferec, Claude] Etab Francais Sang Bretagne, Brest, France	Universite de Bretagne Occidentale; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Universite de Bretagne Occidentale	Hery-Arnaud, G (corresponding author), Univ Brest, EA 3882, Lab Univ Biodivers & Ecol Microbienne, Brest, France.	hery@univ-brest.fr	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; Mounier, Jerome/0000-0002-8290-6898	French Cystic Fibrosis Association "Vaincre la Mucoviscidose" [RC20120600696]	French Cystic Fibrosis Association "Vaincre la Mucoviscidose"	This study was supported by a grant to GHA from the French Cystic Fibrosis Association "Vaincre la Mucoviscidose" (contract No. RC20120600696). http://www.vaincrelamuco.org/ewb_pages/p/projets-finances.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REFERENTIEL MICROBIO, P90; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caldas RR, 2015, J CYST FIBROS, V14, P6, DOI 10.1016/j.jcf.2014.04.008; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Cox MJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011044, 10.1371/journal.pone.0008745]; Crabbe A, 2014, PATHOG DIS, V71, P1, DOI 10.1111/2049-632X.12180; Davies JC, 2013, AM J RESP CRIT CARE, V187, P1219, DOI 10.1164/rccm.201301-0153OC; Delhaes L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036313; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Ferec C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009480; Filkins LM, 2012, J BACTERIOL, V194, P4709, DOI 10.1128/JB.00566-12; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Goddard AF, 2012, P NATL ACAD SCI USA, V109, P13769, DOI 10.1073/pnas.1107435109; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Le Gall F, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-143; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Maeda Y, 2011, J CYST FIBROS, V10, P133, DOI 10.1016/j.jcf.2010.11.003; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Nossa CW, 2010, WORLD J GASTROENTERO, V16, P4135, DOI 10.3748/wjg.v16.i33.4135; Peterson SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058487; Price KE, MICROBIOME, V27; Quinn RA, 2014, MBIO, V5, DOI 10.1128/mBio.00956-13; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; Reznikov LR, 2014, J CYST FIBROS, V13, P515, DOI 10.1016/j.jcf.2014.02.004; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2003, J CLIN MICROBIOL, V41, P3548, DOI 10.1128/JCM.41.8.3548-3558.2003; Rogers GB, 2015, THORAX, V70, P74, DOI 10.1136/thoraxjnl-2014-205826; Rowe SM, 2014, AM J RESP CRIT CARE, V190, P175, DOI 10.1164/rccm.201404-0703OC; Segal LN, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-19; Sibley CD, 2008, P NATL ACAD SCI USA, V105, P15070, DOI 10.1073/pnas.0804326105; Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Van Hoogmoed CG, 2008, ORAL MICROBIOL IMMUN, V23, P43, DOI 10.1111/j.1399-302X.2007.00388.x; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; WHITE C, 1952, BIOMETRICS, V8, P33, DOI 10.2307/3001523; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209; Zemanick ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062917; Zhao JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04345; Zhao JC, 2012, P NATL ACAD SCI USA, V109, P5809, DOI 10.1073/pnas.1120577109	47	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124124	10.1371/journal.pone.0124124	http://dx.doi.org/10.1371/journal.pone.0124124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853698	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400135
J	Han, Y; Shao, Y; Liu, TT; Qu, YL; Li, W; Liu, ZG				Han, Yun; Shao, Yi; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo			Therapeutic Effects of Topical Netrin-4 Inhibits Corneal Neovascularization in Alkali-Burn Rats	PLOS ONE			English	Article							EPITHELIUM-DERIVED FACTOR; GENE-EXPRESSION; ANGIOGENESIS; RECEPTOR; GUIDANCE; IDENTIFICATION; INFLAMMATION; ACTIVATION; MOLECULES; NEOGENIN	Netrins are secreted molecules involved in axon guidance and angiogenesis. However, the role of netrins in the vasculature remains unclear. Netrin-4 and netrin-1 have been found to be either pro-or antiangiogenic factors. Previously, we found that netrin-1 acts as an antiangiogenic factor in rats by inhibiting alkali burn-induced corneal neovascularization. Here, we further investigate the effects of netrin-4, another member of the same netrin family, on neovascularization in vitro and in vivo. We found that netrin-4 functions similarly as netrin-1 in angiogenesis. In vitro angiogenesis assay shows that netrin-4 affected human umbilical vein endothelial cell (HUVEC) tube formation, viability and proliferation, apoptosis, migration, and invasion in a dose-dependent manner. Netrin-4 was topically applied in vivo to alkali-burned rat corneas on day 0 (immediately after injury) and/or day 10 post-injury. Netrin-4 subsequently suppressed and reversed corneal neovascularization. Netrin-4 inhibited corneal epithelial and stromal cell apoptosis, inhibited vascular endothelial growth factor (VEGF), but promoted pigment epithelium-derived factor (PEDF) expression, decreased NK-KB p65 expression, and inhibits neutrophil and macrophage infiltration. These results indicate that netrin-4 shed new light on its potential roles in treatmenting for angiogenic diseases that affect the ocular surface, as well as other tissues.	[Han, Yun; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; [Han, Yun; Liu, Tingting; Qu, Yang-Luowa; Li, Wei; Liu, Zuguo] Fujian Prov Key Lab Ophthalmol & Visual Sci, Xiamen, Fujian, Peoples R China; [Shao, Yi] Nanchang Univ, Affiliated Hosp 1, Dept Ophthalmol, Nanchang, Jiangxi, Peoples R China	Xiamen University; Nanchang University	Liu, ZG (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	zuguoliu@xmu.edu.cn	Li, Wei/P-8985-2015; liu, ting/GZM-3326-2022	Li, Wei/0000-0001-7458-2590; 	National Natural Science Foundation of China (NSFC) [81300729, 81160118, 81330022]; ShanHai Foundation of China [2013SH008]; Clinical Medicine Research Special purpose Foundation of China [L2012052]; Education Department Youth Scientific Research Foundation [GJJ14170]; Health Department Tradition Chinese Medicine Science and Technology Foundation [2012A087]; National Natural Science Foundation of China NSFC [81270978]; National Fund Committee on both sides of the Taiwan Straits joint project [U1205025]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); ShanHai Foundation of China; Clinical Medicine Research Special purpose Foundation of China; Education Department Youth Scientific Research Foundation; Health Department Tradition Chinese Medicine Science and Technology Foundation; National Natural Science Foundation of China NSFC(National Natural Science Foundation of China (NSFC)); National Fund Committee on both sides of the Taiwan Straits joint project	1. This work was supported by grants from the National Natural Science Foundation of China (NSFC No. 81300729[YH], No. 81160118 [YS]), the ShanHai Foundation of China (No. 2013SH008 [YH]), the Clinical Medicine Research Special purpose Foundation of China (No. L2012052 [YS]), Education Department Youth Scientific Research Foundation (No. GJJ14170 [YS]), Health Department Tradition Chinese Medicine Science and Technology Foundation (No. 2012A087 [YS]). 2. YH and YS designed the study, collected and analyzed the data. YH decision to publish and preparation the manuscript. 3. This work was also supported by grants from the international major project in National Natural Science Foundation of China (NSFC No. 81330022), the National Natural Science Foundation of China NSFC No. 81270978), the National Fund Committee on both sides of the Taiwan Straits joint project (No. U1205025). The funders had roles in purchasing reagent, data collection and analysis and decision to publish the manuscript.	Amano S, 1998, INVEST OPHTH VIS SCI, V39, P18; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Becerra SP, 2006, EXP EYE RES, V82, P739, DOI 10.1016/j.exer.2005.10.016; Bijman MNA, 2006, MOL CANCER THER, V5, P2348, DOI 10.1158/1535-7163.MCT-06-0242; Bijnsdorp IV, 2010, NUCLEOS NUCLEOT NUCL, V29, P482, DOI 10.1080/15257771003730201; Castets M, 2009, DEV CELL, V16, P614, DOI 10.1016/j.devcel.2009.02.006; Chang JH, 2001, CURR OPIN OPHTHALMOL, V12, P242, DOI 10.1097/00055735-200108000-00002; Cirulli V, 2007, NAT REV MOL CELL BIO, V8, P296, DOI 10.1038/nrm2142; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Eichmann A, 2005, CURR OPIN NEUROBIOL, V15, P108, DOI 10.1016/j.conb.2005.01.008; Eichmann A, 2005, GENE DEV, V19, P1013, DOI 10.1101/gad.1305405; Eveno C, 2011, AM J PATHOL, V178, P1861, DOI 10.1016/j.ajpath.2010.12.019; Forcet C, 2001, P NATL ACAD SCI USA, V98, P3416, DOI 10.1073/pnas.051378298; Freitas C, 2008, ANGIOGENESIS, V11, P23, DOI 10.1007/s10456-008-9096-2; Han Y, 2012, INVEST OPHTH VIS SCI, V53, P1285, DOI 10.1167/iovs.11-8722; Ho M, 2003, PHYSIOL GENOMICS, V13, P249, DOI 10.1152/physiolgenomics.00186.2002; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Hu YZ, 2012, NEOPLASIA, V14, P219, DOI 10.1593/neo.111396; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Lambert E, 2012, J BIOL CHEM, V287, P3987, DOI 10.1074/jbc.M111.289371; Laria C, 1997, OPHTHALMIC RES, V29, P145, DOI 10.1159/000268009; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Larrivee B, 2007, GENE DEV, V21, P2433, DOI 10.1101/gad.437807; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Li YN, 2012, EXP EYE RES, V96, P24, DOI 10.1016/j.exer.2012.01.007; Liu XC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016712; Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mwaikambo BR, 2006, INVEST OPHTH VIS SCI, V47, P4356, DOI 10.1167/iovs.05-1656; Nacht M, 2009, EXP CELL RES, V315, P784, DOI 10.1016/j.yexcr.2008.11.018; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; Ortego J, 1996, INVEST OPHTH VIS SCI, V37, P2759; Park KW, 2004, P NATL ACAD SCI USA, V101, P16210, DOI 10.1073/pnas.0405984101; Planck SR, 1997, OCUL IMMUNOL INFLAMM, V5, P95, DOI 10.3109/09273949709085057; Stuart PM, 2003, INVEST OPHTH VIS SCI, V44, P93, DOI 10.1167/iovs.02-0299; Sun KLW, 2011, DEVELOPMENT, V138, P2153, DOI 10.1242/dev.044529; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Yamada J, 2003, EXP EYE RES, V76, P161, DOI 10.1016/S0014-4835(02)00293-2	42	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122951	10.1371/journal.pone.0122951	http://dx.doi.org/10.1371/journal.pone.0122951			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853509	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400087
J	Ledger, PM; Miras, Y; Poux, M; Milcent, PY				Ledger, Paul M.; Miras, Yannick; Poux, Matthieu; Milcent, Pierre Yves			The Palaeoenvironmental Impact of Prehistoric Settlement and Proto-Historic Urbanism: Tracing the Emergence of the Oppidum of Corent, Auvergne, France	PLOS ONE			English	Article							RELEVANT SOURCE AREA; LAND-USE CHANGES; CULTURAL LANDSCAPES; VEGETATION HISTORY; RHONE VALLEY; POLLEN; RECORD; SITE	Early human societies and their interactions with the natural world have been extensively explored in palaeoenvironmental studies across Central and Western Europe. Yet, despite an extensive body of scholarship, there is little consideration of the environmental impacts of proto-historic urbanisation. Typically palaeoenvironmental studies of Bronze and Iron Age societies discuss human impact in terms of woodland clearance, landscape openness and evidence for agriculture. Although these features are clearly key indicators of human settlement, and characterise Neolithic and early to Middle Bronze Age impacts at Corent, they do not appear to represent defining features of a protohistoric urban environment. The Late Iron Age Gallic Oppidum of Corent is remarkable for the paucity of evidence for agriculture and strong representation of apophytes associated with disturbance. Increased floristic diversity - a phenomenon also observed in more recent urban environments - was also noted. The same, although somewhat more pronounced, patterns are noted for the Late Bronze Age and hint at the possibility of a nascent urban area. High percentages of pollen from non-native trees such as Platanus, Castanea and Juglans in the late Bronze Age and Gallic period also suggest trade and cultural exchange, notably with the Mediterranean world. Indeed, these findings question the validity of applying Castanea and Juglans as absolute chronological markers of Romanisation. These results clearly indicate the value of local-scale palaeoecological studies and their potential for tracing the phases in the emergence of a proto-historic urban environment.	[Ledger, Paul M.] Univ Blaise Pascal, Clermont Univ, Maison Sci Homme, Clermont Ferrand, France; [Ledger, Paul M.] CNRS, MSH, USR 3550, Clermont Ferrand, France; [Ledger, Paul M.; Miras, Yannick] CNRS, GEOLAB, UMR 6042, Clermont Ferrand, France; [Ledger, Paul M.] Univ Aberdeen, Dept Archaeol, Aberdeen, Scotland; [Miras, Yannick] Univ Blaise Pascal, Clermont Univ, GEOLAB, Clermont Ferrand, France; [Poux, Matthieu] Univ Lyon 2, ARAR, UMR 5138, Archeol & Archeometrie, Lyon, France; [Milcent, Pierre Yves] Univ Toulouse Jean Jaures, TRACES, UMR 5608, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Universite de Limoges; University of Aberdeen; Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); Universite de Limoges; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite Lyon 2; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures	Ledger, PM (corresponding author), Univ Blaise Pascal, Clermont Univ, Maison Sci Homme, BP 10448, Clermont Ferrand, France.	p.ledger@abdn.ac.uk	Miras, Yannick/AAC-3110-2019		Conseil Regional d'Auvergne	Conseil Regional d'Auvergne(Region Auvergne-Rhone-Alpes)	The study was funded by the Conseil Regional d'Auvergne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen S., 1978, DANMARKS GEOLOGISKE, V1978, P69; Andrieu-Ponel V, 2000, HOLOCENE, V10, P341, DOI 10.1191/095968300669147926; [Anonymous], 2007, AGE FER BOUCLE LOIRE; Antonetti P, 2006, ATALS FLORE AUVERGNE; Bennett KD, 2014, PSIMPOLL PSCOMB PROG; Berglund BE, 2003, QUATERN INT, V105, P7, DOI 10.1016/S1040-6182(02)00144-1; Berglund BE, 1996, PALAEOECOLOGICAL EVE; Beug H.J, 2004, LEITFADEN POLLENBEST; Birks H.H., 1988, CULTURAL LANDSCAPE P, P179; Birks HJB, 1992, HOLOCENE, V2, P1, DOI 10.1177/095968369200200101; BIRKS HJB, 1970, NEW PHYTOL, V69, P807, DOI 10.1111/j.1469-8137.1970.tb02464.x; Blaauw M, 2010, QUAT GEOCHRONOL, V5, P512, DOI 10.1016/j.quageo.2010.01.002; BROWN TA, 1989, QUATERNARY RES, V32, P205, DOI 10.1016/0033-5894(89)90076-8; Brun C, 2011, VEG HIST ARCHAEOBOT, V20, P135, DOI 10.1007/s00334-010-0277-8; Bunting MJ, 2004, HOLOCENE, V14, P651, DOI 10.1191/0959683604hl744rp; BUNTING MJ, 2000, HUMAN ECODYNAMICS, P63; Cabanis M, 2013, QUATERNAIRE, V24, P129; CLARK R L, 1982, Pollen et Spores, V24, P523; Collis J, 1984, OPPIDA EARLIST TOWNS; Davies AL, 2004, HOLOCENE, V14, P233, DOI 10.1191/0959683604hl701rp; de Beaulieu J.-L., 1988, CAHIERS MICROPALE ON, V3, P5; Dimbleby G.W., 1985, PALYNOLOGY ARCHAEOLO; Doyen E, 2013, HOLOCENE, V23, P961, DOI 10.1177/0959683612475142; Edwards K.J., 1982, ARCHAEOLOGICAL ASPEC, V146, P5; EDWARDS KJ, 1997, SCOTLAND ENV ARCHAEO, P63; Ejarque A, 2010, J ARCHAEOL SCI, V37, P1; Ellis EC, 2013, P NATL ACAD SCI USA, V110, P7978, DOI 10.1073/pnas.1217241110; Fernandez-Gotz M, 2014, ANTIQUITY, V88, P304, DOI 10.1017/S0003598X00050468; Fernandez-Gotz M, 2013, ANTIQUITY, V87, P473, DOI 10.1017/S0003598X00049073; Galinie H, 2009, AGE FER BOUCLE LOIRE, P199; Grimm E.C., 1993, TILIA PROGRAM ANAL D; GRIMM EC, 1987, COMPUT GEOSCI, V13, P13, DOI 10.1016/0098-3004(87)90022-7; Guichard V, 1992, RAPPORT CAMPAGN FOUI; Hatte C, 2013, RADIOCARBON, V55, P979, DOI 10.1017/S0033822200058124; Hellman S, 2009, REV PALAEOBOT PALYNO, V153, P245, DOI 10.1016/j.revpalbo.2008.08.006; Hellman S, 2009, REV PALAEOBOT PALYNO, V153, P259, DOI 10.1016/j.revpalbo.2008.08.008; Hillbrand M, 2014, HOLOCENE, V24, P559, DOI 10.1177/0959683614522307; Hjelle KL, 1997, REV PALAEOBOT PALYNO, V99, P1, DOI 10.1016/S0034-6667(97)00041-9; IVERSEN JOHS, 1941, DANMARKS GEOL UNDERS OGELSE 2 RALKKE, V66, P1; Jouffroy-Bapicot I, 2013, HOLOCENE, V23, P1888, DOI 10.1177/0959683613508161; Juvigne E, 1988, REV SCI NATURELLES A, V53, P7; Kolaczek P, 2013, REV PALAEOBOT PALYNO, V189, P29, DOI 10.1016/j.revpalbo.2012.11.006; Lavrieux M, 2013, HOLOCENE, V23, P1317, DOI 10.1177/0959683613484616; Ledger PM, 2015, BOREAS, V44, P197, DOI 10.1111/bor.12089; Leps J, 2003, MULTIVARIATE ANAL EC; Mercuri AM, 2013, QUATERN INT, V303, P24, DOI 10.1016/j.quaint.2013.01.005; Michelin Y, 2001, QUATERNAIRE, V1-2, P31; Milcent P.-Y., 2014, TRANSALPINARE MELANG, P181, DOI DOI 10.1016/B978-0-444-53156-8.00019-2; Milcent P.-Y., 2004, MEMOIRE 34 SOC PREHI, V1; Milcent P.-Y., 2014, B APRAB, V12, P89; Milcent P-Y, 2012, FRAGE PROTOURBANISAT, P91; Milcent PY, 2009, AGE BRONZE AGE FER F, P453; Miras Y, 2004, VEG HIST ARCHAEOBOT, V13, P91, DOI 10.1007/s00334-004-0033-z; Miras Yannick, 2009, Revue des Sciences Naturelles d'Auvergne, V73, P71; Moore P.D., 1991, BLACKWELL SCI PUBLI; Nehlig P, 2003, GEOLOGUES, V130-131, P1; PEGLAR SM, 1993, REV PALAEOBOT PALYNO, V76, P1, DOI 10.1016/0034-6667(93)90079-A; Petite C, 2011, ASPECTS ROMANISATION, V21, P335; Poux M, 2001, CORENT RAPPORT FOUIL, P1; Poux M., 2012, CORENT VOYAGE COEUR, DOI DOI 10.1016/j.sedgeo.2010.04.012; PRAT B, 2006, THESIS U BLAISE PASC; REILLE M, 1993, QUATERNARY SCI REV, V12, P47, DOI 10.1016/0277-3791(93)90048-Q; Reille M., 1992, POLLEN SPORES EUROPE; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Richard H., 2007, ENV CULTURES AGE BRO, P227; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Seppa H, 1997, VEG HIST ARCHAEOBOT, V6, P91, DOI 10.1007/BF01261957; STOCKMARR J, 1971, Pollen et Spores, V13, P615; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Tixier, 1985, REV ARCHEOLOGIQUE CT, V24, P17, DOI [10.1016/j.acvd.2013.12.002, DOI 10.1016/J.ACVD.2013.12.002]; Trement F., 2007, GALLIA ARCHE OLOGIE, V64, P289, DOI DOI 10.1177/0959683619826637; van Geel B, 2003, J ARCHAEOL SCI, V30, P873, DOI 10.1016/S0305-4403(02)00265-0; Van Geel B., 2001, TRACKING ENV CHANGE, V3, P99, DOI DOI 10.1007/0-306-47668-1_6; van Geel B, 2006, NOVA HEDWIGIA, V82, P313, DOI 10.1127/0029-5035/2006/0082-0313	74	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121517	10.1371/journal.pone.0121517	http://dx.doi.org/10.1371/journal.pone.0121517			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	CF3WA	25853251	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400040
J	Aljedai, A; Buckle, AM; Hiwarkar, P; Syed, F				Aljedai, Abdullah; Buckle, Anne-Marie; Hiwarkar, Prashant; Syed, Farhatullah			Potential Role of Notch Signalling in CD34(+) Chronic Myeloid Leukaemia Cells: Cross-Talk between Notch and BCR-ABL	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; GAMMA-SECRETASE INHIBITORS; HEMATOPOIETIC STEM; INTRACELLULAR DOMAIN; PROGENITOR CELLS; KINASE-ACTIVITY; BLAST CRISIS; IN-VIVO; IMATINIB; CML	Notch signalling is critical for haemopoietic stem cell (HSC) self-renewal and survival. The role of Notch signalling has been reported recently in chronic myeloid leukaemia (CML) - a stem cell disease characterized by BCR-ABL tyrosine kinase activation. Therefore, we studied the relationship between BCR-ABL and Notch signalling and assessed the expression patterns of Notch and its downstream target Hes1 in CD34(+) stem and progenitor cells from chronic-phase CML patients and bone marrow (BM) from normal subjects (NBM). We found significant upregulation (p<0.05) of Notch1, Notch2 and Hes1 on the most primitive CD34(+)Thy(+) subset of CML CD34(+) cells suggesting that active Notch signalling in CML primitive progenitors. In addition, Notch1 was also expressed in distinct lymphoid and myeloid progenitors within the CD34(+) population of primary CML cells. To further delineate the possible role and interactions of Notch with BCR-ABL in CD34(+) primary cells from chronic-phase CML, we used P-crkl detection as a surrogate assay of BCR-ABL tyrosine kinase activity. Our data revealed that Imatinib (IM) induced BCR-ABL inhibition results in significant (p<0.05) upregulation of Notch activity, assessed by Hes1 expression. Similarly, inhibition of Notch leads to hyperactivation of BCR-ABL. This antagonistic relationship between Notch and BCR-ABL signalling was confirmed in K562 and ALL-SIL cell lines. In K562, we further validated this antagonistic relationship by inhibiting histone deacetylase (HDAC) - an effector pathway of Hes1, using valproic acid (VPA) - a HDAC inhibitor. Finally, we also confirmed the potential antagonism between Notch and BCR/ABL in In Vivo, using publically available GSE-database, by analysing gene expression profile of paired samples from chronic-phase CML patients pre- and post-Imatinib therapy. Thus, we have demonstrated an antagonistic relationship between Notch and BCR-ABL in CML. A combined inhibition of Notch and BCR-ABL may therefore provide superior clinical response over tyrosine-kinase inhibitor monotherapy by targeting both quiescent leukaemic stem cells and differentiated leukaemic cells and hence must be explored.	[Aljedai, Abdullah; Buckle, Anne-Marie; Syed, Farhatullah] Univ Manchester, Fac Life Sci, Manchester Inst Biotechnol, Manchester, Lancs, England; [Hiwarkar, Prashant] Great Ormond St Hosp Sick Children, Dept Paediat Haematol, London, England; [Syed, Farhatullah] Univ Manchester, Manchester Inst Biotechnol, Inst Inflammat & Repair, Manchester, Lancs, England	University of Manchester; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester	Aljedai, A (corresponding author), King Saud Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh 11451, Saudi Arabia.	aaljedai@ksu.edu.sa	ALJEDAI, ABDULLAH/HCH-6903-2022	Aljedai, Abdullah/0000-0002-8331-5651	Ministry of Saudi, Government of Saudi Arabia	Ministry of Saudi, Government of Saudi Arabia	For this work the funding was provided to A.A. by Ministry of Saudi, Government of Saudi Arabia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2005, FEBS LETT, V579, P6199, DOI 10.1016/j.febslet.2005.09.093; Aste-Amezaga M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009094; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Bruennert D, 2009, LEUKEMIA, V23, P983, DOI 10.1038/leu.2008.337; Burchert A, 2005, LEUKEMIA, V19, P1774, DOI 10.1038/sj.leu.2403898; Burthem J, 2007, LEUKEMIA, V21, P1708, DOI 10.1038/sj.leu.2404762; Chadwick N, 2007, STEM CELLS, V25, P203, DOI 10.1634/stemcells.2005-0303; Chadwick N, 2010, BLOOD CELL MOL DIS, V45, P201, DOI 10.1016/j.bcmd.2010.07.006; Chadwick N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-35; Chen YY, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-21; Chomel JC, 2014, M S-MED SCI, V30, P452, DOI 10.1051/medsci/20143004022; Chu S, 2004, BLOOD, V103, P3167, DOI 10.1182/blood-2003-04-1271; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; Copland M, 2006, BLOOD, V107, P4532, DOI 10.1182/blood-2005-07-2947; Crowner D, 2003, CURR BIOL, V13, P967, DOI 10.1016/S0960-9822(03)00325-7; De Keersmaecker K, 2008, HAEMATOLOGICA, V93, P533, DOI 10.3324/haematol.11894; Diaz-Blanco E, 2007, LEUKEMIA, V21, P494, DOI 10.1038/sj.leu.2404549; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Eisele YS, 2007, MOL BIOL CELL, V18, P3591, DOI 10.1091/mbc.E07-01-0035; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Giniger E, 1998, NEURON, V20, P667, DOI 10.1016/S0896-6273(00)81007-7; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Graux C, 2009, LEUKEMIA, V23, P125, DOI 10.1038/leu.2008.278; Guruharsha K, 2012, NATURE REV GENETICS; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; He F, 2009, LEUKEMIA RES, V33, P798, DOI 10.1016/j.leukres.2008.09.016; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; Jamieson C, 2010, BLOOD, V115, P2726, DOI 10.1182/blood-2009-12-252585; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kinstrie R, 2013, CURR HEMATOL MALIG R, V8, P14, DOI 10.1007/s11899-012-0148-8; Kogoshi H, 2007, ONCOL REP, V18, P77; Kolb EA, 2012, PEDIATR BLOOD CANCER, V58, P815, DOI 10.1002/pbc.23290; Liu N, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-23; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Martone RL, 2009, J PHARMACOL EXP THER, V331, P598, DOI 10.1124/jpet.109.152975; Mizuno T, 2008, ONCOGENE, V27, P3465, DOI 10.1038/sj.onc.1211007; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakahara F, 2014, BLOOD, V123, P3932, DOI 10.1182/blood-2013-01-476747; Nakahara F, 2010, BLOOD, V115, P2872, DOI 10.1182/blood-2009-05-222836; Neumann F, 2005, LEUKEMIA, V19, P458, DOI 10.1038/sj.leu.2403615; ODA T, 1994, J BIOL CHEM, V269, P22925; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Panin VM, 1998, SEMIN CELL DEV BIOL, V9, P609, DOI 10.1006/scdb.1998.0263; Pellicano F, 2011, LEUKEMIA, V25, P1159, DOI 10.1038/leu.2011.67; Pellicano F, 2009, BLOOD, V114, P4186, DOI 10.1182/blood-2009-05-219550; Petzer AL, 1996, BLOOD, V88, P2162, DOI 10.1182/blood.V88.6.2162.bloodjournal8862162; Portillo V, 2013, EUROPEAN J HAEMATOLO; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Samon JB, 2012, MOL CANCER THER, V11, P1565, DOI 10.1158/1535-7163.MCT-11-0938; Sang LY, 2010, TRENDS MOL MED, V16, P17, DOI 10.1016/j.molmed.2009.11.001; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Sinclair A, 2013, BRIT J PHARMACOL, V169, P1693, DOI 10.1111/bph.12183; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Suresh S, 2013, J PATHOL, V231, P378, DOI 10.1002/path.4246; Tejada FNH, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00054; Tickenbrock L, 2008, INT J ONCOL, V33, P1215, DOI 10.3892/ijo_00000111; Tolcher AW, 2012, J CLIN ONCOL, V30, P2348, DOI 10.1200/JCO.2011.36.8282; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yang Chun-xiu, 2011, Chinese Journal of Biologicals, V24, P1278; Yang ZS, 2013, ONCOL LETT, V5, P1390, DOI 10.3892/ol.2013.1159; Yin DD, 2009, LEUKEMIA RES, V33, P109, DOI 10.1016/j.leukres.2008.06.023	63	18	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123016	10.1371/journal.pone.0123016	http://dx.doi.org/10.1371/journal.pone.0123016			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849484	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800196
J	Binelli, M; Scolari, SC; Pugliesi, G; Van Hoeck, V; Gonella-Diaza, AM; Andrade, SCS; Gasparin, GR; Coutinho, LL				Binelli, Mario; Scolari, Saara C.; Pugliesi, Guilherme; Van Hoeck, Veerle; Gonella-Diaza, Angela M.; Andrade, Sonia C. S.; Gasparin, Gustavo R.; Coutinho, Luiz L.			The Transcriptome Signature of the Receptive Bovine Uterus Determined at Early Gestation	PLOS ONE			English	Article							GENE-EXPRESSION; ENDOMETRIAL RECEPTIVITY; UTERINE RECEPTIVITY; EARLY-PREGNANCY; EMBRYO; IMPLANTATION; PROGESTERONE; MARKERS; FERTILITY; CATTLE	Pregnancy success is critical to the profitability of cattle operations. However, the molecular events driving the uterine tissue towards embryo receptivity are poorly understood. This study aimed to characterize the uterine transcriptome profiles of pregnant (P) versus nonpregnant (NP) cows during early pregnancy and attempted to define a potential set of marker genes that can be valuable for predicting pregnancy outcome. Therefore, beef cows were synchronized (n=51) and artificially inseminated (n=36) at detected estrus. Six days after AI (D6), jugular blood samples and a biopsy from the uterine horn contralateral to the ovary containing the corpus luteum were collected. Based on pregnancy outcome on D30, samples were retrospectively allocated to the following groups: P (n=6) and NP (n=5). Both groups had similar plasma progesterone concentrations on D6. Uterine biopsies were submitted to RNA-Seq analysis in a Illumina platform. The 272,685,768 million filtered reads were mapped to the Bos Taurus reference genome and 14,654 genes were analyzed for differential expression between groups. Transcriptome data showed that 216 genes are differently expressed when comparing NP versus P uterine tissue (Padj <= 0.1). More specifically, 36 genes were up-regulated in P cows and 180 are up-regulated in NP cows. Functional enrichment and pathway analyses revealed enriched expression of genes associated with extracellular matrix remodeling in the NP cows and nucleotide binding, microsome and vesicular fraction in the P cows. From the 40 top-ranked genes, the transcript levels of nine genes were re-evaluated using qRT-PCR. In conclusion, this study characterized a unique set of genes, expressed in the uterus 6 days after insemination, that indicate a receptive state leading to pregnancy success. Furthermore, expression of such genes can be used as potential markers to efficiently predict pregnancy success.	[Binelli, Mario; Scolari, Saara C.; Pugliesi, Guilherme; Van Hoeck, Veerle; Gonella-Diaza, Angela M.; Andrade, Sonia C. S.] FMVZ USP, Dept Anim Reprod, Lab Fisiol & Endocrinol Mol, Sao Paulo, Brazil; [Gasparin, Gustavo R.; Coutinho, Luiz L.] ESALQ USP, Dept Zootecnia, Lab Genet Anim, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Binelli, M (corresponding author), FMVZ USP, Dept Anim Reprod, Lab Fisiol & Endocrinol Mol, Sao Paulo, Brazil.	binelli@usp.br	Coutinho, Luiz L/C-8455-2012; pugliesi, Guilherme/A-9149-2013; Andrade, Sonia/GLS-1234-2022; Andrade, Sonia CS/F-8267-2014; Coutinho, Luiz/P-5233-2019; Pugliesi, Guilherme/AAK-9557-2020	Coutinho, Luiz L/0000-0002-7266-8881; Andrade, Sonia/0000-0002-1302-5261; Andrade, Sonia CS/0000-0002-1302-5261; Coutinho, Luiz/0000-0002-7266-8881; Pugliesi, Guilherme/0000-0001-5739-0677	LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular) [211]; Fundacao de Amparo A Pesquisa do Estado de Sao Paulo [2011/03226-4, 2012/23532-5]; CNPq; CAPES	LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular); Fundacao de Amparo A Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by LFEM (Laboratorio de Fisiologia e Endocrinologia Molecular)(Project #211), Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (2011/03226-4 and 2012/23532-5), CNPq and CAPES.	Bauersachs S, 2006, REPRODUCTION, V132, P319, DOI 10.1530/rep.1.00996; Baumann CG, 2007, MOL REPROD DEV, V74, P1345, DOI 10.1002/mrd.20604; Beltman ME, 2013, REPROD FERT DEVELOP, V25, P966, DOI 10.1071/RD12232; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berg DK, 2010, THERIOGENOLOGY, V73, P250, DOI 10.1016/j.theriogenology.2009.09.005; Binelli M, 2014, ANIM REPROD, V11, P246; BRENNER CA, 1989, GENE DEV, V3, P848, DOI 10.1101/gad.3.6.848; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Clemente M, 2009, REPRODUCTION, V138, P507, DOI 10.1530/REP-09-0152; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diaz-Gimeno P, 2011, FERTIL STERIL, V95, P50, DOI 10.1016/j.fertnstert.2010.04.063; Fatemi HM, 2013, REPROD BIOMED ONLINE, V27, P530, DOI 10.1016/j.rbmo.2013.05.018; Favaro RR, 2013, PLACENTA, V34, P1128, DOI 10.1016/j.placenta.2013.09.012; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Forde N, 2011, BIOL REPROD, V85, P144, DOI 10.1095/biolreprod.110.090019; Forde N, 2011, BIOL REPROD, V84, P266, DOI 10.1095/biolreprod.110.085910; Forde N, 2010, PHYSIOL GENOMICS, V41, P53, DOI 10.1152/physiolgenomics.00162.2009; Forde N, 2012, J REPROD DEVELOP, V58, P189, DOI 10.1262/jrd.2011-021; Garrido-Gomez T, 2013, FERTIL STERIL, V99, P1078, DOI 10.1016/j.fertnstert.2012.12.005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giudice LC, 1999, HUM REPROD, V14, P3, DOI 10.1093/humrep/14.suppl_2.3; Grimard B, 2006, ANIM REPROD SCI, V91, P31, DOI 10.1016/j.anireprosci.2005.03.003; Groothuis PG, 2007, HUM REPROD UPDATE, V13, P405, DOI 10.1093/humupd/dmm009; ILESANMI AO, 1993, MICROSC RES TECHNIQ, V25, P208, DOI 10.1002/jemt.1070250304; Kaloglu C, 2010, TISSUE CELL, V42, P301, DOI 10.1016/j.tice.2010.07.004; Kim JY, 2011, BIOL REPROD, V84, P62, DOI 10.1095/biolreprod.110.085738; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Llobat L, 2012, REPROD DOMEST ANIM, V47, P281, DOI 10.1111/j.1439-0531.2011.01855.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mesquita FS, 2014, THERIOGENOLOGY, V81, P861, DOI 10.1016/j.theriogenology.2013.12.022; Minten MA, 2013, PLOS ONE, DOI [10.1371/ journal. pone. 0069444, DOI 10.1371/J0URNAL.P0NE.0069444]; Murphy CR, 1995, HUM REPROD UPDATE, V1, P567, DOI 10.1093/humupd/1.6.567; Nissi R, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-2; Pugliesi G, 2014, REPROD DOMEST ANIM, V49, pE35, DOI 10.1111/rda.12345; Rashid NA, 2011, AM J REPROD IMMUNOL, V66, P23, DOI 10.1111/j.1600-0897.2011.01048.x; Revel A, 2012, FERTIL STERIL, V97, P1028, DOI 10.1016/j.fertnstert.2012.03.039; Robert C, 2010, REPRODUCTION, V140, P787, DOI 10.1530/REP-10-0191; Ruiz-Alonso M, 2013, FERTIL STERIL, V100, P818, DOI 10.1016/j.fertnstert.2013.05.004; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Spencer T. E., 2004, J ANIM SCI, V82, P4; Ulbrich SE, 2009, BIOL REPROD, V81, P795, DOI 10.1095/biolreprod.108.075184; Walker CG, 2013, PHYSIOL GENOMICS, V45, P276, DOI 10.1152/physiolgenomics.00145.2012; Walker CG, 2012, PHYSIOL GENOMICS, V44, P47, DOI 10.1152/physiolgenomics.00254.2010	44	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122874	10.1371/journal.pone.0122874	http://dx.doi.org/10.1371/journal.pone.0122874			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849079	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800168
J	Liu, W; Shi, XY; Yang, YD; Cheng, XM; Liu, Q; Han, H; Yang, BH; He, CY; Wang, YL; Jiang, B; Wang, ZT; Wang, CH				Liu, Wei; Shi, Xiaoyuan; Yang, Yadi; Cheng, Xuemei; Liu, Qing; Han, Han; Yang, Baohua; He, Chunyong; Wang, Yongli; Jiang, Bo; Wang, Zhengtao; Wang, Changhong			In Vitro and In Vivo Metabolism and Inhibitory Activities of Vasicine, a Potent Acetylcholinesterase and Butyrylcholinesterase Inhibitor	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; IDENTIFICATION; DRUG; TIME; ALKALOIDS; PEGANUM; DISCOVERY; SEEDS	Vasicine (VAS), a potential natural cholinesterase inhibitor, exhibited promising anticholinesterase activity in preclinical models and has been in development for treatment of Alzheimer's disease. This study systematically investigated the in vitro and in vivo metabolism of VAS in rat using ultra performance liquid chromatography combined with electrospray ionization quadrupole time-of-flight mass spectrometry. A total of 72 metabolites were found based on a detailed analysis of their H-1-NMR and C-13 NMR data. Six key metabolites were isolated from rat urine and elucidated as vasicinone, vasicinol, vasicinolone, 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, 9-oxo-1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-yl hydrogen sulfate, and 1,2,3,9-tetrahydropyrrolo [2,1-b] quinazolin-3-beta-D-glucuronide. The metabolic pathway of VAS in vivo and in vitro mainly involved monohydroxylation, dihydroxylation, trihydroxylation, oxidation, desaturation, sulfation, and glucuronidation. The main metabolic soft spots in the chemical structure of VAS were the 3-hydroxyl group and the C-9 site. All 72 metabolites were found in the urine sample, and 15, 25, 45, 18, and 11 metabolites were identified from rat feces, plasma, bile, rat liver micro-somes, and rat primary hepatocyte incubations, respectively. Results indicated that renal clearance was the major excretion pathway of VAS. The acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities of VAS and its main metabolites were also evaluated. The results indicated that although most metabolites maintained potential inhibitory activity against AChE and BChE, but weaker than that of VAS. VAS undergoes metabolic inactivation process in vivo in respect to cholinesterase inhibitory activity.	[Liu, Wei; Shi, Xiaoyuan; Yang, Yadi; Han, Han; Yang, Baohua; He, Chunyong; Wang, Yongli; Jiang, Bo; Wang, Zhengtao; Wang, Changhong] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China; [Wang, Zhengtao; Wang, Changhong] MOE Key Lab Standardizat Chinese Med, Shanghai, Peoples R China; [Wang, Zhengtao; Wang, Changhong] SATCM Key Lab New Resources & Qual Evaluat Chines, Shanghai, Peoples R China; [Cheng, Xuemei; Liu, Qing; Wang, Yongli; Wang, Zhengtao; Wang, Changhong] Shanghai R&D Ctr Standardizat Chinese Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine	Wang, CH (corresponding author), Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China.	wchcxm@hotmail.com	han, han/HDL-7807-2022; Wang, Chang-hong/AAD-2543-2020; Wang, Zhengtao/AAH-7360-2019	Wang, Chang-hong/0000-0001-7578-4856; Wang, Zhengtao/0000-0003-2797-4625	Xinjiang Uygur Autonomous Region of China [U1130303]; National Natural Science Foundation of China [U1130303, 81173119]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2012ZX0910320-051]; Program of Shanghai Subject Chief Scientist [13XD1403500]	Xinjiang Uygur Autonomous Region of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China; Program of Shanghai Subject Chief Scientist	This work was financially supported by the Key Projects of Joint Funds of the National Natural Science Foundation of China and Xinjiang Uygur Autonomous Region of China (No. U1130303), the National Natural Science Foundation of China (Grant 81173119), the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program", China (Grants 2012ZX0910320-051), and the Program of Shanghai Subject Chief Scientist (13XD1403500) awarded to Professor Chang-hong Wang for financial support of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atal C., 1983, INDIAN DRUGS, V20, P431; Bateman KP, 2007, RAPID COMMUN MASS SP, V21, P1485, DOI 10.1002/rcm.2996; Bhide M, 1976, B HAFFKIN I, V4, P45; Chattopadhyay N, 2011, CARBOHYD POLYM, V83, P1970, DOI 10.1016/j.carbpol.2010.11.002; Cheng CR, 2012, DRUG METAB DISPOS, V40, P2307, DOI 10.1124/dmd.112.047506; Cheng XM, 2010, PHYTOCHEM ANALYSIS, V21, P279, DOI 10.1002/pca.1198; Gao H, 2008, FOOD CHEM, V108, P965, DOI 10.1016/j.foodchem.2007.12.002; HANAI T, 1983, J HIGH RES CHROMATOG, V6, P20, DOI 10.1002/jhrc.1240060105; Holcapek M, 2008, ANAL BIOANAL CHEM, V391, P59, DOI 10.1007/s00216-008-1962-7; Hua HM, 2002, CHEM PHARM BULL, V50, P1393, DOI 10.1248/cpb.50.1393; Ibanez M, 2011, RAPID COMMUN MASS SP, V25, P3103, DOI 10.1002/rcm.5183; Joshi BS, 1996, TETRAHEDRON-ASYMMETR, V7, P25, DOI 10.1016/0957-4166(95)00412-2; Levsen K, 2005, J CHROMATOGR A, V1067, P55, DOI 10.1016/j.chroma.2004.08.165; Li LA, 2011, DRUG METAB DISPOS, V39, P472, DOI 10.1124/dmd.110.036723; Li SP, 2014, J PHARMACEUT BIOMED, V92, P53, DOI 10.1016/j.jpba.2014.01.003; Lin JH, 1997, PHARMACOL REV, V49, P403; Liu W, 2014, J PHARMACEUT BIOMED, V94, P215, DOI 10.1016/j.jpba.2014.02.004; [刘伟 Liu Wei], 2013, [国际药学研究杂志, Journal of International Pharmaceutical Research], V40, P386; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahindroo N, 2005, MED CHEM RES, V14, P347, DOI 10.1007/s00044-006-0141-7; Nepali K, 2013, MED CHEM RES, V22, P1, DOI 10.1007/s00044-012-0002-5; Niwa T, 2000, DRUG METAB DISPOS, V28, P1128; Rachana, 2011, Indo Global Journal of Pharmaceutical Sciences, V1, P85; Rashkes YV, 1983, CHEM NAT COMPD, V19, P64; Sayeed Ahmad, 2009, Natural Product Radiance, V8, P549; SCHRENK D, 1992, CARCINOGENESIS, V13, P453, DOI 10.1093/carcin/13.3.453; Singh B, 2013, PHYTOMEDICINE, V20, P441, DOI 10.1016/j.phymed.2012.12.015; Srinivasarao D., 2006, Indian Journal of Allergy, Asthma & Immunology, V20, P1; Swamy GYSK, 2005, J CHEM CRYSTALLOGR, V35, P183, DOI 10.1007/s10870-005-2955-4; Trunzer M, 2009, J MED CHEM, V52, P329, DOI 10.1021/jm8008663; Walsky RL, 2004, DRUG METAB DISPOS, V32, P647, DOI 10.1124/dmd.32.6.647; Wen Fang-fang, 2012, Zhongguo Zhong Yao Za Zhi, V37, P2971; Zhang HY, 2009, J MASS SPECTROM, V44, P999, DOI 10.1002/jms.1610; Zhao T, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/717232; Zheng XY, 2011, JPC-J PLANAR CHROMAT, V24, P470, DOI 10.1556/JPC.24.2011.6.3; Zheng XY, 2009, ARCH PHARM RES, V32, P1245, DOI 10.1007/s12272-009-1910-x	36	14	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122366	10.1371/journal.pone.0122366	http://dx.doi.org/10.1371/journal.pone.0122366			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849329	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800122
J	Lyons, C; Fernandes, P; Fanning, LJ; Houston, A; Brint, E				Lyons, Caitriona; Fernandes, Philana; Fanning, Liam J.; Houston, Aileen; Brint, Elizabeth			Engagement of Fas on Macrophages Modulates Poly I:C Induced Cytokine Production with Specific Enhancement of IP-10	PLOS ONE			English	Article							NF-KAPPA-B; DOMAIN-CONTAINING PROTEIN; HEPATITIS-C VIRUS; RIG-I; DEATH DOMAIN; INDUCED APOPTOSIS; INFECTED-CELLS; ACTIVATION; FADD; IL-1-BETA	Viral double-stranded RNA (dsRNA) is recognised by pathogen recognition receptors such as Toll-Like Receptor 3 (TLR3) and retinoic acid inducible gene-I (RIG-I), and results in cytokine and interferon production. Fas, a well characterised death receptor, has recently been shown to play a role in the inflammatory response. In this study we investigated the role of Fas in the anti-viral immune response. Stimulation of Fas on macrophages did not induce significant cytokine production. However, activation of Fas modified the response of macrophages to the viral dsRNA analogue poly I:C. In particular, poly I:C-induced IP-10 production was significantly enhanced. A similar augmentation of IP-10 by Fas was observed following stimulation with both poly A:U and Sendai virus. Fas activation suppressed poly I:C-induced phosphorylation of the MAP kinases p38 and JNK, while overexpression of the Fas adaptor protein, Fas-associated protein with death domain (FADD), activated AP-1 and inhibited poly I:C-induced IP-10 production. Consistent with an inhibitory role for AP-1 in IP-10 production, mutation of the AP-1 binding site on the IP-10 promoter resulted in augmented poly I:C-induced IP-10. These results demonstrate that engagement of the Fas receptor plays a role in modifying the innate immune response to viral RNA.	[Lyons, Caitriona; Brint, Elizabeth] Natl Univ Ireland Univ Coll Cork, Dept Pathol, Cork, Ireland; [Fernandes, Philana; Fanning, Liam J.; Houston, Aileen] Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland; [Houston, Aileen; Brint, Elizabeth] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland	University College Cork; University College Cork; University College Cork	Houston, A (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Med, Cork, Ireland.	a.houston@ucc.ie	Houston, Aileen/ABF-2473-2020; FANNING, LIAM J/F-5281-2015	Houston, Aileen/0000-0003-1362-5256; FANNING, LIAM J/0000-0001-6629-8418; Brint, Elizabeth/0000-0001-9214-149X	Science Foundation Ireland [10/RFP/CAN2894, 10/RFP/BIC2737]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	The authors would like to acknowledge Science Foundation Ireland for financial support (grant numbers 10/RFP/CAN2894 and 10/RFP/BIC2737. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Bannerman DD, 2002, J CLIN INVEST, V109, P419, DOI 10.1172/JCI14774; Baum A, 2011, VIRULENCE, V2, P166, DOI 10.4161/viru.2.2.15481; Berkova Z, 2009, JNCI-J NATL CANCER I, V101, P399, DOI 10.1093/jnci/djn516; Bossaller L, 2012, J IMMUNOL, V189, P5508, DOI 10.4049/jimmunol.1202121; Brint EK, 2002, J BIOL CHEM, V277, P49205, DOI 10.1074/jbc.M209685200; Brownell J, 2014, J VIROL, V88, P1582, DOI 10.1128/JVI.02007-13; Brownell J, 2013, CLIN CANCER RES, V19, P1347, DOI 10.1158/1078-0432.CCR-12-0928; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Chinnaiyan AM, 1996, J BIOL CHEM, V271, P4961; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fernandes P, 2014, J IMMUNOL; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Fukui M, 2003, J IMMUNOL, V171, P1868, DOI 10.4049/jimmunol.171.4.1868; Garvey TL, 2002, J VIROL, V76, P697, DOI 10.1128/JVI.76.2.697-706.2002; Kaiser WJ, 2005, J IMMUNOL, V174, P4942, DOI 10.4049/jimmunol.174.8.4942; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Krzyzowska M, 2014, IMMUNOBIOLOGY, V219, P64, DOI 10.1016/j.imbio.2013.08.002; Krzyzowska M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070308; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lee SM, 2011, CELL IMMUNOL, V271, P157, DOI 10.1016/j.cellimm.2011.06.019; Liu ML, 2011, ONCOL LETT, V2, P583, DOI 10.3892/ol.2011.300; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Palsson-McDermott EM, 2009, NAT IMMUNOL, V10, P579, DOI 10.1038/ni.1727; Roskams T, 2000, J PATHOL, V191, P150; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Yount JS, 2008, J IMMUNOL, V180, P4910, DOI 10.4049/jimmunol.180.7.4910; Zhande R, 2007, MOL CELL BIOL, V27, P7394, DOI 10.1128/MCB.00600-07; Zhang X, 2015, J CELL MOL MED, V19, P555, DOI 10.1111/jcmm.12456	34	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123635	10.1371/journal.pone.0123635	http://dx.doi.org/10.1371/journal.pone.0123635			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849666	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800247
J	Pollizzi, KN; Waickman, AT; Patel, CH; Sun, IH; Powell, JD				Pollizzi, Kristen N.; Waickman, Adam T.; Patel, Chirag H.; Sun, Im Hong; Powell, Jonathan D.			Cellular Size as a Means of Tracking mTOR Activity and Cell Fate of CD4+T Cells upon Antigen Recognition	PLOS ONE			English	Article							REGULATORY T-CELLS; MAMMALIAN TARGET; IN-VIVO; RESPIRATORY CAPACITY; DIFFERENTIATION; ACTIVATION; INDUCTION; RAPAMYCIN; MEMORY; GENE	mTOR is a central integrator of metabolic and immunological stimuli, dictating immune cell activation, proliferation and differentiation. In this study, we demonstrate that within a clonal population of activated T cells, there exist both mTOR(hi) and mTOR(lo) cells exhibiting highly divergent metabolic and immunologic functions. By taking advantage of the role of mTOR activation in controlling cellular size, we demonstrate that upon antigen recognition, mTORhi CD4+ T cells are destined to become highly glycolytic effector cells. Conversely, mTOR(lo) T cells preferentially develop into long-lived cells that express high levels of Bcl-2, CD25, and CD62L. Furthermore, mTOR(lo) T cells have a greater propensity to differentiate into suppressive Foxp3+ T regulatory cells, and this paradigm was also observed in human CD4+ T cells. Overall, these studies provide the opportunity to track the development of effector and memory T cells from naive precursors, as well as facilitate the interrogation of immunologic and metabolic programs that inform these fates.	[Pollizzi, Kristen N.; Waickman, Adam T.; Patel, Chirag H.; Sun, Im Hong; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD 21287 USA.	poweljo@jhmi.edu	Waickman, Adam/AHB-5028-2022	Sun, Im Hong/0000-0003-0288-2062; Waickman, Adam/0000-0002-4536-6714	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI072677, AI77610, AI091481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247, R01AI077610, P01AI072677, R01AI091481] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health/National Institute of Allergy and Infectious Diseases: AI072677, AI77610 and AI091481 to JDP. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Choi SW, 2009, J NEUROCHEM, V109, P1179, DOI 10.1111/j.1471-4159.2009.06055.x; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, MOL IMMUNOL, V46, P2694, DOI 10.1016/j.molimm.2009.05.185; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gottschalk RA, 2010, J EXP MED, V207, P1701, DOI 10.1084/jem.20091999; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; He S, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028291, 10.1371/journal.pone.0020107]; Heikamp EB, 2014, NAT IMMUNOL, V15, P457, DOI 10.1038/ni.2867; Hernandez O, 2007, GENESIS, V45, P101, DOI 10.1002/dvg.20271; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Kang J, 2008, J LEUKOCYTE BIOL, V83, P1230, DOI 10.1189/jlb.1207851; King CG, 2012, IMMUNITY, V37, P709, DOI 10.1016/j.immuni.2012.06.021; Kuczma M, 2009, J IMMUNOL, V183, P3731, DOI 10.4049/jimmunol.0800601; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee CH, 2007, ANNU REV PHARMACOL, V47, P443, DOI 10.1146/annurev.pharmtox.47.120505.105359; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2014, NAT REV IMMUNOL, V14, P435, DOI 10.1038/nri3701; Powell JD, 2013, COLD SH Q B, V78, P125, DOI 10.1101/sqb.2013.78.020214; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Qiao GL, 2013, J IMMUNOL, V191, P632, DOI 10.4049/jimmunol.1202068; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Sauer S, 2008, P NATL ACAD SCI US; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; van der Windt GJW, 2013, P NATL ACAD SCI USA, V110, P14336, DOI 10.1073/pnas.1221740110; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Waickman AT, 2012, J IMMUNOL, V188, P4721, DOI 10.4049/jimmunol.1103143; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; YAMAGATA K, 1994, J BIOL CHEM, V269, P16333; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zhang LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030592; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	49	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121710	10.1371/journal.pone.0121710	http://dx.doi.org/10.1371/journal.pone.0121710			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849206	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800073
J	Vitorino, HA; Mantovanelli, L; Zanotto, FP; Esposito, BP				Vitorino, Hector Aguilar; Mantovanelli, Luca; Zanotto, Flavia Pinheiro; Esposito, Breno Pannia			Iron Metallodrugs: Stability, Redox Activity and Toxicity against Artemia salina	PLOS ONE			English	Article							3 AGE CLASSES; IN-VITRO; IRON(III) COMPLEXES; TMH-FERROCENE; LABILE IRON; BOUND-IRON; METALS; LARVAE; (3,5,5-TRIMETHYLHEXANOYL)FERROCENE; BIOAVAILABILITY	Iron metallodrugs comprise mineral supplements, anti-hypertensive agents and, more recently, magnetic nanomaterials, with both therapeutic and diagnostic roles. As biologically-active metal compounds, concern has been raised regarding the impact of these compounds when emitted to the environment and associated ecotoxicological effects for the fauna. In this work we assessed the relative stability of several iron compounds (supplements based on glucoheptonate, dextran or glycinate, as well as 3,5,5-trimethylhexanoyl (TMH) derivatives of ferrocene) against high affinity models of biological binding, calcein and aprotransferrin, via a fluorimetric method. Also, the redox-activity of each compound was determined in a physiologically relevant medium. Toxicity toward Artemia salina at different developmental stages was measured, as well as the amount of lipid peroxidation. Our results show that polymer-coated iron metallodrugs are stable, non-redox-active and non-toxic at the concentrations studied (up to 300 mu M). However, TMH derivatives of ferrocene were less stable and more redox-active than the parent compound, and TMH-ferrocene displayed toxicity and lipid peroxidation to A. salina, unlike the other compounds. Our results indicate that iron metallodrugs based on polymer coating do not present direct toxicity at low levels of emission; however other iron species (eg. metallocenes), may be deleterious for aquatic organisms. We suggest that ecotoxicity depends more on metal speciation than on the total amount of metal present in the metallodrugs. Future studies with discarded metallodrugs should consider the chemical speciation of the metal present in the composition of the drug.	[Vitorino, Hector Aguilar; Esposito, Breno Pannia] Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil; [Mantovanelli, Luca; Zanotto, Flavia Pinheiro] Univ Sao Paulo, Inst Biociencias, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Esposito, BP (corresponding author), Univ Sao Paulo, Inst Quim, Sao Paulo, Brazil.	breno@iq.usp.br	ZANOTTO, FLAVIA P/D-4620-2012; Vitorino, Hector Aguilar/T-5780-2019; Pannia Esposito, Breno/B-7136-2008	Vitorino, Hector Aguilar/0000-0002-6891-0524; PINHEIRO ZANOTTO, FLAVIA/0000-0001-5941-0432; Pannia Esposito, Breno/0000-0002-1447-435X	Coordination for the Improvement of Higher Education Personnel, Brazil; Sao Paulo Research Foundation, Brazil [2011/50318-1]	Coordination for the Improvement of Higher Education Personnel, Brazil; Sao Paulo Research Foundation, Brazil	HAV received a PhD grant from Coordination for the Improvement of Higher Education Personnel, Brazil. This work was funded by Sao Paulo Research Foundation, Brazil (2011/50318-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Bari M Abdul Alim, 2007, Pak J Biol Sci, V10, P2423, DOI 10.3923/pjbs.2007.2423.2429; Ali AA, 2011, CHAOS SOLITON FRACT, V44, P306, DOI 10.1016/j.chaos.2011.02.007; Ashtari K, 2012, INT J BIOL MACROMOL, V50, P1063, DOI 10.1016/j.ijbiomac.2011.12.025; Barahona MV, 1996, B ENVIRON CONTAM TOX, V56, P271, DOI 10.1007/s001289900041; Biot C, 1997, J MED CHEM, V40, P3715, DOI 10.1021/jm970401y; Bound JP, 2006, ENVIRON TOXICOL PHAR, V21, P301, DOI 10.1016/j.etap.2005.09.006; BREUER W, 1995, AM J PHYSIOL-CELL PH, V268, pC1354, DOI 10.1152/ajpcell.1995.268.6.C1354; Breuer W, 2001, ANAL BIOCHEM, V299, P194, DOI 10.1006/abio.2001.5378; Carland M, 2005, METALLOTHERAPEUTIC D, P313, DOI 10.1002/0470864052; Silva TD, 2009, J COORD CHEM, V62, P958, DOI 10.1080/00958970802385845; Esposito BP, 2002, EUR J CLIN INVEST, V32, P42, DOI 10.1046/j.1365-2362.2002.0320s1042.x; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Esposito BP, 2002, ANAL BIOCHEM, V304, P1, DOI 10.1006/abio.2002.5611; Eybl V, 2002, TOXICOL LETT, V128, P169, DOI 10.1016/S0378-4274(01)00541-0; Fraga Cesar G., 2005, Molecular Aspects of Medicine, V26, P235, DOI 10.1016/j.mam.2005.07.013; Gambardella C, 2014, ENVIRON MONIT ASSESS, V186, P4249, DOI 10.1007/s10661-014-3695-8; Graminha AE, 2008, POLYHEDRON, V27, P547, DOI 10.1016/j.poly.2007.10.008; Heilmann JB, 2008, J ORGANOMET CHEM, V693, P1716, DOI 10.1016/j.jorganchem.2007.12.011; HERMESLIMA M, 1995, FREE RADICAL BIO MED, V19, P271, DOI 10.1016/0891-5849(95)00020-X; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Li SH, 2013, BIOMATERIALS, V34, P902, DOI 10.1016/j.biomaterials.2012.10.069; Libralato G, 2014, MAR ENVIRON RES, V101, P38, DOI 10.1016/j.marenvres.2014.08.002; Lykkesfeldt J, 2007, J BIOCHEM MOL TOXIC, V21, P145, DOI 10.1002/jbt.20170; Malecki EA, 2002, BIOL TRACE ELEM RES, V86, P73, DOI 10.1385/BTER:86:1:73; Malecki EA, 1999, FASEB J, V13, pA573; Mizutani K, 2012, BBA-GEN SUBJECTS, V1820, P203, DOI 10.1016/j.bbagen.2011.08.003; Mohamed Azza H., 2014, Canadian Journal of Pure and Applied Sciences, V8, P3019; NIELSEN P, 1993, INT J BIOCHEM, V25, P223, DOI 10.1016/0020-711X(93)90010-C; NIELSEN P, 1993, BIOCHEM PHARMACOL, V45, P385, DOI 10.1016/0006-2952(93)90074-7; Robb SJ, 1998, BRAIN RES, V788, P125, DOI 10.1016/S0006-8993(97)01543-6; Ronconi L, 2007, COORDIN CHEM REV, V251, P1633, DOI 10.1016/j.ccr.2006.11.017; SanchezFortun S, 1997, B ENVIRON CONTAM TOX, V59, P445, DOI 10.1007/s001289900498; Slaveykova VI, 2005, ENVIRON CHEM, V2, P9, DOI 10.1071/EN04076; STRAHM U, 1979, J PHYS CHEM-US, V83, P1689, DOI 10.1021/j100476a003; Wade LG., 2002, ORGANIC CHEM; Worms I, 2006, BIOCHIMIE, V88, P1721, DOI 10.1016/j.biochi.2006.09.008; Wu X., 2005, METALLOTHERAPEUTIC D, P179	37	20	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121997	10.1371/journal.pone.0121997	http://dx.doi.org/10.1371/journal.pone.0121997			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849743	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800091
J	Ye, CX; Zhao, W; Li, MH; Zhuang, JL; Yan, X; Lu, Q; Chang, CJ; Huang, XJ; Zhou, J; Xie, BX; Zhang, Z; Yao, X; Yan, J; Guo, HQ				Ye, Changxiao; Zhao, Wei; Li, Minghui; Zhuang, Junlong; Yan, Xiang; Lu, Qun; Chang, Cunjie; Huang, Xiaojing; Zhou, Ji; Xie, Bingxian; Zhang, Zhen; Yao, Xin; Yan, Jun; Guo, Hongqian			delta-Tocotrienol Induces Human Bladder Cancer Cell Growth Arrest, Apoptosis and Chemosensitization through Inhibition of STAT3 Pathway	PLOS ONE			English	Article							VITAMIN-E; TYROSINE KINASE; SIGNALING PATHWAY; TUMOR ANGIOGENESIS; GAMMA-TOCOTRIENOL; STEM-CELLS; ACTIVATION; INDUCTION; CARCINOMA; RISK	Vitamin E intake has been implicated in reduction of bladder cancer risk. However, the mechanisms remain elusive. Here we reported that d-tocotrienol (delta-T3), one of vitamin E isomers, possessed the most potent cytotoxic capacity against human bladder cancer cells, compared with other Vitamin E isomers. delta-T3 inhibited cancer cell proliferation and colonogenicity through induction of G1 phase arrest and apoptosis. Western blotting assay revealed that delta-T3 increased the expression levels of cell cycle inhibitors (p21, p27), proapoptotic protein (Bax) and suppressed expression levels of cell cycle protein (Cyclin D1), anti-apoptotic proteins (Bcl-2, Bcl-xL and Mcl-1), resulting in the Caspase-3 activation and cleavage of PARP. Moreover, the delta-T3 treatment inhibited ETK phosphorylation level and induced SHP-1 expression, which was correlated with downregulation of STAT3 activation. In line with this, delta-T3 reduced the STAT3 protein level in nuclear fraction, as well as its transcription activity. Knockdown of SHP-1 partially reversed delta-T3-induced cell growth arrest. Importantly, low dose of delta-T3 sensitized Gemcitabine-induced cytotoxic effects on human bladder cancer cells. Overall, our findings demonstrated, for the first time, the cytotoxic effects of delta-T3 on bladder cancer cells and suggest that delta-T3 might be a promising chemosensitization reagent for Gemcitabine in bladder cancer treatment.	[Ye, Changxiao; Zhao, Wei; Chang, Cunjie; Huang, Xiaojing; Xie, Bingxian; Yan, Jun] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China; [Ye, Changxiao; Li, Minghui; Zhuang, Junlong; Yan, Xiang; Lu, Qun; Guo, Hongqian] Nanjing Univ, Nanjing Drum Tower Hosp, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Guo, Hongqian] Nanjing Urol Res Ctr, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Ji; Yao, Xin] Nanjing Med Univ, Affiliated Hosp 1, Dept Resp Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhang, Zhen] Wenzhou Med Coll, Sch Life Sci, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou 325035, Zhejiang, Peoples R China	Nanjing University; Nanjing University; Nanjing Medical University; Wenzhou Medical University	Yan, J (corresponding author), Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China.	yanjun@nicemice.cn; dr.ghq@163.com	Xie, Bingxian/Y-6487-2019; Zhao, Wei/AAC-6849-2020; Yan, Jun/Q-3031-2017	Zhao, Wei/0000-0003-2421-7311; Yan, Jun/0000-0002-1303-1952	Ministry of Science and Technology of the People's Republic of China [2011CB944104]; National Natural Science Foundation of China [81172009, 81372168]; Doctoral Fund of Ministry of Education of China [20110091120028]	Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China)	This work was supported by Ministry of Science and Technology of the People's Republic of China (2011CB944104), the National Natural Science Foundation of China (81172009, 81372168), Doctoral Fund of Ministry of Education of China (20110091120028) to Dr. J. Yan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043; Brinkman MT, 2010, CANCER CAUSE CONTROL, V21, P609, DOI 10.1007/s10552-009-9490-0; Castillo-Martin M, 2010, UROL ONCOL-SEMIN ORI, V28, P401, DOI 10.1016/j.urolonc.2009.04.019; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; Chen CL, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-78; Dong YM, 2010, CARCINOGENESIS, V31, P2097, DOI 10.1093/carcin/bgq167; Guo SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017778; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Ho PL, 2012, CANCER RES, V72, P3135, DOI 10.1158/0008-5472.CAN-11-3195; Holopainen T, 2012, CANCER RES, V72, P3512, DOI 10.1158/0008-5472.CAN-11-1070; Husain K, 2011, MOL CANCER THER, V10, P2363, DOI 10.1158/1535-7163.MCT-11-0424; Itoh M, 2006, ONCOGENE, V25, P1195, DOI 10.1038/sj.onc.1209149; Ji XM, 2011, J CELL BIOCHEM, V112, P2773, DOI 10.1002/jcb.23184; Jiang XN, 2007, J BIOL CHEM, V282, P32689, DOI 10.1074/jbc.M703412200; Kanai K, 2010, CANCER SCI, V101, P216, DOI 10.1111/j.1349-7006.2009.01362.x; Kannappan R, 2012, GENES NUTR, V7, P43, DOI 10.1007/s12263-011-0220-3; Kannappan R, 2010, J BIOL CHEM, V285, P33520, DOI 10.1074/jbc.M110.158378; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Michaud DS, 2002, BRIT J CANCER, V87, P960, DOI 10.1038/sj.bjc.6600604; Miyazawa T, 2009, J NUTR BIOCHEM, V20, P79, DOI 10.1016/j.jnutbio.2008.09.003; Neri B, 2002, ANTICANCER RES, V22, P2981; Oka T, 2002, CANCER RES, V62, P6390; Pathania AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110411; Pierpaoli E, 2010, LIFE SCI, V86, P668, DOI 10.1016/j.lfs.2010.02.018; Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x; Sen CK, 2007, VITAM HORM, V76, P203, DOI 10.1016/S0083-6729(07)76008-9; Shin-Kang S, 2011, FREE RADICAL BIO MED, V51, P1164, DOI 10.1016/j.freeradbiomed.2011.06.008; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Siveen KS, 2014, BBA-REV CANCER, V1845, P136, DOI 10.1016/j.bbcan.2013.12.005; Svatek RS, 2014, EUR UROL, V66, P253, DOI 10.1016/j.eururo.2014.01.006; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Xiong AL, 2014, CANCERS, V6, P926, DOI 10.3390/cancers6020926; Yafi FA, 2011, CURR ONCOL, V18, pE25; Yap WN, 2010, CANCER LETT, V291, P187, DOI 10.1016/j.canlet.2009.10.012; Yeung C, 2014, PHARMACOECONOMICS, V32, P1093, DOI 10.1007/s40273-014-0194-2; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang JS, 2011, TOXICOLOGY, V285, P8, DOI 10.1016/j.tox.2011.03.011	38	24	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122712	10.1371/journal.pone.0122712	http://dx.doi.org/10.1371/journal.pone.0122712			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849286	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800157
J	van der Logt, EMJ; Kuperus, DAJ; van Setten, JW; van den Heuvel, MC; Boers, JE; Schuuring, E; Kibbelaar, RE				van der Logt, Elise M. J.; Kuperus, Deborah A. J.; van Setten, Jan W.; van den Heuvel, Marius C.; Boers, James. E.; Schuuring, Ed; Kibbelaar, Robby E.			Fully Automated Fluorescent in situ Hybridization (FISH) Staining and Digital Analysis of HER2 in Breast Cancer: A Validation Study	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; AMPLIFICATION; TUMORIGENESIS; CHEMOTHERAPY; EXPRESSION; EFFICACY; SAFETY	HER2 assessment is routinely used to select patients with invasive breast cancer that might benefit from HER2-targeted therapy. The aim of this study was to validate a fully automated in situ hybridization (ISH) procedure that combines the automated Leica HER2 fluorescent ISH system for Bond with supervised automated analysis with the Visia imaging D-Sight digital imaging platform. HER2 assessment was performed on 328 formalin-fixed/paraffin-embedded invasive breast cancer tumors on tissue microarrays (TMA) and 100 (50 selected IHC 2+ and 50 random IHC scores) full-sized slides of resections/biopsies obtained for diagnostic purposes previously. For digital analysis slides were pre-screened at 20x and 100x magnification for all fluorescent signals and supervised-automated scoring was performed on at least two pictures (in total at least 20 nuclei were counted) with the D-Sight HER2 FISH analysis module by two observers independently. Results were compared to data obtained previously with the manual Abbott FISH test. The overall agreement with Abbott FISH data among TMA samples and 50 selected IHC 2+ cases was 98.8% (kappa = 0.94) and 93.8% (kappa = 0.88), respectively. The results of 50 additionally tested unselected IHC cases were concordant with previously obtained IHC and/or FISH data. The combination of the Leica FISH system with the D-Sight digital imaging platform is a feasible method for HER2 assessment in routine clinical practice for patients with invasive breast cancer.	[van der Logt, Elise M. J.; Kuperus, Deborah A. J.; van Setten, Jan W.; van den Heuvel, Marius C.; Kibbelaar, Robby E.] Dept Pathol Pathol Friesland, Leeuwarden, Netherlands; [van der Logt, Elise M. J.; Schuuring, Ed] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [Boers, James. E.] Isala Klin, Dept Pathol, Zwolle, Netherlands	University of Groningen; Isala Clinics	van der Logt, EMJ (corresponding author), Dept Pathol Pathol Friesland, Leeuwarden, Netherlands.	e.van.der.logt@pathologiefriesland.nl						Baasner S, 1996, ONCOGENE, V13, P901; Baselga J, 1998, CANCER RES, V58, P2825; Boers J, 2012, VIRCHOWS ARCH, V461, pS236; Brugmann A, 2011, APPL IMMUNOHISTO M M, V19, P203, DOI 10.1097/PAI.0b013e3181f7118e; Cobleigh MA, 1999, J CLIN ONCOL, V17, P2639, DOI 10.1200/JCO.1999.17.9.2639; Dekker TJA, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3208; Del Bimbo A., 2010, 2010 IEEE International Conference on Imaging Systems and Techniques (IST 2010), P407, DOI 10.1109/IST.2010.5548461; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Furrer D, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-17; Goddard KAB, 2012, AM J MANAG CARE, V18, P704; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HUDZIAK RM, 1987, P NATL ACAD SCI USA, V84, P7159, DOI 10.1073/pnas.84.20.7159; Konsti J, 2008, J CLIN PATHOL, V61, P278, DOI 10.1136/jcp.2007.048991; Moelans CB, 2010, CELL ONCOL, V32, P149, DOI 10.3233/CLO-2010-0514; Moerland E, 2006, CELL ONCOL, V28, P151; Netten H, 1997, CYTOMETRY, V28, P1; Nitta H, 2008, DIAGN PATHOL, V3, DOI 10.1186/1746-1596-3-41; Ohlschlegel C, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-13; Owens Marilyn A, 2004, Clin Breast Cancer, V5, P63, DOI 10.3816/CBC.2004.n.011; Pajor G, 2012, CYTOM PART A, V81A, P649, DOI 10.1002/cyto.a.22082; Perez EA, 2014, CANCER TREAT REV, V40, P276, DOI 10.1016/j.ctrv.2013.09.001; Press MF, 1997, J CLIN ONCOL, V15, P2894, DOI 10.1200/JCO.1997.15.8.2894; Sjogren S, 1998, J CLIN ONCOL, V16, P462; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Theodosiou Z, 2008, BREAST, V17, P80, DOI 10.1016/j.breast.2007.07.041; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yaziji H, 2004, JAMA-J AM MED ASSOC, V291, P1972, DOI 10.1001/jama.291.16.1972	30	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123201	10.1371/journal.pone.0123201	http://dx.doi.org/10.1371/journal.pone.0123201			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844540	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700020
J	Sodring, M; Oostindjer, M; Egelandsdal, B; Paulsen, JE				Sodring, Marianne; Oostindjer, Marije; Egelandsdal, Bjorg; Paulsen, Jan Erik			Effects of Hemin and Nitrite on Intestinal Tumorigenesis in the A/J Min/ plus Mouse Model	PLOS ONE			English	Article							ABERRANT CRYPT FOCI; COLON-CANCER; RED MEAT; DIETARY HEME; LIPID-PEROXIDATION; COLORECTAL-CANCER; SIGNAL-TRANSDUCTION; PROCESSED MEAT; IRON; APC	Red and processed meats are considered risk factors for colorectal cancer (CRC); however, the underlying mechanisms are still unclear. One cause for the potential link between CRC and meat is the heme iron in red meat. Two pathways by which heme and CRC promotion may be linked have been suggested: fat peroxidation and N-nitrosation. In the present work we have used the novel A/J Min/+ mouse model to test the effects of dietary hemin (a model of red meat), and hemin in combination with nitrite (a model of processed meat) on intestinal tumorigenesis. Mice were fed a low Ca2+ and vitamin D semi-synthetic diet with added hemin and/or nitrite for 8 weeks post weaning, before termination followed by excision and examination of the intestinal tract. Our results indicate that dietary hemin decreased the number of colonic lesions in the A/J Min/+ mouse. However, our results also showed that the opposite occurred in the small intestine, where dietary hemin appeared to stimulate tumor growth. Furthermore, we find that nitrite, which did not have an effect in the colon, appeared to have a suppressive effect on tumor growth in the small intestine.	[Sodring, Marianne; Paulsen, Jan Erik] Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, N-0033 Oslo, Norway; [Oostindjer, Marije; Egelandsdal, Bjorg] Norwegian Univ Life Sci, Dept Chem Biotechnol & Food Sci, N-1432 As, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences	Sodring, M (corresponding author), Norwegian Univ Life Sci, Dept Food Safety & Infect Biol, POB 8146 Dep, N-0033 Oslo, Norway.	marianne.sodring@nmbu.no		Sodring, Marianne/0000-0003-0236-8549; Oostindjer, Marije/0000-0002-0997-0041				Barnes CJ, 1998, GASTROENTEROLOGY, V114, P873, DOI 10.1016/S0016-5085(98)70305-1; Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chen FP, 2013, NUTR CANCER, V65, P195, DOI 10.1080/01635581.2013.756532; Chin J, 1997, NUTR RES, V17, P1381, DOI 10.1016/S0271-5317(97)00121-8; Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009; Cross AJ, 2003, CANCER RES, V63, P2358; de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331; de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278; Demeyer D, 2014, CRIT REV FO IN PRESS; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Fearnhead NS, 2001, ABC APC HUM MOL GENE, P10; Ferlay J, 2013, IARC CANCERBASE; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fodde R, 2001, TRENDS MOL MED, V7, P369, DOI 10.1016/S1471-4914(01)02050-0; Fodde R, 2010, J PATHOL, V221, P239, DOI 10.1002/path.2718; Half E, 2009, ORPHANET J RARE DIS, V4, DOI 10.1186/1750-1172-4-22; IGNARRO LJ, 1990, HYPERTENSION, V16, P477, DOI 10.1161/01.HYP.16.5.477; Ijssennagger N, 2013, CARCINOGENESIS, V34, P1628, DOI 10.1093/carcin/bgt084; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; IJssennagger N, 2012, GUT, V61, P1041, DOI 10.1136/gutjnl-2011-300239; Ilyas M, 1999, EUR J CANCER, V35, P335, DOI 10.1016/S0959-8049(98)00431-6; Jacoby RF, 1996, CANCER RES, V56, P710; Kanner J, 2007, MOL NUTR FOOD RES, V51, P1094, DOI 10.1002/mnfr.200600303; Kelloff GJ, 2004, CLIN CANCER RES, V10, P3908, DOI 10.1158/1078-0432.CCR-03-0789; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Lai C, 1997, CANCER LETT, V112, P87, DOI 10.1016/S0304-3835(96)04549-1; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Olstorn HB., 2009, EFFECT ACRYLAMIDE GL; Oostindjer M, 2014, MEAT SCI, V97, P583, DOI 10.1016/j.meatsci.2014.02.011; Paulsen JE, 2005, CANCER RES, V65, P121; Paulsen JE, 2001, CANCER RES, V61, P5010; Paulsen JE, 2000, TOXICOL LETT, V112, P403, DOI 10.1016/S0378-4274(99)00262-3; PENCE BC, 1995, CARCINOGENESIS, V16, P1157, DOI 10.1093/carcin/16.5.1157; Petersson J, 2007, AM J PHYSIOL-GASTR L, V292, pG718, DOI 10.1152/ajpgi.00435.2006; Pierre F, 2007, CARCINOGENESIS, V28, P321, DOI 10.1093/carcin/bgl127; Pierre F, 2003, CARCINOGENESIS, V24, P1683, DOI 10.1093/carcin/bgg130; Radulescu S, 2012, CELL REP, V2, P270, DOI 10.1016/j.celrep.2012.07.003; Reeves P G, 1997, J Nutr, V127, p838S, DOI 10.1093/jn/127.5.838S; Rimbach G, 1997, J TRACE ELEM MED BIO, V11, P99, DOI 10.1016/S0946-672X(97)80033-8; Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872; Sawa T, 1998, CANCER EPIDEM BIOMAR, V7, P1007; Sesink ALA, 1999, CANCER RES, V59, P5704; Sesink ALA, 2000, CARCINOGENESIS, V21, P1909, DOI 10.1093/carcin/21.10.1909; Stimson J, 1997, NUTR RES, V17, P1683, DOI 10.1016/S0271-5317(97)00175-9; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Svendsen C, 2012, LAB ANIM-UK, V46, P207, DOI 10.1258/la.2012.011055; Taketo MM, 2009, GASTROENTEROLOGY, V136, P780, DOI 10.1053/j.gastro.2008.12.049; van Es JH, 2001, EXP CELL RES, V264, P126, DOI 10.1006/excr.2000.5142; Van Hecke T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101122; Weitzberg E, 2013, ANNU REV NUTR, V33, P129, DOI 10.1146/annurev-nutr-071812-161159; Winter J, 2014, MOL NUTR FOOD RES, V58, P550, DOI 10.1002/mnfr.201300430; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Wu D, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/436307; Xue X, 2012, CANCER RES, V72, P2285, DOI 10.1158/0008-5472.CAN-11-3836; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	57	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122880	10.1371/journal.pone.0122880	http://dx.doi.org/10.1371/journal.pone.0122880			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836260	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000352139000116
J	Edukulla, R; Singh, B; Jegga, AG; Sontake, V; Dillon, SR; Madala, SK				Edukulla, Ramakrishna; Singh, Brijendra; Jegga, Anil G.; Sontake, Vishwaraj; Dillon, Stacey R.; Madala, Satish K.			Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELLS; EPIDERMAL-KERATINOCYTES; SCRATCHING BEHAVIOR; SIGNAL-TRANSDUCTION; IL-4 RECEPTOR; NC/NGA MICE; INTERLEUKIN-31; STAT6; ACTIVATION; RESPONSIVENESS	Interleukin 31 receptor alpha(IL-31RA) is a novel Type I cytokine receptor that pairs with oncostatin M receptor to mediate IL-31 signaling. Binding of IL-31 to its receptor results in the phosphorylation and activation of STATs, MAPK, and JNK signaling pathways. IL-31 plays a pathogenic role in tissue inflammation, particularly in allergic diseases. Recent studies demonstrate IL-31RA expression and signaling in non-hematopoietic cells, but this receptor is poorly studied in immune cells. Macrophages are key immune-effector cells that play a critical role in Th2-cytokine-mediated allergic diseases. Here, we demonstrate that Th2 cytokines IL-4 and IL-13 are capable of up-regulating IL-31RA expression on both peritoneal and bone marrow-derived macrophages from mice. Our data also demonstrate that IL-4R alpha-driven IL-31RA expression is STAT6 dependent in macrophages. Notably, the inflammation-associated genes Fizz1 and serum amyloid A (SAA) are significantly up-regulated in M2 macrophages stimulated with IL-31, but not in IL-4 receptor-deficient macrophages. Furthermore, the absence of Type II IL-4 receptor signaling is sufficient to attenuate the expression of IL-31RA in vivo during allergic asthma induced by soluble egg antigen, which may suggest a role for IL-31 signaling in Th2 cytokine-driven inflammation and allergic responses. Our study reveals an important counter-regulatory role between Th2 cytokine and IL-31 signaling involved in allergic diseases.	[Edukulla, Ramakrishna; Singh, Brijendra; Sontake, Vishwaraj; Madala, Satish K.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Med, Cincinnati, OH 45229 USA; [Jegga, Anil G.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Madala, Satish K.] ZymoGenetics Inc, Seattle, WA 98102 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Zymogenet Inc.	Madala, SK (corresponding author), MLC 2021 3333 Burnet Ave, Cincinnati, OH 45229 USA.	satish.madala@cchmc.org	Singh, Brijendra/AAQ-2550-2020; Jegga, Anil/H-6140-2011; Sontake, Vishwaraj/ABD-7278-2020; Regan, Clinton/E-6250-2012	Jegga, Anil/0000-0002-4881-7752; Sontake, Vishwaraj/0000-0002-8532-7680; Singh, Brijendra/0000-0002-0113-4831	National Institutes of Health [1R03AR062832]; Parker B. Francis Fellowship; American Heart Association [12SDG9130040]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR062832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R03AR062832 (to S. K. M.), a Parker B. Francis Fellowship (to S. K. M.), and American Heart Association Grant 12SDG9130040 (to S. K. M.). S. R. Dillon is an employee and stockholder of Bristol-Myers Squibb. None of the remaining authors have a financial relationship with a commercial entity that has an interest in the subject of this manuscript.	[Anonymous], 2005, APPL PHYS REV, V97, P1; Bilsborough J, 2006, J ALLERGY CLIN IMMUN, V117, P418, DOI 10.1016/j.jaci.2005.10.046; Bilsborough J, 2010, J IMMUNOL, V185, P6023, DOI 10.4049/jimmunol.0902769; Brandt Eric B, 2011, J Clin Cell Immunol, V2; Chattopadhyay S, 2007, J BIOL CHEM, V282, P3014, DOI 10.1074/jbc.M609655200; Cheung PFY, 2010, INT IMMUNOL, V22, P453, DOI 10.1093/intimm/dxq027; Cornelissen C, 2012, EUR J CELL BIOL, V91, P552, DOI 10.1016/j.ejcb.2011.07.006; Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084; Gonzales AJ, 2013, VET DERMATOL, V24, P48, DOI 10.1111/j.1365-3164.2012.01098.x; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Grimstad O, 2009, EXP DERMATOL, V18, P35, DOI 10.1111/j.1600-0625.2008.00766.x; Heise R, 2009, J INVEST DERMATOL, V129, P240, DOI 10.1038/jid.2008.183; Heller NM, 2004, AM J RESP CELL MOL, V31, P573, DOI 10.1165/rcmb.2004-0195OC; Horejs-Hoeck J, 2012, J IMMUNOL, V188, P5319, DOI 10.4049/jimmunol.1101044; Ip WK, 2007, IMMUNOLOGY, V122, P532, DOI 10.1111/j.1365-2567.2007.02668.x; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Kasraie S, 2010, ALLERGY, V65, P712, DOI 10.1111/j.1398-9995.2009.02255.x; Kawakami K, 2001, BLOOD, V97, P2673, DOI 10.1182/blood.V97.9.2673; Kuperman DA, 2005, J IMMUNOL, V175, P3746, DOI 10.4049/jimmunol.175.6.3746; Madala SK, 2010, J IMMUNOL, V184, P3955, DOI 10.4049/jimmunol.0903008; Maier E, 2014, TLS-TIMES LIT SUPPL, P6; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Moynihan BJ, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-84; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Neis MM, 2006, J ALLERGY CLIN IMMUN, V118, P930, DOI 10.1016/j.jaci.2006.07.015; Nobbe S, 2012, ACTA DERM-VENEREOL, V92, P24, DOI 10.2340/00015555-1191; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Rabenhorst A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-014-0423-y; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sonkoly E, 2006, J ALLERGY CLIN IMMUN, V117, P411, DOI 10.1016/j.jaci.2005.10.033; Takaoka A, 2006, EXP DERMATOL, V15, P161, DOI 10.1111/j.1600-0625.2006.00405.x; Takeda K, 1996, NATURE, V380, P627, DOI 10.1038/380627a0; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Wilson MS, 2007, J CLIN INVEST, V117, P2941, DOI 10.1172/JCI31546; Zhang Q, 2008, CYTOKINE GROWTH F R, V19, P347, DOI 10.1016/j.cytogfr.2008.08.003	40	28	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13510	13520		10.1074/jbc.M114.622126	http://dx.doi.org/10.1074/jbc.M114.622126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847241	Green Published, hybrid			2022-12-26	WOS:000354975700045
J	Petropoulos, IN; Green, P; Chan, AWS; Alam, U; Fadavi, H; Marshall, A; Asghar, O; Efron, N; Tavakoli, M; Malik, RA				Petropoulos, Ioannis N.; Green, Patrick; Chan, Agnes W. S.; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Efron, Nathan; Tavakoli, Mitra; Malik, Rayaz A.			Corneal Confocal Microscopy Detects Neuropathy in Patients with Type 1 Diabetes without Retinopathy or Microalbuminuria	PLOS ONE			English	Article							NERVE-FIBER DAMAGE; PERIPHERAL NEUROPATHY; PREVALENCE; RISK; POLYNEUROPATHY; COMPLICATIONS; NEPHROPATHY; PROGRESSION; SURROGATE; SEVERITY	Objective Corneal innervation is increasingly used as a surrogate marker of human diabetic peripheral neuropathy (DPN) however its temporal relationship with the other microvascular complications of diabetes is not fully established. In this cross-sectional, observational study we aimed to assess whether neuropathy occurred in patients with type 1 diabetes, without retinopathy or microalbuminuria. Materials and Methods All participants underwent detailed assessment of peripheral neuropathy [neuropathy disability score (NDS), vibration perception threshold (VPT), peroneal motor nerve conduction velocity (PMNCV), sural sensory nerve conduction velocity (SSNCV) and in vivo corneal confocal microscopy (IVCCM)], retinopathy (digital fundus photography) and albuminuria status [albumin: creatinine ratio (ACR)]. Results 53 patients with Type 1 diabetes with (n=37) and without retinopathy (n= 16) were compared to control subjects (n=27). SSNCV, corneal nerve fibre (CNFD) and branch (CNBD) density and length (CNFL) were reduced significantly (p<0.001) in diabetic patients without retinopathy compared to control subjects. Furthermore, CNFD, CNBD and CNFL were also significantly (p<0.001) reduced in diabetic patients without microalbuminuria (n=39), compared to control subjects. Greater neuropathic severity was associated with established retinopathy and microalbuminuria. Conclusions IVCCM detects early small fibre damage in the absence of retinopathy or microalbuminuria in patients with Type 1 diabetes.	[Petropoulos, Ioannis N.; Green, Patrick; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Tavakoli, Mitra; Malik, Rayaz A.] Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester, Lancs, England; [Petropoulos, Ioannis N.; Green, Patrick; Alam, Uazman; Fadavi, Hassan; Marshall, Andrew; Asghar, Omar; Tavakoli, Mitra; Malik, Rayaz A.] Manchester Acad Hlth Sci Ctr, Cent Manchester Natl Hlth Syst Fdn Trust, Manchester, Lancs, England; [Petropoulos, Ioannis N.; Malik, Rayaz A.] Qatar Fdn, Weill Cornell Med Coll Qatar, Div Res, Doha, Qatar; [Chan, Agnes W. S.] Queen Marys Univ, Barts & London Natl Hlth Syst Trust, London, England; [Efron, Nathan] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4001, Australia; [Efron, Nathan] Queensland Univ Technol, Sch Optometry & Vis Sci, Brisbane, Qld 4001, Australia	University of Manchester; University of Manchester; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Barts Health NHS Trust; University of London; Queen Mary University London; Queensland University of Technology (QUT); Queensland University of Technology (QUT)	Malik, RA (corresponding author), Univ Manchester, Ctr Endocrinol & Diabet, Inst Human Dev, Manchester, Lancs, England.	ram2045@qatar-med.cornell.edu	Efron, Nathan/I-9766-2012; Green, Patrick/AAD-7594-2020; Malik, Rayaz/H-9231-2019; Marshall, Andrew/AAE-5203-2019; Alam, Uazman/I-9173-2019; Tavakoli, Mitra/F-6707-2011; TAVAKOLI, MITRA/N-1402-2016	Efron, Nathan/0000-0002-7037-779X; Malik, Rayaz/0000-0002-7188-8903; Alam, Uazman/0000-0002-3190-1122; TAVAKOLI, MITRA/0000-0003-2319-1543; Green, Patrick/0000-0002-4805-7298	National Institutes of Health [R105991]; Juvenile Diabetes Research Foundation International [27-2008-362]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation)	This study was sponsored by awards from the National Institutes of Health, grant number R105991 (http://www.nih.gov/) and the Juvenile Diabetes Research Foundation International, grant number 27-2008-362 (http://www.jdrf.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2012, CLIN EXP OPTOM, V95, P256, DOI 10.1111/j.1444-0938.2012.00733.x; Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Ahmed A, 2012, DIABETES CARE, V35, P821, DOI 10.2337/dc11-1396; [Anonymous], 1981, INVEST OPHTH VIS SCI, V21, P210; Bitirgen G, 2014, DIABETIC MED, V31, P431, DOI 10.1111/dme.12324; Candrilli SD, 2007, J DIABETES COMPLICAT, V21, P306, DOI 10.1016/j.jdiacomp.2006.08.002; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; Dyck PJ, 1999, DIABETES CARE, V22, P1479, DOI 10.2337/diacare.22.9.1479; Edwards K, 2012, CLIN EXP OPTOM, V95, P348, DOI 10.1111/j.1444-0938.2012.00740.x; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Grunwald JE, 2012, ARCH OPHTHALMOL-CHIC, V130, P1136, DOI 10.1001/archophthalmol.2012.1800; Ishibashi F, 2012, J DIABETES INVEST, V3, P191, DOI 10.1111/j.2040-1124.2011.00157.x; Kohner EM, 1998, ARCH OPHTHALMOL-CHIC, V116, P297, DOI 10.1001/archopht.116.3.297; KROLEWSKI AS, 1992, DIABETES, V41, P430, DOI 10.2337/diabetes.41.4.430; Lorenzi M, 2010, INVEST OPHTH VIS SCI, V51, P6770, DOI 10.1167/iovs.10-5785; Lovestam-Adrian M, 1999, DIABETES RES CLIN PR, V45, P15, DOI 10.1016/S0168-8227(99)00055-8; Malik RA, 2003, DIABETOLOGIA, V46, P683, DOI 10.1007/s00125-003-1086-8; Nitoda E, 2012, CURR EYE RES, V37, P898, DOI 10.3109/02713683.2012.683507; Petropoulos IN, 2013, CORNEA, V32, pE83, DOI 10.1097/ICO.0b013e3182749419; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Ra H, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-29; RASSAM SMB, 1995, EXP PHYSIOL, V80, P53, DOI 10.1113/expphysiol.1995.sp003834; Sampson G, 2012, DIABETOLOGIA, V1-7, DOI [10.1007/s00125-012-2694-y, DOI 10.1007/S00125-012-2694-Y]; Shahidi AM, 2012, DIABETIC MED, V29, pE106, DOI 10.1111/j.1464-5491.2012.03588.x; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tavakoli M, 2010, DIABETES CARE, V33, P1792, DOI 10.2337/dc10-0253; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wu T, 2012, DIABETIC MED, V29, pE297, DOI 10.1111/j.1464-5491.2012.03678.x; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697; Zhivov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052157	31	55	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123517	10.1371/journal.pone.0123517	http://dx.doi.org/10.1371/journal.pone.0123517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853247	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400103
J	Ricigliano, VAG; Handel, AE; Sandve, GK; Annibali, V; Ristori, G; Mechelli, R; Cader, MZ; Salvetti, M				Ricigliano, Vito A. G.; Handel, Adam E.; Sandve, Geir K.; Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Cader, M. Zameel; Salvetti, Marco			EBNA2 Binds to Genomic Intervals Associated with Multiple Sclerosis and Overlaps with Vitamin D Receptor Occupancy	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BACILLE-CALMETTE-GUERIN; LEUKEMIA-CELLS; CHIP-SEQ; HYPERBROWSER; ACTIVATION; GENES; MAP	Epstein-Barr virus (EBV) is a non-heritable factor that associates with multiple sclerosis (MS). However its causal relationship with the disease is still unclear. The virus establishes a complex co-existence with the host that includes regulatory influences on gene expression. Hence, if EBV contributes to the pathogenesis of MS it may do so by interacting with disease predisposing genes. To verify this hypothesis we evaluated EBV nuclear antigen 2 (EBNA2, a protein that recent works by our and other groups have implicated in disease development) binding inside MS associated genomic intervals. We found that EBNA2 binding occurs within MS susceptibility sites more than expected by chance (factor of observed vs expected overlap [O/E] = 5.392-fold, p < 2.0e-05). This remains significant after controlling for multiple genomic confounders. We then asked whether this observation is significant per se or should also be viewed in the context of other disease relevant gene-environment interactions, such as those attributable to vitamin D. We therefore verified the overlap between EBNA2 genomic occupancy and vitamin D receptor (VDR) binding sites. EBNA2 shows a striking overlap with VDR binding sites (O/E = 96.16-fold, p < 2.0e-05), even after controlling for the chromatin accessibility state of shared regions (p < 0.001). Furthermore, MS susceptibility regions are preferentially targeted by both EBNA2 and VDR than by EBNA2 alone (enrichment difference = 1.722-fold, p = 0.0267). Taken together, these findings demonstrate that EBV participates in the gene-environment interactions that predispose to MS.	[Ricigliano, Vito A. G.; Cader, M. Zameel] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Ricigliano, Vito A. G.] IRCCS, Fdn Santa Lucia, Neuroimmunol Unit, Rome, Italy; [Handel, Adam E.] Univ Oxford, Med Res Council Funct Genom Unit, Oxford OX1 3PT, England; [Handel, Adam E.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Handel, Adam E.] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Sandve, Geir K.] Univ Oslo, Dept Informat, Blindern, Norway; [Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Salvetti, Marco] Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies CENTERS, Neurol, I-00185 Rome, Italy; [Annibali, Viviana; Ristori, Giovanni; Mechelli, Rosella; Salvetti, Marco] Univ Roma La Sapienza, Fac Med & Psychol, Dept Neurosci Mental Hlth & Sensory Organs, I-00185 Rome, Italy	University of Oxford; IRCCS Santa Lucia; University of Oxford; University of Oxford; University of Oxford; University of Oslo; Sapienza University Rome; Sapienza University Rome	Mechelli, R (corresponding author), Univ Roma La Sapienza, Fac Med & Psychol, Ctr Expt Neurol Therapies CENTERS, Neurol, I-00185 Rome, Italy.	rosella.mechelli@uniroma1.it	Salvetti, Marco/K-3836-2016; Whelan, Timothy/D-3185-2017; Evans, Diane/F-9258-2017; Mechelli, Rosella/AAB-4967-2022	Whelan, Timothy/0000-0001-9844-2023; Mechelli, Rosella/0000-0001-5842-3100; Handel, Adam/0000-0001-8385-6346; Cader, Zameel/0000-0002-6952-406X; Ricigliano, Vito A. G./0000-0002-8860-3548; Sandve, Geir Kjetil/0000-0002-4959-1409; RISTORI, Giovanni/0000-0002-6598-6777	Oxford Biomedical Research Centre; Fondazione Italiana Sclerosi Multipla [2011/R/31]; National Institute for Health Research [ACF-2011-18-008] Funding Source: researchfish	Oxford Biomedical Research Centre; Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); National Institute for Health Research(National Institute for Health Research (NIHR))	M.Z.C. is supported by Oxford Biomedical Research Centre; M.S. is supported by Fondazione Italiana Sclerosi Multipla (grant number 2011/R/31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almohmeed YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061110; Arvey A, 2012, CELL HOST MICROBE, V12, P233, DOI 10.1016/j.chom.2012.06.008; Banwell B, 2007, LANCET NEUROL, V6, P773, DOI 10.1016/S1474-4422(07)70196-5; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Brenner SR, 2014, NEUROLOGY, V82, P41, DOI [10.1212/01.wnl.0000438216.93319.ab, DOI 10.1212/01.WNL.0000438216.93319.AB]; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Cree BAC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011296; Disanto G, 2012, HUM MOL GENET, V21, P3575, DOI 10.1093/hmg/dds189; Disanto G, 2011, EXPERT REV NEUROTHER, V11, P1221, DOI [10.1586/ern.11.97, 10.1586/ERN.11.97]; Franciotta D, 2008, LANCET NEUROL, V7, P852, DOI 10.1016/S1474-4422(08)70192-3; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Handel AE, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-163; Hauser SL, 2008, NEW ENGL J MED, V358, P676, DOI 10.1056/NEJMoa0706383; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kakalacheva K, 2011, FEBS LETT, V585, P3724, DOI 10.1016/j.febslet.2011.04.006; Koch MW, 2013, NAT REV NEUROL, V9, P35, DOI 10.1038/nrneurol.2012.226; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Maier S, 2006, J VIROL, V80, P9761, DOI 10.1128/JVI.00665-06; McClellan MJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003636; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mechelli R, NEUROLOGY IN PRESS; Mechelli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063300; Pelajo CF, 2010, AUTOIMMUN REV, V9, P507, DOI 10.1016/j.autrev.2010.02.011; Pender MP, 2011, NEUROSCIENTIST, V17, P351, DOI 10.1177/1073858410381531; Pepper C, 2003, BLOOD, V101, P2454, DOI 10.1182/blood-2002-07-1984; Querol L, 2013, NEUROLOGY, V81, P956, DOI 10.1212/WNL.0b013e3182a43b48; Ramagopalan SV, 2010, GENOME RES, V20, P1352, DOI 10.1101/gr.107920.110; REITSMA PH, 1983, NATURE, V306, P492, DOI 10.1038/306492a0; Ristori G, 1999, NEUROLOGY, V53, P1588, DOI 10.1212/WNL.53.7.1588; Ristori G, 2014, NEUROLOGY, V82, P41, DOI 10.1212/01.wnl.0000438216.93319.ab; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Simon KC, 2012, CURR OPIN NEUROL, V25, P246, DOI 10.1097/WCO.0b013e3283533a7e; Terrier B, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4060; Yenamandra SP, 2010, CELL MOL LIFE SCI, V67, P4249, DOI 10.1007/s00018-010-0441-4; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao B, 2011, P NATL ACAD SCI USA, V108, P14902, DOI 10.1073/pnas.1108892108	44	32	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119605	10.1371/journal.pone.0119605	http://dx.doi.org/10.1371/journal.pone.0119605			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853421	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400005
J	Thompson, ML; Mzilikazi, N; Bennett, NC; McKechnie, AE				Thompson, Michelle L.; Mzilikazi, Nomakwezi; Bennett, Nigel C.; McKechnie, Andrew E.			Solar Radiation during Rewarming from Torpor in Elephant Shrews: Supplementation or Substitution of Endogenous Heat Production?	PLOS ONE			English	Article							EVAPORATIVE WATER-LOSS; MAXIMUM METABOLIC-RATE; NONSHIVERING THERMOGENESIS; THERMAL-ACCLIMATION; DJUNGARIAN HAMSTER; SUMMIT METABOLISM; HETEROTHERMY; BASKING; PATTERNS; RODENTIA	Many small mammals bask in the sun during rewarming from heterothermy, but the implications of this behaviour for their energy balance remain little understood. Specifically, it remains unclear whether solar radiation supplements endogenous metabolic thermogenesis (i.e., rewarming occurs through the additive effects of internally-produced and external heat), or whether solar radiation reduces the energy required to rewarm by substituting (i.e, replacing) metabolic heat production. To address this question, we examined patterns of torpor and rewarming rates in eastern rock elephant shrews (Elephantulus myurus) housed in outdoor cages with access to either natural levels of solar radiation or levels that were experimentally reduced by means of shade cloth. We also tested whether acclimation to solar radiation availability was manifested via phenotypic flexibility in basal metabolic rate (BMR), non-shivering thermogenesis (NST) capacity and/or summit metabolism (M-sum). Rewarming rates varied significantly among treatments, with elephant shrews experiencing natural solar radiation levels rewarming faster than conspecifics experiencing solar radiation levels equivalent to approximately 20% or 40% of natural levels. BMR differed significantly between individuals experiencing natural levels of solar radiation and conspecifics experiencing approximately 20% of natural levels, but no between-treatment difference was evident for NST capacity or Msum. The positive relationship between solar radiation availability and rewarming rate, together with the absence of acclimation in maximum non-shivering and total heat production capacities, suggests that under the conditions of this study solar radiation supplemented rather than substituted metabolic thermogenesis as a source of heat during rewarming from heterothermy.	[Thompson, Michelle L.; Mzilikazi, Nomakwezi; McKechnie, Andrew E.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0028 Hatfield, South Africa; [Bennett, Nigel C.] Univ Pretoria, South African Res Chair Mammal Behav Ecol & Physi, Dept Zool & Entomol, ZA-0028 Hatfield, South Africa	University of Pretoria; University of Pretoria	McKechnie, AE (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, Private Bag X20, ZA-0028 Hatfield, South Africa.	aemckechnie@zoology.up.ac.za	; Bennett, Nigel/E-4238-2010	Mzilikazi, Nomakwezi/0000-0002-0038-7431; Bennett, Nigel/0000-0001-9748-2947	National Research Foundation; University of Pretoria	National Research Foundation; University of Pretoria	This work was supported by the National Research Foundation - www.nrf.ac.za (AEM NCB NM) and the University of Pretoria - www.up.ac.za (AEM NCB). Funding covered equipment, running costs and a student bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Careau V, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1104; Cooper CE, 2009, PHYSIOL BIOCHEM ZOOL, V82, P438, DOI 10.1086/603654; Cooper CE, 2003, J EXP BIOL, V206, P2771, DOI 10.1242/jeb.00484; Dawson TJ, 2014, J COMP PHYSIOL B, V184, P273, DOI 10.1007/s00360-013-0794-8; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2003, J COMP PHYSIOL B, V173, P55, DOI 10.1007/s00360-002-0311-y; Geiser F, 2002, NATURWISSENSCHAFTEN, V89, P412, DOI 10.1007/s00114-002-0349-4; Geiser F, 2007, J COMP PHYSIOL B, V177, P885, DOI 10.1007/s00360-007-0186-z; Genz A., 2021, MVTNORM MULTIVARIATE; HELDMAIER G, 1989, J BIOL RHYTHM, V4, P251, DOI 10.1177/074873048900400211; HELDMAIER G, 1981, SCIENCE, V212, P917, DOI 10.1126/science.7233183; HELDMAIER G, 1981, OECOLOGIA, V48, P265, DOI 10.1007/BF00347975; HINDS DS, 1993, J EXP BIOL, V182, P41; Justo R, 2005, LIFE SCI, V76, P1147, DOI 10.1016/j.lfs.2004.08.019; Lovegrove BG, 2005, J COMP PHYSIOL B, V175, P231, DOI 10.1007/s00360-005-0477-1; Lovegrove BG, 2001, J COMP PHYSIOL B, V171, P1, DOI 10.1007/s003600000139; Lovegrove BG, 1999, J COMP PHYSIOL B, V169, P11, DOI 10.1007/s003600050188; Marom S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P944, DOI 10.1086/505999; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; McKechnie Andrew E., 2004, Biological Papers of the University of Alaska, V27, P63; Minnaar IA, 2014, J EXP BIOL, V217, P1363, DOI 10.1242/jeb.098400; Mzilikazi N, 2006, J COMP PHYSIOL B, V176, P75, DOI 10.1007/s00360-005-0035-x; Mzilikazi N, 2004, PHYSIOL BIOCHEM ZOOL, V77, P285, DOI 10.1086/381470; Mzilikazi N, 2002, OECOLOGIA, V133, P307, DOI 10.1007/s00442-002-1052-z; Mzilikazi N, 2007, AM J PHYSIOL-REG I, V293, pR2120, DOI 10.1152/ajpregu.00427.2007; Nespolo RF, 2001, J ARID ENVIRON, V48, P581, DOI 10.1006/jare.2000.0778; Nespolo RF, 2001, PHYSIOL BIOCHEM ZOOL, V74, P325, DOI 10.1086/320420; Nespolo RF, 1999, J MAMMAL, V80, P742, DOI 10.2307/1383243; Novoa FF, 2005, REV CHIL HIST NAT, V78, P207; PINHEIRO J., 2009, NLME LINEAR NONLINEA; Rezende EL, 2009, J EXP BIOL, V212, P2795, DOI 10.1242/jeb.032789; RUF T, 1992, PHYSIOL ZOOL, V65, P994, DOI 10.1086/physzool.65.5.30158554; Schleucher E., 2006, ACTA ZOOL SINICA, V52, P393; Smit B, 2011, J BIOL RHYTHM, V26, P241, DOI 10.1177/0748730411402632; Swanson DL, 1996, J THERM BIOL, V21, P221, DOI 10.1016/0306-4565(96)00005-8; THOMAS DW, 1990, J MAMMAL, V71, P475, DOI 10.2307/1381967; TUCKER VA, 1965, J CELL COMPAR PHYSL, V65, P393, DOI 10.1002/jcp.1030650313; WALSBERG GE, 1988, J COMP PHYSIOL B, V158, P213, DOI 10.1007/BF01075835; Walsberg GE, 1997, PHYSIOL ZOOL, V70, P150, DOI 10.1086/639566; WALSBERG GE, 1995, J EXP BIOL, V198, P1499; WANG LCH, 1979, CAN J ZOOL, V57, P149, DOI 10.1139/z79-012; Warnecke L, 2008, NATURWISSENSCHAFTEN, V95, P73, DOI 10.1007/s00114-007-0293-4; Warnecke L, 2010, J COMP PHYSIOL B, V180, P437, DOI 10.1007/s00360-009-0417-6; Willis CKR, 2007, PHYSIOL BIOCHEM ZOOL, V80, P643, DOI 10.1086/521085; Wunder BA, 1996, ADAPTATIONS COLD	48	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120442	10.1371/journal.pone.0120442	http://dx.doi.org/10.1371/journal.pone.0120442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853244	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400013
J	Brinks, R; Hoyer, A; Kuss, O; Rathmann, W				Brinks, Ralph; Hoyer, Annika; Kuss, Oliver; Rathmann, Wolfgang			Projected Effect of Increased Active Travel in German Urban Regions on the Risk of Type 2 Diabetes	PLOS ONE			English	Article							PREVALENCE; MELLITUS; SMOKING; COSTS	Background Future transportation policy is likely to reduce emissions in the cities and urban regions by strengthening active travel. Increased walking and cycling are known to have positive effects on health outcomes. This work estimates effects of increased active travel on type 2 diabetes in Germany, where 64% of the population live in urban regions. Methods Based on the effect size of an increased active travel scenario reported from a recent meta-analysis, we project the change in the life time risk, the proportion of prevented cases and the change in diabetes free life time in a German birth cohort (born 1985) compared to business as usual. Results The absolute risk reduction of developing type 2 diabetes before the age of 80 is 6.4% [95% confidence interval: 3.7-9.7%] for men and 4.7% [2.2-7.7%] for women, respectively. Compared to business as usual, the increased active travel scenario prevents 14.0% [8.1-21.2%] of the future cases of diabetes in men and 15.8%[9.3-23.1%] in women. Diabetes free survival increases by 1.7 [1.0-2.7] years in men and 1.4 [0.6-2.3] in women. Conclusions Our projection predicts a substantial impact of increased active travel on the future burden of type 2 diabetes. The most striking effect may be seen in the number of prevented cases. In all urban regions with an increased active travel transport policy, about one out of seven male and one out of six female cases can be prevented.	[Brinks, Ralph; Hoyer, Annika; Kuss, Oliver; Rathmann, Wolfgang] Inst Epidemiol & Biometry, German Diabet Ctr, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ)	Brinks, R (corresponding author), Inst Epidemiol & Biometry, German Diabet Ctr, Dusseldorf, Germany.	ralph.brinks@ddz.uni-duesseldorf.de		Kuss, Oliver/0000-0003-3301-5869				Amer Diabet Associat, 2008, DIABETES CARE, V31, pS61, DOI 10.2337/dc08-S061; [Anonymous], 2013, DIABETES ATLAS; Brinks R, 2014, THEOR POPUL BIOL, V92, P62, DOI 10.1016/j.tpb.2013.11.006; Brinks R, 2012, EUR J EPIDEMIOL, V27, P791, DOI 10.1007/s10654-012-9726-2; Bundesinstitut fur Stadt-und Raumforschung, 2012, BEVOLKERUNGSWACHSTUM; Bundesministerium fur Verkehr Bau und Stadtentwicklung, 2012, NATIONALER RADVERKEH; Carstensen B, 2008, DIABETOLOGIA, V51, P2187, DOI 10.1007/s00125-008-1156-z; Destatis Statistisches Bundesamt, 2013, VERKEHRSUNFALLE ZEIT; Efron B., 1993, MONOGRAPHS ON STATIS; Heidemann C, 2013, BUNDESGESUNDHEITSBLA, V56, P668, DOI 10.1007/s00103-012-1662-5; Imai K, 2007, J AM STAT ASSOC, V102, P1199, DOI 10.1198/016214507000000040; Intergovernmental Panel on Climate Change, 2014, FIFTH ASSESSMENT REP; Jarrett J, 2012, LANCET, V379, P2198, DOI 10.1016/S0140-6736(12)60766-1; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Kalbfleisch J., 2002, THE STATISTICAL ANAL; Lustig RH, 2012, NATURE, V482, P27, DOI 10.1038/482027a; Mann JI, 2004, NUTR METAB CARDIOVAS, V14, P373, DOI 10.1016/S0939-4753(04)80028-0; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; Organisation for Economic Co-operation and Development (OECD), 2013, URBAN POPULATION IN; Persson LG, 2006, SCAND J PRIM HEALTH, V24, P75, DOI 10.1080/02813430500439395; Spijkerman AMW, 2014, DIABETES CARE, V37, P3164, DOI 10.2337/dc14-1020; SULLIVAN DF, 1971, HSMHA HEALTH REP, V86, P347, DOI 10.2307/4594169; Waldeyer R, 2013, DIABETIC MED, V30, P999, DOI 10.1111/dme.12177; Woodcock J, 2009, LANCET, V374, P1930, DOI 10.1016/S0140-6736(09)61714-1	24	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122145	10.1371/journal.pone.0122145	http://dx.doi.org/10.1371/journal.pone.0122145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849819	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800104
J	Chen, YJ; Lu, CT; Huang, KY; Wu, HY; Chen, YJ; Lee, TY				Chen, Yi-Ju; Lu, Cheng-Tsung; Huang, Kai-Yao; Wu, Hsin-Yi; Chen, Yu-Ju; Lee, Tzong-Yi			GSHSite: Exploiting an Iteratively Statistical Method to Identify S-Glutathionylation Sites with Substrate Specificity	PLOS ONE			English	Article							PHOSPHORYLATION SITES; OXIDATIVE STRESS; PROTEIN GLUTATHIONYLATION; WEB SERVER; PSI-BLAST; PREDICTION; SEQUENCES; CYSTEINE; IDENTIFICATION; THIOREDOXIN	S-glutathionylation, the covalent attachment of a glutathione (GSH) to the sulfur atom of cysteine, is a selective and reversible protein post-translational modification (PTM) that regulates protein activity, localization, and stability. Despite its implication in the regulation of protein functions and cell signaling, the substrate specificity of cysteine S-glutathionylation remains unknown. Based on a total of 1783 experimentally identified S-glutathionylation sites from mouse macrophages, this work presents an informatics investigation on S-glutathionylation sites including structural factors such as the flanking amino acids composition and the accessible surface area (ASA). TwoSampleLogo presents that positively charged amino acids flanking the S-glutathionylated cysteine may influence the formation of S-glutathionylation in closed three-dimensional environment. A statistical method is further applied to iteratively detect the conserved substrate motifs with statistical significance. Support vector machine (SVM) is then applied to generate predictive model considering the substrate motifs. According to five-fold cross-validation, the SVMs trained with substrate motifs could achieve an enhanced sensitivity, specificity, and accuracy, and provides a promising performance in an independent test set. The effectiveness of the proposed method is demonstrated by the correct identification of previously reported S-glutathionylation sites of mouse thioredoxin (TXN) and human protein tyrosine phosphatase 1b (PTP1B). Finally, the constructed models are adopted to implement an effective web-based tool, named GSHSite (http://csb.cse.yzu.edu.tw/GSHSite/), for identifying uncharacterized GSH substrate sites on the protein sequences.	[Chen, Yi-Ju; Wu, Hsin-Yi; Chen, Yu-Ju] Acad Sinica, Inst Chem, Taipei, Taiwan; [Lu, Cheng-Tsung; Huang, Kai-Yao; Lee, Tzong-Yi] Yuan Ze Univ, Dept Comp Sci & Engn, Taoyuan, Taiwan; [Lee, Tzong-Yi] Yuan Ze Univ, Innovat Ctr Big Data & Digital Convergence, Taoyuan, Taiwan	Academia Sinica - Taiwan; Yuan Ze University; Yuan Ze University	Chen, YJ (corresponding author), Acad Sinica, Inst Chem, Taipei, Taiwan.	yujuchen@gate.sinica.edu.tw; francis@saturn.yzu.edu.tw	Chen, Yi-Ju/AFU-9499-2022; Chen, Yu-Ju/E-9481-2015; Chen, Yi-Ju/AAP-9052-2021	Chen, Yu-Ju/0000-0002-3178-6697; Chen, Yi-Ju/0000-0002-7203-9188	Ministry of Science and Technology of Taiwan [MOST 103-2221-E-155-020-MY3, 103-2633-E-155-002, 100-2628-M-001-003-MY4]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	The authors sincerely appreciate the Ministry of Science and Technology of Taiwan for financially supporting this research under Contract Number MOST 103-2221-E-155-020-MY3 and 103-2633-E-155-002 to TYL and 100-2628-M-001-003-MY4 to YiJC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2003, BIOINFORMATICS, V19, P1849, DOI 10.1093/bioinformatics/btg249; Ahmad S, 2003, PROTEINS, V50, P629, DOI 10.1002/prot.10328; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bretana NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040694; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casagrande S, 2002, P NATL ACAD SCI USA, V99, P9745, DOI 10.1073/pnas.152168599; Chang C.-C., 2011, ACM T INTEL SYST TEC, V2, P1, DOI [10.1145/1961189.1961199, DOI 10.1145/1961189.1961199]; Chang WC, 2009, J COMPUT CHEM; Chen YY, 2008, J BIOL CHEM, V283, P35265, DOI 10.1074/jbc.M805287200; Chiang BY, 2012, ANGEW CHEM INT EDIT, V51, P5871, DOI 10.1002/anie.201200321; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dalle-Donne I, 2008, ANTIOXID REDOX SIGN, V10, P445, DOI 10.1089/ars.2007.1716; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Dosztanyi Z, 2003, NUCLEIC ACIDS RES, V31, P3359, DOI 10.1093/nar/gkg589; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Ghezzi P, 2013, BBA-GEN SUBJECTS, V1830, P3165, DOI 10.1016/j.bbagen.2013.02.009; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hsu JBK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027567; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang HD, 2005, J COMPUT CHEM, V26, P1032, DOI 10.1002/jcc.20235; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Lee TY, 2012, BIOINFORMATICS, V28, P2293, DOI 10.1093/bioinformatics/bts436; Lee TY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-261; Lee TY, 2011, BIOINFORMATICS, V27, P1780, DOI 10.1093/bioinformatics/btr291; Lee TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017331; Lind C, 2002, ARCH BIOCHEM BIOPHYS, V406, P229, DOI 10.1016/S0003-9861(02)00468-X; Lu CT, 2011, J COMPUT AID MOL DES, V25, P987, DOI 10.1007/s10822-011-9477-2; Marino SM, 2012, J BIOL CHEM, V287, P4419, DOI 10.1074/jbc.R111.275578; Mieyal JJ, 2012, ANTIOXID REDOX SIGN, V16, P471, DOI 10.1089/ars.2011.4454; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; Newman SF, 2007, J NEUROSCI RES, V85, P1506, DOI 10.1002/jnr.21275; Pang CNI, 2007, J PROTEOME RES, V6, P1833, DOI 10.1021/pr060674u; Pastore A, 2012, EUR J PHARM SCI, V46, P279, DOI 10.1016/j.ejps.2012.03.010; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shien DM, 2009, J COMPUT CHEM, V30, P1532, DOI 10.1002/jcc.21232; Silva GM, 2008, FEBS J, V275, P2942, DOI 10.1111/j.1742-4658.2008.06441.x; Su D, 2014, FREE RADICAL BIO MED, V67, P460, DOI 10.1016/j.freeradbiomed.2013.12.004; Sun CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055512; Sun MA, 2012, BIOINFORMATICS, V28, P2551, DOI 10.1093/bioinformatics/bts468; Tatusova TA, 1999, FEMS MICROBIOL LETT, V174, P247, DOI 10.1016/S0378-1097(99)00149-4; Vacic V, 2006, BIOINFORMATICS, V22, P1536, DOI 10.1093/bioinformatics/btl151; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu C, 2010, MOL CELL PR IN PRESS; Wu CG, 2011, J PROTEOMICS, V74, P2498, DOI 10.1016/j.jprot.2011.06.001; Wu C, 2010, MOL CELL PROTEOMICS, V9, P2262, DOI 10.1074/mcp.M110.000034; Xie D, 2005, NUCLEIC ACIDS RES, V33, pW105, DOI 10.1093/nar/gki359	50	30	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118752	10.1371/journal.pone.0118752	http://dx.doi.org/10.1371/journal.pone.0118752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849935	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800008
J	Dvashi, Z; Goldberg, M; Adir, O; Shapira, M; Pollack, A				Dvashi, Zeev; Goldberg, Mordechai; Adir, Orit; Shapira, Michal; Pollack, Ayala			TGF-beta 1 Induced Transdifferentiation of RPE Cells is Mediated by TAK1	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RETINAL-PIGMENT EPITHELIUM; COLLAGEN GEL CONTRACTION; BETA SIGNAL-TRANSDUCTION; TGF-BETA; PROLIFERATIVE VITREORETINOPATHY; GROWTH-FACTOR; KINASE KINASE; MAPK KINASE; ACTIVATION	Background and Aim Proliferative vitreoretinopathy (PVR) is an active process that develops as a complication upon retinal detachment (RD), accompanied by formation of fibrotic tissue. The main cells involved in the development of fibrotic tissue during PVR are the retinal pigment epithelial (RPE) cells. The RPE cells undergo epithelial-mesenchymal transition (EMT) which leads to complex retinal detachment and loss of vision. Transforming growth factor-beta 1 (TGF-beta 1) is considered as the main player in the EMT of RPE cells, even though the mechanism is not fully understood. This study was performed to determine the possible involvement of transforming growth factor beta activated kinase 1 (TAK1) in the EMT process of the RPE cells. Methodology ARPE-19 Cells were treated with 5Z-7 oxozeaenol (TAK1 inhibitor) or SB431542 (TGF-beta 1 receptor kinase inhibitor) followed by TGF-beta 1 stimulation. Immunofluorescence, scratch assay Real time PCR and collagen contraction assay assessed the EMT features. The phosphorylation of Smad2/3 and p38 was examined using western blots analysis. Results This study demonstrates that stimulation of RPE cells with TGF-beta 1 increases alpha-SMA expression, cell migration and cell contractility, all of which are EMT features. Remarkably, addition of TAK1 inhibitor abolishes all these processes. Furthermore, we show hereby that TAK1 regulates not only the activation of the non-canonical cascade of TGF-beta 1 (p38), but also the canonical cascade, the Smad2/3 activation. Thus, the outcome of the TGF-beta response in RPE cells is TAK1 dependent. Conclusions/Significance This work demonstrated TAK1, a component of the non-canonical pathway of TGF-beta 1, is a key player in the EMT process, thus provides deep insight into the pathogenesis of PVR. The ability to halt the process of EMT in RPE cells may reduce the severity of the fibrotic response that occurs upon PVR, leading to a better prognosis and increase the probability of success in RD treatment.	[Dvashi, Zeev; Goldberg, Mordechai; Adir, Orit; Shapira, Michal; Pollack, Ayala] Hadassah Hebrew Univ Jerusalem, Kaplan Med Ctr, Rehovot, Israel	Hebrew University of Jerusalem; Kaplan Medical Center	Pollack, A (corresponding author), Hadassah Hebrew Univ Jerusalem, Kaplan Med Ctr, Rehovot, Israel.	ayala_p@clalit.org.il			Ministry of Industry and Trade (KAMIN)	Ministry of Industry and Trade (KAMIN)	This work was supported by grants to Ayala Pollack by the Chief Scientist at the Ministry of Industry and Trade (KAMIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown KA, 2007, J CELL BIOCHEM, V101, P9, DOI 10.1002/jcb.21255; Cao LN, 2013, INVEST OPHTH VIS SCI, V54, P3738, DOI 10.1167/iovs.13-11612; Casaroli-Marano RP, 1999, INVEST OPHTH VIS SCI, V40, P2062; CHARTERIS DG, 1995, BRIT J OPHTHALMOL, V79, P953, DOI 10.1136/bjo.79.10.953; Conner SH, 2006, BIOCHEM J, V399, P427, DOI 10.1042/BJ20061077; DESMOULIERE A, 1993, J CELL BIOL, V122, P103, DOI 10.1083/jcb.122.1.103; Dunn KC, 1998, INVEST OPHTH VIS SCI, V39, P2744; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Garweg JG, 2013, SURV OPHTHALMOL, V58, P321, DOI 10.1016/j.survophthal.2012.12.004; GRISANTI S, 1995, INVEST OPHTH VIS SCI, V36, P391; Hanada M, 2001, J BIOL CHEM, V276, P5753, DOI 10.1074/jbc.M007773200; He SK, 2008, INVEST OPHTH VIS SCI, V49, P4078, DOI 10.1167/iovs.07-1302; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; HO PC, 1985, BRIT J OPHTHALMOL, V69, P584, DOI 10.1136/bjo.69.8.584; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kajino T, 2007, J BIOL CHEM, V282, P9475, DOI 10.1074/jbc.M700875200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kamaraju SK, 2005, J BIOL CHEM, V280, P1024, DOI 10.1074/jbc.M403960200; Kim SI, 2007, AM J PHYSIOL-RENAL, V292, pF1471, DOI 10.1152/ajprenal.00485.2006; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Lam CRI, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.339; Lambert H M, 1995, Semin Ophthalmol, V10, P49, DOI 10.3109/08820539509059979; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lee H, 2007, INVEST OPHTH VIS SCI, V48, P4291, DOI 10.1167/iovs.07-0086; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Li HS, 2011, J NAT GAS CHEM, V20, P1, DOI 10.1016/S1003-9953(10)60156-9; Ma FY, 2011, AM J PHYSIOL-RENAL, V300, pF1410, DOI 10.1152/ajprenal.00018.2011; Ma J, 2012, CLIN EXP OPHTHALMOL, V40, pE76, DOI 10.1111/j.1442-9071.2011.02618.x; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Ninomiya-Tsuji J, 2003, J BIOL CHEM, V278, P18485, DOI 10.1074/jbc.M207453200; Raviv S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004360; Saika S, 2006, LAB INVEST, V86, P106, DOI 10.1038/labinvest.3700375; Saika S, 2005, LAB INVEST, V85, P838, DOI 10.1038/labinvest.3700294; Saika S, 2008, PROG RETIN EYE RES, V27, P177, DOI 10.1016/j.preteyeres.2007.12.002; SAKAMOTO T, 1994, CURR EYE RES, V13, P451, DOI 10.3109/02713689408999873; Strippoli R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031492; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Symeonidis C, 2011, ACTA OPHTHALMOL, V89, P339, DOI 10.1111/j.1755-3768.2009.01701.x; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Tamiya S, 2010, INVEST OPHTH VIS SCI, V51, P2755, DOI 10.1167/iovs.09-4725; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Umazume K, 2013, INVEST OPHTH VIS SCI, V54, P1150, DOI 10.1167/iovs.12-10418; Wang WF, 1997, J BIOL CHEM, V272, P22771, DOI 10.1074/jbc.272.36.22771; West-Mays JA, 2006, INT J BIOCHEM CELL B, V38, P1625, DOI 10.1016/j.biocel.2006.03.010; YAMAGUCHI K, 1995, SCIENCE, V270, P2008, DOI 10.1126/science.270.5244.2008; Yoon YS, 2005, ONCOGENE, V24, P1895, DOI 10.1038/sj.onc.1208262; Yumoto K, 2013, J BIOL CHEM, V288, P13467, DOI 10.1074/jbc.M112.431775; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	50	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122229	10.1371/journal.pone.0122229	http://dx.doi.org/10.1371/journal.pone.0122229			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849436	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800110
J	Forlano, PM; Ghahramani, ZN; Monestime, CM; Kurochkin, P; Chernenko, A; Milkis, D				Forlano, Paul M.; Ghahramani, Zachary N.; Monestime, Camillia M.; Kurochkin, Philip; Chernenko, Alena; Milkis, Dmitriy			Catecholaminergic Innervation of Central and Peripheral Auditory Circuitry Varies with Reproductive State in Female Midshipman Fish, Porichthys notatus	PLOS ONE			English	Article							GUINEA-PIG COCHLEA; VOCAL PLAINFIN MIDSHIPMAN; MESSENGER-RNA EXPRESSION; SEASONALLY BREEDING SONGBIRD; DOPAMINE-MELATONIN NEURONS; BRAIN TYROSINE-HYDROXYLASE; EEL ANGUILLA-ANGUILLA; TELEOST FISH; HAIR CELL; INNER-EAR	In seasonal breeding vertebrates, hormone regulation of catecholamines, which include dopamine and noradrenaline, may function, in part, to modulate behavioral responses to conspecific vocalizations. However, natural seasonal changes in catecholamine innervation of auditory nuclei is largely unexplored, especially in the peripheral auditory system, where encoding of social acoustic stimuli is initiated. The plainfin midshipman fish, Porichthys notatus, has proven to be an excellent model to explore mechanisms underlying seasonal peripheral auditory plasticity related to reproductive social behavior. Recently, we demonstrated robust catecholaminergic (CA) innervation throughout the auditory system in midshipman. Most notably, dopaminergic neurons in the diencephalon have widespread projections to auditory circuitry including direct innervation of the saccule, the main endorgan of hearing, and the cholinergic octavolateralis efferent nucleus (OE) which also projects to the inner ear. Here, we tested the hypothesis that gravid, reproductive summer females show differential CA innervation of the auditory system compared to non-reproductive winter females. We utilized quantitative immunofluorescence to measure tyrosine hydroxylase immunoreactive (TH-ir) fiber density throughout central auditory nuclei and the sensory epithelium of the saccule. Reproductive females exhibited greater density of TH-ir innervation in two forebrain areas including the auditory thalamus and greater density of TH-ir on somata and dendrites of the OE. In contrast, non-reproductive females had greater numbers of TH-ir terminals in the saccule and greater TH-ir fiber density in a region of the auditory hindbrain as well as greater numbers of TH-ir neurons in the preoptic area. These data provide evidence that catecholamines may function, in part, to seasonally modulate the sensitivity of the inner ear and, in turn, the appropriate behavioral response to reproductive acoustic signals.	[Forlano, Paul M.; Ghahramani, Zachary N.; Monestime, Camillia M.; Kurochkin, Philip; Chernenko, Alena; Milkis, Dmitriy] CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA; [Forlano, Paul M.] CUNY, Program Neurosci, New York, NY 10021 USA; [Forlano, Paul M.; Ghahramani, Zachary N.] CUNY, Program Ecol Evolutionary Biol & Behav, New York, NY 10021 USA; [Forlano, Paul M.] CUNY, Grad Ctr, Program Behav & Cognit Neurosci, New York, NY USA; [Forlano, Paul M.] CUNY Brooklyn Coll, Aquat Res & Environm Assessment Ctr, Brooklyn, NY 11210 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; City University of New York (CUNY) System; Brooklyn College (CUNY)	Forlano, PM (corresponding author), CUNY Brooklyn Coll, Dept Biol, Brooklyn, NY 11210 USA.	pforlano@brooklyn.cuny.edu	Ghahramani, Zachary Nadar/Q-4844-2019	Ghahramani, Zachary Nadar/0000-0002-4136-7832; Forlano, Paul/0000-0003-4258-5708	National Institutes of Health (NIH) [SC2DA034996]; PSC-CUNY Award - Professional Staff Congress [64519-00 42]; City University of New York; NIH MARC [GM08078]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM008078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [SC2DA034996] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PSC-CUNY Award - Professional Staff Congress; City University of New York; NIH MARC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) SC2DA034996 to PMF (www.nih.gov), PSC-CUNY Award 64519-00 42 jointly funded by The Professional Staff Congress and The City University of New York to PMF (www.rfcuny.org) and NIH MARC GM08078 to CMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2002, BEHAV BRAIN RES, V133, P221, DOI 10.1016/S0166-4328(02)00005-0; Bass AH, 2000, J COMP NEUROL, V419, P505, DOI 10.1002/(SICI)1096-9861(20000417)419:4<505::AID-CNE7>3.0.CO;2-3; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; Bass AH, 1996, AM SCI, V84, P352; BASS AH, 1994, J NEUROSCI, V14, P4025; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Boyle R, 2009, J NEUROPHYSIOL, V102, P1513, DOI 10.1152/jn.91367.2008; BRANTLEY RK, 1988, J COMP NEUROL, V275, P87, DOI 10.1002/cne.902750108; Callard GV, 2001, J STEROID BIOCHEM, V79, P305, DOI 10.1016/S0960-0760(01)00147-9; Caras ML, 2013, FRONT NEUROENDOCRIN, V34, P285, DOI 10.1016/j.yfrne.2013.07.006; Chagnaud BP, 2013, J NEUROSCI, V33, P18775, DOI 10.1523/JNEUROSCI.3140-13.2013; Chagnaud BP, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1349; Chaube R, 2003, GEN COMP ENDOCR, V130, P29, DOI 10.1016/S0016-6480(02)00529-4; Chaube R, 2002, J EXP ZOOL, V293, P585, DOI 10.1002/jez.10185; Coffin AB, 2012, J NEUROSCI, V32, P1366, DOI 10.1523/JNEUROSCI.4928-11.2012; DALDIN C, 1995, HEARING RES, V90, P202, DOI 10.1016/0378-5955(95)00167-5; DALDIN C, 1995, EUR ARCH OTO-RHINO-L, V252, P270; Darrow KN, 2006, J COMP NEUROL, V498, P403, DOI 10.1002/cne.21050; Drescher MJ, 2010, NEUROSCIENCE, V171, P1054, DOI 10.1016/j.neuroscience.2010.09.051; Dufour S, 2010, J FISH BIOL, V76, P129, DOI 10.1111/j.1095-8649.2009.02499.x; Edds-Walton PL, 2010, HEARING RES, V262, P45, DOI 10.1016/j.heares.2010.01.008; El Halawani ME, 2009, GEN COMP ENDOCR, V163, P123, DOI 10.1016/j.ygcen.2008.11.030; EYBALIN M, 1993, NEUROSCIENCE, V54, P133, DOI 10.1016/0306-4522(93)90389-W; Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002; Fergus DJ, 2013, J COMP NEUROL, V521, P2850, DOI 10.1002/cne.23320; Filippi A, 2014, J COMP NEUROL, V522, P2019, DOI 10.1002/cne.23524; Fontaine R, 2013, ENDOCRINOLOGY, V154, P807, DOI 10.1210/en.2012-1759; Forlano P. M., 2014, FRONT NEUROENDOCRINO; Forlano PM, 2006, FRONT NEUROENDOCRIN, V27, P247, DOI 10.1016/j.yfrne.2006.05.002; Forlano PM, 2014, J COMP NEUROL, V522, P2887, DOI 10.1002/cne.23596; Forlano PM, 2011, HORM BEHAV, V59, P616, DOI 10.1016/j.yhbeh.2010.10.006; Forlano PM, 2010, J COMP NEUROL, V518, P493, DOI 10.1002/cne.22233; Forlano PM, 2005, J NEUROBIOL, V65, P37, DOI 10.1002/neu.20179; Forlano PM, 2005, J NEUROBIOL, V65, P50, DOI 10.1002/neu.20178; Forlano PM, 2005, J COMP NEUROL, V483, P91, DOI 10.1002/cne.20397; Forlano PM, 2001, J NEUROSCI, V21, P8943, DOI 10.1523/JNEUROSCI.21-22-08943.2001; FURUKAWA T, 1981, J PHYSIOL-LONDON, V315, P203, DOI 10.1113/jphysiol.1981.sp013742; Gaborjan A, 1999, NEUROSCIENCE, V90, P131, DOI 10.1016/S0306-4522(98)00461-8; Garrett AR, 2011, AUDIOL NEURO-OTOL, V16, P145, DOI 10.1159/000316674; Goebrecht GKE, 2014, J CHEM NEUROANAT, V56, P13, DOI 10.1016/j.jchemneu.2014.01.001; Goodson JL, 2002, J COMP NEUROL, V448, P298, DOI 10.1002/cne.10258; Heimovics SA, 2011, NEUROSCIENCE, V182, P133, DOI 10.1016/j.neuroscience.2011.03.012; Heimovics SA, 2012, ENDOCRINOLOGY, V153, P1364, DOI 10.1210/en.2011-1525; Hurley LM, 2004, CURR OPIN NEUROBIOL, V14, P488, DOI 10.1016/j.conb.2004.06.007; Joshua M, 2009, CURR OPIN NEUROBIOL, V19, P615, DOI 10.1016/j.conb.2009.10.001; Kang SW, 2010, NEUROSCIENCE, V170, P200, DOI 10.1016/j.neuroscience.2010.06.082; Kapsimali M, 2000, J COMP NEUROL, V419, P320, DOI 10.1002/(SICI)1096-9861(20000410)419:3<320::AID-CNE5>3.0.CO;2-F; KHAN KM, 1991, NEUROSCI LETT, V131, P109, DOI 10.1016/0304-3940(91)90348-W; Kittelberger JM, 2013, J COMP NEUROL, V521, P791, DOI 10.1002/cne.23202; Koppl C, 2011, SPRINGER HANDB AUDIT, V38, P217, DOI 10.1007/978-1-4419-7070-1_8; LeBlanc MM, 2007, BRAIN RES, V1171, P93, DOI 10.1016/j.brainres.2007.06.086; Linard B, 1996, NEUROENDOCRINOLOGY, V63, P156, DOI 10.1159/000126952; LU Z, 1995, J COMP PHYSIOL A, V176, P747; Lynch KS, 2008, BRAIN BEHAV EVOLUT, V72, P207, DOI 10.1159/000157357; Lynch KS, 2012, BRAIN BEHAV EVOLUT, V79, P252, DOI 10.1159/000337533; MA PM, 1994, J COMP NEUROL, V344, P256, DOI 10.1002/cne.903440207; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Maison SF, 2012, J NEUROSCI, V32, P344, DOI 10.1523/JNEUROSCI.4720-11.2012; Mamta SK, 2014, GEN COMP ENDOCR, V197, P18, DOI 10.1016/j.ygcen.2013.11.022; Maney DL, 2001, NEUROSCI LETT, V311, P189, DOI 10.1016/S0304-3940(01)02157-7; Maney DL, 2013, HEARING RES, V305, P19, DOI 10.1016/j.heares.2013.04.011; Maney DL, 2011, FRONT NEUROENDOCRIN, V32, P287, DOI 10.1016/j.yfrne.2010.12.002; Matragrano LL, 2013, DEV NEUROBIOL, V73, P455, DOI 10.1002/dneu.22072; Matragrano LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039388; Matragrano LL, 2011, EUR J NEUROSCI, V34, P416, DOI 10.1111/j.1460-9568.2011.07751.x; Mazurais D, 1999, J COMP NEUROL, V409, P313, DOI 10.1002/(SICI)1096-9861(19990628)409:2<313::AID-CNE11>3.0.CO;2-1; McCormick CA, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P283; Mccormick C.A., 1999, COMP HEARING FISH AM, P155; McIver EL, 2014, J EXP BIOL, V217, P2377, DOI 10.1242/jeb.102772; McKibben JR, 1998, J ACOUST SOC AM, V104, P3520, DOI 10.1121/1.423938; McLean DL, 2004, J COMP NEUROL, V480, P38, DOI 10.1002/cne.20280; NAKAJIMA Y, 1974, J COMP NEUROL, V156, P403, DOI 10.1002/cne.901560403; Niu X, 2006, NEUROSCIENCE, V137, P981, DOI 10.1016/j.neuroscience.2005.10.044; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; Pasqualini C, 2009, ENDOCRINOLOGY, V150, P1377, DOI 10.1210/en.2008-0578; Pawlisch BA, 2012, GEN COMP ENDOCR, V179, P359, DOI 10.1016/j.ygcen.2012.09.007; Petersen CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070474; Rabbitt RD, 2011, CURR OPIN OTOLARYNGO, V19, P376, DOI 10.1097/MOO.0b013e32834a5be1; Remage-Healey L, 2014, HORM BEHAV, V66, P552, DOI 10.1016/j.yhbeh.2014.07.014; Rink E, 2001, BRAIN RES, V889, P316, DOI 10.1016/S0006-8993(00)03174-7; Riters LV, 2002, J COMP NEUROL, V444, P63, DOI 10.1002/cne.10131; Rohmann KN, 2013, CURR BIOL, V23, P678, DOI 10.1016/j.cub.2013.03.014; Rohmann KN, 2011, J EXP BIOL, V214, P1931, DOI 10.1242/jeb.054114; Ruel J, 2001, EUR J NEUROSCI, V14, P977, DOI 10.1046/j.0953-816x.2001.01721.x; Ruel J, 2007, HEARING RES, V227, P19, DOI 10.1016/j.heares.2006.08.017; Sabban EL, 2010, PHYSIOL BEHAV, V99, P163, DOI 10.1016/j.physbeh.2009.07.011; Schweitzer J, 2012, DEV NEUROBIOL, V72, P256, DOI 10.1002/dneu.20911; Sebert ME, 2008, J NEUROENDOCRINOL, V20, P917, DOI 10.1111/j.1365-2826.2008.01744.x; Sisneros JA, 2004, SCIENCE, V305, P404, DOI 10.1126/science.1097218; Sisneros JA, 2004, GEN COMP ENDOCR, V136, P101, DOI 10.1016/j.ygcen.2003.12.007; Sisneros JA, 2003, J NEUROSCI, V23, P1049; Sisneros JA, 2009, INTEGR ZOOL, V4, P33, DOI 10.1111/j.1749-4877.2008.00133.x; Sisneros JA, 2009, J NEUROPHYSIOL, V102, P1121, DOI 10.1152/jn.00236.2009; Sisneros JA, 2009, HEARING RES, V252, P9, DOI 10.1016/j.heares.2008.12.007; Smeets WJAJ, 2000, BRAIN RES REV, V33, P308, DOI 10.1016/S0165-0173(00)00034-5; Sugihara I, 2001, HEARING RES, V153, P91, DOI 10.1016/S0378-5955(00)00259-8; Tay TL, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1171; Tomchik SM, 2006, J NEUROPHYSIOL, V95, P3562, DOI 10.1152/jn.00063.2006; Uz T, 2005, MOL BRAIN RES, V136, P45, DOI 10.1016/j.molbrainres.2005.01.002; Weeg MS, 2005, J NEUROSCI, V25, P5967, DOI 10.1523/JNEUROSCI.0019-05.2005; Weeg MS, 2002, J NEUROPHYSIOL, V88, P1252, DOI 10.1152/jn.2002.88.3.1252; Weeg MS, 2000, J COMP NEUROL, V418, P41; Weltzien FA, 2006, ENDOCRINOLOGY, V147, P2964, DOI 10.1210/en.2005-1477; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021; Zeddies DG, 2010, J ACOUST SOC AM, V127, P3104, DOI 10.1121/1.3365261; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	106	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121914	10.1371/journal.pone.0121914	http://dx.doi.org/10.1371/journal.pone.0121914			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849450	Green Published, gold			2022-12-26	WOS:000352477800087
J	Kalinowska, M; Castillo, C; Francesconi, A				Kalinowska, Magdalena; Castillo, Catherine; Francesconi, Anna			Quantitative Profiling of Brain Lipid Raft Proteome in a Mouse Model of Fragile X Syndrome	PLOS ONE			English	Article							AUTISM SPECTRUM DISORDERS; LEMLI-OPITZ-SYNDROME; DETERGENT-RESISTANT MEMBRANES; LONG-TERM DEPRESSION; DE-NOVO MUTATIONS; LARGE GENE LISTS; MESSENGER-RNAS; VISUAL-CORTEX; AMPA RECEPTOR; MICE LACKING	Fragile X Syndrome, a leading cause of inherited intellectual disability and autism, arises from transcriptional silencing of the FMR1 gene encoding an RNA-binding protein, Fragile X Mental Retardation Protein (FMRP). FMRP can regulate the expression of approximately 4% of brain transcripts through its role in regulation of mRNA transport, stability and translation, thus providing a molecular rationale for its potential pleiotropic effects on neuronal and brain circuitry function. Several intracellular signaling pathways are dysregulated in the absence of FMRP suggesting that cellular deficits may be broad and could result in homeostatic changes. Lipid rafts are specialized regions of the plasma membrane, enriched in cholesterol and glycosphingolipids, involved in regulation of intracellular signaling. Among transcripts targeted by FMRP, a subset encodes proteins involved in lipid biosynthesis and homeostasis, dysregulation of which could affect the integrity and function of lipid rafts. Using a quantitative mass spectrometry-based approach we analyzed the lipid raft proteome of Fmr1 knockout mice, an animal model of Fragile X syndrome, and identified candidate proteins that are differentially represented in Fmr1 knockout mice lipid rafts. Furthermore, network analysis of these candidate proteins reveals connectivity between them and predicts functional connectivity with genes encoding components of myelin sheath, axonal processes and growth cones. Our findings provide insight to aid identification of molecular and cellular dysfunctions arising from Fmr1 silencing and for uncovering shared pathologies between Fragile X syndrome and other autism spectrum disorders.	[Kalinowska, Magdalena; Castillo, Catherine; Francesconi, Anna] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA	Yeshiva University	Francesconi, A (corresponding author), Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, New York, NY 10461 USA.	anna.francesconi@einstein.yu.edu			Autism Speaks [7287]; NIH [MH082870]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH082870] Funding Source: NIH RePORTER	Autism Speaks; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from Autism Speaks (grant # 7287), www.autismspeaks.org; and NIH grant MH082870 to A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Behan AT, 2009, MOL PSYCHIATR, V14, P601, DOI 10.1038/mp.2008.7; BERRYKRAVIS E, 1993, AM J MED GENET, V45, P81, DOI 10.1002/ajmg.1320450120; Bukelis I, 2007, AM J PSYCHIAT, V164, P1655, DOI 10.1176/appi.ajp.2007.07020315; Chadwick W., 2010, INT J ALZHEIMERS DIS, V2010, DOI [10.4061/2010/604792, DOI 10.4061/2010/604792]; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DeBruin LS, 2007, NEUROCHEM RES, V32, P213, DOI 10.1007/s11064-006-9137-4; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Donati RJ, 2008, J NEUROSCI, V28, P3042, DOI 10.1523/JNEUROSCI.5713-07.2008; Fagni L, 2012, ADV EXP MED BIOL, V970, P63, DOI 10.1007/978-3-7091-0932-8_3; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Francesconi A, 2009, J NEUROSCI, V29, P3590, DOI 10.1523/JNEUROSCI.5824-08.2009; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Giampetruzzi A, 2013, MOL CELL NEUROSCI, V56, P333, DOI 10.1016/j.mcn.2013.07.009; Gielen E, 2006, GLIA, V54, P499, DOI 10.1002/glia.20406; Giuffrida R, 2005, J NEUROSCI, V25, P8908, DOI 10.1523/JNEUROSCI.0932-05.2005; Gross C, 2012, MOL MED, V18, P336, DOI 10.2119/molmed.2011.00363; Gross C, 2010, J NEUROSCI, V30, P10624, DOI 10.1523/JNEUROSCI.0402-10.2010; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Hagerman RJ, 2005, CURR OPIN PSYCHIATR, V18, P490, DOI 10.1097/01.yco.0000179485.39520.b0; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Hering H, 2003, J NEUROSCI, V23, P3262; Herrera-Molina R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034295; Hoeffer CA, 2012, GENES BRAIN BEHAV, V11, P332, DOI 10.1111/j.1601-183X.2012.00768.x; Hoeft F, 2010, P NATL ACAD SCI USA, V107, P9335, DOI 10.1073/pnas.1002762107; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Hu HL, 2008, J NEUROSCI, V28, P7847, DOI 10.1523/JNEUROSCI.1496-08.2008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inoue K, 2005, NEUROGENETICS, V6, P1, DOI 10.1007/s10048-004-0207-y; Irwin SA, 2002, AM J MED GENET, V111, P140, DOI 10.1002/ajmg.10500; Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278; Jia JY, 2006, MOL CELL PROTEOMICS, V5, P2060, DOI 10.1074/mcp.M600161-MCP200; JIANG L, 2008, NEUROBIOL AGING; Kelley DJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000931; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Kokubo H, 2003, BRAIN RES, V965, P83, DOI 10.1016/S0006-8993(02)04140-9; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Kumari R, 2013, J BIOL CHEM, V288, P32004, DOI 10.1074/jbc.M113.475863; Kumari R, 2011, METHODS MOL BIOL, V746, P411, DOI 10.1007/978-1-61779-126-0_24; Ledesma MD, 1999, EMBO J, V18, P1761, DOI 10.1093/emboj/18.7.1761; Ledesma MD, 1998, P NATL ACAD SCI USA, V95, P3966, DOI 10.1073/pnas.95.7.3966; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; MAHANTHAPPA NK, 1992, DEV BIOL, V150, P47, DOI 10.1016/0012-1606(92)90006-3; Martosella J, 2006, J PROTEOME RES, V5, P1301, DOI 10.1021/pr060051g; Maurin T, 2014, NEUROSCI BIOBEHAV RE; Mayeux-Portas V, 2000, CURR BIOL, V10, P68, DOI 10.1016/S0960-9822(99)00278-X; Molander-Melin M, 2005, J NEUROCHEM, V92, P171, DOI 10.1111/j.1471-4159.2004.02849.x; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nakamura K, 2014, EPILEPSIA, V55, pE13, DOI 10.1111/epi.12508; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Neale BM, 2012, NATURE, V485, P242, DOI 10.1038/nature11011; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; NostenBertrand M, 1996, NATURE, V379, P826, DOI 10.1038/379826a0; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Pacey LKK, 2013, HUM MOL GENET, V22, P3920, DOI 10.1093/hmg/ddt246; Parikshak NN, 2013, CELL, V155, P1008, DOI 10.1016/j.cell.2013.10.031; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Rakheja D, 2008, PEDIATR DEVEL PATHOL, V11, P128, DOI 10.2350/06-10-0179.1; Ronesi JA, 2008, J NEUROSCI, V28, P543, DOI 10.1523/JNEUROSCI.5019-07.2008; Ronesi JA, 2012, NAT NEUROSCI, V15, P431, DOI 10.1038/nn.3033; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Sharma A, 2010, J NEUROSCI, V30, P694, DOI 10.1523/JNEUROSCI.3696-09.2010; Shiraishi Y, 2004, J COMP NEUROL, V473, P582, DOI 10.1002/cne.20116; Sikora DM, 2006, AM J MED GENET A, V140A, P1511, DOI 10.1002/ajmg.a.31294; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stam AJ, 2009, APPL CLIN GENET, V2, P7, DOI 10.2147/TACG.S4683; Straiker A, 2013, NEUROBIOL DIS, V56, P1, DOI 10.1016/j.nbd.2013.04.002; Takemoto-Kimura S, 2007, NEURON, V54, P755, DOI 10.1016/j.neuron.2007.05.021; Thevenon J, 2013, EUR J HUM GENET, V21, P82, DOI 10.1038/ejhg.2012.116; Thomsen MS, 2013, BRAIN STRUCT FUNCT; Tiede A, 1998, BIOCHEM J, V334, P609, DOI 10.1042/bj3340609; Wang H, 2008, NEURON, V59, P634, DOI 10.1016/j.neuron.2008.06.027; Yamagata M, 2005, J NEUROSCI, V25, P8457, DOI 10.1523/JNEUROSCI.1976-05.2005; Yu HW, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-17; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zuberi K, 2013, NUCLEIC ACIDS RES, V41, pW115, DOI 10.1093/nar/gkt533	90	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121464	10.1371/journal.pone.0121464	http://dx.doi.org/10.1371/journal.pone.0121464			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849048	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800059
J	Li, J; Zeng, GF; Qi, YW; Tang, XD; Zhang, JJ; Wu, ZY; Liang, J; Shi, L; Liu, HW; Zhang, PH				Li, Jin; Zeng, Guofang; Qi, Yawei; Tang, Xudong; Zhang, Jingjing; Wu, Zeyong; Liang, Jie; Shi, Lei; Liu, Hongwei; Zhang, Peihua			Xenotransplantation of Human Adipose-Derived Stem Cells in Zebrafish Embryos	PLOS ONE			English	Article							IN-UTERO TRANSPLANTATION; CORD BLOOD; MODEL; DIFFERENTIATION; ENGRAFTMENT; XENOGRAFTS; EXPRESSION; MOUSE	Zebrafish is a widely used animal model with well-characterized background in developmental biology. The fate of human adipose-derived stem cells (ADSCs) after their xenotransplantation into the developing embryos of zebrafish is unknown. Therefore, human ADSCs were firstly isolated, and then transduced with lentiviral vector system carrying a green fluorescent protein (GFP) reporter gene, and followed by detection of their cell viability and the expression of cell surface antigens. These GFP-expressing human ADSCs were transplanted into the zebrafish embryos at 3.3-4.3 hour post-fertilization (hpf). Green fluorescent signal, the proliferation and differentiation of human ADSCs in recipient embryos were respectively examined using fluorescent microscopy and immunohistochemical staining. The results indicated that human ADSCs did not change their cell viability and the expression levels of cell surface antigens after GFP transduction. Microscopic examination demonstrated that green fluorescent signals of GFP expressed in the transplanted cells were observed in the embryos and larva fish at post-transplantation. The positive staining of Ki-67 revealed the survival and proliferation of human ADSCs in fish larvae after transplantation. The expression of CD105 was observable in the xenotransplanted ADSCs, but CD31 expression was undetectable. Therefore, our results indicate that human ADSCs xenotransplanted in the zebrafish embryos not only can survive and proliferate at across-species circumstance, but also seem to maintain their undifferentiation status in a short term. This xenograft model of zebrafish embryos may provide a promising and useful technical platform for the investigation of biology and physiology of stem cells in vivo.	[Li, Jin; Zeng, Guofang; Qi, Yawei; Wu, Zeyong; Liang, Jie; Zhang, Peihua] Guangdong Med Coll, Affiliated Hosp, Inst Plast Surg, Zhanjiang, Guangdong, Peoples R China; [Tang, Xudong] Guangdong Med Coll, Inst Biochem & Mol Biol, Zhanjiang, Guangdong, Peoples R China; [Zhang, Jingjing] Guangdong Med Coll, Affiliated Hosp, Clin Res Ctr, Zhanjiang, Guangdong, Peoples R China; [Shi, Lei] S China Univ Technol, Sch Light Ind & Food Sci, Guangzhou 510641, Guangdong, Peoples R China; [Liu, Hongwei] Jinan Univ, Affiliated Hosp 1, Dept Plast Surg, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China	Guangdong Medical University; Guangdong Medical University; Guangdong Medical University; South China University of Technology; Jinan University	Liu, HW (corresponding author), Jinan Univ, Affiliated Hosp 1, Dept Plast Surg, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China.	liuhongwei0521@hotmail.com; Zhangpeihua128@126.com	Zhang, Jing/HII-4294-2022		Scientific Research Starting Foundation for the Doctors of Guangdong Medical College [B2012036]; Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen [2011YXGZ008]	Scientific Research Starting Foundation for the Doctors of Guangdong Medical College; Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen	This work was partly supported by the Scientific Research Starting Foundation for the Doctors of Guangdong Medical College (grant number: B2012036). GFZ received this funding. In addition, this work was also partly supported by the Open Project Program of State Key Laboratory of Meat Products for Security and Production Technology in Xiamen (grant number: 2011YXGZ008). PHZ received this funding. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abe T, 2012, EXP HEMATOL, V40, P436, DOI 10.1016/j.exphem.2012.01.018; Nguyen AT, 2011, DIS MODEL MECH, V4, P801, DOI 10.1242/dmm.007831; Bansal N, 2014, PROSTATE, V74, P187, DOI 10.1002/pros.22740; Bayati V, 2011, TISSUE CELL, V43, P359, DOI 10.1016/j.tice.2011.07.004; Bershteyn M, 2014, NATURE, V507, P99, DOI 10.1038/nature12923; Blackburn JS, 2014, DIS MODEL MECH, V7, P755, DOI 10.1242/dmm.015842; Chen CP, 2009, HUM REPROD, V24, P154, DOI 10.1093/humrep/den356; Chen X, 2009, EXP MOL PATHOL, V87, P173, DOI 10.1016/j.yexmp.2009.07.009; De Santis M, 2011, Minerva Ginecol, V63, P387; Efthymiou AG, 2014, EXPERT OPIN BIOL TH, V31, P1; Eguiara A, 2011, CELL CYCLE, V10, P3751, DOI 10.4161/cc.10.21.17921; Etchin J, 2011, METHOD CELL BIOL, V105, P309, DOI 10.1016/B978-0-12-381320-6.00013-8; Fisher JE, 2013, LIVER TRANSPLANT, V19, P328, DOI 10.1002/lt.23598; Flake AW, 1998, ANN NY ACAD SCI, V850, P300, DOI 10.1111/j.1749-6632.1998.tb10487.x; Gahremanpour A, 2013, XENOTRANSPLANTATION, V20, P110, DOI 10.1111/xen.12026; Harding MJ, 2014, DEVELOPMENT, V141, P2549, DOI 10.1242/dev.101444; Jung DW, 2012, MOL BIOSYST, V8, P1930, DOI 10.1039/c2mb05501e; Lee LMJ, 2005, DEV DYNAM, V233, P1560, DOI 10.1002/dvdy.20471; Liao XB, 2008, STEM CELLS DEV, V17, P303, DOI 10.1089/scd.2007.0086; Mazo M, 2012, CELL TRANSPLANT, V21, P2723, DOI 10.3727/096368912X638847; Mushtaq MY, 2013, BIOTECHNOL GENET ENG, V29, P187, DOI 10.1080/02648725.2013.801238; Nie CL, 2011, CELL TRANSPLANT, V20, P205, DOI 10.3727/096368910X520065; Ripoll CB, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-3; Roubelakis MG, 2011, J CELL MOL MED, V15, P1896, DOI 10.1111/j.1582-4934.2010.01180.x; Sabaawy HE, 2006, P NATL ACAD SCI USA, V103, P15166, DOI 10.1073/pnas.0603349103; Saez-Lara MJ, 2006, XENOTRANSPLANTATION, V13, P529, DOI 10.1111/j.1399-3089.2006.00344.x; Santo VE, 2012, J CONTROL RELEASE, V162, P19, DOI 10.1016/j.jconrel.2012.06.001; Tat Jennifer, 2013, Drug Discov Today Technol, V10, pe83, DOI 10.1016/j.ddtec.2012.04.006; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yang XJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061801, 10.1371/journal.pone.0062181]; Yoon IS, 2011, J BIOSCI BIOENG, V112, P402, DOI 10.1016/j.jbiosc.2011.06.018; Yu G, 2011, METHODS MOL BIOL, V702, P17, DOI 10.1007/978-1-61737-960-4_2; Zeng FY, 2006, P NATL ACAD SCI USA, V103, P7801, DOI 10.1073/pnas.0602646103; Zeng FY, 2005, DNA CELL BIOL, V24, P403, DOI 10.1089/dna.2005.24.403; Zeng GF, 2013, ORGANOGENESIS, V9, P287, DOI 10.4161/org.27153; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	36	4	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123264	10.1371/journal.pone.0123264	http://dx.doi.org/10.1371/journal.pone.0123264			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849455	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800219
J	Mucke, J; Mohlenbruch, M; Kickingereder, P; Kieslich, PJ; Baumer, P; Gumbinger, C; Purrucker, J; Mundiyanapurath, S; Schlemmer, HP; Bendszus, M; Radbruch, A				Mucke, Johanna; Moehlenbruch, Markus; Kickingereder, Philipp; Kieslich, Pascal J.; Baeumer, Philipp; Gumbinger, Christoph; Purrucker, Jan; Mundiyanapurath, Sibu; Schlemmer, Heinz-Peter; Bendszus, Martin; Radbruch, Alexander			Asymmetry of Deep Medullary Veins on Susceptibility Weighted MRI in Patients with Acute MCA Stroke Is Associated with Poor Outcome	PLOS ONE			English	Article							ISCHEMIC-STROKE; CLINICAL-APPLICATIONS; SCALE; NXY-059; BURDEN; SIZE	Background and Purpose Due to its sensitivity to deoxyhemoglobin, susceptibility weighted imaging (SWI) enables the visualization of deep medullary veins (DMV) in patients with acute stroke, which are difficult to depict under physiological circumstances. This study assesses the asymmetric appearance of prominent DMV as an independent predictor for stroke severity and outcome. Materials and Methods SWI of 86 patients with acute middle cerebral artery (MCA) stroke were included. A scoring system from 0 (no visible DMV) to 3 (very prominent DMV) was applied for both hemispheres separately. A difference of scores between ipsi- and contralateral side was defined as asymmetric (AMV+). Occurrence of AMV+ was correlated with the National Institute of Health Stroke Scale (NIHSS) Score on admission and discharge, as well as the modified Rankin Scale (mRS) at discharge. Ordinal regression analysis was used to evaluate NIHSS and mRS as predictors of stroke severity, clinical course of disease and outcome. Results 55 patients displayed AMV+ while 31 did not show an asymmetry (AMV-). Median NIHSS on admission was 17 (11-21) in the AMV+ group and 9 (5-15) in the AMV-group (p = 0.001). On discharge median NIHSS was 11 (5-20) for AMV+ and 5 (2-14) for AMV-(p = 0.005). The median mRS at discharge was 4 (3-5) in the AMV+ group and 3 (1-4) in AMV-(p = 0.001). Odds ratio was 3.19 (95% CI: 1.24-8.21) for AMV+ to achieve a higher mRS than AMV-(p = 0.016). Conclusion The asymmetric appearance of DMV on SWI is a fast and easily evaluable parameter for the prediction of stroke severity and can be used as an additional imaging parameter in patients with acute MCA stroke.	[Mucke, Johanna; Moehlenbruch, Markus; Kickingereder, Philipp; Baeumer, Philipp; Bendszus, Martin; Radbruch, Alexander] Heidelberg Univ, Dept Neuroradiol, INF 400, D-69120 Heidelberg, Germany; [Kieslich, Pascal J.] Univ Mannheim, Dept Psychol, D-68131 Mannheim, Germany; [Gumbinger, Christoph; Purrucker, Jan; Mundiyanapurath, Sibu] Heidelberg Univ, Dept Neurol, D-69120 Heidelberg, Germany; [Schlemmer, Heinz-Peter; Radbruch, Alexander] German Canc Res Ctr, Dept Radiol, INF 280, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Mannheim; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Radbruch, A (corresponding author), Heidelberg Univ, Dept Neuroradiol, INF 400, D-69120 Heidelberg, Germany.	a.radbruch@dkfz.de	Vollmuth, Philipp/AAK-3267-2021; Radbruch, Alexander/ABA-6277-2021; Mucke, Johanna/AAG-7722-2020	Kieslich, Pascal J./0000-0002-0853-9364; Gumbinger, Christoph/0000-0002-6137-1169; Vollmuth (ne Kickingereder), Philipp/0000-0002-6224-0064; Radbruch, Alexander/0000-0001-6238-6525; Mundiyanapurath, Sibu/0000-0003-4637-4641				Albers GW, 2006, ANN NEUROL, V60, P508, DOI 10.1002/ana.20976; Barreto AD, 2008, STROKE, V39, P3231, DOI 10.1161/STROKEAHA.108.521054; Bath P, 2009, STROKE, V40, P888, DOI 10.1161/STROKEAHA.108.519207; Friedman DP, 1997, AM J ROENTGENOL, V168, P1103, DOI 10.2214/ajr.168.4.9124123; Gasparotti R, 2011, INSIGHTS IMAGING, V2, P335, DOI 10.1007/s13244-011-0086-3; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HOOSHMAND I, 1974, NEURORADIOLOGY, V7, P75, DOI 10.1007/BF00341874; Jensen-Kondering U, 2013, WORLD J RADIOL, V5, P156, DOI 10.4329/wjr.v5.i4.156; Kane I, 2009, J NEUROL, V256, P1832, DOI 10.1007/s00415-009-5202-7; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Lee M, 2012, INT J STROKE, V7, P293, DOI 10.1111/j.1747-4949.2011.00726.x; Lees KR, 2006, STROKE, V37, P2970, DOI 10.1161/01.STR.0000249410.91473.44; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063013; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Nandigam RNK, 2009, AM J NEURORADIOL, V30, P338, DOI 10.3174/ajnr.A1355; Nazliel B, 2008, STROKE, V39, P2264, DOI 10.1161/STROKEAHA.107.508127; Parthasarathy R, 2013, STROKE A JOURNAL OF; Puetz V, 2008, INT J STROKE, V3, P230, DOI 10.1111/j.1747-4949.2008.00221.x; Purrucker JC, 2014, J NEUROL NEUROSURG P; Radbruch A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063459; Reichenbach JR, 2001, NMR BIOMED, V14, P453, DOI 10.1002/nbm.722; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; Santhosh K, 2009, CLIN RADIOL, V64, P74, DOI 10.1016/j.crad.2008.04.022; Saver JL, 2007, STROKE, V38, P414, DOI 10.1161/01.STR.0000254580.39297.3c; Scott SC, 1997, J CLIN EPIDEMIOL, V50, P45, DOI 10.1016/S0895-4356(96)00312-5; Sehgal V, 2005, J MAGN RESON IMAGING, V22, P439, DOI 10.1002/jmri.20404; Somford DM, 2002, RADIOLOGY, V223, P667, DOI 10.1148/radiol.2233011017; Sulter G, 1999, STROKE, V30, P1538, DOI 10.1161/01.STR.30.8.1538; Tong KA, 2008, AM J NEURORADIOL, V29, P9, DOI 10.3174/ajnr.A0786; Veerbeek JM, 2011, STROKE, V42, P1482, DOI 10.1161/STROKEAHA.110.604090; Viallon M, 2010, EUR NEUROL, V64, P286, DOI 10.1159/000321162; Woo D, 1999, STROKE, V30, P2355, DOI 10.1161/01.STR.30.11.2355	34	37	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120801	10.1371/journal.pone.0120801	http://dx.doi.org/10.1371/journal.pone.0120801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849958	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800033
J	Nega, D; Dana, D; Tefera, T; Eshetu, T				Nega, Desalegn; Dana, Daniel; Tefera, Tamirat; Eshetu, Teferi			Prevalence and Predictors of Asymptomatic Malaria Parasitemia among Pregnant Women in the Rural Surroundings of Arbaminch Town, South Ethiopia	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; TRANSMISSION; BURDEN; AREA; SPP.	Background In Sub-Saharan African countries, including Ethiopia, malaria in pregnancy is a major public health threat which results in significant morbidities and mortalities among pregnant women and their fetuses. In malaria endemic areas, Plasmodium infections tend to remain asymptomatic yet causing significant problems like maternal anemia, low birth weight, premature births, and still birth. This study was conducted to determine the prevalence and predictors of asymptomatic Plasmodium infection among pregnant women in the rural surroundings of Arba Minch Town, Southern Ethiopia. Methods A community based cross-sectional study comprising multistage sampling was conducted between April and June, 2013. Socio-demographic data were collected by using a semi-structured questionnaire. Plasmodium infection was diagnosed by using Giemsa-stained blood smear microscopy and a rapid diagnostic test (SD BIOLINE Malaria Ag Pf/Pv POCT, standard diagnostics, inc., Korea). Results Of the total 341 pregnant women participated in this study, 9.1% (31/341) and 9.7% (33/341) were confirmed to be infected with Plasmodium species by microscopy and rapid diagnostic tests (RDTs), respectively. The geometric mean of parasite density was 2392 parasites per microliter (mu l); 2275/mu l for P. falciparum and 2032/mu l for P. vivax. Parasitemia was more likely to occur in primigravidae (Adjusted odds ratio (AOR): 9.4, 95% confidence interval (CI): 4.3-60.5), secundigravidae (AOR: 6.3, 95% CI: 2.9-27.3), using insecticide treated bed net (ITN) sometimes (AOR: 3.2, 95% CI: 1.8-57.9), not using ITN at all (AOR: 4.6, 95% CI: 1.4-14.4) compared to multigravidae and using ITN always, respectively. Conclusion Asymptomatic malaria in this study is low compared to other studies' findings. Nevertheless, given the high risk of malaria during pregnancy, pregnant women essentially be screened for asymptomatic Plasmodium infection and be treated promptly via the antenatal care (ANC) services.	[Nega, Desalegn] Ethiopian Publ Hlth Inst, Directorate Parasit Bacterial & Zoonot Dis Res, Malaria & Other Parasit & Vector Borne Dis Res Te, Addis Ababa, Ethiopia; [Dana, Daniel; Tefera, Tamirat; Eshetu, Teferi] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Oromia, Ethiopia	Jimma University	Tefera, T (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Oromia, Ethiopia.	tamirat.tefera@ju.edu.et		Temesgen, Tamirat Tefera/0000-0002-6946-5055; Dana, Daniel/0000-0002-1941-5076	JIMMA UNIVERSITY	JIMMA UNIVERSITY	Funding was provided by JIMMA UNIVERSITY (www.ju.edu.et). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-174; Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; Alves FP, 2005, J MED ENTOMOL, V42, P777, DOI 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2; [Anonymous], MAL OP PLAN FY 2012; [Anonymous], 2012, NAT MAL GUID; [Anonymous], PLOS ONE; [Anonymous], 2012, J DENT MED SCI; [Anonymous], 2013, WHO POL BRIEF IMPL I; [Anonymous], ETH NAT MAL IND SURV; [Anonymous], 13 WORLD C PUBL HLTH; Astatkie A, 2010, ETHIOP J HEALTH DEV, V24, P15; Baliraine FN, 2009, J INFECT DIS, V200, P66, DOI 10.1086/599317; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; Dal-Bianco MP, 2007, AM J TROP MED HYG, V77, P939, DOI 10.4269/ajtmh.2007.77.939; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Douamba Z, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/198317; Fried M, 1998, NATURE, V395, P851, DOI 10.1038/27570; Getachew Million, 2013, BMC Res Notes, V6, P263, DOI 10.1186/1756-0500-6-263; Getachew M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-296; Isah AY, 2011, ANN AFR MED, V10, P171, DOI 10.4103/1596-3519.82070; Laishram DD, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-29; Cucunuba ZM, 2013, T ROY SOC TROP MED H, V107, P129, DOI 10.1093/trstmh/trs021; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Nwagha UI, 2009, T ROY SOC TROP MED H, V103, P16, DOI 10.1016/j.trstmh.2008.07.016; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Sullivan AD, 1999, J INFECT DIS, V179, P1580, DOI 10.1086/314752; Van Geertruyden JP, 2005, TROP MED INT HEALTH, V10, P681, DOI 10.1111/j.1365-3156.2005.01431.x; Verhoeff FH, 1999, ANN TROP MED PARASIT, V93, pS25, DOI 10.1080/00034989957718; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Yavo W, 2002, B SOC PATHOL EXOT, V95, P238	31	27	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123630	10.1371/journal.pone.0123630	http://dx.doi.org/10.1371/journal.pone.0123630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849587	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800246
J	Omidvar, V; Fellner, M				Omidvar, Vahid; Fellner, Martin			DNA Methylation and Transcriptomic Changes in Response to Different Lights and Stresses in 7B-1 Male-Sterile Tomato	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; CYTOSINE METHYLATION; HYPOCOTYL ELONGATION; SEED-GERMINATION; GENE-EXPRESSION; ABIOTIC-STRESS; ARABIDOPSIS; RNA; PROTEIN; GROWTH	We reported earlier that 7B-1 mutant in tomato (Solanum lycopersicum L., cv. Rutgers), an ABA overproducer, is defective in blue light (B) signaling leading to B-specific resistance to abiotic and biotic stresses. Using a methylation-sensitive amplified polymorphism (MSAP) assay, a number of genes were identified, which were differentially methylated between 7B-1 and its wild type (WT) seedlings in white (W), blue (B), red (R) lights and dark (D) or in response to exogenous ABA and mannitol-induced stresses. The genomic methylation level was almost similar in different lights between 7B-1 and WT seedlings, while significant differences were observed in response to stresses in D, but not B. Using a cDNA-AFLP assay, several transcripts were identified, which were differentially regulated between 7B-1 and WT by B or D or in response to stresses. Blue light receptors cryptochrome 1 and 2 (CRY1 and CRY2) and phototropin 1 and 2 (PHOT1 and PHOT2) were not affected by the 7B-1 mutation at the transcriptional level, instead the mutation had likely affected downstream components of the light signaling pathway. 5-azacytidine (5-azaC) induced DNA hypomethylation, inhibited stem elongation and differentially regulated the expression of a number of genes in 7B-1. In addition, it was shown that mir167 and mir390 were tightly linked to auxin signaling pathway in 5-azaC-treated 7B-1 seedlings via the regulation of auxin-response factor (ARF) transcripts. Our data showed that DNA methylation remodeling is an active epigenetic response to different lights and stresses in 7B-1 and WT, and highlighted the differences in epigenetic and transcriptional regulation of light and stress responses between 7B-1 and WT. Furthermore, it shed lights on the crosstalk between DNA hypomethylation and miRNA regulation of ARFs expression. This information could also be used as a benchmark for future studies of male-sterility in other crops.	[Omidvar, Vahid] Palacky Univ, Lab Growth Regulators, Grp Mol Physiol, CR-77147 Olomouc, Czech Republic; ASCR, Inst Expt Bot, Olomouc, Czech Republic	Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Omidvar, V (corresponding author), Palacky Univ, Lab Growth Regulators, Grp Mol Physiol, CR-77147 Olomouc, Czech Republic.	Vahid.omidvar@upol.cz; Martin.fellner@upol.cz	Fellner, Martin/B-2068-2010		Operational Programs Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/30.0004]; Ministry of Education, Youth and Sports [LO1204]	Operational Programs Education for Competitiveness-European Social Fund; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the Operational Programs Education for Competitiveness-European Social Fund, project no. CZ.1.07/2.3.00/30.0004 to MF, and by Ministry of Education, Youth and Sports, project no. LO1204.	Ahmad JN, 2013, PLANT PATHOL, V62, P205, DOI 10.1111/j.1365-3059.2012.02605.x; Bachem CWB, 1996, PLANT J, V9, P745, DOI 10.1046/j.1365-313X.1996.9050745.x; Barak S, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/15592324.2014.977729; Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bergougnoux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045255; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Boyko A, 2007, NUCLEIC ACIDS RES, V35, P1714, DOI 10.1093/nar/gkm029; Bustos R, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001102; Cao XF, 2002, CURR BIOL, V12, P1138, DOI 10.1016/S0960-9822(02)00925-9; Chaulk SG, 2000, BIOCHEMISTRY-US, V39, P10448, DOI 10.1021/bi0009136; Chen H, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-281; Chen LG, 2012, BBA-GENE REGUL MECH, V1819, P120, DOI 10.1016/j.bbagrm.2011.09.002; Cho JN, 2012, DEV CELL, V22, P736, DOI 10.1016/j.devcel.2012.01.024; Choi CS, 2007, MOL GENET GENOMICS, V277, P589, DOI 10.1007/s00438-007-0209-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Ding JH, 2012, MOL PLANT, V5, P1210, DOI 10.1093/mp/sss095; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Fellner M, 2002, PLANTA, V214, P675, DOI 10.1007/s004250100671; Fellner M, 2001, J EXP BOT, V52, P725, DOI 10.1093/jexbot/52.357.725; Gonzalez RM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-94; Guilfoyle TJ, 2001, J PLANT GROWTH REGUL, V20, P281, DOI 10.1007/s003440010026; Hlavinka J, 2013, PLANT SCI, V209, P75, DOI 10.1016/j.plantsci.2013.04.010; Jensen PJ, 1998, PLANT PHYSIOL, V116, P455, DOI 10.1104/pp.116.2.455; Khan A, 2014, PLANT J, V79, DOI 10.1111/tpj.12533; Kim H, 2014, J EXP BOT, V65, P453, DOI 10.1093/jxb/ert397; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Labra M, 2002, PLANT BIOLOGY, V4, P694, DOI 10.1055/s-2002-37398; Li H, 2004, DEV CELL, V7, P193, DOI 10.1016/j.devcel.2004.07.002; Li TC, 2011, AFR J BIOTECHNOL, V10, P6220; Li YS, 2013, MOL BIOTECHNOL, V54, P703, DOI 10.1007/s12033-012-9614-8; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorsch JR, 2002, CELL, V109, P797, DOI 10.1016/S0092-8674(02)00804-8; Lu TT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-721; Marfil CF, 2012, PLANT CELL REP, V31, P1449, DOI 10.1007/s00299-012-1260-x; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Motchoulski A, 1999, SCIENCE, V286, P961, DOI 10.1126/science.286.5441.961; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Oh E, 2014, ELIFE, V3, DOI 10.7554/eLife.03031; Pedmale UV, 2007, J BIOL CHEM, V282, P19992, DOI 10.1074/jbc.M702551200; Portis E, 2004, PLANT SCI, V166, P169, DOI 10.1016/j.plantsci.2003.09.004; Raduwan H, 2013, J BIOL CHEM, V288, P8380, DOI 10.1074/jbc.M112.359935; Santiago J, 2009, PLANT J, V60, P575, DOI 10.1111/j.1365-313X.2009.03981.x; Sawhney V. K., 1997, Pollen biotechnology for crop production and improvement., P183, DOI 10.1017/CBO9780511525469.010; Sawhney VK, 2004, J HORTIC SCI BIOTECH, V79, P138, DOI 10.1080/14620316.2004.11511726; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sha AH, 2005, MOL GENET GENOMICS, V273, P484, DOI 10.1007/s00438-005-1148-3; Shan XH, 2013, J PLANT BIOL, V56, P32, DOI 10.1007/s12374-012-0251-3; Sheoran IS, 2009, J PROTEOMICS, V71, P624, DOI 10.1016/j.jprot.2008.10.006; Singh A, 2012, PLANT SIGNAL BEHAV, V7, P847, DOI 10.4161/psb.20385; Singh A, 2012, J BIOL CHEM, V287, P25995, DOI 10.1074/jbc.M111.333906; Steward N, 2002, J BIOL CHEM, V277, P37741, DOI 10.1074/jbc.M204050200; Szalontai B, 2012, J PLANT PHYSIOL, V169, P1767, DOI 10.1016/j.jplph.2012.07.010; Tatra GS, 2000, PHYSIOL PLANTARUM, V109, P313, DOI 10.1034/j.1399-3054.2000.100313.x; Thanananta T, 2006, AFR J BIOTECHNOL, V5, P1375; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Ueno K, 2005, PLANT CELL PHYSIOL, V46, P955, DOI 10.1093/pcp/pci104; Vashisht AA, 2005, PLANT J, V44, P76, DOI 10.1111/j.1365-313X.2005.02511.x; Wada Y, 2004, MOL GENET GENOMICS, V271, P658, DOI 10.1007/s00438-004-1018-4; Wang WS, 2011, J GENET GENOMICS, V38, P419, DOI 10.1016/j.jgg.2011.07.006; Wang Y, 2014, P NATL ACAD SCI USA, V111, P533, DOI 10.1073/pnas.1305438111; Williams L, 2005, P NATL ACAD SCI USA, V102, P9703, DOI 10.1073/pnas.0504029102; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Xin M, 2001, BMC PLANT BIOL, V11, P61; Xing DH, 2011, WIRES RNA, V2, P445, DOI 10.1002/wrna.59; Yan HR, 2014, PLANT CELL PHYSIOL, V55, P2060, DOI 10.1093/pcp/pcu133; Yu YW, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004025; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zhong SL, 2013, NAT BIOTECHNOL, V31, P154, DOI 10.1038/nbt.2462	70	21	23	1	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121864	10.1371/journal.pone.0121864	http://dx.doi.org/10.1371/journal.pone.0121864			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849771	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800080
J	De Mukhopadhyay, K; Liu, Z; Bandyopadhyay, A; Kirma, NB; Tekmal, RR; Wang, S; Sun, LZ				De Mukhopadhyay, Keya; Liu, Zhao; Bandyopadhyay, Abhik; Kirma, Nameer B.; Tekmal, Rajeshwar R.; Wang, Shui; Sun, Lu-Zhe			Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells	PLOS ONE			English	Article							ADIPOSE STROMAL CELLS; INHIBITORS; GENE; METASTASIS; INDUCTION; PROMOTER; ALPHA; MCF-7; CYP19	In postmenopausal women, local estrogen produced by adipose stromal cells in the breast is believed to support estrogen receptor alpha (ERa) positive breast cancer cell survival and growth. This raises the question of how the ERa positive metastatic breast cancer cells survive after they enter blood and lymph circulation, where estrogen level is very low in postmenopausal women. In this study, we show that the aromatase expression increased when ERa positive breast cancer cells were cultured in suspension. Furthermore, treatment with the aromatase substrate, testosterone, inhibited suspension culture-induced apoptosis whereas an aromatase inhibitor attenuated the effect of testosterone suggesting that suspended circulating ERa positive breast cancer cells may up-regulate intracrine estrogen activity for survival. Consistent with this notion, a moderate level of ectopic aromatase expression rendered a non-tumorigenic ERa positive breast cancer cell line not only tumorigenic but also metastatic in female nude mice without exogenous estrogen supplementation. The increased malignant phenotype was confirmed to be due to aromatase expression as the growth of orthotopic tumors regressed with systemic administration of an aromatase inhibitor. Thus, our study provides experimental evidence that aromatase plays an important role in the survival of metastatic ERa breast cancer cells by suppressing anoikis.	[De Mukhopadhyay, Keya; Liu, Zhao; Bandyopadhyay, Abhik; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Kirma, Nameer B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Tekmal, Rajeshwar R.; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Wang, Shui] Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Nanjing Medical University	Wang, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Breast Surg, Nanjing, Jiangsu, Peoples R China.	ws0801@hotmail.com; sunl@uthscsa.edu	, LuZhe/AAW-4095-2021		National Natural Science Foundation of China [81172505]; National Institutes of Health [R01CA79683, R01ES022057]; Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant [2 P30 CA054174]; NATIONAL CANCER INSTITUTE [R01CA079683, P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES022057] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by funding from the National Natural Science Foundation of China Grant #81172505 (SW), National Institutes of Health Grants R01CA79683 and R01ES022057 (LZS), and the Cancer Therapy and Research Center at the University of Texas Health Science Center at San Antonio through the NCI Cancer Center Support Grant 2 P30 CA054174.	Bandyopadhyay A, 2006, CANCER RES, V66, P6714, DOI 10.1158/0008-5472.CAN-05-3565; Briest S, 2008, EXPERT REV ANTICANC, V8, P1, DOI 10.1586/14737140.8.1.1; Briest S, 2007, REV ENDOCR METAB DIS, V8, P215, DOI 10.1007/s11154-007-9039-z; Fierro FA, 2004, CLIN EXP METASTAS, V21, P313, DOI 10.1023/B:CLIN.0000046130.79363.33; Ghosh S, 2005, ONCOGENE, V24, P2236, DOI 10.1038/sj.onc.1208415; Ghosh S, 2007, AM J PHYSIOL-ENDOC M, V292, pE246, DOI 10.1152/ajpendo.00242.2006; Ghosh S, 2009, MOL ENDOCRINOL, V23, P662, DOI 10.1210/me.2008-0468; Guillemette C, 2004, BREAST CANCER RES, V6, P246, DOI 10.1186/bcr936; Kinoshita Y, 2003, CANCER RES, V63, P3546; Labrie F, 1998, STEROIDS, V63, P322, DOI 10.1016/S0039-128X(98)00007-5; MULDER KM, 1989, MOL ENDOCRINOL, V3, P1215, DOI 10.1210/mend-3-8-1215; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; Parker BS, 2003, CANCER BIOL THER, V2, P14; Rose D P, 2004, Obes Rev, V5, P153, DOI 10.1111/j.1467-789X.2004.00142.x; Russo J, 2006, J STEROID BIOCHEM, V102, P89, DOI 10.1016/j.jsbmb.2006.09.004; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Salhab M, 2006, BREAST CANCER RES TR, V99, P155, DOI 10.1007/s10549-006-9198-8; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Simpson ER, 2002, RECENT PROG HORM RES, V57, P317, DOI 10.1210/rp.57.1.317; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; STRAMM LE, 1987, EXP EYE RES, V44, P17, DOI 10.1016/S0014-4835(87)80021-0; TUBIANAHULIN M, 1991, BONE, V12, pS9, DOI 10.1016/8756-3282(91)90059-R; WANG TTY, 1995, CANCER RES, V55, P2487; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; YUE W, 1994, CANCER RES, V54, P5092	26	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121136	10.1371/journal.pone.0121136	http://dx.doi.org/10.1371/journal.pone.0121136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837259	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000039
J	Hajarizadeh, B; Grady, B; Page, K; Kim, AY; McGovern, BH; Cox, AL; Rice, TM; Sacks-Davis, R; Bruneau, J; Morris, M; Amin, J; Schinkel, J; Applegate, T; Maher, L; Hellard, M; Lloyd, AR; Prins, M; Dore, GJ; Grebely, J				Hajarizadeh, Behzad; Grady, Bart; Page, Kimberly; Kim, Arthur Y.; McGovern, Barbara H.; Cox, Andrea L.; Rice, Thomas M.; Sacks-Davis, Rachel; Bruneau, Julie; Morris, Meghan; Amin, Janaki; Schinkel, Janke; Applegate, Tanya; Maher, Lisa; Hellard, Margaret; Lloyd, Andrew R.; Prins, Maria; Dore, Gregory J.; Grebely, Jason		InC3 Study Grp	Patterns of Hepatitis C Virus RNA Levels during Acute Infection: The InC3 Study	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; INJECTION-DRUG USERS; NATURAL-HISTORY; HCV RNA; IL28B GENOTYPE; VIREMIA; EPIDEMIOLOGY; PERSISTENCE; EVOLUTION; DIAGNOSIS	Background Understanding the patterns of HCV RNA levels during acute hepatitis C virus (HCV) infection provides insights into immunopathogenesis and is important for vaccine design. This study evaluated patterns of HCV RNA levels and associated factors among individuals with acute infection. Methods Data were from an international collaboration of nine prospective cohorts of acute HCV (InC3 Study). Participants with well-characterized acute HCV infection (detected within three months post-infection and interval between the peak and subsequent HCV RNA levels <= 120 days) were categorised by a priori-defined patterns of HCV RNA levels: i) spontaneous clearance, ii) partial viral control with persistence (>= 1 log IU/mL decline in HCV RNA levels following peak) and iii) viral plateau with persistence (increase or < 1 log IU/mL decline in HCV RNA levels following peak). Factors associated with HCV RNA patterns were assessed using multinomial logistic regression. Results Among 643 individuals with acute HCV, 162 with well-characterized acute HCV were identified: spontaneous clearance (32%), partial viral control with persistence (27%), and viral plateau with persistence (41%). HCV RNA levels reached a high viraemic phase within two months following infection, with higher levels in the spontaneous clearance and partial viral control groups, compared to the viral plateau group (median: 6.0, 6.2, 5.3 log IU/mL, respectively; P=0.018). In the two groups with persistence, Interferon lambda 3 (IFNL3) CC genotype was independently associated with partial viral control compared to viral plateau (adjusted odds ratio [AOR]: 2.75; 95% CI: 1.08, 7.02). In the two groups with viral control, female sex was independently associated with spontaneous clearance compared to partial viral control (AOR: 2.86; 95% CI: 1.04, 7.83). Conclusions Among individuals with acute HCV, a spectrum of HCV RNA patterns is evident. IFNL3 CC genotype is associated with initial viral control, while female sex is associated with ultimate spontaneous clearance.	[Hajarizadeh, Behzad; Amin, Janaki; Applegate, Tanya; Maher, Lisa; Dore, Gregory J.; Grebely, Jason] Univ New S Wales, Kirby Inst, UNSW Australia, Sydney, NSW, Australia; [Grady, Bart; Prins, Maria] GGD Publ Hlth Serv Amsterdam, Cluster Infect Dis, Amsterdam, Netherlands; [Page, Kimberly; Rice, Thomas M.; Morris, Meghan] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kim, Arthur Y.] Harvard Univ, Sch Med, Boston, MA USA; [McGovern, Barbara H.] Tufts Med Sch, Boston, MA USA; [McGovern, Barbara H.] Abbvie, Chicago, IL USA; [Cox, Andrea L.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21205 USA; [Sacks-Davis, Rachel; Hellard, Margaret] Burnet Inst, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Bruneau, Julie] Univ Montreal, CRCHUM, Montreal, PQ, Canada; [Schinkel, Janke; Prins, Maria] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Lloyd, Andrew R.] UNSW Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Public Health Service Amsterdam; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Tufts Medical Center; Tufts University; AbbVie; Johns Hopkins University; Johns Hopkins Medicine; Burnet Institute; Monash University; Universite de Montreal; University of Amsterdam; Academic Medical Center Amsterdam; University of New South Wales Sydney	Hajarizadeh, B (corresponding author), Univ New S Wales, Kirby Inst, UNSW Australia, Sydney, NSW, Australia.	bhajarizadeh@kirby.unsw.edu.au	Hajarizadeh, Behzad/AAY-9361-2021; Lloyd, Andrew/AAF-6071-2022; Dore, Gregory John/ABD-5665-2021; Lloyd, Andrew/AFJ-8960-2022; Lauer, Georg/J-1467-2018	Hajarizadeh, Behzad/0000-0003-2212-2028; Lloyd, Andrew/0000-0001-6277-8887; Dore, Gregory John/0000-0002-4741-2622; Lloyd, Andrew/0000-0001-6277-8887; Amin, Janaki/0000-0003-2161-9366; Lauer, Georg/0000-0002-9792-4271; Maher, Lisa/0000-0001-6020-6519; Page, Kimberly/0000-0002-7120-1673; Sacks-Davis, Rachel/0000-0003-0860-2762; Cox, Andrea/0000-0002-9331-2462; Applegate, Tanya/0000-0002-8657-4261	National Institute on Drug Abuse Award [R01DA031056]; Australian Government Department of Health and Ageing; Australian Postgraduate PhD Award; National Health and Medical Research Council (NHMRC) Career Development Fellowship; NHMRC Practitioner Research Fellowships; NHMRC Senior Research Fellowships; VicHealth Senior Research Fellowship; NHMRC postgraduate scholarship; Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship; National Institutes of Health [RO1 DA 15999-01]; NIH [U19 AI088791, U19 AI066345, R01 DA033541, MOP-103138, MOP-210232]; Netherlands National Institute for Public Health and the Environment; NHMRC Project [630483]; Abbvie; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI088791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA016017, R01DA031056, R01DA033541, R01DA015999] Funding Source: NIH RePORTER; Alberta Innovates [201201140] Funding Source: researchfish	National Institute on Drug Abuse Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian Postgraduate PhD Award; National Health and Medical Research Council (NHMRC) Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowships(National Health and Medical Research Council (NHMRC) of Australia); VicHealth Senior Research Fellowship; NHMRC postgraduate scholarship(National Health and Medical Research Council (NHMRC) of Australia); Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands National Institute for Public Health and the Environment; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia); Abbvie(AbbVie); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Alberta Innovates	The InC<INF>3</INF> Study is supported by the National Institute on Drug Abuse Award Number R01DA031056. The Kirby Institute is funded by the Australian Government Department of Health and Ageing. BH is supported by an Australian Postgraduate PhD Award. JG is supported by a National Health and Medical Research Council (NHMRC) Career Development Fellowship. GD and AL are supported by NHMRC Practitioner Research Fellowships. MH and LM are supported by NHMRC Senior Research Fellowships and MH additionally by a VicHealth Senior Research Fellowship. RSD was supported by an NHMRC postgraduate scholarship and a Centre for Research Excellence into Injecting Drug Use postgraduate top-up scholarship. ATAHC is supported by National Institutes of Health grant number: RO1 DA 15999-01. Other research support includes NIH U19 AI088791 (AC), NIH U19 AI066345 (AK, BM), R01 DA033541 (AK), MOP-103138, MOP-210232 (JB), the Netherlands National Institute for Public Health and the Environment (MP), and NHMRC Project Grant #630483 (LM). BM received funding in the form of salary from the commercial company Abbvie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlenstiel Golo, 2013, Immune Netw, V13, P168, DOI 10.4110/in.2013.13.5.168; Badr G, 2008, J VIROL, V82, P10017, DOI 10.1128/JVI.01083-08; Balagopal A, 2010, GASTROENTEROLOGY, V139, P1865, DOI 10.1053/j.gastro.2010.10.004; Bowen DG, 2005, NATURE, V436, P946, DOI 10.1038/nature04079; Bull RA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002243; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Busch MP, 2001, TRANSFUS CLIN BIOL, V8, P200, DOI 10.1016/S1246-7820(01)00125-2; Cox AL, 2005, CLIN INFECT DIS, V40, P951, DOI 10.1086/428578; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Floreani A, 2011, EUR J GASTROEN HEPAT, V23, P997, DOI 10.1097/MEG.0b013e32834ae863; Glynn SA, 2005, TRANSFUSION, V45, P994, DOI 10.1111/j.1537-2995.2005.04390.x; Grady BPX, 2015, J VIRAL HEPATITIS, V22, P263, DOI 10.1111/jvh.12303; Grebely J, 2013, INT J EPIDEMIOL, V42, P1649, DOI 10.1093/ije/dys167; Grebely J, 2014, HEPATOLOGY, V59, P109, DOI 10.1002/hep.26639; Grebely J, 2012, LANCET INFECT DIS, V12, P408, DOI 10.1016/S1473-3099(12)70010-5; Grebely J, 2011, NAT REV GASTRO HEPAT, V8, P265, DOI 10.1038/nrgastro.2011.32; Grebely J, 2010, HEPATOLOGY, V52, P1216, DOI 10.1002/hep.23850; Hajarizadeh B, 2015, J VIRAL HEPATITIS, V22, P708, DOI 10.1111/jvh.12384; Hajarizadeh B, 2014, J CLIN VIROL, V61, P430, DOI 10.1016/j.jcv.2014.08.027; Hajarizadeh B, 2014, J MED VIROL, V86, P1722, DOI 10.1002/jmv.24010; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Harris HE, 2007, J VIRAL HEPATITIS, V14, P213, DOI 10.1111/j.1365-2893.2006.00795.x; Heller T, 2005, SEMIN LIVER DIS, V25, P7, DOI 10.1055/s-2005-864778; Hofer H, 2003, HEPATOLOGY, V37, P60, DOI 10.1053/jhep.2003.50019; Liu L, 2012, HEPATOLOGY, V55, P1684, DOI 10.1002/hep.25575; McGovern BH, 2009, CLIN INFECT DIS, V49, P1051, DOI 10.1086/605561; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Naggie S, 2012, HEPATOLOGY, V56, P444, DOI 10.1002/hep.25647; Page K, 2009, J INFECT DIS, V200, P1216, DOI 10.1086/605947; Page-Shafer K, 2008, J CLIN MICROBIOL, V46, P499, DOI 10.1128/JCM.01229-07; Ray SC, 1999, J VIROL, V73, P2938, DOI 10.1128/JVI.73.4.2938-2946.1999; Sacks-Davis R, 2013, 20 INT S HEP C VIR R; Smith JA, 2010, J INFECT DIS, V202, P1770, DOI 10.1086/657317; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; Thomson EC, 2011, J GEN VIROL, V92, P2227, DOI 10.1099/vir.0.033910-0; Thomson EC, 2011, GUT, V60, P837, DOI 10.1136/gut.2010.217166; Tillmann HL, 2010, GASTROENTEROLOGY, V139, P1586, DOI 10.1053/j.gastro.2010.07.005; Uccellini L, 2012, HEPATOLOGY, V56, P86, DOI 10.1002/hep.25652; van de Laar TJW, 2009, J HEPATOL, V51, P667, DOI 10.1016/j.jhep.2009.05.027; van den Berg CHBS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027555; Villa E, 2011, GASTROENTEROLOGY, V140, P818, DOI 10.1053/j.gastro.2010.12.027; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Wang CC, 2007, J INFECT DIS, V196, P1474, DOI 10.1086/522608; Zeuzem S, 2012, J VIRAL HEPATITIS, V19, P766, DOI 10.1111/j.1365-2893.2012.01624.x; Zhang MD, 2006, BLOOD, V107, P892, DOI 10.1182/blood-2005-07-2781	47	30	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122232	10.1371/journal.pone.0122232	http://dx.doi.org/10.1371/journal.pone.0122232			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837807	Green Published, gold			2022-12-26	WOS:000352139000087
J	Pardini, EA; Vickstrom, KE; Knight, TM				Pardini, Eleanor A.; Vickstrom, Kyle E.; Knight, Tiffany M.			Early Successional Microhabitats Allow the Persistence of Endangered Plants in Coastal Sand Dunes	PLOS ONE			English	Article							POPULATION VIABILITY; GRASSLAND MANAGEMENT; CONSERVATION; DISTURBANCE; BURIAL; BIODIVERSITY; DYNAMICS; REGIMES; KEY	Many species are adapted to disturbance and occur within dynamic, mosaic landscapes that contain early and late successional microhabitats. Human modification of disturbance regimes alters the availability of microhabitats and may affect the viability of species in these ecosystems. Because restoring historical disturbance regimes is typically expensive and requires action at large spatial scales, such restoration projects must be justified by linking the persistence of species with successional microhabitats. Coastal sand dune ecosystems worldwide are characterized by their endemic biodiversity and frequent disturbance. Dune-stabilizing invasive plants alter successional dynamics and may threaten species in these ecosystems. We examined the distribution and population dynamics of two federally endangered plant species, the annual Layia carnosa and the perennial Lupinus tidestromii, within a dune ecosystem in northern California, USA. We parameterized a matrix population model for L. tidestromii and examined the magnitude by which the successional stage of the habitat (early or late) influenced population dynamics. Both species had higher frequencies and L. tidestromii had higher frequency of seedlings in early successional habitats. Lupinus tidestromii plants in early successional microhabitats had higher projected rates of population growth than those associated with stabilized, late successional habitats, due primarily to higher rates of recruitment in early successional microhabitats. These results support the idea that restoration of disturbance is critical in historically dynamic landscapes. Our results suggest that large-scale restorations are necessary to allow persistence of the endemic plant species that characterize these ecosystems.	[Pardini, Eleanor A.; Vickstrom, Kyle E.; Knight, Tiffany M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pardini, EA (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	epardini@wustl.edu			National Science Foundation DEB Award [0743731]	National Science Foundation DEB Award	Funding for this project was provided by National Science Foundation DEB Award number 0743731 to TMK and EAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, MARINE COASTAL ECOSY; BARBOUR MG, 1976, J BIOGEOGR, V3, P55; BOYD RS, 1988, AM J BOT, V75, P1540, DOI 10.2307/2444704; BRECKON G J, 1974, Madrono, V22, P333; Brunbjerg AK, 2014, BIOL CONSERV, V174, P101, DOI 10.1016/j.biocon.2014.04.002; Brys R, 2004, J APPL ECOL, V41, P1080, DOI 10.1111/j.0021-8901.2004.00981.x; Caswell, 2000, MATRIX POPULATION MO; Clarke K. R., 2009, PRIMER V6 USER MANUA; Cowles Henry C., 1899, ECOLOGICAL RELATIONS, V27, P95117; Crone EE, 2011, ECOL LETT, V14, P1, DOI 10.1111/j.1461-0248.2010.01540.x; Dangremond EM, 2010, ECOLOGY, V91, P2261, DOI 10.1890/09-0418.1; Driscoll DA, 2010, BIOL CONSERV, V143, P1928, DOI 10.1016/j.biocon.2010.05.026; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Evens J.G., 2008, NATURAL HIST POINT R; Hacker SD, 2012, OIKOS, V121, P138, DOI 10.1111/j.1600-0706.2011.18887.x; Hilton MJ, 2006, NEW ZEAL GEOGR, V62, P105, DOI 10.1111/j.1745-7939.2006.00054.x; Hyland T, 2005, CONTR EUR BEACHGR AM; Kollmann J, 2007, BIOL INVASIONS, V9, P31, DOI 10.1007/s10530-006-9003-y; Kollmann J, 2011, RESTOR ECOL, V19, P371, DOI 10.1111/j.1526-100X.2009.00569.x; KRUCKEBERG AR, 1985, ANNU REV ECOL SYST, V16, P447, DOI 10.1146/annurev.es.16.110185.002311; Lennartsson T, 2001, J ECOL, V89, P451, DOI 10.1046/j.1365-2745.2001.00566.x; Liu H, 2005, ECOL APPL, V15, P210, DOI 10.1890/03-5382; Mack MC, 1998, TRENDS ECOL EVOL, V13, P195, DOI 10.1016/S0169-5347(97)01286-X; Martinez M., 2004, ECOL STUD, V171, P390; Math Works, 2012, MATLAB R2012B; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; Maun MA, 2004, ECOL STU AN, V171, P119; MIYANISHI K, 2007, PLANT DISTURBANCE EC, P249; Muir JJ, 2010, CONDOR, V112, P507, DOI 10.1525/cond.2010.090196; Parsons L. P., 2012, ANN REPORT 2001 2011; Pascarella JB, 1998, ECOLOGY, V79, P547, DOI 10.2307/176952; Pickart AJ, 1998, ECOLOGY RESTORATION; Pickart AJ, 2007, CONTR EUR BEACHGR AM; Pickart AJ, 2007, TERRESTRIAL VEGETATION OF CALIFORNIA, 3RD EDITION, P155; Pickart Andrea J., 2008, Grasslands, V18, P4; Pitts WD, 1979, AM MIDL NAT, V10, P38; Quintana-Ascencio PF, 2003, CONSERV BIOL, V17, P433, DOI 10.1046/j.1523-1739.2003.01431.x; Skinner MW, 1994, CNPS SPECIAL PUBLICA, V1; Smith M, 2005, ECOL APPL, V15, P1036, DOI 10.1890/04-0434; USFWS, 2009, LUP TID CLOV LUP 5 Y, P22; USFWS, 2007, REC PLAN PAC COAST P; USFWS, 1998, 7 COAST PLANTS MYRTL, P141; vanderMeulen F, 1996, OCEAN COAST MANAGE, V30, P177, DOI 10.1016/0964-5691(95)00060-7; Wiedemann AM, 1996, LANDSCAPE URBAN PLAN, V34, P287, DOI 10.1016/0169-2046(95)00240-5	44	23	23	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119567	10.1371/journal.pone.0119567	http://dx.doi.org/10.1371/journal.pone.0119567			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835390	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000011
J	Sarrou, S; Liakopoulos, A; Chasioti, M; Foka, A; Fthenakis, G; Billinis, C; Spyrou, V; Pantelidi, K; Roussaki-Schulze, A; Lachanas, V; Makaritsis, K; Skoulakis, C; Daikos, GL; Dalekos, G; Spiliopoulou, I; Petinaki, E				Sarrou, Styliani; Liakopoulos, Apostolos; Chasioti, Markella; Foka, Antigoni; Fthenakis, Georgios; Billinis, Charalampos; Spyrou, Vassiliki; Pantelidi, Kleoniki; Roussaki-Schulze, Angeliki; Lachanas, Vassilios; Makaritsis, Konstantinos; Skoulakis, Charalampos; Daikos, Georgios L.; Dalekos, Georgios; Spiliopoulou, Iris; Petinaki, Efthymia			Dissemination of Methicillin-Susceptible CC398 Staphylococcus aureus Strains in a Rural Greek Area	PLOS ONE			English	Article							PIG FARMERS; RESISTANT; GENES; BACTERIOPHAGES; ST398-T571; HOSPITALS; DIVERSITY; ERM(T)	A large collection of Staphylococcus aureus including a. 745 clinically significant isolates that were consecutively recovered from human infections during 2012-2013, b. 19 methicillin- susceptible (MSSA), randomly selected between 2006-2011 from our Staphylococcal Collection, c. 16 human colonizing isolates, and d. 10 strains from colonized animals was investigated for the presence and the molecular characteristics of CC398. The study was conducted in Thessaly, a rural region in Greece. The differentiation of livestock-associated clade from the human clade was based on canSNPs combined with the presence of the phi 3 bacteriophage and the tetM, scn, sak, and chp genes. Among the 745 isolates, two MRSA (0.8% of total MRSA) and thirteen MSSA (2.65% of total MSSA) were found to belong to CC398, while, between MSSA of our Staphylococcal Collection, one CC398, isolated in 2010, was detected. One human individual, without prior contact with animals, was found to be colonized by a MSSA CC398. No CC398 was identified among the 10 S. aureus isolated from animals. Based on the molecular markers, the 17 CC398 strains were equally placed in the livestock-associated and in the human clades. This is the first report for the dissemination of S. aureus CC398 among humans in Greece.	[Sarrou, Styliani; Liakopoulos, Apostolos; Petinaki, Efthymia] Univ Hosp Larissa, Dept Microbiol, Larisa, Greece; [Chasioti, Markella; Pantelidi, Kleoniki; Roussaki-Schulze, Angeliki] Univ Hosp Larissa, Dept Dermatol, Larisa, Greece; [Foka, Antigoni; Spiliopoulou, Iris] Univ Patras, Sch Med, Dept Microbiol, Natl Staphylococcal Reference Lab, GR-26110 Patras, Greece; [Fthenakis, Georgios; Billinis, Charalampos] Univ Thessaly, Fac Vet Med, Kardhitsa, Greece; [Spyrou, Vassiliki] Technol Educ Inst Thessaly, Larisa, Greece; [Lachanas, Vassilios; Skoulakis, Charalampos] Univ Hosp Larissa, Dept Otorhinolaryngol, Larisa, Greece; [Daikos, Georgios L.] Univ Athens, Dept Propaedeut Med 1, Athens, Greece; [Makaritsis, Konstantinos; Dalekos, Georgios] Univ Hosp Larissa, Dept Med, Larisa, Greece; [Makaritsis, Konstantinos; Dalekos, Georgios] Univ Hosp Larissa, Res Lab Internal Med, Larisa, Greece	General University Hospital of Larissa; General University Hospital of Larissa; University of Patras; University of Thessaly; General University Hospital of Larissa; National & Kapodistrian University of Athens; General University Hospital of Larissa; General University Hospital of Larissa	Petinaki, E (corresponding author), Univ Hosp Larissa, Dept Microbiol, Larisa, Greece.	petinaki@med.uth.gr	Lachanas, Vasileios A/H-6807-2019; Daikos, George L./ABD-8378-2021	Lachanas, Vasileios A/0000-0002-4501-3257; Skoulakis, Charalampos/0000-0003-1711-6811; Liakopoulos, Apostolos/0000-0002-3240-8444; Sarrou, Styliani/0000-0001-8134-9228				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Camoez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072828; Chini V, 2006, CLIN MICROBIOL INFEC, V12, P29, DOI 10.1111/j.1469-0691.2005.01295.x; Chroboczek T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068462; Drougka E, 2014, CLIN MICROBIOL INFEC, V20, pO796, DOI 10.1111/1469-0691.12624; Drougka E, 2012, Indian J Med Microbiol, V30, P232, DOI 10.4103/0255-0857.96706; European Committee on Antimicrobial Susceptibility Testing (EUCAST), 2012, BREAKPOINT TABLES IN; Goerke C, 2009, J BACTERIOL, V191, P3462, DOI 10.1128/JB.01804-08; Gomez-Sanz E, 2013, J ANTIMICROB CHEMOTH, V68, P471, DOI 10.1093/jac/dks411; Gomez-Sanz E, 2010, FOODBORNE PATHOG DIS, V7, P1269, DOI 10.1089/fpd.2010.0610; He WQ, 2013, INT J ANTIMICROB AG, V42, P211, DOI 10.1016/j.ijantimicag.2013.04.031; Khanna T, 2008, VET MICROBIOL, V128, P298, DOI 10.1016/j.vetmic.2007.10.006; Kock R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055040; Kumagai R, 2007, VET MICROBIOL, V122, P190, DOI 10.1016/j.vetmic.2007.01.008; Lozano C, 2011, CLIN MICROBIOL INFEC, V17, P923, DOI 10.1111/j.1469-0691.2010.03437.x; McCarthy AJ, 2012, APPL ENVIRON MICROB, V78, P8845, DOI 10.1128/AEM.02398-12; Stegger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079645; Uhlemann AC, 2013, CLIN INFECT DIS, V57, P700, DOI 10.1093/cid/cit375; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, EMERG INFECT DIS, V17, P502, DOI 10.3201/eid1703.101036; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vandendriessche S, 2011, J ANTIMICROB CHEMOTH, V66, P2455, DOI 10.1093/jac/dkr348; Yan XM, 2014, INT J MED MICROBIOL, V304, P379, DOI 10.1016/j.ijmm.2013.12.003; Zhao CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038577	26	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122761	10.1371/journal.pone.0122761	http://dx.doi.org/10.1371/journal.pone.0122761			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835293	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000110
J	Shaeib, F; Khan, SN; Ali, I; Najafi, T; Maitra, D; Abdulhamid, I; Saed, GM; Pennathur, S; Abu-Soud, HM				Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Abdulhamid, Ibrahim; Saed, Ghassan M.; Pennathur, Subramaniam; Abu-Soud, Husam M.			Melatonin Prevents Myeloperoxidase Heme Destruction and the Generation of Free Iron Mediated by Self-Generated Hypochlorous Acid	PLOS ONE			English	Article							NITRIC-OXIDE; MAMMALIAN PEROXIDASES; CATALYTIC-ACTIVITY; HYDROGEN-PEROXIDE; ANTIOXIDANT ACTIVITY; TAURINE CHLORAMINE; POTENTIAL ROLE; MECHANISM; CHLORIDE; OXIDATION	Myeloperoxidase (MPO) generated hypochlorous acid (HOCl) formed during catalysis is able to destroy the MPO heme moiety through a feedback mechanism, resulting in the accumulation of free iron. Here we show that the presence of melatonin (MLT) can prevent HOCl-mediated MPO heme destruction using a combination of UV-visible photometry, hydrogen peroxide (H2O2)-specific electrode, and ferrozine assay techniques. High performance liquid chromatography (HPLC) analysis showed that MPO heme protection was at the expense of MLT oxidation. The full protection of the MPO heme requires the presence of a 1:2 MLT to H2O2 ratio. Melatonin prevents HOCl-mediated MPO heme destruction through multiple pathways. These include competition with chloride, the natural co-substrate; switching the MPO activity from a two electron oxidation to a one electron pathway causing the buildup of the inactive Compound II, and its subsequent decay to MPO-Fe(III) instead of generating HOCl; binding to MPO above the heme iron, thereby preventing the access of H2O2 to the catalytic site of the enzyme; and direct scavenging of HOCl. Collectively, in addition to acting as an antioxidant and MPO inhibitor, MLT can exert its protective effect by preventing the release of free iron mediated by self-generated HOCl. Our work may establish a direct mechanistic link by which MLT exerts its antioxidant protective effect in chronic inflammatory diseases with MPO elevation.	[Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet, Detroit, MI 48202 USA; [Shaeib, Faten; Khan, Sana N.; Ali, Iyad; Najafi, Tohid; Maitra, Dhiman; Saed, Ghassan M.; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Gynecol, Detroit, MI USA; [Ali, Iyad] An Najah Natl Univ, Fac Med, Dept Biochem & Genet, Nablus, Israel; [Najafi, Tohid; Abu-Soud, Husam M.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI USA; [Abdulhamid, Ibrahim] Childrens Hosp Michigan, Detroit, MI 48201 USA; [Pennathur, Subramaniam] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA	Wayne State University; Wayne State University; An Najah National University; Wayne State University; Children's Hospital of Michigan; University of Michigan System; University of Michigan	Abu-Soud, HM (corresponding author), Wayne State Univ, Sch Med, CS Mott Ctr Human Growth & Dev, Dept Obstet, Detroit, MI 48202 USA.	habusoud@med.wayne.edu	; Ali, Imran/F-7710-2010	, dhiman/0000-0002-8775-2963; Ali, Iyad/0000-0002-3921-6859; Ali, Imran/0000-0001-6511-8374	National Institutes of Health [RO1 HL066367, HL094230, DK097153]; Children's Hospital of Michigan, Detroit, Michigan, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066367, R01HL094230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097153, P30DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Michigan, Detroit, Michigan, USA; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant to H. M.A-S. from National Institutes of Health RO1 HL066367, HL094230, and DK097153 and a grant from the Children's Hospital of Michigan, Detroit, Michigan, USA. I.A. is a Senior Fulbright Research Scholar in Dr. Abu-Soud lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Soud HM, 2000, J BIOL CHEM, V275, P37524, DOI 10.1074/jbc.275.48.37524; Abu-Soud HM, 2000, J BIOL CHEM, V275, P5425, DOI 10.1074/jbc.275.8.5425; Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Abu-Soud HM, 2012, FREE RADICAL BIO MED, V52, P616, DOI 10.1016/j.freeradbiomed.2011.10.496; Allegra M, 2001, BIOCHEM BIOPH RES CO, V282, P380, DOI 10.1006/bbrc.2001.4582; Allen RC, 2011, INFECT IMMUN, V79, P474, DOI 10.1128/IAI.00910-09; ANDREWS PC, 1982, J BIOL CHEM, V257, P13240; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Banerjee J, 2012, J PINEAL RES, V53, P122, DOI 10.1111/j.1600-079X.2012.00977.x; Bonini MG, 2007, FREE RADICAL BIO MED, V42, P530, DOI 10.1016/j.freeradbiomed.2006.11.019; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrillo-Vico A, 2005, ENDOCRINE, V27, P189, DOI 10.1385/ENDO:27:2:189; CARTER P, 1971, ANAL BIOCHEM, V40, P450, DOI 10.1016/0003-2697(71)90405-2; Carvalho LC, 2010, BIOORG MED CHEM LETT, V20, P6475, DOI 10.1016/j.bmcl.2010.09.067; Chau Lee-Young, 2000, Proceedings of the National Science Council Republic of China Part B Life Sciences, V24, P151; Comai S, 2014, J PSYCHIATR NEUROSCI, V39, P6, DOI 10.1503/jpn.130009; Davies MJ, 2008, ANTIOXID REDOX SIGN, V10, P1199, DOI 10.1089/ars.2007.1927; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; Dellegar SM, 1999, BIOCHEM BIOPH RES CO, V257, P431, DOI 10.1006/bbrc.1999.0438; Furtmuller PG, 2000, REDOX REP, V5, P173, DOI 10.1179/135100000101535717; Galano A, 2013, J PINEAL RES, V54, P245, DOI 10.1111/jpi.12010; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Galijasevic S, 2004, J BIOL CHEM, V279, P39465, DOI 10.1074/jbc.M406003200; Galijasevic S, 2003, P NATL ACAD SCI USA, V100, P14766, DOI 10.1073/pnas.2435008100; Galijasevic S, 2008, FREE RADICAL BIO MED, V44, P1570, DOI 10.1016/j.freeradbiomed.2008.01.003; Galijasevic S, 2008, BIOCHEMISTRY-US, V47, P2668, DOI 10.1021/bi702016q; Galijasevic S, 2009, FREE RADICAL BIO MED, V47, P431, DOI 10.1016/j.freeradbiomed.2009.05.017; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Gulcin I, 2003, J PINEAL RES, V34, P278; Hallingback HR, 2006, BIOCHEMISTRY-US, V45, P2940, DOI 10.1021/bi051510e; Hantke K, 2001, CURR OPIN MICROBIOL, V4, P172, DOI 10.1016/S1369-5274(00)00184-3; Hardeland R, 2009, BIOFACTORS, V35, P183, DOI 10.1002/biof.23; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; Jung-Hynes B, 2010, J PINEAL RES, V49, P60, DOI 10.1111/j.1600-079X.2010.00767.x; Jung-Hynes B, 2010, J PINEAL RES, V48, P9, DOI 10.1111/j.1600-079X.2009.00729.x; Lu T, 2008, BRIT J PHARMACOL, V154, P1308, DOI 10.1038/bjp.2008.173; Maitra D, 2013, FREE RADICAL BIO MED, V63, P90, DOI 10.1016/j.freeradbiomed.2013.04.009; Maitra D, 2012, J PINEAL RES, V53, P198, DOI 10.1111/j.1600-079X.2012.00988.x; Maitra D, 2011, FREE RADICAL BIO MED, V51, P374, DOI 10.1016/j.freeradbiomed.2011.04.011; Maitra D, 2011, FREE RADICAL BIO MED, V51, P364, DOI 10.1016/j.freeradbiomed.2011.03.040; Reiter RM, 2011, MEDIATED BUSINESS INTERACTIONS: INTERCULTURAL COMMUNICATION BETWEEN SPEAKERS OF SPANISH, P22; Marshall KA, 1996, FREE RADICAL BIO MED, V21, P307, DOI 10.1016/0891-5849(96)00046-9; Mauriz JL, 2013, J PINEAL RES, V54, P1, DOI 10.1111/j.1600-079X.2012.01014.x; MOHAMED AO, 1993, AM J TROP MED HYG, V49, P799, DOI 10.4269/ajtmh.1993.49.799; Nicholls SJ, 2005, ARTERIOSCL THROM VAS, V25, P1102, DOI 10.1161/01.ATV.0000163262.83456.6d; Ogino T, 2009, ADV EXP MED BIOL, V643, P451, DOI 10.1007/978-0-387-75681-3_47; Ohshima H, 2003, ARCH BIOCHEM BIOPHYS, V417, P3, DOI 10.1016/S0003-9861(03)00283-2; Ong WY, 2004, ANN NY ACAD SCI, V1012, P51, DOI 10.1196/annals.1306.005; Park SY, 2010, J PINEAL RES, V48, P178, DOI 10.1111/j.1600-079X.2009.00742.x; Paumann-Page M, 2013, ARCH BIOCHEM BIOPHYS, V539, P51, DOI 10.1016/j.abb.2013.09.004; Pennathur S, 2010, FREE RADICAL BIO MED, V49, P205, DOI 10.1016/j.freeradbiomed.2010.04.003; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Proteasa G, 2007, BIOCHEMISTRY-US, V46, P398, DOI 10.1021/bi0609725; RAKITA RM, 1990, BIOCHEMISTRY-US, V29, P1075, DOI 10.1021/bi00456a033; REITER RJ, 1991, ENDOCR REV, V12, P151, DOI 10.1210/edrv-12-2-151; REITER RJ, 1991, MOL CELL ENDOCRINOL, V79, pC153, DOI 10.1016/0303-7207(91)90087-9; Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Rozov SV, 2003, J PINEAL RES, V35, P245, DOI 10.1034/j.1600-079X.2003.00081.x; Schaffer SW, 2009, CAN J PHYSIOL PHARM, V87, P91, DOI 10.1139/Y08-110; Schiller J, 2003, CURR MED CHEM, V10, P2123, DOI 10.2174/0929867033456828; Sliskovic I, 2009, FREE RADICAL BIO MED, V47, P1005, DOI 10.1016/j.freeradbiomed.2009.07.007; Souza CEA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027641; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tekbas OF, 2008, J PINEAL RES, V44, P222, DOI 10.1111/j.1600-079X.2007.00516.x; Tesoriere L, 1999, J PINEAL RES, V27, P95, DOI 10.1111/j.1600-079X.1999.tb00602.x; Trinder D, 2002, GUT, V51, P290, DOI 10.1136/gut.51.2.290; Tzikas S, 2014, J ALZHEIMERS DIS, V39, P557, DOI 10.3233/JAD-131469; van der Vliet A, 2000, AM J PHYSIOL-LUNG C, V279, pL537, DOI 10.1152/ajplung.2000.279.3.L537; vanDalen CJ, 1997, BIOCHEM J, V327, P487; Gomez FJV, 2012, J PINEAL RES, V52, P349, DOI 10.1111/j.1600-079X.2011.00949.x; Wang L, 2007, J Burns Wounds, V6, pe5; Weinberg ED, 2000, MICROBES INFECT, V2, P85, DOI 10.1016/S1286-4579(00)00281-1; Weinberg ED, 2000, BIOMETALS, V13, P85, DOI 10.1023/A:1009293500209; Ximenes VF, 2010, J PINEAL RES, V49, P115, DOI 10.1111/j.1600-079X.2010.00772.x; Ximenes VF, 2005, J BIOL CHEM, V280, P38160, DOI 10.1074/jbc.M506384200; Yang YTT, 2012, LIFE SCI, V90, P682, DOI 10.1016/j.lfs.2012.03.002	77	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120737	10.1371/journal.pone.0120737	http://dx.doi.org/10.1371/journal.pone.0120737			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835505	gold, Green Submitted, Green Published			2022-12-26	WOS:000352139000032
J	Gohari, IM; Parreira, VR; Nowell, VJ; Nicholson, VM; Oliphant, K; Prescott, JF				Gohari, Iman Mehdizadeh; Parreira, Valeria R.; Nowell, Victoria J.; Nicholson, Vivian M.; Oliphant, Kaitlyn; Prescott, John F.			A Novel Pore-Forming Toxin in Type A Clostridium perfringens Is Associated with Both Fatal Canine Hemorrhagic Gastroenteritis and Fatal Foal Necrotizing Enterocolitis	PLOS ONE			English	Article							ADULT HORSES; GENE; EXPRESSION; NETB; IDENTIFICATION; DIFFICILE; ENTERITIS; DIARRHEA; FECES; CPB2	A role for type A Clostridium perfringens in acute hemorrhagic and necrotizing gastroenteritis in dogs and in necrotizing enterocolitis of neonatal foals has long been suspected but incompletely characterized. The supernatants of an isolate made from a dog and from a foal that died from these diseases were both found to be highly cytotoxic for an equine ovarian (EO) cell line. Partial genome sequencing of the canine isolate revealed three novel putative toxin genes encoding proteins related to the pore-forming Leukocidin/Hemolysin Superfamily; these were designated netE, netF, and netG. netE and netF were located on one large conjugative plasmid, and netG was located with a cpe enterotoxin gene on a second large conjugative plasmid. Mutation and complementation showed that only netF was associated with the cytotoxicity. Although netE and netG were not associated with cytotoxicity, immuno-blotting with specific antisera showed these proteins to be expressed in vitro. There was a highly significant association between the presence of netF with type A strains isolated from cases of canine acute hemorrhagic gastroenteritis and foal necrotizing enterocolitis. netE and netF were found in all cytotoxic isolates, as was cpe, but netG was less consistently present. Pulsed-field gel electrophoresis showed that netF-positive isolates belonged to a clonal population; some canine and equine netF-positive isolates were genetically indistinguishable. Equine antisera to recombinant Net proteins showed that only antiserum to rNetF had high supernatant cytotoxin neutralizing activity. The identifica-tion of this novel necrotizing toxin is an important advance in understanding the virulence of type A C. perfringens in specific enteric disease of animals.	[Gohari, Iman Mehdizadeh; Parreira, Valeria R.; Nowell, Victoria J.; Nicholson, Vivian M.; Oliphant, Kaitlyn; Prescott, John F.] Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	University of Guelph	Prescott, JF (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON N1G 2W1, Canada.	prescott@uoguelph.ca			Natural Sciences and Engineering Discovery Grant; Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program); Ontario Centres of Excellence (C4 Proof of Principle grant program); Equine Guelph - University of Guelph	Natural Sciences and Engineering Discovery Grant; Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program); Ontario Centres of Excellence (C4 Proof of Principle grant program); Equine Guelph - University of Guelph	Funding was provided from Natural Sciences and Engineering Discovery Grant, by the Ontario Ministry of Agriculture, Food and Rural Affairs (Proof of Principle grant program), and by the Ontario Centres of Excellence (C4 Proof of Principle grant program). Equine Guelph - University of Guelph funds supported the initial steps of this study.	Alonzo F, 2014, MICROBIOL MOL BIOL R, V78, P199, DOI 10.1128/MMBR.00055-13; Bacciarini LN, 2003, VET PATHOL, V40, P376, DOI 10.1354/vp.40-4-376; Bannam TL, 2006, J BACTERIOL, V188, P4942, DOI 10.1128/JB.00298-06; Bannam TL, 2011, MBIO, V2, DOI 10.1128/mBio.00190-11; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; BURROWS CF, 1977, J AM ANIM HOSP ASSOC, V13, P451; Chalmers G, 2008, VET MICROBIOL, V127, P116, DOI 10.1016/j.vetmic.2007.08.008; Chase K, 2009, J HERED, V100, pS37, DOI 10.1093/jhered/esp011; Cheung JK, 2010, INFECT IMMUN, V78, P3064, DOI 10.1128/IAI.00123-10; Cheung JK, 2004, J BACTERIOL, V186, P3321, DOI 10.1128/JB.186.11.3321-3330.2004; da Costa SPF, 2014, TOXINS, V6, P1049, DOI 10.3390/toxins6031049; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Deguchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005598; Diab SS, 2012, VET PATHOL, V49, P255, DOI 10.1177/0300985811404710; Donahue M, 2002, EQUINE DIS Q, V10, P4; Donaldson MT, 1999, J AM VET MED ASSOC, V215, P358; East LM, 1998, J AM VET MED ASSOC, V212, P1751; East LM, 2000, PREV VET MED, V46, P61, DOI 10.1016/S0167-5877(00)00131-8; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; GLASER AL, 1995, J GEN VIROL, V76, P2223, DOI 10.1099/0022-1317-76-9-2223; Gohari IM, 2014, CAN J VET RES, V78, P1; Hazlett MJ, 2011, J VET DIAGN INVEST, V23, P373, DOI 10.1177/104063871102300232; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Herholz C, 1999, J CLIN MICROBIOL, V37, P358, DOI 10.1128/JCM.37.2.358-361.1999; Hibberd MC, 2011, J CLIN MICROBIOL, V49, P1556, DOI 10.1128/JCM.01884-10; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; Huyet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066673; Jost BH, 2006, VET MICROBIOL, V116, P158, DOI 10.1016/j.vetmic.2006.03.025; KANOE M, 1990, MICROBIOS, V64, P153; Keyburn AL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040026; Kircanski J, 2012, VET MICROBIOL, V159, P371, DOI 10.1016/j.vetmic.2012.04.007; Kircanski J, 2012, J VET DIAGN INVEST, V24, P895, DOI 10.1177/1040638712453584; Lepp D, 2013, J BACTERIOL, V195, P1152, DOI 10.1128/JB.01032-12; Lepp D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010795; Li JH, 2013, MICROBIOL MOL BIOL R, V77, P208, DOI 10.1128/MMBR.00062-12; Ma ML, 2014, INFECT IMMUN, V82, P2958, DOI 10.1128/IAI.01848-14; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marks SL, 2012, INFECTIOUS DISEASES, P393; McGavin MD, 2007, PATHOLOGIC BASIS OF; Netherwood T, 1998, VET J, V155, P289, DOI 10.1016/S1090-0233(05)80025-5; Nowell VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032271; Obana N, 2011, J BACTERIOL, V193, P4417, DOI 10.1128/JB.00262-11; Ohtani K, 2010, ANAEROBE, V16, P258, DOI 10.1016/j.anaerobe.2009.10.003; Parreira VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049753; Popoff MR, 2013, TOXICON, V75, P63, DOI 10.1016/j.toxicon.2013.05.003; PRESCOTT JF, 1978, VET REC, V103, P116, DOI 10.1136/vr.103.6.116; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; QUIGLEY JD, 1995, J DAIRY SCI, V78, P1573, DOI 10.3168/jds.S0022-0302(95)76780-7; Roth F, 1999, FEMS IMMUNOL MED MIC, V24, P353, DOI 10.1016/S0928-8244(99)00053-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sasaki J, 1999, J VET MED SCI, V61, P175, DOI 10.1292/jvms.61.175; Savva CG, 2013, J BIOL CHEM, V288, P3512, DOI 10.1074/jbc.M112.430223; Schlegel BJ, 2012, CAN VET J, V53, P555; Shimizu T, 2002, MOL MICROBIOL, V43, P257, DOI 10.1046/j.1365-2958.2002.02743.x; Songer JG, 1996, CLIN MICROBIOL REV, V9, P216, DOI 10.1128/CMR.9.2.216; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Thompson DR, 2006, VET MICROBIOL, V113, P25, DOI 10.1016/j.vetmic.2005.10.015; Tillotson K, 2002, J AM VET MED ASSOC, V220, P342, DOI 10.2460/javma.2002.220.342; Timoney JF, 2005, VET REC, V157, P810, DOI 10.1136/vr.157.25.810; TRAUBDARGATZ JL, 1993, VET CLIN N AM-EQUINE, V9, P411, DOI 10.1016/S0749-0739(17)30407-8; Unterer S, 2014, J VET INTERN MED, V28, P52, DOI 10.1111/jvim.12236; Vilei EM, 2005, MOL MICROBIOL, V57, P1570, DOI 10.1111/j.1365-2958.2005.04789.x; Waters M, 2005, J CLIN MICROBIOL, V43, P4002, DOI 10.1128/JCM.43.8.4002-4009.2005; Weese JS, 2001, J VET INTERN MED, V15, P374, DOI 10.1892/0891-6640(2001)015&lt;0374:TRODAE&gt;2.3.CO;2; Yan XX, 2013, MBIO, V4, DOI 10.1128/mBio.00019-13; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	67	75	78	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122684	10.1371/journal.pone.0122684	http://dx.doi.org/10.1371/journal.pone.0122684			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853427	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400077
J	Rivera-Barahona, A; Sanchez-Alcudia, R; Viecelli, HM; Rufenacht, V; Perez, B; Ugarte, M; Haberle, J; Thony, B; Desviat, LR				Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Viecelli, Hiu Man; Ruefenacht, Veronique; Perez, Belen; Ugarte, Magdalena; Haeberle, Johannes; Thoeny, Beat; Ruiz Desviat, Lourdes			Functional Characterization of the spf/ash Splicing Variation in OTC Deficiency of Mice and Man	PLOS ONE			English	Article							ORNITHINE TRANSCARBAMYLASE DEFICIENCY; UREA CYCLE DISORDERS; MUTATIONS; GENE; DISEASE; MOUSE; SITE; THERAPEUTICS; DELIVERY; CARBAMOYLTRANSFERASE	The spf/ash mouse model of ornithine transcarbamylase (OTC) deficiency, a severe urea cycle disorder, is caused by a mutation (c.386G>A; p.R129H) in the last nucleotide of exon 4 of the Otc gene, affecting the 5' splice site and resulting in partial use of a cryptic splice site 48 bp into the adjacent intron. The equivalent nucleotide change and predicted amino acid change is found in OTC deficient patients. Here we have used liver tissue and minigene assays to dissect the transcriptional profile resulting from the "spf/ash" mutation in mice and man. For the mutant mouse, we confirmed liver transcripts corresponding to partial intron 4 retention by the use of the c.386+48 cryptic site and to normally spliced transcripts, with exon 4 always containing the c.386G>A (p.R129H) variant. In contrast, the OTC patient exhibited exon 4 skipping or c.386G>A (p.R129H)-variant exon 4 retention by using the natural or a cryptic splice site at nucleotide position c.386+4. The corresponding OTC tissue enzyme activities were between 3-6% of normal control in mouse and human liver. The use of the cryptic splice sites was reproduced in minigenes carrying murine or human mutant sequences. Some normally spliced transcripts could be detected in minigenes in both cases. Antisense oligonucleotides designed to block the murine cryptic +48 site were used in minigenes in an attempt to redirect splicing to the natural site. The results highlight the relevance of in depth investigations of the molecular mechanisms of splicing mutations and potential therapeutic approaches. Notably, they emphasize the fact that findings in animal models may not be applicable for human patients due to the different genomic context of the mutations.	[Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ruiz Desviat, Lourdes] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] CIBERER, Madrid, Spain; [Rivera-Barahona, Ana; Sanchez-Alcudia, Rocio; Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] Hosp La Paz, Inst Invest Biomed, IdiPAZ, Madrid, Spain; [Viecelli, Hiu Man; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp, Div Metab, Zurich, Switzerland; [Viecelli, Hiu Man; Ruefenacht, Veronique; Haeberle, Johannes] Univ Childrens Hosp, CRC, Zurich, Switzerland; [Perez, Belen; Ugarte, Magdalena; Ruiz Desviat, Lourdes] CEDEM, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Hospital Universitario La Paz; University Children's Hospital Zurich; University Children's Hospital Zurich	Desviat, LR (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	lruiz@cbm.csic.es	Rivera, Ana/X-2910-2019; DESVIAT, LOURDES R/L-3055-2013	Rivera, Ana/0000-0002-7376-6176; DESVIAT, LOURDES R/0000-0003-0492-3323; Haberle, Johannes/0000-0003-0635-091X; Grisch-Chan, Hiu Man/0000-0002-5343-2013; Thony, Beat/0000-0002-8420-4769	Ministerio de Economia y Competitividad [SAF2010-17272]; Fundacion Ramon Areces; Centro de Diagnostico de Enfermedades Moleculares	Ministerio de Economia y Competitividad(Spanish Government); Fundacion Ramon Areces; Centro de Diagnostico de Enfermedades Moleculares	This work was supported by Grant SAF2010-17272 from Ministerio de Economia y Competitividad (to LRD), Institutional grant from Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa, University fellowship (to AR), and a Postdoctoral fellowship from Centro de Diagnostico de Enfermedades Moleculares (to RS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanis EF, 2012, HUM MOL GENET, V21, P2389, DOI 10.1093/hmg/dds045; Arrabal L, 2011, NEUROGENETICS, V12, P183, DOI 10.1007/s10048-011-0279-4; Ausems MGEM, 1997, AM J MED GENET, V68, P236, DOI 10.1002/(SICI)1096-8628(19970120)68:2<236::AID-AJMG23>3.0.CO;2-U; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; Baralle M, 2006, FEBS LETT, V580, P4449, DOI 10.1016/j.febslet.2006.07.018; BRIAND P, 1983, BIOCHIM BIOPHYS ACTA, V760, P389, DOI 10.1016/0304-4165(83)90379-3; BROWN GW, 1959, J BIOL CHEM, V234, P1769; Cavallari N, 2012, BBA-MOL BASIS DIS, V1822, P1109, DOI 10.1016/j.bbadis.2012.03.001; CAVARD C, 1988, NUCLEIC ACIDS RES, V16, P2099, DOI 10.1093/nar/16.5.2099; Clavero S, 2004, HUM GENET, V115, P239, DOI 10.1007/s00439-004-1147-1; Cunningham SC, 2011, MOL THER, V19, P854, DOI 10.1038/mt.2011.32; De Conti L, 2012, RNA BIOL, V9, P911, DOI 10.4161/rna.20386; DEMARS R, 1976, P NATL ACAD SCI USA, V73, P1693, DOI 10.1073/pnas.73.5.1693; Desviat LR, 2012, METHODS MOL BIOL, V867, P37, DOI 10.1007/978-1-61779-767-5_3; Engel K, 2008, MOL GENET METAB, V94, P292, DOI 10.1016/j.ymgme.2008.03.009; GARCIAPEREZ MA, 1995, HUM GENET, V95, P183; Genet S, 2000, J INHERIT METAB DIS, V23, P669, DOI 10.1023/A:1005614409241; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hammond SM, 2011, TRENDS GENET, V27, P196, DOI 10.1016/j.tig.2011.02.004; Hartmann L, 2010, AM J HUM GENET, V87, P480, DOI 10.1016/j.ajhg.2010.08.016; Heintz C, 2012, MOL GENET METAB, V106, P403, DOI 10.1016/j.ymgme.2012.05.013; HODGES PE, 1989, P NATL ACAD SCI USA, V86, P4142, DOI 10.1073/pnas.86.11.4142; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Lanpher BC, 1993, GENEREVIEWS; Lee JH, 2014, PEDIATR NEUROL, V51, P354, DOI 10.1016/j.pediatrneurol.2014.03.029; MATSUURA T, 1994, HUM MUTAT, V3, P402, DOI 10.1002/humu.1380030415; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Moller LB, 2000, AM J HUM GENET, V66, P1211, DOI 10.1086/302857; Perez B, 2014, NUCLEIC ACID THER, V24, P48, DOI 10.1089/nat.2013.0453; Perez B, 2010, J INHERIT METAB DIS, V33, P397, DOI 10.1007/s10545-010-9135-1; Perez-Carro R, 2014, CLIN GENET, V86, P167, DOI 10.1111/cge.12243; Roca X, 2008, GENOME RES, V18, P77, DOI 10.1101/gr.6859308; Ruegger CM, 2014, J INHERIT METAB DIS, V37, P21, DOI 10.1007/s10545-013-9624-0; Sehgal A, 2013, J HEPATOL, V59, P1354, DOI 10.1016/j.jhep.2013.05.045; Shchelochkov OA, 2009, MOL GENET METAB, V96, P97, DOI 10.1016/j.ymgme.2008.11.167; Singh RK, 2012, TRENDS MOL MED, V18, P472, DOI 10.1016/j.molmed.2012.06.006; Spitali P, 2012, CELL, V148, P1085, DOI 10.1016/j.cell.2012.02.014; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tuchman M, 1996, HUM GENET, V97, P274, DOI 10.1007/BF02185751; TUCHMAN M, 1994, HUM MUTAT, V4, P57, DOI 10.1002/humu.1380040109; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; Yuste-Checa P, 2015, CLIN GENET, V87, P42, DOI 10.1111/cge.12402	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122966	10.1371/journal.pone.0122966	http://dx.doi.org/10.1371/journal.pone.0122966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853564	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400088
J	Biscere, T; Rodolfo-Metalpa, R; Lorrain, A; Chauvaud, L; Thebault, J; Clavier, J; Houlbreque, F				Biscere, Tom; Rodolfo-Metalpa, Riccardo; Lorrain, Anne; Chauvaud, Laurent; Thebault, Julien; Clavier, Jacques; Houlbreque, Fanny			Responses of Two Scleractinian Corals to Cobalt Pollution and Ocean Acidification	PLOS ONE			English	Article							STYLOPHORA-PISTILLATA; FERTILIZATION SUCCESS; CLIMATE-CHANGE; NEW-CALEDONIA; CLADOCORA-CAESPITOSA; CARBONATE CHEMISTRY; METAL CONTAMINATION; PARTIAL-PRESSURE; SYMBIOTIC ALGAE; HEAVY-METALS	The effects of ocean acidification alone or in combination with warming on coral metabolism have been extensively investigated, whereas none of these studies consider that most coral reefs near shore are already impacted by other natural anthropogenic inputs such as metal pollution. It is likely that projected ocean acidification levels will aggravate coral reef health. We first investigated how ocean acidification interacts with one near shore locally abundant metal on the physiology of two major reef-building corals: Stylophora pistillata and Acropora muricata. Two pH levels (pH(T) 8.02; pCO(2) 366 mu atm and pH(T) 7.75; pCO(2) 1140 mu atm) and two cobalt concentrations (natural, 0.03 mu g L-1 and polluted, 0.2 mu g L-1) were tested during five weeks in aquaria. We found that, for both species, cobalt input decreased significantly their growth rates by 28% while it stimulated their photosystem II, with higher values of rETR(max) (relative Electron Transport Rate). Elevated pCO(2) levels acted differently on the coral rETR(max) values and did not affect their growth rates. No consistent interaction was found between pCO(2) levels and cobalt concentrations. We also measured in situ the effect of higher cobalt concentrations (1.06 +/- 0.16 mu g L-1) on A. muricata using benthic chamber experiments. At this elevated concentration, cobalt decreased simultaneously coral growth and photosynthetic rates, indicating that the toxic threshold for this pollutant has been reached for both host cells and zooxanthellae. Our results from both aquaria and in situ experiments, suggest that these coral species are not particularly sensitive to high pCO(2) conditions but they are to ecologically relevant cobalt concentrations. Our study reveals that some reefs may be yet subjected to deleterious pollution levels, and even if no interaction between pCO(2) levels and cobalt concentration has been found, it is likely that coral metabolism will be weakened if they are subjected to additional threats such as temperature increase, other heavy metals, and eutrophication.	[Biscere, Tom; Rodolfo-Metalpa, Riccardo; Houlbreque, Fanny] ENTROPIE UMR9220, Inst Rech Dev, Lab Excellence CORAIL, Noumea 98848, New Caledonia; [Lorrain, Anne] IRD Noumea, IRD R LEMAR 195, Noumea 98848, New Caledonia; [Chauvaud, Laurent; Thebault, Julien; Clavier, Jacques] Univ Brest, Inst Univ Europeen Mer, CNRS IRD UBO UMR6539, Lab Sci Environm Marin, F-29280 Plouzane, France	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM)	Houlbreque, F (corresponding author), ENTROPIE UMR9220, Inst Rech Dev, Lab Excellence CORAIL, BP A5, Noumea 98848, New Caledonia.	fanny.houlbreque@ird.fr	Houlbreque, Fanny/L-9072-2017; Thébault, Julien/F-6198-2011; Lorrain, Anne/A-4152-2009; /AAL-3738-2021	Houlbreque, Fanny/0000-0002-3976-6690; Thébault, Julien/0000-0002-3111-4428; Lorrain, Anne/0000-0002-1289-2072; 	Laboratoire d'Excellence (LabEX Corail); Institut de Recherche pour le Developpement (IRD); Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO)	Laboratoire d'Excellence (LabEX Corail); Institut de Recherche pour le Developpement (IRD); Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO)	Part of this study was supported by the Laboratoire d'Excellence (LabEX Corail), the Institut de Recherche pour le Developpement (IRD) and the Institut National des Sciences de l'Univers (INSU) through the PNEC/CITRIX IBANOE program of Initiative Structurante Ecosphere Continentale et Cotiere (EC2CO).	Agostini S, 2012, CORAL REEFS, V31, P147, DOI 10.1007/s00338-011-0831-6; Agostini Sylvain, 2009, Galaxea - Tokyo, V11, P1; Ali AAM, 2010, HELGOLAND MAR RES, V65, P67; Atkinson MJ, 1995, CORAL REEFS, V14, P215, DOI 10.1007/BF00334344; Bielmyer GK, 2010, AQUAT TOXICOL, V97, P125, DOI 10.1016/j.aquatox.2009.12.021; BLANKENSHIP ML, 1975, J PHYCOL, V11, P211, DOI 10.1111/j.1529-8817.1975.tb02769.x; Brading P, 2011, LIMNOL OCEANOGR, V56, P927, DOI 10.4319/lo.2011.56.3.0927; BROWN MT, 1998, METAL METABOLISM AQU, P185; BURRIS JE, 1983, MAR BIOL, V75, P113, DOI 10.1007/BF00405992; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; CHISHOLM JRM, 1991, LIMNOL OCEANOGR, V36, P1232, DOI 10.4319/lo.1991.36.6.1232; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Comeau S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2374; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; DAVIES PS, 1989, MAR BIOL, V101, P389; Dickson A.G., 2007, GUIDE BEST PRACTICES; Enriquez S, 2005, LIMNOL OCEANOGR, V50, P1025, DOI 10.4319/lo.2005.50.4.1025; Enriquez S, 2010, DEVEL APPL PHYCOL, V4, P187, DOI 10.1007/978-90-481-9268-7_9; Erez J, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P151, DOI 10.1007/978-94-007-0114-4_10; Ferrier-Pages C, 2005, CORAL REEFS, V24, P636, DOI 10.1007/s00338-005-0045-x; Ferrier-Pages C, 2001, J EXP MAR BIOL ECOL, V259, P249, DOI 10.1016/S0022-0981(01)00241-6; Ferrier-Pages C, 2000, CORAL REEFS, V19, P103, DOI 10.1007/s003380000078; Fichez R, 2005, AQUAT LIVING RESOUR, V18, P125, DOI 10.1051/alr:2005015; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; Fujita M, 2014, CHEMOSPHERE, V95, P628, DOI 10.1016/j.chemosphere.2013.10.023; Gattuso JP, 1999, AM ZOOL, V39, P160; Godinot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025024; GUZMAN HM, 1992, MAR POLLUT BULL, V24, P554, DOI 10.1016/0025-326X(92)90708-E; HARLAND AD, 1989, MAR POLLUT BULL, V20, P353, DOI 10.1016/0025-326X(89)90159-8; Hedouin L, 2006, SCI TOTAL ENVIRON, V366, P154, DOI 10.1016/j.scitotenv.2005.10.022; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 1999, MAR ECOL PROG SER, V183, P73, DOI 10.3354/meps183073; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Houlbreque F, 2012, CORAL REEFS, V31, P101, DOI 10.1007/s00338-011-0819-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Iguchi A, 2012, MAR ENVIRON RES, V73, P32, DOI 10.1016/j.marenvres.2011.10.008; JEFFREY SW, 1975, BIOCHEM PHYSIOL PFL, V167, P191, DOI 10.1016/s0015-3796(17)30778-3; Jones RJ, 1997, MAR ECOL PROG SER, V149, P163, DOI 10.3354/meps149163; Jury CP, 2010, GLOBAL CHANGE BIOL, V16, P1632, DOI 10.1111/j.1365-2486.2009.02057.x; Kaniewska P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034659; Kennish R, 1997, OECOLOGIA, V109, P209, DOI 10.1007/s004420050075; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002576; LEDERMAN TC, 1981, BOT MAR, V24, P125, DOI 10.1515/botm.1981.24.3.125; Lewis C, 2013, MAR BIOL, V160, P2089, DOI 10.1007/s00227-012-2081-8; MARSH JA, 1970, ECOLOGY, V51, P254; Marubini F, 1996, MAR BIOL, V127, P319, DOI 10.1007/BF00942117; Metian M, 2008, ENVIRON POLLUT, V152, P543, DOI 10.1016/j.envpol.2007.07.009; Mitchelmore CL, 2007, AQUAT TOXICOL, V85, P48, DOI 10.1016/j.aquatox.2007.07.015; MOREL FMM, 1994, NATURE, V369, P740, DOI 10.1038/369740a0; Moreton BM, 2009, GEOSTAND GEOANAL RES, V33, P205, DOI 10.1111/j.1751-908X.2009.00899.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Panzeca C, 2009, ESTUAR COAST SHELF S, V85, P223, DOI 10.1016/j.ecss.2009.08.016; Pascal PY, 2010, MAR POLLUT BULL, V60, P2201, DOI 10.1016/j.marpolbul.2010.08.018; Point D, 2007, ESTUAR COAST SHELF S, V72, P457, DOI 10.1016/j.ecss.2006.11.013; PRICE NM, 1990, NATURE, V344, P658, DOI 10.1038/344658a0; Ralph PJ, 2005, AQUAT BOT, V82, P222, DOI 10.1016/j.aquabot.2005.02.006; REICHELT AJ, 1994, AUST J MAR FRESH RES, V45, P1237, DOI 10.1071/MF9941237; Reichelt-Brushett AJ, 1999, MAR POLLUT BULL, V38, P182, DOI 10.1016/S0025-326X(98)00183-0; Reichelt-Brushett AJ, 2005, CORAL REEFS, V24, P524, DOI 10.1007/s00338-005-0013-5; Reichelt-Brushett AJ, 2005, AQUAT TOXICOL, V74, P280, DOI 10.1016/j.aquatox.2005.05.011; Reichelt-Brushett AJ, 2000, MAR POLLUT BULL, V41, P385, DOI 10.1016/S0025-326X(00)00131-4; Reichelt-Brushett A, 2012, OCEANOGRAPHY, V25, P40, DOI 10.5670/oceanog.2012.66; Reynaud S, 2003, GLOBAL CHANGE BIOL, V9, P1660, DOI 10.1046/j.1365-2486.2003.00678.x; Ries JB, 2009, GEOLOGY, V37, P1131, DOI 10.1130/G30210A.1; Ritz C, 2008, USE R, P1; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rodolfo-Metalpa R, 2010, BIOGEOSCIENCES, V7, P289, DOI 10.5194/bg-7-289-2010; Rodolfo-Metalpa R, 2008, J EXP BIOL, V211, P1579, DOI 10.1242/jeb.016345; Sabdono A., 2009, Research Journal of Environmental Sciences, V3, P96, DOI 10.3923/rjes.2009.96.102; Schneider K, 2006, LIMNOL OCEANOGR, V51, P1284, DOI 10.4319/lo.2006.51.3.1284; STAMBLER N, 1991, Pacific Science, V45, P299; Tanaka K, 2013, APPL GEOCHEM, V37, P79, DOI 10.1016/j.apgeochem.2013.07.005; Venn AA, 2013, P NATL ACAD SCI USA, V110, P1634, DOI 10.1073/pnas.1216153110; Vermaat JE, 2009, PERSPECT PLANT ECOL, V11, P137, DOI 10.1016/j.ppees.2009.01.002; Wantiez L, 2008, REV ECOL-TERRE VIE, V63, P117; Whitall D, 2014, MAR POLLUT BULL, V80, P293, DOI 10.1016/j.marpolbul.2013.12.053	79	34	34	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122898	10.1371/journal.pone.0122898	http://dx.doi.org/10.1371/journal.pone.0122898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849317	Green Published, gold			2022-12-26	WOS:000352477800170
J	Ghali, JR; O'Sullivan, KM; Eggenhuizen, PJ; Holdsworth, SR; Kitching, AR				Ghali, Joanna R.; O'Sullivan, Kim M.; Eggenhuizen, Peter J.; Holdsworth, Stephen R.; Kitching, A. Richard			FMS-Like Tyrosine Kinase 3 Ligand Treatment Does Not Ameliorate Experimental Rapidly Progressive Glomerulonephritis	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; T-REGULATORY CELLS; FLT3 LIGAND; CRESCENTIC GLOMERULONEPHRITIS; STEADY-STATE; GENERATION; RECEPTOR; MICE; INFLAMMATION; PROGENITORS	Fms-like tyrosine kinase 3-ligand (FL) is a growth factor that may expand dendritic cell and regulatory T cell populations. We hypothesised that FL-induced regulatory T cells would protect mice from experimental rapidly progressive glomerulonephritis. To determine if FL was able to enhance regulatory T cell populations, C57BL/6 mice received 10 days of daily intraperitoneal injections of either FL or phosphate buffered saline. To induce accelerated autologous-phase anti-mouse glomerular basement membrane glomerulonephritis, mice were sensitized to sheep globulin 4 days prior to the induction of glomerulonephritis with sheep anti-mouse glomerular basement membrane globulin, and experiments ended 10 days later. FL was administered before, throughout and during the sensitization phase of this glomerulonephritis model. Renal disease and systemic immunity to the nephritogenic antigen were assessed. FL increased regulatory T cell and plasmacytoid dendritic cell proportions within spleen and lymph nodes. FL administration prior to glomerulonephritis did not protect mice from renal injury. When FL was given throughout the model, FL treated mice had reduced survival, with more interstitial neutrophils and glomerular CD11c+ cells than controls. Systemic immune responses showed increased IL-17A production from splenocytes, with more CD11c+ cells, but reduced plasmacytoid dendritic cell proportions in spleen and lymph nodes, despite increased regulatory T cell proportions. Under homeostatic conditions, FL expanded regulatory T cell and plasmacytoid dendritic cell populations, but FL enhanced systemic inflammatory responses and conventional dendritic cell populations when given during experimental glomerulonephritis, suggesting selective attempts to suppress pathogenic immunity by dendritic cell manipulation may be harmful.	[Ghali, Joanna R.; O'Sullivan, Kim M.; Eggenhuizen, Peter J.; Holdsworth, Stephen R.; Kitching, A. Richard] Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia; [Ghali, Joanna R.; Holdsworth, Stephen R.; Kitching, A. Richard] Monash Hlth, Dept Nephrol, Clayton, Vic, Australia; [Kitching, A. Richard] Monash Hlth, Dept Paediat Nephrol, Clayton, Vic, Australia	Monash University	Ghali, JR (corresponding author), Monash Univ, Ctr Inflammatory Dis, Dept Med, Clayton, Vic, Australia.	joanna.ghali@monash.edu	Kitching, A Richard/B-6947-2013	Kitching, A Richard/0000-0002-2713-2391; Eggenhuizen, Peter/0000-0002-7102-3547; O'Sullivan, Kim Maree/0000-0002-3098-7948	National Health and Medical Research Council [1017559, 1048575]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	JRG and ARK have been supported by the National Health and Medical Research Council Grant Numbers 1017559 and 1048575 respectively (https://www.nhmrc.gov.au). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal DK, 2001, INT IMMUNOPHARMACOL, V1, P2081, DOI 10.1016/S1567-5769(01)00122-9; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Coates PTH, 2004, TRANSPLANTATION, V77, P1080, DOI 10.1097/01.TP.0000122183.60680.C9; Collins CB, 2012, GUT, V61, P1154, DOI 10.1136/gutjnl-2011-300820; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; D'Amico A, 2003, J EXP MED, V198, P293, DOI 10.1084/jem.20030107; Darrasse-Jeze G, 2009, J EXP MED, V206, P1853, DOI 10.1084/jem.20090746; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Diener KR, 2008, EXP HEMATOL, V36, P51, DOI 10.1016/j.exphem.2007.08.024; Edwan JH, 2004, J IMMUNOL, V172, P5016, DOI 10.4049/jimmunol.172.8.5016; Gonzalez IT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046755; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kitching AR, 2005, J AM SOC NEPHROL, V16, P2023, DOI 10.1681/ASN.2004121075; Kitching AR, 2000, J IMMUNOL, V165, P4649, DOI 10.4049/jimmunol.165.8.4649; Klein O, 2013, EUR J IMMUNOL, V43, P533, DOI 10.1002/eji.201242603; Li W, 2001, J IMMUNOL, V166, P5619, DOI 10.4049/jimmunol.166.9.5619; Liao GX, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00035; LIGLER FS, 1983, J CLIN IMMUNOL, V3, P368, DOI 10.1007/BF00915798; Maraskovsky E, 1996, J EXP MED, V184, P1953, DOI 10.1084/jem.184.5.1953; Marroquin CE, 2002, J IMMUNOTHER, V25, P278, DOI 10.1097/00002371-200205000-00011; McGee HS, 2010, AM J RESP CELL MOL, V43, P520, DOI 10.1165/rcmb.2009-0241OC; Mcgee HS, 2010, AM J RESP CELL MOL, V42, P331, DOI 10.1165/rcmb.2008-0397OC; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; O'Keeffe M, 2005, INT IMMUNOL, V17, P307, DOI 10.1093/intimm/dxh210; Ooi JD, 2012, P NATL ACAD SCI USA, V109, pE2615, DOI 10.1073/pnas.1210147109; Ooi JD, 2011, KIDNEY INT, V79, P977, DOI 10.1038/ki.2010.541; Ostmann A, 2013, J AM SOC NEPHROL, V24, P930, DOI 10.1681/ASN.2012070684; Papenfuss TL, 2007, J LEUKOCYTE BIOL, V82, P1510, DOI 10.1189/jlb.0406257; Paust HJ, 2011, KIDNEY INT, V80, P155, DOI 10.1038/ki.2011.108; Rini BI, 2002, J IMMUNOTHER, V25, P269, DOI 10.1097/00002371-200205000-00010; Rogers NM, 2013, AM J TRANSPLANT, V13, P1125, DOI 10.1111/ajt.12229; Salama AD, 2003, KIDNEY INT, V64, P1685, DOI 10.1046/j.1523-1755.2003.00259.x; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shurin MR, 1998, CYTOKINE GROWTH F R, V9, P37, DOI 10.1016/S1359-6101(97)00035-X; Shurin MR, 1997, CELL IMMUNOL, V179, P174, DOI 10.1006/cimm.1997.1152; Summers SA, 2011, AM J PATHOL, V178, P580, DOI 10.1016/j.ajpath.2010.10.013; Svensson MND, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054884; Swee LK, 2009, BLOOD, V113, P6277, DOI 10.1182/blood-2008-06-161026; Takagi H, 2011, IMMUNITY, V35, P958, DOI 10.1016/j.immuni.2011.10.014; Tipping PG, 1997, EUR J IMMUNOL, V27, P530, DOI 10.1002/eji.1830270226; Van Belle TL, 2010, J AUTOIMMUN, V34, P445, DOI 10.1016/j.jaut.2009.11.010; Whartenby KA, 2005, P NATL ACAD SCI USA, V102, P16741, DOI 10.1073/pnas.0506088102; Wolf D, 2005, J AM SOC NEPHROL, V16, P1360, DOI 10.1681/ASN.2004100837; Yamano T, 2011, BLOOD, V117, P2640, DOI 10.1182/blood-2010-07-293860	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123118	10.1371/journal.pone.0123118	http://dx.doi.org/10.1371/journal.pone.0123118			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849330	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800206
J	Jensen, TK; Andersen, LB; Kyhl, HB; Nielsen, F; Christesen, HT; Grandjean, P				Jensen, Tina Kold; Andersen, Louise Bjorkholt; Kyhl, Henriette Boye; Nielsen, Flemming; Christesen, Henrik Thybo; Grandjean, Philippe			Association between Perfluorinated Compound Exposure and Miscarriage in Danish Pregnant Women	PLOS ONE			English	Article							PERFLUOROOCTANOIC ACID EXPOSURE; SERUM-LEVELS; POPULATION; HEALTH	Perfluorinated alkylated substances (PFAS) have been extensively used in consumer products and humans are widely exposed to these persistent compounds. A recent study found no association between exposure to perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) and miscarriage, but no studies have examined adverse effect of the more recently introduced PFASs. We therefore conducted a case-control study within a population-based, prospective cohort during 2010-2012. Newly pregnant women residing in the Municipality of Odense, Denmark were invited to enroll in the Odense Child Cohort at their first antenatal visit before pregnancy week 12. Among a total of 2,874 participating women, 88 suffered a miscarriage and 59 had stored serum samples, of which 56 occurred before gestational week 12. They were compared to a random sample (N=336) of delivering women, who had also donated serum samples before week 12. Using a case-control design, 51 of the women suffering a miscarriage were matched on parity and gestational day of serum sampling with 204 delivering women. In a multiple logistic regression with adjustment for age, BMI, parity and gestational age at serum sampling, women with the highest tertile of exposure to perfluorononanoic acid (PFNA) and perfluorodecanoic acid (PFDA) in pregnancy had odds ratios for miscarriage of 16.5 (95% CI 7.4-36.6-36.5) and 2.67 (1.31-5.44), respectively, as compared to the lowest tertile. In the matched data set, the OR were 37.9 (9.9-145.2) and 3.71 (1.60-8.60), respectively. The association with perfluorohexane sulfonic acid (PFHxS) was in the same direction, but not statistically significant, while no association was found with PFOA and PFOS. Our findings require confirmation due to the possible public health importance, given that all pregnant women are exposed to these widely used compounds.	[Jensen, Tina Kold; Nielsen, Flemming; Grandjean, Philippe] Univ Southern Denmark, Dept Environm Med, Odense, Denmark; [Jensen, Tina Kold; Kyhl, Henriette Boye] Hans Christian Andersen Childrens Hosp, Odense Child Cohort, Odense, Denmark; [Jensen, Tina Kold] Odense Univ Hosp, OPEN Odense Patient Data Explorat Network, DK-5000 Odense, Denmark; [Andersen, Louise Bjorkholt; Christesen, Henrik Thybo] Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, DK-5000 Odense, Denmark; [Andersen, Louise Bjorkholt; Christesen, Henrik Thybo] Univ Southern Denmark, Inst Clin Res, Odense, Denmark	University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark	Jensen, TK (corresponding author), Univ Southern Denmark, Dept Environm Med, Odense, Denmark.	tkjensen@health.sdu.dk	Christesen, Henrik/AAR-9023-2021; Grandjean, Philippe/I-2962-2014	Christesen, Henrik/0000-0001-5330-6853; Jensen, Tina Kold/0000-0003-2311-5778; Bjorkholt Andersen, Louise/0000-0002-3331-7149; Grandjean, Philippe/0000-0003-4046-9658; Nielsen, Flemming/0000-0002-5657-405X	Danish Agency for Science, Technology and Innovation [09067180]; Danish Council for Strategic Research, Program Commission on Health, Food and Welfare [2101-08-0058]; Danish Ministry of Health; Danish Environmental Protection Agency; Municipality of Odense; Odense University Hospital	Danish Agency for Science, Technology and Innovation; Danish Council for Strategic Research, Program Commission on Health, Food and Welfare; Danish Ministry of Health; Danish Environmental Protection Agency; Municipality of Odense; Odense University Hospital	This work was supported by the Danish Agency for Science, Technology and Innovation (09067180), the Danish Council for Strategic Research, Program Commission on Health, Food and Welfare (project 2101-08-0058), the Danish Ministry of Health and the Danish Environmental Protection Agency. The Municipality of Odense and Odense University Hospital provides core-funding support for the Odense Child Cohort study. Other contributors are: the Mental Health Service in the Region of Southern Denmark, K.A. Rohde's and wife's Foundation, the Ronald McDonald Child Foundation, the Health Insurance Foundation and the Odense University Hospital Research Fund. No funders had any influence on design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Agency UeP, 2013, PERFLUROOCTANOIC ACI; Andersen LB, 2013, CLIN ENDOCRINOL, V79, P333, DOI 10.1111/cen.12147; Berger U, 2011, ANAL BIOANAL CHEM, V400, P1625, DOI 10.1007/s00216-011-4823-8; Calafat AM, 2007, ENVIRON HEALTH PERSP, V115, P1596, DOI 10.1289/ehp.10598; Darrow L. A., 2013, ENV HLTH PERSPECT, V121, P1207, DOI DOI 10.1289/EHP.1206372; Darrow LA, 2014, EPIDEMIOLOGY, V25, P505, DOI 10.1097/EDE.0000000000000103; Fromme H, 2010, ENVIRON SCI TECHNOL, V44, P7123, DOI 10.1021/es101184f; Guo W, 2014, CHEMOSPHERE, V116, P75, DOI 10.1016/j.chemosphere.2014.04.007; Haug LS, 2009, J CHROMATOGR A, V1216, P385, DOI 10.1016/j.chroma.2008.10.113; Kuklenyik Z, 2005, ANAL CHEM, V77, P6085, DOI 10.1021/ac050671l; Lau C, 2006, TOXICOL SCI, V90, P510, DOI 10.1093/toxsci/kfj105; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614; Savitz DA, 2012, ENVIRON HEALTH PERSP, V120, P1201, DOI 10.1289/ehp.1104752; Savitz DA, 2012, EPIDEMIOLOGY, V23, P386, DOI 10.1097/EDE.0b013e31824cb93b; Steenland K, 2010, ENVIRON HEALTH PERSP, V118, P1100, DOI 10.1289/ehp.0901827; Stein CR, 2009, AM J EPIDEMIOL, V170, P837, DOI 10.1093/aje/kwp212; Tefre de Renzy-Martin K FH, 2013, REPRODUCTION IN PRES; Whitworth KW, 2012, AM J EPIDEMIOL, V175, P1209, DOI 10.1093/aje/kwr459	19	62	64	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123496	10.1371/journal.pone.0123496	http://dx.doi.org/10.1371/journal.pone.0123496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848775	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800238
J	Monteiro, S; Carreira, A; Freitas, R; Pinheiro, AM; Ferreira, RB				Monteiro, Sara; Carreira, Alexandra; Freitas, Regina; Pinheiro, Ana Margarida; Ferreira, Ricardo Boavida			A Nontoxic Polypeptide Oligomer with a Fungicide Potency under Agricultural Conditions Which Is Equal or Greater than That of Their Chemical Counterparts	PLOS ONE			English	Article							SEED STORAGE PROTEINS; CHITIN-BINDING PROTEINS; ANTIFUNGAL PROTEINS; CALLOSOBRUCHUS-MACULATUS; 3-DIMENSIONAL STRUCTURE; DISEASE RESISTANCE; VICILINS; AGGREGATION; RESOLUTION; PHASEOLIN	There are literally hundreds of polypeptides described in the literature which exhibit fungicide activity. Tens of them have had attempted protection by patent applications but none, as far as we are aware, have found application under real agricultural conditions. The reasons behind may be multiple where the sensitivity to the Sun UV radiation can come in first place. Here we describe a multifunctional glyco-oligomer with 210 kDa which is mainly composed by a 20 kDa polypeptide termed Blad that has been previously shown to be a stable intermediary product of beta-conglutin catabolism. This oligomer accumulates exclusively in the cotyledons of Lupinus species, between days 4 and 12 after the onset of germination. Blad-oligomer reveals a plethora of biochemical properties, like lectin and catalytic activities, which are not unusual per si, but are remarkable when found to coexist in the same protein molecule. With this vast range of chemical characteristics, antifungal activity arises almost as a natural consequence. The biological significance and potential technological applications of Blad-oligomer as a plant fungicide to agriculture, its uniqueness stems from being of polypeptidic in nature, and with efficacies which are either equal or greater than the top fungicides currently in the market are addressed.	[Monteiro, Sara; Freitas, Regina; Pinheiro, Ana Margarida; Ferreira, Ricardo Boavida] Univ Lisbon, Ctr Bot Aplicada Agr, Inst Super Agron, P-1699 Lisbon, Portugal; [Monteiro, Sara; Carreira, Alexandra] Converde, SA, Cantanhede, Portugal; [Ferreira, Ricardo Boavida] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780156 Oeiras, Portugal	Universidade de Lisboa; Universidade Nova de Lisboa	Monteiro, S (corresponding author), Univ Lisbon, Ctr Bot Aplicada Agr, Inst Super Agron, P-1699 Lisbon, Portugal.	sam@cev.com.pt		Monteiro, Sara/0000-0002-7069-0591; Freitas, Regina/0000-0001-8605-2925; Ferreira, Ricardo Boavida/0000-0002-5027-7564	Fundacao para a Ciencia e a Tecnologia, Agencia de Inovacao: Project Resoidio [SFRH//BPD/5712/2001, SFRH/BD/87561/2012, PRAXIS/3/3.2/HORT/2140/95]; CONVERDE SA	Fundacao para a Ciencia e a Tecnologia, Agencia de Inovacao: Project Resoidio; CONVERDE SA	This work was funded by Fundacao para a Ciencia e a Tecnologia: Grant number: SFRH//BPD/5712/2001 to SM; Grant number: SFRH/BD/87561/2012 to AMP; Project number: PRAXIS/3/3.2/HORT/2140/95, Agencia de Inovacao: Project Resoidio. The funder CONVERDE SA provided support in the form of salaries for authors SM and AC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	ABELES FB, 1970, PLANT PHYSIOL, V45, P395, DOI 10.1104/pp.45.4.395; [Anonymous], 2008, M38 A2 REFERENCE MET, DOI [10.1007/s11046-014-9730-z, DOI 10.1007/S11046-014-9730-Z]; ARGOS P, 1985, EMBO J, V4, P1111, DOI 10.1002/j.1460-2075.1985.tb03747.x; Austin AT, 2014, NEW PHYTOL, V204, P257, DOI 10.1111/nph.13062; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Blackwell J, 1988, METHOD ENZYMOL, V161, P465; Boucher I, 1995, J BIOL CHEM, V270, P31077, DOI 10.1074/jbc.270.52.31077; Boyd LA, 2013, TRENDS GENET, V29, P233, DOI 10.1016/j.tig.2012.10.011; Bruno J, 2010, CLIN EXP DERMATOL, V35, P658, DOI [10.1111/j.1365-2230.2009.03698.x, DOI 10.1111/J.1365-2230.2009.03698.X]; Casey R., 1986, Oxford surveys of plant molecular and cell biology. Volume 3., P1; Coultate TP, 1989, FOOD THE CHEMISTRY O; Barros MED, 2007, J MED MICROBIOL, V56, P514, DOI 10.1099/jmm.0.46542-0; El Gueddari NE, 2002, NEW PHYTOL, V156, P103, DOI 10.1046/j.1469-8137.2002.00487.x; Faye L, 1985, ANAL BIOCHEM, V118, P131, DOI [10.1016/0003-2697(85)90498-1, DOI 10.1016/0003-2697(85)90498-1]; Ferreira RB, 2003, FEBS LETT, V534, P106, DOI 10.1016/S0014-5793(02)03801-2; Ferreira RB, 1999, J AGR FOOD CHEM, V47, P3009, DOI 10.1021/jf981151c; Ferreira RB, 2006, CRIT REV PLANT SCI, V25, P505, DOI 10.1080/07352680601054610; FERREIRA RMB, 1995, J EXP BOT, V46, P211, DOI 10.1093/jxb/46.2.211; Firmino F, 1996, BRAZ J MED BIOL RES, V29, P749; Gomes VM, 1997, J AGR FOOD CHEM, V45, P4110, DOI 10.1021/jf960942g; Hegedus N, 2013, FUNGAL BIOL REV, V26, P132, DOI 10.1016/j.fbr.2012.07.002; HIGGINS TJV, 1984, ANNU REV PLANT PHYS, V35, P191, DOI 10.1146/annurev.pp.35.060184.001203; ISELI B, 1993, PLANT PHYSIOL, V103, P221, DOI 10.1104/pp.103.1.221; Juliana M, 2012, PEPTIDE SCI, V98, P406, DOI [10.1002/bip.22068, DOI 10.1002/BIP.22068]; KO TP, 1993, PLANT PHYSIOL, V101, P729, DOI 10.1104/pp.101.3.729; Lamberth C, 2013, SCIENCE, V341, P742, DOI 10.1126/science.1237227; LAWRENCE MC, 1990, EMBO J, V9, P9, DOI 10.1002/j.1460-2075.1990.tb08074.x; LAWRENCE MC, 1994, J MOL BIOL, V238, P748, DOI 10.1006/jmbi.1994.1333; LEE C, 1987, ANAL BIOCHEM, V166, P308, DOI 10.1016/0003-2697(87)90579-3; MELO TS, 1994, PHYTOCHEMISTRY, V37, P641, DOI 10.1016/S0031-9422(00)90331-5; Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Monteiro S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008542; Ng TB, 2004, PEPTIDES, V25, P1215, DOI 10.1016/j.peptides.2004.03.012; NICHOLS EJ, 1980, PLANT PHYSIOL, V66, P199, DOI 10.1104/pp.66.2.199; OECD, 1998, GUIDELINE FOR THE TE; Oliveira GB, 2014, COMP BIOCHEM PHYS B, V168, P45, DOI 10.1016/j.cbpb.2013.11.001; Patil DN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063779; RAIKHEL NV, 1993, ANNU REV PLANT PHYS, V44, P591, DOI 10.1146/annurev.pp.44.060193.003111; Ramos Paula Cristina Rodrigues Dos, 1997, Planta (Heidelberg), V203, P26; Sales MP, 1996, BRAZ J MED BIOL RES, V29, P319; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Santos CN, 1997, J AGR FOOD CHEM, V45, P3821, DOI 10.1021/jf970075v; Schulenberg B, 2003, J BIOL CHEM, V278, P27251, DOI 10.1074/jbc.C300189200; Schulze-Lefert P, 2003, ANNU REV PHYTOPATHOL, V41, P641, DOI 10.1146/annurev.phyto.41.061002.083300; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Shutov AD, 1995, J MOL EVOL, V41, P1057, DOI 10.1007/BF00173187; Slavokhotova AA, 2014, FEBS J, V281, P4754, DOI 10.1111/febs.13015; Theis T, 2004, CELL MOL LIFE SCI, V61, P437, DOI 10.1007/s00018-003-3231-4; UENO M, 1991, J BIOL CHEM, V266, P3146; van den Burg HA, 2003, J BIOL CHEM, V278, P27340, DOI 10.1074/jbc.M212196200; Yunes ANA, 1998, J SCI FOOD AGR, V76, P111, DOI 10.1002/(SICI)1097-0010(199801)76:1&lt;111::AID-JSFA932&gt;3.0.CO;2-4	53	19	22	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122095	10.1371/journal.pone.0122095	http://dx.doi.org/10.1371/journal.pone.0122095			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849076	Green Published, gold			2022-12-26	WOS:000352477800096
J	Poos, K; Smida, J; Maugg, D; Eckstein, G; Baumhoer, D; Nathrath, M; Korsching, E				Poos, Kathrin; Smida, Jan; Maugg, Doris; Eckstein, Gertrud; Baumhoer, Daniel; Nathrath, Michaela; Korsching, Eberhard			Genomic Heterogeneity of Osteosarcoma - Shift from Single Candidates to Functional Modules	PLOS ONE			English	Article							HIGH-GRADE OSTEOSARCOMA; TUMOR-SUPPRESSOR GENE; COPY-NUMBER; PROGNOSTIC-SIGNIFICANCE; ALLELIC IMBALANCES; CHROMOSOME 6Q; EXPRESSION; NETWORK; HYBRIDIZATION; REVEALS	Osteosarcoma (OS), a bone tumor, exhibit a complex karyotype. On the genomic level a highly variable degree of alterations in nearly all chromosomal regions and between individual tumors is observable. This hampers the identification of common drivers in OS biology. To identify the common molecular mechanisms involved in the maintenance of OS, we follow the hypothesis that all the copy number-associated differences between the patients are intercepted on the level of the functional modules. The implementation is based on a network approach utilizing copy number associated genes in OS, paired expression data and protein interaction data. The resulting functional modules of tightly connected genes were interpreted regarding their biological functions in OS and their potential prognostic significance. We identified an osteosarcoma network assembling well-known and lesserknown candidates. The derived network shows a significant connectivity and modularity suggesting that the genes affected by the heterogeneous genetic alterations share the same biological context. The network modules participate in several critical aspects of cancer biology like DNA damage response, cell growth, and cell motility which is in line with the hypothesis of specifically deregulated but functional modules in cancer. Further, we could deduce genes with possible prognostic significance in OS for further investigation (e.g. EZR, CDKN2A, MAP3K5). Several of those module genes were located on chromosome 6q. The given systems biological approach provides evidence that heterogeneity on the genomic and expression level is ordered by the biological system on the level of the functional modules. Different genomic aberrations are pointing to the same cellular network vicinity to form vital, but already neoplastically altered, functional modules maintaining OS. This observation, exemplarily now shown for OS, has been under discussion already for a longer time, but often in a hypothetical manner, and can here be exemplified for OS.	[Poos, Kathrin; Korsching, Eberhard] Univ Hosp Munster, Inst Bioinformat, Munster, Germany; [Smida, Jan; Maugg, Doris; Baumhoer, Daniel; Nathrath, Michaela] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Osteosarcoma, Neuherberg, Germany; [Smida, Jan; Maugg, Doris; Nathrath, Michaela] Tech Univ Munich, Klinikum Rechts Isar, Childrens Canc Res Ctr, D-80290 Munich, Germany; [Smida, Jan; Maugg, Doris; Nathrath, Michaela] Tech Univ Munich, Klinikum Rechts Isar, Dept Pediat, D-80290 Munich, Germany; [Eckstein, Gertrud] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Baumhoer, Daniel] Univ Basel Hosp, Bone Tumor Reference Ctr, Inst Pathol, CH-4031 Basel, Switzerland	University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Basel	Korsching, E (corresponding author), Univ Hosp Munster, Inst Bioinformat, Munster, Germany.	korschi@uni-muenster.de	Smida, Jan/P-2486-2014	Smida, Jan/0000-0001-6055-8207	Translational Sarcoma Research Network [FKZ 01GM0870, FKZ 01GM0869]; BMBF [FZK 01KT1310]; Foundation for the Preservation of the Basel Bone Tumor Center; Deutsche Forschungsgemeinschaft; Open Access Publication Fund of the University of Munster (WWU)	Translational Sarcoma Research Network; BMBF(Federal Ministry of Education & Research (BMBF)); Foundation for the Preservation of the Basel Bone Tumor Center; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of the University of Munster (WWU)	This work was funded by the Translational Sarcoma Research Network (FKZ 01GM0870 to JS, MN, DM and FKZ 01GM0869 to KP, EK), the European TRANSCAN I consortium - PROspective VAlidation of Biomarkers in Ewing Sarcoma for personalized translational medicine both supported by the BMBF (FZK 01KT1310 to KP, EK) and the Foundation for the Preservation of the Basel Bone Tumor Center [to DB]. The authors acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publication Fund of the University of Munster. Funding for open access charge: Deutsche Forschungsgemeinschaft (DFG) and Open Access Publication Fund of the University of Munster (WWU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal P, 2012, TUMOR SUPPRESSOR GEN; Angstadt AY, 2012, CANCER GENET-NY, V205, P572, DOI 10.1016/j.cancergen.2012.09.005; Aoyama T, 2008, BIOCHEM BIOPH RES CO, V365, P124, DOI 10.1016/j.bbrc.2007.10.135; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Batanian JR, 2002, J CLIN PATHOL-MOL PA, V55, P389, DOI 10.1136/mp.55.6.389; Baumhoer D, 2012, CANCER GENET-NY, V205, P212, DOI 10.1016/j.cancergen.2012.03.001; Bayani J, 2003, GENE CHROMOSOME CANC, V36, P7, DOI 10.1002/gcc.10132; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Both J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115835; Both J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030907; Calvert George T., 2012, Sarcoma, V2012, P152382, DOI 10.1155/2012/152382; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chauveinc L, 2001, Ophthalmic Genet, V22, P77, DOI 10.1076/opge.22.2.77.2228; Cheng WH, 2012, BIOCHEM BIOPH RES CO, V420, P24, DOI 10.1016/j.bbrc.2012.02.104; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Clark JCM, 2008, J CANCER RES CLIN, V134, P281, DOI 10.1007/s00432-007-0330-x; COX PM, 1991, BRIT J CANCER, V63, P651, DOI 10.1038/bjc.1991.151; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Dohi O, 2008, CANCER SCI, V99, P518, DOI 10.1111/j.1349-7006.2007.00673.x; Engin F, 2009, HUM MOL GENET, V18, P1464, DOI 10.1093/hmg/ddp057; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ferrari S, 2008, PEDIATR BLOOD CANCER, V50, P752, DOI 10.1002/pbc.21360; FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812; Flores RJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-50; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman R, 2013, GRAPH PACKAGE HANDLE; Gkantsidis C., 2003, P 5 WORKSH ALG ENG E; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kong Colin, 2009, Expert Opin Med Diagn, V3, P13; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kuijjer ML, 2013, INT J CANCER, V133, P2512, DOI 10.1002/ijc.28124; Kuijjer ML, 2012, GENE CHROMOSOME CANC, V51, P696, DOI 10.1002/gcc.21956; Kusuzaki K, 1999, CANCER LETT, V137, P27, DOI 10.1016/S0304-3835(98)00336-X; Kusuzaki K, 1999, CANCER LETT, V141, P131, DOI 10.1016/S0304-3835(99)00092-0; Lafleur EA, 2004, CLIN CANCER RES, V10, P8114, DOI 10.1158/1078-0432.CCR-04-0353; Luo Y, 2013, ARCH MED SCI, V9, P569, DOI 10.5114/aoms.2012.30956; Man TK, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-45; Martin Jeff W., 2012, Sarcoma, V2012, P627254, DOI 10.1155/2012/627254; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Na KY, 2012, PATHOLOGY, V44, P540, DOI 10.1097/PAT.0b013e32835803bc; Namlos HM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048086; Nathrath MH, 2002, ONCOGENE, V21, P5975, DOI 10.1038/sj.onc.1205764; Natrajan R, 2006, J PATHOL, V210, P49, DOI 10.1002/path.2021; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nielsen GP, 1998, AM J PATHOL, V153, P159, DOI 10.1016/S0002-9440(10)65556-3; Noviello C, 1996, CLIN CANCER RES, V2, P1601; Ohata N, 2006, INT J MOL MED, V18, P1153; ORPHANOS V, 1995, BRIT J CANCER, V71, P666, DOI 10.1038/bjc.1995.132; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Picci P, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-6; Poos K, 2014, STRUCTURING OSTEOSAR; Poos K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003210; PORTER DE, 1992, J BONE JOINT SURG BR, V74, P883; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rehman I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030885; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Rosenberg A, 2013, WHO CLASSIFICATION T, V5; SALZERKUNTSCHIK M, 1983, PATHOLOGE, V4, P135; Sau A, 2012, MOL BIOSYST, V8, P994, DOI 10.1039/c1mb05295k; Savage Sharon A., 2011, Sarcoma, V2011, P548151, DOI 10.1155/2011/548151; Serra M, 2001, MODERN PATHOL, V14, P710, DOI 10.1038/modpathol.3880377; Smida J, 2010, CLIN CANCER RES, V16, P4256, DOI 10.1158/1078-0432.CCR-10-0284; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tarkkanen M, 1999, CANCER GENET CYTOGEN, V114, P35, DOI 10.1016/S0165-4608(99)00031-X; Tsuchiya T, 2000, CANCER GENET CYTOGEN, V120, P91, DOI 10.1016/S0165-4608(99)00255-1; Tzeng HE, 2013, BIOCHEM PHARMACOL, V85, P531, DOI 10.1016/j.bcp.2012.11.021; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang Z, 2007, PLOS COMPUT BIOL, V3, P1011, DOI 10.1371/journal.pcbi.0030107; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yang ZZ, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-80; Zielenska M, 2004, CYTOGENET GENOME RES, V107, P77, DOI 10.1159/000079574	77	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123082	10.1371/journal.pone.0123082	http://dx.doi.org/10.1371/journal.pone.0123082			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848766	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800202
J	Rahaman, H; Khan, MKA; Hassan, MI; Islam, A; Moosavi-Movahedi, AA; Ahmad, F				Rahaman, Hamidur; Khan, Md. Khurshid Alam; Hassan, Md. Imtaiyaz; Islam, Asimul; Moosavi-Movahedi, Ali Akbar; Ahmad, Faizan			Heterogeneity of Equilibrium Molten Globule State of Cytochrome c Induced by Weak Salt Denaturants under Physiological Condition	PLOS ONE			English	Article							THERMODYNAMIC CHARACTERIZATION; GUANIDINE-HYDROCHLORIDE; CIRCULAR-DICHROISM; FERRICYTOCHROME-C; ANION-BINDING; ALKALINE TRANSITION; INTERMEDIATE STATE; HYDROGEN-EXCHANGE; INFRARED-SPECTRA; SURFACE-CHARGES	While many proteins are recognized to undergo folding via intermediate(s), the heterogeneity of equilibrium folding intermediate(s) along the folding pathway is less understood. In our present study, FTIR spectroscopy, far- and near-UV circular dichroism (CD), ANS and tryptophan fluorescence, near IR absorbance spectroscopy and dynamic light scattering (DLS) were used to study the structural and thermodynamic characteristics of the native (N), denatured (D) and intermediate state (X) of goat cytochorme c (cyt-c) induced by weak salt denaturants (LiBr, LiCl and LiClO4) at pH 6.0 and 25 degrees C. The LiBr-induced denaturation of cyt-c measured by Soret absorption (Delta epsilon(400)) and CD ([theta](409)), is a three-step process, N <-> X <-> D. It is observed that the X state obtained along the denaturation pathway of cyt-c possesses common structural and thermodynamic characteristics of the molten globule (MG) state. The MG state of cyt-c induced by LiBr is compared for its structural and thermodynamic parameters with those found in other solvent conditions such as LiCl, LiClO4 and acidic pH. Our observations suggest: (1) that the LiBr-induced MG state of cyt-c retains the native Met80-Fe(III) axial bond and Trp59-propionate interactions; (2) that LiBr-induced MG state of cyt-c is more compact retaining the hydrophobic interactions in comparison to the MG states induced by LiCl, LiClO4 and 0.5 M NaCl at pH 2.0; and (3) that there exists heterogeneity of equilibrium intermediates along the unfolding pathway of cyt-c as highly ordered (X1), classical (X2) and disordered (X3), i.e., D <-> X3 <-> X2 <-> X1 <-> N.	[Rahaman, Hamidur; Khan, Md. Khurshid Alam; Hassan, Md. Imtaiyaz; Islam, Asimul; Ahmad, Faizan] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India; [Moosavi-Movahedi, Ali Akbar] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran	Jamia Millia Islamia; University of Tehran	Ahmad, F (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.	fahmad@jmi.ac.in	Hamidur, Rahaman Md/ABE-4554-2021; Hassan, Imtaiyaz/ABF-6485-2020; Hassan, Mohammad/GZA-7507-2022; Hassan, Md Imtaiyaz/G-7072-2017; Ahmad, Faizan/AGH-4493-2022; Islam, Asimul/V-4526-2019	Hamidur, Rahaman Md/0000-0001-5998-177X; Hassan, Imtaiyaz/0000-0002-3663-4940; Hassan, Mohammad/0000-0002-1712-0004; Hassan, Md Imtaiyaz/0000-0002-3663-4940; Ahmad, Faizan/0000-0001-7021-7502; Islam, Asimul/0000-0001-9060-7970; Khan, Md. Khurshid/0000-0002-3205-0729; Moosavi-Movahedi, Ali Akbar/0000-0002-1707-8432	Council of Scientific and Industrial Research (CSIR); Department of Science and Technology (DST); University Grants Commission	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology (DST)(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	This work was supported by grants from the Council of Scientific and Industrial Research (CSIR) and the Department of Science and Technology (DST) to FA. HR and MKAK are thankful to the University Grants Commission and CSIR for their fellowships, respectively. MIH is thankful to the DST for the award of the Young Scientist grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD F, 1982, J BIOL CHEM, V257, P2935; Arai M, 2000, ADV PROTEIN CHEM, V53, P209; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; BARRICK D, 1994, J MOL BIOL, V237, P588, DOI 10.1006/jmbi.1994.1257; Battistuzzi G, 2001, EUR J INORG CHEM, P2989; Battistuzzi G, 1997, ARCH BIOCHEM BIOPHYS, V339, P283, DOI 10.1006/abbi.1996.9862; BATTISTUZZI G, 1995, EUR J BIOCHEM, V233, P335, DOI 10.1111/j.1432-1033.1995.335_1.x; Battistuzzi G, 1996, EUR J BIOCHEM, V241, P208, DOI 10.1111/j.1432-1033.1996.0208t.x; BOWLER BE, 1994, BIOCHEMISTRY-US, V33, P2402, DOI 10.1021/bi00175a008; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; Bychkova VE, 1996, BIOCHEMISTRY-US, V35, P6058, DOI 10.1021/bi9522460; Chamani J, 2006, J COLLOID INTERF SCI, V297, P561, DOI 10.1016/j.jcis.2005.11.035; Colon W, 1996, NAT STRUCT BIOL, V3, P1019, DOI 10.1038/nsb1296-1019; Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126; Dev S, 2006, J BIOSCIENCES, V31, P551, DOI 10.1007/BF02708406; DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022; DONG AC, 1994, METHOD ENZYMOL, V232, P139; DONG AC, 1995, J PHARM SCI-US, V84, P415, DOI 10.1002/jps.2600840407; Dong AC, 2005, ARCH BIOCHEM BIOPHYS, V436, P154, DOI 10.1016/j.abb.2005.01.006; Dunker AK, 2005, FEBS J, V272, P5129, DOI 10.1111/j.1742-4658.2005.04948.x; Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002; Goldbeck RA, 2009, INT J MOL SCI, V10, P1476, DOI 10.3390/ijms10041476; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; HAGIHARA Y, 1994, J MOL BIOL, V237, P336, DOI 10.1006/jmbi.1994.1234; Haque MA, 2015, INT J BIOL MACROMOL, V72, P1406, DOI 10.1016/j.ijbiomac.2014.10.053; JENG MF, 1990, BIOCHEMISTRY-US, V29, P10433, DOI 10.1021/bi00498a001; KARPLUS M, 1976, NATURE, V260, P404, DOI 10.1038/260404a0; KATAOKA M, 1993, J MOL BIOL, V229, P591, DOI 10.1006/jmbi.1993.1064; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Khan MKA, 2010, J BIOL INORG CHEM, V15, P1319, DOI 10.1007/s00775-010-0691-5; Khan MKA, 2009, J BIOL INORG CHEM, V14, P751, DOI 10.1007/s00775-009-0488-6; KIM PS, 1982, ANNU REV BIOCHEM, V51, P459, DOI 10.1146/annurev.bi.51.070182.002331; Kokai E, 2006, ARCH BIOCHEM BIOPHYS, V451, P59, DOI 10.1016/j.abb.2006.03.020; KRIMM S, 1986, ADV PROTEIN CHEM, V38, P181, DOI 10.1016/S0065-3233(08)60528-8; KURODA Y, 1992, J MOL BIOL, V223, P1139, DOI 10.1016/0022-2836(92)90265-L; Latypov RF, 2006, J MOL BIOL, V357, P1009, DOI 10.1016/j.jmb.2006.01.055; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; MARGOLIASH E, 1959, BIOCHEM J, V71, P570, DOI 10.1042/bj0710570; MIYAZAWA T, 1961, J AM CHEM SOC, V83, P712, DOI 10.1021/ja01464a042; MOENCH SJ, 1991, EUR J BIOCHEM, V197, P631, DOI 10.1111/j.1432-1033.1991.tb15953.x; Mok KH, 2005, P NATL ACAD SCI USA, V102, P8899, DOI 10.1073/pnas.0500661102; Moza B, 2006, BIOCHEMISTRY-US, V45, P4695, DOI 10.1021/bi052357r; Moza B, 2003, BBA-PROTEINS PROTEOM, V1646, P49, DOI 10.1016/S1570-9639(02)00548-4; Nakayama K, 2001, BIOCHEM BIOPH RES CO, V282, P853, DOI 10.1006/bbrc.2001.4627; NATH U, 1995, BIOCHEMISTRY-US, V34, P1702, DOI 10.1021/bi00005a027; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; POTEKHIN S, 1989, BIOPHYS CHEM, V34, P55, DOI 10.1016/0301-4622(89)80041-9; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Ptitsyn OB, 1995, ADV PROTEIN CHEM, V47, P83, DOI 10.1016/S0065-3233(08)60546-X; Qureshi SH, 2003, BIOCHEMISTRY-US, V42, P1684, DOI 10.1021/bi0271042; Radivojac P, 2006, PROTEINS, V63, P398, DOI 10.1002/prot.20873; Rahaman H, 2008, BIOPHYS CHEM, V138, P23, DOI 10.1016/j.bpc.2008.08.008; Rahaman H, 2013, J CHEM THERMODYN, V58, P351, DOI 10.1016/j.jct.2012.11.024; Rao DK, 2006, BIOCHEMISTRY-US, V45, P3412, DOI 10.1021/bi051882n; Santucci R, 2000, BIOCHEMISTRY-US, V39, P12632, DOI 10.1021/bi000516v; Schechter E, 1967, BIOPOLYMERS, V5, P788; SCHEJTER A, 1984, BIOCHEMISTRY-US, V23, P1081, DOI 10.1021/bi00301a007; Schwartz R., 2014, NEW MEDIA SOC, V1, P1; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Silkstone GG, 2005, J AM CHEM SOC, V127, P92, DOI 10.1021/ja045719b; Sinibaldi F, 2003, J BIOL INORG CHEM, V8, P663, DOI 10.1007/s00775-003-0462-7; Sinibaldi F, 2003, BIOCHEMISTRY-US, V42, P7604, DOI 10.1021/bi034132r; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; TANEJA S, 1994, BIOCHEM J, V303, P147, DOI 10.1042/bj3030147; Thomas YG, 2000, BIOPOLYMERS, V57, P29, DOI 10.1002/(SICI)1097-0282(2000)57:1<29::AID-BIP5>3.0.CO;2-V; Tompa P, 2006, BIOPHYS J, V91, P2243, DOI 10.1529/biophysj.106.084723; TSONG TY, 1975, BIOCHEMISTRY-US, V14, P1542, DOI 10.1021/bi00678a031; Ubaid-Ullah S, 2014, J BIOMOL STRUCT DYN, V32, P2005, DOI 10.1080/07391102.2013.848826; UVERSKY VN, 1992, FEBS LETT, V314, P89, DOI 10.1016/0014-5793(92)81468-2; Verbaro D, 2009, BIOCHEMISTRY-US, V48, P2990, DOI 10.1021/bi802208f; Vivian JT, 2001, BIOPHYS J, V80, P2093, DOI 10.1016/S0006-3495(01)76183-8; WETLAUFE.DB, 1973, P NATL ACAD SCI USA, V70, P697, DOI 10.1073/pnas.70.3.697; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WILLIAMS G, 1982, FEBS LETT, V150, P293, DOI 10.1016/0014-5793(82)80754-0; Xu YJ, 1998, NAT STRUCT BIOL, V5, P774, DOI 10.1038/1810; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zaidi S, 2014, CELL MOL LIFE SCI, V71, P229, DOI 10.1007/s00018-013-1341-1	79	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120465	10.1371/journal.pone.0120465	http://dx.doi.org/10.1371/journal.pone.0120465			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849212	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800025
J	Tellez, G; Latorre, JD; Kuttappan, VA; Hargis, BM; Hernandez-Velasco, X				Tellez, Guillermo; Latorre, Juan D.; Kuttappan, Vivek A.; Hargis, Billy M.; Hernandez-Velasco, Xochitl			Rye Affects Bacterial Translocation, Intestinal Viscosity, Microbiota Composition and Bone Mineralization in Turkey Poults	PLOS ONE			English	Article							POLYSACCHARIDE-DEGRADING ENZYMES; CELIAC-DISEASE; GROWTH PROMOTERS; GUT MICROBIOTA; T-CELLS; BROILERS; DIET; PERFORMANCE; GLUTEN; HEALTH	Previously, we have reported that rye significantly increased both viscosity and Clostridium perfringens proliferation when compared with corn in an in vitro digestive model. Two independent trials were conducted to evaluate the effect of rye as a source of energy on bacterial translocation, intestinal viscosity, gut microbiota composition, and bone mineralization, when compared with corn in turkey poults. In each experiment, day-of-hatch, turkey poults were randomly assigned to either a corn or a rye diet (n = 0/group). At 10 d of age, in both experiments, 12 birds/group were given an oral gavage dose of fluorescein isothiocyanate dextran (FITC-d). After 2.5 h of oral gavage, blood and liver samples were collected to evaluate the passage of FITC-d and bacterial translocation (BT) respectively. Duodenum, ileum and cecum gut sections were collected to evaluate intestinal viscosity and to enumerate gut microbiota. Tibias were collected for observation of bone parameters. Broilers fed with a rye diet showed increased (p<0.05) intestinal viscosity, BT, and serum FITC-d. Bacterial enumeration revealed that turkey poults fed with rye had increased the number of total lactic acid bacteria (LAB) in all three sections of the gastrointestinal tract evaluated when compared to turkey poults fed with corn. Turkey poults fed with rye also had significantly higher coliforms in duodenum and ileum but not in the ceca, whereas the total number of anaer-obes increased only in duodenum. A significant reduction in bone strength and bone mineralization was observed in turkey poults fed with rye when compared with corn fed turkey poults. In conclusion, rye evoked mucosal damage in turkey poults that increased intestinal viscosity, increased leakage through the intestinal tract, and altered the microbiota composition and bone mineralization. Studies to evaluate dietary inclusion of selected Direct-Fed Microbial (DFM) candidates that produce exogenous enzymes in rye fed turkey poults are currently being evaluated.	[Tellez, Guillermo; Latorre, Juan D.; Kuttappan, Vivek A.; Hargis, Billy M.] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Hernandez-Velasco, Xochitl] Univ Nacl Autonoma Mexico, Fac Med Vet & Zootecnia, Mexico City 04510, DF, Mexico	University of Arkansas System; University of Arkansas Fayetteville; Universidad Nacional Autonoma de Mexico	Tellez, G (corresponding author), Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.	gtellez@uark.edu	Latorre, Juan D/AAM-5522-2021	Latorre, Juan D/0000-0001-6250-566X				Annett CB, 2002, AVIAN PATHOL, V31, P599, DOI 10.1080/0307945021000024544; Assimakopoulos Stelios F, 2011, World J Gastrointest Pathophysiol, V2, P123, DOI 10.4291/wjgp.v2.i6.123; BEDFORD MR, 1993, POULTRY SCI, V72, P137, DOI 10.3382/ps.0720137; BEDFORD MR, 1991, POULTRY SCI, V70, P1571, DOI 10.3382/ps.0701571; Bedford MR, 1998, NUTR RES REV, V11, P91, DOI 10.1079/NRR19980007; Bianchi ML, 2008, OSTEOPOROSIS INT, V19, P1705, DOI 10.1007/s00198-008-0624-0; Bianchi ML, 2010, ARCH BIOCHEM BIOPHYS, V503, P54, DOI 10.1016/j.abb.2010.06.026; CAMPBELL GL, 1983, BRIT POULTRY SCI, V24, P191, DOI 10.1080/00071668308416730; Capriles VD, 2009, NUTR REV, V67, P599, DOI 10.1111/j.1753-4887.2009.00232.x; Caruso R, 2020, NAT REV IMMUNOL, V20, P411, DOI [10.4161/gmic.20228, 10.1038/s41577-019-0268-7]; CHOCT M, 1995, J NUTR, V125, P485; Choct M, 2009, BRIT POULTRY SCI, V50, P9, DOI 10.1080/00071660802538632; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; DUNSFORD BR, 1989, J ANIM SCI, V67, P1855; Hofacre C. L., 2001, Science and technology in the feed industry. Proceedings of Alltech's 17th Annual Symposium: a time for answers, P79; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Horwaitz W, 2000, OFFICIAL METHODS ANA, P1; Hrncir T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-65; Huyghebaert G, 2011, VET J, V187, P182, DOI 10.1016/j.tvjl.2010.03.003; Ilan Y, 2012, WORLD J GASTROENTERO, V18, P2609, DOI 10.3748/wjg.v18.i21.2609; James SP, 2005, J ALLERGY CLIN IMMUN, V115, P25, DOI 10.1016/j.jaci.2004.11.011; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kiarie E, 2013, NUTR RES REV, V26, P71, DOI 10.1017/S0954422413000048; Kotake S, 2009, ARTHRITIS RHEUM-US, V60, P3158, DOI 10.1002/art.24886; Kupfer Sonia S, 2012, Gastrointest Endosc Clin N Am, V22, P639, DOI 10.1016/j.giec.2012.07.003; Latorre Juan D, 2014, Front Vet Sci, V1, P26, DOI 10.3389/fvets.2014.00026; Leffler D, 2011, JAMA-J AM MED ASSOC, V306, P1582, DOI [10.1001/jama.2011.1312, 10.1001/jama.306.14.1582]; MACAULIFFE T, 1971, POULTRY SCI, V50, P1130, DOI 10.3382/ps.0501130; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Maslowski KM, 2011, NAT IMMUNOL, V12, P5, DOI 10.1038/ni0111-5; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Murphy TC, 2009, BRIT POULTRY SCI, V50, P716, DOI 10.1080/00071660903389950; National Research Council, 1994, NUTR REQ POULTR; Ouwehand A., 2002, European Journal of Nutrition, V41; RENNIE JS, 1993, BRIT J NUTR, V69, P809, DOI 10.1079/BJN19930081; Salminen S, 2006, J PEDIATR-US, V149, pS115, DOI 10.1016/j.jpeds.2006.06.062; Salzman NH, 2011, CURR OPIN MICROBIOL, V14, P99, DOI 10.1016/j.mib.2010.09.018; SAS Institute Inc, 2002, SAS US GUID; Schuppan D, 2009, GASTROENTEROLOGY, V137, P1912, DOI 10.1053/j.gastro.2009.09.008; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Shirzadi H, 2010, AFR J BIOTECHNOL, V9, P1517; Silva MA, 2012, DIGEST DIS SCI, V57, P38, DOI 10.1007/s10620-011-1847-z; Stepniak D, 2006, HUM IMMUNOL, V67, P460, DOI 10.1016/j.humimm.2006.03.011; Strohle Alexander, 2013, Med Monatsschr Pharm, V36, P369; Teirlynck E, 2009, BRIT J NUTR, V102, P1453, DOI 10.1017/S0007114509990407; Tellez G, 2014, POULT SCI S1, V93, P214; Tellez G, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00339; Timbermont L, 2011, AVIAN PATHOL, V40, P341, DOI 10.1080/03079457.2011.590967; Van Leeuwen P, 2004, BRIT POULTRY SCI, V45, P41, DOI 10.1080/00071660410001668842; Wideman Robert F, 2012, Front Endocrinol (Lausanne), V3, P183, DOI 10.3389/fendo.2012.00183; Williamson D, 2002, MOL BIOTECHNOL, V22, P293, DOI 10.1385/MB:22:3:293; Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100; Yan YT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006073; Yegani M, 2008, POULTRY SCI, V87, P2052, DOI 10.3382/ps.2008-00091; Zhang BF, 1997, POULTRY SCI, V76, P1698, DOI 10.1093/ps/76.12.1698	55	32	32	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122390	10.1371/journal.pone.0122390	http://dx.doi.org/10.1371/journal.pone.0122390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849537	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800125
J	Hausmann, S; Brandt, E; Kochel, C; Einsele, H; Bargou, RC; Seggewiss-Bernhardt, R; Stuhmer, T				Hausmann, Stefan; Brandt, Evelyn; Koechel, Carolin; Einsele, Hermann; Bargou, Ralf C.; Seggewiss-Bernhardt, Ruth; Stuehmer, Thorsten			Loss of Serum and Glucocorticoid-Regulated Kinase 3 (SGK3) Does Not Affect Proliferation and Survival of Multiple Myeloma Cell Lines	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT; AKT; INHIBITION; CANCER; PHOSPHORYLATION; DOWNSTREAM; ACTIVATION; MECHANISM; ISOFORMS; PATHWAY	Multiple myeloma (MM) is a generally fatal plasma cell cancer that often shows activation of the phosphoinositide 3-kinase/Akt (PI3K/Akt) pathway. Targeted pharmacologic therapies, however, have not yet progressed beyond the clinical trial stage, and given the complexity of the PI3K/Akt signalling system (e.g. multiple protein isoforms, diverse feedback regulation mechanisms, strong variability between patients) it is mandatory to characterise its ramifications in order to better guide informed decisions about the best therapeutic approaches. Here we explore whether serum and glucocorticoid-regulated kinase 3 (SGK3), a potential downstream effector of PI3K, plays a role in oncogenic signalling in MM cells-either in concert with or independent of Akt. SGK3 was expressed in all MM cell lines and in all primary MM samples tested. Four MM cell lines representing a broad range of intrinsic Akt activation (very strong: MM. 1s, moderate: L 363 and JJN-3, absent: AMO-1) were chosen to test the effects of transient SGK3 knockdown alone and in combination with pharmacological inhibition of Akt, PI3K-p110a, or in the context of serum starvation. Although the electroporation protocol led to strong SGK3 depletion for at least 5 days its absence had no substantial effect on the activation status of potential downstream substrates, or on the survival, viability or proliferation of MM cells in all experimental contexts tested. We conclude that it is unlikely that SGK3 plays a significant role for oncogenic signalling in multiple myeloma.	[Hausmann, Stefan; Brandt, Evelyn; Koechel, Carolin; Einsele, Hermann; Stuehmer, Thorsten] Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany; [Bargou, Ralf C.; Seggewiss-Bernhardt, Ruth] Univ Hosp Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany	University of Wurzburg; University of Wurzburg	Stuhmer, T (corresponding author), Univ Hosp Wurzburg, Div Hematol & Oncol, Dept Internal Med 2, Wurzburg, Germany.	stuehmer_t@ukw.de			Wilhelm Sander-Stiftung [2011.114.1]; Deutsche Forschungsgemeinschaft [KFO 216]	Wilhelm Sander-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Wilhelm Sander-Stiftung (www.sanst.de)(Grant No. 2011.114.1 to RS-B, TS) and the Deutsche Forschungsgemeinschaft (www.dfg.de)(KFO 216 (RCB, HE, TS)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azab F, 2014, BRIT J HAEMATOL, V165, P89, DOI 10.1111/bjh.12734; Bruhn Maressa A, 2013, Cancer Manag Res, V5, P281, DOI 10.2147/CMAR.S35178; Burger R, 2001, Hematol J, V2, P42, DOI 10.1038/sj.thj.6200075; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; De Marco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055362; Dienstmann R, 2014, MOL CANCER THER, V13, P1021, DOI 10.1158/1535-7163.MCT-13-0639; Fagerli UM, 2011, ONCOGENE, V30, P3198, DOI 10.1038/onc.2011.79; Fensterle J, 2014, ANTI-CANCER AGENT ME, V14, P629, DOI 10.2174/1871520614666140309225912; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hofmann C, 2014, BRIT J HAEMATOL, V166, P529, DOI 10.1111/bjh.12920; Hsu JH, 2001, BLOOD, V98, P2853, DOI 10.1182/blood.V98.9.2853; Ismail SI, 2010, LEUKEMIA RES, V34, P824, DOI 10.1016/j.leukres.2009.11.018; Keane NA, 2014, EXPERT OPIN THER TAR, V18, P897, DOI 10.1517/14728222.2014.924507; Kuehl WM, 2012, J CLIN INVEST, V122, P3456, DOI 10.1172/JCI61188; Kumar SK, 2014, LEUKEMIA, V28, P1122, DOI 10.1038/leu.2013.313; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Leich E, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2012.47; Liu M, 2012, HEPATOLOGY, V55, P1754, DOI 10.1002/hep.25584; Logie L, 2007, DIABETES, V56, P2218, DOI 10.2337/db07-0343; Logue SE, 2009, NAT PROTOC, V4, P1383, DOI 10.1038/nprot.2009.143; Lohr JG, 2014, CANCER CELL, V25, P91, DOI 10.1016/j.ccr.2013.12.015; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mimura N, 2014, CANCER RES, V74, P4458, DOI 10.1158/0008-5472.CAN-13-3652; Moreau P, 2013, ANN ONCOL, V24, P133, DOI 10.1093/annonc/mdt297; Morgan GJ, 2012, NAT REV CANCER, V12, P335, DOI 10.1038/nrc3257; Munugalavadla V, 2014, ONCOGENE, V33, P316, DOI 10.1038/onc.2012.594; Pene F, 2002, ONCOGENE, V21, P6587, DOI 10.1038/sj.onc.1205923; Porta C, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00064; Ramakrishnan V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050005; Rehan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109705; Roberts DJ, 2015, CELL DEATH DIFFER, V22, P248, DOI 10.1038/cdd.2014.173; Sahin I, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.24; Spencer A, 2014, BLOOD, V124, P2190, DOI 10.1182/blood-2014-03-559963; Steinbrunn T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097443; Steinbrunn T, 2012, BRIT J HAEMATOL, V159, P430, DOI 10.1111/bjh.12039; Stuhmer T, 2010, BRIT J HAEMATOL, V149, P529, DOI 10.1111/j.1365-2141.2010.08126.x; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Tu YP, 2000, CANCER RES, V60, P6763; Uphoff CC, 2004, METH MOLEC MED, V88, P319; Usmani SZ, 2013, LEUKEMIA, V27, P226, DOI 10.1038/leu.2012.160; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Wang YZ, 2014, MOL ENDOCRINOL, V28, P935, DOI 10.1210/me.2013-1339; Wang YZ, 2014, J BIOL CHEM, V289, P4815, DOI 10.1074/jbc.M113.518480; Wang YZ, 2011, MOL ENDOCRINOL, V25, P72, DOI 10.1210/me.2010-0294; Yan L, 2009, P 100 ANN M AM ASS C; Zollinger A, 2008, BLOOD, V112, P3403, DOI 10.1182/blood-2007-11-119362	48	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122689	10.1371/journal.pone.0122689	http://dx.doi.org/10.1371/journal.pone.0122689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837824	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000106
J	Hughes, MLR; Liu, BN; Halls, ML; Wagstaff, KM; Patil, R; Velkov, T; Jans, DA; Bunnett, NW; Scanlon, MJ; Porter, CJH				Hughes, Maria L. R.; Liu, Bonan; Halls, Michelle L.; Wagstaff, Kylie M.; Patil, Rahul; Velkov, Tony; Jans, David A.; Bunnett, Nigel W.; Scanlon, Martin J.; Porter, Christopher J. H.			Fatty Acid-binding Proteins 1 and 2 Differentially Modulate the Activation of Peroxisome Proliferator-activated Receptor alpha in a Ligand-selective Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOIC ACID; STRUCTURAL BASIS; GENE-EXPRESSION; HUMAN PROTEOME; LIVING CELLS; PPAR-GAMMA; LOCALIZATION; PATHWAYS; NUCLEUS; TARGETS	Nuclear hormone receptors (NHRs) regulate the expression of proteins that control aspects of reproduction, development and metabolism, and are major therapeutic targets. However, NHRs are ubiquitous and participate in multiple physiological processes. Drugs that act at NHRs are therefore commonly restricted by toxicity, often at nontarget organs. For endogenous NHR ligands, intracellular lipid-binding proteins, including the fatty acid-binding proteins (FABPs), can chaperone ligands to the nucleus and promote NHR activation. Drugs also bind FABPs, raising the possibility that FABPs similarly regulate drug activity at the NHRs. Here, we investigate the ability of FABP1 and FABP2 (intracellular lipid-binding proteins that are highly expressed in tissues involved in lipid metabolism, including the liver and intestine) to influence drug-mediated activation of the lipid regulator peroxisome proliferator-activated receptor (PPAR) alpha. We show by quantitative fluorescence imaging and gene reporter assays that drug binding to FABP1 and FABP2 promotes nuclear localization and PPAR alpha activation in a drug-and FABP-dependent manner. We further show that nuclear accumulation of FABP1 and FABP2 is dependent on the presence of PPAR alpha. Nuclear accumulation of FABP on drug binding is driven largely by reduced nuclear egress rather than an increased rate of nuclear entry. Importin binding assays indicate that nuclear access occurs via an importin-independent mechanism. Together, the data suggest that specific drug-FABP complexes can interact with PPAR alpha to effect nuclear accumulation of FABP and NHR activation. Because FABPs are expressed in a regionally selective manner, this may provide a means to tailor the patterns of NHR drug activation in a tissue-specific manner.	[Hughes, Maria L. R.; Liu, Bonan; Velkov, Tony; Porter, Christopher J. H.] Monash Univ, Drug Delivery Disposit & Dynam, Parkville, Vic 3052, Australia; [Halls, Michelle L.; Bunnett, Nigel W.] Monash Univ, Drug Discovery Biol, Parkville, Vic 3052, Australia; [Patil, Rahul; Scanlon, Martin J.] Monash Univ, Med Chem, Parkville, Vic 3052, Australia; [Bunnett, Nigel W.; Porter, Christopher J. H.] Monash Univ, ARC Ctr Excellence Convergent Bionano Sci & Techn, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Wagstaff, Kylie M.; Jans, David A.] Monash Univ, Fac Med Nursing & Hlth Sci, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Bunnett, Nigel W.] Univ Melbourne, Dept Pharmacol, Melbourne, Vic 3010, Australia	Monash University; Monash University; Monash University; Monash University; Monash University; University of Melbourne	Bunnett, NW (corresponding author), Monash Inst Pharmaceut Sci, Drug Discovery Biol, 381 Royal Parade, Parkville, Vic 3052, Australia.	nigel.bunnett@monash.edu; martin.scanlon@monash.edu; chris.porter@monash.edu	Porter, Christopher JH/C-6333-2011	Porter, Christopher JH/0000-0003-3474-7551; Wagstaff, Kylie/0000-0003-4791-1410; Halls, Michelle/0000-0001-8555-8959; Scanlon, Martin/0000-0002-9230-7506; Jans, David/0000-0001-5115-4745; velkov, tony/0000-0002-0017-7952; Bunnett, Nigel W./0000-0003-3367-0644	ARC [DP120102930]; ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology; National Health and Medical Research Council [63303, 1049682, 1031886]; Monash University	ARC(Australian Research Council); ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Monash University(Monash University)	This work was supported by ARC Grant DP120102930 and the ARC Centres of Excellence for Coherent X-ray Science and Convergent Bio-Nano Science and Technology, National Health and Medical Research Council Grants 63303, 1049682, and 1031886, and Monash University.	Armstrong EH, 2014, J BIOL CHEM, V289, P14941, DOI 10.1074/jbc.M113.514646; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Bernlohr DA, 1997, ANNU REV NUTR, V17, P277, DOI 10.1146/annurev.nutr.17.1.277; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Budhu A, 2001, J MOL BIOL, V305, P939, DOI 10.1006/jmbi.2000.4340; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Gillilan RE, 2007, J MOL BIOL, V372, P1246, DOI 10.1016/j.jmb.2007.07.040; Hostetler HA, 2009, J LIPID RES, V50, P1663, DOI 10.1194/jlr.M900058-JLR200; Huang H, 2002, J BIOL CHEM, V277, P29139, DOI 10.1074/jbc.M202923200; Huang H, 2004, BIOCHEMISTRY-US, V43, P2484, DOI 10.1021/bi0352318; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Kuusisto HV, 2012, FASEB J, V26, P1181, DOI 10.1096/fj.11-191585; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Patil R, 2014, ACS CHEM BIOL, V9, P2526, DOI 10.1021/cb5005178; Peters JM, 2012, NAT REV CANCER, V12, P181, DOI 10.1038/nrc3214; Richieri GV, 2000, BIOCHEMISTRY-US, V39, P7197, DOI 10.1021/bi000314z; Schoonjans K, 1996, J LIPID RES, V37, P907; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Umemoto T, 2012, GENES CELLS, V17, P576, DOI 10.1111/j.1365-2443.2012.01607.x; Veerkamp JH, 1999, MOL CELL BIOCHEM, V192, P137, DOI 10.1023/A:1006866119264; Velkov T, 2005, J BIOL CHEM, V280, P17769, DOI 10.1074/jbc.M410193200; Wagstaff KM, 2006, ANAL BIOCHEM, V348, P49, DOI 10.1016/j.ab.2005.10.029; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Wolfrum C, 2000, BIOCHEMISTRY-US, V39, P14363, DOI 10.1021/bi0051187; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898	33	36	36	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13895	13906		10.1074/jbc.M114.605998	http://dx.doi.org/10.1074/jbc.M114.605998			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25847235	Green Published, hybrid			2022-12-26	WOS:000355313000022
J	Yang, G; Geng, XR; Liu, ZQ; Liu, JQ; Liu, XY; Xu, LZ; Zhang, HP; Sun, YX; Liu, ZG; Yang, PC				Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Zhang, Huan-Ping; Sun, Ying-Xue; Liu, Zhi-Gang; Yang, Ping-Chang			Thrombospondin-1 (TSP1)-producing B Cells Restore Antigen (Ag)-specific Immune Tolerance in an Allergic Environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; FOOD ALLERGY; DENDRITIC CELLS; INDUCTION; BETA; INFLAMMATION; DISEASE; PLAYS	Restoration of the antigen (Ag)-specific immune tolerance in an allergic environment is refractory. B cells are involved in immune regulation. Whether B cells facilitate the generation of Ag-specific immune tolerance in an allergic environment requires further investigation. This paper aims to elucidate the mechanism by which B cells restore the Ag-specific immune tolerance in an allergic environment. In this study, a B cell-deficient mouse model was created by injecting an anti-CD20 antibody. The frequency of tolerogenic dendritic cell (TolDC) was assessed by flow cytometry. The levels of cytokines were determined by enzyme-linked immunosorbent assay. The expression of thrombospondin-1 (TSP1) was assessed by quantitative real-time RT-PCR, Western blotting, and methylation-specific PCR. The results showed that B cells were required in the generation of the TGF-beta-producing TolDCs in mice. B cell-derived TSP1 converted the latent TGF-beta to the active TGF-beta in DCs, which generated TGF-beta-producing TolDCs. Exposure to IL-13 inhibited the expression of TSP1 in B cells by enhancing the TSP1 gene DNA methylation. Treating food allergy mice with Ag-specific immunotherapy and IL-13 antagonists restored the generation of TolDCs and enhanced the effect of specific immunotherapy. In conclusion, B cells play a critical role in the restoration of specific immune tolerance in an allergic environment. Blocking IL-13 in an allergic environment facilitated the generation of TolDCs and enhanced the therapeutic effect of immunotherapy.	[Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, Sch Med, Shenzhen Key Lab Allergy & Immunol, ENT Inst, Shenzhen 518060, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Liu, Xiao-Yu; Xu, Ling-Zhi; Liu, Zhi-Gang; Yang, Ping-Chang] Shenzhen Univ, State Key Lab Resp Dis Allergy, Shenzhen 518060, Peoples R China; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi; Zhang, Huan-Ping; Sun, Ying-Xue; Yang, Ping-Chang] McMaster Univ, Brain Body Inst, Hamilton, ON L8N 4A6, Canada; [Yang, Gui; Geng, Xiao-Rui; Liu, Zhi-Qiang; Liu, Jiang-Qi] Longgang Cent Hosp, Shenzhen 518116, Peoples R China	Shenzhen University; Shenzhen University; State Key Laboratory of Respiratory Disease; McMaster University	Liu, ZG (corresponding author), Med Sch Bldg Rm 722,3688 Nanhai Ave, Shenzhen 518060, Peoples R China.	lzg@szu.edu.cn; pcy2356@szu.edu.cn	Yang, Ping-Chang/K-4669-2019		Natural Science Foundation of SZU [000004]; Shenzhen Innovation of Science and Technology Commission [JCYJ20140418095735538, JCYJ20140411150916749]; Natural Science Foundation of China [81373176, 31400856]	Natural Science Foundation of SZU; Shenzhen Innovation of Science and Technology Commission; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Natural Science Foundation of SZU (000004), the Shenzhen Innovation of Science and Technology Commission (JCYJ20140418095735538 and JCYJ20140411150916749), and the Natural Science Foundation of China (81373176 and 31400856).	Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2011, ALLERGY, V66, P1038, DOI 10.1111/j.1398-9995.2011.02585.x; Chen X, 2011, J LEUKOCYTE BIOL, V90, P751, DOI 10.1189/jlb.1210696; Gilbert RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027501; Grimbert P, 2006, J IMMUNOL, V177, P3534, DOI 10.4049/jimmunol.177.6.3534; Hayashi H, 2012, HEPATOLOGY, V55, P1562, DOI 10.1002/hep.24800; He SH, 2011, GASTROENTEROLOGY, V141, P249, DOI 10.1053/j.gastro.2011.04.006; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Horn M, 2012, J THROMB HAEMOST, V10, P647, DOI 10.1111/j.1538-7836.2012.04640.x; JAFFE E, 1990, GENOMICS, V7, P123, DOI 10.1016/0888-7543(90)90528-3; Kim JS, 2012, CURR OPIN GASTROEN, V28, P99, DOI 10.1097/MOG.0b013e32834e7b60; Kushwah R, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-20; Leonard SA, 2012, J ALLERGY CLIN IMMUN, V129, P1579, DOI 10.1016/j.jaci.2012.04.009; Liu ZQ, 2013, ALLERGY, V68, P1241, DOI 10.1111/all.12218; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Lo-Man R, 2011, IMMUNOTHERAPY-UK, V3, P19, DOI [10.2217/IMT.11.34, 10.2217/imt.11.34]; Maldonado RA, 2010, ADV IMMUNOL, V108, P111, DOI [10.1016/B978-0-12-380995-7.00004-5, 10.1016/S0065-2776(10)08004_1]; Mayer CT, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00183; Okada Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044338; Ooi AT, 2012, AM J TRANSL RES, V4, P219; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Seidel-Guyenot W, 2004, EUR J IMMUNOL, V34, P3082, DOI 10.1002/eji.200425402; Sid B, 2004, CRIT REV ONCOL HEMAT, V49, P245, DOI 10.1016/j.critrevonc.2003.09.009; Smits HH, 2012, AUTOIMMUNITY, V45, P415, DOI 10.3109/08916934.2012.665525; Tang MX, 2011, MOL CELL BIOCHEM, V346, P49, DOI 10.1007/s11010-010-0590-7; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Wu ZQ, 2013, CELL IMMUNOL, V283, P75, DOI 10.1016/j.cellimm.2013.06.014; Zhang HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03345; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183	31	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12858	12867		10.1074/jbc.M114.623421	http://dx.doi.org/10.1074/jbc.M114.623421			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25839231	hybrid, Green Published			2022-12-26	WOS:000354569000036
J	Campanozzi, A; Avallone, S; Barbato, A; Iacone, R; Russo, O; De Filippo, G; D'Angelo, G; Pensabene, L; Malamisura, B; Cecere, G; Micillo, M; Francavilla, R; Tetro, A; Lombardi, G; Tonelli, L; Castellucci, G; Ferraro, L; Di Biase, R; Lezo, A; Salvatore, S; Paoletti, S; Siani, A; Galeone, D; Strazzullo, P				Campanozzi, Angelo; Avallone, Sonia; Barbato, Antonio; Iacone, Roberto; Russo, Ornella; De Filippo, Gianpaolo; D'Angelo, Giuseppina; Pensabene, Licia; Malamisura, Basilio; Cecere, Gaetano; Micillo, Maria; Francavilla, Ruggiero; Tetro, Anna; Lombardi, Giuliano; Tonelli, Lisa; Castellucci, Giuseppe; Ferraro, Luigi; Di Biase, Rita; Lezo, Antonella; Salvatore, Silvia; Paoletti, Silvia; Siani, Alfonso; Galeone, Daniela; Strazzullo, Pasquale		MINISAL-GIRCSI Program Study Grp	High Sodium and Low Potassium Intake among Italian Children: Relationship with Age, Body Mass and Blood Pressure	PLOS ONE			English	Article							DIETARY SALT INTAKE; CARDIOVASCULAR-DISEASE; METAANALYSIS; EXCRETION; CONSUMPTION; ADOLESCENTS; OBESITY; STROKE	Background Hypertension is the leading cause of death in developed countries and reduction of salt intake is recommended as a key preventive measure. Objective To assess the dietary sodium and potassium intakes in a national sample of Italian children and adolescents and to examine their relationships with BMI and blood pressure (BP) in the framework of the MINISAL survey, a program supported by the Italian Ministry of Health. Population and Methods The study population included 1424 healthy subjects (766 boys, 658 girls) aged 6-18 years (mean age: 10.1 +/- 2.9) who were consecutively recruited in participating National Health Service centers in 10 Italian regions. Electrolyte intake was estimated from 24 hour urine collections tested for completeness by the concomitant measurement of creatinine content. Anthropometric indices and BP were measured with standardized procedures. Results The average estimated sodium intake was 129 mmol (7.4 g of salt) per day among boys and 117 mmol (6.7 g of salt) among girls. Ninety-three percent of the boys and 89% of the girls had a consumption higher than the recommended age-specific standard dietary target. The estimated average daily potassium intakes were 39 mmol (1.53 g) and 36 mmol (1.40 g), respectively, over 96% of the boys and 98% of the girls having a potassium intake lower than the recommended adequate intake. The mean sodium/potassium ratio was similar among boys and girls (3.5 and 3.4, respectively) and over 3-fold greater than the desirable level. Sodium intake was directly related to age, body mass and BP in the whole population. Conclusions The Italian pediatric population is characterized by excessive sodium and deficient potassium intake. These data suggest that future campaigns should focus on children and adolescents as a major target in the framework of a population strategy of cardiovascular prevention.	[Campanozzi, Angelo; D'Angelo, Giuseppina] Univ Foggia, Pediat, Foggia, Italy; [Avallone, Sonia; Barbato, Antonio; Iacone, Roberto; Russo, Ornella; De Filippo, Gianpaolo; Strazzullo, Pasquale] Univ Naples Federico II, Sch Med, ESH Excellence Ctr Hypertens, Dept Clin Med & Surg, Naples, Italy; [De Filippo, Gianpaolo] Hop Bicetre, AP HP, Serv Endocrinol & Diabetol Pediat, Le Kremlin Bicetre, France; [Pensabene, Licia] Magna Graecia Univ Catanzaro, Pediat, Catanzaro, Italy; [Malamisura, Basilio] Pediat Hosp Cava Tirreni SA, Ancona, Italy; [Cecere, Gaetano; Micillo, Maria] ASL Naples, Pediat, Naples, Italy; [Francavilla, Ruggiero] Univ Bari, Pediat, Bari, Italy; [Tetro, Anna] San Paolo Hosp, Pediat, Bari, Italy; [Lombardi, Giuliano] Santo Spirito Hosp, Pediat, Pescara, Italy; [Tonelli, Lisa] Univ Marche, Pediat, Ancona, Italy; [Castellucci, Giuseppe; Ferraro, Luigi] ASL Umbria, Pediat, Perugia, Italy; [Di Biase, Rita] Univ Modena, Pediat, I-41100 Modena, Italy; [Lezo, Antonella] Univ Turin, Pediat, I-10124 Turin, Italy; [Salvatore, Silvia] Univ Insubria, Pediat, Varese, Italy; [Paoletti, Silvia] ASL Roma, Pediat, Rome, Italy; [Siani, Alfonso] CNR, Inst Food Sci & Technol, Epidemiol & Populat Genet, Avellino, AS, Italy; Italian Minist Hlth, Ctr Dis Prevent & Control, Rome, Italy	University of Foggia; University of Naples Federico II; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Magna Graecia University of Catanzaro; Universita degli Studi di Bari Aldo Moro; Marche Polytechnic University; Universita di Modena e Reggio Emilia; University of Turin; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR)	Strazzullo, P (corresponding author), Univ Naples Federico II, Sch Med, ESH Excellence Ctr Hypertens, Dept Clin Med & Surg, Naples, Italy.	strazzul@unina.it	Salvatore, Silvia/AAL-4325-2020; Barbato, Antonio/AAG-3313-2020; Campanozzi, Angelo/AAR-6227-2020; Siani, Alfonso/B-7925-2015; Pensabene, Licia/AAW-2755-2020; FRANCAVILLA, RUGGIERO/S-1391-2019; Iacone, Roberto/M-2867-2016; De+Filippo, Gianpaolo/AAE-5584-2019	Campanozzi, Angelo/0000-0002-3489-2524; FRANCAVILLA, RUGGIERO/0000-0002-4603-974X; Iacone, Roberto/0000-0003-3360-3855; Barbato, Antonio/0000-0002-4660-821X; Salvatore, Silvia/0000-0003-4339-556X	Italian Ministry of Health through MINISAL-GIRCSI intervention program; Italian Ministry of Health through MENO SALE PIU SALUTE intervention program	Italian Ministry of Health through MINISAL-GIRCSI intervention program; Italian Ministry of Health through MENO SALE PIU SALUTE intervention program	This publication has been made possible thanks to the support of the Italian Ministry of Health through funding of the MINISAL-GIRCSI and MENO SALE PIU SALUTE intervention programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1326; Aburto NJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1378; Ad hoc Committee of the Italian Society of Human Nutrition (SINU) and the Institute for Food Research and Nutrition (INRAN), 2012, 35 SINU SCI M BOL OC; [Anonymous], 2002, VITAL HLTH STAT; Beauchamp GK, 2009, J PEDIATR GASTR NUTR, V48, pS25, DOI 10.1097/MPG.0b013e31819774a5; Bordini B, 2011, PEDIATR REV, V32, P281, DOI 10.1542/pir.32-7-281; COOPER R, 1983, HYPERTENSION, V5, P135, DOI 10.1161/01.HYP.5.1.135; D'Elia L, 2011, J AM COLL CARDIOL, V57, P1210, DOI 10.1016/j.jacc.2010.09.070; Donfrancesco C, 2013, NUTR METAB CARDIOVAS, V23, P850, DOI 10.1016/j.numecd.2012.04.004; Franks PW, 2010, NEW ENGL J MED, V362, P485, DOI 10.1056/NEJMoa0904130; Grimes CA, 2013, PEDIATRICS, V131, P14, DOI 10.1542/peds.2012-1628; He FJ, 2008, PHYSIOL PLANTARUM, V133, P725, DOI 10.1111/j.1399-3054.2007.01033.x; He FJ, 2008, HYPERTENSION, V51, P629, DOI 10.1161/HYPERTENSIONAHA.107.100990; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; *I MED NAT AC, 2010, STRAT RED SOD INT US; Jennings A, 2010, INT J FOOD SCI NUTR, V61, P68, DOI 10.3109/09637480903229009; Kristbjornsdottir OK, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-94; Lava SA, 2014, PEDIAT NEPHROL; Manci G, 2013, J HYPERTENS, V31, P1281, DOI [DOI 10.1097/01.HJH.0000431740.32696.CC, 10.1093/eurheartj/eht151]; Marras AR, 2009, CARDIOL YOUNG, V19, P233, DOI 10.1017/S1047951109003722; McGill CR, 2008, J AM COLL NUTR, V27, P44, DOI 10.1080/07315724.2008.10719673; Meneton P, 2009, EUR J CLIN NUTR, V63, P1169, DOI 10.1038/ejcn.2009.57; Remer T, 2002, AM J CLIN NUTR, V75, P561, DOI 10.1093/ajcn/75.3.561; ROCCHINI AP, 1989, NEW ENGL J MED, V321, P580, DOI 10.1056/NEJM198908313210905; SimonsMorton DG, 1997, PEDIATR NEPHROL, V11, P244, DOI 10.1007/s004670050271; Stein LJ, 2012, AM J CLIN NUTR, V95, P123, DOI 10.3945/ajcn.111.014282; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P787, DOI 10.1016/j.numecd.2012.04.003; Strazzullo P, 2012, NUTR METAB CARDIOVAS, V22, P161, DOI 10.1016/j.numecd.2011.10.004; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Thomson BM, 2008, BR J NUTR, V9, P614; WHO Expert Committee on Problems Related to Alcohol Consumption, 2007, World Health Organ Tech Rep Ser, P1	31	51	52	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121183	10.1371/journal.pone.0121183	http://dx.doi.org/10.1371/journal.pone.0121183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853242	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400031
J	Gregory, NJ; Lopez, B; Graham, G; Marshman, P; Bate, S; Kargas, N				Gregory, Nicola Jean; Lopez, Beatriz; Graham, Gemma; Marshman, Paul; Bate, Sarah; Kargas, Niko			Reduced Gaze Following and Attention to Heads when Viewing a "Live" Social Scene	PLOS ONE			English	Article							JOINT VISUAL-ATTENTION; EYE-GAZE; SACCADE GENERATION; COGNITIVE-ETHOLOGY; CUES; INFORMATION; DIRECTION; ALLOCATION; SHIFTS; OVERT	Social stimuli are known to both attract and direct our attention, but most research on social attention has been conducted in highly controlled laboratory settings lacking in social context. This study examined the role of social context on viewing behaviour of participants whilst they watched a dynamic social scene, under three different conditions. In two social groups, participants believed they were watching a live webcam of other participants. The socially-engaged group believed they would later complete a group task with the people in the video, whilst the non-engaged group believed they would not meet the people in the scene. In a third condition, participants simply free-viewed the same video with the knowledge that it was pre-recorded, with no suggestion of a later interaction. Results demonstrated that the social context in which the stimulus was viewed significantly influenced viewing behaviour. Specifically, participants in the social conditions allocated less visual attention towards the heads of the actors in the scene and followed their gaze less than those in the free-viewing group. These findings suggest that by underestimating the impact of social context in social attention, researchers risk coming to inaccurate conclusions about how we attend to others in the real world.	[Gregory, Nicola Jean; Bate, Sarah] Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England; [Gregory, Nicola Jean; Lopez, Beatriz; Graham, Gemma; Marshman, Paul; Kargas, Niko] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	Bournemouth University; University of Portsmouth	Gregory, NJ (corresponding author), Bournemouth Univ, Fac Sci & Technol, Psychol Res Ctr, Poole BH12 5BB, Dorset, England.	ngregory@bournemouth.ac.uk	Gregory, Nicola/H-8057-2019	Lopez, Beatriz/0000-0001-5621-6044; Kargas, Niko/0000-0002-0052-5363	Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award; Department of Psychology, University of Portsmouth	Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award; Department of Psychology, University of Portsmouth	NG and SB were supported by a Bournemouth University Fusion Investment Fund Staff Networking and Mobility Award. BL and NG were supported by a research grant from the Department of Psychology, University of Portsmouth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, DIAGNOSTIC AND STATI; BARONCOHEN S, 1995, BRIT J DEV PSYCHOL, V13, P379, DOI 10.1111/j.2044-835X.1995.tb00687.x; BARONCOHEN S, 1996, BRIT J PSYCHIAT, V168, P158, DOI DOI 10.1192/BJP.168.2.158; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Bonifacci P, 2008, COGN PROCESS, V9, P127, DOI 10.1007/s10339-007-0198-3; BUTTERWORTH G, 1991, BRIT J DEV PSYCHOL, V9, P55, DOI 10.1111/j.2044-835X.1991.tb00862.x; Carpenter M, 1998, MONOGR SOC RES CHILD, V63, pV; Chawarska K, 2003, CHILD DEV, V74, P1108, DOI 10.1111/1467-8624.00595; D'Entremont B, 1997, INFANT BEHAV DEV, V20, P569, DOI 10.1016/S0163-6383(97)90048-5; Dodd MD, 2011, ATTEN PERCEPT PSYCHO, V73, P24, DOI 10.3758/s13414-010-0001-x; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fletcher-Watson S, 2009, NEUROPSYCHOLOGIA, V47, P248, DOI 10.1016/j.neuropsychologia.2008.07.016; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Fox E, 2007, EMOTION, V7, P478, DOI 10.1037/1528-3542.7.3.478; Freeth M, 2010, J AUTISM DEV DISORD, V40, P534, DOI 10.1007/s10803-009-0893-2; Freeth M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053286; Freeth M, 2011, J AUTISM DEV DISORD, V41, P364, DOI 10.1007/s10803-010-1053-4; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gallup AC, 2012, BIOL LETTERS, V8, P520, DOI 10.1098/rsbl.2012.0160; Gallup AC, 2012, P NATL ACAD SCI USA, V109, P7245, DOI 10.1073/pnas.1116141109; Godijn R, 2002, J EXP PSYCHOL HUMAN, V28, P1039, DOI 10.1037//0096-1523.28.5.1039; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Gregory NJ, 2012, PERCEPTION, V41, P131, DOI 10.1068/p7085; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Henderson JM., 1992, EYE MOVEMENTS VISUAL, P260, DOI [DOI 10.1007/978-1-4612-2852-3_15, 10.1007/978-1-4612-2852-3_15]; Hietanen JK, 2006, NEUROIMAGE, V33, P406, DOI 10.1016/j.neuroimage.2006.06.048; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kawakami K, 2014, J PERS SOC PSYCHOL, V107, P1, DOI 10.1037/a0036838; Kingstone A, 2008, BRIT J PSYCHOL, V99, P317, DOI 10.1348/000712607X251243; Kingstone A, 2009, CURR OPIN NEUROBIOL, V19, P52, DOI 10.1016/j.conb.2009.05.004; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Kuhn G, 2008, VIS COGN, V16, P391, DOI 10.1080/13506280701479750; Kuhn G, 2007, PERCEPT PSYCHOPHYS, V69, P966, DOI 10.3758/BF03193934; Kuhn G, 2006, CURR BIOL, V16, pR950, DOI 10.1016/j.cub.2006.10.012; Kuhn G, 2010, EXP BRAIN RES, V201, P155, DOI 10.1007/s00221-009-2019-7; Kuhn G, 2009, VIS COGN, V17, P925, DOI 10.1080/13506280902826775; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Langton SRH, 1999, VIS COGN, V6, P541, DOI 10.1080/135062899394939; Langton SRH, 2000, J EXP PSYCHOL HUMAN, V26, P747, DOI 10.1037//0096-1523.26.2.747; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; MORISSETTE P, 1995, BRIT J DEV PSYCHOL, V13, P163, DOI 10.1111/j.2044-835X.1995.tb00671.x; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Quadflieg S, 2004, PSYCHON B REV, V11, P826, DOI 10.3758/BF03196708; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Risko EF, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00143; Risko EF, 2011, ATTEN PERCEPT PSYCHO, V73, P291, DOI 10.3758/s13414-010-0042-1; Sato W, 2010, PSYCHOLOGIA, V53, P27, DOI 10.2117/psysoc.2010.27; SCAIFE M, 1975, NATURE, V253, P265, DOI 10.1038/253265a0; Skarratt PA, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00196; Smilek D, 2006, BRAIN RES, V1080, P101, DOI 10.1016/j.brainres.2005.12.090; Stoesz BM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00193; Swettenham J, 2003, PHILOS T R SOC B, V358, P325, DOI 10.1098/rstb.2002.1203; TAJFEL H, 1974, SOC SCI INFORM, V13, P65, DOI 10.1177/053901847401300204; Treue S, 2003, CURR OPIN NEUROBIOL, V13, P428, DOI 10.1016/S0959-4388(03)00105-3; Vecera SP, 2006, NEUROPSYCHOLOGIA, V44, P150, DOI 10.1016/j.neuropsychologia.2005.04.010; Walter H, 2005, BRAIN RES BULL, V67, P368, DOI 10.1016/j.brainresbull.2005.06.016; Yarbus A. L., 1967, EYE MOVEMENTS AND VI; Zwickel J, 2010, PSYCHON B REV, V17, P257, DOI 10.3758/PBR.17.2.257	67	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121792	10.1371/journal.pone.0121792	http://dx.doi.org/10.1371/journal.pone.0121792			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853239	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000352478400049
J	Oh, SW; Han, KH; Han, SY				Oh, Se Won; Han, Kum Hyun; Han, Sang Youb			Associations between Renal Hyperfiltration and Serum Alkaline Phosphatase	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; METABOLIC SYNDROME; HEMODIALYSIS-PATIENTS; RISK; MICROALBUMINURIA; DIAGNOSIS; DISEASE	Renal hyperfiltration, which is associated with renal injury, occurs in diabetic or obese individuals. Serum alkaline phosphatase (ALP) level is also elevated in patients with diabetes (DM) or metabolic syndrome (MS), and increased urinary excretion of ALP has been demonstrated in patients who have hyperfiltration and tubular damage. However, little was investigated about the association between hyperfiltration and serum ALP level. A retrospective observational study of the 21,308 adults in the Korea National Health and Nutrition Examination Survey IV-V databases (2008-2011) was performed. Renal hyperfiltration was defined as exceeding the age- and sex-specific 97.5(th) percentile. We divided participants into 4 groups according to their estimated glomerular filtration rate (eGFR): > 120, 90-119, 60-89, and < 60 mL/min/1.73 m(2). The participants with eGFR > 120 mL/min/1.73 m(2) showed the highest risk for MS, in the highest ALP quartiles (3.848, 95% CI, 1.876-7.892), compared to the lowest quartile. Similarly, the highest risk for DM, in the highest ALP quartiles, was observed in participants with eGFR > 120 ml/min/1.73 m(2) (2.166, 95% CI, 1.084-4.329). ALP quartiles were significantly associated with albuminuria in participants with eGFR >= 60 ml/min/1.73m(2). The highest ALP quartile had a 1.631-fold risk elevation for albuminuria with adjustment of age and sex. (95% CI, 1.158-2.297, P = 0.005). After adjustment, the highest ALP quartile had a 1.624-fold risk elevation, for renal hyperfiltration (95% CI, 1.204-2.192, P = 0.002). In addition, hyperfiltration was significantly associated with hemoglobin, triglyceride, white blood cell count, DM, smoking, and alcohol consumption (P<0.05). The relationship between serum ALP and metabolic disorders is stronger in participants with an upper-normal range of eGFR. Higher ALP levels are significantly associated with renal hyperfiltration in Korean general population.	[Oh, Se Won; Han, Kum Hyun; Han, Sang Youb] Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med,Div Nephrol, Goyang, South Korea	Inje University	Han, SY (corresponding author), Inje Univ, Coll Med, Ilsan Paik Hosp, Dept Internal Med,Div Nephrol, Goyang, South Korea.	hansy@paik.ac.kr	Oh, Se Won/G-2632-2017	Oh, Se Won/0000-0003-3795-9322				Blayney MJ, 2008, KIDNEY INT, V74, P655, DOI 10.1038/ki.2008.248; Bulum T, 2014, RENAL FAILURE, V36, P372, DOI 10.3109/0886022X.2013.872569; Canales BK, 2012, NUTRITION, V28, P76, DOI 10.1016/j.nut.2011.03.003; Chagnac A, 2008, NEPHROL DIAL TRANSPL, V23, P3946, DOI 10.1093/ndt/gfn379; De Carvalho JAM, 2011, CLIN CHIM ACTA, V412, P1407, DOI 10.1016/j.cca.2011.04.015; Deji N, 2009, AM J PHYSIOL-RENAL, V296, pF118, DOI 10.1152/ajprenal.00110.2008; Ficociello LH, 2009, DIABETES CARE, V32, P889, DOI 10.2337/dc08-1560; Fletcher S, 1997, NEPHRON, V75, P412, DOI 10.1159/000189578; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Heemskerk S, 2007, PFLUG ARCH EUR J PHY, V454, P321, DOI 10.1007/s00424-007-0210-x; Heemskerk S, 2009, CRIT CARE MED, V37, P417, DOI 10.1097/CCM.0b013e31819598af; Helal I, 2012, NAT REV NEPHROL, V8, P293, DOI 10.1038/nrneph.2012.19; Jorna FH, 2004, NEPHROL DIAL TRANSPL, V19, P1168, DOI 10.1093/ndt/gfh018; Kaliannan K, 2013, P NATL ACAD SCI USA, V110, P7003, DOI 10.1073/pnas.1220180110; Kim MK, 2013, ENDOCR J, V60, P321, DOI 10.1507/endocrj.EJ12-0331; Krishnamurthy VR, 2011, AM J MED, V124, DOI 10.1016/j.amjmed.2010.11.030; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lomashvili KA, 2008, KIDNEY INT, V73, P1024, DOI 10.1038/ki.2008.26; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Nannipieri M, 2005, DIABETES CARE, V28, P1757, DOI 10.2337/diacare.28.7.1757; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; NOUWEN EJ, 1994, KIDNEY INT, pS43; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Palatini P, 2012, NEPHROL DIAL TRANSPL, V27, P1708, DOI 10.1093/ndt/gfs037; Salgueira M, 2005, NEFROLOGIA, V25, P668; TAPSON JS, 1988, NEPHRON, V48, P126, DOI 10.1159/000184890; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; VERPOOTEN GF, 1989, KIDNEY INT, V36, P617, DOI 10.1038/ki.1989.238; Wong H, 2004, AM J KIDNEY DIS, V43, P624, DOI 10.1053/j.ajkd.2003.12.026; Wuerzner G, 2010, AM J KIDNEY DIS, V56, P303, DOI 10.1053/j.ajkd.2010.03.017; Zerbini G, 2006, DIABETES, V55, P2620, DOI 10.2337/db06-0592	32	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122921	10.1371/journal.pone.0122921	http://dx.doi.org/10.1371/journal.pone.0122921			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853240	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400085
J	Amorim, CEG; Daub, JT; Salzano, FM; Foll, M; Excoffier, L				Amorim, Carlos Eduardo G.; Daub, Josephine T.; Salzano, Francisco M.; Foll, Matthieu; Excoffier, Laurent			Detection of Convergent Genome-Wide Signals of Adaptation to Tropical Forests in Humans	PLOS ONE			English	Article							EPITHELIAL CHEMOKINE MEC/CCL28; AFRICAN RAIN-FORESTS; GENETIC-STRUCTURE; EVOLUTION; LOCI; DIVERSITY; SELECTION; HISTORY; ASSOCIATION; POPULATIONS	Tropical forests are believed to be very harsh environments for human life. It is unclear whether human beings would have ever subsisted in those environments without external resources. It is therefore possible that humans have developed recent biological adaptations in response to specific selective pressures to cope with this challenge. To understand such biological adaptations we analyzed genome-wide SNP data under a Bayesian statistics framework, looking for outlier markers with an overly large extent of differentiation between populations living in a tropical forest, as compared to genetically related populations living outside the forest in Africa and the Americas. The most significant positive selection signals were found in genes related to lipid metabolism, the immune system, body development, and RNA Polymerase III transcription initiation. The results are discussed in the light of putative tropical forest selective pressures, namely food scarcity, high prevalence of pathogens, difficulty to move, and inefficient thermoregulation. Agreement between our results and previous studies on the pygmy phenotype, a putative prototype of forest adaptation, were found, suggesting that a few genetic regions previously described as associated with short stature may be evolving under similar positive selection in Africa and the Americas. In general, convergent evolution was less pervasive than local adaptation in one single continent, suggesting that Africans and Amerindians may have followed different routes to adapt to similar environmental selective pressures.	[Amorim, Carlos Eduardo G.; Daub, Josephine T.; Excoffier, Laurent] Inst Ecol & Evolut, Computat & Mol Populat Genet Lab, Bern, Switzerland; [Amorim, Carlos Eduardo G.; Daub, Josephine T.; Foll, Matthieu; Excoffier, Laurent] Swiss Inst Bioinformat, Lausanne, Switzerland; [Amorim, Carlos Eduardo G.; Salzano, Francisco M.] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, Porto Alegre, RS, Brazil; [Amorim, Carlos Eduardo G.] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Foll, Matthieu] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Foll, Matthieu] Int Agcy Res Canc, Genet Canc Susceptibil Grp, F-69372 Lyon, France	Swiss Institute of Bioinformatics; Universidade Federal do Rio Grande do Sul; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; World Health Organization; International Agency for Research on Cancer (IARC)	Amorim, CEG (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	cg2827@columbia.edu	Foll, Matthieu/A-8561-2014; Salzano, Francisco M/L-7916-2015; Excoffier, Laurent/D-3498-2013; Daub, Josephine/H-8488-2015	Foll, Matthieu/0000-0001-9006-8436; Excoffier, Laurent/0000-0002-7507-6494; Daub, Josephine/0000-0003-1424-6602	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX); CAPES Foundation [BEX 8279/11-0]; Swiss NSF grants [31003A-143393, PDFMP3_130309]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swiss NSF grants	This research was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) to CEGA and FMS . Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul, Programa de Apoio a Nucleos de Excelencia (FAPERGS/PRONEX) to FMS . CAPES Foundation grant (BEX 8279/11-0) to CEGA . Swiss NSF grants (31003A-143393 and PDFMP3_130309) to LE . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; BAILEY RC, 1989, AM ANTHROPOL, V91, P59, DOI 10.1525/aa.1989.91.1.02a00040; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cann HM, 2002, SCIENCE, V296, P261; Castelletti E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000969; Chung SY, 2009, CANCER SCI, V100, P2109, DOI 10.1111/j.1349-7006.2009.01277.x; Combes V, 2005, AM J PATHOL, V166, P295, DOI 10.1016/S0002-9440(10)62253-5; Daub JT, 2013, MOL BIOL EVOL, V30, P1544, DOI 10.1093/molbev/mst080; Doll A, 2001, CYTOGENET CELL GENET, V95, P20, DOI 10.1159/000057012; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Excoffier L, 2009, HEREDITY, V103, P285, DOI 10.1038/hdy.2009.74; Ezzat MHM, 2009, INT J DERMATOL, V48, P822, DOI 10.1111/j.1365-4632.2009.04069.x; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Foll M, 2014, AM J HUM GENET, V95, P394, DOI 10.1016/j.ajhg.2014.09.002; Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Herraez DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007888; Hunemeier T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038862; ISA-Instituto Socioambiental, 2013, POV IND BRAS; Kaindl AM, 2005, HUM MUTAT, V26, DOI 10.1002/humu.9357; Kriska T, 2010, J LIPID RES, V51, P3174, DOI 10.1194/jlr.M008342; Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08; Lee Richard, 2004, CAMBRIDGE ENCY HUNTE, pxiii; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Meimaridou E, 2012, NAT GENET, V44, P740, DOI 10.1038/ng.2299; Mendizabal I, 2012, HUM GENET, V131, P1305, DOI 10.1007/s00439-012-1157-3; Mercader J, 2002, EVOL ANTHROPOL, V11, P117, DOI 10.1002/evan.10022; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Micale L, 2008, EUR J HUM GENET, V16, P1038, DOI 10.1038/ejhg.2008.68; Migliano AB, 2007, P NATL ACAD SCI USA, V104, P20216, DOI 10.1073/pnas.0708024105; Migliano AB, 2013, HUM BIOL, V85, P251, DOI 10.3378/027.085.0313; Ohenjo N, 2006, LANCET, V367, P1937, DOI 10.1016/S0140-6736(06)68849-1; Perry GH, 2009, TRENDS ECOL EVOL, V24, P218, DOI 10.1016/j.tree.2008.11.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratnam J, 2011, GLOBAL ECOL BIOGEOGR, V20, P653, DOI 10.1111/j.1466-8238.2010.00634.x; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sandqvist A, 2009, MOL BIOL CELL, V20, P1340, DOI 10.1091/mbc.E08-08-0864; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sun L, 2005, P NATL ACAD SCI USA, V102, P17130, DOI 10.1073/pnas.0508480102; Tintle Nathan L, 2009, BMC Proc, V3 Suppl 7, pS96; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; Walker RS, 2008, CURR ANTHROPOL, V49, P115, DOI 10.1086/524763; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Zhang W, 2007, REPRODUCTION, V133, P511, DOI 10.1530/REP-06-0125	56	23	23	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121557	10.1371/journal.pone.0121557	http://dx.doi.org/10.1371/journal.pone.0121557			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849546	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800064
J	Chen, CL; Liu, SS; Liu, Q; Niu, JH; Liu, P; Zhao, JL; Jian, H				Chen, Changlong; Liu, Shusen; Liu, Qian; Niu, Junhai; Liu, Pei; Zhao, Jianlong; Jian, Heng			An ANNEXIN-Like Protein from the Cereal Cyst Nematode Heterodera avenae Suppresses Plant Defense	PLOS ONE			English	Article							INNATE IMMUNITY; MOLECULAR CHARACTERIZATION; GLOBODERA-ROSTOCHIENSIS; FUNCTIONAL-ANALYSIS; PARASITIC NEMATODE; DISEASE RESISTANCE; SIGNALING NETWORKS; KINASE KINASE; CELL-DEATH; GENE	Parasitism genes encoding secreted effector proteins of plant-parasitic nematodes play important roles in facilitating parasitism. An annexin-like gene was isolated from the cereal cyst nematode Heterodera avenae (termed Ha-annexin) and had high similarity to annexin 2, which encodes a secreted protein of Globodera pallida. Ha-annexin encodes a predicted 326 amino acid protein containing four conserved annexin domains. Southern blotting revealed that there are at least two homologies in the H. avenae genome. Ha-annexin transcripts were expressed within the subventral gland cells of the pre-parasitic second-stage juveniles by in situ hybridization. Additionally, expression of these transcripts were relatively higher in the parasitic second-stage juveniles by quantitative real-time RT-PCR analysis, coinciding with the time when feeding cell formation is initiated. Knockdown of Ha-annexin by method of barley stripe mosaic virus-based host-induced gene silencing (BSMV-HIGS) caused impaired nematode infections at 7 dpi and reduced females at 40 dpi, indicating important roles of the gene in parasitism at least in early stage in vivo. Transiently expression of Ha-ANNEXIN in onion epidermal cells and Nicotiana benthamiana leaf cells showed the whole cell-localization. Using transient expression assays in N. benthamiana, we found that Ha-ANNEXIN could suppress programmed cell death triggered by the pro-apoptotic mouse protein BAX and the induction of marker genes of PAMP-triggered immunity (PTI) in N. benthamiana. In addition, Ha-ANNEXIN targeted a point in the mitogen-activated protein kinase (MAPK) signaling pathway downstream of two kinases MKK1 and NPK1 in N. benthamiana.	[Chen, Changlong; Liu, Shusen; Liu, Qian; Liu, Pei; Zhao, Jianlong; Jian, Heng] China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China; [Liu, Shusen] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Anhui, Peoples R China; [Niu, Junhai] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China	China Agricultural University; Anhui Academy of Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Jian, H (corresponding author), China Agr Univ, Dept Plant Pathol, Beijing 100094, Peoples R China.	hengjian@cau.edu.cn	Jian, Heng/Y-2845-2019		National Key Basic Research Program of China [2013CB127501]; Special Fund for Agro-scientific Research in the Public Interest in China [201503114, 200903040]	National Key Basic Research Program of China(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest in China	This research was supported by funding from the National Key Basic Research Program of China (No. 2013CB127501) and the Special Fund for Agro-scientific Research in the Public Interest in China (Nos. 201503114 and 200903040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Bayer EM, 2006, PROTEOMICS, V6, P301, DOI 10.1002/pmic.200500046; Becker A, 2010, TRENDS PLANT SCI, V15, P1, DOI 10.1016/j.tplants.2009.09.002; Bindschedler LV, 2008, PHYTOCHEMISTRY, V69, P1962, DOI 10.1016/j.phytochem.2008.04.007; Bonfil David J., 2004, Precision Agriculture, V5, P329, DOI 10.1023/B:PRAG.0000040804.97462.02; BYBD DW, 1983, J NEMATOL, V15, P142; Chen S. H., 2013, CELL TRANSPLANT, V12, P12, DOI DOI 10.1016/J.TECTO.2012.08.030; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; CHRISTMAS P, 1991, J BIOL CHEM, V266, P2499; Chronis D, 2013, PLANT J, V74, P185, DOI 10.1111/tpj.12125; CREUTZ CE, 1992, SCIENCE, V258, P924, DOI 10.1126/science.1439804; Daigle SN, 1999, J CELL SCI, V112, P1901; Davis EL, 2000, ANNU REV PHYTOPATHOL, V38, P365, DOI 10.1146/annurev.phyto.38.1.365; de Boer JM, 1998, J NEMATOL, V30, P309; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Dou DL, 2008, PLANT CELL, V20, P1118, DOI 10.1105/tpc.107.057067; Farrow SC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00524; Fioretti L, 2001, NEMATOLOGY, V3, P45, DOI 10.1163/156854101300106883; Gao BL, 2003, MOL PLANT MICROBE IN, V16, P720, DOI 10.1094/MPMI.2003.16.8.720; Gao MH, 2008, CELL RES, V18, P1190, DOI 10.1038/cr.2008.300; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Hewezi T, 2013, MOL PLANT MICROBE IN, V26, P9, DOI 10.1094/MPMI-05-12-0106-FI; Huang GZ, 2003, MOL PLANT MICROBE IN, V16, P376, DOI 10.1094/MPMI.2003.16.5.376; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jaouannet M, 2013, MOL PLANT MICROBE IN, V26, P97, DOI 10.1094/MPMI-05-12-0130-R; Jin HL, 2002, DEV CELL, V3, P291, DOI 10.1016/S1534-5807(02)00205-8; Kazan K, 2014, PLANT CELL, V26, P2285, DOI 10.1105/tpc.114.125419; Kovtun Y, 1998, NATURE, V395, P716, DOI 10.1038/27240; Kumar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096311; Kwon HK, 2005, PLANT CELL PHYSIOL, V46, P843, DOI 10.1093/pcp/pci089; Laohavisit A, 2011, NEW PHYTOL, V189, P40, DOI 10.1111/j.1469-8137.2010.03533.x; Laohavisit A, 2009, PLANT SCI, V177, P532, DOI 10.1016/j.plantsci.2009.09.008; Lee WS, 2012, PLANT PHYSIOL, V160, P582, DOI 10.1104/pp.112.203489; Li RJ, 2015, PLANT CELL REP, V34, P5, DOI 10.1007/s00299-014-1676-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Long H, 2013, PLANT PATHOL, V62, P953, DOI 10.1111/ppa.12000; Long HB, 2012, EUR J PLANT PATHOL, V134, P391, DOI 10.1007/s10658-012-9997-1; Long HB, 2012, NEMATOLOGY, V14, P571, DOI 10.1163/156854111X614674; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Meijer HJG, 2006, MOL PLANT MICROBE IN, V19, P1348, DOI 10.1094/MPMI-19-1348; Meng XZ, 2013, ANNU REV PHYTOPATHOL, V51, P245, DOI 10.1146/annurev-phyto-082712-102314; Meszaros T, 2006, PLANT J, V48, P485, DOI 10.1111/j.1365-313X.2006.02888.x; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Nicol J., 2004, COMMUN AGRIC APPL BI, V72, P677; Panwar V, 2013, PLANT MOL BIOL, V81, P595, DOI 10.1007/s11103-013-0022-7; Patel N, 2010, J EXP BOT, V61, P235, DOI 10.1093/jxb/erp293; Peng DeLiang, 2009, Cereal cyst nematodes: status, research and outlook. Proceedings of the First Workshop of the International Cereal Cyst Nematode Initiative, Antalya, Turkey, 21-23 October 2009, P29; Postma WJ, 2012, PLANT PHYSIOL, V160, P944, DOI 10.1104/pp.112.200188; Rodriguez MCS, 2010, ANNU REV PLANT BIOL, V61, P621, DOI 10.1146/annurev-arplant-042809-112252; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Senthil-Kumar M, 2011, TRENDS PLANT SCI, V16, P656, DOI 10.1016/j.tplants.2011.08.006; Tena G, 2011, CURR OPIN PLANT BIOL, V14, P519, DOI 10.1016/j.pbi.2011.05.006; Thakur PK, 2014, INDIAN J EXP BIOL, V52, P223; Wang QQ, 2011, PLANT CELL, V23, P2064, DOI 10.1105/tpc.111.086082; Wang XH, 2005, MOL PLANT PATHOL, V6, P187, DOI [10.1111/j.1364-3703.2005.00270.x, 10.1111/J.1364-3703.2005.00270.X]; Waterhouse PM, 2001, NATURE, V411, P834, DOI 10.1038/35081168; Yuan C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026468	58	44	50	13	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122256	10.1371/journal.pone.0122256	http://dx.doi.org/10.1371/journal.pone.0122256			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849616	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800113
J	Curtis, KM; Aenlle, KK; Frisch, RN; Howard, GA				Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.			TAp63 gamma and Delta Np63 beta Promote Osteoblastic Differentiation of Human Mesenchymal Stem Cells: Regulation by Vitamin D3 Metabolites	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; OSTEOGENIC DIFFERENTIATION; P53 HOMOLOG; P63; LIMB; PLURIPOTENT; EXPANSION; VARIANTS; KNOCKOUT; ISOFORMS	The transcription factor p63 is required for skeletal formation, and is important for the regulation of 1a, 25(OH)(2)D-3 receptor (VDR) in human mesenchymal stem cells (hMSC). Herein we report that TAp63 gamma and Delta Np63 beta appear to be an integral part of the osteoblastic differentiation of hMSC and are differentially regulated by the vitamin D-3 metabolites 1a,25(OH)(2)D-3 and 24R,25(OH)(2)D-3. We compared the endogenous expression of p63 isoforms (TA- and Delta Np63) and splice variants (p63 alpha, -beta, -gamma), in naive hMSC and during osteoblastic differentiation of hMSC. TAp63 alpha and -beta were the predominant p63 variants in naive, proliferating hMSC. In contrast, under osteoblastic differentiation conditions, expression of p63 changed from the TAp63 alpha and -beta to the TAp63 gamma and Delta Np63 beta variants. Transient overexpression of the p63 variants demonstrated that TAp63 beta, Delta Np63 beta, and Delta Np63 gamma increased alkaline phosphatase activity and Delta Np63 alpha and -gamma increased the expression of mRNA for osteocalcin and osterix. Our results support the hypothesis that TAp63 alpha and -beta promote a naive state in hMSC. Moreover, TAp63 gamma is increased during and promotes early osteoblastic differentiation through the expression of pro-osteogenic genes; VDR, Osterix, Runx2 and Osteopontin Delta Np63 beta also appears to support osteogenic maturation through increased alkaline phosphatase activity. Treatment with 1a, 25(OH)(2)D-3 increased the expression of mRNA for.Np63, while addition of 24R, 25(OH) 2D3 increased the expression of TA- and Delta Np63 gamma variants. These novel findings demonstrate for the first time that p63 variants are differentially expressed in naive hMSC (TAp63 alpha, beta), are important during the osteoblastic differentiation of hMSC (TAp63 gamma and Delta Np63 beta), and are differentially regulated by the vitamin D3 metabolites, 1a, 25(OH)(2)D-3 and 24R, 25(OH)(2)D-3. The molecular nuances and mechanisms of osteoblastic differentiation presented here will hopefully improve our understanding of bone development, complications in bone repair (mal-and non-union fractures), osteoporosis and possibly lead to new modalities of treatment.	[Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.] Bruce W Carter Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33125 USA; [Curtis, Kevin M.; Aenlle, Kristina K.; Frisch, Rachel N.; Howard, Guy A.] Bruce W Carter Vet Affairs Med Ctr, Res Serv, Miami, FL USA; [Curtis, Kevin M.; Howard, Guy A.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Howard, Guy A.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA	Geriatric Research Education & Clinical Center; University of Miami; University of Miami	Howard, GA (corresponding author), Bruce W Carter Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Miami, FL 33125 USA.	GHoward1@med.miami.edu			Department of Veterans Affairs Merit Review, National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award [5F32AR062990-03]; Department of Medicine, University of Miami Miller School of Medicine; Department of Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR062990] Funding Source: NIH RePORTER	Department of Veterans Affairs Merit Review, National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award; Department of Medicine, University of Miami Miller School of Medicine; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was funded through a Department of Veterans Affairs Merit Review (GAH), National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health Award Number 5F32AR062990-03 (KMC), and by funds from the Department of Medicine, University of Miami Miller School of Medicine. Dr. Guy Howard is the recipient of a Senior Research Career Scientist award from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenlle KK, 2014, MOL ENDOCRINOL, V28, P722, DOI 10.1210/me.2013-1286; Atlasi Y, 2008, STEM CELLS, V26, P3068, DOI 10.1634/stemcells.2008-0530; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chen KT, 2012, BONE, V51, P69, DOI 10.1016/j.bone.2012.04.002; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Curtis KM, 2014, MOL ENDOCRINOL, V28, P644, DOI 10.1210/me.2013-1241; Curtis KM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-61; D'Ippolito G, 2006, REJUV RES, V9, P10, DOI 10.1089/rej.2006.9.10; D'Ippolito G, 1999, J BONE MINER RES, V14, P1115, DOI 10.1359/jbmr.1999.14.7.1115; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; Delcroix GJR, 2010, DIFFERENTIATION, V80, P213, DOI 10.1016/j.diff.2010.07.001; Gu JX, 2013, INT J CLIN EXP PATHO, V6, P2872; Kim S, 2009, EXP DERMATOL, V18, P1016, DOI 10.1111/j.1600-0625.2009.00894.x; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Li FF, 2012, GENE, V495, P95, DOI 10.1016/j.gene.2011.12.057; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Liu SB, 2013, J BIOANAL BIOMED S, VS3, P004, DOI [10.4172/1948-593X.S3-004, DOI 10.4172/1948-593X.S3-004]; Lu YJ, 2013, GENE, V519, P251, DOI 10.1016/j.gene.2013.02.021; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Ogawa E, 2008, J BIOL CHEM, V283, P34241, DOI 10.1074/jbc.M804101200; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Romano RA, 2012, DEVELOPMENT, V139, P772, DOI 10.1242/dev.071191; Sareen D, 2014, STEM CELL TRANSL MED, V3, P1002, DOI 10.5966/sctm.2014-0076; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Studer D, 2012, TISSUE ENG PART C-ME, V18, P761, DOI 10.1089/ten.tec.2012.0081; Talos F, 2010, CELL DEATH DIFFER, V17, P184, DOI 10.1038/cdd.2009.158; van Bokhoven H, 2002, AM J HUM GENET, V71, P1, DOI 10.1086/341450; Warner SMB, 2013, AM J RESP CELL MOL, V49, P978, DOI 10.1165/rcmb.2012-0447OC; Weinstein RS, 2012, ENDOCRIN METAB CLIN, V41, P595, DOI 10.1016/j.ecl.2012.04.004; Wolff S, 2009, CELL DEATH DIFFER, V16, P1108, DOI 10.1038/cdd.2009.25; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang A, 2002, TRENDS GENET, V18, P90, DOI 10.1016/S0168-9525(02)02595-7; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Zhang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026504	37	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123642	10.1371/journal.pone.0123642	http://dx.doi.org/10.1371/journal.pone.0123642			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849854	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800248
J	Kawahara, T; Miyamoto, H; Ito, H; Terao, H; Uemura, H; Kubota, Y; Matsuzaki, J				Kawahara, Takashi; Miyamoto, Hiroshi; Ito, Hiroki; Terao, Hideyuki; Uemura, Hiroji; Kubota, Yoshinobu; Matsuzaki, Junichi			Discolored Ureteral Stents: Findings in Urinalysis and Urine Culture	PLOS ONE			English	Article							ENDOUROLOGICAL MANAGEMENT; ENCRUSTATION; INCRUSTATION; BIOFILM	Objective Discolored ureteral stents are sometimes encountered in daily clinical practice; however, the mechanism(s) underlying the development of discolored ureteral stents remain unknown. In this study, we retrospectively analyzed the characteristics of discolored ureteral stents based on the results of a urinalysis and urine culture. Materials & Methods We identified a total of 26 patients with discolored ureteral stents and compared the findings in the urinalyses and urine culture in 21 discolored versus 45 non-colored ureteral stents. Results The median and mean (+/- SD) duration of stenting time was 78.0 and 81.3 (+/- 21.3) days for the discolored ureteral stents and 69.0 and 74.9 (+/- 19.8) days for the non-colored ureteral stents, respectively (P = 0.25). The discolored ureteral stents were associated with a higher mean urine pH than the non-colored ureteral stents (mean: 6.4 vs 6.0, P < 0.05). There were no significant differences between the two groups in the RBC (P = 0.51) and WBC (P = 0.35) counts in the urinalyses. In addition, the rate of a positive culture in the patients with discolored stents [20 of 21 (95.2%)] was significantly (P < 0.01) higher than that observed in the patients with non-colored ureteral stents [33 of 45 (73.3%)]. Conclusions In this study, the subjects with discolored ureteral stents showed a significantly higher likelihood of having a positive urine culture and also demonstrated higher pH values in the urinalyses. However, no clear cut-off point to predict discoloration was indicated.	[Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Uemura, Hiroji; Kubota, Yoshinobu] Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan; [Kawahara, Takashi; Ito, Hiroki; Terao, Hideyuki; Matsuzaki, Junichi] Ohguchi Higashi Gen Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Kawahara, Takashi; Miyamoto, Hiroshi] Johns Hopkins Univ, Sch Med, Dept Pathol & Urol, Baltimore, MD USA	Yokohama City University; Johns Hopkins University	Kawahara, T (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Urol, Yokohama, Kanagawa 232, Japan.	takashi_tk2001@yahoo.co.jp		Miyamoto, Hiroshi/0000-0001-7610-7769	Department of Defense Prostate Cancer Research Program [W81XWH-13-1-0412]	Department of Defense Prostate Cancer Research Program(United States Department of Defense)	This work was supported by Department of Defense Prostate Cancer Research Program (W81XWH-13-1-0412): HM.	Borboroglu PG, 2000, J UROLOGY, V164, P648, DOI 10.1016/S0022-5347(05)67272-2; Bultitude MF, 2003, UROLOGY, V62, P622, DOI 10.1016/S0090-4295(03)00506-5; Chew B, 2012, J ENDOUROL; ELFAQIH SR, 1991, J UROLOGY, V146, P1487, DOI 10.1016/S0022-5347(17)38146-6; Joshi H, 2012, J ENDOUROL, V26, P924, DOI 10.1089/end.2012.0192; Kawahara T, 2012, BMJ CASE REP, V2012; Kawahara T, 2012, J ENDOUROL, V26, P178, DOI 10.1089/end.2011.0385; Kawahara T, 2012, UROL INT, V88, P48, DOI 10.1159/000332431; KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x; Kim TH, 2012, J BIOMED MATER RES A, V100A, P1512, DOI 10.1002/jbm.a.34086; Mohan-Pillai K, 1999, J ENDOUROL, V13, P377, DOI 10.1089/end.1999.13.377; Murthy KVR, 2010, INT BRAZ J UROL, V36, P420, DOI 10.1590/S1677-55382010000400005; Robert M, 1997, UROL INT, V58, P100, DOI 10.1159/000282959; SCHULZE KA, 1985, UROLOGY, V25, P616, DOI 10.1016/0090-4295(85)90293-6; Wollin TA, 1998, J ENDOUROL, V12, P101, DOI 10.1089/end.1998.12.101; Xu CL, 2009, LASER MED SCI, V24, P140, DOI 10.1007/s10103-007-0537-8; ZIMSKIND PD, 1967, J UROLOGY, V97, P840, DOI 10.1016/S0022-5347(17)63130-6	17	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122984	10.1371/journal.pone.0122984	http://dx.doi.org/10.1371/journal.pone.0122984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849790	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800188
J	Xu, HD; Zhao, MF; Lou, GH; Zheng, M; Cao, QY; Chen, Z				Xu, Hangdi; Zhao, Mingfei; Lou, Guohua; Zheng, Min; Cao, Qingyi; Chen, Zhi			New Point Mutations in Surface and Core Genes of Hepatitis B Virus Associated with Acute on Chronic Liver Failure Identified by Complete Genomic Sequencing	PLOS ONE			English	Article							ASYMPTOMATIC CARRIER STATE; E-ANTIGEN; GENOTYPE; PRECORE; MUTANTS; DOMAINS	The objective of this study was to identify new viral biomarkers associated with acute on chronic liver failure (ACLF) by complete genomic sequencing of HBV. Hepatitis B virus mutations associated with ACLF were screened by Illumina high-throughput sequencing in twelve ACLF cases and twelve age-matched mild chronic hepatitis B patients, which were validated in 438 chronic hepatitis B patients (80 asymptomatic carriers, 152 mild chronic hepatitis B patients, 102 severe chronic hepatitis B patients and 104 ACLF patients) by direct sequencing. The results of Illumina sequencing showed that the mutations at 7 sites (T216C, G285A, A1846T, G1896A, C1913A/G, A2159G, and A2189C) of 12 ACLF patients were significantly higher than those of 12 controls. In the validation cohorts, a significantly higher ratio of genotype B to C was found in patients with ACLF than in patients with nonACLF. Multivariate analysis showed that T216C, G1896A, C1913A/G and A2159G/C were independent risk factors for ACLF. C216 in any combination, A/G1913 in any combination, and G/C2159 in any combination had high specificity for ACLF. In summary, T216C and A2159G/C mutations were novel factors independently associated with ACLF. Combined mutations in hepatitis B cases could play important roles in ACLF development.	[Xu, Hangdi] Zhejiang Univ, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Zhao, Mingfei] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou 310003, Zhejiang, Peoples R China; [Lou, Guohua; Zheng, Min; Cao, Qingyi; Chen, Zhi] Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Inst Infect Dis,State Key Lab Diag & Trea, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University	Chen, Z (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Collaborat Innovat Ctr Diag & Treatment Infect Di, Sch Med,Inst Infect Dis,State Key Lab Diag & Trea, Hangzhou 310003, Zhejiang, Peoples R China.	zju.zhichen@gmail.com			National Natural Science Foundation of China [81272679]; 12-5 State S&T Projects of China [2012ZX10002005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 12-5 State S&T Projects of China(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (81272679), and the 12-5 State S&T Projects of China (2012ZX10002005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen M, 2005, J VIROL, V79, P3016, DOI 10.1128/JVI.79.5.3016-3027.2005; Chen MT, 2004, P NATL ACAD SCI USA, V101, P14913, DOI 10.1073/pnas.0406282101; Chinese Association of Infectious Diseases and Parasitology Hepatology, 2000, CHINESE J HEPATOLOGY, V6, P324; Dai CY, 2011, HEPATOLOGY, V54, P1108, DOI 10.1002/hep.24328; Frelin L, 2009, J VIROL, V83, P1379, DOI 10.1128/JVI.01902-08; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liaw YF, 2011, HEPATOLOGY, V54, P91, DOI 10.1002/hep.24361; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu Q, 2007, J GASTROEN HEPATOL, V22, P2101, DOI 10.1111/j.1440-1746.2006.04362.x; Margeridon-Thermet S, 2009, J INFECT DIS, V199, P1275, DOI 10.1086/597808; Ni YH, 2003, GUT, V52, P122, DOI 10.1136/gut.52.1.122; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Ren X, 2010, J VIRAL HEPATITIS, V17, P887, DOI 10.1111/j.1365-2893.2009.01254.x; SALFELD J, 1989, J VIROL, V63, P798, DOI 10.1128/JVI.63.2.798-808.1989; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Siegler VD, 2013, J VIROL, V87, P1491, DOI 10.1128/JVI.02500-12; Sonneveld MJ, 2012, HEPATOLOGY, V56, P67, DOI 10.1002/hep.25636; SUMMERS J, 1982, CELL, V29, P403, DOI 10.1016/0092-8674(82)90157-X; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Taylor BC, 2009, HEPATOLOGY, V49, pS85, DOI 10.1002/hep.22929; Wright CF, 2011, J VIROL, V85, P2266, DOI 10.1128/JVI.01396-10; Xiao L, 2011, J MED VIROL, V83, P1544, DOI 10.1002/jmv.22159; Yan T, 2011, J MED VIROL, V83, P996, DOI 10.1002/jmv.22067; Yang HI, 2008, JNCI-J NATL CANCER I, V100, P1134, DOI 10.1093/jnci/djn243; Yin JH, 2008, CARCINOGENESIS, V29, P1685, DOI 10.1093/carcin/bgm301; Yin JH, 2011, AM J GASTROENTEROL, V106, P81, DOI 10.1038/ajg.2010.399; Zhu Y, 2010, CANCER EPIDEM BIOMAR, V19, P2623, DOI 10.1158/1055-9965.EPI-10-0469; 吴光华, 2008, [自然科学进展, Progress in Natural Science], V18, P121	29	3	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123139	10.1371/journal.pone.0123139	http://dx.doi.org/10.1371/journal.pone.0123139			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849554	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800209
J	Zhu, D; Xie, H; Wang, XY; Yu, HY; Gao, W				Zhu, Dan; Xie, Hong; Wang, Xinyu; Yu, Haiyi; Gao, Wei			Correlation of Plasma Catestatin Level and the Prognosis of Patients with Acute Myocardial Infarction	PLOS ONE			English	Article							INHIBITORY PEPTIDE CATESTATIN; CHROMOGRANIN-A FRAGMENT; CATECHOLAMINE RELEASE; HEART-FAILURE; IN-VIVO; ACTIVATION; MECHANISM; HUMANS; ACTS; TERM	Catestatin is a peptide which is a potent inhibitor of catecholamine secretion and played essential functions in the cardiovascular system. Previous research found that dramatic changes of catestatin were associated with hemodynamics in acute myocardial infarction (AMI) during the first week after the AMI symptoms onset, but whether catestatin is also involved in the pathophysiological progression after AMI and then a predictor for outcomes is not clear. The aim of this study is to determine the correlation of plasma catestatin levels at different time points and the prognosis of AMI. 100 participants recruited were all patients with AMI, all of who received successful primary percutaneous coronary intervention (PCI) within 12h from the AMI symptom onset in our center; the concentrations of plasma catestatin were evaluated from blood samples of those 100 participants. Subsequent 65 months' follow-up was performed after discharging to evaluate cardiac adverse events and the association between catestatin levels and prognosis of AMI was examined. We confirmed the dramatic change of catestatin concentrations in the first week of AMI, and the levels of catestatin on D3 were much higher in adverse events group than those in non-adverse events group (p<0.0001), but the ratio of D7/D3 was significantly lower. In addition, the Kaplan-Meier analysis showed that the groups in which the levels on D3 were higher (p<0.0001) and the ratios of D7/D3 were lower (p<0.0001), patients trended to be more susceptive to adverse events after AMI. Furthermore, according to the analysis, we surmised catestatin level on D3 as an appropriate predictor for outcomes in patients with AMI with good specificity as well as sensitivity. All of the evidence confirmed that catestatin plays an important role in the progress of AMI, and may act as a promising target for prognostic prediction.	[Zhu, Dan; Xie, Hong; Wang, Xinyu; Yu, Haiyi; Gao, Wei] Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptided, Beijing, Peoples R China	Peking University	Xie, H (corresponding author), Peking Univ, Hosp 3, Dept Cardiol,Minist Hlth, Key Lab Cardiovasc Mol Biol & Regulatory Peptided, Beijing, Peoples R China.	ycy2255@sohu.com		Gao, Wei/0000-0003-3541-9568	National Natural Science Foundation of China [81200167]; Ph.D. Programs Foundation of the Ministry of Education of China [20120001120131]; International cooperation projects of the Ministry of Science and Technology [2013DFG32940]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); International cooperation projects of the Ministry of Science and Technology	This work was supported by grants from the National Natural Science Foundation of China (No. 81200167) and the Ph.D. Programs Foundation of the Ministry of Education of China (No. 20120001120131), and the International cooperation projects of the Ministry of Science and Technology (No. 2013DFG32940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angelone T, 2008, ENDOCRINOLOGY, V149, P4780, DOI 10.1210/en.2008-0318; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Brar BK, 2010, REGUL PEPTIDES, V165, P63, DOI 10.1016/j.regpep.2010.07.153; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; Durakoglugil ME, 2015, ANATOL J CARDIOL, V15, P577, DOI 10.5152/akd.2014.5536; FOY SG, 1995, EUR HEART J, V16, P770, DOI 10.1093/oxfordjournals.eurheartj.a060995; Fung MM, 2010, CLIN EXP HYPERTENS, V32, P278, DOI 10.3109/10641960903265246; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Herrero CJ, 2002, J NEUROSCI, V22, P377, DOI 10.1523/JNEUROSCI.22-02-00377.2002; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Husebye T, 2013, EUR J HEART FAIL, V15, P565, DOI 10.1093/eurjhf/hfs215; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; JEWITT DE, 1969, LANCET, V1, P635; Jons C, 2011, HEART RHYTHM, V8, P342, DOI 10.1016/j.hrthm.2010.09.090; Kennedy BP, 1998, PEPTIDES, V19, P1241, DOI 10.1016/S0196-9781(98)00086-2; Kruger PG, 2003, REGUL PEPTIDES, V114, P29, DOI 10.1016/S0167-0115(03)00069-7; Mahata SK, 2000, MOL ENDOCRINOL, V14, P1525, DOI 10.1210/me.14.10.1525; Mahata SK, 1999, J BIOL CHEM, V274, P2920, DOI 10.1074/jbc.274.5.2920; Mahata SK, 1997, J CLIN INVEST, V100, P1623, DOI 10.1172/JCI119686; Mahata SK, 2010, REGUL PEPTIDES, V165, P52, DOI 10.1016/j.regpep.2010.09.007; Meng L, 2013, POSTGRAD MED J, V89, P193, DOI 10.1136/postgradmedj-2012-131060; O'Connor DT, 2002, J HYPERTENS, V20, P1335, DOI 10.1097/00004872-200207000-00020; Omland T, 2003, AM J MED, V114, P25, DOI 10.1016/S0002-9343(02)01425-0; Penna C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102536; Penna C, 2010, CELL MOL NEUROBIOL, V30, P1171, DOI 10.1007/s10571-010-9598-5; Perrelli MG, 2013, PFLUG ARCH EUR J PHY, V465, P1031, DOI 10.1007/s00424-013-1217-0; Petersen CL, 2003, CARDIOLOGY, V100, P23, DOI 10.1159/000072388; Pieroni M, 2007, EUR HEART J, V28, P1117, DOI 10.1093/eurheartj/ehm022; SIGURDSSON A, 1993, AM HEART J, V126, P1068, DOI 10.1016/0002-8703(93)90656-T; Taylor CV, 2000, J BIOL CHEM, V275, P22905, DOI 10.1074/jbc.M001232200; White HD, 2008, LANCET, V372, P570, DOI 10.1016/S0140-6736(08)61237-4; Zhu D, 2011, BIOMARKERS, V16, P691, DOI 10.3109/1354750X.2011.629058	32	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122993	10.1371/journal.pone.0122993	http://dx.doi.org/10.1371/journal.pone.0122993			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848973	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800191
J	Giabicani, E; Lemaire, P; Brauner, R				Giabicani, Eloise; Lemaire, Pierre; Brauner, Raja			Models for Predicting the Adult Height and Age at First Menstruation of Girls with Idiopathic Central Precocious Puberty	PLOS ONE			English	Article							LONG-TERM TREATMENT; BODY-MASS INDEX; FINAL HEIGHT; HORMONE ANALOGS; GNRH AGONIST; FOLLOW-UP; GROWTH; DIAGNOSIS; PATTERN; ONSET	Background It is difficult to determine whether to treat a given girl who has idiopathic central precocious puberty (CPP) with gonadotropin-releasing hormone analog (GnRHa) in terms of adult height (AH). The objective was to provide an easy tool for predicting AH and age at first menstruation at initial evaluation to help guide the decision regarding whether to treat. Methods Data analysis using multiple linear regression models was performed in 134 girls with CPP. Among them 78 were given GnRHa because of low predicted AH (n=45), pubertal luteinising hormone (LH)/follicle-stimulating hormone peaks (FSH) ratio (n=50) and/or high plasma estradiol concentration (n=45). 56 girls were followed without treatment. Results In the whole population, the actual AH (162.1 +/- 5.61 cm) was similar to target height (161.7 +/- 4.91 cm) and to AH predicted by the Bayley and Pinneau method (161.9 +/- 7.98 cm). Separated models for treated and untreated girls provide very close estimations, leading to a unique formula for both groups. The AH (cm) could be calculated at the initial evaluation: 2.21 (height at initial evaluation, SD) + 2.32 (target height, SD) -1.83 (LH/FSH peaks ratio) + 159.68. The actual AH was lower than the calculated AH by more than 1 SD (5.6 cm) in 11 girls (8.0%). The time between onset of puberty and first menstruation (in untreated girls) can be estimated with: 10.9 - 0.57 (LH/FSH peaks ratio). The formulae are available at http://www.kamick.org/lemaire/med/girls-cpp15.html. Conclusions We established formulae that can be used at an initial evaluation to predict the AH, and the time between onset of puberty and first menstruation after spontaneous puberty. The similarity of the formulae for both groups suggests that the treatment had no significant effect on	[Giabicani, Eloise; Brauner, Raja] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Lemaire, Pierre] Univ Grenoble Alpes, F-38000 Grenoble, France; [Lemaire, Pierre] CNRS, G SCOP, F-38000 Grenoble, France; [Brauner, Raja] Univ Paris 05, Paris, France	Fondation Adolphe de Rothschild; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Brauner, R (corresponding author), Univ Paris 05, Paris, France.	raja.brauner@wanadoo.fr	Giabicani, Eloïse/AAM-8783-2020	GIABICANI, Eloise/0000-0001-5360-8616				Adan L, 2002, CLIN ENDOCRINOL, V56, P297, DOI 10.1046/j.1365-2265.2002.01488.x; Allali S, 2011, MED SCI MONITOR, V17, pPH41, DOI 10.12659/MSM.881794; Armengaud JB, 2009, J CLIN ENDOCR METAB, V94, P2835, DOI 10.1210/jc.2009-0314; Arrigo T, 1999, EUR J ENDOCRINOL, V141, P140, DOI 10.1530/eje.0.1410140; BAYLEY N, 1952, J PEDIATR-US, V40, P423, DOI 10.1016/S0022-3476(52)80205-7; BRAUNER R, 1994, J CLIN ENDOCR METAB, V79, P415, DOI 10.1210/jc.79.2.415; BRAUNER R, 1991, HORM RES, V36, P116, DOI 10.1159/000182143; Brauner R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011282; Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783; Cassio A, 1999, ARCH DIS CHILD, V81, P329, DOI 10.1136/adc.81.4.329; Chalumeau M, 2003, J PEDIATR-US, V143, P445, DOI 10.1067/S0022-3476(03)00328-7; de Vries L, 2004, J CLIN ENDOCR METAB, V89, P1794, DOI 10.1210/jc.2003-030361; FONTOURA M, 1989, ARCH DIS CHILD, V64, P1170, DOI 10.1136/adc.64.8.1170; Giabicani E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070931; Greulich WW., 1959, RADIOGRAPH ATLAS SKE, V2; Klein KO, 2001, J CLIN ENDOCR METAB, V86, P4711, DOI 10.1210/jc.86.10.4711; Lazar L, 2007, J CLIN ENDOCR METAB, V92, P3483, DOI 10.1210/jc.2007-0321; Lemaire P, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-172; MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291, DOI 10.1136/adc.44.235.291; OERTER KE, 1990, J CLIN ENDOCR METAB, V71, P1251, DOI 10.1210/jcem-71-5-1251; Oostdijk W, 1996, ARCH DIS CHILD, V75, P292, DOI 10.1136/adc.75.4.292; Palmert MR, 1999, J CLIN ENDOCR METAB, V84, P415, DOI 10.1210/jc.84.2.415; Pasquino AM, 2008, J CLIN ENDOCR METAB, V93, P190, DOI 10.1210/jc.2007-1216; PERIGNON F, 1992, J CLIN ENDOCR METAB, V75, P1170, DOI 10.1210/jc.75.4.1170; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sempe A, 1979, AUXOLOGIE METHODE SE; Tanaka T, 2005, J CLIN ENDOCR METAB, V90, P1371, DOI 10.1210/jc.2004-1863; Tanner J M, 1970, Arch Dis Child, V45, P819; Willemsen RH, 2014, NAT REV ENDOCRINOL, V10, P352, DOI 10.1038/nrendo.2014.40; Witten I.H., 2000, DATA MINING PRACTICA	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120588	10.1371/journal.pone.0120588	http://dx.doi.org/10.1371/journal.pone.0120588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837693	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000026
J	Ramel, F; Brasseur, G; Pieulle, L; Valette, O; Hirschler-Rea, A; Fardeau, ML; Dolla, A				Ramel, Fanny; Brasseur, Gael; Pieulle, Laetitia; Valette, Odile; Hirschler-Rea, Agnes; Fardeau, Marie Laure; Dolla, Alain			Growth of the Obligate Anaerobe Desulfovibrio vulgaris Hildenborough under Continuous Low Oxygen Concentration Sparging: Impact of the Membrane- Bound Oxygen Reductases	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; PYRUVATE-FERREDOXIN OXIDOREDUCTASE; SP STRAIN MB; CYTOCHROME BD; MICROBIAL MAT; VULGATIS HILDENBOROUGH; AZOTOBACTER-VINELANDII; OXIDATIVE STRESS; DEPENDENT GROWTH; SP. NOV	Although obligate anaerobe, the sulfate-reducing bacterium Desulfovibrio vulgaris Hilden-borough (DvH) exhibits high aerotolerance that involves several enzymatic systems, including two membrane-bound oxygen reductases, a bd-quinol oxidase and a cc(b/o)o(3) cytochrome oxidase. Effect of constant low oxygen concentration on growth and morphology of the wild-type, single (Delta bd,Delta cox) and double deletion (Delta coxbd) mutant strains of the genes encoding these oxygen reductases was studied. When both wild-type and deletion mutant strains were cultured in lactate/sulfate medium under constant 0.02% O-2 sparging, they were able to grow but the final biomasses and the growth yield were lower than that obtained under anaerobic conditions. At the end of the growth, lactate was not completely consumed and when conditions were then switched to anaerobic, growth resumed. Time-lapse microscopy revealed that a large majority of the cells were then able to divide (over 97%) but the time to recover a complete division event was longer for single deletion mutant Delta bd than for the three other strains. Determination of the molar growth yields on lactate suggested that a part of the energy gained from lactate oxidation was derived toward cells protection/repairing against oxidative conditions rather than biosynthesis, and that this part was higher in the single deletion mutant Delta bd and, to a lesser extent, Delta cox strains. Our data show that when DvH encounters oxidative conditions, it is able to stop growing and to rapidly resume growing when conditions are switched to anaerobic, suggesting that it enters active dormancy sate under oxidative conditions. We propose that the pyruvate-ferredoxin oxidoreductase (PFOR) plays a central role in this phenomenon by reversibly switching from an oxidative-sensitive fully active state to an oxidative-insensitive inactive state. The oxygen reductases, and especially the bd-quinol oxidase, would have a crucial function by maintaining reducing conditions that permit PFOR to stay in its active state.	[Ramel, Fanny; Brasseur, Gael; Pieulle, Laetitia; Valette, Odile; Dolla, Alain] Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France; [Hirschler-Rea, Agnes; Fardeau, Marie Laure] Aix Marseille Univ, Univ Toulon, CNRS, IRD,MIO,UM110, F-13288 Marseille 09, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Dolla, A (corresponding author), Aix Marseille Univ, CNRS, LCB UMR7283, Marseille, France.	dolla@imm.cnrs.fr			French national Research Agency (ANR) [2011BSV601201]	French national Research Agency (ANR)(French National Research Agency (ANR))	AD, GB, LP and FR were funded by the French national Research Agency (ANR grant #2011BSV601201). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgarten A, 2001, ARCH MICROBIOL, V176, P306, DOI 10.1007/s002030100329; Belevich I, 2007, BIOCHEMISTRY-US, V46, P11177, DOI 10.1021/bi700862u; Blaabjerg V, 1998, AQUAT MICROB ECOL, V15, P311, DOI 10.3354/ame015311; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brzezinski P, 2008, J BIOENERG BIOMEMBR, V40, P521, DOI 10.1007/s10863-008-9181-7; CANFIELD DE, 1991, SCIENCE, V251, P1471, DOI 10.1126/science.11538266; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; CYPIONKA H, 1985, FEMS MICROBIOL ECOL, V31, P39, DOI 10.1016/0378-1097(85)90045-X; DANNENBERG S, 1992, ARCH MICROBIOL, V158, P93, DOI 10.1007/BF00245211; DILLING W, 1990, FEMS MICROBIOL LETT, V71, P123; Eschemann A, 1999, ENVIRON MICROBIOL, V1, P489, DOI 10.1046/j.1462-2920.1999.00057.x; Figueiredo MCO, 2012, ANAEROBE, V18, P454, DOI 10.1016/j.anaerobe.2012.06.001; Fournier M, 2004, J BIOL CHEM, V279, P1787, DOI 10.1074/jbc.M307965200; Fournier M, 2006, BIOCHIMIE, V88, P85, DOI 10.1016/j.biochi.2005.06.012; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; FRUND C, 1992, APPL ENVIRON MICROB, V58, P70; HARDY JA, 1981, CURR MICROBIOL, V6, P259, DOI 10.1007/BF01566873; Johnson MS, 1997, J BACTERIOL, V179, P5598, DOI 10.1128/jb.179.17.5598-5601.1997; JORGENSEN BB, 1991, APPL ENVIRON MICROB, V57, P847; Junemann S, 1997, BBA-BIOENERGETICS, V1321, P107, DOI 10.1016/S0005-2728(97)00046-7; Krekeler D, 1998, FEMS MICROBIOL ECOL, V25, P89, DOI 10.1016/S0168-6496(97)00085-8; Krekeler D, 1997, ARCH MICROBIOL, V167, P369, DOI 10.1007/s002030050457; Kuhnigk T, 1996, SYST APPL MICROBIOL, V19, P139, DOI 10.1016/S0723-2020(96)80039-7; KUO J, 1993, AUST J MAR FRESH RES, V44, P75; Kusel K, 1999, APPL ENVIRON MICROB, V65, P5117; Lamrabet O, 2011, MICROBIOL-SGM, V157, P2720, DOI 10.1099/mic.0.049171-0; LeGall J, 1996, ANAEROBE, V2, P1, DOI 10.1006/anae.1996.0001; Lemos RS, 2001, FEBS LETT, V496, P40, DOI 10.1016/S0014-5793(01)02399-7; Machado P, 2006, CURR MICROBIOL, V52, P274, DOI 10.1007/s00284-005-0165-0; MARSCHALL C, 1993, ARCH MICROBIOL, V159, P168, DOI 10.1007/BF00250278; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Nielsen LB, 2001, ENVIRON MICROBIOL, V3, P63, DOI 10.1046/j.1462-2920.2001.00160.x; Okabe S, 1999, APPL ENVIRON MICROB, V65, P5107; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; Poole RK, 1997, BIOSCIENCE REP, V17, P303, DOI 10.1023/A:1027336712748; Postgate J.R., 1979, SULFATE REDUCING BAC; Postgate J.R., 1984, SULFATE REDUCING BAC, V2nd; Ramel F, 2013, MICROBIOL-SGM, V159, P2663, DOI 10.1099/mic.0.071282-0; RISATTI JB, 1994, P NATL ACAD SCI USA, V91, P10173, DOI 10.1073/pnas.91.21.10173; Saas H, 1997, FEMS MICROBIOL ECOL, V22, P245; Santana M, 2008, ANAEROBE, V14, P145, DOI 10.1016/j.anaerobe.2008.03.001; Santegoeds CM, 1998, APPL ENVIRON MICROB, V64, P3731; Sass H, 1998, SYST APPL MICROBIOL, V21, P212, DOI 10.1016/S0723-2020(98)80025-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sigalevich P, 2000, APPL ENVIRON MICROB, V66, P5019, DOI 10.1128/AEM.66.11.5019-5023.2000; Sigalevich P, 2000, APPL ENVIRON MICROB, V66, P5013, DOI 10.1128/AEM.66.11.5013-5018.2000; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; STAMS AJM, 1982, FEMS MICROBIOL LETT, V13, P389, DOI 10.1016/0378-1097(82)90197-5; Teske A, 1996, APPL ENVIRON MICROB, V62, P1405, DOI 10.1128/AEM.62.4.1405-1415.1996; VANDIJK C, 1983, FEBS LETT, V156, P340, DOI 10.1016/0014-5793(83)80525-0; VISSCHER PT, 1992, FEMS MICROBIOL ECOL, V86, P283, DOI 10.1016/0378-1097(92)90792-M; Vita N, 2008, BIOCHEMISTRY-US, V47, P957, DOI 10.1021/bi7014713; Wildschut JD, 2006, J BACTERIOL, V188, P6253, DOI 10.1128/JB.00425-06; Yurkiw MA, 2012, ENVIRON MICROBIOL, V14, P2711, DOI 10.1111/j.1462-2920.2012.02859.x; Zhang WW, 2006, ANTON LEEUW INT J G, V89, P221, DOI 10.1007/s10482-005-9024-z; Zhou GQ, 2013, ISME J, V7, P1752, DOI 10.1038/ismej.2013.62	60	21	23	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123455	10.1371/journal.pone.0123455	http://dx.doi.org/10.1371/journal.pone.0123455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837676	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000145
J	Srivastava, P; Sinha-Mahapatra, SK; Ghosh, A; Srivastava, I; Dhingra, NK				Srivastava, Prerna; Sinha-Mahapatra, Sumit K.; Ghosh, Abhinaba; Srivastava, Ipsit; Dhingra, Narender K.			Differential Alterations in the Expression of Neurotransmitter Receptors in Inner Retina following Loss of Photoreceptors in rd1 Mouse	PLOS ONE			English	Article							BIPOLAR CELLS EXPRESS; OSCILLATORY ACTIVITY; GLUTAMATE RECEPTORS; GLYCINE RECEPTORS; ALPHA-1 SUBUNIT; GANGLION-CELLS; RHO SUBUNITS; RAT RETINA; MODEL; LOCALIZATION	Loss of photoreceptors leads to significant remodeling in inner retina of rd1 mouse, a widely used model of retinal degeneration. Several morphological and physiological alterations occur in the second-and third-order retinal neurons. Synaptic activity in the excitatory bipolar cells and the predominantly inhibitory amacrine cells is enhanced. Retinal ganglion cells (RGCs) exhibit hyperactivity and aberrant spiking pattern, which adversely affects the quality of signals they can carry to the brain. To further understand the pathophysiology of retinal degeneration, and how it may lead to aberrant spiking in RGCs, we asked how loss of photoreceptors affects some of the neurotransmitter receptors in rd1 mouse. Using Western blotting, we measured the levels of several neurotransmitter receptors in adult rd1 mouse retina. We found significantly higher levels of AMPA, glycine and GABAa receptors, but lower levels of GABAc receptors in rd1 mouse than in wild-type. Since GABAa receptor is expressed in several retinal layers, we employed quantitative immunohistochemistry to measure GABAa receptor levels in specific retinal layers. We found that the levels of GABAa receptors in inner plexiform layer of wild-type and rd1 mice were similar, whereas those in outer plexiform layer and inner nuclear layer combined were higher in rd1 mouse. Specifically, we found that the number of GABAa-immunoreactive somas in the inner nuclear layer of rd1 mouse retina was significantly higher than in wild-type. These findings provide further insights into neurochemical remodeling in the inner retina of rd1 mouse, and how it might lead to oscillatory activity in RGCs.	[Srivastava, Prerna; Sinha-Mahapatra, Sumit K.; Ghosh, Abhinaba; Srivastava, Ipsit; Dhingra, Narender K.] Natl Brain Res Ctr, Manesar Gurgaon, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Dhingra, NK (corresponding author), Natl Brain Res Ctr, Manesar Gurgaon, Haryana, India.	naren@nbrc.ac.in	Ghosh, Abhinaba/AAU-4280-2021	Srivastava, Prerna/0000-0002-3429-7039	National Brain Research Centre	National Brain Research Centre	This work was supported by funds from National Brain Research Centre. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borowska J, 2011, J NEUROSCI, V31, P5000, DOI 10.1523/JNEUROSCI.5800-10.2011; Boudard DL, 2009, EUR J NEUROSCI, V30, P1527, DOI 10.1111/j.1460-9568.2009.06935.x; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; Choi H, 2014, J NEUROPHYSIOL, V112, P1491, DOI 10.1152/jn.00437.2014; Dagar S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090250; Delyfer MN, 2005, MOL VIS, V11, P688; Enz R, 1999, EUR J NEUROSCI, V11, P41, DOI 10.1046/j.1460-9568.1999.00423.x; Enz R, 1996, J NEUROSCI, V16, P4479; ENZ R, 1995, EUR J NEUROSCI, V7, P1495, DOI 10.1111/j.1460-9568.1995.tb01144.x; GAO B, 1993, NEUROSCIENCE, V54, P881, DOI 10.1016/0306-4522(93)90582-Z; Gargini C, 2007, J COMP NEUROL, V500, P222, DOI 10.1002/cne.21144; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Haverkamp S, 2004, J COMP NEUROL, V477, P399, DOI 10.1002/cne.20267; Jones BW, 2005, EXP EYE RES, V81, P123, DOI 10.1016/j.exer.2005.03.006; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Koulen P, 1996, J NEUROSCI, V16, P2127; Kralic JE, 2002, J PHARMACOL EXP THER, V302, P1037, DOI 10.1124/jpet.102.036665; Liu LO, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-7; Lukasiewicz PD, 2004, VISION RES, V44, P3289, DOI 10.1016/j.visres.2004.07.023; Margolis DJ, 2008, J NEUROSCI, V28, P6526, DOI 10.1523/JNEUROSCI.1533-08.2008; Margolis DJ, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/507037; MATZENBACH B, 1994, J BIOL CHEM, V269, P2607; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; MURASHIMA YL, 1990, J NEUROCHEM, V54, P893, DOI 10.1111/j.1471-4159.1990.tb02335.x; Nagar S, 2009, NEUROSCIENCE, V160, P517, DOI 10.1016/j.neuroscience.2009.02.056; Poria D, 2015, J NEUROPHYSIOL, V113, P420, DOI 10.1152/jn.00702.2014; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; Punzo C, 2007, INVEST OPHTH VIS SCI, V48, P849, DOI 10.1167/iovs.05-1555; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Samardzija M, 2012, EXP EYE RES, V99, P17, DOI 10.1016/j.exer.2012.04.004; SASSOEPOGNETTO M, 1994, J NEUROSCI, V14, P5131; Stasheff SF, 2008, J NEUROPHYSIOL, V99, P1408, DOI 10.1152/jn.00144.2007; Sterling P., 2004, SYNAPTIC ORG BRAIN, P217; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Toychiev AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077658; Trenholm S, 2012, J PHYSIOL-LONDON, V590, P2501, DOI 10.1113/jphysiol.2011.225060; Varela C, 2003, VISION RES, V43, P879, DOI 10.1016/S0042-6989(02)00493-5; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; WOODFORD BJ, 1989, CELL TISSUE RES, V256, P495; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yazulla S, 1997, VISION RES, V37, P3471, DOI 10.1016/S0042-6989(96)00223-4; Yee CW, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00008	44	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123896	10.1371/journal.pone.0123896	http://dx.doi.org/10.1371/journal.pone.0123896			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835503	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000152
J	Tung, WP; Chen, YH; Cheng, WC; Chuang, MF; Hsu, WT; Kam, YC; Lehtinen, RM				Tung, Wan-Ping; Chen, Yi-Huey; Cheng, Wei-Chun; Chuang, Ming-Feng; Hsu, Wan-Tso; Kam, Yeong-Choy; Lehtinen, Richard M.			Parentage of Overlapping Offspring of an Arboreal-Breeding Frog with No Nest Defense: Implications for Nest Site Selection and Reproductive Strategy	PLOS ONE			English	Article							CHIRIXALUS-EIFFINGERI ANURA; HEMIDACTYLIUM-SCUTATUM CAUDATA; EXTRA-PAIR PATERNITY; OOPHAGOUS TADPOLES; CLUTCH OVERLAP; MATE FIDELITY; FITNESS CONSEQUENCES; MOVEMENT PATTERNS; BROODING BEHAVIOR; NATURAL-HISTORY	Overlapping offspring occurs when eggs are laid in a nest containing offspring from earlier reproduction. Earlier studies showed that the parentage is not always obvious due to difficulties in field observation and/or alternative breeding tactics. To unveil the parentage between overlapping offspring and parents is critical in understanding oviposition site selection and the reproductive strategies of parents. Amplectant pairs of an arboreal-breeding frog, Kurixalus eiffingeri, lay eggs in tadpole-occupied nests where offspring of different life stages (embryos and tadpoles) coexist. We used five microsatellite DNA markers to assess the parentage between parents and overlapping offspring. We also tested the hypothesis that the male or female frog would breed in the same breeding site because of the scarcity of nest sites. Results showed varied parentage patterns, which may differ from the phenomenon of overlapping egg clutches reported earlier. Parentage analyses showed that only 58 and 25% of the tadpole-occupied stumps were reused by the same male and female respectively, partially confirming our prediction. Re-nesting by the same individual was more common in males than females, which is most likely related to the cost of tadpole feeding and/or feeding schemes of females. On the other hand, results of parentage analyses showed that about 42 and 75% of male and female respectively bred in tadpole-occupied stumps where tadpoles were genetically unrelated. Results of a nest-choice experiment revealed that 40% of frogs chose tadpole-occupied bamboo cups when we presented identical stumps, without or with tadpoles, suggesting that the habitat saturation hypothesis does not fully explain why frogs used the tadpole-occupied stumps. Several possible benefits of overlapping offspring with different life stages were proposed. Our study highlights the importance of integrating molecular data with field observations to better understand the reproductive biology and nest site selection of anuran amphibians.	[Tung, Wan-Ping; Cheng, Wei-Chun; Chuang, Ming-Feng; Hsu, Wan-Tso; Kam, Yeong-Choy] Tunghai Univ, Dept Life Sci, Taichung 407, Taiwan; [Chen, Yi-Huey] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Lehtinen, Richard M.] Coll Wooster, Dept Biol, Wooster, OH 44691 USA	Tunghai University; Chinese Culture University; College of Wooster	Kam, YC (corresponding author), Tunghai Univ, Dept Life Sci, Taichung 407, Taiwan.	biyckam@thu.edu.tw	Chuang, Ming-Feng/GWQ-6299-2022	Chuang, Ming-Feng/0000-0002-7328-2577	National Science Council grant (NSC) [101-2621-B-029-002-MY3]	National Science Council grant (NSC)	This study was supported by a National Science Council grant to YCK (NSC 101-2621-B-029-002-MY3).	[Anonymous], 2008, STAPFIA; Avise JC, 2002, ANNU REV GENET, V36, P19, DOI 10.1146/annurev.genet.36.030602.090831; BACHMANN MD, 1984, HERPETOLOGICA, V40, P436; BARCLAY RMR, 1988, AUK, V105, P53, DOI 10.1093/auk/105.1.53; BREITENBACH GL, 1982, J HERPETOL, V16, P341, DOI 10.2307/1563563; Bried J, 2003, ANIM BEHAV, V65, P235, DOI 10.1006/anbe.2002.2045; BURLEY N, 1980, AM NAT, V115, P223, DOI 10.1086/283556; Burrowes PA, 2000, HERPETOLOGICA, V56, P375; Campobello D, 2011, BEHAV ECOL, V22, P422, DOI 10.1093/beheco/arq225; Carreno CA, 1998, COPEIA, P183; Cezilly F, 2000, ANIM BEHAV, V59, P1143, DOI 10.1006/anbe.2000.1422; Chen YH, 2001, HERPETOLOGICA, V57, P438; Chen YH, 2007, ZOOL SCI, V24, P434, DOI 10.2108/zsj.24.434; Chen YH, 2011, BEHAV ECOL SOCIOBIOL, V65, P2329, DOI 10.1007/s00265-011-1243-x; Cheng WC, 2013, ETHOLOGY, V119, P286, DOI 10.1111/eth.12062; Chiu CT, 2006, BEHAVIOUR, V143, P123, DOI 10.1163/156853906775133605; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Crump Martha L., 1995, Amphibian Biology, V2, P518; DAUGHERTY CH, 1982, HERPETOLOGICA, V38, P468; DeWoody JA, 2001, J HERED, V92, P167, DOI 10.1093/jhered/92.2.167; Doligez B, 2002, SCIENCE, V297, P1168, DOI 10.1126/science.1072838; Doody JS, 2009, Q REV BIOL, V84, P229, DOI 10.1086/605078; DOW H, 1983, J ANIM ECOL, V52, P681, DOI 10.2307/4447; Edgerly JS, 1998, J ANIM ECOL, V67, P805, DOI 10.1046/j.1365-2656.1998.00243.x; Ewen JG, 2004, NEW ZEAL J ECOL, V28, P233; FORESTER DC, 1979, COPEIA, P332; FORESTER DC, 1983, COPEIA, P1098; GROSS MR, 1985, AM ZOOL, V25, P807; Gruter C, 2011, NEOTROP ENTOMOL, V40, P55, DOI 10.1590/S1519-566X2011000100008; HARRIS RN, 1995, ANIM BEHAV, V50, P1309, DOI 10.1016/0003-3472(95)80046-8; HARRIS RN, 1980, HERPETOLOGICA, V36, P141; Heg D, 2003, ANIM BEHAV, V66, P175, DOI 10.1006/anbe.2003.2188; Hetmanski T, 2005, POL J ECOL, V53, P523; HOM CL, 1990, HERPETOLOGICA, V46, P304; Hoover JP, 2003, ECOLOGY, V84, P416, DOI 10.1890/0012-9658(2003)084[0416:DRFSFI]2.0.CO;2; Johannesen E, 2002, EMU, V102, P241, DOI 10.1071/MU01061; Johnson M, 2008, AUK, V125, P76, DOI 10.1525/auk.2008.125.1.76; Junca FA, 1996, J HERPETOL, V30, P292, DOI 10.2307/1565530; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kam YC, 1997, ZOOL STUD, V36, P186; Kam YC, 2000, ZOOL STUD, V39, P67; Kam YC, 1998, HERPETOLOGICA, V54, P425; Kam YC, 1998, PHYSIOL ZOOL, V71, P534, DOI 10.1086/515957; Kam YC, 1996, J HERPETOL, V30, P52, DOI 10.2307/1564706; Kam YC, 2000, BEHAVIOUR, V137, P137, DOI 10.1163/156853900501917; Kitching R.L., 2000, FOOD WEBS CONTAINER, DOI [10.1017/CBO9780511542107, DOI 10.1017/CBO9780511542107]; Knouft JH, 2004, COPEIA, P915, DOI 10.1643/CE-03-169R1; Krebs JR, 1993, INTRO BEHAV ECOLOGY; Lannoo J.M., 1987, FIELDIANA ZOOL, V38, P1, DOI DOI 10.5962/BHL.TITLE.2932; Laurila A, 1998, BIOL J LINN SOC, V63, P221; Lehtinen RM, 2004, MISC PUBL MUS ZOOL, V193, P1; Liang MF, 2002, J ZOOL, V256, P207, DOI 10.1017/S0952836902000249; Lin YS, 2008, ZOOL STUD, V47, P129; Lin YS, 2008, HERPETOLOGICA, V64, P413, DOI 10.1655/08-020R1.1; LOWTHER P E, 1979, Bird-Banding, V50, P160; MacDougallShackleton EA, 1996, ANIM BEHAV, V52, P1177, DOI 10.1006/anbe.1996.0265; Manica A, 2004, AM NAT, V164, P517, DOI 10.1086/423792; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; McCarthy MA, 2004, J APPL ECOL, V41, P780, DOI 10.1111/j.0021-8901.2004.00919.x; Mokany A, 2003, AUSTRAL ECOL, V28, P33, DOI 10.1046/j.1442-9993.2003.01239.x; MOLLER AP, 1990, ANIM BEHAV, V40, P1070, DOI 10.1016/S0003-3472(05)80173-3; Murphy PJ, 2003, BEHAV ECOL, V14, P626, DOI 10.1093/beheco/arg042; Naves LC, 2006, OIKOS, V115, P263; Petrie M, 1998, TRENDS ECOL EVOL, V13, P52, DOI 10.1016/S0169-5347(97)01232-9; Redmond LJ, 2009, WILSON J ORNITHOL, V121, P1, DOI 10.1676/07-166.1; Reid JM, 2003, J ANIM ECOL, V72, P765, DOI 10.1046/j.1365-2656.2003.00750.x; Roberts JD, 2011, ADV STUD BEHAV, V43, P1, DOI 10.1016/B978-0-12-380896-7.00001-0; Rowe KMC, 2007, BEHAV ECOL SOCIOBIOL, V61, P1283, DOI 10.1007/s00265-007-0359-5; Rudolf VHW, 2005, OECOLOGIA, V142, P316, DOI 10.1007/s00442-004-1668-2; SAS, 2001, SAS STAT US GUID; Schulte L, 2014, ANIM COGN, V17, P267, DOI 10.1007/s10071-013-0659-2; Schulte LM, 2010, SALAMANDRA, V46, P180; Shang K- S, 2009, FIELD GUIDE AMPHIBIA; SMITH C, 1995, REV FISH BIOL FISHER, V5, P7, DOI 10.1007/BF01103363; SONERUD GA, 1987, ORNIS SCAND, V18, P323, DOI 10.2307/3676904; Srivastava DS, 2004, TRENDS ECOL EVOL, V19, P379, DOI 10.1016/j.tree.2004.04.010; TESSIER C, 1991, J HERPETOL, V25, P213, DOI 10.2307/1564652; TRAVIS J, 1987, ECOLOGY, V68, P611, DOI 10.2307/1938466; UEDA H, 1986, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V8, P109; Vergara P, 2006, IBIS, V148, P672, DOI 10.1111/j.1474-919X.2006.00565.x; Vieites DR, 2004, NATURE, V431, P305, DOI 10.1038/nature02879; Wang JL, 2004, GENETICS, V166, P1963, DOI 10.1534/genetics.166.4.1963; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WELLS KD, 1977, ECOLOGY, V58, P750, DOI 10.2307/1936211; WESTMORELAND D, 1989, ANIM BEHAV, V38, P1062, DOI 10.1016/S0003-3472(89)80145-9; WESTMORELAND D, 1986, AUK, V103, P196; WOODRUFF DS, 1977, HERPETOLOGICA, V33, P296; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; [No title captured]	89	3	3	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123221	10.1371/journal.pone.0123221	http://dx.doi.org/10.1371/journal.pone.0123221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835716	Green Published, gold			2022-12-26	WOS:000352139000134
J	Wong, LP; Shakir, SMM; Atefi, N; AbuBakar, S				Wong, Li Ping; Shakir, Sharina Mahavera Mohamad; Atefi, Narges; AbuBakar, Sazaly			Factors Affecting Dengue Prevention Practices: Nationwide Survey of the Malaysian Public	PLOS ONE			English	Article							KNOWLEDGE; FEVER; ATTITUDES; BELIEFS; URBAN; MODEL	Background Efforts to stamp dengue in many dengue endemic countries has met little success. There is a need to re-examine and understand how the public at large view the dengue prevention efforts. This study aimed to examine the demographic factors, theoretical constructs of the Health Belief Model and knowledge about dengue and how these influence the practice of dengue prevention. Methods A national telephone survey was carried out with 2,512 individuals of the Malaysian public aged 18-60 years. Results The majority (73%) of the Malaysian public had a total dengue prevention score of 51-100 (of a possible score of 1-100). Multivariate analysis suggests significant correlates of higher dengue prevention practices with demographic background, perception of susceptibility to dengue, perceived density of mosquitoes in the neighbourhood and knowledge about dengue. Households of lower income of which the majority (40.7%) were from the rural areas, were associated with the highest odds [OR = 1.33; 95% CI = 1.09-1.67; p = 0.004] of dengue prevention. Dengue prevention practices were also less likely to be undertaken in neighbourhoods where the responders perceived there is no and/or low density of mosquitoes. Dengue prevention practices are also less likely to be practiced by skilled workers [OR = 0.78; 95% CI = 0.63-0.95; p = 0.029] compared to those unemployed. Higher perceived susceptibility to dengue was associated with higher dengue prevention practices and participants with higher dengue knowledge were found to have a higher level of involvement in dengue prevention practices. Conclusion Results from the study suggest that in formulating approaches to contain dengue, strategies should be developed to cultivate dengue prevention practices among urban population and target areas with low density of mosquitoes where public perceived a less likely chance of getting dengue. Dengue prevention campaigns should focus on messages highlighting the risk of contracting dengue and education to increase knowledge about dengue.	[Wong, Li Ping; Shakir, Sharina Mahavera Mohamad; Atefi, Narges] Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Wong, Li Ping] Univ Malaya, Julius Ctr Univ Malaya, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur, Malaysia; [AbuBakar, Sazaly] Univ Malaya, Trop Infect Dis Res & Educ Ctr, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Wong, LP (corresponding author), Univ Malaya, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.	wonglp@ummc.edu.my	WONG, LI PING/B-2782-2010; abubakar, sazaly/B-3957-2010	WONG, LI PING/0000-0002-0107-0532; abubakar, sazaly/0000-0002-9267-1420; Mohamad Shakir, Sharina Mahavera/0000-0001-8649-3800	Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease	Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease	This study was solely funded by Ministry of Higher Education, Malaysia Long Term Research Grant Scheme (LRGS) for Infectious Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dubai SAR, 2013, SE ASIAN J TROP MED, V44, P37; Artwanichakul K., 2012, European Journal of Social Sciences, V32, P485; Barreto FR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-51; Boland M, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-208; GLANZ K, 1997, HLTH BEHAV HLTH ED T; Hairi Farizah, 2003, Asia Pac J Public Health, V15, P37, DOI 10.1177/101053950301500107; Isa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002401; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Lam S. K., 1993, Tropical Medicine, V35, P303; Lennon J. L., 2005, Dengue Bulletin, V29, P217; Naing C, 2011, J COMMUN HEALTH, V36, P1044, DOI 10.1007/s10900-011-9407-1; Nalongsack S, 2009, NAGOYA J MED SCI, V71, P29; Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005; Phuanukoonnon S, 2006, ACTA TROP, V99, P6, DOI 10.1016/j.actatropica.2006.05.012; Pulford J, 2012, SOC SCI MED, V75, P2283, DOI 10.1016/j.socscimed.2012.08.030; Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009; Samuelsen H, 2004, SOC SCI MED, V59, P2361, DOI 10.1016/j.socscimed.2004.03.031; Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853; Shepard D.S., 2013, BURDEN DENGUE MALAYS; Shuaib F, 2010, W INDIAN MED J, V59, P139; Thompson F, 2009, INT J HLTH PROMOTION, V48; Vanwambeke Sophie O, 2006, Int J Health Geogr, V5, P5, DOI 10.1186/1476-072X-5-5; WHO, 2014, EM DIS SURV RESP WPR; WHO, 2014, DENG SEV DENG 2014; Wong LP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002789; Yboa BC, 2013, AM J PUBLIC HLTH RES, V1, P47, DOI [10.12691/ajphr-1-2-2, DOI 10.12691/AJPHR-1-2-2]	26	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122890	10.1371/journal.pone.0122890	http://dx.doi.org/10.1371/journal.pone.0122890			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25836366	gold, Green Published			2022-12-26	WOS:000352139000117
J	Zhang, JY; Ding, TD; Zhang, ZJ; Xu, LP; Zhang, CL				Zhang, Jianying; Ding, Tengda; Zhang, Zhijian; Xu, Liping; Zhang, Chunlong			Enhanced Adsorption of Trivalent Arsenic from Water by Functionalized Diatom Silica Shells	PLOS ONE			English	Article							ACTIVATED ALUMINA; AQUEOUS-SOLUTION; WASTE-WATER; REMOVAL; XPS; OXIDE; KINETICS; SURFACE; EQUILIBRIUM; COPPER(II)	The potential of porous diatom silica shells as a naturally abundant low-cost sorbent for the removal of arsenic in aqueous solutions was investigated in a batch study. The objective of this work was to chemically modify the silica shells of a diatom Melosira sp. with bifunctional (thiol and amino) groups to effectively remove arsenic in its toxic As(III) form (arsenite) predominant in the aquatic environment. Sorption experiments with this novel sorbent were conducted under varying conditions of pH, time, dosage, and As(III) concentration. A maximum adsorption capacity of 10.99 mg g(-1) was achieved within 26 h for a solution containing 12 mg L-1 As(III) at pH 4 and sorbent dosage of 2 g L-1. The functionalized diatom silica shells had a surface morphological change which was accompanied by increased pore size at the expense of reduced specific surface area and total pore volume. As(III) adsorption was best fitted with the Langmuir-Freundlich model, and the adsorption kinetic data using pore surface diffusion model showed that both the external (film) and internal (intraparticle) diffusion can be rate-determining for As(III) adsorption. Fourier transform infrared spectroscopy (FTIR) indicated that the thiol and amino groups potentially responsible for As(III) adsorption were grafted on the surface of diatom silica shells. X-ray photoelectron spectroscopy (XPS) further verified that this unique sorbent proceeded via a chemisorption mechanism through the exchange between oxygen-containing groups of neutral As(III) and thiol groups, and through the surface complexation between As(III) and protonated nitrogen and hydroxyl groups. Results indicate that this functionalized bioadsorbent with a high As(III) adsorption capacity holds promise for the treatment of As(III) containing wastewater.	[Zhang, Jianying; Ding, Tengda; Zhang, Zhijian; Xu, Liping] Zhejiang Univ, Inst Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhang, Jianying] Zhejiang Prov Key Lab Organ Pollut Proc & Control, Hangzhou, Zhejiang, Peoples R China; [Ding, Tengda] Jiangxi Acad Sci, Inst Sci & Technol Strategy, Nanchang, Jiangxi, Peoples R China; [Zhang, Chunlong] Univ Houston Clear Lake City, Dept Environm Sci, Houston, TX 77058 USA	Zhejiang University; University of Houston System; University of Houston; University of Houston Clear Lake	Zhang, JY (corresponding author), Zhejiang Univ, Inst Environm Sci, Hangzhou 310003, Zhejiang, Peoples R China.	zjy@zju.edu.cn	Ding, Tengda/GWM-8175-2022; Zhang, Jianying/I-9351-2014; Zhang, Chunlong/N-2564-2014; Ding, Tengda/ABG-1481-2021	Zhang, Jianying/0000-0002-1636-5544; Zhang, Chunlong/0000-0003-4782-5424; 	National Natural Science Foundation of China [21177106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (Grant 21177106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MH, 2013, APPL SURF SCI, V273, P507, DOI 10.1016/j.apsusc.2013.02.070; Albarelli JQ, 2012, ADSORPT SCI TECHNOL, V30, P227, DOI 10.1260/0263-6174.30.3.227; Alves CCO, 2013, LWT-FOOD SCI TECHNOL, V51, P1, DOI 10.1016/j.lwt.2012.11.012; Benhamou A, 2013, J COLLOID INTERF SCI, V404, P135, DOI 10.1016/j.jcis.2013.04.026; Chang CF, 2012, WATER RES, V46, P2869, DOI 10.1016/j.watres.2012.02.041; Chang FF, 2009, J COLLOID INTERF SCI, V338, P353, DOI 10.1016/j.jcis.2009.06.049; Chen JP, 2006, LANGMUIR, V22, P8906, DOI 10.1021/la060770+; Cui H, 2013, WATER RES, V47, P6258, DOI 10.1016/j.watres.2013.07.040; DRIEHAUS W, 1995, WATER RES, V29, P297, DOI 10.1016/0043-1354(94)E0089-O; Gimenez J, 2007, J HAZARD MATER, V141, P575, DOI 10.1016/j.jhazmat.2006.07.020; Gong B, 1999, SURF INTERFACE ANAL, V28, P126, DOI 10.1002/(SICI)1096-9918(199908)28:1<126::AID-SIA633>3.0.CO;2-V; Goswami B, 2012, LUMINESCENCE, V27, P16, DOI 10.1002/bio.1315; Hao JM, 2009, MICROPOR MESOPOR MAT, V124, P1, DOI 10.1016/j.micromeso.2009.03.021; Heredia A, 2012, PHYCOL RES, V60, P229, DOI 10.1111/j.1440-1835.2012.00652.x; Huang CP, 2007, J CHEM TECHNOL BIOT, V82, P289, DOI 10.1002/jctb.1671; Knoerr R, 2013, MICROPOR MESOPOR MAT, V169, P185, DOI 10.1016/j.micromeso.2012.09.036; Kumar PS, 2010, DESALINATION, V261, P52, DOI 10.1016/j.desal.2010.05.032; Liang XF, 2009, COLLOID SURFACE A, V349, P61, DOI 10.1016/j.colsurfa.2009.07.052; Lim SF, 2009, LANGMUIR, V25, P4973, DOI 10.1021/la802974x; Lin TF, 2001, WATER RES, V35, P2049, DOI 10.1016/S0043-1354(00)00467-X; Deng LP, 2007, J HAZARD MATER, V143, P220, DOI 10.1016/j.jhazmat.2006.09.009; Lu P, 2011, ENVIRON EARTH SCI, V62, P1673, DOI 10.1007/s12665-010-0652-x; Mertens J, 2012, ENVIRON SCI TECHNOL, V46, P7310, DOI 10.1021/es204508t; Mirji SA, 2006, SURF INTERFACE ANAL, V38, P158, DOI 10.1002/sia.2309; Mudhoo A, 2011, CRIT REV ENV SCI TEC, V41, P435, DOI 10.1080/10643380902945771; Nakamura N, 2004, SURF COAT TECH, V186, P339, DOI 10.1016/j.surfcoat.2003.12.005; Pena M, 2006, ENVIRON SCI TECHNOL, V40, P1257, DOI 10.1021/es052040e; Petit C, 2010, CARBON, V48, P1779, DOI 10.1016/j.carbon.2010.01.024; Rahman MS, 2009, CHEM ENG J, V149, P273, DOI 10.1016/j.cej.2008.11.029; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Sari A, 2011, CHEM ENG J, V167, P155, DOI 10.1016/j.cej.2010.12.014; Sharma VK, 2009, ENVIRON INT, V35, P743, DOI 10.1016/j.envint.2009.01.005; Sumper M, 2006, ADV FUNCT MATER, V16, P17, DOI 10.1002/adfm.200500616; Teixeira MC, 2005, ENVIRON SCI TECHNOL, V39, P895, DOI 10.1021/es049513m; Tesson B, 2010, J STRUCT BIOL, V169, P62, DOI 10.1016/j.jsb.2009.08.013; Travlou NA, 2013, LANGMUIR, V29, P1657, DOI 10.1021/la304696y; Wang GJ, 2009, ADV FUNCT MATER, V19, P2768, DOI 10.1002/adfm.200900402; Weng CH, 2007, SEP PURIF TECHNOL, V54, P187, DOI 10.1016/j.seppur.2006.09.009; Wu K, 2011, J ENVIRON ENG-ASCE, V137, P1122, DOI 10.1061/(ASCE)EE.1943-7870.0000432; Wu YH, 2010, WORLD J MICROB BIOT, V26, P249, DOI 10.1007/s11274-009-0167-3; Yagi S, 2013, APPL SURF SCI, V267, P45, DOI 10.1016/j.apsusc.2012.05.098; Yu Y, 2012, SCI TECHNOL ADV MAT, P13	42	30	31	2	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123395	10.1371/journal.pone.0123395	http://dx.doi.org/10.1371/journal.pone.0123395			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837498	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000142
J	Radhakrishnan, J; Bazarek, S; Chandran, B; Gazmuri, RJ				Radhakrishnan, Jeejabai; Bazarek, Stanley; Chandran, Bala; Gazmuri, Raul J.			Cyclophilin-D: a resident regulator of mitochondrial gene expression	FASEB JOURNAL			English	Article						respiratory complexes; membrane potential; transcription; oxygen consumption	PERMEABILITY TRANSITION PORE; ADENINE-NUCLEOTIDE TRANSLOCASE; CELL-DEATH; CYCLOSPORINE-A; BINDING-PROTEIN; RNA GRANULES; TRANSCRIPTION; METABOLISM; INHIBITOR; COMPLEXES	Cyclophilin-D (Cyp-D) is a mitochondrial matrix peptidyl-prolyl isomerase. Because cyclophilins can regulate nuclear gene expression, we examined whether Cyp-D could regulate mitochondrial gene expression. We demonstrated in HEK 293T cells that transfected Cyp-D interacts with mitochondrial transcription factors B1 and B2 (TFB2M) but not with mitochondrial transcription factor A. We also demonstrated that Cyp-D interacts in vivo with TFB2M. Genetic silencing of Cyp-D and pharmacologic inhibition of Cyp-D markedly reduced mitochondrial transcription to 18 +/- 5% (P < 0.05) and 24 +/- 3% (P < 0.05) of respective controls. The level of interaction between Cyp-D and TFB2M correlated with the level of nascent mitochondrial RNA intensity (r = 0.896; P = 0.0156). Cyp-D silencing down-regulated mitochondrial transcripts initiated from the heavy strand promoter 2 [i.e., NADH dehydrogenase 1 (ND1) by 11-fold, P < 0.005; cytochrome oxidase 1 (COX1) by 4-fold, P < 0.001; and ATP synthase subunit 6 (ATP6) by 6.5-fold, P < 0.005); but not NADH dehydrogenase6 (ND6)], which is initiated from the light strand promoter. Cyp-D silencing reduced mitochondrial membrane potential and cellular oxygen consumption (from 59 +/- 5 to 34 +/- 1 mu mol oxygen/min/10(6) cells, P < 0.001); the latter without a statistically significant reversal after uncoupling electrontransport from ATP synthesis, consistent with downregulation of electron transport complexes. Accordingly, these studies provide novel evidence that Cyp-D could play a key role in regulating mitochondrial gene expression.	[Radhakrishnan, Jeejabai; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Dept Med, N Chicago, IL 60064 USA; [Radhakrishnan, Jeejabai; Gazmuri, Raul J.] Rosalind Franklin Univ Med & Sci, Resuscitat Inst, N Chicago, IL 60064 USA; [Bazarek, Stanley] Rosalind Franklin Univ Med & Sci, Ctr Stem Cell & Regenerat Med, Dept Neurosci, N Chicago, IL 60064 USA; [Chandran, Bala] Rosalind Franklin Univ Med & Sci, HM Bligh Canc Res Labs, Dept Microbiol & Immunol, N Chicago, IL 60064 USA; [Gazmuri, Raul J.] Captain James A Lovell Fed Hlth Care Ctr, N Chicago, IL USA	Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science	Radhakrishnan, J (corresponding author), Rosalind Franklin Univ Med & Sci, Dept Med, 3333 Green Bay Rd, N Chicago, IL 60064 USA.	jeejabai.radhakrishnan@rosalindfranklin.edu; raul.gazmuri@rosalindfranklin.edu		Gazmuri, Raul J./0000-0002-3848-7227	U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest"	U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest"	The authors thank Dr. Bala Chandran [Professor and Chair, Director, H. M. Cancer Research Laboratories, Department of Microbiology and Immunology, Rosalind Franklin University of Medicine and Science (RFUMS)], for the support with cell culture and lentiviral facility and for the help with equipment including the Applied Biosystems Real-Time PCR machine. The authors also thank Dr. Daniel Peterson (Department of Neuroscience, RFUMS) for the anti-BrU antibody, the Alexa 488-conjugated secondary antibody, and support with the confocal microscope facility. The authors thank Dr. Patricia Loomis (Confocal Microscopy Core Facility, RFUMS) for assisting with confocal studies. This work was partially supported by a U.S. Veterans Affairs Merit Review grant entitled "Myocardial Effects of Erythropoietin during Resuscitation from Cardiac Arrest," a gift for cardiovascular research administered by the Hines VA Research Service entitled "Mechanisms of Cytochrome c Release during Resuscitation-Adeno-Associated Viral Gene Transfer (Pilot Grant)," and a DePaul-Rosalind Franklin University Collaborative Pilot Research Grant entitled" Molecular Mechanisms by which Cyclophilin-D Modulates Transcription of Mitochondrial Genes. "The authors declare no conflicts of interest.	Allalou A, 2009, COMPUT METH PROG BIO, V94, P58, DOI 10.1016/j.cmpb.2008.08.006; Antonicka H, 2013, CELL METAB, V17, P386, DOI 10.1016/j.cmet.2013.02.006; Asin-Cayuela J, 2007, TRENDS BIOCHEM SCI, V32, P111, DOI 10.1016/j.tibs.2007.01.003; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Bonawitz ND, 2006, MOL CELL, V24, P813, DOI 10.1016/j.molcel.2006.11.024; Borowski LS, 2010, BBA-BIOENERGETICS, V1797, P1066, DOI 10.1016/j.bbabio.2010.01.028; Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311; BROEKEMEIER KM, 1989, J BIOL CHEM, V264, P7826; Crompton M, 1998, EUR J BIOCHEM, V258, P729, DOI 10.1046/j.1432-1327.1998.2580729.x; Elrod JW, 2013, CIRC J, V77, P1111, DOI 10.1253/circj.CJ-13-0321; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gothel SF, 1999, CELL MOL LIFE SCI, V55, P423, DOI 10.1007/s000180050299; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hangen E, 2010, CELL DEATH DIFFER, V17, P1155, DOI 10.1038/cdd.2009.211; Iborra FJ, 1998, J CELL SCI, V111, P2269; Jackson DA, 1998, MOL BIOL CELL, V9, P1523, DOI 10.1091/mbc.9.6.1523; Jourdain AA, 2013, CELL METAB, V17, P399, DOI 10.1016/j.cmet.2013.02.005; Leon C, 2008, J PHARM SCI-US, V97, P2350, DOI 10.1002/jps.21141; Lin DT, 2002, J BIOL CHEM, V277, P31134, DOI 10.1074/jbc.M112035200; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; McClintock DS, 2002, MOL CELL BIOL, V22, P94, DOI 10.1128/MCB.22.1.94-104.2002; McCulloch V, 2003, MOL CELL BIOL, V23, P5816, DOI 10.1128/MCB.23.16.5816-5824.2003; Menazza S, 2013, J MOL CELL CARDIOL, V56, P81, DOI 10.1016/j.yjmcc.2012.12.004; MITCHELL P, 1979, SCIENCE, V206, P1148, DOI 10.1126/science.388618; Nagao A, 2008, METHOD ENZYMOL, V447, P489, DOI 10.1016/S0076-6879(08)02223-4; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shoubridge EA, 2002, NAT GENET, V31, P227, DOI 10.1038/ng0702-227; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Tavecchio M, 2013, J BIOL CHEM, V288, P5553, DOI 10.1074/jbc.M112.433045; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Watanabe A, 2011, CARDIOVASC RES, V90, P57, DOI 10.1093/cvr/cvq374; Wolf AR, 2014, CELL REP, V7, P918, DOI 10.1016/j.celrep.2014.03.035; Wolff S, 2008, CELL RES, V18, P733, DOI 10.1038/cr.2008.62; YANG WM, 1995, J BIOL CHEM, V270, P15187, DOI 10.1074/jbc.270.25.15187; Zheng HW, 2002, NATURE, V419, P849, DOI 10.1038/nature01116	44	16	16	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2734	2748		10.1096/fj.14-263855	http://dx.doi.org/10.1096/fj.14-263855			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837584				2022-12-26	WOS:000356859100006
J	Arts, N; Cane, S; Hennequart, M; Lamy, J; Bommer, G; Van den Eynde, B; De Plaen, E				Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Bommer, Guido; Van den Eynde, Benoit; De Plaen, Etienne			microRNA-155, Induced by Interleukin-1 beta, Represses the Expression of Microphthalmia-Associated Transcription Factor (MITF-M) in Melanoma Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; TUMORAL IMMUNE RESISTANCE; CYTOLYTIC T-LYMPHOCYTES; GROWTH-FACTOR-BETA; HLA-A2 MELANOMAS; ANTIGEN; GENE; MOUSE; 2,3-DIOXYGENASE; IDENTIFICATION	Loss of expression of surface antigens represents a significant problem for cancer immunotherapy. Microphthalmia-associated transcription factor (MITF-M) regulates melanocyte fate by driving expression of many differentiation genes, whose protein products can be recognized by cytolytic T lymphocytes. We previously reported that interleukin-1 beta (IL-1 beta) can downregulate MITF-M levels. Here we show that downregulation of MITF-M expression by IL-1 beta was paralleled by an upregulation of miR-155 expression in four melanoma lines. We confirmed that miR-155 was able to target endogenous MITF-M in melanoma cells and demonstrated a role for miR-155 in the IL-1 beta-induced repression of MITF-M by using an antagomiR. Notably, we also observed a strong negative correlation between MITF-M and miR-155 levels in a mouse model of melanoma. Taken together, our results indicate that MITF-M downregulation by inflammatory stimuli might be partly due to miR-155 upregulation. This could represent a novel mechanism of melanoma immune escape in an inflammatory microenvironment.	[Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Van den Eynde, Benoit; De Plaen, Etienne] Ludwig Inst Canc Res, Brussels, Belgium; [Arts, Nathalie; Cane, Stefania; Hennequart, Marc; Lamy, Juliette; Van den Eynde, Benoit; De Plaen, Etienne] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Bommer, Guido] Catholic Univ Louvain, Duve Inst, B-1200 Brussels, Belgium	Ludwig Institute for Cancer Research; Universite Catholique Louvain; Universite Catholique Louvain	De Plaen, E (corresponding author), Ludwig Inst Canc Res, Brussels, Belgium.	Etienne.Deplaen@bru.licr.org	Bommer, Guido/A-8425-2011	Bommer, Guido/0000-0001-6898-4884; Cane, Stefania/0000-0003-4324-4681; Hennequart, Marc/0000-0003-4360-6830	Fonds National de la Recherche Scientifique (FNRS) (Belgium); Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium); Fondation Contre le Cancer (Belgium); FNRS (FRSM) [3.4.559.08.F]	Fonds National de la Recherche Scientifique (FNRS) (Belgium)(Fonds de la Recherche Scientifique - FNRS); Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium); Fondation Contre le Cancer (Belgium); FNRS (FRSM)(Fonds de la Recherche Scientifique - FNRS)	N.A. was supported by a FRIA Grant from the Fonds National de la Recherche Scientifique (FNRS) (Belgium) and the Centre du Cancer (Cliniques Universitaires Saint-Luc, UCL, Belgium). S.C., M.H., and J.L. were supported by a Televie Grant from the Fonds National de la Recherche Scientifique (FNRS) (Belgium). This work was supported in part by Grants from the Fondation Contre le Cancer (Belgium) and from the FNRS (FRSM, Grant 3.4.559.08.F). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell RE, 2011, PIGM CELL MELANOMA R, V24, P1088, DOI 10.1111/j.1755-148X.2011.00931.x; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; BENNICELLI JL, 1989, CANCER RES, V49, P930; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Cheli Y, 2011, ONCOGENE, V30, P2307, DOI 10.1038/onc.2010.598; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; Elaraj DM, 2006, CLIN CANCER RES, V12, P1088, DOI 10.1158/1078-0432.CCR-05-1603; Englaro W, 1999, ONCOGENE, V18, P1553, DOI 10.1038/sj.onc.1202446; Gallimore A, 2008, IMMUNOLOGY, V123, P157, DOI 10.1111/j.1365-2567.2007.02748.x; Gauthy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076186; Goswami S, 2010, J BIOL CHEM, V285, P20532, DOI 10.1074/jbc.M110.109298; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Hoek KS, 2010, PIGM CELL MELANOMA R, V23, P746, DOI 10.1111/j.1755-148X.2010.00757.x; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Huijbers IJ, 2006, CANCER RES, V66, P3278, DOI 10.1158/0008-5472.CAN-05-3216; Kholmanskikh O, 2010, INT J CANCER, V127, P1625, DOI 10.1002/ijc.25182; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185; Le Poole IC, 2002, AM J PATHOL, V160, P521, DOI 10.1016/S0002-9440(10)64871-7; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Pierrat MJ, 2012, J BIOL CHEM, V287, P17996, DOI 10.1074/jbc.M112.358341; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Romero P, 2002, IMMUNOL REV, V188, P81, DOI 10.1034/j.1600-065X.2002.18808.x; Saez-Ayala M, 2013, CANCER CELL, V24, P105, DOI 10.1016/j.ccr.2013.05.009; SCHWARTZENTRUBER DJ, 1991, J IMMUNOL, V146, P3674; Shibahara S, 2001, J INVEST DERM SYMP P, V6, P99, DOI 10.1046/j.0022-202x.2001.00010.x; Soudja SM, 2010, CANCER RES, V70, P3515, DOI 10.1158/0008-5472.CAN-09-4354; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; SWOPE VB, 1991, J INVEST DERMATOL, V96, P180, DOI 10.1111/1523-1747.ep12460991; Thomas AJ, 2008, PIGM CELL MELANOMA R, V21, P598, DOI 10.1111/j.1755-148X.2008.00506.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; Voelter Verena, 2008, Cancer Immun, V8, P6; Watanabe KI, 2002, PIGM CELL RES, V15, P201, DOI 10.1034/j.1600-0749.2002.01080.x; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yin QY, 2008, J BIOL CHEM, V283, P2654, DOI 10.1074/jbc.M708218200; Zarour H, 1996, J INVEST DERMATOL, V107, P63, DOI 10.1111/1523-1747.ep12298177	42	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122517	10.1371/journal.pone.0122517	http://dx.doi.org/10.1371/journal.pone.0122517			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853464	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400069
J	Choi, SI; Maeng, YS; Kim, TI; Lee, Y; Kim, YS; Kim, EK				Choi, Seung-Il; Maeng, Yong-Sun; Kim, Tae-Im; Lee, Yangsin; Kim, Yong-Sun; Kim, Eung Kweon			Lysosomal Trafficking of TGFBIp via Caveolae-Mediated Endocytosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KERATO-EPITHELIN MUTATIONS; EXTRACELLULAR-MATRIX; LIPID RAFTS; CELL-LINE; ENDOTHELIAL-CELLS; PROTEIN TGFBI; INTEGRIN; BETA-IG-H3; RECEPTOR	Transforming growth factor-beta-induced protein (TGFBIp) is ubiquitously expressed in the extracellular matrix (ECM) of various tissues and cell lines. Progressive accumulation of mutant TGFBIp is directly involved in the pathogenesis of TGFBI-linked corneal dystrophy. Recent studies reported that mutant TGFBIp accumulates in cells; however, the trafficking of TGFBIp is poorly understood. Therefore, we investigated TGFBIp trafficking to determine the route of its internalization and secretion and to elucidate its roles in the pathogenesis of granular corneal dystrophy type 2 (GCD2). Our data indicate that newly synthesized TGFBIp was secreted via the endoplasmic reticulum/Golgi-dependent secretory pathway, and this secretion was delayed in the corneal fibroblasts of patients with GCD2. We also found that TGFBIp was internalized by caveolae-mediated endocytosis, and the internalized TGFBIp accumulated after treatment with bafilomycin A1, an inhibitor of lysosomal degradation. In addition, the proteasome inhibitor MG 132 inhibits the endocytosis of TGFBIp. Co-immunoprecipitation revealed that TGFBIp interacted with integrin alpha(V)beta(3). Moreover, treatment with arginine-glycine-aspartic acid (RGD) tripeptide suppressed the internalization of TGFBIp. These insights on TGFBIp trafficking could lead to the identification of novel targets and the development of new therapies for TGFBI-linked corneal dystrophy.	[Choi, Seung-Il; Maeng, Yong-Sun; Kim, Tae-Im; Kim, Eung Kweon] Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea; [Kim, Tae-Im; Kim, Eung Kweon] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Inst Vis Res,Brain Korea Plus Project Med Sci 21, Seoul, South Korea; [Lee, Yangsin] Yonsei Univ, Grad Sch, Dept Integrated Omics Biomed Sci, Seoul, South Korea; [Kim, Yong-Sun] Hallym Univ, Ilsong Inst Life Sci, Anyang, South Korea; [Kim, Yong-Sun] Hallym Univ, Coll Med, Dept Microbiol, Chunchon, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Hallym University; Hallym University	Kim, EK (corresponding author), Yonsei Univ, Coll Med, Corneal Dystrophy Res Inst, Dept Ophthalmol, Seoul, South Korea.	eungkkim@yuhs.ac		Maeng, Yong-Sun/0000-0003-1694-8405; choi, seung-il/0000-0001-7168-8795; Kim, Eung Kweon/0000-0002-1453-8042; Kim, Tae-im/0000-0001-6414-3842	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF 2013R1A1A2012958]; National Research Foundation of Korea (NRF) grant - Korean government (MEST) [2011-0028699]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; National Research Foundation of Korea (NRF) grant - Korean government (MEST)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF 2013R1A1A2012958) and by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2011-0028699). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2007, CANCER CELL, V12, P514, DOI 10.1016/j.ccr.2007.11.014; Bae JS, 2002, BIOCHEM BIOPH RES CO, V294, P940, DOI 10.1016/S0006-291X(02)00576-4; Billings PC, 2000, J CELL BIOCHEM, V79, P261, DOI 10.1002/1097-4644(20001101)79:2<261::AID-JCB90>3.0.CO;2-#; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Carrard G, 2002, INT J BIOCHEM CELL B, V34, P1461, DOI 10.1016/S1357-2725(02)00085-7; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Cheng ZL, 2010, BIOSCIENCE REP, V30, P201, DOI 10.1042/BSR20090158; Choi SI, 2013, J PINEAL RES, V54, P361, DOI 10.1111/jpi.12039; Choi SI, 2012, AUTOPHAGY, V8, P1782, DOI 10.4161/auto.22067; Choi SI, 2011, INVEST OPHTH VIS SCI, V52, P3293, DOI 10.1167/iovs.10-6405; Choi SI, 2009, AM J PATHOL, V175, P248, DOI 10.2353/ajpath.2009.081001; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Dieudonne SC, 2000, J CELL BIOCHEM, V76, P231, DOI 10.1002/(SICI)1097-4644(20000201)76:2<231::AID-JCB7>3.0.CO;2-X; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Fabbri M, 2005, MOL BIOL CELL, V16, P5793, DOI 10.1091/mbc.E05-05-0413; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Friguet B, 2000, ANN NY ACAD SCI, V908, P143; Galvez BG, 2004, MOL BIOL CELL, V15, P678, DOI 10.1091/mbc.E03-07-0516; GODYNA S, 1995, J CELL BIOL, V129, P1403, DOI 10.1083/jcb.129.5.1403; GRIFFITHS G, 1983, J CELL BIOL, V96, P835, DOI 10.1083/jcb.96.3.835; Hicke L, 1996, CELL, V84, P277, DOI 10.1016/S0092-8674(00)80982-4; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; HU DD, 1995, J BIOL CHEM, V270, P26232, DOI 10.1074/jbc.270.44.26232; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jester JV, 2003, INVEST OPHTH VIS SCI, V44, P1850, DOI 10.1167/iovs.02-0973; Johnson MS, 2009, BBA-BIOMEMBRANES, V1788, P779, DOI 10.1016/j.bbamem.2008.12.013; Jurkunas UV, 2009, INVEST OPHTH VIS SCI, V50, P1129, DOI 10.1167/iovs.08-2525; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Keller JN, 2000, MECH AGEING DEV, V113, P61, DOI 10.1016/S0047-6374(99)00101-3; Kim BH, 2005, NEUROREPORT, V16, P425, DOI 10.1097/00001756-200504040-00002; Kim BY, 2009, J BIOL CHEM, V284, P19580, DOI 10.1074/jbc.M109.013607; Kim JE, 2000, J CELL BIOCHEM, V77, P169, DOI 10.1002/(SICI)1097-4644(20000501)77:2<169::AID-JCB1>3.0.CO;2-L; Kim JE, 2000, J BIOL CHEM, V275, P30907, DOI 10.1074/jbc.M002752200; Kim JE, 2002, J BIOL CHEM, V277, P46159, DOI 10.1074/jbc.M207055200; Kim TI, 2011, AM J PATHOL, V179, P684, DOI 10.1016/j.ajpath.2011.04.005; Klintworth GK, 1999, AM J OPHTHALMOL, V128, P747, DOI 10.1016/S0002-9394(99)00358-X; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Kurban G, 2006, CANCER RES, V66, P1313, DOI 10.1158/0008-5472.CAN-05-2560; Le PU, 2003, J CELL SCI, V116, P1059, DOI 10.1242/jcs.00327; LEBARON RG, 1995, J INVEST DERMATOL, V104, P844, DOI 10.1111/1523-1747.ep12607024; Lim JS, 2010, AGING CELL, V9, P243, DOI 10.1111/j.1474-9726.2010.00554.x; Liotta LA, 2001, NATURE, V411, P375, DOI 10.1038/35077241; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; Marchina E, 1996, INT J BIOCHEM CELL B, V28, P1141, DOI 10.1016/1357-2725(96)00055-6; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Memmo LM, 1998, J CELL SCI, V111, P425; Munier FL, 1997, NAT GENET, V15, P247, DOI 10.1038/ng0397-247; Munier FL, 2002, INVEST OPHTH VIS SCI, V43, P949; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; Mutsaers SE, 1997, INT J BIOCHEM CELL B, V29, P5, DOI 10.1016/S1357-2725(96)00115-X; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nishimura T, 2007, DEV CELL, V13, P15, DOI 10.1016/j.devcel.2007.05.003; Park SW, 2004, EXP MOL MED, V36, P211, DOI 10.1038/emm.2004.29; Park WY, 2000, J BIOL CHEM, V275, P20847, DOI 10.1074/jbc.M908162199; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Pellinen T, 2006, J CELL SCI, V119, P3723, DOI 10.1242/jcs.03216; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Poole AR, 2003, BIOCHEM SOC SYMP, V70, P115, DOI 10.1042/bss0700115; RAUB TJ, 1989, EXP CELL RES, V184, P407, DOI 10.1016/0014-4827(89)90340-6; Rawe IM, 1997, INVEST OPHTH VIS SCI, V38, P893; Runager K, 2008, EXP EYE RES, V87, P298, DOI 10.1016/j.exer.2007.12.001; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Shang F, 2004, EXP EYE RES, V78, P1, DOI 10.1016/j.exer.2003.10.003; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Shi F, 2008, J CELL SCI, V121, P2360, DOI 10.1242/jcs.014977; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simon KO, 1997, J BIOL CHEM, V272, P29380, DOI 10.1074/jbc.272.46.29380; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SKONIER J, 1994, DNA CELL BIOL, V13, P571, DOI 10.1089/dna.1994.13.571; SKONIER J, 1992, DNA CELL BIOL, V11, P511, DOI 10.1089/dna.1992.11.511; Son HN, 2013, BBA-MOL CELL RES, V1833, P2378, DOI 10.1016/j.bbamcr.2013.06.012; TARTAKOFF AM, 1983, CELL, V32, P1026, DOI 10.1016/0092-8674(83)90286-6; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; Tumbarello DA, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-36; VANAMERSFOORT ES, 1994, CYTOMETRY, V17, P294, DOI 10.1002/cyto.990170404; VanNhieu GT, 1996, J BIOL CHEM, V271, P7665, DOI 10.1074/jbc.271.13.7665; Vu TH, 1998, CELL, V93, P411, DOI 10.1016/S0092-8674(00)81169-1; Wheaton K, 2001, J CELL PHYSIOL, V187, P226, DOI 10.1002/jcp.1071; Wienke D, 2003, MOL BIOL CELL, V14, P3592, DOI 10.1091/mbc.E02-12-0814; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yu AX, 2001, J BIOL CHEM, V276, P381, DOI 10.1074/jbc.M007991200; Yuan C, 2004, MOL VIS, V10, P351; Zamilpa R, 2009, MATRIX BIOL, V28, P347, DOI 10.1016/j.matbio.2009.05.004; Zhang AY, 2006, HYPERTENSION, V47, P74, DOI 10.1161/01.HYP.0000196727.53300.62	89	24	24	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0119561	10.1371/journal.pone.0119561	http://dx.doi.org/10.1371/journal.pone.0119561			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853243	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400004
J	Eberlein, U; Peper, M; Fernandez, M; Lassmann, M; Scherthan, H				Eberlein, Uta; Peper, Michel; Fernandez, Maria; Lassmann, Michael; Scherthan, Harry			Calibration of the gamma-H2AX DNA Double Strand Break Focus Assay for Internal Radiation Exposure of Blood Lymphocytes	PLOS ONE			English	Article							IN-VIVO FORMATION; RADIOIODINE THERAPY; DOSE-RESPONSE; 53BP1; REPAIR; DAMAGE; DOSIMETRY; PHOSPHORYLATION; ACCUMULATION; IRRADIATION	DNA double strand break (DSB) formation induced by ionizing radiation exposure is indicated by the DSB biomarkers gamma-H2AX and 53BP1. Knowledge about DSB foci formation in-vitro after internal irradiation of whole blood samples with radionuclides in solution will help us to gain detailed insights about dose-response relationships in patients after molecular radiotherapy (MRT). Therefore, we studied the induction of radiation-induced co-localizing gamma-H2AX and 53BP1 foci as surrogate markers for DSBs in-vitro, and correlated the obtained foci per cell values with the in-vitro absorbed doses to the blood for the two most frequently used radionuclides in MRT (I-131 and Lu-177). This approach led to an in-vitro calibration curve. Overall, 55 blood samples of three healthy volunteers were analyzed. For each experiment several vials containing a mixture of whole blood and radioactive solutions with different concentrations of isotonic NaCl-diluted radionuclides with known activities were prepared. Leukocytes were recovered by density centrifugation after incubation and constant blending for 1 h at 37 degrees C. After ethanol fixation they were subjected to two-color immunofluorescence staining and the average frequencies of the co-localizing gamma-H2AX and 53BP1 foci/nucleus were determined using a fluorescence microscope equipped with a red/green double band pass filter. The exact activity was determined in parallel in each blood sample by calibrated germanium detector measurements. The absorbed dose rates to the blood per nuclear disintegrations occurring in 1 ml of blood were calculated for both isotopes by a Monte Carlo simulation. The measured blood doses in our samples ranged from 6 to 95 mGy. A linear relationship was found between the number of DSB-marking foci/nucleus and the absorbed dose to the blood for both radionuclides studied. There were only minor nuclide-specific intra-and inter-subject deviations.	[Eberlein, Uta; Fernandez, Maria; Lassmann, Michael] Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany; [Peper, Michel; Scherthan, Harry] Univ Ulm, Bundeswehr Inst Radiobiol, Munich, Germany	University of Wurzburg; Ulm University	Eberlein, U (corresponding author), Univ Wurzburg, Dept Nucl Med, D-97070 Wurzburg, Germany.	eberlein_u@ukw.de	Lassmann, Michael/D-6809-2019	Lassmann, Michael/0000-0002-2556-1977	Deutsche Forschungsgemeinschaft (DFG) [LA 2304/3-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG), grant number LA 2304/3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson L, 2001, MOL CELL BIOL, V21, P1719, DOI 10.1128/MCB.21.5.1719-1729.2001; Beels L, 2012, EUR J RADIOL, V81, P1495, DOI 10.1016/j.ejrad.2011.04.063; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Doai M, 2013, ANN NUCL MED, V27, P233, DOI 10.1007/s12149-012-0678-0; Eberlein U, 2014, EUR J NUCL MED MOL I, V41, pS284; Eberlein U, 2013, EUR J NUCL MED MOL I, V40, pS160; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Golfier S, 2009, RADIAT PROT DOSIM, V134, P55, DOI 10.1093/rpd/ncp061; Hanscheid H, 2014, PHYS MED BIOL, V59, P1515, DOI 10.1088/0031-9155/59/6/1515; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Krawczyk PM, 2012, J CELL SCI, V125, P2127, DOI 10.1242/jcs.089847; Kuo LJ, 2008, IN VIVO, V22, P305; Laboratoire National Henri Becquerel, 2014, LABORATOIRE NATIONAL; Lamkowski A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087458; Lassmann M, 2015, CURR RADIOPHARM, V8, P139, DOI 10.2174/1874471008666150313104212; Lassmann M, 2010, J NUCL MED, V51, P1318, DOI 10.2967/jnumed.109.071357; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; May MS, 2012, EUR J NUCL MED MOL I, V39, P1712, DOI 10.1007/s00259-012-2201-1; National Institute of Standards and Technology (NIST)., 2014, COMPOSITIONS OF MATE; Panier S, 2014, NAT REV MOL CELL BIO, V15, P7, DOI 10.1038/nrm3719; Pelowitz DB, 2011, REPORT NO LA UR 11 0; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rothkamm K, 2013, RADIAT RES, V180, P149, DOI 10.1667/RR3238.1; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Scherthan H, 2008, BIOCHEM BIOPH RES CO, V371, P694, DOI 10.1016/j.bbrc.2008.04.127; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Takahashi A, 2005, CANCER LETT, V229, P171, DOI 10.1016/j.canlet.2005.07.016; Vandevoorde C, 2015, EUR RADIOL, V25, P800, DOI 10.1007/s00330-014-3463-8; Ward IM, 2003, J BIOL CHEM, V278, P19579, DOI 10.1074/jbc.C300117200	38	34	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123174	10.1371/journal.pone.0123174	http://dx.doi.org/10.1371/journal.pone.0123174			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853575	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400097
J	Jensen, RH; Mollerup, S; Mourier, T; Hansen, TA; Fridholm, H; Nielsen, LP; Willerslev, E; Hansen, AJ; Vinner, L				Jensen, Randi Holm; Mollerup, Sarah; Mourier, Tobias; Hansen, Thomas Arn; Fridholm, Helena; Nielsen, Lars Peter; Willerslev, Eske; Hansen, Anders Johannes; Vinner, Lasse			Target-Dependent Enrichment of Virions Determines the Reduction of High-Throughput Sequencing in Virus Discovery	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS DNA; IDENTIFICATION; INFECTION; AMPLIFICATION; CORONAVIRUS; CASKI	Viral infections cause many different diseases stemming both from well-characterized viral pathogens but also from emerging viruses, and the search for novel viruses continues to be of great importance. High-throughput sequencing is an important technology for this purpose. However, viral nucleic acids often constitute a minute proportion of the total genetic material in a sample from infected tissue. Techniques to enrich viral targets in high-throughput sequencing have been reported, but the sensitivity of such methods is not well established. This study compares different library preparation techniques targeting both DNA and RNA with and without virion enrichment. By optimizing the selection of intact virus particles, both by physical and enzymatic approaches, we assessed the effectiveness of the specific enrichment of viral sequences as compared to non-enriched sample preparations by selectively looking for and counting read sequences obtained from shotgun sequencing. Using shotgun sequencing of total DNA or RNA, viral targets were detected at concentrations corresponding to the predicted level, providing a foundation for estimating the effectiveness of virion enrichment. Virion enrichment typically produced a 1000-fold increase in the proportion of DNA virus sequences. For RNA virions the gain was less pronounced with a maximum 13-fold increase. This enrichment varied between the different sample concentrations, with no clear trend. Despite that less sequencing was required to identify target sequences, it was not evident from our data that a lower detection level was achieved by virion enrichment compared to shotgun sequencing.	[Jensen, Randi Holm; Mollerup, Sarah; Mourier, Tobias; Hansen, Thomas Arn; Fridholm, Helena; Willerslev, Eske; Hansen, Anders Johannes; Vinner, Lasse] Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark; [Nielsen, Lars Peter] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	University of Copenhagen; Statens Serum Institut	Jensen, RH (corresponding author), Univ Copenhagen, Nat Hist Museum, Ctr GeoGenet, Copenhagen, Denmark.	randi.jensen@snm.ku.dk	Willerslev, Eske/AAA-5686-2019; Hansen, Anders Johannes/A-5608-2013; Willerslev, Eske/A-9619-2011	Hansen, Anders Johannes/0000-0002-1890-2702; Willerslev, Eske/0000-0002-7081-6748; Mollerup, Sarah/0000-0003-2429-4018; Vinner, Lasse/0000-0002-3081-3702	Danish National Advanced Technology foundation - The GenomeDenmark platform [019-2011-2]	Danish National Advanced Technology foundation - The GenomeDenmark platform	This work was supported by the Danish National Advanced Technology foundation - The GenomeDenmark platform, grant no. 019-2011-2 (http://hoejteknologifonden.dk).	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; Bexfield N, 2011, VET J, V190, P191, DOI 10.1016/j.tvjl.2010.10.014; Chan JFW, 2013, J FORMOS MED ASSOC, V112, P372, DOI 10.1016/j.jfma.2013.05.010; Chandriani S, 2013, P NATL ACAD SCI USA, V110, pE1407, DOI 10.1073/pnas.1219217110; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Cheval J, 2011, J CLIN MICROBIOL, V49, P3268, DOI 10.1128/JCM.00850-11; Culley AI, 2003, NATURE, V424, P1054, DOI 10.1038/nature01886; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Delwart E, 2012, CURR OPIN VIROL, V2, P344, DOI 10.1016/j.coviro.2012.02.012; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Erlandsson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022631; FOLKS TM, 1986, J EXP MED, V164, P280, DOI 10.1084/jem.164.1.280; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; GENDELMAN HE, 1987, VIROLOGY, V160, P323, DOI 10.1016/0042-6822(87)90002-X; Geng HY, 2013, SCI CHINA LIFE SCI, V56, P683, DOI 10.1007/s11427-013-4519-8; Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924; Greninger AL, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-82; Gullapalli Rama R, 2012, J Pathol Inform, V3, P40, DOI 10.4103/2153-3539.103013; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hu Y, 2005, J VIROL METHODS, V127, P80, DOI 10.1016/j.jviromet.2005.02.016; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005; Kapoor A, 2013, MBIO, V4, DOI 10.1128/mBio.00216-13; Kapoor A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011948; Kircher M, 2011, NUCLEIC ACIDS RES, V40, P1; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; LIZARD G, 1993, J IMMUNOL METHODS, V157, P31, DOI 10.1016/0022-1759(93)90067-H; Malboeuf CM, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks794; McClenahan SD, 2014, BIOLOGICALS, V42, P34, DOI 10.1016/j.biologicals.2013.11.002; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Meissner JD, 1999, J GEN VIROL, V80, P1725, DOI 10.1099/0022-1317-80-7-1725; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Moore RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019838; Palacios G, 2008, NEW ENGL J MED, V358, P991, DOI 10.1056/NEJMoa073785; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Phan TG, 2012, J VIROL, V86, P11024, DOI 10.1128/JVI.01427-12; RADECKE F, 1995, EMBO J, V14, P5773, DOI 10.1002/j.1460-2075.1995.tb00266.x; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Vinner L, 2014, INVESTIGATION OF HUM; Virgin HW, 2014, CELL, V157, P142, DOI 10.1016/j.cell.2014.02.032; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Xu BL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002369; zur Hausen H, 2009, VIROLOGY, V392, P1, DOI 10.1016/j.virol.2009.06.001; zur Hausen H, 2009, INT J CANCER, V125, P1764, DOI 10.1002/ijc.24365	51	25	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122636	10.1371/journal.pone.0122636	http://dx.doi.org/10.1371/journal.pone.0122636			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853649	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400071
J	Benchimol, EI; Manuel, DG; To, T; Mack, DR; Nguyen, GC; Gommerman, JL; Croitoru, K; Mojaverian, N; Wang, X; Quach, P; Guttmann, A				Benchimol, Eric I.; Manuel, Douglas G.; To, Teresa; Mack, David R.; Nguyen, Geoffrey C.; Gommerman, Jennifer L.; Croitoru, Kenneth; Mojaverian, Nassim; Wang, Xuesong; Quach, Pauline; Guttmann, Astrid			Asthma, Type 1 and Type 2 Diabetes Mellitus, and Inflammatory Bowel Disease amongst South Asian Immigrants to Canada and Their Children: A Population-Based Cohort Study	PLOS ONE			English	Article							ADMINISTRATIVE DATA ALGORITHM; ULCERATIVE-COLITIS; BRITISH-COLUMBIA; PREVALENCE; ONTARIO; RISK; LEICESTERSHIRE; VALIDATION; WHITE; UK	BACKGROUND There is a high and rising rate of immune-mediated diseases in the Western world. Immigrants from South Asia have been reported to be at higher risk upon arrival to the West. We determined the risk of immune-mediated diseases in South Asian and other immigrants to Ontario, Canada, and their Ontario-born children. METHODS Population-based cohorts of patients with asthma, type 1 diabetes (T1DM), type 2 diabetes (T2DM), and inflammatory bowel disease (IBD) were derived from health administrative data. We determined the standardized incidence, and the adjusted risk of these diseases in immigrants from South Asia, immigrants from other regions, compared with non-immigrant residents of Ontario. The risk of these diseases in the Ontario-born children of immigrants were compared to the children of non-immigrants. RESULTS Compared to non-immigrants, adults from South Asia had higher risk of asthma (IRR 1.56, 95%CI 1.51-1.61) and T2DM (IRR 2.59, 95%CI 2.53-2.65). Adults from South Asia had lower incidence of IBD than non-immigrants (IRR 0.32, 95%CI 0.22-0.49), as did immigrants from other regions (IRR 0.29, 95%CI 0.20-0.42). Compared to non-immigrant children, the incidence of asthma (IRR 0.66, 95%CI 0.62-0.71) and IBD (IRR 0.47, 95%CI 0.33-0.67) was low amongst immigrant children from South Asia. However, the risk in Ontario-born children of South Asian immigrants relative to the children of non-immigrants was higher for asthma (IRR 1.75, 95%CI 1.69-1.81) and less attenuated for IBD (IRR 0.90, 95%CI 0.65-1.22). CONCLUSION Early-life environmental exposures may trigger a genetic predisposition to the development of asthma and IBD in South Asian immigrants and their Canada-born children.	[Benchimol, Eric I.; Mack, David R.; Quach, Pauline] Childrens Hosp Eastern Ontario, Ctr Inflammatory Bowel Dis, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada; [Benchimol, Eric I.; Mack, David R.] Univ Ottawa, Dept Pediat, Ottawa, ON K1N 6N5, Canada; [Benchimol, Eric I.] Univ Ottawa, Sch Epidemiol Publ Hlth & Preventat Med, Ottawa, ON K1N 6N5, Canada; [Manuel, Douglas G.] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Benchimol, Eric I.; Manuel, Douglas G.; Nguyen, Geoffrey C.; Mojaverian, Nassim; Wang, Xuesong; Quach, Pauline; Guttmann, Astrid] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Manuel, Douglas G.] Ottawa Hosp Res Inst, Ottawa, ON, Canada; [To, Teresa] Hosp Sick Children, Res Inst, Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Guttmann, Astrid] Hosp Sick Children, Div Pediat Med, Toronto, ON M5G 1X8, Canada; [Nguyen, Geoffrey C.; Croitoru, Kenneth] Mt Sinai Ctr Inflammatory Bowel Dis, Toronto, ON, Canada; [To, Teresa] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Nguyen, Geoffrey C.; Croitoru, Kenneth] Univ Toronto, Dept Med, Toronto, ON, Canada; [To, Teresa; Gommerman, Jennifer L.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Nguyen, Geoffrey C.; Guttmann, Astrid] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Guttmann, Astrid] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A1, Canada	University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Benchimol, EI (corresponding author), Childrens Hosp Eastern Ontario, Ctr Inflammatory Bowel Dis, Div Gastroenterol Hepatol & Nutr, Ottawa, ON K1H 8L1, Canada.	ebenchimol@cheo.on.ca	Croitoru, Kenneth/C-4604-2015; Benchimol, Eric Ian/A-7711-2010; Nguyen, Geoffrey C/C-4614-2015; Manuel, Doug/D-7100-2014	Croitoru, Kenneth/0000-0003-1231-0180; Benchimol, Eric Ian/0000-0001-8855-3598; Nguyen, Geoffrey C/0000-0001-7083-7429; Manuel, Doug/0000-0003-0912-0845; Gommerman, Jennifer/0000-0003-4576-6168	Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund; Faculty of Medicine, University of Toronto	Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund; Faculty of Medicine, University of Toronto(University of Toronto)	Funding from: (1) Ontario Ministry of Health and Long-Term Care Academic Health Sciences Centre Alternate Funding Plan Innovation Fund. The funders had no role in the study design or conduct, interpretation of the results, or authorship of the manuscript. Researchers were considered independent from the funders. (2) Faculty of Medicine, University of Toronto. The funders had no role in the study design or conduct, interpretation of the results, or authorship of the manuscript. Researchers were considered independent from the funders.	Agrawal S, 2013, INT J TUBERC LUNG D, V17, P275, DOI 10.5588/ijtld.12.0438; Amed S, 2010, DIABETES CARE, V33, P786, DOI 10.2337/dc09-1013; [Anonymous], 2013, WORLD BANK COUNTR LE; Aujnarain Amiirah, 2013, Curr Gastroenterol Rep, V15, P326, DOI 10.1007/s11894-013-0326-4; Barreiro-de Acosta M, 2011, J CROHNS COLITIS, V5, P566, DOI 10.1016/j.crohns.2011.05.009; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Benchimol EI, 2014, J CLIN EPIDEMIOL, V67, P887, DOI 10.1016/j.jclinepi.2014.02.019; Carlsson AC, 2013, DIABETES RES CLIN PR, V100, P404, DOI 10.1016/j.diabres.2013.03.014; Carr I, 1999, AM J GASTROENTEROL, V94, P2918, DOI 10.1016/S0002-9270(99)00494-3; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Creatore MI, 2010, CAN MED ASSOC J, V182, P781, DOI 10.1503/cmaj.091551; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; GUJRAL JS, 1994, DIABETIC MED, V11, P570, DOI 10.1111/j.1464-5491.1994.tb02037.x; Guttmann A, 2010, PEDIATR DIABETES, V11, P122, DOI 10.1111/j.1399-5448.2009.00539.x; HAWTHORNE K, 1993, DIABETIC MED, V10, P8, DOI 10.1111/j.1464-5491.1993.tb01989.x; Huang YJ, 2013, CURR ALLERGY ASTHM R, V13, P453, DOI 10.1007/s11882-013-0355-y; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Mangat BK, 2011, CAN J GASTROENTEROL, V25, P73, DOI 10.1155/2011/640920; McDonald JT, 2004, SOC SCI MED, V59, P1613, DOI 10.1016/j.socscimed.2004.02.004; Milan A., 2010, PORTRAIT COUPLES MIX; PARTRIDGE MR, 1979, CLIN ALLERGY, V9, P489, DOI 10.1111/j.1365-2222.1979.tb02513.x; Penno MAS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-124; Pinsk V, 2007, AM J GASTROENTEROL, V102, P1077, DOI 10.1111/j.1572-0241.2007.01124.x; Ranasinghe P, 2013, J DIABETES, V5, P34, DOI 10.1111/1753-0407.12003; Raymond NT, 2001, DIABETOLOGIA, V44, pB32, DOI 10.1007/PL00002951; Sood A, 2003, GUT, V52, P1587, DOI 10.1136/gut.52.11.1587; Statistics Canada, POP DWELL COUNTS CAN; Subbarao P, 2009, CAN MED ASSOC J, V181, pE181, DOI 10.1503/cmaj.080612; To T, 2006, PEDIAT ALLERG IMM-UK, V17, P69, DOI 10.1111/j.1399-3038.2005.00346.x; Tsironi E, 2004, AM J GASTROENTEROL, V99, P1749, DOI 10.1111/j.1572-0241.2004.30445.x; Wandell PE, 2010, CURR DIABETES REV, V6, P126, DOI 10.2174/157339910790909404	31	36	36	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123599	10.1371/journal.pone.0123599	http://dx.doi.org/10.1371/journal.pone.0123599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849480	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800244
J	Freund, Y; Bloom, B; Bokobza, J; Baarir, N; Laribi, S; Harris, T; Navarro, V; Bernard, M; Pearse, R; Riou, B; Hausfater, P				Freund, Yonathan; Bloom, Benjamin; Bokobza, Jerome; Baarir, Nacera; Laribi, Said; Harris, Tim; Navarro, Vincent; Bernard, Maguy; Pearse, Rupert; Riou, Bruno; Hausfater, Pierre		BISTRO Investigators	Predictive Value of S100-B and Copeptin for Outcomes following Seizure: The BISTRO International Cohort Study	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT; EARLY EPILEPSY; BRAIN-DAMAGE; PROTEIN; RECURRENCE; MANAGEMENT; MARKER; RISK; ILAE; EPIDEMIOLOGY	Objective To evaluate the performance of S100-B protein and copeptin, in addition to clinical variables, in predicting outcomes of patients attending the emergency department (ED) following a seizure. Methods We prospectively included adult patients presented with an acute seizure, in four EDs in France and the United Kingdom. Participants were followed up for 28 days. The primary endpoint was a composite of seizure recurrence, all-cause mortality, hospitalization or rehospitalisation, or return visit in the ED within seven days. Results Among the 389 participants included in the analysis, 156 (40%) experienced the primary endpoint within seven days and 195 (54%) at 28 days. Mean levels of both S100-B (0.11 mu g/l [95% CI 0.07-0.20] vs 0.09 mu g/l [0.07-0.14]) and copeptin (23 pmol/l [9-104] vs 17 pmol/l [84-3]) were higher in participants meeting the primary endpoint. However, both biomarkers were poorly predictive of the primary outcome with a respective area under the receiving operator characteristic curve of 0.57 [0.51-0.64] and 0.59 [0.54-0.64]. Multivariable logistic regression analysis identified higher age (odds ratio [OR] 1.3 per decade [1.1-1.5]), provoked seizure (OR 4.93 [2.5-9.8]), complex partial seizure (OR 4.09 [1.8-9.1]) and first seizure (OR 1.83 [1.1-3.0]) as independent predictors of the primary outcome. A second regression analysis including the biomarkers showed no additional predictive benefit (S100-B OR 3.89 [0.80-18.9] copeptin OR 1 [1.00-1.00]). Conclusion The plasma biomarkers S100-B and copeptin did not improve prediction of poor outcome following seizure. Higher age, a first seizure, a provoked seizure and a partial complex seizure are independently associated with adverse outcomes.	[Freund, Yonathan; Riou, Bruno; Hausfater, Pierre] Univ Paris 06, Sorbonne Univ, UMRS INSERM 1166, IHU ICAN, Paris, France; [Freund, Yonathan; Bokobza, Jerome; Riou, Bruno; Hausfater, Pierre] Hop La Pitie Salpetriere, AP HP, Emergency Dept, Paris, France; [Bloom, Benjamin; Harris, Tim] Royal London Hosp, Emergency Dept, London E1 1BB, England; [Baarir, Nacera] Hop Tenon, AP HP, Emergency Dept, F-75970 Paris, France; [Laribi, Said] Hop Lariboisiere, AP HP, Emergency Dept, F-75475 Paris, France; [Navarro, Vincent] Hop La Pitie Salpetriere, AP HP, Dept Neurol, Paris, France; [Bernard, Maguy] Hop La Pitie Salpetriere, AP HP, Dept Biochem, Paris, France; [Pearse, Rupert] Royal London Hosp, Adult Crit Care Unit, London E1 1BB, England; [Bernard, Maguy] Univ Paris 5 Paris Cite, Paris, France; [Bloom, Benjamin; Pearse, Rupert] Queen Mary Univ London, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Barts Health NHS Trust; Royal London Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Barts Health NHS Trust; Royal London Hospital; UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London	Freund, Y (corresponding author), Univ Paris 06, Sorbonne Univ, UMRS INSERM 1166, IHU ICAN, Paris, France.	yonathanfreund@gmail.com	Laribi, Said/S-3693-2016; bokobza, jerome/AAC-9671-2020; Pearse, Rupert/H-5426-2011	Laribi, Said/0000-0003-4648-4672; Pearse, Rupert/0000-0002-4373-5934; Bloom, Ben/0000-0002-3016-4925; Freund, Yonathan/0000-0002-0262-3848	ThermoFisher BRAHMS; French society of emergency medicine (SFMU); Assistance Publique-Hopitaux de Paris; National Institute for Health Research [RP_2014-04-022, CS/08/08/17] Funding Source: researchfish	ThermoFisher BRAHMS; French society of emergency medicine (SFMU); Assistance Publique-Hopitaux de Paris; National Institute for Health Research(National Institute for Health Research (NIHR))	Roche Diagnostics France (Meylan, France) provided free reagents and kits for S100B assays, and Thermo Fisher scientific B.R.A.H.M.S (Aktiengesellschaft, Hennigsdorf, Germany) provided free reagents and kits for copeptin assays. ThermoFisher BRAHMS provided the copeptin assays free of charge, and funded our biochemistry technicians' time of work in order to process all the analysis. Roche diagnostic provided the S100B assays free of charge. The corresponding author had full access to all the data in the study and final responsibility for the decision to submit for publication. Yonathan Freund received a grant from the French society of emergency medicine (SFMU) and from the Assistance Publique-Hopitaux de Paris for this study. The funders had no role in the study design, data collection, analysis, and interpretation, or the writing of the report.	Atici Y, 2012, SEIZURE-EUR J EPILEP, V21, P175, DOI 10.1016/j.seizure.2011.11.003; BERG AT, 1991, NEUROLOGY, V41, P965, DOI 10.1212/WNL.41.7.965; Bottiger BW, 2001, CIRCULATION, V103, P2694; Breen DP, 2005, POSTGRAD MED J, V81, P715, DOI 10.1136/pgmj.2004.031203; Brown JWL, 2014, J NEUROL NEUROSUR PS, V2013; Choquet C, 2008, EUR J EMERG MED, V15, P261, DOI 10.1097/MEJ.0b013e3282fce63d; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Dong XQ, 2011, J TRAUMA, V71, P1194, DOI 10.1097/TA.0b013e31821283f2; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Fisher RS, 2014, EPILEPSIA, V55, P475, DOI 10.1111/epi.12550; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gabayan GZ, 2013, ANN EMERG MED, V62, P136, DOI 10.1016/j.annemergmed.2013.01.017; Holland P, 2009, EPILEPSIA, V50, P1030, DOI 10.1111/j.1528-1167.2008.01819.x; Huff JS, 2014, ANN EMERG MED, V63, P437, DOI 10.1016/j.annemergmed.2014.01.018; Huff JS, 2001, ACAD EMERG MED, V8, P622, DOI 10.1111/j.1553-2712.2001.tb00175.x; Katan M, 2009, ANN NEUROL, V66, P799, DOI 10.1002/ana.21783; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; KRUMHOLZ A, 1989, EPILEPSIA, V30, P175, DOI 10.1111/j.1528-1157.1989.tb05451.x; Lawn N, 2014, EPILEPSY BEHAV, V33, P122, DOI 10.1016/j.yebeh.2014.02.008; Marinas A, 2011, EPILEPSY BEHAV, V21, P223, DOI 10.1016/j.yebeh.2011.01.025; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Mercier E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1757; Mikkonen K, 2012, SEIZURE-EUR J EPILEP, V21, P144, DOI 10.1016/j.seizure.2011.10.006; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Pallin DJ, 2008, INT J EMERG MED, V1, P97, DOI 10.1007/s12245-008-0024-4; Panayiotopoulos CP, 2012, EPILEPSIA, V53, P399, DOI 10.1111/j.1528-1167.2011.03381.x; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; RATHLEV NK, 1994, ANN EMERG MED, V23, P513, DOI 10.1016/S0196-0644(94)70070-2; Sauvin G, 2013, ACAD EMERG MED, V20, P33, DOI 10.1111/acem.12052; Song KJ, 2010, RESUSCITATION, V81, P337, DOI 10.1016/j.resuscitation.2009.10.012; Sun GW, 1996, J CLIN EPIDEMIOL, V49, P907, DOI 10.1016/0895-4356(96)00025-X; TARDY B, 1995, AM J EMERG MED, V13, P1, DOI 10.1016/0735-6757(95)90229-5; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027; Zweifel C, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-34	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122405	10.1371/journal.pone.0122405	http://dx.doi.org/10.1371/journal.pone.0122405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849778	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800128
J	Hildebrand, A; Kasuga, T; Fan, ZL				Hildebrand, Amanda; Kasuga, Takao; Fan, Zhiliang			Production of Cellobionate from Cellulose Using an Engineered Neurospora crassa Strain with Laccase and Redox Mediator Addition	PLOS ONE			English	Article							LACTOBIONIC ACID PRODUCTION; PAPER PULP; DEHYDROGENASE; PURIFICATION; WHEY; EXPRESSION; INDUCTION; COPPER	We report a novel production process for cellobionic acid from cellulose using an engineered fungal strain with the exogenous addition of laccase and a redox mediator. A previously engineered strain of Neurospora crassa (F5 Delta ace-1 Delta cre-1 Delta ndvB) was shown to produce cellobionate directly from cellulose without the addition of exogenous cellulases. Specifically, N. crassa produces cellulases, which hydrolyze cellulose to cellobiose, and cellobiose dehydrogenase (CDH), which oxidizes cellobiose to cellobionate. However, the conversion of cellobiose to cellobionate is limited by the slow re-oxidation of CDH by molecular oxygen. By adding low concentrations of laccase and a redox mediator to the fermentation, CDH can be efficiently oxidized by the redox mediator, with in-situ re-oxidation of the redox mediator by laccase. The conversion of cellulose to cellobionate was optimized by evaluating pH, buffer, and laccase and redox mediator addition time on the yield of cellobionate. Mass and material balances were performed, and the use of the native N. crassa laccase in such a conversion system was evaluated against the exogenous Pleurotus ostreatus laccase. This paper describes a working concept of cellobionate production from cellulose using the CDH-ATBS-laccase system in a fermentation system.	[Hildebrand, Amanda; Fan, Zhiliang] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Kasuga, Takao] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kasuga, Takao] USDA ARS, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Agriculture (USDA)	Fan, ZL (corresponding author), Univ Calif Davis, Dept Biol & Agr Engn, One Shields Ave, Davis, CA 95616 USA.	jzfan@ucdavis.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2011-67009-20060]; EPA Star fellowship; Cota-Robles fellowship; ARS [ARS-0423014] Funding Source: Federal RePORTER	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; EPA Star fellowship(United States Environmental Protection Agency); Cota-Robles fellowship; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The project was supported by the Agriculture and Food Research Initiative Competitive Grant No. 2011-67009-20060 from the USDA National Institute of Food and Agriculture. The authors also acknowledge funding support to Amanda Hildebrand from EPA Star fellowship and Cota-Robles fellowship.	Alonso S, 2013, BIOTECHNOL ADV, V31, P1275, DOI 10.1016/j.biotechadv.2013.04.010; Alonso S, 2012, BIORESOURCE TECHNOL, V109, P140, DOI 10.1016/j.biortech.2012.01.045; Alonso S, 2011, BIORESOURCE TECHNOL, V102, P9730, DOI 10.1016/j.biortech.2011.07.089; Arora DS, 2010, APPL BIOCHEM BIOTECH, V160, P1760, DOI 10.1007/s12010-009-8676-y; Baminger U, 2001, J MOL CATAL B-ENZYM, V11, P541, DOI 10.1016/S1381-1177(00)00034-5; Baminger U, 1999, J MICROBIOL METH, V35, P253, DOI 10.1016/S0167-7012(99)00022-6; BAO WJ, 1993, ARCH BIOCHEM BIOPHYS, V300, P705, DOI 10.1006/abbi.1993.1098; Camarero S, 2005, APPL ENVIRON MICROB, V71, P1775, DOI 10.1128/AEM.71.4.1775-1784.2005; Camarero S, 2007, ENZYME MICROB TECH, V40, P1264, DOI 10.1016/j.enzmictec.2006.09.016; Canas AI, 2007, ENVIRON SCI TECHNOL, V41, P2964, DOI 10.1021/es062328j; Demain AL, 2007, IND BIOTECHNOL, V3, P269, DOI DOI 10.1089/IND.2007.3.269; Fan ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031693; FROEHNER SC, 1974, J BACTERIOL, V120, P450, DOI 10.1128/JB.120.1.450-457.1974; GESSNER MO, 1991, MICROBIAL ECOL, V22, P285, DOI 10.1007/BF02540230; Gutierrez A, 2007, ENVIRON SCI TECHNOL, V41, P4124, DOI 10.1021/es062723+; Henriksson G, 2000, J BIOTECHNOL, V78, P93, DOI 10.1016/S0168-1656(00)00206-6; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; HUBER M, 1987, FEBS LETT, V219, P335, DOI 10.1016/0014-5793(87)80247-8; Jang YS, 2012, BIOTECHNOL BIOENG, V109, P2437, DOI 10.1002/bit.24599; Kunamneni A, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-32; LINDEN RM, 1991, CURR GENET, V19, P375; Luke AK, 2001, ENZYME MICROB TECH, V29, P348, DOI 10.1016/S0141-0229(01)00390-8; LYND LR, 1991, SCIENCE, V251, P1318, DOI 10.1126/science.251.4999.1318; Madhavi V, 2009, BIORESOURCES, V4, P1694; McCluskey K, 2010, J BIOSCIENCES, V35, P119, DOI 10.1007/s12038-010-0014-6; Miyamoto Y, 2000, BIOTECHNOL LETT, V22, P427, DOI 10.1023/A:1005617903152; More S.S., 2011, ENZYM RES; Murakami H., 2003, Journal of Applied Glycoscience, V50, P117; Okamoto Kenji, 2000, Mycoscience, V41, P7, DOI 10.1007/BF02464380; Roy BP, 1996, APPL ENVIRON MICROB, V62, P4417, DOI 10.1128/AEM.62.12.4417-4427.1996; Sauer M, 2008, TRENDS BIOTECHNOL, V26, P100, DOI 10.1016/j.tibtech.2007.11.006; SCHILLING B, 1992, CURR GENET, V22, P197, DOI 10.1007/BF00351726; TAMARU H, 1989, J BACTERIOL, V171, P6288, DOI 10.1128/jb.171.11.6288-6293.1989; Van Hecke W, 2009, BIOTECHNOL BIOENG, V102, P1475, DOI 10.1002/bit.22165; Wu WH, 2013, ENZYME MICROB TECH, V52, P184, DOI 10.1016/j.enzmictec.2012.12.010; Zhang RF, 2011, PROTEIN EXPRES PURIF, V75, P63, DOI 10.1016/j.pep.2010.08.003	36	11	11	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123006	10.1371/journal.pone.0123006	http://dx.doi.org/10.1371/journal.pone.0123006			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849253	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800193
J	Liu, YS; Cai, JF; Zhan, ZF; Guo, D; Ye, J; Chen, Z; Qu, XB				Liu, Yunsong; Cai, Jian-Feng; Zhan, Zhifang; Guo, Di; Ye, Jing; Chen, Zhong; Qu, Xiaobo			Balanced Sparse Model for Tight Frames in Compressed Sensing Magnetic Resonance Imaging	PLOS ONE			English	Article							RECONSTRUCTION; REPRESENTATIONS; MRI; RESTORATION; ALGORITHMS	Compressed sensing has shown to be promising to accelerate magnetic resonance imaging. In this new technology, magnetic resonance images are usually reconstructed by enforcing its sparsity in sparse image reconstruction models, including both synthesis and analysis models. The synthesis model assumes that an image is a sparse combination of atom signals while the analysis model assumes that an image is sparse after the application of an analysis operator. Balanced model is a new sparse model that bridges analysis and synthesis models by introducing a penalty term on the distance of frame coefficients to the range of the analysis operator. In this paper, we study the performance of the balanced model in tight frame based compressed sensing magnetic resonance imaging and propose a new efficient numerical algorithm to solve the optimization problem. By tuning the balancing parameter, the new model achieves solutions of three models. It is found that the balanced model has a comparable performance with the analysis model. Besides, both of them achieve better results than the synthesis model no matter what value the balancing parameter is. Experiment shows that our proposed numerical algorithm constrained split augmented Lagrangian shrinkage algorithm for balanced model (C-SALSA-B) converges faster than previously proposed algorithms accelerated proximal algorithm (APG) and alternating directional method of multipliers for balanced model (ADMM-B).	[Liu, Yunsong; Zhan, Zhifang; Ye, Jing; Chen, Zhong; Qu, Xiaobo] Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen, Peoples R China; [Cai, Jian-Feng] Univ Iowa, Dept Math, Iowa City, IA USA; [Guo, Di] Xiamen Univ Technol, Sch Comp & Informat Engn, Xiamen, Peoples R China	Xiamen University; University of Iowa; Xiamen University of Technology	Qu, XB (corresponding author), Xiamen Univ, Fujian Prov Key Lab Plasma & Magnet Resonance, Dept Elect Sci, Xiamen, Peoples R China.	quxiaobo@xmu.edu.cn	Cai, Jian-Feng/L-1808-2016; Chen, Zhong/G-4601-2010; Qu, Xiaobo/D-5017-2009; Cai, Jianfeng/AAB-9478-2019; Guo, Di/HGA-5929-2022; Liu, Yunsong/W-5029-2019	Cai, Jian-Feng/0000-0003-2571-570X; Qu, Xiaobo/0000-0002-8675-5820; chen, zhong/0000-0002-1473-2224	National Natural Science Foundation of China [61201045, 61302174, 11375147]; Fundamental Research Funds for the Central Universities [2013SH002]; Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province [54600321, 2013GDDSIPL-07]; Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology [YKJ12021R]; Simons Foundation [281384]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province; Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology; Simons Foundation	This work was partially supported by the National Natural Science Foundation of China (61201045, 61302174 and 11375147) (http://www.nsfc.gov.cn/), Fundamental Research Funds for the Central Universities (2013SH002 (http://www.moe.gov.cn/), Open Fund from Key Lab of Digital Signal and Image Processing of Guangdong Province (54600321 and 2013GDDSIPL-07)(http://imagelab.stu.edu.cn/), Scientific Research Foundation for the Introduction of Talent at Xiamen University of Technology (YKJ12021R)(http://ky.xmut.edu.cn/), and a grant from the Simons Foundation (#281384 to J.-F. Cai). (http://www.simonsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso MV, 2011, IEEE T IMAGE PROCESS, V20, P681, DOI 10.1109/TIP.2010.2076294; Baraniuk R, 1993, RICE WAVELET TOOLBOX; Beck A, 2009, SIAM J IMAGING SCI, V2, P183, DOI 10.1137/080716542; Bertsekas D., 1996, CONSTRAINED OPTIMIZA; Cai JF, 2008, SIAM J SCI COMPUT, V30, P1205, DOI 10.1137/040615298; Cai JF, 2008, APPL COMPUT HARMON A, V24, P131, DOI 10.1016/j.acha.2007.10.002; Cai JF, 2014, APPL COMPUT HARMON A, V37, P89, DOI 10.1016/j.acha.2013.10.001; Cai JF, 2010, J COMPUT MATH, V28, P289, DOI [10.4208/jcm.2009.10-m1002, 10.4208/jcm.1001-m1002]; Cai JF, 2009, MULTISCALE MODEL SIM, V8, P337, DOI 10.1137/090753504; Cai JF, 2009, ADV COMPUT MATH, V31, P87, DOI 10.1007/s10444-008-9084-5; Candes EJ, 2004, COMMUN PUR APPL MATH, V57, P219, DOI 10.1002/cpa.10116; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2003, ANN STAT, V31, P1561, DOI 10.1214/aos/1065705119; Candes EJ, 2008, CR MATH, V346, P589, DOI 10.1016/j.crma.2008.03.014; Candes EJ, 2011, APPL COMPUT HARMON A, V31, P59, DOI 10.1016/j.acha.2010.10.002; Chang HC, 2013, QUANT IMAGING MED SU, V3, P73, DOI 10.3978/j.issn.2223-4292.2013.03.05; Chen C., 2012, ADV NEURAL INFORM PR, P1124; Chen C, 2014, MED IMAGE ANAL, V18, P834, DOI 10.1016/j.media.2013.12.004; Chen HJ, 2013, QUANT IMAGING MED SU, V3, P298, DOI 10.3978/j.issn.2223-4292.2013.12.01; Combettes PL, 2005, MULTISCALE MODEL SIM, V4, P1168, DOI 10.1137/050626090; Daubechies I, 2003, APPL COMPUT HARMON A, V14, P1, DOI 10.1016/S1063-5203(02)00511-0; Do MN, 2005, IEEE T IMAGE PROCESS, V14, P2091, DOI 10.1109/TIP.2005.859376; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Elad M, 2007, INVERSE PROBL, V23, P947, DOI 10.1088/0266-5611/23/3/007; Elad M, 2006, IEEE T IMAGE PROCESS, V15, P3736, DOI 10.1109/TIP.2006.881969; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; Guerquin-Kern M, 2011, IEEE T MED IMAGING, V30, P1649, DOI 10.1109/TMI.2011.2140121; Haacke E. M., 1999, MAGNETIC RESONANCE I; Huang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079709; Huang JZ, 2011, MED IMAGE ANAL, V15, P670, DOI 10.1016/j.media.2011.06.001; Huang Y, 2013, ARXIV13022712; Kayvanrad MH, 2014, MAGNETIC RESONANCE I; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; Liang D, 2012, MAGN RESON MED, V68, P41, DOI 10.1002/mrm.23197; Lu YM, 2007, IEEE T IMAGE PROCESS, V16, P918, DOI 10.1109/TIP.2007.891785; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Ma S., 2008, P IEEE C COMP VIS PA, P1, DOI DOI 10.1109/CVPR.2008.4587391; Majumdar A, 2012, SIGNAL PROCESS-IMAGE, V27, P1035, DOI 10.1016/j.image.2012.08.002; Mallat S, 2009, APPL COMPUT HARMON A, V26, P161, DOI 10.1016/j.acha.2008.03.004; Nam S, 2013, APPL COMPUT HARMON A, V34, P30, DOI 10.1016/j.acha.2012.03.006; Pang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056098; Qu XB, 2014, MED IMAGE ANAL, V18, P843, DOI 10.1016/j.media.2013.09.007; Qu XB, 2012, MAGN RESON IMAGING, V30, P964, DOI 10.1016/j.mri.2012.02.019; Qu XB, 2010, INVERSE PROBL SCI EN, V18, P737, DOI 10.1080/17415977.2010.492509; Rauhut H, 2008, IEEE T INFORM THEORY, V54, P2210, DOI 10.1109/TIT.2008.920190; Ravishankar S, 2011, IEEE T MED IMAGING, V30, P1028, DOI 10.1109/TMI.2010.2090538; Selesnick IW, 2009, P SPIE; Shen ZW, 2011, SIAM J IMAGING SCI, V4, P573, DOI 10.1137/090779437; Vetterli M., 2014, FDN SIGNAL PROCESSIN; Winston GP, 2012, QUANT IMAGING MED SU, V2, P254, DOI 10.3978/j.issn.2223-4292.2012.12.05; Xie SL, 2012, IEEE T IMAGE PROCESS, V21, P4557, DOI 10.1109/TIP.2012.2206043; Yang JF, 2011, SIAM J SCI COMPUT, V33, P250, DOI 10.1137/090777761; Yang JF, 2010, IEEE J-STSP, V4, P288, DOI 10.1109/JSTSP.2010.2042333; Yin WT, 2008, SIAM J IMAGING SCI, V1, P143, DOI 10.1137/070703983; Zhao B, 2012, IEEE T MED IMAGING, V31, P1809, DOI 10.1109/TMI.2012.2203921; Zhu ZL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045302	58	30	32	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119584	10.1371/journal.pone.0119584	http://dx.doi.org/10.1371/journal.pone.0119584			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849209	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800013
J	Martagon, AJ; Lin, JZ; Cimini, SL; Webb, P; Phillips, KJ				Martagon, Alexandro J.; Lin, Jean Z.; Cimini, Stephanie L.; Webb, Paul; Phillips, Kevin J.			The Amelioration of Hepatic Steatosis by Thyroid Hormone Receptor Agonists Is Insufficient to Restore Insulin Sensitivity in Ob/Ob Mice	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; BETA AGONISTS; CHOLESTEROL; DISEASE; PATHOGENESIS; CONTRIBUTES; METABOLISM; RESISTANCE; IMPROVES; EXCESS	Thyroid hormone receptor (TR) agonists have been proposed as therapeutic agents to treat non-alcoholic fatty liver disease (NAFLD) and insulin resistance. We investigated the ability of the TR agonists GC-1 and KB2115 to reduce hepatic steatosis in ob/ob mice. Both compounds markedly reduced hepatic triglyceride levels and ameliorated hepatic steatosis. However, the amelioration of fatty liver was not sufficient to improve insulin sensitivity in these mice and reductions in hepatic triglycerides did not correlate with improvements in insulin sensitivity or glycemic control. Instead, the effects of TR activation on glycemia varied widely and were found to depend upon the time of treatment as well as the compound and dosage used. Lower doses of GC-1 were found to further impair glycemic control, while a higher dose of the same compound resulted in substantially improved glucose tolerance and insulin sensitivity, despite all doses being equally effective at reducing hepatic triglyceride levels. Improvements in glycemic control and insulin sensitivity were observed only in treatments that also increased body temperature, suggesting that the induction of thermogenesis may play a role in mediating these beneficial effects. These data illustrate that the relationship between TR activation and insulin sensitivity is complex and suggests that although TR agonists may have value in treating NAFLD, their effect on insulin sensitivity must also be considered.	[Martagon, Alexandro J.; Lin, Jean Z.; Cimini, Stephanie L.; Webb, Paul; Phillips, Kevin J.] Houston Methodist Res Inst, Diabet & Metab Dis Program, Houston, TX 77030 USA; [Martagon, Alexandro J.] Escuela Biotecnol Alimentos, Inst Tecnol & Estudios Superiores Monterrey, Monterrey, NL, Mexico; [Lin, Jean Z.] Univ Houston, Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; Tecnologico de Monterrey; University of Houston System; University of Houston	Phillips, KJ (corresponding author), Houston Methodist Res Inst, Diabet & Metab Dis Program, Houston, TX 77030 USA.	KPhillips@HoustonMethodist.org	Martagon, Alexandro/P-2609-2019	Martagon, Alexandro/0000-0003-2135-6295; egge, Stephanie/0000-0001-8232-0443	NIH National Institute of Diabetes and Digestive and Kidney Diseases [DK090849]; Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina [0020ENS325]; Consejo Nacional de Ciencia y Tecnologia [387520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090849] Funding Source: NIH RePORTER	NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases DK090849 (PW). A.J.M. was supported by Tecnologico de Monterrey, Direccion de Posgrado de la Escuela de Medicina (0020ENS325) and Consejo Nacional de Ciencia y Tecnologia (387520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams LA, 2005, CAN MED ASSOC J, V172, P899, DOI 10.1503/cmaj.045232; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Baxter JD, 2009, NAT REV DRUG DISCOV, V8, P308, DOI 10.1038/nrd2830; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bryzgalova G, 2008, J STEROID BIOCHEM, V111, P262, DOI 10.1016/j.jsbmb.2008.06.010; Cable EE, 2009, HEPATOLOGY, V49, P407, DOI 10.1002/hep.22572; Charlton M, 2001, LIVER TRANSPLANT, V7, P608, DOI 10.1053/jlts.2001.25453; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Contos MJ, 2001, LIVER TRANSPLANT, V7, P363, DOI 10.1053/jlts.2001.23011; DeFronzo RA, 1997, DIABETES REV, V5, P177; Dimitriadis GD, 2001, EXP CLIN ENDOCR DIAB, V109, pS225, DOI 10.1055/s-2001-18584; Erion MD, 2007, P NATL ACAD SCI USA, V104, P15490, DOI 10.1073/pnas.0702759104; Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947; Flowers JB, 2007, DIABETES, V56, P1228, DOI 10.2337/db06-1142; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hammond LE, 2005, J BIOL CHEM, V280, P25629, DOI 10.1074/jbc.M503181200; Hoppener JWM, 1999, DIABETOLOGIA, V42, P427, DOI 10.1007/s001250051175; Klieverik LP, 2009, P NATL ACAD SCI USA, V106, P5966, DOI 10.1073/pnas.0805355106; Ladenson PW, 2010, NEW ENGL J MED, V362, P906, DOI 10.1056/NEJMoa0905633; Lam BP, 2009, ANN HEPATOL, V8, pS51, DOI 10.1016/S1665-2681(19)31827-7; Lin JZ, 2012, ENDOCRINOLOGY, V153, P6136, DOI 10.1210/en.2011-2081; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MULLER MJ, 1980, LIFE SCI, V27, P827; Nedergaard J, 2011, CELL METAB, V13, P238, DOI 10.1016/j.cmet.2011.02.009; Perra A, 2008, FASEB J, V22, P2981, DOI 10.1096/fj.08-108464; Ratziu V, 2010, J HEPATOL, V53, P372, DOI 10.1016/j.jhep.2010.04.008; Rohdenburg GL, 1920, ENDOCRINOLOGY, V4, P63, DOI 10.1210/endo-4-1-63; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Schwabedissen HEMZ, 2011, HEPATOLOGY, V54, P644, DOI 10.1002/hep.24391; Skarulis MC, 2010, J CLIN ENDOCR METAB, V95, P256, DOI 10.1210/jc.2009-0543; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Sun Z, 2013, TRENDS ENDOCRIN MET, V24, P4, DOI 10.1016/j.tem.2012.09.005; Trinh KY, 1998, J BIOL CHEM, V273, P31615, DOI 10.1074/jbc.273.47.31615; Trost SU, 2000, ENDOCRINOLOGY, V141, P3057, DOI 10.1210/en.141.9.3057; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012; Visser WE, 2011, MOL ENDOCRINOL, V25, P1, DOI 10.1210/me.2010-0095; Vujovic M, 2009, ENDOCRINOLOGY, V150, P2940, DOI 10.1210/en.2008-1085; Wei YZ, 2009, AM J PATHOL, V174, P1329, DOI 10.2353/ajpath.2009.080697; Wendel AA, 2010, DIABETES, V59, P1321, DOI 10.2337/db09-1380; Yuan C, 2012, ENDOCRINOLOGY, V153, P501, DOI 10.1210/en.2011-1325	41	23	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122987	10.1371/journal.pone.0122987	http://dx.doi.org/10.1371/journal.pone.0122987			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849936	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800189
J	Mennecozzi, M; Landesmann, B; Palosaari, T; Harris, G; Whelan, M				Mennecozzi, Milena; Landesmann, Brigitte; Palosaari, Taina; Harris, Georgina; Whelan, Maurice			Sex Differences in Liver Toxicity-Do Female and Male Human Primary Hepatocytes React Differently to Toxicants In Vitro?	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ADVERSE DRUG-REACTIONS; GENDER-DIFFERENCES; GENE-EXPRESSION; AGE; DICLOFENAC; INJURY; CELL; PHARMACOKINETICS; METABOLITES	There is increasing amount of evidence for sex variation in drug efficiency and toxicity profiles. Women are more susceptible than men to acute liver injury from xenobiotics. In general, this is attributed to sex differences at a physiological level as well as differences in pharmacokinetics and pharmacodynamics, but neither of these can give a sufficient explanation for the diverse responses to xenobiotics. Existing data are mainly based on animal models and limited data exist on in vitro sex differences relevant to humans. To date, male and female human hepatocytes have not yet been compared in terms of their responses to hepatotoxic drugs. We investigated whether sex-specific differences in acute hepatotoxicity can be observed in vitro by comparing hepatotoxic drug effects in male and female primary human hepatocytes. Significant sex-related differences were found for certain parameters and individual drugs, showing an overall higher sensitivity of female primary hepatocytes to hepatotoxicants. Moreover, our work demonstrated that high content screening is feasible with pooled primary human hepatocytes in suspension.	[Mennecozzi, Milena; Landesmann, Brigitte; Palosaari, Taina; Whelan, Maurice] Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Varese, Italy; [Harris, Georgina] Johns Hopkins Sch Publ Hlth, Ctr Alternat Anim Testing, Baltimore, MD USA	European Commission Joint Research Centre; EC JRC ISPRA Site; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Landesmann, B (corresponding author), Commiss European Communities, Joint Res Ctr, Inst Hlth & Consumer Protect, I-21020 Ispra, Varese, Italy.	brigitte.landesmann@ec.europa.eu						Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; [Anonymous], 2001, GAO 01 286R; Aydin S, 2010, BIOGERONTOLOGY, V11, P335, DOI 10.1007/s10522-009-9257-8; BANKS AT, 1995, HEPATOLOGY, V22, P820, DOI 10.1016/0270-9139(95)90303-8; Beery AK, 2011, NEUROSCI BIOBEHAV R, V35, P565, DOI 10.1016/j.neubiorev.2010.07.002; Boelsterli UA, 2003, TOXICOL APPL PHARM, V192, P307, DOI 10.1016/S0041-008X(03)00368-5; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Clayton JA, 2014, NATURE, V509, P282, DOI 10.1038/509282a; Csete M, 2008, ANESTH ANALG, V107, P232, DOI 10.1213/ane.0b013e318163feaf; de Mirecki-Garrido M, 2012, PHARMACEUTICALS, V5, P758, DOI 10.3390/ph5070758; Dever JT, 2009, TOXICOL APPL PHARM, V236, P358, DOI 10.1016/j.taap.2009.02.009; Faria G, 2009, TOXICOL APPL PHARM, V234, P256, DOI 10.1016/j.taap.2008.10.012; Fattinger K, 2000, BRIT J CLIN PHARMACO, V49, P158, DOI 10.1046/j.1365-2125.2000.00132.x; Federman DD, 2006, NEW ENGL J MED, V354, P1507, DOI 10.1056/NEJMra052529; FLETCHER CV, 1994, J ADOLESCENT HEALTH, V15, P619, DOI 10.1016/S1054-139X(94)90628-9; Flynn TJ, 2010, TOXICOL LETT, V198, P232, DOI 10.1016/j.toxlet.2010.07.003; Food and Drug Administration, 1977, GUID GEN CONS CLIN E, P77; Franconi F, 2007, PHARMACOL RES, V55, P81, DOI 10.1016/j.phrs.2006.11.001; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI [10.1146/annurev.pharmtox.44.101802.121453, 10.2165/00003088-200948030-00001]; Gendered Innovations, 2019, GENDERED INNOVATIONS; Gochfeld M, 2007, ENVIRON RES, V104, P4, DOI 10.1016/j.envres.2005.12.005; Gray J, 2007, CLIN PHARMACOL THER, V82, P15, DOI 10.1038/sj.clpt.6100261; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hammes SR, 2014, MOL ENDOCRINOL, V28, P1209, DOI 10.1210/me.2014-1209; Hayden EC, 2010, NATURE, V464, P332, DOI 10.1038/464332b; Henderson VW, 2010, PROG BRAIN RES, V182, P77, DOI 10.1016/S0079-6123(10)82003-5; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Lucena MI, 2009, HEPATOLOGY, V49, P2001, DOI 10.1002/hep.22895; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Justo R, 2005, AM J PHYSIOL-CELL PH, V289, pC372, DOI 10.1152/ajpcell.00035.2005; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; KAHN D, 1993, DIGEST DIS SCI, V38, P1485, DOI 10.1007/BF01308608; Kanazawa H, 2002, J CHROMATOGR A, V949, P1, DOI 10.1016/S0021-9673(01)01508-4; Lacroix I, 2004, FUND CLIN PHARMACOL, V18, P201, DOI 10.1111/j.1472-8206.2004.00224.x; Lahita RG, 2010, PRINCIPLES GENDER SP; Lash LH, 2001, J PHARMACOL EXP THER, V297, P155; Liu L, 2010, TOXICOLOGY, V271, P57, DOI 10.1016/j.tox.2010.03.004; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Manda G., 2009, CURR CHEM BIOL, V3, P22, DOI [10.2174/187231309787158271, DOI 10.2174/187231309787158271, DOI 10.2174/22127968109030]; Marino IR, 1995, HEPATOLOGY, V22, P1754, DOI 10.1016/0270-9139(95)90202-3; Martin RM, 1998, BRIT J CLIN PHARMACO, V46, P505, DOI 10.1046/j.1365-2125.1998.00817.x; Masubuchi Y, 2002, HEPATOLOGY, V35, P544, DOI 10.1053/jhep.2002.31871; Meibohm B, 2002, CLIN PHARMACOKINET, V41, P329, DOI 10.2165/00003088-200241050-00002; Miller MA, 2001, INT J TOXICOL, V20, P149, DOI 10.1080/109158101317097728; Miller VM, 2012, AM J PHYSIOL-LUNG C, V302, pL801, DOI 10.1152/ajplung.00095.2012; Nicolson TJ, 2010, TRENDS PHARMACOL SCI, V31, P108, DOI 10.1016/j.tips.2009.12.001; O'connor N, 2003, QJM-INT J MED, V96, P787, DOI 10.1093/qjmed/hcg138; Oliveira PJ, 2012, J LIPIDS, V2012, P1; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Parkinson A, 2004, TOXICOL APPL PHARM, V199, P193, DOI 10.1016/j.taap.2004.01.010; Pauli-Magnus C, 2000, J PHARMACOL EXP THER, V293, P376; Peyrou M, 2007, TOXICOL IN VITRO, V21, P878, DOI 10.1016/j.tiv.2007.03.001; PILLAY P, 1990, DIGEST DIS SCI, V35, P686, DOI 10.1007/BF01540167; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rustgi VK, 2002, LIVER TRANSPLANT, V8, P514, DOI 10.1053/jlts.2002.33457; Sanz A, 2007, EXP GERONTOL, V42, P173, DOI 10.1016/j.exger.2006.10.003; Sari FR, 2011, CARDIOVASC PATHOL, V20, P281, DOI 10.1016/j.carpath.2010.07.006; Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Soldin OP, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/187103; Straface Elisabetta, 2012, Handb Exp Pharmacol, P49, DOI 10.1007/978-3-642-30726-3_3; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tadic SD, 2002, J APPL PHYSIOL, V93, P1057, DOI 10.1152/japplphysiol.00568.2001; Tang W, 2003, CURR DRUG METAB, V4, P319, DOI 10.2174/1389200033489398; Taylor K Efua, 2011, Biol Sex Differ, V2, P11, DOI 10.1186/2042-6410-2-11; Torgrimson BN, 2005, J APPL PHYSIOL, V99, P785, DOI 10.1152/japplphysiol.00376.2005; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Uhl K, 2007, CLIN PHARMACOL THER, V81, P600, DOI 10.1038/sj.clpt.6100112; Vahter M, 2007, ENVIRON RES, V104, P70, DOI 10.1016/j.envres.2006.10.001; Vickers AEM, 2009, CHEM-BIOL INTERACT, V179, P9, DOI 10.1016/j.cbi.2008.10.010; Wald C, 2010, SCIENCE, V327, P1571, DOI 10.1126/science.327.5973.1571; Waxman DJ, 2009, MOL PHARMACOL, V76, P215, DOI 10.1124/mol.109.056705; World Health Organization, WHAT DO WE MEAN SEX; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Yang Lun, 2012, J Drug Metab Toxicol, V3, P1000119, DOI 10.4172/2157-7609.1000119; Zopf Y, 2008, EUR J CLIN PHARMACOL, V64, P999, DOI 10.1007/s00228-008-0494-6; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	79	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122786	10.1371/journal.pone.0122786	http://dx.doi.org/10.1371/journal.pone.0122786			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849576	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800161
J	von Bondorff, MB; Tormakangas, T; Salonen, M; von Bonsdorff, ME; Osmond, C; Kajantie, E; Eriksson, JG				von Bondorff, Mikaela B.; Tormakangas, Timo; Salonen, Minna; von Bonsdorff, Monika E.; Osmond, Clive; Kajantie, Eero; Eriksson, Johan G.			Early Life Origins of All-Cause and Cause-Specific Disability Pension: Findings from the Helsinki Birth Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; FOLLOW-UP; FETAL-GROWTH; AGE 60; RISK; WEIGHT; CHILDHOOD; DETERMINANTS; STRESS; SIZE	Background There is some evidence linking sub-optimal prenatal development to an increased risk of disability pension (DP). Our aim was to investigate whether body size at birth was associated with transitioning into all-cause and cause-specific DP during the adult work career. Methods 10 682 people born in 1934-44 belonging to the Helsinki Birth Cohort Study had data on birth weight extracted from birth records, and on time, type and reason of retirement between 1971 and 2011 extracted from the Finnish Centre for Pensions. Results Altogether 21.3% transitioned into DP during the 40-year follow-up, mainly due to mental disorders, musculoskeletal disorders and cardiovascular disease. Average age of transitioning into DP was 51.3 (SD 8.4) for men and 52.2 (SD 7.6) for women. Cohort members who did not transition into DP retired 10 years later on average. Among men, higher birth weight was associated with a lower hazard of transitioning into DP, adjusted hazard ratio (HR) being 0.94 (95% confidence interval [CI] 0.88-0.99 for 1 SD increase in birth weight). For DP due to mental disorders the adjusted HR was 0.90, 95% CI 0.81, 0.99. A similar but non-significant trend was found for DP due to cardiovascular disease. Among women there were no associations between body size at birth and all-cause DP (p for interaction gender*birth weight on DP p = 0.007). Conclusions Among men disability pension, particularly due to mental disorders, may have its origins in prenatal development. Given that those who retire due to mental health problems are relatively young, the loss to the workforce is substantial.	[von Bondorff, Mikaela B.; Tormakangas, Timo; von Bonsdorff, Monika E.] Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland; [von Bondorff, Mikaela B.; Tormakangas, Timo; von Bonsdorff, Monika E.] Univ Jyvaskyla, Dept Hlth Sci, Jyvaskyla, Finland; [Salonen, Minna; Kajantie, Eero; Eriksson, Johan G.] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Div Welf & Hlth Promot, Diabet Prevent Unit, Helsinki, Finland; [Salonen, Minna; Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Osmond, Clive] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Kajantie, Eero] Univ Helsinki, Cent Hosp, Hosp Children & Adolescents, Helsinki, Finland; [Kajantie, Eero] Univ Helsinki, Helsinki, Finland; [Kajantie, Eero] Oulu Univ Hosp, Dept Obstet & Gynaecol, Oulu, Finland; [Kajantie, Eero] Univ Oulu, Oulu, Finland; [Eriksson, Johan G.] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Helsinki Univ Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland	University of Jyvaskyla; University of Jyvaskyla; Finland National Institute for Health & Welfare; Folkhalsan Research Center; University of Southampton; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Oulu; University of Oulu; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Vaasa Central Hospital	von Bondorff, MB (corresponding author), Univ Jyvaskyla, Gerontol Res Ctr, Jyvaskyla, Finland.	mikaela.vonbonsdorff@jyu.fi	; von Bonsdorff, Mikaela/A-5218-2015; von Bonsdorff, Monika/D-3049-2014	Tormakangas, Timo/0000-0001-7268-5297; von Bonsdorff, Mikaela/0000-0001-8530-5230; Osmond, Clive/0000-0002-9054-4655; von Bonsdorff, Monika/0000-0002-4689-2126; Eriksson, Johan/0000-0002-2516-2060	Emil Aaltonen Foundation; Finnish Foundation for Diabetes Research; Novo Nordisk Foundation; Signe; Ane Gyllenberg Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Liv och Halsa; Finnish Foundation for Cardiovascular Research; Academy of Finland MBvB [257239]; Academy of Finland MEvB [250681, 127437, 129306, 130326, 134791, 2639249, 129369, 129907, 135072, 129255, 126775]; European Commission [278603]; Novo Nordisk Fonden [NNF12OC1016374] Funding Source: researchfish	Emil Aaltonen Foundation; Finnish Foundation for Diabetes Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Signe; Ane Gyllenberg Foundation; Samfundet Folkhalsan; Finska Lakaresallskapet; Liv och Halsa; Finnish Foundation for Cardiovascular Research; Academy of Finland MBvB(Academy of Finland); Academy of Finland MEvB(Academy of Finland); European Commission(European CommissionEuropean Commission Joint Research Centre); Novo Nordisk Fonden(Novo Nordisk Foundation)	HBCS was supported by Emil Aaltonen Foundation, Finnish Foundation for Diabetes Research, Novo Nordisk Foundation, Signe and Ane Gyllenberg Foundation, Samfundet Folkhalsan, Finska Lakaresallskapet, Liv och Halsa, Finnish Foundation for Cardiovascular Research. The Academy of Finland supported MBvB (grant no. 257239); MEvB (grant no. 250681) EK (grant no. 127437, 129306, 130326, 134791 and 2639249) JGE (grant no. 129369, 129907, 135072, 129255 and 126775). The research leading to these results has received funding from the European Commission within the 7th Framework Programme (DORIAN, grant agreement no 278603). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SICKN DIS WORK BREAK; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2004, J AM COLL NUTR, V23, p588S, DOI 10.1080/07315724.2004.10719428; Barker DJP, 1998, MOTHERS BABIES HLTH; Central Statistical Office of Finland, 1989, CLASS SOC GROUPS HDB, V17; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Gravseth HM, 2007, EUR J EPIDEMIOL, V22, P533, DOI 10.1007/s10654-007-9139-9; Gunnar M, 2007, ANNU REV PSYCHOL, V58, P145, DOI 10.1146/annurev.psych.58.110405.085605; Harkonmaki K, 2007, J EPIDEMIOL COMMUN H, V61, P479, DOI 10.1136/jech.2006.052670; Helgertz J, 2014, SOC SCI MED, V119, P249, DOI 10.1016/j.socscimed.2013.11.052; Hultman CM, 1999, BRIT MED J, V318, P421, DOI 10.1136/bmj.318.7181.421; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; ILMARINEN J, 1991, SCAND J WORK ENV HEA, V17, P12; Jones A, 2006, J CLIN ENDOCR METAB, V91, P1868, DOI 10.1210/jc.2005-2077; Kajantie E, 2007, J CLIN ENDOCR METAB, V92, P4094, DOI 10.1210/jc.2007-1539; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Krokstad S, 2002, INT J EPIDEMIOL, V31, P1183, DOI 10.1093/ije/31.6.1183; Kuh D, 2003, J EPIDEMIOL COMMUN H, V57, P778, DOI 10.1136/jech.57.10.778; Lahti M, 2013, J PERS SOC PSYCHOL, V105, P154, DOI 10.1037/a0032300; Laine S, 2009, J EPIDEMIOL COMMUN H, V63, P24, DOI 10.1136/jech.2007.071407; Lampl M, 2010, AM J HUM BIOL, V22, P431, DOI 10.1002/ajhb.21014; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Muller M, 2014, PEDIATRICS, V134, P761, DOI 10.1542/peds.2014-1108; OECD, 2011, PENS GLANC 2011 RET; OECD, 2003, TRANSF DIS AB POL PR; Official Statistics of Finland, 2013, PENS INS FINL 2011; Osler M, 2005, BRIT J PSYCHIAT, V186, P400, DOI 10.1192/bjp.186.5.400; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Phillips DIW, 2006, J PHYSIOL-LONDON, V572, P45, DOI 10.1113/jphysiol.2005.104695; Raikkonen K, 2007, BRIT J PSYCHIAT, V190, P469, DOI 10.1192/bjp.bp.106.022145; Rees S, 2004, NEUROSCI LETT, V361, P111, DOI 10.1016/j.neulet.2004.02.002; Siipi J, 1962, HELSINGIN KAUPUNGIN, P137; Steunenberg B, 2010, J AFFECT DISORDERS, V123, P164, DOI 10.1016/j.jad.2009.08.002; Thompson C, 2001, BRIT J PSYCHIAT, V179, P450, DOI 10.1192/bjp.179.5.450; von Bonsdorff MB, 2011, AM J EPIDEMIOL, V174, P1336, DOI 10.1093/aje/kwr270; Wahlbeck K, 2001, ARCH GEN PSYCHIAT, V58, P48, DOI 10.1001/archpsyc.58.1.48; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886	38	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122134	10.1371/journal.pone.0122134	http://dx.doi.org/10.1371/journal.pone.0122134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849578	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000352477800102
J	Wilkie, R; Hay, EM; Croft, P; Pransky, G				Wilkie, Ross; Hay, Elaine M.; Croft, Peter; Pransky, Glenn			Exploring How Pain Leads to Productivity Loss in Primary Care Consulters for Osteoarthritis: A Prospective Cohort Study	PLOS ONE			English	Article							LOW-BACK-PAIN; COPING STRATEGIES; WORK; DISABILITY; ARTHRITIS; RISK; PARTICIPATION; POPULATION; MANAGEMENT; INJURIES	Objective Osteoarthritis pain has become a leading cause of decreased productivity and work disability in older workers, a major concern in primary care. How osteoarthritis pain leads to decreased productivity at work is unclear; the aim of this study was to elucidate causal mechanisms and thus identify potential opportunities for intervention. Methods Population-based prospective cohort study of primary care consulters with osteoarthritis. Path analysis was used to test proposed mechanisms by examining the association between pain at baseline, and onset of work productivity loss at three years for mediation by physical limitation, depression, poor sleep and poor coping mechanisms. Results High pain intensity was associated with onset of work productivity loss (Adjusted Odds Ratio 2.5; 95% CI 1.3, 4.8). About half of the effect of pain on work productivity was a direct effect, and half was mediated by the impact of pain on physical function. Depression, poor sleep quality and poor coping did not mediate the association between high pain intensity and onset of work productivity loss. Conclusions As pain is a major cause of work productivity loss, results suggest that decreasing pain should be a major focus. However, successfully improving function may have an indirect effect by decreasing the impact of pain on work productivity, especially important as significant pain reduction is often difficult to achieve. Although depression, sleep problems, and coping strategies may be directly related to work productivity loss, addressing these issues may not have much effect on the significant impact of pain on work productivity.	[Wilkie, Ross; Hay, Elaine M.; Croft, Peter] Keele Univ, Primary Care Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Pransky, Glenn] Liberty Mutual Res Inst, Ctr Disabil Res, Hopkinton, MA 01748 USA	Keele University	Wilkie, R (corresponding author), Keele Univ, Primary Care Sci, Arthrit Res UK Primary Care Ctr, Keele ST5 5BG, Staffs, England.	r.wilkie@keele.ac.uk			Medical Research Council, United Kingdom [G9900220]; North Staffordshire Primary Care R D Consortium; MRC [G0501798, G0900038] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E500579/1] Funding Source: researchfish; Medical Research Council [G0501798, G0900038] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10183] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); North Staffordshire Primary Care R D Consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study is supported financially by the Medical Research Council, United Kingdom (grant code: G9900220) and by the North Staffordshire Primary Care R & D Consortium.	Altman RD, 2010, AM J MANAG CARE, V16, pS41; Bieleman HJ, 2011, J RHEUMATOL, V38, P1835, DOI 10.3899/jrheum.101210; Buis ML, 2010, STATA J, V10, P11, DOI 10.1177/1536867X1001000104; Burton Wayne N, 2006, Dis Manag, V9, P131, DOI 10.1089/dis.2006.9.131; Carroll LJ, 2013, DISABIL REHABIL, V35, P1182, DOI 10.3109/09638288.2012.723791; Chaparro LE, 2013, COCHRANE DATABASE SY, P8; Chou R, 2014, ANN INTERN MED, V160, DOI 10.7326/0003-4819-160-11-201406030-01006; Chou R, 2009, SPINE, V34, P1094, DOI 10.1097/BRS.0b013e3181a105fc; DiBonaventura MD, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-30; Franche RL, 2005, J OCCUP REHABIL, V15, P607, DOI 10.1007/s10926-005-8038-8; Gignac MAM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1753, DOI 10.1002/art.24889; Golightly YM, 2015, INT J BEHAV MED, V22, P101, DOI 10.1007/s12529-013-9365-3; Hayward RA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-8; JENKINS CD, 1988, J CLIN EPIDEMIOL, V41, P313, DOI 10.1016/0895-4356(88)90138-2; Jensen MP, 2003, PAIN, V104, P453, DOI 10.1016/S0304-3959(03)00076-9; Jordan K, 2007, BRIT J GEN PRACT, V57, P7; Karlson KB, 2011, RES SOC STRAT MOBIL, V29, P221, DOI 10.1016/j.rssm.2010.12.005; Lacey RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083948; Li X, 2006, MED CARE, V44, P304, DOI 10.1097/01.mlr.0000204257.25875.04; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Loisel P, 1997, SPINE, V22, P2911, DOI 10.1097/00007632-199712150-00014; Manchikanti L, 2001, PAIN PHYSICIAN, V4, P101; Mody GM, 2012, BEST PRACT RES CL RH, V26, P237, DOI 10.1016/j.berh.2012.03.002; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; NHS Information, 2000, CLIN TERMS VERS 3 RE; Pransky GS, 2005, AM J IND MED, V47, P104, DOI 10.1002/ajim.20122; Ricci JA, 2005, ARTHRIT RHEUM-ARTHR, V53, P673, DOI 10.1002/art.21453; Shaw WS, 2009, J OCCUP ENVIRON MED, V51, P185, DOI 10.1097/JOM.0b013e318192bcf8; Shaw WS, 2005, SPINE, V30, P572, DOI 10.1097/01.brs.0000154628.37515.ef; Stewart WF, 2003, J OCCUP ENVIRON MED, V45, P1234, DOI 10.1097/01.jom.0000099999.27348.78; Streiner DL, 2005, CAN J PSYCHIAT, V50, P115, DOI 10.1177/070674370505000207; Tang K, 2011, J RHEUMATOL, V38, P1776, DOI 10.3899/jrheum.110405; Tang NKY, 2012, SLEEP, V35, P675, DOI 10.5665/sleep.1830; Vasseljen O, 2013, PAIN, V154, P1237, DOI 10.1016/j.pain.2013.03.032; Ware J., 1993, SF 36 HLTH SURVEY MA; Wilkie R, 2014, RHEUMATOLOGY, V53, P459, DOI 10.1093/rheumatology/ket336; Wilkie R, 2013, ARTHRIT CARE RES, V65, P910, DOI 10.1002/acr.21918; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	38	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120042	10.1371/journal.pone.0120042	http://dx.doi.org/10.1371/journal.pone.0120042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849594	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800018
J	Kimura, M; Tamura, Y; Takei, M; Yamamoto, T; Ono, T; Kuwana, M; Fukuda, K; Satoh, T				Kimura, Mai; Tamura, Yuichi; Takei, Makoto; Yamamoto, Tsunehisa; Ono, Tomohiko; Kuwana, Masataka; Fukuda, Keiichi; Satoh, Toru			Rapid Initiation of Intravenous Epoprostenol Infusion Is the Favored Option in Patients with Advanced Pulmonary Arterial Hypertension	PLOS ONE			English	Article							VASCULAR-RESISTANCE; THERAPY; PROSTACYCLIN; SURVIVAL; REDUCTION; TRIAL	Background Intravenous infusion (IVI) of epoprostenol is an effective treatment for patients with advanced pulmonary arterial hypertension (PAH). However, there is no widely accepted standard method for initiating the IVI therapy. This study evaluated the hemodynamic improvements achieved with IVI epoprostenol to determine the optimal protocol for treatment initiation. Methods and Results We retrospectively analyzed 42 consecutive PAH patients who underwent IVI epoprostenol in Keio University Hospital from 2001 to 2013. The study group comprised 30 women with a mean age of 34.3 +/- 1.9 years. The etiology of PAH was idiopathic or heritable PAH (I/HPAH) in 38 cases, PAH associated with connective tissue disease in 3, and Eissenmenger's syndrome in the remaining case. We divided the patients into rapid-and slow-initiation therapy groups according to the cumulative epoprostenol dose administered during the first 180 days, and compared the hemodynamic changes between the groups. The median cumulative doses were 6142 +/- 165 mu g/kg and 3998 +/- 132 mu g/kg epoprostenol, respectively. While there were no significant differences in mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), or cardiac index (CI) between the groups before the IVI epoprostenol therapy, the rapid-initiation therapy group achieved significant improvements in these hemodynamic data compared with the slow-initiation therapy group (P < 0.005) at the follow-up right-heart catheterization (RHC). Conclusion Rapid initiation of IVI epoprostenol therapy achieved the optimal hemodynamic improvements in patients with severe PAH.	[Kimura, Mai; Tamura, Yuichi; Takei, Makoto; Yamamoto, Tsunehisa; Ono, Tomohiko; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Kuwana, Masataka] Nippon Med Sch, Dept Rheumatol, Tokyo 113, Japan; [Satoh, Toru] Kyorin Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Keio University; Nippon Medical School; Kyorin University	Tamura, Y (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	u1@ta-mu.net	Fukuda, Keiichi/L-3777-2013	Yamamoto, Tsunehisa/0000-0002-5241-9482; Tamura, Yuichi/0000-0002-4437-8019	Health and Labor Sciences Research Grants in Japan; Health and Labor Sciences Research Grants in Japan	Health and Labor Sciences Research Grants in Japan; Health and Labor Sciences Research Grants in Japan	This work was supported by Health and Labor Sciences Research Grants in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagi S, 2010, CIRC J, V74, P2200, DOI 10.1253/circj.CJ-10-0190; Archer S, 2000, CIRCULATION, V102, P2781, DOI 10.1161/01.CIR.102.22.2781; Badesch DB, 2000, ANN INTERN MED, V132, P425, DOI 10.7326/0003-4819-132-6-200003210-00002; Badesch DB, 2004, CHEST, V126, p35S, DOI 10.1378/chest.126.1_suppl.35S; Barst RJ, 1996, NEW ENGL J MED, V334, P296, DOI 10.1056/NEJM199602013340504; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; Galie N, 2013, J AM COLL CARDIOL, V62, pD60, DOI 10.1016/j.jacc.2013.10.031; Homma S, 2010, CIRC J, V74, P2062, DOI 10.1253/circj.CJ-10-0854; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; McLaughlin VV, 2006, CIRCULATION, V114, P1417, DOI 10.1161/CIRCULATIONAHA.104.503540; McLaughlin VV, 1998, NEW ENGL J MED, V338, P273, DOI 10.1056/NEJM199801293380501; McLaughlin VV, 2002, CIRCULATION, V106, P1477, DOI 10.1161/01.CIR.0000029100.82385.58; RUBIN LJ, 1990, ANN INTERN MED, V112, P485, DOI 10.7326/0003-4819-112-7-485; Sakuma M, 2009, CIRC J, V73, P523, DOI 10.1253/circj.CJ-07-1020; Sitbon O, 2002, J AM COLL CARDIOL, V40, P780, DOI 10.1016/S0735-1097(02)02012-0; Sitbon O, 2014, EUR RESPIR J, V43, P1691, DOI 10.1183/09031936.00116313	16	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121894	10.1371/journal.pone.0121894	http://dx.doi.org/10.1371/journal.pone.0121894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844932	gold, Green Published, Green Submitted			2022-12-26	WOS:000352475700011
J	Musella, V; Callari, M; Di Buduo, E; Scuro, M; Dugo, M; Miodini, P; Bianchini, G; Paolini, B; Gianni, L; Daidone, MG; Cappelletti, V				Musella, Valeria; Callari, Maurizio; Di Buduo, Eleonora; Scuro, Manuela; Dugo, Matteo; Miodini, Patrizia; Bianchini, Giampaolo; Paolini, Biagio; Gianni, Luca; Daidone, Maria Grazia; Cappelletti, Vera			Use of Formalin-Fixed Paraffin-Embedded Samples for Gene Expression Studies in Breast Cancer Patients	PLOS ONE			English	Article							ARCHIVAL MATERIAL; RNA; TISSUES; CLASSIFICATION; AMPLIFICATION; PERFORMANCE; VALIDATION; ESTROGEN; SURVIVAL; SUBTYPE	To obtain gene expression profiles from samples collected in clinical trials, we conducted a pilot study to assess feasibility and estimate sample attrition rates when profiling formalin-fixed, paraffin-embedded specimens. Ten matched fresh-frozen and fixed breast cancer samples were profiled using the Illumina HT-12 and Ref-8 chips, respectively. The profiles obtained with Ref 8, were neither technically nor biologically reliable since they failed to yield the expected separation between estrogen receptor positive and negative samples. With the use of Affymetrix HG-U133 2.0 Plus chips on fixed samples and a quantitative polymerase chain reaction -based sample pre-assessment step, results were satisfactory in terms of biological reliability, despite the low number of present calls (M = 21%+/- 5). Compared with the Illumina DASL WG platform, Affymetrix data showed a wider interquartile range (1.32 vs 0.57, P<2.2 E-16,) and larger fold changes. The Affymetrix chips were used to run a pilot study on 60 fixed breast cancers. By including in the workflow the sample pre-assessment steps, 96% of the samples predicted to give good results (44/46), were in fact rated as satisfactory from the point of view of technical and biological meaningfulness. Our gene expression profiles showed strong agreement with immunohistochemistry data, were able to reproduce breast cancer molecular subtypes, and allowed the validation of an estrogen receptor status classifier derived in frozen samples. The approach is therefore suitable to profile formalin-fixed paraffin-embedded samples collected in clinical trials, provided that quality controls are run both before (sample pre-assessment) and after hybridization on the array.	[Musella, Valeria; Callari, Maurizio; Di Buduo, Eleonora; Dugo, Matteo; Miodini, Patrizia; Daidone, Maria Grazia; Cappelletti, Vera] Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy; [Scuro, Manuela; Paolini, Biagio] Fdn IRCCS Ist Nazl Tumori, Dept Pathol, Milan, Italy; [Bianchini, Giampaolo; Gianni, Luca] Univ Milan, Osped San Raffaele, Dept Med Oncol, I-20127 Milan, Italy	Fondazione IRCCS Istituto Nazionale Tumori Milan; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Daidone, MG (corresponding author), Fdn IRCCS Ist Nazl Tumori, Dept Expt Oncol & Mol Med, Milan, Italy.	mariagrazia.daidone@istitutotumori.mi.it	Cappelletti, Vera/B-9310-2017; Callari, Maurizio/AAF-7089-2019; Daidone, Maria Grazia/E-9232-2017; Musella, Valeria/H-4458-2016; Dugo, Matteo/H-6860-2014; Paolini, Biagio/E-9240-2017; Miodini, Patrizia/B-1054-2019	Cappelletti, Vera/0000-0002-9709-0676; Callari, Maurizio/0000-0001-5239-0918; Daidone, Maria Grazia/0000-0002-4786-1321; Musella, Valeria/0000-0001-9517-2670; Dugo, Matteo/0000-0001-9786-2763; Paolini, Biagio/0000-0001-7535-7715; Miodini, Patrizia/0000-0001-5815-211X; GIANNI, LUCA/0000-0002-2372-9625; Bianchini, Giampaolo/0000-0002-6790-6267	Italian Association for Cancer Research (AIRC) [IG 4915, IG 10611]; Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili)	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili)	This work was supported by: the Italian Association for Cancer Research (AIRC) [IG 4915 to LG] and [IG 10611 to MGD] and the Ministero della Salute (Progetto Oncologico di Medicina Molecolare: I Tumori Femminili). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdueva D, 2010, J MOL DIAGN, V12, P409, DOI 10.2353/jmoldx.2010.090155; Allen WL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-687; Bianchini G, 2013, J CLIN ONCOL; Bianchini G, 2010, J CLIN ONCOL, V28, P4316, DOI 10.1200/JCO.2009.27.2419; Bibikova M, 2004, AM J PATHOL, V165, P1799, DOI 10.1016/S0002-9440(10)63435-9; Bibikova Marina, 2008, V439, P159, DOI 10.1007/978-1-59745-188-8_11; Budczies J, 2011, J HISTOCHEM CYTOCHEM, V59, P146, DOI 10.1369/jhc.2010.956607; Callari M, 2014, MOL ONCOL, V8, P1278, DOI 10.1016/j.molonc.2014.04.010; Callari M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086511; Conway C, 2009, CLIN CANCER RES, V15, P6939, DOI 10.1158/1078-0432.CCR-09-1631; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; De Cecco L, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-409; Deben C, 2013, DIAGN MOL PATHOL, V22, P59, DOI 10.1097/PDM.0b013e318269de3b; Dressler LG, 1999, BREAST CANCER RES TR, V58, P31, DOI 10.1023/A:1006354627669; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Fountzilas E, 2012, ANN ONCOL, V23, P2146, DOI 10.1093/annonc/mdr576; Frank M, 2007, VIRCHOWS ARCH, V450, P699, DOI 10.1007/s00428-007-0412-9; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hedegaard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098187; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Kim S, 2014, ANN HEMATOL, V93, P437, DOI 10.1007/s00277-013-1884-0; Linton KM, 2008, BRIT J CANCER, V98, P1403, DOI 10.1038/sj.bjc.6604316; Linton KM, 2009, BIOTECHNIQUES, V47, P587, DOI 10.2144/000113169; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mehta R, 2011, CLIN BREAST CANCER, V11, P20, DOI 10.3816/CBC.2011.n.004; Mittempergher L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017163; Musella V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053406; Paik S, 2006, CLIN CANCER RES, V12, p1019S, DOI 10.1158/1078-0432.CCR-05-2296; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; Paik S, 2011, BREAST, V20, pS87, DOI 10.1016/S0960-9776(11)70301-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pentheroudakis G, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-111; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Ribeiro-Silva A, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-118; Roberts L, 2009, GENOMICS, V94, P341, DOI 10.1016/j.ygeno.2009.07.007; RONCHI E, 1986, TUMORI, V72, P251, DOI 10.1177/030089168607200305; Scicchitano MS, 2006, J HISTOCHEM CYTOCHEM, V54, P1229, DOI 10.1369/jhc.6A6999.2006; Sfakianos GP, 2013, GYNECOL ONCOL, V129, P159, DOI 10.1016/j.ygyno.2012.12.030; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Thomas Marlene, 2013, J Clin Bioinforma, V3, P10, DOI 10.1186/2043-9113-3-10; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; Vargas AC, 2012, BREAST CANCER RES TR, V135, P153, DOI 10.1007/s10549-012-2123-4; von AS, 2007, PLOS ONE, V2, pe1261; Waldron L, 2012, CLIN CANCER RES, V18, P6136, DOI 10.1158/1078-0432.CCR-12-1915; Williams PM, 2010, J MOL DIAGN, V12, P680, DOI 10.2353/jmoldx.2010.090164	48	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123194	10.1371/journal.pone.0123194	http://dx.doi.org/10.1371/journal.pone.0123194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844937	Green Submitted, gold, Green Published			2022-12-26	WOS:000352475700019
J	Cascella, K; Jollivet, D; Papot, C; Leger, N; Corre, E; Ravaux, J; Clark, MS; Toullec, JY				Cascella, Kevin; Jollivet, Didier; Papot, Claire; Leger, Nelly; Corre, Erwan; Ravaux, Juliette; Clark, Melody S.; Toullec, Jean-Yves			Diversification, Evolution and Sub-Functionalization of 70kDa Heat-Shock Proteins in Two Sister Species of Antarctic Krill: Differences in Thermal Habitats, Responses and Implications under Climate Change	PLOS ONE			English	Article							EUPHAUSIA-CRYSTALLOROPHIAS; DROSOPHILA-MELANOGASTER; RIMICARIS-EXOCULATA; RELAXED SELECTION; GENE-EXPRESSION; TERMINAL DOMAIN; SOUTH GEORGIA; HSP70; ADAPTATION; LIMITS	Background A comparative thermal tolerance study was undertaken on two sister species of Euphausiids (Antarctic krills) Euphausia superba and Euphausia crystallorophias. Both are essential components of the Southern Ocean ecosystem, but occupy distinct environmental geographical locations with slightly different temperature regimes. They therefore provide a useful model system for the investigation of adaptations to thermal tolerance. Methodology/Principal Finding Initial CTmax studies showed that E. superba was slightly more thermotolerant than E. crystallorophias. Five Hsp70 mRNAs were characterized from the RNAseq data of both species and subsequent expression kinetics studies revealed notable differences in induction of each of the 5 orthologues between the two species, with E. crystallorophias reacting more rapidly than E. superba. Furthermore, analyses conducted to estimate the evolutionary rates and selection strengths acting on each gene tended to support the hypothesis that diversifying selection has contributed to the diversification of this gene family, and led to the selective relaxation on the inducible C form with its possible loss of function in the two krill species. Conclusions The sensitivity of the epipelagic species E. crystallorophias to temperature variations and/or its adaptation to cold is enhanced when compared with its sister species, E. superba. These results indicate that ice krill could be the first of the two species to be impacted by the warming of coastal waters of the Austral ocean in the coming years due to climate change.	[Cascella, Kevin; Jollivet, Didier; Toullec, Jean-Yves] Univ Paris 06, Sorbonne Univ, CNRS, Equipe ABICE,Stn Biol Roscoff,UMR 7144, F-29680 Roscoff, France; [Cascella, Kevin; Jollivet, Didier; Toullec, Jean-Yves] CNRS, Stn Biol Roscoff, Adaptat & Div Milieu Marin, UMR 7144, F-29680 Roscoff, France; [Papot, Claire] Univ Lille 1, CNRS, Ecoimmunol Marine Annelids, UMR8198, F-59655 Villeneuve Dascq, France; [Leger, Nelly; Ravaux, Juliette] Univ Paris 06, Sorbonne Univ, CNRS, Equipe AMEX,UMR 7208, F-75005 Paris, France; [Leger, Nelly; Ravaux, Juliette] Univ Paris 06, CNRS 7208, BOREA, F-75005 Paris, France; [Corre, Erwan] Univ Paris 06, Sorbonne Univ, CNRS,ABiMS,FR 2424, Anal & Bioinformat Marine Sci,Stn Biol Roscoff, F-29680 Roscoff, France; [Corre, Erwan] CNRS, Stn Biol Roscoff, FR 2424, F-29680 Roscoff, France; [Clark, Melody S.] British Antarctic Survey, NERC, Cambridge CB3 0ET, England	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Toullec, JY (corresponding author), Univ Paris 06, Sorbonne Univ, CNRS, Equipe ABICE,Stn Biol Roscoff,UMR 7144, F-29680 Roscoff, France.	jean-yves.toullec@sb-roscoff.fr	corre, erwan/O-4669-2019; Clark, Melody S/D-7371-2014	corre, erwan/0000-0001-6354-2278; Clark, Melody S/0000-0002-3442-3824; Papot, Claire/0000-0002-8324-2261	Emergence-UPMC research program; Region Bretagne; Institut Paul Emile Victor (IPEV) (KREVET program); "Region Bretagne" (SAD-1 - DRAKAR program); Polar Sciences for Planet Earth programme; British Antarctic Survey; Natural Environment Research Council; Natural Environment Research Council [bas0100025] Funding Source: researchfish; NERC [bas0100025] Funding Source: UKRI	Emergence-UPMC research program; Region Bretagne(Region Bretagne); Institut Paul Emile Victor (IPEV) (KREVET program); "Region Bretagne" (SAD-1 - DRAKAR program); Polar Sciences for Planet Earth programme; British Antarctic Survey; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KC received a PhD grant by the Emergence-UPMC 2011 research program and the "Region Bretagne". JYT benefited from funding provided by Institut Paul Emile Victor (IPEV) (KREVET program) and also by the "Region Bretagne" (SAD-1 - DRAKAR program). MSC was funded by the Polar Sciences for Planet Earth programme, by the British Antarctic Survey and the Natural Environment Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Atkinson A, 2008, MAR ECOL PROG SER, V362, P1, DOI 10.3354/meps07498; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; Bedulina DS, 2013, MOL ECOL, V22, P1416, DOI 10.1111/mec.12136; Bender T, 2011, MOL BIOL CELL, V22, P541, DOI 10.1091/mbc.E10-08-0718; Bettencourt BR, 2001, MOL BIOL EVOL, V18, P1272, DOI 10.1093/oxfordjournals.molbev.a003912; Bettencourt BR, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-5; Blamowska M, 2012, J CELL BIOL, V199, P125, DOI 10.1083/jcb.201205012; Clark MS, 2008, POLAR BIOL, V31, P1059, DOI 10.1007/s00300-008-0447-7; Clark MS, 2008, CELL STRESS CHAPERON, V13, P39, DOI 10.1007/s12192-008-0014-8; Clark MS, 2008, CELL STRESS CHAPERON, V13, P51, DOI 10.1007/s12192-008-0015-7; Clark MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015919; Clark MS, 2009, MAR GENOM, V2, P11, DOI 10.1016/j.margen.2009.03.003; Clark MS, 2009, CELL STRESS CHAPERON, V14, P649, DOI 10.1007/s12192-009-0117-x; Clarke A, 1996, TRENDS ECOL EVOL, V11, P212, DOI 10.1016/0169-5347(96)10029-X; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Clarke A, 2007, PHILOS T R SOC B, V362, P149, DOI 10.1098/rstb.2006.1958; Cottin D, 2010, J EXP MAR BIOL ECOL, V393, P9, DOI 10.1016/j.jembe.2010.06.008; Cui ZX, 2010, FISH SHELLFISH IMMUN, V28, P56, DOI 10.1016/j.fsi.2009.09.018; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Fuertes MA, 2004, BBA-PROTEINS PROTEOM, V1699, P45, DOI 10.1016/j.bbapap.2003.12.007; Gojobori J, 2009, TRENDS GENET, V25, P198, DOI 10.1016/j.tig.2009.03.008; Guglielmo L, 2009, POLAR BIOL, V32, P347, DOI 10.1007/s00300-008-0546-5; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hill SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072246; Hill SL, 2012, DEEP-SEA RES PT II, V59, P237, DOI 10.1016/j.dsr2.2011.09.001; Hofmann GE, 2000, J EXP BIOL, V203, P2331; Hunt BG, 2011, P NATL ACAD SCI USA, V108, P15936, DOI 10.1073/pnas.1104825108; Jarman SN, 2000, MOL PHYLOGENET EVOL, V17, P26, DOI 10.1006/mpev.2000.0823; Jarman SN, 2001, BIOL J LINN SOC, V73, P199, DOI 10.1006/bjls.2001.0538; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kondrashov FA, 2012, P ROY SOC B-BIOL SCI, V279, P5048, DOI 10.1098/rspb.2012.1108; Koshi JM, 1996, J MOL EVOL, V42, P313, DOI 10.1007/BF02198858; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Laursen JR, 1997, J INVERTEBR PATHOL, V70, P226, DOI 10.1006/jipa.1997.4686; Liu J, 2004, CELL STRESS CHAPERON, V9, P313, DOI 10.1379/CSC-40R.1; Luan W, 2010, CELL STRESS CHAPERON, V15, P83, DOI 10.1007/s12192-009-0124-y; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch VJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-2; Mackey AP, 2012, DEEP-SEA RES PT II, V59, P130, DOI 10.1016/j.dsr2.2011.08.011; Meredith MP, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024042; Morley SA, 2012, MAR ECOL PROG SER, V450, P81, DOI 10.3354/meps09577; Morley SA, 2010, ANTARCT SCI, V22, P774, DOI 10.1017/S0954102010000465; Morris JP, 2013, MOL ECOL, V22, P1494, DOI 10.1111/mec.12216; NEI M, 1986, MOL BIOL EVOL, V3, P418; Pakhomov EA, 1996, DEEP-SEA RES PT I, V43, P59, DOI 10.1016/0967-0637(95)00094-1; Pakhomov EA, 1998, J MARINE SYST, V17, P313, DOI 10.1016/S0924-7963(98)00046-3; Park H, 2007, CELL STRESS CHAPERON, V12, P275, DOI 10.1379/CSC-271.1; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Patarnello T, 1996, MAR BIOL, V126, P603, DOI 10.1007/BF00351327; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2007, OECOLOGIA, V154, P479, DOI 10.1007/s00442-007-0858-0; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Portner HO, 2007, PHILOS T R SOC B, V362, P2233, DOI 10.1098/rstb.2006.1947; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; PRIVALOV PL, 1990, CRIT REV BIOCHEM MOL, V25, P281, DOI 10.3109/10409239009090612; Ravaux J, 2007, GENE, V386, P162, DOI 10.1016/j.gene.2006.09.001; Ravaux J, 2012, J COMP PHYSIOL B, V182, P899, DOI 10.1007/s00360-012-0666-7; Rogers AD, 2007, PHILOS T R SOC B, V362, P2191, DOI 10.1098/rstb.2006.1948; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Schoville SD, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-170; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Smith WO, 2014, ANNU REV MAR SCI, V6, P469, DOI 10.1146/annurev-marine-010213-135114; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; Tomanek L, 2010, J EXP BIOL, V213, P971, DOI 10.1242/jeb.038034; Toullec JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071609; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Voos W, 2013, BBA-MOL CELL RES, V1833, P388, DOI 10.1016/j.bbamcr.2012.06.005; Yang ZH, 2003, SYST BIOL, V52, P705, DOI 10.1080/10635150390235557; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zuiderweg ER, 2012, TOP CURR CHEM	79	34	35	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121642	10.1371/journal.pone.0121642	http://dx.doi.org/10.1371/journal.pone.0121642			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835552	Green Published, Green Accepted, gold			2022-12-26	WOS:000352139000053
J	Huynh, TP; Barwe, SP; Lee, SJ; McSpadden, R; Franco, OE; Hayward, SW; Damoiseaux, R; Grubbs, SS; Petrelli, NJ; Rajasekaran, AK				Huynh, Thu P.; Barwe, Sonali P.; Lee, Seung J.; McSpadden, Ryan; Franco, Omar E.; Hayward, Simon W.; Damoiseaux, Robert; Grubbs, Stephen S.; Petrelli, Nicholas J.; Rajasekaran, Ayyappan K.			Glucocorticoids Suppress Renal Cell Carcinoma Progression by Enhancing Na, K-ATPase Beta-1 Subunit Expression	PLOS ONE			English	Article							TO-MESENCHYMAL TRANSITION; IN-VIVO; ANTITUMOR-ACTIVITY; NA,K-ATPASE; DEXAMETHASONE; CANCER; GENE; PHARMACOKINETICS; BETA(1)-SUBUNIT; NA+,K+-ATPASE	Glucocorticoids are commonly used as palliative or chemotherapeutic clinical agents for treatment of a variety of cancers. Although steroid treatment is beneficial, the mechanisms by which steroids improve outcome in cancer patients are not well understood. Na, K-ATPase beta-subunit isoform 1 (NaK-beta(1)) is a cell-cell adhesion molecule, and its expression is down-regulated in cancer cells undergoing epithelial-to mesenchymal-transition (EMT), a key event associated with cancer progression to metastatic disease. In this study, we performed high-throughput screening to identify small molecules that could up-regulate NaK-beta(1) expression in cancer cells. Compounds related to the glucocorticoids were identified as drug candidates enhancing NaK-beta(1) expression. Of these compounds, triamcinolone, dexamethasone, and fluorometholone were validated to increase NaK-beta(1) expression at the cell surface, enhance cell-cell adhesion, attenuate motility and invasiveness and induce mesenchymal to epithelial like transition of renal cell carcinoma (RCC) cells in vitro. Treatment of NaK-beta(1) knockdown cells with these drug candidates confirmed that these compounds mediate their effects through up-regulating NaK-beta(1). Furthermore, we demonstrated that these compounds attenuate tumor growth in subcutaneous RCC xenografts and reduce local invasiveness in orthotopically-implanted tumors. Our results strongly indicate that the addition of glucocorticoids in the treatment of RCC may improve outcome for RCC patients by augmenting NaK-beta(1) cell-cell adhesion function.	[Huynh, Thu P.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Huynh, Thu P.; Barwe, Sonali P.; Lee, Seung J.; McSpadden, Ryan] Alfred I DuPont Hosp Children, Nemours Ctr Childhood Canc Res, Wilmington, DE USA; [Franco, Omar E.; Hayward, Simon W.] Vanderbilt Univ, Dept Urol Surg, Nashville, TN 37235 USA; [Grubbs, Stephen S.; Petrelli, Nicholas J.; Rajasekaran, Ayyappan K.] Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA; [Rajasekaran, Ayyappan K.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Rajasekaran, Ayyappan K.] Therapy Architects, Wilmington, DE USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Nemours Alfred I. duPont Hospital for Children; Vanderbilt University; Christiana Care Health System; Helen F. Graham Cancer Center & Research Institute; University of Delaware	Rajasekaran, AK (corresponding author), Christiana Care Hlth Syst, Helen F Graham Canc Ctr, Newark, DE 19718 USA.	arakaran687@gmail.com	Damoiseaux, Robert/F-1086-2011; Damoiseaux, Robert/S-6712-2019	Damoiseaux, Robert/0000-0002-7611-7534; Damoiseaux, Robert/0000-0002-7611-7534; Barwe, Sonali/0000-0003-4162-3004; McSpadden, Ryan/0000-0002-6249-6772; Hayward, Simon/0000-0002-6059-6550; Lee, Seung Joon/0000-0001-6690-2830	National Institutes of Health [DK56216, P20GM103464, F31CA117050]; NATIONAL CANCER INSTITUTE [F31CA117050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding provided by National Institutes of Health Grants DK56216, P20GM103464 and F31CA117050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAPRO MS, 1983, CANCER TREAT REP, V67, P1013; ABBOTT A, 1993, BIOCHEMISTRY-US, V32, P3511, DOI 10.1021/bi00064a040; Arafa HMM, 2006, TOXICOLOGY, V222, P103, DOI 10.1016/j.tox.2006.02.007; Arai Y, 2008, CANCER INVEST, V26, P35, DOI 10.1080/07357900701638418; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Avila J, 1997, ANN NY ACAD SCI, V834, P653, DOI 10.1111/j.1749-6632.1997.tb52341.x; Bab-Dinitz E, 2009, BIOCHEMISTRY-US, V48, P8684, DOI 10.1021/bi900868e; Barwe SP, 2006, CELL MOL BIOL, V52, P41, DOI 10.1170/T759; Barwe SP, 2007, J MOL BIOL, V365, P706, DOI 10.1016/j.jmb.2006.10.029; Barwe SP, 2012, J CELL SCI, V125, P5711, DOI 10.1242/jcs.108795; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; BRADY ME, 1987, EUR J CLIN PHARMACOL, V32, P593, DOI 10.1007/BF02455994; Chalaka S, 1999, AM J PHYSIOL-LUNG C, V277, pL197, DOI 10.1152/ajplung.1999.277.1.L197; Demoe JH, 2009, CANCER RES, V69, P1509, DOI 10.1158/0008-5472.CAN-08-3133; Derfoul A, 1998, J BIOL CHEM, V273, P20702, DOI 10.1074/jbc.273.33.20702; Eble JN, 2004, PATHOLOGY GENETICS T; Espineda C, 2003, CANCER-AM CANCER SOC, V97, P1859, DOI 10.1002/cncr.11267; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Gassler N, 2005, BRIT J CANCER, V92, P1084, DOI 10.1038/sj.bjc.6602453; Gorospe M, 1999, MOL CELL BIOL, V19, P1289; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hao H, 2003, BBA-GENE STRUCT EXPR, V1630, P55, DOI 10.1016/j.bbaexp.2003.09.003; Hao H, 2003, AM J PHYSIOL-LUNG C, V285, pL593, DOI 10.1152/ajplung.00037.2003; Hayward SW, 1999, PROSTATE, V39, P205; Hayward SW, 1998, DIFFERENTIATION, V63, P131, DOI 10.1046/j.1432-0436.1998.6330131.x; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; Jang YH, 2013, LAB INVEST, V93, P194, DOI 10.1038/labinvest.2012.166; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamata M, 2006, BIOCHEM BIOPH RES CO, V348, P1101, DOI 10.1016/j.bbrc.2006.07.158; Kitamura N, 2005, P NATL ACAD SCI USA, V102, P2796, DOI 10.1073/pnas.0409344102; Murphy AM, 2009, UROLOGY, V73, P1293, DOI 10.1016/j.urology.2008.12.072; Piette C, 2009, J BIOL CHEM, V284, P32483, DOI 10.1074/jbc.M109.014589; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Reeves DJ, 2009, CANCER CHEMOTH PHARM, V64, P11, DOI 10.1007/s00280-009-0983-z; Selvakumar P, 2014, EPIGENETICS-US, V9, P579, DOI 10.4161/epi.27795; Shoshani L, 2005, MOL BIOL CELL, V16, P1071, DOI 10.1091/mbc.E04-03-0267; Siemann DW, 2009, INT J RADIAT ONCOL, V73, P897, DOI 10.1016/j.ijrobp.2008.10.031; SUN Y, 1992, AM J PHYSIOL, V262, pC1491, DOI 10.1152/ajpcell.1992.262.6.C1491; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Tummala R, 2009, CANCER CHEMOTH PHARM, V64, P1187, DOI 10.1007/s00280-009-0985-x; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang H, 2004, CLIN CANCER RES, V10, P1633, DOI 10.1158/1078-0432.CCR-0829-3; Xu JQ, 2009, NATL VITAL STAT REPO, V58; Yu WD, 1998, J NATL CANCER I, V90, P134, DOI 10.1093/jnci/90.2.134; Zhang LA, 2010, FEBS LETT, V584, P4646, DOI 10.1016/j.febslet.2010.10.038; Zhang Q, 2009, EXPERT OPIN THER PAT, V19, P731, DOI 10.1517/13543770902967674	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122442	10.1371/journal.pone.0122442	http://dx.doi.org/10.1371/journal.pone.0122442			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836370	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000097
J	Johnson, AMF; Costanzo, A; Gareau, MG; Armando, AM; Quehenberger, O; Jameson, JM; Olefsky, JM				Johnson, Andrew M. F.; Costanzo, Anne; Gareau, Melanie G.; Armando, Aaron M.; Quehenberger, Oswald; Jameson, Julie M.; Olefsky, Jerrold M.			High Fat Diet Causes Depletion of Intestinal Eosinophils Associated with Intestinal Permeability	PLOS ONE			English	Article							INSULIN-RESISTANCE; INDUCED OBESITY; GUT MICROBIOTA; PROBIOTIC TREATMENT; METABOLIC SYNDROME; INFLAMMATION; MICE; HOMEOSTASIS; ENDOTOXEMIA; ADIPOSE	The development of intestinal permeability and the penetration of microbial products are key factors associated with the onset of metabolic disease. However, the mechanisms underlying this remain unclear. Here we show that, unlike liver or adipose tissue, high fat diet (HFD)/obesity in mice does not cause monocyte/macrophage infiltration into the intestine or pro-inflammatory changes in gene expression. Rather HFD causes depletion of intestinal eosinophils associated with the onset of intestinal permeability. Intestinal eosinophil numbers were restored by returning HFD fed mice to normal chow and were unchanged in leptin-deficient (Ob/Ob) mice, indicating that eosinophil depletion is caused specifically by a high fat diet and not obesity per se. Analysis of different aspects of intestinal permeability in HFD fed and Ob/Ob mice shows an association between eosinophil depletion and ileal paracelullar permeability, as well as leakage of albumin into the feces, but not overall permeability to FITC dextran. These findings provide the first evidence that a high fat diet causes intestinal eosinophil depletion, rather than inflammation, which may contribute to defective barrier integrity and the onset of metabolic disease.	[Johnson, Andrew M. F.; Quehenberger, Oswald; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA; [Armando, Aaron M.; Quehenberger, Oswald] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Gareau, Melanie G.] Univ Calif San Diego, Dept Gastroenterol, San Diego, CA 92103 USA; [Costanzo, Anne; Jameson, Julie M.] Calif State Univ San Marcos, Dept Biol, San Marcos, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; California State University System; California State University San Marcos	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, San Diego, CA 92103 USA.	jolefsky@ucsd.edu			A.D.A mentor-based fellowship [7-09-MN-37];  [D.K.0033651];  [D.K.074868];  [D.K.063491];  [D.K.09062]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER	A.D.A mentor-based fellowship; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the following grants D.K.0033651, D.K.074868, D.K.063491 and D.K.09062 (J.O.). A.M.F.J. was supported by an A.D.A mentor-based fellowship (7-09-MN-37). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar J, 2011, DIABETOLOGIA, V54, P3055, DOI 10.1007/s00125-011-2329-8; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brignardello J, 2010, ALIMENT PHARM THER, V32, P1307, DOI 10.1111/j.1365-2036.2010.04475.x; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Carlens J, 2009, J IMMUNOL, V183, P5600, DOI 10.4049/jimmunol.0801581; Chu VT, 2014, IMMUNITY, V40, P582, DOI 10.1016/j.immuni.2014.02.014; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Farache J, 2013, IMMUNOL CELL BIOL, V91, P232, DOI 10.1038/icb.2012.79; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Gareau MG, 2007, GUT, V56, P1522, DOI 10.1136/gut.2006.117176; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hogan SP, 2001, NAT IMMUNOL, V2, P353, DOI 10.1038/86365; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Lee JJ, 2010, CLIN EXP ALLERGY, V40, P563, DOI 10.1111/j.1365-2222.2010.03484.x; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Liu ZH, 2012, J NUTR BIOCHEM, V23, P1207, DOI 10.1016/j.jnutbio.2011.07.002; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Suzuki T, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-19; Svensson-Frej M, 2011, J INNATE IMMUN, V3, P565, DOI 10.1159/000328799; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Teixeira TFS, 2012, NUTR RES, V32, P637, DOI 10.1016/j.nutres.2012.07.003; Teixeira TFS, 2012, CLIN NUTR, V31, P735, DOI 10.1016/j.clnu.2012.02.009; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wen T, 2013, P NATL ACAD SCI USA, V110, P6067, DOI 10.1073/pnas.1220572110; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	42	88	92	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122195	10.1371/journal.pone.0122195	http://dx.doi.org/10.1371/journal.pone.0122195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837594	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000083
J	Piao, HL; Takahashi, K; Yamaguchi, Y; Wang, C; Liu, KX; Naruse, K				Piao, Hulin; Takahashi, Ken; Yamaguchi, Yohei; Wang, Chen; Liu, Kexiang; Naruse, Keiji			Transient Receptor Potential Melastatin-4 Is Involved in Hypoxia-Reoxygenation Injury in the Cardiomyocytes	PLOS ONE			English	Article							MYOCARDIAL REPERFUSION; SMOOTH-MUSCLE; CELL-DEATH; TRPM4; CHANNELS; PATHOPHYSIOLOGY; INHIBITION; MECHANISMS; ISCHEMIA; SYSTEM	Ischemic heart disease still remains the most common cause of cardiac death. During ischemia-reperfusion (I/R), reactive oxygen species (ROS) are produced in excess in cardiac tissue, where they induce cell death. Our previous study showed that 9-phenanthrol (9-Phe), a specific inhibitor of the TRPM4 channel, preserves cardiac contractile function and protects the heart from I/R injury-related infarction in the excised rat heart. Accordingly, we hypothesized that TRPM4 channels are involved in the 9-Phe-mediated cardioprotection against ROS-induced injury. In rats, intravenous 9-Phe mitigated the development of myocardial infarction caused by the occlusion of the left anterior descending artery. Immunohistochemical analysis indicated that TRPM4 proteins are expressed in ventricular myocytes susceptible to I/R injury. Hydrogen peroxide (H2O2) is among the main ROS overproduced during I/R. In the cardiomyocyte cell line H9c2, pretreatment with 9-Phe prevented cell death induced by conditions mimicking I/R, namely 200 mu M H2O2 and hypoxia-reoxygenation. Gene silencing of TRPM4 preserved the viability of H9c2 cardiomyocytes exposed to 200 mu M H2O2. These results suggest that the cardioprotective effects of 9-Phe are mediated through the inhibition of the TRPM4 channels.	[Piao, Hulin; Liu, Kexiang] Jilin Univ, Affiliated Hosp 2, Dept Cardiovasc Surg, Changchun, Peoples R China; [Piao, Hulin; Takahashi, Ken; Yamaguchi, Yohei; Naruse, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama, Japan; [Wang, Chen] Dalian Med Univ, Grad Sch, Dept Cardiol, Dalian, Peoples R China	Jilin University; Okayama University; Dalian Medical University	Takahashi, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cardiovasc Physiol, Okayama, Japan.	takah-k2@okayama-u.ac.jp	Sokabe, Masahiro/I-1565-2012; TAKAHASHI, Ken/B-1622-2011	TAKAHASHI, Ken/0000-0002-7580-8691; naruse, keiji/0000-0003-4100-6444; Wang, Chen/0000-0002-7143-811X	China Scholarship Council; Okayama University	China Scholarship Council(China Scholarship Council); Okayama University	The work of Hulin Piao was supported by a scholarship from the China Scholarship Council. This work was funded by a Grant-in-Aid for Strategic Research Promotion by the Okayama University.	Abriel H, 2012, BIOCHEM PHARMACOL, V84, P873, DOI 10.1016/j.bcp.2012.06.021; Becerra A, 2011, CARDIOVASC RES, V91, P677, DOI 10.1093/cvr/cvr135; BOLLI R, 1988, J AM COLL CARDIOL, V12, P239, DOI 10.1016/0735-1097(88)90381-6; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Goel M, 2007, AM J PHYSIOL-HEART C, V292, pH874, DOI 10.1152/ajpheart.00785.2006; Gonzales AL, 2010, AM J PHYSIOL-CELL PH, V299, pC1195, DOI 10.1152/ajpcell.00269.2010; Grand T, 2008, BRIT J PHARMACOL, V153, P1697, DOI 10.1038/bjp.2008.38; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Jang Y, 2012, ARCH PHARM RES, V35, P1823, DOI 10.1007/s12272-012-1016-8; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li CY, 2002, AM J PHYSIOL-CELL PH, V282, pC227, DOI 10.1152/ajpcell.00112.2001; Matsushima S, 2014, TRENDS CARDIOVAS MED, V24, P202, DOI 10.1016/j.tcm.2014.03.003; Raedschelders K, 2012, PHARMACOL THERAPEUT, V133, P230, DOI 10.1016/j.pharmthera.2011.11.004; Saikumar P, 1998, ONCOGENE, V17, P3341, DOI 10.1038/sj.onc.1202579; Sanada S, 2011, AM J PHYSIOL-HEART C, V301, pH1723, DOI 10.1152/ajpheart.00553.2011; Sarmiento D, 2014, MICROVASC RES; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Serafini N, 2012, J IMMUNOL, V189, P3689, DOI 10.4049/jimmunol.1102969; Simon F, 2010, J BIOL CHEM, V285, P37150, DOI 10.1074/jbc.M110.155390; SLEZAK J, 1995, AM J PATHOL, V147, P772; Tullio F, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0392-7; Visovatti S., 2010, HURSTS THE HEART, P1316; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070587; Yang XR, 2006, AM J PHYSIOL-LUNG C, V290, pL1267, DOI 10.1152/ajplung.00515.2005; Yoo JC, 2010, BIOCHEM BIOPH RES CO, V391, P806, DOI 10.1016/j.bbrc.2009.11.142	25	30	30	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121703	10.1371/journal.pone.0121703	http://dx.doi.org/10.1371/journal.pone.0121703			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836769	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000058
J	Shi, YL; Soderlund, M; Xiang, JH; Lu, YN				Shi, Yingli; Soderlund, Marcus; Xiang, Jianhai; Lu, Yuanan			Function and Regulation Domains of a Newly Isolated Putative beta-Actin Promoter from Pacific White Shrimp	PLOS ONE			English	Article							SPOT SYNDROME VIRUS; TRANSGENE INHERITANCE; PENAEUS-MONODON; GENE-TRANSFER; TIGER SHRIMP; EXPRESSION; CLONING; IDENTIFICATION; SEQUENCES; ENHANCER	Current development of transgenic shrimp research has been hampered due to the lack of the suitable promoters and efficient transfection methods for crustaceans. A 1642 bp sequence, containing 5'-upstream sequence, exon 1, intron 1 and partial exon 2, which is responsible for transcriptional initiation of the newly reported shrimp beta-actin (actinT1), has been isolated from the Pacific white shrimp (Litopenaeus vannamei) and named as SbaP. To determine its function and potential application in marine biotechnology, the sequence and functional domains were examined by constitutive expression of the luciferase reporter gene. We have identified 5' regions that play a central role in the expression of the mu-actin gene. The proximal promoter (-1642/-1325) contains two highly conserved transcriptional sites, CCAAT box and CArG motif. Two negative (-1140/-924, -222/-21) and one positive (-810/-425) regulatory elements have been identified in intron1. Transient transfection assay with a construct containing proximal promoter and enhancer (SbaP Delta-222/+1 Delta-1325/-924) regions of the shrimp beta-actin coupled with luciferase and EGFP (enhanced green fluorescent protein) showed that the promoter was not only functional in sf21 cells, but promoter activity was more than 8-fold higher than a viral-origin promoter (ie1, white spot syndrome virus immediate early gene promoter). Furthermore, SbaP Delta-222/+1 Delta-1325/924 drove a successful expression of luciferase injection assay in vivo injection and also showed higher promoter activity than the ie1 promoter, suggesting that the expression vectors constructed with SbaP Delta-222/+1 Delta-1325/-924 have important potential in gene transfer studies for shrimp and other crustacean species.	[Shi, Yingli; Soderlund, Marcus; Lu, Yuanan] Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA; [Shi, Yingli; Xiang, Jianhai] Chinese Acad Sci, Key Lab Expt Marine Biol, Inst Oceanol, Qingdao, Shandong, Peoples R China; [Shi, Yingli] Univ Chinese Acad Sci, Beijing, Peoples R China	University of Hawaii System; University of Hawaii Manoa; Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Lu, YN (corresponding author), Univ Hawaii Manoa, Dept Publ Hlth Sci, Honolulu, HI 96822 USA.	yuanan@hawaii.edu	xiang, jianhai/A-4767-2012	xiang, jianhai/0000-0001-5395-7787	University of Hawaii at Manoa OVCRGE [399767]; University of Hawaii Sea Grant [661160]	University of Hawaii at Manoa OVCRGE; University of Hawaii Sea Grant	This work was supported in part by a University of Hawaii at Manoa OVCRGE grant (No. 399767) and University of Hawaii Sea Grant (661160). However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MS, 1996, MOL REPROD DEV, V45, P117, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;117::AID-MRD2&gt;3.0.CO;2-W; Arenal Amilcar, 2000, Biotecnologia Aplicada, V17, P247; Beckmann S, 2007, EXP PARASITOL, V117, P292, DOI 10.1016/j.exppara.2007.04.007; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Cho YS, 2011, TRANSGENIC RES, V20, P1333, DOI 10.1007/s11248-011-9501-2; FAO, 2012, FISH AQ STAT, P18; Flegel T.W., 2008, DIS ASIAN AQUACULTUR, V6, P355; Green MR, 2012, MOL CLONING LAB MANU, V1; Hanley S, 1998, MOL MAR BIOL BIOTECH, V7, P165; Huang XD, 2010, VIROLOGY, V406, P176, DOI 10.1016/j.virol.2010.06.046; KAWAMOTO T, 1988, MOL CELL BIOL, V8, P267, DOI 10.1128/MCB.8.1.267; Kosuga M, 2000, CELL TRANSPLANT, V9, P675, DOI 10.1177/096368970000900513; LACY E, 1983, CELL, V34, P343, DOI 10.1016/0092-8674(83)90369-0; LARSEN NI, 1995, NUCLEIC ACIDS RES, V23, P1223, DOI 10.1093/nar/23.7.1223; Lee SY, 2009, FISH AQUAT SCI, V12, P90; Liu WJ, 2005, VIROLOGY, V334, P327, DOI 10.1016/j.virol.2005.01.047; LIU ZJ, 1991, GENE, V108, P211, DOI 10.1016/0378-1119(91)90436-F; LIU ZJ, 1990, MOL CELL BIOL, V10, P3432, DOI 10.1128/MCB.10.7.3432; Liu ZY, 2001, CHINESE SCI BULL, V46, P766, DOI 10.1007/BF03187219; MIWA T, 1987, P NATL ACAD SCI USA, V84, P6702, DOI 10.1073/pnas.84.19.6702; Musthaq SS, 2009, VIROLOGY, V391, P315, DOI 10.1016/j.virol.2009.06.017; NG SY, 1989, NUCLEIC ACIDS RES, V17, P601, DOI 10.1093/nar/17.2.601; NG SY, 1985, MOL CELL BIOL, V5, P2720, DOI 10.1128/MCB.5.10.2720; Noh JK, 2003, MAR BIOTECHNOL, V5, P244, DOI 10.1007/s10126-002-0066-1; Pawlowski WP, 1996, MOL BIOTECHNOL, V6, P17, DOI 10.1007/BF02762320; PENMAN DJ, 1991, MOL REPROD DEV, V30, P201, DOI 10.1002/mrd.1080300306; Ponprateep S, 2012, FISH SHELLFISH IMMUN, V32, P26, DOI 10.1016/j.fsi.2011.10.010; QUITSCHKE WW, 1989, J BIOL CHEM, V264, P9539; Rattanachai A, 2004, FISHERIES SCI, V70, P765, DOI 10.1111/j.1444-2906.2004.00869.x; SANDS AT, 1993, MOL REPROD DEV, V34, P117, DOI 10.1002/mrd.1080340202; Sun PS, 2007, MAR BIOL, V151, P2145, DOI 10.1007/s00227-007-0646-8; Sun PS, 2005, AQUACULTURE, V243, P19, DOI 10.1016/j.aquaculture.2004.09.037; Tseng FS, 2000, THERIOGENOLOGY, V54, P1421, DOI 10.1016/S0093-691X(00)00464-7; Yazawa R, 2005, J EXP ZOOL PART A, V303A, P1104, DOI 10.1002/jez.a.235; Zhang JQ, 2006, J BIOTECHNOL, V125, P173, DOI 10.1016/j.jbiotec.2006.03.010; Zhao C, 2013, FISH SHELLFISH IMMUN, V34, P397, DOI 10.1016/j.fsi.2012.09.022	36	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122262	10.1371/journal.pone.0122262	http://dx.doi.org/10.1371/journal.pone.0122262			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835297	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000090
J	Simonit, S; Connors, JP; Yoo, J; Kinzig, A; Perrings, C				Simonit, Silvio; Connors, John P.; Yoo, James; Kinzig, Ann; Perrings, Charles			The Impact of Forest Thinning on the Reliability of Water Supply in Central Arizona	PLOS ONE			English	Article							ECOSYSTEM SERVICES; CLIMATE-CHANGE; SUSTAINABILITY; MANAGEMENT; YIELD; US; BIODIVERSITY; CONSERVATION; WILDFIRE; MARKETS	Economic growth in Central Arizona, as in other semiarid systems characterized by low and variable rainfall, has historically depended on the effectiveness of strategies to manage water supply risks. Traditionally, the management of supply risks includes three elements: hard infrastructures, landscape management within the watershed, and a supporting set of institutions of which water markets are frequently the most important. In this paper we model the interactions between these elements. A forest restoration initiative in Central Arizona (the Four Forest Restoration Initiative, or 4FRI) will result in thinning of ponderosa pine forests in the upper watershed, with potential implications for both sedimentation rates and water delivery to reservoirs. Specifically, we model the net effect of ponderosa pine forest thinning across the Salt and Verde River watersheds on the reliability and cost of water supply to the Phoenix metropolitan area. We conclude that the sediment impacts of forest thinning (up to 50% of canopy cover) are unlikely to compromise the reliability of the reservoir system while thinning has the potential to increase annual water supply by 8%. This represents an estimated net present value of surface water storage of $104 million, considering both water consumption and hydropower generation.	[Simonit, Silvio; Connors, John P.; Kinzig, Ann; Perrings, Charles] Arizona State Univ, Sch Life Sci, EcoServ Grp, Tempe, AZ 85281 USA; [Simonit, Silvio] IUCN, Reg Off Mexico, Cent Amer & Caribbean, San Jose, Costa Rica; [Connors, John P.] Arizona State Univ, Sch Geog Sci & Urban Planning, Tempe, AZ USA; [Yoo, James] Calif Baptist Univ, Riverside, CA USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; California Baptist University	Simonit, S (corresponding author), Arizona State Univ, Sch Life Sci, EcoServ Grp, Tempe, AZ 85281 USA.	silvio.simonit@iucn.org			Biodiversity and Ecosystem Services Research Training Network (BESTNet) [0639252]; National Science Foundation	Biodiversity and Ecosystem Services Research Training Network (BESTNet); National Science Foundation(National Science Foundation (NSF))	The authors acknowledge support from the Biodiversity and Ecosystem Services Research Training Network (BESTNet) for research coordination Grant 0639252, from the National Science Foundation (www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADWR, 2010, DEM SUPPL A IN PRESS; ADWR, 2009, REG GROUNDW FLOW MOD; Arizona Department of Water Resources, 2014, AR NEXT CENT STRAT V; Arizona Department of Water Resources, 2009, CTR HIGHL PLANN AR, V5; AZ Department of Administration Office of Employment and Population Statistics, 2014, POP PROJ; BAKER MB, 1986, WATER RESOUR RES, V22, P67, DOI 10.1029/WR022i001p00067; Barbier EB, 2011, ANNU REV RESOUR ECON, V3, P337, DOI 10.1146/annurev-resource-083110-120115; BASSOW SL, 1994, ECOL APPL, V4, P593, DOI 10.2307/1941960; BAZZAZ FA, 1996, GLOBAL CHANGE TERRES, P43; BOSCH JM, 1982, J HYDROL, V55, P3, DOI 10.1016/0022-1694(82)90117-2; Brewer J., 2006, U MICH J L REFORM, V40, P1021; Cayan DR, 2010, P NATL ACAD SCI USA, V107, P21271, DOI 10.1073/pnas.0912391107; Claassen R, 2008, ECOL ECON, V65, P737, DOI 10.1016/j.ecolecon.2007.07.032; Clark EHI, 1986, ERODING SOILS OFF FA; Conte M, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P89; Covington W. W., 1994, Journal of Sustainable Forestry, V2, P153, DOI 10.1300/J091v02n01_07; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dore S, 2010, ECOL APPL, V20, P663, DOI 10.1890/09-0934.1; DUNNE T, 1979, J HYDROL, V42, P281, DOI 10.1016/0022-1694(79)90052-0; Gober P, 2010, P NATL ACAD SCI USA, V107, P21295, DOI 10.1073/pnas.0911113107; Gould BW, 1964, WATER RESOURCES USE, P161; Grafton RQ, 2012, WATER POLICY, V14, P175, DOI 10.2166/wp.2011.016; Grafton RQ, 2011, REV ENV ECON POLICY, V5, P219, DOI 10.1093/reep/rer002; Huffaker R, 2006, J ECON DYN CONTROL, V30, P2553, DOI 10.1016/j.jedc.2005.08.003; Jacobs KL, 2004, HYDROGEOL J, V12, P52, DOI 10.1007/s10040-003-0308-y; MacDonald GM, 2010, P NATL ACAD SCI USA, V107, P21256, DOI 10.1073/pnas.0909651107; McMahon TA, 1986, RIVER RESERVOIR YIEL; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; Reclamation Bo., 1995, THEODORE ROOSEVELT R; Sabo JL, 2010, P NATL ACAD SCI USA, V107, P21263, DOI 10.1073/pnas.1009734108; Sahin V, 1996, J HYDROL, V178, P293, DOI 10.1016/0022-1694(95)02825-0; Seager R, 2010, P NATL ACAD SCI USA, V107, P21277, DOI 10.1073/pnas.0910856107; Selig M, 2010, REPORT 4 FOREST REST; Simonit S, 2013, P NATL ACAD SCI USA, V110, P9326, DOI 10.1073/pnas.1112242110; Strand RI, 1982, RESERVOIR SEDIMENTAT; Tallis H, 2009, ANN NY ACAD SCI, V1162, P265, DOI 10.1111/j.1749-6632.2009.04152.x; Turpie JK, 2008, ECOL ECON, V65, P788, DOI 10.1016/j.ecolecon.2007.12.024; van Noordwijk M., 1998, P223; Vogel RM, 1999, J WATER RES PL-ASCE, V125, P245, DOI 10.1061/(ASCE)0733-9496(1999)125:5(245); Vogel RM, 1996, HYDROLOG SCI J, V41, P75, DOI 10.1080/02626669609491480; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Williams AP, 2010, P NATL ACAD SCI USA, V107, P21289, DOI 10.1073/pnas.0914211107; Winnett SM, 1998, CLIMATE RES, V11, P39, DOI 10.3354/cr011039; Worster Donald, 1985, RIVERS EMPIRE WATER; Yoo J, 2014, APPLIED ECONOMICS PE, V91, P57	46	12	12	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121596	10.1371/journal.pone.0121596	http://dx.doi.org/10.1371/journal.pone.0121596			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835003	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000049
J	Lee, D; Kim, EJ; Kilgore, PE; Kim, SA; Takahashi, H; Ohnishi, M; Anh, DD; Dong, BQ; Kim, JS; Tomono, J; Miyamoto, S; Notomi, T; Kim, DW; Seki, M				Lee, DoKyung; Kim, Eun Jin; Kilgore, Paul E.; Kim, Soon Ae; Takahashi, Hideyuki; Ohnishi, Makoto; Dang Duc Anh; Dong, Bai Qing; Kim, Jung Soo; Tomono, Jun; Miyamoto, Shigehiko; Notomi, Tsugunori; Kim, Dong Wook; Seki, Mitsuko			Clinical Evaluation of a Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Neisseria meningitidis in Cerebrospinal Fluid	PLOS ONE			English	Article							INFLUENZAE TYPE-B; POLYMERASE-CHAIN-REACTION; HAEMOPHILUS-INFLUENZAE; MENINGOCOCCAL DISEASE; BACTERIAL-MENINGITIS; COLORIMETRIC DETECTION; PCR; EPIDEMIOLOGY; DIAGNOSIS; CHILDREN	Background Neisseria meningitidis (Nm) is a leading causative agent of bacterial meningitis in humans. Traditionally, meningococcal meningitis has been diagnosed by bacterial culture. However, isolation of bacteria from patients' cerebrospinal fluid (CSF) is time consuming and sometimes yields negative results. Recently, polymerase chain reaction (PCR)-based diagnostic methods of detecting Nm have been considered the gold standard because of their superior sensitivity and specificity compared with culture. In this study, we developed a loop-mediated isothermal amplification (LAMP) method and evaluated its ability to detect Nm in cerebrospinal fluid (CSF). Methodology/Principal Findings We developed a meningococcal LAMP assay (Nm LAMP) that targets the ctrA gene. The primer specificity was validated using 16 strains of N. meningitidis (serogroup A, B, C, D, 29-E, W-135, X, Y, and Z) and 19 non-N. meningitidis species. Within 60 min, the Nm LAMP detected down to ten copies per reaction with sensitivity 1000-fold more than that of conventional PCR. The LAMP assays were evaluated using a set of 1574 randomly selected CSF specimens from children with suspected meningitis collected between 1998 and 2002 in Vietnam, China, and Korea. The LAMP method was shown to be more sensitive than PCR methods for CSF samples (31 CSF samples were positive by LAMP vs. 25 by PCR). The detection rate of the LAMP method was substantially higher than that of the PCR method. In a comparative analysis of the PCR and LAMP assays, the clinical sensitivity, specificity, positive predictive value, and negative predictive value of the LAMP assay were 100%, 99.6%, 80.6%, and 100%, respectively. Conclusions/Significance Compared to PCR, LAMP detected Nm with higher analytical and clinical sensitivity. This sensitive and specific LAMP method offers significant advantages for screening patients on a population basis and for diagnosis in clinical settings.	[Lee, DoKyung; Kim, Eun Jin; Kim, Dong Wook] Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea; [Lee, DoKyung; Kim, Eun Jin; Kim, Dong Wook] Hanyang Univ, Pharmacol Res Inst, Ansan, South Korea; [Kilgore, Paul E.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharm Practice, Detroit, MI USA; [Kim, Soon Ae] Int Vaccine Inst, Translat Res Div, Seoul, South Korea; [Takahashi, Hideyuki; Ohnishi, Makoto] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Dang Duc Anh] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam; [Dong, Bai Qing] Guangxi Zhuang Autonomous Reg Hlth Bur, Nanning, Guangxi, Peoples R China; [Kim, Jung Soo] Chonbuk Natl Univ, Sch Med, Jeonju 561756, South Korea; [Tomono, Jun; Miyamoto, Shigehiko] Kaneka Corp, Osaka, Japan; [Notomi, Tsugunori] Eiken Chem Co Ltd, Ohtawara, Tochigi, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dept Oral Hlth Sci, Tokyo 101, Japan; [Seki, Mitsuko] Nihon Univ, Sch Dent, Dent Res Ctr, Tokyo 101, Japan	Hanyang University; Hanyang University; Wayne State University; International Vaccine Institute; National Institute of Infectious Diseases (NIID); National Institute of Hygiene & Epidemiology (NIHE); Jeonbuk National University; Kaneka Corporation; Nihon University; Nihon University	Kim, DW (corresponding author), Hanyang Univ, Coll Pharm, Dept Pharm, Ansan, South Korea.	dongwook@hanyang.ac.kr; seki.mitsuko@nihon-u.ac.jp	Kilgore, Paul E/L-1462-2013; Kilgore, Paul/AAD-2869-2019; Kim, Dong Wook/H-8253-2015	Kilgore, Paul E/0000-0003-3214-4482; Kilgore, Paul/0000-0003-3214-4482; Kim, Dong Wook/0000-0001-5351-7597; Kim, Soon Ae/0000-0002-5945-2832	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (National Research Foundation of Korea, NRF); National Research Foundation (NRF) of Korea [2012R1A2A2A01009741];  [10201004]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions); Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (National Research Foundation of Korea, NRF); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); 	MS was supported by the Grant-in-Aid for Scientific Research (C) (No. 10201004) and a grant to promote multi-disciplinary research projects from the Ministry of Education, Culture, Sports, Science and Technology of Japan. MS and DWK were supported by the Japan Society for the Promotion of Science (JSPS) Bilateral Joint Research Projects/Seminars (JSPS's Counterpart Institutions; National Research Foundation of Korea, NRF). DWK was supported by the grant 2012R1A2A2A01009741 from National Research Foundation (NRF) of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anh DD, 2006, AM J TROP MED HYG, V74, P509, DOI 10.4269/ajtmh.2006.74.509; [Anonymous], 2001, Wkly Epidemiol Rec, V76, P282; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Francois P, 2011, FEMS IMMUNOL MED MIC, V62, P41, DOI 10.1111/j.1574-695X.2011.00785.x; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Isenberg HD., 1998, ESSENTIAL PROCEDURES; Kaneko H, 2007, J BIOCHEM BIOPH METH, V70, P499, DOI 10.1016/j.jbbm.2006.08.008; Kennedy WA, 2007, EPIDEMIOL INFECT, V135, P1217, DOI 10.1017/S0950268806007734; Kim DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042954; Kim DW, 2011, J CLIN MICROBIOL, V49, P3621, DOI 10.1128/JCM.00515-11; Kim JS, 2004, VACCINE, V22, P3952, DOI 10.1016/j.vaccine.2004.04.003; Kim SA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-310; McKenna JP, 2011, DIAGN MICR INFEC DIS, V69, P137, DOI 10.1016/j.diagmicrobio.2010.10.008; Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016; Mori Y, 2004, J BIOCHEM BIOPH METH, V59, P145, DOI 10.1016/j.jbbm.2003.12.005; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Huy NT, 2012, FEMS MICROBIOL LETT, V337, P25, DOI 10.1111/1574-6968.12002; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Stephens DS, 2009, VACCINE, V27, pB71, DOI 10.1016/j.vaccine.2009.04.070; Taha MK, 2005, J CLIN MICROBIOL, V43, P144, DOI 10.1128/JCM.43.1.144-149.2005; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tzanakaki G, 2003, FEMS IMMUNOL MED MIC, V39, P31, DOI 10.1016/S0928-8244(03)00175-5; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P1904, DOI 10.4161/hv.21666; Vyse A, 2011, EPIDEMIOL INFECT, V139, P967, DOI 10.1017/S0950268811000574; World Health Organization, 2010, IN VACC RES REP 2008, DOI [10.1371/journal.pone.0095708, DOI 10.1371/JOURNAL.PONE.0095708]; Wylie PAL, 1997, BRIT MED J, V315, P774, DOI 10.1136/bmj.315.7111.774	27	50	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122922	10.1371/journal.pone.0122922	http://dx.doi.org/10.1371/journal.pone.0122922			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853422	gold, Green Published			2022-12-26	WOS:000352478400086
J	van de Put, MAJ; Vehof, J; Hooymans, JMM; Los, LI				van de Put, Mathijs A. J.; Vehof, Jelle; Hooymans, Johanna. M. M.; Los, Leonoor I.			Postoperative Metamorphopsia in Macula-Off Rhegmatogenous Retinal Detachment: Associations with Visual Function, Vision Related Quality of Life, and Optical Coherence Tomography Findings	PLOS ONE			English	Article							SURGERY	Purpose To evaluate postoperative metamorphopsia in macula-off rhegmatogenous retinal detachment (RRD) and its association with visual function, vision related quality of life, and optical coherence tomography (OCT) findings. Methods 45 patients with primary macula-off RRD were included. At 12 months postoperatively, data on metamorphopsia using sine amsler charts (SAC), best corrected visual acuity (BCVA), letter contrast sensitivity, color vision (saturated and desaturated color confusion indexes), critical print size, reading acuity, the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ-25), and OCT, were obtained. Results Metamorphopsia was present in 39 patients (88.6%), with most of them (n = 35, 77.8%) showing only mild metamorphopsia (SAC score = 1). Patients with metamorphopsia had significantly worse postoperative BCVA (p = 0.02), critical print size (p<0.0005), and reading acuity (p = 0.001) compared to patients without metamorphopsia. Other visual function outcomes and NEI-VFQ-25 overall composite score were all also somewhat lower in patients with metamorphopsia, but this did not reach statistical significance. No association with OCT findings was present. Conclusion The prevalence of postoperative metamorphopsia in macula-off RRD patients is high, however, the degree of metamorphopsia is relatively low. When metamorphopsia is present, visual functions seem to be compromised, while vision related quality of life is only mildly affected.	[van de Put, Mathijs A. J.; Vehof, Jelle; Hooymans, Johanna. M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Vehof, Jelle] St Thomas Hosp, Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Hooymans, Johanna. M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl						Bouwens MD, 2003, GRAEF ARCH CLIN EXP, V241, P89, DOI 10.1007/s00417-002-0613-5; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; Cappello E, 2009, RETINA-J RET VIT DIS, V29, P1111, DOI 10.1097/IAE.0b013e3181a3b832; Chan A, 2006, ARCH OPHTHALMOL-CHIC, V124, P193, DOI 10.1001/archopht.124.2.193; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2014, AM J OPHTHALMOL, V157, P214, DOI 10.1016/j.ajo.2013.08.007; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Ricker LJAG, 2011, RETINA-J RET VIT DIS, V31, P1505, DOI 10.1097/IAE.0b013e31820a6910; Rossetti A, 2010, EYE, V44, P4012, DOI [10.1021/es903673q, DOI 10.1021/ES903673Q]; Shiragami C, 2010, OPHTHALMOLOGY, V117, P86, DOI 10.1016/j.ophtha.2009.06.025; Van de Put M, 2013, ACTA OPHTHALMOL, V91, DOI 10.1111/j.1755-3768.2013.2411.x; van de Put MAJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099787; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Van der Sterre GW, NATL EYE I VISUAL FU; Wang Y, 2005, ACTA OPHTHALMOL SCAN, V83, P168, DOI 10.1111/j.1600-0420.2005.00413.x	21	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120543	10.1371/journal.pone.0120543	http://dx.doi.org/10.1371/journal.pone.0120543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853573	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400016
J	Bianchi, R; Teijeira, A; Proulx, ST; Christiansen, AJ; Seidel, CD; Rulicke, T; Makinen, T; Hagerling, R; Halin, C; Detmar, M				Bianchi, Roberta; Teijeira, Alvaro; Proulx, Steven T.; Christiansen, Ailsa J.; Seidel, Catharina D.; Ruelicke, Thomas; Maekinen, Taija; Haegerling, Rene; Halin, Cornelia; Detmar, Michael			A Transgenic Prox1-Cre-tdTomato Reporter Mouse for Lymphatic Vessel Research	PLOS ONE			English	Article							DENDRITIC CELL-MIGRATION; RED FLUORESCENT PROTEIN; VALVE FORMATION; INFLAMMATION; LYMPHANGIOGENESIS; PROX1; MICE; EXPRESSION; GENE; ENDOTHELIUM	The lymphatic vascular system plays an active role in immune cell trafficking, inflammation and cancer spread. In order to provide an in vivo tool to improve our understanding of lymphatic vessel function in physiological and pathological conditions, we generated and characterized a tdTomato reporter mouse and crossed it with a mouse line expressing Cre recombinase under the control of the lymphatic specific promoter Prox1 in an inducible fashion. We found that the tdTomato fluorescent signal recapitulates the expression pattern of Prox1 in lymphatic vessels and other known Prox1-expressing organs. Importantly, tdTomato co-localized with the lymphatic markers Prox1, LYVE-1 and podoplanin as assessed by whole-mount immunofluorescence and FACS analysis. The tdTomato reporter was brighter than a previously established red fluorescent reporter line. We confirmed the applicability of this animal model to intravital microscopy of dendritic cell migration into and within lymphatic vessels, and to fluorescence-activated single cell analysis of lymphatic endothelial cells. Additionally, we were able to describe the early morphological changes of the lymphatic vasculature upon induction of skin inflammation. The Prox1-Cre-tdTomato reporter mouse thus shows great potential for lymphatic research.	[Bianchi, Roberta; Teijeira, Alvaro; Proulx, Steven T.; Christiansen, Ailsa J.; Seidel, Catharina D.; Halin, Cornelia; Detmar, Michael] ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland; [Ruelicke, Thomas] Univ Vet Med, Inst Lab Anim Sci, Vienna, Austria; [Maekinen, Taija] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Haegerling, Rene] Max Planck Inst Mol Biomed, Dept Vasc Cell Biol, Mammalian Cell Signaling Lab, D-48149 Munster, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Veterinary Medicine Vienna; Uppsala University; Max Planck Society	Detmar, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Zurich, Switzerland.	michael.detmar@pharma.ethz.ch	Makinen, Taija/C-5765-2014; Teijeira, Alvaro/I-6903-2017; Makinen, Taija/CAI-2233-2022	Makinen, Taija/0000-0002-9338-1257; Teijeira, Alvaro/0000-0002-7339-4464; Makinen, Taija/0000-0002-9338-1257; Hagerling, Rene/0000-0002-6830-2043; Proulx, Steven/0000-0003-2154-8502; Halin, Cornelia/0000-0002-7899-2850; Christiansen, Ailsa/0000-0002-8151-7444	Swiss National Science Foundation [31003A-130627]; Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Advanced European Research Council Grant LYVICAM; Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich(Leducq Foundation)	This work was supported by Swiss National Science Foundation grant 31003A-130627, Advanced European Research Council Grant LYVICAM, the Leducq Foundation Transatlantic Network of Excellence grant Lymph Vessels in Obesity and Cardiovascular Disease, Oncosuisse and Krebsliga Zurich (to M.D.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebischer D, 2014, ANGIOGENESIS, V17, P383, DOI 10.1007/s10456-013-9404-3; Alitalo A, 2012, ONCOGENE, V31, P4499, DOI 10.1038/onc.2011.602; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Buchholz F, 1996, NUCLEIC ACIDS RES, V24, P3118, DOI 10.1093/nar/24.15.3118; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; CLARK AJ, 1994, REPROD FERT DEVELOP, V6, P589, DOI 10.1071/RD9940589; Dieterich LC, 2014, ANGIOGENESIS, V17, P359, DOI 10.1007/s10456-013-9406-1; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Hagerling R, 2011, BIOCHEM SOC T, V39, P1674, DOI 10.1042/BST20110722; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Halin C, 2008, METHOD ENZYMOL, V445, P1, DOI 10.1016/S0076-6879(08)03001-2; Hong YK, 2002, DEV DYNAM, V225, P351, DOI 10.1002/dvdy.10163; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Jurisic G, 2009, CELL TISSUE RES, V335, P97, DOI 10.1007/s00441-008-0644-2; Kataoka K, 2008, CARCINOGENESIS, V29, P1108, DOI 10.1093/carcin/bgn061; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Mumprecht V, 2010, CANCER RES, V70, P8842, DOI 10.1158/0008-5472.CAN-10-0896; Nitschke M, 2012, BLOOD, V120, P2249, DOI 10.1182/blood-2012-03-417923; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Pham THM, 2010, J EXP MED, V207, P17, DOI 10.1084/jem.20091619; Proulx ST, 2013, BIOMATERIALS, V34, P5128, DOI 10.1016/j.biomaterials.2013.03.034; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Sawicki JA, 1998, EXP CELL RES, V244, P367, DOI 10.1006/excr.1998.4175; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tal O, 2011, J EXP MED, V208, P2141, DOI 10.1084/jem.20102392; Truman LA, 2013, LYMPHAT RES BIOL, V11, P187, DOI 10.1089/lrb.2013.0013; Truman LA, 2012, AM J PATHOL, V180, P1715, DOI 10.1016/j.ajpath.2011.12.026; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1	35	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122976	10.1371/journal.pone.0122976	http://dx.doi.org/10.1371/journal.pone.0122976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849579	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800186
J	Buchholz, M; Honstein, T; Kirchhoff, S; Kreider, R; Schmidt, H; Sipos, B; Gress, TM				Buchholz, Malte; Honstein, Tatjana; Kirchhoff, Sandra; Kreider, Ramona; Schmidt, Harald; Sipos, Bence; Gress, Thomas M.			A Multistep High-Content Screening Approach to Identify Novel Functionally Relevant Target Genes in Pancreatic Cancer	PLOS ONE			English	Article							CELL-LINES; EXPRESSION PROFILES; CARCINOMA CELLS; DIFFERENTIATION; OVEREXPRESSION; IDENTIFICATION; GEMCITABINE; INVASION; ADENOCARCINOMA; ESTABLISHMENT	In order to foster the systematic identification of novel genes with important functional roles in pancreatic cancer, we have devised a multi-stage screening strategy to provide a rational basis for the selection of highly relevant novel candidate genes based on the results of functional high-content analyses. The workflow comprised three consecutive stages: 1) serial gene expression profiling analyses of primary human pancreatic tissues as well as a number of in vivo and in vitro models of tumor-relevant characteristics in order to identify genes with conspicuous expression patterns; 2) use of 'reverse transfection array' technology for large-scale parallelized functional analyses of potential candidate genes in cell-based assays; and 3) selection of individual candidate genes for further in-depth examination of their cellular roles. A total of 14 genes, among them 8 from "druggable" gene families, were classified as high priority candidates for individual functional characterization. As an example to demonstrate the validity of the approach, comprehensive functional data on candidate gene ADRBK1/GRK2, which has previously not been implicated in pancreatic cancer, is presented.	[Buchholz, Malte; Honstein, Tatjana; Kirchhoff, Sandra; Kreider, Ramona; Schmidt, Harald; Gress, Thomas M.] Univ Marburg, Clin Gastroenterol Endocrinol Metab & Infectiol, Marburg, Germany; [Sipos, Bence] Univ Tubingen Hosp, Dept Pathol & Neuropathol, Tubingen, Germany	Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Buchholz, M (corresponding author), Univ Marburg, Clin Gastroenterol Endocrinol Metab & Infectiol, Marburg, Germany.	malte.buchholz@staff.uni-marburg.de		Gress, Thomas/0000-0002-9333-5461	EU [LSHB-CT-2006-018771, 602783]; German federal ministry of education and research (BMBF) [PKB-01GS08, 01GS08178]; German Research Foundation (DFG) [Bu 1536/3-1]	EU(European Commission); German federal ministry of education and research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG))	This work was funded in part by EU FP6 grant LSHB-CT-2006-018771 (Integrated Project "MolDiag-Paca"), the German federal ministry of education and research (BMBF) within the framework of the program of medical genome research (PaCaNet; project ID PKB-01GS08 and 01GS08178), the German Research Foundation (DFG; grant Bu 1536/3-1 to M.B.), and EU FP7 grant no. 602783 (large-scale integrated project "CAM-PaC"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgart S, 2012, GASTROENTEROLOGY, V142, P388, DOI 10.1053/j.gastro.2011.11.001; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bookout AL, 2003, J BIOL CHEM, V278, P37569, DOI 10.1074/jbc.M306276200; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Buchholz M, 2003, CANCER RES, V63, P4945; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Burris H, 1997, EUR J CANCER, V33, pS18, DOI 10.1016/S0959-8049(96)00324-3; Chen R, 2005, GASTROENTEROLOGY, V129, P1187, DOI 10.1053/j.gastro.2005.08.001; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Crnogorac-Jurcevic T, 2005, GASTROENTEROLOGY, V129, P1454, DOI 10.1053/j.gastro.2005.08.012; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; DREXLER HG, 1995, LEUKEMIA RES, V19, P681, DOI 10.1016/0145-2126(95)00036-N; ELSASSER HP, 1992, VIRCHOWS ARCH B, V61, P295, DOI 10.1007/BF02890431; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Evron T, 2012, TRENDS PHARMACOL SCI, V33, P154, DOI 10.1016/j.tips.2011.12.003; Fensterer H, 2004, GENE CHROMOSOME CANC, V39, P224, DOI 10.1002/gcc.20000; Gress TM, 2012, J MOL MED, V90, P457, DOI 10.1007/s00109-011-0832-5; Gress TM, 1996, ONCOGENE, V13, P1819; Gress TM, 1997, GENE CHROMOSOME CANC, V19, P97, DOI 10.1002/(SICI)1098-2264(199706)19:2<97::AID-GCC5>3.0.CO;2-V; Han HY, 2002, CANCER RES, V62, P2890; Harada T, 2008, ONCOGENE, V27, P1951, DOI 10.1038/sj.onc.1210832; Holzmann K, 2004, CANCER RES, V64, P4428, DOI 10.1158/0008-5472.CAN-04-0431; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Iacobuzio-Donahue CA, 2002, AM J PATHOL, V160, P1239, DOI 10.1016/S0002-9440(10)62551-5; Iwamura T, 1997, CANCER RES, V57, P1206; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kuhnemuth B, 2015, ONCOGENE, V34, P177, DOI 10.1038/onc.2013.530; Lehnert L, 1999, ANN NY ACAD SCI, V880, P83, DOI 10.1111/j.1749-6632.1999.tb09512.x; LIEBER M, 1975, INT J CANCER, V15, P741, DOI 10.1002/ijc.2910150505; Logsdon CD, 2003, CANCER RES, V63, P2649; Mannherz O, 2006, GENOMICS, V87, P665, DOI 10.1016/j.ygeno.2005.12.009; Maurice JP, 1999, AM J PHYSIOL-HEART C, V276, pH1853, DOI 10.1152/ajpheart.1999.276.6.H1853; Metaye T, 2008, J ENDOCRINOL, V198, P101, DOI 10.1677/JOE-07-0562; Michl P, 2013, GUT, V62, P317, DOI 10.1136/gutjnl-2012-303588; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Plath T, 2002, J NATL CANCER I, V94, P129, DOI 10.1093/jnci/94.2.129; Prasad NB, 2005, CANCER RES, V65, P1619, DOI 10.1158/0008-5472.CAN-04-1413; Rivas V, 2013, J CLIN INVEST, V123, P4714, DOI 10.1172/JCI67333; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson JC, 2000, EMBO REP, V1, P287, DOI 10.1093/embo-reports/kvd058; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; VILA MR, 1995, LAB INVEST, V72, P395; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wei ZY, 2012, J CELL PHYSIOL, V227, P2371, DOI 10.1002/jcp.22972; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Xu LJ, 2014, INT J ONCOL, V44, P459, DOI 10.3892/ijo.2013.2189; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114; ZUR HAUSEN HARALD, 1967, J VIROL, V1, P1174	51	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122946	10.1371/journal.pone.0122946	http://dx.doi.org/10.1371/journal.pone.0122946			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849100	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800180
J	de Oliveira, JT; Santos, AL; Gomes, C; Barros, R; Ribeiro, C; Mendes, N; de Matos, AJ; Vasconcelos, MH; Oliveira, MJ; Reis, CA; Gartner, F				de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; de Matos, Augusto J.; Helena Vasconcelos, M.; Oliveira, Maria Jose; Reis, Celso A.; Gaertner, Fatima			Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness	PLOS ONE			English	Article							BREAST-CANCER; LEWIS-X; EXPRESSION; SIALIDASE; SIALYLATION; INFLUENZA; CARCINOMA; SURVIVAL; ROLES; GLYCOSYLATION	Oseltamivir phosphate is a widely used anti-influenza sialidase inhibitor. Sialylation, governed by sialyltransferases and sialidases, is strongly implicated in the oncogenesis and progression of breast cancer. In this study we evaluated the biological behavior of canine mammary tumor cells upon oseltamivir phosphate treatment (a sialidase inhibitor) in vitro and in vivo. Our in vitro results showed that oseltamivir phosphate impairs sialidase activity leading to increased sialylation in CMA07 and CMT-U27 canine mammary cancer cells. Surprisingly, oseltamivir phosphate stimulated, CMT-U27 cell migration and invasion capacity in vitro, in a dose-dependent manner. CMT-U27 tumors xenograft of oseltamivir phosphate-treated nude mice showed increased sialylation, namely alpha 2,6 terminal structures and SLe(x) expression. Remarkably, a trend towards increased lung metastases was observed in oseltamivir phosphate-treated nude mice. Taken together, our findings revealed that oseltamivir impairs canine mammary cancer cell sialidase activity, altering the sialylation pattern of canine mammary tumors, and leading, surprisingly, to in vitro and in vivo increased mammary tumor aggressiveness.	[de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; Helena Vasconcelos, M.; Oliveira, Maria Jose; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Invest & Inovacao Saude, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.; Santos, Ana L.; Gomes, Catarina; Barros, Rita; Ribeiro, Claudia; Mendes, Nuno; Helena Vasconcelos, M.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.; de Matos, Augusto J.; Reis, Celso A.; Gaertner, Fatima] Univ Porto, Inst Ciencias Biomed Abel Salazar, P-4200465 Oporto, Portugal; [de Oliveira, Joana T.] Lusophone Univ Humanities & Technol, Fac Vet Med, Lisbon, Portugal; [de Matos, Augusto J.] Food & Agrarian Sci & Technol Inst ICETA, Anim Sci & Study Cent CECA, Oporto, Portugal; [Helena Vasconcelos, M.] Univ Porto, Fac Pharm, Dept Biol Sci, P-4200465 Oporto, Portugal; [Oliveira, Maria Jose] Univ Porto, Inst Biomed Engn INEB, P-4200465 Oporto, Portugal; [Oliveira, Maria Jose; Reis, Celso A.] Univ Porto, Fac Med, Dept Pathol & Oncol, P-4200465 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Lusofona University; Universidade de Lisboa; Universidade do Porto; Universidade do Porto; Universidade do Porto	de Oliveira, JT (corresponding author), Univ Porto, IPATIMUP, Inst Mol Pathol & Immunol, Rua Dr Roberto Frias S-N, P-4200465 Oporto, Portugal.	joanao@ipatimup.pt	Gomes, Catarina/AAU-4636-2020; Vasconcelos, M. Helena/J-9547-2013; Barros, Rita/C-1072-2012; REIS, Celso A/B-9969-2008; Gomes, Catarina/CAJ-5505-2022; Gomes, Catarina/AAC-3325-2021; Oliveira, Maria Jose/K-3275-2013; Ribeiro, Ana Claudia/E-6906-2015; Gartner, Maria de Fatima/A-3530-2010	Barros, Rita/0000-0002-1667-7329; REIS, Celso A/0000-0002-0286-6639; Gomes, Catarina/0000-0002-0352-6783; Oliveira, Maria Jose/0000-0002-0724-0272; Ribeiro, Ana Claudia/0000-0002-1723-5055; Vasconcelos, M. Helena/0000-0002-7801-4643; Mendes, Nuno/0000-0002-0570-2277; Gartner, Maria de Fatima/0000-0002-5302-0086	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology;  [PTDC/CVT/117610/2010]	Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao (POCI) do Quadro Comunitario de Apoio III"; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); 	This work was supported by the Portuguese agency "Fundacao para a Ciencia e a Tecnologia, Programa Operacional Ciencia e Inovacao 2010 (POCI 2010) do Quadro Comunitario de Apoio III" and Project grant no. PTDC/CVT/117610/2010. RB (SFRH/BPD/68276/2010) and CG (SFRH/BPD/96510/2013) acknowledge the Portuguese Foundation for Science and Technology. Institute of Molecular Pathology and Immunology is an Associate Laboratory of the Portuguese Ministry of Ministry of Science, Technology and Higher Education and is partially supported by the Portuguese Foundation for Science and Technology.	Amith Schammim R, 2010, J Vis Exp, DOI 10.3791/2142; Brown JR, 2006, CLIN CANCER RES, V12, P2894, DOI 10.1158/1078-0432.CCR-05-2745; Bull C, 2013, MOL CANCER THER, V12, P1935, DOI 10.1158/1535-7163.MCT-13-0279; Carvalho AS, 2010, INT J BIOCHEM CELL B, V42, P80, DOI 10.1016/j.biocel.2009.09.010; Chavas LMG, 2010, J MED CHEM, V53, P2998, DOI 10.1021/jm100078r; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Cheng P, 2005, WORLD J GASTROENTERO, V11, P5117; Coory M, 2014, J CLIN EPIDEMIOL, V67, P966, DOI 10.1016/j.jclinepi.2014.03.006; Crain SM, 2004, BRAIN RES, V995, P260, DOI 10.1016/j.brainres.2003.09.068; Croce MV, 2007, PATHOL ONCOL RES, V13, P130, DOI 10.1007/BF02893488; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio F, 2001, GLYCOCONJUGATE J, V18, P841, DOI 10.1023/A:1022288022969; de la Cruz MSD, 2014, PRIMARY CARE, V41, P283, DOI 10.1016/j.pop.2014.02.006; de Oliveira JT, 2009, VET J, V182, P491, DOI 10.1016/j.tvjl.2008.09.007; de Oliveira JT, 2010, GLYCOBIOLOGY, V20, P1341, DOI 10.1093/glycob/cwq103; de Oliveira JT, 2011, INT J DEV BIOL, V55, P823, DOI 10.1387/ijdb.113359jt; Engelhard D, 2013, TRANSPL INFECT DIS, V15, P219, DOI 10.1111/tid.12054; Finlay TM, 2010, GLYCOCONJUGATE J, V27, P583, DOI 10.1007/s10719-010-9302-5; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gilmour AM, 2013, CELL SIGNAL, V25, P2587, DOI 10.1016/j.cellsig.2013.08.008; Gomes C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066737; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hata K, 2008, ANTIMICROB AGENTS CH, V52, P3484, DOI 10.1128/AAC.00344-08; HELLMEN E, 1992, IN VITRO CELL DEV-AN, V28A, P309, DOI 10.1007/BF02877054; Holmes S, 2013, CANCER EPIDEMIOL, V37, P881, DOI 10.1016/j.canep.2013.09.001; Horm TM, 2013, CELL ADHES MIGR, V7, P187, DOI 10.4161/cam.23131; Ibrahim NK, 2013, J CANCER, V4, P577, DOI 10.7150/jca.7028; Izumi Y, 2007, NEUROSCI LETT, V426, P54, DOI 10.1016/j.neulet.2007.08.054; Jandus C, 2011, BIOCHEM PHARMACOL, V82, P323, DOI 10.1016/j.bcp.2011.05.018; Jayant S, 2007, PHARM RES, V24, P2120, DOI 10.1007/s11095-007-9406-1; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2545; Jeschke U, 2005, ANTICANCER RES, V25, P1615; Marcos NT, 2004, CANCER RES, V64, P7050, DOI 10.1158/0008-5472.CAN-04-1921; Marcos Nuno T, 2011, Front Biosci (Elite Ed), V3, P1443; Matos AJF, 2012, VET J, V193, P24, DOI 10.1016/j.tvjl.2011.12.019; Matsuura N, 1997, JPN J CLIN ONCOL, V27, P135, DOI 10.1093/jjco/27.3.135; MIYAGI T, 1993, J BIOL CHEM, V268, P26435; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Moore ML, 2007, J IMMUNOL, V178, P2651, DOI 10.4049/jimmunol.178.5.2651; Morimoto K, 2008, DRUG METAB DISPOS, V36, P6, DOI 10.1124/dmd.107.017699; O I, 2000, BIOCHEM BIOPH RES CO, V268, P106, DOI 10.1006/bbrc.1999.2061; O'Shea LK, 2014, ONCOTARGETS THER, V7, P117, DOI 10.2147/OTT.S55344; Ochoa-Alvarez JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041845; Paoloni M, 2008, NAT REV CANCER, V8, P147, DOI 10.1038/nrc2273; Pinho S, 2007, CANCER LETT, V249, P157, DOI 10.1016/j.canlet.2006.08.010; Reis CA, 2010, J CLIN PATHOL, V63, P322, DOI 10.1136/jcp.2009.071035; Sarkar AK, 1997, J BIOL CHEM, V272, P25608, DOI 10.1074/jbc.272.41.25608; Sawada M, 2002, INT J CANCER, V97, P180, DOI 10.1002/ijc.1598; Sawada M, 1998, ACTA BIOCHIM POL, V45, P343, DOI 10.18388/abp.1998_4229; Schunemann HJ, 2007, LANCET INFECT DIS, V7, P21, DOI 10.1016/S1473-3099(06)70684-3; Seto B, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-29; Tsai CS, 2013, P NATL ACAD SCI USA, V110, P2466, DOI 10.1073/pnas.1222183110; Varki A., 2009, ESSENTIALS GLYCOBIOL; Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816; Wilson JC, 2003, CURR DRUG TARGETS, V4, P389, DOI 10.2174/1389450033491019; Woronowicz A, 2007, GLYCOBIOLOGY, V17, P10, DOI 10.1093/glycob/cwl049; Ye TH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085887; Yeung SJ, 2008, CELL MOL LIFE SCI, V65, P3981, DOI 10.1007/s00018-008-8224-x; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	60	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121590	10.1371/journal.pone.0121590	http://dx.doi.org/10.1371/journal.pone.0121590			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850034	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800069
J	de Paola, I; Pirone, L; Palmieri, M; Balasco, N; Esposito, L; Russo, L; Mazza, D; Di Marcotullio, L; Di Gaetano, S; Malgieri, G; Vitagliano, L; Pedone, E; Zaccaro, L				de Paola, Ivan; Pirone, Luciano; Palmieri, Maddalena; Balasco, Nicole; Esposito, Luciana; Russo, Luigi; Mazza, Daniela; Di Marcotullio, Lucia; Di Gaetano, Sonia; Malgieri, Gaetano; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura			Cullin3-BTB Interface: A Novel Target for Stapled Peptides	PLOS ONE			English	Article							HISTONE DEACETYLASE; SECONDARY STRUCTURE; ESSENTIAL DYNAMICS; UBIQUITIN LIGASES; PROTEIN; DOMAIN; TETRAMERIZATION; PROGRAM; FAMILY; IDENTIFICATION	Cullin3 (Cul3), a key factor of protein ubiquitination, is able to interact with dozens of different proteins containing a BTB (Bric-a-brac, Tramtrack and Broad Complex) domain. We here targeted the Cul3-BTB interface by using the intriguing approach of stabilizing the alpha-helical conformation of Cul3-based peptides through the "stapling" with a hydrocarbon cross-linker. In particular, by combining theoretical and experimental techniques, we designed and characterized stapled Cul3-based peptides embedding the helix 2 of the protein (residues 49-68). Intriguingly, CD and NMR experiments demonstrate that these stapled peptides were able to adopt the helical structure that the fragment assumes in the parent protein. We also show that some of these peptides were able to bind to the BTB of the tetrameric KCTD11, a substrate adaptor involved in HDAC1 degradation, with high affinity (similar to 300-600 nM). Cul3-derived staple peptides are also able to bind the BTB of the pentameric KCTD5. Interestingly, the affinity of these peptides is of the same order of magnitude of that reported for the interaction of full-length Cul3 with some BTB containing proteins. Moreover, present data indicate that stapling endows these peptides with an increased serum stability. Altogether, these findings indicate that the designed stapled peptides can efficiently mimic protein-protein interactions and are potentially able to modulate fundamental biological processes involving Cul3.	[de Paola, Ivan; Balasco, Nicole; Esposito, Luciana; Di Gaetano, Sonia; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura] CNR, Inst Biostruct & Bioimaging, Naples, Italy; [Pirone, Luciano] CNR, Inst Crystallog, I-70126 Bari, Italy; [Palmieri, Maddalena; Balasco, Nicole; Russo, Luigi; Malgieri, Gaetano] Univ Naples 2, Caserta, Italy; [Esposito, Luciana; Di Gaetano, Sonia; Vitagliano, Luigi; Pedone, Emilia; Zaccaro, Laura] Interuniv Ctr Res Bioact Peptides CIRPEB, Naples, Italy; [Mazza, Daniela; Di Marcotullio, Lucia] Univ Roma La Sapienza, Dept Mol Med, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR); Universita della Campania Vanvitelli; Sapienza University Rome	Pedone, E (corresponding author), CNR, Inst Biostruct & Bioimaging, Naples, Italy.	empedone@unina.it; lzaccaro@unina.it	Pedone, Emilia/HDN-2342-2022; Malgieri, Gaetano/N-1678-2016; esposito, luciana/Q-3182-2017; Pirone, Luciano/ABG-2892-2020; Pedone, Emilia Maria/K-2229-2015; Pirone, Luciano/G-7256-2015; Mazzà, Daniela/AAK-3687-2021; de Paola, Ivan/B-6867-2017	Pedone, Emilia/0000-0003-0203-8611; esposito, luciana/0000-0001-6431-2677; Pirone, Luciano/0000-0002-7014-4689; Pedone, Emilia Maria/0000-0003-0203-8611; Pirone, Luciano/0000-0002-7014-4689; Mazzà, Daniela/0000-0003-4754-9394; de Paola, Ivan/0000-0003-1508-6591; RUSSO, Luigi/0000-0002-1577-176X; Di Gaetano, Sonia/0000-0001-5523-3619; Balasco, Nicole/0000-0001-7862-9448; DI MARCOTULLIO, LUCIA/0000-0003-0274-7178; MALGIERI, Gaetano/0000-0002-4070-9458	Italian MIUR [FIRB RBAP114AMK 006]	Italian MIUR(Ministry of Education, Universities and Research (MIUR))	This work was funded by the Italian MIUR for financial support (FIRB RBAP114AMK 006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadei A, 1999, PROTEINS, V36, P419, DOI 10.1002/(SICI)1097-0134(19990901)36:4<419::AID-PROT5>3.3.CO;2-L; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Azizieh R, 2011, MOL NEUROBIOL, V44, P111, DOI 10.1007/s12035-011-8194-0; Balasco N, 2014, BIOCH BIOPHYS ACTA; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Berjanskii MV, 2006, NUCLEIC ACIDS RES, V34, pW63, DOI 10.1093/nar/gkl341; Bernal F, 2007, J AM CHEM SOC, V129, P5298, DOI 10.1021/ja076886p; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Bird GH, 2014, ACS CHEM BIOL, V9, P831, DOI 10.1021/cb4003305; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Blackwell HE, 1998, ANGEW CHEM INT EDIT, V37, P3281, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3281::AID-ANIE3281>3.0.CO;2-V; Canettieri G, 2010, NAT CELL BIOL, V12, P132, DOI 10.1038/ncb2013; Canning P, 2013, J BIOL CHEM, V288, P7803, DOI 10.1074/jbc.M112.437996; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Correale S, 2011, BIOCHIMIE, V93, P715, DOI 10.1016/j.biochi.2010.12.014; De Smaele E, 2011, NEOPLASIA, V13, P374, DOI 10.1593/neo.101630; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Di Marcotullio L, 2004, P NATL ACAD SCI USA, V101, P10833, DOI 10.1073/pnas.0400690101; Di Marcotullio L, 2011, BBA-REV CANCER, V1815, P241, DOI 10.1016/j.bbcan.2011.01.002; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Golzio C, 2012, NATURE, V485, P363, DOI 10.1038/nature11091; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hu X, 2012, MOL BIOL REP, V39, P9911, DOI 10.1007/s11033-012-1858-7; Huang T, 2012, BIOCHEM BIOPH RES CO, V417, P182, DOI 10.1016/j.bbrc.2011.11.081; Joseph TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043985; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Merlino A, 2002, BIOPOLYMERS, V65, P274, DOI 10.1002/bip.10225; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Phillips C, 2011, J AM CHEM SOC, V133, P9696, DOI 10.1021/ja202946k; Pintard L, 2004, EMBO J, V23, P1681, DOI 10.1038/sj.emboj.7600186; Pirone L, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/162674; Pirone L, 2011, J PEPT SCI, V17, P373, DOI 10.1002/psc.1366; Schwarzinger S, 2000, J BIOMOL NMR, V18, P43, DOI 10.1023/A:1008386816521; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Sviridov DO, 2011, BIOCHEM BIOPH RES CO, V410, P446, DOI 10.1016/j.bbrc.2011.05.154; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2014, J MED CHEM; Williams MJ, 2012, CELL MOL LIFE SCI, V69, P3819, DOI 10.1007/s00018-012-1022-5; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010	48	24	24	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121149	10.1371/journal.pone.0121149	http://dx.doi.org/10.1371/journal.pone.0121149			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848797	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800046
J	Diogo, D; Bastarache, L; Liao, KP; Graham, RR; Fulton, RS; Greenberg, JD; Eyre, S; Bowes, J; Cui, J; Lee, A; Pappas, DA; Kremer, JM; Barton, A; Coenen, MJH; Franke, B; Kiemeney, LA; Mariette, X; Richard-Miceli, C; Canhao, H; Fonseca, JE; de Vries, N; Tak, PP; Crusius, JBA; Nurmohamed, MT; Kurreeman, F; Mikuls, TR; Okada, Y; Stahl, EA; Larson, DE; Deluca, TL; O'Laughlin, M; Fronick, CC; Fulton, LL; Kosoy, R; Ransom, M; Bhangale, TR; Ortmann, W; Cagan, A; Gainer, V; Karlson, EW; Kohane, I; Murphy, SN; Martin, J; Zhernakova, A; Klareskog, L; Padyukov, L; Worthington, J; Mardis, ER; Seldin, MF; Gregersen, PK; Behrens, T; Raychaudhuri, S; Denny, JC; Plenge, RM				Diogo, Dorothee; Bastarache, Lisa; Liao, Katherine P.; Graham, Robert R.; Fulton, Robert S.; Greenberg, Jeffrey D.; Eyre, Steve; Bowes, John; Cui, Jing; Lee, Annette; Pappas, Dimitrios A.; Kremer, Joel M.; Barton, Anne; Coenen, Marieke J. H.; Franke, Barbara; Kiemeney, Lambertus A.; Mariette, Xavier; Richard-Miceli, Corrine; Canhao, Helena; Fonseca, Joao E.; de Vries, Niek; Tak, Paul P.; Crusius, J. Bart A.; Nurmohamed, Michael T.; Kurreeman, Fina; Mikuls, Ted R.; Okada, Yukinori; Stahl, Eli A.; Larson, David E.; Deluca, Tracie L.; O'Laughlin, Michelle; Fronick, Catrina C.; Fulton, Lucinda L.; Kosoy, Roman; Ransom, Michael; Bhangale, Tushar R.; Ortmann, Ward; Cagan, Andrew; Gainer, Vivian; Karlson, Elizabeth W.; Kohane, Isaac; Murphy, Shawn N.; Martin, Javier; Zhernakova, Alexandra; Klareskog, Lars; Padyukov, Leonid; Worthington, Jane; Mardis, Elaine R.; Seldin, Michael F.; Gregersen, Peter K.; Behrens, Timothy; Raychaudhuri, Soumya; Denny, Joshua C.; Plenge, Robert M.			TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RARE VARIANTS; COMMON VARIANTS; CROHNS-DISEASE; SUSCEPTIBILITY LOCI; MEDICAL-RECORDS; LIPID-LEVELS; ANTI-TNF; RISK; GENES	Despite the success of genome-wide association studies (GWAS) in detecting a large number of loci for complex phenotypes such as rheumatoid arthritis (RA) susceptibility, the lack of information on the causal genes leaves important challenges to interpret GWAS results in the context of the disease biology. Here, we genetically fine-map the RA risk locus at 19p13 to define causal variants, and explore the pleiotropic effects of these same variants in other complex traits. First, we combined Immunochip dense genotyping (n = 23,092 case/control samples), Exomechip genotyping (n = 18,409 case/control samples) and targeted exon-sequencing (n = 2,236 case/controls samples) to demonstrate that three protein- coding variants in TYK2 (tyrosine kinase 2) independently protect against RA: P1104A (rs34536443, OR = 0.66, P = 2.3x10(-21)), A928V (rs35018800, OR = 0.53, P = 1.2x10(-9)), and I684S (rs12720356, OR = 0.86, P = 4.6x10(-7)). Second, we show that the same three TYK2 variants protect against systemic lupus erythematosus (SLE, P-omnibus = 6x10(-18)), and provide suggestive evidence that two of the TYK2 variants (P1104A and A928V) may also protect against inflammatory bowel disease (IBD; P-omnibus = 0.005). Finally, in a phenome-wide association study (PheWAS) assessing >500 phenotypes using electronic medical records (EMR) in >29,000 subjects, we found no convincing evidence for association of P1104A and A928V with complex phenotypes other than autoimmune diseases such as RA, SLE and IBD. Together, our results demonstrate the role of TYK2 in the pathogenesis of RA, SLE and IBD, and provide supporting evidence for TYK2 as a promising drug target for the treatment of autoimmune diseases.	[Diogo, Dorothee; Liao, Katherine P.; Cui, Jing; Pappas, Dimitrios A.; Okada, Yukinori; Stahl, Eli A.; Karlson, Elizabeth W.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Diogo, Dorothee; Okada, Yukinori; Stahl, Eli A.; Raychaudhuri, Soumya; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA USA; [Diogo, Dorothee; Okada, Yukinori; Stahl, Eli A.; Raychaudhuri, Soumya; Plenge, Robert M.] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Diogo, Dorothee; Raychaudhuri, Soumya] Partners HealthCare Ctr Personalized Genet Med, Boston, MA USA; [Bastarache, Lisa; Denny, Joshua C.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Graham, Robert R.; Bhangale, Tushar R.; Ortmann, Ward; Behrens, Timothy] Genentech Inc, ITGR Human Genet Grp, San Francisco, CA 94080 USA; [Fulton, Robert S.; Larson, David E.; Deluca, Tracie L.; O'Laughlin, Michelle; Fronick, Catrina C.; Fulton, Lucinda L.; Mardis, Elaine R.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Greenberg, Jeffrey D.] NYU, Hosp Joint Dis, New York, NY USA; [Eyre, Steve; Bowes, John; Barton, Anne; Worthington, Jane; Raychaudhuri, Soumya] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Lee, Annette; Gregersen, Peter K.] North Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY USA; [Pappas, Dimitrios A.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Kremer, Joel M.] Albany Med Coll, Albany, NY 12208 USA; [Kremer, Joel M.] Ctr Rheumatol, Albany, NY USA; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Med Ctr, Donders Ctr Neurosci, Dept Psychiat & Human Genet, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, NL-6525 ED Nijmegen, Netherlands; [Mariette, Xavier; Richard-Miceli, Corrine] Univ Paris Sud, Orsay, France; [Mariette, Xavier; Richard-Miceli, Corrine] Hop Bicetre, INSERM, AP HP, U1012, Paris, France; [Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Fac Med, Inst Mol Med, Rheumatol Res Unit, P-1699 Lisbon, Portugal; [Canhao, Helena; Fonseca, Joao E.] Hosp Santa Maria, CHLN, Dept Rheumatol, Lisbon, Portugal; [de Vries, Niek; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Dept Clin Immunol & Rheumatol, Amsterdam Rheumatol & Immunol Ctr, NL-1105 AZ Amsterdam, Netherlands; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Dept Med Microbiol & Infect Control, Immunogenet Lab, Amsterdam, Netherlands; [Nurmohamed, Michael T.] Amsterdam Rheumatol & Immunol Ctr, Dept Rheumatol, Amsterdam, Netherlands; [Kurreeman, Fina; Zhernakova, Alexandra] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [Mikuls, Ted R.; Seldin, Michael F.] Omaha VA, Div Rheumatol & Immunol, Omaha, NE USA; [Mikuls, Ted R.; Seldin, Michael F.] Univ Nebraska Med Ctr, Omaha, NE USA; [Kosoy, Roman; Ransom, Michael] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Cagan, Andrew; Gainer, Vivian; Kohane, Isaac; Murphy, Shawn N.] Partners Healthcare, Informat Syst, Charlestown, MA USA; [Martin, Javier] CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada 18100, Spain; [Zhernakova, Alexandra] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Klareskog, Lars; Padyukov, Leonid] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Klareskog, Lars; Padyukov, Leonid] Karolinska Univ Hosp Solna, Stockholm, Sweden; [Denny, Joshua C.] Vanderbilt Univ, Dept Med, Nashville, TN USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Partners Healthcare System; Vanderbilt University; Roche Holding; Genentech; Washington University (WUSTL); New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC; University of Manchester; Northwell Health; Columbia University; Albany Medical College; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Nebraska System; University of Nebraska Medical Center; University of California System; University of California Davis; Partners Healthcare System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); University of Groningen; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Vanderbilt University	Diogo, D (corresponding author), Merck Res Labs, Boston, MA 02115 USA.	dorothee.diogo@merck.com	Martin, Javier/B-8141-2008; Franke, Barbara/D-4836-2009; Zhernakova, Alexandra/ABA-9372-2020; Canhao, Helena/C-9611-2018; Coenen, Marieke/A-2159-2010; Martín, María/HDL-9512-2022; Denny, Josh/AAL-3359-2021; Mardis, Elaine/W-2202-2019; Kiemeney, Lambertus A./D-3357-2009; Martín, Javier/AAV-5209-2021; Padyukov, Leonid/A-4890-2009; Barton, Anne/N-2053-2014; de Vries, Niek/J-9348-2013	Martin, Javier/0000-0002-2202-0622; Franke, Barbara/0000-0003-4375-6572; Canhao, Helena/0000-0003-1894-4870; Coenen, Marieke/0000-0001-8796-2031; Denny, Josh/0000-0002-3049-7332; Kiemeney, Lambertus A./0000-0002-2368-1326; Padyukov, Leonid/0000-0003-2950-5670; Barton, Anne/0000-0003-3316-2527; Zhernakova, Alexandra/0000-0002-4574-0841; Larson, David/0000-0001-7934-5906; DIOGO, DOROTHEE/0000-0003-2913-5913; Nurmohamed, Michael/0000-0002-6274-1934; Raychaudhuri, Soumya/0000-0002-1901-8265; de Vries, Niek/0000-0002-6257-8604	National Institutes of Health (NIH) [U01-GM092691, R01-AR063759]; NIH [U01-GM092691, R01-AR057108, R01-AR056768, R01-AR059648]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049880, R01AR063759, UH2AR067677, R01AR059648, R01AR057108, K08AR060257, R01AR056768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM092691] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	DD was supported by grants from the National Institutes of Health (NIH) (U01-GM092691 and R01-AR063759). RMP was supported by grants from the NIH (R01-AR057108, R01-AR056768, U01-GM092691, R01-AR059648) and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Argiriadi MA, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-22; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Beaudoin M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003723; Bonnefond A, 2012, NAT GENET, V44, P297, DOI 10.1038/ng.1053; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Canhao H, 2011, ACTA REUMATOL PORT, V36, P45; Carroll MD, 2012, JAMA-J AM MED ASSOC, V308, P1545, DOI 10.1001/jama.2012.13260; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Couturier N, 2011, BRAIN, V134, P693, DOI 10.1093/brain/awr010; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Crosslin DR, 2012, HUM GENET, V131, P639, DOI 10.1007/s00439-011-1103-9; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; Curtis JR, 2011, ANN RHEUM DIS, V70, P1401, DOI 10.1136/ard.2010.146365; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Diogo D, 2014, CURR OPIN RHEUMATOL, V26, P85, DOI 10.1097/BOR.0000000000000012; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Eyre S, 2012, NAT GENET, V44, P1336, DOI 10.1038/ng.2462; Falush D, 2003, GENETICS, V164, P1567; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Flannick J, 2014, NAT GENET; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Garber K, 2013, NAT BIOTECHNOL, V31, P3, DOI 10.1038/nbt0113-3; Garber K, 2011, NAT BIOTECHNOL, V29, P467, DOI 10.1038/nbt0611-467; Graham DSC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002341; Gregersen PK, 1998, ARTHRIT CARE RES, V11, P1, DOI 10.1002/art.1790110102; Guthridge JM, 2014, AM J HUM GENET, V94, P586, DOI 10.1016/j.ajhg.2014.03.008; Hebbring SJ, 2013, GENES IMMUN, V14, P187, DOI 10.1038/gene.2013.2; Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195; Hellquist A, 2009, J RHEUMATOL, V36, P1631, DOI 10.3899/jrheum.081160; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Jordan CT, 2012, AM J HUM GENET, V90, P796, DOI 10.1016/j.ajhg.2012.03.013; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kho AN, 2012, J AM MED INFORM ASSN, V19, P212, DOI 10.1136/amiajnl-2011-000439; Kievit W, 2007, ANN RHEUM DIS, V66, P1473, DOI 10.1136/ard.2007.072447; Kilic SS, 2012, J PEDIATR-US, V160, P1055, DOI 10.1016/j.jpeds.2012.01.056; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kremer JM, 2006, AUTOIMMUN REV, V5, P46, DOI 10.1016/j.autrev.2005.07.006; Kremer JM, 2012, ARTHRITIS RHEUM-US, V64, P970, DOI 10.1002/art.33419; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lee S, 2012, BIOSTATISTICS, V13, P762, DOI 10.1093/biostatistics/kxs014; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Z, 2013, J IMMUNOL, V190, P2335, DOI 10.4049/jimmunol.1203118; Liao KP, 2014, ANN RHEUM DIS, V73, P1170, DOI 10.1136/annrheumdis-2012-203202; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Liu CY, 2008, MOL MED, V14, P575, DOI 10.2119/2008-00056.Liu; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Manjarrez-Orduno N, 2012, NAT GENET, V44, P1227, DOI 10.1038/ng.2439; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mero IL, 2010, EUR J HUM GENET, V18, P502, DOI 10.1038/ejhg.2009.195; Miceli-Richard C, 2008, ANN RHEUM DIS, V67, P478, DOI 10.1136/ard.2007.074104; Mikuls TR, 2011, RHEUMATOLOGY, V50, P101, DOI 10.1093/rheumatology/keq232; Mima T, 2009, CURR OPIN RHEUMATOL, V21, P224, DOI 10.1097/BOR.0b013e3283295fec; Minegishi Y, 2006, IMMUNITY, V25, P745, DOI 10.1016/j.immuni.2006.09.009; Momozawa Y, 2011, NAT GENET, V43, P43, DOI 10.1038/ng.733; Morris DL, 2014, GENES IMMUN, V15, P210, DOI 10.1038/gene.2014.6; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Parkes M, 2013, NAT REV GENET, V14, P661, DOI 10.1038/nrg3502; Patkar NM, 2009, J CLIN EPIDEMIOL, V62, P321, DOI 10.1016/j.jclinepi.2008.06.006; Pearce LR, 2013, CELL, V155, P765, DOI 10.1016/j.cell.2013.09.058; Petri M, 2009, LUPUS, V18, P980, DOI 10.1177/0961203309105529; Plant D, 2011, ARTHRITIS RHEUM-US, V63, P645, DOI 10.1002/art.30130; Plenge RM, 2013, NAT REV DRUG DISCOV, V12, P581, DOI 10.1038/nrd4051; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Seddon JM, 2013, NAT GENET, V45, P1366, DOI 10.1038/ng.2741; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS146; Solovieff N, 2013, NAT REV GENET, V14, P483, DOI 10.1038/nrg3461; Strobl B, 2011, FRONT BIOSCI-LANDMRK, V16, P3224, DOI 10.2741/3908; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Van Limbergen J, 2013, INFLAMM BOWEL DIS, V19, pE79, DOI 10.1097/mib.0b013e318280e790; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Waterworth DM, 2010, ARTERIOSCL THROM VAS, V30, P2264, DOI 10.1161/ATVBAHA.109.201020	94	85	88	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122271	10.1371/journal.pone.0122271	http://dx.doi.org/10.1371/journal.pone.0122271			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849893	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800115
J	Ishii, R; Tokuda, T; Tatebe, H; Ohmichi, T; Kasai, T; Nakagawa, M; Mizuno, T; El-Agnaf, OMA				Ishii, Ryotaro; Tokuda, Takahiko; Tatebe, Harutsugu; Ohmichi, Takuma; Kasai, Takashi; Nakagawa, Masanori; Mizuno, Toshiki; El-Agnaf, Omar M. A.			Decrease in Plasma Levels of alpha-Synuclein Is Evident in Patients with Parkinson's Disease after Elimination of Heterophilic Antibody Interference	PLOS ONE			English	Article							MULTIPLE SYSTEM ATROPHY; DRUG-NAIVE PATIENTS; CEREBROSPINAL-FLUID; ELEVATED LEVELS; NERVOUS-SYSTEM; LEWY BODIES; DEMENTIA; CSF; PATHOLOGY; PROTEIN	There is substantial biochemical, pathological, and genetic evidence that alpha-synuclein (Asyn) is a principal molecule in the pathogenesis of Parkinson disease (PD). We previously reported that total A-syn levels in cerebrospinal fluid (CSF), measured with the specific enzyme-linked immunosorbent assay (ELISA) developed by ourselves, were decreased in patients with PD, and suggested the usefulness of A-syn in CSF and plasma as a biomarker for the diagnosis of PD. After our report, a considerable number of studies have investigated the levels A-syn in CSF and in blood, but have reported inconclusive results. Such discrepancies have often been attributed not only to the use of different antibodies in the ELISAs but also to interference from hemolysis. In this study we measured the levels of A-syn in CSF and plasma by using our own sandwich ELISA with or without heterophilic antibody (HA) inhibitor in 30 patients with PD and 58 age-matched controls. We thereby revealed that HA interfered with ELISA measurements of A-syn and are accordingly considered to be an important confounder in A-syn ELISAs. HA produced falsely exaggerated signals in A-syn ELISAs more prominently in plasma samples than in CSF samples. After elimination of HA interference, it was found that hemolysis did not have a significant effect on the signals obtained using our A-syn ELISA. Furthermore, plasma levels of A-syn were significantly lower in the PD group compared with the control group following elimination of HA interference with an HA inhibitor. Our results demonstrate that HA was a major confounder that should be controlled in A-syn ELISAs, and that plasma A-syn could be a useful biomarker for the diagnosis of PD if adequately quantified following elimination of HA interference.	[Ishii, Ryotaro; Tokuda, Takahiko; Tatebe, Harutsugu; Ohmichi, Takuma; Kasai, Takashi; Mizuno, Toshiki] Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan; [Tokuda, Takahiko] Kyoto Prefectural Univ Med, Dept Mol Pathobiol Brain Dis, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Zaitaku Homecare, Kyoto, Japan; [Tatebe, Harutsugu] Kyoto Prefectural Univ Med, Dept Med Educ & Primary Care, Kyoto, Japan; [Nakagawa, Masanori] Kyoto Prefectural Univ Med, Med Ctr N, Kyoto, Japan; [El-Agnaf, Omar M. A.] Qatar Fdn, Educ City, HBKU, Coll Sci Engn & Technol, Doha, Qatar	Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Kyoto Prefectural University of Medicine; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Tokuda, T (corresponding author), Kyoto Prefectural Univ Med, Dept Neurol, Kyoto, Japan.	ttokuda@koto.kpu-m.ac.jp	Ishii, Ryotaro/K-4595-2019; Mizuno, Toshiki/AAH-7155-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan [23591252]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid (No. 23591252 to T.T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts MB, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.001; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Cersosimo MG, 2013, J NEUROL, V260, P1332, DOI 10.1007/s00415-012-6801-2; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Foulds PG, 2012, NEUROBIOL DIS, V45, P188, DOI 10.1016/j.nbd.2011.08.003; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Fumimura Y, 2007, J NEUROPATH EXP NEUR, V66, P354, DOI 10.1097/nen.0b013e3180517454; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Ikemura M, 2008, J NEUROPATH EXP NEUR, V67, P945, DOI 10.1097/NEN.0b013e318186de48; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kasai T, 2014, J NEUROL, V261, P1203, DOI 10.1007/s00415-014-7334-7; Kricka LJ, 1999, CLIN CHEM, V45, P942; Laske C, 2011, DEMENT GERIATR COGN, V31, P413, DOI 10.1159/000329763; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Levinson SS, 2002, CLIN CHIM ACTA, V325, P1, DOI 10.1016/S0009-8981(02)00275-9; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Mitsui J, 2006, J NEUROL SCI, V243, P101, DOI 10.1016/j.jns.2005.11.034; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2013, NEUROSCI LETT, V532, P44, DOI 10.1016/j.neulet.2012.11.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Ohrfelt A, 2009, NEUROSCI LETT, V450, P332, DOI 10.1016/j.neulet.2008.11.015; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Preissner CM, 2003, J CLIN ENDOCR METAB, V88, P3069, DOI 10.1210/jc.2003-030122; Reesink FE, 2010, J ALZHEIMERS DIS, V22, P87, DOI 10.3233/JAD-2010-100186; Sehlin D, 2010, J ALZHEIMERS DIS, V21, P1295, DOI 10.3233/JAD-2010-100609; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tamaoka A, 1996, J NEUROL SCI, V141, P65, DOI 10.1016/0022-510X(96)00143-8; Tateno F, 2012, ALZ DIS ASSOC DIS, V26, P213, DOI 10.1097/WAD.0b013e31823899cc; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wennstrom M, 2012, J ALZHEIMERS DIS, V29, P125, DOI [10.3233/JAD-2011-111655, 10.3233/JAD-2012-111655]; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435	39	40	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123162	10.1371/journal.pone.0123162	http://dx.doi.org/10.1371/journal.pone.0123162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849645	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800211
J	Memarian, N; Madsen, SK; Macey, PM; Fried, I; Engel, J; Thompson, PM; Staba, RJ				Memarian, Negar; Madsen, Sarah K.; Macey, Paul M.; Fried, Itzhak; Engel, Jerome, Jr.; Thompson, Paul M.; Staba, Richard J.			Ictal Depth EEG and MRI Structural Evidence for Two Different Epileptogenic Networks in Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							SEIZURE-ONSET PATTERNS; HIPPOCAMPAL SCLEROSIS; CORTICAL EFFERENTS; ENTORHINAL CORTEX; RHESUS-MONKEY; ATROPHY; ABNORMALITIES; CONNECTIONS; RECORDINGS; SUBTYPES	Hypersynchronous (HYP) and low voltage fast (LVF) activity are two separate ictal depth EEG onsets patterns often recorded in presurgical patients with MTLE. Evidence suggests the mechanisms generating HYP and LVF onset seizures are distinct, including differential involvement of hippocampal and extra-hippocampal sites. Yet the extent of extra-hippocampal structural alterations, which could support these two common seizures, is not known. In the current study, preoperative MRI from 24 patients with HYP or LVF onset seizures were analyzed to determine changes in cortical thickness and relate structural changes to spatiotemporal properties of the ictal EEG. Overall, onset and initial ipsilateral spread of HYP onset seizures involved mesial temporal structures, whereas LVF onset seizures involved mesial and lateral temporal as well as orbitofrontal cortex. MRI analysis found reduced cortical thickness correlated with longer duration of epilepsy. However, in patients with HYP onsets, the most affected areas were on the medial surface of each hemisphere, including parahippocampal regions and cingulate gyrus, whereas in patients with LVF onsets, the lateral surface of the anterior temporal lobe and orbitofrontal cortex showed the greatest effect. Most patients with HYP onset seizures were seizure-free after resective surgery, while a higher proportion of patients with LVF onset seizures had only worthwhile improvement. Our findings confirm the view that recurrent seizures cause progressive changes in cortical thickness, and provide information concerning the structural basis of two different epileptogenic networks responsible for MTLE. One, identified by HYP ictal onsets, chiefly involves hippocampus and is associated with excellent outcome after standardized anteromedial temporal resection, while the other also involves lateral temporal and orbitofrontal cortex and a seizure-free surgical outcome occurs less after this procedure. These results suggest that a more extensive tailored resection may be required for patients with the second type of MTLE.	[Memarian, Negar; Engel, Jerome, Jr.; Staba, Richard J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Madsen, Sarah K.; Thompson, Paul M.] Univ So Calif, Keck Sch Med, Inst Neuroimaging & Informat, Dept Neurol,Imaging Genet Ctr, Los Angeles, CA 90033 USA; [Macey, Paul M.] Univ Calif Los Angeles, UCLA Sch Nursing, Los Angeles, CA USA; [Fried, Itzhak] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Staba, RJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA.	rstaba@mednet.ucla.edu	Macey, Paul M./B-5037-2008; Staba, Richard/AAN-3149-2021; Thompson, Paul M/C-4194-2018	Macey, Paul M./0000-0003-4093-7458; Thompson, Paul M/0000-0002-4720-8867	National Institute of Neurological Disorders and Stroke [071048, 033310]; Natural Sciences and Engineering Research Council of Canada	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was supported by the National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/) grants 071048 (RS) and 033310 (JE), and a Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) fellowship (NM).	Abbie AA, 1940, J COMP NEUROL, V72, P429, DOI 10.1002/cne.900720302; Akiake H, 1974, IEEE T AUTOMATIC CON, V19, P716; Bartolomei F, 2005, EPILEPSIA, V46, P677, DOI 10.1111/j.1528-1167.2005.43804.x; Bartolomei F, 2004, EPILEPSY RES, V61, P89, DOI 10.1016/j.eplepsyres.2004.06.006; Bartolomei F, 1999, CLIN NEUROPHYSIOL, V110, P1741, DOI 10.1016/S1388-2457(99)00107-8; Bartolomei F, 2008, BRAIN, V131, P1818, DOI 10.1093/brain/awn111; Bartolomei F, 2010, EPILEPSIA, V51, P2147, DOI 10.1111/j.1528-1167.2010.02690.x; Bernasconi N, 2005, NEUROLOGY, V65, P223, DOI 10.1212/01.wnl.0000169066.46912.fa; Bernhardt BC, 2012, NEUROLOGY, V78, P129, DOI 10.1212/WNL.0b013e31823efd0d; Blumcke I, 2007, ACTA NEUROPATHOL, V113, P235, DOI 10.1007/s00401-006-0187-0; Bonilha L, 2003, J NEUROL NEUROSUR PS, V74, P1627, DOI 10.1136/jnnp.74.12.1627; Bonilha L, 2006, NEUROIMAGE, V32, P1070, DOI 10.1016/j.neuroimage.2006.05.038; Bonilha L, 2012, EPILEPSIA, V53, P1, DOI 10.1111/j.1528-1167.2011.03298.x; Bonilha L, 2010, EPILEPSIA, V51, P519, DOI 10.1111/j.1528-1167.2009.02506.x; Bragin A, 2005, EPILEPSIA, V46, P59, DOI 10.1111/j.1528-1167.2005.01010.x; Bragin A, 2007, EPILEPSIA, V48, P1883, DOI 10.1111/j.1528-1167.2007.01149.x; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; Chabardes S, 2005, BRAIN, V128, P1818, DOI 10.1093/brain/awh512; Chassoux F, 2004, BRAIN, V127, P164, DOI 10.1093/brain/awh014; Coan AC, 2014, EPILEPSIA, V55, P1187, DOI 10.1111/epi.12670; Coan AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085843; de Curtis M, 2009, EPILEPSIA, V50, P2514, DOI 10.1111/j.1528-1167.2009.02249.x; EBEL RL, 1951, PSYCHOMETRIKA, V16, P407; ENGEL J, 1983, TRENDS NEUROSCI, V6, P60, DOI 10.1016/0166-2236(83)90027-9; Engel J Jr, 1989, Acta Neurochir Suppl (Wien), V46, P3; Engel Jr J, 1993, SURG TREATMENT EPILE, P727; Fahoum F, 2012, EPILEPSIA, V53, P1618, DOI 10.1111/j.1528-1167.2012.03533.x; Fried I, 1993, Neurosurg Clin N Am, V4, P233; IBM Corp, 2013, SPSS TWOSTEP CLUST C; Isnard J, 2000, ANN NEUROL, V48, P614, DOI 10.1002/1531-8249(200010)48:4<614::AID-ANA8>3.0.CO;2-S; Jehi LE, 2010, J NEUROSURG, V113, P1186, DOI 10.3171/2010.8.JNS10180; Joshi SH, 2012, IEEE T MED IMAGING, V31, P1195, DOI 10.1109/TMI.2012.2186975; Kahane P, 2002, EPILEPTIC DISORD, V4, pS51; Kahane P, 2010, EPILEPSIA, V51, P59, DOI 10.1111/j.1528-1167.2009.02448.x; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; LIEB JP, 1991, EPILEPSIA, V32, P822, DOI 10.1111/j.1528-1157.1991.tb05539.x; Lin JJ, 2007, CEREB CORTEX, V17, P2007, DOI 10.1093/cercor/bhl109; Lin JJ, 2008, EPILEPSY RES, V82, P162, DOI 10.1016/j.eplepsyres.2008.07.020; Liu RSN, 2003, ANN NEUROL, V53, P312, DOI 10.1002/ana.10463; Maillard L, 2004, EPILEPSIA, V45, P1590, DOI 10.1111/j.0013-9580.2004.09704.x; McDonald CR, 2008, EPILEPSIA, V49, P794, DOI 10.1111/j.1528-1167.2008.01539.x; MESULAM MM, 1982, J COMP NEUROL, V212, P1, DOI 10.1002/cne.902120102; Mueller SG, 2009, NEUROIMAGE, V46, P353, DOI 10.1016/j.neuroimage.2009.02.020; Munoz M, 2005, EUR J NEUROSCI, V22, P1368, DOI 10.1111/j.1460-9568.2005.04299.x; Ogren JA, 2009, EPILEPSIA, V50, P1361, DOI 10.1111/j.1528-1167.2008.01881.x; PANDYA DN, 1981, EXP BRAIN RES, V42, P319, DOI 10.1007/BF00237497; Perucca P, 2013, BRAIN; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Ryvlin P, 2005, CURR OPIN NEUROL, V18, P125, DOI 10.1097/01.wco.0000162852.22026.6f; Sanides F., 1970, PRIMATE BRAIN ADV PR, P137; Scanlon C, 2013, J NEUROL, V260, P2320, DOI 10.1007/s00415-013-6974-3; SPENCER SS, 1992, ELECTROEN CLIN NEURO, V83, P104, DOI 10.1016/0013-4694(92)90023-B; SPENCER SS, 1994, EPILEPSIA, V35, P721, DOI 10.1111/j.1528-1157.1994.tb02502.x; Spencer SS, 1996, EPILEPSIA, V37, P455, DOI 10.1111/j.1528-1157.1996.tb00591.x; Talairach J., 1973, PROGR NEUROL SURG, V5, P297, DOI [DOI 10.1159/000394343, 10.1159/000394343]; Thom M, 2010, ANN NEUROL, V68, P424, DOI 10.1002/ana.22142; Thompson PM, 2004, NEUROIMAGE, V23, pS2, DOI 10.1016/j.neuroimage.2004.07.071; Thompson PM, 2004, NEUROIMAGE, V22, P1754, DOI 10.1016/j.neuroimage.2004.03.040; Van Paesschen W, 2003, BRAIN, V126, P1103, DOI 10.1093/brain/awg108; Velasco AL, 2000, NEURAL PLAST, V7, P49, DOI 10.1155/NP.2000.49; Wennberg R, 2002, EPILEPSIA, V43, P716, DOI 10.1046/j.1528-1157.2002.31101.x	64	24	26	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123588	10.1371/journal.pone.0123588	http://dx.doi.org/10.1371/journal.pone.0123588			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849340	Green Published, gold			2022-12-26	WOS:000352477800242
J	Petersen, MK				Petersen, Michael Kai			Latent Semantics of Action Verbs Reflect Phonetic Parameters of Intensity and Emotional Content	PLOS ONE			English	Article							SPEECH; ORGANIZATION; ENCODES	Conjuring up our thoughts, language reflects statistical patterns of word co-occurrences which in turn come to describe how we perceive the world. Whether counting how frequently nouns and verbs combine in Google search queries, or extracting eigenvectors from term document matrices made up of Wikipedia lines and Shakespeare plots, the resulting latent semantics capture not only the associative links which form concepts, but also spatial dimensions embedded within the surface structure of language. As both the shape and movements of objects have been found to be associated with phonetic contrasts already in toddlers, this study explores whether articulatory and acoustic parameters may likewise differentiate the latent semantics of action verbs. Selecting 3 x 20 emotion-, face-, and handrelated verbs known to activate premotor areas in the brain, their mutual cosine similarities were computed using latent semantic analysis LSA, and the resulting adjacency matrices were compared based on two different large scale text corpora: HAWIK and TASA. Applying hierarchical clustering to identify common structures across the two text corpora, the verbs largely divide into combined mouth and hand movements versus emotional expressions. Transforming the verbs into their constituent phonemes, and projecting them into an articulatory space framed by tongue height and formant frequencies, the clustered small and large size movements appear differentiated by front versus back vowels corresponding to increasing levels of arousal. Whereas the clustered emotional verbs seem characterized by sequences of close versus open jaw produced phonemes, generating up-or downwards shifts in formant frequencies that may influence their perceived valence. Suggesting, that the latent semantics of action verbs reflect parameters of intensity and emotional polarity that appear correlated with the articulatory contrasts and acoustic characteristics of phonemes.	Tech Univ Denmark, DTU Compute, Cognit Syst, DK-2800 Lyngby, Denmark	Technical University of Denmark	Petersen, MK (corresponding author), Tech Univ Denmark, DTU Compute, Cognit Syst, Bldg 324, DK-2800 Lyngby, Denmark.	mkai@dtu.dk		Petersen, Michael Kai/0000-0002-2156-9226				Barsalou L., 2008, SYMBOLS EMBODIMENT D, P245, DOI [DOI 10.1093/ACPROF:OSO/9780199217274.003.0013, 10.1093/acprof:oso/9780199217274.003.0013, DOI 10.1093/ACPROF:OSO/9780199217274.003]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bouchard KE, 2013, NATURE, V495, P327, DOI 10.1038/nature11911; Boussidan A, 2009, DISTRIBUTIONAL SEMAN, P35; Bradley MM, 2010, ECTIVE NORMS ENGLISH; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Catford J. C., 1988, PRACTICAL INTRO PHON; Changizi M., 2011, HARNESSED LANGUAGE M; CMU, 1976, CMU PRON DICT; Engel AK, 2013, TRENDS COGN SCI, V17, P202, DOI 10.1016/j.tics.2013.03.006; Furnas G. W., 1988, 11th International Conference on Research and Development in Information Retrieval, P465; Gentilucci M, 2006, NEUROSCI BIOBEHAV R, V30, P949, DOI 10.1016/j.neubiorev.2006.02.004; Glenberg A. M., 2011, CORTEX; Graziano MSA, 2002, NEURON, V36, P349, DOI 10.1016/S0896-6273(02)01003-6; Griffiths TL, 2007, PSYCHOL REV, V114, P211, DOI 10.1037/0033-295X.114.2.211; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Konkle T, 2012, NEURON, V74, P1114, DOI 10.1016/j.neuron.2012.04.036; Kousta ST, 2011, J EXP PSYCHOL GEN, V140, P14, DOI 10.1037/a0021446; Ladefoged P, 1989, WORKING PAPERS PHONE, P73; Lako George, 1999, PHILOS FLESH EMBODIE; Landauer TK, 1997, PSYCHOL REV, V104, P211, DOI 10.1037/0033-295X.104.2.211; Landauer TK, 2013, HDB LATENT SEMANTIC; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; LeDoux J, 2012, NEURON, V73, P653, DOI 10.1016/j.neuron.2012.02.004; Louwerse MM, 2012, COGNITIVE SCI, V36, P1556, DOI 10.1111/cogs.12000; Louwerse MM, 2011, TOP COGN SCI, V3, P273, DOI 10.1111/j.1756-8765.2010.01106.x; Louwerse MM, 2009, COGNITIVE SCI, V33, P51, DOI 10.1111/j.1551-6709.2008.01003.x; Maurer D, 2006, DEVELOPMENTAL SCI, V9, P316, DOI 10.1111/j.1467-7687.2006.00495.x; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Mesgarani N, 2014, SCIENCE, V343, P1006, DOI 10.1126/science.1245994; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Monaghan P, 2007, COGNITIVE PSYCHOL, V55, P259, DOI 10.1016/j.cogpsych.2006.12.001; Moreno-Dominguez D, 2014, HUM BRAIN MAPP, V35, P5000, DOI 10.1002/hbm.22528; Moseley R., 2011, CEREB CORTEX, P1; MURPHY GL, 1993, J MEM LANG, V32, P301, DOI 10.1006/jmla.1993.1016; Myers-Schulz B, 2013, COGNITION EMOTION, V27, P1105, DOI 10.1080/02699931.2012.754739; Otis K., 2008, P 30 ANN C COGNITIVE, P65; Petersen MK, 2012, LSA SOFTWARE HAWIK C; Pulvermuller F, 2013, TRENDS COGN SCI, V17, P458, DOI 10.1016/j.tics.2013.06.004; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Recio G, 2014, BRAIN LANG, V134, P34, DOI 10.1016/j.bandl.2014.03.009; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Shimodaira H, 2004, ANN STAT, V32, P2616, DOI 10.1214/009053604000000823; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x	46	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121575	10.1371/journal.pone.0121575	http://dx.doi.org/10.1371/journal.pone.0121575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849977	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800068
J	Song, YL; Yu, MH				Song, Yinglei; Yu, Menghong			On the Treewidths of Graphs of Bounded Degree	PLOS ONE			English	Article							TREE-WIDTH; MINORS; ALGORITHMS	In this paper, we develop a new technique to study the treewidth of graphs with bounded degree. We show that the treewidth of a graph G = (V, E) with maximum vertex degree d is at most (1-Ce-(4.06 root d))vertical bar V vertical bar for sufficiently large d, where C is a constant.	[Song, Yinglei; Yu, Menghong] Jiangsu Univ Sci & Technol Zhenjiang, Sch Elect & Informat Sci, Zhenjiang 212003, Jiangsu, Peoples R China	Jiangsu University of Science & Technology	Song, YL (corresponding author), Jiangsu Univ Sci & Technol Zhenjiang, Sch Elect & Informat Sci, Zhenjiang 212003, Jiangsu, Peoples R China.	yingleisong@gmail.com; ymhzj2691@163.com			New Faculty Start-up Funding at Jiangsu University of Science and Technology, China [635301202]	New Faculty Start-up Funding at Jiangsu University of Science and Technology, China	This work is fully supported by the New Faculty Start-up Funding at Jiangsu University of Science and Technology, China, under the funding number 635301202. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNBORG S, 1989, DISCRETE APPL MATH, V23, P11, DOI 10.1016/0166-218X(89)90031-0; ARNBORG S, 1987, SIAM J ALGEBRA DISCR, V8, P277, DOI 10.1137/0608024; BAKER BS, 1994, J ACM, V41, P153, DOI 10.1145/174644.174650; Bodlaender HL, 2004, LECT NOTES COMPUT SC, V3221, P628; Bodlaender HL, 1997, DISCRETE APPL MATH, V79, P45, DOI 10.1016/S0166-218X(97)00031-0; BODLAENDER HL, 1991, LECT NOTES COMPUT SC, V510, P544; Bodlaender HL, 1996, SIAM J COMPUT, V25, P1305, DOI 10.1137/S0097539793251219; COURCELLE B, 1990, INFORM COMPUT, V85, P12, DOI 10.1016/0890-5401(90)90043-H; Eppstein D., 1999, Journal of Graph Algorithms and Applications, V3; Kneis J, 2005, LECT NOTES COMPUT SC, V3787, P385; Kosowski A, 2012, LECT NOTES COMPUT SC, V7392, P610, DOI 10.1007/978-3-642-31585-5_54; Lucena B, 2003, SIAM J DISCRETE MATH, V16, P345, DOI 10.1137/S0895480101397773; ROBERTSON N, 1995, J COMB THEORY B, V63, P65, DOI 10.1006/jctb.1995.1006; ROBERTSON N, 1990, J COMB THEORY B, V48, P227, DOI 10.1016/0095-8956(90)90120-O; ROBERTSON N, 1986, J COMB THEORY B, V41, P92, DOI 10.1016/0095-8956(86)90030-4; ROBERTSON N, 1984, J COMB THEORY B, V36, P49, DOI 10.1016/0095-8956(84)90013-3; ROBERTSON N, 1991, J COMB THEORY B, V52, P153, DOI 10.1016/0095-8956(91)90061-N; ROBERTSON N, 1986, J ALGORITHM, V7, P309, DOI 10.1016/0196-6774(86)90023-4	18	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120880	10.1371/journal.pone.0120880	http://dx.doi.org/10.1371/journal.pone.0120880			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849278	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800037
J	Zhang, JB; Lin, J; Zhao, XD				Zhang, Jian Bo; Lin, Ji; Zhao, Xiao Dong			Analysis of Bias in Measurements of Potassium, Sodium and Hemoglobin by an Emergency Department-Based Blood Gas Analyzer Relative to Hospital Laboratory Autoanalyzer Results	PLOS ONE			English	Article							HEPARIN; POINT	Objective The emergency departments (EDs) of Chinese hospitals are gradually being equipped with blood gas machines. These machines, along with the measurement of biochemical markers by the hospital laboratory, facilitate the care of patients with severe conditions who present to the ED. However, discrepancies have been noted between the Arterial Blood Gas (ABG) analyzers in the ED and the hospital laboratory autoanalyzer in relation to electrolyte and hemoglobin measurements. The present study was performed to determine whether the ABG and laboratory measurements of potassium, sodium, and hemoglobin levels are equivalent, and whether ABG analyzer results can be used to guide clinical care before the laboratory results become available. Materials and Methods Study power analyses revealed that 200 consecutive patients who presented to our ED would allow this prospective single-center cohort study to detect significant differences between ABG- and laboratory-measured potassium, sodium, and hemoglobin levels. Paired arterial and venous blood samples were collected within 30 minutes. Arterial blood samples were measured in the ED by an ABL 90 FLEX blood gas analyzer. The biochemistry and blood cell counts of the venous samples were measured in the hospital laboratory. The potassium, sodium, and hemoglobin concentrations obtained by both methods were compared by using paired Student's t-test, Spearman's correlation, Bland-Altman plots, and Deming regression. Results The mean ABG and laboratory potassium values were 3.77 +/- 0.44 and 4.2 +/- 0.55, respectively (P<0.0001). The mean ABG and laboratory sodium values were 137.89 +/- 5.44 and 140.93 +/- 5.50, respectively (P<0.0001). The mean ABG and laboratory Hemoglobin values were 12.28 +/- 2.62 and 12.35 +/- 2.60, respectively (P = 0.24). Conclusion Although there are the statistical difference and acceptable biases between ABG- and laboratory-measured potassium and sodium, the biases do not exceed USCLIA-determined limits. In parallel, there are no statistical differences and biases beyond USCLIA-determined limits between ABG- and laboratory-measured hemoglobin. Therefore, all three variables measured by ABG were reliable.	[Zhang, Jian Bo; Zhao, Xiao Dong] Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Emergency Dept, Beijing 100048, Peoples R China; [Lin, Ji] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Chinese People's Liberation Army General Hospital	Zhao, XD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Affiliated Hosp 1, Emergency Dept, Beijing 100048, Peoples R China.	zxd63715@126.com						Arthurs O, 2010, POINT CARE, V9, P21, DOI 10.1097/POC.0b013e3181d2d6b0; Bloom BM, 2013, EUROPEAN J EMERGENCY; Chacko B, 2011, INDIAN J CRIT CARE M, V15, P24, DOI 10.4103/0972-5229.78219; Chhapola V, 2013, INDIAN J PEDIATR, V80, P731, DOI 10.1007/s12098-013-0977-z; De Koninck AS, 2012, CLIN CHEM LAB MED, V50, P1083, DOI 10.1515/cclm-2011-0685; Jain A, 2009, INT J EMERG MED, V2, P117, DOI 10.1007/s12245-009-0091-1; Price CP, 2002, CLIN CHEM LAB MED, V40, P246, DOI 10.1515/CCLM.2002.040; van Berkel M, 2011, CLIN CHEM LAB MED, V49, P249, DOI 10.1515/CCLM.2011.047; Yip PM, 2006, CLIN BIOCHEM, V39, P391, DOI 10.1016/j.clinbiochem.2005.12.006	9	26	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122383	10.1371/journal.pone.0122383	http://dx.doi.org/10.1371/journal.pone.0122383			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849375	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800123
J	James, BD; Boyle, PA; Yu, L; Han, SD; Bennett, DA				James, Bryan D.; Boyle, Patricia A.; Yu, Lei; Han, S. Duke; Bennett, David A.			Cognitive Decline Is Associated with Risk Aversion and Temporal Discounting in Older Adults without Dementia	PLOS ONE			English	Article							DECISION-MAKING; RUSH MEMORY; HEALTH; CONNECTIVITY; INTELLIGENCE; PREFERENCES; IMPATIENCE; ABILITY	Risk aversion and temporal discounting are preferences that are strongly linked to suboptimal financial and health decision making ability. Prior studies have shown they differ by age and cognitive ability, but it remains unclear whether differences are due to age-related cognitive decline or lower cognitive abilities over the life span. We tested the hypothesis that cognitive decline is associated with higher risk aversion and temporal discounting in 455 older persons without dementia from the Memory and Aging Project, a longitudinal cohort study of aging in Chicago. All underwent repeated annual cognitive evaluations using a detailed battery including 19 tests. Risk aversion was measured using standard behavioral economics questions: participants were asked to choose between a certain monetary payment versus a gamble in which they could gain more or nothing; potential gamble gains varied across questions. Temporal discounting: participants were asked to choose between an immediate, smaller payment and a delayed, larger one; two sets of questions addressed small and large stakes based on payment amount. Regression analyses were used to examine whether prior rate of cognitive decline predicted level of risk aversion and temporal discounting, controlling for age, sex, and education. Over an average of 5.5 (SD = 2.9) years, cognition declined at an average of 0.016 units per year (SD = 0.03). More rapid cognitive decline predicted higher levels of risk aversion (p = 0.002) and temporal discounting (small stakes: p = 0.01, high stakes: p = 0.006). Further, associations between cognitive decline and risk aversion (p = 0.015) and large stakes temporal discounting (p = 0.026) persisted in analyses restricted to persons without any cognitive impairment (i.e., no dementia or mild cognitive impairment); the association of cognitive decline and small stakes temporal discounting was no longer statistically significant (p = 0.078). These findings are consistent with the hypothesis that subtle age-related changes in cognition can detrimentally affect individual preferences that are critical for maintaining health and well being.	[James, Bryan D.; Boyle, Patricia A.; Yu, Lei; Han, S. Duke; Bennett, David A.] Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [James, Bryan D.] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Boyle, Patricia A.; Han, S. Duke] Rush Univ, Med Ctr, Dept Behav Sci, Chicago, IL 60612 USA; [Yu, Lei; Han, S. Duke; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Han, S. Duke] VA Long Beach Healthcare Syst, Dept Mental Hlth, Long Beach, CA USA	Rush University; Rush University; Rush University; Rush University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	James, BD (corresponding author), Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	Bryan_James@rush.edu	Han/N-1246-2019; Yu, Lei/AAT-3685-2020	James, Bryan/0000-0003-1932-151X	National Institutes of Health [R01AG17917, R01AG34374, R01AG33678, K23AG40625]; Robert C. Borwell Endowment Fund; NATIONAL INSTITUTE ON AGING [R01AG033678, R01AG034374, K23AG040625, R01AG017917] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert C. Borwell Endowment Fund; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding is provided by National Institutes of Health grants R01AG17917, R01AG34374, R01AG33678, and K23AG40625, and the Robert C. Borwell Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARP, 1999, AARP POLL NEARL ONE; Agarwal S., 2009, AGE REASON FINANCIAL; Anderson LR, 2008, J HEALTH ECON, V27, P1260, DOI 10.1016/j.jhealeco.2008.05.011; [Anonymous], 2009, SAS 9 2 HELP DOC; Barsky RB, 1997, Q J ECON, V112, P537, DOI 10.1162/003355397555280; Benjamin DJ, 2013, J EUR ECON ASSOC, V11, P1231, DOI 10.1111/jeea.12055; Bennett DA, 2005, NEUROEPIDEMIOLOGY, V25, P163, DOI 10.1159/000087446; Bennett DA, 2002, NEUROLOGY, V59, P198, DOI 10.1212/WNL.59.2.198; Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646; Bickel WK, 2001, ADDICTION, V96, P73, DOI 10.1046/j.1360-0443.2001.961736.x; Boyle PA, 2013, PSYCHOL AGING, V28, P614, DOI 10.1037/a0033103; Boyle PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067376; Boyle PA, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-48; Boyle PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043647; Boyle PA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00205; Boyle PA, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-53; Chabris CF, 2008, J RISK UNCERTAINTY, V37, P237, DOI 10.1007/s11166-008-9053-x; COHN RA, 1975, J FINANC, V30, P605, DOI 10.2307/2978738; Cramer JS, 2002, J ECON BEHAV ORGAN, V48, P29, DOI 10.1016/S0167-2681(01)00222-0; Critchfield TS, 2001, J APPL BEHAV ANAL, V34, P101, DOI 10.1901/jaba.2001.34-101; de Wit H, 2007, PERS INDIV DIFFER, V42, P111, DOI 10.1016/j.paid.2006.06.026; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; Denburg NL, 2005, NEUROPSYCHOLOGIA, V43, P1099, DOI 10.1016/j.neuropsychologia.2004.09.012; Dohmen T, 2010, AM ECON REV, V100, P1238, DOI 10.1257/aer.100.3.1238; Donkers B, 1999, SUBJECTIVE MEASURES; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Guiso L., 2004, ROLE RISK AVERSION P; Han SD, 2013, EXP GERONTOL, V48, P1489, DOI 10.1016/j.exger.2013.10.003; Han SD, 2012, BEHAV BRAIN RES, V227, P233, DOI 10.1016/j.bbr.2011.10.026; Harrison GW, 2007, ECONOMETRICA, V75, P433, DOI 10.1111/j.1468-0262.2006.00753.x; Harrison GW, 2008, RES EXP ECON, V12, P41, DOI 10.1016/S0193-2306(08)00003-3; Hatfield J, 2009, ACCIDENT ANAL PREV, V41, P25, DOI 10.1016/j.aap.2008.08.023; Hesketh B, 1998, J VOCAT BEHAV, V52, P89, DOI 10.1006/jvbe.1996.1570; Hinson JM, 2003, J EXP PSYCHOL LEARN, V29, P298, DOI 10.1037/0278-7393.29.2.298; Hsu M, 2008, ADV HEALTH ECON HEAL, V20, P203, DOI 10.1016/S0731-2199(08)20009-9; Kimball MS, 2009, AM ECON REV, V99, P363, DOI 10.1257/aer.99.2.363; Kirby KN, 1997, J EXP PSYCHOL GEN, V126, P54, DOI 10.1037/0096-3445.126.1.54; Kirby KN, 1996, PSYCHON B REV, V3, P100, DOI 10.3758/BF03210748; Kirby KN, 2005, LEARN INDIVID DIFFER, V15, P213, DOI 10.1016/j.lindif.2005.01.003; Laibson D, 1997, Q J ECON, V112, P443, DOI 10.1162/003355397555253; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Read D, 2004, ORGAN BEHAV HUM DEC, V94, P22, DOI 10.1016/j.obhdp.2004.01.002; Roberto K., 2011, METLIFE STUDY ELDER; Samanez-Larkin Gregory R, 2013, APS Obs, V26, P30; Samanez-Larkin GR, 2010, J NEUROSCI, V30, P1426, DOI 10.1523/JNEUROSCI.4902-09.2010; Shamosh NA, 2008, PSYCHOL SCI, V19, P904, DOI 10.1111/j.1467-9280.2008.02175.x; Shamosh NA, 2008, INTELLIGENCE, V36, P289, DOI 10.1016/j.intell.2007.09.004; Skarupski KA, 2009, GERONTOLOGIST, V49, P828, DOI 10.1093/geront/gnp055; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; Willner P, 2010, AJIDD-AM J INTELLECT, V115, P157, DOI 10.1352/1944-7558-115.2.157; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wilson RS, 2005, J INT NEUROPSYCH SOC, V11, P400, DOI 10.1017/S1355617705050459	52	33	35	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121900	10.1371/journal.pone.0121900	http://dx.doi.org/10.1371/journal.pone.0121900			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25838074	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000067
J	Kim, JK; Won, CI; Cha, J; Lee, K; Kim, DS				Kim, Jae-Kwan; Won, Chung-In; Cha, Jehyun; Lee, Kichun; Kim, Deok-Soo			Optimal Ligand Descriptor for Pocket Recognition Based on the Beta-Shape	PLOS ONE			English	Article							VORONOI-DIAGRAM; BINDING-SITES; PROTEIN SURFACES; DOCKING; INHIBITORS; CAVITIES; SEARCH; IDENTIFICATION; VISUALIZATION; COMPUTATION	Structure-based virtual screening is one of the most important and common computational methods for the identification of predicted hit at the beginning of drug discovery. Pocket recognition and definition is frequently a prerequisite of structure-based virtual screening, reducing the search space of the predicted protein-ligand complex. In this paper, we present an optimal ligand shape descriptor for a pocket recognition algorithm based on the beta-shape, which is a derivative structure of the Voronoi diagram of atoms. We investigate six candidates for a shape descriptor for a ligand using statistical analysis: the minimum enclosing sphere, three measures from the principal component analysis of atoms, the van der Waals volume, and the beta-shape volume. Among them, the van der Waals volume of a ligand is the optimal shape descriptor for pocket recognition and best tunes the pocket recognition algorithm based on the beta-shape for efficient virtual screening. The performance of the proposed algorithm is verified by a benchmark test.	[Kim, Jae-Kwan; Won, Chung-In; Kim, Deok-Soo] Hanyang Univ, Voronoi Diagram Res Ctr, Seoul 133791, South Korea; [Cha, Jehyun; Kim, Deok-Soo] Hanyang Univ, Sch Mech Engn, Seoul 133791, South Korea; [Lee, Kichun] Hanyang Univ, Dept Ind Engn, Seoul 133791, South Korea	Hanyang University; Hanyang University; Hanyang University	Kim, DS (corresponding author), Hanyang Univ, Voronoi Diagram Res Ctr, Seoul 133791, South Korea.	dskim@hanyang.ac.kr	Kim, Deok-Soo/K-8661-2015		National Research Foundation grant - MSIP, Republic of Korea [2012R1A2A1A05026395]; Small and Medium Business Administration (SMBA), Republic of Korea [201400000002667]	National Research Foundation grant - MSIP, Republic of Korea; Small and Medium Business Administration (SMBA), Republic of Korea	J-KK, C-IW, JC, and D-SK were supported by the National Research Foundation grant funded by MSIP (No. 2012R1A2A1A05026395), Republic of Korea. KL was supported by the grant (201400000002667) funded by Small and Medium Business Administration (SMBA), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JC, 2004, CURR OPIN CHEM BIOL, V8, P365, DOI 10.1016/j.cbpa.2004.05.001; [Anonymous], 2006, J ZHEJIANG UNIV-SC A, DOI DOI 10.1631/JZUS.2006.A1492; Blundell TL, 2004, CURR OPIN PHARMACOL, V4, P490, DOI 10.1016/j.coph.2004.04.007; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Bush WS, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-238; CambridgeSoft, 2004, TECHNICAL REPORT; Campbell SJ, 2003, CURR OPIN STRUC BIOL, V13, P389, DOI 10.1016/S0959-440X(03)00075-7; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; CHERFILS J, 1993, CURR OPIN STRUC BIOL, V3, P265, DOI 10.1016/S0959-440X(05)80162-9; Cho Y, 2012, J ADV MECH DES SYST, V6, P389, DOI 10.1299/jamdsm.6.389; Coleman RG, 2010, J CHEM INF MODEL, V50, P589, DOI 10.1021/ci900397t; Davis J., 2006, P 23 INT C MACH LEAR, V23, P233, DOI DOI 10.1145/1143844.1143874; Durrant JD, 2011, J MOL GRAPH MODEL, V29, P773, DOI 10.1016/j.jmgm.2010.10.007; Dutta S, 2009, MOL BIOTECHNOL, V42, P1, DOI 10.1007/s12033-008-9127-7; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Edelsbrunner H., 1992, Weighted alpha shapes; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Finn PW, 1999, ALGORITHMICA, V25, P347, DOI 10.1007/PL00008282; Ghose AK, 1999, J COMB CHEM, V1, P55, DOI 10.1021/cc9800071; Ghosh S, 2006, CURR OPIN CHEM BIOL, V10, P194, DOI 10.1016/j.cbpa.2006.04.002; GOODMAN LA, 1954, J AM STAT ASSOC, V49, P732, DOI 10.2307/2281536; Halperin I, 2002, PROTEINS, V47, P409, DOI 10.1002/prot.10115; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Hardy L.W., 2003, CURR DRUG DISCOV, V3, P15; Hartshorn MJ, 2007, J MED CHEM, V50, P726, DOI 10.1021/jm061277y; HO CMW, 1990, J COMPUT AID MOL DES, V4, P337, DOI 10.1007/BF00117400; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Jorgensen WL, 2004, SCIENCE, V303, P1813, DOI 10.1126/science.1096361; Kendall MG, 1938, BIOMETRIKA, V30, P81, DOI 10.2307/2332226; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kim CM, 2006, COMPUT AIDED DESIGN, V38, P1192, DOI 10.1016/j.cad.2006.07.007; Kim DS, 2006, COMPUT AIDED DESIGN, V38, P808, DOI 10.1016/j.cad.2006.04.008; Kim Deok-Soo, 2014, Biodesign, V2, P26; Kim DS, 2012, J COMPUT CHEM, V33, P1252, DOI 10.1002/jcc.22956; Kim DS, 2011, J BIOMOL STRUCT DYN, V29, P219, DOI 10.1080/07391102.2011.10507384; Kim DS, 2010, COMPUT AIDED DESIGN, V42, P911, DOI 10.1016/j.cad.2010.06.004; Kim DS, 2010, COMPUT AIDED DESIGN, V42, P874, DOI 10.1016/j.cad.2010.06.002; Kim D, 2008, J MOL GRAPH MODEL, V26, P1104, DOI 10.1016/j.jmgm.2007.10.002; Kim DS, 2005, COMPUT AIDED DESIGN, V37, P1412, DOI 10.1016/j.cad.2005.02.013; Kim JK, 2014, J COMPUT DES ENG, V1, P79, DOI 10.7315/JCDE.2014.008; Kim JK, 2014, PROTEINS, V82, P1829, DOI 10.1002/prot.24537; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Laskowski RA, 1996, PROTEIN SCI, V5, P2438; Lee C., 2010, THESIS HANYANG U SEO; LEVITT DG, 1992, J MOL GRAPH MODEL, V10, P229, DOI 10.1016/0263-7855(92)80074-N; Lewis D. D., 1994, SIGIR '94. Proceedings of the Seventeenth Annual International ACM-SIGIR Conference on Research and Development in Information Retrieval, P3; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Linn S, 2006, EPIDEMIOLOGIC PERSPE, V3; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Mehio W, 2010, BIOINFORMATICS, V26, P2549, DOI 10.1093/bioinformatics/btq490; Nayal M, 2006, PROTEINS, V63, P892, DOI 10.1002/prot.20897; Neyman J, 1928, BIOMETRIKA, V20A, P175, DOI 10.2307/2331945; Peters KP, 1996, J MOL BIOL, V256, P201, DOI 10.1006/jmbi.1996.0077; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Politi A, 2010, J MOL GRAPH MODEL, V29, P425, DOI 10.1016/j.jmgm.2010.08.003; Saranya N, 2009, BIOORG MED CHEM LETT, V19, P5769, DOI 10.1016/j.bmcl.2009.07.140; Scheswohl DM, 2008, J MOL SIGNALING, P3; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schulz-Gasch T, 2003, J MOL MODEL, V9, P47, DOI 10.1007/s00894-002-0112-y; Shin WH, 2013, J COMPUT CHEM, V34, P2647, DOI 10.1002/jcc.23438; Sitry D, 2002, J BIOL CHEM, V277, P42233, DOI 10.1074/jbc.M205254200; Taha MO, 2010, J MOL GRAPH MODEL, V28, P383, DOI 10.1016/j.jmgm.2009.09.005; Velez DR, 2007, GENET EPIDEMIOL, V31, P306, DOI 10.1002/gepi.20211; VOORINTHOLT R, 1989, J MOL GRAPHICS, V7, P243, DOI 10.1016/0263-7855(89)80010-4; Wickens TD, 1989, MULTIWAY CONTIGENCY; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3	68	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122787	10.1371/journal.pone.0122787	http://dx.doi.org/10.1371/journal.pone.0122787			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835497	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000112
J	Piludu, M; Piras, M; Pichiri, G; Coni, P; Orru, G; Cabras, T; Messana, I; Faa, G; Castagnola, M				Piludu, Marco; Piras, Monica; Pichiri, Giuseppina; Coni, Pierpaolo; Orru, Germano; Cabras, Tiziana; Messana, Irene; Faa, Gavino; Castagnola, Massimo			Thymosin Beta 4 May Translocate from the Cytoplasm in to the Nucleus in HepG2 Cells following Serum Starvation. An Ultrastructural Study	PLOS ONE			English	Article							F-ACTIN; TRANSPORT; COMPLEX; EXPRESSION; ENVELOPE; BINDING; TISSUES; PROTEIN; PEPTIDE; CAPG	Due to its actin-sequestering properties, thymosin beta-4 (T beta 4) is considered to play a significant role in the cellular metabolism. Several physiological properties of T beta 4 have been reported;, however, many questions concerning its cellular function remain to be ascertained. To better understand the role of this small peptide we have analyzed by means of transmission immunoelectron microscopy techniques the ultrastructural localization of T beta 4 in HepG2 cells. Samples of HepG2 cells were fixed in a mixture of 3% formaldehyde and 0.1% glutaraldehyde in 0.1 M cacodylate buffer and processed for standard electron microscopic techniques. The samples were dehydrated in a cold graded methanol series and embedded in LR gold resin. Ultrathin sections were labeled with rabbit antibodies to T beta 4, followed by gold-labeled goat anti-rabbit, stained with uranyl acetate and bismuth subnitrate, observed and photographed in a JEOL 100S transmission electron microscope. Highresolution electron microscopy showed that T beta 4 was mainly restricted to the cytoplasm of HepG2 growing in complete medium. A strong T beta 4 reactivity was detected in the perinuclear region of the cytoplasmic compartment where gold particles appeared strictly associated to the nuclear membrane. In the nucleus specific T beta 4 labeling was observed in the nucleolus. The above electron microscopic results confirm and extend previous observations at light microscopic level, highlighting the subcellular distribution of T beta 4 in both cytoplasmic and nuclear compartments of HepG2 cells. The meaning of T beta 4 presence in the nucleolus is not on the best of our knowledge clarified yet. It could account for the interaction of T beta 4 with nucleolar actin and according with this hypothesis, T beta 4 could contribute together with the other nucleolar acting binding proteins to modulate the transcription activity of the RNA polymerases.	[Piludu, Marco] Univ Cagliari, Dept Biomed Sci, Cagliari, Italy; [Piras, Monica; Pichiri, Giuseppina; Coni, Pierpaolo; Faa, Gavino] Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy; [Cabras, Tiziana; Messana, Irene] Univ Cagliari, Dipartimento Sci Vita & Ambiente, Cagliari, Italy; [Orru, Germano] Univ Cagliari, Dept Surg Sci, OBL, Cagliari, Italy; [Castagnola, Massimo] Univ Cattolica, Ist Biochim & Biochim Clin, Rome, Italy; [Castagnola, Massimo] CNR, Ist Chim Riconoscimento Mol, Ist Sci, Int ISI, Rome, Italy	University of Cagliari; University of Cagliari; University of Cagliari; University of Cagliari; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR)	Pichiri, G (corresponding author), Univ Cagliari, Dipartimento Citomorfol, Div Anat Patol, Cagliari, Italy.	pichiri@unica.it	Castagnola, Massimo/AAM-6355-2021; Castagnola, Massimo/AAB-2825-2019; Piras, M/AAW-6255-2020; Messana, Irene/L-2478-2019; Cabras, Tiziana/AAF-6231-2020	Castagnola, Massimo/0000-0002-0959-7259; Messana, Irene/0000-0002-1436-6105; Coni, Pierpaolo/0000-0001-5602-8887; Pichiri, Giuseppina/0000-0001-8700-8854; Orru, Germano/0000-0003-1032-4431; Piras, Monica/0000-0002-1068-1781; Faa, Gavino/0000-0002-6129-0975	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy	Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy(Fondazione Banco di Sardegna)	The authors acknowledge the financial support of Fondazione Banco di Sardegna, Cagliari, Sardinia, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281; Brieger A, 2007, BIOCHEM BIOPH RES CO, V364, P731, DOI 10.1016/j.bbrc.2007.10.010; D'Angelo MA, 2006, CELL MOL LIFE SCI, V63, P316, DOI 10.1007/s00018-005-5361-3; Durzynska J, 2014, ONCOL REP, V32, P893, DOI 10.3892/or.2014.3329; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Goldstein AL, 2007, ANN NY ACAD SCI, V1112, P1, DOI 10.1196/annals.1415.045; Hubert T, 2008, BIOCHEM BIOPH RES CO, V377, P699, DOI 10.1016/j.bbrc.2008.10.048; Huff T, 2001, INT J BIOCHEM CELL B, V33, P205, DOI 10.1016/S1357-2725(00)00087-X; Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCormack SA, 1999, AM J PHYSIOL-CELL PH, V276, pC459, DOI 10.1152/ajpcell.1999.276.2.C459; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nemolato S, 2012, CANCER BIOL THER, V13, DOI 10.4161/cbt.13.4.18691; Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308; Pichiri G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067999; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Van Impe K, 2008, TRAFFIC, V9, P695, DOI 10.1111/j.1600-0854.2008.00720.x; WATTS JD, 1990, EUR J BIOCHEM, V192, P643, DOI 10.1111/j.1432-1033.1990.tb19271.x; Wirsching HG, 2014, BRAIN, V137, P433, DOI 10.1093/brain/awt333; Wu XY, 2006, NAT CELL BIOL, V8, P756, DOI 10.1038/ncb1433; YU FX, 1994, CELL MOTIL CYTOSKEL, V27, P13, DOI 10.1002/cm.970270103; Zoubek RE, 2007, ANN NY ACAD SCI, V1112, P442, DOI 10.1196/annals.1415.031	25	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119642	10.1371/journal.pone.0119642	http://dx.doi.org/10.1371/journal.pone.0119642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835495	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000012
J	Lee, S; Hennigar, SR; Alam, S; Nishida, K; Kelleher, SL				Lee, Sooyeon; Hennigar, Stephen R.; Alam, Samina; Nishida, Keigo; Kelleher, Shannon L.			Essential Role for Zinc Transporter 2 (ZnT2)-mediated Zinc Transport in Mammary Gland Development and Function during Lactation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY ACTIVATION; SIGNAL TRANSDUCER; IN-VITRO; MACROPHAGES; ZNT2; PROLACTIN; BREAST; TISSUE; PROLIFERATION; DEFICIENCY	The zinc transporter ZnT2 (SLC30A2) imports zinc into vesicles in secreting mammary epithelial cells (MECs) and is critical for zinc efflux into milk during lactation. Recent studies show that ZnT2 also imports zinc into mitochondria and is expressed in the non-lactating mammary gland and non-secreting MECs, highlighting the importance of ZnT2 in general mammary gland biology. In this study we used nulliparous and lactating ZnT2-null mice and characterized the consequences on mammary gland development, function during lactation, and milk composition. We found that ZnT2 was primarily expressed in MECs and to a limited extent in macrophages in the nulliparous mammary gland and loss of ZnT2 impaired mammary expansion during development. Secondly, we found that lactating ZnT2-null mice had substantial defects in mammary gland architecture and MEC function during secretion, including fewer, condensed and disorganized alveoli, impaired Stat5 activation, and unpolarized MECs. Loss of ZnT2 led to reduced milk volume and milk containing less protein, fat, and lactose compared with wild-type littermates, implicating ZnT2 in the regulation of mammary differentiation and optimal milk production during lactation. Together, these results demonstrate that ZnT2-mediated zinc transport is critical for mammary gland function, suggesting that defects in ZnT2 not only reduce milk zinc concentration but may compromise breast health and increase the risk for lactation insufficiency in lactating women.	[Lee, Sooyeon; Kelleher, Shannon L.] Penn State Univ, Interdisciplinary Grad Physiol Program, University Pk, PA 16802 USA; [Lee, Sooyeon; Hennigar, Stephen R.; Kelleher, Shannon L.] Penn State Univ, Dept Nutr Sci, University Pk, PA 16802 USA; [Lee, Sooyeon; Alam, Samina; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Alam, Samina; Kelleher, Shannon L.] Penn State Hershey Coll Med, Dept Surg, Hershey, PA 17033 USA; [Nishida, Keigo] RIKEN Ctr Integrat Med Sci IMS RCAI, RCAI, Lab Homeostat Network, Yokohama, Kanagawa 2300045, Japan; [Nishida, Keigo] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Lab Immune Regulat, Suzuka 5138670, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; RIKEN	Kelleher, SL (corresponding author), 500 Univ Dr, Hershey, PA USA.	slk39@psu.edu	Regan, Clinton/E-6250-2012; alam, samina/V-1599-2018	Lee, Sooyeon/0000-0002-1076-3314	National Institutes of Health [R01HD058614]; Penn State Hershey College of Medicine Department of Surgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Hershey College of Medicine Department of Surgery; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD058614 (to S. L. K.). This work was also supported by the Penn State Hershey College of Medicine Department of Surgery.	Arbour MW, 2013, J MIDWIFERY WOM HEAL, V58, P457, DOI 10.1111/jmwh.12070; Bachiller PR, 2013, AM J PHYSIOL-LUNG C, V305, pL569, DOI 10.1152/ajplung.00401.2012; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Bhardwaj P, 2013, CANCER PREV RES, V6, P282, DOI 10.1158/1940-6207.CAPR-12-0467; Bostanci Z, 2015, REPROD TOXICOL, V54, P84, DOI 10.1016/j.reprotox.2014.07.076; Bostanci Z, 2014, EXP CELL RES, V321, P190, DOI 10.1016/j.yexcr.2013.12.005; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Campbell JJ, 2009, ORGANOGENESIS, V5, P43, DOI 10.4161/org.5.2.8321; Chapman RS, 2000, ADV EXP MED BIOL, V480, P129; Chen CC, 2012, GENE DEV, V26, P2154, DOI 10.1101/gad.197343.112; Chen Y, 2003, J BIOL CHEM, V278, P16520, DOI 10.1074/jbc.M210572200; Chowanadisai W, 2006, J BIOL CHEM, V281, P39699, DOI 10.1074/jbc.M605821200; Chua ACL, 2010, DEVELOPMENT, V137, P4229, DOI 10.1242/dev.059261; CLEGG MS, 1981, BIOL TRACE ELEM RES, V3, P107, DOI 10.1007/BF02990451; Colitti M, 2009, TISSUE CELL, V41, P326, DOI 10.1016/j.tice.2009.02.004; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dempsey C, 2012, J NUTR, V142, P655, DOI 10.3945/jn.111.150623; Dorea JG, 2002, J AM COLL NUTR, V21, P84, DOI 10.1080/07315724.2002.10719198; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; Fata JE, 1999, DEV BIOL, V211, P238, DOI 10.1006/dbio.1999.9313; Feuermann Y, 2009, INT J ENDOCRINOL, V2009, DOI 10.1155/2009/427260; Fleming JM, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3215; Gouon-Evans V, 2000, DEVELOPMENT, V127, P2269; GRIGOR MR, 1986, J NUTR, V116, P1789, DOI 10.1093/jn/116.9.1789; Guo L, 2010, P NATL ACAD SCI USA, V107, P2818, DOI 10.1073/pnas.0914941107; Hanania R, 2012, J BIOL CHEM, V287, P8468, DOI 10.1074/jbc.M111.290676; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hovey RC, 2010, J MAMMARY GLAND BIOL, V15, P279, DOI 10.1007/s10911-010-9187-8; Humphreys RC, 1996, DEVELOPMENT, V122, P4013; Iavnilovitch E, 2002, MOL CANCER RES, V1, P32; Itsumura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064045; Jevitt C, 2007, J MIDWIFERY WOM HEAL, V52, P606, DOI 10.1016/j.jmwh.2007.04.006; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Kelleher SL, 2011, ADV NUTR, V2, P101, DOI 10.3945/an.110.000232; Kelleher SL, 2012, J CELL PHYSIOL, V227, P1761, DOI 10.1002/jcp.22900; Kelleher SL, 2003, J NUTR, V133, P3378, DOI 10.1093/jn/133.11.3378; Khokha R, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004333; Landskroner-Eiger S, 2010, DEV BIOL, V344, P968, DOI 10.1016/j.ydbio.2010.06.019; Lasry I, 2014, J BIOL CHEM, V289, P7275, DOI 10.1074/jbc.M113.533786; Lopez V, 2011, CANCER LETT, V304, P41, DOI 10.1016/j.canlet.2011.01.027; Lopez V, 2009, BIOCHEM J, V422, P43, DOI 10.1042/BJ20081189; McCormick N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011078; McCormick NH, 2012, AM J PHYSIOL-CELL PH, V303, pC291, DOI 10.1152/ajpcell.00443.2011; McManaman JL, 2003, ADV DRUG DELIVER REV, V55, P629, DOI 10.1016/S0169-409X(03)00033-4; Michalczyk AA, 2002, BIOCHEM J, V364, P105, DOI 10.1042/bj3640105; Miletta MC, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/259189; Miyoshi K, 2001, J CELL BIOL, V155, P531, DOI 10.1083/jcb.200107065; Moynihan AT, 2006, AM J OBSTET GYNECOL, V195, P504, DOI 10.1016/j.ajog.2006.01.106; MUTCH PB, 1980, AM J PHYSIOL, V238, pE26, DOI 10.1152/ajpendo.1980.238.1.E26; Neville MC, 2007, J MAMMARY GLAND BIOL, V12, P205, DOI 10.1007/s10911-007-9060-6; Neville MC, 2009, J MAMMARY GLAND BIOL, V14, P269, DOI 10.1007/s10911-009-9150-8; O'Brien J, 2012, DEVELOPMENT, V139, P269, DOI 10.1242/dev.071696; Palmiter RD, 2004, PFLUG ARCH EUR J PHY, V447, P744, DOI 10.1007/s00424-003-1070-7; Palmiter RD, 1996, EMBO J, V15, P1784, DOI 10.1002/j.1460-2075.1996.tb00527.x; Piela Z, 1998, CUTIS, V61, P197; Qian LX, 2009, AM J PHYSIOL-CELL PH, V297, pC369, DOI 10.1152/ajpcell.00589.2008; Reed JR, 2010, J MAMMARY GLAND BIOL, V15, P329, DOI 10.1007/s10911-010-9188-7; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Schwertfeger KL, 2006, J MAMMARY GLAND BIOL, V11, P229, DOI 10.1007/s10911-006-9028-y; Seo YA, 2014, J BIOL CHEM, V289, P23653, DOI 10.1074/jbc.M113.531145; Seo YA, 2011, AM J PHYSIOL-CELL PH, V300, pC1479, DOI 10.1152/ajpcell.00420.2010; Shankar AH, 1998, AM J CLIN NUTR, V68, p447S, DOI 10.1093/ajcn/68.2.447S; SHISHEVA A, 1992, DIABETES, V41, P982, DOI 10.2337/diabetes.41.8.982; Stelwagen K, 1999, MOL CELL ENDOCRINOL, V156, P55, DOI 10.1016/S0303-7207(99)00145-8; Taraboletti G, 2002, AM J PATHOL, V160, P673, DOI 10.1016/S0002-9440(10)64887-0; Thorn SR, 2010, ENDOCRINOLOGY, V151, P3985, DOI 10.1210/en.2010-0029; Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Watson C J, 1996, Rev Reprod, V1, P1; Watson CJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1401; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Wiseman BS, 2003, J CELL BIOL, V162, P1123, DOI 10.1083/jcb.200302090; Zhang LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028432, 10.1371/journal.pone.0020963, 10.1371/journal.pone.0026129, 10.1371/journal.pone.0028953]	78	50	50	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13064	13078		10.1074/jbc.M115.637439	http://dx.doi.org/10.1074/jbc.M115.637439			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851903	hybrid, Green Published			2022-12-26	WOS:000354975700011
J	Chen, XQ; Kim, IK; Honaker, Y; Paudyal, SC; Koh, WK; Sparks, M; Li, S; Piwnica-Worms, H; Ellenberger, T; You, ZS				Chen, Xiaoqing; Kim, In-Kwon; Honaker, Yuchi; Paudyal, Sharad C.; Koh, Won Kyun; Sparks, Melanie; Li, Shan; Piwnica-Worms, Helen; Ellenberger, Tom; You, Zhongsheng			14-3-3 Proteins Restrain the Exo1 Nuclease to Prevent Overresection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						14-3-3 protein; checkpoint control; DNA damage response; DNA repair; proliferating cell nuclear antigen (PCNA); DNA resection; Exo1	DNA END RESECTION; HUMAN EXONUCLEASE 1; DAMAGE RESPONSE; REPAIR DEFECTS; FUNCTIONAL MRX; CANCER; ATR; PHOSPHORYLATION; RECOMBINATION; REPLICATION	Background: Proper regulation of DSB resection is key to genome maintenance. Results: 14-3-3s bind to Exo1 and restrain its damage association and resection activity by counteracting the function of PCNA. Conclusion: Exo1 activity is controlled by both positive and negative regulators to ensure a proper level of DNA end resection. Significance: Our data reveal a key mechanism that controls the DNA end resection process. The DNA end resection process dictates the cellular response to DNA double strand break damage and is essential for genome maintenance. Although insufficient DNA resection hinders homology-directed repair and ATR (ataxia telangiectasia and Rad3 related)-dependent checkpoint activation, overresection produces excessive single-stranded DNA that could lead to genomic instability. However, the mechanisms controlling DNA end resection are poorly understood. Here we show that the major resection nuclease Exo1 is regulated both positively and negatively by protein-protein interactions to ensure a proper level of DNA resection. We have shown previously that the sliding DNA clamp proliferating cell nuclear antigen (PCNA) associates with the C-terminal domain of Exo1 and promotes Exo1 damage association and DNA resection. In this report, we show that 14-3-3 proteins interact with a central region of Exo1 and negatively regulate Exo1 damage recruitment and subsequent resection. 14-3-3s limit Exo1 damage association, at least in part, by suppressing its association with PCNA. Disruption of the Exo1 interaction with 14-3-3 proteins results in elevated sensitivity of cells to DNA damage. Unlike Exo1, the Dna2 resection pathway is apparently not regulated by PCNA and 14-3-3s. Our results provide critical insights into the mechanism and regulation of the DNA end resection process and may have implications for cancer treatment.	[Chen, Xiaoqing; Honaker, Yuchi; Paudyal, Sharad C.; Koh, Won Kyun; Sparks, Melanie; Li, Shan; Piwnica-Worms, Helen; You, Zhongsheng] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Kim, In-Kwon; Ellenberger, Tom] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Piwnica-Worms, Helen] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77230 USA	Washington University (WUSTL); Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	You, ZS (corresponding author), Washington Univ, Sch Med, Campus Box 8228,660 S Euclid Ave, St Louis, MO 63110 USA.	zyou@wustl.edu	chen, xia/GXM-5435-2022; Regan, Clinton/E-6250-2012; chen, xi/GXH-3653-2022; Classen, Scott/AAY-8176-2020; chen, xia/GYR-3948-2022	You, Zhongsheng/0000-0002-9719-8791; Koh, Won Kyun/0000-0001-8068-7348; Paudyal, Sharad/0000-0002-1658-6400	National Institutes of Health [R01GM098535, P01CA92584]; American Cancer Society [RSG-13-212-01-DMC]; Washington University; NATIONAL CANCER INSTITUTE [P01CA092584, T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM098535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Washington University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM098535 (to Z. Y.) and P01CA92584 (to T. E.). This work was also supported by American Cancer Society Research Scholar Grant RSG-13-212-01-DMC (to Z. Y.) and a Washington University Siteman Career Award in Breast Cancer Research (to Z. Y.).	Adkins NL, 2013, NAT STRUCT MOL BIOL, V20, P836, DOI 10.1038/nsmb.2585; Andersen SD, 2012, DNA REPAIR, V11, P267, DOI 10.1016/j.dnarep.2011.11.007; Bardwell PD, 2004, NAT IMMUNOL, V5, P224, DOI 10.1038/ni1031; Bertuch AA, 2004, GENETICS, V166, P1651, DOI 10.1534/genetics.166.4.1651; Bolderson E, 2010, NUCLEIC ACIDS RES, V38, P1821, DOI 10.1093/nar/gkp1164; Bonetti D, 2015, EMBO REP, V16, P351, DOI 10.15252/embr.201439764; Cannavo E, 2013, P NATL ACAD SCI USA, V110, pE1661, DOI 10.1073/pnas.1305166110; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Chen XQ, 2013, NUCLEIC ACIDS RES, V41, P9325, DOI 10.1093/nar/gkt672; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo V, 2004, METH MOL B, V241, P255; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157; El-Shemerly M, 2008, NUCLEIC ACIDS RES, V36, P511, DOI 10.1093/nar/gkm1052; Engels K, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001367; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Karanja KK, 2014, CELL CYCLE, V13, P1540, DOI 10.4161/cc.28476; Karras GI, 2013, MOL CELL, V49, P536, DOI 10.1016/j.molcel.2012.11.016; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Knipscheer Puck, 2012, Methods Mol Biol, V920, P221, DOI 10.1007/978-1-61779-998-3_16; Langerak P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002271; Liao SR, 2008, NUCLEIC ACIDS RES, V36, P6091, DOI 10.1093/nar/gkn616; Liao SR, 2011, NUCLEIC ACIDS RES, V39, P5967, DOI 10.1093/nar/gkr216; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Maringele L, 2004, GENE DEV, V18, P2663, DOI 10.1101/gad.316504; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Mimitou EP, 2010, EMBO J, V29, P3358, DOI 10.1038/emboj.2010.193; Mimitou EP, 2009, DNA REPAIR, V8, P983, DOI 10.1016/j.dnarep.2009.04.017; Morin I, 2008, EMBO J, V27, P2400, DOI 10.1038/emboj.2008.171; Morrison DK, 2009, TRENDS CELL BIOL, V19, P16, DOI 10.1016/j.tcb.2008.10.003; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Ngo GHP, 2014, NUCLEIC ACIDS RES, V42, P10516, DOI 10.1093/nar/gku746; Nicolette ML, 2010, NAT STRUCT MOL BIOL, V17, P1478, DOI 10.1038/nsmb.1957; Nimonkar AV, 2008, P NATL ACAD SCI USA, V105, P16906, DOI 10.1073/pnas.0809380105; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Reinhardt HC, 2013, NAT REV MOL CELL BIO, V14, P563, DOI 10.1038/nrm3640; Rossiello F, 2014, CURR OPIN GENET DEV, V26, P89, DOI 10.1016/j.gde.2014.06.009; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Schaetzlein S, 2013, P NATL ACAD SCI USA, V110, pE2470, DOI 10.1073/pnas.1308512110; Segurado M, 2008, GENE DEV, V22, P1816, DOI 10.1101/gad.477208; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shim EY, 2010, EMBO J, V29, P3370, DOI 10.1038/emboj.2010.219; Shiotani B, 2013, CELL REP, V3, P1651, DOI 10.1016/j.celrep.2013.04.018; Shiotani B, 2009, MOL CELL, V33, P547, DOI 10.1016/j.molcel.2009.01.024; Stracker Travis H., 2013, Frontiers in Genetics, V4, P37, DOI 10.3389/fgene.2013.00037; Sun J, 2012, J BIOL CHEM, V287, P4936, DOI 10.1074/jbc.M111.306167; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Tomimatsu N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4561; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; Tsutakawa SE, 2014, DNA REPAIR, V19, P95, DOI 10.1016/j.dnarep.2014.03.022; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wei KC, 2003, GENE DEV, V17, P603, DOI 10.1101/gad.1060603; Xu ZM, 2010, NAT STRUCT MOL BIOL, V17, P1124, DOI 10.1038/nsmb.1884; Yang SH, 2013, EMBO J, V32, P126, DOI 10.1038/emboj.2012.314; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Zhang JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001946; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	71	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2015	290	19					12300	12312		10.1074/jbc.M115.644005	http://dx.doi.org/10.1074/jbc.M115.644005			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH9XA	25833945	Green Published, hybrid			2022-12-26	WOS:000354388600040
J	Avila-Pedretti, G; Tornero, J; Fernandez-Nebro, A; Blanco, F; Gonzalez-Alvaro, I; Canete, JD; Maymo, J; Alperiz, M; Fernandez-Gutienrez, B; Olive, A; Corominas, H; Erra, A; Aterido, A; Lasanta, ML; Tortosa, R; Julia, A; Marsal, S				Avila-Pedretti, Gabriela; Tornero, Jesus; Fernandez-Nebro, Antonio; Blanco, Francisco; Gonzalez-Alvaro, Isidoro; Canete, Juan D.; Maymo, Joan; Alperiz, Mercedes; Fernandez-Gutierrez, Benjamin; Olive, Alex; Corominas, Hector; Erra, Alba; Aterido, Adria; Lopez Lasanta, Maria; Tortosa, Rauel; Julia, Antonio; Marsal, Sara			Variation at FCGR2A and Functionally Related Genes Is Associated with the Response to Anti-TNF Therapy in Rheumatoid Arthritis	PLOS ONE			English	Article							C-RECEPTOR POLYMORPHISMS; FC-GAMMA RECEPTORS; DENDRITIC CELLS; EXPRESSION; IGG; RNA; VALIDATION; ACTIVATION; RITUXIMAB; CRITERIA	Objective Anti-TNF therapies have been highly efficacious in the management of rheumatoid arthritis (RA), but 25-30% of patients do not show a significant clinical response. There is increasing evidence that genetic variation at the Fc receptor FCGR2A is associated with the response to anti-TNF therapy. We aimed to validate this genetic association in a patient cohort from the Spanish population, and also to identify new genes functionally related to FCGR2A that are also associated with anti-TNF response. Methods A total of 348 RA patients treated with an anti-TNF therapy were included and genotyped for FCGR2A polymorphism rs1081274. Response to therapy was determined at 12 weeks, and was tested for association globally and independently for each anti-TNF drug (infliximab, etanercept and adalimumab). Using gene expression profiles from macrophages obtained from synovial fluid of RA patients, we searched for genes highly correlated with FCGR2A expression. Tag SNPs were selected from each candidate gene and tested for association with the response to therapy. Results We found a significant association between FCGR2A and the response to adalimumab (P=0.022). Analyzing the subset of anti-CCP positive RA patients (78%), we also found a significant association between FCGR2A and the response to infliximab (P=0.035). DHX32 and RGS12 were the most consistently correlated genes with FCGR2A expression in RA synovial fluid macrophages (P<0.001). We found a significant association between the genetic variation at DHX32 (rs12356233, corrected P=0.019) and a nominally significant association between RGS12 and the response to adalimumab (rs4690093, uncorrected P=0.040). In the anti-CCP positive group of patients, we also found a nominally significant association between RGS12 and the response to infliximab (rs2857859, uncorrected P=0.042). Conclusions In the present study we have validated the FCGR2A association in an independent population, and we have identified new genes associated with the response to anti-TNF therapy in RA.	[Avila-Pedretti, Gabriela; Aterido, Adria; Lopez Lasanta, Maria; Tortosa, Rauel; Julia, Antonio; Marsal, Sara] Vall dHebron Hosp, Res Inst, Rheumatol Res Group, Barcelona, Spain; [Tornero, Jesus] Hosp Univ Guadalajara, Dept Rheumatol, Guadalajara, Spain; [Fernandez-Nebro, Antonio] Univ Malaga, Hosp Reg, Inst Invest Biomed Malaga, UGC Reumatol, E-29071 Malaga, Spain; [Blanco, Francisco] INIBIC Hosp Univ A Coruna, Dept Rheumatol, La Coruna, Spain; [Gonzalez-Alvaro, Isidoro] Hosp Univ La Princesa, Dept Rheumatol, IIS La Princesa, Madrid, Spain; [Canete, Juan D.] Hosp Clin Barcelona, Dept Rheumatol, Barcelona, Spain; [Maymo, Joan] Hosp del Mar, Dept Rheumatol, Barcelona, Spain; [Alperiz, Mercedes] Hosp Univ Cent Asturias, Dept Rheumatol, Oviedo, Spain; [Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Olive, Alex] Hosp Badalona Germans Trias & Pujol, Dept Rheumatol, Madrid, Spain; [Corominas, Hector] Hosp Moises Broggi, Dept Rheumatol, Barcelona, Spain; [Erra, Alba] Hosp St Rafael, Dept Rheumatol, Barcelona, Spain	Hospital Universitari Vall d'Hebron; Universidad de Malaga; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); University of Barcelona; Hospital Clinic de Barcelona; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Central University Hospital Asturias; Hospital Clinico San Carlos; Hospital Germans Trias i Pujol	Marsal, S (corresponding author), Vall dHebron Hosp, Res Inst, Rheumatol Res Group, Barcelona, Spain.	sara.marsal@vhir.org	Fernandez-Nebro, Antonio/K-7628-2012; Corominas, Hèctor/P-5045-2019; Cañete, Juan D/AAV-8910-2021; Blanco Garcia, Francisco J/C-3192-2014	Fernandez-Nebro, Antonio/0000-0002-2962-9844; Corominas, Hèctor/0000-0002-7738-6787; Cañete, Juan D/0000-0003-2606-0573; Lopez Lasanta, Maria/0000-0002-8462-8406; marsal, sara/0000-0001-5515-3854; Blanco Garcia, Francisco J/0000-0001-9821-7635; Julia Cano, Antonio/0000-0001-6064-3620; Avila-Pedretti, Gabriela/0000-0002-6526-6278	Spanish Ministry of Economy and Competitiveness [PSE-010000-2006-6, IPT-010000-2010-36]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness grants (PSE-010000-2006-6 and IPT-010000-2010-36). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhaleem M, 2005, ANTICANCER RES, V25, P2645; Abdelhaleem M, 2002, LEUKEMIA RES, V26, P945, DOI 10.1016/S0145-2126(02)00040-1; Acosta-Colman I, 2013, PHARMACOGENOMICS, V14, P727, DOI [10.2217/PGS.13.60, 10.2217/pgs.13.60]; Alli Z, 2005, CELL IMMUNOL, V237, P141, DOI 10.1016/j.cellimm.2005.12.003; Alli Z, 2007, ANTICANCER RES, V27, P373; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Arora T, 2009, CYTOKINE, V45, P124, DOI 10.1016/j.cyto.2008.11.008; Baccala R, 2009, NAT REV RHEUMATOL, V5, P448, DOI 10.1038/nrrheum.2009.136; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett T, 2006, METHOD ENZYMOL, V411, P352, DOI 10.1016/S0076-6879(06)11019-8; Bossini-Castillo L, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204591; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Burska AN, 2014, PHARMACOGENOMICS J, V14, P93, DOI 10.1038/tpj.2013.48; Canete JD, 2009, ANN RHEUM DIS, V68, P1547, DOI 10.1136/ard.2008.096982; Criswell LA, 2004, ARTHRITIS RHEUM-US, V50, P2750, DOI 10.1002/art.20469; Cui J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003394; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Emery P, 2011, ANN RHEUM DIS, V70, P2063, DOI 10.1136/ard.2010.148015; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Ivan E, 2006, HUM IMMUNOL, V67, P479, DOI 10.1016/j.humimm.2005.12.001; Krintel SB, 2012, PHARMACOGENET GENOM, V22, P577, DOI 10.1097/FPC.0b013e3283544043; Kuhn KA, 2006, J CLIN INVEST, V116, P961, DOI 10.1172/JCI25422; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Mathews RJ, 2014, ANN RHEUM DIS, V73, P1202, DOI 10.1136/annrheumdis-2013-203276; Meylan E, 2006, MOL CELL, V22, P561, DOI 10.1016/j.molcel.2006.05.012; Mimoto F, 2014, MOL IMMUNOL, V58, P132, DOI 10.1016/j.molimm.2013.11.017; Mitoma H, 2013, IMMUNITY, V39, P123, DOI 10.1016/j.immuni.2013.07.001; Montes A, 2014, PHARMACOGENET GENOM, V24, P238, DOI 10.1097/FPC.0000000000000042; Musolino A, 2008, J CLIN ONCOL, V26, P1789, DOI 10.1200/JCO.2007.14.8957; Narendra SC, 2014, J LEUKOCYTE BIOL, V95, P661, DOI 10.1189/jlb.0613320; Padyukov L, 2011, ANN RHEUM DIS, V70, P259, DOI 10.1136/ard.2009.126821; Paiva M, 2008, CANCER GENET CYTOGEN, V183, P35, DOI 10.1016/j.cancergencyto.2008.02.001; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Salliot C, 2011, ANN RHEUM DIS, V70, P266, DOI 10.1136/ard.2010.132134; Siberil S, 2006, IMMUNOL LETT, V106, P111, DOI 10.1016/j.imlet.2006.05.009; Smolen JS, 2006, CLIN EXP RHEUMATOL, V24, pS7; Takai T, 2002, NAT REV IMMUNOL, V2, P580, DOI 10.1038/nri856; Team R Core, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Yang SY, 2007, J BONE MINER RES, V22, P45, DOI 10.1359/JBMR.061007; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	49	28	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122088	10.1371/journal.pone.0122088	http://dx.doi.org/10.1371/journal.pone.0122088			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848939	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800095
J	Li, L; Chen, ZH; Bei, WC; Su, ZP; Huang, Q; Zhang, L; Chen, HC; Zhou, R				Li, Lu; Chen, Zhaohui; Bei, Weicheng; Su, Zhipeng; Huang, Qi; Zhang, Liang; Chen, Huanchun; Zhou, Rui			Catecholamines Promote Actinobacillus pleuropneumoniae Growth by Regulating Iron Metabolism	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; OUTER-MEMBRANE PROTEIN; TRANSCRIPTIONAL RESPONSE; SALMONELLA-ENTERICA; MOLECULAR-CLONING; GENE-EXPRESSION; NOREPINEPHRINE; RESTRICTION; TRANSFERRIN; VIRULENCE	Catecholamines are host stress hormones that can induce the growth of many bacteria by facilitating iron utilization and/or regulate the expression of virulence genes through specific hormone receptors. Whether these two responsive pathways are interconnected is unknown. In our previous study, it was found that catecholamines can regulate the expression of a great number of genes of Actinobacillus pleuropneumoniae, an important swine respiratory pathogen. However, bacterial growth was not affected by catecholamines in rich medium. In this study, it was discovered that catecholamines affected A. pleuropneumoniae growth in chemically defined medium (CDM). We found that serum inhibited A. pleuropneumoniae growth in CDM, while epinephrine, norepinephrine and dopamine promoted A. pleuropneumoniae growth in the CDM containing serum. The known bacterial hormone receptor QseC didn't play roles in this process. Ion-supplementation and transcriptome analysis indicated that serum addition resulted in iron-restricted conditions which were alleviated by the addition of catecholamines. Transferrin, one of the components in serum, inhibited the growth of A. pleuropneumoniae in CDM, an effect reversed by addition of catecholamines in a TonB2-dependent manner. Our data demonstrate that catecholamines promote A. pleuropneumoniae growth by regulating iron-acquisition and metabolism, which is independent of the adrenergic receptor QseC.	[Li, Lu; Chen, Zhaohui; Bei, Weicheng; Su, Zhipeng; Huang, Qi; Zhang, Liang; Chen, Huanchun; Zhou, Rui] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Li, L (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	lilu@mail.hzau.edu.cn; rzhou@mail.hzau.edu.cn		Huang, Qi/0000-0002-1600-1169	National Natural Science Foundation of China [31201932]; National Basic Research Program of China (973 Program) [2012CB518802]; Special Fund for Agro-scientific Research in the Public Interest [201303034-11]; Fundamental Research Funds for the Central Universities [2662014BQ021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (31201932) (http://www.nsfc.gov.cn/, National Basic Research Program of China (973 Program, 2012CB518802) (http://www.973.gov.cn/Default_3.aspx, Special Fund for Agro-scientific Research in the Public Interest (201303034-11) (http://www.moa.gov.cn/) and Fundamental Research Funds for the Central Universities (2662014BQ021) (http://www.hzau.edu.cn/2014/ch/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MT, 2006, J BACTERIOL, V188, P5731, DOI 10.1128/JB.00495-06; Archambault M, 2003, CAN J VET RES, V67, P271; Armstrong SK, 2012, MOL MICROBIOL, V84, P446, DOI 10.1111/j.1365-2958.2012.08032.x; Bansal T, 2007, INFECT IMMUN, V75, P4597, DOI 10.1128/IAI.00630-07; Bearson BL, 2008, MICROBES INFECT, V10, P807, DOI 10.1016/j.micinf.2008.04.011; Beddek AJ, 2004, INFECT IMMUN, V72, P701, DOI 10.1128/IAI.72.2.701-708.2004; Bei WC, 2005, FEMS MICROBIOL LETT, V243, P21, DOI 10.1016/j.femsle.2004.11.033; Belay T, 2003, LIFE SCI, V73, P1527, DOI 10.1016/S0024-3205(03)00472-7; Bosse JT, 2002, MICROBES INFECT, V4, P225, DOI 10.1016/S1286-4579(01)01534-9; Burton CL, 2002, INFECT IMMUN, V70, P5913, DOI 10.1128/IAI.70.11.5913-5923.2002; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin N, 1996, FEMS MICROBIOL LETT, V143, P1, DOI 10.1111/j.1574-6968.1996.tb08452.x; Clarke MB, 2006, P NATL ACAD SCI USA, V103, P10420, DOI 10.1073/pnas.0604343103; DENEER HG, 1989, INFECT IMMUN, V57, P798, DOI 10.1128/IAI.57.3.798-804.1989; Deslandes V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-72; Diarra MS, 1996, APPL ENVIRON MICROB, V62, P853, DOI 10.1128/AEM.62.3.853-859.1996; Dowd SE, 2007, FEMS MICROBIOL LETT, V273, P214, DOI 10.1111/j.1574-6968.2007.00800.x; DSILVA CG, 1995, VET MICROBIOL, V44, P11, DOI 10.1016/0378-1135(94)00109-A; Freestone PPE, 2003, FEMS MICROBIOL LETT, V222, P39, DOI 10.1016/S0378-1097(03)00243-X; Freestone PPE, 2000, J BACTERIOL, V182, P6091, DOI 10.1128/JB.182.21.6091-6098.2000; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; Freestone PPE, 2007, FEMS MICROBIOL LETT, V269, P221, DOI 10.1111/j.1574-6968.2006.00619.x; Freestone PPE, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-8; Hughes DT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000553; Jacques M, 2004, CAN J VET RES, V68, P81; Karavolos MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-458; Kendall MM, 2007, INFECT IMMUN, V75, P4875, DOI 10.1128/IAI.00550-07; Kinney KS, 1999, MICROB PATHOGENESIS, V26, P85, DOI 10.1006/mpat.1998.0251; Klitgaard K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-698; Li L, 2008, MICROB PATHOGENESIS, V45, P192, DOI 10.1016/j.micpath.2008.05.008; Li L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031121; Li L, 2011, MICROB PATHOGENESIS, V50, P293, DOI 10.1016/j.micpath.2011.02.002; Lone AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006139; Lyte M, 1996, J LAB CLIN MED, V128, P392, DOI 10.1016/S0022-2143(96)80011-4; Lyte M, 1997, BIOCHEM BIOPH RES CO, V232, P682, DOI 10.1006/bbrc.1997.6356; LYTE M, 1992, MED HYPOTHESES, V37, P255, DOI 10.1016/0306-9877(92)90197-K; Mikael LG, 2002, MICROBIOL-SGM, V148, P2869, DOI 10.1099/00221287-148-9-2869; NIVEN DF, 1989, MOL MICROBIOL, V3, P1083, DOI 10.1111/j.1365-2958.1989.tb00258.x; Reading NC, 2009, P NATL ACAD SCI USA, V106, P5889, DOI 10.1073/pnas.0811409106; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Srikumar R, 2004, MICROBIOL-SGM, V150, P1723, DOI 10.1099/mic.0.27046-0; Wagner TK, 2006, FEMS IMMUNOL MED MIC, V48, P192, DOI 10.1111/j.1574-695X.2006.00147.x; Xu ZF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001450; Xu ZF, 2010, J BACTERIOL, V192, P5625, DOI 10.1128/JB.00535-10	44	14	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121887	10.1371/journal.pone.0121887	http://dx.doi.org/10.1371/journal.pone.0121887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849041	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800083
J	Zhu, JW; Lu, DH; Sveinsson, O; Wirdefeldt, K; Fall, K; Piehl, F; Valdimarsdottir, U; Fang, F				Zhu, Jianwei; Lu, Donghao; Sveinsson, Olafur; Wirdefeldt, Karin; Fall, Katja; Piehl, Fredrik; Valdimarsdottir, Unnur; Fang, Fang			Is a Cancer Diagnosis Associated with Subsequent Risk of Transient Global Amnesia?	PLOS ONE			English	Article							CARDIOVASCULAR DEATH; EMOTIONAL AROUSAL; SUICIDE; PREVALENCE; DISORDERS; DISTRESS; THERAPY	Background Psychological stress has been associated with transient global amnesia (TGA). Whether a cancer diagnosis, a severely stressful life event, is associated with subsequent risk of TGA has not been studied. Methods Based on the Swedish Cancer Register and Patient Register, we conducted a prospective cohort study including 5,365,608 Swedes at age 30 and above during 2001-2009 to examine the relative risk of TGA among cancer patients, as compared to cancer-free individuals. Incidence rate ratios (IRRs) and their 95% confidence intervals (CIs) derived from Poisson regression were used as estimates of the association between cancer diagnosis and the risk of TGA. Results During the study 322,558 individuals (6.01%) received a first diagnosis of cancer. We identified 210 cases of TGA among the cancer patients (incidence rate, 0.22 per 1000 person-years) and 4,887 TGA cases among the cancer-free individuals (incidence rate, 0.12 per 1000 person-years). Overall, after adjustment for age, sex, calendar year, socioeconomic status, education and civil status, cancer patients had no increased risk of TGA than the cancer-free individuals (IRR, 0.99; 95% CI, 0.86-1.13). The IRRs did not differ over time since cancer diagnosis or across individual cancer types. The null association was neither modified by sex, calendar period or age. Conclusion Our study did not provide support for the hypothesis that patients with a new diagnosis of cancer display a higher risk of TGA than cancer-free individuals.	[Zhu, Jianwei; Lu, Donghao; Wirdefeldt, Karin; Fang, Fang] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sveinsson, Olafur; Piehl, Fredrik] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden; [Wirdefeldt, Karin] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Fall, Katja] Univ Orebro, Clin Epidemiol & Biostat Unit, SE-70182 Orebro, Sweden; [Valdimarsdottir, Unnur] Univ Iceland, Ctr Publ Hlth, Reykjavik, Iceland; [Zhu, Jianwei] Shandong Univ, Shandong Prov Hosp, Dept Orthoped, Jinan 250100, Peoples R China	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University; University of Iceland; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Zhu, JW (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Jianwei.zhu@ki.se	Fall, Katja/AAE-1876-2021	Fall, Katja/0000-0002-3649-2639; Lu, Donghao/0000-0002-4186-8661; Piehl, Fredrik/0000-0001-8329-5219; Valdimarsdottir, Unnur/0000-0001-5382-946X; Fang, Fang/0000-0002-3310-6456; Zhu, Jianwei/0000-0002-6236-6628	Swedish Research Council for Health, Working Life and Welfare [2012-0498]; Swedish Research Council [SIMSAM 80748301, 340-2013-5867]; China Scholarship Council [201309370015]; Swedish Society for Medical Research; Lindhes Advokatbyra AB [LA2014-0352]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); China Scholarship Council(China Scholarship Council); Swedish Society for Medical Research; Lindhes Advokatbyra AB	This work was supported by the Swedish Research Council for Health, Working Life and Welfare (No. 2012-0498), URL: http://www.forte.se/en/; Swedish Research Council (SIMSAM 80748301 and 340-2013-5867), URL: http://www.vr.se/inenglish/researchfunding.4.12fff4451215cbd83e4800021418.html; China Scholarship Council (No. 201309370015), URL: http://www.csc.edu.cn/; Swedish Society for Medical Research, URL: http://www.ssmf.se/; Karolinska Institutet, URL: http://ki.se/start; Lindhes Advokatbyra AB (LA2014-0352), URL: http://www.lindhes.se/hem. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Bartsch T, 2013, NAT REV NEUROL, V9, P86, DOI 10.1038/nrneurol.2012.264; Bartsch T, 2010, LANCET NEUROL, V9, P205, DOI 10.1016/S1474-4422(09)70344-8; Brigo F, 2014, ACTA NEUROL BELG; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Dohring J, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00287; Dropkin MJ, 1999, CANCER PRACT, V7, P309, DOI 10.1046/j.1523-5394.1999.76006.x; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2012, NEW ENGL J MED, V366, P1310, DOI 10.1056/NEJMoa1110307; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; FISHER CM, 1982, ARCH NEUROL-CHICAGO, V39, P605, DOI 10.1001/archneur.1982.00510220003001; FISHER CM, 1964, ACTA NEUROL SCAND, V40, P7; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; HODGES JR, 1990, BRAIN, V113, P639, DOI 10.1093/brain/113.3.639; Inzitari D, 1997, ARCH NEUROL-CHICAGO, V54, P866, DOI 10.1001/archneur.1997.00550190056015; Johnson TV, 2012, PSYCHO-ONCOLOGY, V21, P351, DOI 10.1002/pon.1905; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Kirshner HS, 2011, CURR NEUROL NEUROSCI, V11, P578, DOI 10.1007/s11910-011-0224-9; KOSKI KJ, 1990, ACTA NEUROL SCAND, V81, P358; Lu D, 2013, ANN ONCOL, V24, P3112, DOI 10.1093/annonc/mdt415; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; MERRIAM AE, 1992, PSYCHOSOMATICS, V33, P109, DOI 10.1016/S0033-3182(92)72029-5; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Pantoni L, 2000, ACTA NEUROL SCAND, V102, P275, DOI 10.1034/j.1600-0404.2000.102005275.x; Quinette P, 2006, BRAIN, V129, P1640, DOI 10.1093/brain/awl105; Salvo N, 2012, CLIN ONCOL-UK, V24, P139, DOI 10.1016/j.clon.2011.05.003; Sander D, 2000, LANCET, V356, P1982, DOI 10.1016/S0140-6736(00)03313-4; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Steginga SK, 2004, UROLOGY, V63, P751, DOI 10.1016/j.urology.2003.11.017; Wade J, 2013, J CLIN ONCOL, V31, P4235, DOI 10.1200/JCO.2012.45.4801; ZORZON M, 1995, STROKE, V26, P1536, DOI 10.1161/01.STR.26.9.1536	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122960	10.1371/journal.pone.0122960	http://dx.doi.org/10.1371/journal.pone.0122960			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849383	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800183
J	Wujcicka, W; Paradowska, E; Studzinska, M; Gaj, Z; Wilczynski, J; Lesnikowski, Z; Nowakowska, D				Wujcicka, Wioletta; Paradowska, Edyta; Studzinska, Miroslawa; Gaj, Zuzanna; Wilczynski, Jan; Lesnikowski, Zbigniew; Nowakowska, Dorota			TLR9 2848 GA Heterozygotic Status Possibly Predisposes Fetuses and Newborns to Congenital Infection with Human Cytomegalovirus	PLOS ONE			English	Article							TOLL-LIKE-RECEPTOR-4 POLYMORPHISMS; TOXOPLASMA-GONDII; HYPORESPONSIVENESS; SEROPREVALENCE; EXPRESSION; MANAGEMENT; RESPONSES; GENOTYPE; MOTHER; WOMEN	Background Some single nucleotide polymorphisms (SNP), located in Toll-like receptor (TLR) genes, were reported to be associated with human cytomegalovirus (HCMV) infections. The study was aimed to assess the correlation of SNPs at TLR4 and TLR9 genes with the occurrence of congenital cytomegaly, based on available samples. Methods Reported case-control study included both HCMV infected and non-infected fetuses and newborns. The specimens were classified to the molecular analyses, based on serological features of the recent infection and HCMV DNAemia in body fluids. TLR SNPs were studied, using multiplex nested PCR-RFLP assay, and determined genotypes were confirmed by sequencing. Hardy-Weinberg equilibrium was assessed for the identified genotypes. The linkage disequilibrium was also estimated for TLR4 SNPs. A relationship between the status of TLR genotypes and congenital cytomegaly development was estimated, using a logistic regression model. Results Hardy Weinberg equilibrium was observed for almost all SNPs, both infected and non-infected patients, with exception of TLR4 896 A>G polymorphism in the control group (P <= 0.050). TLR4 896 A>G and 1196 C>T SNPs were found in linkage disequilibrium in both study groups (P <= 0.050). The CC genotype at TLR4 1196 SNP and the GA variant at TLR9 2848 G>A SNP were significantly associated with HCMV infection (P <= 0.050). The risk of congenital cytomegaly was higher in heterozygotes at TLR9 SNP than in the carriers of other genotypic variants at the reported locus (OR 4.81; P <= 0.050). The GC haplotype at TLR4 SNPs and GCA variants at TLR4 and TLR9 SNPs were significantly associated with HCMV infection (P <= 0.0001). The ACA variants were more frequent among fetuses and neonates with symptomatic, rather than asymptomatic cytomegaly (P <= 0.0001). Conclusions TLR4 and TLR9 polymorphisms may contribute to the development of congenital infection with HCMV in fetuses and neonates. The TLR9 2848 GA heterozygotic status possibly predisposes to HCMV infection, increasing the risk of congenital cytomegaly development.	[Wujcicka, Wioletta; Gaj, Zuzanna] Polish Mothers Mem Hosp, Res Inst, Ctr Med Lab Diagnost, Sci Lab, Lodz, Poland; [Wilczynski, Jan; Nowakowska, Dorota] Polish Mothers Mem Hosp, Res Inst, Dept Perinatol & Gynecol, Lodz, Poland; [Paradowska, Edyta; Studzinska, Miroslawa; Lesnikowski, Zbigniew] Polish Acad Sci, Inst Med Biol, Lab Mol Virol & Biol Chem, Lodz, Poland	Polish Mother's Memorial Hospital - Research Institute; Polish Mother's Memorial Hospital - Research Institute; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Nowakowska, D (corresponding author), Polish Mothers Mem Hosp, Res Inst, Dept Perinatol & Gynecol, Lodz, Poland.	dnowakowska@yahoo.com	Lesnikowski, Zbigniew/AAG-7006-2020; Gaj, Zuzanna/O-3749-2014	Lesnikowski, Zbigniew/0000-0003-3158-5796; Paradowska, Edyta/0000-0001-9446-0136; Wujcicka, Wioletta/0000-0002-2907-1414; Gaj, Zuzanna/0000-0002-1803-1935; Studzinska, Miroslawa/0000-0002-4851-2190	Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant [2012/63-MN]	Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant	Sponsor: the Polish Ministry of Science & Higher Education, Polish Mother's Memorial Hospital-Research Institute-Young Researcher Internal Grant No. 2012/63-MN.	Arav-Boger Ravit, 2012, BMC Res Notes, V5, P140, DOI 10.1186/1756-0500-5-140; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Belderbos ME, 2009, CLIN IMMUNOL, V133, P228, DOI 10.1016/j.clim.2009.07.003; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Britt W, 2011, INFECT DIS FETUS NEW, P707; Caron JE, 2010, NEONATOLOGY, V97, P266, DOI 10.1159/000255165; De Paschale Massimo, 2009, Infect Dis Obstet Gynecol, V2009, P206505, DOI 10.1155/2009/206505; Ducloux D, 2005, KIDNEY INT, V67, P2454, DOI 10.1111/j.1523-1755.2005.00354.x; Figueroa L, 2012, J IMMUNOL, V188, P4506, DOI 10.4049/jimmunol.1200202; GIBRAT JF, 1987, J MOL BIOL, V198, P425, DOI 10.1016/0022-2836(87)90292-0; Harwani SC, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-133; Hassan-Walker AF, 2001, J MED VIROL, V64, P283, DOI 10.1002/jmv.1048; Hollier LM, 2005, CLIN PERINATOL, V32, P671, DOI 10.1016/j.clp.2005.05.003; Iversen AC, 2009, J IMMUNOL, V182, P5672, DOI 10.4049/jimmunol.0801268; Jablonska A, 2014, INT J INFECT DIS, V25, P11, DOI 10.1016/j.ijid.2014.04.001; Kirchner M, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-9; Kruger B, 2010, CLIN SCI, V119, P535, DOI 10.1042/CS20100190; Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346; Meena NK, 2013, J CLIN GASTROENTEROL, V47, P773, DOI 10.1097/MCG.0b013e31828a6e93; Nelson CT, 1997, CLIN PERINATOL, V24, P151, DOI 10.1016/S0095-5108(18)30189-1; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Pandey S, 2011, MOL BIOL REP, V38, P4715, DOI 10.1007/s11033-010-0607-z; Paradowska E, 2006, APMIS, V114, P764, DOI 10.1111/j.1600-0463.2006.apm_31.x; Pedraza-Sanchez S, 2013, CLIN VACCINE IMMUNOL, V20, P962, DOI 10.1128/CVI.00609-12; Peixoto-Rangel AL, 2009, MEM I OSWALDO CRUZ, V104, P1187, DOI 10.1590/S0074-02762009000800019; Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414; Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002; Ricci E, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-49; Roszak A, 2012, MOL BIOL REP, V39, P8425, DOI 10.1007/s11033-012-1695-8; Rycel M, 2014, EUR J CLIN IN PRESS; Rycel Magdalena, 2013, Ginekol Pol, V84, P1005; Sanders MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-112; Tamer GS, 2009, CLIN INVEST MED, V32, pE43; Taniguchi R, 2013, INT J INFECT DIS, V17, pE1092, DOI 10.1016/j.ijid.2013.06.004; Temperton NJ, 2003, J MED VIROL, V70, P86, DOI 10.1002/jmv.10357; Varani S, 2007, J IMMUNOL, V179, P7767, DOI 10.4049/jimmunol.179.11.7767; Wujcicka W, 2014, EUR J CLIN MICROBIOL, V33, P1951, DOI 10.1007/s10096-014-2170-3; Wujcicka W, 2014, EUR J CLIN MICROBIOL, V33, P703, DOI 10.1007/s10096-013-2017-3; Wujcicka W, 2013, EUR J CLIN MICROBIOL, V32, P503, DOI 10.1007/s10096-012-1763-y; Wujcicka W, 2014, PATHOG DIS, V70, P3, DOI 10.1111/2049-632X.12083; Yamakawa N, 2013, INT IMMUNOL, V25, P45, DOI 10.1093/intimm/dxs084; Yew KH, 2011, ACTA VIROL, V55, P243, DOI 10.4149/av_2011_03_243; Yew KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044500; Yew KH, 2010, MOL IMMUNOL, V47, P883, DOI 10.1016/j.molimm.2009.10.009	47	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122831	10.1371/journal.pone.0122831	http://dx.doi.org/10.1371/journal.pone.0122831			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844529	gold, Green Published, Green Submitted			2022-12-26	WOS:000352475700016
J	Marshall, JK; Lindner, P; Tait, N; Maddocks, T; Riepsamen, A; van der Linden, J				Marshall, Jean K.; Lindner, Pernilla; Tait, Noel; Maddocks, Tracy; Riepsamen, Angelique; van der Linden, Jan			Intra-Operative Tissue Oxygen Tension Is Increased by Local Insufflation of Humidified-Warm CO2 during Open Abdominal Surgery in a Rat Model	PLOS ONE			English	Article							CONTROLLED RESPIRATORY SUPPORT; CARDIOTHORACIC WOUND CAVITY; SURGICAL SITE INFECTION; SUPPLEMENTAL PERIOPERATIVE OXYGEN; CARBON-DIOXIDE PNEUMOPERITONEUM; RANDOMIZED CLINICAL-TRIAL; GAS-DIFFUSER; POSTOPERATIVE-PATIENTS; TEMPERATURE; HYPERCAPNIA	Introduction Maintenance of high tissue oxygenation (PtO2) is recommended during surgery because PtO2 is highly predictive of surgical site infection and colonic anastomotic leakage. However, surgical site perfusion is often sub-optimal, creating an obstructive hurdle for traditional, systemically applied therapies to maintain or increase surgical site PtO2. This research tested the hypothesis that insufflation of humidified-warm CO2 into the abdominal cavity would increase sub-peritoneal PtO2 during open abdominal surgery. Materials and Methods 15 Wistar rats underwent laparotomy under general anesthesia. Three sets of randomized cross-over experiments were conducted in which the abdominal cavity was subjected to alternating exposure to 1) humidified-warm CO2 & ambient air; 2) humidified-warm CO2 & dry-cold CO2; and 3) dry-cold CO2 & ambient air. Sub-peritoneal PtO2 and tissue temperature were measured with a polarographic oxygen probe. Results Upon insufflation of humidified-warm CO2, PtO2 increased by 29.8 mmHg (SD 13.3; p<0.001), or 96.6%(SD 51.9), and tissue temperature by 3.0 degrees C (SD 1.7 p<0.001), in comparison with exposure to ambient air. Smaller, but significant, increases in PtO2 were seen in experiments 2 and 3. Tissue temperature decreased upon exposure to dry-cold CO2 compared with ambient air (-1.4 degrees C, SD 0.5, p = 0.001). Conclusions In a rat model, insufflation of humidified-warm CO2 into the abdominal cavity during open abdominal surgery causes an immediate and potentially clinically significant increase in PtO2. The effect is an additive result of the delivery of CO2 and avoidance of evaporative cooling via the delivery of the CO2 gas humidified at body temperature.	[Marshall, Jean K.; Maddocks, Tracy] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Marshall, Jean K.] Univ Wollongong, Grad Sch Med, Wollongong, NSW, Australia; [Lindner, Pernilla; van der Linden, Jan] Karolinska Univ Hosp, Karolinska Inst, Dept Cardiothorac Surg & Anesthesiol, Stockholm, Sweden; [Tait, Noel] Moruya Dist Hosp, Moruya, Australia; [Riepsamen, Angelique] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of Wollongong; University of Wollongong; Karolinska Institutet; Karolinska University Hospital; University of New South Wales Sydney	Marshall, JK (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	jkm972@uow.edu.au		Riepsamen, Angelique/0000-0002-7633-6294	Fisher & Paykel Healthcare Ltd (Auckland, New Zealand)	Fisher & Paykel Healthcare Ltd (Auckland, New Zealand)	This research was funded by Fisher & Paykel Healthcare Ltd (Auckland, New Zealand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akca O, 2006, BRIT J ANAESTH, V96, P708, DOI 10.1093/bja/ael093; Akca O, 2003, ANAESTHESIA, V58, P536, DOI 10.1046/j.1365-2044.2003.03193.x; Akca O, 1999, LANCET, V354, P41, DOI 10.1016/S0140-6736(99)00874-0; Akca O, 2002, ANESTHESIOLOGY, V97, P801, DOI 10.1097/00000542-200210000-00009; Allen DB, 1997, ARCH SURG-CHICAGO, V132, P991; [Anonymous], 2013, BRIT J ANAESTH, DOI DOI 10.1093/BJA/AET233; Arkilic CF, 2003, SURGERY, V133, P49, DOI 10.1067/msy.2003.80; BABIOR BM, 1978, NEW ENGL J MED, V298, P721, DOI 10.1056/NEJM197803302981305; BABIOR BM, 1978, NEW ENGL J MED, V298, P659, DOI 10.1056/NEJM197803232981205; Bakri MH, 2008, ANESTH ANALG, V106, P1619, DOI 10.1213/ane.0b013e3181732e82; Bourdel N, 2007, HUM REPROD, V22, P1149, DOI 10.1093/humrep/del482; Buggy DJ, 2002, ANESTHESIOLOGY, V97, P952, DOI 10.1097/00000542-200210000-00030; Cater JE, 2014, MED ENG PHYS; CHANG N, 1983, ANN SURG, V197, P470, DOI 10.1097/00000658-198304000-00017; Davis B, 2013, SURG CLIN N AM, V93, P61, DOI 10.1016/j.suc.2012.09.014; de Vries A, 2013, INT J SURG, V11, P1118, DOI 10.1016/j.ijsu.2013.09.005; DIJI A, 1959, J APPL PHYSIOL, V14, P414, DOI 10.1152/jappl.1959.14.3.414; Fleshman J, 2007, ANN SURG, V246, P655, DOI 10.1097/SLA.0b013e318155a762; Frey JM, 2012, ANESTH ANALG, V115, P1204, DOI 10.1213/ANE.0b013e31826ac49f; Frey JM, 2010, WOUND REPAIR REGEN, V18, P378, DOI 10.1111/j.1524-475X.2010.00602.x; Frey JMK, 2012, WORLD J SURG, V36, P2567, DOI 10.1007/s00268-012-1735-5; Gianotti L, 2011, SURG ENDOSC, V25, P1835, DOI 10.1007/s00464-010-1475-2; Govinda R, 2010, ANESTH ANALG, V111, P946, DOI 10.1213/ANE.0b013e3181e80a94; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Hager H, 2006, ANESTH ANALG, V103, P677, DOI 10.1213/01.ane.0000229715.71464.90; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; HARTMANN M, 1992, EUR J SURG, V158, P521; Hopf HW, 2007, ANTIOXID REDOX SIGN, V9, P1183, DOI 10.1089/ars.2007.1641; Hopf HW, 1997, ARCH SURG-CHICAGO, V132, P997; HUNT TK, 2008, ANGIOGENESIS INTEGRA, P541; Ikeda T, 1998, AM J SURG, V175, P33, DOI 10.1016/S0002-9610(97)00237-7; JENSEN JA, 1991, ARCH SURG-CHICAGO, V126, P1131; JONSSON K, 1987, BRIT J SURG, V74, P263, DOI 10.1002/bjs.1800740413; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; JONSSON K, 1986, Surgical Forum (Chicago), V37, P86; Kabon B, 2003, ANESTH ANALG, V97, P1812, DOI 10.1213/01.ANE.0000087040.48267.54; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Matsuzaki S, 2007, HUM REPROD, V22, P2702, DOI 10.1093/humrep/dem114; Matsuzaki S, 2010, SURG ENDOSC, V24, P2871, DOI 10.1007/s00464-010-1069-z; Minamiyama Motomu, 2010, Journal of Biorheology, V24, P42, DOI 10.1007/s12573-010-0023-y; Mynbaev OA, 2014, INT J SURG, V12, P190, DOI 10.1016/j.ijsu.2013.11.009; National Health and Medical Research Council, 2008, GUID PROM WELLB AN U; Neudecker J, 2002, SURG ENDOSC, V16, P1121, DOI 10.1007/s00464-001-9166-7; NHMRC, 2013, AUSTR COD CAR US AN, V8th; Persson M, 2004, J CARDIOTHOR VASC AN, V18, P180, DOI 10.1053/j.jvca.2004.01.024; Persson M, 2003, J HOSP INFECT, V55, P152, DOI 10.1016/S0195-6701(03)00288-3; Persson M, 2003, J CARDIOTHOR VASC AN, V17, P329, DOI 10.1016/S1053-0770(03)00050-8; Persson M, 2008, MED HYPOTHESES, V71, P8, DOI 10.1016/j.mehy.2007.12.016; Qadan M, 2009, EXPERT REV ANTI-INFE, V7, P1043, DOI 10.1586/ERI.09.88; Reshef A, 2013, SURG ENDOSC, V27, P1717, DOI 10.1007/s00464-012-2663-z; ROE CF, 1971, AM J SURG, V122, P13, DOI 10.1016/0002-9610(71)90338-2; Saklani AP, 2013, COLORECTAL DIS, V15, P80, DOI 10.1111/j.1463-1318.2012.03098.x; Sammour T, 2010, MINIM INVASIV THER, V19, P219, DOI 10.3109/13645701003644475; Sessler Daniel I, 2006, Anesthesiol Clin, V24, P279, DOI 10.1016/j.atc.2006.01.005; Sheffield Clark W., 1996, Wound Repair and Regeneration, V4, P339, DOI 10.1046/j.1524-475X.1996.40310.x; SHERIDAN WG, 1987, DIS COLON RECTUM, V30, P867, DOI 10.1007/BF02555426; Svenarud P, 2003, J THORAC CARDIOV SUR, V125, P1043, DOI 10.1067/mtc.2003.50; Svenarud P, 2003, ANESTH ANALG, V96, P321, DOI 10.1097/00000539-200302000-00005; Taflampas P, 2009, SURG TODAY, V39, P183, DOI 10.1007/s00595-008-3835-2; Treschan TA, 2003, ANESTH ANALG, V96, P1553, DOI 10.1213/01.ANE.0000063824.43113.DB; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; Yoshida Makiko, 2007, J Surg Educ, V64, P302, DOI 10.1016/j.jsurg.2007.08.003	62	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122838	10.1371/journal.pone.0122838	http://dx.doi.org/10.1371/journal.pone.0122838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835954	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000115
J	Oertel, D; Schmitz, S; Freudl, R				Oertel, Dan; Schmitz, Sabrina; Freudl, Roland			A TatABC-Type Tat Translocase Is Required for Unimpaired Aerobic Growth of Corynebacterium glutamicum ATCC13032	PLOS ONE			English	Article							SEC-INDEPENDENT PROTEIN; TWIN-ARGININE TRANSLOCASE; ESCHERICHIA-COLI; STREPTOMYCES-COELICOLOR; RESPIRATORY-CHAIN; EXPORT PATHWAY; FUNCTIONAL-ANALYSIS; SIGNAL PEPTIDES; SYSTEM; TRANSPORT	The twin-arginine translocation (Tat) system transports folded proteins across the cytoplasmic membrane of bacteria and the thylakoid membrane of plant chloroplasts. Escherichia coli and other Gram-negative bacteria possess a TatABC-type Tat translocase in which each of the three inner membrane proteins TatA, TatB, and TatC performs a mechanistically distinct function. In contrast, low-GC Gram-positive bacteria, such as Bacillus subtilis, use a TatAC-type minimal Tat transiocase in which the TatB function is carried out by a bifunctional TatA. In high-GC Gram-positive Actinobacteria, such as Mycobacterium tuberculosis and Corynebacterium glutamicum, tatA, tatB, and tatC genes can be identified, suggesting that these organisms, just like E. coli, might use TatABC-type Tat translocases as well. However, since contrary to this view a previous study has suggested that C. glutamicum might in fact use a TatAC translocase with TatB only playing a minor role, we reexamined the requirement of TatB for Tat-dependent protein translocation in this microorganism. Under aerobic conditions, the misassembly of the Rieske iron-sulfur protein QcrA was identified as a major reason for the severe growth defect of Tat-defective C. glutamicum mutant strains. Furthermore, our results clearly show that TatB, besides TatA and TatC, is strictly required for unimpaired aerobic growth. In addition, TatB was also found to be essential for the secretion of a heterologous Tat-dependent model protein into the C. glutamicum culture supernatant. Together with our finding that expression of the C. glutamicum TatB in an E. coli Delta tatB mutant strain resulted in the formation of an active Tat translocase, our results clearly indicate that a TatABC translocase is used as the physiologically relevant functional unit for Tat-dependent protein translocation in C. glutamicum and, most likely, also in other TatB-containing Actinobacteria.	[Oertel, Dan; Schmitz, Sabrina; Freudl, Roland] Forschungszentrum Julich, Biotechnol IBG1, Inst Bio & Geowissensch 1, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Freudl, R (corresponding author), Forschungszentrum Julich, Biotechnol IBG1, Inst Bio & Geowissensch 1, D-52425 Julich, Germany.	r.freudl@fz-juelich.de	Freudl, Roland/N-4179-2017	Freudl, Roland/0000-0003-0743-1279	Bio.NRW; local government of North Rhine Westphalia [w0805wb003c]	Bio.NRW; local government of North Rhine Westphalia	This research was supported by Bio.NRW, a funding initiative of the local government of North Rhine Westphalia (ExpressO: grant no. w0805wb003c). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami M, 2003, MOL CELL, V12, P937, DOI 10.1016/S1097-2765(03)00398-8; Barnett JP, 2008, J BIOL CHEM, V283, P2534, DOI 10.1074/jbc.M708134200; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 1996, MOL MICROBIOL, V22, P393, DOI 10.1046/j.1365-2958.1996.00114.x; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Blaudeck N, 2005, J BIOL CHEM, V280, P3426, DOI 10.1074/jbc.M411210200; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Bruser T, 2003, MICROBIOL RES, V158, P7, DOI 10.1078/0944-5013-00176; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Chagnot C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00303; Cristobal S, 1999, EMBO J, V18, P2982, DOI 10.1093/emboj/18.11.2982; De Keersmaeker S, 2005, BIOCHEM BIOPH RES CO, V335, P973, DOI 10.1016/j.bbrc.2005.07.165; Denks K, 2014, MOL MEMBR BIOL, V31, P58, DOI 10.3109/09687688.2014.907455; Desvaux M, 2004, TRENDS MICROBIOL, V12, P306, DOI 10.1016/j.tim.2004.05.002; Desvaux M, 2009, TRENDS MICROBIOL, V17, P139, DOI 10.1016/j.tim.2009.01.004; EIKMANNS BJ, 1991, GENE, V102, P93, DOI 10.1016/0378-1119(91)90545-M; EIKMANNS BJ, 1994, MICROBIOL-SGM, V140, P1817, DOI 10.1099/13500872-140-8-1817; Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102; Goosens VJ, 2014, J BIOL CHEM, V289, P13124, DOI 10.1074/jbc.M113.529677; Goosens VJ, 2014, BBA-MOL CELL RES, V1843, P1698, DOI 10.1016/j.bbamcr.2013.10.008; Goosens VJ, 2013, J PROTEOME RES, V12, P796, DOI 10.1021/pr300866f; Hicks MG, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-64; Hopkins A, 2014, J BACTERIOL, V196, P50, DOI 10.1128/JB.00776-13; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Jack RL, 2001, J BACTERIOL, V183, P1801, DOI 10.1128/JB.183.5.1801-1804.2001; Jongbloed JDH, 2006, TRENDS MICROBIOL, V14, P2, DOI 10.1016/j.tim.2005.11.001; Jongbloed JDH, 2004, MOL MICROBIOL, V54, P1319, DOI 10.1111/j.1365-2958.2004.04341.x; Keller R, 2012, J CELL BIOL, V199, P303, DOI 10.1083/jcb.201204149; Kikuchi Y., 2002, International Patent Cooperation Treaty patent, Patent No. [WO2002/081694, 2002081694]; Kikuchi Y, 2006, APPL ENVIRON MICROB, V72, P7183, DOI 10.1128/AEM.01528-06; Kinoshita S., 1957, J GEN APPL MICROBIOL, V3, P193, DOI [10.2323/jgam.3.193, DOI 10.2323/JGAM.3.193]; Kirchner O, 2003, J BIOTECHNOL, V104, P287, DOI 10.1016/S0168-1656(03)00148-2; Koch-Koerfges A, 2013, BBA-BIOENERGETICS, V1827, P699, DOI 10.1016/j.bbabio.2013.02.004; Lausberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039867; Meissner D, 2007, APPL MICROBIOL BIOT, V76, P633, DOI 10.1007/s00253-007-0934-8; Mendel S, 2008, J MOL BIOL, V375, P661, DOI 10.1016/j.jmb.2007.09.087; Mori H, 2002, J CELL BIOL, V157, P205, DOI 10.1083/jcb.200202048; Niebisch A, 2001, ARCH MICROBIOL, V175, P282, DOI 10.1007/s002030100262; Okibe N, 2011, J MICROBIOL METH, V85, P155, DOI 10.1016/j.mimet.2011.02.012; Palmer T, 2012, NAT REV MICROBIOL, V10, P483, DOI 10.1038/nrmicro2814; Saint-Joanis B, 2006, J BACTERIOL, V188, P6669, DOI 10.1128/JB.00631-06; Sambrook J., 2001, MOL CLONING LAB MANU; Samorski M, 2005, BIOTECHNOL BIOENG, V92, P61, DOI 10.1002/bit.20573; Sargent F, 1998, EMBO J, V17, P3640, DOI 10.1093/emboj/17.13.3640; Sargent F, 1999, J BIOL CHEM, V274, P36073, DOI 10.1074/jbc.274.51.36073; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Scherr N, 2009, CURR OPIN MICROBIOL, V12, P699, DOI 10.1016/j.mib.2009.10.003; Simone D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078742; Stanley NR, 2000, J BIOL CHEM, V275, P11591, DOI 10.1074/jbc.275.16.11591; Sutcliffe IC, 2010, TRENDS MICROBIOL, V18, P464, DOI 10.1016/j.tim.2010.06.005; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; Willemse J, 2012, J BACTERIOL, V194, P6272, DOI 10.1128/JB.01425-12	55	10	11	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123413	10.1371/journal.pone.0123413	http://dx.doi.org/10.1371/journal.pone.0123413			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837592	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000143
J	Stinca, A; Chirico, GB; Incerti, G; Bonanomi, G				Stinca, Adriano; Chirico, Giovanni Battista; Incerti, Guido; Bonanomi, Giuliano			Regime Shift by an Exotic Nitrogen-Fixing Shrub Mediates Plant Facilitation in Primary Succession	PLOS ONE			English	Article							SOIL-WATER REPELLENCY; NURSE PLANTS; INVASION; IMPACTS; FOREST; DECOMPOSITION; FEEDBACKS; DYNAMICS; TREES; RESTORATION	Ecosystem invasion by non-native, nitrogen-fixing species is a global phenomenon with serious ecological consequences. However, in the Mediterranean basin few studies addressed the impact of invasion by nitrogen-fixing shrubs on soil quality and hydrological properties at local scale, and the possible effects on succession dynamics and ecosystem invasibility by further species. In this multidisciplinary study we investigated the impact of Genista aetnensis (Biv.) DC., an exotic nitrogen-fixing shrub, on the Vesuvius Grand Cone (Southern Italy). Specifically, we tested the hypotheses that the invasion of Genista aetnensis has a significant impact on soil quality, soil hydrological regime, local microclimate and plant community structure, and that its impact increases during the plant ontogenetic cycle. We showed that Genista aetnensis, in a relatively short time-span (i.e. similar to 40 years), has been able to build-up an island of fertility under its canopy, by accumulating considerable stocks of C, N, and P in the soil, and by also improving the soil hydrological properties. Moreover, Genista aetnensis mitigates the daily range of soil temperature, reducing the exposure of coexisting plants to extremely high temperatures and water loss by soil evaporation, particularly during the growing season. Such amelioration of soil quality, coupled with the mitigation of below-canopy microclimatic conditions, has enhanced plant colonization of the barren Grand Cone slopes, by both herbaceous and woody species. These results suggest that the invasion of Genista aetnensis could eventually drive to the spread of other, more resource-demanding exotic species, promoting alternative successional trajectories that may dramatically affect the local landscape. Our study is the first record of the invasion of Genista aetnensis, an additional example of the regime shifts driven by N-fixing shrubs in Mediterranean region. Further studies are needed to identity specific management practices that can limit the spread and impacts of this species.	[Stinca, Adriano; Chirico, Giovanni Battista; Incerti, Guido; Bonanomi, Giuliano] Univ Naples Federico II, Dept Agr, Naples, Italy	University of Naples Federico II	Stinca, A (corresponding author), Univ Naples Federico II, Dept Agr, Via Univ 100, Naples, Italy.	adriano.stinca@unina.it	Chirico, Giovanni Battista/E-7330-2016; Incerti, Guido/B-5106-2017; Incerti, Guido/O-5870-2019	Chirico, Giovanni Battista/0000-0002-9536-4741; Incerti, Guido/0000-0003-1288-8708; Incerti, Guido/0000-0003-1288-8708; BONANOMI, Giuliano/0000-0002-1831-4361; Stinca, Adriano/0000-0002-8275-0184	Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy); MED For Climadapt (Vesuvius National Park, Italy)	Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy); MED For Climadapt (Vesuvius National Park, Italy)	This research was partly founded by projects Piante Aliene della Regione Campania (Regione Campania, Servizio Fitosanitario Regionale, Italy) and MED For Climadapt (Vesuvius National Park, Italy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGOSTINI R, 1975, Archivio Botanico e Biogeografico Italiano, V51, P11; AGOSTINI RENZO, 1959, DELPINOA N S, V1, P42; Aguilera LE, 1999, J ARID ENVIRON, V42, P61, DOI 10.1006/jare.1999.0503; Alef K., 1995, METHODS APPL SOIL MI, DOI 10.1016/B978-0-12-513840-6.X5014-9; Barnes PW, 1999, J VEG SCI, V10, P525, DOI 10.2307/3237187; BAUMGARDNER MF, 1985, ADV AGRON, V38, P1, DOI 10.1016/S0065-2113(08)60672-0; BELSKY AJ, 1993, J APPL ECOL, V30, P143, DOI 10.2307/2404278; Berg B, 1996, CAN J BOT, V74, P659, DOI 10.1139/b96-084; Berg B., 2008, PLANT LITTER DECOMPO, DOI [DOI 10.1007/978-3-662-05349-2, 10.1007/978-3-662-05349-2]; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Birken AS, 2006, ECOL APPL, V16, P1103, DOI 10.1890/1051-0761(2006)016[1103:POTIAF]2.0.CO;2; Bloem J., 2006, MICROBIOLOGICAL METH; Bonanomi G, 2005, OIKOS, V111, P311, DOI 10.1111/j.0030-1299.2005.13975.x; Bonanomi G, 2008, PLANT ECOL, V197, P207, DOI 10.1007/s11258-007-9371-0; Bonanomi G, 2013, SOIL BIOL BIOCHEM, V56, P40, DOI 10.1016/j.soilbio.2012.03.003; Bonanomi G, 2012, J VEG SCI, V23, P236, DOI 10.1111/j.1654-1103.2011.01353.x; Bonanomi G, 2011, PLANT ECOL, V212, P1777, DOI 10.1007/s11258-011-9948-5; Bonanomi G, 2011, APPL SOIL ECOL, V47, P184, DOI 10.1016/j.apsoil.2010.12.007; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Carrillo-Garcia A, 1999, RESTOR ECOL, V7, P321, DOI 10.1046/j.1526-100X.1999.72027.x; Cass A, 1999, SOIL ANAL INTERPRETA, P95; Castro J, 2004, RESTOR ECOL, V12, P352, DOI 10.1111/j.1061-2971.2004.0316.x; Castro SA, 2005, DIVERS DISTRIB, V11, P183, DOI 10.1111/j.1366-9516.2005.00145.x; Castroviejo S., 1986, FLORA IBRICA PLANTAS; Chirico GB, 2003, HYDROL PROCESS, V17, P2239, DOI 10.1002/hyp.1330; Conti F., 2005, ANNOTATED CHECKLIST, V4, P227; Conti F., 2007, NAT VICENTINA, V10, P5; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Daehler CC, 1998, BIOL CONSERV, V84, P167, DOI 10.1016/S0006-3207(97)00096-7; DANTONIO CM, 1992, ANNU REV ECOL SYST, V23, P63, DOI 10.1146/annurev.es.23.110192.000431; Davis MA, 2000, J ECOL, V88, P528, DOI 10.1046/j.1365-2745.2000.00473.x; DeBano L. F., 1981, PSW46 USDA FOR SERV; Diamantopoulos E, 2013, J HYDROL, V486, P175, DOI 10.1016/j.jhydrol.2013.01.020; DiTomaso JM, 2007, WEEDS CALIFORNIA OTH, V1; Doerr SH, 2000, EARTH-SCI REV, V51, P33, DOI 10.1016/S0012-8252(00)00011-8; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; El-Keblawy A, 2007, PLANT ECOL, V190, P23, DOI 10.1007/s11258-006-9188-2; Facelli JM, 2000, ECOGRAPHY, V23, P479, DOI 10.1034/j.1600-0587.2000.230410.x; FRANCO AC, 1989, J ECOL, V77, P870, DOI 10.2307/2260991; Gaertner M, 2014, DIVERS DISTRIB, V20, P733, DOI 10.1111/ddi.12182; Gaertner M, 2009, PROG PHYS GEOG, V33, P319, DOI 10.1177/0309133309341607; Geerts S, 2013, S AFR J BOT, V87, P134, DOI 10.1016/j.sajb.2013.03.019; Gessner Mark O., 2005, P115, DOI 10.1007/1-4020-3466-0_17; Godinez-Alvarez H, 1998, J ARID ENVIRON, V39, P21, DOI 10.1006/jare.1998.0376; Gomez-Aparicio L, 2004, ECOL APPL, V14, P1128, DOI 10.1890/03-5084; Gotelli NJ, 2013, ECOSIMR 1 00; Haubensak KA, 2004, PLANT ECOL, V175, P71, DOI 10.1023/B:VEGE.0000048088.32708.58; Incerti G, 2013, ACTA OECOL, V49, P116, DOI 10.1016/j.actao.2013.03.012; Kamijo T, 2002, FOLIA GEOBOT, V37, P71, DOI 10.1007/BF02803192; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Levine JM, 2003, P ROY SOC B-BIOL SCI, V270, P775, DOI 10.1098/rspb.2003.2327; LONSDALE WM, 1993, J ECOL, V81, P513, DOI 10.2307/2261529; Marchante E, 2008, APPL SOIL ECOL, V40, P210, DOI 10.1016/j.apsoil.2008.04.004; Maron JL, 1996, OECOLOGIA, V105, P302, DOI 10.1007/BF00328732; Mataix-Solera J, 2007, HYDROL PROCESS, V21, P2300, DOI 10.1002/hyp.6750; Mazzoleni S, 2007, COMMUNITY ECOL, V8, P103, DOI 10.1556/ComEc.8.2007.1.12; Mazzoleni S., 1993, PRIMARY SUCCESSION L, P101; Mazzoleni S, 1989, ANN BOT ROMA S6, V47, P97; MCGHIE DA, 1981, AUST J AGR RES, V32, P609, DOI 10.1071/AR9810609; Miriti MN, 2006, J ECOL, V94, P973, DOI 10.1111/j.1365-2745.2006.01138.x; Mooney H.A., 2000, INVASIVE SPECIES CHA; Moro MJ, 1997, ECOGRAPHY, V20, P175, DOI 10.1111/j.1600-0587.1997.tb00360.x; Motti R, 2009, LAB MONITORAGGIO BIO, P17; Munzbergova Z, 2002, J VEG SCI, V13, P227, DOI 10.1658/1100-9233(2002)013[0227:ATAKSI]2.0.CO;2; Nossov DR, 2011, J ECOL, V99, P621, DOI 10.1111/j.1365-2745.2010.01792.x; Piccolo F., 2005, ADV GEOSCI, V2, P151, DOI [10.5194/adgeo-2-151-2005, DOI 10.5194/ADGEO-2-151-2005]; Pickart AJ, 1998, RESTOR ECOL, V6, P59, DOI 10.1046/j.1526-100x.1998.00618.x; Pignatti S., 1982, FLORA DITALIA, VVolume I; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Rawls WJ, 2003, GEODERMA, V116, P61, DOI 10.1016/S0016-7061(03)00094-6; Rejmanek M, 2013, DIVERS DISTRIB, V19, P1093, DOI 10.1111/ddi.12075; Rey PJ, 2000, J ECOL, V88, P622, DOI 10.1046/j.1365-2745.2000.00472.x; Ricciardi M, 1988, B SOC NAT NAPOLI, V96, P3; Rillig MC, 2005, PEDOBIOLOGIA, V49, P395, DOI 10.1016/j.pedobi.2005.04.004; Romano N, 2011, HYDROL EARTH SYST SC, V15, P3877, DOI 10.5194/hess-15-3877-2011; Sanjurjo MJF, 2003, GEODERMA, V115, P223, DOI 10.1016/S0016-7061(03)00013-2; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Soliveres S, 2010, PERSPECT PLANT ECOL, V12, P227, DOI 10.1016/j.ppees.2010.02.003; Sparks D.L., 1996, SSSA BOOK SERIES, V5, P437; Sparks D. L, 1996, SSSA BOOK SERIES, V5; Stinca A., 2013, Informatore Botanico Italiano, V45, P35; Stinca A, 2013, THESIS U NAPLES FEDE; Stinca Adriano, 2014, Hacquetia, V13, P355, DOI 10.2478/hacq-2014-0011; Stinca Adriano, 2009, Webbia, V64, P235; Tutin T.G., 1964, FLORA EUROPAEA, V1-5; Tutin TG, 1993, FLORA EUROPAEA, V1; VANDERPUTTEN WH, 1993, NATURE, V362, P53; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; WORKNEH F, 1993, PHYTOPATHOLOGY, V83, P581, DOI 10.1094/Phyto-83-581; York CA, 2000, J HYDROL, V231, P126, DOI 10.1016/S0022-1694(00)00189-X; [No title captured], DOI DOI 10.2307/2937039; [No title captured]	95	25	27	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123128	10.1371/journal.pone.0123128	http://dx.doi.org/10.1371/journal.pone.0123128			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835015	Green Published, gold			2022-12-26	WOS:000352139000129
J	Zorn, JA; Wang, Q; Fujimura, E; Barros, T; Kuriyan, J				Zorn, Julie A.; Wang, Qi; Fujimura, Eric; Barros, Tiago; Kuriyan, John			Crystal Structure of the FLT3 Kinase Domain Bound to the Inhibitor Quizartinib (AC220)	PLOS ONE			English	Article							TYROSINE KINASE; STI-571 INHIBITION; AUTOINHIBITION; COMPLEX	More than 30% of acute myeloid leukemia (AML) patients possess activating mutations in the receptor tyrosine kinase FMS-like tyrosine kinase 3 or FLT3. A small-molecule inhibitor of FLT3 (known as quizartinib or AC220) that is currently in clinical trials appears promising for the treatment of AML. Here, we report the co-crystal structure of the kinase domain of FLT3 in complex with quizartinib. FLT3 with quizartinib bound adopts an "Abl-like" inactive conformation with the activation loop stabilized in the "DFG-out" orientation and folded back onto the kinase domain. This conformation is similar to that observed for the uncomplexed intracellular domain of FLT3 as well as for related receptor tyrosine kinases, except for a localized induced fit in the activation loop. The co-crystal structure reveals the interactions between quizartinib and the active site of FLT3 that are key for achieving its high potency against both wild-type FLT3 as well as a FLT3 variant observed in many AML patients. This co-complex further provides a structural rationale for quizartinib-resistance mutations.	[Zorn, Julie A.; Wang, Qi; Fujimura, Eric; Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Zorn, Julie A.; Wang, Qi; Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Calif Inst Quantitat Biosci, Berkeley, CA 94720 USA; [Barros, Tiago; Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kuriyan, J (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu	Barros, Tiago/B-8455-2014	Barros, Tiago/0000-0002-9807-7625	National Institutes of Health National Cancer Institute [F32 CA177087-02]; Cancer Research Institute; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [F32CA177087] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cancer Research Institute; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JAZ is supported by a postdoctoral fellowship from the National Institutes of Health National Cancer Institute (F32 CA177087-02). QW is supported by an Irvington Institute postdoctoral fellowship from the Cancer Research Institute. JK and TB are funded by Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Chao Q, 2009, J MED CHEM, V52, P7808, DOI 10.1021/jm9007533; Cohen P, 2013, ACS CHEM BIOL, V8, P96, DOI 10.1021/cb300610s; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Gunawardane RN, 2013, MOL CANCER THER, V12, P438, DOI 10.1158/1535-7163.MCT-12-0305; Hubbard SR, 2004, NAT REV MOL CELL BIO, V5, P464, DOI 10.1038/nrm1399; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Laham LE, 2000, ONCOGENE, V19, P3961, DOI 10.1038/sj.onc.1203738; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Levis M, 2005, INT J HEMATOL, V82, P100, DOI 10.1532/IJH97.05079; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu Y, 2006, NAT CHEM BIOL, V2, P358, DOI 10.1038/nchembio799; McTigue M, 2012, P NATL ACAD SCI USA, V109, P18281, DOI 10.1073/pnas.1207759109; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel HK, 2009, BIOORG MED CHEM LETT, V19, P5182, DOI 10.1016/j.bmcl.2009.07.024; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2014, COLD SPRING HARB PER, V6, P3, DOI DOI 10.1101/CSHPERSPECT.A008912; Schwartz PA, 2011, BIOORG CHEM, V39, P192, DOI 10.1016/j.bioorg.2011.07.004; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Smith CC, 2014, P NATL ACAD SCI USA, V111, P5319, DOI 10.1073/pnas.1320661111; Solowiej J, 2009, BIOCHEMISTRY-US, V48, P7019, DOI 10.1021/bi900522y; Sudhindra A, 2014, CURR HEMATOL MALIG R, V9, P174, DOI 10.1007/s11899-014-0203-8; Verstraete K, 2011, BLOOD, V118, P60, DOI 10.1182/blood-2011-01-329532; Wang Q, 2014, METHOD ENZYMOL, V548, P23, DOI 10.1016/B978-0-12-397918-6.00002-1; Wybenga-Groot LE, 2001, CELL, V106, P745, DOI 10.1016/S0092-8674(01)00496-2; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034; Zhao Z, 2014, ACS CHEM BIOL, V9, P1230, DOI 10.1021/cb500129t	39	62	63	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121177	10.1371/journal.pone.0121177	http://dx.doi.org/10.1371/journal.pone.0121177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837374	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000040
J	Yoo, SW; Motari, MG; Susuki, K; Prendergast, J; Mountney, A; Hurtado, A; Schnaar, RL				Yoo, Seung-Wan; Motari, Mary G.; Susuki, Keiichiro; Prendergast, Jillian; Mountney, Andrea; Hurtado, Andres; Schnaar, Ronald L.			Sialylation regulates brain structure and function	FASEB JOURNAL			English	Article						animal models; behavior; gangliosides; myelin; oligodendrocyte precursor cells	MYELIN-ASSOCIATED GLYCOPROTEIN; LACKING COMPLEX GANGLIOSIDES; GM3 SYNTHASE DEFICIENCY; GROWTH-FACTOR RECEPTOR; CRUCIAL ROLE; CELL-GROWTH; MICE; EXPRESSION; DIFFERENTIATION; BIOSYNTHESIS	Every cell expresses a molecularly diverse surface glycan coat (glycocalyx) comprising its interface with its cellular environment. In vertebrates, the terminal sugars of the glycocalyx are often sialic acids, 9-carbon backbone anionic sugars implicated in intermolecular and intercellular interactions. The vertebrate brain is particularly enriched in sialic acid-containing glycolipids termed gangliosides. Human congenital disorders of ganglioside biosynthesis result in paraplegia, epilepsy, and intellectual disability. To better understand sialoglycan functions in the nervous system, we studied brain anatomy, histology, biochemistry, and behavior in mice with engineered mutations in St3gal2 and St3gal3, sialyltransferase genes responsible for terminal sialylation of gangliosides and some glycoproteins. St3gal2/3 double-null mice displayed dysmyelination marked by a 40% reduction in major myelin proteins, 30% fewer myelinated axons, a 33% decrease in myelin thickness, and molecular disruptions at nodes of Ranvier. In part, these changes may be due to dysregulation of ganglioside-mediated oligodendroglial precursor cell proliferation. Neuronal markers were also reduced up to 40%, and hippocampal neurons had smaller dendritic arbors. Young adult St3gal2/3 double-nullmice displayed impaired motor coordination, disturbed gait, and profound cognitive disability. Comparisons among sialyltransferase mutant mice provide insights into the functional roles of brain gangliosides and sialoglycoproteins consistent with related human congenital disorders.	[Yoo, Seung-Wan; Motari, Mary G.; Prendergast, Jillian; Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Hurtado, Andres] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Schnaar, Ronald L.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Susuki, Keiichiro] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Mountney, Andrea] Walter Reed Army Inst Res, Ctr Mil Psychiat & Neurosci, Brain Trauma Neuroprotect & Neurorestorat Branch, Silver Spring, MD USA; [Hurtado, Andres] Kennedy Krieger, Hugo W Moser Res Inst, Int Ctr Spinal Cord Injury, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Baylor College of Medicine; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Schnaar, RL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, 725 North Wolfe St, Baltimore, MD 21205 USA.	schnaar@jhu.edu	Schnaar, Ronald L/S-8967-2016	Schnaar, Ronald L/0000-0002-7701-5484; Prendergast, Jillian/0000-0001-7965-4143	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS037096, NS057338]; U.S. National Multiple Sclerosis Society grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057338, R37NS037096, R01NS037096] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. National Multiple Sclerosis Society grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Jamey D. Marth (University of California, Santa Barbara, Santa Barbara, CA, USA) for providing founder mice for these studies and Alison Nairn (University of Georgia, Athens, GA, USA) for expert transcript analyses. This work was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS037096 and NS057338 (to R.L.S.) and a U.S. National Multiple Sclerosis Society grant (to Dr. Matthew N. Rasband, Department of Neuroscience, Baylor College of Medicine in support of K.S.). The views of the authors do not purport or reflect the position of the U.S. Department of the Army or the U.S. Department of Defense (para 4-3, AR 360-5). All research was conducted in compliance with the Animal Welfare Act, the Guide for the Care and Use of Laboratory Animals (U.S. National Research Council), and other federal statutes and regulations relating to animals and experiments involving animals.	ABE A, 1995, J LIPID RES, V36, P611; Audry M, 2011, GLYCOBIOLOGY, V21, P716, DOI 10.1093/glycob/cwq189; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Boccuto L, 2014, HUM MOL GENET, V23, P418, DOI 10.1093/hmg/ddt434; Boukhris A, 2013, AM J HUM GENET, V93, P118, DOI 10.1016/j.ajhg.2013.05.006; Chiavegatto S, 2000, EXP NEUROL, V166, P227, DOI 10.1006/exnr.2000.7504; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; Collins BE, 1997, J BIOL CHEM, V272, P1248, DOI 10.1074/jbc.272.2.1248; Cummings RD, 2014, CHEM BIOL, V21, P1, DOI 10.1016/j.chembiol.2013.12.010; Edvardson S, 2013, EPILEPSIA, V54, pe24, DOI 10.1111/epi.12050; Ellies LG, 2002, BLOOD, V100, P3618, DOI 10.1182/blood-2002-04-1007; Farrer RG, 1999, J NEUROSCI RES, V57, P371, DOI 10.1002/(SICI)1097-4547(19990801)57:3<371::AID-JNR9>3.0.CO;2-O; Fragaki K, 2013, EUR J HUM GENET, V21, P528, DOI 10.1038/ejhg.2012.202; FRUTTIGER M, 1995, EUR J NEUROSCI, V7, P511, DOI 10.1111/j.1460-9568.1995.tb00347.x; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hamers FPT, 2001, J NEUROTRAUM, V18, P187, DOI 10.1089/08977150150502613; Harlalka GV, 2013, BRAIN, V136, P3618, DOI 10.1093/brain/awt270; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hu H, 2011, AM J HUM GENET, V89, P407, DOI 10.1016/j.ajhg.2011.08.008; Kaucic K, 2006, METHOD ENZYMOL, V417, P168, DOI 10.1016/S0076-6879(06)17013-5; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Li RX, 2000, J BIOL CHEM, V275, P34213, DOI 10.1074/jbc.M906368199; Liu LP, 2010, NAT NEUROSCI, V13, P319, DOI 10.1038/nn.2491; Liu YH, 2004, J BIOL CHEM, V279, P36481, DOI 10.1074/jbc.M402880200; Matsuhashi H, 2003, J NEUROCHEM, V84, P53, DOI 10.1046/j.1471-4159.2003.01257.x; McKinnon RD, 2005, J NEUROSCI, V25, P3499, DOI 10.1523/JNEUROSCI.5049-04.2005; Miljan Erik A, 2002, Sci STKE, V2002, pre15, DOI 10.1126/stke.2002.160.re15; Mitsuda T, 2002, J BIOL CHEM, V277, P11239, DOI 10.1074/jbc.M107756200; Mountney A, 2013, J NEUROSCI METH, V212, P1, DOI 10.1016/j.jneumeth.2012.08.025; Nairn AV, 2010, METHOD ENZYMOL, V479, P73, DOI 10.1016/S0076-6879(10)79004-2; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Pan BH, 2005, EXP NEUROL, V195, P208, DOI 10.1016/j.expneurol.2005.04.017; Rodriguiz RM., 2006, ANIMAL MODELS COGNIT, P223; Schafer DP, 2004, J NEUROSCI, V24, P3176, DOI 10.1523/JNEUROSCI.5427-03.2004; Schnaar RL, 2014, HDB GLYCOSYLTRANSFER, P657; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Sheikh KA, 1999, P NATL ACAD SCI USA, V96, P7532, DOI 10.1073/pnas.96.13.7532; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Sun J, 2004, GLYCOBIOLOGY, V14, P851, DOI 10.1093/glycob/cwh107; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Susuki K, 2013, NEURON, V78, P469, DOI 10.1016/j.neuron.2013.03.005; SVENNERHOLM L, 1994, PROG BRAIN RES, V101, pR11; Tajima O, 2009, BEHAV BRAIN RES, V198, P74, DOI 10.1016/j.bbr.2008.10.024; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; van der Voorn JP, 2004, ACTA NEUROPATHOL, V107, P539, DOI 10.1007/s00401-004-0848-9; Varki A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005462; Wang H, 2013, AM J MED GENET A, V161A, P875, DOI 10.1002/ajmg.a.35826; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; Yamashita T, 2005, P NATL ACAD SCI USA, V102, P2725, DOI 10.1073/pnas.0407785102; Yang LJS, 1996, P NATL ACAD SCI USA, V93, P814, DOI 10.1073/pnas.93.2.814; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014; YIM SH, 1995, DEV NEUROSCI-BASEL, V17, P171, DOI 10.1159/000111285; Zhu Q, 2014, DEVELOPMENT, V141, P548, DOI 10.1242/dev.095323	58	54	54	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3040	3053		10.1096/fj.15-270983	http://dx.doi.org/10.1096/fj.15-270983			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25846372	Green Published			2022-12-26	WOS:000356859100031
J	Saha, K; Eckert, RL				Saha, Kamalika; Eckert, Richard L.			Methylosome Protein 50 and PKC delta/p38 delta Protein Signaling Control Keratinocyte Proliferation via Opposing Effects on p21(Cip1) Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN INVOLUCRIN PROMOTER; ARGININE METHYLTRANSFERASE 5; KINASE-C-DELTA; HUMAN EPIDERMAL-KERATINOCYTES; DISTAL REGULATORY REGION; TARGET GENES; LUNG-CANCER; DIFFERENTIATION; TRANSCRIPTION; METHYLATION	Protein arginine methyltransferase 5 (PRMT5) is a key epigenetic regulator that symmetrically dimethylates arginine residues on histones H3 and H4 to silence gene expression. PRMT5 is frequently observed in a complex with the cofactor methylosome protein 50 (MEP50), which is required for PRMT5 activity. PKC delta/p38 delta signaling, a key controller of keratinocyte proliferation and differentiation, increases p21(Cip1) expression to suppress keratinocyte proliferation. We now show that MEP50 enhances keratinocyte proliferation and survival via mechanisms that include silencing of p21(Cip1) expression. This is associated with enhanced PRMT5-MEP50 interaction at the p21(Cip1) promoter and enhanced arginine dimethylation of the promoter-associated histones H3 and H4. It is also associated with a MEP50-dependent reduction in the level of p53, a key controller of p21(Cip1) gene expression. We confirm an important biological role for MEP50 and PRMT5 in regulating keratinocyte proliferation using a stratified epidermal equivalent model that mimics in vivo epidermal keratinocyte differentiation. In this model, PRMT5 or MEP50 knockdown results in reduced keratinocyte proliferation. We further show that PKC delta/p38 delta signaling suppresses MEP50 expression, leading to reduced H3/H4 arginine dimethylation at the p21(Cip1) promoter, and that this is associated with enhanced p21(Cip1) expression and reduced cell proliferation. These findings describe an opposing action between PKC delta/p38 delta MAPK signaling and PRMT5/MEP50 epigenetic silencing mechanisms in regulating cell proliferation.	[Saha, Kamalika; Eckert, Richard L.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Dermatol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Dept Obstet & Gynecol, Baltimore, MD 21201 USA; [Eckert, Richard L.] Univ Maryland, Sch Med, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Eckert, RL (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	reckert@umaryland.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [R21AR065266, RO1CA131064]; Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA131064, R01CA131074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR065266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AR065266 and RO1CA131064 (to R. L. E.). This work was also supported by a pilot award from the Greenebaum Cancer Center.	Adhikary G, 2010, J INVEST DERMATOL, V130, P2017, DOI 10.1038/jid.2010.108; Aggarwal P, 2010, CANCER CELL, V18, P329, DOI 10.1016/j.ccr.2010.08.012; Antonysamy S, 2012, P NATL ACAD SCI USA, V109, P17960, DOI 10.1073/pnas.1209814109; Banks EB, 1999, BIOCHEM J, V337, P507, DOI 10.1042/0264-6021:3370507; Banks EB, 1998, BIOCHEM J, V331, P61, DOI 10.1042/bj3310061; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Chew YC, 2013, J BIOL CHEM, V288, P17759, DOI 10.1074/jbc.M113.477133; Chew YC, 2012, J BIOL CHEM, V287, P16168, DOI 10.1074/jbc.M111.305292; Chew YC, 2011, J BIOL CHEM, V286, P28772, DOI 10.1074/jbc.M110.205245; Crish JF, 2008, J INVEST DERMATOL, V128, P530, DOI 10.1038/sj.jid.5701049; Crish JF, 2006, J INVEST DERMATOL, V126, P305, DOI 10.1038/sj.jid.5700019; Crish JF, 1998, J BIOL CHEM, V273, P30460, DOI 10.1074/jbc.273.46.30460; Crish JF, 2002, ONCOGENE, V21, P738, DOI 10.1038/sj.onc.1205038; Eckert RL, 2004, J INVEST DERMATOL, V123, P13, DOI 10.1111/j.0022-202X.2004.22723.x; Eckert RL, 2003, J INVEST DERMATOL, V120, P823, DOI 10.1046/j.1523-1747.2003.12120.x; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Efimova T, 2004, MOL CELL BIOL, V24, P8167, DOI 10.1128/MCB.24.18.8167-8183.2004; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Efimova T, 2000, J BIOL CHEM, V275, P1601, DOI 10.1074/jbc.275.3.1601; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fabbrizio E, 2002, EMBO REP, V3, P641, DOI 10.1093/embo-reports/kvf136; GERDES J, 1984, J IMMUNOL, V133, P1710; Gu Z, 2013, ONCOGENE, V32, P1888, DOI 10.1038/onc.2012.207; Gu ZP, 2012, BIOCHEM J, V446, P235, DOI 10.1042/BJ20120768; Han BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036941; Ho MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057008; Kanade SR, 2012, J BIOL CHEM, V287, P7313, DOI 10.1074/jbc.M111.331660; Karkhanis V, 2011, TRENDS BIOCHEM SCI, V36, P633, DOI 10.1016/j.tibs.2011.09.001; Krause CD, 2007, PHARMACOL THERAPEUT, V113, P50, DOI 10.1016/j.pharmthera.2006.06.007; Li JJ, 2000, MOL CARCINOGEN, V29, P159, DOI 10.1002/1098-2744(200011)29:3<159::AID-MC5>3.0.CO;2-W; Ligr M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026250; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Molina-Serrano D, 2013, BIOCHEM SOC T, V41, P751, DOI 10.1042/BST20130003; Nicholas C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074710; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Peng Y, 2010, J CELL MOL MED, V14, P2780, DOI 10.1111/j.1582-4934.2009.00936.x; Poumay Y, 2004, ARCH DERMATOL RES, V296, P203, DOI 10.1007/s00403-004-0507-y; Rorke EA, 2010, ONCOGENE, V29, P5873, DOI 10.1038/onc.2010.315; Rorke EA, 2015, J INVEST DERMATOL, V135, P170, DOI 10.1038/jid.2014.310; Saha K, 2014, J BIOL CHEM, V289, P11443, DOI 10.1074/jbc.M113.543165; Tae S, 2011, NUCLEIC ACIDS RES, V39, P5424, DOI 10.1093/nar/gkr170; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wei TYW, 2014, CELL SIGNAL, V26, P2940, DOI 10.1016/j.cellsig.2014.09.014; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	50	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13521	13530		10.1074/jbc.M115.642868	http://dx.doi.org/10.1074/jbc.M115.642868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851901	hybrid, Green Published			2022-12-26	WOS:000354975700046
J	Silva, AT; Hatry, C; Thiem, JD; Gutowsky, LFG; Hatin, D; Zhu, DZ; Dawson, JW; Katopodis, C; Cooke, SJ				Silva, Ana T.; Hatry, Charles; Thiem, Jason D.; Gutowsky, Lee F. G.; Hatin, Daniel; Zhu, David Z.; Dawson, Jeffery W.; Katopodis, Christos; Cooke, Steven J.			Behaviour and Locomotor Activity of a Migratory Catostomid during Fishway Passage	PLOS ONE			English	Article							SWIMMING PERFORMANCE; ENERGY-EXPENDITURE; PHYSIOLOGY; REDHORSE; COSTS; FLOW; ACCELEROMETER; ACCELERATION; FLEXIBILITY; STURGEON	Fishways have been developed to restore longitudinal connectivity in rivers. Despite their potential for aiding fish passage, fishways may represent a source of significant energetic expenditure for fish as they are highly turbulent environments. Nonetheless, our understanding of the physiological mechanisms underpinning fishway passage of fish is still limited. We examined swimming behaviour and activity of silver redhorse (Moxostoma anisurum) during its upriver spawning migration in a vertical slot fishway. We used an accelerometer-derived instantaneous activity metric (overall dynamic body acceleration) to estimate location-specific swimming activity. Silver redhorse demonstrated progressive increases in activity during upstream fishway passage. Moreover, location-specific passage duration decreased with an increasing number of passage attempts. Turning basins and the most upstream basin were found to delay fish passage. No relationship was found between basin-specific passage duration and activity and the respective values from previous basins. The results demonstrate that successful fishway passage requires periods of high activity. The resultant energetic expenditure may affect fitness, foraging behaviour and increase susceptibility to predation, compromising population sustainability. This study highlights the need to understand the physiological mechanisms underpinning fishway passage to improve future designs and interpretation of biological evaluations.	[Silva, Ana T.; Hatry, Charles; Thiem, Jason D.; Gutowsky, Lee F. G.; Cooke, Steven J.] Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada; [Hatin, Daniel] Faune & Parcs, Minist Forets, Quebec City, PQ, Canada; [Zhu, David Z.] Univ Alberta, Dept Civil & Environm Engn, Edmonton, AB, Canada; [Dawson, Jeffery W.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Katopodis, Christos] Katopodis Ecohydraul Ltd, Winnipeg, MB, Canada	Carleton University; University of Alberta; Carleton University	Silva, AT (corresponding author), Carleton Univ, Dept Biol, Fish Ecol & Conservat Physiol Lab, Ottawa, ON K1S 5B6, Canada.	anamtsilva@isa.ulisboa.pt	Cooke, Steven J/F-4193-2010; Thiem, Jason/ABB-2169-2021	Cooke, Steven J/0000-0002-5407-0659; Thiem, Jason/0000-0002-5585-8560; T. Silva, Ana/0000-0003-3605-6164; Gutowsky, Lee/0000-0003-1244-9465	NSERC HydroNet Strategic Network Grant; Canadian Wildlife Federation; Quebec MRNF; Post-Doc Fellowship from NSERC HydroNet; NSERC-CGSM (Alexander Graham Bell) scholarship; Ontario graduate scholarship (OGS); Carleton University; Canada Research Chair program; Katopodis Ecohydraulics Ltd.	NSERC HydroNet Strategic Network Grant; Canadian Wildlife Federation; Quebec MRNF; Post-Doc Fellowship from NSERC HydroNet; NSERC-CGSM (Alexander Graham Bell) scholarship; Ontario graduate scholarship (OGS)(Ontario Graduate Scholarship); Carleton University; Canada Research Chair program(Canada Research Chairs); Katopodis Ecohydraulics Ltd.	Project funding was provided by an NSERC HydroNet Strategic Network Grant. Equipment support was provided by the Canada Foundation for Innovation, the Ontario Research Fund and the NSERC RTI program. Additional support was provided by the Canadian Wildlife Federation. Significant financial contribution was also provided by the Quebec MRNF. ATS was supported by a Post-Doc Fellowship from NSERC HydroNet, CH was supported by an NSERC-CGSM (Alexander Graham Bell) scholarship, an Ontario graduate scholarship (OGS), and additional graduate scholarships from Carleton University. JDT was supported by a President's graduate scholarship from Carleton University and Cooke SJ was supported by the Canada Research Chair program. Katopodis Ecohydraulics Ltd., provided support in the form of devidends for author CK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section".	Alexandre CM, 2013, ECOL ENG, V51, P191, DOI 10.1016/j.ecoleng.2012.12.047; BOISCLAIR D, 1989, CAN J FISH AQUAT SCI, V46, P1859, DOI 10.1139/f89-234; Bouten CVC, 1997, IEEE T BIO-MED ENG, V44, P136, DOI 10.1109/10.554760; Brown Richard S., 1999, North American Journal of Fisheries Management, V19, P867, DOI 10.1577/1548-8675(1999)019&lt;0867:ETCTRF&gt;2.0.CO;2; Bunt CM, 2012, RIVER RES APPL, V28, P457, DOI 10.1002/rra.1565; Bunt CM, 2001, ECOL FRESHW FISH, V10, P57, DOI 10.1111/j.1600-0633.2001.tb00194.x; Bunt CM, 1999, THESIS; Burnett NJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P587, DOI 10.1086/677219; Burnham K. P., 2002, MODEL SELECTION AND; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Castro-Santos T, 2009, AMERICAN FISHERIES S; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Collins MR, 2002, J APPL ICHTHYOL, V18, P491, DOI 10.1046/j.1439-0426.2002.00386.x; Cooke SJ, 2005, BIOL CONSERV, V121, P317, DOI 10.1016/j.biocon.2004.05.015; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Cooke SJ, 2013, ECOL ENG, V58, P123, DOI 10.1016/j.ecoleng.2013.06.005; Cotel AJ, 2006, T AM FISH SOC, V135, P610, DOI 10.1577/T04-196.1; DILL LM, 1983, CAN J FISH AQUAT SCI, V40, P398, DOI 10.1139/f83-058; Fulton CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054033; Gleiss AC, 2009, TAGGING AND TRACKING; Gleiss AC, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1350; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; Gleiss AC, 2010, J EXP MAR BIOL ECOL, V385, P85, DOI 10.1016/j.jembe.2010.01.012; Green JA, 2009, J EXP BIOL, V212, P745, DOI 10.1242/jeb.030049; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Halsey LG, 2011, COMP BIOCHEM PHYS A, V158, P305, DOI 10.1016/j.cbpa.2010.09.002; Hasler CT, 2009, ENVIRON REV, V17, P179, DOI 10.1139/A09-008; Hatry C, 2014, PHYSIOL BIOCHEM ZOOL, V87, P148, DOI 10.1086/671900; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hinch SG, 2000, T AM FISH SOC, V129, P598, DOI 10.1577/1548-8659(2000)129<0598:EOSSAA>2.0.CO;2; Kieffer J.D., 1992, Reviews in Fish Biology and Fisheries, V2, P125, DOI 10.1007/BF00042881; Lacey RWJ, 2012, RIVER RES APPL, V28, P429, DOI 10.1002/rra.1584; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; Lucas M. C., 2001, MIGRATION OF FRESHWA; Lupandin AI, 2005, BIOL BULL+, V32, P461, DOI 10.1007/s10525-005-0125-z; Lyons GN, 2013, COMP BIOCHEM PHYS A, V166, P278, DOI 10.1016/j.cbpa.2013.06.024; Mallen-Cooper M, 2007, FISHERIES MANAG ECOL, V14, P319, DOI 10.1111/j.1365-2400.2007.00557.x; Marriner BA, 2014, ECOL ENG, V63, P88, DOI 10.1016/j.ecoleng.2013.12.010; McElroy B, 2012, ECOLOGY, V93, P29, DOI 10.1890/11-1082.1; McNab BK, 2002, THE PHYSIOLOGICAL EC; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Noonan MJ, 2012, FISH FISH, V13, P450, DOI 10.1111/j.1467-2979.2011.00445.x; Odling-Smee L, 2003, FISH FISH, V4, P235, DOI 10.1046/j.1467-2979.2003.00127.x; Ohlberger J, 2005, J EXP ZOOL PART A, V303A, P657, DOI 10.1002/jez.a.181; Payne NL, 2014, J EXP BIOL, V217, P317, DOI 10.1242/jeb.093922; Peake S, 1997, CAN J FISH AQUAT SCI, V54, P1361, DOI 10.1139/cjfas-54-6-1361; Pinheiro J, 2012, NONLINEAR MIXED EFFE; Pope SB, 2000, TURBULENT FLOWS CAMB; Przybilla A, 2010, J EXP BIOL, V213, P2976, DOI 10.1242/jeb.041632; Ristroph L, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.178103; Robson AA, 2012, J R SOC INTERFACE, V9, P1486, DOI 10.1098/rsif.2011.0713; Roscoe DW, 2011, RIVER RES APPL, V27, P693, DOI 10.1002/rra.1384; Sato K, 2002, J EXP BIOL, V205, P1189; Shepard ELC, 2009, P ROY SOC B-BIOL SCI, V276, P3149, DOI 10.1098/rspb.2009.0683; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shepard ELC, 2009, AQUAT BIOL, V4, P235, DOI 10.3354/ab00104; Silva AT, 2012, ECOL ENG, V44, P314, DOI 10.1016/j.ecoleng.2012.04.015; Silva AT, 2011, RIVER RES APPL, V27, P360, DOI 10.1002/rra.1363; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; Tarrade L, 2008, HYDROBIOLOGIA, V609, P177, DOI 10.1007/s10750-008-9416-y; Thiem J, 2013, THESIS; Thiem J. D., 2011, Endangered Species Research, V15, P1, DOI 10.3354/esr00360; Tomlinson S, 2014, TRENDS ECOL EVOL, V29, P280, DOI 10.1016/j.tree.2014.03.003; Walsh SJ, 1998, ENVIRON BIOL FISH, V51, P429, DOI 10.1023/A:1007486632102; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Winter J.D., 1983, P371; Wright S, 2014, MAR ECOL PROG SER, V496, P19, DOI 10.3354/meps10528; Yoda K, 2001, J EXP BIOL, V204, P685; Young JL, 2006, FISH FISH, V7, P262, DOI 10.1111/j.1467-2979.2006.00225.x; Zuur AF, 2009, USE R, pVII	71	22	22	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123051	10.1371/journal.pone.0123051	http://dx.doi.org/10.1371/journal.pone.0123051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853245	Green Published, gold			2022-12-26	WOS:000352478400094
J	Ibinda, F; Bauni, E; Kariuki, SM; Fegan, G; Lewa, J; Mwikamba, M; Boga, M; Odhiambo, R; Mwagandi, K; Seale, AC; Berkley, JA; Dorfman, JR; Newton, CRJC				Ibinda, Fredrick; Bauni, Evasius; Kariuki, Symon M.; Fegan, Greg; Lewa, Joy; Mwikamba, Monica; Boga, Mwanamvua; Odhiambo, Rachael; Mwagandi, Kiponda; Seale, Anna C.; Berkley, James A.; Dorfman, Jeffrey R.; Newton, Charles R. J. C.			Incidence and Risk Factors for Neonatal Tetanus in Admissions to Kilifi County Hospital, Kenya	PLOS ONE			English	Article							MATERNAL HIV-INFECTION; PLACENTAL MALARIA; ANTIBODY TRANSFER; MORTALITY; IMMUNOGLOBULIN; IMMUNITY; NIGERIA	Background Neonatal Tetanus (NT) is a preventable cause of mortality and neurological sequelae that occurs at higher incidence in resource-poor countries, presumably because of low maternal immunisation rates and unhygienic cord care practices. We aimed to determine changes in the incidence of NT, characterize and investigate the associated risk factors and mortality in a prospective cohort study including all admissions over a 15-year period at a County hospital on the Kenyan coast, a region with relatively high historical NT rates within Kenya. Methods We assessed all neonatal admissions to Kilifi County Hospital in Kenya (1999-2013) and identified cases of NT (standard clinical case definition) admitted during this time. Poisson regression was used to examine change in incidence of NT using accurate denominator data from an area of active demographic surveillance. Logistic regression was used to investigate the risk factors for NT and factors associated with mortality in NT amongst were tested for anti-tetanus antibodies. Results There were 191 NT admissions, of whom 187 (98%) were home deliveries. Incidence of NT declined significantly (Incidence Rate Ratio: 0.85 (95% Confidence interval 0.81-0.89), P < 0.001) but the case fatality (62%) did not change over the study period (P = 0.536). Younger infant age at admission (P = 0.001) was the only independent predictor of mortality. Compared to neonatal hospital admittee controls, the proportion of home births was higher among the cases. Sera tested for antitetanus antibodies showed most mothers (50/61, 82%) had undetectable levels of antitetanus antibodies, and most (8/9, 89%) mothers with detectable antibodies had a neonate without protective levels. Conclusions Incidence of NT in Kilifi County has significantly reduced, with reductions following immunisation campaigns. Our results suggest immunisation efforts are effective if sustained and efforts should continue to expand coverage.	[Ibinda, Fredrick; Bauni, Evasius; Kariuki, Symon M.; Fegan, Greg; Lewa, Joy; Mwikamba, Monica; Boga, Mwanamvua; Odhiambo, Rachael; Mwagandi, Kiponda; Seale, Anna C.; Berkley, James A.; Newton, Charles R. J. C.] Ctr Geog Med Res Coast, KEMRI, Wellcome Trust Res Programme, Kilifi, Kenya; [Fegan, Greg; Seale, Anna C.; Berkley, James A.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Clin Med, Oxford, England; [Dorfman, Jeffrey R.] Int Ctr Genet Engn & Biotechnol, Cape Town, South Africa; [Dorfman, Jeffrey R.] Univ Cape Town, Div Immunol, ZA-7925 Cape Town, South Africa; [Newton, Charles R. J. C.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford; International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; University of Oxford	Ibinda, F (corresponding author), Ctr Geog Med Res Coast, KEMRI, Wellcome Trust Res Programme, Kilifi, Kenya.	fibinda@.kemri-wellcome.org	Newton, Charles RJC/B-7578-2014; Dorfman, Jeffrey R/B-4854-2011; Fegan, Greg W/O-8079-2018; Dorfman, Jeffrey R/M-4218-2017; Newton, Charles/V-7872-2019	Newton, Charles RJC/0000-0002-6999-5507; Dorfman, Jeffrey R/0000-0001-9938-8911; Fegan, Greg W/0000-0002-2663-2765; Newton, Charles/0000-0002-6999-5507; Seale, Anna/0000-0002-0129-3146	Wellcome Trust [083744, 099782, 101140, 083579]	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by the Wellcome Trust Senior Clinical Fellowship to Professor Charles Newton (No. 083744). Symon Kariuki was supported by the Wellcome Trust training fellowship (099782), Fredrick Ibinda by the Wellcome Trust masters training fellowship (101140), and James Berkley by the Wellcome Trust intermediate clinical fellowship (083579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, MAT NEON TET MNT EL; [Anonymous], 1993, IMMUNOLOGICAL BASIS; BAGCCHI S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F5808; Barlow JL, 2001, TROP MED INT HEALTH, V6, P305, DOI 10.1046/j.1365-3156.2001.00705.x; Beltran A, 2007, SOUTH MED J, V100, P83, DOI 10.1097/SMJ.0b013e31802e2717; BJERREGAARD P, 1993, INT J EPIDEMIOL, V22, P163, DOI 10.1093/ije/22.1.163; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Borrow R, 2006, IMMUNIZATION VACCINE; BRAIR ME, 1994, LANCET, V343, P208, DOI 10.1016/S0140-6736(94)90991-1; CRONE NE, 1992, NEUROLOGY, V42, P761, DOI 10.1212/WNL.42.4.761; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; deMoraesPinto MI, 1996, J INFECT DIS, V173, P1077, DOI 10.1093/infdis/173.5.1077; Dey A C, 2011, Mymensingh Med J, V20, P54; Dietz V, 1996, B WORLD HEALTH ORGAN, V74, P619; El Arifeen S, 2012, LANCET, V379, P1022, DOI 10.1016/S0140-6736(11)61848-5; Fetuga BM, 2010, WORLD J PEDIATR, V6, P71, DOI 10.1007/s12519-010-0010-9; Galazka A. M., 1998, THERMOSTABILITY VACC; HLADY WG, 1992, AM J PUBLIC HEALTH, V82, P1365, DOI 10.2105/AJPH.82.10.1365; Jacobsen Geir W, 2011, Tidsskr Nor Laegeforen, V131, P701, DOI 10.4045/tidsskr.10.1023; Kenya National Bureau of statistics, 2010, KEN DEM HLTH SURV 20; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Liu L.L., 2005, P AS PAC MICR C SUZH, VVol. 4, DOI DOI 10.1177/105122840528286416385023; Lum S H, 2009, Med J Malaysia, V64, P80; Maitha E, 2009, P 26 IUSSP INT POP C; Mwaniki Michael K, 2010, BMC Public Health, V10, P591, DOI 10.1186/1471-2458-10-591; Naik Ashish K, 2013, Int J Prev Med, V4, P1395; Okoko BJ, 2001, J INFECT DIS, V184, P627, DOI 10.1086/322808; Onalo R, 2011, J INFECT DEV COUNTR, V5, P255, DOI 10.3855/jidc.1666; Poudel P, 2008, Nepal Med Coll J, V10, P170; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Seale AC, 2013, PEDIATR RES, V74, P73, DOI 10.1038/pr.2013.207; SESARDIC D, 1993, BIOLOGICALS, V21, P67, DOI 10.1006/biol.1993.1048; Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7; SOKAL DC, 1988, B WORLD HEALTH ORGAN, V66, P69; Soofi S, 2012, LANCET, V379, P1029, DOI 10.1016/S0140-6736(11)61877-1; STANFIELD JP, 1984, B WORLD HEALTH ORGAN, V62, P647; Taylor AM, 2006, BJA EDUC, V6, P101, DOI 10.1093/bjaceaccp/mkl014; Thwaites CL, 2014, LANCET; UNICEF WHO UNFPA., 2000, MAT NEON TET EL 2005; WHO, 2006, WEEKL EP REC, P197	43	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122606	10.1371/journal.pone.0122606	http://dx.doi.org/10.1371/journal.pone.0122606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849440	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000352477800147
J	Jin, SS; Chang, CQ; Zhang, LT; Liu, Y; Huang, XR; Chen, ZM				Jin, Shasha; Chang, Cuiqing; Zhang, Lantao; Liu, Yang; Huang, Xianren; Chen, Zhimin			Chlorogenic Acid Improves Late Diabetes through Adiponectin Receptor Signaling Pathways in db/db Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; COFFEE CONSUMPTION; DECAFFEINATED COFFEE; GLUT4 TRANSLOCATION; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; LONG-TERM; METABOLISM; RISK	The aim of this study was to examine the effects of chlorogenic acid (CGA) on glucose and lipid metabolism in late diabetic db/db mice, as well as on adiponectin receptors and their signaling molecules, to provide evidence for CGA in the prevention of type 2 diabetes. We randomly divided 16 female db/db mice into db/db-CGA and db/db-control (CON) groups equally; db/m mice were used as control mice. The mice in both the db/db-CGA and db/m-CGA groups were administered 80 mg/kg/d CGA by lavage for 12 weeks, whereas the mice in both CON groups were given equal volumes of phosphate-buffered saline (PBS) by lavage. At the end of the intervention, we assessed body fat and the parameters of glucose and lipid metabolism in the plasma, liver and skeletal muscle tissues as well as the levels of aldose reductase (AR) and transforming growth factor-beta 1 (TGF-beta 1) in the kidneys and measured adiponectin receptors and the protein expression of their signaling molecules in liver and muscle tissues. After 12 weeks of intervention, compared with the db/db-CON group, the percentage of body fat, fasting plasma glucose (FPG) and glycosylated hemoglobin (HbA1c) in the db/db-CGA group were all significantly decreased; TGF-beta 1 protein expression and AR activity in the kidney were both decreased; and the adiponectin level in visceral adipose was increased. The protein expression of adiponectin receptors (ADPNRs), the phosphorylation of AMP-activated protein kinase (AMPK) in the liver and muscle, and the mRNA and protein levels of peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the liver were all significantly greater. CGA could lower the levels of fasting plasma glucose and HbA1c during late diabetes and improve kidney fibrosis to some extent through the modulation of adiponectin receptor signaling pathways in db/db mice.	[Jin, Shasha; Chang, Cuiqing; Zhang, Lantao; Liu, Yang; Huang, Xianren; Chen, Zhimin] Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China	Peking University	Chang, CQ (corresponding author), Peking Univ, Hosp 3, Inst Sports Med, Beijing 100871, Peoples R China.	changcuiqing@126.com			National Natural Sciences Foundation of China [30872112]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	Funding from the National Natural Sciences Foundation of China (30872112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abidov M, 2006, Georgian Med News, P66; Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; Bassoli BK, 2008, CELL BIOCHEM FUNCT, V26, P320, DOI 10.1002/cbf.1444; Battram DS, 2006, J NUTR, V136, P1276, DOI 10.1093/jn/136.5.1276; Ceddia RB, 2005, DIABETOLOGIA, V48, P132, DOI 10.1007/s00125-004-1609-y; Chen XL, 2008, METABOLISM, V57, P1516, DOI 10.1016/j.metabol.2008.06.005; Cho AS, 2010, FOOD CHEM TOXICOL, V48, P937, DOI 10.1016/j.fct.2010.01.003; CHOI ME, 1993, KIDNEY INT, V44, P948, DOI 10.1038/ki.1993.336; de Oliveira RB, 2011, J ETHNOPHARMACOL, V133, P434, DOI 10.1016/j.jep.2010.10.019; de Sotillo DVR, 2002, J NUTR BIOCHEM, V13, P717, DOI 10.1016/S0955-2863(02)00231-0; Herrera-Arellano A, 2004, PHYTOMEDICINE, V11, P561, DOI 10.1016/j.phymed.2004.01.006; Hosch SE, 2006, CELL METAB, V4, P5, DOI 10.1016/j.cmet.2006.06.003; Imatoh T, 2011, EUR J NUTR, V50, P279, DOI 10.1007/s00394-010-0136-5; Johnston KL, 2003, AM J CLIN NUTR, V78, P728, DOI 10.1093/ajcn/78.4.728; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Karthikesan K, 2010, GEN PHYSIOL BIOPHYS, V29, P23, DOI 10.4149/gpb_2010_01_23; Kawano Y, 2013, OBES SURG, V23, P1947, DOI 10.1007/s11695-013-1035-7; Kim CS, 2011, ARCH PHARM RES, V34, P847, DOI 10.1007/s12272-011-0519-z; Kim YS, 2011, BIOL PHARM BULL, V34, P925, DOI 10.1248/bpb.34.925; Kurth-Kraczek EJ, 1999, DIABETES, V48, P1667, DOI 10.2337/diabetes.48.8.1667; Lafontan M, 2008, DIABETES METAB, V34, P317, DOI 10.1016/j.diabet.2008.04.001; Li BQ, 2010, DRUG CHEM TOXICOL, V33, P415, DOI 10.3109/01480540903580055; Li SY, 2009, BIOMED ENVIRON SCI, V22, P122, DOI 10.1016/S0895-3988(09)60034-9; LIKE AA, 1972, AM J PATHOL, V66, P193; Lin WY, 2011, EUR J CLIN INVEST, V41, P659, DOI 10.1111/j.1365-2362.2010.02455.x; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Olthof MR, 2001, AM J CLIN NUTR, V73, P532; Ong KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032718; Pereira MA, 2006, ARCH INTERN MED, V166, P1311, DOI 10.1001/archinte.166.12.1311; Peters KE, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-15; Salazar-Martinez E, 2004, ANN INTERN MED, V140, P1, DOI 10.7326/0003-4819-140-1-200401060-00005; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; SHARMA K, 1995, DIABETES, V44, P1139, DOI 10.2337/diabetes.44.10.1139; Thom E, 2007, J INT MED RES, V35, P900, DOI 10.1177/147323000703500620; TOMLINSON DR, 1994, TRENDS PHARMACOL SCI, V15, P293, DOI 10.1016/0165-6147(94)90010-8; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207; VANDERJAGT DL, 1990, J BIOL CHEM, V265, P20982; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Williams CJ, 2008, DIABETES CARE, V31, P504, DOI 10.2337/dc07-1952; Yamashita K, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.6; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Zhang Lan-tao, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P281, DOI 10.3881/j.issn.1000-503X.2011.03.015; Ziyadeh FN, 2000, P NATL ACAD SCI USA, V97, P8015, DOI 10.1073/pnas.120055097; 郭晓红, 2010, [生理科学进展, Progress in Physiological Sciences], V41, P471	47	69	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120842	10.1371/journal.pone.0120842	http://dx.doi.org/10.1371/journal.pone.0120842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849026	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800035
J	Lai, CL; Wu, CF; Kuo, RNC; Yang, YY; Chen, MF; Chan, KA; Lai, MS				Lai, Chao-Lun; Wu, Ching-Fen; Kuo, Raymond Nien-Chen; Yang, Yen-Yun; Chen, Ming-Fong; Chan, K. Arnold; Lai, Mei-Shu			Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database	PLOS ONE			English	Article							BARE-METAL STENTS; RANDOMIZED-TRIALS; TAIWAN SOCIETY; FOLLOW-UP; SCANDINAVIAN ORGANIZATION; BALLOON ANGIOPLASTY; CARDIOLOGY TSOC; 2012 GUIDELINES; EFFICACY; SAFETY	The clinical outcomes of different limus-based drug-eluting stents (DES) in a real-world setting have not been well defined. The aim of this study was to investigate the clinical outcomes of three different limus-based DES, namely sirolimus-eluting stent (SES), Endeavor zotarolimus-eluting stent (E-ZES) and everolimus-eluting stent (EES), using a national insurance claims database. We identified all patients who received implantation of single SES, E-ZES or EES between January 1, 2007 and December 31, 2009 from the National Health Insurance claims database, Taiwan. Follow-up was through December 31, 2011 for all selected clinical outcomes. The primary end-point was all-cause mortality. Secondary end-points included acute coronary events, heart failure needing hospitalization, and cerebrovascular disease. Cox regression model adjusting for baseline characteristics was used to compare the relative risks of different outcomes among the three different limus-based DES. Totally, 6584 patients were evaluated (n=2142 for SES, n=3445 for E-ZES, and n=997 for EES). After adjusting for baseline characteristics, we found no statistically significant difference in the risk of all-cause mortality in three DES groups (adjusted hazard ratio [HR]: 1.14, 95% confidence interval [CI]: 0.94-1.38, p=0.20 in E-ZES group compared with SES group; adjusted HR: 0.77, 95% CI: 0.54-1.10, p=0.15 in EES group compared with SES group). Similarly, we found no difference in the three stent groups in risks of acute coronary events, heart failure needing hospitalization, and cerebrovascular disease. In conclusion, we observed no difference in all-cause mortality, acute coronary events, heart failure needing hospitalization, and cerebrovascular disease in patients treated with SES, E-ZES, and EES in a real-world population-based setting in Taiwan.	[Lai, Chao-Lun] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Internal Med, Hsinchu, Taiwan; [Lai, Chao-Lun] Natl Taiwan Univ Hosp, Hsin Chu Branch, Ctr Crit Care Med, Hsinchu, Taiwan; [Lai, Chao-Lun] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10764, Taiwan; [Lai, Chao-Lun; Lai, Mei-Shu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Wu, Ching-Fen] Mennonite Christian Hosp, Dept Internal Med, Hualien, Taiwan; [Kuo, Raymond Nien-Chen] Natl Taiwan Univ, Coll Publ Hlth, Inst Hlth Policy & Management, Taipei 10764, Taiwan; [Kuo, Raymond Nien-Chen; Yang, Yen-Yun; Lai, Mei-Shu] Natl Taiwan Univ Hosp, Natl Ctr Excellence Clin Trial & Res, Ctr Comparat Effectiveness Res, Taipei, Taiwan; [Chen, Ming-Fong] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ Hosp, Dept Med Res, Taipei, Taiwan; [Chan, K. Arnold] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Lai, MS (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	mslai@ntu.edu.tw	Chen, Ming/GVU-8412-2022; Kuo, Raymond N./N-2558-2018	Kuo, Raymond N./0000-0003-4980-853X; Chan, Kinwei/0000-0001-8161-1986; Lai, Chao-Lun/0000-0002-0362-245X; Lai, Mei-shu/0000-0001-6130-3468	Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan [DOH101-TD-B-111-001, DOH102-TD-B-111-001]	Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan	This study was supported by grants from the Science and Technology Unit, Ministry of Health and Welfare, Executive Yuan, Taiwan (DOH101-TD-B-111-001 and DOH102-TD-B-111-001). The funding agency did not have any input in study design, data analysis, and interpretation of findings, or in the decision to submit the manuscript for publication.	Caixeta A, 2009, J AM COLL CARDIOL, V54, P894, DOI 10.1016/j.jacc.2009.04.077; Camenzind E, 2012, LANCET, V380, P1396, DOI 10.1016/S0140-6736(12)61336-1; Cassese S, 2011, INT J CARDIOL, V150, P84, DOI 10.1016/j.ijcard.2011.01.015; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Chiang CE, 2010, J FORMOS MED ASSOC, V109, P740, DOI 10.1016/S0929-6646(10)60120-9; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802; Fu HH, 2004, HEALTH POLICY, V70, P185, DOI 10.1016/j.healthpol.2004.02.006; Garg S, 2010, J AM COLL CARDIOL, V56, pS1, DOI 10.1016/j.jacc.2010.06.007; Hofma SH, 2012, J AM COLL CARDIOL, V60, P381, DOI 10.1016/j.jacc.2012.01.073; Jensen LO, 2012, J AM COLL CARDIOL, V60, P1140, DOI 10.1016/j.jacc.2012.07.004; Jensen LO, 2012, CIRCULATION, V125, P1246, DOI 10.1161/CIRCULATIONAHA.111.063644; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Kaltoft A, 2009, J AM COLL CARDIOL, V53, P658, DOI 10.1016/j.jacc.2008.09.058; Kandzari DE, 2006, J AM COLL CARDIOL, V48, P2440, DOI 10.1016/j.jacc.2006.08.035; Kandzari DE, 2011, JACC-CARDIOVASC INTE, V4, P543, DOI 10.1016/j.jcin.2010.12.014; Kimura T, 2012, CIRCULATION, V126, P1225, DOI 10.1161/CIRCULATIONAHA.112.104059; Leon MB, 2010, JACC-CARDIOVASC INTE, V3, P1043, DOI 10.1016/j.jcin.2010.07.008; Li YH, 2012, ACTA CARDIOL SIN, V28, P63; Lu TH, 2000, INT J EPIDEMIOL, V29, P336, DOI 10.1093/ije/29.2.336; Maeng M, 2012, JACC-CARDIOVASC INTE, V5, P812, DOI 10.1016/j.jcin.2012.04.008; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Navarese EP, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6530; Park DW, 2010, J AM COLL CARDIOL, V56, P1187, DOI 10.1016/j.jacc.2010.03.086; Park KW, 2013, AM HEART J, V165, P241, DOI 10.1016/j.ahj.2012.08.007; Park KW, 2011, J AM COLL CARDIOL, V58, P1844, DOI 10.1016/j.jacc.2011.07.031; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rasmussen K, 2010, LANCET, V375, P1090, DOI 10.1016/S0140-6736(10)60208-5; Schomig A, 2007, J AM COLL CARDIOL, V50, P1373, DOI 10.1016/j.jacc.2007.06.047; SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801; Simsek C, 2010, CATHETER CARDIO INTE, V76, P41, DOI 10.1002/ccd.22533; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2007, NEW ENGL J MED, V356, P998, DOI 10.1056/NEJMoa067193; Stone GW, 2009, CIRCULATION, V119, P680, DOI 10.1161/CIRCULATIONAHA.108.803528; Townsend JC, 2012, VASC HEALTH RISK MAN, V8, P393, DOI 10.2147/VHRM.S23388; Wang CC, 2012, ACTA CARDIOL SIN, V28, P161	36	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122860	10.1371/journal.pone.0122860	http://dx.doi.org/10.1371/journal.pone.0122860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848942	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800167
J	Mariani, S; Di Bello, C; Bonello, L; Tondat, F; Pacchioni, D; Molinaro, L; Barreca, A; Macri, L; Chiusa, L; di Celle, PF; Cassoni, P; Sapino, A				Mariani, Sara; Di Bello, Cristiana; Bonello, Lisa; Tondat, Fabrizio; Pacchioni, Donatella; Molinaro, Luca; Barreca, Antonella; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia; Cassoni, Paola; Sapino, Anna			Flexible Lab-Tailored Cut-Offs for Suitability of Formalin-Fixed Tumor Samples for Diagnostic Mutational Analyses	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; CELL LUNG-CANCER; KRAS; EGFR; DNA; ADENOCARCINOMA; FLUOROURACIL; PANITUMUMAB; LEUCOVORIN; PERCENTAGE	The selection of proper tissues from formalin-fixed and paraffin-embedded tumors before diagnostic molecular testing is responsibility of the pathologist and represents a crucial step to produce reliable test results. The international guidelines suggest two cut-offs, one for the percentage and one for the number of tumor cells, in order to enrich the tumor content before DNA extraction. The aim of the present work was two-fold: to evaluate to what extent a low percentage or absolute number of tumor cells can be qualified for somatic mutation testing; and to determine how assay sensitivities can guide pathologists towards a better definition of morphology-based adequacy cut-offs. We tested 1797 tumor specimens from melanomas, colorectal and lung adenocarcinomas. Respectively, their BRAF, K-RAS and EGFR genes were analyzed at specific exons by mutation-enriched PCR, pyrosequencing, direct sequencing and real-time PCR methods. We demonstrate that poorly cellular specimens do not modify the frequency distribution of either mutated or wild-type DNA samples nor that of specific mutations. This observation suggests that currently recommended cutoffs for adequacy of specimens to be processed for molecular assays seem to be too much stringent in a laboratory context that performs highly sensitive routine analytical methods. In conclusion, new cut-offs are needed based on test sensitivities and documented tumor heterogeneity.	[Mariani, Sara; Barreca, Antonella; Cassoni, Paola; Sapino, Anna] Univ Turin, Dept Med Sci, Turin, Italy; [Di Bello, Cristiana; Pacchioni, Donatella; Molinaro, Luca; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia] Univ Citta Salute & Sci, Azienda Osped, Turin, Italy; [Di Bello, Cristiana; Pacchioni, Donatella; Molinaro, Luca; Macri, Luigia; Chiusa, Luigi; di Celle, Paola Francia] Presidio Osped Molinette Torino, Turin, Italy; [Bonello, Lisa; Tondat, Fabrizio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin	Sapino, A (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	anna.sapino@unito.it	Sapino, Anna/AGY-9901-2022; Cassoni, Paola/I-8544-2018; Sapino, Anna/J-4113-2018	Sapino, Anna/0000-0003-3542-9571; Sapino, Anna/0000-0003-3542-9571; MARIANI, Sara/0000-0003-3761-3612	Lanzavecchia-Lastretti Foundation for "Progetto Melanoma"	Lanzavecchia-Lastretti Foundation for "Progetto Melanoma"	This study was supported by the Lanzavecchia-Lastretti Foundation for "Progetto Melanoma." The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awada A, 2013, CURR OPIN ONCOL, V25, P296, DOI 10.1097/CCO.0b013e32835ff318; Dancey JE, 2012, CELL, V148, P409, DOI 10.1016/j.cell.2012.01.014; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Fuery CJ, 2000, CLIN CHEM, V46, P620; Heinzerling L, 2013, BRIT J CANCER, V109, P2833, DOI 10.1038/bjc.2013.622; Hlinkova K, 2013, DIAGN MOL PATHOL, V22, P70, DOI 10.1097/PDM.0b013e31827e6984; Jancik S, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-79; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kaneda H, 2004, LUNG CANCER, V46, P247, DOI 10.1016/j.lungcan.2004.04.032; Kirkham A, 2013, FORENSIC SCI INT-GEN, V7, P92, DOI 10.1016/j.fsigen.2012.07.003; Lee JT, 2010, PIGM CELL MELANOMA R, V23, P820, DOI 10.1111/j.1755-148X.2010.00763.x; Lewandowska MA, 2013, MOL DIAGN THER, V17, P193, DOI 10.1007/s40291-013-0025-8; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Marks JL, 2008, J THORAC ONCOL, V3, P111, DOI 10.1097/JTO.0b013e318160c607; Mixich F, 2007, J GASTROINTEST LIVER, V16, P5; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; RANEK L, 1976, ACTA CYTOL, V20, P151; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schwartzberg LS, 2014, J CLIN ONCOL, V32, P2240, DOI 10.1200/JCO.2013.53.2473; Smits AJJ, 2014, MODERN PATHOL, V27, P168, DOI 10.1038/modpathol.2013.134; Snedecor GW, 1980, STAT METHODS, V7th; Sun LN, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-30; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Vignot S, 2013, B CANCER, V100, P561, DOI 10.1684/bdc.2013.1767; Vucic EA, 2012, GENOME RES, V22, P188, DOI 10.1101/gr.124354.111; Yu SR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068022	27	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121815	10.1371/journal.pone.0121815	http://dx.doi.org/10.1371/journal.pone.0121815			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844806	Green Published, Green Submitted, gold			2022-12-26	WOS:000352475700010
J	Amagloh, FK; Chiridza, T; Lemercier, ME; Broomfield, A; Morel, PCH; Coad, J				Amagloh, Francis Kweku; Chiridza, Tracy; Lemercier, Marie-Eve; Broomfield, Anne; Morel, Patrick C. H.; Coad, Jane			Sweetpotato- and Cereal-Based Infant Foods: Protein Quality Assessment, and Effect on Body Composition Using Sprague Dawley Rats as a Model	PLOS ONE			English	Article							VITAMIN-A; COMPLEMENTARY FOODS; DIGESTIBILITY; CHILDREN	The Protein Digestibility Corrected Amino Acid Score (PDCAAS) of sweetpotato-based complementary foods (OFSP ComFa and CFSP ComFa) and cereal-based infant products (Weanimix and Cerelac) was assessed using 3 wk-old male Sprague Dawley rats weighing between 53-67 g as a model for human infants. Also, the effect of consumption of the infant formulations on lean mass, bone mass content and fat mass was evaluated by Dual-Energy X-ray Absorptiometry (DEXA) using 6 wk-old Sprague Dawley rats (initial weight, 206-229 g). The ComFa products and Weanimix are household-level formulations, and Cerelac is a commercial infant cereal. The true protein digestibility score for Cerelac was 96.27%, and about 1.8% (P<0.0001) higher than that for OFSP ComFa, CFSP ComFa and Weanimix. However, OFSP ComFa had the highest un-truncated PDCAAS by a difference of 4.1%, than CFSP ComFa, and about 20% difference compared with both the Weanimix and Cerelac. All the products investigated had PDCAAS greater than 70%, the minimum protein quality requirement for complementary foods. Among the rats assigned to the four formulations, their bone mass and fat mass composition were not significantly different (P=0.08 and P=0.85, respectively). However, the rats on CFSP ComFa had higher lean mass than those on Cerelac (321.67 vs. 297.19 g; P=0.03). The findings from the PDCAAS and the DEXA-measured body composition studies indicate that complementary foods could be formulated from readily available agricultural resources at the household-level to support growth as would a nutritionally adequate industrial-manufactured infant cereal. Nonetheless, it should be noted that the findings of our studies are based on an animal model.	[Amagloh, Francis Kweku] Univ Dev Studies, Fac Agr, Dept Biotechnol, Food Proc & Technol Unit, Nyankpala, Ghana; [Chiridza, Tracy; Broomfield, Anne; Coad, Jane] Massey Univ, Coll Hlth, Te Kura Hauora Tangata, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand; [Lemercier, Marie-Eve] Inst Polytech LaSalle Beauvais, Beauvais, France; [Morel, Patrick C. H.] Massey Univ, Inst Vet Anim & Biomed Sci, Coll Sci, Palmerston North, New Zealand	University for Development Studies; Massey University; UniLaSalle; Massey University	Coad, J (corresponding author), Massey Univ, Coll Hlth, Te Kura Hauora Tangata, Inst Food Nutr & Human Hlth, Palmerston North, New Zealand.	J.Coad@massey.ac.nz	Amagloh, Francis Kweku/J-6219-2014	Amagloh, Francis Kweku/0000-0001-7243-0972	Nutricia Research Foundation, the Netherlands [2012-E6]	Nutricia Research Foundation, the Netherlands(Netherlands Government)	This work was supported by the Nutricia Research Foundation, the Netherlands (Project number: 2012-E6).	Agble R, 1997, SCN NEWS, P9; Amagloh FK, 2012, MATERN CHILD NUTR, V8, P512, DOI 10.1111/j.1740-8709.2011.00343.x; Amagloh FK, 2014, FOOD NUTR BULL, V35, P51, DOI 10.1177/156482651403500107; Amagloh FK, 2012, FOOD NUTR BULL, V33, P3, DOI 10.1177/156482651203300101; Amuna P., 2000, Nutrition & Food Science, P116, DOI 10.1108/00346650010319688; AOAC, 2006, OFFICIAL METHODS ANA, V18th ed.; AOAC, 2005, OFFICIAL METHODS ANA; Bertin E, 1998, J NUTR, V128, P1550, DOI 10.1093/jn/128.9.1550; Codex Alimentarius Commission, 2006, 022006 CACMRL, P1; Dewey KG, 2003, DIV HLTH PROM PROT F; Ejigui J, 2011, INT J FOOD SCI NUTR, V62, P484, DOI 10.3109/09637486.2010.547461; FAO/WHO, 1991, REP JOINT FAO WHO EX, P51; FAO/WHO/UNU (Expert Consultation), 2007, WHO TECHN REP SER, V935; Hotz C, 2012, J NUTR; Kannan S, 2001, J AGR FOOD CHEM, V49, P5070, DOI 10.1021/jf010323u; Lartey A, 1999, AM J CLIN NUTR, V70, P391; Low JW, 2007, J NUTR, V137, P1320; Mensa-Wilmot Y, 2001, NUTR RES, V21, P849, DOI 10.1016/S0271-5317(01)00302-5; Mouquet C, 2003, FOOD CHEM, V82, P249, DOI 10.1016/S0308-8146(02)00545-9; Nnam NM, 2000, PLANT FOOD HUM NUTR, V55, P255, DOI 10.1023/A:1008176903750; Ruel MT, 2013, LANCET, V382, P536, DOI 10.1016/S0140-6736(13)60843-0; Schaafsma G, 2000, J NUTR, V130, p1865S, DOI 10.1093/jn/130.7.1865S; Serrem CA, 2011, J SCI FOOD AGR, V91, P1814, DOI 10.1002/jsfa.4389; Sun MJ, 2012, J FOOD COMPOS ANAL, V26, P104, DOI 10.1016/j.jfca.2012.03.008; Tizazu S., 2011, African Journal of Food, Agriculture, Nutrition and Development, V11, P5083; van Jaarsveld PJ, 2005, AM J CLIN NUTR, V81, P1080	26	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120121	10.1371/journal.pone.0120121	http://dx.doi.org/10.1371/journal.pone.0120121			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836365	Green Published, gold			2022-12-26	WOS:000352139000017
J	Guix, S; Perez-Bosque, A; Miro, L; Moreto, M; Bosch, A; Pinto, RM				Guix, Susana; Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel; Bosch, Albert; Pinto, Rosa M.			Type I Interferon Response Is Delayed in Human Astrovirus Infections	PLOS ONE			English	Article							TERMINAL NSP1A PROTEIN; VIRUS; INDUCTION; APOPTOSIS; IMMUNITY; REPLICATION; ASSOCIATION; INHIBITION; COMPLEMENT; PATHWAY	Type I interferon (IFN) activation and its subsequent effects are important in the response to viral infections. Here we show that human astroviruses (HAstVs), which are important agents of acute gastroenteritis in children, induce a mild and delayed IFN response upon infecting CaCo-2 cells. Although IFN-beta mRNA is detected within infected cells and supernatant from infected cells show antiviral activity against the replication of other well-known IFN-sensitive viruses, these responses occur at late stages of infection once genome replication has taken place. On the other hand, HAstV replication can be partially reduced by the addition of exogenous IFN, and inhibition of IFN activation by BX795 enhances viral replication, indicating that HAstVs are IFN-sensitive viruses. Finally, different levels of IFN response were observed in cells infected with different HAstV mutants with changes in the hypervariable region of nsP1a/4, suggesting that nsP1a/4 genotype may potentially have clinical implications due to its correlation with the viral replication phenotype and the antiviral responses induced within infected cells.	[Guix, Susana; Bosch, Albert; Pinto, Rosa M.] Univ Barcelona, Dept Microbiol, Enter Virus Grp, Barcelona, Spain; [Guix, Susana; Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel; Bosch, Albert; Pinto, Rosa M.] Univ Barcelona, Nutr & Food Safety Res Inst INSA UB, Santa Coloma de Gramenet, Spain; [Perez-Bosque, Anna; Miro, Lluisa; Moreto, Miquel] Univ Barcelona, Dept Physiol, Digest Physiol & Nutr Adaptat Grp, Barcelona, Spain	University of Barcelona; University of Barcelona; University of Barcelona	Guix, S (corresponding author), Univ Barcelona, Dept Microbiol, Enter Virus Grp, Barcelona, Spain.	susanaguix@ub.edu	Perez-Bosque, Anna/R-6383-2019; Guix, Susana/D-4318-2014; Pinto, Rosa M/K-2859-2014	Perez-Bosque, Anna/0000-0003-2175-9684; Guix, Susana/0000-0002-1588-3198; Pinto, Rosa M/0000-0003-1382-6648	Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya [2009SGR00024]; Institute of Nutrition and Food Safety, University of Barcelona [FRI-2011]; XRB-Biotechnology Reference Network (Generalitat de Catalunya)	Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya; Institute of Nutrition and Food Safety, University of Barcelona; XRB-Biotechnology Reference Network (Generalitat de Catalunya)(Generalitat de Catalunya)	This work was supported by the following grants: 2009SGR00024 (Projectes de recerca per potenciar els grups de recerca consolidats, Agencia de Gestio d'Ajuts Universitaris i de Recerca. Generalitat de Catalunya; www.gencat.cat/agaur), FRI-2011 (Institute of Nutrition and Food Safety, University of Barcelona; www.ub.edu/insa), and XRB-Biotechnology Reference Network (Generalitat de Catalunya; www.gencat.cat/agaur).	Abad FX, 2001, APPL ENVIRON MICROB, V67, P3904, DOI 10.1128/AEM.67.9.3904-3907.2001; Appleton H, 1975, Lancet, V1, P1297; Barro M, 2007, J VIROL, V81, P4473, DOI 10.1128/JVI.02498-06; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Bonaparte RS, 2008, J VIROL, V82, P817, DOI 10.1128/JVI.01847-07; Bosch A, 2014, CLIN MICROBIOL REV, V27, P1048, DOI 10.1128/CMR.00013-14; Caballero S, 2003, J MED VIROL, V71, P245, DOI 10.1002/jmv.10476; Chang KO, 2007, J VIROL, V81, P12111, DOI 10.1128/JVI.00560-07; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Fuentes C, 2012, J VIROL, V86, P10070, DOI 10.1128/JVI.00797-12; Geigenmuller U, 1997, J VIROL, V71, P1713; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Graff JW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000280; Gronemus JQ, 2010, MOL IMMUNOL, V48, P305, DOI 10.1016/j.molimm.2010.07.012; Guix S, 2004, J VIROL, V78, P13627, DOI 10.1128/JVI.78.24.13627-13636.2004; Guix S, 2005, VIROLOGY, V333, P124, DOI 10.1016/j.virol.2004.12.023; Guix S, 2004, VIROLOGY, V319, P249, DOI 10.1016/j.virol.2003.10.036; Guix S, 2002, J CLIN MICROBIOL, V40, P133, DOI 10.1128/JCM.40.1.133-139.2002; Hair PS, 2010, MOL IMMUNOL, V47, P792, DOI 10.1016/j.molimm.2009.10.006; Holm GH, 2007, J BIOL CHEM, V282, P21953, DOI 10.1074/jbc.M702112200; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Koci MD, 2005, VIRAL IMMUNOL, V18, P11, DOI 10.1089/vim.2005.18.11; Koci MD, 2004, J VIROL, V78, P1564, DOI 10.1128/JVI.78.3.1564-1574.2004; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Lei Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005466; Mendez E, 2004, J VIROL, V78, P8601, DOI 10.1128/JVI.78.16.8601-8608.2004; Mendez E., 2007, FIELDS VIROLOGY, V5, P981; Mendez E, 2007, J VIROL, V81, P10649, DOI 10.1128/JVI.00785-07; Moser LA, 2005, VIRAL IMMUNOL, V18, P4, DOI 10.1089/vim.2005.18.4; Moser LA, 2007, J VIROL, V81, P11937, DOI 10.1128/JVI.00942-07; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nighot PK, 2010, VIROLOGY, V401, P146, DOI 10.1016/j.virol.2010.02.004; Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Rintahaka J, 2008, J IMMUNOL, V180, P1749, DOI 10.4049/jimmunol.180.3.1749; Sano D, 2010, ENVIRON SCI TECHNOL, V44, P808, DOI 10.1021/es9018964; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz-Cherry S., 2013, ASTROVIRUS RES ESSEN; Tam JCH, 2014, SCIENCE, V345, P1134, DOI 10.1126/science.1256070; THOUVENELLE ML, 1995, AVIAN DIS, V39, P343, DOI 10.2307/1591877; Versteeg GA, 2010, CURR OPIN MICROBIOL, V13, P508, DOI 10.1016/j.mib.2010.05.009; WILLCOCKS MM, 1994, J VIROL, V68, P6057, DOI 10.1128/JVI.68.9.6057-6058.1994; Yokoyama CC, 2012, J VIROL, V86, P12262, DOI 10.1128/JVI.02018-12; Zhou HX, 2007, J VIROL, V81, P568, DOI 10.1128/JVI.01512-06	47	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123087	10.1371/journal.pone.0123087	http://dx.doi.org/10.1371/journal.pone.0123087			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837699	gold, Green Submitted, Green Published			2022-12-26	WOS:000352139000126
J	Hipp, JF; Siegel, M				Hipp, Joerg F.; Siegel, Markus			Accounting for Linear Transformations of EEG and MEG Data in Source Analysis	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SIGNAL-SPACE PROJECTION; GAMMA-BAND ACTIVITY; MUSCLE ARTIFACTS; EYE ACTIVITY; BRAIN; SEPARATION; REMOVAL; IDENTIFICATION; LOCALIZATION	Analyses of electro- and magnetoencephalography (EEG, MEG) data often involve a linear modification of signals at the sensor level. Examples include re-referencing of the EEG, computation of synthetic gradiometer in MEG, or the removal of artifactual independent components to clean EEG and MEG data. A question of practical relevance is, if such modifications must be accounted for by adapting the physical forward model (leadfield) before subsequent source analysis. Here, we show that two scenarios need to be differentiated. In the first scenario, which corresponds to re-referencing the EEG and synthetic gradiometer computation in MEG, the leadfield must be adapted before source analysis. In the second scenario, which corresponds to removing artifactual components to 'clean' the data, the leadfield must not be changed. We demonstrate and discuss the consequences of wrongly modifying the leadfield in the latter case for an example. Future EEG and MEG studies employing source analyses should carefully consider whether and, if so, how the leadfield must be modified as explicated here.	[Hipp, Joerg F.; Siegel, Markus] Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany; [Hipp, Joerg F.; Siegel, Markus] Univ Tubingen, MEG Ctr, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hipp, JF (corresponding author), Univ Tubingen, Ctr Integrat Neurosci, Tubingen, Germany.	joerg.hipp@cin.uni-tuebingen.de; markus.siegel@uni-tuebingen.de	Hipp, Joerg F/D-8936-2014; Siegel, Markus/H-5225-2012	Hipp, Joerg F/0000-0002-7875-2988; Siegel, Markus/0000-0001-5115-936X	Deutsche Forschungsgemeinschaft [EXC 307]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft, EXC 307 (www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; De Clercq W, 2006, IEEE T BIO-MED ENG, V53, P2583, DOI 10.1109/TBME.2006.879459; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Goncharova II, 2003, CLIN NEUROPHYSIOL, V114, P1580, DOI 10.1016/S1388-2457(03)00093-2; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Hall SD, 2005, NEUROIMAGE, V26, P13, DOI 10.1016/j.neuroimage.2005.01.009; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Haufe S, 2014, NEUROIMAGE, V101, P583, DOI 10.1016/j.neuroimage.2014.06.073; He B, 1997, IEEE T BIO-MED ENG, V44, P529, DOI 10.1109/10.594893; HE B, 1987, IEEE T BIO-MED ENG, V34, P406, DOI 10.1109/TBME.1987.326056; Hipp JF, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00338; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; James CJ, 2005, PHYSIOL MEAS, V26, pR15, DOI 10.1088/0967-3334/26/1/R02; Jung TP, 2000, CLIN NEUROPHYSIOL, V111, P1745, DOI 10.1016/S1388-2457(00)00386-2; Keren AS, 2010, NEUROIMAGE, V49, P2248, DOI 10.1016/j.neuroimage.2009.10.057; Lins Otavio G., 1993, Brain Topography, V6, P65, DOI 10.1007/BF01234128; Mantini D, 2008, NEUROIMAGE, V40, P160, DOI 10.1016/j.neuroimage.2007.11.022; Mitra PP, 1999, BIOPHYS J, V76, P691, DOI 10.1016/S0006-3495(99)77236-X; Muthukumaraswamy SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00138; Nolte G, 1999, IEEE T BIO-MED ENG, V46, P400, DOI 10.1109/10.752937; Nunez P. L, 2006, ELECTRIC FIELDS OF T; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Siegel M, 2007, CEREB CORTEX, V17, P732, DOI 10.1093/cercor/bhk025; Taulu S, 2004, BRAIN TOPOGR, V16, P269, DOI 10.1023/b:brat.0000032864.93890.f9; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; THOMSON DJ, 1982, P IEEE, V70, P1055, DOI 10.1109/PROC.1982.12433; Uusitalo MA, 1997, MED BIOL ENG COMPUT, V35, P135, DOI 10.1007/BF02534144; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Vigario R, 1998, ADV NEUR IN, V10, P229; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024	37	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121048	10.1371/journal.pone.0121048	http://dx.doi.org/10.1371/journal.pone.0121048			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836951	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000038
J	Kwan, P; Ding, J; Tredget, EE				Kwan, Peter; Ding, Jie; Tredget, Edward E.			MicroRNA 181b Regulates Decorin Production by Dermal Fibroblasts and May Be a Potential Therapy for Hypertrophic Scar	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TRANSCRIPTIONAL CONTROL; FIBROTIC RESPONSE; EXPRESSION; TARGETS; CELLS; DIFFERENTIATION; PROTEOGLYCAN; SKIN; IDENTIFICATION	Hypertrophic scarring is a frequent fibroproliferative complication following deep dermal burns leading to impaired function and lifelong disfigurement. Decorin reduces fibrosis and induces regeneration in many tissues, and is significantly downregulated in hypertrophic scar and normal deep dermal fibroblasts. It was hypothesized that microRNAs in these fibroblasts downregulate decorin and blocking them would increase decorin and may prevent hypertrophic scarring. Lower decorin levels were found in hypertrophic scar as compared to normal skin, and in deep as compared to superficial dermis. A decorin 3' un-translated region reporter assay demonstrated microRNA decreased decorin in deep dermal fibroblasts, and microRNA screening predicted miR-24, 181b, 421, 526b, or 543 as candidates. After finding increased levels of mir-181b in deep dermal fibroblasts, it was demonstrated that TGF-beta(1) stimulation decreased miR-24 but increased miR-181b and that hypertrophic scar and deep dermis contained increased levels of miR-181b. By blocking miR-181b with an antagomiR, it was possible to increase decorin protein expression in dermal fibroblasts. This suggests miR-181b is involved in the differential expression of decorin in skin and wound healing. Furthermore, blocking miR-181b reversed TGF-beta(1) induced decorin down-regulation and myofibroblast differentiation in hypertrophic scar fibroblasts, suggesting a potential therapy for hypertrophic scar.	[Kwan, Peter; Tredget, Edward E.] Univ Alberta, Fac Med & Dent, Dept Surg, Div Plast Surg, Edmonton, AB, Canada; [Kwan, Peter; Ding, Jie; Tredget, Edward E.] Univ Alberta, Wound Healing Res Grp, Dept Surg, Fac Med & Dent, Edmonton, AB, Canada; [Tredget, Edward E.] Univ Alberta Hosp, Dept Med, Div Crit Care, Edmonton, AB T6G 2B7, Canada	University of Alberta; University of Alberta; University of Alberta	Tredget, EE (corresponding author), Univ Alberta, Fac Med & Dent, Dept Surg, Div Plast Surg, Edmonton, AB, Canada.	etredget@ualberta.ca			Canadian Institutes of Health Research; Firefighters' Burn Trust Fund of the University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Firefighters' Burn Trust Fund of the University of Alberta(University of Alberta)	The funding source for this work has been the Canadian Institutes of Health Research and the Firefighters' Burn Trust Fund of the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, PLOS ONE, DOI DOI 10.1371/J0URNAL.P0NE.0005610; Armour A, 2007, WOUND REPAIR REGEN, V15, pS6, DOI 10.1111/j.1524-475X.2007.00219.x; Arnold CP, 2011, GENOME RES, V21, P798, DOI 10.1101/gr.111385.110; Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bock O, 2006, ARCH DERMATOL RES, V297, P433, DOI 10.1007/s00403-006-0651-7; Boutla A, 2003, NUCLEIC ACIDS RES, V31, P4973, DOI 10.1093/nar/gkg707; BREUER B, 1990, BIOCHEM J, V269, P551, DOI 10.1042/bj2690551; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; Dunkin CSJ, 2007, PLAST RECONSTR SURG, V119, P1722, DOI 10.1097/01.prs.0000258829.07399.f0; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gangemi EN, 2008, ARCH FACIAL PLAST S, V10, P93, DOI 10.1001/archfaci.10.2.93; Goldoni S, 2009, J CELL BIOL, V185, P743, DOI 10.1083/jcb.200901129; Honardoust D, 2012, J BURN CARE RES, V33, P218, DOI 10.1097/BCR.0b013e3182335980; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang X, 2010, FEBS J, V277, P2015, DOI 10.1111/j.1742-4658.2010.07632.x; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Kolb M, 2001, AM J RESP CRIT CARE, V163, P770, DOI 10.1164/ajrccm.163.3.2006084; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Kwan P, 2009, HAND CLIN, V25, P511, DOI 10.1016/j.hcl.2009.06.007; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li LH, 2009, AM J PHYSIOL-HEART C, V297, pH1504, DOI 10.1152/ajpheart.00194.2009; LINARES HA, 1972, J INVEST DERMATOL, V59, P323, DOI 10.1111/1523-1747.ep12627386; Moscatello DK, 1998, J CLIN INVEST, V101, P406, DOI 10.1172/JCI846; Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373; Niessen FB, 1999, PLAST RECONSTR SURG, V104, P1435, DOI 10.1097/00006534-199910000-00031; Pfaffl M. W., 2004, QUANTIFICATION STRAT; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Reed CC, 2005, ONCOGENE, V24, P1104, DOI 10.1038/sj.onc.1208329; Rittie L, 2005, METH MOLEC MED, V117, P83; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; SANTRA M, 1994, J BIOL CHEM, V269, P579; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Schafer M, 2007, ANNU REV CELL DEV BI, V23, P69, DOI 10.1146/annurev.cellbio.23.090506.123609; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Scott PG, 1998, CLIN SCI, V94, P541, DOI 10.1042/cs0940541; Scott PG, 1996, CLIN SCI, V90, P417, DOI 10.1042/cs0900417; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Sun Q, 2008, NUCLEIC ACIDS RES, V36, P2690, DOI 10.1093/nar/gkn032; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Tredget EE, 1997, SURG CLIN N AM, V77, P701, DOI 10.1016/S0039-6109(05)70576-4; Vial C, 2011, J BIOL CHEM, V286, P24242, DOI 10.1074/jbc.M110.189365; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang HJ, 2005, EXP MOL PATHOL, V78, P17, DOI 10.1016/j.yexmp.2004.07.006; Wang JF, 2008, LAB INVEST, V88, P1278, DOI 10.1038/labinvest.2008.101; Wang Ting-Fang, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4189; Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Zhang Z, 2007, BURNS, V33, P634, DOI 10.1016/j.burns.2006.08.018; Zhang Z, 2009, BURNS, V35, P527, DOI 10.1016/j.burns.2008.08.021	59	42	42	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123054	10.1371/journal.pone.0123054	http://dx.doi.org/10.1371/journal.pone.0123054			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837671	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000125
J	Sen, A; Sun, R; Krahn, MP				Sen, Arnab; Sun, Rui; Krahn, Michael P.			Localization and Function of Pals1-associated Tight Junction Protein in Drosophila Is Regulated by Two Distinct Apical Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN EPITHELIAL-CELLS; RHO-ASSOCIATED KINASE; PHOTORECEPTOR MORPHOGENESIS; E-CADHERIN; POLARITY COMPLEXES; CRUMBS COMPLEX; BASAL POLARITY; DOMAIN; PATJ; BAZOOKA	The transmembrane protein Crumbs (Crb) and its intracellular adaptor protein Pals1 (Stardust, Sdt in Drosophila) play a crucial role in the establishment and maintenance of apical-basal polarity in epithelial cells in various organisms. In contrast, the multiple PDZ domain-containing protein Pals1-associated tight junction protein (PATJ), which has been described to form a complex with Crb/Sdt, is not essential for apical basal polarity or for the stability of the Crb/Sdt complex in the Drosophila epidermis. Here we show that, in the embryonic epidermis, Sdt is essential for the correct subcellular localization of PATJ in differentiated epithelial cells but not during cellularization. Consistently, the L27 domain of PATJ is crucial for the correct localization and function of the protein. Our data further indicate that the four PDZ domains of PATJ function, to a large extent, in redundancy, regulating the function of the protein. Interestingly, the PATJ-Sdt heterodimer is not only recruited to the apical cell-cell contacts by binding to Crb but depends on functional Bazooka (Baz). However, biochemical experiments show that PATJ associates with both complexes, the Baz-Sdt and the Crb-Sdt complex, in the mature epithelium of the embryonic epidermis, suggesting a role of these two complexes for the function of PATJ during the development of Drosophila.	[Sen, Arnab; Sun, Rui; Krahn, Michael P.] Univ Regensburg, Inst Mol & Cellular Anat, D-93053 Regensburg, Germany	University of Regensburg	Krahn, MP (corresponding author), Univ Regensburg, Inst Mol & Cellular Anat, Univ Str 31, D-93053 Regensburg, Germany.	Michael.Krahn@vkl.uni-Regensburg.de	Krahn, Michael/AAD-4476-2022	Krahn, Michael/0000-0001-7718-9890	Deutsche Forschungsgemeinschaft [DFG3901/1-1, DFG3901/2-1];  [SFB699]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); 	This work was supported by Deutsche Forschungsgemeinschaft Grants DFG3901/1-1 and DFG3901/2-1 (to M. P. K.) and by SFB699.	Adachi M, 2009, MOL CELL BIOL, V29, P2372, DOI 10.1128/MCB.01505-08; Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Benton R, 2003, CURR BIOL, V13, P1330, DOI 10.1016/S0960-9822(03)00508-6; Berger S, 2007, GENETICS, V176, P2189, DOI 10.1534/genetics.107.071449; Bulgakova NA, 2013, J CELL BIOL, V201, P887, DOI 10.1083/jcb.201211159; CHOU TB, 1993, DEVELOPMENT, V119, P1359; Desai R, 2013, NAT CELL BIOL, V15, P261, DOI 10.1038/ncb2685; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; Feng W, 2005, P NATL ACAD SCI USA, V102, P6861, DOI 10.1073/pnas.0409346102; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; Kempkens O, 2006, EUR J CELL BIOL, V85, P753, DOI 10.1016/j.ejcb.2006.03.003; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Klose S, 2013, G3-GENES GENOM GENET, V3, P153, DOI 10.1534/g3.112.005074; Krahn MP, 2010, J CELL BIOL, V190, P751, DOI 10.1083/jcb.201006029; Krahn MP, 2010, CURR BIOL, V20, P636, DOI 10.1016/j.cub.2010.01.065; Krahn MP, 2009, DEV CELL, V16, P901, DOI 10.1016/j.devcel.2009.04.011; Laprise P, 2006, DEV CELL, V11, P363, DOI 10.1016/j.devcel.2006.06.001; Lemmers C, 2004, MOL BIOL CELL, V15, P1324, DOI 10.1091/mbc.E03-04-0235; Li YH, 2004, EMBO J, V23, P2723, DOI 10.1038/sj.emboj.7600294; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Makarova O, 2003, GENE, V302, P21, DOI 10.1016/S0378111902010843; McKim KS, 1996, GENETICS, V144, P215; Medina E, 2002, J CELL BIOL, V158, P941, DOI 10.1083/jcb.200203080; Michel D, 2005, J CELL SCI, V118, P4049, DOI 10.1242/jcs.02528; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Nakajima H, 2011, J CELL BIOL, V195, P245, DOI 10.1083/jcb.201104118; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; Oshiro N, 1998, J BIOL CHEM, V273, P34663, DOI 10.1074/jbc.273.52.34663; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Penalva C, 2012, DEVELOPMENT, V139, P4549, DOI 10.1242/dev.085449; Penkert RR, 2004, NAT STRUCT MOL BIOL, V11, P1122, DOI 10.1038/nsmb839; Richard M, 2006, DEV DYNAM, V235, P895, DOI 10.1002/dvdy.20595; Roh MH, 2003, J CELL SCI, V116, P2895, DOI 10.1242/jcs.00500; Roh MH, 2002, J CELL BIOL, V157, P161, DOI 10.1083/jcb.200109010; Roignot J., 2013, COLD SPRING HARB PER, V5; Sen A, 2012, J CELL BIOL, V199, P685, DOI 10.1083/jcb.201206064; Shahab J., 2015, BIOL OPEN; Shewan AM, 2005, MOL BIOL CELL, V16, P4531, DOI 10.1091/mbc.E05-04-0330; Shin K, 2005, J CELL BIOL, V168, P705, DOI 10.1083/jcb.200408064; Shin K, 2007, EMBO REP, V8, P158, DOI 10.1038/sj.embor.7400890; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Straight SW, 2004, MOL BIOL CELL, V15, P1981, DOI 10.1091/mbc.E03-08-0620; Tanentzapf G, 2000, J CELL BIOL, V151, P891, DOI 10.1083/jcb.151.4.891; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 2012, ANNU REV CELL DEV BI, V28, P655, DOI 10.1146/annurev-cellbio-092910-154033; Wang Q, 2004, J BIOL CHEM, V279, P30715, DOI 10.1074/jbc.M401930200; Wodarz A, 2000, J CELL BIOL, V150, P1361, DOI 10.1083/jcb.150.6.1361; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zhou WK, 2012, DEVELOPMENT, V139, P2891, DOI 10.1242/dev.083162	58	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13224	13233		10.1074/jbc.M114.629014	http://dx.doi.org/10.1074/jbc.M114.629014			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847234	hybrid, Green Published			2022-12-26	WOS:000354975700024
J	Zhao, Q; Ahmed, M; Guo, HF; Cheung, IY; Cheung, NKV				Zhao, Qi; Ahmed, Mahiuddin; Guo, Hong-fen; Cheung, Irene Y.; Cheung, Nai-Kong V.			Alteration of Electrostatic Surface Potential Enhances Affinity and Tumor Killing Properties of Anti-ganglioside GD2 Monoclonal Antibody hu3F8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; CANCER-IMMUNOTHERAPY; NEUROBLASTOMA; MATURATION; DISPLAY; GANGLIOSIDES; GLYCOLIPIDS; SPECIFICITY; THERAPY; TARGETS	Ganglioside GD2 is highly expressed on neuroectodermal tumors and an attractive therapeutic target for antibodies that have already shown some clinical efficacy. To further improve the current antibodies, which have modest affinity, we sought to improve affinity by using a combined method of random mutagenesis and in silico assisted design to affinity-mature the anti-GD2 monoclonal antibody hu3F8. Using yeast display, mutants in the Fv with enhanced binding over the parental clone were FACS-sorted and cloned. In silico modeling identified the minimal key interacting residues involved in the important charged interactions with the sialic acid groups of GD2. Two mutations, D32H (L-CDR1) and E1K (L-FR1) altered the electrostatic surface potential of the antigen binding site, allowing for an increase in positive charge to enhance the interaction with the negatively charged GD2-pentasaccharide headgroup. Purified scFv and IgG mutant forms were then tested for antigen specificity by ELISA, for tissue specificity by immunohistochemistry, for affinity by BIACORE, for antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-mediated cytotoxicity in vitro, and for anti-tumor efficacy in xenografted humanized mice. The nearly 7-fold improvement in affinity of hu3F8 with a single D32H (L-CDR1) mutation translated into a similar to 12-fold improvement in NK92MI-transfected CD16-mediated ADCC, a 6-fold improvement in CD32-mediated ADCC, and a 2.5-fold improvement in complement-mediated cytotoxicity while maintaining restricted normal tissue cross-reactivity and achieving substantial improvement in tumor ablation in vivo. Despite increasing GD2 affinity, the double mutation D32H (L-CDR1) and E1K (L-FR1) did not further improve antitumor efficacy.	[Zhao, Qi; Ahmed, Mahiuddin; Guo, Hong-fen; Cheung, Irene Y.; Cheung, Nai-Kong V.] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Cheung, NKV (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10065 USA.	cheungn@mskcc.org		Zhao, Qi/0000-0002-5969-6407	National Institutes of Health Cancer Center Core Support Grant [P30 CA008748-48]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health Cancer Center Core Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr. Mamoru Ito (Central Institute for Experimental Animals, Kawasaki, Japan) for providing the DKO mice and the MSK Small-Animal Imaging Core Facility and Molecular Cytology Core Facility for providing technical services. Technical services provided by the MSK Small-Animal Imaging Core Facility and Molecular Cytology Core Facility were supported in part by National Institutes of Health Cancer Center Core Support Grant P30 CA008748-48. We thank the Consortium for Functional Genomics, Emory University (Atlanta, GA), and Dr. Steven Robert of the Scripps Research Institute (La Jolla, CA) for providing biotin-GD2. We thank Yi Feng and Hoa Tran for excellent technical support and Drs. Ming Cheng and Hong Xu for reviewing the manuscript.	Ahmed M, 2014, FEBS LETT, V588, P288, DOI 10.1016/j.febslet.2013.11.030; Ahmed M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063359; Barderas R, 2008, P NATL ACAD SCI USA, V105, P9029, DOI 10.1073/pnas.0801221105; Boder ET, 2012, ARCH BIOCHEM BIOPHYS, V526, P99, DOI 10.1016/j.abb.2012.03.009; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chester MA, 1998, EUR J BIOCHEM, V257, P293; Cheung IY, 2012, J CLIN ONCOL, V30, P426, DOI 10.1200/JCO.2011.37.6236; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Cheung NKV, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19864; Cheung NKV, 2012, J CLIN ONCOL, V30, P3264, DOI 10.1200/JCO.2011.41.3807; CHEUNG NKV, 1987, J CLIN ONCOL, V5, P1430, DOI 10.1200/JCO.1987.5.9.1430; Durrant LG, 2012, CLIN EXP IMMUNOL, V167, P206, DOI 10.1111/j.1365-2249.2011.04516.x; FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370; Fredman P, 2003, BIODRUGS, V17, P155, DOI 10.2165/00063030-200317030-00002; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Heimburg-Molinaro Jamie, 2009, V534, P341, DOI 10.1007/978-1-59745-022-5_24; Hu J, 2009, J IMMUNOL, V183, P5748, DOI 10.4049/jimmunol.0901409; Inoue H, 2013, J BIOCHEM, V154, P325, DOI 10.1093/jb/mvt058; Kushner BH, 2001, J CLIN ONCOL, V19, P4189, DOI 10.1200/JCO.2001.19.22.4189; Leyland-Jones B, 2001, ANTI-CANCER DRUG, V12, pS11, DOI 10.1097/00001813-200112004-00003; Magnani John L, 2009, Discov Med, V8, P247; Nakanishi T, 2013, PROTEIN ENG DES SEL, V26, P113, DOI 10.1093/protein/gzs088; Navid F, 2010, CURR CANCER DRUG TAR, V10, P200, DOI 10.2174/156800910791054167; Shusterman S, 2010, J CLIN ONCOL, V28, P4969, DOI 10.1200/JCO.2009.27.8861; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Thomas R, 2002, J BIOL CHEM, V277, P2059, DOI 10.1074/jbc.M104364200; Valjakka J, 2002, J BIOL CHEM, V277, P44021, DOI 10.1074/jbc.M208392200; Votsmeier C, 2012, MABS-AUSTIN, V4, P341, DOI 10.4161/mabs.19981; Wang LL, 2014, GLYCOBIOLOGY, V24, P507, DOI 10.1093/glycob/cwu019; Wang Y, 2011, J BIOL CHEM, V286, P44218, DOI 10.1074/jbc.M111.290783; Wittrup KD, 2012, METHOD ENZYMOL, V503, P255, DOI 10.1016/B978-0-12-396962-0.00010-0; Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537; Zhao Qi, 2012, Methods Mol Biol, V899, P73, DOI 10.1007/978-1-61779-921-1_5; Zhao Q, 2011, MOL CANCER THER, V10, P1677, DOI 10.1158/1535-7163.MCT-11-0281; Zhao Q, 2009, PROTEIN EXPRES PURIF, V68, P190, DOI 10.1016/j.pep.2009.08.004	36	22	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13017	13027		10.1074/jbc.M115.650903	http://dx.doi.org/10.1074/jbc.M115.650903			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851904	hybrid, Green Published			2022-12-26	WOS:000354975700004
J	Dong, J; Zhang, Y; Chen, YT; Niu, XD; Zhang, Y; Li, R; Yang, C; Wang, Q; Li, XM; Deng, XM				Dong, Jing; Zhang, Yong; Chen, Yutao; Niu, Xiaodi; Zhang, Yu; Li, Rui; Yang, Cheng; Wang, Quan; Li, Xuemei; Deng, Xuming			Baicalin Inhibits the Lethality of Ricin in Mice by Inducing Protein Oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOME-INACTIVATING PROTEINS; SMALL-MOLECULE INHIBITORS; SHIGA TOXIN; ENDOPLASMIC-RETICULUM; RETROGRADE TRANSPORT; BIOLOGICAL-ACTIVITY; ALPHA-HEMOLYSIN; ANTIBODIES; CELLS; IDENTIFICATION	Toxic ribosome-inactivating proteins abolish cell viability by inhibiting protein synthesis. Ricin, a member of these lethal proteins, is a potential bioterrorism agent. Despite the grave challenge posed by these toxins to public health, post-exposure treatment for intoxication caused by these agents currently is unavailable. In this study, we report the identification of baicalin extracted from Chinese herbal medicine as a compound capable of inhibiting the activity of ricin. More importantly, post-exposure treatment with baicalin significantly increased the survival of mice poisoned by ricin. We determined the mechanism of action of baicalin by solving the crystal structure of its complex with the A chain of ricin (RTA) at 2.2 angstrom resolution, which revealed that baicalin interacts with two RTA molecules at a novel binding site by hydrogen bond networks and electrostatic force interactions, suggesting its role as molecular glue of the RTA. Further biochemical and biophysical analyses validated the amino acids directly involved in binding the inhibitor, which is consistent with the hypothesis that baicalin exerts its inhibitory effects by inducing RTA to form oligomers in solution, a mechanism that is distinctly different from previously reported inhibitors. This work offers promising leads for the development of therapeutics against ricin and probably other ribosome-inactivating proteins.	[Dong, Jing; Zhang, Yong; Zhang, Yu; Li, Rui; Deng, Xuming] Jilin Univ, Coll Vet Med, Inst Zoonosis, Key Lab Zoonosis,Minist Educ, Changchun 130062, Peoples R China; [Dong, Jing] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Wuhan 430223, Peoples R China; [Chen, Yutao; Wang, Quan; Li, Xuemei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Niu, Xiaodi] Jilin Univ, Dept Food Qual & Safety, Changchun 130062, Peoples R China; [Yang, Cheng] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Jilin University; Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Jilin University; Nankai University	Li, XM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China.	lixm@sun5.ibp.ac.cn; dengxm@jlu.edu.cn	dong, jing/ABE-3368-2021	dong, jing/0000-0002-4589-1471	National Basic Research Program of China [2013CB127205]; National Nature Science Foundation of China [31130053]; National 863 Program of China [2012AA020303]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K22AA020303] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Program of China(National High Technology Research and Development Program of China); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Basic Research Program of China Grant 2013CB127205 (to X. M. D.), National Nature Science Foundation of China Grant 31130053 (to X. M. D.), and National 863 Program of China Grant 2012AA020303 (to X. M. D.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bitzan M, 2009, ANTIMICROB AGENTS CH, V53, P3081, DOI 10.1128/AAC.01661-08; Dowling TC, 2005, ANTIMICROB AGENTS CH, V49, P1808, DOI 10.1128/AAC.49.5.1808-1812.2005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENDO Y, 1988, J BIOL CHEM, V263, P7917; Food and Drug Administration, 2005, GUID FOR IND, P25; Hale ML, 2001, PHARMACOL TOXICOL, V88, P255, DOI 10.1034/j.1600-0773.2001.d01-113.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Mantis NJ, 2006, INFECT IMMUN, V74, P3455, DOI 10.1128/IAI.02088-05; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller DJ, 2002, J MED CHEM, V45, P90, DOI 10.1021/jm010186s; MLSNA D, 1993, PROTEIN SCI, V2, P429; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neal LM, 2010, INFECT IMMUN, V78, P552, DOI 10.1128/IAI.00796-09; NICOLSON GL, 1972, BIOCHIM BIOPHYS ACTA, V266, P543, DOI 10.1016/0005-2736(72)90109-5; Niu XD, 2013, EUR J MED CHEM, V62, P320, DOI 10.1016/j.ejmech.2013.01.008; O'Hara JM, 2012, CURR TOP MICROBIOL, V357, P209, DOI 10.1007/82_2011_193; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pruet JM, 2011, EUR J MED CHEM, V46, P3608, DOI 10.1016/j.ejmech.2011.05.025; Qiu JZ, 2012, J INFECT DIS, V206, P292, DOI 10.1093/infdis/jis336; Rapak A, 1997, P NATL ACAD SCI USA, V94, P3783, DOI 10.1073/pnas.94.8.3783; Rasooly R, 2012, J BIOL CHEM, V287, P27924, DOI 10.1074/jbc.M112.362988; Roche JK, 2008, LAB INVEST, V88, P1178, DOI 10.1038/labinvest.2008.83; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Smith MJ, 2009, INFECT IMMUN, V77, P2730, DOI 10.1128/IAI.00005-09; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Takahashi H, 2011, BBA-MOL CELL RES, V1813, P1465, DOI 10.1016/j.bbamcr.2011.05.003; Tzipori S, 2004, CLIN MICROBIOL REV, V17, P926, DOI 10.1128/CMR.17.4.926-941.2004; Vance DJ, 2013, J BIOL CHEM, V288, P36538, DOI 10.1074/jbc.M113.519207; Wahome PG, 2012, CURR TOP MICROBIOL, V357, P179, DOI 10.1007/82_2011_177; Wahome PG, 2010, TOXICON, V56, P313, DOI 10.1016/j.toxicon.2010.03.016; Zhang J, 1999, ACTA BIOCH BIOPH SIN, V31, P472; Zhang X., 2006, J MED RES, V7, P16; Zhu YW, 2013, J BIOL CHEM, V288, P28311, DOI 10.1074/jbc.A113.480830	36	8	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12899	12907		10.1074/jbc.M114.632828	http://dx.doi.org/10.1074/jbc.M114.632828			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847243	Green Published, hybrid			2022-12-26	WOS:000354569000039
J	Kawahara, T; Imawatari, R; Kawahara, C; Inazu, T; Suzuki, G				Kawahara, Tetsuya; Imawatari, Ryuichiro; Kawahara, Chie; Inazu, Tetsuya; Suzuki, Gen			Incidence of Type 2 Diabetes in Pre-Diabetic Japanese Individuals Categorized by HbA(1c) Levels: A Historical Cohort Study	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; MIDDLE-AGED JAPANESE; HEMOGLOBIN A1C; RISK-FACTORS; MELLITUS; WOMEN; US; METAANALYSIS; POPULATION; PREVENTION	Objective Reported incidence of type 2 diabetes estimated at the pre-diabetic stage differs widely (2.3-18.1% per year). Because clinicians need to know the risk of incident diabetes after a diagnosis of pre-diabetes, our objective was to estimate precise incidence of diabetes using baseline HbA(1c) levels. Methods A historical cohort study using electronic medical record data obtained between January 2008 and December 2013. A total of 52,781 individuals with HbA(1c) < 6.5% were assigned to one of six groups categorized by baseline HbA(1c) level: <= 5.5% (n=34,616), 5.6-5.7% (n=9,388), 5.8-5.9% (n= 4,664), 6.0-6.1% (n=2,338), 6.2-6.3% (n=1,257), and 6.4% (n=518). Participants were tracked until a subsequent diagnosis of diabetes or end of follow-up during a period of 5 years. Results During the follow-up period (mean 3.7 years), 4,369 participants developed diabetes. The incidence of diabetes in the first year was 0.7, 1.5, 2.9, 9.2, 30.4, and 44.0% in the six HbA(1c) groups, respectively. At five years the incidence was 3.6, 8.9, 13.8, 27.5, 51.6, and 67.8%, respectively (p < 0.0001 comparing the HbA(1c) <= 5.5% group to the other groups). After adjustment for confounding factors, the hazard ratios compared with the HbA(1c) <= 5.5% group were significantly elevated: 2.3 (95% CI 2.0-2.5), 3.4 (95% CI 2.9-3.7), 8.8 (95% CI 8.0-10.1), 26.3 (95% CI 23.3-30.1), and 48.7 (95% CI 40.8-58.1) in the five HbA(1c) groups (p < 0.0001). Conclusion By fractionating baseline HbA(1c) levels into narrower HbA(1c) range groups, accuracy of estimating the incidence of type 2 diabetes in subsequent years was increased. The risk of developing diabetes increased with increasing HbA(1c) levels, especially with the HbA(1c) level >= 6.2% in the first follow-up year.	[Kawahara, Tetsuya; Imawatari, Ryuichiro] Kokura Med Assoc, Hlth Testing Ctr, Kitakyushu, Fukuoka, Japan; [Imawatari, Ryuichiro] Kitakyushu Med Assoc Comm Hlth Promot, Kitakyushu, Fukuoka, Japan; [Imawatari, Ryuichiro] Kokura Med Assoc, Kitakyushu, Fukuoka, Japan; [Kawahara, Chie] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Kitakyushu, Fukuoka 807, Japan; [Inazu, Tetsuya] Ritsumeikan Univ, Dept Pharm, Shiga, Japan; [Suzuki, Gen] Int Univ Hlth & Welf Clin, Dept Internal Med, Otawara, Tochigi, Japan	University of Occupational & Environmental Health - Japan; Ritsumeikan University; International University of Health & Welfare	Kawahara, T (corresponding author), Kokura Med Assoc, Hlth Testing Ctr, Kitakyushu, Fukuoka, Japan.	k-tetsuy@med.uoeh-u.ac.jp		Kawahara, Tetsuya/0000-0002-1268-4871				Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; American Diabetes A Economic costs of diabetes in the U.S, 2008, DIABETES CARE, V31, P596, DOI [10.2337/dc08-9017, DOI 10.2337/DC08-9017]; [Anonymous], 2008, HLTH SCREEN NINGEN D, V22, P874; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Bi YF, 2012, DIABETES-METAB RES, V28, P32, DOI 10.1002/dmrr.2352; Cheng PY, 2011, DIABETES CARE, V34, P610, DOI 10.2337/dc10-0625; Divajeva D, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-456; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Edelman D, 2004, J GEN INTERN MED, V19, P1175, DOI 10.1111/j.1525-1497.2004.40178.x; Goto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074699; HELMRICH SP, 1991, NEW ENGL J MED, V325, P147, DOI 10.1056/NEJM199107183250302; Herman WH, 2011, MED CLIN N AM, V95, P373, DOI 10.1016/j.mcna.2010.11.010; InternationalDiabetesFederation, 2013, DIAB ATL, P155; Kankeu HT, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-31; Kashiwagi A, 2012, J DIABETES INVEST, V3, P39, DOI 10.1111/j.2040-1124.2012.00207.x; Liu XQ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-729; Ministry of Education C Sports Science and Technology Ministry of Health Labour and Welfare, 2002, ETH GUID EP RES; Nakanishi N, 2004, DIABETOLOGIA, V47, P1768, DOI 10.1007/s00125-004-1528-y; Narayan KMV, 2007, DIABETES CARE, V30, P1562, DOI 10.2337/dc06-2544; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Pradhan AD, 2007, AM J MED, V120, P720, DOI 10.1016/j.amjmed.2007.03.022; Rana JS, 2007, DIABETES CARE, V30, P53, DOI 10.2337/dc06-1456; Sato KK, 2009, DIABETES CARE, V32, P644, DOI 10.2337/dc08-1631; Seino Y, 2010, J DIABETES INVEST, V1, P1, DOI 10.1111/j.2040-1124.2010.00005.x; Shi L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077919; Shimazaki T, 2007, TRANSL RES, V149, P196, DOI 10.1016/j.trsl.2006.09.008; Toshihiro M, 2008, DIABETIC MED, V25, P1211, DOI 10.1111/j.1464-5491.2008.02566.x; Upadhyay RP, 2013, DIABETES RES CLIN PR, V102, P1, DOI 10.1016/j.diabres.2013.06.011; van't Riet E, 2010, DIABETES CARE, V33, P763, DOI 10.2337/dc09-1586; Waki K, 2005, DIABETIC MED, V22, P323, DOI 10.1111/j.1464-5491.2004.01403.x; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122698	10.1371/journal.pone.0122698	http://dx.doi.org/10.1371/journal.pone.0122698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853519	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400078
J	Vangipurapu, J; Stancakova, A; Kuulasmaa, T; Kuusisto, J; Laakso, M				Vangipurapu, Jagadish; Stancakova, Alena; Kuulasmaa, Teemu; Kuusisto, Johanna; Laakso, Markku			Both Fasting and Glucose-Stimulated Proinsulin Levels Predict Hyperglycemia and Incident Type 2 Diabetes: A Population-Based Study of 9,396 Finnish Men	PLOS ONE			English	Article							ACUTE INSULIN-RESPONSE; DISPROPORTIONATELY ELEVATED PROINSULIN; BETA-CELL DYSFUNCTION; INDEPENDENTLY PREDICT; HYPERPROINSULINEMIA; RESISTANCE; TOLERANCE; MELLITUS; SENSITIVITY; SECRETION	Background Hyperproinsulinemia is an indicator of beta-cell dysfunction, and fasting proinsulin levels are elevated in patients with hyperglycemia. It is not known whether proinsulin levels after a glucose load are better predictors of hyperglycemia and type 2 diabetes than fasting proinsulin. Methods Participants were 9,396 Finnish men (mean +/- SD, age 57.3 +/- 7.1 years, BMI 27.0 +/- 4.0 kg/ m(2)) of the population-based METabolic Syndrome In Men Study who were non-diabetic at the recruitment, and who participated in a 6-year follow-up study. Proinsulin and insulin levels were measured in the fasting state and 30 and 120 min after an oral glucose load. Area under the curve (AUC) and proinsulin to insulin ratios were calculated. Results Fasting proinsulin, proinsulin at 30 min and proinsulin AUC during the first 30 min of an oral glucose tolerance test significantly predicted both the worsening of hyperglycemia and type 2 diabetes after adjustment for confounding factors. Further adjustment for insulin sensitivity (Matsuda index) or insulin secretion (Disposition index) weakened these associations. Insulin sensitivity had a major impact on these associations. Conclusion Our results suggest that proinsulin in the fasting state and after an oral glucose load similarly predict the worsening of hyperglycemia and conversion to type 2 diabetes.	[Vangipurapu, Jagadish; Stancakova, Alena; Kuulasmaa, Teemu; Kuusisto, Johanna; Laakso, Markku] Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Internal Med, Kuopio, Finland; [Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Laakso, M (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Inst Clin Med, Internal Med, Kuopio, Finland.	markku.laakso@kuh.fi	Stancakova, Alena/AAN-6723-2020	Stancakova, Alena/0000-0002-1375-0252	Academy of Finland; Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; EVO Grant from the Kuopio University Hospital [5263]	Academy of Finland(Academy of Finland); Finnish Diabetes Research Foundation; Finnish Cardiovascular Research Foundation; University of eastern Finland, Kuopio, Finland; EVO Grant from the Kuopio University Hospital	This work has been supported by the grants from the Academy of Finland, the Finnish Diabetes Research Foundation, the Finnish Cardiovascular Research Foundation, the Strategic Research Funding from the University of eastern Finland, Kuopio, Finland, and EVO Grant 5263 from the Kuopio University Hospital to ML. The funding bodies named above had no role in the design and conduct of the study; collection management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	ALARCON C, 1995, J CLIN INVEST, V95, P1032, DOI 10.1172/JCI117748; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; BIRKELAND KI, 1994, DIABETES CARE, V17, P1307, DOI 10.2337/diacare.17.11.1307; Breuer TGK, 2010, EUR J ENDOCRINOL, V163, P551, DOI 10.1530/EJE-10-0330; Festa A, 2008, DIABETES, V57, P1638, DOI 10.2337/db07-0954; Grill V, 2002, AM J EPIDEMIOL, V155, P834, DOI 10.1093/aje/155.9.834; HAFFNER SM, 1994, DIABETES, V43, P1490, DOI 10.2337/diabetes.43.12.1490; Hanley AJG, 2002, DIABETES, V51, P1263, DOI 10.2337/diabetes.51.4.1263; Huyghe JR, 2013, NAT GENET, V45, P197, DOI 10.1038/ng.2507; Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725; Kahn SE, 1996, DIABETIC MED, V13, pS63; Larsson H, 1999, J CLIN ENDOCR METAB, V84, P2068, DOI 10.1210/jc.84.6.2068; LEAHY JL, 1992, DIABETES CARE, V15, P442, DOI 10.2337/diacare.15.3.442; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Loopstra-Masters RC, 2011, DIABETOLOGIA, V54, P3047, DOI 10.1007/s00125-011-2322-2; Lorenzo C, 2014, ACTA DIABETOL, V51, P617, DOI 10.1007/s00592-014-0565-3; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Mykkanen L, 1997, DIABETES, V46, P1990, DOI 10.2337/diabetes.46.12.1990; MYKKANEN L, 1995, DIABETOLOGIA, V38, P1176, DOI 10.1007/BF00422366; Ozawa S, 2014, ENDOCR J, V61, P607, DOI 10.1507/endocrj.EJ13-0506; Pfutzner A, 2004, DIABETES CARE, V27, P682, DOI 10.2337/diacare.27.3.682; Pradhan AD, 2003, AM J MED, V114, P438, DOI 10.1016/S0002-9343(03)00061-5; RHODES CJ, 1994, DIABETES, V43, P511, DOI 10.2337/diabetes.43.4.511; Roder ME, 1998, J CLIN ENDOCR METAB, V83, P604, DOI 10.1210/jc.83.2.604; SAAD MF, 1990, J CLIN ENDOCR METAB, V70, P1247, DOI 10.1210/jcem-70-5-1247; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Stancakova A, 2009, DIABETES, V58, P1212, DOI 10.2337/db08-1607; Stumvoll M, 2001, J CLIN ENDOCR METAB, V86, P1235, DOI 10.1210/jc.86.3.1235; Vauhkonen IKJ, 2000, EUR J ENDOCRINOL, V143, P251, DOI 10.1530/eje.0.1430251; WARD WK, 1987, DIABETOLOGIA, V30, P698, DOI 10.1007/BF00296991; Wareham NJ, 1999, DIABETES CARE, V22, P262, DOI 10.2337/diacare.22.2.262; Weiss R, 2005, DIABETES, V54, P1735, DOI 10.2337/diabetes.54.6.1735; Zethelius B, 2004, DIABETES CARE, V27, P1433, DOI 10.2337/diacare.27.6.1433; Zethelius B, 2003, DIABETOLOGIA, V46, P20, DOI 10.1007/s00125-002-0995-2	35	35	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124028	10.1371/journal.pone.0124028	http://dx.doi.org/10.1371/journal.pone.0124028			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853252	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400130
J	Bianchi, N; Finotti, A; Ferracin, M; Lampronti, I; Zuccato, C; Breveglieri, G; Brognara, E; Fabbri, E; Borgatti, M; Negrini, M; Gambari, R				Bianchi, Nicoletta; Finotti, Alessia; Ferracin, Manuela; Lampronti, Ilaria; Zuccato, Cristina; Breveglieri, Giulia; Brognara, Eleonora; Fabbri, Enrica; Borgatti, Monica; Negrini, Massimo; Gambari, Roberto			Increase of microRNA-210, Decrease of Raptor Gene Expression and Alteration of Mammalian Target of Rapamycin Regulated Proteins following Mithramycin Treatment of Human Erythroid Cells	PLOS ONE			English	Article							GLOBIN MESSENGER-RNA; IN-VIVO; INDUCED INHIBITION; BETA-GLOBIN; S6 KINASE; DIFFERENTIATION; HYPOXIA; TRANSLATION; MIR-210; MTOR	Expression and regulation of microRNAs is an emerging issue in erythroid differentiation and globin gene expression in hemoglobin disorders. In the first part of this study microarray analysis was performed both in mithramycin-induced K562 cells and erythroid precursors from healthy subjects or beta-thalassemia patients producing low or high levels of fetal hemoglobin. We demonstrated that: (a) microRNA-210 expression is higher in erythroid precursors from beta-thalassemia patients with high production of fetal hemoglobin; (b) microRNA-210 increases as a consequence of mithramycin treatment of K562 cells and human erythroid progenitors both from healthy and beta-thalassemia subjects; (c) this increase is associated with erythroid induction and elevated expression of gamma-globin genes; (d) an anti-microRNA against microRNA-210 interferes with the mithramycin-induced changes of gene expression. In the second part of the study we have obtained convergent evidences suggesting raptor mRNA as a putative target of microRNA-210. Indeed, microRNA-210 binding sites of its 3'-UTR region were involved in expression and are targets of microRNA-210-mediated modulation in a luciferase reporter assays. Furthermore, (i) raptor mRNA and protein are down-regulated upon mithramycin-induction both in K562 cells and erythroid progenitors from healthy and beta-thalassemia subjects. In addition, (ii) administration of antimicroRNA-210 to K562 cells decreased endogenous microRNA-210 and increased raptor mRNA and protein expression. Finally, (iii) treatment of K562 cells with premicroRNA-210 led to a decrease of raptor mRNA and protein. In conclusion, microRNA-210 and raptor are involved in mithramycin-mediated erythroid differentiation of K562 cells and participate to the fine-tuning and control of gamma-globin gene expression in erythroid precursor cells.	[Bianchi, Nicoletta; Finotti, Alessia; Lampronti, Ilaria; Zuccato, Cristina; Breveglieri, Giulia; Brognara, Eleonora; Fabbri, Enrica; Borgatti, Monica; Gambari, Roberto] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy; [Finotti, Alessia; Gambari, Roberto] Univ Ferrara, Ctr Biotechnol, Lab Dev Pharmacol & Pharmacogen Therapy Thalassae, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Ferracin, Manuela; Negrini, Massimo] Univ Ferrara, Lab Technol Adv Therapies, I-44100 Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Gambari, R (corresponding author), Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy.	gam@unife.it	Zuccato, Cristina/L-2919-2015; Breveglieri, Giulia/C-5806-2016; Gambari, Roberto/F-9555-2015; Finotti, Alessia/C-6268-2012; Ferracin, Manuela/K-2097-2016; Bianchi, Nicoletta/H-1902-2015; Borgatti, Monica/G-2611-2015; Negrini, Massimo/J-2377-2016; Fabbri, Enrica/O-8059-2015; Lampronti, Ilaria/F-5522-2016	Zuccato, Cristina/0000-0002-1380-0539; Breveglieri, Giulia/0000-0002-9013-1738; Gambari, Roberto/0000-0001-9205-6033; Finotti, Alessia/0000-0002-7638-515X; Ferracin, Manuela/0000-0002-1595-6887; Bianchi, Nicoletta/0000-0001-9280-6017; Borgatti, Monica/0000-0001-8470-2496; Negrini, Massimo/0000-0002-0007-1920; Fabbri, Enrica/0000-0002-9836-8262; Brognara, Eleonora/0000-0002-7845-5895; Lampronti, Ilaria/0000-0002-1972-7766	FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo); CIB (ConsorzioInteruniversitarioBiotecnologie); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia) [306201-FP7-HEALTH-2012-INNOVATION- 1]; Telethon [GGP10124]; COFIN; Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo; Associazione per la Lotta alla Talassemia (ALT) Ferrara; AIRC	FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo)(Fondazione Cariparo); CIB (ConsorzioInteruniversitarioBiotecnologie); UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia); Telethon(Fondazione Telethon); COFIN; Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo; Associazione per la Lotta alla Talassemia (ALT) Ferrara; AIRC(Fondazione AIRC per la ricerca sul cancro)	Roberto Gambari is granted by FondazioneCariparo (Cassa di Risparmio di Padova e Rovigo), by CIB (ConsorzioInteruniversitarioBiotecnologie), by UE THALAMOSS Project (Thalassemia Modular Stratification System for Personalized Therapy of Beta-Thalassemia; n.306201-FP7-HEALTH-2012-INNOVATION- 1), by Telethon (contract GGP10124) and by COFIN-2010. This research is also supported by Associazione Veneta per la Lotta alla Talassemia (AVLT) Rovigo, by Associazione per la Lotta alla Talassemia (ALT) Ferrara and by AIRC-2012.	Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; Bianchi N, 2001, BRIT J HAEMATOL, V113, P951, DOI 10.1046/j.1365-2141.2001.02843.x; Bianchi N, 1999, BRIT J HAEMATOL, V104, P258, DOI 10.1046/j.1365-2141.1999.01173.x; Bianchi N, 2009, BMB REP, V42, P493, DOI 10.5483/BMBRep.2009.42.8.493; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruchova H, 2007, EXP HEMATOL, V35, P1657, DOI 10.1016/j.exphem.2007.08.021; Camps C, 2008, CLIN CANCER RES, V14, P1340, DOI 10.1158/1078-0432.CCR-07-1755; Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Choong ML, 2007, EXP HEMATOL, V35, P551, DOI 10.1016/j.exphem.2006.12.002; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; Corn PG, 2008, CANCER BIOL THER, V7, P265, DOI 10.4161/cbt.7.2.5745; Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154; Daisy Narayan A, 2005, BRIT J HAEMATOL, V128, P562, DOI 10.1111/j.1365-2141.2004.05336.x; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Du TT, 2009, BIOCHEM BIOPH RES CO, V381, P688, DOI 10.1016/j.bbrc.2009.02.122; Dudkin L, 2001, CLIN CANCER RES, V7, P1758; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fasanaro P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044651; Fasanaro P, 2009, J BIOL CHEM, V284, P35134, DOI 10.1074/jbc.M109.052779; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Felli N, 2009, HAEMATOL-HEMATOL J, V94, P479, DOI 10.3324/haematol.2008.002345; Feriotto G, 2008, ACTA HAEMATOL-BASEL, V119, P28, DOI 10.1159/000114204; FIBACH E, 1989, BLOOD, V73, P100; Fibach E, 2003, BLOOD, V102, P1276, DOI 10.1182/blood-2002-10-3096; Fibach E, 2006, EUR J HAEMATOL, V77, P437, DOI 10.1111/j.1600-0609.2006.00731.x; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Gambari R, 2007, CURR MED CHEM, V14, P199, DOI 10.2174/092986707779313318; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Goyal BR, 2009, FUND CLIN PHARMACOL, V23, P367, DOI 10.1111/j.1472-8206.2009.00694.x; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; He J, 2013, NUCLEIC ACIDS RES, V41, P498, DOI 10.1093/nar/gks995; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019; Ivan M, 2008, J CELL MOL MED, V12, P1426, DOI 10.1111/j.1582-4934.2008.00398.x; Kawasome H, 1998, P NATL ACAD SCI USA, V95, P5033, DOI 10.1073/pnas.95.9.5033; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387; Kosaka N, 2008, BRIT J HAEMATOL, V142, P293, DOI 10.1111/j.1365-2141.2008.07151.x; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Krutzfeldt J, 2007, NUCLEIC ACIDS RES, V35, P2885, DOI 10.1093/nar/gkm024; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; LANE HA, 1993, NATURE, V363, P170, DOI 10.1038/363170a0; Lawrence JC, 1997, TRENDS BIOCHEM SCI, V22, P345, DOI 10.1016/S0968-0004(97)01101-8; Lawrie CH, 2007, BRIT J HAEMATOL, V137, P503, DOI 10.1111/j.1365-2141.2007.06611.x; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin CJ, 2009, MOL CANCER THER, V8, P1606, DOI 10.1158/1535-7163.MCT-08-1152; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Masaki S, 2007, BIOCHEM BIOPH RES CO, V364, P509, DOI 10.1016/j.bbrc.2007.10.077; Meister G, 2004, RNA, V10, P544, DOI 10.1261/rna.5235104; Mischiati C, 2004, BRIT J HAEMATOL, V126, P612, DOI 10.1111/j.1365-2141.2004.05083.x; Nakada C, 2011, J PATHOL, V224, P280, DOI 10.1002/path.2860; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Noman MZ, 2012, CANCER RES, V72, P4929; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; PRICE DJ, 1992, SCIENCE, V257, P973, DOI 10.1126/science.1380182; Pulkkinen K, 2008, FEBS LETT, V582, P2397, DOI 10.1016/j.febslet.2008.05.048; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Rogers HM, 2008, EXP HEMATOL, V36, P17, DOI 10.1016/j.exphem.2007.08.014; Sarakul O, 2013, BLOOD CELL MOL DIS, V51, P98, DOI 10.1016/j.bcmd.2013.03.005; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Song B, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-29; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Spinello I, 2009, ONCOGENE, V28, P2276, DOI 10.1038/onc.2009.87; Sun K, 2011, ACTA PHARMACOL SIN, V32, P375, DOI 10.1038/aps.2010.206; Thomas G, 1997, CURR OPIN CELL BIOL, V9, P782, DOI 10.1016/S0955-0674(97)80078-6; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Wang Q, 2008, BLOOD, V111, P588, DOI 10.1182/blood-2007-05-092718; Wilton SD, 2005, CURR GENE THER, V5, P467, DOI 10.2174/156652305774329249; Yan LX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2803; Yang GH, 2009, J CELL BIOCHEM, V107, P548, DOI 10.1002/jcb.22156; Yu J, 2006, BIOCHEM BIOPH RES CO, V349, P59, DOI 10.1016/j.bbrc.2006.07.207	79	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121567	10.1371/journal.pone.0121567	http://dx.doi.org/10.1371/journal.pone.0121567			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849663	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800066
J	Chadwick, AC; Holme, RL; Chen, YL; Thomas, MJ; Sorci-Thomas, MG; Silverstein, RL; Pritchard, KA; Sahoo, D				Chadwick, Alexandra C.; Holme, Rebecca L.; Chen, Yiliang; Thomas, Michael J.; Sorci-Thomas, Mary G.; Silverstein, Roy L.; Pritchard, Kirkwood A., Jr.; Sahoo, Daisy			Acrolein Impairs the Cholesterol Transport Functions of High Density Lipoproteins	PLOS ONE			English	Article							RECEPTOR CLASS-B; APOLIPOPROTEIN-A-I; SCAVENGER RECEPTOR; SR-BI; OXIDATIVE STRESS; APOA-I; SELECTIVE UPTAKE; HEART-DISEASE; HDL; PLASMA	High density lipoproteins (HDL) are considered athero-protective, primarily due to their role in reverse cholesterol transport, where they transport cholesterol from peripheral tissues to the liver for excretion. The current study was designed to determine the impact of HDL modification by acrolein, a highly reactive aldehyde found in high abundance in cigarette smoke, on the cholesterol transport functions of HDL. HDL was chemically-modified with acrolein and immunoblot and mass spectrometry analyses confirmed apolipoprotein crosslinking, as well as acrolein adducts on apolipoproteins A-I and A-II. The ability of acrolein-modified HDL (acro-HDL) to serve as an acceptor of free cholesterol (FC) from COS-7 cells transiently expressing SR-BI was significantly decreased. Further, in contrast to native HDL, acroHDL promotes higher neutral lipid accumulation in murine macrophages as judged by Oil Red O staining. The ability of acro-HDL to mediate efficient selective uptake of HDL-cholesteryl esters (CE) into SR-BI-expressing cells was reduced compared to native HDL. Together, the findings from our studies suggest that acrolein modification of HDL produces a dysfunctional particle that may ultimately promote atherogenesis by impairing functions that are critical in the reverse cholesterol transport pathway.	[Silverstein, Roy L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Chadwick, Alexandra C.; Holme, Rebecca L.; Sahoo, Daisy] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Chen, Yiliang; Silverstein, Roy L.] Blood Ctr Wisconsin, Blood Res Inst, Milwaukee, WI USA; [Thomas, Michael J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27103 USA; [Sorci-Thomas, Mary G.] Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol, Winston Salem, NC 27103 USA; [Pritchard, Kirkwood A., Jr.] Childrens Res Inst, Dept Surg, Milwaukee, WI USA; [Sahoo, Daisy] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Versiti Blood Center of Wisconsin; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Medical College of Wisconsin	Sahoo, D (corresponding author), Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA.	dsahoo@mcw.edu		Sorci-Thomas, Mary/0000-0002-6464-5006; Chen, Yiliang/0000-0001-9786-8305	National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI) [R01HL58012, R01HL112270, R01HL112276, PO1HL087018, R01HL111614]; American Heart Association (AHA) Predoctoral Fellowship [AHA14PRE185800221]; AHA Postdoctoral Fellowship [AHA13POST14800034]; NIH Shared Instrumentation [1S10RR17846]; North Carolina Biotechnology [2007-IDG-1021]; National Cancer Institute center grant [5P30CA12197]; NATIONAL CANCER INSTITUTE [P30CA012197] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017846] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112270, P01HL087018, R01HL127649, R01HL111614, R01HL112276, R01HL058012] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association (AHA) Predoctoral Fellowship(American Heart Association); AHA Postdoctoral Fellowship(American Heart Association); NIH Shared Instrumentation(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology; National Cancer Institute center grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Institutes of Health, National Heart, Lung and Blood Institute (NIH/NHLBI) (R01HL58012 to D. S., R01HL112270 to K.A.P., R01HL112276 to M.G.T., and PO1HL087018 and R01HL111614 to R.L.S.), as well as an American Heart Association (AHA) Predoctoral Fellowship (AHA14PRE185800221 to A.C.C.) and AHA Postdoctoral Fellowship (AHA13POST14800034 to Y.C.). Mass spectrometers were acquired with funds (to M.J.T.) from several agencies: Waters Q-TOF mass spectrometer from NIH Shared Instrumentation Grant 1S10RR17846 and Advion Nanomate from the North Carolina Biotechnology Grant 2007-IDG-1021. MS analyses were performed in the Mass Spectrometer Facility of the Comprehensive Cancer Center of Wake Forest University School of Medicine supported in part by National Cancer Institute center grant 5P30CA12197. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Aseervatham GSB, 2013, ENVIRON SCI POLLUT R, V20, P4356, DOI 10.1007/s11356-013-1748-0; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; BONNEFONTROUSSELOT D, 1995, BBA-LIPID LIPID MET, V1255, P23, DOI 10.1016/0005-2760(94)00211-G; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Chadwick AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045660; Conklin DJ, 2010, TOXICOL APPL PHARM, V243, P1, DOI 10.1016/j.taap.2009.12.010; Connelly MA, 2003, J BIOL CHEM, V278, P25773, DOI 10.1074/jbc.M302820200; Connelly MA, 1999, J BIOL CHEM, V274, P41, DOI 10.1074/jbc.274.1.41; Connelly MA, 2001, BIOCHEMISTRY-US, V40, P5249, DOI 10.1021/bi002825r; de Beer MC, 2001, J LIPID RES, V42, P309; DeJarnett N, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000934; FERON VJ, 1991, MUTAT RES, V259, P363, DOI 10.1016/0165-1218(91)90128-9; Ferretti G, 2006, ATHEROSCLEROSIS, V184, P1, DOI 10.1016/j.atherosclerosis.2005.08.008; Fullana A, 2004, J AGR FOOD CHEM, V52, P5207, DOI 10.1021/jf035241f; Gillard BK, 2005, BIOCHEMISTRY-US, V44, P471, DOI 10.1021/bi048591j; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; GLASS C, 1985, J BIOL CHEM, V260, P744; GLOMSET JA, 1968, J LIPID RES, V9, P155; Gu XJ, 1998, J BIOL CHEM, V273, P35388, DOI 10.1074/jbc.273.41.26338; Gugliucci A, 2007, CLIN CHIM ACTA, V384, P105, DOI 10.1016/j.cca.2007.06.012; Ishii T, 2007, FREE RADICAL RES, V41, P1253, DOI 10.1080/10715760701678652; IZARD C, 1977, MUTAT RES, V47, P115; Jairam VU, 2012, BIOCH GEN MOL BIOL, P383; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; JOHNSTONE RAW, 1959, CHEM REV, V59, P885, DOI 10.1021/cr50029a004; Larach DB, 2012, CURR CARDIOL REP, V14, P684, DOI 10.1007/s11886-012-0317-3; Li HH, 2001, J LIPID RES, V42, P2084; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACALA LJ, 1983, J LIPID RES, V24, P1243; MAZIERE JC, 1993, ATHEROSCLEROSIS, V104, P213, DOI 10.1016/0021-9150(93)90192-W; MCCALL M, 1995, ARTERIOSCL THROM VAS, V15, P1599, DOI 10.1161/01.ATV.15.10.1599; MCCALL MR, 1994, ARTERIOSCLER THROMB, V14, P248, DOI 10.1161/01.ATV.14.2.248; Mizel SB, 2009, CLIN VACCINE IMMUNOL, V16, P21, DOI 10.1128/CVI.00333-08; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Navab M, 2009, J LIPID RES, V50, pS145, DOI 10.1194/jlr.R800036-JLR200; Nieland TJF, 2011, BIOCHEMISTRY-US, V50, P1818, DOI 10.1021/bi101657j; Obama T, 2007, PROTEOMICS, V7, P2132, DOI 10.1002/pmic.200700111; Otocka-Kmiecik A, 2012, PROG LIPID RES, V51, P314, DOI 10.1016/j.plipres.2012.03.003; Papale GA, 2010, ARCH BIOCHEM BIOPHYS, V496, P132, DOI 10.1016/j.abb.2010.02.011; Parathath S, 2004, J BIOL CHEM, V279, P41310, DOI 10.1074/jbc.M404952200; Parathath S, 2007, J LIPID RES, V48, P1386, DOI 10.1194/jlr.M700086-JLR200; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; PITTMAN RC, 1984, J LIPID RES, V25, P1577; PITTMAN RC, 1987, J BIOL CHEM, V262, P2443; Raveh O, 2000, FREE RADICAL BIO MED, V29, P131, DOI 10.1016/S0891-5849(00)00332-4; Sakata K, 2003, BIOCHEM BIOPH RES CO, V305, P143, DOI 10.1016/S0006-291X(03)00716-2; SALMON S, 1992, BIOCHIM BIOPHYS ACTA, V1125, P230, DOI 10.1016/0005-2760(92)90050-6; Shao BH, 2012, BBA-MOL CELL BIOL L, V1821, P490, DOI 10.1016/j.bbalip.2011.11.011; Shao BH, 2011, J PROTEOMICS, V74, P2289, DOI 10.1016/j.jprot.2011.04.001; Shao B, 2009, J LIPID RES, V50, P599, DOI 10.1194/jlr.E900001-JLR200; Shao BH, 2005, ANN NY ACAD SCI, V1043, P396, DOI 10.1196/annals.1333.046; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; SorciThomas MG, 1996, J LIPID RES, V37, P673; Srivastava S, 2011, ATHEROSCLEROSIS, V215, P301, DOI 10.1016/j.atherosclerosis.2011.01.001; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Stevens JF, 2008, MOL NUTR FOOD RES, V52, P7, DOI 10.1002/mnfr.200700412; Tamamizu-Kato S, 2007, BIOCHEMISTRY-US, V46, P8392, DOI 10.1021/bi700289k; Toth PP, 2013, J CLIN LIPIDOL, V7, P484, DOI 10.1016/j.jacl.2013.08.001; Watanabe K, 2013, ATHEROSCLEROSIS, V227, P51, DOI 10.1016/j.atherosclerosis.2012.12.020; WITZ G, 1989, FREE RADICAL BIO MED, V7, P333, DOI 10.1016/0891-5849(89)90137-8; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yoshida M, 2010, ATHEROSCLEROSIS, V211, P475, DOI 10.1016/j.atherosclerosis.2010.03.031; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	66	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123138	10.1371/journal.pone.0123138	http://dx.doi.org/10.1371/journal.pone.0123138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849485	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800208
J	Drovetski, SV; Semenov, G; Red'kin, YA; Sotnikov, VN; Fadeev, IV; Koblik, EA				Drovetski, Sergei V.; Semenov, Georgy; Red'kin, Yaroslav A.; Sotnikov, Vladimir N.; Fadeev, Igor V.; Koblik, Evgeniy A.			Effects of Asymmetric Nuclear Introgression, Introgressive Mitochondrial Sweep, and Purifying Selection on Phylogenetic Reconstruction and Divergence Estimates in the Pacific Clade of Locustella Warblers	PLOS ONE			English	Article							GENETIC CONSEQUENCES; SPECIATION; EVOLUTION	When isolated but reproductively compatible populations expand geographically and meet, simulations predict asymmetric introgression of neutral loci from a local to invading taxon. Genetic introgression may affect phylogenetic reconstruction by obscuring topology and divergence estimates. We combined phylogenetic analysis of sequences from one mtDNA and 12 nuDNA loci with analysis of gene flow among 5 species of Pacific Locustella warblers to test for presence of genetic introgression and its effects on tree topology and divergence estimates. Our data showed that nuDNA introgression was substantial and asymmetrical among all members of superspecies groups whereas mtDNA showed no introgression except a single species pair where the invader's mtDNA was swept by mtDNA of the local species. This introgressive sweep of mtDNA had the opposite direction of the nuDNA introgression and resulted in the paraphyly of the local species' mtDNA haplotypes with respect to those of the invader. he multilocus nuDNA species tree resolved all inter- and intraspecific relationships despite substantial introgression. However, the node ages on the species tree may be underestimated as suggested by the differences in node age estimates based on non-introgressing mtDNA and introgressing nuDNA. In turn, the introgressive sweep and strong purifying selection appear to elongate internal branches in the mtDNA gene tree.	[Drovetski, Sergei V.] Univ Tromso Arctic Univ Norway, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway; [Semenov, Georgy] Russian Acad Sci, Inst Systemat & Ecol Anim, Themat Grp Bird Ecol, Siberian Branch, Novosibirsk, Russia; [Red'kin, Yaroslav A.; Koblik, Evgeniy A.] Moscow MV Lomonosov State Univ, Dept Ornithol, Zool Museum, Moscow, Russia; [Sotnikov, Vladimir N.] Kirov City Zool Museum, Kirov, Russia; [Fadeev, Igor V.] State Darwin Museum, Dept Collect, Moscow, Russia	UiT The Arctic University of Tromso; Russian Academy of Sciences; Lomonosov Moscow State University	Drovetski, SV (corresponding author), Univ Tromso Arctic Univ Norway, Tromso Univ Museum, Dept Nat Hist, Tromso, Norway.	sdrovetski@gmail.com	Red'kin, Yaroslav/AAE-4218-2021; Koblik, Evgeny/AAE-4252-2021; Drovetski, Sergei/A-6002-2011	Drovetski, Sergei/0000-0002-1832-5597	CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal	CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal	This study was supported by the startup funds to SVD from CIBIO, Centro de Investigacao em Biodiversidade e Recursos Geneticos, Portugal. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstrom P, 2011, MOL PHYLOGENET EVOL, V58, P513, DOI 10.1016/j.ympev.2010.12.012; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Clements JF, 2013, EBIRD CLEMENTS CHECK; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Drovetski SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087570; Drovetski SV, 2013, ECOL EVOL, V3, P1518, DOI 10.1002/ece3.539; Drovetski SV, 2005, CONSERV GENET, V6, P875, DOI 10.1007/s10592-005-9074-9; Drovetski SV, 2004, J AVIAN BIOL, V35, P105; Drummond A.J., 2012, MOL BIOL EVOL; Egea R, 2008, NUCLEIC ACIDS RES, V36, pW157, DOI 10.1093/nar/gkn337; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Gill F., IOC WORLD BIRD LIST; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; HUDSON RR, 1987, GENETICS, V116, P153; Huelsenbeck JP, 1997, ANNU REV ECOL SYST, V28, P437, DOI 10.1146/annurev.ecolsys.28.1.437; Kalyakin MV, 1993, P ZOOLOGICAL MUSEUM, V30, P164; Kutschera VE, 2014, MOL BIOL EVOL, V31, P2004, DOI 10.1093/molbev/msu186; Leache AD, 2014, SYST BIOL, V63, P17, DOI 10.1093/sysbio/syt049; Lerner HRL, 2011, CURR BIOL, V21, P1838, DOI 10.1016/j.cub.2011.09.039; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Peters JL, 2014, MOL ECOL, V23, P2961, DOI 10.1111/mec.12799; Rheindt FE, 2011, AUK, V128, P620, DOI 10.1525/auk.2011.128.4.620; STEPANYAN L S, 1972, Zoologicheskii Zhurnal, V51, P1896; Stepanyan L. S., 2003, CONSPECTUS ORNITHOLO; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tyrberg T., 1998, PLEISTOCENE BIRDS PA	36	18	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122590	10.1371/journal.pone.0122590	http://dx.doi.org/10.1371/journal.pone.0122590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849039	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800143
J	Fishman, E; Boecker, L; Helbich, M				Fishman, Elliot; Bocker, Lars; Helbich, Marco			Adult Active Transport in the Netherlands: An Analysis of Its Contribution to Physical Activity Requirements	PLOS ONE			English	Article							WEATHER CONDITIONS; BICYCLE; TRAVEL; WORK; MODE	Introduction Modern, urban lifestyles have engineered physical activity out of everyday life and this presents a major threat to human health. The Netherlands is a world leader in active travel, particularly cycling, but little research has sought to quantify the cumulative amount of physical activity through everyday walking and cycling. Methods Using data collected as part of the Dutch National Travel Survey (2010 - 2012), this paper determines the degree to which Dutch walking and cycling contributes to meeting minimum level of physical activity of 150 minutes of moderate intensity aerobic activity throughout the week. The sample includes 74,465 individuals who recorded at least some travel on the day surveyed. As physical activity benefits are cumulative, all walking and cycling trips are analysed, including those to and from public transport. These trips are then converted into an established measure of physical activity intensity, known as metabolic equivalents of tasks. Multivariate Tobit regression models were performed on a range of socio-demographic, transport resources, urban form and meteorological characteristics. Results The results reveal that Dutch men and women participate in 24 and 28 minutes of daily physical activity through walking and cycling, which is 41% and 55% more than the minimum recommended level. It should be noted however that some 57% of the entire sample failed to record any walking or cycling, and an investigation of this particular group serves as an important topic of future research. Active transport was positively related with age, income, bicycle ownership, urban density and air temperature. Car ownership had a strong negative relationship with physically active travel. Conclusion The results of this analysis demonstrate the significance of active transport to counter the emerging issue of sedentary lifestyle disease. The Dutch experience provides other countries with a highly relevant case study in the creation of environments and cultures that support healthy, active living.	[Fishman, Elliot; Helbich, Marco] Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands; [Bocker, Lars] Univ Utrecht, Fac Geosci, Dept Innovat Environm & Energy Sci, Utrecht, Netherlands	Utrecht University; Utrecht University	Fishman, E (corresponding author), Univ Utrecht, Fac Geosci, Dept Human Geog & Spatial Planning, Utrecht, Netherlands.	info@sensibletransport.org.au		Bocker, Lars/0000-0001-8631-8391				Aaheim H.A., 2005, CICERO REPORT; Ahmed F., 2010, P 33 AUSTR TRANSP RE; Ahmed F, 2012, COMMUTER CYCLIST S S; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Aultman-Hall L, 2009, TRANSPORT RES REC, P35, DOI 10.3141/2140-0; Australian Bureau of Statistics, 2013, CENSUS 2011; Bauman A., 2008, CYCLING GETTING AUST; Bell AC, 2006, ASIA-PAC J PUBLIC HE, V18, P62, DOI 10.1177/10105395060180011001; Bocker L, 2014, WEATHER CLIM SOC, V6, P468, DOI 10.1175/WCAS-D-13-00066.1; Bocker L, 2013, J TRANSP GEOGR, V28, P176, DOI 10.1016/j.jtrangeo.2012.11.004; Buehler R, 2012, TRANSPORTATION, V39, P409, DOI 10.1007/s11116-011-9355-8; Cameron AC, 2013, REGRESSION ANALYSIS; Central Bureau of Statistics, 2014, RESEARCH TRAVEL IN N; Costagliola MA, 2014, SCI TOTAL ENVIRON, V468, P1043, DOI 10.1016/j.scitotenv.2013.09.025; Creemers L, 2014, THEORETICAL AND APPL, P1; Delbosc A, 2013, TRANSPORT REV, V33, P271, DOI 10.1080/01441647.2013.801929; Dieleman FM, 2002, URBAN STUD, V39, P507, DOI 10.1080/00420980220112801; Ewing R, 2014, HEALTH PLACE, V26, P118, DOI 10.1016/j.healthplace.2013.12.008; Frank LD, 2004, AM J PREV MED, V27, P87, DOI 10.1016/j.amepre.2004.04.011; Garrard J, 2009, TAKING ACTION ON OBE; Giles-Corti B, 2014, EVIDENCE REVIEW LOW; Gojanovic B, 2011, MED SCI SPORT EXER, V43, P2204, DOI 10.1249/MSS.0b013e31821cbdc8; Goodman A, 2013, PLOS ONE, V8; Goodwin P, 2013, TRANSPORT REV, V33, P243, DOI 10.1080/01441647.2013.804133; Greene William H., 2003, ECONOMETRIC ANAL, V5; Hanson S., 1977, TRANSP RES REC, V629, P43; Harms L, 2013, 13TH WCTR; Heesch KC, 2014, PREV MED, V63, P29, DOI 10.1016/j.ypmed.2014.03.003; Heinen E, 2011, SUSTAIN URBAN AREAS, V43; Heinen E, 2011, TRANSPORT RES REC, P9, DOI 10.3141/2230-02; Heinen E, 2010, TRANSPORT REV, V30, P59, DOI 10.1080/01441640903187001; Helbich M, 2014, J TRANSP GEOGR, V38, P38, DOI 10.1016/j.jtrangeo.2014.05.009; Hertogh EM, 2010, MED SCI SPORT EXER, V42, P886, DOI 10.1249/MSS.0b013e3181c4d964; Hobbs Suzanne Havala, 2008, Healthc Pap, V9, P8; Loader C, 2014, CHARTING TRANSPORT; Louis J, 2012, AM J PHYS MED REHAB, V91, P931, DOI 10.1097/PHM.0b013e318269d9bb; de Rezende LFM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105620; Merom D, 2010, AM J PREV MED, V39, P113, DOI 10.1016/j.amepre.2010.04.007; Ministerie van Infrastructure en Millieu, 2013, MOBILITEITSBALANS 20; Ministerie van Verkeer en Waterstaat, 2009, CYCLING IN THE NETHE; Mulley C, 2013, RES TRANSP BUS MANAG, V7, P27, DOI 10.1016/j.rtbm.2013.01.001; Onderzoek Verplaatsingen in Nederland, 2013, ONDERZOEKSBESCHRIJVI; Pucher J, 2012, URBAN IND ENVIRON, P1; Pucher J, 2008, TRANSPORT REV, V28, P495, DOI 10.1080/01441640701806612; Pucher J, 2011, AM J PUBLIC HEALTH, V101, pS310, DOI 10.2105/AJPH.2010.300067; Pucher J, 2011, J TRANSP GEOGR, V19, P332, DOI 10.1016/j.jtrangeo.2010.02.007; Rietveld P, 2004, TRANSPORT RES A-POL, V38, P531, DOI 10.1016/j.tra.2004.05.003; Rissel C, 2012, THE CONVERSATION; Rissel C, 2012, INT J ENV RES PUB HE, V9, P2454, DOI 10.3390/ijerph9072454; Sabir M, 2011, WEATHER AND TRAVEL B; Scheepers E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073105; Schepers JP, 2014, ACCIDENT ANAL PREV, V73, P174, DOI 10.1016/j.aap.2014.09.010; Simons M, 2009, MED SCI SPORT EXER, V41, P2097, DOI 10.1249/MSS.0b013e3181a6aaa4; Sperlich B, 2012, EUR J APPL PHYSIOL, V112, P4015, DOI 10.1007/s00421-012-2382-0; Tully MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099636; Van Mechelen W, 1997, BRIT J SPORT MED, V31, P264, DOI 10.1136/bjsm.31.4.264; Veall M.R., 1996, J ECON SURV, V10, P241, DOI [10.1111/j.1467-6419.1996.tb00013.x, DOI 10.1111/J.1467-6419.1996.TB00013.X]; Woodcock J, 2014, BMJ, V348; World Health Organization, 2010, GLOBAL RECOMMENDATIO; World Health Organization, 2009, GLOBAL HEALTH RISKS	60	65	68	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121871	10.1371/journal.pone.0121871	http://dx.doi.org/10.1371/journal.pone.0121871			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849902	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800081
J	Jin, PY; Peng, JJ; Zou, HD; Wang, WW; Fu, J; Shen, BJ; Bai, XL; Xu, X; Zhang, X				Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin; Xu, Xun; Zhang, Xi			A Five-Year Prospective Study of Diabetic Retinopathy Progression in Chinese Type 2 Diabetes Patients with "Well-Controlled" Blood Glucose	PLOS ONE			English	Article							MACULAR EDEMA; RISK-FACTORS; PREVALENCE; REGRESSION; DISEASE; SYSTEM	Purpose To determine the progression rate and risk factors for diabetic retinopathy (DR) in Chinese type 2 diabetic patients who have reached the target hemoglobin A1c (HbA1c) level recommended by the American Diabetes Association. Methods This was a 5-year community-based prospective study. The study population consisted of patients with type 2 diabetes with HbA1c less than 7.0%. Demographic information, systemic examination results and ophthalmological test results for each participant were collected. The outcome of this study was the progression of DR, which was defined as an increase in DR grade in one or both eyes at the final visit in comparison to the baseline status. The association between each potential risk factor and DR progression was studied. Results A total of 453 patients with HbA1c less than 7.0% were included in the study group. In 146 patients (32.22%), DR developed or progressed during the five-year follow-up. Baseline HbA1c level was the only independent risk factor for DR progression (p<0.01, OR = 2.84, 95%CI: 2.11 similar to 3.82). The logistic regression function suggested that the possibility of DR progression increased fastest when baseline HbA1c increased from 5.2% to 6.4%. The 5-year DR progression rate in patients with baseline HbA1c less than 5.2%, between 5.2% and 6.4%, and over 6.4% were 19.62%, 24.41%, and 76.83%, respectively. Conclusions To slow the progression of DR in Chinese patients with type 2 diabetes, more intensive glucose control is recommended.	[Jin, Peiyao; Peng, Jinjuan; Zou, Haidong; Xu, Xun; Zhang, Xi] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China; [Zou, Haidong] Shanghai Eye Dis Prevent & Treatment Ctr, Dept Preventat Ophthalmol, Shanghai 200040, Peoples R China; [Wang, Weiwei; Fu, Jiong; Shen, Binjie; Bai, Xuelin] Beixinjing Community Hlth Serv Ctr, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zou, HD (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 20080, Peoples R China.	zouhaidong@hotmail.com	Dagdelen, Selcuk/A-9432-2017	Dagdelen, Selcuk/0000-0002-0513-1750; Zou, Haidong/0000-0002-6831-7560	Chinese National Nature Science Foundation [81371069]; Shanghai Pujiang Program [0001652]; Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee [13B141]	Chinese National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee	This study was funded by the Chinese National Nature Science Foundation (project number 81371069), Shanghai Pujiang Program (project number PJ(2012) 0001652), Shanghai New Hundred Talents Program from Shanghai Medical and Family Planning Commitee (project number 13B141). The sponsor or funding organization had no role in the design or conduct of this research.	Association AD, 2008, CLIN PRACT REC 2008; Bao YQ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2249; Beulens JWJ, 2009, DIABETOLOGIA, V52, P2027, DOI 10.1007/s00125-009-1457-x; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Consultation WHO, 1999, DEF DIAGN CLASS DIAB; GERRITZEN FM, 1973, DIABETES, V22, P122, DOI 10.2337/diab.22.2.122; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gibbins RL, 1998, DIABETOLOGIA, V41, P59, DOI 10.1007/s001250050867; Giordano C, 2011, EUR J INTERN MED, V22, P266, DOI 10.1016/j.ejim.2011.02.009; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Han Jae Ryong, 2004, Korean J Ophthalmol, V18, P41; Hellstedt T, 1996, BRIT J OPHTHALMOL, V80, P135, DOI 10.1136/bjo.80.2.135; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Lopez F, 2007, EUROPEAN OPHTHALMIC, P68; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Peng JJ, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-250; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; ROY S, 1990, P NATL ACAD SCI USA, V87, P404, DOI 10.1073/pnas.87.1.404; Rudnisky CJ, 2012, CAN J OPHTHALMOL, V47, P365, DOI 10.1016/j.jcjo.2012.04.006; Ruggenenti P, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/106384; Schoenlau Frank, 2001, International Ophthalmology, V24, P161, DOI 10.1023/A:1021160924583; Sjolie AK, 2011, DIABETIC MED, V28, P345, DOI 10.1111/j.1464-5491.2010.03210.x; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Steigerwalt R, 2009, J OCUL PHARMACOL TH, V25, P537, DOI 10.1089/jop.2009.0023; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; VANEWIJK PH, 1994, J R STAT SOC C-APPL, V43, P477; Wang N, 2008, OPHTHALMOLOGICA, V222, P32, DOI 10.1159/000109276; WHITE MC, 1981, BRIT J OPHTHALMOL, V65, P307, DOI 10.1136/bjo.65.5.307; White NH, 2010, DIABETES, V59, P1244, DOI 10.2337/db09-1216; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Wu YF, 2006, BMJ-BRIT MED J, V333, P362, DOI 10.1136/bmj.333.7564.362; Xie XW, 2009, EUR J OPHTHALMOL, V19, P91, DOI 10.1177/112067210901900114; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zavrelova H, 2011, DIABETES CARE, V34, P867, DOI 10.2337/dc10-1741; Zheng Z, 2009, DIABETES, V58, P954, DOI 10.2337/db07-1524; [邹海东 ZOU Hai dong], 2006, [中华眼底病杂志, Chinese Journal of Ocular Fundus Diseases], V22, P31	39	12	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123449	10.1371/journal.pone.0123449	http://dx.doi.org/10.1371/journal.pone.0123449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849536	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800233
J	Philipsen, A; Jorgensen, ME; Vistisen, D; Sandbaek, A; Almdal, TP; Christiansen, JS; Lauritzen, T; Witte, DR				Philipsen, Annelotte; Jorgensen, Marit E.; Vistisen, Dorte; Sandbaek, Annelli; Almdal, Thomas P.; Christiansen, Jens S.; Lauritzen, Torsten; Witte, Daniel R.			Associations between Ultrasound Measures of Abdominal Fat Distribution and Indices of Glucose Metabolism in a Population at High Risk of Type 2 Diabetes: The ADDITION-PRO Study	PLOS ONE			English	Article							SUBCUTANEOUS ADIPOSE-TISSUE; INSULIN-RESISTANCE ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; VISCERAL ADIPOSITY; TOLERANCE TEST; OLDER MEN; SENSITIVITY; OBESE; ULTRASONOGRAPHY; REPRODUCIBILITY	Aims Visceral adipose tissue measured by CT or MRI is strongly associated with an adverse metabolic risk profile. We assessed whether similar associations can be found with ultrasonography, by quantifying the strength of the relationship between different measures of obesity and indices of glucose metabolism in a population at high risk of type 2 diabetes. Methods A cross-sectional analysis of 1342 participants of the ADDITION-PRO study. We measured visceral adipose tissue and subcutaneous adipose tissue with ultrasonography, anthropometrics and body fat percentage by bioelectrical impedance. Indices of glucose metabolism were derived from a three point oral glucose tolerance test. Linear regression of obesity measures on indices of glucose metabolism was performed. Results Mean age was 66.2 years, BMI 26.9kg/m(2), subcutaneous adipose tissue 2.5cm and visceral adipose tissue 8.0cm. All measures of obesity were positively associated with indicators of glycaemia and inversely associated with indicators of insulin sensitivity. Associations were of equivalent magnitude except for subcutaneous adipose tissue and the visceral/subcutaneous adipose tissue ratio, which showed weaker associations. One standard deviation difference in BMI, visceral adipose tissue, waist circumference, waist/height ratio and body fat percentage corresponded approximately to 0.2mmol/l higher fasting glucose, 0.7mmol/l higher 2-hr glucose, 0.06-0.1% higher HbA1c, 30% lower HOMA index of insulin sensitivity, 20% lower Gutt's index of insulin sensitivity, and 100 unit higher Stumvoll's index of beta-cell function. After adjustment for waist circumference visceral adipose tissue was still significantly associated with glucose intolerance and insulin resistance, whereas there was a trend towards inverse or no associations with subcutaneous adipose tissue. After adjustment, a 1cm increase in visceral adipose tissue was associated with similar to 5% lower insulin sensitivity (p <= 0.0004) and similar to 0.18mmol/l higher 2-hr glucose (p <= 0.001). Conclusion Visceral and subcutaneous adipose tissue assessed by ultrasonography are significantly associated with glucose metabolism, even after adjustment for other measures of obesity.	[Philipsen, Annelotte; Jorgensen, Marit E.; Vistisen, Dorte] Steno Diabet Ctr AS, Gentofte, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten; Witte, Daniel R.] Aarhus Univ, Dept Publ Hlth, Sect Gen Practice, Aarhus, Denmark; [Almdal, Thomas P.] Gentofte Univ Hosp, Dept Internal Med F, Gentofte, Denmark; [Christiansen, Jens S.] Aarhus Univ Hosp, Dept Endocrinol, DK-8000 Aarhus, Denmark	Steno Diabetes Center; Aarhus University; University of Copenhagen; Herlev & Gentofte Hospital; Aarhus University	Philipsen, A (corresponding author), Steno Diabet Ctr AS, Gentofte, Denmark.	aphi@steno.dk	Witte, Daniel R/C-1722-2008; Witte, Daniel/AAF-9535-2019	Witte, Daniel R/0000-0002-0769-2922; Witte, Daniel/0000-0002-0769-2922; Jorgensen, Marit Eika/0000-0001-8356-5565; Vistisen, Dorte/0000-0001-5045-5351	European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes [74550801]; Steno Diabetes Center A/S	European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes; Steno Diabetes Center A/S	The ADDITION-PRO study was funded by an unrestricted grant from the European Foundation for the Study of Diabetes/Pfizer for Research into Cardiovascular Disease Risk Reduction in Patients with Diabetes (74550801); and by internal research and equipment funds from Steno Diabetes Center A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemelmans RHH, 2012, OBESITY, V20, P834, DOI 10.1038/oby.2011.321; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; De Lucia, 2011, OBESITY, V19, P1892; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Goodpaster BH, 2005, ARCH INTERN MED, V165, P777, DOI 10.1001/archinte.165.7.777; Gutt M, 2000, DIABETES RES CLIN PR, V47, P177, DOI 10.1016/S0168-8227(99)00116-3; Hanley AJG, 2009, DIABETOLOGIA, V52, P2079, DOI 10.1007/s00125-009-1464-y; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Jorgensen ME, 2013, DIABETES CARE, V36, P2988, DOI 10.2337/dc12-2703; Kanhai DA, 2012, INT J OBESITY, V36, P695, DOI 10.1038/ijo.2011.115; Klein S, 2007, OBESITY, V15, P1061, DOI 10.1038/oby.2007.632; Neeland IJ, 2013, OBESITY, V21, pE439, DOI [10.1002/oby.20135, 10.1038/oby.20135]; Neeland IJ, 2012, JAMA-J AM MED ASSOC, V308, P1150, DOI 10.1001/2012.jama.11132; Philipsen A, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.23; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Preis SR, 2010, OBESITY, V18, P2191, DOI 10.1038/oby.2010.59; *R FDN STAT COMP, 2009, R LANG ENV STAT COMP; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Stolk RP, 2001, INT J OBESITY, V25, P1346, DOI 10.1038/sj.ijo.0801734; Stumvoll M, 2000, DIABETES CARE, V23, P295, DOI 10.2337/diacare.23.3.295; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Wagenknecht LE, 2003, DIABETES, V52, P2490, DOI 10.2337/diabetes.52.10.2490; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Wander PL, 2013, DIABETES CARE, V36, P289, DOI 10.2337/dc12-0198; Wildman RP, 2008, ARCH INTERN MED, V168, P1617, DOI 10.1001/archinte.168.15.1617	28	24	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123062	10.1371/journal.pone.0123062	http://dx.doi.org/10.1371/journal.pone.0123062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849815	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800200
J	Abascal, JFPJ; Abella, M; Sisniega, A; Vaquero, JJ; Desco, M				Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel			Investigation of Different Sparsity Transforms for the PICCS Algorithm in Small-Animal Respiratory Gated CT	PLOS ONE			English	Article							BEAM COMPUTED-TOMOGRAPHY; COMPRESSED SENSING PICCS; DIFFUSE OPTICAL TOMOGRAPHY; SPLIT BREGMAN METHOD; IMAGE-RECONSTRUCTION; MICRO-CT; TEMPORAL RESOLUTION; PERFORMANCE; REGULARIZATION; PROJECTIONS	Respiratory gating helps to overcome the problem of breathing motion in cardiothoracic small-animal imaging by acquiring multiple images for each projection angle and then assigning projections to different phases. When this approach is used with a dose similar to that of a static acquisition, a low number of noisy projections are available for the reconstruction of each respiratory phase, thus leading to streak artifacts in the reconstructed images. This problem can be alleviated using a prior image constrained compressed sensing (PICCS) algorithm, which enables accurate reconstruction of highly undersampled data when a prior image is available. We compared variants of the PICCS algorithm with different transforms in the prior penalty function: gradient, unitary, and wavelet transform. In all cases the problem was solved using the Split Bregman approach, which is efficient for convex constrained optimization. The algorithms were evaluated using simulations generated from data previously acquired on a micro-CT scanner following a high-dose protocol (four times the dose of a standard static protocol). The resulting data were used to simulate scenarios with different dose levels and numbers of projections. All compressed sensing methods performed very similarly in terms of noise, spatiotemporal resolution, and streak reduction, and filtered back-projection was greatly improved. Nevertheless, the wavelet domain was found to be less prone to patchy cartoon-like artifacts than the commonly used gradient domain.	[Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel] Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain; [Abascal, Juan F. P. J.; Abella, Monica; Sisniega, Alejandro; Jose Vaquero, Juan; Desco, Manuel] Inst Invest Sanitaria Gregorio Maranon IiSGM, Madrid, Spain; [Desco, Manuel] Ctr Invest Red Salud Mental CIBERSAM, Madrid, Spain	Universidad Carlos III de Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM	Abella, M (corresponding author), Univ Carlos III Madrid, Dept Bioingn & Ingn Aeroespacial, Madrid, Spain.	monica.abella@uc3m.es	ABASCAL, JUAN FPJ/L-7062-2014; Desco, Manuel/AAD-7137-2019; Vaquero, Juan José/D-3033-2009; ABELLA, MONICA/AAE-7616-2019	ABASCAL, JUAN FPJ/0000-0002-2757-8676; Desco, Manuel/0000-0003-0989-3231; Vaquero, Juan José/0000-0001-9200-361X; ABELLA, MONICA/0000-0002-4847-7233; Sisniega, Alejandro/0000-0003-2030-2711	RIC-RETIC network from the Ministerio de Economia y Competitividad [RD12/0042/0057]; Ministerio de Ciencia e Innovacion [TEC2010-21619-C04-01, PI11/00616]; Innovative Medicines Initiative [115337]; European Union's Seventh Framework Programme (FP7); EFPIA companies	RIC-RETIC network from the Ministerio de Economia y Competitividad; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Innovative Medicines Initiative; European Union's Seventh Framework Programme (FP7); EFPIA companies	This work was partially funded by the RIC-RETIC network (RD12/0042/0057) from the Ministerio de Economia y Competitividad (www.mineco.gob.es/) and projects TEC2010-21619-C04-01 and PI11/00616 from Ministerio de Ciencia e Innovacion (www.micinn.es/). The research leading to these results was supported by funding from the Innovative Medicines Initiative (www.imi.europa.eu) Joint Undertaking under grant agreement no 115337, the resources of which comprise financial contributions from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies ("in kind contribution"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal JFPJ, 2011, MED PHYS, V38, P6275, DOI 10.1118/1.3656063; Abascal J, 2012, IEEE NUCL SCI CONF R, P3344; Abella M, 2012, COMPUT METH PROG BIO, V107, P218, DOI 10.1016/j.cmpb.2011.06.008; Bruckstein AM, 2009, SIAM REV, V51, P34, DOI 10.1137/060657704; Buckheit JB, 1995, WAVELAB REFERENCE MA; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Candes EJ, 2005, P SPIE C WAV APPL SI, P5914; Candes E, 2007, INVERSE PROBL, V23, P969, DOI 10.1088/0266-5611/23/3/008; Chamorro-Servent J, 2011, OPT EXPRESS, V19, P11490, DOI 10.1364/OE.19.011490; Chavarrias C, 2008, PHYS MED BIOL, V53, P4683, DOI 10.1088/0031-9155/53/17/015; Chen GH, 2008, MED PHYS, V35, P660, DOI 10.1118/1.2836423; Dong B, 2012, J SCI COMPUTING, P1; Goldstein T, 2009, SIAM J IMAGING SCI, V2, P323, DOI 10.1137/080725891; HANSEN PC, 1993, SIAM J SCI COMPUT, V14, P1487, DOI 10.1137/0914086; Lauzier PT, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/9/2461; Lee H, 2012, PHYS MED BIOL, V57, P2287, DOI 10.1088/0031-9155/57/8/2287; Leng S, 2008, PHYS MED BIOL, V53, P5653, DOI 10.1088/0031-9155/53/20/006; Leng S, 2008, MED PHYS, V35, P4649, DOI 10.1118/1.2977736; MCKINNON GC, 1981, IEEE T BIO-MED ENG, V28, P123, DOI 10.1109/TBME.1981.324785; Montesinos P, 2013, MAGNETIC RESONANCE M; Moscato P, 2003, HDB METAHEURISTICS I; Nett BE, 2010, PHYS MED BIOL, V55, P2333, DOI 10.1088/0031-9155/55/8/014; Osher S, 2005, MULTISCALE MODEL SIM, V4, P460, DOI 10.1137/040605412; Pan XC, 2009, INVERSE PROBL, V25, DOI 10.1088/0266-5611/25/12/123009; Qi ZH, 2011, PHYS MED BIOL, V56, P6709, DOI 10.1088/0031-9155/56/20/013; Ramani S, 2012, IEEE T MED IMAGING, V31, P677, DOI 10.1109/TMI.2011.2175233; Ramirez-Giraldo JC, 2011, MED PHYS, V38, P2157, DOI 10.1118/1.3560878; Ritschl L, 2011, PHYS MED BIOL, V56, P1545, DOI 10.1088/0031-9155/56/6/003; Sawall S, 2011, MED PHYS, V38, P1416, DOI 10.1118/1.3551993; Setzer S, 2010, J VIS COMMUN IMAGE R, V21, P193, DOI 10.1016/j.jvcir.2009.10.006; Sidky EY, 2008, PHYS MED BIOL, V53, P4777, DOI 10.1088/0031-9155/53/17/021; Song J, 2007, MED PHYS, V34, P4476, DOI 10.1118/1.2795830; Starck JL, 2005, IEEE T IMAGE PROCESS, V14, P1570, DOI 10.1109/TIP.2005.852206; Stayman JW, 2011, SPIE MED IMAGING, V7961; Tang J, 2010, MED PHYS, V37, P4377, DOI 10.1118/1.3460318; Tang J, 2009, PHYS MED BIOL, V54, P5781, DOI 10.1088/0031-9155/54/19/008; Vandeghinste B, 2012, SPIE MED IMAGING; Vaquero JJ, 2008, IEEE T NUCL SCI, V55, P898, DOI 10.1109/TNS.2008.922814; Xu Q, 2012, IEEE T MED IMAGING, V31, P1682, DOI 10.1109/TMI.2012.2195669; Yang SY, 2013, INFORM SCIENCES, V252, P144, DOI 10.1016/j.ins.2013.06.029; Yu HY, 2009, PHYS MED BIOL, V54, P2791, DOI 10.1088/0031-9155/54/9/014; Zhang QH, 2007, MED PHYS, V34, P4772, DOI 10.1118/1.2804576; Zhang QH, 2010, MED PHYS, V37, P2901, DOI 10.1118/1.3397460	43	9	10	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120140	10.1371/journal.pone.0120140	http://dx.doi.org/10.1371/journal.pone.0120140			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836670	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000018
J	Hayashi, Y; Yasugi, F; Arai, M				Hayashi, Yuuki; Yasugi, Fumitaka; Arai, Munehito			Role of Cysteine Residues in the Structure, Stability, and Alkane Producing Activity of Cyanobacterial Aldehyde Deformylating Oxygenase	PLOS ONE			English	Article							SHORT-CHAIN ALKANES; ESCHERICHIA-COLI; DIHYDROFOLATE-REDUCTASE; BIOSYNTHESIS; DECARBONYLATION; PROTEIN; OXIDATION; KINETICS; ENZYMES; FORMATE	Aldehyde deformylating oxygenase (AD) is a key enzyme for alkane biosynthesis in cyanobacteria, and it can be used as a catalyst for alkane production in vitro and in vivo. However, three free Cys residues in AD may impair its catalytic activity by undesired disulfide bond formation and oxidation. To develop Cys-deficient mutants of AD, we examined the roles of the Cys residues in the structure, stability, and alkane producing activity of AD from Nostoc punctiforme PCC 73102 by systematic Cys-to-Ala/Ser mutagenesis. The C71A/S mutations reduced the hydrocarbon producing activity of AD and facilitated the formation of a dimer, indicating that the conserved Cys71, which is located in close proximity to the substrate-binding site, plays crucial roles in maintaining the activity, structure, and stability of AD. On the other hand, mutations at Cys107 and Cys117 did not affect the hydrocarbon producing activity of AD. Therefore, we propose that the C107A/C117A double mutant is preferable to wild type AD for alkane production and that the double mutant may be used as a pseudo-wild type protein for further improvement of the alkane producing activity of AD.	[Hayashi, Yuuki; Yasugi, Fumitaka; Arai, Munehito] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; [Arai, Munehito] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Arai, M (corresponding author), Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.	arai@bio.c.u-tokyo.ac.jp	Arai, Munehito/A-1258-2012; Hayashi, Yuuki/Q-7515-2019	Arai, Munehito/0000-0002-1223-2242; Hayashi, Yuuki/0000-0002-7073-0151	Precursory Research for Embryonic Science and Technology (PRESTO), Japan; Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Hokuto Foundation for Bioscience; Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation; Yazaki Memorial Foundation for Science and Technology; Grants-in-Aid for Scientific Research [25117504] Funding Source: KAKEN	Precursory Research for Embryonic Science and Technology (PRESTO), Japan; Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hokuto Foundation for Bioscience(Hokuto Foundation for Bioscience); Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation; Yazaki Memorial Foundation for Science and Technology; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (MA), Grants-in-Aid for Scientific Research from Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan (MA, YH), Hokuto Foundation for Bioscience (YH), Tonen General Sekiyu Research & Development Encouragement & Assistance Foundation (YH), and Yazaki Memorial Foundation for Science and Technology (YH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Arai M, 2005, J MOL BIOL, V347, P337, DOI 10.1016/j.jmb.2005.01.033; CHEESBROUGH TM, 1984, P NATL ACAD SCI-BIOL, V81, P6613, DOI 10.1073/pnas.81.21.6613; Choi YJ, 2013, NATURE, V502, P571, DOI 10.1038/nature12536; Das D, 2011, ANGEW CHEM INT EDIT, V50, P7148, DOI 10.1002/anie.201101552; DENNIS MW, 1991, ARCH BIOCHEM BIOPHYS, V287, P268, DOI 10.1016/0003-9861(91)90478-2; Eser BE, 2011, BIOCHEMISTRY-US, V50, P10743, DOI 10.1021/bi2012417; Harger M, 2013, ACS SYNTH BIOL, V2, P59, DOI 10.1021/sb300061x; Hari SB, 2010, PROTEIN SCI, V19, P670, DOI 10.1002/pro.342; HARTLEY BS, 1960, ANNU REV BIOCHEM, V29, P45, DOI 10.1146/annurev.bi.29.070160.000401; Howard TP, 2013, P NATL ACAD SCI USA, V110, P7636, DOI 10.1073/pnas.1215966110; IWAKURA M, 1995, J BIOCHEM, V117, P480, DOI 10.1093/oxfordjournals.jbchem.a124733; Khara B, 2013, CHEMBIOCHEM, V14, P1204, DOI 10.1002/cbic.201300307; KOLATTUKUDY PE, 1968, SCIENCE, V159, P498, DOI 10.1126/science.159.3814.498; KOLATTUKUDY PE, 1968, PLANT PHYSIOL, V43, P1466, DOI 10.1104/pp.43.9.1466; Kong B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085890; Krebs C, 2011, CURR OPIN CHEM BIOL, V15, P291, DOI 10.1016/j.cbpa.2011.02.019; LEPOCK JR, 1990, J BIOL CHEM, V265, P21612; Li N, 2012, BIOCHEMISTRY-US, V51, P7908, DOI 10.1021/bi300912n; Li N, 2011, J AM CHEM SOC, V133, P6158, DOI 10.1021/ja2013517; Lilie H, 1998, CURR OPIN BIOTECH, V9, P497, DOI 10.1016/S0958-1669(98)80035-9; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PERRY LJ, 1987, PROTEIN ENG, V1, P101, DOI 10.1093/protein/1.2.101; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Takenawa T, 2009, J BIOCHEM, V145, P517, DOI 10.1093/jb/mvp003; Warui DM, 2011, J AM CHEM SOC, V133, P3316, DOI 10.1021/ja111607x; Welch M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007002	28	21	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122217	10.1371/journal.pone.0122217	http://dx.doi.org/10.1371/journal.pone.0122217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837679	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000085
J	Murshid, A; Gong, JL; Prince, T; Borges, TJ; Calderwood, SK				Murshid, Ayesha; Gong, Jianlin; Prince, Thomas; Borges, Thiago J.; Calderwood, Stuart K.			Scavenger Receptor SREC-I Mediated Entry of TLR4 into Lipid Microdomains and Triggered Inflammatory Cytokine Release in RAW 264.7 Cells upon LPS Activation	PLOS ONE			English	Article							NF-KAPPA-B; GPI-ANCHORED PROTEINS; HEAT-SHOCK PROTEINS; DENDRITIC CELLS; RECOGNITION; ANTIGEN; PATHWAYS; INTERNALIZATION; MACROPHAGES; SIGNALS	Scavenger receptor associated with endothelial cells I (SREC-I) was shown to be expressed in immune cells and to play a role in the endocytosis of peptides and antigen presentation. As our previous studies indicated that SREC-I required intact Toll-like receptor 4 (TLR4) expression for its functions in tumor immunity, we examined potential interactions between these two receptors. We have shown here that SREC-I became associated with TLR4 on binding bacterial lipopolysaccharides (LPS) in RAW 264.7 and HEK 293 cells overexpressing these two receptors. The receptors then became internalized together in intracellular endosomes. SREC-I promoted TLR4-induced signal transduction through the NF-kB and MAP kinase pathways, leading to enhanced inflammatory cytokine release. Activation of inflammatory signaling through SREC-I/TLR4 complexes appeared to involve recruitment of the receptors into detergent-insoluble, cholesterol-rich lipid microdomains that contained the small GTPase Cdc42 and the non-receptor tyrosine kinase c-src. Under conditions of SREC-I activation by LPS, TLR4 activity required Cdc42 as well as cholesterol and actin polymerization for signaling through NF-kB and MAP kinase pathways in RAW 264.7 cells. SREC-I appeared to respond differently to another ligand, the molecular chaperone Hsp90 that, while triggering SREC-I-TLR4 binding caused only faint activation of the NF-kB pathway. Our experiments therefore indicated that SREC-I could bind LPS and might be involved in innate inflammatory immune responses to extracellular danger signals in RAW 264.7 cells or bone marrow-derived macrophages.	[Murshid, Ayesha; Prince, Thomas; Borges, Thiago J.; Calderwood, Stuart K.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Life Sci,Mol & Cellular Radiat Oncol, Boston, MA 02215 USA; [Gong, Jianlin] Boston Univ, Med Ctr, Stress Response Ctr, Boston, MA USA; [Borges, Thiago J.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Sch Biosci, Porto Alegre, RS, Brazil; [Borges, Thiago J.] Pontificia Univ Catolica Rio Grande Sul PUCRS, Biomed Res Inst, Porto Alegre, RS, Brazil	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston University; Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul	Calderwood, SK (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Life Sci,Mol & Cellular Radiat Oncol, Boston, MA 02215 USA.	scalderw@bidmc.harvard.edu	Borges, Thiago/Q-3711-2019	Borges, Thiago/0000-0002-6554-0169	 [NIHRO1CA47407-25];  [NIHRO1CA176326-01];  [NIHRO1CA119045]; NATIONAL CANCER INSTITUTE [R01CA047407, R01CA176326, R01CA119045] Funding Source: NIH RePORTER	; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by NIHRO1CA47407-25, NIHRO1CA176326-01, NIHRO1CA119045, www.cancer.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 2002, J BIOL CHEM, V277, P24014, DOI 10.1074/jbc.M201854200; Akira S, 2003, SCAND J INFECT DIS, V35, P555, DOI 10.1080/00365540310015683; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Asea A, 2000, NAT MED, V6, P435, DOI 10.1038/74697; Beauvillain C, 2010, J HEPATOL, V52, P644, DOI 10.1016/j.jhep.2009.11.031; Berwin B, 2004, J BIOL CHEM, V279, P51250, DOI 10.1074/jbc.M406202200; Berwin B, 2003, EMBO J, V22, P6127, DOI 10.1093/emboj/cdg572; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bowdish DME, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000474; Calderwood SK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00075; Chen YY, 2010, EUR J IMMUNOL, V40, P1451, DOI 10.1002/eji.200939891; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Dunzendorfer S, 2004, J IMMUNOL, V173, P1166, DOI 10.4049/jimmunol.173.2.1166; Dziarski R, 2000, J ENDOTOXIN RES, V6, P401, DOI 10.1179/096805100101532243; Enomoto Y, 2006, J IMMUNOL, V177, P5946, DOI 10.4049/jimmunol.177.9.5946; Facciponte JG, 2007, EUR J IMMUNOL, V37, P2268, DOI 10.1002/eji.200737127; Fenton MJ, 1998, J LEUKOCYTE BIOL, V64, P25, DOI 10.1002/jlb.64.1.25; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gong JL, 2009, J IMMUNOL, V183, P3092, DOI 10.4049/jimmunol.0901235; Guo CQ, 2012, IMMUNOL CELL BIOL, V90, P101, DOI 10.1038/icb.2011.10; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Hu J, 2004, CARCINOGENESIS, V25, P1991, DOI 10.1093/carcin/bgh198; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Kawai T, 1999, IMMUNITY, V11, P115, DOI 10.1016/S1074-7613(00)80086-2; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Mayor S, 1998, EMBO J, V17, P4626, DOI 10.1093/emboj/17.16.4626; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Murshid A, 2012, MOL CHAPERONES SCAVE, P215; Murshid Ayesha, 2013, Methods Mol Biol, V960, P209, DOI 10.1007/978-1-62703-218-6_17; Murshid A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00063; Murshid A, 2010, J IMMUNOL, V185, P2903, DOI 10.4049/jimmunol.0903635; O'Neill L, 2000, BIOCHEM SOC T, V28, P557, DOI 10.1042/bst0280557; Pfistershammer K, 2008, J LEUKOCYTE BIOL, V83, P131, DOI 10.1189/jlb.0407231; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Theriault JR, 2006, J IMMUNOL, V177, P8604, DOI 10.4049/jimmunol.177.12.8604; Todt JC, 2008, J LEUKOCYTE BIOL, V84, P510, DOI 10.1189/jlb.0307135; Toshchakov VU, 2005, J IMMUNOL, V175, P494, DOI 10.4049/jimmunol.175.1.494; Tuyt LML, 1999, J IMMUNOL, V162, P4893; Uto T, 2007, J IMMUNOL, V178, P2979, DOI 10.4049/jimmunol.178.5.2979; Vogel SN, 1998, PROG CLIN BIOL RES, V397, P137; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Wang XY, 2007, CANCER RES, V67, P4996, DOI 10.1158/0008-5472.CAN-06-3138; Watanabe S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060078; Yi H, 2013, CANCER RES, V71, P6611; Yu XF, 2011, J BIOL CHEM, V286, P18795, DOI 10.1074/jbc.M111.224345; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105; Zietara N, 2009, J IMMUNOL, V183, P1099, DOI 10.4049/jimmunol.0803214; Zuo D, 2011, HEPATOLOGY, V57, P228	55	31	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122529	10.1371/journal.pone.0122529	http://dx.doi.org/10.1371/journal.pone.0122529			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836976	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000099
J	Smith, EL; Rashidi, H; Kanczler, JM; Shakesheff, KM; Oreffo, ROC				Smith, Emma L.; Rashidi, Hassan; Kanczler, Janos M.; Shakesheff, Kevin M.; Oreffo, Richard O. C.			The Effects of 1 alpha, 25-dihydroxyvitamin D-3 and Transforming Growth Factor-beta 3 on Bone Development in an Ex Vivo Organotypic Culture System of Embryonic Chick Femora	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; VITAMIN-D-RECEPTOR; FACTOR-BETA; ENDOCHONDRAL OSSIFICATION; D DEFICIENCY; 1,25-DIHYDROXYVITAMIN-D3; DIFFERENTIATION; CARTILAGE; FETAL; STIMULATION	Transforming growth factor-beta3 (TGF-beta 3) and 1 alpha, 25-dihydroxyvitamin D-3 (1 alpha, 25 (OH) D-2(3)) are essential factors in chondrogenesis and osteogenesis respectively. These factors also play a fundamental role in the developmental processes and the maintenance of skeletal integrity, but their respective direct effects on these processes are not fully understood. Using an organotypic bone rudiment culture system the current study has examined the direct roles the osteotropic factors 1 alpha, 25 (OH) D-2(3) and TGF-beta 3 exert on the development and modulation of the three dimensional structure of the embryonic femur. Isolated embryonic chick femurs (E11) were organotypically cultured for 10 days in basal media, or basal media supplemented with either 1 alpha, 25 (OH) D-2(3) (25 nM) or TGF-beta 3 (5 ng/mL & 15 ng/mL). Analyses of the femurs were undertaken using micro-computed tomography (mu CT), histology and immunohistochemistry. 1 alpha, 25 (OH)(2)D-3 supplemented cultures enhanced osteogenesis directly in the developing femurs with elevated levels of osteogenic markers such as type 1 collagen. In marked contrast organotypic femur cultures supplemented with TGF-beta 3 (5 ng/mL & 15 ng/mL) demonstrated enhanced chondrogenesis with a reduction in osteogenesis. These studies demonstrate the efficacy of the ex vivo organotypic embryonic femur culture employed to elucidate the direct roles of these molecules, 1 alpha, 25 (OH) 2D3 and TGF-beta 3 on the structural development of embryonic bone within a three dimensional framework. We conclude that 1 alpha, 25(OH)(2)D and TGF-beta 3 modify directly the various cell populations in bone rudiment organotypic cultures effecting tissue metabolism resulting in significant changes in embryonic bone growth and modulation. Understanding the roles of osteotropic agents in the process of skeletal development is integral to developing new strategies for the recapitulation of bone tissue in later life.	[Smith, Emma L.; Kanczler, Janos M.; Oreffo, Richard O. C.] Univ Southampton, Human Dev & Hlth, Bone & Joint Res Grp, Southampton, Hants, England; [Rashidi, Hassan; Shakesheff, Kevin M.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham, England	University of Southampton; University of Nottingham	Oreffo, ROC (corresponding author), Univ Southampton, Human Dev & Hlth, Bone & Joint Res Grp, Southampton, Hants, England.	roco@soton.ac.uk	Rashidi, Hassan/N-9313-2014; Shakesheff, Kevin/AAR-6603-2021; Shakesheff, Kevin M/O-6371-2018; Oreffo, Richard OC/A-4615-2011	Rashidi, Hassan/0000-0001-8078-6688; Shakesheff, Kevin M/0000-0003-3236-2439; Oreffo, Richard OC/0000-0001-5995-6726; Kanczler, Janos/0000-0001-7249-0414	Biotechnology and Biological Sciences Research Council, UK [BB/G010579/1]; Biotechnology and Biological Sciences Research Council [BB/G010579/1] Funding Source: researchfish; BBSRC [BB/G010579/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the strategic longer and larger grant (sLOLA) from the Biotechnology and Biological Sciences Research Council, UK-grant number BB/G010579/1. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; BAGI CM, 1992, J BONE MINER RES, V7, P29; BERESFORD JN, 1986, ENDOCRINOLOGY, V119, P1776, DOI 10.1210/endo-119-4-1776; Bouffi C, 2010, BIOMATERIALS, V31, P6485, DOI 10.1016/j.biomaterials.2010.05.013; Brady K, 2014, STEM CELLS DEV, V23, P541, DOI 10.1089/scd.2013.0301; Cheah FSH, 2010, MECH DEVELOP, V127, P329, DOI 10.1016/j.mod.2010.04.003; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Curtis KM, 2014, MOL ENDOCRINOL, V28, P644, DOI 10.1210/me.2013-1241; Davies JH, 2011, J PEDIATR ORTHOPED, V31, P798, DOI 10.1097/BPO.0b013e31822f1af1; DeLuca HF, 2004, AM J CLIN NUTR, V80, p1689S, DOI 10.1093/ajcn/80.6.1689S; Dror DK, 2011, CURR OPIN OBSTET GYN, V23, P422, DOI 10.1097/GCO.0b013e32834cb791; Endo H, 1980, VITAMIN D3 METABOLIT; Farquharson C, 1996, J ENDOCRINOL, V149, P277, DOI 10.1677/joe.0.1490277; GRYNPAS MD, 1988, J BONE MINER RES, V3, P159; Harada S, 2012, J BONE MINER RES, V27, P461, DOI 10.1002/jbmr.555; Harvey Nicholas, 2004, J Br Menopause Soc, V10, P14, DOI 10.1258/136218004322986726; Hechavarria D, 2010, MED ENG PHYS, V32, P1065, DOI 10.1016/j.medengphy.2010.07.010; Hewison M, 2010, J BONE MINER RES, V25, P11, DOI 10.1002/jbmr.2; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; HOWARD GA, 1981, J BIOL CHEM, V256, P7738; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kanczler JM, 2012, TISSUE ENG PART C-ME, V18, P747, DOI 10.1089/ten.tec.2012.0033; Kovacs Christopher S, 2011, Curr Osteoporos Rep, V9, P274, DOI 10.1007/s11914-011-0073-0; Lanske B, 2007, J NUTR BIOCHEM, V18, P771, DOI 10.1016/j.jnutbio.2007.02.002; Lee CH, 2010, LANCET, V376, P440, DOI 10.1016/S0140-6736(10)60668-X; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Lieben L, 2012, J CLIN INVEST, V122, P1803, DOI 10.1172/JCI45890; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Longaker MT, 2001, J CRANIOFAC SURG, V12, P389, DOI 10.1097/00001665-200107000-00016; Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; MATSUMOTO T, 1991, BONE, V12, P27, DOI 10.1016/8756-3282(91)90051-J; Matsunaga S, 1999, INT J ONCOL, V14, P1063; Mehlhorn AT, 2006, TISSUE ENG, V12, P1393, DOI 10.1089/ten.2006.12.1393; Moioli EK, 2007, WOUND REPAIR REGEN, V15, P413, DOI 10.1111/j.1524-475X.2007.00244.x; Mrugala D, 2008, ANN RHEUM DIS, V67, P288, DOI 10.1136/ard.2007.076620; NARBAITZ R, 1989, CALCIFIED TISSUE INT, V44, P348, DOI 10.1007/BF02556316; Opperman L, 1998, J CRANIOFACIAL GENET, V19, P164; Opperman LA, 2000, DEV DYNAM, V219, P237, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1044>3.0.CO;2-F; Park JS, 2009, J BIOMED MATER RES A, V91A, P408, DOI 10.1002/jbm.a.32271; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poisson E, 2009, TRANSFORMING GROWTH; ROARK EF, 1994, DEV DYNAM, V200, P103, DOI 10.1002/aja.1002000203; Smith EL, 2013, EUR CELLS MATER, V26, P91, DOI 10.22203/eCM.v026a07; Smith EL, 2012, TISSUE ENG PART C-ME, V18, P984, DOI [10.1089/ten.tec.2012.0132, 10.1089/ten.TEC.2012.0132]; St-Arnaud R, 2010, J STEROID BIOCHEM, V121, P254, DOI 10.1016/j.jsbmb.2010.02.002; SUDA S, 1985, CALCIFIED TISSUE INT, V37, P82, DOI 10.1007/BF02557684; Tang QO, 2009, TGF BETA3 POTENTIAL; THORP BH, 1992, DEVELOPMENT, V114, P907; THORP BH, 1994, BONE, V15, P59, DOI 10.1016/8756-3282(94)90892-3; Turner NJ, 2013, BIRTH DEFECTS RES C, V99, P149, DOI 10.1002/bdrc.21040; Woeckel VJ, 2013, GENE, V512, P438, DOI 10.1016/j.gene.2012.07.051; Yamamoto Y, 2013, ENDOCRINOLOGY, V154, P1008, DOI 10.1210/en.2012-1542; Yoshida T, 2012, ENDOCRIN METAB CLIN, V41, P557, DOI 10.1016/j.ecl.2012.04.003	54	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121653	10.1371/journal.pone.0121653	http://dx.doi.org/10.1371/journal.pone.0121653			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835745	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352139000054
J	Holkar, SS; Kamerkar, SC; Pucadyil, TJ				Holkar, Sachin S.; Kamerkar, Sukrut C.; Pucadyil, Thomas J.			Spatial Control of Epsin-induced Clathrin Assembly by Membrane Curvature	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHOCK COGNATE PROTEIN; MEDIATED ENDOCYTOSIS; AMPHIPATHIC HELICES; VESICLE FORMATION; BAR DOMAINS; MECHANISM; BINDING; AP180; CARGO; INTERNALIZATION	Epsins belong to the family of highly conserved clathrin-associated sorting proteins that are indispensable for clathrin-mediated endocytosis, but their precise functions remain unclear. We have developed an assay system of budded supported membrane tubes displaying planar and highly curved membrane surfaces to analyze intrinsic membrane curvature preference shown by clathrin-associated sorting proteins. Using real-time fluorescence microscopy, we find that epsin preferentially partitions to and assembles clathrin on highly curved membrane surfaces. Sorting of epsin to regions of high curvature strictly depends on binding to phosphatidylinositol 4,5-bisphosphate. Fluorescently labeled clathrins rapidly assemble as foci, which in turn cluster epsin, while maintaining tube integrity. Clathrin foci grow in intensity with a typical time constant of similar to 75 s, similar to the time scales for coated pit formation seen in cells. Epsin therefore effectively senses membrane curvature to spatially control clathrin assembly. Our results highlight the potential role of membrane curvature in orchestrating the myriad molecular interactions necessary for the success of clathrin-mediated membrane budding.	[Holkar, Sachin S.; Kamerkar, Sukrut C.; Pucadyil, Thomas J.] Indian Inst Sci Educ & Res, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India	Indian Institute of Science Education & Research (IISER) Pune	Pucadyil, TJ (corresponding author), Indian Inst Sci Educ & Res, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	pucadyil@iiserpune.ac.in	Pucadyil, Thomas/AAJ-3974-2020	Pucadyil, Thomas/0000-0002-2907-9889; KAMERKAR, SUKRUT/0000-0003-2848-7132	Indian Institute of Science Education and Research; Wellcome Trust-Department of Biotechnology (DBT) India Alliance; Council for Scientific and Industrial Research (CSIR)	Indian Institute of Science Education and Research; Wellcome Trust-Department of Biotechnology (DBT) India Alliance(Wellcome Trust DBT India Alliance); Council for Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by intramural funds from the Indian Institute of Science Education and Research and the Wellcome Trust-Department of Biotechnology (DBT) India Alliance.r Supported by graduate research fellowships from the Council for Scientific and Industrial Research (CSIR).	Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bhatia VK, 2010, SEMIN CELL DEV BIOL, V21, P381, DOI 10.1016/j.semcdb.2009.12.004; Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985; Boucrot E, 2012, CELL, V149, P124, DOI 10.1016/j.cell.2012.01.047; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; Capraro BR, 2010, J AM CHEM SOC, V132, P1200, DOI 10.1021/ja907936c; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Dannhauser PN, 2015, TRAFFIC, V16, P519, DOI 10.1111/tra.12263; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Ha JH, 1997, J BIOL CHEM, V272, P27796, DOI 10.1074/jbc.272.44.27796; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Hsieh WT, 2012, LANGMUIR, V28, P12838, DOI 10.1021/la302205b; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Kelly BT, 2014, SCIENCE, V345, P459, DOI 10.1126/science.1254836; Kunding AH, 2008, BIOPHYS J, V95, P1176, DOI 10.1529/biophysj.108.128819; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Messa M, 2014, ELIFE, V3, DOI 10.7554/eLife.03311; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Neumann S, 2013, J BIOL CHEM, V288, P25119, DOI 10.1074/jbc.M113.490474; Perrais D, 2005, DEV CELL, V9, P581, DOI 10.1016/j.devcel.2005.10.002; Pucadyil TJ, 2010, BIOPHYS J, V99, P517, DOI 10.1016/j.bpj.2010.04.036; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Rosenthal JA, 1999, J BIOL CHEM, V274, P33959, DOI 10.1074/jbc.274.48.33959; Rothnie A, 2011, P NATL ACAD SCI USA, V108, P6927, DOI 10.1073/pnas.1018845108; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Saleem M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7249; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Stahelin RV, 2003, J BIOL CHEM, V278, P28993, DOI 10.1074/jbc.M302865200; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Turner DK, 2013, APPL SPECTROSC, V67, P692, DOI 10.1366/12-06848; Yoon Y, 2010, J BIOL CHEM, V285, P531, DOI 10.1074/jbc.M109.068015	39	18	18	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14267	14276		10.1074/jbc.M115.653394	http://dx.doi.org/10.1074/jbc.M115.653394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25837255	Green Published, hybrid			2022-12-26	WOS:000355754600001
J	Law, C; Cheung, P				Law, Cindy; Cheung, Peter			Expression of Non-acetylatable H2A.Z in Myoblast Cells Blocks Myoblast Differentiation through Disruption of MyoD Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE VARIANT H2A.Z; NUCLEOSOME SURFACE; VERTEBRATE H2A.Z; GENES; PROMOTERS; HETEROCHROMATIN; TRANSCRIPTION; RECRUITMENT; ACTIVATION; ENHANCERS	H2A.Z is a histone H2A variant that is essential for viability in Tetrahymena and Drosophila and also during embryonic development of mice. Although implicated in diverse cellular processes, including transcriptional regulation, chromosome segregation, and heterochromatin formation, its essential function in cells remains unknown. Cellular differentiation is part of the developmental process of multicellular organisms. To elucidate the roles of H2A.Z and H2A.Z acetylation in cellular differentiation, we examined the effects of expressing wild type (WT) or a non-acetylatable form of H2A.Z in the growth and differentiation of the myoblast C2C12 cell line. Ectopic expression of wild type or mutant H2A.Z resulted in distinct phenotypes in the differentiation of the C2C12 cells and the formation of myotubes. Most strikingly, expression of the H2A.Z non-acetylatable mutant (H2A. Z-Ac-mut) resulted in a complete block of myoblast differentiation. We determined that this phenotype is caused by a loss of MyoD expression in the Ac-mut-expressing cells prior to and after induction of differentiation. Moreover, chromatin accessibility assays showed that the promoter region of MyoD is less accessible in the differentiation-defective cells. Altogether, these new findings show that expression of the Ac-mut form of H2A.Z resulted in a dominant phenotype that blocked differentiation due to chromatin changes at the MyoD promoter.	[Law, Cindy; Cheung, Peter] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Cheung, Peter] York Univ, Dept Biol, N York, ON M3J 1P3, Canada	University of Toronto; York University - Canada	Cheung, P (corresponding author), York Univ, Dept Biol, Life Sci Bldg,Rm 331A, N York, ON M3J 1P3, Canada.	pmcheung@yorku.ca			Canadian Research Chair program; Canadian Cancer Society Research Institute operating grant; National Sciences and Engineering Research Council of Canada	Canadian Research Chair program(Canada Research Chairs); Canadian Cancer Society Research Institute operating grant; National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by the Canadian Research Chair program and by a Canadian Cancer Society Research Institute operating grant (to P. C.).; Supported in part by a National Sciences and Engineering Research Council of Canada postgraduate scholarship.	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernacchioni C, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-15; Bruce K, 2005, NUCLEIC ACIDS RES, V33, P5633, DOI 10.1093/nar/gki874; Brunk BP, 1996, DEV BIOL, V177, P490, DOI 10.1006/dbio.1996.0180; Chen JCJ, 2002, DEV BIOL, V245, P213, DOI 10.1006/dbio.2002.0638; Chen Jennifer C J, 2003, Reprod Biol Endocrinol, V1, P101, DOI 10.1186/1477-7827-1-101; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Cuadrado A, 2010, EMBO J, V29, P2014, DOI 10.1038/emboj.2010.85; Dhillon N, 2006, MOL CELL BIOL, V26, P489, DOI 10.1128/MCB.26.2.489-501.2006; Draker R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003047; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Draker R, 2009, BIOCHEM CELL BIOL, V87, P19, DOI 10.1139/O08-117; Dryhurst D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-86; Faast R, 2001, CURR BIOL, V11, P1183, DOI 10.1016/S0960-9822(01)00329-3; Fan JY, 2004, MOL CELL, V16, P655, DOI 10.1016/j.molcel.2004.10.023; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Gevry N, 2007, GENE DEV, V21, P1869, DOI 10.1101/gad.1545707; GOLDHAMER DJ, 1992, SCIENCE, V256, P538, DOI 10.1126/science.1315077; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; GUO K, 1995, MOL CELL BIOL, V15, P3823; Harada A, 2012, EMBO J, V31, P2994, DOI 10.1038/emboj.2012.136; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Jackson JD, 2000, NUCLEIC ACIDS RES, V28, P3811, DOI 10.1093/nar/28.19.3811; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Ku MC, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R85, 10.1186/gb-2012-13-10-r85]; Kucharczuk KL, 1999, DEVELOPMENT, V126, P1957; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Larochelle M, 2003, EMBO J, V22, P4512, DOI 10.1093/emboj/cdg427; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Liu XW, 1996, MOL CELL BIOL, V16, P4305; Matsuda R, 2010, NUCLEIC ACIDS RES, V38, P4263, DOI 10.1093/nar/gkq171; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rangasamy D, 2004, NAT STRUCT MOL BIOL, V11, P650, DOI 10.1038/nsmb786; Rangasamy D, 2003, EMBO J, V22, P1599, DOI 10.1093/emboj/cdg160; Ridgway P, 2004, J BIOL CHEM, V279, P43815, DOI 10.1074/jbc.M408409200; Sarcinella E, 2007, MOL CELL BIOL, V27, P6457, DOI 10.1128/MCB.00241-07; Taberlay PC, 2011, CELL, V147, P1283, DOI 10.1016/j.cell.2011.10.040; THATCHER TH, 1994, NUCLEIC ACIDS RES, V22, P174, DOI 10.1093/nar/22.2.174; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; VANDAAL A, 1992, MOL BIOL CELL, V3, P593, DOI 10.1091/mbc.3.6.593; Wan YK, 2009, MOL CELL BIOL, V29, P2346, DOI 10.1128/MCB.01233-08; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yang JH, 2011, P NATL ACAD SCI USA, V108, P85, DOI 10.1073/pnas.1009830108; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	54	16	16	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13234	13249		10.1074/jbc.M114.595462	http://dx.doi.org/10.1074/jbc.M114.595462			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25839232	Green Published, hybrid			2022-12-26	WOS:000354975700025
J	Longman, D; Wells, JCK; Stock, JT				Longman, Daniel; Wells, Jonathan C. K.; Stock, Jay T.			Can Persistence Hunting Signal Male Quality? A Test Considering Digit Ratio in Endurance Athletes	PLOS ONE			English	Article							RUNNING PERFORMANCE; REPRODUCTIVE SUCCESS; GENDER-DIFFERENCES; MATE SELECTION; ACHE FORAGERS; LENGTH RATIO; 2ND; TESTOSTERONE; ABILITY; FINGER	Various theories have been posed to explain the fitness payoffs of hunting success among hunter-gatherers. 'Having' theories refer to the acquisition of resources, and include the direct provisioning hypothesis. In contrast, 'getting' theories concern the signalling of male resourcefulness and other desirable traits, such as athleticism and intelligence, via hunting prowess. We investigated the association between androgenisation and endurance running ability as a potential signalling mechanism, whereby running prowess, vital for persistence hunting, might be used as a reliable signal of male reproductive fitness by females. Digit ratio (2D:4D) was used as a proxy for prenatal androgenisation in 439 males and 103 females, while a half marathon race (21km), representing a distance/duration comparable with that of persistence hunting, was used to assess running ability. Digit ratio was significantly and positively correlated with half-marathon time in males (right hand: r = 0.45, p < 0.001; left hand: r = 0.42, p < 0.001) and females (right hand: r = 0.26, p < 0.01; left hand: r = 0.23, p = 0.02). Sex-interaction analysis showed that this correlation was significantly stronger in males than females, suggesting that androgenisation may have experienced stronger selective pressure from endurance running in males. As digit ratio has previously been shown to predict reproductive success, our results are consistent with the hypothesis that endurance running ability may signal reproductive potential in males, through its association with prenatal androgen exposure. However, further work is required to establish whether and how females respond to this signalling for fitness.	[Longman, Daniel; Stock, Jay T.] Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England; [Wells, Jonathan C. K.] UCL, Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Cambridge; University of London; University College London	Longman, D (corresponding author), Univ Cambridge, Dept Archaeol & Anthropol, Cambridge, England.	dannylongman@gmail.com	Stock, Jay T/B-6453-2011; Wells, Jonathan/A-4604-2009	Stock, Jay T/0000-0003-0147-8631; Wells, Jonathan/0000-0003-0411-8025; Longman, Danny/0000-0003-3025-7053				Altman J, 1988, RIGHTS GAME RIGHTS C; BAKER F, 1888, AM ANTHROPOL, V1, P51, DOI DOI 10.1525/AA.1888.1.1.02A00040; Bam J, 1997, MED SCI SPORT EXER, V29, P244, DOI 10.1097/00005768-199702000-00013; Baumeister RF, 2001, PERS SOC PSYCHOL REV, V5, P242, DOI 10.1207/S15327957PSPR0503_5; Berenbaum SA, 2009, ENDOCRINOLOGY, V150, P5119, DOI 10.1210/en.2009-0774; Biesele Meagan, 2001, AFR STUDY MONOGR, V26, P67; Bird RB, 2005, CURR ANTHROPOL, V46, P221, DOI 10.1086/427115; Bird RB, 2001, BEHAV ECOL SOCIOBIOL, V50, P9; Bird RB, 2002, EVOL HUM BEHAV, V23, P297; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blurton Jones N. G., 2000, ADAPTATION HUMAN BEH, P65; Bribiescas RG, 2001, FOUND HUM B, P107; BROOKS GA, 1994, J APPL PHYSIOL, V76, P2253, DOI 10.1152/jappl.1994.76.6.2253; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Bunn H, 2001, HUNTING POWER SCAVEN; BUSS DM, 1989, BEHAV BRAIN SCI, V12, P1, DOI 10.1017/S0140525X00023992; Buunk BP, 2002, PERS RELATIONSHIP, V9, P271, DOI 10.1111/1475-6811.00018; CARRIER DR, 1984, CURR ANTHROPOL, V25, P483, DOI 10.1086/203165; Cashdan EA., 1990, RISK UNCERTAINTY TRI, P145; Cheuvront SN, 2005, SPORTS MED, V35, P1017, DOI 10.2165/00007256-200535120-00002; Coast JR, 2004, CAN J APPL PHYSIOL, V29, P139, DOI 10.1139/h04-010; Cohen J., 1983, APPL MULTIPLE REGRES; Dalla Vecchia L, 2014, OPEN HEART, V1, DOI 10.1136/openhrt-2013-000005; Dijkstra P, 2002, EUR J SOC PSYCHOL, V32, P829, DOI 10.1002/ejsp.125; Dion T, 2013, EUR J APPL PHYSIOL, V113, P3011, DOI 10.1007/s00421-013-2730-8; Duffield R, 2004, J SCI MED SPORT, V7, P302, DOI 10.1016/S1440-2440(04)80025-2; Eichenberger E, 2012, OPEN ACCESS J SPORTS, V3, P73, DOI 10.2147/OAJSM.S33836; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Enloe J., 2003, FARMING, V21, P1, DOI [10.3828/bfarm.2003.1.1, DOI 10.3828/BFARM.2003.1.1]; Frederick DA, 2007, PERS SOC PSYCHOL B, V33, P1167, DOI 10.1177/0146167207303022; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Gallup AC, 2007, EVOL HUM BEHAV, V28, P423, DOI 10.1016/j.evolhumbehav.2007.07.001; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Gurven M, 2000, EVOL HUM BEHAV, V21, P263, DOI 10.1016/S1090-5138(00)00032-5; HAGERMAN FC, 1992, MED SCI SPORT EXER, V24, pS309; Hawkes K, 2002, EVOL ANTHROPOL, V11, P58, DOI 10.1002/evan.20005; HAWKES K, 1993, CURR ANTHROPOL, V34, P341, DOI 10.1086/204182; HAWKES K, 1991, ETHOL SOCIOBIOL, V12, P29, DOI 10.1016/0162-3095(91)90011-E; Hawkes K, 2001, CURR ANTHROPOL, V42, P681, DOI 10.1086/322559; HAWKES K, 1993, CURR ANTHROPOL, V34, P706; Hawkes K., 1992, EVOL ECOL, P269; HEGLUND NC, 1988, J EXP BIOL, V138, P301; HILL K, 1993, CURR ANTHROPOL, V34, P701, DOI 10.1086/204213; Hill R, 2012, J SPORT SCI, V30, P129, DOI 10.1080/02640414.2011.637947; Honekopp J, 2007, PSYCHONEUROENDOCRINO, V32, P313, DOI 10.1016/j.psyneuen.2007.01.007; Hoffman M, 2008, MED SCI SPORT EXER, V40, P2008; Honekopp J, 2010, PERS INDIV DIFFER, V48, P4, DOI 10.1016/j.paid.2009.08.009; Kadi F, 2008, BRIT J PHARMACOL, V154, P522, DOI 10.1038/bjp.2008.118; KAPLAN H, 1985, CURR ANTHROPOL, V26, P131, DOI 10.1086/203235; KAPLAN H, 1985, CURR ANTHROPOL, V26, P223, DOI 10.1086/203251; Kishigami N, 2000, SENRI ETHNOLOGICAL S, V53, P171; Kondo T, 1997, NATURE, V390, P29, DOI 10.1038/36234; Kostelanetz R, 1993, DICT AVANT GARDES; Kratochvil L, 2009, BIOL LETTERS, V5, P643, DOI 10.1098/rsbl.2009.0346; Lee R. B., MAN HUNTER, P3; Liebenberg L, 2006, CURR ANTHROPOL, V47, P1017, DOI 10.1086/508695; Lieberman D., 2006, 1 HUMANS ORIGIN EARL; Lippi G, 2010, BRIT MED BULL, V93, P27, DOI 10.1093/bmb/ldp007; Lutchmaya S, 2004, EARLY HUM DEV, V77, P23, DOI 10.1016/j.earlhumdev.2003.12.002; Manning JT, 2009, AM J HUM BIOL, V21, P210, DOI 10.1002/ajhb.20855; Manning JT, 2008, AM J HUM BIOL, V20, P451, DOI 10.1002/ajhb.20767; Manning JT, 2007, AM J HUM BIOL, V19, P416, DOI 10.1002/ajhb.20603; Manning JT, 2000, EVOL HUM BEHAV, V21, P163, DOI 10.1016/S1090-5138(00)00029-5; Manning JT, 2005, ARCH SEX BEHAV, V34, P329, DOI 10.1007/s10508-005-3121-y; Manning JT, 2002, J SPORT MED PHYS FIT, V42, P446; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; Manning JT, 2001, EVOL HUM BEHAV, V22, P61, DOI 10.1016/S1090-5138(00)00063-5; McArdle WD., 2001, EXERCISE PHYSL ENERG; McDougall C., 2009, BORN RUN HIDDEN TRIB; Minetti AE, 2003, NATURE, V426, P785, DOI 10.1038/426785a; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Nettle D, 2008, AM NAT, V172, P658, DOI 10.1086/591690; Noakes T., 2003, LORE RUNNING; Okten A, 2002, EARLY HUM DEV, V70, P47, DOI 10.1016/S0378-3782(02)00073-7; Oomah SR, 2011, J AM SOC ECHOCARDIOG, V24, P207, DOI 10.1016/j.echo.2010.10.012; Patton JQ, 2005, EVOL HUM BEHAV, V26, P137, DOI 10.1016/j.evolhumbehav.2004.08.008; PATTON JQ, 2004, FDN HUMAN SOCIALITY, P96; Paul SN, 2006, BRIT J SPORT MED, V40, P981, DOI 10.1136/bjsm.2006.027193; Pennington C., 1963, TARAHUMARA MEXICO; Pokrywka L, 2005, AM J HUM BIOL, V17, P796, DOI 10.1002/ajhb.20449; Pollet TV, 2008, BIOL LETTERS, V4, P31, DOI 10.1098/rsbl.2007.0543; Preacher K, CALCULATION TEST DIF; Schapera I., 1930, KHOISAN PEOPLES S AF; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Smith EA, 2000, EVOL HUM BEHAV, V21, P245, DOI 10.1016/S1090-5138(00)00031-3; Smith EA, 2004, HUM NATURE-INT BIOS, V15, P343, DOI 10.1007/s12110-004-1013-9; Sparling PB, 1998, MED SCI SPORT EXER, V30, P1725, DOI 10.1097/00005768-199812000-00011; Speechly DP, 1996, MED SCI SPORT EXER, V28, P359, DOI 10.1097/00005768-199603000-00011; Steyn H. P., 1984, S AFRICAN ARCHAEOLOG, P117; Sugiyama L.S., 2000, HUMAN BEHAV ADAPTATI, P371; Tatem AJ, 2004, NATURE, V431, P525, DOI 10.1038/431525a; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Trivers R, 2013, HUM BIOL, V85, P623, DOI 10.3378/027.085.0409; Trumble BC, 2013, P R SOC B, V281; TUCKER VA, 1975, AM SCI, V63, P413; Weissner P, 1996, FOOD STATUS QUEST IN; Wells JCK, 2011, AM J HUM BIOL, V23, P291, DOI 10.1002/ajhb.21151; WHIPP BJ, 1992, NATURE, V355, P25, DOI 10.1038/355025a0; Wilmore JH, 1999, PHYSL SPORT EXERCISE; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	100	17	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121560	10.1371/journal.pone.0121560	http://dx.doi.org/10.1371/journal.pone.0121560			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853679	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400044
J	Baglioni, M; Russo, F; Geraci, F; Rizzo, M; Rainaldi, G; Pellegrini, M				Baglioni, Miriam; Russo, Francesco; Geraci, Filippo; Rizzo, Milena; Rainaldi, Giuseppe; Pellegrini, Marco			A New Method for Discovering Disease-Specific MiRNA-Target Regulatory Networks	PLOS ONE			English	Article							CENTRALITY; GENES; EXPRESSION; IDENTIFICATION; RESOURCE; INVASION; FAMILY; CELLS	Genes and their expression regulation are among the key factors in the comprehension of the genesis and development of complex diseases. In this context, microRNAs (miRNAs) are post-transcriptional regulators that play an important role in gene expression since they are frequently deregulated in pathologies like cardiovascular disease and cancer. In vitro validation of miRNA -targets regulation is often too expensive and time consuming to be carried out for every possible alternative. As a result, a tool able to provide some criteria to prioritize trials is becoming a pressing need. Moreover, before planning in vitro experiments, the scientist needs to evaluate the miRNA-target genes interaction network. In this paper we describe the miRable method whose purpose is to identify new potentially relevant genes and their interaction networks associate to a specific pathology. To achieve this goal miRable follows a system biology approach integrating together general-purpose medical knowledge (literature, Protein-Protein Interaction networks, prediction tools) and pathology specific data (gene expression data). A case study on Prostate Cancer has shown that miRable is able to: 1) find new potential miRNA-targets pairs, 2) highlight novel genes potentially involved in a disease but never or little studied before, 3) reconstruct all possible regulatory subnetworks starting from the literature to expand the knowledge on the regulation of miRNA regulatory mechanisms.	[Baglioni, Miriam; Geraci, Filippo] CNR, Inst Informat & Telemat, I-56124 Pisa, Italy; [Russo, Francesco; Rainaldi, Giuseppe; Pellegrini, Marco] CNR, Inst Informat & Telemat, Lab Integrat Syst Med, I-56124 Pisa, Italy; [Russo, Francesco; Rizzo, Milena; Rainaldi, Giuseppe; Pellegrini, Marco] CNR, Inst Clin Physiol IFC, I-56124 Pisa, Italy; [Russo, Francesco] Univ Pisa, Dept Comp Sci, I-56127 Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Informatica e Telematica (IIT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Pisa	Russo, F (corresponding author), CNR, Inst Informat & Telemat, Lab Integrat Syst Med, Via G Moruzzi 1, I-56124 Pisa, Italy.	francesco.russo@iit.cnr.it	Pellegrini, Marco/AAX-9568-2020; Rizzo, Milena/L-1481-2016; Baglioni, Miriam/AAL-5697-2021; Russo, Francesco/X-3055-2018	Rizzo, Milena/0000-0001-5924-8615; GERACI, FILIPPO/0000-0001-6993-6761; Russo, Francesco/0000-0001-9257-4359; Baglioni, Miriam/0000-0002-2273-9004; Pellegrini, Marco/0000-0003-3151-9481	Progetto Istituto Toscano Tumori Grant [2012 Prot.A00GRT]; Flagship project InterOmics - Italian MIUR organization [PB.P05]; Flagship project InterOmics - CNR organization [PB.P05]; joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM)	Progetto Istituto Toscano Tumori Grant; Flagship project InterOmics - Italian MIUR organization; Flagship project InterOmics - CNR organization; joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM)	FR has been supported by a fellowship sponsored by Progetto Istituto Toscano Tumori Grant 2012 Prot.A00GRT. The present work is partially supported by the Flagship project InterOmics(PB.P05), funded by the Italian MIUR and CNR organizations, and by the joint IIT-IFC Laboratory of Integrative Systems Medicine (LISM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bartel DP, 2000, CELL, V136, P25; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bisognin A, 2012, NUCLEIC ACIDS RES, V40, pW13, DOI 10.1093/nar/gks460; Boldi P, 2014, AXIOMS CENTRALITY; BONACICH P, 1987, AM J SOCIOL, V92, P1170, DOI 10.1086/228631; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Fioretti FM, 2014, J MOL ENDOCRINOL, V52, pR257, DOI 10.1530/JME-14-0030; Fisher R.A., 1948, AM STAT, V2, P30, DOI DOI 10.2307/2681650; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Fu C, 2014, TUMOUR BIOL; HAGE P, 1995, SOC NETWORKS, V17, P57, DOI 10.1016/0378-8733(94)00248-9; Hirata H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055502; Hsu SD, 2014, NUCLEIC ACIDS RES, V42, pD78, DOI 10.1093/nar/gkt1266; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Jourquin J, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S20; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Koschutzki D, 2005, LECT NOTES COMPUT SC, V3418, P16; Kwak SY, 2014, BBA-MOL CELL RES, V1843, P508, DOI 10.1016/j.bbamcr.2013.11.021; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Liu Y, 2012, J IMMUNOL, V188, P5500, DOI 10.4049/jimmunol.1103505; Muniategui A, 2013, BRIEF BIOINFORM, V14, P263, DOI 10.1093/bib/bbs028; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Ries J, 2014, ONCOL REP, V31, P1429, DOI 10.3892/or.2014.2983; Russo F, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S3-S4; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Tang YF, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S3-S6; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wang LG, 2009, AM J TRANSL RES, V1, P62; Xiao J, 2012, PROSTATE, V72, P1514, DOI 10.1002/pros.22501	35	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122473	10.1371/journal.pone.0122473	http://dx.doi.org/10.1371/journal.pone.0122473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848944	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800131
J	Balanovsky, O; Zhabagin, M; Agdzhoyan, A; Chukhryaeva, M; Zaporozhchenko, V; Utevska, O; Highnam, G; Sabitov, Z; Greenspan, E; Dibirova, K; Skhalyakho, R; Kuznetsova, M; Koshel, S; Yusupov, Y; Nymadawa, P; Zhumadilov, Z; Pocheshkhova, E; Haber, M; Zalloua, PA; Yepiskoposyan, L; Dybo, A; Tyler-Smith, C; Balanovska, E				Balanovsky, Oleg; Zhabagin, Maxat; Agdzhoyan, Anastasiya; Chukhryaeva, Marina; Zaporozhchenko, Valery; Utevska, Olga; Highnam, Gareth; Sabitov, Zhaxylyk; Greenspan, Elliott; Dibirova, Khadizhat; Skhalyakho, Roza; Kuznetsova, Marina; Koshel, Sergey; Yusupov, Yuldash; Nymadawa, Pagbajabyn; Zhumadilov, Zhaxybay; Pocheshkhova, Elvira; Haber, Marc; Zalloua, Pierre A.; Yepiskoposyan, Levon; Dybo, Anna; Tyler-Smith, Chris; Balanovska, Elena			Deep Phylogenetic Analysis of Haplogroup G1 Provides Estimates of SNP and STR Mutation Rates on the Human Y-Chromosome and Reveals Migrations of Iranic Speakers	PLOS ONE			English	Article							MTDNA VARIATION; EAST-ASIA; POPULATION; ORIGIN; HERITAGE	Y-chromosomal haplogroup G1 is a minor component of the overall gene pool of South-West and Central Asia but reaches up to 80% frequency in some populations scattered within this area. We have genotyped the G1-defining marker M285 in 27 Eurasian populations (n = 5,346), analyzed 367 M285-positive samples using 17 Y-STRs, and sequenced similar to 11 Mb of the Y-chromosome in 20 of these samples to an average coverage of 67X. This allowed detailed phylogenetic reconstruction. We identified five branches, all with high geographical specificity: G1-L1323 in Kazakhs, the closely related G1-GG1 in Mongols, G1-GG265 in Armenians and its distant brother clade G1-GG162 in Bashkirs, and G1-GG362 in West Indians. The haplotype diversity, which decreased from West Iran to Central Asia, allows us to hypothesize that this rare haplogroup could have been carried by the expansion of Iranic speakers northwards to the Eurasian steppe and via founder effects became a predominant genetic component of some populations, including the Argyn tribe of the Kazakhs. The remarkable agreement between genetic and genealogical trees of Argyns allowed us to calibrate the molecular clock using a historical date (1405 AD) of the most recent common genealogical ancestor. The mutation rate for Y-chromosomal sequence data obtained was 0.78x10(-9) per bp per year, falling within the range of published rates. The mutation rate for Y-chromosomal STRs was 0.0022 per locus per generation, very close to the so-called genealogical rate. The "clan-based" approach to estimating the mutation rate provides a third, middle way between direct farther-to-son comparisons and using archeologically known migrations, whose dates are subject to revision and of uncertain relationship to genetic events.	[Balanovsky, Oleg; Zhabagin, Maxat; Agdzhoyan, Anastasiya; Chukhryaeva, Marina; Dibirova, Khadizhat; Skhalyakho, Roza] Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia; [Balanovsky, Oleg; Chukhryaeva, Marina; Zaporozhchenko, Valery; Dibirova, Khadizhat; Skhalyakho, Roza; Kuznetsova, Marina; Balanovska, Elena] Russian Acad Sci, Med Genet Res Ctr, Moscow, Russia; [Zhabagin, Maxat; Sabitov, Zhaxylyk] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan; [Utevska, Olga] Kharkov Natl Univ, Dept Genet & Citol, Kharkov, Ukraine; [Highnam, Gareth; Greenspan, Elliott] Gene Gene Ltd, Houston, TX USA; [Sabitov, Zhaxylyk] Gumilov Eurasian Natl Univ, Astana, Kazakhstan; [Koshel, Sergey] Moscow MV Lomonosov State Univ, Fac Geog, Moscow, Russia; [Yusupov, Yuldash] Inst Humanitarian Res Republ Bashkortostan, Ufa, Russia; [Nymadawa, Pagbajabyn] Mongolian Acad Med Sci, Ulaanbaatar, Mongolia; [Zhumadilov, Zhaxybay] Krasnodar State Med Univ, Krasnodar, Russia; [Pocheshkhova, Elvira; Haber, Marc; Tyler-Smith, Chris] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Zalloua, Pierre A.] Lebanese Amer Univ, Beirut, Lebanon; [Yepiskoposyan, Levon] Natl Acad Sci Republ Armenia, Inst Mol Biol, Yerevan, Armenia; [Dybo, Anna] Russian Acad Sci, Inst Linguist, Moscow, Russia	Russian Academy of Sciences; Vavilov Institute of General Genetics; Research Centre for Medical Genetics; Russian Academy of Sciences; Nazarbayev University; Ministry of Education & Science of Ukraine; VN Karazin Kharkiv National University; L.N. Gumilyov Eurasian National University; Lomonosov Moscow State University; Mongolian Academy of Sciences; Kuban State Medical University; Wellcome Trust Sanger Institute; Lebanese American University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Institute of Linguistics, Russian Academy of Sciences; Russian Academy of Sciences	Balanovsky, O (corresponding author), Russian Acad Sci, Vavilov Inst Gen Genet, Moscow, Russia.	balanovsky@inbox.ru	Pocheshkhova, Elvira/P-2207-2017; Zhabagin, Maxat/P-9956-2015; Sabitov, Zhaxylyk M./P-7576-2014; Nymadawa, Pagbajab/AAE-7344-2019; Haber, Marc/Y-5090-2019; Koshel, Sergey M/B-2662-2012; Agdzhoyan, Anastasia/G-1540-2014; Dybo, Anna/F-8623-2016	Pocheshkhova, Elvira/0000-0002-8991-7194; Zhabagin, Maxat/0000-0003-3414-0610; Sabitov, Zhaxylyk M./0000-0001-7186-156X; Nymadawa, Pagbajab/0000-0002-3189-2772; Haber, Marc/0000-0003-1000-1448; Koshel, Sergey M/0000-0002-4540-2922; Agdzhoyan, Anastasia/0000-0002-8776-2934; Dybo, Anna/0000-0002-6077-7183; Shalaho, Roza/0000-0002-4005-1887; zalloua, pierre/0000-0002-8494-5081; Utevska, Olga/0000-0002-5787-0467; Yusupov, Yuldash/0000-0002-7210-7136	Russian Scientific Foundation [14-14-00827]; Center for Life Sciences of Nazarbayev University; RFBR [13-04-01711]; Wellcome Trust [098051]; Russian Science Foundation [14-14-00827] Funding Source: Russian Science Foundation	Russian Scientific Foundation(Russian Science Foundation (RSF)); Center for Life Sciences of Nazarbayev University; RFBR(Russian Foundation for Basic Research (RFBR)); Wellcome Trust(Wellcome TrustEuropean Commission); Russian Science Foundation(Russian Science Foundation (RSF))	This study received primary support from the Russian Scientific Foundation grant 14-14-00827, including funding for genotyping, data analysis, and completing the paper. MZ and his research has been funded by research project and research grant from Center for Life Sciences of Nazarbayev University. Analyses related to Indo-European problem were funded by RFBR grant 13-04-01711. CTS is supported by The Wellcome Trust (grant 098051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero KK, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-59; Balanovsky O, 2008, AM J HUM GENET, V82, P236, DOI 10.1016/j.ajhg.2007.09.019; Balanovsky O, 2011, MOL BIOL EVOL, V28, P2905, DOI 10.1093/molbev/msr126; BANDELT HJ, 1995, GENETICS, V141, P743; Biro AZ, 2009, AM J PHYS ANTHROPOL, V139, P305, DOI 10.1002/ajpa.20984; Boattini A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065441; Cadenas AM, 2008, EUR J HUM GENET, V16, P374, DOI 10.1038/sj.ejhg.5201934; Chennakrishnaiah S, 2013, GENE, V526, P96, DOI 10.1016/j.gene.2013.04.074; Cinnioglu C, 2004, HUM GENET, V114, P127, DOI 10.1007/s00439-003-1031-4; Di Cristofaro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076748; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Eaaswarkhanth M, 2010, EUR J HUM GENET, V18, P354, DOI 10.1038/ejhg.2009.168; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Forster P, 2001, MOL BIOL EVOL, V18, P1864, DOI 10.1093/oxfordjournals.molbev.a003728; Forster P, 1996, AM J HUM GENET, V59, P935; Francalacci P, 2013, SCIENCE, V341, P565, DOI 10.1126/science.1237947; Ge JY, 2009, FORENSIC SCI INT-GEN, V3, P179, DOI 10.1016/j.fsigen.2009.01.007; Ginzburg V, 1956, WORKS KIRGHIZ ARCHAE, V1, P85; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Grugni V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041252; Gusmao L, 2005, HUM MUTAT, V26, P520, DOI 10.1002/humu.20254; Haber M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034288; Haber M, 2011, EUR J HUM GENET, V19, P334, DOI 10.1038/ejhg.2010.177; Heath T., 2008, THESIS; Herrera KJ, 2012, EUR J HUM GENET, V20, P313, DOI 10.1038/ejhg.2011.192; Karafet T, 2001, AM J HUM GENET, V69, P615, DOI 10.1086/323299; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kazarnitskiy A. A., 2012, POPULATION AZOV CASP; Khachikyan L, 1969, B YEREVAN STATE U, V2, P115; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Koshel S.M., 2012, SOVREMENNAYA GEOGRAF, P158; Lashgary Z, 2011, ANN HUM BIOL, V38, P364, DOI 10.3109/03014460.2010.535562; Mallory JP., 1989, SEARCH INDO EUROPEAN, DOI DOI 10.1038/nature11698; Margaryan A, 2012, HUM BIOL, V84, P405, DOI 10.3378/027.084.0404; Masanov N, 2011, NOMADIC KAZAKHS CIVI, P740; Mendez FL, 2013, AM J HUM GENET, V92, P454, DOI 10.1016/j.ajhg.2013.02.002; Nei M., 1987, MOL EVOLUTIONARY GEN; Oransky I, 1960, INTRO IRANIAN PHILOL, P62; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Regueiro M, 2006, HUM HERED, V61, P132, DOI 10.1159/000093774; Rootsi S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3928; Rootsi S, 2012, EUR J HUM GENET, V20, P1275, DOI 10.1038/ejhg.2012.86; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sanchez-Diz P, 2008, INT J LEGAL MED, V122, P529, DOI 10.1007/s00414-008-0265-z; Sengupta S, 2006, AM J HUM GENET, V78, P202, DOI 10.1086/499411; Torlakian BG, 1981, ETHNOGRAPHY FOLKLORE, V13, P24; Wei W, 2013, GENOME RES, V23, P388, DOI 10.1101/gr.143198.112; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; Xue YL, 2006, GENETICS, V172, P2431, DOI 10.1534/genetics.105.054270; Yunusbayev B, 2012, MOL BIOL EVOL, V29, P359, DOI 10.1093/molbev/msr221; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhong H, 2010, J HUM GENET, V55, P428, DOI 10.1038/jhg.2010.40	55	32	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122968	10.1371/journal.pone.0122968	http://dx.doi.org/10.1371/journal.pone.0122968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849548	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800185
J	Braicu, C; Pileczki, V; Pop, L; Petric, RC; Chira, S; Pointiere, E; Achimas-Cadariu, P; Berindan-Neagoe, I				Braicu, Cornelia; Pileczki, Valentina; Pop, Laura; Petric, Roxana Cojocneanu; Chira, Sergiu; Pointiere, Eve; Achimas-Cadariu, Patriciu; Berindan-Neagoe, Ioana			Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model	PLOS ONE			English	Article							MUTANT P53; GREEN TEA; APOPTOSIS; AUTOPHAGY; PROLIFERATION; INHIBITION; MIGRATION	Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the administration of a natural compound, epigallocatechingallate (EGCG). RT(2)Profiler PCR Array technology was used to evaluate the impact of dual treatment on the main genes involved in apoptosis in the Hs578T cell culture model of TNBC. Gene expression analysis revealed 28 genes were significantly altered (16 upregulated and 12 downregulated) in response to combined p53 siRNA and EGCG treatment. Further analysis revealed that p53 siRNA and EGCG dual therapy leads to the activation of pro-apoptotic genes and the inhibition of pro-survival genes, autophagy, and cell network formation. These results indicate that this dual therapy targets both the apoptotic and angiogenic pathways, which may improve treatment effectiveness for tumors resistant to conventional treatment.	[Braicu, Cornelia; Pileczki, Valentina; Pop, Laura; Petric, Roxana Cojocneanu; Chira, Sergiu; Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Res Ctr Funct Genom Biomed & Translat Med, Cluj Napoca, Romania; [Pileczki, Valentina] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Cluj Napoca, Romania; [Petric, Roxana Cojocneanu] Univ Babes Bolyai, Fac Biol & Geol, R-3400 Cluj Napoca, Romania; [Pointiere, Eve] Haute Ecole Louvain Hainaut, Fleurus, Belgium; [Achimas-Cadariu, Patriciu] Oncol Inst Prof Dr Ion Chiricuta, Dept Surg, Cluj Napoca, Romania; [Achimas-Cadariu, Patriciu] Iuliu Hatieganu Univ Med & Pharm, Dept Surg Oncol & Gynaecol Oncol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Iuliu Hatieganu Univ Med & Pharm, Dept Immunol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] Oncol Inst Prof Dr Ion Chiricuta, Dept Funct Genom & Expt Pathol, Cluj Napoca, Romania; [Berindan-Neagoe, Ioana] MD Anderson Canc Ctr Houston, Dept Expt Therapeut, Houston, TX USA	Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Babes Bolyai University from Cluj; Oncology Institute Prof. Dr. Ion Chiricuta; Iuliu Hatieganu University of Medicine & Pharmacy; Iuliu Hatieganu University of Medicine & Pharmacy; Oncology Institute Prof. Dr. Ion Chiricuta; University of Texas System; UTMD Anderson Cancer Center	Achimas-Cadariu, P (corresponding author), Oncol Inst Prof Dr Ion Chiricuta, Dept Surg, Cluj Napoca, Romania.	pachimas@umfcluj.ro; ioananeagoe29@gmail.com	Pop, Laura/AAY-8349-2020; Berindan-Neagoe, Ioana/AAH-9854-2019; Chira, Sergiu/AAD-4885-2020; Pileczki, Valentina/ABB-6273-2020; Pop, Laura A/B-8218-2012	Pop, Laura/0000-0002-5806-0220; Chira, Sergiu/0000-0001-6075-7468; Pop, Laura A/0000-0002-5806-0220; Cojocneanu, Roxana-Maria/0000-0002-7450-9454	Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE) [709/2010]; NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION (PNII); European Social Fund; Human Resources Development Operational Programme [POSDRU/159/1.5/S/138776]	Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE); NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION (PNII); European Social Fund(European Social Fund (ESF)); Human Resources Development Operational Programme	This work was financed by the Sectoral Operational Program for Increasing the Economic Competitiveness (POSCCE) 709/2010 grant with the title: "Clinical and economical impact of proteom and transcriptom molecular profiling in neoadjuvant therapy of triple negative breast cancer (BREASTIMPACT)". Cornelia Braicu has received a research grant financed by THE NATIONAL PLAN FOR RESEARCH, DEVELOPMENT AND INNOVATION 2007-2013 (PNII) with title: "Modulation of pro/anticarcinogenic effect of toxic chemical agents in breast cancer multitargeted therapy (CANCERTER-p53). Valentina Pileczki, Laura Pop, and Roxana Cojocneanu Petric has received a fellowships under the frame of European Social Fund, Human Resources Development Operational Programme 2007-2013, project no. POSDRU/159/1.5/S/138776 with title: "Model colaborativ institutional pentru translatarea cercetarii stiintifice biomedicale in practica clinica-TRANCENT". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atencio IA, 2006, CANCER GENE THER, V13, P169, DOI 10.1038/sj.cgt.7700870; Berindan-Neagoe I, 2012, INT J NANOMED, V7, P6035, DOI 10.2147/IJN.S36523; Braicu C, 2013, MOL CELL BIOCHEM, V381, P61, DOI 10.1007/s11010-013-1688-5; Braicu C, 2013, J NANOSCI NANOTECHNO, V13, P632, DOI 10.1166/jnn.2013.6882; Braicu C, 2013, J DRUG TARGET, V21, P250, DOI 10.3109/1061186X.2012.740673; Chen CA, 2008, CANCER BIOL THER, V7, P303, DOI 10.4161/cbt.7.2.5333; Chen WC, 2014, FOOD FUNCT, V5, P1856, DOI [10.1039/c4fo00145a, 10.1039/C4FO00145A]; Chiorean R, 2013, BREAST, V22, P1026, DOI 10.1016/j.breast.2013.08.007; Chittaranjan S, 2014, CLIN CANCER RES, V20, P3159, DOI 10.1158/1078-0432.CCR-13-2060; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Dai FJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052162; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Jiang Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.200; Johnson R, 2013, PHARMACEUTICS, V1, DOI [10.3390/pharmaceutics5020329, DOI 10.3390/PHARMACEUTICS5020329]; Kanwar Jyoti, 2012, Front Biosci (Elite Ed), V4, P111; Liu K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.51; Liu K, 2013, LIVER INT, V33, P1566, DOI 10.1111/liv.12238; Pal SK, 2011, BREAST CANCER RES TR, V125, P627, DOI 10.1007/s10549-010-1293-1; Sharma C, 2012, ASIAN PAC J CANCER P, V13, P4815, DOI 10.7314/APJCP.2012.13.9.4815; Storvold Gro Leite, 2006, Critical Reviews in Oncogenesis, V12, P127; Suzuki Y, 2012, P JPN ACAD B-PHYS, V88, P88, DOI 10.2183/pjab.88.88; Tachibana H, 2011, P JPN ACAD B-PHYS, V87, P66, DOI 10.2183/pjab.87.66; Teodoro JG, 2007, J MOL MED-JMM, V85, P1175, DOI 10.1007/s00109-007-0221-2; Walerych D, 2012, CARCINOGENESIS, V33, P2007, DOI 10.1093/carcin/bgs232; White E, 2015, J CLIN INVEST, V125, P42, DOI 10.1172/JCI73941; Yadav BS, 2014, WORLD J CLIN ONCOL, V5, P125, DOI 10.5306/wjco.v5.i2.125	27	22	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120936	10.1371/journal.pone.0120936	http://dx.doi.org/10.1371/journal.pone.0120936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849487	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800040
J	Hashimoto, M; Yamazaki, T; Hamaguchi, M; Morimoto, T; Yamori, M; Asai, K; Isobe, Y; Furu, M; Ito, H; Fujii, T; Terao, C; Mori, M; Matsuo, T; Yoshitomi, H; Yamamoto, K; Yamamoto, W; Bessho, K; Mimori, T				Hashimoto, Motomu; Yamazaki, Toru; Hamaguchi, Masahide; Morimoto, Takeshi; Yamori, Masashi; Asai, Keita; Isobe, Yu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Terao, Chikashi; Mori, Masato; Matsuo, Takashi; Yoshitomi, Hiroyuki; Yamamoto, Keiichi; Yamamoto, Wataru; Bessho, Kazuhisa; Mimori, Tsuneyo			Periodontitis and Porphyromonas gingivalis in Preclinical Stage of Arthritis Patients	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; SHARED EPITOPE; RISK-FACTOR; TOOTH LOSS; DISEASE; ASSOCIATION; RECOMMENDATIONS; AUTOIMMUNITY; INFECTIONS; MICROBIOTA	Purpose To determine whether the presence of periodontitis (PD) and Porphyromonas gingivalis (Pg) in the subgingival biofilm associates with the development of rheumatoid arthritis (RA) in treatment naive preclinical stage of arthritis patients. Methods We conducted a prospective cohort study of 72 consecutive patients with arthralgia who had never been treated with any anti-rheumatic drugs or glucocorticoids. Periodontal status at baseline was assessed by dentists. PD was defined stringently by the maximal probing depth. 4 mm, or by the classification by the 5th European Workshop in Periodontology (EWP) in 2005 using attachment loss. Up to eight plaque samples were obtained from each patient and the presence of Pg was determined by Taqman PCR. The patients were followed up for 2 years and introduction rate of methotrexate (MTX) treatment on the diagnosis of RA was compared in patients with or without PD or Pg. Results Patients with PD (probing depth >= 4mm) had higher arthritis activity (p = 0.02) and higher risk for future introduction of MTX treatment on the diagnosis of RA during the follow up than patients without PD (Hazard ratio 2.68, p = 0.03). Arthritis activity and risk for MTX introduction increased with the severity of PD assessed by EWP, although not statistically significant. On the other hand, presence of Pg was not associated with arthritis activity (p = 0.72) or the risk for MTX introduction (p = 0.45). Conclusion In treatment naive arthralgia patients, PD, but not the presence of Pg, associates with arthritis activity and future requirement of MTX treatment on the diagnosis of RA.	[Hashimoto, Motomu; Furu, Moritoshi; Ito, Hiromu; Fujii, Takao; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan; [Yamazaki, Toru; Yamori, Masashi; Asai, Keita; Isobe, Yu; Bessho, Kazuhisa] Kyoto Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Kyoto, Japan; [Hamaguchi, Masahide] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto, Japan; [Morimoto, Takeshi] Hyogo Coll Med, Dept Internal Med, Div Gen Med, Kobe, Hyogo, Japan; [Ito, Hiromu] Kyoto Univ, Grad Sch Med, Dept Orthoped Surg, Kyoto, Japan; [Fujii, Takao; Mori, Masato; Matsuo, Takashi; Mimori, Tsuneyo] Kyoto Univ, Grad Sch Med, Dept Rheumatol & Clin Immunol, Kyoto, Japan; [Terao, Chikashi] Kyoto Univ, Grad Sch Med, Ctr Genom Med, Kyoto, Japan; [Yoshitomi, Hiroyuki] Kyoto Univ, Ctr Innovat Immunoregulat Technol & Therapeut, Grad Sch Med, Kyoto, Japan; [Yamamoto, Keiichi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Osaka, Japan; [Yamamoto, Wataru] Kurashiki Sweet Hosp, Dept Hlth Informat Management, Kurashiki, Okayama, Japan	Kyoto University; Kyoto University; Kyoto Prefectural University of Medicine; Hyogo College of Medicine; University of Hyogo; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Osaka University	Hashimoto, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Control Rheumat Dis, Kyoto, Japan.	mohashim@kuhp.kyoto-u.ac.jp	Yamamoto, Keiichi/AFQ-9006-2022	Yamamoto, Keiichi/0000-0003-3278-5001; Hamaguchi, Masahide/0000-0002-8651-4445; , Hiroyuki/0000-0001-7339-9030	Ministry of Education, Culture, Sports, Science in Japan [23791113]	Ministry of Education, Culture, Sports, Science in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid (23791113) for Scientific Research from the Ministry of Education, Culture, Sports, Science in Japan (M. Hashimoto) http://kaken.nii.ac.jp/d/p/23791113.ja.html.	Aletaha D, 2010, ARTHRITIS RHEUM-US, V62, P2569, DOI 10.1002/art.27584; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; de Oliveira C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2451; de Pablo P, 2008, J RHEUMATOL, V35, P70; Demmer RT, 2011, J CLIN PERIODONTOL, V38, P998, DOI 10.1111/j.1600-051X.2011.01776.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Detert J, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3106; Hashimoto M, 2010, J EXP MED, V207, P1135, DOI 10.1084/jem.20092301; Hitchon CA, 2010, J RHEUMATOL, V37, P1105, DOI 10.3899/jrheum.091323; Kennish L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001117; Lundberg K, 2010, NAT REV RHEUMATOL, V6, P727, DOI 10.1038/nrrheum.2010.139; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Machado P, 2011, ANN RHEUM DIS, V70, P15, DOI 10.1136/ard.2010.130625; Marotte H, 2006, ANN RHEUM DIS, V65, P905, DOI 10.1136/ard.2005.036913; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; McGraw WT, 1999, INFECT IMMUN, V67, P3248, DOI 10.1128/IAI.67.7.3248-3256.1999; Mikuls TR, 2012, ARTHRITIS RHEUM-US, V64, P3522, DOI 10.1002/art.34595; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Ozmeric N, 2000, ACTA ODONTOL SCAND, V58, P183, DOI 10.1080/000163500429190; Potikuri D, 2012, ANN RHEUM DIS, V71, P1541, DOI 10.1136/annrheumdis-2011-200380; Rosenstein ED, 2004, INFLAMMATION, V28, P311, DOI 10.1007/s10753-004-6641-z; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Scher JU, 2011, NAT REV RHEUMATOL, V7, P569, DOI 10.1038/nrrheum.2011.121; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Spahr A, 2006, ARCH INTERN MED, V166, P554, DOI 10.1001/archinte.166.5.554; Suzuki N, 2005, CLIN MED RES, V3, P176, DOI 10.3121/cmr.3.3.176; Terao C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059341; Terao C, 2011, ANN RHEUM DIS, V70, P2134, DOI 10.1136/annrheumdis-2011-200353; Tonetti MS, 2005, J CLIN PERIODONTOL, V32, P210, DOI 10.1111/j.1600-051X.2005.00822.x; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Wara-aswapati N, 2009, ORAL DIS, V15, P354, DOI 10.1111/j.1601-0825.2009.01562.x; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; Wegner N, 2010, IMMUNOL REV, V233, P34, DOI 10.1111/j.0105-2896.2009.00850.x; Wolff B, 2014, RHEUMATOLOGY, V53, P526, DOI 10.1093/rheumatology/ket362; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xiong X, 2013, J PUBLIC HEALTH DENT, V73, P41, DOI 10.1111/jphd.12004	38	33	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122121	10.1371/journal.pone.0122121	http://dx.doi.org/10.1371/journal.pone.0122121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849461	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800100
J	Kaur, S; Jobling, S; Jones, CS; Noble, LR; Routledge, EJ; Lockyer, AE				Kaur, Satwant; Jobling, Susan; Jones, Catherine S.; Noble, Leslie R.; Routledge, Edwin J.; Lockyer, Anne E.			The Nuclear Receptors of Biomphalaria glabrata and Lottia gigantea: Implications for Developing New Model Organisms	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTOR; VERTEBRATE SEX STEROIDS; LIGAND-BINDING DOMAIN; FRESH-WATER SNAIL; SCHISTOSOMA-MANSONI; HORMONE-RECEPTOR; ENDOCRINE DISRUPTION; MARISA-CORNUARIETIS; EXPRESSION ANALYSIS; SIGNALING PATHWAYS	Nuclear receptors (NRs) are transcription regulators involved in an array of diverse physiological functions including key roles in endocrine and metabolic function. The aim of this study was to identify nuclear receptors in the fully sequenced genome of the gastropod snail, Biomphalaria glabrata, intermediate host for Schistosoma mansoni and compare these to known vertebrate NRs, with a view to assessing the snail's potential as a invertebrate model organism for endocrine function, both as a prospective new test organism and to elucidate the fundamental genetic and mechanistic causes of disease. For comparative purposes, the genome of a second gastropod, the owl limpet, Lottia gigantea was also investigated for nuclear receptors. Thirty-nine and thirty-three putative NRs were identified from the B. glabrata and L. gigantea genomes respectively, based on the presence of a conserved DNA-binding domain and/or ligand-binding domain. Nuclear receptor transcript expression was confirmed and sequences were subjected to a comparative phylogenetic analysis, which demonstrated that these molluscs have representatives of all the major NR subfamilies (1-6). Many of the identified NRs are conserved between vertebrates and invertebrates, however differences exist, most notably, the absence of receptors of Group 3C, which includes some of the vertebrate endocrine hormone targets. The mollusc genomes also contain NR homologues that are present in insects and nematodes but not in vertebrates, such as Group 1J (HR48/DAF12/HR96). The identification of many shared receptors between humans and molluscs indicates the potential for molluscs as model organisms; however the absence of several steroid hormone receptors indicates snail endocrine systems are fundamentally different.	[Kaur, Satwant; Jobling, Susan; Routledge, Edwin J.; Lockyer, Anne E.] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England; [Jones, Catherine S.; Noble, Leslie R.] Univ Aberdeen, Sch Biol Sci, Aberdeen, Scotland	Brunel University; University of Aberdeen	Lockyer, AE (corresponding author), Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England.	anne.lockyer@brunel.ac.uk	Lockyer, Anne/AAO-4327-2021; Routledge, Edwin John/V-2336-2019; Routledge, Edwin/AGI-0283-2022	Routledge, Edwin/0000-0001-7695-364X; Kaur, Satwant/0000-0002-8653-6791; Lockyer, Anne/0000-0002-3498-2423; Noble, leslie/0000-0003-3076-0759	National Centre for the Replacement, Refinement and Reduction of Animals in Research [G0900802]; National Centre for the Replacement [G0900802/1] Funding Source: researchfish	National Centre for the Replacement, Refinement and Reduction of Animals in Research(UK Research & Innovation (UKRI)National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs)); National Centre for the Replacement	This work was funded by the National Centre for the Replacement, Refinement and Reduction of Animals in Research, Grant Ref: G0900802 to CSJ, LRN, SJ & EJR [www.nc3rs.org.uk]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Adema CM, 2006, MEM I OSWALDO CRUZ, V101, P167, DOI 10.1590/S0074-02762006000900027; Adema CM, 2010, MOL IMMUNOL, V47, P849, DOI 10.1016/j.molimm.2009.10.019; Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Antebi A, 2000, GENE DEV, V14, P1512; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Auwerx J, 1999, CELL, V97, P161; Baker ME, 2004, MOL CELL ENDOCRINOL, V215, P55, DOI 10.1016/j.mce.2003.11.007; Baker ME, 2008, BIOCHEM BIOPH RES CO, V375, P623, DOI 10.1016/j.bbrc.2008.08.047; Bannister R, 2007, ENVIRON SCI TECHNOL, V41, P2643, DOI 10.1021/es062565m; Bannister R, 2013, AQUAT TOXICOL, V140, P19, DOI 10.1016/j.aquatox.2013.05.002; Bardet PL, 2006, TRENDS ENDOCRIN MET, V17, P166, DOI 10.1016/j.tem.2006.03.005; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benoit G, 2004, TRENDS CELL BIOL, V14, P369, DOI 10.1016/j.tcb.2004.05.007; Bertrand W, 2004, MOL BIOL EVOL, V21, P1923, DOI 10.1093/molbev/msh200; Bonneton F, 2008, INSECT BIOCHEM MOLEC, V38, P416, DOI 10.1016/j.ibmb.2007.10.006; Bouton D, 2005, J MOL ENDOCRINOL, V34, P567, DOI 10.1677/jme.1.01766; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Bridgham JT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000191; Burge CB, 1998, CURR OPIN STRUC BIOL, V8, P346, DOI 10.1016/S0959-440X(98)80069-9; Carter CJ, 2010, DEV BIOL, V343, P124, DOI 10.1016/j.ydbio.2010.03.023; Castro LFC, 2007, AQUAT TOXICOL, V85, P57, DOI 10.1016/j.aquatox.2007.07.016; Castro LFC, 2007, AQUAT TOXICOL, V84, P465, DOI 10.1016/j.aquatox.2007.07.008; Chen LM, 2008, MOL ENDOCRINOL, V22, P858, DOI 10.1210/me.2007-0181; Chitsulo L, 2004, NAT REV MICROBIOL, V2, P12, DOI 10.1038/nrmicro801; Chung Arthur C, 2003, Nucl Recept Signal, V1, pe007; Daniel A, 1999, DEVELOPMENT, V126, P2945; de Groot A, 2005, J MOL BIOL, V354, P841, DOI 10.1016/j.jmb.2005.09.090; Ding XF, 2013, J ZHEJIANG UNIV-SC B, V14, P171, DOI 10.1631/jzus.B1200357; Eick GN, 2011, MOL CELL ENDOCRINOL, V334, P31, DOI 10.1016/j.mce.2010.09.003; Enmark E, 2001, TRENDS PHARMACOL SCI, V22, P611, DOI 10.1016/S0165-6147(00)01859-9; Escobedo G, 2005, TRENDS PARASITOL, V21, P588, DOI 10.1016/j.pt.2005.09.013; Ford ES, 2008, DIABETES CARE, V31, P587, DOI 10.2337/dc07-1030; GARCIA M, 1995, GEN COMP ENDOCR, V97, P76, DOI 10.1006/gcen.1995.1008; Glass CK, 2000, GENE DEV, V14, P121; Golden SH, 2009, J CLIN ENDOCR METAB, V94, P1853, DOI 10.1210/jc.2008-2291; Greenspan RJ, 2005, CURR BIOL, V15, pR671, DOI 10.1016/j.cub.2005.08.018; Gutierrez-Mazariegos J, 2014, ENDOCRINOLOGY, V155, P4275, DOI 10.1210/en.2014-1181; Hanington PC, 2010, P NATL ACAD SCI USA, V107, P21087, DOI 10.1073/pnas.1011242107; Hanington PC, 2010, INT J PARASITOL, V40, P819, DOI 10.1016/j.ijpara.2009.12.005; Hertel LA, 2005, DEV COMP IMMUNOL, V29, P295, DOI 10.1016/j.dci.2004.08.003; Heyland A, 2005, J EXP BIOL, V208, P4355, DOI 10.1242/jeb.01877; Hultin CL, 2014, GENE, V540, P26, DOI 10.1016/j.gene.2014.02.039; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Jiang YG, 2006, DEV COMP IMMUNOL, V30, P855, DOI 10.1016/j.dci.2005.12.004; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kajiwara M, 2006, GEN COMP ENDOCR, V148, P315, DOI 10.1016/j.ygcen.2006.03.016; Katsu Y, 2010, ENDOCRINOLOGY, V151, P639, DOI 10.1210/en.2009-0766; Keay J, 2006, ENDOCRINOLOGY, V147, P3861, DOI 10.1210/en.2006-0363; Keay J, 2009, ENDOCRINOLOGY, V150, P1731, DOI 10.1210/en.2008-1338; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; KLIEWER SA, 1992, NATURE, V358, P771, DOI 10.1038/358771a0; Knight M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001212; Kohler HR, 2007, ECOTOXICOLOGY, V16, P131, DOI 10.1007/s10646-006-0111-3; Kumkate S, 2009, J PARASITOL, V95, P1391, DOI 10.1645/GE-2080.1; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; Laguerre M, 2010, FEBS LETT, V584, P4458, DOI 10.1016/j.febslet.2010.10.004; le Maire A, 2009, EMBO REP, V10, P367, DOI 10.1038/embor.2009.8; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levin ER, 2008, AM J PHYSIOL-REG I, V295, pR1425, DOI 10.1152/ajpregu.90605.2008; Li TR, 2000, DEVELOPMENT, V127, P2897; Lima D, 2011, AQUAT TOXICOL, V101, P221, DOI 10.1016/j.aquatox.2010.09.022; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Lockyer AE, 2004, CAN J ZOOL, V82, P251, DOI [10.1139/z03-215, 10.1139/Z03-215]; Lockyer AE, 2007, DEV COMP IMMUNOL, V31, P763, DOI 10.1016/j.dci.2006.11.004; Lockyer AE, 2007, MOL BIOCHEM PARASIT, V151, P18, DOI 10.1016/j.molbiopara.2006.09.009; Lockyer AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051102; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; Markov GV, 2011, MOL CELL ENDOCRINOL, V334, P21, DOI 10.1016/j.mce.2010.10.017; Markov GV, 2009, P NATL ACAD SCI USA, V106, P11913, DOI 10.1073/pnas.0812138106; Matsumoto T, 2007, GEN COMP ENDOCR, V151, P195, DOI 10.1016/j.ygcen.2007.01.016; Matthiessen P, 1998, ENVIRON TOXICOL CHEM, V17, P37, DOI 10.1002/etc.5620170106; Matthiessen Peter, 2008, Integrated Environmental Assessment and Management, V4, P274, DOI 10.1897/IEAM_2008-003.1; Mitta G, 2005, DEV COMP IMMUNOL, V29, P393, DOI 10.1016/j.dci.2004.10.002; Mu XM, 2004, MOL CELL BIOL, V24, P5887, DOI 10.1128/MCB.24.13.5887-5899.2004; Oehlmann J, 2003, PURE APPL CHEM, V75, P2207, DOI 10.1351/pac200375112207; Omran NEE, 2012, REPROD BIOL, V12, P301, DOI 10.1016/j.repbio.2012.10.002; Pascoal S, 2013, MOL ECOL, V22, P1589, DOI 10.1111/mec.12137; Pawlak M, 2012, CURR TOP MED CHEM, V12, P486, DOI 10.2174/156802612799436641; Puinean AM, 2006, AQUAT TOXICOL, V79, P376, DOI 10.1016/j.aquatox.2006.07.006; Raghavan N, 2006, TRENDS PARASITOL, V22, P148, DOI 10.1016/j.pt.2006.02.008; Rapado LN, 2014, MOLECULES, V19, P5205, DOI 10.3390/molecules19045205; Robinson-Rechavi M, 2005, J MOL EVOL, V60, P577, DOI 10.1007/s00239-004-0175-8; Robinson-Rechavi M, 2003, J CELL SCI, V116, P585, DOI 10.1242/jcs.00247; Robinson-Rechavi M, 2001, TRENDS GENET, V17, P554, DOI 10.1016/S0168-9525(01)02417-9; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schiffelers MJWA, 2014, REGUL TOXICOL PHARM, V69, P41, DOI 10.1016/j.yrtph.2014.02.007; Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Scott AP, 2012, STEROIDS, V77, P1450, DOI 10.1016/j.steroids.2012.08.009; SHIFF CJ, 1991, TROP MED PARASITOL, V42, P11; Simakov O, 2013, NATURE, V493, P526, DOI 10.1038/nature11696; Simoncini T, 2003, EUR J ENDOCRINOL, V148, P281, DOI 10.1530/eje.0.1480281; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Sluder AE, 2001, TRENDS GENET, V17, P206, DOI 10.1016/S0168-9525(01)02242-9; Snow MI, 2000, BBA-GENE STRUCT EXPR, V1494, P104, DOI 10.1016/S0167-4781(00)00224-4; Stange D, 2012, ECOTOX ENVIRON SAFE, V75, P94, DOI 10.1016/j.ecoenv.2011.09.003; Sternberg RM, 2008, GEN COMP ENDOCR, V156, P15, DOI 10.1016/j.ygcen.2007.12.002; Sternberg RM, 2010, ECOTOXICOLOGY, V19, P4, DOI 10.1007/s10646-009-0397-z; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Tallarico LDF, 2014, ECOTOX ENVIRON SAFE, V110, P208, DOI 10.1016/j.ecoenv.2014.09.005; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas P, 2006, J STEROID BIOCHEM, V102, P175, DOI 10.1016/j.jsbmb.2006.09.017; Thomson SA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-500; Thornton JW, 2003, SCIENCE, V301, P1714, DOI 10.1126/science.1086185; Thummel CS, 1996, TRENDS GENET, V12, P306, DOI 10.1016/0168-9525(96)10032-9; Tillmann M, 2001, ECOTOXICOLOGY, V10, P373, DOI 10.1023/A:1012279231373; Tyler CR, 1998, CRIT REV TOXICOL, V28, P319, DOI 10.1080/10408449891344236; UEDA H, 1992, MOL CELL BIOL, V12, P5667, DOI 10.1128/MCB.12.12.5667; Urushitani H, 2013, AQUAT TOXICOL, V142, P403, DOI 10.1016/j.aquatox.2013.09.008; Velarde RA, 2006, INSECT MOL BIOL, V15, P583, DOI 10.1111/j.1365-2583.2006.00679.x; Vogeler S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-369; WHITEHEAD DL, 1982, EXPERIENTIA, V38, P1249, DOI 10.1007/BF01959769; Wu W, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-150; Wu WJ, 2011, MOL CELL ENDOCRINOL, V334, P56, DOI 10.1016/j.mce.2010.06.011; Wu WJ, 2006, GENE, V366, P303, DOI 10.1016/j.gene.2005.09.013; Wurtz JM, 1996, NAT STRUCT BIOL, V3, P87, DOI 10.1038/nsb0196-87; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhang H, 2012, COMP BIOCHEM PHYS C, V156, P51, DOI 10.1016/j.cbpc.2012.03.007; Zhang ZD, 2004, GENOME RES, V14, P580, DOI 10.1101/gr.2160004	124	36	37	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121259	10.1371/journal.pone.0121259	http://dx.doi.org/10.1371/journal.pone.0121259			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849443	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800051
J	Kim, DY; Abdelwahab, MG; Lee, SH; O'Neill, D; Thompson, RJ; Duff, HJ; Sullivan, PG; Rho, JM				Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek; Thompson, Roger J.; Duff, Henry J.; Sullivan, Patrick G.; Rho, Jong M.			Ketones Prevent Oxidative Impairment of Hippocampal Synaptic Integrity through K-ATP Channels	PLOS ONE			English	Article							SENSITIVE POTASSIUM CHANNELS; KETOGENIC DIET; NEURODEGENERATIVE DISEASES; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; GRANULE NEURONS; TAU PATHOLOGIES; ROS PRODUCTION; MOUSE MODEL; STRESS	Dietary and metabolic therapies are increasingly being considered for a variety of neurological disorders, based in part on growing evidence for the neuroprotective properties of the ketogenic diet (KD) and ketones. Earlier, we demonstrated that ketones afford hippocampal synaptic protection against exogenous oxidative stress, but the mechanisms underlying these actions remain unclear. Recent studies have shown that ketones may modulate neuronal firing through interactions with ATP-sensitive potassium (K-ATP) channels. Here, we used a combination of electrophysiological, pharmacological, and biochemical assays to determine whether hippocampal synaptic protection by ketones is a consequence of K-ATP channel activation. Ketones dose-dependently reversed oxidative impairment of hippocampal synaptic integrity, neuronal viability, and bioenergetic capacity, and this action was mirrored by the K-ATP channel activator diazoxide. Inhibition of K-ATP channels reversed ketoneevoked hippocampal protection, and genetic ablation of the inwardly rectifying K+ channel subunit Kir6.2, a critical component of K-ATP channels, partially negated the synaptic protection afforded by ketones. This partial protection was completely reversed by co-application of the KATP blocker, 5-hydoxydecanoate (5HD). We conclude that, under conditions of oxidative injury, ketones induce synaptic protection in part through activation of K-ATP channels.	[Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Kim, Do Young; Abdelwahab, Mohammed G.; Lee, Soo Han; O'Neill, Derek] St Josephs Hosp, Barrow Neurol Inst, Dept Neurobiol, Phoenix, AZ USA; [Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Dept Cell Biol, Calgary, AB, Canada; [Thompson, Roger J.] Univ Calgary, Hotchkiss Brain Inst, Dept Anat, Calgary, AB, Canada; [Duff, Henry J.] Univ Calgary, Libin Cardiovasc Inst Alberta, Calgary, AB, Canada; [Sullivan, Patrick G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY USA; [Rho, Jong M.] Alberta Childrens Prov Gen Hosp, Dept Pediat, Calgary, AB, Canada; [Rho, Jong M.] Alberta Childrens Prov Gen Hosp, Dept Clin Neurosci, Calgary, AB, Canada	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; University of Calgary; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Kentucky; Alberta Childrens Hospital; University of Calgary; Alberta Childrens Hospital; University of Calgary	Kim, DY (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA.	doyoung.kim@dignityhealth.org	Lee, Soohan/AAP-6976-2020; Thompson, Roger/L-3930-2016	Thompson, Roger/0000-0002-7019-7246	NIH [NS 070261]; Canadian Institutes of Health Research; Barrow Neurological Foundation; Arizona Biomedical Research Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070261] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Barrow Neurological Foundation; Arizona Biomedical Research Commission; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS 070261 (DYK/JMR), the Canadian Institutes of Health Research (JMR), the Barrow Neurological Foundation and the Arizona Biomedical Research Commission (DYK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; Avshalumov MV, 2002, J NEUROPHYSIOL, V87, P2896, DOI 10.1152/jn.2002.87.6.2896; BENARI Y, 1990, NEUROSCIENCE, V37, P55, DOI 10.1016/0306-4522(90)90191-6; Betourne A, 2009, NEUROPHARMACOLOGY, V56, P615, DOI 10.1016/j.neuropharm.2008.11.001; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; Chen Y, 1996, NEUROSCI LETT, V218, P204, DOI 10.1016/S0304-3940(96)13149-9; Choeiri C, 2006, BEHAV BRAIN RES, V172, P233, DOI 10.1016/j.bbr.2006.05.005; Costa ADT, 2009, J BIOENERG BIOMEMBR, V41, P123, DOI 10.1007/s10863-009-9213-y; Dargusch R, 2002, J NEUROCHEM, V81, P1394, DOI 10.1046/j.1471-4159.2002.00950.x; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; Domoki F, 2005, AM J PHYSIOL-HEART C, V289, pH368, DOI 10.1152/ajpheart.00887.2004; Drose S, 2009, BBA-GEN SUBJECTS, V1790, P558, DOI 10.1016/j.bbagen.2009.01.011; Hartman AL, 2007, PEDIATR NEUROL, V36, P281, DOI 10.1016/j.pediatrneurol.2007.02.008; HEURTEAUX C, 1995, P NATL ACAD SCI USA, V92, P4666, DOI 10.1073/pnas.92.10.4666; HONORE E, 1993, PFLUG ARCH EUR J PHY, V424, P113, DOI 10.1007/BF00374601; Huang CW, 2007, J NEUROSCI RES, V85, P1468, DOI 10.1002/jnr.21284; Ienco EC, 2011, J ALZHEIMERS DIS, V24, P111, DOI 10.3233/JAD-2011-110164; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Jarrett SG, 2008, J NEUROCHEM, V106, P1044, DOI 10.1111/j.1471-4159.2008.05460.x; Kamsler A, 2003, J NEUROSCI, V23, P269; Kane GC, 2005, J MOL CELL CARDIOL, V38, P937, DOI 10.1016/j.yjmcc.2005.02.026; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kim DY, 2008, CURR OPIN CLIN NUTR, V11, P113, DOI 10.1097/MCO.0b013e3282f44c06; Kim DY, 2007, J NEUROCHEM, V101, P1316, DOI 10.1111/j.1471-4159.2007.04483.x; Kim DY, 2010, J NEUROCHEM, V114, P130, DOI 10.1111/j.1471-4159.2010.06728.x; KIRSCH GE, 1990, AM J PHYSIOL, V259, pH820, DOI 10.1152/ajpheart.1990.259.3.H820; Kleman AM, 2008, J NEUROSCI METH, V167, P292, DOI 10.1016/j.jneumeth.2007.08.028; Krikorian R, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.10.006; Liang HW, 2005, BRAIN RES, V1042, P169, DOI 10.1016/j.brainres.2005.02.031; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu B, 2010, MOL CELL BIOCHEM, V337, P25, DOI 10.1007/s11010-009-0283-2; Liu D, 2010, J ALZHEIMERS DIS, V22, P443, DOI 10.3233/JAD-2010-101017; Lund TM, 2015, J NEUROCHEM, V132, P520, DOI 10.1111/jnc.12975; Lund TM, 2009, J NEUROCHEM, V110, P80, DOI 10.1111/j.1471-4159.2009.06115.x; Ma WY, 2007, J NEUROSCI, V27, P3618, DOI 10.1523/JNEUROSCI.0132-07.2007; Maalouf M, 2007, NEUROSCIENCE, V145, P256, DOI 10.1016/j.neuroscience.2006.11.065; Maalouf M, 2008, J NEUROSCI RES, V86, P3322, DOI 10.1002/jnr.21782; Milder J, 2012, EPILEPSY RES, V100, P295, DOI 10.1016/j.eplepsyres.2011.09.021; Nagy K, 2004, J NEUROSCI RES, V76, P697, DOI 10.1002/jnr.20120; Neal EG, 2008, LANCET NEUROL, V7, P500, DOI 10.1016/S1474-4422(08)70092-9; Nordli DR, 1997, EPILEPSIA, V38, P743, DOI 10.1111/j.1528-1157.1997.tb01460.x; Robin E, 2011, BRAIN RES, V1375, P137, DOI 10.1016/j.brainres.2010.12.054; Sakurai T, 2000, Nihon Ronen Igakkai Zasshi, V37, P962; Schroder UH, 2004, EUR J PHARMACOL, V502, P99, DOI 10.1016/j.ejphar.2004.08.046; Simao F, 2011, J NUTR BIOCHEM, V22, P921, DOI 10.1016/j.jnutbio.2010.07.013; Smith SL, 2005, CNS DRUG REV, V11, P113; Sun XL, 2010, CLIN EXP PHARMACOL P, V37, P243, DOI 10.1111/j.1440-1681.2009.05190.x; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Tanner GR, 2011, J NEUROSCI, V31, P8689, DOI 10.1523/JNEUROSCI.5951-10.2011; Teshima Y, 2003, STROKE, V34, P1796, DOI 10.1161/01.STR.0000077017.60947.AE; Thio LL, 2000, NEUROLOGY, V54, P325, DOI 10.1212/WNL.54.2.325; Wang L, 2011, NEUROSCI LETT, V491, P63, DOI 10.1016/j.neulet.2010.12.065; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Xie J, 2010, J NEUROSCI RES, V88, P428, DOI 10.1002/jnr.22213	56	35	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119316	10.1371/journal.pone.0119316	http://dx.doi.org/10.1371/journal.pone.0119316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848768	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800010
J	Negmadjanov, U; Godic, Z; Rizvi, F; Emelyanova, L; Ross, G; Richards, J; Holmuhamedov, EL; Jahangir, A				Negmadjanov, Ulugbek; Godic, Zarko; Rizvi, Farhan; Emelyanova, Larisa; Ross, Gracious; Richards, John; Holmuhamedov, Ekhson L.; Jahangir, Arshad			TGF-beta 1-Mediated Differentiation of Fibroblasts Is Associated with Increased Mitochondrial Content and Cellular Respiration	PLOS ONE			English	Article							PRESSURE WOUND THERAPY; HEART-DISEASE; MYOFIBROBLASTS; ATP; EXPOSURE; MYOCYTES	Objectivs Cytokine-dependent activation of fibroblasts to myofibroblasts, a key event in fibrosis, is accompanied by phenotypic changes with increased secretory and contractile properties dependent on increased energy utilization, yet changes in the energetic profile of these cells are not fully described. We hypothesize that the TGF-beta 1-mediated transformation of myofibroblasts is associated with an increase in mitochondrial content and function when compared to naive fibroblasts. Methods Cultured NIH/3T3 mouse fibroblasts treated with TGF-beta 1, a profibrotic cytokine, or vehicle were assessed for transformation to myofibroblasts (appearance of alpha-smooth muscle actin [alpha-SMA] stress fibers) and associated changes in mitochondrial content and functions using laser confocal microscopy, Seahorse respirometry, multi-well plate reader and biochemical protocols. Expression of mitochondrial-specific proteins was determined using western blotting, and the mitochondrial DNA quantified using Mitochondrial DNA isolation kit. Results Treatment with TGF-beta 1 (5 ng/mL) induced transformation of naive fibroblasts into myofibroblasts with a threefold increase in the expression of alpha-SMA (6.85 +/- 0.27 RU) compared to cells not treated with TGF-beta 1 (2.52 +/- 0.11 RU). TGF-beta 1 exposure increased the number of mitochondria in the cells, as monitored by membrane potential sensitive dye tetramethylrhodamine, and expression of mitochondria-specific proteins; voltage-dependent anion channels (0.54 +/- 0.05 vs. 0.23 +/- 0.05 RU) and adenine nucleotide transporter (0.61 +/- 0.11 vs. 0.22 +/- 0.05 RU), as well as mitochondrial DNA content (530 +/- 12 mu g DNA/10(6) cells vs. 307 +/- 9 mu g DNA/10(6) cells in control). TGF-beta 1 treatment was associated with an increase in mitochondrial function with a twofold increase in baseline oxygen consumption rate (2.25 +/- 0.03 vs. 1.13 +/- 0.1 nmol O-2/min/10(6) cells) and FCCP-induced mitochondrial respiration (2.87 +/- 0.03 vs. 1.46 +/- 0.15 nmol O-2/min/10(6) cells). Conclusions TGF-beta 1 induced differentiation of fibroblasts is accompanied by energetic remodeling of myofibroblasts with an increase in mitochondrial respiration and mitochondrial content.	[Negmadjanov, Ulugbek; Godic, Zarko; Rizvi, Farhan; Emelyanova, Larisa; Ross, Gracious; Holmuhamedov, Ekhson L.; Jahangir, Arshad] Aurora Hlth Care, Sheikh Khalifa bin Hamad Al Thani Ctr Integrat Re, Aurora Res Inst, Milwaukee, WI 53215 USA; [Richards, John] Aurora Hlth Care, Immunol Lab, Aurora, WI 53215 USA; [Jahangir, Arshad] Aurora Hlth Care, Aurora Cardiovasc Serv, Aurora, WI 53215 USA		Jahangir, A (corresponding author), Aurora Hlth Care, Sheikh Khalifa bin Hamad Al Thani Ctr Integrat Re, Aurora Res Inst, Milwaukee, WI 53215 USA.	Publishing44@aurora.org	Holmuhamedov, Ekhson L/P-5228-2016; Jahangir, Arshad/M-7916-2016	Holmuhamedov, Ekhson L/0000-0002-0809-350X; 	National Heart, Lung, and Blood Institute [HL089542, HL101240]; Aurora Health Care, Cardiovascular Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089542, R01HL101240] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Aurora Health Care, Cardiovascular Research Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the National Heart, Lung, and Blood Institute (HL089542 and HL101240) and intramural support from Aurora Health Care, Cardiovascular Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baracca A, 2013, INT J BIOCHEM CELL B, V45, P1356, DOI 10.1016/j.biocel.2013.03.013; Baudino TA, 2008, MICROSC MICROANAL, V14, P117, DOI 10.1017/S1431927608080021; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Baum JR, 2012, AM J PHYSIOL-HEART C, V302, pH790, DOI 10.1152/ajpheart.00498.2011; Biovision Inc. Mitochondrial DNA Isolation Kit, MIT DNA IS KIT; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Chiang B, 2007, AM J SURG, V193, P213, DOI 10.1016/j.amjsurg.2006.08.069; Corradi D, 2008, NAT CLIN PRACT CARD, V5, P782, DOI 10.1038/ncpcardio1370; Daskalopoulos EP, 2013, METHODS MOL BIOL, V1037, P355, DOI 10.1007/978-1-62703-505-7_21; Detillieux KA, 2003, CARDIOVASC RES, V57, P8, DOI 10.1016/S0008-6363(02)00708-3; Dzeja PP, 2001, CIRC RES, V89, P744, DOI 10.1161/res.89.9.744; Fillmore N, 2014, BRIT J PHARMACOL, V171, P2080, DOI 10.1111/bph.12475; Friedman JR, 2014, NATURE, V505, P335, DOI 10.1038/nature12985; Furuya S, 2013, INT REV CEL MOL BIO, V304, P133, DOI 10.1016/B978-0-12-407696-9.00003-8; Gerencser AA, 2009, ANAL CHEM, V81, P6868, DOI 10.1021/ac900881z; Gout E, 2014, P NATL ACAD SCI USA, V111, pE4560, DOI 10.1073/pnas.1406251111; Holmuhamedov E, 2009, ARCH BIOCHEM BIOPHYS, V481, P226, DOI 10.1016/j.abb.2008.10.036; Holmuhamedov EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044667; Holmuhamedov EL, 2012, J BIOL CHEM, V287, P7692, DOI 10.1074/jbc.M111.293399; Honda E, 2013, TOHOKU J EXP MED, V230, P67, DOI 10.1620/tjem.230.67; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Langevin HM, 2005, AM J PHYSIOL-CELL PH, V288, pC747, DOI 10.1152/ajpcell.00420.2004; McNulty AK, 2007, WOUND REPAIR REGEN, V15, P838, DOI 10.1111/j.1524-475X.2007.00287.x; McNulty AK, 2009, WOUND REPAIR REGEN, V17, P192, DOI 10.1111/j.1524-475X.2009.00460.x; Moruzzi N, 2014, INT J BIOCHEM CELL B, V53, P66, DOI 10.1016/j.biocel.2014.04.026; Nemutlu E, 2012, PHYSIOL GENOMICS, V44, P386, DOI 10.1152/physiolgenomics.00152.2011; Noseda M, 2009, DEV CELL, V16, P161, DOI 10.1016/j.devcel.2009.01.020; Pereira SL, 2011, CARDIOVASC TOXICOL, V11, P180, DOI 10.1007/s12012-011-9112-4; Preston CC, 2008, MECH AGEING DEV, V129, P304, DOI 10.1016/j.mad.2008.02.010; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Rosenkranz S, 2004, CARDIOVASC RES, V63, P423, DOI 10.1016/j.cardiores.2004.04.030; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SOLMI R, 1994, BIOCHEM MOL BIOL INT, V33, P477; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; WANG D, 1990, BIOCHEM BIOPH RES CO, V166, P251, DOI 10.1016/0006-291X(90)91938-O; Weber KT, 2013, NAT REV CARDIOL, V10, P15, DOI 10.1038/nrcardio.2012.158; Zhou LF, 2008, AM J PHYSIOL-HEART C, V295, pH939, DOI 10.1152/ajpheart.00561.2008	42	57	57	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123046	10.1371/journal.pone.0123046	http://dx.doi.org/10.1371/journal.pone.0123046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849590	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800198
J	Will, U; Clayton, M; Wertheim, I; Leante, L; Berg, E				Will, Udo; Clayton, Martin; Wertheim, Ira; Leante, Laura; Berg, Eric			Pulse and Entrainment to Non-Isochronous Auditory Stimuli: The Case of North Indian Alap	PLOS ONE			English	Article							SENSORIMOTOR SYNCHRONIZATION; TIME; PERFORMANCE; PERCEPTION; ATTENTION; TEMPO; BEAT	Pulse is often understood as a feature of a (quasi-) isochronous event sequence that is picked up by an entrained subject. However, entrainment does not only occur between quasiperiodic rhythms. This paper demonstrates the expression of pulse by subjects listening to non-periodic musical stimuli and investigates the processes behind this behaviour. The stimuli are extracts from the introductory sections of North Indian (Hindustani) classical music performances (alap, jor and jhala). The first of three experiments demonstrates regular motor responses to both irregular alap and more regular jor sections: responses to alap appear related to individual spontaneous tempi, while for jor they relate to the stimulus event rate. A second experiment investigated whether subjects respond to average periodicities of the alap section, and whether their responses show phase alignment to the musical events. In the third experiment we investigated responses to a broader sample of performances, testing their relationship to spontaneous tempo, and the effect of prior experience with this music. Our results suggest an entrainment model in which pulse is understood as the experience of one's internal periodicity: it is not necessarily linked to temporally regular, structured sensory input streams; it can arise spontaneously through the performance of repetitive motor actions, or on exposure to event sequences with rather irregular temporal structures. Greater regularity in the external event sequence leads to entrainment between motor responses and stimulus sequence, modifying subjects' internal periodicities in such a way that they are either identical or harmonically related to each other. This can be considered as the basis for shared (rhythmic) experience and may be an important process supporting 'social' effects of temporally regular music.	[Will, Udo; Wertheim, Ira; Berg, Eric] Ohio State Univ, SoM, Cognit Ethnomusicol, Columbus, OH 43210 USA; [Clayton, Martin; Leante, Laura] Univ Durham, Mus Dept, Durham, England	University System of Ohio; Ohio State University; Durham University	Will, U (corresponding author), Ohio State Univ, SoM, Cognit Ethnomusicol, Columbus, OH 43210 USA.	will.51@osu.edu	Clayton, Martin/AAU-8333-2020	Clayton, Martin/0000-0002-9670-5077; Will, Udo/0000-0002-2593-1827	UK's Arts and Humanities Research Council [RGST/6186/APN19244, SG/AN6186/APN19110]; British Academy's International Networks scheme	UK's Arts and Humanities Research Council; British Academy's International Networks scheme	The research was funded by the UK's Arts and Humanities Research Council (grants RGST/6186/APN19244 and SG/AN6186/APN19110), and the British Academy's International Networks scheme.	Batschelet E, 1981, CIRCULAR STAT BIOL; Berg ET, 2004, THESIS OSU COLUMBUS; Clayton M., 2000, TIME INDIAN MUSIC RH; Clayton M, 2005, ESEM COUNTERPOINT SE, V11; Clayton MRL, 2007, MUSIC SCI, V11, P27, DOI 10.1177/102986490701100102; COLLYER CE, 1994, PERCEPT PSYCHOPHYS, V55, P443, DOI 10.3758/BF03205301; Drake C, 2000, COGNITION, V77, P251, DOI 10.1016/S0010-0277(00)00106-2; Fisher NI, 1995, STAT ANAL CIRCULAR D; Foote J, 2002, P INT C MUS INF RETR, P265; Fraisse P., 1974, CHRONOBIOLOGY, P517; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Jones M. R., 1990, PSYCHOMUSICOLOGY, V9, P193, DOI DOI 10.1037/H0094147; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; KAY BA, 1987, J EXP PSYCHOL HUMAN, V13, P178, DOI 10.1037/0096-1523.13.2.178; Kreuz T, 2004, NIC SERIES, V21; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MacDougall HG, 2005, J APPL PHYSIOL, V99, P1164, DOI 10.1152/japplphysiol.00138.2005; Madison G, 2002, PSYCHOL RES-PSYCH FO, V66, P201, DOI 10.1007/s00426-001-0085-y; Mardia K.V., 2000, STAT DIRECTIONAL DAT, Vsecond; Moelants D, 2002, P 7 INT C MUSIC PERC, P1, DOI DOI 10.1044/1059-0889(2002/ER01); Neda Z, 2000, NATURE, V403, P849, DOI 10.1038/35002660; Oda GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023895; Parlitz U, 1996, PHYS REV E, V54, P2115, DOI 10.1103/PhysRevE.54.2115; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Pikovsky A, 2001, SYNCHRONIZATION UNIV; Pikovsky A.S., 1985, SOV J COMMUN TECHNOL, V30, P85; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Repp BH, 2005, PSYCHON B REV, V12, P969, DOI 10.3758/BF03206433; Repp BH, 2006, ACTA PSYCHOL, V121, P81, DOI 10.1016/j.actpsy.2005.06.006; Repp BH, 2004, Q J EXP PSYCHOL-A, V57, P499, DOI 10.1080/02724980343000369; Riley MA, 2003, NEUROSCI LETT, V342, P45, DOI 10.1016/S0304-3940(03)00229-5; Schmidt RC, 1997, ECOL PSYCHOL, V9, P189, DOI 10.1207/s15326969eco0903_2; van Noorden L, 1999, J NEW MUSIC RES, V28, P43, DOI 10.1076/jnmr.28.1.43.3122; Wallin JEW, 1911, PSYCHOL REV, V18, P100, DOI 10.1037/h0070543; Webber Jr C.L., 2005, TUTORIALS CONT NONLI, V94, P26; WIDDESS R, 1994, ETHNOMUSICOLOGY, V38, P59, DOI 10.2307/852268; Will U., 2011, MUSIC SCI RHYTHMIC B, P86; Will U, 2007, NEUROSCI LETT, V424, P55, DOI 10.1016/j.neulet.2007.07.036	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123247	10.1371/journal.pone.0123247	http://dx.doi.org/10.1371/journal.pone.0123247			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849357	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000352477800218
J	Ho, CY; Li, PC; Chiang, YC; Young, ST; Chu, WC				Ho, Cheng-Yu; Li, Pei-Chun; Chiang, Yuan-Chuan; Young, Shuenn-Tsong; Chu, Woei-Chyn			The Binaural Masking-Level Difference of Mandarin Tone Detection and the Binaural Intelligibility-Level Difference of Mandarin Tone Recognition in the Presence of Speech-Spectrum Noise	PLOS ONE			English	Article							INFORMATION; CUES	Binaural hearing involves using information relating to the differences between the signals that arrive at the two ears, and it can make it easier to detect and recognize signals in a noisy environment. This phenomenon of binaural hearing is quantified in laboratory studies as the binaural masking-level difference (BMLD). Mandarin is one of the most commonly used languages, but there are no publication values of BMLD or BILD based on Mandarin tones. Therefore, this study investigated the BMLD and BILD of Mandarin tones. The BMLDs of Mandarin tone detection were measured based on the detection threshold differences for the four tones of the voiced vowels /i/(i. e., /i1/, /i2/, /i3/, and /i4/) and /u/(i. e., /u1/, /u2/, /u3/, and /u4/) in the presence of speech-spectrum noise when presented interaurally in phase (S0N0) and interaurally in antiphase (S pi N0). The BILDs of Mandarin tone recognition in speech-spectrum noise were determined as the differences in the target-to-masker ratio (TMR) required for 50% correct tone recognitions between the S0N0 and SpN(0) conditions. The detection thresholds for the four tones of /i/ and /u/ differed significantly (p<0.001) between the S0N0 and SpN(0) conditions. The average detection thresholds of Mandarin tones were all lower in the SpN(0) condition than in the S0N0 condition, and the BMLDs ranged from 7.3 to 11.5 dB. The TMR for 50% correct Mandarin tone recognitions differed significantly (p<0.001) between the S(0)N0 and SpN(0) conditions, at -13.4 and -18.0 dB, respectively, with a mean BILD of 4.6 dB. The study showed that the thresholds of Mandarin tone detection and recognition in the presence of speech- spectrum noise are improved when phase inversion is applied to the target speech. The average BILDs of Mandarin tones are smaller than the average BMLDs of Mandarin tones.	[Ho, Cheng-Yu; Young, Shuenn-Tsong; Chu, Woei-Chyn] Natl Yang Ming Univ, Sch Biomed Sci & Engn, Dept Biomed Engn, Taipei 112, Taiwan; [Ho, Cheng-Yu; Young, Shuenn-Tsong] Mackay Med Coll, Holist Educ Ctr, New Taipei City, Taiwan; [Li, Pei-Chun] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan; [Chiang, Yuan-Chuan] Natl Taipei Univ Nursing & Hlth Sci, Dept Speech & Hearing Disorders & Sci, Taipei, Taiwan	National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; National Taipei University of Nursing & Health Science (NTUNHS)	Li, PC (corresponding author), Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City, Taiwan.	ankhli@gmail.com; woeichyn@gmail.com			Taiwan National Science Council [NSC 101-2220-E-715-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the Taiwan National Science Council (# NSC 101-2220-E-715-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American National Standards Institute, 2004, S36 ANSI; Blauert J, 1997, SPATIAL HEARING PSYC, P262; CAMBRON NK, 1991, EAR HEARING, V12, P64, DOI 10.1097/00003446-199102000-00009; CARHART R, 1966, J ACOUST SOC AM, V39, P1037, DOI 10.1121/1.1909990; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; Garcia-Perez MA, 1998, VISION RES, V38, P1861, DOI 10.1016/S0042-6989(97)00340-4; HIRSH IJ, 1948, J ACOUST SOC AM, V20, P536, DOI 10.1121/1.1906407; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hugo Fastl, 2006, PSYCHOACOUSTICS FACT, P296; Johansson MSK, 2002, INT J AUDIOL, V41, P279, DOI 10.3109/14992020209077187; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Lawson G, 2011, SPEECH AUDIOMETRY, P23; Lee CY, 2000, LEXICAL TONE SPOKEN; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LEVITT H, 1967, J ACOUST SOC AM, V42, P601, DOI 10.1121/1.1910629; LICKLIDER JCR, 1948, J ACOUST SOC AM, V20, P150, DOI 10.1121/1.1906358; Lin M., 1988, J CHINESE LINGUIST, V204, P182; Liu SY, 2004, LANG SPEECH, V47, P109, DOI 10.1177/00238309040470020101; Moore BCJ, 2003, INTRO PSYCHOL HEARIN, P267; Musiek FE, 1999, CONT PERSPECTIVES HE, P380; NOFFSINGER D, 1972, ACTA OTO-LARYNGOL, P1; OLSEN WO, 1976, AUDIOLOGY, V15, P287; QUARANTA A, 1977, ARCH OTOLARYNGOL, V103, P482; Rosners B., 2006, FUNDAMENTALS BIOSTAT, P492; STEVENS KN, 1955, J ACOUST SOC AM, V27, P484, DOI 10.1121/1.1907943; Sun CF, 2006, CHINESE: A LINGUISTIC INTRODUCTION, P34, DOI 10.1017/CBO9780511755019.006; Tsai KS, 2009, EAR HEARING, V30, P90, DOI 10.1097/AUD.0b013e31818f28a6; Tseng CY, 1990, ACOUSTIC PHONETIC ST; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; WILSON RH, 1982, J SPEECH HEAR RES, V25, P235, DOI 10.1044/jshr.2502.235	31	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120977	10.1371/journal.pone.0120977	http://dx.doi.org/10.1371/journal.pone.0120977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835987	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000035
J	Ohtsu, I; Kawano, Y; Suzuki, M; Morigasaki, S; Saiki, K; Yamazaki, S; Nonaka, G; Takagi, H				Ohtsu, Iwao; Kawano, Yusuke; Suzuki, Marina; Morigasaki, Susumu; Saiki, Kyohei; Yamazaki, Shunsuke; Nonaka, Gen; Takagi, Hiroshi			Uptake of L-cystine via an ABC transporter contributes defense of oxidative stress in the L-cystine export-dependent manner in Escherichia coli	PLOS ONE			English	Article							SERINE ACETYLTRANSFERASE; FLUORESCEINS	Intracellular thiols like L-cystine and L-cystine play a critical role in the regulation of cellular processes. Here we show that Escherichia coli has two L-cystine transporters, the symporter YdjN and the ATP-binding cassette importer FliY-YecSC. These proteins import L-cystine, an oxidized product of L-cystine from the periplasm to the cytoplasm. The symporter YdjN, which is expected to be a new member of the L-cystine regulon, is a low affinity L-cystine transporter (K-m = 1.1 mu M) that is mainly involved in L-cystine uptake from outside as a nutrient. E. coli has only two L-cystine importers because.ydjN.yecS mutant cells are not capable of growing in the minimal medium containing L-cystine as a sole sulfur source. Another protein YecSC is the FliY-dependent L-cystine transporter that functions cooperatively with the L-cystine transporter YdeD, which exports L-cystine as reducing equivalents from the cytoplasm to the periplasm, to prevent E. coli cells from oxidative stress. The exported L-cystine can reduce the periplasmic hydrogen peroxide to water, and then generated L-cystine is imported back into the cytoplasm via the ATP-binding cassette transporter YecSC with a high affinity to L-cystine (K-m = 110 nM) in a manner dependent on FliY, the periplasmic L-cystine-binding protein. The double disruption of ydeD and fliY increased cellular levels of lipid peroxides. From these findings, we propose that the hydrogen peroxide-inducible L-cystine/L-cystine shuttle system plays a role of detoxification of hydrogen peroxide before lipid peroxidation occurs, and then might specific prevent damage to membrane lipids.	[Ohtsu, Iwao; Kawano, Yusuke; Suzuki, Marina; Morigasaki, Susumu; Saiki, Kyohei; Takagi, Hiroshi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan; [Yamazaki, Shunsuke; Nonaka, Gen] Ajinomoto Co Inc, Res Inst Biosci Prod & Fine Chem, Kawasaki, Kanagawa, Japan	Nara Institute of Science & Technology; Ajinomoto Co Inc	Ohtsu, I (corresponding author), Nara Inst Sci & Technol, Grad Sch Biol Sci, Ikoma, Nara, Japan.	iohtsu@bs.naist.jp	Morigasaki, Susumu/Q-6981-2017	Morigasaki, Susumu/0000-0002-6938-5119; Takagi, Hiroshi/0000-0002-1786-3174; Ohtsu, Iwao/0000-0002-3553-0306; Kawano, Yusuke/0000-0002-6845-8902	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Ajinomoto Co., Inc	Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry; KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ajinomoto Co., Inc	This work was supported by the Programme for Promotion of Basic and Applied Researches for Innovations in Bio-oriented Industry (to IO). This work was also supported by KAKENHI [Grant-in-Aid for Young Scientists on priority areas (B)] from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (to IO) and by a grant from Ajinomoto Co., Inc (to IO and HT). This work was supported by the funds described in manuscript, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Burguiere P, 2004, J BACTERIOL, V186, P4875, DOI 10.1128/JB.186.15.4875-4884.2004; DENK D, 1987, J GEN MICROBIOL, V133, P515; Hindson VJ, 2003, BIOCHEM J, V375, P745, DOI 10.1042/BJ20030429; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Kawano Y, 2015, J BIOSCI BIOENG, V119, P176, DOI 10.1016/j.jbiosc.2014.07.006; LEIVE L, 1965, J BIOL CHEM, V240, P4370; Lo R, 2009, J BACTERIOL, V191, P1827, DOI 10.1128/JB.01553-08; Maeda H, 2005, ANGEW CHEM INT EDIT, V44, P2922, DOI 10.1002/anie.200500114; Maeda H, 2004, ANGEW CHEM INT EDIT, V43, P2389, DOI 10.1002/anie.200452381; Maeda H, 2007, CHEM-EUR J, V13, P1946, DOI 10.1002/chem.200600522; Manchado M, 2000, J BACTERIOL, V182, P6842, DOI 10.1128/JB.182.23.6842-6844.2000; Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094; Ohtsu I, 2010, J BIOL CHEM, V285, P17479, DOI 10.1074/jbc.M109.081356; Park S, 2005, P NATL ACAD SCI USA, V102, P9317, DOI 10.1073/pnas.0502051102; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Semchyshyn H, 2005, CELL BIOL INT, V29, P898, DOI 10.1016/j.cellbi.2005.08.002; Tani A, 2008, MICROBIOL-SGM, V154, P3437, DOI 10.1099/mic.0.2007/016048-0; Wiriyathanawudhiwong N, 2009, APPL MICROBIOL BIOT, V81, P903, DOI 10.1007/s00253-008-1686-9	20	39	41	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120619	10.1371/journal.pone.0120619	http://dx.doi.org/10.1371/journal.pone.0120619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837721	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000027
J	Hussaarts, L; Garcia-Tardon, N; van Beek, L; Heemskerk, MM; Haeberlein, S; van der Zon, GC; Ozir-Fazalalikhan, A; Berbee, JFP; van Dijk, KW; van Harmelen, V; Yazdanbakhsh, M; Guigas, B				Hussaarts, Leonie; Garcia-Tardon, Noemi; van Beek, Lianne; Heemskerk, Mattijs M.; Haeberlein, Simone; van der Zon, Gerard C.; Ozir-Fazalalikhan, Arifa; Berbee, Jimmy F. P.; van Dijk, Ko Willems; van Harmelen, Vanessa; Yazdanbakhsh, Maria; Guigas, Bruno			Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice	FASEB JOURNAL			English	Article						immunometabolism; eosinophils; type 2 inflammation; Schistosoma mansoni	TUMOR-NECROSIS-FACTOR; T-CELLS; INFLAMMATION; FAT; RESISTANCE; EOSINOPHILS; RECRUITMENT; MODULATION; ADIPOCYTES; INHIBITION	Chronic low-grade inflammation associated with obesity contributes to insulin resistance and type 2 diabetes. Helminth parasites are the strongest natural inducers of type 2 immune responses, and short-lived infection with rodent nematodes was reported to improve glucose tolerance in obesemice. Here, we investigated the effects of chronic infection (12 weeks) with Schistosoma mansoni, a helminth that infects millions of humans worldwide, on whole-body metabolic homeostasis and white adipose tissue (WAT) immune cell composition in high-fat diet-induced obeseC57BL/6male mice. Our data indicate that chronic helminth infection reduced body weight gain (-62%), fat mass gain (-89%), and adipocyte size; lowered whole-body insulin resistance (-23%) and glucose intolerance (-16%); and improved peripheral glucose uptake (+25%) andWATinsulin sensitivity. Analysis of immune cell composition by flow cytometry and quantitative PCR (qPCR) revealed that S. mansoni promoted strong increases in WAT eosinophils and alternatively activated (M2) macrophages. Importantly, injections with S. mansoni-soluble egg antigens (SEA) recapitulated the beneficial effect of parasite infection on whole-body metabolic homeostasis and induced type 2 immune responses inWAT and liver. Taken together, we provide novel data suggesting that chronic helminth infection and helminth-derived molecules protect against metabolic disorders by promoting a T helper 2 (Th2) response, eosinophilia, and WAT M2 polarization.	[Hussaarts, Leonie; Garcia-Tardon, Noemi; Haeberlein, Simone; Ozir-Fazalalikhan, Arifa; Yazdanbakhsh, Maria; Guigas, Bruno] Leiden Univ, Med Ctr, Dept Parasitol, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [van Beek, Lianne; Heemskerk, Mattijs M.; van Dijk, Ko Willems; van Harmelen, Vanessa] Leiden Univ, Med Ctr, Dept Human Genet, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [van der Zon, Gerard C.; Guigas, Bruno] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands; [Berbee, Jimmy F. P.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Einthoven Lab Expt Vasc Med, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Guigas, B (corresponding author), Leiden Univ, Med Ctr, Dept Parasitol, POB 9600,Postal Zone L4-Q, NL-2300 RC Leiden, Netherlands.	b.g.a.guigas@lumc.nl	Yazdanbakhsh, Maria/AAI-3996-2020; Haeberlein, Simone/AAM-2685-2020; Ozir-Fazalalikhan, A/V-5436-2018; Guigas, Bruno/M-2515-2015; van Dijk, Ko Willems/A-1798-2008; van Dijk, Ko Willems/AAT-4681-2021	Yazdanbakhsh, Maria/0000-0002-7666-1441; Ozir-Fazalalikhan, A/0000-0002-0613-8372; Guigas, Bruno/0000-0002-8856-5799; van Dijk, Ko Willems/0000-0002-2172-7394; van Dijk, Ko Willems/0000-0002-2172-7394; van Harmelen, Vanessa/0000-0003-0111-9858	European Federation for the Study of Diabetes; EFSD/Lilly Research Grant; Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences [KNAW-57-SPIN3-JRP]; EU [HEALTH-F3-2009-241642]; Dutch Organization for Scientific Research [91214131]; Leiden University Medical Center	European Federation for the Study of Diabetes; EFSD/Lilly Research Grant; Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences; EU(European Commission); Dutch Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Leiden University Medical Center	The authors thank Bart Everts (Leiden University Medical Center, Leiden, The Netherlands) for critically reading the manuscript. This work was supported by an EFSD/Lilly Research Grant Fellowship from the European Federation for the Study of Diabetes (to B.G.), a Scientific Programme Indonesia-Netherlands-The Royal Netherlands Academy of Sciences Grant (SPIN-KNAW; KNAW-57-SPIN3-JRP; to M.Y. and B.G.), the EU-funded project IDEA (HEALTH-F3-2009-241642; to M.Y.), a ZonMW TOP Grant from the Dutch Organization for Scientific Research (91214131; to M.Y. and B.G.), and a grant from the Board of Directors of the Leiden University Medical Center (to V.V.H.).	Ackermans MT, 2001, J CLIN ENDOCR METAB, V86, P2220, DOI 10.1210/jc.86.5.2220; Aravindhan V, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000707; Bhargava P, 2012, NAT MED, V18, P1665, DOI 10.1038/nm.2962; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen YH, 2013, J CLIN ENDOCR METAB, V98, pE283, DOI 10.1210/jc.2012-2517; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704; DeFuria J, 2013, P NATL ACAD SCI USA, V110, P5133, DOI 10.1073/pnas.1215840110; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Everts B, 2012, J EXP MED, V209, P1753, DOI 10.1084/jem.20111381; Everts B, 2009, J EXP MED, V206, P1673, DOI 10.1084/jem.20082460; FEINGOLD KR, 1992, ENDOCRINOLOGY, V130, P10, DOI 10.1210/en.130.1.10; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Geerling JJ, 2014, DIABETES, V63, P880, DOI 10.2337/db13-0194; GREEN A, 1994, ENDOCRINOLOGY, V134, P2581, DOI 10.1210/en.134.6.2581; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Harnett W, 2010, NAT REV IMMUNOL, V10, P278, DOI 10.1038/nri2730; Herman WH, 2012, DIABETES CARE, V35, P943, DOI 10.2337/dc12-0298; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hussaarts L, 2011, J ALLERGY CLIN IMMUN, V128, P733, DOI 10.1016/j.jaci.2011.05.012; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morinaga H., 2014, DIABETES; Movita D, 2012, J LEUKOCYTE BIOL, V92, P723, DOI 10.1189/jlb.1111566; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okano M, 1999, J IMMUNOL, V163, P6712; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Pearce EJ, 2002, NAT REV IMMUNOL, V2, P499, DOI 10.1038/nri843; Ricardo-Gonzalez RR, 2010, P NATL ACAD SCI USA, V107, P22617, DOI 10.1073/pnas.1009152108; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; Stanya KJ, 2013, J CLIN INVEST, V123, P261, DOI 10.1172/JCI64941; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; Wammes LJ, 2014, LANCET INFECT DIS, V14, P1150, DOI 10.1016/S1473-3099(14)70771-6; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; World Health Organization, 2013, SCHIST; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yang ZH, 2013, INFECT IMMUN, V81, P1905, DOI 10.1128/IAI.00053-13	52	126	130	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3027	3039		10.1096/fj.14-266239	http://dx.doi.org/10.1096/fj.14-266239			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25852044				2022-12-26	WOS:000356859100030
J	Majumder, A; Syed, KM; Joseph, S; Scambler, PJ; Dutta, D				Majumder, Aditi; Syed, Khaja Mohieddin; Joseph, Sunu; Scambler, Peter J.; Dutta, Debasree			Histone Chaperone HIRA in Regulation of Transcription Factor RUNX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; DEFINITIVE HEMATOPOIESIS; HEMOGENIC ENDOTHELIUM; AORTIC ENDOTHELIUM; YOLK-SAC; C-MYB; GENE; EXPRESSION; LEUKEMIA; COMPLEX	RUNX1 (Runt-related transcription factor 1) is indispensable for the generation of hemogenic endothelium. However, the regulation of RUNX1 during this developmental process is poorly understood. We investigated the role of the histone chaperone HIRA (histone cell cycle regulation-defective homolog A) from this perspective and report that HIRA significantly contributes toward the regulation of RUNX1 in the transition of differentiating mouse embryonic stem cells from hemogenic to hematopoietic stage. Direct interaction of HIRA and RUNX1 activates the downstream targets of RUNX1 implicated in generation of hematopoietic stem cells. At the molecular level, HIRA-mediated incorporation of histone H3.3 variant within the Runx1 + 24 mouse conserved noncoding element is essential for the expression of Runx1 during endothelial to hematopoietic transition. An inactive chromatin at the intronic enhancer of Runx1 in absence of HIRA significantly repressed the transition of cells from hemogenic to hematopoietic fate. We expect that the HIRA-RUNX1 axis might open up a novel approach in understanding leukemogenesis in future.	[Majumder, Aditi; Syed, Khaja Mohieddin; Joseph, Sunu; Dutta, Debasree] Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thiruvananthapuram 695014, Kerala, India; [Scambler, Peter J.] UCL, Inst Child Hlth, London WC1E 6BT, England	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); University of London; University College London	Dutta, D (corresponding author), Rajiv Gandhi Ctr Biotechnol, Canc Res Program, Thycaud PO, Thiruvananthapuram 695014, Kerala, India.	debasreedutta@rgcb.res.in	Scambler, Peter/AAZ-6026-2020	Scambler, Peter/0000-0002-1487-4628	Department of Science & Technology, India [SB/FT/LS-158/2012]; Department of Biotechnology, India; Department of Biotechnology (DBT), India [DBT/JRF/13/AL/452]; DBT [BT/PR5754/MED/31/167/2012]; British Heart Foundation [RG/15/13/28570]; British Heart Foundation [RG/10/13/28570, PG/15/6/31211] Funding Source: researchfish	Department of Science & Technology, India(Department of Science & Technology (India)); Department of Biotechnology, India(Department of Biotechnology (DBT) India); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by Grant SB/FT/LS-158/2012 from the Department of Science & Technology, India, and by intramural funding from the Department of Biotechnology, India.; Supported by Fellowship DBT/JRF/13/AL/452 from the Department of Biotechnology (DBT), India.; Supported by DBT Fellowship BT/PR5754/MED/31/167/2012.; Supported by British Heart Foundation Grant RG/15/13/28570.	Bakshi R, 2010, J CELL PHYSIOL, V225, P569, DOI 10.1002/jcp.22240; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Burgess RJ, 2013, NAT STRUCT MOL BIOL, V20, P14, DOI 10.1038/nsmb.2461; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chiang PM, 2011, DEVELOPMENT, V138, P2833, DOI 10.1242/dev.061440; Clarke RL, 2013, NAT CELL BIOL, V15, P502, DOI 10.1038/ncb2724; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Dutta D, 2011, STEM CELLS, V29, P618, DOI 10.1002/stem.605; Dutta D, 2010, J BIOL CHEM, V285, P41567, DOI 10.1074/jbc.M110.190025; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; HERNANDEZMUNAIN C, 1994, MOL CELL BIOL, V14, P473, DOI 10.1128/MCB.14.1.473; Hoogenkamp M, 2007, MOL CELL BIOL, V27, P7425, DOI 10.1128/MCB.00905-07; Jin H, 2012, BLOOD, V119, P5239, DOI 10.1182/blood-2011-12-398362; Koh CP, 2013, LEUKEMIA, V27, P1793, DOI 10.1038/leu.2013.200; Lancrin C, 2012, BLOOD, V120, P314, DOI 10.1182/blood-2011-10-386094; Lichtinger M, 2012, EMBO J, V31, P4318, DOI 10.1038/emboj.2012.275; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Ng CEL, 2010, STEM CELLS, V28, P1869, DOI 10.1002/stem.507; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Palis J, 1999, DEVELOPMENT, V126, P5073; Pchelintsev NA, 2013, CELL REP, V3, P1012, DOI 10.1016/j.celrep.2013.03.026; Ray S, 2009, J BIOL CHEM, V284, P4978, DOI 10.1074/jbc.M807329200; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Soni S, 2014, P NATL ACAD SCI USA, V111, P13337, DOI 10.1073/pnas.1405422111; Soza-Ried C, 2010, P NATL ACAD SCI USA, V107, P17304, DOI 10.1073/pnas.1004640107; Staibano S, 2009, HISTOPATHOLOGY, V54, P580, DOI 10.1111/j.1365-2559.2009.03266.x; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zaidi SK, 2009, CANCER RES, V69, P8249, DOI 10.1158/0008-5472.CAN-09-1567	34	18	18	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13053	13063		10.1074/jbc.M114.615492	http://dx.doi.org/10.1074/jbc.M114.615492			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847244	Green Published, hybrid			2022-12-26	WOS:000354975700010
J	Loesch, K; Galaviz, S; Hamoui, Z; Clanton, R; Akabani, G; Deveau, M; DeJesus, M; Ioerger, T; Sacchettini, JC; Wallis, D				Loesch, Kimberly; Galaviz, Stacy; Hamoui, Zaher; Clanton, Ryan; Akabani, Gamal; Deveau, Michael; DeJesus, Michael; Ioerger, Thomas; Sacchettini, James C.; Wallis, Deeann			Functional Genomics Screening Utilizing Mutant Mouse Embryonic Stem Cells Identifies Novel Radiation-Response Genes	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-8; CANCER-INITIATING CELLS; TERATOCARCINOMA CELLS; KLF8 TRANSCRIPTION; BINDING-PROTEIN; DNA-REPAIR; EXPRESSION; RADIOSENSITIZATION; RADIOTHERAPY; PALLIATION	Elucidating the genetic determinants of radiation response is crucial to optimizing and individualizing radiotherapy for cancer patients. In order to identify genes that are involved in enhanced sensitivity or resistance to radiation, a library of stable mutant murine embryonic stem cells (ESCs), each with a defined mutation, was screened for cell viability and gene expression in response to radiation exposure. We focused on a cancer-relevant subset of over 500 mutant ESC lines. We identified 13 genes; 7 genes that have been previously implicated in radiation response and 6 other genes that have never been implicated in radiation response. After screening, proteomic analysis showed enrichment for genes involved in cellular component disassembly (e.g. Dstn and Pex14) and regulation of growth (e.g. Adnp2, Epc1, and Ing4). Overall, the best targets with the highest potential for sensitizing cancer cells to radiation were Dstn and Map2k6, and the best targets for enhancing resistance to radiation were Iqgap and Vcan. Hence, we provide compelling evidence that screening mutant ESCs is a powerful approach to identify genes that alter radiation response. Ultimately, this knowledge can be used to define genetic variants or therapeutic targets that will enhance clinical therapy.	[Loesch, Kimberly; Galaviz, Stacy; Sacchettini, James C.; Wallis, Deeann] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Hamoui, Zaher; Clanton, Ryan; Akabani, Gamal] Texas A&M Univ, Dept Nucl Engn, College Stn, TX 77843 USA; [Akabani, Gamal] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Akabani, Gamal] Texas A&M Univ, Texas A&M Inst Preclin Studies, College Stn, TX 77843 USA; [Deveau, Michael] Texas A&M Univ, Dept Small Anim Clin Sci, College Stn, TX 77843 USA; [DeJesus, Michael; Ioerger, Thomas] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Wallis, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dwallis@tamu.edu		Clanton, Ryan/0000-0002-3148-0575; De Jesus, Michael/0000-0003-3867-0299	Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program [CA093155]; U.S. Nuclear Regulatory Commission [NRS-38-10-923]; NATIONAL CANCER INSTITUTE [R43CA093155] Funding Source: NIH RePORTER	Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program; U.S. Nuclear Regulatory Commission; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Department of Defense Congressionally Directed Medical Research Program Peer Reviewed Cancer Research Program [grant number CA093155]. This project is partially funded by the U.S. Nuclear Regulatory Commission, grant number NRS-38-10-923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres JL, 1998, ONCOGENE, V16, P2229, DOI 10.1038/sj.onc.1201752; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Chen G, 2012, MOL BIOL REP, V39, P9809, DOI 10.1007/s11033-012-1847-x; Chiani F, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap007; Choi KJ, 2011, ONCOL REP, V26, P55, DOI 10.3892/or.2011.1260; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; De-Zolt Silke, 2009, V530, P29, DOI 10.1007/978-1-59745-471-1_3; Dragun AE, 2011, CANCER-AM CANCER SOC, V117, P2590, DOI 10.1002/cncr.25821; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hansen GM, 2008, GENOME RES, V18, P1670, DOI 10.1101/gr.078352.108; Hensbergen PJ, 2005, J INVEST DERMATOL, V124, P818, DOI 10.1111/j.0022-202X.2005.23597.x; Higgins GS, 2010, CANCER RES, V70, P2984, DOI 10.1158/0008-5472.CAN-09-4040; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Kim KS, 2014, INT J RADIAT BIOL, V90, P71, DOI 10.3109/09553002.2014.859763; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Knott A, 2009, BIOGERONTOLOGY, V10, P181, DOI 10.1007/s10522-008-9165-3; Koch U, 2010, SEMIN CANCER BIOL, V20, P116, DOI 10.1016/j.semcancer.2010.02.003; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lahiri SK, 2012, AM J TRANSL RES, V4, P357; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Ling C, 2012, CANCER GENE THER, V19, P697, DOI 10.1038/cgt.2012.50; Lu H, 2012, J BIOL CHEM, V287, P43720, DOI 10.1074/jbc.M112.418053; Lu X, 2006, CANCER RES, V66, P1052, DOI 10.1158/0008-5472.CAN-05-3459; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCBURNEY MW, 1977, AM J PATHOL, V89, P685; Menzel T, 2011, EMBO REP, V12, P705, DOI 10.1038/embor.2011.99; Moncharmont C, 2012, CANCER LETT, V322, P139, DOI 10.1016/j.canlet.2012.03.024; Oakley DJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar028; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; PAPAIOANNOU VE, 1978, J EMBRYOL EXP MORPH, V44, P93; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Saretzki G, 2004, STEM CELLS, V22, P962, DOI 10.1634/stemcells.22-6-962; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Schoenhals M, 2009, BIOCHEM BIOPH RES CO, V383, P157, DOI 10.1016/j.bbrc.2009.02.156; Seigel GM, 2007, MOL VIS, V13, P823; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Sudo H, 2007, BIOCHEM BIOPH RES CO, V364, P695, DOI 10.1016/j.bbrc.2007.10.074; TONG D, 1982, CANCER, V50, P893, DOI 10.1002/1097-0142(19820901)50:5<893::AID-CNCR2820500515>3.0.CO;2-Y; Uematsu M, 1998, CANCER-AM CANCER SOC, V82, P1062, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1062::AID-CNCR8>3.0.CO;2-G; Vaisnav M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104858; Vallis KA, 2002, RADIAT RES, V157, P8, DOI 10.1667/0033-7587(2002)157[0008:IORRGI]2.0.CO;2; van Vliet J, 2000, NUCLEIC ACIDS RES, V28, P1955; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XF, 2000, MOL CELL BIOL, V20, P4543, DOI 10.1128/MCB.20.13.4543-4552.2000; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu JSY, 2003, INT J RADIAT ONCOL, V55, P594, DOI 10.1016/S0360-3016(02)04147-0; Yang HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059319; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45; Zhao D, 2014, CELL BIOCHEM BIOPHYS, V70, P887, DOI 10.1007/s12013-014-9995-3; Zhao YX, 2012, J RADIAT RES, V53, P686, DOI 10.1093/jrr/rrs024; Zheng M, 2008, CANCER RES, V68, P7570, DOI 10.1158/0008-5472.CAN-08-0632	57	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120534	10.1371/journal.pone.0120534	http://dx.doi.org/10.1371/journal.pone.0120534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853515	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400015
J	Zhang, FQ; Xu, Y; Cao, HB; Jin, CH; Cheng, ZH; Wang, GQ; Shugart, YY				Zhang, Fuquan; Xu, Yong; Cao, Hongbao; Jin, Chunhui; Cheng, Zaohuo; Wang, Guoqiang; Shugart, Yin Yao			Mapsnp: An R Package to Plot a Genomic Map for Single Nucleotide Polymorphisms	PLOS ONE			English	Article							BROWSER; SOFTWARE	Single-nucleotide polymorphism (SNP) is one of the most common sources of genetic variations of the genome. Currently, SNPs are a main target for most genetic association studies. Visualizing genomic coordinates of SNPs, including their physical location relative to their host gene, and the structure of the relevant transcripts, may provide intuitive supplements to the understanding of their functions. Nevertheless, to date, no such easy-to-use programming tools exist. Therefore, we developed an R package, "mapsnp", to plot genomic map for a panel of SNPs within a genome region of interest, including the relative chromosome location and the transcripts in the region. mapsnp is a simple and flexible software package which can be used to visualize a genomic map for SNPs, integrating a chromosome ideogram, genomic coordinates, SNP locations and SNP labels.	[Zhang, Fuquan; Jin, Chunhui; Cheng, Zaohuo; Wang, Guoqiang] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Fuquan; Cao, Hongbao; Shugart, Yin Yao] NIMH, Intramural Res Program, Unit Stat Genom, NIH, Bethesda, MD 20892 USA; [Xu, Yong] Shanxi Med Univ, Hosp 1, Dept Psychiat, Taiyuan, Peoples R China	Nanjing Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Shanxi Medical University	Wang, GQ (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Wuxi, Jiangsu, Peoples R China.	wuwangguoqiang@126.com; kay1yao@mail.nih.gov		YAO, YIN/0000-0003-3053-8429; Zhang, Fuquan/0000-0003-3204-8191	Wuxi Hospital Management Center key joint scientific and technical project in medicine [YGZXL1315]; National Natural Science Foundation of China [81000583, 81278412]; China Postdoctoral Science Foundation [2013M541207]; Program for New Century Excellent Talents in University; Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002930, ZIAMH002929] Funding Source: NIH RePORTER	Wuxi Hospital Management Center key joint scientific and technical project in medicine; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by Wuxi Hospital Management Center key joint scientific and technical project in medicine (YGZXL1315), the National Natural Science Foundation of China (81000583, 81278412), China Postdoctoral Science Foundation (2013M541207), Program for New Century Excellent Talents in University (YX), and Program for the Top Young Academic Leaders of Higher Learning Institutions of Shanxi (YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acland A, 2014, NUCLEIC ACIDS RES, V42, pD7, DOI 10.1093/nar/gkt1146; Carlson M, 2014, TXDB HSAPIENS UCSC H; Durinck S, 2014, GENOMEGRAPHS PLOTTIN; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hahne F, 2014, GVIZ PLOTTING DATA A; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Nicol JW, 2009, BIOINFORMATICS, V25, P2730, DOI 10.1093/bioinformatics/btp472; RCoreTeam, 2014, R LANG ENV STAT COMP; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77; Zhang FQ, 2014, NEUROSCI LETT, V562, P24, DOI 10.1016/j.neulet.2013.12.001	14	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123609	10.1371/journal.pone.0123609	http://dx.doi.org/10.1371/journal.pone.0123609			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853637	Green Submitted, gold, Green Published			2022-12-26	WOS:000352478400107
J	Fortanier, AC; Venekamp, RP; de Hoog, MLA; Uiterwaal, CSPM; van der Gugten, AC; van der Ent, CK; Hoes, AW; Schilder, AGM				Fortanier, Alexandre C.; Venekamp, Roderick P.; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; van der Gugten, Anne C.; van der Ent, Cornelis K.; Hoes, Arno W.; Schilder, Anne G. M.			Parent-Reported Symptoms of Acute Otitis Media during the First Year of Life: What Is beneath the Surface?	PLOS ONE			English	Article							CHILDREN; BURDEN; MANAGEMENT; COHORT	Background Most estimates of the incidence of acute otitis media (AOM) are based on general practitioner (GP) or pediatrician diagnoses. It is likely that these figures underestimate the community incidence of AOM since parents do not visit their doctor every time their child suffers from acute ear symptoms. The impact of these symptom episodes may be substantial since they affect the child's quality of life and parents' productivity. Methods To determine AOM symptoms in the community, we measured parent-reported AOM symptoms daily for 12 consecutive months in 1,260 children participating in a prospective birth cohort in the Netherlands. The mean age of these children was at study enrollment 0.9 months (standard deviation 0.6). A parent-reported AOM symptom episode was defined as fever (temperature 38 degrees C or above) plus at least one of the following symptoms: ear pain and ear discharge. These febrile AOM symptom episodes were linked to GP-consultations and diagnoses in the GP electronic health records. Results With an estimated 624 parent-reported symptom episodes per 1,000 child-years (95% CI: 577 to 674) incidence of febrile AOM symptoms during the child's first year is high. The GP was consulted in half of these symptom episodes and AOM was diagnosed in 49% of these consultations. Conclusions and Relevance The incidence of febrile AOM symptoms in the first year of life is high in Dutch children and leads to a GP-consultation in only half of the cases. This suggests that AOM symptomatology in the community is underestimated when focusing on GP-diagnosed AOM episodes alone, since a considerable proportion of febrile AOM symptom episodes are treated symptomatically by parents at home and do not come to the attention of the GP. Having data on community AOM symptomatology available for each country is important when the potential impact of preventive and therapeutic interventions for AOM are studied.	[Fortanier, Alexandre C.; Venekamp, Roderick P.; de Hoog, Marieke L. A.; Uiterwaal, Cuno S. P. M.; Hoes, Arno W.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Hoog, Marieke L. A.; Schilder, Anne G. M.] Univ Med Ctr Utrecht, Dept Otorhinolaryngol, Utrecht, Netherlands; [van der Gugten, Anne C.; van der Ent, Cornelis K.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Pediat Pulmonol, Utrecht, Netherlands; [Schilder, Anne G. M.] UCL, Ear Inst, London, England	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; University of London; University College London	Venekamp, RP (corresponding author), Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands.	r.p.venekamp@umcutrecht.nl		Venekamp, Roderick P/0000-0002-1446-9614; Van der Ent, Cornelis/0000-0002-2501-4121; Schilder, Anne/0000-0002-5496-4580	Netherlands Organization for Health Research and Development (ZonMW); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands; National Institute for Health Research, Research Professorship Award (NIHR); National Institute for Health Research [NIHR-RP-011-045] Funding Source: researchfish	Netherlands Organization for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); University Medical Center Utrecht; GlaxoSmithKline, The Netherlands(Netherlands GovernmentGlaxoSmithKline); National Institute for Health Research, Research Professorship Award (NIHR); National Institute for Health Research(National Institute for Health Research (NIHR))	The WHISTLER-project was supported by grants from The Netherlands Organization for Health Research and Development (ZonMW), by the University Medical Center Utrecht, and by an unrestricted grant from GlaxoSmithKline, The Netherlands. The evidENT team at UCL, United Kingdom is supported by a National Institute for Health Research, Research Professorship Award (NIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELMAN CLM, 1993, BRIT MED J, V306, P895, DOI 10.1136/bmj.306.6882.895; Barber C, 2014, INT J PEDIATR OTORHI, V78, P300, DOI 10.1016/j.ijporl.2013.11.030; Casey JR, 2013, PEDIATR INFECT DIS J, V32, P805, DOI 10.1097/INF.0b013e31828d9acc; Damoiseaux RAMJ, 2000, BRIT MED J, V320, P350, DOI 10.1136/bmj.320.7231.350; Greenberg D, 2003, EUR J PEDIATR, V162, P576, DOI 10.1007/s00431-003-1260-5; Katier N, 2004, EUR J EPIDEMIOL, V19, P895, DOI 10.1023/B:EJEP.0000040530.98310.0c; Kontiokari T, 1998, PEDIATR INFECT DIS J, V17, P676, DOI 10.1097/00006454-199808000-00003; Laine MK, 2010, PEDIATRICS, V125, pE1154, DOI 10.1542/peds.2009-2689; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Liese JG, 2014, EPIDEMIOL INFECT, V142, P1778, DOI 10.1017/S0950268813002744; Magnus MC, 2012, PEDIATR INFECT DIS J, V31, P951, DOI 10.1097/INF.0b013e31825d2f76; Mandel EM, 2008, INT J PEDIATR OTORHI, V72, P491, DOI 10.1016/j.ijporl.2007.12.008; Monasta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036226; Schnabel E, 2009, EUR J PEDIATR, V168, P1251, DOI 10.1007/s00431-008-0921-9; Shaikh N, 2009, PEDIATR INFECT DIS J, V28, P5, DOI 10.1097/INF.0b013e318185a387; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Tahtinen PA, 2009, FAM PRACT, V26, P488, DOI 10.1093/fampra/cmp055; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Uitti JM, 2013, PEDIATRICS, V131, pE398, DOI 10.1542/peds.2012-1188; Van Lier EA OP, 2013, 1502020012013 RIVM; VANBUCHEM FL, 1985, BRIT MED J, V290, P1033, DOI 10.1136/bmj.290.6474.1033; Wolleswinkel-van den Bosch J, 2010, VACCINE, V28, pG39, DOI [10.1016/j.vaccine.2010.06.014, DOI 10.1016/J.VACCINE.2010.06.014]; Yawn BP, 1996, CLIN THER, V18, P877, DOI 10.1016/S0149-2918(96)80048-8	23	15	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121572	10.1371/journal.pone.0121572	http://dx.doi.org/10.1371/journal.pone.0121572			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849847	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800067
J	Huang, BL; Mackem, S				Huang, Bau-Lin; Mackem, Susan			Tamoxifen-Dependent, Inducible Bmp2CreER Drives Selective Recombinase Activity in Early Interdigital Mesenchyme and Digit Collateral Ligaments	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VERTEBRATE LIMB; MOUSE; EXPRESSION; IDENTITY; TENDONS; MICE	During limb development, the interdigital mesenchyme has been proposed to play a signaling role instructing morphogenesis of different digit types, as well as undergoing programmed cell death necessary to free digits in animals not adapted for swimming or flying. We have generated a conditional, tamoxifen-dependent Cre line, Bmp2CreER, which drives highly selective recombination restricted to the distal limb mesoderm, largely restricted to the interdigits, and selectively active in digit ligament but not tendon progenitors at later stages. The Bmp2CreER provides a valuable new tool to dissect roles of interdigital mesenchyme and potentially investigate divergence of ligament and tendon lineages.	[Huang, Bau-Lin; Mackem, Susan] NCI Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC)	Mackem, S (corresponding author), NCI Frederick, Canc & Dev Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA.	mackems@mail.nih.gov	Huang, Bau-Lin/S-4133-2019; Huang, Bau-Lin/K-8317-2019	Huang, Bau-Lin/0000-0003-3747-6697; 	Center for Cancer Research, National Cancer Institute, NIH; NATIONAL CANCER INSTITUTE [ZIABC011119] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Center for Cancer Research, National Cancer Institute, NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Dahn RD, 2000, SCIENCE, V289, P438, DOI 10.1126/science.289.5478.438; Dathe K, 2009, AM J HUM GENET, V84, P483, DOI 10.1016/j.ajhg.2009.03.001; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Grieshammer U, 2008, GENESIS, V46, P69, DOI 10.1002/dvg.20366; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Mariani FV, 2008, NATURE, V453, P401, DOI 10.1038/nature06876; MARTIN P, 1990, International Journal of Developmental Biology, V34, P323; Nagy A., 2003, MANIPULATING MOUSE E, Vx; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nguyen MT, 2009, DEV DYNAM, V238, P467, DOI 10.1002/dvdy.21846; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Pizette S, 1999, DEVELOPMENT, V126, P883; Pregizer S, 2009, CYTOKINE GROWTH F R, V20, P509, DOI 10.1016/j.cytogfr.2009.10.011; Rabinowitz AH, 2012, DEV BIOL, V368, P165, DOI 10.1016/j.ydbio.2012.05.035; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sanz-Ezquerro JJ, 2003, CURR BIOL, V13, P1830, DOI 10.1016/j.cub.2003.09.040; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Watson SS, 2009, DEV DYNAM, V238, P693, DOI 10.1002/dvdy.21866; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	25	2	2	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123325	10.1371/journal.pone.0123325	http://dx.doi.org/10.1371/journal.pone.0123325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850076	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800224
J	Jones, MS; Tadepalli, S; Bridges, DF; Wu, VCH; Drummond, F				Jones, Matthew S.; Tadepalli, Shravani; Bridges, David F.; Wu, Vivian C. H.; Drummond, Frank			Suppression of Escherichia coli O157:H7 by Dung Beetles (Coleoptera: Scarabaeidae) Using the Lowbush Blueberry Agroecosystem as a Model System	PLOS ONE			English	Article							CONTAMINATED MANURE; O157-H7 INFECTIONS; FOOD SAFETY; OUTBREAK; CATTLE; TRANSMISSION; SALMONELLA; SURVIVAL; SPINACH; FIELDS	Wildlife as a source of microbial contamination is a food safety concern. Deer feces (scat) have been determined as a point source for Escherichia coli O157:H7 contamination of fresh produce. The ecological role of the scooped scarab (Onthophagus hecate (Panzer)), a generalist dung beetle species common in Maine blueberry fields, was explored as a biological control agent and alternatively as a pathogen vector between deer scat and food. A large-scale field survey of wildlife scat indicated that pathogenic E. coli O157: H7 was present, albeit at a low prevalence (1.9% of samples, n = 318), in the Maine lowbush blueberry agroecosystem. A manipulative field experiment verified that, should contact occur between deer scat and blueberry plants and fruit during the summer, contamination with E. coli O157: H7 can occur and persist for more than 72 h. For both the positive control and an experimental scat inoculation treatment, the levels of the bacterial population decreased over time, but at different rates (treatment x time interaction: F ((1.9,18.8)) = 358.486, P < 0.0001). The positive control inoculation, which resulted in a higher initial E. coli level on fruit, decayed at a faster rate than inoculation of fruit via scat in the experimental treatment. We conducted 2 laboratory studies to elucidate aspects of dung beetle feeding ecology as it relates to suppression of E. coli O157:H7 from deer scat to lowbush blueberry fruit. In both experiments, dung beetles buried the same amount of scat whether or not the scat was inoculated with the pathogen (F-(1,F-6) = 0.001; P = 0.999 and (F ((2,17)) = 4.10, P = 0.147). Beetles feeding on E. coli inoculated deer scat were not found to vector the pathogen to fruit. In two studies, beetles lowered the amount of pathogenic E. coli persisting in soils compared to soils without beetles (F ((2,9)) = 7.757; P = 0.05 and F ((2,17)) = 8.0621, P = 0.004). Our study suggests that the dung beetle species, Onthophagus hecate, has the potential to contribute to the suppression of E. coli O157:H7 in agricultural landscapes.	[Jones, Matthew S.; Bridges, David F.; Drummond, Frank] Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA; [Jones, Matthew S.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Tadepalli, Shravani; Wu, Vivian C. H.] Univ Maine, Sch Food & Agr, Orono, ME USA; [Drummond, Frank] Univ Maine, Cooperat Extens, Orono, ME USA	University of Maine System; University of Maine Orono; Washington State University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono	Jones, MS (corresponding author), Univ Maine, Sch Biol & Ecol, Orono, ME 04469 USA.	matthew.s.jones@wsu.edu; vivian.wu@umit.maine.edu; frank.drummond@umit.maine.edu		Bridges, David/0000-0002-8507-6498; Wu, Vivian C.H./0000-0002-1525-1078	Center for Produce Safety; Maine Agricultural and Forest Experiment Station at the University of Maine [3406]; USDA National Institute of Food and Agriculture [ME08562-10]	Center for Produce Safety; Maine Agricultural and Forest Experiment Station at the University of Maine; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This research was supported by the Center for Produce Safety and the Maine Agricultural and Forest Experiment Station at the University of Maine with external publication number 3406. This work is based upon research supported in part by Hatch Grant number ME08562-10 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackers ML, 1998, J INFECT DIS, V177, P1588, DOI 10.1086/515323; ANDERSON JR, 1978, CALIF AGR, V32, P31; Atwill ER, 2008, P 23 VERT PEST C SAN, P5; Bertone M, 2006, NCSU COOP EXT; BESSER RE, 1993, JAMA-J AM MED ASSOC, V269, P2217, DOI 10.1001/jama.269.17.2217; Bialka KL, 2007, J FOOD SCI, V72, pM391, DOI 10.1111/j.1750-3841.2007.00517.x; Bugguide. net, 2004, SPECIES ONTHOPHAGUS; Cody SH, 1999, ANN INTERN MED, V130, P202, DOI 10.7326/0003-4819-130-3-199902020-00005; Collins JD, 2004, REV SCI TECH OIE, V23, P685, DOI 10.20506/rst.23.2.1510; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Feng P., 2011, BACTERIOLOGICAL ANAL; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; FINCHER GT, 1981, J GEORGIA ENTOMOL SO, V16, P316; Fischer JR, 2001, APPL ENVIRON MICROB, V67, P1218, DOI 10.1128/AEM.67.3.1218-1224.2001; Franz E, 2005, APPL ENVIRON MICROB, V71, P6165, DOI 10.1128/AEM.71.10.6165-6174.2005; Gillespie JR, 2000, J AM VET MED ASSOC, V216, P662, DOI 10.2460/javma.2000.216.662; Han Y, 2004, J FOOD PROTECT, V67, P2450, DOI 10.4315/0362-028X-67.11.2450; Holldobler B., 1990, pi; HOLTER P, 1979, OIKOS, V32, P393, DOI 10.2307/3544751; Howden H. F., 1963, Proceedings of the United States National Museum, V114, P1; Hwang JS, 2008, EUR J ENTOMOL, V105, P355, DOI 10.14411/eje.2008.042; Islam M, 2005, FOOD MICROBIOL, V22, P63, DOI 10.1016/j.fm.2004.04.007; Janisiewicz WJ, 1999, APPL ENVIRON MICROB, V65, P1; Jay MT, 2007, EMERG INFECT DIS, V13, P1908, DOI 10.3201/eid1312.070763; Johannessen GS, 2005, APPL ENVIRON MICROB, V71, P2221, DOI 10.1128/AEM.71.5.2221-2225.2005; Jones M. J, 2013, THESIS; Koehler S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-3; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Laidler MR, 2013, CLIN INFECT DIS, P1; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Moyne AL, 2011, FOOD MICROBIOL, V28, P1417, DOI 10.1016/j.fm.2011.02.001; NEALIS VG, 1977, CAN J ZOOL, V55, P138, DOI 10.1139/z77-017; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; OBRIEN RG, 1985, PSYCHOL BULL, V97, P316, DOI 10.1037/0033-2909.97.2.316; Rasmussen MA, 2001, CRIT REV MICROBIOL, V27, P57, DOI 10.1080/20014091096701; Renter DG, 2006, J WILDLIFE DIS, V42, P699, DOI 10.7589/0090-3558-42.3.699; Renter DG, 2001, J WILDLIFE DIS, V37, P755, DOI 10.7589/0090-3558-37.4.755; ROGERS LL, 1987, J WILDLIFE MANAGE, V51, P330, DOI 10.2307/3801011; Ryan U, 2011, EXP PARASITOL, V129, P1, DOI 10.1016/j.exppara.2011.06.009; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Wendel AM, 2009, CLIN INFECT DIS, V48, P1079, DOI 10.1086/597399; Wheater P.C., 2011, PRACTICAL FIELD ECOL; Xu JG, 2003, MICROBIOL IMMUNOL, V47, P45, DOI 10.1111/j.1348-0421.2003.tb02784.x; Yarborough DE, 2013, COMMUNICATION	45	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120904	10.1371/journal.pone.0120904	http://dx.doi.org/10.1371/journal.pone.0120904			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849430	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800039
J	Mansouri, M; Salamonsen, RF; Lim, E; Akmeliawati, R; Lovell, NH				Mansouri, Mahdi; Salamonsen, Robert F.; Lim, Einly; Akmeliawati, Rini; Lovell, Nigel H.			Preload-Based Starling-Like Control for Rotary Blood Pumps: Numerical Comparison with Pulsatility Control and Constant Speed Operation	PLOS ONE			English	Article							LEFT-VENTRICULAR ASSIST; HEART-FAILURE PATIENTS; NONINVASIVE ESTIMATION; PHYSIOLOGICAL CONTROL; HEMODYNAMIC-RESPONSE; DEVICE; FLOW; PRESSURE; EXERCISE; PERFORMANCE	In this study, we evaluate a preload-based Starling-like controller for implantable rotary blood pumps (IRBPs) using left ventricular end-diastolic pressure (PLVED) as the feedback variable. Simulations are conducted using a validated mathematical model. The controller emulates the response of the natural left ventricle (LV) to changes in PLVED. We report the performance of the preload-based Starling-like controller in comparison with our recently designed pulsatility controller and constant speed operation. In handling the transition from a baseline state to test states, which include vigorous exercise, blood loss and a major reduction in the LV contractility (LVC), the preload controller outperformed pulsatility control and constant speed operation in all three test scenarios. In exercise, preload-control achieved an increase of 54% in mean pump flow ((Q) over bar (P)) with minimum loading on the LV, while pulsatility control achieved only a 5% increase in flow and a decrease in mean pump speed. In a hemorrhage scenario, the preload control maintained the greatest safety margin against LV suction. PLVED for the preload controller was 4.9 mmHg, compared with 0.4 mmHg for the pulsatility controller and 0.2 mmHg for the constant speed mode. This was associated with an adequate mean arterial pressure (MAP) of 84 mmHg. In transition to low LVC, (Q) over bar (P) for preload control remained constant at 5.22 L/min with a PLVED of 8.0 mmHg. With regards to pulsatility control, (Q) over bar (P) fell to the nonviable level of 2.4 L/min with an associated PLVED of 16 mmHg and a MAP of 55 mmHg. Consequently, pulsatility control was deemed inferior to constant speed mode with a PLVED of 11 mmHg and a (Q) over bar (P) of 5.13 L/min in low LVC scenario. We conclude that pulsatility control imposes a danger to the patient in the severely reduced LVC scenario, which can be overcome by using a preload-based Starling-like control approach.	[Mansouri, Mahdi; Lim, Einly] Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Salamonsen, Robert F.] Alfred Hosp, Dept Intens Care, Prahran, Vic 3181, Australia; [Salamonsen, Robert F.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Akmeliawati, Rini] Int Islamic Univ Malaysia, Dept Mechatron Engn, Kuala Lumpur, Malaysia; [Lovell, Nigel H.] Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia	Universiti Malaya; Florey Institute of Neuroscience & Mental Health; Monash University; International Islamic University Malaysia; University of New South Wales Sydney	Mansouri, M (corresponding author), Univ Malaya, Dept Biomed Engn, Kuala Lumpur, Malaysia.	mh.mansouri@gmail.com	MANSOURI/J-5902-2015; Lovell, Nigel H/AGF-6679-2022; Akmeliawati, Rini/T-4776-2018; LIM, EINLY/B-8861-2010	MANSOURI/0000-0002-7702-3249; Lovell, Nigel H/0000-0003-1637-1079; LIM, EINLY/0000-0003-2037-4213; Akmeliawati, Rini/0000-0003-0660-2312; Mansouri, Majdi/0000-0001-6390-4304	Australian Research Council Linkages scheme; University of Malaya [UM.C/HIR/MOHE/ENG/50]	Australian Research Council Linkages scheme(Australian Research Council); University of Malaya(Universiti Malaya)	Australian Research Council Linkages scheme and the University of Malaya (UM.C/HIR/MOHE/ENG/50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto T, 1999, ARTIF ORGANS, V23, P797, DOI 10.1046/j.1525-1594.1999.06426.x; AlOmari AH, 2011, PHYSIOL MEAS, V32, P1035, DOI 10.1088/0967-3334/32/8/004; AlOmari AH, 2009, PHYSIOL MEAS, V30, P371, DOI 10.1088/0967-3334/30/4/003; AlOmari AHH, 2013, PHYSIOL MEAS, V34, pR1, DOI 10.1088/0967-3334/34/1/R1; Arndt A, 2008, ARTIF ORGANS, V32, P761, DOI 10.1111/j.1525-1594.2008.00628.x; Arndt A, 2010, ARTIF ORGANS, V34, P726, DOI 10.1111/j.1525-1594.2010.01092.x; Bakouri MA, 2014, ARTIF ORGANS, V38, P587, DOI 10.1111/aor.12223; Bakshi VU, 2007, LINEAR CONTROL SYSTE; BERNE RM, 1981, ANNU REV PHYSIOL, V43, P357, DOI 10.1146/annurev.ph.43.030181.002041; Boston JR, 2003, IEEE ROBOT AUTOM MAG, V10, P54, DOI 10.1109/MRA.2003.1191711; Bullister E, 2002, ARTIF ORGANS, V26, P931, DOI 10.1046/j.1525-1594.2002.07126.x; Choi S, 2005, INT J CONTROL AUTOM, V3, P100; Choi S, 2007, ARTIF ORGANS, V31, P114, DOI 10.1111/j.1525-1594.2007.00350.x; Endo G, 2002, ASAIO J, V48, P83, DOI 10.1097/00002480-200201000-00016; Esmore DS, 2008, J HEART LUNG TRANSPL, V27, P479, DOI 10.1016/j.healun.2008.02.003; Farrar DJ, 2007, ASAIO J, V53, P310, DOI 10.1097/MAT.0b013e3180536694; Gaddum NR, 2014, ARTIF ORGANS, V38, pE46, DOI 10.1111/aor.12221; Giridharan G, 2005, P AMER CONTR CONF, P3823, DOI 10.1109/ACC.2005.1470570; Giridharan GA, 2002, ARTIF ORGANS, V26, P980, DOI 10.1046/j.1525-1594.2002.07136.x; Guyton A.C., 2005, HAEMOLYTIC ANOEMIA M, V10th, P388; Guyton AC, 1963, CIRCULATORY PHYSL CA, P237; Haddad F, 2008, CIRCULATION, V117, P1717, DOI 10.1161/CIRCULATIONAHA.107.653584; Jacquet L, 2011, ARTIF ORGANS, V35, P682, DOI 10.1111/j.1525-1594.2011.01227.x; Karantonis DM, 2006, ARTIF ORGANS, V30, P671, DOI 10.1111/j.1525-1594.2006.00283.x; Konieczny G, 2010, ACTA PHYS POL A, V118, P1183, DOI 10.12693/APhysPolA.118.1183; Letsou GV, 2013, EUR J CARDIO-THORAC, V44, P573, DOI 10.1093/ejcts/ezt106; Lim E, 2009, CHARACTERISATION CAR; Lim E, 2015, ARTIF ORGANS, V39, pE24, DOI 10.1111/aor.12370; Lim E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077357; Lim E, 2012, ARTIF ORGANS, V36, pE125, DOI 10.1111/j.1525-1594.2012.01448.x; Lim E, 2012, ARTIF ORGANS, V36, pE110, DOI 10.1111/j.1525-1594.2012.01449.x; Lim E, 2010, IEEE T BIO-MED ENG, V57, P254, DOI 10.1109/TBME.2009.2031629; Maeda K, 1998, AM HEART J, V135, P825, DOI 10.1016/S0002-8703(98)70041-9; Mancini D, 1998, CIRCULATION, V98, P1178, DOI 10.1161/01.CIR.98.12.1178; Reesink K, 2007, ARTIF ORGANS, V31, P542, DOI 10.1111/j.1525-1594.2007.00420.x; Saito I, 2010, P 32 ANN INT C IEEE; Salamonsen RF, 2013, ARTIF ORGANS, V37, P695, DOI 10.1111/aor.12070; Salamonsen RF, 2011, ARTIF ORGANS, V35, pE47, DOI 10.1111/j.1525-1594.2010.01168.x; Salamonsen RF, 2012, ARTIF ORGANS, V36, P787, DOI 10.1111/j.1525-1594.2012.01457.x; Schima H, 2006, J HEART LUNG TRANSPL, V25, P167, DOI 10.1016/j.healun.2005.09.008; Slaughter MS, 2009, J HEART LUNG TRANSPL, V28, P39, DOI 10.1016/j.healun.2008.10.007; Starling EH, 1927, J PHYSIOL-LONDON, V52, P243; Troughton RW, 2011, J CARDIOVASC TRANSL, V4, P3, DOI 10.1007/s12265-010-9229-z; Wu Y, 2003, ARTIF ORGANS, V27, P926, DOI 10.1046/j.1525-1594.2003.00032.x; Zhou MD, 2012, BIOMED MICRODEVICES, V14, P235, DOI 10.1007/s10544-011-9601-z	45	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121413	10.1371/journal.pone.0121413	http://dx.doi.org/10.1371/journal.pone.0121413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849979	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800057
J	Maubant, S; Tesson, B; Maire, V; Ye, ML; Rigaill, G; Gentien, D; Cruzalegui, F; Tucker, GC; Roman-Roman, S; Dubois, T				Maubant, Sylvie; Tesson, Bruno; Maire, Virginie; Ye, Mengliang; Rigaill, Guillem; Gentien, David; Cruzalegui, Francisco; Tucker, Gordon C.; Roman-Roman, Sergio; Dubois, Thierry			Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; WNT SIGNALING PATHWAY; MAMMARY EPITHELIAL-CELLS; BETA-CATENIN; TARGET GENES; CANDIDATE TARGETS; UP-REGULATION; STEM-CELLS; EXPRESSION; ACTIVATION	The canonical Wnt/beta-catenin pathway is activated in triple-negative breast cancer (TNBC). The activation of this pathway leads to the expression of specific target genes depending on the cell/tissue context. Here, we analyzed the transcriptome of two different TNBC cell lines to define a comprehensive list of Wnt target genes. The treatment of cells with Wnt3a for 6h up-regulated the expression (fold change > 1.3) of 59 genes in MDA-MB-468 cells and 241 genes in HCC38 cells. Thirty genes were common to both cell lines. Beta-catenin may also be a transcriptional repressor and we found that 18 and 166 genes were down-regulated in response to Wnt3a treatment for 6h in MDA-MB-468 and HCC38 cells, respectively, of which six were common to both cell lines. Only half of the activated and the repressed transcripts have been previously described as Wnt target genes. Therefore, our study reveals 137 novel genes that may be positively regulated by Wnt3a and 104 novel genes that may be negatively regulated by Wnt3a. These genes are involved in the Wnt pathway itself, and also in TGF beta, p53 and Hedgehog pathways. Thorough characterization of these novel potential Wnt target genes may reveal new regulators of the canonical Wnt pathway. The comparison of our list of Wnt target genes with those published in other cellular contexts confirms the notion that Wnt target genes are tissue-, cell line-and treatment-specific. Genes up-regulated in Wnt3a-stimulated cell lines were more strongly expressed in TNBC than in luminal A breast cancer samples. These genes were also overexpressed, but to a much lesser extent, in HER2+ and luminal B tumors. We identified 72 Wnt target genes higher expressed in TNBCs (17 with a fold change >1.3) which may reflect the chronic activation of the canonical Wnt pathway that occurs in TNBC tumors.	[Maubant, Sylvie; Tesson, Bruno; Maire, Virginie; Ye, Mengliang; Dubois, Thierry] Inst Curie, Ctr Rech, Translat Res Dept, Breast Canc Biol Grp, Paris, France; [Tesson, Bruno] Inst Curie, Ctr Rech, Bioinformat Biostat Epidemiol & Computat Syst Bio, INSERM U900, Paris, France; [Tesson, Bruno] Mines ParisTech, Fontainebleau, France; [Rigaill, Guillem] Univ Evry Val Essonne, CNRS, INRA, Unite Rech Genom Vegetale, Evry, France; [Gentien, David] Inst Curie, Ctr Rech, Translat Res Dept, Platform Mol Biol Facil, Paris, France; [Cruzalegui, Francisco; Tucker, Gordon C.] Inst Rech SERVIER, Pole Innovat Therapeut Oncol, Croissy Sur Seine, France; [Roman-Roman, Sergio] Inst Curie, Ctr Rech, Translat Res Dept, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Servier; Institut de Recherches Internationales Servier; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Dubois, T (corresponding author), Inst Curie, Ctr Rech, Translat Res Dept, Breast Canc Biol Grp, Paris, France.	thierry.dubois@curie.fr	Gentien, David/L-7757-2017; Roman-Roman, Sergio/K-9993-2014; Gentien, David/O-9356-2019; Dubois, Thierry/D-2852-2017	Gentien, David/0000-0001-8317-5188; Roman-Roman, Sergio/0000-0001-6459-2613; Dubois, Thierry/0000-0003-4739-6164; Rigaill, Guillem/0000-0002-7176-7511	Institut de Recherches Servier; Institut Curie; Institut de Recherche Servier	Institut de Recherches Servier; Institut Curie; Institut de Recherche Servier	This work was supported by Institut de Recherches Servier and Institut Curie. Co-authors Francisco Cruzalegui and Gordon C. Tucker are employed by Institut de Recherche Servier. Institut de Recherche Servier provided support in the form of salaries for authors FC and GCT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama T, 2006, ONCOGENE, V25, P7538, DOI 10.1038/sj.onc.1210063; Angonin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074666; Archbold HC, 2012, ACTA PHYSIOL, V204, P74, DOI 10.1111/j.1748-1716.2011.02293.x; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilir B, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-280; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Chen SQ, 2007, J CELL COMMUN SIGNAL, V1, P175, DOI 10.1007/s12079-007-0015-x; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Creyghton MP, 2005, GENE DEV, V19, P376, DOI 10.1101/gad.328905; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Furuuchi K, 2000, AM J PATHOL, V156, P1997, DOI 10.1016/S0002-9440(10)65072-9; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Goel S, 2012, J BIOL CHEM, V287, P16454, DOI 10.1074/jbc.M112.362137; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; Herbst A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-74; Hoverter NP, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.139pe43; INGHAM PW, 2012, GENE DEV, V4, DOI DOI 10.1101/CSHPERSPECT.A011221; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jackson A, 2005, BONE, V36, P585, DOI 10.1016/j.bone.2005.01.007; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jonsson M, 2000, EUR J CANCER, V36, P242, DOI 10.1016/S0959-8049(99)00276-2; Kamiya N, 2011, BIOCHEM BIOPH RES CO, V414, P326, DOI 10.1016/j.bbrc.2011.09.060; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Katoh M, 2007, INT J MOL MED, V19, P273; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim JS, 2002, CANCER RES, V62, P2744; King TD, 2012, J CELL BIOCHEM, V113, P13, DOI 10.1002/jcb.23350; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Labbe E, 2007, CANCER RES, V67, P75, DOI 10.1158/0008-5472.CAN-06-2559; Lai SL, 2009, CELL RES, V19, P532, DOI 10.1038/cr.2009.41; Laplante M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011593; Lee HS, 2007, LIFE SCI, V80, P690, DOI 10.1016/j.lfs.2006.10.024; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu BY, 2012, CANCER RES, V72, P1568, DOI 10.1158/0008-5472.CAN-11-3668; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maire V, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063712, 10.1371/journal.pone.0077372]; Maire V, 2013, CANCER RES, V73, P813, DOI 10.1158/0008-5472.CAN-12-2633; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; Metzger O, 2012, J CLIN ONCOL, V30, P1879, DOI 10.1200/JCO.2011.38.2010; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Mokry M, 2012, NUCLEIC ACIDS RES, V40, P148, DOI 10.1093/nar/gkr720; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Nakopoulou L, 2006, MODERN PATHOL, V19, P556, DOI 10.1038/modpathol.3800562; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Pecina-Slaus N, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-22; Polakis P, 2000, GENE DEV, V14, P1837; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Prasad CP, 2007, ONCOLOGY-BASEL, V73, P112, DOI 10.1159/000120999; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Railo A, 2009, EXP CELL RES, V315, P2690, DOI 10.1016/j.yexcr.2009.06.021; Reichling T, 2005, CANCER RES, V65, P166; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Rohrs S, 2009, CELL BIOL INT, V33, P501, DOI 10.1016/j.cellbi.2009.01.016; Schaale K, 2011, EUR J CELL BIOL, V90, P553, DOI 10.1016/j.ejcb.2010.11.004; Schwartz DR, 2003, CANCER RES, V63, P2913; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; Shin H, 2010, J DERMATOL SCI, V58, P91, DOI 10.1016/j.jdermsci.2010.02.011; Silva CM, 2004, ONCOGENE, V23, P8017, DOI 10.1038/sj.onc.1208159; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; So EY, 2010, INT J BIOL SCI, V6, P675; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Staal FJT, 2004, J IMMUNOL, V172, P1099, DOI 10.4049/jimmunol.172.2.1099; Takahashi M, 2002, CANCER RES, V62, P5651; Takahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086582; Tang W, 2008, P NATL ACAD SCI USA, V105, P9697, DOI 10.1073/pnas.0804709105; Teo JL, 2010, ADV DRUG DELIVER REV, V62, P1149, DOI 10.1016/j.addr.2010.09.012; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tomimaru Y, 2013, LIVER INT, V33, P1100, DOI 10.1111/liv.12188; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van Raay TJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018650; van Veelen W, 2011, GUT, V60, P1204, DOI 10.1136/gut.2010.233460; Vlad A, 2008, CELL SIGNAL, V20, P795, DOI 10.1016/j.cellsig.2007.10.031; Waaler J, 2011, CANCER RES, V71, P197, DOI 10.1158/0008-5472.CAN-10-1282; Wan XH, 2012, CLIN CANCER RES, V18, P726, DOI 10.1158/1078-0432.CCR-11-2521; Wang ZGC, 2004, CANCER RES, V64, P64, DOI 10.1158/0008-5472.CAN-03-2570; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Yang M, 2005, P NATL ACAD SCI USA, V102, P6027, DOI 10.1073/pnas.0501535102; Zhang J, 2010, ONCOGENE, V29, P539, DOI 10.1038/onc.2009.339; Zhou YH, 2013, J MOL HISTOL, V44, P555, DOI 10.1007/s10735-013-9504-9; Ziegler S, 2005, FEBS J, V272, P1600, DOI 10.1111/j.1742-4658.2005.04581.x; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	98	47	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122333	10.1371/journal.pone.0122333	http://dx.doi.org/10.1371/journal.pone.0122333			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848952	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800119
J	Moser, EK; Sun, J; Kim, TS; Braciale, TJ				Moser, Emily K.; Sun, Jie; Kim, Taeg S.; Braciale, Thomas J.			IL-21R Signaling Suppresses IL-17(+) Gamma Delta T Cell Responses and Production of IL-17 Related Cytokines in the Lung at Steady State and After Influenza A Virus Infection	PLOS ONE			English	Article							NEUTROPHIL RECRUITMENT; IMMUNOGLOBULIN-M; INTERLEUKIN-21; RECEPTOR; MICE; DIFFERENTIATION; PARTICIPATE; POPULATION; DEFICIENCY; EXPRESSION	Influenza A virus (IAV) infection of the respiratory tract elicits a robust immune response, which is required for efficient virus clearance but at the same time can contribute to lung damage and enhanced morbidity. IL-21 is a member of the type I cytokine family and has many different immune-modulatory functions during acute and chronic virus infections, although its role in IAV infection has not been fully evaluated. In this report we evaluated the contributions of IL-21/IL-21 receptor (IL-21R) signaling to host defense in a mouse model of primary IAV infection using IL-21R knock out (KO) mice. We found that lack of IL-21R signaling had no significant impact on virus clearance, adaptive T cell responses, or myeloid cell accumulations in the respiratory tract. However, a subset of inflammatory cytokines were elevated in the bronchoalveolar lavage fluid of IL-21R KO mice, including IL-17. Although there was only a small increase in Th17 cells in the lungs of IL-21R KO mice, we observed a dramatic increase in gamma delta (gamma delta) T cells capable of producing IL-17 both after IAV infection and at steady state in the respiratory tract. Finally, we found that IL-21R signaling suppressed the accumulation of IL-17(+) gamma delta T cells in the respiratory tract intrinsically. Thus, our study reveals a previously unrecognized role of IL-21R signaling in regulating IL-17 production by gamma delta T cells.	[Moser, Emily K.; Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA; [Moser, Emily K.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Sun, Jie] Indiana Univ, Herman B Wells Ctr Pediat, Indianapolis, IN 46204 USA; [Kim, Taeg S.; Braciale, Thomas J.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA	University of Virginia; University of Virginia; Indiana University System; Indiana University-Purdue University Indianapolis; University of Virginia	Braciale, TJ (corresponding author), Univ Virginia, Beirne B Carter Ctr Immunol Res, Charlottesville, VA 22903 USA.	tjb2r@virginia.edu	Moser, Emily/AAS-6618-2020	Moser, Emily/0000-0001-6386-5894	National Institutes of Health [AI-15608, AI-083024, HL-33391]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126647, R01HL033391] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024, R01AI037293, R01AI015608, R37AI015608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007055] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the following grants from the National Institutes of Health: AI-15608, AI-083024, and HL-33391. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamayooran G, 2012, J IMMUNOL, V189, P5849, DOI 10.4049/jimmunol.1200585; Barin JG, 2012, EUR J IMMUNOL, V42, P726, DOI 10.1002/eji.201141737; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; EICHELBERGER M, 1991, J EXP MED, V174, P875, DOI 10.1084/jem.174.4.875; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Girardi M, 2006, J INVEST DERMATOL, V126, P25, DOI 10.1038/sj.jid.5700003; Graham MB, 1997, J EXP MED, V186, P2063, DOI 10.1084/jem.186.12.2063; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Harada Y, 2003, J EXP MED, V197, P1779, DOI 10.1084/jem.20021457; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Hufford MM, 2011, J EXP MED, V208, P167, DOI 10.1084/jem.20101850; KAVALER J, 1991, EUR J IMMUNOL, V21, P2687, DOI 10.1002/eji.1830211107; Kisielow J, 2013, CURR OPIN IMMUNOL, V25, P181, DOI 10.1016/j.coi.2013.03.002; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Kotlarz D, 2013, J EXP MED, V210, P433, DOI 10.1084/jem.20111229; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leonard WJ, 2008, J LEUKOCYTE BIOL, V84, P348, DOI 10.1189/jlb.0308149; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; McKinstry KK, 2009, J IMMUNOL, V182, P7353, DOI 10.4049/jimmunol.0900657; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Novy P, 2011, J IMMUNOL, V186, P2729, DOI 10.4049/jimmunol.1003009; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Rankin AL, 2011, J IMMUNOL, V186, P667, DOI 10.4049/jimmunol.0903207; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Reichel CA, 2012, BLOOD, V120, P880, DOI 10.1182/blood-2012-01-402164; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Rothaeusler K, 2010, EUR J IMMUNOL, V40, P366, DOI 10.1002/eji.200939798; Sciammas R, 1999, MICROBES INFECT, V1, P203, DOI 10.1016/S1286-4579(99)80035-5; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Tu WW, 2011, J EXP MED, V208, P1511, DOI 10.1084/jem.20110226; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Vermijlen D, 2007, J IMMUNOL, V178, P4304, DOI 10.4049/jimmunol.178.7.4304; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120169	10.1371/journal.pone.0120169	http://dx.doi.org/10.1371/journal.pone.0120169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849970	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800021
J	Nagu, TJ; Aboud, S; Mwiru, R; Matee, M; Fawzi, W; Mugusi, F				Nagu, Tumaini J.; Aboud, Said; Mwiru, Ramadhani; Matee, Mecky; Fawzi, Wafaie; Mugusi, Ferdinand			Multi Drug and Other Forms of Drug Resistant Tuberculosis Are Uncommon among Treatment Naive Tuberculosis Patients in Tanzania	PLOS ONE			English	Article							MDR; TB	Background Surveillance and effective management of drug resistance is important to sustaining tuberculosis (TB) control efforts. We aimed to determine resistance rates to first line anti tuberculosis drugs and to describe factors associated with the resistance to any of the first line anti tuberculosis drugs in Dar es Salaam Tanzania. Materials Newly diagnosed, TB patients with neither history of tuberculosis treatment nor isoniazid prophylaxis were included into the study. Sputum specimens were cultured on either mycobacteria growth indicator tube 960 (MGIT 960) or Lowenstein Jenstein (LJ) medium supplemented with either glycerol (GLJ) or pyruvate (PLJ). Drug susceptibility for isoniazid, rifampicin, streptomycin and ethambutol was determined by either Lowenstein-Jensen (LJ) medium or mycobacteria growth indicator tube 960 (MGIT 960). Results A total of 933 newly diagnosed TB patients, were included into the study. Multi drug resistance (MDR) tuberculosis was detected among 2 (0.2%) patients. Resistance to any of the four tested drugs was detected among 54 (5.8%) patients. Mono-resistance to isoniazid, rifampicin, streptomycin and ethambutol were 21(2.3%), 3 (0.3%), 13 (1.4%), 9 (1.0%) respectively. Conclusion Primary resistance to first line anti tuberculosis drugs is still low in this setting. Continued vigilance including periodic national surveillance of anti-tuberculosis resistance is recommended.	[Nagu, Tumaini J.; Mugusi, Ferdinand] Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania; [Nagu, Tumaini J.] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Aboud, Said; Matee, Mecky] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Mwiru, Ramadhani] Management & Dev Hlth, Dar Es Salaam, Tanzania; [Fawzi, Wafaie] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Harvard University; Harvard T.H. Chan School of Public Health	Nagu, TJ (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Internal Med, Dar Es Salaam, Tanzania.	jtjoyce20@hotmail.com			global health scholarship program for junior scientists and Swedish International Development Agency (SIDA)	global health scholarship program for junior scientists and Swedish International Development Agency (SIDA)	This study was funded by the global health scholarship program for junior scientists and Swedish International Development Agency (SIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard C, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.33.20555; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Dooley KE, 2013, J INFECT DIS, V207, P1352, DOI 10.1093/infdis/jis460; Kibiki GS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-51; Kruijshaar M, 2008, BMJ-BRIT MED J, V336, P1201, DOI [10.1136/bmj.39560.630613.80, DOI 10.1136/BMJ.39560.630613.80]; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Matee M, 2009, APMIS, V117, P263, DOI 10.1111/j.1600-0463.2008.02429.x; Ministry of Health and Social Welfare, MAN NAT TUB LEPR PRO; Ministry of Health and Social Welfare, 2012, NAT TUB LEPR PROGR A; Ministry of Health and Social Welfare National AIDS Control Programme, 2012, NAT GUID MAN HIV AID; Nagu TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091229; Sanchez-Padilla E, 2013, INT J TUBERC LUNG D, V17, P1036, DOI 10.5588/ijtld.12.0842; Satti H, 2013, INT J TUBERC LUNG D, V17, P100, DOI 10.5588/ijtld.12.0344; Urassa Willy, 2008, BMC Res Notes, V1, P58, DOI 10.1186/1756-0500-1-58; van Heurck R, 2013, ACTA CLIN BELG, V68, P321, DOI 10.2143/ACB.3269; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; WHO, 2008, ANT DRUG RES WORLD W; World Health Organisation, 2014, ANT RES GLOB REP SUR, P43; World Health Organization, WHOHTMTB2009; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7; YANG ZH, 1995, J CLIN MICROBIOL, V33, P1064, DOI 10.1128/JCM.33.5.1064-1069.1995; Zignol M, 2014, B WORLD HEALTH ORGAN, V90, P111	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118601	10.1371/journal.pone.0118601	http://dx.doi.org/10.1371/journal.pone.0118601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849784	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800007
J	Rong, GH; Bai, WL; Dong, Z; Wang, CP; Lu, YY; Zeng, Z; Qu, JH; Lou, M; Wang, H; Gao, XD; Chang, XJ; An, LJ; Li, HY; Chen, Y; Hu, KQ; Yang, YP				Rong, Guanghua; Bai, Wenlin; Dong, Zheng; Wang, Chunping; Lu, Yinying; Zeng, Zhen; Qu, Jianhui; Lou, Min; Wang, Hong; Gao, Xudong; Chang, Xiujuan; An, Linjing; Li, Hongyan; Chen, Yan; Hu, Ke-Qin; Yang, Yongping			Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; CIRRHOSIS; COMPLICATIONS; CRYOTHERAPY; RESECTION	Background Accumulating evidences have suggested that percutaneous cryoablation could be a valuable alternative ablation therapy for HCC but there has been no large cohort-based analysis on its long-term outcomes. Methods A series of 866 patients with Child-Pugh class A-B cirrhosis and HCC within Milan criteria who underwent percutaneous cryoablation was long-term followed. The safety, efficacy, 5year survival, and prognostic factors of percutaneous cryoablation in the treatment of HCC were analyzed. Results A total of 1197 HCC lesions were ablated with 1401 cryoablation sessions. Complete response (CR) was achieved in 1163 (97.2%) lesions and 832 (96.1%) patients with 34 (2.8%) major complications, but no treatment-related mortality. After a median of 30.9 months follow-up, 502 (60.3%) patients who achieved CR developed different types of recurrence. The cumulative local tumor recurrence rate was 24.2% at 5-years. Multiple tumor lesions, tumor size > 3 cm, and repeated ablation of same lesion were independent risk factors associated with local recurrence. The 5-year overall survival (OS) rates were 59.5%. Age < 36 years, HCC family history, baseline hepatitis B virus DNA > 10(6) copies/ml, and three HCC lesions were independently and significantly negative predictors to the postcryoablation OS. Conclusions Percutaneous cryoablation is an effective therapy for patients with HCC within Milan criteria, with comparable efficacy, safety and long-term survival to the reported outcomes of radiofrequency ablation.	[Rong, Guanghua; Bai, Wenlin; Dong, Zheng; Wang, Chunping; Lu, Yinying; Zeng, Zhen; Qu, Jianhui; Lou, Min; Wang, Hong; Gao, Xudong; Chang, Xiujuan; An, Linjing; Li, Hongyan; Chen, Yan; Yang, Yongping] 302 Hosp, Ctr Therapeut Res Liver Canc, Beijing 100039, Peoples R China; [Hu, Ke-Qin] Univ Calif Irvine, Div Gastroenterol Hepatol, Orange, CA 92868 USA	Fifth Medical Center of Chinese PLA General Hospital; University of California System; University of California Irvine	Hu, KQ (corresponding author), Univ Calif Irvine, Div Gastroenterol Hepatol, 101 City Dr,Bldg 56,Ste 237, Orange, CA 92868 USA.	kqhu@uci.edu; yongpingyang@hotmail.com	RONG, GUANGHUA/G-6529-2012	RONG, GUANGHUA/0000-0002-6419-1227	Outstanding Medical Talents Foundation of PLA [04J020]; Chinese National Natural Science Foundation [81202362]; Capital Medical Research and Development Fund, China [2009-2041]	Outstanding Medical Talents Foundation of PLA; Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Capital Medical Research and Development Fund, China	This work was funded by Outstanding Medical Talents Foundation of PLA (No. 04J020), Chinese National Natural Science Foundation (No. 81202362), and the Capital Medical Research and Development Fund (No. 2009-2041), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Choi D, 2007, EUR RADIOL, V17, P684, DOI 10.1007/s00330-006-0461-5; Dunne RM, 2014, EUR J RADIOL, V83, P632, DOI 10.1016/j.ejrad.2014.01.007; EASL-EORTC, 2011, J HEPATOL, V56, P908; Ei Shigenori, 2014, ANN SURG ONCOL, P1; Goldberg SN, 2005, J VASC INTERV RADIOL, V16, P765, DOI 10.1097/01.RVI.0000170858.46668.65; Haen SP, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/160250; Hu KQ, 2014, J CLIN GASTROENTEROL, V48, P3, DOI [10.1097/MCG.0000000000000201, 10.1097/MCG.0b013e3182a6633d]; Hutchinson M, 2013, IMAGE GUIDED CANC TH, P491, DOI DOI 10.1007/978-1-4419-0751-6_35; Kim YS, 2013, J HEPATOL, V58, P89, DOI 10.1016/j.jhep.2012.09.020; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Lencioni R, 2010, HEPATOLOGY, V52, P762, DOI 10.1002/hep.23725; Li ZW, 2013, ONCOL LETT, V6, P239, DOI 10.3892/ol.2013.1314; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; Seifert JK, 1999, WORLD J SURG, V23, P109, DOI 10.1007/PL00013173; Seifert JK, 2002, WORLD J SURG, V26, P1333, DOI 10.1007/s00268-002-6139-5; Shiina S, 2012, AM J GASTROENTEROL, V107, P569, DOI 10.1038/ajg.2011.425; STEWART GJ, 1995, CRYOBIOLOGY, V32, P215, DOI 10.1006/cryo.1995.1021; Tatli S, 2010, DIAGN INTERV RADIOL, V16, P90, DOI 10.4261/1305-3825.DIR.1922-08.0; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Wang C, 2012, INFECT DIS INFO, V25, P312, DOI [10.1097/QCO.0b013e328352b664, DOI 10.1097/QC0.0B013E328352B664]; Wang CP, 2012, WORLD J GASTROENTERO, V18, P6587, DOI 10.3748/wjg.v18.i45.6587; Wang CP, 2015, HEPATOLOGY, V61, P1579, DOI 10.1002/hep.27548; Wang HW, 2005, RADIOLOGY, V235, P289, DOI 10.1148/radiol.2351030747; Yang YP, 2012, J HEPATO-BIL-PAN SCI, V19, P674, DOI 10.1007/s00534-011-0490-6; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x	28	47	53	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123065	10.1371/journal.pone.0123065	http://dx.doi.org/10.1371/journal.pone.0123065			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849963	gold, Green Published			2022-12-26	WOS:000352477800201
J	Shaw, AJ; Ingham, SA; Atkinson, G; Folland, JP				Shaw, Andrew J.; Ingham, Stephen A.; Atkinson, Greg; Folland, Jonathan P.			The Correlation between Running Economy and Maximal Oxygen Uptake: Cross-Sectional and Longitudinal Relationships in Highly Trained Distance Runners	PLOS ONE			English	Article							INVERSE RELATIONSHIP; PERFORMANCE; EXERCISE; EFFICIENCY; VO2MAX; TIME; COST	A positive relationship between running economy and maximal oxygen uptake ((V) over dotO(2max)) has been postulated in trained athletes, but previous evidence is equivocal and could have been confounded by statistical artefacts. Whether this relationship is preserved in response to running training (changes in running economy and (V) over dotO(2max)) has yet to be explored. This study examined the relationships of (i) running economy and (V) over dotO(2max) between runners, and (ii) the changes in running economy and (V) over dotO(2max) that occur within runners in response to habitual training. 168 trained distance runners (males, n = 98, (V) over dotO(2max) 73.0 +/- 6.3 mL.kg(-1).min(-1); females, n = 70, (V) over dotO(2max) 65.2 +/- 5.9 mL.kg(-1).min(-1)) performed a discontinuous submaximal running test to determine running economy (kcal.km(-1)). A continuous incremental treadmill running test to volitional exhaustion was used to determine (V) over dotO(2max) 54 participants (males, n = 27; females, n = 27) also completed at least one follow up assessment. Partial correlation analysis revealed small positive relationships between running economy and (V) over dotO(2max) (males r = 0.26, females r = 0.25; P<0.006), in addition to moderate positive relationships between the changes in running economy and VO2max in response to habitual training (r = 0.35; P<0.001). In conclusion, the current investigation demonstrates that only a small to moderate relationship exists between running economy and (V) over dotO(2max) in highly trained distance runners. With >85% of the variance in these parameters unexplained by this relationship, these findings reaffirm that running economy and (V) over dotO(2max) are primarily determined independently.	[Shaw, Andrew J.; Ingham, Stephen A.] Univ Loughborough, English Inst Sport, Loughborough, Leics, England; [Shaw, Andrew J.; Folland, Jonathan P.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Atkinson, Greg] Univ Teesside, Hlth & Social Care Inst, Middlesbrough, Cleveland, England	Loughborough University; Loughborough University; University of Teesside	Shaw, AJ (corresponding author), Univ Loughborough, English Inst Sport, Loughborough, Leics, England.	a.shaw@lboro.ac.uk	Atkinson, Greg/ABA-2278-2021	Atkinson, Greg/0000-0002-5459-9042				Atkinson G, 2003, MED SCI SPORT EXER, V35, P1242, DOI 10.1249/01.MSS.0000074560.08128.5D; Bishop D, 1998, MED SCI SPORT EXER, V30, P1270, DOI 10.1097/00005768-199808000-00014; Bland JM, 2009, BMJ-BRIT MED J, V446, P1; BLOMQVIST CG, 1983, ANNU REV PHYSIOL, V45, P169, DOI 10.1146/annurev.ph.45.030183.001125; BRANDON LJ, 1995, SPORTS MED, V19, P268, DOI 10.2165/00007256-199519040-00004; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; Di Michele R, 2014, J SCI MED SPORT, V17, P414, DOI 10.1016/j.jsams.2013.05.012; di Prampero PE, 2003, EUR J APPL PHYSIOL, V90, P420, DOI 10.1007/s00421-003-0926-z; Fletcher JR, 2009, J APPL PHYSIOL, V107, P1918, DOI 10.1152/japplphysiol.00307.2009; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Helgerud J, 2010, EUR J APPL PHYSIOL, V108, P1099, DOI 10.1007/s00421-009-1218-z; Hopker J, 2012, INT J SPORTS MED, V33, P789, DOI 10.1055/s-0032-1304640; Hopker J, 2009, MED SCI SPORT EXER, V41, P912, DOI 10.1249/MSS.0b013e31818f2ab2; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Hunter GR, 2011, MED SCI SPORT EXER, V43, P1492, DOI 10.1249/MSS.0b013e318210464a; Iaia FM, 2009, J APPL PHYSIOL, V106, P73, DOI 10.1152/japplphysiol.90676.2008; Ingham SA, 2008, MED SCI SPORT EXER, V40, P345, DOI 10.1249/mss.0b013e31815a83dc; Jeukendrup AE, 2005, INT J SPORTS MED, V26, pS28, DOI 10.1055/s-2004-830512; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; JOYNER MJ, 1991, J APPL PHYSIOL, V70, P683, DOI 10.1152/jappl.1991.70.2.683; Lucia A, 2002, MED SCI SPORT EXER, V34, P2079, DOI 10.1249/01.MSS.0000039306.92778.DF; Mclaughlin JE, 2010, MED SCI SPORT EXER, V42, P991, DOI 10.1249/MSS.0b013e3181c0669d; MORGAN DW, 1994, INT J SPORTS MED, V15, P426, DOI 10.1055/s-2007-1021082; Moya-Larano Jordi, 2008, Web Ecology, V8, P35; Noakes TD, 2004, MED SCI SPORT EXER, V36, P1083, DOI 10.1249/01.MSS.0000128140.85727.2D; PATE RR, 1992, MED SCI SPORT EXER, V24, P1128; Pearson K., 1896, P ROY SOC LONDON, V60, P489, DOI DOI 10.1098/RSPL.1896.0076; Peronnet F., 1991, CANAD J SPORT SCI, V9, P16; PUGH LGCE, 1970, J PHYSIOL-LONDON, V207, P823, DOI 10.1113/jphysiol.1970.sp009097; Rietjens GJWM, 2001, INT J SPORTS MED, V22, P291, DOI 10.1055/s-2001-14342; Santalla A, 2009, MED SCI SPORT EXER, V41, P1096, DOI 10.1249/MSS.0b013e318191c802; Sawyer BJ, 2010, MED SCI SPORT EXER, V42, P2122, DOI 10.1249/MSS.0b013e3181de2da7; Schmidt W, 2008, SCAND J MED SCI SPOR, V18, P57, DOI 10.1111/j.1600-0838.2008.00833.x; Scholz MN, 2008, J EXP BIOL, V211, P3266, DOI 10.1242/jeb.018812; Shaw AJ, 2014, MED SCI SPORT EXER, V46, P1968, DOI 10.1249/MSS.0000000000000311; Shaw AJ, 2013, APPL PHYSIOL NUTR ME, V38, P1268, DOI 10.1139/apnm-2013-0055; Tartaruga MP, 2012, RES Q EXERCISE SPORT, V83, P367; Wagner P D, 2000, Exerc Sport Sci Rev, V28, P10	38	19	19	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123101	10.1371/journal.pone.0123101	http://dx.doi.org/10.1371/journal.pone.0123101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849090	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800204
J	Su, JJ; Zhou, HG; Tao, YH; Guo, JC; Guo, ZL; Zhang, S; Zhang, Y; Huang, YY; Tang, YP; Dong, Q; Hu, RM				Su, Jingjing; Zhou, Houguang; Tao, Yinghong; Guo, Jingchun; Guo, Zhuangli; Zhang, Shuo; Zhang, Yu; Huang, Yanyan; Tang, Yuping; Dong, Qiang; Hu, Renming			G-CSF Protects Human Brain Vascular Endothelial Cells Injury Induced by High Glucose, Free Fatty Acids and Hypoxia through MAPK and Akt Signaling	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; PROGENITOR CELLS; BONE-MARROW; NEURONAL APOPTOSIS; DIABETES-MELLITUS; OXIDATIVE STRESS; MOBILIZATION; MODEL; PHOSPHORYLATION	Granulocyte-colony stimulating factor (G-CSF) has been shown to play a neuroprotective role in ischemic stroke by mobilizing bone marrow (BM)-derived endothelial progenitor cells (EPCs), promoting angiogenesis, and inhibiting apoptosis. Impairments in mobilization and function of the BM-derived EPCs have previously been reported in animal and human studies of diabetes where there is both reduction in the levels of the BM-derived EPCs and its ability to promote angiogenesis. This is hypothesized to account for the pathogenesis of diabetic vascular complications such as stroke. Here, we sought to investigate the effects of GCSF on diabetes-associated cerebral vascular defect. We observed that pretreatment of the cultured human brain vascular endothelial cells (HBVECs) with G-CSF largely prevented cell death induced by the combination stimulus with high glucose, free fatty acids (FFA) and hypoxia by increasing cell viability, decreasing apoptosis and caspase-3 activity. Cell ultrastructure measured by transmission electron microscope (TEM) revealed that G-CSF treatment nicely reduced combination stimulus-induced cell apoptosis. The results from fluorescent probe Fluo-3/AM showed that G-CSF greatly suppressed the levels of intracellular calcium ions under combination stimulus. We also found that G-CSF enhanced the expression of cell cycle proteins such as human cell division cycle protein 14A (hCdc14A), cyclinB and cyclinE, inhibited p53 activity, and facilitated cell cycle progression following combination stimulus. In addition, activation of extracellular signal-regulated kinase1/2 (ERK1/2) and Akt, and deactivation of c-Jun N terminal kinase (JNK) and p38 were proved to be required for the pro-survival effects of G-CSF on HBVECs exposed to combination stimulus. Overall, G-CSF is capable of alleviating HBVECs injury triggered by the combination administration with high glucose, FFA and hypoxia involving the mitogen-activated protein kinases (MAPK) and Akt signaling cascades. G-CSF may represent a promising therapeutic agent for diabetic stroke.	[Su, Jingjing] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 9, Dept Neurol, Shanghai 200011, Peoples R China; [Zhou, Houguang; Zhang, Yu; Huang, Yanyan] Fudan Univ, Huashan Hosp, Dept Geriatr Neurol, Shanghai 200040, Peoples R China; [Tao, Yinghong] Ouyang Hosp, Dept Gen Med, Shanghai, Peoples R China; [Guo, Jingchun] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, State Key Lab Med Neurobiol,Dept Neurobiol, Shanghai 200032, Peoples R China; [Guo, Zhuangli] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Emergency Neurol, Qingdao 266100, Peoples R China; [Zhang, Shuo; Hu, Renming] Fudan Univ, Huashan Hosp, Dept Endocrine, Shanghai 200040, Peoples R China; [Tang, Yuping; Dong, Qiang] Fudan Univ, Huashan Hosp, Dept Neurol, Shanghai 200040, Peoples R China	Shanghai Jiao Tong University; Fudan University; Fudan University; Qingdao University; Fudan University; Fudan University	Zhou, HG (corresponding author), Fudan Univ, Huashan Hosp, Dept Geriatr Neurol, Shanghai 200040, Peoples R China.	zhg7376@163.com; renminghu@fudan.edu.cn	huang, yan/GWM-4747-2022		National Natural Scientific Foundation of China [81170322, 81200941]; Shanghai Natural Scientific Foundation of China [11ZR1405300]; Shanghai Municipal Outstanding Talent Development Foundation [2012052]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Natural Scientific Foundation of China; Shanghai Municipal Outstanding Talent Development Foundation	This work was supported by National Natural Scientific Foundation of China (81170322, 81200941), Shanghai Natural Scientific Foundation of China (11ZR1405300) and Shanghai Municipal Outstanding Talent Development Foundation (2012052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Albiero M, 2013, VASC PHARMACOL, V58, P253, DOI 10.1016/j.vph.2013.01.003; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barthelmes D, 2013, BLOOD CELL MOL DIS, V51, P163, DOI 10.1016/j.bcmd.2013.05.002; Bejot Y, 2010, DIABETES METAB, V36, pS84, DOI 10.1016/S1262-3636(10)70472-9; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chen WF, 2008, NEUROSCIENCE, V153, P31, DOI 10.1016/j.neuroscience.2008.01.062; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; de la Puente P, 2013, CLIN CANCER RES, V19, P3360, DOI 10.1158/1078-0432.CCR-13-0462; DEMETRI GD, 1991, BLOOD, V78, P2791; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Fadini GP, 2014, STEM CELL TRANSL MED, V3, P949, DOI 10.5966/sctm.2014-0052; Fadini Gian Paolo, 2012, Exp Diabetes Res, V2012, P742976, DOI 10.1155/2012/742976; Fadini GP, 2005, J AM COLL CARDIOL, V45, P1449, DOI 10.1016/j.jacc.2004.11.067; Fan B, 2013, METABOLISM, V62, P1168, DOI 10.1016/j.metabol.2013.02.013; Floel A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019767; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; GWAG BJ, 1995, NEUROSCIENCE, V68, P615, DOI 10.1016/0306-4522(95)00232-8; Kong T, 2009, J NEUROSURG, V111, P155, DOI 10.3171/2008.12.JNS08172; Lan XF, 2008, TOHOKU J EXP MED, V216, P117, DOI 10.1620/tjem.216.117; Lee ST, 2008, BRAIN RES, V1194, P130, DOI 10.1016/j.brainres.2007.11.058; Li B, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt67; Li C, 2012, CLIN EXP PHARMACOL P, V39, P739, DOI 10.1111/j.1440-1681.2012.05700.x; Li JM, 2012, MOL BIOL REP, V39, P5, DOI 10.1007/s11033-011-0703-8; Lu CZ, 2006, BIOCHEM SOC T, V34, P1327, DOI 10.1042/BST0341327; Mukherjee D, 2009, BEST PRACT RES CL EN, V23, P335, DOI 10.1016/j.beem.2008.10.015; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; OConnor PM, 1997, CANCER SURV, V29, P151; Ohtsuki F, 1997, BRIT J HAEMATOL, V98, P520, DOI 10.1046/j.1365-2141.1997.2643079.x; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Powell TM, 2005, ARTERIOSCL THROM VAS, V25, P296, DOI 10.1161/01.ATV.0000151690.43777.e4; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Shah QA, 2014, CELL PROLIFERAT, V47, P290, DOI 10.1111/cpr.12111; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sicinska E, 2006, MOL CELL BIOL, V26, P8052, DOI 10.1128/MCB.00800-06; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Song SJ, 2011, NEUROSCI LETT, V487, P153, DOI 10.1016/j.neulet.2010.10.012; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Su JJ, 2014, CNS NEUROSCI THER, V20, P264, DOI 10.1111/cns.12206; Su JJ, 2015, CELL SIGNAL, V27, P47, DOI 10.1016/j.cellsig.2014.10.003; Sugiyama Y, 2011, STROKE, V42, P770, DOI 10.1161/STROKEAHA.110.597799; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Tousoulis D, 2013, INT J CARDIOL, V168, P4769, DOI 10.1016/j.ijcard.2013.07.229; Ueda K, 2006, ARTERIOSCL THROM VAS, V26, pE108, DOI 10.1161/01.ATV.0000219697.99134.10; Wolf G, 1999, KIDNEY INT, V56, P1262, DOI 10.1046/j.1523-1755.1999.00695.x; Zhan KH, 2013, MICROVASC RES, V90, P1, DOI 10.1016/j.mvr.2013.06.010; Zhou HG, 2013, CNS NEUROSCI THER, V19, P252, DOI 10.1111/cns.12068; Zhou WJ, 2009, HYPERTENS RES, V32, P306, DOI 10.1038/hr.2009.16	51	21	24	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120707	10.1371/journal.pone.0120707	http://dx.doi.org/10.1371/journal.pone.0120707			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849550	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800029
J	Sugimori, N; Espinoza, JL; Trung, LQ; Takami, A; Kondo, Y; An, DT; Sasaki, M; Wakayama, T; Nakao, S				Sugimori, Naomi; Espinoza, J. Luis; Ly Quoc Trung; Takami, Akiyoshi; Kondo, Yukio; Dao Thi An; Sasaki, Motoko; Wakayama, Tomohiko; Nakao, Shinji			Paraptosis Cell Death Induction by the Thiamine Analog Benfotiamine in Leukemia Cells	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; DOUBLE-BLIND; LINE; INHIBITION; METABOLISM; EXPRESSION; PROGENITOR; RELEVANCE; MEDIATION; DAMAGE	Benfotiamine is a synthetic thiamine analogue that stimulates transketolase, a cellular enzyme essential for glucose metabolism. Currently, benfotiamine is used to treat diabetic neuropathy. We recently reported that oral benfotiamine induced a temporary but remarkable recovery from acute myeloid leukemia in an elderly patient who was ineligible for standard chemotherapy due to dementia and renal failure. In the present study we present evidences that benfotiamine possess antitumor activity against leukemia cells. In a panel of nine myeloid leukemia cell lines benfotiamine impaired the viability of HL-60, NB4, K562 and KG1 cells and also inhibited the growing of primary leukemic blasts. The antitumor activity of benfotiamine is not mediated by apoptosis, necrosis or autophagy, but rather occurs though paraptosis cell death induction. Mechanistic studies revealed that benfotiamine inhibited the activity of constitutively active ERK1/2 and concomitantly increased the phosphorylation of JNK1/2 kinase in leukemic cells. In addition, benfotiamine induced the down regulation of the cell cycle regulator CDK3 which resulted in G1 cell cycle arrest in the sensitive leukemic cells. Moreover, combination index studies showed that benfotiamine enhanced the antiproliferative activities of cytarabine against leukemia cells. These findings suggest that benfotiamine has antitumor therapeutic potential.	[Sugimori, Naomi; Espinoza, J. Luis; Ly Quoc Trung; Takami, Akiyoshi; Kondo, Yukio; Dao Thi An; Nakao, Shinji] Kanazawa Univ, Dept Hematol Oncol, Kanazawa Univ Hosp, Kanazawa, Ishikawa, Japan; [Takami, Akiyoshi] Aichi Med Univ, Sch Med, Dept Hematol Oncol, Nagakute, Aichi 48011, Japan; [Sasaki, Motoko] Kanazawa Univ, Dept Pathol, Kanazawa, Ishikawa, Japan; [Wakayama, Tomohiko] Kanazawa Univ, Dept Anat & Histol, Kanazawa, Ishikawa, Japan	Kanazawa University; Aichi Medical University; Kanazawa University; Kanazawa University	Espinoza, JL (corresponding author), Kanazawa Univ, Dept Hematol Oncol, Kanazawa Univ Hosp, Japan Takaramachi 13-1, Kanazawa, Ishikawa, Japan.	luis@staff.kanazawa-u.ac.jp	Sasaki, Motoko/K-5913-2015; Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Sasaki, Motoko/0000-0003-2514-760X; Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666	Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports and Technology of Japan; Grants-in-Aid for Scientific Research [24591418] Funding Source: KAKEN	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan. The grant sources played no role in the study design, data collection and analysis, the decision to publish or the preparation of the manuscript.	Alkhalaf A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040427; Alkhalaf A, 2010, DIABETES CARE, V33, P1598, DOI 10.2337/dc09-2241; Ariyoshi-Kishino K, 2010, ANTICANCER RES, V30, P5069; Balakumar P, 2010, PHARMACOL RES, V61, P482, DOI 10.1016/j.phrs.2010.02.008; Beltramo E, 2008, ACTA DIABETOL, V45, P131, DOI 10.1007/s00592-008-0042-y; Bury M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.85; Castro-Obregon S, 2002, CELL DEATH DIFFER, V9, P807, DOI 10.1038/sj.cdd.4401035; Doepfner KT, 2007, CRIT REV ONCOL HEMAT, V63, P215, DOI 10.1016/j.critrevonc.2007.05.005; Edwards LG, 1996, LEUKEMIA RES, V20, P17, DOI 10.1016/0145-2126(95)00095-X; Eleni LD, 2010, J ONCOL, V2010, DOI 10.1155/2010/943823; Espinoza JL, 2013, CANCER SCI, V104, P657, DOI 10.1111/cas.12141; Espinoza JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051306; Fey MF, 2010, ANN ONCOL, V21, pv158, DOI 10.1093/annonc/mdq179; Fraser DA, 2011, GENES NUTR; Fraser DA, 2012, DIABETES CARE, V35, P1095, DOI 10.2337/dc11-1895; FURUKAWA T, 1994, LEUKEMIA, V8, P171; KITAMURA T, 1991, INT IMMUNOL, V3, P571, DOI 10.1093/intimm/3.6.571; KOCHI M, 1985, CANCER TREAT REP, V69, P533; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; LANOTTE M, 1991, BLOOD, V77, P1080; Marchetti V, 2006, DIABETES, V55, P2231, DOI 10.2337/db06-0369; Motyckova G, 2011, CURR TREAT OPTION ON, V12, P341, DOI 10.1007/s11864-011-0162-4; Sakai I, 2002, BLOOD, V100, P2926, DOI 10.1182/blood-2002-01-0073; Sanchez-Ramirez GM, 2006, EUR J PHARMACOL, V530, P48, DOI 10.1016/j.ejphar.2005.11.016; Scheibe RJ, 2000, J CELL BIOCHEM, V76, P420, DOI 10.1002/(SICI)1097-4644(20000301)76:3<420::AID-JCB10>3.0.CO;2-F; Schmid U, 2008, DIABETES-METAB RES, V24, P371, DOI 10.1002/dmrr.860; Schupp N, 2008, N-S ARCH PHARMACOL, V378, P283, DOI 10.1007/s00210-008-0310-y; Shoeb M, 2012, FREE RADICAL BIO MED, V52, P182, DOI 10.1016/j.freeradbiomed.2011.10.444; Sperandio S, 2004, CELL DEATH DIFFER, V11, P1066, DOI 10.1038/sj.cdd.4401465; T Hoa N, 2007, LAB INVEST, V87, P115, DOI 10.1038/labinvest.3700506; Trung LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055183; Volvert Marie-Laure, 2008, BMC Pharmacology, V8, P10, DOI 10.1186/1471-2210-8-10; Yanada M, 2012, INT J HEMATOL, V96, P186, DOI 10.1007/s12185-012-1137-3; Ziems M., 2000, Biofactors, V11, P109	34	21	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120709	10.1371/journal.pone.0120709	http://dx.doi.org/10.1371/journal.pone.0120709			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849583	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800030
J	White, RL; Bennett, PM				White, Rachel L.; Bennett, Peter M.			Elevational Distribution and Extinction Risk in Birds	PLOS ONE			English	Article							CLIMATE-CHANGE; GLOBAL DISTRIBUTION; SPECIES RICHNESS; ALTITUDINAL MIGRATION; POPULATION DECLINES; RANGE SHIFTS; CONSERVATION; DIVERSITY; PATTERNS; THREAT	Mountainous regions are hotspots of terrestrial biodiversity. Unlike islands, which have been the focus of extensive research on extinction dynamics, fewer studies have examined mountain ranges even though they face increasing threats from human pressures - notably habitat conversion and climate change. Limits to the taxonomic and geographical extent and resolution of previously available information have precluded an explicit assessment of the relative role of elevational distribution in determining extinction risk. We use a new global species-level avian database to quantify the influence of elevational distribution (range, maximum and midpoint) on extinction risk in birds at the global scale. We also tested this relationship within biogeographic realms, higher taxonomic levels, and across phylogenetic contrasts. Potential confounding variables (i.e. phylogenetic, distributional, morphological, life history and niche breadth) were also tested and controlled for. We show that the three measures of elevational distribution are strong negative predictors of avian extinction risk, with elevational range comparable and complementary to that of geographical range size. Extinction risk was also found to be positively associated with body weight, development and adult survival, but negatively associated with reproduction and niche breadth. The robust and consistent findings from this study demonstrate the importance of elevational distribution as a key driver of variation in extinction dynamics in birds. Our results also highlight elevational distribution as a missing criterion in current schemes for quantifying extinction risk and setting species conservation priorities in birds. Further research is recommended to test for generality across non-avian taxa, which will require an advance in our knowledge of species' current elevational ranges and increased efforts to digitise and centralise such data.	[White, Rachel L.; Bennett, Peter M.] Univ Kent, Durrell Inst Conservat & Ecol, Canterbury, Kent, England	University of Kent	White, RL (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	rlwhite27@gmail.com		White, Rachel/0000-0003-0694-7847	University of Kent Postgraduate Research Scholarship	University of Kent Postgraduate Research Scholarship	This work was funded through a University of Kent Postgraduate Research Scholarship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachman S, 2004, ECOGRAPHY, V27, P299, DOI 10.1111/j.0906-7590.2004.03759.x; Badyaev AV, 1998, OIKOS, V82, P319, DOI 10.2307/3546972; Balmford A, 1996, TRENDS ECOL EVOL, V11, P193, DOI 10.1016/0169-5347(96)10026-4; Bennett P. M., 2002, OX ECOL EV; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bennett PM, 1986, THESIS U SUSSEX; Bielby J, 2010, BIODIVERS CONSERV, V19, P113, DOI 10.1007/s10531-009-9709-0; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blackburn TM, 2002, ECOL LETT, V5, P568, DOI 10.1046/j.1461-0248.2002.00360.x; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Cardillo M, 2008, P ROY SOC B-BIOL SCI, V275, P1441, DOI 10.1098/rspb.2008.0179; Caruso NM, 2013, DIVERS DISTRIB, V19, P38, DOI 10.1111/j.1472-4642.2012.00938.x; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Davies RG, 2007, P ROY SOC B-BIOL SCI, V274, P1189, DOI 10.1098/rspb.2006.0061; Davies RG, 2006, P ROY SOC B-BIOL SCI, V273, P2127, DOI 10.1098/rspb.2006.3551; del Hoyo J, 2013, HDB BIRDS WORLD; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Gage GS, 2004, ANIM CONSERV, V7, P161, DOI 10.1017/S1367943004001246; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; GASTON KJ, 1994, ECOGRAPHY, V17, P198, DOI 10.1111/j.1600-0587.1994.tb00094.x; Grenyer R, 2006, NATURE, V444, P93, DOI 10.1038/nature05237; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Hall J, 2009, BIOL CONSERV, V142, P2510, DOI 10.1016/j.biocon.2009.05.028; Hanna E, 2013, BIOL CONSERV, V158, P196, DOI 10.1016/j.biocon.2012.08.014; Harris G, 2008, CONSERV BIOL, V22, P163, DOI 10.1111/j.1523-1739.2007.00798.x; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hawkins BA, 2007, AM NAT, V170, pS16, DOI 10.1086/519009; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Joppa LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008273; Keane A, 2005, BIOL CONSERV, V126, P216, DOI 10.1016/j.biocon.2005.05.011; Kruger O, 2008, ANIM CONSERV, V11, P83, DOI 10.1111/j.1469-1795.2007.00155.x; La Marca E, 2005, BIOTROPICA, V37, P190, DOI 10.1111/j.1744-7429.2005.00026.x; La Sorte FA, 2010, P ROY SOC B-BIOL SCI, V277, P3401, DOI 10.1098/rspb.2010.0612; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Legendre P., 2012, R PROGR DOC; Loarie SR, 2009, NATURE, V462, P1052, DOI 10.1038/nature08649; MACARTHUR RH, 1972, ECOLOGY, V53, P330, DOI 10.2307/1934090; Mace GM, 2008, CONSERV BIOL, V22, P1424, DOI 10.1111/j.1523-1739.2008.01044.x; Mackas RH, 2010, CAN J ZOOL, V88, P369, DOI 10.1139/Z10-013; Manne LL, 1999, NATURE, V399, P258, DOI 10.1038/20436; Manne LL, 2001, ANIM CONSERV, V4, P221, DOI 10.1017/S1367943001001263; McCain CM, 2009, GLOBAL ECOL BIOGEOGR, V18, P346, DOI 10.1111/j.1466-8238.2008.00443.x; McCain CM, 2004, J BIOGEOGR, V31, P19, DOI 10.1046/j.0305-0270.2003.00992.x; Morrison C, 2003, J ANIM ECOL, V72, P270, DOI 10.1046/j.1365-2656.2003.00696.x; Nogues-Bravo D, 2008, NATURE, V453, P216, DOI 10.1038/nature06812; Normand S, 2009, GLOBAL ECOL BIOGEOGR, V18, P437, DOI 10.1111/j.1466-8238.2009.00451.x; Norris K, 2004, P ROY SOC B-BIOL SCI, V271, P123, DOI 10.1098/rspb.2003.2576; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; ORME C. D. L., 2012, CAPER COMP ANAL PHYL; Orme CDL, 2005, NATURE, V436, P1016, DOI 10.1038/nature03850; Owens IPF, 2000, P NATL ACAD SCI USA, V97, P12144, DOI 10.1073/pnas.200223397; Patterson BD, 1998, J BIOGEOGR, V25, P593, DOI 10.1046/j.1365-2699.1998.2530593.x; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Price M., 2011, MOUNTAIN FORESTS CHA; Purvis A, 2005, CONSERV BIOL SER, V8, P295; Purvis A, 2008, ANNU REV ECOL EVOL S, V39, P301, DOI 10.1146/annurev-ecolsys-063008-102010; R Development Core Team, 2012, R LANG ENV STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Rapacciuolo G, 2014, GLOBAL CHANGE BIOL, V20, P2841, DOI 10.1111/gcb.12638; Ripley B, 2012, MASS SUPPORT FUNCTIO; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; Rodriguez-Rodriguez D, 2012, MT RES DEV, V32, P197, DOI 10.1659/MRD-JOURNAL-D-10-00111.1; Rodriguez-Rodriguez D, 2011, BIOL CONSERV, V144, P2978, DOI 10.1016/j.biocon.2011.08.023; Schnell JK, 2013, CONSERV BIOL, V27, P520, DOI 10.1111/cobi.12047; Sekercioglu CH, 2008, CONSERV BIOL, V22, P140, DOI 10.1111/j.1523-1739.2007.00852.x; Sekercioglu CH, 2012, BIOL CONSERV, V148, P1, DOI 10.1016/j.biocon.2011.10.019; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Shoo LP, 2005, BIOL CONSERV, V125, P335, DOI 10.1016/j.biocon.2005.04.003; Sibley CG, 1990, DISTRIBUTION TAXONOM; Storch D, 2006, ECOL LETT, V9, P1308, DOI 10.1111/j.1461-0248.2006.00984.x; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sutherland WJ, 2003, NATURE, V423, P276, DOI 10.1038/nature01607; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, P NATL ACAD SCI USA, V106, P19637, DOI 10.1073/pnas.0901562106; Tobias JA, 2009, J EVOLUTION BIOL, V22, P623, DOI 10.1111/j.1420-9101.2008.01678.x; White RL, 2013, THESIS U KENT; Williams SE, 2003, P ROY SOC B-BIOL SCI, V270, P1887, DOI 10.1098/rspb.2003.2464; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	89	26	28	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121849	10.1371/journal.pone.0121849	http://dx.doi.org/10.1371/journal.pone.0121849			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849620	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352477800079
J	Won, JH; Tsogtbartarr, O; Son, W; Singh, A; Choi, KW; Cho, KO				Won, Jong-Hoon; Tsogtbartarr, Orkhon; Son, Wonseok; Singh, Amit; Choi, Kwang-Wook; Cho, Kyung-Ok			Cell Type-Specific Responses to Wingless, Hedgehog and Decapentaplegic Are Essential for Patterning Early Eye-Antenna Disc in Drosophila	PLOS ONE			English	Article							POLARITY GENE HEDGEHOG; MORPHOGENETIC FURROW; IMAGINAL DISKS; PERIPODIAL EPITHELIUM; PLANAR POLARITY; TRACHEAL SYSTEM; RETINA; HEAD; PROLIFERATION; INITIATION	The Drosophila eye-antenna imaginal disc (ead) is a flattened sac of two-layered epithelia, from which most head structures are derived. Secreted morphogens like Wingless (Wg), Hedgehog (Hh), and Decapentaplegic (Dpp) are important for early patterning of ead, but the underlying mechanisms are still largely unknown. To understand how these morphogens function in the ead of early larval stages, we used wg-LacZ and dpp-Gal4 markers for the examination of wild-type and mutant eads. We found that the ead immediately after hatching was crescent-shaped with the Bolwig's nerve at the ventral edge, suggesting that it consists of dorsal domain. In a subsequent step, transcriptional induction of dpp in the cells along the Bolwig's nerve was followed by rapid growth of the ventral domain. Both Wg and Hh were required for the formation of the ventral domain. Wg was crucial for the growth of the entire ead, but Hh was essential for cell division only in the dorsal domain. In the ventral domain, Hh regulated dpp transcription. Based on these data, we propose that signaling among distinct groups of cells expressing Wg, Dpp, or Hh in the ead of the first-instar larvae are critical for coordinated growth and patterning of ead.	[Won, Jong-Hoon; Tsogtbartarr, Orkhon; Son, Wonseok; Choi, Kwang-Wook; Cho, Kyung-Ok] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Singh, Amit] Univ Dayton, Ctr Tissue Regenerat & Engn Dayton TREND, Dept Biol, Dayton, OH 45469 USA	Korea Advanced Institute of Science & Technology (KAIST); University of Dayton	Cho, KO (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 291 Daehak Ro, Taejon 305701, South Korea.	kocho@kaist.ac.kr	Choi, Kwang-Wook/C-1707-2011; Singh, Amit/T-5619-2019; Cho, Kyung-Ok/C-1705-2011	Choi, Kwang-Wook/0000-0002-8997-3065; Singh, Amit/0000-0002-2962-2255; Son, Wonseok/0000-0003-1623-1236; Cho, Kyung-Ok/0000-0002-0760-2560	KAIST [G04080077, N10100001]; National Research Foundation [R1A1A301573]	KAIST; National Research Foundation	This research was supported by a KAIST Grant G04080077, N10100001, and National Research Foundation R1A1A301573. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre C, 1999, DEVELOPMENT, V126, P5689; Atkins M, 2009, DEV DYNAM, V238, P2139, DOI 10.1002/dvdy.22034; Auerbach C., 1936, P R SOC EDINB, V58, P787; Baena-Lopez LA, 2012, CURR OPIN CELL BIOL, V24, P166, DOI 10.1016/j.ceb.2011.12.010; Beitel GJ, 2000, DEVELOPMENT, V127, P3271; Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027; Bolwig N, 1946, THESIS KOBENHAVNS U; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; Brook WJ, 1996, SCIENCE, V273, P1373, DOI 10.1126/science.273.5280.1373; CARROLL SB, 1989, GENE DEV, V3, P905, DOI 10.1101/gad.3.6.905; Chanut F, 1997, DEVELOPMENT, V124, P559; Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0; Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Duman-Scheel M, 2002, NATURE, V417, P299, DOI 10.1038/417299a; Estella C, 2012, CURR TOP DEV BIOL, V98, P173, DOI 10.1016/B978-0-12-386499-4.00007-0; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Gibson MC, 2000, CELL, V103, P343, DOI 10.1016/S0092-8674(00)00125-2; Gibson MC, 2002, DEV CELL, V3, P451, DOI 10.1016/S1534-5807(02)00264-2; Hartenstein Volker, 1993; HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Ho KS, 2005, DEVELOPMENT, V132, P1401, DOI 10.1242/dev.01689; Hummel T, 2000, NEURON, V26, P357, DOI 10.1016/S0896-6273(00)81169-1; Jurgens G, 1993, TERMINAL REGIONS BOD, P687; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0; Lee OK, 2003, NAT CELL BIOL, V5, P987, DOI 10.1038/ncb1055; Lee T, 1996, GENE DEV, V10, P2912, DOI 10.1101/gad.10.22.2912; Lim J, 2004, GENESIS, V39, P26, DOI 10.1002/gene.20022; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Vviii; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243; MATHI SK, 1988, TISSUE CELL, V20, P461, DOI 10.1016/0040-8166(88)90077-8; McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092; MILNER MJ, 1984, ROUX ARCH DEV BIOL, V193, P406; MORATA G, 1979, DEV BIOL, V70, P355, DOI 10.1016/0012-1606(79)90033-2; Neumann CJ, 1996, DEVELOPMENT, V122, P1781; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Pignoni F, 1997, DEVELOPMENT, V124, P271; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Price MH, 2006, J CELL SCI, V119, P403, DOI 10.1242/jcs.02761; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Reifegerste R, 1997, MECH DEVELOP, V68, P69, DOI 10.1016/S0925-4773(97)00127-5; Royet J, 1997, DEVELOPMENT, V124, P4793; SCHMIDTOTT U, 1994, P NATL ACAD SCI USA, V91, P8363, DOI 10.1073/pnas.91.18.8363; Schmucker D, 1997, DEVELOPMENT, V124, P937; SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4; Stultz BG, 2006, DEV BIOL, V296, P329, DOI 10.1016/j.ydbio.2006.05.034; Takaesu NT, 2002, GENESIS, V34, P16, DOI 10.1002/gene.10109; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; TREISMAN JE, 1995, DEVELOPMENT, V121, P3519; Wehrli M, 1998, DEVELOPMENT, V125, P1421; Wernet MF, 2012, CURR BIOL, V22, P12, DOI 10.1016/j.cub.2011.11.028; WOODS DF, 1991, CELL, V66, P451, DOI 10.1016/0092-8674(81)90009-X; XU T, 1993, DEVELOPMENT, V117, P1223; YOUNOSSIHARTENSTEIN A, 1993, DEV BIOL, V158, P430, DOI 10.1006/dbio.1993.1201; ZECCA M, 1995, DEVELOPMENT, V121, P2265	59	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121999	10.1371/journal.pone.0121999	http://dx.doi.org/10.1371/journal.pone.0121999			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849899	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800092
J	Aeinehband, S; Lindblom, RPF; Al Nimer, F; Vijayaraghavan, S; Sandholm, K; Khademi, M; Olsson, T; Nilsson, B; Ekdahl, KN; Darreh-Shori, T; Piehl, F				Aeinehband, Shahin; Lindblom, Rickard P. F.; Al Nimer, Faiez; Vijayaraghavan, Swetha; Sandholm, Kerstin; Khademi, Mohsen; Olsson, Tomas; Nilsson, Bo; Ekdahl, Kristina Nilsson; Darreh-Shori, Taher; Piehl, Fredrik			Complement Component C3 and Butyrylcholinesterase Activity Are Associated with Neurodegeneration and Clinical Disability in Multiple Sclerosis	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; REGULATOR FACTOR-H; CEREBROSPINAL-FLUID; BIOLOGICAL MARKERS; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; INHIBITION; ACTIVATION; PROGRESSION; EXPRESSION	Dysregulation of the complement system is evident in many CNS diseases but mechanisms regulating complement activation in the CNS remain unclear. In a recent large rat genomewide expression profiling and linkage analysis we found co-regulation of complement C3 immediately downstream of butyrylcholinesterase (BuChE), an enzyme hydrolyzing acetylcholine (ACh), a classical neurotransmitter with immunoregulatory effects. We here determined levels of neurofilament-light (NFL), a marker for ongoing nerve injury, C3 and activity of the two main ACh hydrolyzing enzymes, acetylcholinesterase (AChE) and BuChE, in cerebrospinal fluid (CSF) from patients with MS (n = 48) and non-inflammatory controls (n = 18). C3 levels were elevated in MS patients compared to controls and correlated both to disability and NFL. C3 levels were not induced by relapses, but were increased in patients with >= 9 cerebral lesions on magnetic resonance imaging and in patients with progressive disease. BuChE activity did not differ at the group level, but was correlated to both C3 and NFL levels in individual samples. In conclusion, we show that CSF C3 correlates both to a marker for ongoing nerve injury and degree of disease disability. Moreover, our results also suggest a potential link between intrathecal cholinergic activity and complement activation. These results motivate further efforts directed at elucidating the regulation and effector functions of the complement system in MS, and its relation to cholinergic tone.	[Aeinehband, Shahin; Lindblom, Rickard P. F.; Al Nimer, Faiez; Khademi, Mohsen; Olsson, Tomas; Piehl, Fredrik] Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden; [Vijayaraghavan, Swetha; Darreh-Shori, Taher] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Alzheimer Neurobiol Ctr, Stockholm, Sweden; [Nilsson, Bo; Ekdahl, Kristina Nilsson] Uppsala Univ, Dept Immunol Genet & Pathol, Div Clin Immunol, Uppsala, Sweden; [Sandholm, Kerstin; Ekdahl, Kristina Nilsson] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Karolinska Institutet; Karolinska Institutet; Uppsala University; Linnaeus University	Aeinehband, S (corresponding author), Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, Stockholm, Sweden.	shahin.aeinehband@ki.se	DARREH-SHORI, TAHER/G-3931-2013; Nimer, Faiez Al/ABB-9465-2020; Nilsson, Bo/B-3102-2012; Ekdahl, Kristina Nilsson/B-5301-2012	Nilsson, Bo/0000-0003-0057-2730; Olsson, Tomas/0000-0002-2938-1877; Darreh-Shori, Taher/0000-0003-1176-6258; Khademi, Mohsen/0000-0003-0801-1444; Lindblom, Rickard/0000-0001-7913-4981; Al Nimer, Faiez/0000-0003-0937-5995; Piehl, Fredrik/0000-0001-8329-5219				Antonelli T, 2013, NEUROL SCI, V34, P769, DOI 10.1007/s10072-012-1265-9; Axelsson M, 2014, MULT SCLER J, V20, P43, DOI 10.1177/1352458513490544; Beecham AH, 2013, NAT GENET, V45, P1353, DOI 10.1038/ng.2770; Chiu IM, 2009, P NATL ACAD SCI USA, V106, P20960, DOI 10.1073/pnas.0911405106; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Confavreux C, 2006, BRAIN, V129, P606, DOI 10.1093/brain/awl007; Darreh-Shori T, 2008, NEUROBIOL AGING, V29, P168, DOI 10.1016/j.neurobiolaging.2006.09.020; Darreh-Shori T, 2006, NEUROBIOL DIS, V24, P326, DOI 10.1016/j.nbd.2006.07.013; Darreh-Shori T, 2013, NEUROBIOL AGING, V34, P2465, DOI 10.1016/j.neurobiolaging.2013.04.027; Darvesh S, 2003, NAT REV NEUROSCI, V4, P131, DOI 10.1038/nrn1035; Darvesh S, 1998, J COMP NEUROL, V393, P374; Darvesh S, 2001, CELL MOL NEUROBIOL, V21, P285, DOI 10.1023/A:1010947205224; Darvesh S, 2010, CHEM-BIOL INTERACT, V187, P425, DOI 10.1016/j.cbi.2010.01.037; De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Fonseca MI, 2009, J IMMUNOL, V183, P1375, DOI 10.4049/jimmunol.0901005; Frischer JM, 2009, BRAIN, V132, P1175, DOI 10.1093/brain/awp070; Gunnarsson M, 2011, ANN NEUROL, V69, P83, DOI 10.1002/ana.22247; Henningsson AJ, 2007, J NEUROIMMUNOL, V183, P200, DOI 10.1016/j.jneuroim.2006.10.022; Holton P, 2013, ANN HUM GENET, V77, P85, DOI 10.1111/ahg.12000; Iacobaeus E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019138; Ingram G, 2012, MULT SCLER J, V18, P1401, DOI 10.1177/1352458512438238; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Ingram G, 2011, J CELL BIOCHEM, V112, P2653, DOI 10.1002/jcb.23204; Ingram G, 2010, BRAIN, V133, P1602, DOI 10.1093/brain/awq085; Khademi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063172; Kooi EJ, 2011, ACTA NEUROPATHOL, V122, P313, DOI 10.1007/s00401-011-0849-4; Krafft PR, 2012, STROKE, V43, P844, DOI 10.1161/STROKEAHA.111.639989; Kuhle J, 2013, MULT SCLER J, V19, P1597, DOI 10.1177/1352458513482374; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Lehmann DJ, 1997, HUM MOL GENET, V6, P1933, DOI 10.1093/hmg/6.11.1933; Leray E, 2010, BRAIN, V133, P1900, DOI 10.1093/brain/awq076; Li Y, 2011, J CELL BIOCHEM, V112, P1930, DOI 10.1002/jcb.23113; Lindblom RPF, 2014, J IMMUNOL, V192, P1138, DOI 10.4049/jimmunol.1301233; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Malmsten L, 2014, J CELL MOL MED, V18, P1874, DOI 10.1111/jcmm.12343; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Nizri E, 2006, NEUROPHARMACOLOGY, V50, P540, DOI 10.1016/j.neuropharm.2005.10.013; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Ramaglia V, 2012, P NATL ACAD SCI USA, V109, P965, DOI 10.1073/pnas.1111924109; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; RUBERG M, 1987, J NEUROL NEUROSUR PS, V50, P538, DOI 10.1136/jnnp.50.5.538; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Shi FD, 2009, J IMMUNOL, V182, P1730, DOI 10.4049/jimmunol.182.3.1730; Sifringer M, 2013, DEV NEUROSCI-BASEL, V35, P255, DOI 10.1159/000346723; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Stoop MP, 2008, PROTEOMICS, V8, P1576, DOI 10.1002/pmic.200700446; Swanberg M, 2006, NEUROBIOL DIS, V24, P67, DOI 10.1016/j.nbd.2006.05.016; Tallantyre EC, 2010, MULT SCLER J, V16, P406, DOI 10.1177/1352458510364992; Teunissen CE, 2011, MULT SCLER J, V17, P838, DOI 10.1177/1352458511399614; Teunissen CE, 2005, LANCET NEUROL, V4, P32, DOI 10.1016/S1474-4422(04)00964-0; van Gool WA, 2010, LANCET, V375, P773, DOI 10.1016/S0140-6736(09)61158-2; Vijayaraghavan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065936; Wang Y, 2011, AM J PATHOL, V178, P1509, DOI 10.1016/j.ajpath.2011.01.006; Weiner HL, 2008, J NEUROL, V255, P3, DOI 10.1007/s00415-008-1002-8; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	56	41	41	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122048	10.1371/journal.pone.0122048	http://dx.doi.org/10.1371/journal.pone.0122048			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835709	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000074
J	Dvey-Aharon, Z; Fogelson, N; Peled, A; Intrator, N				Dvey-Aharon, Zack; Fogelson, Noa; Peled, Avi; Intrator, Nathan			Schizophrenia Detection and Classification by Advanced Analysis of EEG Recordings Using a Single Electrode Approach	PLOS ONE			English	Article							CONTEXTUAL PROCESSING DEFICITS; FUNCTIONAL CONNECTIVITY	Electroencephalographic (EEG) analysis has emerged as a powerful tool for brain state interpretation and diagnosis, but not for the diagnosis of mental disorders; this may be explained by its low spatial resolution or depth sensitivity. This paper concerns the diagnosis of schizophrenia using EEG, which currently suffers from several cardinal problems: it heavily depends on assumptions, conditions and prior knowledge regarding the patient. Additionally, the diagnostic experiments take hours, and the accuracy of the analysis is low or unreliable. This article presents the "TFFO" (Time-Frequency transformation followed by Feature-Optimization), a novel approach for schizophrenia detection showing great success in classification accuracy with no false positives. The methodology is designed for single electrode recording, and it attempts to make the data acquisition process feasible and quick for most patients.	[Dvey-Aharon, Zack; Intrator, Nathan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Fogelson, Noa] Chaim Sheba Med Ctr, Joseph Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel; [Fogelson, Noa] Univ A Coruna, Dept Psychol, La Coruna, Spain; [Peled, Avi] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, IL-32000 Haifa, Israel; [Peled, Avi] Shaar Menashe Mental Hlth Ctr, Inst Psychiat Studies, Hadera, Israel	Tel Aviv University; Chaim Sheba Medical Center; Universidade da Coruna; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Dvey-Aharon, Z (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	zackdvey@tau.ac.il		Fogelson, Noa/0000-0003-2239-2212	regional government of Galicia, Spain [INCITE09 106 232 PR, 2009/013, 2009/002]; Spanish Ministry of Science and Innovation [PSI2012-34212]	regional government of Galicia, Spain; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the regional government of Galicia, Spain [INCITE09 106 232 PR to NF, 2009/013, 2009/002] and by the Spanish Ministry of Science and Innovation [PSI2012-34212 to NF]".	ANDREASEN NC, 1982, ARCH GEN PSYCHIAT, V39, P789; [Anonymous], 2006, PHYSIOL MEAS; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Berger H, 1940, PSYCHE, V6; Bestelmeyer PEG, 2009, PSYCHIAT RES, V169, P212, DOI 10.1016/j.psychres.2008.06.035; Carretie L, 1997, ELECTROEN CLIN NEURO, V103, P298, DOI 10.1016/S0013-4694(96)96565-7; FENTON GW, 1980, BRIT J PSYCHIAT, V136, P445, DOI 10.1192/bjp.136.5.445; Fogelson N, 2011, PSYCHOPHYSIOLOGY, V48, P1217, DOI 10.1111/j.1469-8986.2011.01195.x; Fogelson N, 2011, CLIN NEUROPHYSIOL, V122, P539, DOI 10.1016/j.clinph.2010.07.017; Fogelson N, 2010, CORTEX, V46, P498, DOI 10.1016/j.cortex.2009.05.007; Fogelson N, 2009, BRAIN, V132, P3002, DOI 10.1093/brain/awp230; Geva AB, 1998, IEEE T BIO-MED ENG, V45, P1205, DOI 10.1109/10.720198; Halkidi M, 2002, CLUSTERING VALIDITY, P237; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Koenig T, 2001, SCHIZOPHR RES, V50, P55, DOI 10.1016/S0920-9964(00)00154-7; Laton J, 2014, J NEUROL SCI, V347, P262, DOI 10.1016/j.jns.2014.10.015; Lotte F, 2007, J NEURAL ENG, V4, pR1, DOI 10.1088/1741-2560/4/2/R01; Neuhaus AH, 2014, SCHIZOPHRENIA BULL, V40, P1062, DOI 10.1093/schbul/sbt151; Neuhaus AH, 2011, NEUROIMAGE, V55, P514, DOI 10.1016/j.neuroimage.2010.12.038; Oude DB, 2007, EGG BASED EMOTION RE; Peled A, 2001, INT J NEUROSCI, V106, P47, DOI 10.3109/00207450109149737; Petrantonakis PC, 2010, IEEE T INF TECHNOL B, V14, P186, DOI 10.1109/TITB.2009.2034649; Podlipsky I, 2012, J NEUROSCI METH, V203, P377, DOI 10.1016/j.jneumeth.2011.10.015; Roach BJ, 2008, SCHIZOPHRENIA BULL, V34, P907, DOI 10.1093/schbul/sbn093; Stockwell RG, 1996, IEEE T SIGNAL PROCES, V44, P998, DOI 10.1109/78.492555; Tomioka R., 2007, NIPS, V19, P1377, DOI DOI 10.1109/ISMS.2014.46; Zhdanov A, 2007, INFERRING FUNCTIONAL; Zhdanov A, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P393, DOI 10.1007/978-1-4020-8387-7_67	28	45	47	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123033	10.1371/journal.pone.0123033	http://dx.doi.org/10.1371/journal.pone.0123033			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837521	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000122
J	Guiro, K; Patel, SA; Greco, SJ; Rameshwar, P; Arinzeh, TL				Guiro, Khadidiatou; Patel, Shyam A.; Greco, Steven J.; Rameshwar, Pranela; Arinzeh, Treena L.			Investigating Breast Cancer Cell Behavior Using Tissue Engineering Scaffolds	PLOS ONE			English	Article							DRUG-RESISTANCE; MESENCHYMAL TRANSITION; MAMMOGRAPHIC DENSITY; BONE-MARROW; IN-VITRO; 3D; CULTURE; METASTASIS; MIGRATION; MATRIX	Despite early detection through the use of mammograms and aggressive intervention, breast cancer (BC) remains a clinical dilemma. BC can resurge after > 10 years of remission. Studies indicate that BC cells (BCCs) with self-renewal and chemoresistance could be involved in dormancy. The majority of studies use in vitro, two-dimensional (2-D) monolayer cultures, which do not recapitulate the in vivo microenvironment. Thus, to determine the effect of three-dimensional (3-D) microenvironment on BCCs, this study fabricated tissue engineering scaffolds made of poly (e-caprolactone) (PCL) having aligned or random fibers. Random and aligned fibers mimic, respectively, the random and highly organized collagen fibers found in the tumor extracellular matrix. Chemoresistant BCCs were obtained by treating with carboplatin. Western blot analysis of carboplatin resistant (treated) MDA-MB-231 (highly invasive, basal-like) and T47D (low-invasive, luminal) BCCs showed an increase in Bcl-2, Oct-4 and Sox-2, suggesting protection from apoptosis and increase in stem-like markers. Further studies with MDA-MB-231 BCCs seeded on the scaffolds showed little to no change in cell number over time for non-treated BCCs whereas on tissue culture polystyrene (TCP), non-treated BCCs displayed a significant increase in cell number at days 4 and 7 as compared to day 1 (p<0.05). Treated BCCs did not proliferate on TCP and the fibrous scaffolds. Little to no cyclin D1 was expressed for non-treated BCCs on TCP. On fibrous scaffolds, non-treated BCCs stained for cyclin D1 during the 7-day culture period. Treated BCCs expressed cyclin D1 on TCP and fibrous scaffolds during the 7-day culture period. Proliferation, viability and cell cycle analysis indicated that this 3-D culture prompted the aggressive BCCs to adopt a dormant phenotype, while the treated BCCs retained their phenotype. The findings indicate that random and aligned fibrous PCL scaffolds may provide a useful system to study how the 3-D microenvironment affects the behavior of BCCs.	[Guiro, Khadidiatou; Arinzeh, Treena L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Patel, Shyam A.; Greco, Steven J.; Rameshwar, Pranela] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ USA	New Jersey Institute of Technology; Rutgers State University New Brunswick; Rutgers State University Medical Center	Arinzeh, TL (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	arinzeh@njit.edu			Department of Defense; Wallace H. Coulter Foundation	Department of Defense(United States Department of Defense); Wallace H. Coulter Foundation	This work was funded by the Department of Defense and the Wallace H. Coulter Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; Beck MT, 2002, ONCOGENE, V21, P5047, DOI 10.1038/sj.onc.1205637; Becker S, 2006, BREAST CANCER RES TR, V97, P91, DOI 10.1007/s10549-005-9095-6; Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037; Benton G, 2009, J CELL PHYSIOL, V221, P18, DOI 10.1002/jcp.21832; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Box C, 2010, SEMIN CANCER BIOL, V20, P128, DOI 10.1016/j.semcancer.2010.06.004; Boyd NF, 2002, NEW ENGL J MED, V347, P886, DOI 10.1056/NEJMoa013390; Braun S, 2009, CANCER INVEST, V27, P598, DOI 10.1080/07357900802574496; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen AA, 2009, BIOMATERIALS, V30, P1113, DOI 10.1016/j.biomaterials.2008.10.055; Cheng N, 2008, TISSUE ENG PT A, V14, P1, DOI 10.1089/ten.a.2007.0131; Chowdhury F, 2010, NAT MATER, V9, P82, DOI [10.1038/NMAT2563, 10.1038/nmat2563]; Cichon MA, 2012, INTEGR BIOL-UK, V4, P440, DOI 10.1039/c1ib00090j; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; De Wever O, 2008, INT J CANCER, V123, P2229, DOI 10.1002/ijc.23925; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; ELIOPOULOS AG, 1995, ONCOGENE, V11, P1217; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; FISHER RF, 1982, Q J EXP PHYSIOL CMS, V67, P213; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Foroni L, 2013, EXP CELL RES, V319, P1515, DOI 10.1016/j.yexcr.2013.03.035; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; Goerges AL, 2003, J BIOL CHEM, V278, P19518, DOI 10.1074/jbc.M211208200; Gonzalez-Angulo AM, 2007, ADV EXP MED BIOL, V608, P1; Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002; Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hartman O, 2009, BIOMACROMOLECULES, V10, P2019, DOI 10.1021/bm8012764; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Hirschhaeuser F, 2010, J BIOTECHNOL, V148, P3, DOI 10.1016/j.jbiotec.2010.01.012; Hitomi M, 1999, CURR BIOL, V9, P1075, DOI 10.1016/S0960-9822(99)80476-X; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Hu M, 2008, EUR J CANCER, V44, P2760, DOI 10.1016/j.ejca.2008.09.038; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Jorgensen HG, 2005, LEUKEMIA, V19, P1184, DOI 10.1038/sj.leu.2403785; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; KEELY PJ, 1995, DIFFERENTIATION, V59, P1, DOI 10.1046/j.1432-0436.1995.5910001.x; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kong HJ, 2006, P NATL ACAD SCI USA, V103, P18534, DOI 10.1073/pnas.0605960103; Kuschert GSV, 1998, BIOCHEMISTRY-US, V37, P11193, DOI 10.1021/bi972867o; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee YS, 2011, ACTA BIOMATER, V7, P3877, DOI 10.1016/j.actbio.2011.07.013; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li D, 2004, ADV MATER, V16, P361, DOI 10.1002/adma.200306226; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Lu JY, 2003, CLIN EXP METASTAS, V20, P121, DOI 10.1023/A:1022645116030; Luqmani YA, 2005, MED PRIN PRACT, V14, P35, DOI 10.1159/000086183; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mazzoleni G, 2009, GENES NUTR, V4, P13, DOI 10.1007/s12263-008-0107-0; McLane JS, 2014, ACTA BIOMATER, V10, P4811, DOI 10.1016/j.actbio.2014.07.016; Meads MB, 2009, NAT REV CANCER, V9, P665, DOI 10.1038/nrc2714; Morris SR, 2007, REV ENDOCR METAB DIS, V8, P185, DOI 10.1007/s11154-007-9035-3; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pajerowski JD, 2007, P NATL ACAD SCI USA, V104, P15619, DOI 10.1073/pnas.0702576104; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Patel SA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00906; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Remmerbach TW, 2009, CANCER RES, V69, P1728, DOI 10.1158/0008-5472.CAN-08-4073; Richardson Alan, 2008, Curr Mol Pharmacol, V1, P244; Simon DN, 2011, NAT REV MOL CELL BIO, V12, P695, DOI 10.1038/nrm3207; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Wang F, 2004, RAPID PROTOTYPING J, V10, P42, DOI 10.1108/13552540410512525; Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wikman H, 2008, APMIS, V116, P754, DOI 10.1111/j.1600-0463.2008.01033.x; Wolf K, 2005, BIOCHIMIE, V87, P315, DOI 10.1016/j.biochi.2004.10.016; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zhang SG, 2004, NAT BIOTECHNOL, V22, P151, DOI 10.1038/nbt0204-151	94	31	32	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118724	10.1371/journal.pone.0118724	http://dx.doi.org/10.1371/journal.pone.0118724			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837691	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000005
J	Li, Z; Jing, W; Peng, Y; Zhang, XQ; Ma, X; Huang, LK; Yan, YH				Li, Zhou; Jing, Wen; Peng, Yan; Zhang, Xin Quan; Ma, Xiao; Huang, Lin Kai; Yan, Yan-hong			Spermine Alleviates Drought Stress in White Clover with Different Resistance by Influencing Carbohydrate Metabolism and Dehydrins Synthesis	PLOS ONE			English	Article							SUCROSE-PHOSPHATE SYNTHASE; WATER-STRESS; GENE-EXPRESSION; ABIOTIC STRESS; ABSCISIC-ACID; LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; TOLERANCE; ARABIDOPSIS; POLYAMINES	The objective of this research was to analyse whether ameliorating drought stress through exogenously applied spermine (Spm) was related to carbohydrate metabolism, dehydrins accumulation and the transcription of genes encoding dehydrins in two white clovers (drought-susceptible cv. 'Ladino' and drought-resistant cv. 'Haifa') under controlled drying conditions for 10 days. The results show that the application of Spm effectively alleviates negative effects caused by drought stress in both cultivars. Exogenous Spm led to accumulation of more water-soluble carbohydrates (WSC), sucrose, fructose and sorbitol in both cultivars under drought stress, and also significantly elevated glucose content in leaves of drought-resistant cv. 'Haifa', but had no effect on drought-susceptible cv. 'Ladino'. Accordingly, the key enzyme activities of sucrose and sorbitol metabolism changed along with the application of Spm under drought stress. Spm induced a significant increase in sucrose phosphate synthase (SPS) or sorbitol dehydrogenase (SDH) activity, but decrease in sucrose synthetase (SS) activity when two cultivars were subjected to drought. In addition, the improved accumulation of dehydrins induced by exogenous Spm coincided with three genes expression which was responsible for dehydrins synthesis. But Spm-induced transcript level of dehydrin genes increased earlier in cv. 'Ladino' than that in cv. 'Haifa'. Thus, these results suggest that ameliorating drought stress through exogenously applied Spm may be associated with increased carbohydrate accumulation and dehydrins synthesis. There are differences between drought-susceptible and - resistant white clover cultivars related to Spm regulation of WSC metabolism and dehydrins expression.	[Li, Zhou; Jing, Wen; Peng, Yan; Zhang, Xin Quan; Ma, Xiao; Huang, Lin Kai; Yan, Yan-hong] Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu 611130, Peoples R China	Sichuan Agricultural University	Peng, Y (corresponding author), Sichuan Agr Univ, Coll Anim Sci & Technol, Dept Grassland Sci, Chengdu 611130, Peoples R China.	pengyanlee@163.com			National Science Foundation of China [31372371]; National Support Program [2011BAD17B03]; Sichuan Province Breeding Program [2011NZ0098-11]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Support Program; Sichuan Province Breeding Program	This study was funded by the National Science Foundation of China (Grant No. 31372371), National Support Program (Grant No. 2011BAD17B03), and Sichuan Province Breeding Program (Grant No. 2011NZ0098-11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Hakimi A., 1995, Journal of Genetics and Breeding, V49, P237; Alcazar R, 2006, PHYSIOL PLANTARUM, V128, P448, DOI 10.1111/j.1399-3054.2006.00780.x; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BARRS HD, 1962, AUST J BIOL SCI, V15, P413, DOI 10.1071/BI9620413; Beck EH, 2007, J BIOSCIENCES, V32, P501, DOI 10.1007/s12038-007-0049-5; Bian HW, 2002, J PLANT PHYSIOL, V159, P1139, DOI 10.1078/0176-1617-00824; BLACKMAN SA, 1992, PLANT PHYSIOL, V100, P225, DOI 10.1104/pp.100.1.225; BLUM A, 1981, CROP SCI, V21, P43, DOI 10.2135/cropsci1981.0011183X002100010013x; CASTRILLO M, 1992, J EXP BOT, V43, P1557, DOI 10.1093/jxb/43.12.1557; Cerny M, 2011, J EXP BOT, V62, P921, DOI 10.1093/jxb/erq322; CLOSE TJ, 1993, PLANT MOL BIOL, V23, P279, DOI 10.1007/BF00029004; Close TJ, 1997, PHYSIOL PLANTARUM, V100, P291, DOI 10.1034/j.1399-3054.1997.1000210.x; Cona A, 2006, J EXP BOT, V57, P2277, DOI 10.1093/jxb/erj195; Cui SM, 2004, J JPN SOC HORTIC SCI, V73, P25, DOI 10.2503/jjshs.73.25; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; Farooq M, 2009, ACTA PHYSIOL PLANT, V31, P937, DOI 10.1007/s11738-009-0307-2; Aguayo MF, 2013, PLANT SCI, V205, P63, DOI 10.1016/j.plantsci.2013.01.012; Fresneau C, 2007, J EXP BOT, V58, P2983, DOI 10.1093/jxb/erm150; Fu JM, 2010, J AM SOC HORTIC SCI, V135, P506, DOI 10.21273/JASHS.135.6.506; Fu JM, 2009, J AM SOC HORTIC SCI, V134, P41, DOI 10.21273/JASHS.134.1.41; GONZALEZ EM, 1995, J EXP BOT, V46, P1515, DOI 10.1093/jxb/46.10.1515; Groppa MD, 2008, AMINO ACIDS, V34, P35, DOI 10.1007/s00726-007-0501-8; Gupta AK, 2005, J BIOSCIENCES, V30, P761, DOI 10.1007/BF02703574; Gupta K, 2013, ACTA PHYSIOL PLANT, V35, P2015, DOI 10.1007/s11738-013-1239-4; Han B, 1996, J EXP BOT, V47, P933, DOI 10.1093/jxb/47.7.933; He LX, 2002, PLANT CELL PHYSIOL, V43, P196, DOI 10.1093/pcp/pcf021; Heyen BJ, 2002, PLANT PHYSIOL, V130, P675, DOI 10.1104/pp.002550; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P1, DOI DOI 10.1007/S12374-010-9112-0; Hu LX, 2010, J PLANT PHYSIOL, V167, P103, DOI 10.1016/j.jplph.2009.07.008; Jain M, 2010, PLANT SOIL ENVIRON, V56, P263, DOI 10.17221/233/2009-PSE; Jang SJ, 2012, MOL CELLS, V34, P251, DOI 10.1007/s10059-012-0067-5; Jie Zhang, 2010, African Journal of Biotechnology, V9, P5320; Karlsson BH, 1999, J AM SOC HORTIC SCI, V124, P245, DOI 10.21273/JASHS.124.3.245; Kasukabe Y, 2004, PLANT CELL PHYSIOL, V45, P712, DOI 10.1093/pcp/pch083; Kaur K, 2007, INDIAN J BIOCHEM BIO, V44, P223; KHAYAT E, 1987, PLANT PHYSIOL, V84, P447, DOI 10.1104/pp.84.2.447; Khedr AHA, 2003, J EXP BOT, V54, P2553, DOI 10.1093/jxb/erg277; Kubis J, 2008, J PLANT PHYSIOL, V165, P397, DOI 10.1016/j.jplph.2007.02.005; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; Lalonde S, 2003, PLANT CELL ENVIRON, V26, P37, DOI 10.1046/j.1365-3040.2003.00847.x; LEE SP, 1993, PLANT PHYSIOL, V101, P1089, DOI 10.1104/pp.101.3.1089; Legay S, 2011, FUNCT INTEGR GENOMIC, V11, P275, DOI 10.1007/s10142-010-0206-z; Li CZ, 2004, PLANT SCI, V166, P303, DOI 10.1016/j.plantsci.2003.09.019; Li F, 2012, PLANT GROWTH REGUL, V68, P475, DOI 10.1007/s10725-012-9737-8; Li F, 2012, PLANT MOL BIOL REP, V30, P123, DOI 10.1007/s11105-011-0323-4; Li TH, 2005, TREE PHYSIOL, V25, P495, DOI 10.1093/treephys/25.4.495; Li Zhou, 2014, Plant Omics, V7, P517; Livingston DP, 2009, CELL MOL LIFE SCI, V66, P2007, DOI 10.1007/s00018-009-0002-x; Lo Bianco R, 1999, J AM SOC HORTIC SCI, V124, P381, DOI 10.21273/JASHS.124.4.381; Lo Bianco R, 2000, PHYSIOL PLANTARUM, V108, P71, DOI 10.1034/j.1399-3054.2000.108001071.x; Lo Bianco R, 2002, J AM SOC HORTIC SCI, V127, P115, DOI 10.21273/JASHS.127.1.115; Marco F, 2011, OMICS, V15, P775, DOI 10.1089/omi.2011.0084; MENDICINO J, 1960, J BIOL CHEM, V235, P3347; Naya L, 2007, PLANT PHYSIOL, V144, P1104, DOI 10.1104/pp.107.099648; Nylander M, 2001, PLANT MOL BIOL, V45, P263, DOI 10.1023/A:1006469128280; Oufir M, 2008, PLANT SCI, V175, P839, DOI 10.1016/j.plantsci.2008.08.010; Parmentier-Line CM, 2002, PLANT SCI, V162, P273, DOI 10.1016/S0168-9452(01)00563-5; Radhakrishnan R, 2013, J PLANT GROWTH REGUL, V32, P22, DOI 10.1007/s00344-012-9274-8; Robyt JF, 1987, BIOCH TECHNIQUES THE, P267; Sagor GHM, 2013, TRANSGENIC RES, V22, P595, DOI 10.1007/s11248-012-9666-3; Scott P, 2000, ANN BOT-LONDON, V85, P159, DOI 10.1006/anbo.1999.1006; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Shen Ye, 2004, Agricultural Sciences in China, V3, P575; Takahama U, 1997, PHYSIOL PLANTARUM, V101, P845; Tang W, 2005, PLANT GROWTH REGUL, V46, P31, DOI 10.1007/s10725-005-6395-0; TING SV, 1956, J AGR FOOD CHEM, V4, P263, DOI 10.1021/jf60061a009; Tun NN, 2006, PLANT CELL PHYSIOL, V47, P346, DOI 10.1093/pcp/pci252; Vaseva I, 2011, SCI HORTIC-AMSTERDAM, V130, P653, DOI 10.1016/j.scienta.2011.08.021; Walters C, 1997, SEED SCI RES, V7, P125, DOI 10.1017/S0960258500003469; Wang XJ, 2002, J EXP BOT, V53, P551, DOI 10.1093/jexbot/53.368.551; Wi SJ, 2014, PLANTA, V239, P979, DOI 10.1007/s00425-014-2027-0; Xia XJ, 2009, PLANT PHYSIOL, V150, P801, DOI 10.1104/pp.109.138230; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Yang JC, 2002, PLANTA, V215, P645, DOI 10.1007/s00425-002-0789-2; Yang ZM, 2013, J AM SOC HORTIC SCI, V138, P24, DOI 10.21273/JASHS.138.1.24; Zhao WC, 2009, CHINESE AGR SCI B, V25, P148; Zhou Q, 2010, PLANT PHYSIOL BIOCH, V48, P417, DOI 10.1016/j.plaphy.2010.03.003	77	35	39	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120708	10.1371/journal.pone.0120708	http://dx.doi.org/10.1371/journal.pone.0120708			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835290	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000030
J	Williams, ID; Baum, JK; Heenan, A; Hanson, KM; Nadon, MO; Brainard, RE				Williams, Ivor D.; Baum, Julia K.; Heenan, Adel; Hanson, Katharine M.; Nadon, Marc O.; Brainard, Russell E.			Human, Oceanographic and Habitat Drivers of Central and Western Pacific Coral Reef Fish Assemblages	PLOS ONE			English	Article							GREAT-BARRIER-REEF; BASE-LINES; POPULATION-DENSITY; HAWAIIAN-ISLANDS; STRIP TRANSECT; BIOMASS; DEGRADATION; PHYTOPLANKTON; NORTHWESTERN; ABUNDANCE	Coral reefs around US-and US-affiliated Pacific islands and atolls span wide oceanographic gradients and levels of human impact. Here we examine the relative influence of these factors on coral reef fish biomass, using data from a consistent large-scale ecosystem monitoring program conducted by scientific divers over the course of >2,000 hours of underwater observation at 1,934 sites, across similar to 40 islands and atolls. Consistent with previous smaller-scale studies, our results show sharp declines in reef fish biomass at relatively low human population density, followed by more gradual declines as human population density increased further. Adjusting for other factors, the highest levels of oceanic productivity among our study locations were associated with more than double the biomass of reef fishes (including similar to 4 times the biomass of planktivores and piscivores) compared to islands with lowest oceanic productivity. Our results emphasize that coral reef areas do not all have equal ability to sustain large reef fish stocks, and that what is natural varies significantly amongst locations. Comparisons of biomass estimates derived from visual surveys with predicted biomass in the absence of humans indicated that total reef fish biomass was depleted by 61% to 69% at populated islands in the Mariana Archipelago; by 20% to 78% in the Main Hawaiian islands; and by 21% to 56% in American Samoa.	[Williams, Ivor D.; Heenan, Adel; Brainard, Russell E.] Natl Oceanog & Atmospher Adm, Coral Reef Ecosyst Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI 96814 USA; [Baum, Julia K.] Univ Victoria, Dept Biol, Victoria, BC V8W 2Y2, Canada; [Heenan, Adel; Nadon, Marc O.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Hanson, Katharine M.] Univ Hawaii Manoa, Dept Oceanog, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA; [Nadon, Marc O.] Natl Oceanog & Atmospher Adm, Fisheries Res & Monitoring Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI USA	National Oceanic Atmospheric Admin (NOAA) - USA; University of Victoria; University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA	Williams, ID (corresponding author), Natl Oceanog & Atmospher Adm, Coral Reef Ecosyst Div, Pacif Islands Fisheries Sci Ctr, Honolulu, HI 96814 USA.	ivor.williams@noaa.gov		Baum, Julia/0000-0002-9827-1612; Hanson, Katharine/0000-0002-3972-8520; Williams, Ivor/0000-0002-9444-1020	NOAA's Coral Reef Conservation Program; Natural Sciences and Engineering Research Council of Canada	NOAA's Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding for surveys and to support program operation was provided by NOAA's Coral Reef Conservation Program (http://coralreef.noaa.gov). JKB acknowledges funding from the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, R LANG ENV STAT COMP; Arnold TW., 2010, J WILDLIFE MANAGE, V74, P1937; Ayotte PM, 2011, CORAL REET ECOSYSTEM; Baker JD, 2012, MAR ECOL PROG SER, V469, P175, DOI 10.3354/meps09987; Barton K., 2013, MUMIN MULTIMODEL INT; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Brandt ME, 2009, NPSSFCNRR2009150; Brewer TD, 2012, GLOBAL ENVIRON CHANG, V22, P399, DOI 10.1016/j.gloenvcha.2012.01.006; Brewer TD, 2009, BIOL CONSERV, V142, P1797, DOI 10.1016/j.biocon.2009.03.021; Bruno JF, 2014, MAR POLLUT BULL, V80, P24, DOI 10.1016/j.marpolbul.2014.01.010; Cinner JE, 2013, CONSERV BIOL, V27, P453, DOI 10.1111/j.1523-1739.2012.01933.x; Colvocoresses J, 2007, FISH RES, V85, P130, DOI 10.1016/j.fishres.2007.01.012; DeMartini EE, 1996, B MAR SCI, V58, P804; Dickens LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018965; Dulvy NK, 2002, J EXP MAR BIOL ECOL, V278, P1, DOI 10.1016/S0022-0981(02)00327-1; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Frisch AJ, 2014, MAR BIOL, V161, P61, DOI 10.1007/s00227-013-2315-4; Genin A, 2009, LIMNOL OCEANOGR, V54, P938, DOI 10.4319/lo.2009.54.3.0938; Gove JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061974; Grace-McCaskey C., 2014, H1401 PAC ISL FISH S, P69; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Graham NAJ, 2013, BIOSCIENCE, V63, P397, DOI 10.1525/bio.2013.63.5.13; HAMNER WM, 1988, B MAR SCI, V42, P459; Jennings S, 1996, J APPL ECOL, V33, P400, DOI 10.2307/2404761; JENNINGS S, 1995, J FISH BIOL, V47, P733, DOI 10.1111/j.1095-8649.1995.tb01938.x; JENNINGS S, 1996, REEF FISHERIES, P193; Kulbicki M, 1998, J EXP MAR BIOL ECOL, V222, P11, DOI 10.1016/S0022-0981(97)00133-0; Kulbicki M, 2005, CYBIUM, V29, P235; Kulbicki M, 1999, AQUAT LIVING RESOUR, V12, P315, DOI 10.1016/S0990-7440(99)00116-3; Kulbicki M, 2010, J EXP MAR BIOL ECOL, V387, P15, DOI 10.1016/j.jembe.2010.03.003; Max LM, 2013, MAR ECOL PROG SER, V482, P181, DOI 10.3354/meps10259; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Nadon MO, 2012, CONSERV BIOL, V26, P493, DOI 10.1111/j.1523-1739.2012.01835.x; Parrish FA, 2000, MAR MAMMAL SCI, V16, P392, DOI 10.1111/j.1748-7692.2000.tb00932.x; Pinnegar JK, 2006, MAR BIOL, V148, P1089, DOI 10.1007/s00227-005-0141-z; Polovina JJ, 2011, ICES J MAR SCI, V68, P986, DOI 10.1093/icesjms/fsq198; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Richards BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031374; Richards BL, 2011, B MAR SCI, V87, P55, DOI 10.5343/bms.2010.1019; ROBERTSON DR, 1982, MAR ECOL PROG SER, V7, P253, DOI 10.3354/meps007253; Rodgers KS, 2010, AQUAT CONSERV, V20, P93, DOI 10.1002/aqc.1048; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; Smith SG, 2011, FISH RES, V109, P25, DOI 10.1016/j.fishres.2011.01.012; Sorokin YI, 2009, J MAR BIOL ASSOC UK, V89, P235, DOI 10.1017/S0025315409003063; Stallings CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005333; Taylor BM, 2014, ECOGRAPHY COP; Ward-Paige C, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011722, 10.1371/journal.pone.0011968]; Williams ID, 2011, J MAR BIOL; Wilson SK, 2008, GLOBAL CHANGE BIOL, V14, P2796, DOI 10.1111/j.1365-2486.2008.01696.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wood S., 2012, MGCV GAMS GCV AIC RE; Woodworth-Jefcoats PA, 2013, GLOBAL CHANGE BIOL, V19, P724, DOI 10.1111/gcb.12076; Wyatt ASJ, 2012, CORAL REEFS, V31, P1029, DOI 10.1007/s00338-012-0923-y; Yahel G, 1998, LIMNOL OCEANOGR, V43, P551, DOI 10.4319/lo.1998.43.4.0551; Zuur A. F., 2012, BEGINNERS GUIDE GEN	58	104	105	2	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0120516	10.1371/journal.pone.0120516	http://dx.doi.org/10.1371/journal.pone.0120516			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831196	Green Submitted, Green Published, gold			2022-12-26	WOS:000352135600033
J	Raipuria, M; Bahari, H; Morris, MJ				Raipuria, Mukesh; Bahari, Hasnah; Morris, Margaret J.			Effects of Maternal Diet and Exercise during Pregnancy on Glucose Metabolism in Skeletal Muscle and Fat of Weanling Rats	PLOS ONE			English	Article							HYPOTHALAMIC GENE-EXPRESSION; APPETITE REGULATORS; WEIGHT-GAIN; INSULIN SENSITIVITY; GLUT4 EXPRESSION; OBESITY; INFLAMMATION; PGC-1-ALPHA; IMPACT; CHILDHOOD	Obesity during pregnancy contributes to the development of metabolic disorders in offspring. Maternal exercise may limit gestational weight gain and ameliorate these programming effects. We previously showed benefits of post-weaning voluntary exercise in offspring from obese dams. Here we examined whether voluntary exercise during pregnancy influences lipid and glucose homeostasis in muscle and fat in offspring of both lean and obese dams. Female Sprague-Dawley rats were fed chow (C) or high fat (F) diet for 6 weeks before mating. Half underwent voluntary exercise (CE/FE) with a running wheel introduced 10 days prior to mating and available until the dams delivered; others remained sedentary (CS/FS). Male and female pups were killed at postnatal day (PND) 19 and retroperitoneal fat and gastrocnemius muscle were collected for gene expression. Lean and obese dams achieved similar modest levels of exercise. At PND1, both male and female pups from exercised lean dams were significantly lighter (CE versus CS), with no effect in those from obese dams. At PND19, maternal obesity significantly increased offspring body weight and adiposity, with no effect of maternal exercise. Exercise significantly reduced insulin concentrations in males (CE/FE versus CS/FS), with reduced glucose in male FE pups. In males, maternal obesity significantly decreased muscle myogenic differentiation 1 (MYOD1) and glucose transporter type 4 (GLUT4) mRNA expressions (FS vs CS); these were normalized by exercise. Maternal exercise upregulated adipose GLUT4, interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and peroxisome proliferator activated receptor gamma coactivator 1 alpha (PGC1 alpha) mRNA expression in offspring of dams consuming chow. Modest voluntary exercise during pregnancy was associated with lower birth weight in pups from lean dams. Maternal exercise appeared to decrease the metabolic risk induced by maternal obesity, improving insulin/glucose metabolism, with greater effects in male than female offspring.	[Raipuria, Mukesh; Bahari, Hasnah; Morris, Margaret J.] Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia; [Bahari, Hasnah] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia	University of New South Wales Sydney; Universiti Putra Malaysia	Morris, MJ (corresponding author), Univ New S Wales, Sch Med Sci, Dept Pharmacol, Sydney, NSW 2052, Australia.	m.morris@unsw.edu.au	Bahari, Hasnah/V-8166-2019; Morris, Margaret J/J-4285-2013	Bahari, Hasnah/0000-0001-8302-4136; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia (NHMRC) [568728]; Government of Madhya Pradesh State, India; Australian Centre for Perinatal Science (ACPS); Ministry of Higher Education Malaysia and Universiti Putra Malaysia	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Government of Madhya Pradesh State, India; Australian Centre for Perinatal Science (ACPS); Ministry of Higher Education Malaysia and Universiti Putra Malaysia	The work was in part funded by National Health and Medical Research Council of Australia (NHMRC 568728) to M.J. Morris. Mukesh Raipuria was sponsored by Government of Madhya Pradesh State, India and the Australian Centre for Perinatal Science (ACPS). Hasnah Bahari was sponsored by the Ministry of Higher Education Malaysia and Universiti Putra Malaysia.	Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, DOI [10.1152/ajpregu.00049.02014, DOI 10.1152/AJPREGU.00049.02014]; Baeten JM, 2001, AM J PUBLIC HEALTH, V91, P436, DOI 10.2105/AJPH.91.3.436; Bahari H, 2013, ENDOCRINOLOGY, V154, P3610, DOI 10.1210/en.2013-1059; Bayol SA, 2005, J PHYSIOL-LONDON, V567, P951, DOI 10.1113/jphysiol.2005.088989; Bayol SA, 2009, EUR J NUTR, V48, P62, DOI 10.1007/s00394-008-0760-5; Begum KS, 2011, CLIN EXP OBSTET GYN, V38, P14; BELL RJ, 1995, AUST NZ J OBSTET GYN, V35, P46, DOI 10.1111/j.1479-828X.1995.tb01829.x; Benkalfat NB, 2011, CLIN SCI, V121, P19, DOI 10.1042/CS20100534; Borengasser SJ, 2013, ENDOCRINOLOGY, V154, P4113, DOI 10.1210/en.2012-2255; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Boyle KE, 2013, J CLIN ENDOCR METAB, V98, pE1601, DOI 10.1210/jc.2013-1943; Carter LG, 2013, MED SCI SPORT EXER, V45, P832, DOI 10.1249/MSS.0b013e31827de953; Caruso V, 2013, J NEUROENDOCRINOL, V25, P742, DOI 10.1111/jne.12053; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chan CYY, 2013, EUR J NUTR, V52, P1721, DOI 10.1007/s00394-012-0475-5; Chen H, 2008, ENDOCRINOLOGY, V149, P5348, DOI 10.1210/en.2008-0582; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006259; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Cunningham SA, 2014, NEW ENGL J MED, V370, P403, DOI [10.1056/NEJMoa1309753, 10.1056/NEJMc1402397]; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Du M, 2010, BIOL REPROD, V82, P4, DOI 10.1095/biolreprod.109.077099; Eisele PS, 2014, SEMIN IMMUNOPATHOL, V36, P27, DOI 10.1007/s00281-013-0406-4; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; Hokari F, 2010, J APPL PHYSIOL, V109, P332, DOI 10.1152/japplphysiol.00335.2009; Hopkins SA, 2010, J CLIN ENDOCR METAB, V95, P2080, DOI 10.1210/jc.2009-2255; Hussey SE, 2011, DIABETES OBES METAB, V13, P959, DOI 10.1111/j.1463-1326.2011.01426.x; Kennedy JW, 1999, DIABETES, V48, P1192, DOI 10.2337/diabetes.48.5.1192; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leibowitz KL, 2012, WORLD J PEDIATR, V8, P76, DOI 10.1007/s12519-011-0292-6; Li N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077809; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mingrone G, 2008, DIABETES CARE, V31, P1872, DOI 10.2337/dc08-0432; Morris MJ, 2009, INT J OBESITY, V33, P115, DOI 10.1038/ijo.2008.213; Mottola MF, 2010, MED SCI SPORT EXER, V42, P265, DOI 10.1249/MSS.0b013e3181b5419a; Oken E, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.11.027; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Page KC, 2009, AM J PHYSIOL-REG I, V297, pR1049, DOI 10.1152/ajpregu.90585.2008; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Rajia S, 2013, NUTR METAB CARDIOVAS, V23, P574, DOI 10.1016/j.numecd.2011.12.009; Rajia S, 2010, J NEUROENDOCRINOL, V22, P905, DOI 10.1111/j.1365-2826.2010.02005.x; Ramsay JE, 2002, J CLIN ENDOCR METAB, V87, P4231, DOI 10.1210/jc.2002-020311; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; REN JM, 1994, J BIOL CHEM, V269, P14396; Reynolds RM, 2013, BMJ, V347; Shankar K, 2008, AM J PHYSIOL-REG I, V294, pR528, DOI 10.1152/ajpregu.00316.2007; Simar D, 2012, NUTR METAB CARDIOVAS, V22, P269, DOI 10.1016/j.numecd.2010.11.007; Stettler N, 2003, AM J CLIN NUTR, V77, P1374, DOI 10.1093/ajcn/77.6.1374; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Tong JF, 2009, AM J PHYSIOL-ENDOC M, V296, pE917, DOI 10.1152/ajpendo.90924.2008; TREMBLAY A, 1994, METABOLISM, V43, P814, DOI 10.1016/0026-0495(94)90259-3; van der Burg JW, 2013, EARLY HUM DEV, V89, P949, DOI 10.1016/j.earlhumdev.2013.09.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vega CC, 2013, INT J OBES; Wells JCK, 2011, EUR J CLIN NUTR, V65, P1173, DOI 10.1038/ejcn.2011.132; Zambrano E, 2013, NUTR REV, V71, pS42, DOI 10.1111/nure.12068	60	70	71	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120980	10.1371/journal.pone.0120980	http://dx.doi.org/10.1371/journal.pone.0120980			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853572	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400025
J	Skalicka, V; Ringdal, K; Witvliet, MI				Skalicka, Vera; Ringdal, Kristen; Witvliet, Margot I.			Socioeconomic Inequalities in Mortality and Repeated Measurement of Explanatory Risk Factors in a 25 Years Follow-Up	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BODY-MASS-INDEX; EDUCATIONAL INEQUALITIES; HEALTH BEHAVIORS; BLOOD-PRESSURE; WHITEHALL II; ASSOCIATION; TRENDS; HUNT	Background Socioeconomic inequalities in mortality can be explained by different groups of risk factors. However, little is known whether repeated measurement of risk factors can provide better explanation of socioeconomic inequalities in health. Our study examines the extent to which relative educational and income inequalities in mortality might be explained by explanatory risk factors (behavioral, psychosocial, biomedical risk factors and employment) measured at two points in time, as compared to one measurement at baseline. Methods and Findings From the Norwegian total county population-based HUNT Study (years 1984-86 and 1995-1997, respectively) 61 513 men and women aged 25-80 (82.5% of all enrolled) were followed-up for mortality in 25 years until 2009, employing a discrete time survival analysis. Socioeconomic inequalities in mortality were observed. As compared to their highest socioeconomic counterparts, the lowest educated men had an OR (odds ratio) of 1.41 (95% CI 1.29-1.55) and for the lowest income quartile OR = 1.59 (1.48-1.571), for women OR = 1.35 (1.17-1.55), and OR = 1.40 (1.28-1.52), respectively. Baseline explanatory variables attenuated the association between education and income with mortality by 54% and 54% in men, respectively, and by 69% and 18% in women. After entering time-varying variables, this attainment increased to 63% and 59% in men, respectively, and to 25% (income) in women, with no improvement in regard to education in women. Change in biomedical factors and employment did not amend the explanation. Conclusions Addition of a second measurement for risk factors provided only a modest improvement in explaining educational and income inequalities in mortality in Norwegian men and women. Accounting for change in behavior provided the largest improvement in explained inequalities in mortality for both men and women, as compared to measurement at baseline. Psychosocial factors explained the largest share of income inequalities in mortality for men, but repeated measurement of these factors contributed only to modest improvement in explanation. Further comparative research on the relative importance of explanatory pathways assessed over time is needed.	[Skalicka, Vera; Ringdal, Kristen; Witvliet, Margot I.] Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Skalicka, V (corresponding author), Norwegian Univ Sci & Technol, Dept Sociol & Polit Sci, N-7034 Trondheim, Norway.	vera.skalicka@samfunn.ntnu.no			Norwegian University of Science and Technology	Norwegian University of Science and Technology	Norwegian University of Science and Technology (www.ntnu.no) has supported this work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2008, ANNU REV PUBL HEALTH, V29, P235, DOI 10.1146/annurev.publhealth.29.020907.090852; Aldabe B, 2011, J EPIDEMIOL COMMUN H, V65, P1123, DOI 10.1136/jech.2009.102517; Bartley M., 2004, HLTH INEQUALITY INTR; Blom JW, 2013, AGE, V35, P431, DOI 10.1007/s11357-011-9349-7; Crimmins EM, 2009, J GERONTOL A-BIOL, V64, P286, DOI 10.1093/gerona/gln010; Droyvold WB, 2006, INT J OBESITY, V30, P935, DOI 10.1038/sj.ijo.0803178; Eikemo TA, 2008, J EPIDEMIOL COMMUN H, V62, P3, DOI 10.1136/jech.2007.066787; Ernstsen L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-266; Evans GW, 2010, ANN NY ACAD SCI, V1186, P174, DOI 10.1111/j.1749-6632.2009.05336.x; Ferrie JE, 2002, J EPIDEMIOL COMMUN H, V56, P450, DOI 10.1136/jech.56.6.450; Franks P, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-28; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Institute NPH, 2012, DOD DODS NORG GJENN; Keller HH, 2005, J NUTR HEALTH AGING, V9, P316; Krokstad S, 2004, SOCIOECONOMIC INEQUA; Laaksonen M, 2008, EUR J PUBLIC HEALTH, V18, P38, DOI 10.1093/eurpub/ckm051; Lantz PM, 2005, J HEALTH SOC BEHAV, V46, P274, DOI 10.1177/002214650504600305; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Lynch JW, 1996, AM J EPIDEMIOL, V144, P934, DOI 10.1093/oxfordjournals.aje.a008863; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Mustard CA, 2003, J EPIDEMIOL COMMUN H, V57, P974, DOI 10.1136/jech.57.12.974; NAESS O, 2007, SOSIAL ULIKHET HELSE; NTNU HUNT Research centre, THE HUNT STUD 2014; Pantell M, 2013, AM J PUBLIC HEALTH, V103, P2056, DOI 10.2105/AJPH.2013.301261; Rogers RG, 2010, DEMOGRAPHY, V47, P555, DOI 10.1353/dem.0.0119; Roux AVD, 2002, CIRCULATION, V106, P703, DOI 10.1161/01.CIR.0000025402.84600.CD; Sabia S, 2012, CAN MED ASSOC J, V184, P1985, DOI 10.1503/cmaj.121080; Schrijvers CTM, 1999, AM J PUBLIC HEALTH, V89, P535, DOI 10.2105/AJPH.89.4.535; Siegrist J, 2006, SOCIAL INEQUALITIES, P73; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Skalicka V, 2009, INT J EPIDEMIOL, V38, P1272, DOI 10.1093/ije/dyp262; Steptoe A, 2002, EUR HEART J, V23, P13, DOI 10.1053/euhj.2001.2611; Strand Bjorn Heine, 2003, Tidsskr Nor Laegeforen, V123, P2849; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; Stringhini S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049443; Stringhini S, 2012, AM J EPIDEMIOL, V175, P1275, DOI 10.1093/aje/kwr461; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; UMBERSON D, 1992, SOC SCI MED, V34, P907, DOI 10.1016/0277-9536(92)90259-S; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; van Oort FVA, 2005, J EPIDEMIOL COMMUN H, V59, P214, DOI 10.1136/jech.2003.016493; VanderWeele TJ, 2009, EPIDEMIOLOGY, V20, P18, DOI 10.1097/EDE.0b013e31818f69ce; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; White EW, 2013, ASTM INT MAN SER, P1, DOI 10.1520/MNL72-EB; Zhang Q, 2004, OBES RES, V12, P1622, DOI 10.1038/oby.2004.202	47	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124690	10.1371/journal.pone.0124690	http://dx.doi.org/10.1371/journal.pone.0124690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3WA	25853571	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400142
J	Yates, PM; Heupel, MR; Tobin, AJ; Simpfendorfer, CA				Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.			Ecological Drivers of Shark Distributions along a Tropical Coastline	PLOS ONE			English	Article							JUVENILE SANDBAR SHARKS; BULL SHARKS; CARCHARHINUS-LEUCAS; NURSERY AREA; SPHYRNA-LEWINI; SUMMER NURSERY; LEMON SHARKS; HABITAT USE; FLORIDA; BAY	As coastal species experience increasing anthropogenic pressures there is a growing need to characterise the ecological drivers of their abundance and habitat use, and understand how they may respond to changes in their environment. Accordingly, fishery-independent surveys were undertaken to investigate shark abundance along approximately 400 km of the tropical east coast of Australia. Generalised linear models were used to identify ecological drivers of the abundance of immature blacktip Carcharhinus tilstoni/Carcharhinus limbatus, pigeye Carcharhinus amboinensis, and scalloped hammerhead Sphyma lewini sharks. Results indicated general and species-specific patterns in abundance that were characterised by a range of abiotic and biotic variables. Relationships with turbidity and salinity were similar across multiple species, highlighting the importance of these variables in the functioning of communal shark nurseries. In particular, turbid environments were especially important for all species at typical oceanic salinities. Mangrove proximity, depth, and water temperature were also important; however, their influence varied between species. Ecological drivers may promote spatial diversity in habitat use along environmentally heterogeneous coastlines and may therefore have important implications for population resilience.	[Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia; [Yates, Peter M.; Heupel, Michelle R.; Tobin, Andrew J.; Simpfendorfer, Colin A.] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; [Heupel, Michelle R.] Australian Inst Marine Sci, Townsville, Qld 4810, Australia	James Cook University; James Cook University; Australian Institute of Marine Science	Yates, PM (corresponding author), James Cook Univ, Ctr Sustainable Trop Fisheries & Aquaculture, Townsville, Qld 4811, Australia.	peter.yates2@my.jcu.edu.au	Simpfendorfer, Colin A/G-9681-2011	Simpfendorfer, Colin A/0000-0002-0295-2238; Heupel, Michelle/0000-0002-8245-7332; Yates, Peter/0000-0003-4659-7159	Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub; Australian Postgraduate Award	Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub(Australian Government); Australian Postgraduate Award(Australian Government)	Funding for this research was provided by the Australian Government's National Environmental Research Program under the Tropical Ecosystems Hub (http://www.nerptropical.edu.au/). PMY was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman JT, 2000, ENVIRON BIOL FISH, V58, P33, DOI 10.1023/A:1007657019696; Barnett A, 2012, OIKOS, V121, P882, DOI 10.1111/j.1600-0706.2011.20000.x; Barton K., 2013, MUMIN MULTI MODEL IN; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernal D, 2012, CRC MAR BIOL SER, P211; BLABER SJM, 1995, ESTUAR COAST SHELF S, V40, P177, DOI 10.1016/S0272-7714(05)80004-6; BLABER SJM, 1980, J FISH BIOL, V17, P143, DOI 10.1111/j.1095-8649.1980.tb02749.x; BRANSTETTER S, 1990, NOAA Technical Report NMFS, P17; Breheny P, 2013, VISREG VISUALLIZATIO; Breheny P, 2013, VISUALIZATION REGRES; Bureau of Resources and Energy Economics, 2012, AUSTR BULK COMM EXP, P150; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Chin A, 2012, MAR ECOL PROG SER, V460, P115, DOI 10.3354/meps09722; Chin A, 2010, GLOBAL CHANGE BIOL, V16, P1936, DOI 10.1111/j.1365-2486.2009.02128.x; CLARKE TA, 1971, PAC SCI, V25, P133; Compagno L.J.V., 1984, FAO Fisheries Synopsis, P251; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; CUI G, 1991, FISH RES, V10, P255, DOI 10.1016/0165-7836(91)90079-U; Curtis TH, 2013, MAR COAST FISH, V5, P28, DOI 10.1080/19425120.2012.756438; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Drymon JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097124; Drymon JM, 2013, FISH B-NOAA, V111, P370, DOI 10.7755/FB.111.4.6; Espinoza M, 2011, J EXP MAR BIOL ECOL, V401, P63, DOI 10.1016/j.jembe.2011.03.001; Fox F, 2011, CAR R COMPANION APPL; Francis MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057021; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Froeschke JT, 2010, AQUAT BIOL, V11, P65, DOI 10.3354/ab00290; Furnas M, 1993, CATCHMENTS CORALS TE; Gardiner JM, 2012, CRC MAR BIOL SER, P349; Gelsleichter J, 2005, ARCH ENVIRON CON TOX, V48, P474, DOI 10.1007/s00244-003-0275-2; Giraudoux P., 2013, PGIRMESS DATA ANAL E; GOTCEITAS V, 1989, OECOLOGIA, V80, P158, DOI 10.1007/BF00380145; Great Barrier Reef Marine Park Authority, 2011, EXTR WEATH GREAT BAR, P26; Grech A, 2013, MAR POLLUT BULL, V75, P8, DOI 10.1016/j.marpolbul.2013.07.013; Grubbs R. Dean, 2007, V50, P87; Gutteridge AN, 2011, J FISH BIOL, V78, P1405, DOI 10.1111/j.1095-8649.2011.02945.x; Gutteridge AN, 2011, THESIS U QUEENSLAND; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Harry AV, 2011, MAR FRESHWATER RES, V62, P710, DOI 10.1071/MF10155; Harry AV, 2011, THESIS J COOK U; Heihaus Michael R., 2007, V50, P3; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heithaus MR, 2004, CRC MAR BIOL SER, P487; Heupel Michelle R., 2007, V50, P265; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; Jacoby DMP, 2012, FISH FISH, V13, P399, DOI 10.1111/j.1467-2979.2011.00436.x; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Kinney MJ, 2011, MAR ECOL PROG SER, V439, P263, DOI 10.3354/meps09327; Kinney MJ, 2011, THESIS J COOK U; Knip DM, 2011, MAR FRESHWATER RES, V62, P658, DOI 10.1071/MF10136; Knip DM, 2011, MAR ECOL PROG SER, V425, P233, DOI 10.3354/meps09006; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Last P. R., 2009, SHARKS RAYS AUSTR, V2; McCallister M, 2013, MAR COAST FISH, V5, P200, DOI 10.1080/19425120.2013.786002; McCandless Camilla T., 2007, V50, P45; McCandless CT, 2007, S 50 BETH MD AM FISH; McKenzie L, 2012, REEF RESCUE MARINE M, P230; MORGAN MJ, 1985, Z TIERPSYCHOL, V70, P236; MORRISSEY JF, 1993, ENVIRON BIOL FISH, V38, P311, DOI 10.1007/BF00007524; Oliver T, 2010, ECOL LETT, V13, P473, DOI 10.1111/j.1461-0248.2010.01441.x; Ortega LA, 2009, ENVIRON BIOL FISH, V84, P361, DOI 10.1007/s10641-009-9442-2; PANG PKT, 1977, AM ZOOL, V17, P365; R Core Team, 2021, R LANGUAGE ENV STAT; ROBERTSON AI, 1987, MAR BIOL, V96, P193, DOI 10.1007/BF00427019; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; SIMPFENDORFER CA, 1993, ENVIRON BIOL FISH, V37, P337, DOI 10.1007/BF00005200; Simpfendorfer CA, 2012, CRC MAR BIOL SER, P579; Skaug H, 2012, GLMMADMB GEN LINEAR; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Taylor S, 2007, THESIS U QUEENSLAND; Torres LG, 2006, HYDROBIOLOGIA, V569, P449, DOI 10.1007/s10750-006-0148-6; Rojas YET, 2014, HYDROBIOLOGIA, V726, P81, DOI 10.1007/s10750-013-1753-9; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; Ulrich Glenn F., 2007, V50, P125; Venables WN., 2002, MODERN APPL STAT S, V4; Ward-Paige CA, 2014, MAR ECOL, V2014, P1; White WT, 2004, MAR BIOL, V145, P1023, DOI 10.1007/s00227-004-1386-7; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Yates PM, 2015, MAR FRESHWATER RES, V66, P399, DOI 10.1071/MF14033; Yates PM, 2012, MAR ECOL PROG SER, V458, P269, DOI 10.3354/meps09759; Zuur A.F, 2012, ZERO INFLATED MODELS; Zuur Alain F., 2009, P1	89	31	31	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121346	10.1371/journal.pone.0121346	http://dx.doi.org/10.1371/journal.pone.0121346			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853657	Green Accepted, Green Published, gold			2022-12-26	WOS:000352478400035
J	Berlin, I; Hakes, JK; Hu, MC; Covey, LS				Berlin, Ivan; Hakes, Jahn K.; Hu, Mei-Chen; Covey, Lirio S.			Tobacco Use and Suicide Attempt: Longitudinal Analysis with Retrospective Reports	PLOS ONE			English	Article							PSYCHIATRIC DIAGNOSTIC MODULES; NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-USE-DISORDER; IV AUDADIS-IV; CIGARETTE-SMOKING; COMPLETED SUICIDE; MENTAL-DISORDERS; RISK; IDEATION; ALTITUDE	Background Suicide has been associated with smoking/tobacco use but its association of and change in smoking/tobacco use status with suicide attempt (SA) is not well established. Methods We investigated whether persistent, former tobacco use, initiation, quitting tobacco use, relapse to tobacco use, and DSM-IV nicotine dependence predict independently SA using Wave 1 and 2 data of the National Epidemiologic Survey of Alcohol and Related Conditions. Data from 34,653 US adults interviewed at Wave 1 (2001-02) and Wave 2 (2004-05) were analyzed. The main outcome measure was SA between Wave 1 and Wave 2 as reported at Wave 2. Results Among the 1,673 respondents reporting lifetime SA at Wave 2, 328 individuals reported SA between Wave 1 and Wave 2. Current and former tobacco use at Wave 1 predicted Wave 2 SA independently of socio-demographic characteristics, psychiatric history, and prior SA (Adjusted Odds Ratio (AOR): 1.49; 95% CI: 1.13-1.95, AOR: 1.31; 95% CI: 1.01-1.69, respectively versus never tobacco users). The strongest association with SA was observed among former tobacco users who relapsed after Wave 1 (AOR: 4.66; 95% CI: 3.49-6.24) and among tobacco use initiators after Wave 1 (AOR: 3.16; 95% CI: 2.23-4.49). Persistent tobacco use (current tobacco use at both Wave 1 and Wave 2) also had an increased risk of SA (AOR: 1.89; 95% CI: 1.47-2.42). However, former tobacco users in both Waves 1 and 2 did not show a significantly elevated risk for SA in Wave 2 (AOR: 1.09, 95% CI: 0.78-1.52) suggesting that the risk resided mainly in Wave 1 former tobacco users who relapsed to tobacco use by Wave 2. DSM-IV nicotine dependence did not predict SA at Wave 2. Conclusion In a representative sample of US adults, relapse, tobacco use initiation, and persistent tobacco use, which are amenable to intervention, were associated with risk of SA.	[Berlin, Ivan] Univ Paris 06, AP HP, Hop Pitie Salpetriere, Fac Med,INSERM U1178,Dept Pharmacol, Paris, France; [Hakes, Jahn K.] US Census Bur, Ctr Adm Records Res & Applicat, Suitland, MD USA; [Hu, Mei-Chen; Covey, Lirio S.] Columbia Univ, Med Ctr, New York State Psychiat Inst, Dept Psychiat, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Columbia University; New York State Psychiatry Institute	Berlin, I (corresponding author), Univ Paris 06, AP HP, Hop Pitie Salpetriere, Fac Med,INSERM U1178,Dept Pharmacol, Paris, France.	ivan.berlin@psl.aphp.fr						American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Aubin HJ, 2011, AM J PSYCHIAT, V168, P326, DOI 10.1176/appi.ajp.2010.10101501; Baek JH, 2013, J AFFECT DISORDERS, V150, P1158, DOI 10.1016/j.jad.2013.05.082; Benowitz NL, 2010, NEW ENGL J MED, V362, P2295, DOI 10.1056/NEJMra0809890; Berlin I., 2007, MEDICATION TREATMENT, P109; Berlin I, 2011, NICOTINE TOB RES, V13, P887, DOI 10.1093/ntr/ntr089; Boden JM, 2008, PSYCHOL MED, V38, P433, DOI 10.1017/S0033291707001547; Bolton JM, 2010, AM J PUBLIC HEALTH, V100, P2473, DOI 10.2105/AJPH.2010.192252; Breslau N, 2005, ARCH GEN PSYCHIAT, V62, P328, DOI 10.1001/archpsyc.62.3.328; Bronisch T, 2008, J AFFECT DISORDERS, V108, P135, DOI 10.1016/j.jad.2007.10.010; Center for Disease Control and Prevention, 2004, CURRENT CIGARETTE SM, V60, P1305, DOI 10.4278/ajhp.120604-ARB-283; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; Clarke DE, 2010, SUICIDE LIFE-THREAT, V40, P307, DOI 10.1521/suli.2010.40.4.307; Covey LS, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000876; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Doshi A, 2005, ANN EMERG MED, V46, P369, DOI 10.1016/j.annemergmed.2005.04.018; Erhardt S, 2013, NEUROPSYCHOPHARMACOL, V38, P743, DOI 10.1038/npp.2012.248; Galfalvy H, 2009, INT J NEUROPSYCHOPH, V12, P1327, DOI 10.1017/S1461145709990228; Grant BF, 2009, MOL PSYCHIATR, V14, P1051, DOI 10.1038/mp.2008.41; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P1107, DOI 10.1001/archpsyc.61.11.1107; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2005, SOURCE AND ACCURACY; Grucza RA, 2014, NICOTINE TOB RES, V16, P1487, DOI 10.1093/ntr/ntu106; Harris EC, 1997, BRIT J PSYCHIAT, V170, P205, DOI 10.1192/bjp.170.3.205; Haws CA, 2009, MED HYPOTHESES, V73, P587, DOI 10.1016/j.mehy.2009.05.040; Jenkins GR, 2002, BRIT MED J, V325, P1155, DOI 10.1136/bmj.325.7373.1155; Kessler RC, 2009, MOL PSYCHIATR, V14, P1132, DOI 10.1038/mp.2008.78; Kessler RC, 2007, J NERV MENT DIS, V195, P369, DOI 10.1097/NMD.0b013e3180303eb8; Kim N, 2011, AM J PSYCHIAT, V168, P49, DOI 10.1176/appi.ajp.2010.10020289; Li DJ, 2012, J PSYCHIATR RES, V46, P1257, DOI 10.1016/j.jpsychires.2012.03.013; Malone KM, 2003, AM J PSYCHIAT, V160, P773, DOI 10.1176/appi.ajp.160.4.773; McGee R, 2005, AM J PSYCHIAT, V162, P619, DOI 10.1176/appi.ajp.162.3.619; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Nock MK, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000123; Nordentoft M, 2007, DAN MED BULL, V54, P306; Passamonti L, 2006, BIOL PSYCHIAT, V59, P334, DOI 10.1016/j.biopsych.2005.07.027; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pitman A, 2012, LANCET, V379, P2383, DOI 10.1016/S0140-6736(12)60731-4; Riala K, 2009, ANN EPIDEMIOL, V19, P329, DOI 10.1016/j.annepidem.2008.12.004; Ruan WJ, 2008, DRUG ALCOHOL DEPEN, V92, P27, DOI 10.1016/j.drugalcdep.2007.06.001; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Theil H, 1971, PRINCIPLES EC, P179; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; Wilcox HC, 2004, DRUG ALCOHOL DEPEN, V76, pS53, DOI 10.1016/j.drugalcdep.2004.08.007; World Health Organization, 2012, PUBLIC HEALTH ACTION, V2012; Young SN, 2013, J PSYCHIATR NEUROSCI, V38, P423, DOI 10.1503/jpn.130002	47	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122607	10.1371/journal.pone.0122607	http://dx.doi.org/10.1371/journal.pone.0122607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849514	gold, Green Published			2022-12-26	WOS:000352477800148
J	Mapelli, J; Gandolfi, D; Giuliani, E; Prencipe, FP; Pellati, F; Barbieri, A; D'Angelo, E; Bigiani, A				Mapelli, Jonathan; Gandolfi, Daniela; Giuliani, Enrico; Prencipe, Francesco P.; Pellati, Federica; Barbieri, Alberto; D'Angelo, Egidio; Bigiani, Albertino			The Effect of Desflurane on Neuronal Communication at a Central Synapse	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; LONG-TERM POTENTIATION; VOLATILE ANESTHETICS; RELEVANT CONCENTRATIONS; VESTIBULOOCULAR REFLEX; INHALED ANESTHETICS; POTASSIUM CHANNELS; INFORMATION-THEORY; MOLECULAR TARGETS; SODIUM-CHANNELS	Although general anesthetics are thought to modify critical neuronal functions, their impact on neuronal communication has been poorly examined. We have investigated the effect induced by desflurane, a clinically used general anesthetic, on information transfer at the synapse between mossy fibers and granule cells of cerebellum, where this analysis can be carried out extensively. Mutual information values were assessed by measuring the variability of postsynaptic output in relationship to the variability of a given set of presynaptic inputs. Desflurane synchronized granule cell firing and reduced mutual information in response to physiologically relevant mossy fibers patterns. The decrease in spike variability was due to an increased postsynaptic membrane excitability, which made granule cells more prone to elicit action potentials, and to a strengthened synaptic inhibition, which markedly hampered membrane depolarization. These concomitant actions on granule cells firing indicate that desflurane re-shapes the transfer of information between neurons by providing a less informative neurotransmission rather than completely silencing neuronal activity.	[Mapelli, Jonathan; Gandolfi, Daniela; Bigiani, Albertino] Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy; [Gandolfi, Daniela; D'Angelo, Egidio] Univ Pavia, Dipartimento Sci Sistema Nervoso & Comportamento, I-27100 Pavia, Italy; [Giuliani, Enrico; Barbieri, Alberto] Univ Modena & Reggio Emilia, Dipartimento Med Diagnost Clin & Sanita Pubbl, Modena, Italy; [Prencipe, Francesco P.; Pellati, Federica] Univ Modena & Reggio Emilia, Dipartimento Sci Vita, Modena, Italy; [D'Angelo, Egidio] C Mondino Natl Neurol Inst, Brain Connect Ctr, Pavia, Italy	Universita di Modena e Reggio Emilia; University of Pavia; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia; IRCCS Fondazione Casimiro Mondino	Mapelli, J (corresponding author), Univ Modena & Reggio Emilia, Dipartimento Sci Biomed Metab & Neurosci, Modena, Italy.	jonathan.mapelli@unimore.it	Pellati, Federica/H-5846-2015; D'Angelo, Egidio/AAC-3846-2022; Giuliani, Enrico/L-2158-2016; Barbieri, Alberto/L-1427-2016; Bigiani, Albertino/G-3024-2015	Pellati, Federica/0000-0002-9822-6862; D'Angelo, Egidio/0000-0002-6007-7187; Giuliani, Enrico/0000-0001-7140-7850; Barbieri, Alberto/0000-0002-3904-1323; Bigiani, Albertino/0000-0001-6987-488X; mapelli, jonathan/0000-0002-0381-1576	Fondazione di Vignola	Fondazione di Vignola	This work was financed by a grant of Fondazione di Vignola (www.fondazionedivignola.it/) to JM. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Arleo A, 2010, NEURAL COMPUT, V22, P2031, DOI 10.1162/NECO_a_00006-Arleo; Armano S, 2000, J NEUROSCI, V20, P5208, DOI 10.1523/JNEUROSCI.20-14-05208.2000; Banks MI, 1999, ANESTHESIOLOGY, V90, P120, DOI 10.1097/00000542-199901000-00018; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; Benkwitz C, 2004, ANESTHESIOLOGY, V101, P924, DOI 10.1097/00000542-200410000-00018; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Bower JM, 1997, PROG BRAIN RES, V114, P463; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Cesana E, 2013, J NEUROSCI, V33, P12430, DOI 10.1523/JNEUROSCI.4897-11.2013; Chadderton P, 2004, NATURE, V428, P856, DOI 10.1038/nature02442; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; D'Angelo E, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00093; D'Angelo E, 2009, TRENDS NEUROSCI, V32, P30, DOI 10.1016/j.tins.2008.09.007; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; DANGELO E, 1993, NEUROSCIENCE, V53, P121, DOI 10.1016/0306-4522(93)90290-V; Dayan P, 2001, COMPUTATIONAL NEUROS; Dieudonne S, 1998, J PHYSIOL-LONDON, V510, P845, DOI 10.1111/j.1469-7793.1998.845bj.x; Diwakar S, 2009, J NEUROPHYSIOL, V101, P519, DOI 10.1152/jn.90382.2008; Eckenhoff RG, 1999, ANESTHESIOLOGY, V91, P856, DOI 10.1097/00000542-199909000-00039; Eger EI, 2001, ANESTHESIOLOGY, V94, P915, DOI 10.1097/00000542-200105000-00032; EGER EI, 1965, ANESTHESIOLOGY, V26, P756, DOI 10.1097/00000542-196511000-00010; Flohr H, 1998, TOXICOL LETT, V101, P23, DOI 10.1016/S0378-4274(98)00161-1; Forti L, 2006, J PHYSIOL-LONDON, V574, P711, DOI 10.1113/jphysiol.2006.110858; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Friederich P, 2001, ANESTHESIOLOGY, V95, P954, DOI 10.1097/00000542-200110000-00026; Gandolfi D, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00092; Gandolfi D, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00064; Goldfarb M, 2012, CELL MOL LIFE SCI, V69, P1067, DOI 10.1007/s00018-011-0832-1; Huang JJ, 2014, CEREBELLUM, V13, P97, DOI 10.1007/s12311-013-0523-6; Jenkins A, 1999, ANESTHESIOLOGY, V90, P484, DOI 10.1097/00000542-199902000-00024; Joho RH, 2009, CEREBELLUM, V8, P323, DOI 10.1007/s12311-009-0098-4; Kaisti KK, 2003, ANESTHESIOLOGY, V99, P603, DOI 10.1097/00000542-200309000-00015; Kanichay RT, 2008, J NEUROSCI, V28, P8955, DOI 10.1523/JNEUROSCI.5469-07.2008; KASE M, 1980, J PHYSIOL-LONDON, V300, P539, DOI 10.1113/jphysiol.1980.sp013178; Kofke WA, 2010, CURR OPIN ANESTHESIO, V23, P391, DOI 10.1097/ACO.0b013e328339250b; Lim BG, 2014, ASN NEURO, V6, DOI 10.1042/AN20140004; Lioudyno MI, 2013, J NEUROSCI, V33, P16310, DOI 10.1523/JNEUROSCI.0344-13.2013; LISBERGER SG, 1978, J NEUROPHYSIOL, V41, P764, DOI 10.1152/jn.1978.41.3.764; London M, 2002, NAT NEUROSCI, V5, P332, DOI 10.1038/nn826; Macario A, 2005, AM J HEALTH-SYST PH, V62, P63, DOI 10.1093/ajhp/62.1.63; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Mapelli J, 2007, J NEUROSCI, V27, P1285, DOI 10.1523/JNEUROSCI.4873-06.2007; Mapelli J, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00014; Mapelli J, 2010, J NEUROPHYSIOL, V103, P250, DOI 10.1152/jn.00642.2009; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Mayer J, 2006, ANESTH ANALG, V102, P400, DOI 10.1213/01.ane.0000189561.44016.99; MILES FA, 1980, J NEUROPHYSIOL, V43, P1437, DOI 10.1152/jn.1980.43.5.1437; Mitchell SJ, 2003, NEURON, V38, P433, DOI 10.1016/S0896-6273(03)00200-9; Nemenman I, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000025; Nieus T, 2006, J NEUROPHYSIOL, V95, P686, DOI 10.1152/jn.00696.2005; Nieus TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00246; Nishikawa K, 2003, ANESTHESIOLOGY, V99, P678, DOI 10.1097/00000542-200309000-00024; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nusser Z, 2001, BIOPHYS J, V80, P1251, DOI 10.1016/S0006-3495(01)76101-2; Ogawa SK, 2011, NEUROPHARMACOLOGY, V60, P701, DOI 10.1016/j.neuropharm.2010.11.016; Ordek G, 2013, J NEUROPHYSIOL, V109, P1435, DOI 10.1152/jn.00455.2012; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 2007, J NEUROPHYSIOL, V98, P1064, DOI 10.1152/jn.00559.2007; Pouille F, 2001, SCIENCE, V293, P1159, DOI 10.1126/science.1060342; Prestori F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064828; Quiroga RQ, 2009, NAT REV NEUROSCI, V10, P173, DOI 10.1038/nrn2578; Rancz EA, 2007, NATURE, V450, P1245, DOI 10.1038/nature05995; Rehberg B, 1996, ANESTHESIOLOGY, V84, P1223, DOI 10.1097/00000542-199605000-00025; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Rothman JS, 2009, NATURE, V457, P1015, DOI 10.1038/nature07604; Rudolph U, 2004, NAT REV NEUROSCI, V5, P709, DOI 10.1038/nrn1496; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Sola E, 2004, J PHYSIOL-LONDON, V557, P843, DOI 10.1113/jphysiol.2003.060285; Strong S P, 1998, Pac Symp Biocomput, P621; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Tiesinga PHE, 2002, NETWORK-COMP NEURAL, V13, P41, DOI 10.1088/0954-898X/13/1/302; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Zador A, 1998, J NEUROPHYSIOL, V79, P1219, DOI 10.1152/jn.1998.79.3.1219	79	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123534	10.1371/journal.pone.0123534	http://dx.doi.org/10.1371/journal.pone.0123534			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849222	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800241
J	Nam, J; Choo, KKR; Han, S; Kim, M; Paik, J; Won, D				Nam, Junghyun; Choo, Kim-Kwang Raymond; Han, Sangchul; Kim, Moonseong; Paik, Juryon; Won, Dongho			Efficient and Anonymous Two-Factor User Authentication in Wireless Sensor Networks: Achieving User Anonymity with Lightweight Sensor Computation	PLOS ONE			English	Article							MUTUAL AUTHENTICATION; KEY AGREEMENT; E-SAP; PROTOCOL; SECURITY; SCHEME; CRYPTANALYSIS; IMPROVEMENTS	A smart-card-based user authentication scheme for wireless sensor networks (hereafter referred to as a SCA-WSN scheme) is designed to ensure that only users who possess both a smart card and the corresponding password are allowed to gain access to sensor data and their transmissions. Despite many research efforts in recent years, it remains a challenging task to design an efficient SCA-WSN scheme that achieves user anonymity. The majority of published SCA-WSN schemes use only lightweight cryptographic techniques (rather than public-key cryptographic techniques) for the sake of efficiency, and have been demonstrated to suffer from the inability to provide user anonymity. Some schemes employ elliptic curve cryptography for better security but require sensors with strict resource constraints to perform computationally expensive scalar-point multiplications; despite the increased computational requirements, these schemes do not provide user anonymity. In this paper, we present a new SCA-WSN scheme that not only achieves user anonymity but also is efficient in terms of the computation loads for sensors. Our scheme employs elliptic curve cryptography but restricts its use only to anonymous user-to-gateway authentication, thereby allowing sensors to perform only lightweight cryptographic operations. Our scheme also enjoys provable security in a formal model extended from the widely accepted Bellare-Pointcheval- Rogaway (2000) model to capture the user anonymity property and various SCA-WSN specific attacks (e.g., stolen smart card attacks, node capture attacks, privileged insider attacks, and stolen verifier attacks).	[Nam, Junghyun; Han, Sangchul] Konkuk Univ, Dept Comp Engn, Chungju, Chungcheongbukd, South Korea; [Choo, Kim-Kwang Raymond] Univ S Australia, Sch Informat Technol & Math Sci, Mawson Lakes, SA, Australia; [Kim, Moonseong] Korean Intellectual Property Off, Informat Management Div, Taejon, South Korea; [Paik, Juryon; Won, Dongho] Sungkyunkwan Univ, Dept Comp Engn, Suwon, Gyeonggido, South Korea	Konkuk University; University of South Australia; Sungkyunkwan University (SKKU)	Han, S (corresponding author), Konkuk Univ, Dept Comp Engn, Chungju, Chungcheongbukd, South Korea.	schan@kku.ac.kr	Choo, Kim-Kwang Raymond/A-3634-2009	Choo, Kim-Kwang Raymond/0000-0001-9208-5336; Paik, Juryon/0000-0002-0564-6412	Konkuk University	Konkuk University	This work was supported by Konkuk University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellare M, 2000, LECT NOTES COMPUT SC, V1807, P139; Chen TH, 2010, ETRI J, V32, P704, DOI 10.4218/etrij.10.1510.0134; Chi L, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/637684; Choi Y, 2014, SENSORS-BASEL, V14, P10081, DOI 10.3390/s140610081; Das ML, 2009, IEEE T WIREL COMMUN, V8, P1086, DOI 10.1109/TWC.2008.080128; GOLDWASSER S, 1984, J COMPUT SYST SCI, V28, P270, DOI 10.1016/0022-0000(84)90070-9; Han W, 2011, IACR CRYPTOLOGY EPRI; He D, 2013, MULTIMEDIA SYSTEMS; He DJ, 2010, AD HOC SENS WIREL NE, V10, P361; He DB, 2014, IEEE T CONSUM ELECTR, V60, P30, DOI 10.1109/TCE.2014.6780922; He DB, 2014, WIRELESS PERS COMMUN, V74, P229, DOI 10.1007/s11277-013-1282-x; He DB, 2013, IEEE T CONSUM ELECTR, V59, P811, DOI 10.1109/TCE.2013.6689693; Jiang Q, 2015, PEER PEER NETW APPL, V8, P1070, DOI 10.1007/s12083-014-0285-z; Khan MK, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/347169; Khan MK, 2013, KSII T INTERNET INF, V7, P967, DOI 10.3837/tiis.2013.05.002; Khan MK, 2012, SECUR COMMUN NETW, V5, P1260, DOI 10.1002/sec.573; Khan MK, 2010, SENSORS-BASEL, V10, P2450, DOI 10.3390/s100302450; Kim J, 2014, SENSORS-BASEL, V14, P6443, DOI 10.3390/s140406443; Kocher P., 1999, Advances in Cryptology - CRYPTO'99. 19th Annual International Cryptology Conference. Proceedings, P388; Kumar P, 2013, ETRI J, V35, P889, DOI 10.4218/etrij.13.0113.0103; Kumar P, 2012, SENSORS-BASEL, V12, P1625, DOI 10.3390/s120201625; Kumar P, 2011, SENSORS-BASEL, V11, P5020, DOI 10.3390/s110505020; Li CT, 2013, SENSORS-BASEL, V13, P9589, DOI 10.3390/s130809589; Messerges TS, 2002, IEEE T COMPUT, V51, P541, DOI 10.1109/TC.2002.1004593; NIST: National Institute of Standards and Technology, 1999, REC ELL CURV FED GOV; Rawat P, 2014, J SUPERCOMPUT, V68, P1, DOI 10.1007/s11227-013-1021-9; Shi WB, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/730831; Vaidya B, 2012, SECURITY COMMUNICATI; Wang D, 2014, COMPUT NETW, V73, P41, DOI 10.1016/j.comnet.2014.07.010; Wang D, 2014, AD HOC NETW, V20, P1, DOI 10.1016/j.adhoc.2014.03.003; Xie Q, 2014, WIRELESS PERS COMMUN, V74, P601, DOI 10.1007/s11277-013-1309-3; Xue KP, 2013, J NETW COMPUT APPL, V36, P316, DOI 10.1016/j.jnca.2012.05.010; Yeh HL, 2011, SENSORS-BASEL, V11, P4767, DOI 10.3390/s110504767; Yoo SG, 2012, INT J DISTRIB SENS N, DOI 10.1155/2012/382810	34	50	52	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0116709	10.1371/journal.pone.0116709	http://dx.doi.org/10.1371/journal.pone.0116709			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849359	gold, Green Published, Green Accepted			2022-12-26	WOS:000352477800002
J	Chung, EML; Banahan, C; Patel, N; Janus, J; Marshall, D; Horsfield, MA; Rousseau, C; Keelan, J; Evans, DH; Hague, JP				Chung, Emma M. L.; Banahan, Caroline; Patel, Nikil; Janus, Justyna; Marshall, David; Horsfield, Mark A.; Rousseau, Clement; Keelan, Jonathan; Evans, David H.; Hague, James P.			Size Distribution of Air Bubbles Entering the Brain during Cardiac Surgery	PLOS ONE			English	Article							CARBON-DIOXIDE INSUFFLATION; GASEOUS EMBOLI; BYPASS; TRIAL; BLOOD	Background Thousands of air bubbles enter the cerebral circulation during cardiac surgery, but whether high numbers of bubbles explain post-operative cognitive decline is currently controversial. This study estimates the size distribution of air bubbles and volume of air entering the cerebral arteries intra-operatively based on analysis of transcranial Doppler ultrasound data. Methods Transcranial Doppler ultrasound recordings from ten patients undergoing heart surgery were analysed for the presence of embolic signals. The backscattered intensity of each embolic signal was modelled based on ultrasound scattering theory to provide an estimate of bubble diameter. The impact of showers of bubbles on cerebral blood-flow was then investigated using patient-specific Monte-Carlo simulations to model the accumulation and clearance of bubbles within a model vasculature. Results Analysis of Doppler ultrasound recordings revealed a minimum of 371 and maximum of 6476 bubbles entering the middle cerebral artery territories during surgery. This was estimated to correspond to a total volume of air ranging between 0.003 and 0.12 mL. Based on analysis of a total of 18667 embolic signals, the median diameter of bubbles entering the cerebral arteries was 33 mu m (IQR: 18 to 69 mu m). Although bubble diameters ranged from similar to 5 mu m to 3.5 mm, the majority (85%) were less than 100 mu m. Numerous small bubbles detected during cardiopulmonary bypass were estimated by Monte-Carlo simulation to be benign. However, during weaning from bypass, showers containing large macro-bubbles were observed, which were estimated to transiently affect up to 2.2% of arterioles. Conclusions Detailed analysis of Doppler ultrasound data can be used to provide an estimate of bubble diameter, total volume of air, and the likely impact of embolic showers on cerebral blood flow. Although bubbles are alarmingly numerous during surgery, our simulations suggest that the majority of bubbles are too small to be harmful.	[Chung, Emma M. L.; Banahan, Caroline; Patel, Nikil; Janus, Justyna; Marshall, David; Horsfield, Mark A.; Evans, David H.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Chung, Emma M. L.; Banahan, Caroline] Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Chung, Emma M. L.; Patel, Nikil; Marshall, David; Rousseau, Clement] Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Keelan, Jonathan; Hague, James P.] Open Univ, Dept Phys Sci, Milton Keynes MK7 6AA, Bucks, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Open University - UK	Chung, EML (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	emlc1@le.ac.uk; Jim.Hague@open.ac.uk	Horsfield, Mark A/C-6569-2013; Evans, David/AAN-1100-2020	Horsfield, Mark A/0000-0002-0815-6697; Rousseau, Clement/0000-0002-8063-0584; Chung, Emma/0000-0003-3723-9085; Hague, James/0000-0002-5760-8696; Patel, Nikil/0000-0003-2888-9668	British Heart Foundation [FS/10/46/288350]; National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit; EPSRC [EP/L025884/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [1146445] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was supported by the British Heart Foundation (FS/10/46/288350) and the National Institute for Health Research (NIHR) Leicester Cardiovascular Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banahan C, 2012, ULTRASOUND MED BIOL, V38, P824, DOI 10.1016/j.ultrasmedbio.2012.01.008; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Chaudhuri K, 2012, J THORAC CARDIOV SUR, V144, P646, DOI 10.1016/j.jtcvs.2012.04.010; Chaudhuri K, 2011, J CARDIAC SURG, V26, P189, DOI 10.1111/j.1540-8191.2011.01217.x; Chung EML, 2007, PHYS MED BIOL, V52, P7153, DOI 10.1088/0031-9155/52/23/025; Gerriets T, 2010, EUR HEART J, V31, P360, DOI 10.1093/eurheartj/ehp178; Hague JP, 2013, PHYS MED BIOL, V58, P4381, DOI 10.1088/0031-9155/58/13/4381; Hague JP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051912; Haines DE, 2013, CIRC-ARRHYTHMIA ELEC, V6, P23, DOI 10.1161/CIRCEP.112.973461; Kruis RWJ, 2010, SEMIN CARDIOTHORAC V, V14, P111, DOI 10.1177/1089253210370903; Lynch JE, 2008, PERFUSION-UK, V23, P23, DOI 10.1177/0267659108094350; Mitchell Simon, 2002, J Extra Corpor Technol, V34, P18; MOEHRING MA, 1994, IEEE T BIO-MED ENG, V41, P35, DOI 10.1109/10.277269; MOODY DM, 1995, ANN THORAC SURG, V59, P1304, DOI 10.1016/0003-4975(95)00057-R; Ringelstein EB, 1998, STROKE, V29, P725	15	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122166	10.1371/journal.pone.0122166	http://dx.doi.org/10.1371/journal.pone.0122166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837519	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000352139000082
J	Ogasawara, Y; Yackley, BJ; Greenberg, JA; Rogelj, S; Melancon, CE				Ogasawara, Yasushi; Yackley, Benjamin J.; Greenberg, Jacob A.; Rogelj, Snezna; Melancon, Charles E., III			Expanding our Understanding of Sequence-Function Relationships of Type II Polyketide Biosynthetic Gene Clusters: Bioinformatics-Guided Identification of Frankiamicin A from Frankia sp EAN1pec	PLOS ONE			English	Article							HETEROLOGOUS EXPRESSION; TETRACENOMYCIN-F2 CYCLASE; ENGINEERED BIOSYNTHESIS; CRYSTAL-STRUCTURE; SP STRAINS; CLONING; SYNTHASE; MONOOXYGENASE; DISCOVERY; PURIFICATION	A large and rapidly increasing number of unstudied " orphan" natural product biosynthetic gene clusters are being uncovered in sequenced microbial genomes. An important goal of modern natural products research is to be able to accurately predict natural product structures and biosynthetic pathways from these gene cluster sequences. This requires both development of bioinformatic methods for global analysis of these gene clusters and experimental characterization of select products produced by gene clusters with divergent sequence characteristics. Here, we conduct global bioinformatic analysis of all available type II polyketide gene cluster sequences and identify a conserved set of gene clusters with unique ketosynthase a/a sequence characteristics in the genomes of Frankia species, a group of Actinobacteria with underexploited natural product biosynthetic potential. Through LC-MS profiling of extracts from several Frankia species grown under various conditions, we identified Frankia sp. EAN1pec as producing a compound with spectral characteristics consistent with the type II polyketide produced by this gene cluster. We isolated the compound, a pentangular polyketide which we named frankiamicin A, and elucidated its structure by NMR and labeled precursor feeding. We also propose biosynthetic and regulatory pathways for frankiamicin A based on comparative genomic analysis and literature precedent, and conduct bioactivity assays of the compound. Our findings provide new information linking this set of Frankia gene clusters with the compound they produce, and our approach has implications for accurate functional prediction of the many other type II polyketide clusters present in bacterial genomes.	[Ogasawara, Yasushi; Yackley, Benjamin J.; Greenberg, Jacob A.; Melancon, Charles E., III] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Melancon, Charles E., III] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Melancon, Charles E., III] Univ New Mexico, Ctr Biomed Engn, Albuquerque, NM 87131 USA; [Rogelj, Snezna] New Mexico Inst Min & Technol, Dept Chem, Socorro, NM 87801 USA; [Rogelj, Snezna] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA	University of New Mexico; University of New Mexico; University of New Mexico; New Mexico Institute of Mining Technology; New Mexico Institute of Mining Technology	Melancon, CE (corresponding author), Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA.	cemelanc@unm.edu	Ogasawara, Yasushi/ABG-5942-2020	Ogasawara, Yasushi/0000-0002-3144-3985	University of New Mexico start-up funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103451] Funding Source: NIH RePORTER	University of New Mexico start-up funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by University of New Mexico start-up funds. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; AOYAMA T, 1993, J ANTIBIOT, V46, P914, DOI 10.7164/antibiotics.46.914; Banskota AH, 2009, J ANTIBIOT, V62, P565, DOI 10.1038/ja.2009.77; Bao WL, 1998, BIOCHEMISTRY-US, V37, P8132, DOI 10.1021/bi980466i; Benson DR, 2011, MOL PLANT MICROBE IN, V24, P1310, DOI 10.1094/MPMI-06-11-0150; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blin K, 2013, NUCLEIC ACIDS RES, V41, pW204, DOI 10.1093/nar/gkt449; Bologa CG, 2013, CURR OPIN PHARMACOL, V13, P678, DOI 10.1016/j.coph.2013.07.002; Chen J, 2011, J CELL BIOCHEM, V112, P2694, DOI 10.1002/jcb.23219; Chung JY, 2002, J BACTERIOL, V184, P6115, DOI 10.1128/JB.184.22.6115-6122.2002; Crawford JM, 2010, NAT REV MICROBIOL, V8, P879, DOI 10.1038/nrmicro2465; Dairi T, 1997, BIOSCI BIOTECH BIOCH, V61, P1445, DOI 10.1271/bbb.61.1445; Feng ZY, 2012, J AM CHEM SOC, V134, P2981, DOI 10.1021/ja207662w; Fritzsche K, 2008, J AM CHEM SOC, V130, P8307, DOI 10.1021/ja800251m; Frolova LV, 2013, J MED CHEM, V56, P6886, DOI 10.1021/jm400711t; Grocholski T, 2010, BIOCHEMISTRY-US, V49, P934, DOI 10.1021/bi901985b; Helfrich EJN, 2014, CURR OPIN BIOTECH, V29, P107, DOI 10.1016/j.copbio.2014.03.004; Hertweck C, 2004, CHEM BIOL, V11, P461, DOI 10.1016/j.chembiol.2004.03.018; Hertweck C, 2007, NAT PROD REP, V24, P162, DOI 10.1039/b507395m; Hutchinson CR, 1997, CHEM REV, V97, P2525, DOI 10.1021/cr960022x; Ishida K, 2010, J AM CHEM SOC, V132, P13966, DOI 10.1021/ja105003g; Kang HS, 2014, ACS CHEM BIOL, V9, P1267, DOI 10.1021/cb500141b; Keatinge-Clay A, 2004, NAT STRUCT MOL BIOL, V11, P888, DOI 10.1038/nsmb808; Kendrew SG, 1997, J BACTERIOL, V179, P4305, DOI 10.1128/jb.179.13.4305-4310.1997; Kim BC, 2007, J MICROBIOL BIOTECHN, V17, P830; Kim J, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-169; Klika KD, 2001, J ORG CHEM, V66, P4065, DOI 10.1021/jo001789z; Komatsu M, 2006, MOL MICROBIOL, V62, P1534, DOI 10.1111/j.1365-2958.2006.05461.x; Kudo F, 2011, J ANTIBIOT, V64, P123, DOI 10.1038/ja.2010.145; Lackner G, 2007, J AM CHEM SOC, V129, P9306, DOI 10.1021/ja0718624; Laureti L, 2011, P NATL ACAD SCI USA, V108, P6258, DOI 10.1073/pnas.1019077108; Lechner A, 2011, CHEM BIOL, V18, P1527, DOI 10.1016/j.chembiol.2011.10.014; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li AY, 2002, CHEM BIOL, V9, P1017, DOI 10.1016/S1074-5521(02)00223-5; Li MHT, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-185; Lopez P, 2010, GENE, V461, P5, DOI 10.1016/j.gene.2010.03.016; Martin R, 2001, J ANTIBIOT, V54, P239, DOI 10.7164/antibiotics.54.239; Matharu AL, 1998, CHEM BIOL, V5, P699, DOI 10.1016/S1074-5521(98)90663-9; MATSUDA Y, 1987, J ANTIBIOT, V40, P1104, DOI 10.7164/antibiotics.40.1104; Mayer A, 2005, CHEMBIOCHEM, V6, P2312, DOI 10.1002/cbic.200500205; MCDANIEL R, 1994, P NATL ACAD SCI USA, V91, P11542, DOI 10.1073/pnas.91.24.11542; MCDANIEL R, 1995, J AM CHEM SOC, V117, P6805, DOI 10.1021/ja00131a001; Metsa-Ketela M, 2002, APPL ENVIRON MICROB, V68, P4472, DOI 10.1128/AEM.68.9.4472-4479.2002; Napan KL, 2012, BIOORG MED CHEM LETT, V22, P606, DOI 10.1016/j.bmcl.2011.10.075; Normand P, 2007, GENOME RES, V17, P7, DOI 10.1101/gr.5798407; Oves-Costales D, 2012, RSC DRUG DISCOV, V25, P140, DOI 10.1039/9781849734950-00140; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; RICKARDS RW, 1989, J ANTIBIOT, V42, P336, DOI 10.7164/antibiotics.42.336; Romero D, 2011, CHEM REV, V111, P5492, DOI 10.1021/cr2000509; Scherlach K, 2009, ORG BIOMOL CHEM, V7, P1753, DOI 10.1039/b821578b; Sciara G, 2003, EMBO J, V22, P205, DOI 10.1093/emboj/cdg031; SHEN B, 1993, BIOCHEMISTRY-US, V32, P11149, DOI 10.1021/bi00092a026; SHEN B, 1993, BIOCHEMISTRY-US, V32, P6656, DOI 10.1021/bi00077a019; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Tang Y, 2003, J AM CHEM SOC, V125, P12708, DOI 10.1021/ja0378759; Thompson TB, 2004, J BIOL CHEM, V279, P37956, DOI 10.1074/jbc.M406144200; Tsukamoto M, 1998, Jpn Kokai Tokkyo Koho, Patent No. [JP 10017527, 10017527]; Udwary DW, 2011, APPL ENVIRON MICROB, V77, P3617, DOI 10.1128/AEM.00038-11; Walsh CT, 2010, J AM CHEM SOC, V132, P2469, DOI 10.1021/ja909118a; Weber T, 2009, J BIOTECHNOL, V140, P13, DOI 10.1016/j.jbiotec.2009.01.007; Wendt-Pienkowski E, 2005, J AM CHEM SOC, V127, P16442, DOI 10.1021/ja054376u; Xu Z, 2007, J AM CHEM SOC, V129, P6022, DOI 10.1021/ja069045b; Yamanaka K, 2014, P NATL ACAD SCI USA, V111, P1957, DOI 10.1073/pnas.1319584111; Zaleta-Rivera K, 2010, J AM CHEM SOC, V132, P9122, DOI 10.1021/ja102519v; Zawada RJX, 1999, CHEM BIOL, V6, P607; Zhan JX, 2008, CHEMBIOCHEM, V9, P1710, DOI 10.1002/cbic.200800178; Zhan JX, 2009, CHEMBIOCHEM, V10, P1447, DOI 10.1002/cbic.200900082; Zhang WK, 2012, CHEM BIOL, V19, P422, DOI 10.1016/j.chembiol.2012.01.016; Zhang X, 2008, ANTIMICROB AGENTS CH, V52, P574, DOI 10.1128/AAC.00717-07; Zhao SW, 2014, ELIFE, V3, DOI 10.7554/eLife.03275	72	15	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121505	10.1371/journal.pone.0121505	http://dx.doi.org/10.1371/journal.pone.0121505			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837682	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000045
J	Ali, EAI; Barakat, BM; Hassan, R				Ali, Eman A. I.; Barakat, Bassant M.; Hassan, Ranya			Antioxidant and Angiostatic Effect of Spirulina platensis Suspension in Complete Freund's Adjuvant-Induced Arthritis in Rats	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; OXIDATIVE STRESS; C-PHYCOCYANIN; ANGIOGENESIS; INFLAMMATION; INDOMETHACIN; INTEGRINS; CELECOXIB; DISEASE	Background Currently, natural products have built a well-recognized role in the management of many degenerative diseases, mainly rheumatoid arthritis. Recent studies suggest that Spirulina, a unicellular blue-green alga, may have a variety of health benefits and curative properties and is also competent of acting as an anti-inflammatory, antioxidant and recently anti-angiogenic agent. In the present study, the antioxidant and the immunomodulatory effect of Spirulina platensis as well as its anti-angiogenic effect against complete Freund's adjuvant-induced arthritis (AIA) in rat model were tested. Results We found that the development of arthritis was concealed; moreover it successfully inhibited the development of macroscopic as well as microscopic and histopathological lesions in AIA rats when compared to control. Spirulina treated group showed a higher survival rate and moreover, it reduced the clinical score of RA in a dose dependent manner. Furthermore, Spirulina decreased serum levels of COX-2, TNF-alpha, IL-6, TBARS, VEGF and increased serum levels of GSH compared to the RA non-treated group. Conclusions The present study concluded that Spirulina is able to restrain the changes produced through adjuvant-induced arthritis. The suppressing effect of Spirulina could be attributed, at least in part, to anti-inflammatory, antioxidant and anti-angiogenic properties.	[Ali, Eman A. I.] Suez Canal Univ, Fac Med, Dept Histol & Cell Biol, Ismailia, Egypt; [Barakat, Bassant M.] Al Azhar Univ, Fac Pharm Girls, Dept Pharmacol & Toxicol, Cairo, Egypt; [Hassan, Ranya] Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Al Azhar University; Egyptian Knowledge Bank (EKB); Suez Canal University	Hassan, R (corresponding author), Suez Canal Univ, Fac Med, Dept Clin Pathol, Ismailia, Egypt.	ranyamoustafa@hotmail.com	Hassan, Ranya Moustafa/R-2421-2018	Hassan, Ranya Moustafa/0000-0001-7178-1965; Barakat, Bassant/0000-0003-1800-5814				Abdel-Daim MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072991; Ahn MY, 2013, TOX RESEARCH, V29, P195, DOI 10.5487/TR.2013.29.3.195; Alamanos Y, 2006, SEMIN ARTHRITIS RHEU, V36, P182, DOI 10.1016/j.semarthrit.2006.08.006; ALBANI S, 1997, ARTHRITIS ALLIED CON, P979; Azab SS, 2013, MED CHEM RES, V22, P4269, DOI 10.1007/s00044-012-0420-4; Barton A, 2009, ARTHRIT CARE RES, V61, P1441, DOI 10.1002/art.24672; Belay A., 2020, J AM NUTRACEUTICAL A, V5, P27; Chen JC, 2012, NUTR NEUROSCI, V15, P252, DOI 10.1179/1476830512Y.0000000020; Cho ML, 2002, ARTHRITIS RHEUM, V46, P1202, DOI 10.1002/art.10215; Clavel G, 2003, JOINT BONE SPINE, V70, P321, DOI 10.1016/S1297-319X(03)00088-5; Datta S, 2014, CLIN RHEUMATOL, V33, P1557, DOI 10.1007/s10067-014-2597-z; Dillon J C, 1995, World Rev Nutr Diet, V77, P32; El-Desoky GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059177; El-Sayed RM, 2014, INFLAMMOPHARMACOLOGY, V22, P305, DOI 10.1007/s10787-014-0200-5; Eldahshan OA, 2014, CYTOTECHNOL IN PRESS; Goldbach-Mansky R, 2003, ANNU REV MED, V54, P197, DOI 10.1146/annurev.med.54.101601.152342; Ibrahim A, 2015, CELL J YAKH IN PRESS, P17; Kavanaugh Arthur, 2007, Am J Orthop (Belle Mead NJ), V36, P4; Kimpel D, 2003, ARTHRITIS RHEUM-US, V48, P3557, DOI 10.1002/art.11424; Koch AE, 2000, ANN RHEUM DIS, V59, P65, DOI 10.1136/ard.59.suppl_1.i65; Koch AE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2187; Kumar Narendra, 2009, Inflammopharmacology, V17, P181, DOI 10.1007/s10787-009-0004-1; Kundu S, 2012, FREE RADICAL RES, V46, P1482, DOI 10.3109/10715762.2012.727991; Lee D, 2011, LANCET, V358, P903; Madkour FF, 2013, INDIAN J PHARM SCI, V75, P642; Majithia V, 2007, AM J MED, V120, P936, DOI 10.1016/j.amjmed.2007.04.005; Mi WL, 2008, BRAIN RES BULL, V77, P98, DOI 10.1016/j.brainresbull.2008.04.008; Muller-Ladner U, 2005, NAT CLIN PRACT RHEUM, V1, P102, DOI 10.1038/ncprheum0047; O'Dell JR, 2001, BEST PRACT RES CL RH, V15, P125, DOI 10.1053/berh.2000.0130; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Piliero S J, 1966, Life Sci, V5, P1057, DOI 10.1016/0024-3205(66)90088-9; Ruegg C, 2003, CELL MOL LIFE SCI, V60, P1135, DOI 10.1007/s00018-003-2297-3; Ruegg C, 2004, BBA-REV CANCER, V1654, P51, DOI 10.1016/j.bbcan.2003.09.003; Schramm C, 2004, ARTHRITIS RES THER, V6, pR114, DOI 10.1186/ar1039; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Shih CM, 2009, ANESTH ANALG, V108, P1303, DOI 10.1213/ane.0b013e318193e919; SUN Y, 1990, FREE RADICAL BIO MED, V8, P583, DOI 10.1016/0891-5849(90)90156-D; Taiwo Victor Olusegun, 2008, Veterinarski Arhiv, V78, P167; Ucar A, 1998, INFLAMMATION, V22, P243, DOI 10.1023/A:1022354614385; Vogler GA, 2006, AM COLL LAB, P627, DOI 10.1016/B978-012074903-4/50022-4; Yang LL, 2012, INT J OPHTHALMOL-CHI, V5, P32, DOI 10.3980/j.issn.2222-3959.2012.01.07; Zhang CF, 2014, J ETHNOPHARMACOL, V153, P793, DOI 10.1016/j.jep.2014.03.046	42	40	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121523	10.1371/journal.pone.0121523	http://dx.doi.org/10.1371/journal.pone.0121523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853428	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400041
J	Jackson, JA; Linse, K; Whittle, R; Griffiths, HJ				Jackson, Jennifer A.; Linse, Katrin; Whittle, Rowan; Griffiths, Huw J.			The Evolutionary Origins of the Southern Ocean Philobryid Bivalves: Hidden Biodiversity, Ancient Persistence	PLOS ONE			English	Article							PHYLOGENETIC INFERENCE; LIMOPSIS BIVALVIA; HIGH-LATITUDES; MODELS; SEQUENCES; MAXIMUM; SEA; REPRODUCTION; ALIGNMENTS; ANTARCTICA	Philobryids (Bivalvia: Arcoida) are one of the most speciose marine bivalve families in the Southern Ocean and are common throughout the Southern Hemisphere. Considering this diversity and their brooding reproductive mode (limiting long-distance dispersal), this family may have been present in the Southern Ocean since its inception. However Philobrya and Adacnarca appear only in the Quaternary fossil record of the Antarctic, suggesting a much more recent incursion. Molecular dating provides an independent means of measuring the time of origin and radiation of this poorly known group. Here we present the first combined molecular and morphological investigation of the Philobryidae in the Southern Ocean. Two nuclear loci (18S and 28S) were amplified from 35 Southern Ocean Adacnarca and Philobrya specimens, with a combined sequence length of 2,282 base pairs (bp). Adacnarca specimens (A. nitens and A. limopsoides) were resolved as a strongly supported monophyletic group. Genus Philobrya fell into two strongly supported groups ('sublaevis' and 'magellanica/wandelensis'), paraphyletic with Adacnarca. The A. nitens species complex is identified as at least seven morpho-species through morphological and genetic analysis of taxon clustering. Phylogenetic analyses resolve Philobryidae as a strongly supported monophyletic clade and sister taxon to the Limopsidae, as anticipated by their classification into the superfamily Limopsoidea. Bayesian relaxed clock analyses of divergence times suggest that genus Adacnarca radiated in the Southern Ocean from the Early Paleogene, while P. sublaevis and P. wandelensis clades radiated in the late Miocene, following the formation of the Antarctic Circumpolar Current.	[Jackson, Jennifer A.; Linse, Katrin; Whittle, Rowan; Griffiths, Huw J.] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Jackson, JA (corresponding author), British Antarctic Survey, Madingley Rd, Cambridge CB3 0ET, England.	jennifer.jackson@bas.ac.uk	Griffiths, Huw J/D-4234-2009	Griffiths, Huw J/0000-0003-1764-223X; Linse, Katrin/0000-0003-3477-3047	Natural Environment Research Council; NERC [bas0100026, bas0100030] Funding Source: UKRI; Natural Environment Research Council [bas0100026, bas0100030] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Natural Environment Research Council (http://www.nerc.ac.uk) and is a contribution to British Antarctic Survey core project 'EVOLHIST' under the NERC 'Polar Science for Planet Earth' programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Bowden DA, 2005, MAR ECOL PROG SER, V297, P101, DOI 10.3354/meps297101; BREY T, 1992, MAR ECOL PROG SER, V82, P219, DOI 10.3354/meps082219; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Clarke A, 2003, OCEANOGR MAR BIOL, V41, P47; Clarke A, 2010, PHILOS T R SOC B, V365, P3655, DOI 10.1098/rstb.2010.0270; Dalziel IWD, 2013, GEOLOGY, V41, P947, DOI 10.1130/G34352.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dell RK, 1964, DISCOVERY REPORTS, V33; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fujisawa T, 2013, SYST BIOL; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gordillo S, 2005, SCI MAR, V69, P337, DOI 10.3989/scimar.2005.69s2337; Grant RA, 2011, POLAR BIOL, V34, P775, DOI 10.1007/s00300-010-0932-7; Gutt J, 2007, ANTARCT SCI, V19, P165, DOI 10.1017/S0954102007000247; Heled J, 2012, SYST BIOL, V61, P138, DOI 10.1093/sysbio/syr087; Higgs ND, 2009, MAR BIOL, V156, P1073, DOI 10.1007/s00227-009-1154-9; Janosik AM, 2010, INTEGR COMP BIOL, V50, P981, DOI 10.1093/icb/icq119; KISHINO H, 1990, J MOL EVOL, V31, P151, DOI 10.1007/BF02109483; Kuck P, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-10; Linse K, 2005, EXPEDITION ANTARKTIS, P74; Linse K, 2003, BER POLARFORSCH, V462, P19; Linse K, 2003, EXPEDITIONS ANTARKTI, P101; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; Malchus N, 2005, MAR BIOL RES, V1, P350, DOI 10.1080/17451000500384100; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; NICOL DAVID, 1950, JOUR PALEONTOL, V24, P89; Oliver PG, 2006, ZOOL J LINN SOC-LOND, V148, P237, DOI 10.1111/j.1096-3642.2006.00256.x; OLIVER PG, 1981, MALACOLOGIA, V21, P61; Pearse JS, 2009, SMITHSONIAN AT THE POLES: CONTRIBUTIONS TO INTERNATIONAL POLAR YEAR SCIENCE, P181, DOI 10.5479/si.097884601X.13; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poulin E, 2014, GLOBAL PLANET CHANGE; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rambaut A., 2007, TRACE 1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savill NJ, 2001, GENETICS, V157, P399; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Skelton P.W., 1993, P237; Steiner G, 2000, GEOL SOC SPEC PUBL, V177, P11, DOI 10.1144/GSL.SP.2000.177.01.02; Stiller F, 2004, J PALEONTOL, V78, P414, DOI 10.1666/0022-3360(2004)078<0414:ESNGAS>2.0.CO;2; Strugnell JM, 2008, CLADISTICS, V24, P853, DOI 10.1111/j.1096-0031.2008.00234.x; Tevesz MJS, 1977, TAXONOMY ECOLOGY PHI; Van de Putte AP, 2014, ANTARCTIC BIODIVERSI; Whittle RJ, 2011, PALAEONTOLOGY, V54, P935, DOI 10.1111/j.1475-4983.2011.01061.x; ZACHOS JC, 1994, PALEOCEANOGRAPHY, V9, P353, DOI 10.1029/93PA03266	52	6	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121198	10.1371/journal.pone.0121198	http://dx.doi.org/10.1371/journal.pone.0121198			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853413	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000352478400032
J	Mei, YJ; He, CC; Huang, YC; Liu, Y; Zhang, ZQ; Chen, XD; Shen, P				Mei, Yunjun; He, Congcong; Huang, Yongchi; Liu, Ying; Zhang, Ziqian; Chen, Xiangdong; Shen, Ping			Salinity Regulation of the Interaction of Halovirus SNJ1 with Its Host and Alteration of the Halovirus Replication Strategy to Adapt to the Variable Ecosystem	PLOS ONE			English	Article							BACTERIOPHAGE INFECTING HALOBACTERIUM; NUCLEOTIDE-SEQUENCE; ICOSAHEDRAL VIRUSES; IDENTIFICATION; GLYCOSYLATION; HALOBIUM; ARCHAEA; ENVIRONMENTS; ORGANIZATION; ATTACHMENT	Halovirus is a major force that affects the evolution of extreme halophiles and the biogeochemistry of hypersaline environments. However, until now, the systematic studies on the halovirus ecology and the effects of salt concentration on virus-host systems are lacking. To provide more valuable information for understanding ecological strategies of a virus-host system in the hypersaline ecosystem, we studied the interaction between halovirus SNJ1 and its host Natrinema sp. J7-2 under various NaCl concentrations. We found that the adsorption rate and lytic rate increased with salt concentration, demonstrating that a higher salt concentration promoted viral adsorption and proliferation. Contrary to the lytic rate, the lysogenic rate decreased as the salt concentration increased. Our results also demonstrated that cells incubated at a high salt concentration prior to infection increased the ability of the virus to adsorb and lyse its host cells; therefore, the physiological status of host cells also affected the virus-host interaction. In conclusion, SNJ1 acted as a predator, lysing host cells and releasing progeny viruses in hypersaline environments; in low salt environments, viruses lysogenized host cells to escape the damage from low salinity.	[Mei, Yunjun; He, Congcong] Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China; [Huang, Yongchi] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Hubei, Peoples R China; [Liu, Ying; Zhang, Ziqian; Chen, Xiangdong; Shen, Ping] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China	Wuhan Polytechnic University; Wuhan Polytechnic University; Wuhan University	Mei, YJ (corresponding author), Wuhan Polytech Univ, Sch Chem & Environm Engn, Wuhan, Hubei, Peoples R China.	meiyunjun_2000@163.com; xdchen@whu.edu.cn		Huang, Yongchi/0000-0002-3938-529X	Natural Science Foundation of China [31270215]; National Basic Research Program of China (973 Program) [2011CB808800]; Ministry of Science and Technology of the People's Republic of China; Open Research Fund Program of the State Key Laboratory of Virology of China [2014KF003]; Graduate Education Innovation Fund of Wuhan Polytechnic University [2013cx003]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); Open Research Fund Program of the State Key Laboratory of Virology of China; Graduate Education Innovation Fund of Wuhan Polytechnic University	This work was supported by grants from the Natural Science Foundation of China (no. 31270215, to YM), the National Basic Research Program of China (973 Program, no. 2011CB808800), Ministry of Science and Technology of the People's Republic of China (to XC) Open Research Fund Program of the State Key Laboratory of Virology of China (no. 2014KF003, to YM) and Graduate Education Innovation Fund of Wuhan Polytechnic University (no. 2013cx003, to CH). The	Aalto AP, 2012, P NATL ACAD SCI USA, V109, P7079, DOI 10.1073/pnas.1120174109; Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Atanasova NS, 2012, ENVIRON MICROBIOL, V14, P426, DOI 10.1111/j.1462-2920.2011.02603.x; Bettarel Y, 2006, APPL ENVIRON MICROB, V72, P5274, DOI 10.1128/AEM.00863-06; Calo D, 2011, MOL MICROBIOL, V81, P1166, DOI 10.1111/j.1365-2958.2011.07781.x; Chaban B, 2006, MOL MICROBIOL, V61, P259, DOI 10.1111/j.1365-2958.2006.05226.x; DANIELS LL, 1990, APPL ENVIRON MICROB, V56, P3605, DOI 10.1128/AEM.56.11.3605-3608.1990; Dyall-Smith M, 2003, RES MICROBIOL, V154, P309, DOI 10.1016/S0923-2508(03)00076-7; Eichler J, 2005, MICROBIOL MOL BIOL R, V69, P393, DOI 10.1128/MMBR.69.3.393-425.2005; Guan ZQ, 2012, ENVIRON MICROBIOL, V14, P743, DOI 10.1111/j.1462-2920.2011.02625.x; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jaakkola ST, 2012, J VIROL, V86, P4734, DOI 10.1128/JVI.06666-11; Jaalinoja HT, 2008, P NATL ACAD SCI USA, V105, P8008, DOI 10.1073/pnas.0801758105; Jalasvuori M, 2010, J BACTERIOL, V192, P3231, DOI 10.1128/JB.00124-10; Jalasvuori M, 2009, J VIROL, V83, P9388, DOI 10.1128/JVI.00869-09; Jones GM, 2012, J BACTERIOL, V194, P2693, DOI 10.1128/JB.06686-11; Kaminski L, 2013, MBIO, V4, DOI 10.1128/mBio.00716-13; Kandiba L, 2013, BBA-BIOMEMBRANES, V1828, P938, DOI 10.1016/j.bbamem.2012.11.023; Kandler O, 1985, BACTERIA TREATISE ST; Klein R, 2002, MOL MICROBIOL, V45, P851, DOI 10.1046/j.1365-2958.2002.03064.x; Kukkaro P, 2009, ENV MICROBIOL REP, V1, P71, DOI 10.1111/j.1758-2229.2008.00007.x; MAGRUM LJ, 1978, J MOL EVOL, V11, P1, DOI 10.1007/BF01768019; Matsushita I, 2009, J BIOCHEM, V146, P775, DOI 10.1093/jb/mvp125; Mei YJ, 2007, CAN J MICROBIOL, V53, P1106, DOI 10.1139/W07-072; Meyer BH, 2011, MOL MICROBIOL, V82, P1150, DOI 10.1111/j.1365-2958.2011.07875.x; Ng SYM, 2008, J BACTERIOL, V190, P6039, DOI 10.1128/JB.00546-08; NUTTALL SD, 1995, J VIROL, V69, P2322, DOI 10.1128/JVI.69.4.2322-2327.1995; Oren A, 1990, MICOBIOL MOL BIOL RE, V63, P334; Oren Aharon, 2008, Saline Syst, V4, P2, DOI 10.1186/1746-1448-4-2; PAULING C, 1982, CAN J MICROBIOL, V28, P916, DOI 10.1139/m82-138; Pietila MK, 2014, TRENDS MICROBIOL, V22, P334, DOI 10.1016/j.tim.2014.02.007; Pina M, 2011, FEMS MICROBIOL REV, V35, P1035, DOI 10.1111/j.1574-6976.2011.00280.x; Porter K, 2007, CURR OPIN MICROBIOL, V10, P418, DOI 10.1016/j.mib.2007.05.017; Porter K, 2013, ARCHAEA, V2013, DOI 10.1155/2013/456318; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Roberts Mary F, 2005, Saline Syst, V1, P5, DOI 10.1186/1746-1448-1-5; Roine E, 2010, J VIROL, V84, P3682, DOI 10.1128/JVI.01879-09; SCHNABEL H, 1984, P NATL ACAD SCI-BIOL, V81, P1017, DOI 10.1073/pnas.81.4.1017; Sencilo A, 2012, NUCLEIC ACIDS RES, V40, P5523, DOI 10.1093/nar/gks215; Shen P, 1994, Yi Chuan Xue Bao, V21, P409; Sime-Ngando T, 2011, ENVIRON MICROBIOL, V13, P1956, DOI 10.1111/j.1462-2920.2010.02323.x; Srinivasiah S, 2008, RES MICROBIOL, V159, P349, DOI 10.1016/j.resmic.2008.04.010; STOECKENIUS W, 1967, J CELL BIOL, V34, P365, DOI 10.1083/jcb.34.1.365; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; TORSVIK T, 1974, NATURE, V248, P680, DOI 10.1038/248680a0; TORSVIK T, 1980, J GEN VIROL, V47, P29, DOI 10.1099/0022-1317-47-1-29; VanDyke DJ, 2009, MOL MICROBIOL, V72, P633, DOI 10.1111/j.1365-2958.2009.06671.x; WAIS AC, 1975, NATURE, V256, P314, DOI 10.1038/256314a0; WAIS AC, 1985, FEMS MICROBIOL ECOL, V31, P323, DOI 10.1111/j.1574-6968.1985.tb01167.x; Ye XC, 2003, FEMS MICROBIOL LETT, V221, P53, DOI 10.1016/S0378-1097(03)00175-7; Zhang ZQ, 2012, VIROLOGY, V434, P233, DOI 10.1016/j.virol.2012.05.036; Zhang ZQ., 2012, STUDY TEMPERATE HALO, P84	52	12	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123874	10.1371/journal.pone.0123874	http://dx.doi.org/10.1371/journal.pone.0123874			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853566	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400124
J	Cook, DA; Enders, F; Caraballo, PJ; Nishimura, RA; Lloyd, FJ				Cook, David A.; Enders, Felicity; Caraballo, Pedro J.; Nishimura, Rick A.; Lloyd, Farrell J.			An Automated Clinical Alert System for Newly-Diagnosed Atrial Fibrillation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; DECISION-SUPPORT-SYSTEMS; DRUG-INTERACTION ALERTS; ORDER ENTRY SYSTEMS; WARFARIN USE; AMBULATORY-CARE; MEDICATION ALERTS; PREDICTING STROKE; PATIENT OUTCOMES; RISK FACTOR	Objective Clinical decision support systems that notify providers of abnormal test results have produced mixed results. We sought to develop, implement, and evaluate the impact of a computer-based clinical alert system intended to improve atrial fibrillation stroke prophylaxis, and identify reasons providers do not implement a guideline-concordant response. Materials and Methods We conducted a cohort study with historical controls among patients at a tertiary care hospital. We developed a decision rule to identify newly-diagnosed atrial fibrillation, automatically notify providers, and direct them to online evidence-based management guidelines. We tracked all notifications from December 2009 to February 2010 (notification period) and applied the same decision rule to all patients from December 2008 to February 2009 (control period). Primary outcomes were accuracy of notification (confirmed through chart review) and prescription of warfarin within 30 days. Results During the notification period 604 notifications were triggered, of which 268 (44%) were confirmed as newly-diagnosed atrial fibrillation. The notifications not confirmed as newly-diagnosed involved patients with no recent electrocardiogram at our institution. Thirty-four of 125 high-risk patients (27%) received warfarin in the notification period, compared with 34 of 94 (36%) in the control period (odds ratio, 0.66 [95% CI, 0.37-1.17]; p = 0.16). Common reasons to not prescribe warfarin (identified from chart review of 151 patients) included up-coming surgical procedure, choice to use aspirin, and discrepancy between clinical notes and the medication record. Conclusions An automated system to identify newly-diagnosed atrial fibrillation, notify providers, and encourage access to management guidelines did not change provider behaviors.	[Cook, David A.; Enders, Felicity; Caraballo, Pedro J.; Nishimura, Rick A.; Lloyd, Farrell J.] Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA; [Cook, David A.; Caraballo, Pedro J.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN USA; [Cook, David A.] Mayo Clin, Coll Med, Mayo Clin Online Learning, Rochester, MN USA; [Enders, Felicity] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Nishimura, Rick A.] Mayo Clin, Coll Med, Div Cardiovasc Dis, Rochester, MN USA; [Lloyd, Farrell J.] Mayo Clin, Coll Med, Div Hosp Med, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Cook, DA (corresponding author), Mayo Clin, Knowledge Delivery Ctr, Rochester, MN 55905 USA.	cook.david33@mayo.edu						Agarwal S, 2010, AM J CARDIOVASC DRUG, V10, P37, DOI 10.2165/11318870-000000000-00000; Amer Coll Cardiology Amer Heart, 2006, CIRCULATION, V114, P700, DOI 10.1161/CIRCULATIONAHA.106.177031; Austrian JS, 2011, J AM MED INFORM ASSN, V18, P783, DOI 10.1136/amiajnl-2011-000138; Banzi R, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1288; Cook DA, 2015, ACAD MED, V90, P33, DOI 10.1097/ACM.0000000000000551; Cook DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080318; Cook DA, 2013, JAMA INTERN MED, V173, P1962, DOI 10.1001/jamainternmed.2013.10103; Curran JA, 2011, J CONTIN EDUC HEALTH, V31, P174, DOI 10.1002/chp.20124; Del Fiol G, 2008, J AM MED INFORM ASSN, V15, P752, DOI 10.1197/jamia.M2725; Eva KW, 2007, ACAD MED, V82, pS81, DOI 10.1097/ACM.0b013e31813e6755; Ewen E, 2012, VASC HEALTH RISK MAN, V8, P587, DOI 10.2147/VHRM.S34280; FIHN SD, 1994, J GEN INTERN MED, V9, P131, DOI 10.1007/BF02600026; Fraenkel L, 2012, J AM GERIATR SOC, V60, P1434, DOI 10.1111/j.1532-5415.2012.04080.x; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Gladstone DJ, 2009, STROKE, V40, P235, DOI 10.1161/STROKEAHA.108.516344; Go AS, 1999, ANN INTERN MED, V131, P927, DOI 10.7326/0003-4819-131-12-199912210-00004; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Grimshaw JM, 2012, IMPLEMENT SCI, V7, P1748; Grouin Cyril, 2011, AMIA Annu Symp Proc, V2011, P501; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Haugaa KH, 2013, MAYO CLIN PROC, V88, P315, DOI 10.1016/j.mayocp.2013.01.013; Haynes RB, 2006, JAMA-J AM MED ASSOC, V295, P1801, DOI 10.1001/jama.295.15.1801; Holt TA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-385; Isaac T, 2009, ARCH INTERN MED, V169, P305, DOI 10.1001/archinternmed.2008.551; January CT, 2014, J AM COLL CARDIOL; Kashiouris M, 2013, APPL CLIN INFORM, V4, P212, DOI 10.4338/ACI-2012-12-RA-0053; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Koppel R, 2005, JAMA-J AM MED ASSOC, V293, P1197, DOI 10.1001/jama.293.10.1197; Kruger Kjell, 2011, ISRN Nurs, V2011, P208142, DOI 10.5402/2011/208142; Langemeijer MM, 2011, STUD HEALTH TECHNOL, V169, P930, DOI 10.3233/978-1-60750-806-9-930; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Lobach David, 2012, Evid Rep Technol Assess (Full Rep), P1; Miller AM, 2011, J AM MED INFORM ASSN, V18, pI45, DOI 10.1136/amiajnl-2011-000262; Murphy DR, 2012, AM J MED, V125, P209, DOI 10.1016/j.amjmed.2011.07.029; Nelson JL, 2011, ANN EMERG MED, V57, P500, DOI 10.1016/j.annemergmed.2010.12.008; Nilsson Gunnar H, 2004, BMC Clin Pharmacol, V4, P1, DOI 10.1186/1472-6904-4-1; Partington SL, 2007, THROMB RES, V120, P663, DOI 10.1016/j.thromres.2006.12.019; Paterno MD, 2009, J AM MED INFORM ASSN, V16, P40, DOI 10.1197/jamia.M2808; Reed DA, 2012, J GEN INTERN MED, V27, P917, DOI 10.1007/s11606-012-2017-5; Riedmann D, 2011, J AM MED INFORM ASSN, V18, P760, DOI 10.1136/amiajnl-2010-000006; Rosenman MB, 2012, AM J THER, V19, P330, DOI 10.1097/MJT.0b013e3182546840; Roshanov PS, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f657; Shojania KG, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001096.pub2; Singh H, 2010, AM J MED, V123, P238, DOI 10.1016/j.amjmed.2009.07.027; Sittig DF, 2008, J BIOMED INFORM, V41, P387, DOI 10.1016/j.jbi.2007.09.003; Smithburger PL, 2011, EXPERT OPIN DRUG SAF, V10, P871, DOI 10.1517/14740338.2011.583916; Tulner LR, 2010, DRUG AGING, V27, P39, DOI 10.2165/11319540-000000000-00000; Weingart SN, 2011, DRUG SAFETY, V34, P587, DOI 10.2165/11589360-000000000-00000; Weingart SN, 2009, ARCH INTERN MED, V169, P1465, DOI 10.1001/archinternmed.2009.252; Weingart SN, 2003, ARCH INTERN MED, V163, P2625, DOI 10.1001/archinte.163.21.2625; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	52	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122153	10.1371/journal.pone.0122153	http://dx.doi.org/10.1371/journal.pone.0122153			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849969	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800105
J	De Martino, D; Mori, M; Parisi, V				De Martino, Daniele; Mori, Matteo; Parisi, Valerio			Uniform Sampling of Steady States in Metabolic Networks: Heterogeneous Scales and Rounding	PLOS ONE			English	Article							ESCHERICHIA-COLI; RECONSTRUCTION; MODELS; SPACES	The uniform sampling of convex polytopes is an interesting computational problem with many applications in inference from linear constraints, but the performances of sampling algorithms can be affected by ill-conditioning. This is the case of inferring the feasible steady states in models of metabolic networks, since they can show heterogeneous time scales. In this work we focus on rounding procedures based on building an ellipsoid that closely matches the sampling space, that can be used to define an efficient hit-and-run (HR) Markov Chain Monte Carlo. In this way the uniformity of the sampling of the convex space of interest is rigorously guaranteed, at odds with non markovian methods. We analyze and compare three rounding methods in order to sample the feasible steady states of metabolic networks of three models of growing size up to genomic scale. The first is based on principal component analysis (PCA), the second on linear programming (LP) and finally we employ the Lovazs ellipsoid method (LEM). Our results show that a rounding procedure dramatically improves the performances of the HR in these inference problems and suggest that a combination of LEM or LP with a subsequent PCA perform the best. We finally compare the distributions of the HR with that of two heuristics based on the Artificially Centered hit-andrun (ACHR), gpSampler and optGpSampler. They show a good agreement with the results of the HR for the small network, while on genome scale models present inconsistencies.	[De Martino, Daniele] CLNS, IIT, I-00185 Rome, Italy; [Mori, Matteo; Parisi, Valerio] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy	Sapienza University Rome	De Martino, D (corresponding author), CLNS, IIT, Ple A Moro 2, I-00185 Rome, Italy.	daniele.demartino@roma1.infn.it	de martino, daniele/L-6519-2017; De Martino, Daniele/GQA-9589-2022; Mori, Matteo/Q-6717-2018; Parisi, Valerio/B-1492-2008	Mori, Matteo/0000-0002-6263-8021; De Martino, Daniele/0000-0002-5214-4706	DREAM Seed Project of the Italian Institute of Technology (IIT)	DREAM Seed Project of the Italian Institute of Technology (IIT)	This work is supported by the DREAM Seed Project of the Italian Institute of Technology (IIT). The IIT Platform Computation is gratefully acknowledged.	Abordbar N, 2010, MOL SYS BIO, V6, P422; Massucci FA, 2013, METABOLITES, V3, P838, DOI 10.3390/metabo3030838; Alu-Pentini F, 1985, ANNU REV AUTOMAT PR, V13, P19; Ball K., 1997, FLAVORS GEOMETRY, P31; Bland RG, 1981, OPER RES, V29, P1039, DOI [10.1287/opre.29.6.1039, DOI 10.1287/0PRE.29.6.1039]; Braunstein A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-240; De Martino D, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.052108; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Kapfer S, 2013, SAMPLING POLYTOPE HA; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Kolmogorov AN, 1933, G IST ITAL ATTURI, V4, P8391; Krauth W, 1998, LECT NOTES PHYS, V501, P1; Krzakala F, 2011, PHYS REV X, V2; Lovasz L, 1999, MATH PROGRAM, V86, P443, DOI 10.1007/s101070050099; Lovasz L, 1992, FDN COMPUT SCI, P482; Lovazs L, 1986, CBMS NSF C S SIAM, P50; Lubini M, 2012, MON NOT R ASTRON SOC, V425, P3077, DOI 10.1111/j.1365-2966.2012.21673.x; MacKay D. J. C., 2003, INFORM THEORY INFERE; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Megchelenbrink W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086587; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Price ND, 2004, BIOPHYS J, V87, P2172, DOI 10.1529/biophysj.104.043000; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; Simonovits M, 2003, MATH PROGRAM, V97, P337, DOI 10.1007/s10107-003-0447-x; SMITH RL, 1984, OPER RES, V32, P1296, DOI 10.1287/opre.32.6.1296; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; TURCHIN VF, 1971, THEOR PROBAB APPL+, V16, P720, DOI 10.1137/1116083	31	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122670	10.1371/journal.pone.0122670	http://dx.doi.org/10.1371/journal.pone.0122670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849140	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800156
J	Di Giacomo, C; Vanella, L; Sorrenti, V; Santangelo, R; Barbagallo, I; Calabrese, G; Genovese, C; Mastrojeni, S; Ragusa, S; Acquaviva, R				Di Giacomo, Claudia; Vanella, Luca; Sorrenti, Valeria; Santangelo, Rosa; Barbagallo, Ignazio; Calabrese, Giovanna; Genovese, Carlo; Mastrojeni, Silvana; Ragusa, Salvatore; Acquaviva, Rosaria			Effects of Tithonia diversifolia (Hemsl.) A. Gray Extract on Adipocyte Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; AY DIABETIC MICE; NF-KAPPA-B; HEME OXYGENASE-1; OXIDATIVE STRESS; ENDOTHELIAL-CELLS; SESQUITERPENE LACTONES; LIPID-ACCUMULATION; HYDROGEN-PEROXIDE; ADIPOSE-TISSUE	Tithonia diversifolia (Hemsl.) A. Gray (Asteraceae) is widely used in traditional medicine. There is increasing interest on the in vivo protective effects of natural compounds contained in plants against oxidative damage caused from reactive oxygen species. In the present study the total phenolic and flavonoid contents of aqueous, methanol and dichloromethane extracts of leaves of Tithonia diversifolia (Hemsl.) A. Gray were determined; furthermore, free radical scavenging capacity of each extract and the ability of these extracts to inhibit in vitro plasma lipid peroxidation were also evaluated. Since oxidative stress may be involved in trasformation of pre-adipocytes into adipocytes, to test the hypothesis that Tithonia extract may also affect adipocyte differentiation, human mesenchymal stem cell cultures were treated with Tithonia diversifolia aqueous extract and cell viability, free radical levels, Oil-Red O staining and western bolt analysis for heme oxygenase and 5'-adenosine mono-phoshate-activated protein kinase were carried out. Results obtained in the present study provide evidence that Tithonia diversifolia (Hemsl.) A. Gray exhibits interesting health promoting properties, resulting both from its free radical scavenger capacity and also by induction of protective cellular systems involved in cellular stress defenses and in adipogenesis of mesenchymal cells.	[Di Giacomo, Claudia; Vanella, Luca; Sorrenti, Valeria; Santangelo, Rosa; Barbagallo, Ignazio; Acquaviva, Rosaria] Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy; [Calabrese, Giovanna] IOM Ric SRL, Catania, Italy; [Genovese, Carlo; Mastrojeni, Silvana] Univ Catania, Dept Biomed Sci, Microbiol Sect, Catania, Italy; [Ragusa, Salvatore] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	University of Catania; Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); University of Catania; Magna Graecia University of Catanzaro	Acquaviva, R (corresponding author), Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy.	racquavi@unict.it	Sorrenti, Valeria/AAC-6099-2022; Acquaviva, Rosaria/A-6750-2018; GENOVESE, Carlo/D-7837-2012; Vanella, Luca/J-7354-2016	Acquaviva, Rosaria/0000-0002-3139-1177; GENOVESE, Carlo/0000-0003-2463-9047; Vanella, Luca/0000-0002-6314-6029; Calabrese, Giovanna/0000-0003-1937-5403; Di Giacomo, Claudia/0000-0002-2665-0007; Barbagallo, Ignazio/0000-0002-7761-0662	IOM Ricerca SRL	IOM Ricerca SRL	IOM Ricerca SRL provided support in the form of salaries for author GC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Acquaviva R, 2005, CURR NEUROVASC RES, V2, P141, DOI 10.2174/1567202053586820; Acquaviva R, 2013, MOLECULES, V18, P3241, DOI 10.3390/molecules18033241; Acquaviva R, 2013, NAT PROD RES, V27, P475, DOI 10.1080/14786419.2012.695364; Acquaviva R, 2012, INT J ONCOL, V41, P31, DOI 10.3892/ijo.2012.1428; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Ballard TS, 2010, FOOD CHEM, V120, P1185, DOI 10.1016/j.foodchem.2009.11.063; Balogun E, 2003, BIOCHEM J, V371, P887, DOI 10.1042/BJ20021619; Barbagallo I, 2010, J BONE MINER METAB, V28, P276, DOI 10.1007/s00774-009-0134-y; Bray GA, 2000, NUTRITION, V16, P953, DOI 10.1016/S0899-9007(00)00424-X; Caplan AI, 2008, CELL STEM CELL, V3, P229, DOI 10.1016/j.stem.2008.08.008; Chagas-Paula DA, 2012, CHEM BIODIVERS, V9, P210, DOI 10.1002/cbdv.201100019; Cho HS, 2008, NEUROTOXICOLOGY, V29, P656, DOI 10.1016/j.neuro.2008.03.004; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; CRUSE I, 1988, J BIOL CHEM, V263, P3348; Cuadrado A, 2008, CURR PHARM DESIGN, V14, P429, DOI 10.2174/138161208783597407; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; de Madureira MD, 2002, J ETHNOPHARMACOL, V81, P23, DOI 10.1016/S0378-8741(02)00005-3; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Foresti R, 1999, FREE RADICAL RES, V31, P459, DOI 10.1080/10715769900301031; Goffin E, 2002, PLANTA MED, V68, P543, DOI 10.1055/s-2002-32552; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Gu JQ, 2002, J NAT PROD, V65, P532, DOI 10.1021/np010545m; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Higuchi M, 2013, STEM CELLS DEV, V22, P878, DOI 10.1089/scd.2012.0306; Imhoff BR, 2011, CELL MOL BIOL LETT, V16, P149, DOI 10.2478/s11658-010-0042-0; Jia Z, 1999, FOOD CHEM, V64, P555, DOI 10.1016/S0308-8146(98)00102-2; Kanda Y, 2011, LIFE SCI, V89, P250, DOI 10.1016/j.lfs.2011.06.007; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Kim SK, 2010, CHEM-BIOL INTERACT, V186, P24, DOI 10.1016/j.cbi.2010.04.003; Kuroda M, 2007, CHEM PHARM BULL, V55, P1240, DOI 10.1248/cpb.55.1240; LAUTIER D, 1992, CARCINOGENESIS, V13, P227, DOI 10.1093/carcin/13.2.227; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee H, 2009, J BIOL CHEM, V284, P10601, DOI 10.1074/jbc.M808742200; Lee MY, 2011, J AGR FOOD CHEM, V59, P2347, DOI 10.1021/jf105003n; Li C, 2007, ANTIOXID REDOX SIGN, V9, P2227, DOI 10.1089/ars.2007.1783; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MAINES MD, 1988, FASEB J, V2, P2557, DOI 10.1096/fasebj.2.10.3290025; McCoubrey WK, 1997, EUR J BIOCHEM, V247, P725, DOI 10.1111/j.1432-1033.1997.00725.x; MCCOUBREY WK, 1994, GENE, V139, P155, DOI 10.1016/0378-1119(94)90749-8; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Miura T, 2005, BIOL PHARM BULL, V28, P2152, DOI 10.1248/bpb.28.2152; Miura T, 2002, AM J CHINESE MED, V30, P81, DOI 10.1142/S0192415X02000090; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; NATH KA, 1992, J CLIN INVEST, V90, P267, DOI 10.1172/JCI115847; Novo G, 2011, TRANSL RES, V157, P285, DOI 10.1016/j.trsl.2011.01.003; Owoyele VB, 2004, J ETHNOPHARMACOL, V90, P317, DOI 10.1016/j.jep.2003.10.010; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; RAJU VS, 1994, BBA-GENE STRUCT EXPR, V1217, P273, DOI 10.1016/0167-4781(94)90286-0; Rungeler P, 1998, PLANTA MED, V64, P588, DOI 10.1055/s-2006-957527; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sacerdoti D, 2005, CELL MOL BIOL, V51, P363, DOI 10.1170/T639; Scapagnini G, 2004, ANTIOXID REDOX SIGN, V6, P811, DOI 10.1089/ars.2004.6.811; Scapagnini G, 2002, MOL PHARMACOL, V61, P554, DOI 10.1124/mol.61.3.554; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Siedle B, 2004, J MED CHEM, V47, P6042, DOI 10.1021/jm049937r; Sorisky A, 1999, CRIT REV CL LAB SCI, V36, P1, DOI 10.1080/10408369991239169; Tona L, 2000, PHYTOMEDICINE, V7, P31, DOI 10.1016/S0944-7113(00)80019-7; TRAKSHEL GM, 1989, J BIOL CHEM, V264, P1323; Tyrrell R, 1999, FREE RADICAL RES, V31, P335, DOI 10.1080/10715769900300901; Vigilanza P, 2011, J CELL PHYSIOL, V226, P2016, DOI 10.1002/jcp.22542; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Volti GL, 2008, WORLD J GASTROENTERO, V14, P6122, DOI 10.3748/wjg.14.6122; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Yuan HD, 2010, BIOSCI BIOTECH BIOCH, V74, P322, DOI 10.1271/bbb.90651; Zhao GJ, 2012, FITOTERAPIA, V83, P1590, DOI 10.1016/j.fitote.2012.09.007; Zhou Y, 2009, BIOL PHARM BULL, V32, P993, DOI 10.1248/bpb.32.993; Zhu YZ, 2004, NAT PROD REP, V21, P478, DOI 10.1039/b304821g	72	25	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122320	10.1371/journal.pone.0122320	http://dx.doi.org/10.1371/journal.pone.0122320			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848759	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800118
J	Ding, ZJ; Li, MH; Sun, F; Xi, PG; Sun, LH; Zhang, LH; Jiang, ZD				Ding, Zhaojian; Li, Minhui; Sun, Fei; Xi, Pinggen; Sun, Longhua; Zhang, Lianhui; Jiang, Zide			Mitogen-Activated Protein Kinases Are Associated with the Regulation of Physiological Traits and Virulence in Fusarium oxysporum f. sp cubense	PLOS ONE			English	Article							CELL-WALL INTEGRITY; RICE BLAST FUNGUS; MAP KINASE; OXIDATIVE STRESS; CANDIDA-ALBICANS; CHITIN SYNTHASE; PLANT DEFENSE; BANANA; ACID; MPKA	Fusarium oxysporum f. sp. cubense(FOC) is an important soil-borne fungal pathogen causing devastating vascular wilt disease of banana plants and has become a great concern threatening banana production worldwide. However, little information is known about the molecular mechanisms that govern the expression of virulence determinants of this important fungal pathogen. In this study, we showed that null mutation of three mitogen-activated protein (MAP) kinase genes, designated as FoSlt2, FoMkk2and FoBck1, respectively, led to substantial attenuation in fungal virulence on banana plants. Transcriptional analysis revealed that the MAP kinase signaling pathway plays a key role in regulation of the genes encoding production of chitin, peroxidase, beauvericin and fusaric acid. Biochemical analysis further confirmed the essential role of MAP kinases in modulating the production of fusaric acid, which was a crucial phytotoxin in accelerating development of Fusarium wilt symptoms in banana plants. Additionally, we found that the MAP kinase FoSlt2 was required for siderophore biosynthesis under iron-depletion conditions. Moreover, disruption of the MAP kinase genes resulted in abnormal hypha and increased sensitivity to Congo Red, Calcofluor White and H2O2. Taken together, these results depict the critical roles of MAP kinases in regulation of FOC physiology and virulence.	[Ding, Zhaojian; Li, Minhui; Sun, Fei; Xi, Pinggen; Sun, Longhua; Zhang, Lianhui; Jiang, Zide] South China Agr Univ, Dept Plant Pathol, Guangzhou 510642, Guangdong, Peoples R China; [Ding, Zhaojian; Zhang, Lianhui; Jiang, Zide] South China Agr Univ, Guangdong Prov Key Lab Microbial Signals & Dis Co, Guangzhou 510642, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Zhang, LH (corresponding author), South China Agr Univ, Dept Plant Pathol, Guangzhou 510642, Guangdong, Peoples R China.	lhzhang01@scau.edu.cn; zdjiang@scau.edu.cn		Ding, Zhaojian/0000-0003-2974-388X	Council of Agriculture, China [CAR-32-05]; National Natural Science Foundation of China [31200112]	Council of Agriculture, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Council of Agriculture, China. (No. CAR-32-05) and National Natural Science Foundation of China (31200112). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Desjardins AE, 2007, INT J FOOD MICROBIOL, V119, P47, DOI 10.1016/j.ijfoodmicro.2007.07.024; Di Pietro A, 1998, MOL PLANT MICROBE IN, V11, P91, DOI 10.1094/MPMI.1998.11.2.91; Di Pietro A, 2001, MOL MICROBIOL, V39, P1140, DOI 10.1111/j.1365-2958.2001.02307.x; Dirr F, 2010, INT J MED MICROBIOL, V300, P496, DOI 10.1016/j.ijmm.2010.03.001; Dong X, 2012, PLANT PHYSIOL BIOCH, V60, P171, DOI 10.1016/j.plaphy.2012.08.004; Eisendle M, 2003, MOL MICROBIOL, V49, P359, DOI 10.1046/j.1365-2958.2003.03586.x; Fourie G, 2011, INFECT GENET EVOL, V11, P533, DOI 10.1016/j.meegid.2011.01.012; Fujioka T, 2007, EUKARYOT CELL, V6, P1497, DOI 10.1128/EC.00281-06; HOOYKAAS PJJ, 1979, J GEN MICROBIOL, V110, P99, DOI 10.1099/00221287-110-1-99; Hou ZM, 2002, MOL PLANT MICROBE IN, V15, P1119, DOI 10.1094/MPMI.2002.15.11.1119; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Kapteyn JC, 2000, MOL MICROBIOL, V35, P601, DOI 10.1046/j.1365-2958.2000.01729.x; Leng YQ, 2012, MOL PLANT PATHOL, V13, P375, DOI 10.1111/j.1364-3703.2011.00756.x; Li CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070226; Li MH, 2014, FUNGAL GENET BIOL, V65, P1, DOI 10.1016/j.fgb.2014.01.005; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Logrieco A, 1998, APPL ENVIRON MICROB, V64, P3084; Lopez-Berges MS, 2013, MOL MICROBIOL, V87, P49, DOI 10.1111/mmi.12082; Lopez-Berges MS, 2012, PLANT CELL, V24, P3805, DOI 10.1105/tpc.112.098624; Lorang JM, 2001, APPL ENVIRON MICROB, V67, P1987, DOI 10.1128/AEM.67.5.1987-1994.2001; Muller Sebastian, 2012, BMC Genomics, V13, P519, DOI 10.1186/1471-2164-13-519; Navarro-Garcia F, 1998, MICROBIOL-UK, V144, P411, DOI 10.1099/00221287-144-2-411; Niehaus EM, 2014, APPL MICROBIOL BIOT, V98, P1749, DOI 10.1007/s00253-013-5453-1; O'Brien JA, 2012, PLANTA, V236, P765, DOI 10.1007/s00425-012-1696-9; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Odenbach D, 2009, MOL PLANT PATHOL, V10, P81, DOI 10.1111/j.1364-3703.2008.00515.x; Oide S, 2006, PLANT CELL, V18, P2836, DOI 10.1105/tpc.106.045633; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Qi XZ, 2013, PHYSIOL MOL PLANT P, V84, P76, DOI 10.1016/j.pmpp.2013.07.007; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Rui O, 2007, MOL PLANT PATHOL, V8, P173, DOI 10.1111/J.1364-3703.2007.00383.X; Schoffelmeer EAM, 1999, FUNGAL GENET BIOL, V27, P275, DOI 10.1006/fgbi.1999.1153; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001124; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Valiante V, 2009, FUNGAL GENET BIOL, V46, P909, DOI 10.1016/j.fgb.2009.08.005; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yago JI, 2011, MOL PLANT PATHOL, V12, P653, DOI [10.1111/j.1364-3703.2010.00701.x, 10.1111/J.1364-3703.2010.00701.X]; Zeng FY, 2012, FUNGAL GENET BIOL, V49, P347, DOI 10.1016/j.fgb.2012.02.008; Zhao XH, 2005, PLANT CELL, V17, P1317, DOI 10.1105/tpc.104.029116; Zhao XH, 2007, EUKARYOT CELL, V6, P1701, DOI 10.1128/EC.00216-07	48	19	30	3	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122634	10.1371/journal.pone.0122634	http://dx.doi.org/10.1371/journal.pone.0122634			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849862	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800152
J	Kim, KR; Sung, CO; Kwon, TJ; Lee, J; Robboy, SJ				Kim, Kyu Rae; Sung, Chang Ohk; Kwon, Tae Jeong; Lee, JungBok; Robboy, Stanley J.			Defective Pericyte Recruitment of Villous Stromal Vessels as the Possible Etiologic Cause of Hydropic Change in Complete Hydatidiform Mole	PLOS ONE			English	Article							EARLY-PREGNANCY; MOLECULAR-MECHANISMS; LUMEN FORMATION; VASCULOGENESIS; P57(KIP2); PATHOLOGY; FLUID	The pathogenetic mechanism underlying the hydropic change in complete hydatidiform moles (CHMs) is poorly understood. A growing body of data suggests that pericytes play a role in vascular maturation. Since maturation of villous stromal vessels in CHMs is markedly impaired at early stages, we postulated that a defect in pericytes around stromal vessels in chorionic villi might cause vascular immaturity and subsequent hydropic change. To investigate this, we examined several markers of pericytes, namely, alpha-smooth muscle actin (alpha-SMA), platelet-derived growth factor receptor-beta (PDGFR-beta), and desmin, in 61 normally developing placentas and 41 CHMs with gestational ages of 4-12 weeks. The ultrastructure of villous stromal vessels was also examined. Mature blood vessels from normal placentas show patent vascular lumens and formed hematopoietic components in the villous stroma. alpha-SMA and PDGFR-beta expression in the villous stroma gradually increased and extended from the chorionic plate to peripheral villous branches. The labeled cells formed a reticular network in the villous stroma and, after week 7, encircled villous stromal vessels. In comparison, alpha-SMA and PDGFR-beta expression in the villous stroma and stromal vessels of CHMs was significantly lower (p<0.05). Ultrastructurally, endothelial cells in villous stromal vessels in normal placentas were consistently attached by pericytes after week 7 when the vessels formed distinct lumen, whereas the villous stromal vessels in CHMs consisted of linear chains of endothelial cells, often disclosing primitive clefts without hematopoietic cells inside, and neither pericytes nor basal lamina surrounded the endothelial cells at any gestational age studied. This suggests that pericytes recruitment around villous stromal vessels is defective in CHMs and links to the persistent vascular immaturity of the villous stroma in CHMs, which in turns leads to hydropic villi.	[Kim, Kyu Rae; Sung, Chang Ohk] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Kwon, Tae Jeong] Myong JI Gen Hosp, Dept Pathol, Goyang Si, Gyeongi Do, South Korea; [Lee, JungBok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Clin Epidemiol & Biostat, Seoul, South Korea; [Robboy, Stanley J.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Duke University	Kim, KR (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea.	krkim@amc.seoul.kr		Sung, Chang Ohk/0000-0002-8567-456X	National Research Foundation grant from the Ministry of Education and Science Technology, Korea [2011-0026130]	National Research Foundation grant from the Ministry of Education and Science Technology, Korea	This study was supported by a National Research Foundation grant from the Ministry of Education and Science Technology, Korea (No. 2011-0026130). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Benjamin LE, 1998, DEVELOPMENT, V125, P1591; Borriello A, 2011, MOL CANCER RES, V9, P1269, DOI 10.1158/1541-7786.MCR-11-0220; Chen PL, 2010, BIOCHEM BIOPH RES CO, V391, P936, DOI 10.1016/j.bbrc.2009.11.168; Chen Q, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/917168; Davis GE, 2011, INT REV CEL MOL BIO, V288, P101, DOI 10.1016/B978-0-12-386041-5.00003-0; Demir R, 1997, MICROSC RES TECHNIQ, V38, P29; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Edelman DA, 2006, J SURG RES, V135, P305, DOI 10.1016/j.jss.2006.06.010; Edgar LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085178; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fowler DJ, 2007, ULTRASOUND OBST GYN, V29, P76, DOI 10.1002/uog.3880; HAGIWARA K, 1986, PLACENTA, V7, P199, DOI 10.1016/S0143-4004(86)80158-8; Hamilton N.B., 2010, FRONT NEUROENERGETIC, V2, DOI 10.3389/fnene.2010.00005; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Hussein MRA, 2010, EXP MOL PATHOL, V89, P343, DOI 10.1016/j.yexmp.2010.07.002; Iruela-Arispe ML, 2009, DEV CELL, V16, P222, DOI 10.1016/j.devcel.2009.01.013; Jauniaux E, 1998, AM J OBSTET GYNECOL, V178, P765, DOI 10.1016/S0002-9378(98)70489-2; Kabara M, 2014, LAB INVEST; Keep D, 1996, HUM PATHOL, V27, P708, DOI 10.1016/S0046-8177(96)90402-5; Kim KR, 2009, AM J SURG PATHOL, V33, P176, DOI 10.1097/PAS.0b013e31817fada1; Kim MJ, 2006, AM J SURG PATHOL, V30, P362; Kramann R., 2013, CURR PATHOBIOL REP, V1; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Novac L, 2011, ROM J MORPHOL EMBRYO, V52, P61; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Sebire NJ, 2003, PEDIATR DEVEL PATHOL, V6, P69, DOI 10.1007/s10024-002-0079-9; Sebire NJ, 2001, ULTRASOUND OBST GYN, V18, P662, DOI 10.1046/j.0960-7692.2001.00589.x; Senger DR, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005090; SHEPRO D, 1993, FASEB J, V7, P1031, DOI 10.1096/fasebj.7.11.8370472; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; Stratman AN, 2009, BLOOD, V114, P5091, DOI 10.1182/blood-2009-05-222364; Tury A, 2012, DEV NEUROBIOL, V72, P821, DOI 10.1002/dneu.20999; Wells M, 2007, PATHOLOGY, V39, P88, DOI 10.1080/00313020601137367; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060	42	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122266	10.1371/journal.pone.0122266	http://dx.doi.org/10.1371/journal.pone.0122266			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849742	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800114
J	Lee, S; Gregor, J; Kennel, SJ; Osborne, DR; Wall, J				Lee, Sanghyeb; Gregor, Jens; Kennel, Stephen J.; Osborne, Dustin R.; Wall, Jonathan			GATE Validation of Standard Dual Energy Corrections in Small Animal SPECT-CT	PLOS ONE			English	Article								This paper addresses I-123 and I-125 dual isotope SPECT imaging, which can be challenging because of spectrum overlap in the low energy spectrums of these isotopes. We first quantify the contribution of low-energy photons from each isotope using GATE-based Monte Carlo simulations for the MOBY mouse phantom. We then describe and analyze a simple, but effective method that uses the ratio of detected low and high energy I-123 activity to separate the mixed low energy I-123 and I-125 activities. Performance is compared with correction methods used in conventional tissue biodistribution techniques. The results indicate that the spectrum overlap effects can be significantly reduced, if not entirely eliminated, when attenuation and scatter is either absent or corrected for using standard methods. In particular, we show that relative activity levels of the two isotopes can be accurately estimated for a wide range of organs and provide quantitative validation that standard methods for spectrum overlap correction provide reasonable estimates for reasonable corrections in smallanimal SPECT/CT imaging.	[Lee, Sanghyeb; Gregor, Jens] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA; [Lee, Sanghyeb; Kennel, Stephen J.; Osborne, Dustin R.; Wall, Jonathan] Univ Tennessee, Grad Sch Med, Dept Radiol, Knoxville, TN 37920 USA; [Kennel, Stephen J.; Wall, Jonathan] Univ Tennessee, Grad Sch Med, Dept Med, Knoxville, TN 37920 USA	University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Osborne, DR (corresponding author), Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN 37996 USA.	dosborne@utmck.edu	Osborne, Dustin R/B-1585-2012	Osborne, Dustin R/0000-0003-1324-5464; Wall, Jonathan/0000-0002-5516-8578	National Institutes of Health [1R01DK079984]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079984] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was sponsored by the National Institutes of Health under grant 1R01DK079984. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Du Y, 2003, IEEE T NUCL SCI, V50, P1556, DOI 10.1109/TNS.2003.817404; Jan S, 2004, PHYS MED BIOL, V49, P4543, DOI 10.1088/0031-9155/49/19/007; Lee S, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00058; Mok GSP, 2009, IEEE T NUCL SCI, V56, P2636, DOI 10.1109/TNS.2009.2023444; Ogawa K, IEEE T MED IMAGING, P10; Salmon L, 1961, NUCL INSTRUMENTS MET, V14, DOI [10.1016/0029-554X(61)90071-4, DOI 10.1016/0029-554X(61)90071-4]; Song X, 2004, IEEE T NUCL SCI, V51, P72, DOI 10.1109/TNS.2003.823017; Wall JS, 2006, METHOD ENZYMOL, V412, P161, DOI 10.1016/S0076-6879(06)12011-X; Wall JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066181; Wall JS, 2012, MOL IMAGING BIOL, V14, P402, DOI 10.1007/s11307-011-0524-0; Wall JS, 2011, P NATL ACAD SCI USA, V108, pE586, DOI 10.1073/pnas.1103247108; Wall JS, 2005, AMYLOID, V12, P149, DOI 10.1080/13506120500222359	12	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122780	10.1371/journal.pone.0122780	http://dx.doi.org/10.1371/journal.pone.0122780			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849544	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800160
J	Pulito, C; Terrenato, I; Di Benedetto, A; Korita, E; Goeman, F; Sacconi, A; Biagioni, F; Blandino, G; Strano, S; Muti, P; Mottolese, M; Falvo, E				Pulito, Claudio; Terrenato, Irene; Di Benedetto, Anna; Korita, Etleva; Goeman, Frauke; Sacconi, Andrea; Biagioni, Francesca; Blandino, Giovanni; Strano, Sabrina; Muti, Paola; Mottolese, Marcella; Falvo, Elisabetta			Cdx2 Polymorphism Affects the Activities of Vitamin D Receptor in Human Breast Cancer Cell Lines and Human Breast Carcinomas	PLOS ONE			English	Article							CYP24A1 EXPRESSION; GENE POLYMORPHISMS; VDR GENE; RISK; PROGRESSION; ASSOCIATION; GROWTH; METAANALYSIS; MECHANISMS; PREVENTION	Vitamin D plays a role in cancer development and acts through the vitamin D receptor (VDR). It regulates the action of hormone responsive genes and is involved in cell cycle regulation, differentiation and apoptosis. VDR is a critical component of the vitamin D pathway and different common single nucleotide polymorphisms have been identified. Cdx2 VDR polymorphism can play an important role in breast cancer, modulating the activity of VDR. The objective of this study is to assess the relationship between the Cdx2 VDR polymorphism and the activities of VDR in human breast cancer cell lines and carcinomas breast patients. Cdx2 VDR polymorphism and antiproliferative effects of vitamin D treatment were investigated in a panel of estrogen receptor-positive (MCF7 and T-47D) and estrogen receptor-negative (MDA-MB-231, SUM 159PT, SK-BR-3, BT549, MDA-MB-468, HCC1143, BT20 and HCC1954) human breast cancer cell lines. Furthermore, the potential relationship among Cdx2 VDR polymorphism and a number of biomarkers used in clinical management of breast cancer was assessed in an ad hoc set of breast cancer cases. Vitamin D treatment efficacy was found to be strongly dependent on the Cdx2 VDR status in ER-negative breast cancer cell lines tested. In our series of breast cancer cases, the results indicated that patients with variant homozygote AA were associated with bio-pathological characteristics typical of more aggressive tumours, such as ER negative, HER2 positive and G3. Our results may suggest a potential effect of Cdx2 VDR polymorphism on the efficacy of vitamin D treatment in aggressive breast cancer cells (estrogen receptor negative). These results suggest that Cdx2 polymorphism may be a potential biomarker for vitamin D treatment in breast cancer, independently of the VDR receptor expression.	[Pulito, Claudio; Korita, Etleva; Strano, Sabrina] Regina Elena Inst Canc Res, Mol Chemoprevent Unit, Rome, Italy; [Terrenato, Irene] Regina Elena Inst Canc Res, Dept Epidemiol, Rome, Italy; [Di Benedetto, Anna; Mottolese, Marcella] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy; [Goeman, Frauke; Sacconi, Andrea; Biagioni, Francesca; Blandino, Giovanni] Regina Elena Inst Canc Res, Translat Oncogen Unit, Rome, Italy; [Muti, Paola] McMaster Univ, Dept Oncol, Juravinski Canc Ctr, Hamilton, ON L8V 5C2, Canada; [Falvo, Elisabetta] Regina Elena Inst Canc Res, Lab Pharmacogen, Area Mol Med, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; McMaster University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Falvo, E (corresponding author), CNR Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy.	elisabettafalvo@libero.it	Goeman, Frauke/GVS-9135-2022; Biagioni, Francesca/AAH-2618-2019; Muti, Paola/AAD-9108-2020; sacconi, andrea/J-3669-2018; Terrenato, Irene/B-1308-2017; Strano, Sabrina/K-9654-2016; Goeman, Frauke/K-9307-2016; pulito, claudio/K-6713-2016	sacconi, andrea/0000-0002-8276-0438; Terrenato, Irene/0000-0002-0187-9323; Goeman, Frauke/0000-0002-7803-8821; pulito, claudio/0000-0002-0921-6962; Di Benedetto, Anna/0000-0002-9853-8671; Falvo, Elisabetta/0000-0001-9584-8669; strano, sabrina/0000-0002-6341-4230; Biagioni, Francesca/0000-0002-1529-6313	Progetto oncologico di medicina molecolare tumori femminili - IEO/Ministero della salute [RF-IEO-2007-1128384]	Progetto oncologico di medicina molecolare tumori femminili - IEO/Ministero della salute	This study was supported by the Progetto oncologico di medicina molecolare tumori femminili RF-IEO-2007-1128384 (to P.M. and G.B.) awarded by IEO/Ministero della salute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1994; Anderson LN, 2011, CANCER EPIDEM BIOMAR, V20, P1708, DOI 10.1158/1055-9965.EPI-11-0300; Bortman P, 2002, BRAZ J MED BIOL RES, V35, P1, DOI 10.1590/S0100-879X2002000100001; Brozyna AA, 2014, INT J MOL SCI, V15, P19000, DOI 10.3390/ijms151019000; Brozyna AA, 2014, ANTICANCER RES, V34, P2735; Brozyna AA, 2011, HUM PATHOL, V42, P618, DOI 10.1016/j.humpath.2010.09.014; BURAS RR, 1994, BREAST CANCER RES TR, V31, P191, DOI 10.1007/BF00666153; Chen WY, 2005, CANCER EPIDEM BIOMAR, V14, P2335, DOI 10.1158/1055-9965.EPI-05-0283; Colston KW, 2008, BEST PRACT RES CL EN, V22, P587, DOI 10.1016/j.beem.2008.08.002; Colston KW, 2002, ENDOCR-RELAT CANCER, V9, P45, DOI 10.1677/erc.0.0090045; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; ELSTNER E, 1995, CANCER RES, V55, P2822; Flanagan L, 2003, J STEROID BIOCHEM, V84, P181, DOI 10.1016/S0960-0760(03)00028-1; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Garcia-Martin E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065487; Garland CF, 2007, J STEROID BIOCHEM, V103, P708, DOI 10.1016/j.jsbmb.2006.12.007; Haussler MR, 2013, CALCIFIED TISSUE INT, V92, P77, DOI 10.1007/s00223-012-9619-0; Haussler MR, 2011, BEST PRACT RES CL EN, V25, P543, DOI 10.1016/j.beem.2011.05.010; Huang J, 2013, MOL BIOL REP, V40, P4219, DOI 10.1007/s11033-013-2503-9; Huang QQ, 2014, ASIAN PAC J CANCER P, V15, P847, DOI 10.7314/APJCP.2014.15.2.847; Kostner K, 2009, ANTICANCER RES, V29, P3511; Krishnan AV, 2012, STEROIDS, V77, P1107, DOI 10.1016/j.steroids.2012.06.005; Krishnan AV, 2010, ENDOCRIN METAB CLIN, V39, P401, DOI 10.1016/j.ecl.2010.02.011; Lin J, 2007, ARCH INTERN MED, V167, P1050, DOI 10.1001/archinte.167.10.1050; Lopes N, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3178; Lopes N, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-483; Lowe LC, 2005, EUR J CANCER, V41, P1164, DOI 10.1016/j.ejca.2005.01.017; Marsh S, 2005, METH MOL B, V311, P97; McCullough ML, 2009, ANNU REV NUTR, V29, P111, DOI 10.1146/annurev-nutr-080508-141248; Muti P, 2011, OMICS, V15, P337, DOI 10.1089/omi.2010.0086; Peng XJ, 2007, CARCINOGENESIS, V28, P1000, DOI 10.1093/carcin/bgl230; REMMELE W, 1987, PATHOLOGE, V8, P138; Rose AAN, 2013, BREAST CANCER RES TR, V141, P331, DOI 10.1007/s10549-013-2713-9; Slominski AT, 2014, J STEROID BIOCHEM, V144, P28, DOI 10.1016/j.jsbmb.2013.10.012; Slominski AT, 2014, FASEB J, V28, P2775, DOI 10.1096/fj.13-242040; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Swami S, 2010, CLIN CANCER RES, V6, P3371; Tang CB, 2009, BREAST CANCER RES TR, V117, P391, DOI 10.1007/s10549-008-0262-4; Tavassoli FA, 2003, WHO PATHOLOGY GENETI; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Wang D, 2013, TUMOR BIOL, V34, P3509, DOI 10.1007/s13277-013-0929-2; Welsh J, 2012, ARCH BIOCHEM BIOPHYS, V523, P107, DOI 10.1016/j.abb.2011.10.019; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Zhou ZC, 2013, TUMOR BIOL, V34, P3437, DOI 10.1007/s13277-013-0919-4; ZIEROLD C, 1995, J BIOL CHEM, V270, P1675, DOI 10.1074/jbc.270.4.1675	45	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124894	10.1371/journal.pone.0124894	http://dx.doi.org/10.1371/journal.pone.0124894			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849303	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800277
J	Su, Y; Blazey, TM; Snyder, AZ; Raichle, ME; Hornbeck, RC; Aldea, P; Morris, JC; Benzinger, TLS				Su, Yi; Blazey, Tyler M.; Snyder, Abraham Z.; Raichle, Marcus E.; Hornbeck, Russ C.; Aldea, Patricia; Morris, John C.; Benzinger, Tammie L. S.			Quantitative Amyloid Imaging Using Image-Derived Arterial Input Function	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; GRAPHICAL ANALYSIS; COMPARTMENTAL ANALYSIS; COGNITIVE IMPAIRMENT; C-11 FLUMAZENIL; PRION DISEASE; HUMAN BRAIN; PET DATA	Amyloid PET imaging is an indispensable tool widely used in the investigation, diagnosis and monitoring of Alzheimer's disease (AD). Currently, a reference region based approach is used as the mainstream quantification technique for amyloid imaging. This approach assumes the reference region is amyloid free and has the same tracer influx and washout kinetics as the regions of interest. However, this assumption may not always be valid. The goal of this work is to evaluate an amyloid imaging quantification technique that uses arterial region of interest as the reference to avoid potential bias caused by specific binding in the reference region. 21 participants, age 58 and up, underwent Pittsburgh compound B (PiB) PET imaging and MR imaging including a time-of-flight (TOF) MR angiography (MRA) scan and a structural scan. FreeSurfer based regional analysis was performed to quantify PiB PET data. Arterial input function was estimated based on coregistered TOF MRA using a modeling based technique. Regional distribution volume (V-T) was calculated using Logan graphical analysis with estimated arterial input function. Kinetic modeling was also performed using the estimated arterial input function as a way to evaluate PiB binding (DVRkinetic) without a reference region. As a comparison, Logan graphical analysis was also performed with cerebellar cortex as reference to obtain DVRREF. Excellent agreement was observed between the two distribution volume ratio measurements (r>0.89, ICC>0.80). The estimated cerebellum V-T was in line with literature reported values and the variability of cerebellum V-T in the control group was comparable to reported variability using arterial sampling data. This study suggests that image-based arterial input function is a viable approach to quantify amyloid imaging data, without the need of arterial sampling or a reference region. This technique can be a valuable tool for amyloid imaging, particularly in population where reference normalization may not be accurate.	[Su, Yi; Blazey, Tyler M.; Snyder, Abraham Z.; Raichle, Marcus E.; Hornbeck, Russ C.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Morris, John C.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Su, Yi; Hornbeck, Russ C.; Aldea, Patricia; Morris, John C.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr ADRC, St Louis, MO 63110 USA; [Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Su, Y (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	suy@mir.wustl.edu	Benzinger, Tammie/L-6104-2013	Benzinger, Tammie/0000-0002-8114-0552; Su, Yi/0000-0002-1946-8063	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences Pilot Grant by the Clinical and Translational Science Award (CTSA) program of National Institute of Health [UL1TR000448]; McDonnell Center for Systems Neuroscience New Resource Proposal award; National Institute of Neurological Disorders and Stroke [P30NS048056, P01NS080675]; National Institute of Ageing [P01AG026276, U19AG032438, P50AG005681, P01AG003991]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048056, P01NS080675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG003991, P50AG005681, U19AG032438, P01AG026276] Funding Source: NIH RePORTER	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences Pilot Grant by the Clinical and Translational Science Award (CTSA) program of National Institute of Health; McDonnell Center for Systems Neuroscience New Resource Proposal award; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YS received funds from the Knight Alzheimer's Disease Research Center (http://knightadrc.wustl.edu/) pilot award, Washington University Institute of Clinical and Translational Sciences (http://icts.wustl.edu/) Pilot Grant supported by the Clinical and Translational Science Award (CTSA) program (https://www.ctsacentral.org/) of National Institute of Health (http://www.nih.gov/): UL1TR000448, McDonnell Center for Systems Neuroscience (http://centerserv.wustl.edu/) New Resource Proposal award; AZS received fund from National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/): P30NS048056; MER received fund from National Institute of Neurological Disorders and Stroke: P01NS080675; JCM and TLSB received funds from National Institute of Ageing (http://www.nia.nih.gov/): P01AG026276, U19AG032438, P50AG005681, P01AG003991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Aisen PS, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt2; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benzinger TL, 2014, P NATL ACAD SCI US; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Croteau E, 2010, EUROPEAN J NUCL MED; Derdeyn CP, 1999, RADIOLOGY, V212, P499, DOI 10.1148/radiology.212.2.r99au27499; Edison P, 2012, NEUROIMAGE, V60, P1716, DOI 10.1016/j.neuroimage.2012.01.099; Edison P, 2009, NEUROIMAGE, V48, P329, DOI 10.1016/j.neuroimage.2009.06.079; El Fakhri G, 2005, J NUCL MED, V46, P1264; Fang YHD, 2008, J NUCL MED, V49, P606, DOI 10.2967/jnumed.107.047613; Feng D, 1997, IEEE Trans Inf Technol Biomed, V1, P243, DOI 10.1109/4233.681168; HAJNAL JV, 1995, J COMPUT ASSIST TOMO, V19, P289, DOI 10.1097/00004728-199503000-00022; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; HOUSTON AS, 1984, PHYS MED BIOL, V29, P1109, DOI 10.1088/0031-9155/29/9/007; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; Kaufer DI, 2008, ALZHEIMERS DEMANTIA, V4, pT290; Klunk WE, 2004, ANN NEUROL, V55, P306, DOI 10.1002/ana.20009; KOEPPE RA, 1991, J CEREBR BLOOD F MET, V11, P735, DOI 10.1038/jcbfm.1991.130; Koeppe RA, 1997, J CEREBR BLOOD F MET, V17, P919, DOI 10.1097/00004647-199709000-00001; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Logan J, 2000, NUCL MED BIOL, V27, P661, DOI 10.1016/S0969-8051(00)00137-2; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Lowe VJ, 2009, J NUCL MED, V50, P878, DOI 10.2967/jnumed.108.058529; Mann DMA, 2001, AM J PATHOL, V158, P2165, DOI 10.1016/S0002-9440(10)64688-3; Mathis CA, 2003, J MED CHEM, V46, P2740, DOI 10.1021/jm030026b; Mead S, 2006, BRAIN, V129, P2297, DOI 10.1093/brain/awl226; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Mourik JEM, 2008, NEUROIMAGE, V39, P1041, DOI 10.1016/j.neuroimage.2007.10.022; Nordberg A, 2010, NAT REV NEUROL, V6, P78, DOI 10.1038/nrneurol.2009.217; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Rowe CC, 2008, LANCET NEUROL, V7, P129, DOI 10.1016/S1474-4422(08)70001-2; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Sitek A, 2002, IEEE T MED IMAGING, V21, P216, DOI 10.1109/42.996340; Su Y, 2008, PHYS MED BIOL, V53, P5899, DOI 10.1088/0031-9155/53/21/001; Su Y, 2007, IEEE NUCL SCI CONF R, P4481, DOI 10.1109/NSSMIC.2007.4437106; Su Y, 2007, PHYS MED BIOL, V52, P2313, DOI 10.1088/0031-9155/52/8/018; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073377; Su Y, 2013, J CEREBR BLOOD F MET, V33, P115, DOI 10.1038/jcbfm.2012.143; Vaishnavi SN, 2010, P NATL ACAD SCI USA, V107, P17757, DOI 10.1073/pnas.1010459107; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; WATANABE R, 1993, NEUROPATH APPL NEURO, V19, P253, DOI 10.1111/j.1365-2990.1993.tb00435.x; Wilson DL, 1999, IEEE T MED IMAGING, V18, P938, DOI 10.1109/42.811277; Wong DF, 2010, J NUCL MED, V51, P913, DOI 10.2967/jnumed.109.069088; Zanotti-Fregonara P, 2009, J CEREBR BLOOD F MET, V29, P1825, DOI 10.1038/jcbfm.2009.93; Zanotti-Fregonara P, 2009, J NUCL MED, V50, P461, DOI 10.2967/jnumed.108.059642	53	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122920	10.1371/journal.pone.0122920	http://dx.doi.org/10.1371/journal.pone.0122920			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849581	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800174
J	Ashida, G; Funabiki, K; Kretzberg, J				Ashida, Go; Funabiki, Kazuo; Kretzberg, Jutta			Minimal Conductance-Based Model of Auditory Coincidence Detector Neurons	PLOS ONE			English	Article							INTERAURAL TIME DIFFERENCE; MEDIAL SUPERIOR OLIVE; TO-NOISE RATIO; BRAIN-STEM; NUCLEUS-LAMINARIS; PHASE-LOCKING; SOUND LOCALIZATION; BARN OWL; PRINCIPAL NEURONS; FIRE MODELS	Sound localization is a fundamental sensory function of a wide variety of animals. The interaural time difference (ITD), an important cue for sound localization, is computed in the auditory brainstem. In our previous modeling study, we introduced a two-compartment Hodgkin-Huxley type model to investigate how cellular and synaptic specializations may contribute to precise ITD computation of the barn owl's auditory coincidence detector neuron. Although our model successfully reproduced fundamental physiological properties observed in vivo, it was unsuitable for mathematical analyses and large scale simulations because of a number of nonlinear variables. In the present study, we reduce our former model into three types of conductance-based integrate-and-fire (IF) models. We test their electrophysiological properties using data from published in vivo and in vitro studies. Their robustness to parameter changes and computational efficiencies are also examined. Our numerical results suggest that the single-compartment active IF model is superior to other reduced models in terms of physiological reproducibility and computational performance. This model will allow future theoretical studies that use more rigorous mathematical analysis and network simulations.	[Ashida, Go; Kretzberg, Jutta] Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany; [Funabiki, Kazuo] Osaka Biosci Inst, Syst Biol, Suita, Osaka 565, Japan	Carl von Ossietzky Universitat Oldenburg	Ashida, G (corresponding author), Carl von Ossietzky Univ Oldenburg, Cluster Excellence Hearing4all, Oldenburg, Germany.	go.ashida@uni-oldenburg.de		Ashida, Go/0000-0002-8886-1213	Cluster of Excellence "Hearing4all" at the University of Oldenburg; US-JAPAN Brain Research Cooperative Program	Cluster of Excellence "Hearing4all" at the University of Oldenburg; US-JAPAN Brain Research Cooperative Program	This work was supported by the Cluster of Excellence "Hearing4all" at the University of Oldenburg (GA, JK), by Grant-in-Aid for Scientific Research (B) (KF), and the US-JAPAN Brain Research Cooperative Program (KF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrescu A, 2010, THE D PROGRAMMING LA; Ashida G, 2010, FRONT CELL NEUROSCI, V4, P100; Ashida G, 2007, J NEUROPHYSIOL, V97, P2267, DOI 10.1152/jn.00399.2006; Ashida G, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00151; Ashida G, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00102; Ashida G, 2011, CURR OPIN NEUROBIOL, V21, P745, DOI 10.1016/j.conb.2011.05.008; Aviel Y, 2003, NEURAL COMPUT, V15, P1321, DOI 10.1162/089976603321780290; Borgers C, 2013, SIAM J SCI COMPUT, V35, pB623, DOI 10.1137/120883657; Boettcher FA, 2002, J SPEECH LANG HEAR R, V45, P1249, DOI 10.1044/1092-4388(2002/100); Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brughera AR, 1996, AUDIT NEUROSCI, V2, P219; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; BUGMANN G, 1991, NETWORK-COMP NEURAL, V2, P489, DOI 10.1088/0954-898X/2/4/010; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Carr CE, 2009, J NEUROSCI, V29, P7978, DOI 10.1523/JNEUROSCI.6154-08.2009; CARR CE, 1993, J COMP NEUROL, V334, P337, DOI 10.1002/cne.903340302; CARR CE, 1993, BRAIN RES, V628, P330, DOI 10.1016/0006-8993(93)90975-S; CARR CE, 1990, J NEUROSCI, V10, P3227; Dodla R, 2006, J NEUROPHYSIOL, V95, P2664, DOI 10.1152/jn.00752.2005; Fischer BJ, 2011, P NATL ACAD SCI USA, V108, P18138, DOI 10.1073/pnas.1108921108; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; Funabiki K, 2011, J NEUROSCI, V31, P15245, DOI 10.1523/JNEUROSCI.2127-11.2011; Gai Y, 2009, J NEUROPHYSIOL, V102, P3447, DOI 10.1152/jn.00538.2009; Gedeon T, 2004, J MATH BIOL, V49, P577, DOI 10.1007/s00285-004-0268-4; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W, 2002, SPIKING NEURON MODEL; Gold C, 2006, J NEUROPHYSIOL, V95, P3113, DOI 10.1152/jn.00979.2005; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Golding NL, 2012, J PHYSIOL-LONDON, V590, P5563, DOI 10.1113/jphysiol.2012.229328; Golomb D, 1999, P NATL ACAD SCI USA, V96, P13480, DOI 10.1073/pnas.96.23.13480; Grau-Serrat V, 2003, BIOL CYBERN, V89, P388, DOI 10.1007/s00422-003-0444-4; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Herz AVM, 2006, SCIENCE, V314, P80, DOI 10.1126/science.1127240; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Joris P, 2007, TRENDS NEUROSCI, V30, P70, DOI 10.1016/j.tins.2006.12.004; KEENER JP, 1981, SIAM J APPL MATH, V41, P503, DOI 10.1137/0141042; Kempter R, 1998, NEURAL COMPUT, V10, P1987, DOI 10.1162/089976698300016945; Khurana S, 2011, J NEUROSCI, V31, P8936, DOI 10.1523/JNEUROSCI.1079-11.2011; Klump GM, 2000, SPR HDB AUD, V13, P249; Koppl C, 2008, BIOL CYBERN, V98, P541, DOI 10.1007/s00422-008-0220-6; KONISHI M, 1993, SCI AM, V268, P66, DOI 10.1038/scientificamerican0493-66; Koppl C, 1997, J NEUROSCI, V17, P3312; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Kuokkanen PT, 2010, J NEUROPHYSIOL, V104, P2274, DOI 10.1152/jn.00395.2010; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; Mathews PJ, 2010, NAT NEUROSCI, V13, P601, DOI 10.1038/nn.2530; Mc Laughlin M, 2010, J NEUROSCI, V30, P13472, DOI 10.1523/JNEUROSCI.0294-10.2010; Pecka M, 2008, J NEUROSCI, V28, P6914, DOI 10.1523/JNEUROSCI.1660-08.2008; Pena JL, 1996, J NEUROSCI, V16, P7046; Rathouz M, 1998, J NEUROPHYSIOL, V80, P2824, DOI 10.1152/jn.1998.80.6.2824; REYES AD, 1994, J NEUROSCI, V14, P5352; Reyes AD, 1996, J NEUROSCI, V16, P993; Rothman JS, 2003, J NEUROPHYSIOL, V89, P3097, DOI 10.1152/jn.00127.2002; Rotter S, 1999, BIOL CYBERN, V81, P381, DOI 10.1007/s004220050570; Scott LL, 2005, J NEUROSCI, V25, P7887, DOI 10.1523/JNEUROSCI.1016-05.2005; Svirskis G, 2003, NETWORK-COMP NEURAL, V14, P137, DOI 10.1088/0954-898X/14/1/308; Svirskis G, 2002, J NEUROSCI, V22, P11019; van der Heijden M, 2013, NEURON, V78, P936, DOI 10.1016/j.neuron.2013.04.028; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; Zhou Y, 2005, J NEUROSCI, V25, P3046, DOI 10.1523/JNEUROSCI.3064-04.2005	61	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122796	10.1371/journal.pone.0122796	http://dx.doi.org/10.1371/journal.pone.0122796			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844803	Green Submitted, Green Published, gold			2022-12-26	WOS:000352475700014
J	Zhang, CF; Dai, LS; Wang, L; Qian, C; Wei, GQ; Li, J; Zhu, BJ; Liu, CL				Zhang, Congfen; Dai, Lishang; Wang, Lei; Qian, Cen; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang			Inhibitors of Eicosanoid Biosynthesis Influencing the Transcripts Level of sHSP21.4 Gene Induced by Pathogen Infections, in Antheraea pernyi	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; IMMUNE-RESPONSE; SILKWORM; EXPRESSION; LOCALIZATION; INVOLVEMENT	Small heat shock proteins (sHSPs) can regulate protein folding and protect cells from stress. To investigate the role of sHSPs in the silk-producing insect Antheraea pernyi response to microorganisms, a sHsp gene termed as Ap-sHSP21.4, was identified. This gene encoded a 21.4 kDa protein which shares the conserved structure of insect sHsps and belongs to sHSP21.4 family. Ap-sHSP21.4 was highly expressed in fat body and up-regulated in midgut and fat body of Antheraea pernyi challenged with Escherichia coli, Beauveria bassiana and nuclear polyhedrosis virus (NPV), which was determined by quantitative real-time PCR. Meanwhile, knock down of Ap-sHSP21.4 with dsRNA result in the decrease at the expression levels of several immune response-related genes (defensin, Dopa decarboxylase, Toll1, lysozyme and Kazal-type serine protease inhibitor). Additionally, the impact of eicosanoid biosynthesis on the expression of Ap-sHSP21.4 response to NPV was determined using qPCR, inhibitors of eicosanoid biosynthesis significantly suppress Ap-HSP21.4 expression upon NPV challenge. All together, Ap-sHSP21.4 was involved in the immunity of Antheraea pernyi against microorganism and possibly mediated by eicosanoids pathway. These results will shed light in the understanding of the pathogen-host interaction in Antheraea pernyi.	[Zhang, Congfen; Dai, Lishang; Wang, Lei; Qian, Cen; Wei, Guoqing; Li, Jun; Zhu, Baojian; Liu, Chaoliang] Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China; [Zhang, Congfen] Wannan Med Coll, Dept Pharmacol, Wuhu 241002, Anhui, Peoples R China	Anhui Agricultural University; Wannan Medical College	Zhu, BJ (corresponding author), Anhui Agr Univ, Coll Life Sci, Hefei 230036, Anhui, Peoples R China.	zhubaojian@ahau.edu.cn; clliu@ahau.edu.cn	Zhu, Baojian/ABG-4522-2021		earmarked fund for modern Argo-industry Technology Research System [CARS-22 SYZ10]; Anhui High Schools Natural Science Foundation [KJ2013B320]; National 863 plans projects of China [2011AA100306]; Sericulture Biotechnology Innovation Team [2013xkdt-05]; Ph.D. programs in Biochemistry and Molecular Biology [xk2013042]	earmarked fund for modern Argo-industry Technology Research System; Anhui High Schools Natural Science Foundation; National 863 plans projects of China(National High Technology Research and Development Program of China); Sericulture Biotechnology Innovation Team; Ph.D. programs in Biochemistry and Molecular Biology	This work was supported by the earmarked fund for modern Argo-industry Technology Research System (CARS-22 SYZ10), Anhui High Schools Natural Science Foundation (KJ2013B320), National 863 plans projects of China (2011AA100306), Sericulture Biotechnology Innovation Team (2013xkdt-05), Ph.D. programs in Biochemistry and Molecular Biology (xk2013042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P585, DOI 10.1016/j.dci.2007.09.005; ARRIGO AP, 1981, MOL GEN GENET, V184, P73, DOI 10.1007/BF00271198; Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Bundey S, 2003, ARCH INSECT BIOCHEM, V52, P183, DOI 10.1002/arch.10081; Buyukguzel E, 2007, J INSECT PHYSIOL, V53, P99, DOI 10.1016/j.jinsphys.2006.10.012; Carton Y, 2002, J PARASITOL, V88, P405, DOI 10.1645/0022-3395(2002)088[0405:DIOTCI]2.0.CO;2; Chen KK, 2014, DEV COMP IMMUNOL, V45, P1, DOI 10.1016/j.dci.2014.01.017; Durmus Y, 2008, J INSECT PHYSIOL, V54, P17, DOI 10.1016/j.jinsphys.2007.03.019; Harlow E., 1999, USING ANTIBODIES LAB; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Kokolakis G, 2008, INSECT MOL BIOL, V17, P699, DOI 10.1111/j.1365-2583.2008.00840.x; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Kristensen N.P., 1999, Lepidoptera: Moths and Butterflies. 1. Handbook of Zoology, Vol. IV, part 35. New York: De Gruyter, P7; Li J, 2012, MOL BIOL REP, V39, P3915, DOI 10.1007/s11033-011-1170-y; Li ZW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-215; Liang D, 2007, MOL MED, V13, P229, DOI 10.2119/2007-00004.Liang; Liu QN, 2013, J INSECT PHYSIOL, V59, P848, DOI 10.1016/j.jinsphys.2013.06.001; Liu ZH, 2012, CELL STRESS CHAPERON, V17, P539, DOI 10.1007/s12192-012-0330-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mikkelsen UR, 2013, EUR J APPL PHYSIOL, V113, P1883, DOI 10.1007/s00421-013-2606-y; Morishima I, 1997, FEBS LETT, V419, P83, DOI 10.1016/S0014-5793(97)01418-X; Park JA, 2012, CELL IMMUNOL, V279, P117, DOI 10.1016/j.cellimm.2012.11.005; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Sakano D, 2006, BIOSCI BIOTECH BIOCH, V70, P2443, DOI 10.1271/bbb.60176; Stanley David, 2012, Insects, V3, P492, DOI 10.3390/insects3020492; Stanley David, 2011, Front Endocrinol (Lausanne), V2, P105, DOI 10.3389/fendo.2011.00105; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; StanleySamuelson DW, 1997, COMP BIOCHEM PHYS A, V118, P93, DOI 10.1016/S0300-9629(96)00447-1; STANLEYSAMUELSON DW, 1991, P NATL ACAD SCI USA, V88, P1064, DOI 10.1073/pnas.88.3.1064; Surajit SARKAR, 2011, [Frontiers in Biology, 生物学前沿], V6, P312; Tang T, 2012, J INSECT PHYSIOL, V58, P1226, DOI 10.1016/j.jinsphys.2012.06.007; VELAZQUEZ JM, 1980, CELL, V20, P679, DOI 10.1016/0092-8674(80)90314-1; Wei ZJ, 2011, MOL BIOL REP, V38, P1121, DOI 10.1007/s11033-010-0209-9; Yang JH, 2014, CELL STRESS CHAPERON, V19, P33, DOI 10.1007/s12192-013-0432-0; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	35	21	24	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121296	10.1371/journal.pone.0121296	http://dx.doi.org/10.1371/journal.pone.0121296			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844646	Green Submitted, Green Published, gold			2022-12-26	WOS:000352475700005
J	Lanini, S; Costa, AN; Puro, V; Procaccio, F; Grossi, PA; Vespasiano, F; Ricci, A; Vesconi, S; Ison, MG; Carmeli, Y; Ippolito, G				Lanini, Simone; Costa, Alessandro Nanni; Puro, Vincenzo; Procaccio, Francesco; Grossi, Paolo Antonio; Vespasiano, Francesca; Ricci, Andrea; Vesconi, Sergio; Ison, Michael G.; Carmeli, Yehuda; Ippolito, Giuseppe		Donor-Recipient Infection DRIn Col	Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study	PLOS ONE			English	Article							INFECTION; PNEUMONIAE; ENTEROBACTERIACEAE; PREVALENCE; CARE	Background Bacterial infections remain a challenge to solid organ transplantation. Due to the alarming spread of carbapenem-resistant gram negative bacteria, these organisms have been frequently recognized as cause of severe infections in solid organ transplant recipients. Methods and Findings Between 15 May and 30 September 2012 we enrolled 887 solid organ transplant recipients in Italy with the aim to describe the epidemiology of gram negative bacteria spreading, to explore potential risk factors and to assess the effect of early isolation of gram negative bacteria on recipients' mortality during the first 90 days after transplantation. During the study period 185 clinical isolates of gram negative bacteria were reported, for an incidence of 2.39 per 1000 recipient-days. Positive cultures for gram negative bacteria occurred early after transplantation (median time 26 days; incidence rate 4.33, 1.67 and 1.14 per 1,000 recipient- days in the first, second and third month after SOT, respectively). Forty-nine of these clinical isolates were due to carbapenem-resistant gram negative bacteria (26.5%; incidence 0.63 per 1000 recipient-days). Carbapenems resistance was particularly frequent among Klebsiella spp. isolates (49.1%). Recipients with longer hospital stay and those who received either heart or lung graft were at the highest risk of testing positive for any gram negative bacteria. Moreover recipients with longer hospital stay, lung recipients and those admitted to hospital for more than 48h before transplantation had the highest probability to have culture(s) positive for carbapenem-resistant gram negative bacteria. Forty-four organ recipients died (0.57 per 1000 recipient-days) during the study period. Recipients with at least one positive culture for carbapenem-resistant gram negative bacteria had a 10.23-fold higher mortality rate than those who did not. Conclusion The isolation of gram-negative bacteria is most frequent among recipient with hospital stays >48 hours prior to transplant and in those receiving either heart or lung transplants. Carbapenem-resistant gram negative isolates are associated with significant mortality.	[Lanini, Simone; Puro, Vincenzo; Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy; [Costa, Alessandro Nanni; Procaccio, Francesco; Vespasiano, Francesca; Ricci, Andrea] Italian Natl Inst Hlth ISS, Italian Natl Transplant Ctr, Rome, Italy; [Grossi, Paolo Antonio] Univ Insubria, Osped Circolo, Dept Surg & Morphol Sci, Div Infect Dis, Varese, Italy; [Vesconi, Sergio] Direz Gen Salute Lombardia, Reg Lombardia, Milan, Italy; [Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA; [Ison, Michael G.] Northwestern Univ, Feinberg Sch Med, Div Organ Transplantat, Chicago, IL 60611 USA; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol, IL-69978 Tel Aviv, Israel; [Carmeli, Yehuda] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Lab Mol Epidemiol & Antibiot Res, IL-69978 Tel Aviv, Israel	IRCCS Lazzaro Spallanzani; Istituto Superiore di Sanita (ISS); Ospedale Circolo & Fondazione Macchi; University of Insubria; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Lanini, S (corresponding author), Natl Inst Infect Dis Lazzaro Spallanzani, Dept Epidemiol & Preclin Res, Rome, Italy.	simone.lanini@inmi.it	Vespasiano, Francesca/AFO-2093-2022; Grossi, Paolo Antonio/A-6158-2013; Ippolito, Giuseppe/J-7207-2017; Vespasiano, Francesca/G-5970-2015; Lanini, Simone/C-7523-2012	Grossi, Paolo Antonio/0000-0003-2883-5061; Vespasiano, Francesca/0000-0002-3820-1508; Lanini, Simone/0000-0002-6743-4001; Ippolito, Giuseppe/0000-0002-1076-2979; Ricci, Andrea/0000-0001-8824-4867; puro, vincenzo/0000-0003-0291-4490	Italian Health Ministry; Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS	Italian Health Ministry(Ministry of Health, Italy); Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS	This study has been funded by the Italian Health Ministry (CCM 2012 program) and by Ricerca Corrente "Lazzaro Spallanzani" National Institute for Infectious Diseases (INMI), IRCCS.	Ariza-Heredia EJ, 2012, TRANSPL INFECT DIS, V14, P229, DOI 10.1111/j.1399-3062.2012.00742.x; Bergamasco MD, 2012, TRANSPL INFECT DIS, V14, P198, DOI 10.1111/j.1399-3062.2011.00688.x; Burguete SR, 2013, RESPIROLOGY, V18, P22, DOI 10.1111/j.1440-1843.2012.02196.x; Chaparro C, 2001, AM J RESP CRIT CARE, V163, P43, DOI 10.1164/ajrccm.163.1.9811076; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; European Centre for Disease Prevention and Control, 2011, ANT RES SURV EUR 201; European Centre for Disease Prevention and Control, 2013, CARB PROD BACT EUR I; Fishman JA, 2009, AM J TRANSPLANT, V9, pS3, DOI 10.1111/j.1600-6143.2009.02887.x; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Giani T, 2013, EUROSURVEILLANCE, V18, pe22; Joe H, 2008, COMPUT STAT DATA AN, V52, P5066, DOI 10.1016/j.csda.2008.05.002; Kalpoe JS, 2012, LIVER TRANSPLANT, V18, P468, DOI 10.1002/lt.23374; Lanini S, 2009, INFECT CONT HOSP EP, V30, P659, DOI 10.1086/597596; Pham AD, 2013, ANN THORAC SURG, V96, P596, DOI 10.1016/j.athoracsur.2013.04.023; Raviv Y, 2012, CLIN TRANSPLANT, V26, pE388, DOI 10.1111/j.1399-0012.2012.01671.x; Speich R, 2001, CLIN INFECT DIS, V33, pS58, DOI 10.1086/320906; Stata Multilevel mixed-effects Poisson regression (QR decomposition), 2013, STATA MULTILEVEL MIX, P258; Swaminathan M, 2013, INFECT CONT HOSP EP, V34, P809, DOI 10.1086/671270; Venettoni Sante, 2007, Ann Ist Super Sanita, V43, P279; Wszola M, 2013, TRANSPLANTATION, V95, P878, DOI 10.1097/TP.0b013e318281b953	20	44	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123706	10.1371/journal.pone.0123706	http://dx.doi.org/10.1371/journal.pone.0123706			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835018	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000149
J	Timrott, K; Vondran, FWR; Bektas, H; Klempnauer, J; Jager, MD				Timrott, Kai; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeger, Mark D.			Application of Allogeneic Bone Marrow Cells in View of Residual Alloreactivity: Sirolimus but Not Cyclosporine Evolves Tolerogenic Properties	PLOS ONE			English	Article							MIXED CHIMERISM; TRANSPLANTATION TOLERANCE; ALLOGRAFT TOLERANCE; T-CELLS; IMMUNOLOGICAL-TOLERANCE; THYMOCYTE MATURATION; RAPAMYCIN; RAT; INDUCTION; APOPTOSIS	Background Application of bone marrow cells (BMC) is a promising strategy for tolerance induction, but usually requires strong depletion of the host immune system. This study evaluates the ability of immunosuppressants to evolve tolerogenic properties of BMC in view of residual alloreactivity. Methods The rat model used a major histocompatibility complex (MHC) class II disparate bone marrow transplantation (BMT) setting (LEW.1AR1 (RT1(auu))-> LEW.1AR2 (RT1(aau))). Heart grafts (LEW.1WR1 (RT1(uua))) were disparate for the complete MHC to recipients and for MHC class I to BMC donors. Limited conditioning was performed by total body irradiation of 6 Gy. Cyclosporine (CsA) or Sirolimus (Srl) were administered for 14 or 28 days. Transplantation of heart grafts (HTx) was performed at day 16 or at day 100 after BMT. Chimerism and changes in the T cell pool were detected by flow cytometry. Results Mixed chimeras accepted HTx indefinitely, although the composition of the regenerated T cell pool was not changed to a basically donor MHC class II haplotype. Non-chimeric animals rejected HTx spontaneously. BMC recipients, who received HTx during T cell recovery at day 16, accepted HTx only after pre-treatment with Srl, although chimerism was lost. CsA pre-treatment led to accelerated HTx rejection as did isolated application of BMC. Conclusion Srl evolves tolerogenic properties of allogeneic BMC to achieve indefinite acceptance of partly MHC disparate HTx despite residual alloreactivity and in particular loss of chimerism.	[Timrott, Kai; Vondran, Florian W. R.; Bektas, Hueseyin; Klempnauer, Juergen; Jaeger, Mark D.] Klin Allgemein Viszeral & Transplantat Chirurg, Med Hsch, Hannover, Germany		Timrott, K (corresponding author), Klin Allgemein Viszeral & Transplantat Chirurg, Med Hsch, Hannover, Germany.	timrott.kai@mh-hannover.de						Abraham RT, 1998, CURR OPIN IMMUNOL, V10, P330, DOI 10.1016/S0952-7915(98)80172-6; Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Bektas H, 2005, J HEART LUNG TRANSPL, V24, P614, DOI 10.1016/j.healun.2004.01.016; Buhler LH, 2002, TRANSPLANTATION, V74, P1405, DOI 10.1097/01.TP.0000034627.37442.A4; Coenen JJA, 2006, BLOOD, V107, P1018, DOI 10.1182/blood-2005-07-3032; Damoiseaux JGMC, 2002, SCAND J IMMUNOL, V56, P353, DOI 10.1046/j.1365-3083.2002.01110.x; Domenig C, 2005, J IMMUNOL, V175, P51, DOI 10.4049/jimmunol.175.1.51; FARNSWORTH A, 1988, TRANSPLANTATION, V46, P418, DOI 10.1097/00007890-198809000-00017; Fitzhugh CD, 2013, BONE MARROW TRANSPL, V48, P1335, DOI 10.1038/bmt.2013.60; Hale DA, 2002, TRANSPLANTATION, V74, P477, DOI 10.1097/00007890-200208270-00008; Homma M, 1997, TRANSPLANT P, V29, P1743, DOI 10.1016/S0041-1345(97)00039-0; Huang CA, 2000, J CLIN INVEST, V105, P173, DOI 10.1172/JCI7913; ILDSTAD ST, 1984, NATURE, V307, P168, DOI 10.1038/307168a0; Issa F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00254; Jager MD, 2001, TRANSPLANT P, V33, P176, DOI 10.1016/S0041-1345(00)01962-X; KAWAI T, 1995, TRANSPLANTATION, V59, P256, DOI 10.1097/00007890-199501270-00018; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; KLEMPNAUER J, 1989, IMMUNOGENETICS, V30, P81, DOI 10.1007/BF02421535; Ko S, 1999, NAT MED, V5, P1292, DOI 10.1038/15248; Kurtz J, 2004, TRENDS IMMUNOL, V25, P518, DOI 10.1016/j.it.2004.08.007; Li YS, 1999, NAT MED, V5, P1298, DOI 10.1038/15256; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; LoCascio SA, 2010, TRANSPLANTATION, V90, P1607, DOI 10.1097/TP.0b013e3181ffbaff; Loren AW, 2003, BONE MARROW TRANSPL, V31, P145, DOI 10.1038/sj.bmt.1703806; LUO HY, 1994, EUR J IMMUNOL, V24, P692, DOI 10.1002/eji.1830240331; Neujahr D, 2005, CONTRIB NEPHROL, V146, P65, DOI 10.1159/000082066; Nikolic B, 1998, TRANSPLANTATION, V65, P1216, DOI 10.1097/00007890-199805150-00013; Pasquet L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00080; Powell JD, 2005, TRANSPLANTATION, V80, P1541, DOI 10.1097/01.tp.0000185299.72295.90; Sachs DH, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a015529; Sachs DH, 2011, SEMIN IMMUNOL, V23, P165, DOI 10.1016/j.smim.2011.07.001; SMITH CV, 1992, TRANSPLANTATION, V53, P438; STEPKOWSKI SM, 1991, TRANSPLANTATION, V51, P22, DOI 10.1097/00007890-199101000-00002; Taniguchi H, 1995, J IMMUNOL, V155; Tian LN, 2004, TRANSPLANTATION, V77, P183, DOI 10.1097/01.TP.0000101005.44661.3E; TORRESNAGEL NE, 1994, INT IMMUNOL, V6, P1367, DOI 10.1093/intimm/6.9.1367; Umemura A, 2000, J IMMUNOL, V164, P4452, DOI 10.4049/jimmunol.164.9.4452; Wells AD, 1999, NAT MED, V5, P1303, DOI 10.1038/15260; Xu H, 2012, TRANSPLANTATION, V93, P469, DOI 10.1097/TP.0b013e318242bddf	39	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119950	10.1371/journal.pone.0119950	http://dx.doi.org/10.1371/journal.pone.0119950			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836261	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000016
J	Shearman, JR; Sangsrakru, D; Jomchai, N; Ruang-Areerate, P; Sonthirod, C; Naktang, C; Theerawattanasuk, K; Tragoonrung, S; Tangphatsornruang, S				Shearman, Jeremy R.; Sangsrakru, Duangjai; Jomchai, Nukoon; Ruang-Areerate, Panthita; Sonthirod, Chutima; Naktang, Chaiwat; Theerawattanasuk, Kanikar; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke			SNP Identification from RNA Sequencing and Linkage Map Construction of Rubber Tree for Anchoring the Draft Genome	PLOS ONE			English	Article							HEVEA-BRASILIENSIS; MICROCYCLUS-ULEI; LATEX YIELD; GENE; RESISTANCE; DIVERSITY; POLYMORPHISMS; INVOLVEMENT; DISCOVERY; ALIGNMENT	Hevea brasiliensis, or rubber tree, is an important crop species that accounts for the majority of natural latex production. The rubber tree nuclear genome consists of 18 chromosomes and is roughly 2.15 Gb. The current rubber tree reference genome assembly consists of 1,150,326 scaffolds ranging from 200 to 531,465 bp and totalling 1.1 Gb. Only 143 scaffolds, totalling 7.6 Mb, have been placed into linkage groups. We have performed RNA-seq on 6 varieties of rubber tree to identify SNPs and InDels and used this information to perform target sequence enrichment and high throughput sequencing to genotype a set of SNPs in 149 rubber tree offspring from a cross between RRIM 600 and RRII 105 rubber tree varieties. We used this information to generate a linkage map allowing for the anchoring of 24,424 contigs from 3,009 scaffolds, totalling 115 Mb or 10.4% of the published sequence, into 18 linkage groups. Each linkage group contains between 319 and 1367 SNPs, or 60 to 194 non-redundant marker positions, and ranges from 156 to 336 cM in length. This linkage map includes 20,143 of the 69,300 predicted genes from rubber tree and will be useful for mapping studies and improving the reference genome assembly.	[Shearman, Jeremy R.; Sangsrakru, Duangjai; Jomchai, Nukoon; Ruang-Areerate, Panthita; Sonthirod, Chutima; Naktang, Chaiwat; Tragoonrung, Somvong; Tangphatsornruang, Sithichoke] Natl Ctr Genet Engn & Biotechnol, Khlong Luang 12120, Pathumthani, Thailand; [Theerawattanasuk, Kanikar] RRIT, Minist Agr & Cooperat, Dept Agr, Bangkok 10900, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Ministry of Agriculture & Cooperatives - Thailand	Tangphatsornruang, S (corresponding author), Natl Ctr Genet Engn & Biotechnol, 113 Thailand Sci Pk,Paholyothin Rd, Khlong Luang 12120, Pathumthani, Thailand.	sithichoke.tan@biotec.or.th	Shearman, Jeremy/F-1618-2010; Tangphatsornruang, Sithichoke/G-3633-2010	Tangphatsornruang, Sithichoke/0000-0003-2673-0012	Rubber Research Institute of Thailand (RRIT)	Rubber Research Institute of Thailand (RRIT)	Samples and funding for this work were supplied by the Rubber Research Institute of Thailand (RRIT). The funders participated in study design and data collection.	Adams M. D., 1994, AUTOMATED DNA SEQUEN; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Berthelot K, 2014, BBA-PROTEINS PROTEOM, V1844, P473, DOI 10.1016/j.bbapap.2013.10.017; Campbell MS, 2014, PLANT PHYSIOL, V164, P513, DOI 10.1104/pp.113.230144; Chen MS, 2002, PLANT CELL, V14, P537, DOI 10.1105/tpc.010485; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Gore MA, 2009, PLANT GENOME-US, V2, P121, DOI 10.3835/plantgenome2009.01.0002; Jimenez-Gomez JM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-85; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le Guen V, 2007, NEW PHYTOL, V173, P335, DOI 10.1111/j.1469-8137.2006.01911.x; Le Guen V, 2011, PLANT BREEDING, V130, P294, DOI 10.1111/j.1439-0523.2010.01774.x; Le Guen V, 2003, THEOR APPL GENET, V108, P160, DOI 10.1007/s00122-003-1407-9; Le Guen V, 2011, TREE GENET GENOMES, V7, P877, DOI 10.1007/s11295-011-0381-7; Leonforte A, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-161; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pootakham W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116028; Pramoolkit P, 2014, PLANT PHYSIOL BIOCH, V84, P203, DOI 10.1016/j.plaphy.2014.09.016; Priyadarshan PM, 2004, ADV GENET, V52, P51, DOI 10.1016/S0065-2660(04)52003-5; Rahman AYA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-75; Rastas P, 2013, BIOINFORMATICS, V29, P3128, DOI 10.1093/bioinformatics/btt563; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Shearman JR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-45; Silva CC, 2014, MOL BREEDING, V34, P1035, DOI 10.1007/s11032-014-0095-2; Souza LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061238; Tangphatsornruang S, 2011, GENE, V475, P104, DOI 10.1016/j.gene.2011.01.002; Tungngoen K, 2009, PLANT PHYSIOL, V151, P843, DOI 10.1104/pp.109.140228; Wang XC, 2013, J PROTEOME RES, V12, P5146, DOI 10.1021/pr400378c; Wang Y, 2013, PLANT PHYSIOL BIOCH, V71, P283, DOI 10.1016/j.plaphy.2013.07.020; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Webster CC, 1989, BURNT MILL HARLOW; Yin TF, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r77	37	21	22	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121961	10.1371/journal.pone.0121961	http://dx.doi.org/10.1371/journal.pone.0121961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831195	gold, Green Published, Green Submitted			2022-12-26	WOS:000352135600093
J	Steinckwich, N; Myers, P; Janardhan, KS; Flagler, ND; King, D; Petranka, JG; Putney, JW				Steinckwich, Natacha; Myers, Page; Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra; Petranka, John G.; Putney, James W.			Role of the store-operated calcium entry protein, STIM1, in neutrophil chemotaxis and infiltration into a murine model of psoriasis-inflamed skin	FASEB JOURNAL			English	Article						calcium signaling; chronic inflammatory disease; leukocyte migration	CA2+ INFLUX; ACTIVATION; INTEGRIN; CELLS; POLARIZATION; INFLAMMATION; MECHANISMS; MIGRATION; IMIQUIMOD	Stromal interaction molecule 1 (STIM1) is a Ca2+ sensor protein that initiates store-operated calcium entry (SOCE). STIM1 is known to be involved in the chemoattractant signaling pathway for FPR1 in cell lines, but its role in in vivo functioning of neutrophils is unclear. Plaque-type psoriasis is a chronic inflammatory skin disorder associated with chemoattractants driving neutrophils into the epidermis. We investigated the involvement of STIM1 in neutrophil chemotaxis in vitro, as well as during chronic psoriatic inflammation. To this end, we used conditional knockout (KO) mice lacking STIM1 in cells of myeloid lineage (STIM1(fl/fl) LysM-cre). We demonstrate that STIM1 is required for chemotaxis because of multiple chemoattractants in mouse neutrophils in vitro. Using an imiquimod-induced psoriasis-like skin model, we show that KO mice had less neutrophil infiltration in the epidermis than controls, whereas neither chemoattractant production in the epidermis nor macrophage migration was decreased. KO mice displayed a more rapid reversal of the outward signs of psoriasis (plaques). Thus, KO of STIM1 impairs neutrophil contribution to psoriatic inflammation. Our data provide new insights to our understanding of how STIM1 orchestrates the cellular behavior underlying chemotaxis and illustrate the important role of SOCE in a disease-related pathologic model.	[Steinckwich, Natacha; Petranka, John G.; Putney, James W.] NIEHS, Signal Transduct Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Myers, Page] NIEHS, Comparat Med Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.] NIEHS, Integrated Syst Lab, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra] NIEHS, Cellular & Mol Pathol Branch, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Janardhan, Kyathanahalli S.; Flagler, Norris D.; King, Debra] NIEHS, Natl Toxicol Program, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA; [Flagler, Norris D.; King, Debra] NIEHS, Special Tech Grp, NIH, US Dept HHS, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Putney, JW (corresponding author), NIEHS, POB 12233, Res Triangle Pk, NC 27709 USA.	putney@niehs.nih.gov	Putney, James W/F-7247-2019	Putney, James W/0000-0002-3379-4789	Intramural Research Program of the NIH National Institute of Environmental Health Sciences; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090087, ZICES102546] Funding Source: NIH RePORTER	Intramural Research Program of the NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Drs. Michael Fessler and Xiaoling Li read the manuscript and provided useful comments. The authors thank Gary Bird for fruitful discussion. Mice carrying a floxed STIM1 gene were kindly provided by Dr. Masatsugu Ohora (Tokyo Medical and Dental University, Tokyo, Japan). The YFP-STIM1 construct that was subcloned into a viral vector was provided by Dr. Tobias Meyer (Stanford University, Stanford, CA, USA). The authors also thank Jeff Tucker and Agnes Janoshazi for assistance with the confocal microscopy; Carl Bortner and Maria Sifre for assistance with the flow cytometry; Diane D'Agostin for technical support in mouse colony management and in in situ hybridization experiments; Dr. Shyamal D. Peddada for assistance with statistical analyses; Negin Martin and Charles Romeo for help in producing lentiviral particles; and Julie Foley and the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences histology group members for support in histology. This research was supported by the Intramural Research Program of the NIH National Institute of Environmental Health Sciences. The authors declare no conflicts of interest.	Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Brechard S, 2009, BIOCHEM PHARMACOL, V78, P504, DOI 10.1016/j.bcp.2009.05.006; Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; Davis FM, 2014, ONCOGENE, V33, P2307, DOI 10.1038/onc.2013.187; Dixit N, 2011, J IMMUNOL, V187, P472, DOI 10.4049/jimmunol.1004197; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hellberg C, 1996, BIOCHEM J, V317, P403, DOI 10.1042/bj3170403; JACONI MEE, 1991, J CELL BIOL, V112, P1249, DOI 10.1083/jcb.112.6.1249; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; MARKS PW, 1990, J CELL BIOL, V110, P43, DOI 10.1083/jcb.110.1.43; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Murphy PM, 2000, PHARMACOL REV, V52, P145; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Pettit EJ, 1997, BIOCHEM BIOPH RES CO, V230, P258, DOI 10.1006/bbrc.1996.5931; Reagan WJ, 2011, TOXICOL PATHOL, V39, P435, DOI 10.1177/0192623310396907; Rogalski C, 2002, J INVEST DERMATOL, V118, P49, DOI 10.1046/j.0022-202x.2001.01650.x; Schaff UY, 2008, ANN BIOMED ENG, V36, P632, DOI 10.1007/s10439-008-9453-8; Schaff UY, 2010, BLOOD, V115, P657, DOI 10.1182/blood-2009-05-224659; Schon M, 2007, CURR MED CHEM, V14, P681, DOI 10.2174/092986707780059625; Schon M, 2000, J INVEST DERMATOL, V114, P976, DOI 10.1046/j.1523-1747.2000.00953.x; Sesma JI, 2012, AM J PHYSIOL-CELL PH, V303, pC490, DOI 10.1152/ajpcell.00138.2012; Steinckwich N, 2011, J IMMUNOL, V186, P2182, DOI 10.4049/jimmunol.1001338; Su WH, 2000, BLOOD, V96, P3816, DOI 10.1182/blood.V96.12.3816.h8003816_3816_3822; Toichi E, 2000, J AM ACAD DERMATOL, V43, P391, DOI 10.1067/mjd.2000.103264; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Zhang H, 2014, BLOOD, V123, P2238, DOI 10.1182/blood-2012-08-450403; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zou WY, 2012, CELL PHYSIOL BIOCHEM, V30, P221, DOI 10.1159/000339059	35	26	27	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					3003	3013		10.1096/fj.14-265215	http://dx.doi.org/10.1096/fj.14-265215			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837581	Green Published			2022-12-26	WOS:000356859100028
J	Han, H; Monroe, N; Votteler, J; Shakya, B; Sundquist, WI; Hill, CP				Han, Han; Monroe, Nicole; Votteler, Joerg; Shakya, Binita; Sundquist, Wesley I.; Hill, Christopher P.			Binding of Substrates to the Central Pore of the Vps4 ATPase Is Autoinhibited by the Microtubule Interacting and Trafficking (MIT) Domain and Activated by MIT Interacting Motifs (MIMs)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCRT-III; STRUCTURAL BASIS; MEMBRANE ASSOCIATION; PLASMA-MEMBRANE; PROTEIN; TRANSLOCATION; COMPLEX; RECOGNITION; INSIGHTS; CYTOKINESIS	The endosomal sorting complexes required for transport (ESCRT) pathway drives reverse topology membrane fission events within multiple cellular pathways, including cytokinesis, multivesicular body biogenesis, repair of the plasma membrane, nuclear membrane vesicle formation, and HIV budding. The AAA ATPase Vps4 is recruited to membrane necks shortly before fission, where it catalyzes disassembly of the ESCRT-III lattice. The N-terminal Vps4 microtubule-interacting and trafficking (MIT) domains initially bind the C-terminal MIT-interacting motifs (MIMs) of ESCRT-III subunits, but it is unclear how the enzyme then remodels these substrates in response to ATP hydrolysis. Here, we report quantitative binding studies that demonstrate that residues from helix 5 of the Vps2p subunit of ESCRT-III bind to the central pore of an asymmetric Vps4p hexamer in a manner that is dependent upon the presence of flexible nucleotide analogs that can mimic multiple states in the ATP hydrolysis cycle. We also find that substrate engagement is autoinhibited by the Vps4p MIT domain and that this inhibition is relieved by binding of either Type 1 or Type 2 MIM elements, which bind the Vps4p MIT domain through different interfaces. These observations support the model that Vps4 substrates are initially recruited by an MIM-MIT interaction that activates the Vps4 central pore to engage substrates and generate force, thereby triggering ESCRT-III disassembly.	[Han, Han; Monroe, Nicole; Votteler, Joerg; Shakya, Binita; Sundquist, Wesley I.; Hill, Christopher P.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu; chris@biochem.utah.edu	Regan, Clinton/E-6250-2012		National Institutes of Health [NCI P30CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055434, R01AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM112080] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew Weinstock, Michael Jacobsen, and Michael Kay for peptide synthesis and Frank Whitby for helpful discussions and comments on the manuscript. Portions of this work (mass spectrometry and DNA sequencing) were performed in Core Facilities at the University of Utah, which were supported by National Institutes of Health Grant NCI P30CA042014.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Braig K, 2000, STRUCTURE, V8, P567, DOI 10.1016/S0969-2126(00)00145-3; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chan WC, 2000, FMOC SOLID PHASE PEP; Chaney M, 2001, GENE DEV, V15, P2282, DOI 10.1101/gad.205501; Cormier Catherine Y., 2011, Journal of Structural and Functional Genomics, V12, P55, DOI 10.1007/s10969-011-9100-8; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Forster F, 2013, STRUCTURE, V21, P1551, DOI 10.1016/j.str.2013.08.010; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Inoue M, 2008, TRAFFIC, V9, P2180, DOI 10.1111/j.1600-0854.2008.00831.x; Jimenez AJ, 2014, SCIENCE, V343, P986, DOI 10.1126/science.1247136; Kagawa R, 2004, EMBO J, V23, P2734, DOI 10.1038/sj.emboj.7600293; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lee C, 2002, J BIOL CHEM, V277, P34760, DOI 10.1074/jbc.M204750200; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; McCullough J, 2013, ANNU REV BIOCHEM, V82, P663, DOI 10.1146/annurev-biochem-072909-101058; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Monroe N, 2014, J MOL BIOL, V426, P510, DOI 10.1016/j.jmb.2013.09.043; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2013, J BIOL CHEM, V288, P26810, DOI 10.1074/jbc.M113.497032; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Sysoeva TA, 2013, GENE DEV, V27, P2500, DOI 10.1101/gad.229385.113; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Vild CJ, 2014, J BIOL CHEM, V289, P10378, DOI 10.1074/jbc.M113.532960; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Webster BM, 2014, CELL, V159, P388, DOI 10.1016/j.cell.2014.09.012; Wehman AM, 2011, CURR BIOL, V21, P1951, DOI 10.1016/j.cub.2011.10.040; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	69	26	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13490	13499		10.1074/jbc.M115.642355	http://dx.doi.org/10.1074/jbc.M115.642355			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833946	hybrid, Green Published			2022-12-26	WOS:000354975700043
J	Levefaudes, M; Patin, D; de Sousa-d'Auria, C; Chami, M; Blanot, D; Herve, M; Arthur, M; Houssin, C; Mengin-Lecreulx, D				Levefaudes, Marjorie; Patin, Delphine; de Sousa-d'Auria, Celia; Chami, Mohamed; Blanot, Didier; Herve, Mireille; Arthur, Michel; Houssin, Christine; Mengin-Lecreulx, Dominique			Diaminopimelic Acid Amidation in Corynebacteriales NEW INSIGHTS INTO THE ROLE OF LtsA IN PEPTIDOGLYCAN MODIFICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; ASPARAGINE SYNTHETASE-B; BACILLUS-SUBTILIS 168; ESCHERICHIA-COLI; CELL-WALL; OUTER-MEMBRANE; MYCOBACTERIUM-SMEGMATIS; LYSOZYME RESISTANCE; CYTOPLASMIC STEPS; GENE	A gene named ltsA was earlier identified in Rhodococcus and Corynebacterium species while screening for mutations leading to increased cell susceptibility to lysozyme. The encoded protein belonged to a huge family of glutamine amidotransferases whose members catalyze amide nitrogen transfer from glutamine to various specific acceptor substrates. We here describe detailed physiological and biochemical investigations demonstrating the specific role of LtsA protein from Corynebacterium glutamicum (LtsA(Cg)) in the modification by amidation of cell wall peptidoglycan diaminopimelic acid (DAP) residues. A morphologically altered but viable Delta ltsA mutant was generated, which displays a high susceptibility to lysozyme and beta-lactam antibiotics. Analysis of its peptidoglycan structure revealed a total loss of DAP amidation, a modification that was found in 80% of DAP residues in the wild-type polymer. The cell peptidoglycan content and cross-linking were otherwise not modified in the mutant. Heterologous expression of LtsA(Cg) in Escherichia coli yielded a massive and toxic incorporation of amidated DAP into the peptidoglycan that ultimately led to cell lysis. In vitro assays confirmed the amidotransferase activity of LtsA(Cg) and showed that this enzyme used the peptidoglycan lipid intermediates I and II but not, or only marginally, the UDP-MurNAc pentapeptide nucleotide precursor as acceptor substrates. As is generally the case for glutamine amidotransferases, either glutamine or NH4+ could serve as the donor substrate for LtsA(Cg). The enzyme did not amidate tripeptide-and tetrapeptide-truncated versions of lipid I, indicating a strict specificity for a pentapeptide chain length.	[Levefaudes, Marjorie; Patin, Delphine; de Sousa-d'Auria, Celia; Blanot, Didier; Herve, Mireille; Houssin, Christine; Mengin-Lecreulx, Dominique] Univ Paris 11, CNRS, CEA, Inst Integrat Biol Cell I2BC, F-91198 Gif Sur Yvette, France; [Chami, Mohamed] Univ Basel, Biozentrum, Ctr Cellular Imaging & NanoAnalyt C CINA, CH-4058 Basel, Switzerland; [Arthur, Michel] INSERM, UMR S1138, Ctr Rech Cordeliers, Equipe 12, F-75006 Paris, France; [Arthur, Michel] Univ Paris 06, Sorbonne Univ, UMR S1138, Ctr Rech Cordeliers, F-75006 Paris, France; [Arthur, Michel] Univ Paris 05, Sorbonne Paris Cite, UMR S1138, Ctr Rech Cordeliers, F-75006 Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Basel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Houssin, C (corresponding author), Univ Paris 11, Lab Biol Mol Corynebacteries & Mycobacteries, Bat 409, F-91405 Orsay, France.	christine.houssin@u-psud.fr; dominique.mengin-lecreulx@u-psud.fr	Arthur, Michel/G-3680-2013	Arthur, Michel/0000-0003-1007-636X; Sousa, Celia R/0000-0001-8988-3724; MENGIN-LECREULX, Dominique/0000-0003-3205-0275	CNRS [UMR 8619, UMR 8621]; University of Paris-Sud; Agence Nationale de la Recherche (Bactoprenyl Project) [ANR-11-BSV3-002]	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris-Sud; Agence Nationale de la Recherche (Bactoprenyl Project)(French National Research Agency (ANR))	This work was supported by grants from CNRS (UMR 8619 and UMR 8621), the University of Paris-Sud, and the Agence Nationale de la Recherche (Bactoprenyl Project ANR-11-BSV3-002).	Ammam F, 2013, MOL MICROBIOL, V89, P612, DOI 10.1111/mmi.12299; Arbeloa A, 2004, J BIOL CHEM, V279, P41546, DOI 10.1074/jbc.M407149200; Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1998, J BACTERIOL, V180, P4603, DOI 10.1128/JB.180.17.4603-4612.1998; Barreteau H, 2009, J BACTERIOL, V191, P3657, DOI 10.1128/JB.01824-08; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bera A, 2007, J BACTERIOL, V189, P280, DOI 10.1128/JB.01221-06; Bernard E, 2011, J BACTERIOL, V193, P6323, DOI 10.1128/JB.05060-11; BOEHLEIN SK, 1994, J BIOL CHEM, V269, P7450; BONAMY C, 1990, FEMS MICROBIOL LETT, V66, P263, DOI 10.1016/0378-1097(90)90294-Z; Bouhss A, 2004, J BIOL CHEM, V279, P29974, DOI 10.1074/jbc.M314165200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; DAGERT M, 1979, GENE, V6, P23, DOI 10.1016/0378-1119(79)90082-9; Desmarais SM, 2013, MOL MICROBIOL, V89, P1, DOI 10.1111/mmi.12266; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Figueiredo TA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002508; GEIS A, 1978, BIOCHIM BIOPHYS ACTA, V527, P414, DOI 10.1016/0005-2744(78)90355-8; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; Gupta R, 2010, NAT MED, V16, P466, DOI 10.1038/nm.2120; Hirasawa T, 2000, J BACTERIOL, V182, P2696, DOI 10.1128/JB.182.10.2696-2701.2000; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; HUMBERT R, 1980, J BACTERIOL, V142, P212, DOI 10.1128/JB.142.1.212-220.1980; JAYATISSA PM, 1976, J GEN MICROBIOL, V96, P165, DOI 10.1099/00221287-96-1-165; Kumar P, 2012, MOL MICROBIOL, V86, P367, DOI 10.1111/j.1365-2958.2012.08199.x; LAEMMLI UK, 1973, J MOL BIOL, V80, P575, DOI 10.1016/0022-2836(73)90198-8; Larsen TM, 1999, BIOCHEMISTRY-US, V38, P16146, DOI 10.1021/bi9915768; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lavollay M, 2009, MOL MICROBIOL, V74, P650, DOI 10.1111/j.1365-2958.2009.06887.x; Mahapatra S, 2005, J BACTERIOL, V187, P2747, DOI 10.1128/JB.187.8.2747-2757.2005; Mahapatra S, 2005, J BACTERIOL, V187, P2341, DOI 10.1128/JB.187.7.2341-2347.2005; Mahapatra S, 2008, J BACTERIOL, V190, P655, DOI 10.1128/JB.00982-07; Marchand CH, 2012, J BACTERIOL, V194, P587, DOI 10.1128/JB.06138-11; MAUCK J, 1972, J BIOL CHEM, V247, P1180; MCNEIL M, 1990, J BIOL CHEM, V265, P18200; MENGINLECREULX D, 1982, J BACTERIOL, V151, P1109, DOI 10.1128/JB.151.3.1109-1117.1982; MENGINLECREULX D, 1983, J BACTERIOL, V154, P1284, DOI 10.1128/JB.154.3.1284-1290.1983; MENGINLECREULX D, 1991, J BACTERIOL, V173, P4625, DOI 10.1128/jb.173.15.4625-4636.1991; MENGINLECREULX D, 1985, J BACTERIOL, V163, P208, DOI 10.1128/JB.163.1.208-212.1985; Miller J. H., 1972, EXPT MOL GENETICS, P431; Mitani Y, 2005, J BACTERIOL, V187, P2582, DOI 10.1128/JB.187.8.2582-2591.2005; Munch D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002509; PETIT JF, 1969, BIOCHEM BIOPH RES CO, V35, P478, DOI 10.1016/0006-291X(69)90371-4; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365; Ren H, 2006, ANTIMICROB AGENTS CH, V50, P250, DOI 10.1128/AAC.50.1.250-255.2006; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Slamti L, 2011, J BACTERIOL, V193, P6266, DOI 10.1128/JB.05695-11; Veiga P, 2009, J BACTERIOL, V191, P3752, DOI 10.1128/JB.00126-09; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	56	24	24	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13079	13094		10.1074/jbc.M115.642843	http://dx.doi.org/10.1074/jbc.M115.642843			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847251	Green Published, hybrid			2022-12-26	WOS:000354975700012
J	Ahire, JJ; Neveling, DP; Hattingh, M; Dicks, LMT				Ahire, Jayesh J.; Neveling, Deon P.; Hattingh, Melanie; Dicks, Leon M. T.			Ciprofloxacin-Eluting Nanofibers Inhibits Biofilm Formation by Pseudomonas aeruginosa and a Methicillin-Resistant Staphylococcus aureus	PLOS ONE			English	Article							OXIDE) PEO; ELECTROSPUN; COMBINATIONS; INFECTIONS; DRESSINGS; BACTERIA; RELEASE	Pseudomonas aeruginosa and Staphylococcus aureus are commonly associated with hospital-acquired infections and are known to form biofilms. Ciprofloxacin (CIP), which is normally used to treat these infections, is seldom effective in killing cells in a biofilm. This is mostly due to slow or weak penetration of CIP to the core of biofilms. The problem is accentuated by the release of CIP below MIC (minimal inhibitory concentration) levels following a rapid (burst) release. The aim of this study was to develop a drug carrier that would keep CIP above MIC levels for an extended period. Ciprofloxacin was suspended into poly(D, Llactide) (PDLLA) and poly(ethylene oxide) (PEO), and electrospun into nanofibers (CIP-F). All of the CIP was released from the nanofibers within 2 h, which is typical of a burst release. However, 99% of P. aeruginosa PA01 cells and 91% of S. aureus Xen 30 cells (a methicillin-resistant strain) in biofilms were killed when exposed to CIP-F. CIP levels remained above MIC for 5 days, as shown by growth inhibition of the cells in vitro. The nanofibers were smooth in texture with no bead formation, as revealed by scanning electron and atomic force microscopy. A single vibration peak at 1632 cm(-1), recorded with Fourier transform infrared spectroscopy, indicated that CIP remained in crystal form when incorporated into PDLLA: PEO. No abnormalities in the histology of MCF-12A breast epithelial cells were observed when exposed to CIP-F. This is the first report of the inhibition of biofilm formation by CIP released from PDLLA: PEO nanofibers.	[Ahire, Jayesh J.; Neveling, Deon P.; Hattingh, Melanie; Dicks, Leon M. T.] Univ Stellenbosch, Dept Microbiol, Matieland, Stellenbosch, South Africa	Stellenbosch University	Dicks, LMT (corresponding author), Univ Stellenbosch, Dept Microbiol, Matieland, Stellenbosch, South Africa.	LMTD@sun.ac.za	Dicks, Leon/X-6642-2019; Ahire, Jayesh J/Q-1632-2018; Neveling, Deon/AAH-3763-2020	Ahire, Jayesh J/0000-0002-1142-8630; Neveling, Deon/0000-0003-4090-9684; Dicks, Leon/0000-0002-5157-9046	Claude Leon Foundation, Cape Town, South Africa	Claude Leon Foundation, Cape Town, South Africa	This work was supported by Claude Leon Foundation in the form of Postdoctoral Fellowship to JJA, Cape Town, South Africa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeid M, 2010, J GENET ENG BIOTECHN, V8, P29; Abrigo M, 2014, MACROMOL BIOSCI, V14, P772, DOI 10.1002/mabi.201300561; Ahire JJ, 2015, PROBIOTICS ANTIMICRO, V7, P52, DOI 10.1007/s12602-014-9171-5; Ahire JJ, 2014, CURR MICROBIOL, V69, P587, DOI 10.1007/s00284-014-0635-3; Ahire JJ, 2014, ANTIMICROB AGENTS CH, V58, P2098, DOI 10.1128/AAC.02397-13; Ahmed Z, 2013, SAUDI J BIOL SCI, V20, P79, DOI 10.1016/j.sjbs.2012.10.005; Andrews JM, 2001, J ANTIMICROB CHEMOTH, V48, P5, DOI 10.1093/jac/48.suppl_1.5; Ball C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049792; Bottino MC, 2014, CLIN ORAL INVEST, V18, P2151, DOI 10.1007/s00784-014-1201-x; Cross A., 1983, REV INFECT DIS, V5, P837; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Das RR, 2013, SCI WORLD J, DOI 10.1155/2013/645653; DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14; Demirci S, 2014, POLYM CHEM-UK, V5, P2050, DOI 10.1039/c3py01276j; Hernandez-Borrell J, 2003, INT J PHARMACEUT, V252, P149, DOI 10.1016/S0378-5173(02)00633-6; Heunis TDJ, 2010, J BIOMED BIOTECHNOL, V61, P1; Heunis T, 2011, INT J MOL SCI, V12, P2158, DOI 10.3390/ijms12042158; Heunis TDJ, 2013, ANTIMICROB AGENTS CH, V57, P3928, DOI 10.1128/AAC.00622-13; Hu XL, 2014, J CONTROL RELEASE, V185, P12, DOI 10.1016/j.jconrel.2014.04.018; Jannesari M, 2011, INT J NANOMED, V6, DOI 10.2147/IJN.S17595; Lucena A, 2014, J HOSP INFECT, V87, P234, DOI 10.1016/j.jhin.2014.05.007; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Shawki MM., 2010, ROMANIAN J BIOPHYS, V20, P335; Shive MS, 1997, ADV DRUG DELIV REV, V28, P5; Singh R, 2010, J ANTIMICROB CHEMOTH, V65, P1955, DOI 10.1093/jac/dkq257; Toncheva A, 2012, EUR J PHARM SCI, V47, P642, DOI 10.1016/j.ejps.2012.08.006; Tseng BS, 2013, ENVIRON MICROBIOL, V15, P2865, DOI 10.1111/1462-2920.12155; Wei Q, 2013, INT J MOL SCI, V14, P20983, DOI 10.3390/ijms141020983; Yu DG, 2010, AAPS PHARMSCITECH, V11, P809, DOI 10.1208/s12249-010-9438-4; Zhao TM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-140	30	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123648	10.1371/journal.pone.0123648	http://dx.doi.org/10.1371/journal.pone.0123648			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853255	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400112
J	Cysique, LA; Hey-Cunningham, WJ; Dermody, N; Chan, P; Brew, BJ; Koelsch, KK				Cysique, Lucette A.; Hey-Cunningham, William J.; Dermody, Nadene; Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.			Peripheral Blood Mononuclear Cells HIV DNA Levels Impact Intermittently on Neurocognition	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; IMPAIRMENT; INFECTION; DYNAMICS; THERAPY; PERSIST; COHORT	Objectives To determine the contribution of peripheral blood mononuclear cells' (PBMCs) HIV DNA levels to HIV-associated dementia (HAD) and non-demented HIV-associated neurocognitive disorders (HAND) in chronically HIV-infected adults with long-term viral suppression on combined antiretroviral treatment (cART). Methods Eighty adults with chronic HIV infection on cART (>97% with plasma and CSF HIV RNA <50 copies/mL) were enrolled into a prospective observational cohort and underwent assessments of neurocognition and pre-morbid cognitive ability at two visits 18 months apart. HIV DNA in PBMCs was measured by real-time PCR at the same time-points. Results At baseline, 46% had non-demented HAND; 7.5% had HAD. Neurocognitive decline occurred in 14% and was more likely in those with HAD (p<.03). Low pre-morbid cognitive ability was uniquely associated with HAD (p<.05). Log(10) HIV DNA copies were stable between study visits (2.26 vs. 2.22 per 10(6) PBMC). Baseline HIV DNA levels were higher in those with lower pre-morbid cognitive ability (p<.04), and higher in those with no ART treatment during HIV infection 1st year (p = .03). Baseline HIV DNA was not associated with overall neurocognition. However, % ln HIV DNA change was associated with decline in semantic fluency in unadjusted and adjusted analyses (p = .01-.03), and motor-coordination (p = .02-.12) to a lesser extent. Conclusions PBMC HIV DNA plays a role in HAD pathogenesis, and this is moderated by pre-morbid cognitive ability in the context of long-term viral suppression. While the HIV DNA levels in PBMC are not associated with current non-demented HAND, increasing HIV DNA levels were associated with a decline in neurocognitive functions associated with HAND progression.	[Cysique, Lucette A.; Dermody, Nadene] Neurosci Res Australia, Sydney, NSW, Australia; [Hey-Cunningham, William J.; Koelsch, Kersten K.] UNSW Australia, UNSW Med, Kirby Inst, Sydney, NSW, Australia; [Cysique, Lucette A.; Brew, Bruce J.] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Unit, Sydney, NSW, Australia; [Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.] St Vincents Hosp, Dept Neurol, Sydney, NSW 2010, Australia; [Chan, Phillip; Brew, Bruce J.; Koelsch, Kersten K.] St Vincents Hosp, Dept HIV, Sydney, NSW 2010, Australia; [Cysique, Lucette A.; Hey-Cunningham, William J.; Brew, Bruce J.; Koelsch, Kersten K.] Univ New S Wales, Sydney, NSW, Australia; [Dermody, Nadene] Macquarie Univ, Sydney, NSW 2109, Australia; [Chan, Phillip] Queen Elizabeth Hosp, Hong Kong, Hong Kong, Peoples R China	Neuroscience Research Australia; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney; Macquarie University	Cysique, LA (corresponding author), Neurosci Res Australia, Sydney, NSW, Australia.	lcysique@unsw.edu.au	Cysique, Lucette A./U-1357-2017	Cysique, Lucette A./0000-0002-7711-6373; Chan, Phillip/0000-0002-4071-4409; brew, bruce/0000-0003-0622-1392	National Health and Medical Research Council of Australia (Cysique CIA/PI) [ID568746]; post-doctoral Brain Science UNSW fellowship (Cysique); Mercks Sharp Dome (MSD); National Heath and Medical Research Council of Australia Career Development Fellowship (Cysique CIA/PI) [APP1045400]; Peter Duncan Neurosciences Unit	National Health and Medical Research Council of Australia (Cysique CIA/PI)(National Health and Medical Research Council (NHMRC) of Australia); post-doctoral Brain Science UNSW fellowship (Cysique); Mercks Sharp Dome (MSD); National Heath and Medical Research Council of Australia Career Development Fellowship (Cysique CIA/PI)(National Health and Medical Research Council (NHMRC) of Australia); Peter Duncan Neurosciences Unit	This study was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au) project grant ID568746 (Cysique CIA/PI), the 2009-2012 post-doctoral Brain Science UNSW fellowship (Cysique), 2012 Mercks Sharp Dome (MSD) partial salary support for 2012, the National Heath and Medical Research Council of Australia Career Development Fellowship APP1045400 (Cysique CIA/PI) and the Peter Duncan Neurosciences Unit (Head Prof. Bruce Brew). MSD had no direct participation in the current study design, data analyses and interpretation. Dr. Cysique has otherwise no conflict of interest with the organizations that funded this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus CF, 2010, J VIROL METHODS, V165, P151, DOI 10.1016/j.jviromet.2010.01.012; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Besson GJ, 2014, CLIN INFECT DIS, V59, P1312, DOI 10.1093/cid/ciu585; Brew BJ, 2013, EXPERT OPIN BIOL TH, V13, P403, DOI 10.1517/14712598.2013.748029; Chelune G. J., 1986, ADV CLIN NEUROPSYCHO, V3, P15, DOI DOI 10.1007/978-1-4613-2211-5_4; Cysique LA, 2014, J NEUROVIROL, V20, P258, DOI 10.1007/s13365-014-0242-x; Cysique LA, 2011, J CLIN EXP NEUROPSYC, V33, P505, DOI 10.1080/13803395.2010.535504; Dahl V, 2014, AIDS, V28, P2251, DOI 10.1097/QAD.0000000000000400; Desplats P, 2013, NEUROLOGY, V80, P1415, DOI 10.1212/WNL.0b013e31828c2e9e; DUBREUIL RM, 1993, PCR METH APPL, V3, P57; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; Hopkins GW, 2014, NEW VIEW STAT; Kamat A, 2012, JAIDS-J ACQ IMM DEF, V60, P234, DOI 10.1097/QAI.0b013e318256f3bc; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Kusao I, 2012, J NEUROPSYCH CLIN N, V24, P71, DOI 10.1176/appi.neuropsych.11050109; Lane TA, 2012, NEUROPSYCHOLOGY, V26, P713, DOI 10.1037/a0029964; Murray JM, 2014, J VIROL, V88, P3516, DOI 10.1128/JVI.03331-13; Murray JM, 2012, AIDS, V26, P543, DOI 10.1097/QAD.0b013e328350fb3c; Nelson H., 1991, NATL ADULT READING T; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Robertson KR, 2007, AIDS, V21, P1915, DOI 10.1097/QAD.0b013e32828e4e27; Shiramizu B, 2007, J NEUROPSYCH CLIN N, V19, P157, DOI 10.1176/appi.neuropsych.19.2.157; Shiramizu B, 2009, J NEUROPSYCH CLIN N, V21, P68, DOI 10.1176/appi.neuropsych.21.1.68; Valcour VG, 2009, NEUROLOGY, V72, P992, DOI 10.1212/01.wnl.0000344404.12759.83; Valcour VG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070164; Valcour VG, 2010, J LEUKOCYTE BIOL, V87, P621, DOI 10.1189/jlb.0809571	27	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0120488	10.1371/journal.pone.0120488	http://dx.doi.org/10.1371/journal.pone.0120488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853424	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400014
J	Dumas, P; Barbut, J; Le Ru, B; Silvain, JF; Clamens, AL; d'Alencon, E; Kergoat, GJ				Dumas, Pascaline; Barbut, Jerome; Le Ru, Bruno; Silvain, Jean-Francois; Clamens, Anne-Laure; d'Alencon, Emmanuelle; Kergoat, Gael J.			Phylogenetic Molecular Species Delimitations Unravel Potential New Species in the Pest Genus Spodoptera Guenee, 1852 (Lepidoptera, Noctuidae)	PLOS ONE			English	Article							FALL ARMYWORM LEPIDOPTERA; REPRODUCTIVE ISOLATION MECHANISMS; PARTITIONED BAYESIAN ANALYSES; BRANCH-LENGTH ESTIMATION; YULE-COALESCENT MODEL; FRUGIPERDA LEPIDOPTERA; HOST STRAINS; INTEGRATIVE TAXONOMY; MITOCHONDRIAL-DNA; CRYPTIC SPECIATION	FNowadays molecular species delimitation methods promote the identification of species boundaries within complex taxonomic groups by adopting innovative species concepts and theories (e.g. branching patterns, coalescence). As some of them can efficiently deal with large single-locus datasets, they could speed up the process of species discovery compared to more time consuming molecular methods, and benefit from the existence of large public datasets; these methods can also particularly favour scientific research and actions dealing with threatened or economically important taxa. In this study we aim to investigate and clarify the status of economically important moths species belonging to the genus Spodoptera (Lepidoptera, Noctuidae), a complex group in which previous phylogenetic analyses and integrative approaches already suggested the possible occurrence of cryptic species and taxonomic ambiguities. In this work, the effectiveness of innovative (and faster) species delimitation approaches to infer putative species boundaries has been successfully tested in Spodoptera, by processing the most comprehensive dataset (in terms of number of species and specimens) ever achieved; results are congruent and reliable, irrespective of the set of parameters and phylogenetic models applied. Our analyses confirm the existence of three potential new species clusters (for S. exigua (Hubner, 1808), S. frugiperda (J.E. Smith, 1797) and S. mauritia (Boisduval, 1833)) and support the synonymy of S. marima (Schaus, 1904) with S. ornithogalli (Guenee, 1852). They also highlight the ambiguity of the status of S. cosmiodes (Walker, 1858) and S. descoinsi Lalanne-Cassou & Silvain, 1994. This case study highlights the interest of molecular species delimitation methods as valuable tools for species discovery and to emphasize taxonomic ambiguities.	[Dumas, Pascaline] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Barbut, Jerome] Museum Natl Hist Nat, Direct Collect, USM 602, F-75231 Paris, France; [Le Ru, Bruno; Silvain, Jean-Francois] CNRS, IRD, Lab Evolut Genomes Speciat, Gif Sur Yvette, France; [Le Ru, Bruno; Silvain, Jean-Francois] Univ Paris 11, Orsay, France; [Le Ru, Bruno] African Insect Sci Food & Hlth icipe, Unite Rech IRD 072, Nairobi, Kenya; [Clamens, Anne-Laure] INRA, IRD, CIRAD, Montpellier SupAgro,UMR CBGP 1062, Montferrier Sur Lez, France; [d'Alencon, Emmanuelle] Univ Montpellier 2, DGIMI, UM2, UMR 1333, Montpellier, France; [d'Alencon, Emmanuelle] Univ Montpellier 2, DGIMI, INRA, UMR 1333, Montpellier, France	University of Amsterdam; Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; International Centre of Insect Physiology & Ecology (ICIPE); CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; Universite de Montpellier	Dumas, P (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	pascalinedumas@gmail.com	LE RU, BRUNO/C-5862-2011; d'Alençon, Emmanuelle/AAD-3069-2020; Le Ru, bruno/K-3480-2016; Kergoat, Gael J./AAW-6505-2020	Le Ru, bruno/0000-0002-4208-3727; Kergoat, Gael J./0000-0002-8284-6215; BARBUT, Jerome/0000-0002-5022-2475	INRA (AAP SPE SPODOPTERA); French National Research Agency [ANR-12-BSV7-0004-01 ADA-SPODO]	INRA (AAP SPE SPODOPTERA); French National Research Agency(French National Research Agency (ANR))	Part of the sequencing was supported by a Genoscope project @-Speed-Id (Accurate SPEciEs Delimitation and Identification of eukaryotic biodiversity using DNA markers) proposed by F-BoL, the French Barcode of life initiative and by the program 'Bibliotheque du Vivant' (Project SPODOBAR) supported by a joint "Centre national de la recherche scientifique", "Institut National de la Recherche Agronomique" and "Museum national d'Histoire naturelle" consortium. The project was also supported by INRA (AAP SPE SPODOPTERA) and a grant from the French National Research Agency (ANR-12-BSV7-0004-01 ADA-SPODO).	Alvarez N, 2005, J ZOOL SYST EVOL RES, V43, P29, DOI 10.1111/j.1439-0469.2004.00286.x; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Astrin JJ, 2012, MOL PHYLOGENET EVOL, V63, P1, DOI 10.1016/j.ympev.2011.11.018; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barraclough TG, 2009, BIOL LETTERS, V5, P425, DOI 10.1098/rsbl.2009.0091; Barros EM, 2010, ENTOMOL EXP APPL, V137, P237, DOI 10.1111/j.1570-7458.2010.01058.x; Bergsten J, 2012, SYST BIOL, V61, P851, DOI 10.1093/sysbio/sys037; Blaxter ML, 2004, PHILOS T R SOC B, V359, P669, DOI 10.1098/rstb.2003.1447; Bolnick DI, 2007, ANNU REV ECOL EVOL S, V38, P459, DOI 10.1146/annurev.ecolsys.38.091206.095804; Bond JE, 2002, EVOLUTION, V56, P1123; Bortolussi N, 2006, BIOINFORMATICS, V22, P363, DOI 10.1093/bioinformatics/bti798; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; BROWN ES, 1975, B ENTOMOL RES, V65, P221, DOI 10.1017/S0007485300005939; Brown JM, 2007, SYSTEMATIC BIOL, V56, P643, DOI 10.1080/10635150701546249; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Butcher BA, 2012, ZOOTAXA, P7; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413; Collin R, 2003, BIOL J LINN SOC, V78, P541, DOI 10.1046/j.0024-4066.2002.00166.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dinca V, 2011, P ROY SOC B-BIOL SCI, V278, P347, DOI 10.1098/rspb.2010.1089; Dres M, 2002, PHILOS T R SOC B, V357, P471, DOI 10.1098/rstb.2002.1059; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dumas P, 2015, GENETICA IN PRESS, DOI [10.1007/s10709-015-9829-2, DOI 10.1007/S10709-015-9829-2]; Dupuis JR, 2012, MOL ECOL, V21, P4422, DOI 10.1111/j.1365-294X.2012.05642.x; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Ekman S, 2011, SYST BIOL, V60, P541, DOI 10.1093/sysbio/syr022; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; Erixon P, 2003, SYST BIOL, V52, P665, DOI 10.1080/10635150390235485; Esselstyn JA, 2012, P ROY SOC B-BIOL SCI, V279, P3678, DOI 10.1098/rspb.2012.0705; Ezard T, 2009, PACKAGE SPLITS SPECI; Fletcher D. S., 1956, Bulletin of Entomological Research London, V47, P215, DOI 10.1017/S0007485300046666; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; Frey JE, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-106; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Fujita MK, 2012, TRENDS ECOL EVOL, V27, P480, DOI 10.1016/j.tree.2012.04.012; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Gebiola M, 2012, MOL ECOL, V21, P1190, DOI 10.1111/j.1365-294X.2011.05428.x; Gentile G, 2002, GENETICS, V161, P1561; Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a; Gompert Z, 2006, MOL ECOL, V15, P1759, DOI 10.1111/j.1365-294X.2006.02905.x; Greenberg SM, 2001, ANN ENTOMOL SOC AM, V94, P566, DOI 10.1603/0013-8746(2001)094[0566:FALHOS]2.0.CO;2; Groot AT, 2010, ECOL ENTOMOL, V35, P105, DOI 10.1111/j.1365-2311.2009.01138.x; Groot AT, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-20; Hailer F, 2012, SCIENCE, V336, P344, DOI 10.1126/science.1216424; Hamback PA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-92; Hamilton CA, 2014, MOL PHYLOGENET EVOL, V71, P79, DOI 10.1016/j.ympev.2013.11.007; Hausmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017134; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Huber BA, 2005, ZOOL ANZ, V243, P273, DOI 10.1016/j.jcz.2004.12.001; Huelsenbeck JP, 2004, MOL BIOL EVOL, V21, P1123, DOI 10.1093/molbev/msh123; Janzen DH, 2009, MOL ECOL RESOUR, V9, P1, DOI 10.1111/j.1755-0998.2009.02628.x; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Juarez ML, 2014, ENTOMOL EXP APPL, V152, P182, DOI 10.1111/eea.12215; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kergoat GJ, 2008, SYST ENTOMOL, V33, P289, DOI 10.1111/j.1365-3113.2007.00405.x; Kergoat GJ, 2012, MOL PHYLOGENET EVOL, V65, P855, DOI 10.1016/j.ympev.2012.08.006; Kodandaramaiah U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041058; Lalanne-Cassou B, 1999, ANN SOC ENTOMOL FR, V35, P109; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Le Ru BP, 2014, INVERTEBR SYST, V28, P451, DOI 10.1071/IS13062; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Levy HC, 2002, FLA ENTOMOL, V85, P186, DOI 10.1653/0015-4040(2002)085[0186:SIOSFL]2.0.CO;2; Lima ER, 2009, CHEMOECOLOGY, V19, P29, DOI 10.1007/s00049-009-0005-y; Lohse K, 2009, SYST BIOL, V58, P439, DOI 10.1093/sysbio/syp039; Lu YJ, 1996, FLA ENTOMOL, V79, P48, DOI 10.2307/3495753; Lumley LM, 2010, SYST ENTOMOL, V35, P416, DOI 10.1111/j.1365-3113.2009.00514.x; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Machado V, 2008, ANN ENTOMOL SOC AM, V101, P619, DOI 10.1603/0013-8746(2008)101[619:MCOHSO]2.0.CO;2; Maddison WP, 2010, MESQUITE A MODULAR S; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Martinelli S, 2006, J ECON ENTOMOL, V99, P519, DOI 10.1603/0022-0493-99.2.519; McMichael M, 1999, ANN ENTOMOL SOC AM, V92, P175, DOI 10.1093/aesa/92.2.175; Meagher RL, 2003, FLA ENTOMOL, V86, P450, DOI 10.1653/0015-4040(2003)086[0450:IHSOFA]2.0.CO;2; Meagher RL, 2011, J INSECT BEHAV, V24, P337, DOI 10.1007/s10905-011-9259-7; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Melville J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101847; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitchell A, 2006, SYST ENTOMOL, V31, P21, DOI 10.1111/j.1365-3113.2005.00306.x; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Nagoshi RN, 2008, ANN ENTOMOL SOC AM, V101, P1112, DOI 10.1603/0013-8746-101.6.1112; Nagoshi RN, 2012, ECOL EVOL, V2, P1458, DOI 10.1002/ece3.268; Nagoshi RN, 2009, ENVIRON ENTOMOL, V38, P1546, DOI 10.1603/022.038.0605; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; O'Meara BC, 2006, EVOLUTION, V60, P922; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL J LINN SOC-LOND, V155, P97, DOI 10.1111/j.1096-3642.2008.00424.x; PAIR SD, 1986, FLA ENTOMOL, V69, P468, DOI 10.2307/3495380; Papadopoulou A, 2009, SYST BIOL, V58, P442, DOI 10.1093/sysbio/syp038; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; PASHLEY DP, 1987, ANN ENTOMOL SOC AM, V80, P731, DOI 10.1093/aesa/80.6.731; PASHLEY DP, 1986, ANN ENTOMOL SOC AM, V79, P898, DOI 10.1093/aesa/79.6.898; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Phillips MJ, 2009, GENE, V441, P132, DOI 10.1016/j.gene.2008.08.017; Pogue M.G, 2002, WORLD REVISION GENUS, V43, P1; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prado BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027776; Pringle A, 2005, EVOLUTION, V59, P1886, DOI 10.1111/j.0014-3820.2005.tb01059.x; Prowell DP, 2004, ANN ENTOMOL SOC AM, V97, P1034, DOI 10.1603/0013-8746(2004)097[1034:MGAOHU]2.0.CO;2; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; QUISENBERRY SS, 1991, FLA ENTOMOL, V74, P194, DOI 10.2307/3495297; Rannala B, 2003, GENETICS, V164, P1645; Reid NM, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-196; Riedel A, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-15; Riedel A, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.280.3906; Roe AD, 2007, MOL ECOL, V16, P3617, DOI 10.1111/j.1365-294X.2007.03412.x; Ross KG, 2010, SYST BIOL, V59, P162, DOI 10.1093/sysbio/syp089; Rougerie R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043920; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Salinas-Hernandez H, 2011, NEOTROP ENTOMOL, V40, P421, DOI 10.1590/S1519-566X2011000400002; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schofl G, 2009, J EVOLUTION BIOL, V22, P1447, DOI 10.1111/j.1420-9101.2009.01759.x; Schofl G, 2011, AM NAT, V177, P470, DOI 10.1086/658904; Silvain Jean-Francois, 1997, Revue Francaise d'Entomologie (Nouvelle Serie), V19, P95; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Talavera G, 2013, METHODS ECOL EVOL, V4, P1101, DOI 10.1111/2041-210X.12107; Tang CQ, 2014, METHODS ECOL EVOL, V5, P1086, DOI 10.1111/2041-210X.12246; TODD EL, 1980, ANN ENTOMOL SOC AM, V73, P722, DOI 10.1093/aesa/73.6.722; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Velasquez-Velez MI, 2011, ANN ENTOMOL SOC AM, V104, P826, DOI 10.1603/AN10164; WHITFORD F, 1988, FLA ENTOMOL, V71, P234, DOI 10.2307/3495426; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Williams ST, 2001, MOL BIOL EVOL, V18, P1484, DOI 10.1093/oxfordjournals.molbev.a003934; Wilson EO, 2004, PHILOS T R SOC B, V359, P739, DOI 10.1098/rstb.2003.1440; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Yeates DK, 2011, SYST ENTOMOL, V36, P209, DOI 10.1111/j.1365-3113.2010.00558.x; Zhang JJ, 2013, BIOINFORMATICS, V29, P2869, DOI 10.1093/bioinformatics/btt499	145	53	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122407	10.1371/journal.pone.0122407	http://dx.doi.org/10.1371/journal.pone.0122407			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853412	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400068
J	Liang, CH; Kelsey, KT; McClean, MD; Christensen, BC; Marsit, CJ; Karagas, MR; Waterboer, T; Pawlita, M; Nelson, HH				Liang, Caihua; Kelsey, Karl T.; McClean, Michael D.; Christensen, Brock C.; Marsit, Carmen J.; Karagas, Margaret R.; Waterboer, Tim; Pawlita, Michael; Nelson, Heather H.			A Coding Variant in TMC8 (EVER2) Is Associated with High Risk HPV Infection and Head and Neck Cancer Risk	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; HUMAN-PAPILLOMAVIRUS; PROTEINS; PATHOGENESIS; SEROLOGY; ELISA	HPV infection is a causal agent in many epithelial cancers, yet our understanding of genetic susceptibility to HPV infection and resultant cancer risk is limited. Epidermodysplasia Verruciformis is a rare condition of extreme susceptibility to cutaneous HPV infection primarily attributable to mutations in TMC6 and TMC8. Genetic variation in the TMC6/TMC8 region has been linked to beta-type HPV infection and squamous cell carcinoma of the skin, cervical cancer, HPV persistence and progression to cervical cancer. Here, we have tested the hypothesis that the common TMC8 SNP rs7208422 is associated with high-risk HPV infection and risk of head and neck squamous cell carcinoma (HNSCC). Seropositivity to the HPV L1 protein (HPV16, 18, 11, 31, 33, 35, 45, 52, 58) was measured in 514 cases and 452 population-based controls. Genotype was significantly associated with seropositivity to HPV18 L1 (OR (TT vs AA) = 0.48, 95% CI = 0.22-0.99) and borderline significantly associated with HPV16 L1 (OR (TT vs AA) = 0.58, 95% CI = 0.22-1.17). There was a consistent inverse association between TMC8 genotype and infection with other HPV types, including statistically significant associations for HPV31 and HPV52. Consistent with these results, the variant T genotype was associated with a reduced risk of HNSCC (ORAT: 0.63, 95% CI 0.45-0.89, ORTT: 0.54, 95% CI 0.36-0.81), even among subjects seronegative for all HPV types (ORAT: 0.71, 95% CI 0.45-1.11, ORTT: 0.54, 95% CI 0.31-0.93). Our data indicate that common genetic variation in TMC8 is associated with high-risk HPV infection and HNSCC etiology.	[Liang, Caihua; Kelsey, Karl T.] Brown Univ, Dept Epidemiol, Div Biol & Med, Providence, RI 02912 USA; [Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Div Biol & Med, Providence, RI 02912 USA; [McClean, Michael D.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA; [Christensen, Brock C.; Karagas, Margaret R.] Dartmouth Med Sch, Dept Epidemiol, Lebanon, NH USA; [Christensen, Brock C.; Marsit, Carmen J.; Karagas, Margaret R.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH USA; [Marsit, Carmen J.] Dartmouth Med Sch, Dept Toxicol, Lebanon, NH USA; [Waterboer, Tim; Pawlita, Michael] German Canc Res Ctr, Deutsch Krebsforschungszentrum, Infect & Canc Program, Heidelberg, Germany; [Nelson, Heather H.] Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA; [Nelson, Heather H.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA	Brown University; Brown University; Boston University; Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Nelson, HH (corresponding author), Univ Minnesota, Mason Canc Ctr, Minneapolis, MN 55455 USA.	hhnelson@umn.edu	McClean, Michael D/J-2934-2015; Waterboer, Tim/G-1252-2010	Nelson, Heather/0000-0003-1901-9513; Marsit, Carmen/0000-0003-4566-150X; Pawlita, Michael/0000-0002-4720-8306	 [NIH R01CA118443];  [R01CA078609]; NATIONAL CANCER INSTITUTE [R01CA078609, R01CA118443, R01CA057494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER	; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the following grants: NIH R01CA118443, R01CA078609. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castro FA, 2012, INT J CANCER, V130, P349, DOI 10.1002/ijc.26016; Clifford GM, 2007, CANCER EPIDEM BIOMAR, V16, P1874, DOI 10.1158/1055-9965.EPI-07-0349; Crequer A, 2013, J CLIN IMMUNOL, V33, P14, DOI 10.1007/s10875-012-9749-1; Gaud G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.27; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Lazarczyk M, 2008, J EXP MED, V205, P35, DOI 10.1084/jem.20071311; Lazarczyk M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039995; Lazarczyk M, 2009, MICROBIOL MOL BIOL R, V73, P348, DOI 10.1128/MMBR.00033-08; Michaud DS, 2014, INT J CANCER, V135, P1653, DOI 10.1002/ijc.28811; Patel AS, 2008, J INVEST DERMATOL, V128, P2888, DOI 10.1038/jid.2008.162; Peters ES, 2005, CANCER EPIDEM BIOMAR, V14, P476, DOI 10.1158/1055-9965.EPI-04-0431; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Wang SS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008667; Waterboer T, 2006, J IMMUNOL METHODS, V309, P200, DOI 10.1016/j.jim.2005.11.008; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123716	10.1371/journal.pone.0123716	http://dx.doi.org/10.1371/journal.pone.0123716			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853559	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400115
J	Assinger, A; Volf, I; Schmid, D				Assinger, Alice; Volf, Ivo; Schmid, Diethart			A Novel, Rapid Method to Quantify Intraplatelet Calcium Dynamics by Ratiometric Flow Cytometry	PLOS ONE			English	Article							INDICATORS; GENERATION; PLATELETS; MYOCYTES; FLUO-3; CA-2	Cytosolic free calcium ions represent important second-messengers in platelets. Therefore, quantitative measurement of intraplatelet calcium provides a popular and very sensitive tool to evaluate platelet activation and reactivity. Current protocols for determination of intracellular calcium concentrations in platelets have a number of limitations. Cuvette-based methods do not allow measurement of calcium flux in complex systems, such as whole blood, and therefore require isolation steps that potentially interfere with platelet activation. Flow cytometry has the potential to overcome this limitation, but to date the application of calibrated, quantitative readout of calcium kinetics has only been described for Indo-1. As excitation of Indo-1 requires a laser in the ultraviolet range, such measurements cannot be performed with a standard flow cytometer. Here, we describe a novel, rapid calibration method for ratiometric calcium measurement in platelets using both Ar+-laser excited fluorescence dyes Fluo-4 and Fura Red. We provide appropriate equations that allow rapid quantification of intraplatelet calcium fluxes by measurement of only two standardisation buffers. We demonstrate that this method allows quantitative calcium measurement in platelet rich plasma as well as in whole blood. Further, we show that this method prevents artefacts due to platelet aggregate formation and is therefore an ideal tool to determine basal and agonist induced calcium kinetics.	[Assinger, Alice; Volf, Ivo; Schmid, Diethart] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria	Medical University of Vienna	Schmid, D (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Physiol, Vienna, Austria.	diethart.schmid@meduniwien.ac.at	Schmid, Diethart/C-5049-2009	Schmid, Diethart/0000-0002-2225-9836; Assinger, Alice/0000-0002-5670-5910	Austrian Science Fund [FWF-P24978]; Austrian Science Fund (FWF) [P 24978] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The project was funded by the Austrian Science Fund issued to AA (grant number FWF-P24978); http://www.fwf.ac.at/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey S, 2006, J IMMUNOL METHODS, V311, P220, DOI 10.1016/j.jim.2006.02.005; Dustin LB, 2000, CLIN APPL IMMUNOL RE, V1, P5, DOI DOI 10.1016/S1529-1049(00)00002-7; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Greimers R, 1996, CYTOMETRY, V23, P205, DOI 10.1002/(SICI)1097-0320(19960301)23:3<205::AID-CYTO4>3.0.CO;2-H; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hagen BM, 2012, CELL CALCIUM, V52, P170, DOI 10.1016/j.ceca.2012.05.010; KOLLER E, 1992, METHOD ENZYMOL, V215, P383; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; RAO GHR, 1985, BIOCHEM BIOPH RES CO, V132, P652, DOI 10.1016/0006-291X(85)91182-9; Rinder H M, 1998, Clin Lab Sci, V11, P365; Thomas D, 2000, CELL CALCIUM, V28, P213, DOI 10.1054/ceca.2000.0152; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; WILLIAMS DA, 1990, CELL CALCIUM, V11, P75, DOI 10.1016/0143-4160(90)90061-X	16	19	20	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122527	10.1371/journal.pone.0122527	http://dx.doi.org/10.1371/journal.pone.0122527			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849642	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800139
J	Chamberlain, S; Stolz, U; Dreifuss, B; Nelson, SW; Hammerstedt, H; Andinda, J; Maling, S; Bisanzo, M				Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Maling, Samuel; Bisanzo, Mark			Mortality Related to Acute Illness and Injury in Rural Uganda: Task Shifting to Improve Outcomes	PLOS ONE			English	Article							EMERGENCY CARE; PNEUMONIA; CHILDREN; MALARIA; NEEDS	Background Due to the dual critical shortages of acute care and healthcare workers in resource-limited settings, many people suffer or die from conditions that could be easily treated if existing resources were used in a more timely and effective manner. In order to address this preventable morbidity and mortality, a novel emergency midlevel provider training program was developed in rural Uganda. This is the first study that assesses this unique application of a task-shifting model to acute care by evaluating the outcomes of 10,105 patients. Methods Nurses participated in a two-year training program to become midlevel providers called Emergency Care Practitioners at a rural district hospital. This is a retrospective analysis of the Emergency Department's quality assurance database, including three-day follow-up data. Case fatality rates (CFRs) are reported as the percentage of cases with a specific diagnosis that died within three days of their Emergency Department visit. Findings Overall, three-day mortality was 2.0%. The most common diagnoses of patients who died were malaria (n=60), pneumonia (n=51), malnutrition (n=21), and trauma (n=18). Overall and under-five CFRs were as follows: malaria, 2.0% and 1.9%; pneumonia, 5.5% and 4.1%; and trauma, 1.2% and 1.6%. Malnutrition-related fatality (all cases < 18 years old) was 6.5% overall and 6.8% for under-fives. Interpretation This study describes the outcomes of emergency patients treated by midlevel providers in a resource-limited setting. Our fatality rates are lower than previously published regional rates. These findings suggest this model of task-shifting can be successfully applied to acute care in order to address the shortage of emergency care services in similar settings as part of an integrated approach to health systems strengthening.	[Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Bisanzo, Mark] Global Emergency Care Collaborat, Boston, MA 02114 USA; [Chamberlain, Stacey; Stolz, Uwe; Dreifuss, Bradley; Nelson, Sara W.; Hammerstedt, Heather; Andinda, Jovita; Bisanzo, Mark] Global Emergency Care Collaborat, Kampala, Uganda; [Chamberlain, Stacey] Univ Illinois, Dept Emergency Med, Chicago, IL USA; [Chamberlain, Stacey] Univ Illinois, Ctr Global Hlth, Chicago, IL USA; [Stolz, Uwe; Dreifuss, Bradley] Univ Arizona, Dept Emergency Med, Tucson, AZ USA; [Nelson, Sara W.] Maine Med Ctr, Dept Emergency Med, Portland, ME 04102 USA; [Hammerstedt, Heather] Idaho Emergency Phys, Boise, ID USA; [Andinda, Jovita] Karoli Lwanga Hosp, Nyakibale, Uganda; [Maling, Samuel] Mbarara Univ Sci & Technol, Dept Psychiat, Mbarara, Uganda; [Bisanzo, Mark] Univ Massachusetts, Dept Emergency Med, Worcester, MA 01605 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; Maine Medical Center; Mbarara University of Science & Technology; University of Massachusetts System; University of Massachusetts Worcester	Chamberlain, S (corresponding author), Global Emergency Care Collaborat, Boston, MA 02114 USA.	chamberlain.stacey@gmail.com			Global Emergency Care Collaborative (GECC); GECC	Global Emergency Care Collaborative (GECC); GECC	Global Emergency Care Collaborative (GECC) is a non-profit charitable organization registered in the United States and Uganda, which is funded through private non-corporate, non-governmental donations. GECC was responsible for providing partial salary support for the Emergency Care Practitioners who were the health professionals who cared for emergency patients in this study. Additionally, GECC paid stipends for volunteer research assistants and an onsite Program Director. None of the authors of this study have received any financial compensation for activities related to this study.	Africa Health Workforce Observatory, 2009, HUM RES HLTH COUNTR; [Anonymous], UG MAL CONTR STRAT P; [Anonymous], PRES MAL IN UG MAL O; [Anonymous], CAS FAT RAT HO UNPUB; [Anonymous], 2011, DEMOGRAPHIC HLTH SUR; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Caruso N, 2011, AFR J EMERG MED, V1, P108, DOI 10.1016/j.afjem.2011.08.002; Demyttenaere SV, 2009, CAN J SURG, V52, pE146; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Hammerstedt H, 2014, ANN EMERG MED, DOI [10.1016/j.annemergmed2014.01.035, DOI 10.1016/J.ANNEMERGMED2014.01.035]; Jayaraman S, 2011, WORLD J SURG, V35, P505, DOI 10.1007/s00268-010-0871-z; Kendjo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058686; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Molyneux EM, 2010, ANN TROP PAEDIATR, V30, P165, DOI 10.1179/146532810X12703902516482; Msangeni HA, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-256; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Nantanda R, 2008, ANN TROP PAEDIATR, V28, P253, DOI 10.1179/146532808X375404; Opoka RO, 2008, PEDIATR INFECT DIS J, V27, P319, DOI 10.1097/INF.0b013e31815d74dd; Owor G, 2001, E CENTRAL AFR J S, V6, P57; Periyanayagam U, 2012, AFR J EMERG MED, V2, P151, DOI 10.1016/j.afjem.2012.09.002; Reynolds TA, 2012, J PUBLIC HEALTH POL, V33, pS126, DOI 10.1057/jphp.2012.41; Srinivasan MG, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-14; Steen TW, 2001, INT J TUBERC LUNG D, V5, P775; Terry B, 2012, AFR J EMERG MED, V2, P182, DOI 10.1016/j.afjem.2012.06.005; Wang H, 2010, LANCET, V380, p2071 , DOI DOI 10.1016/S0140-6736(12)61719-X; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	28	29	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122559	10.1371/journal.pone.0122559	http://dx.doi.org/10.1371/journal.pone.0122559			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849960	Green Published, gold			2022-12-26	WOS:000352477800141
J	Elmore, MRP; Lee, RJ; West, BL; Green, KN				Elmore, Monica R. P.; Lee, Rafael J.; West, Brian L.; Green, Kim N.			Characterizing Newly Repopulated Microglia in the Adult Mouse: Impacts on Animal Behavior, Cell Morphology, and Neuroinflammation	PLOS ONE			English	Article							MORRIS WATER MAZE; ALZHEIMERS-DISEASE; IMMUNE-SYSTEM; AGED MICE; BRAIN; INFLAMMATION; NEUROGENESIS; MACROPHAGES; ACTIVATION; INFECTION	Microglia are the primary immune cell in the brain and are postulated to play important roles outside of immunity. Administration of the dual colony-stimulating factor 1 receptor (CSF1R)/c-Kit kinase inhibitor, PLX3397, to adult mice results in the elimination of similar to 99% of microglia, which remain eliminated for as long as treatment continues. Upon removal of the inhibitor, microglia rapidly repopulate the entire adult brain, stemming from a central nervous system (CNS) resident progenitor cell. Using this method of microglial elimination and repopulation, the role of microglia in both healthy and diseased states can be explored. Here, we examine the responsiveness of newly repopulated microglia to an inflammatory stimulus, as well as determine the impact of these cells on behavior, cognition, and neuroinflammation. Two month-old wild-type mice were placed on either control or PLX3397 diet for 21 d to eliminate microglia. PLX3397 diet was then removed in a subset of animals to allow microglia to repopulate and behavioral testing conducted beginning at 14 d repopulation. Finally, inflammatory profiling of the microglia-repopulated brain in response to lipopolysaccharide (LPS; 0.25 mg/kg) or phosphate buffered saline (PBS) was determined 21 d after inhibitor removal using quantitative real time polymerase chain reaction (RT-PCR), as well as detailed analyses of microglial morphologies. We find mice with repopulated microglia to perform similarly to controls by measures of behavior, cognition, and motor function. Compared to control/resident microglia, repopulated microglia had larger cell bodies and less complex branching in their processes, which resolved over time after inhibitor removal. Inflammatory profiling revealed that the mRNA gene expression of repopulated microglia was similar to normal resident microglia and that these new cells appear functional and responsive to LPS. Overall, these data demonstrate that newly repopulated microglia function similarly to the original resident microglia without any apparent adverse effects in healthy adult mice.	[Elmore, Monica R. P.; Lee, Rafael J.; Green, Kim N.] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA; [West, Brian L.] Plexxikon Inc, Berkeley, CA USA	University of California System; University of California Irvine; Plexxikon	Green, KN (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders UCI MI, Irvine, CA 92697 USA.	kngreen@uci.edu		West, Brian/0000-0002-5320-3691	Plexxikon Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS083801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000096] Funding Source: NIH RePORTER	Plexxikon Inc; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Plexxikon Inc provided support in the form of salaries for authors (to BLW), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil R, 2014, J BONE MINER RES, V29, P304, DOI 10.1002/jbmr.2038; Bastos GN, 2008, NEUROSCIENCE, V155, P454, DOI 10.1016/j.neuroscience.2008.06.020; Bilbo SD, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.014.2009; Blank T, 2013, GLIA, V61, P62, DOI 10.1002/glia.22372; Burton MD, 2012, BRAIN BEHAV IMMUN, V26, P732, DOI 10.1016/j.bbi.2011.10.008; Chen J, 2008, BRAIN BEHAV IMMUN, V22, P301, DOI 10.1016/j.bbi.2007.08.014; Chitu V, 2012, BLOOD, V120, P3126, DOI 10.1182/blood-2012-04-425595; Coniglio SJ, 2012, MOL MED, V18, P519, DOI 10.2119/molmed.2011.00217; Cunningham C, 2013, GLIA, V61, P71, DOI 10.1002/glia.22350; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; DeNardo DG, 2011, CANCER DISCOV, V1, P54, DOI 10.1158/2159-8274.CD-10-0028; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Grafen A., 2002, MODERN STAT LIFE SCI; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harry GJ, 2013, PHARMACOL THERAPEUT, V139, P313, DOI 10.1016/j.pharmthera.2013.04.013; He Y., 2012, E HLTH TELECOMM SYST, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0046900; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Jenkins SJ, 2014, TRENDS IMMUNOL, V35, P358, DOI 10.1016/j.it.2014.06.006; Jurgens HA, 2012, J NEUROSCI, V32, P3958, DOI 10.1523/JNEUROSCI.6389-11.2012; Kettenmann H, 2013, NEURON, V77, P10, DOI 10.1016/j.neuron.2012.12.023; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Lamprea MR, 2008, BRAZ J MED BIOL RES, V41, P135, DOI 10.1590/S0100-879X2008000200010; LING EA, 1993, GLIA, V7, P9, DOI 10.1002/glia.440070105; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch MA, 2009, MOL NEUROBIOL, V40, P139, DOI 10.1007/s12035-009-8077-9; Mok S, 2014, CANCER RES, V74, P153, DOI 10.1158/0008-5472.CAN-13-1816; Mongiat LA, 2011, EUR J NEUROSCI, V33, P1055, DOI 10.1111/j.1460-9568.2011.07603.x; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mosher KI, 2014, BIOCHEM PHARMACOL, V88, P594, DOI 10.1016/j.bcp.2014.01.008; Nandi S, 2012, DEV BIOL, V367, P100, DOI 10.1016/j.ydbio.2012.03.026; Neely KM, 2011, J NEUROSCI, V31, P2781, DOI 10.1523/JNEUROSCI.5156-10.2010; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Neumann H, 2013, NAT NEUROSCI, V16, P253, DOI 10.1038/nn.3338; Nicholson AM, 2013, NEUROLOGY, V80, P1033, DOI 10.1212/WNL.0b013e31828726a7; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Patel S, 2009, CURR TOP MED CHEM, V9, P599, DOI 10.2174/156802609789007327; PERRY VH, 1985, NEUROSCIENCE, V15, P313, DOI 10.1016/0306-4522(85)90215-5; Prada CE, 2013, ACTA NEUROPATHOL, V125, P159, DOI 10.1007/s00401-012-1056-7; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Rademakers R, 2012, NAT GENET, V44, P200, DOI 10.1038/ng.1027; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rogers JT, 2011, J NEUROSCI, V31, P16241, DOI 10.1523/JNEUROSCI.3667-11.2011; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Schwarz JM, 2012, HORM BEHAV, V62, P243, DOI 10.1016/j.yhbeh.2012.02.018; Serpente M, 2014, NEUROIMMUNOMODULAT, V21, P79, DOI 10.1159/000356529; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; TREIT D, 1988, PHARMACOL BIOCHEM BE, V31, P959, DOI 10.1016/0091-3057(88)90413-3; Ueno M, 2014, CURR OPIN NEUROBIOL, V27, P8, DOI 10.1016/j.conb.2014.02.004; Varvel NH, 2012, PNAS, P2; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Yirmiya R, 2011, BRAIN BEHAV IMMUN, V25, P181, DOI 10.1016/j.bbi.2010.10.015; Zhan Y, 2014, NAT NEUROSCI, V17, P400, DOI 10.1038/nn.3641	66	125	129	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122912	10.1371/journal.pone.0122912	http://dx.doi.org/10.1371/journal.pone.0122912			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849463	Green Published, gold			2022-12-26	WOS:000352477800172
J	Guo, ZQ; Wang, HQ; Yang, J; Miller, DJ				Guo, Zhiqiang; Wang, Huaiqing; Yang, Jie; Miller, David J.			A Stock Market Forecasting Model Combining Two-Directional Two-Dimensional Principal Component Analysis and Radial Basis Function Neural Network	PLOS ONE			English	Article							ALGORITHM; SYSTEM	In this paper, we propose and implement a hybrid model combining two-directional two-dimensional principal component analysis ((2D)(2)PCA) and a Radial Basis Function Neural Network (RBFNN) to forecast stock market behavior. First, 36 stock market technical variables are selected as the input features, and a sliding window is used to obtain the input data of the model. Next, (2D)(2)PCA is utilized to reduce the dimension of the data and extract its intrinsic features. Finally, an RBFNN accepts the data processed by (2D)(2)PCA to forecast the next day's stock price or movement. The proposed model is used on the Shanghai stock market index, and the experiments show that the model achieves a good level of fitness. The proposed model is then compared with one that uses the traditional dimension reduction method principal component analysis (PCA) and independent component analysis (ICA). The empirical results show that the proposed model outperforms the PCA-based model, as well as alternative models based on ICA and on the multilayer perceptron.	[Guo, Zhiqiang; Yang, Jie] Wuhan Univ Technol, Key Lab Fiber Opt Sensing Technol & Informat Proc, Sch Informat Engn, Wuhan 430070, Peoples R China; [Wang, Huaiqing] South Univ Sci & Technol China, Dept Financial Math & Financial Engn, Shenzhen, Peoples R China; [Miller, David J.] Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA	Wuhan University of Technology; Southern University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Guo, ZQ (corresponding author), Wuhan Univ Technol, Key Lab Fiber Opt Sensing Technol & Informat Proc, Sch Informat Engn, Wuhan 430070, Peoples R China.	guozhiqiang@whut.edu.cn			National Natural Science Foundation of China [51479159]; National Natural Science Foundation of Hubei province, China [2014CFB868]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Hubei province, China	This work is partially supported by the National Natural Science Foundation of China (grant no. 51479159) and National Natural Science Foundation of Hubei province, China (grant no. 2014CFB868).	Ajith A, 2003, P INT C COMP SCI, P337; Ao SI, 2011, SOFT COMPUT, V15, P1041, DOI 10.1007/s00500-010-0580-4; Atsalakis GS, 2009, EXPERT SYST APPL, V36, P5932, DOI 10.1016/j.eswa.2008.07.006; Bartlett MS, 2002, IEEE T NEURAL NETWOR, V13, P1450, DOI 10.1109/TNN.2002.804287; Bin Sun, 2010, 2010 IEEE 17th International Conference on Industrial Engineering and Engineering Management (IE&EM2010), P424, DOI 10.1109/ICIEEM.2010.5646582; Cao Q, 2005, COMPUT OPER RES, V32, P2499, DOI 10.1016/j.cor.2004.03.015; CHEN S, 1991, IEEE T NEURAL NETWOR, V2, P302, DOI 10.1109/72.80341; Dai WS, 2012, EXPERT SYST APPL, V39, P4444, DOI 10.1016/j.eswa.2011.09.145; Ettes D., 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P22, DOI 10.1109/CIFER.2000.844591; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Guo C, 2001, SYSTEMS ENG THEORY P, V31, P1921; Guo K., 2012, J MANAGEMENT SCI CHI, V1; Guo ZQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101113; Guo ZQ, 2013, SOFT COMPUT, V17, P805, DOI 10.1007/s00500-012-0953-y; Hassan R, 2005, 5TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS DESIGN AND APPLICATIONS, PROCEEDINGS, P192; Haugen R. A., 1999, NEW FINANCE CASE EFF, V2nd; Hsu CW, 2003, TECHNICAL REPORT, P1; Huang CJ, 2008, EXPERT SYST APPL, V34, P2870, DOI 10.1016/j.eswa.2007.05.035; Huang L, 2006, APSCC: 2006 IEEE ASIA-PACIFIC CONFERENCE ON SERVICES COMPUTING, PROCEEDINGS, P572; Huang SC, 2010, SMART INNOV SYST TEC, V4, P163; Huang W, 2005, COMPUT OPER RES, V32, P2513, DOI 10.1016/j.cor.2004.03.016; [黄颖 HUANG Ying], 2007, [数学的实践与认识, Mathematics in Practice and Theory], V37, P23; Hyvarinen A, 1997, NEURAL COMPUT, V9, P1483, DOI 10.1162/neco.1997.9.7.1483; Kao LJ, 2013, NEUROCOMPUTING, V99, P534, DOI 10.1016/j.neucom.2012.06.037; Lam SS, 2001, IEEE C EVOL COMPUTAT, P410, DOI 10.1109/CEC.2001.934420; Los CA, 2000, ADV ECONOMETRICS, V14, P329; Lu CJ, 2010, EXPERT SYST APPL, V37, P7056, DOI 10.1016/j.eswa.2010.03.012; Powell M., 1987, RADIAL BASIS FUNCTIO; Ravi V, 2008, APPL SOFT COMPUT, V8, P305, DOI 10.1016/j.asoc.2007.02.001; Teixeira LA, 2010, EXPERT SYST APPL, V37, P6885, DOI 10.1016/j.eswa.2010.03.033; Tiantian Xie, 2011, 2011 IEEE 20th International Symposium on Industrial Electronics (ISIE 2011), P1194, DOI 10.1109/ISIE.2011.5984328; Tsai CF, 2010, DECIS SUPPORT SYST, V50, P258, DOI 10.1016/j.dss.2010.08.028; TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71, DOI 10.1162/jocn.1991.3.1.71; Versace M, 2004, EXPERT SYST APPL, V27, P417, DOI 10.1016/j.eswa.2004.05.018; Wang XL, 2009, INT C MANAGE SCI ENG, P1389, DOI 10.1109/ICMSE.2009.5317961; White H., 1988, IEEE International Conference on Neural Networks (IEEE Cat. No.88CH2632-8), P451, DOI 10.1109/ICNN.1988.23959; Yang J, 2004, IEEE T PATTERN ANAL, V26, P131, DOI 10.1109/TPAMI.2004.1261097; Yang Yiwen, 2000, Proceedings of the IEEE/IAFE/INFORMS 2000 Conference on Computational Intelligence for Financial Engineering (CIFEr) (Cat. No.00TH8520), P155, DOI 10.1109/CIFER.2000.844615; Yee PV, 2001, ADAPT LEARN SYST SIG; Yeh CC, 2009, 29 ANN INT S FOR HON, P21; Zhang Defu., 2004, INT C COMP INT ICCI, P392; Zhang DQ, 2005, NEUROCOMPUTING, V69, P224, DOI 10.1016/j.neucom.2005.06.004; Zorin A, 2000, P INT C TRAD INN SUS, P312	43	20	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122385	10.1371/journal.pone.0122385	http://dx.doi.org/10.1371/journal.pone.0122385			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849483	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800124
J	Konno, S; Munakata, M				Konno, Satoshi; Munakata, Masanori			Moderately Increased Albuminuria Is an Independent Risk Factor of Cardiovascular Events in the General Japanese Population under 75 Years of Age: The Watari Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; BLOOD-PRESSURE; MICROALBUMINURIA; ASSOCIATION	Background Moderately increased albuminuria (formerly called microalbuminuria) is widely recognized as a predictor of cardiovascular disease. However, it is not clear whether this observation is applicable to the Asian population, as studies leading to this conclusion were conducted on Western populations. The aim of this study was to examine the hypothesis if moderately increased albuminuria could be an independent predictor of cardiovascular mortality and morbidity in the Japanese population. Methods and Results The study population consisted of 3093 inhabitants of Watari, Miyagi Prefecture, who participated in an annual health check-up in 2009. We examined anthropometry, sitting blood pressure, fasting blood sample, and urine albumin-to-creatinine ratio (UACR). After baseline assessment, subjects were followed prospectively for up to 60 months. The incidence of major cardiovascular events (stroke, myocardial infarction, revascularization, and cardiovascular death) was determined based on death certificate records or medical claims sent to the National Health Insurance of Japan. Follow-up was discontinued for those who reached 75 years of age because they were moved to a different medical insurance system. We observed 57 cardiovascular events during a mean follow-up period of 47.8 months. The cumulative incidence rate for major cardiovascular events was significantly higher in patients with moderately increased albuminuria (UACR 30-299 mg/gCr) than in those with normoalbuminuria (UACR < 30 mg/gCr) (6.4% vs. 2.2%, p = 0.0002 by log-rank test). Multivariate Cox proportional hazards analyses have revealed that moderately increased albuminuria is an independent predictor of cardiovascular events (HR 2.386, 95% CI: 1.120-4.390). Conclusions Moderately increased albuminuria is an independent predictor of cardiovascular events in the general Japanese population under 75 years of age.	[Konno, Satoshi; Munakata, Masanori] Tohoku Rosai Hosp, Div Hypertens, Sendai, Miyagi, Japan; [Konno, Satoshi; Munakata, Masanori] Tohoku Rosai Hosp, Res Ctr Life Style Related Dis, Sendai, Miyagi, Japan		Munakata, M (corresponding author), Tohoku Rosai Hosp, Div Hypertens, Sendai, Miyagi, Japan.	munakata@tohokuh.rofuku.go.jp			Japan Labor, Health, and Welfare Organization	Japan Labor, Health, and Welfare Organization(Ministry of Health, Labour and Welfare, Japan)	The Watari study was made possible by Grants-in-Aid from the Japan Labor, Health, and Welfare Organization. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, CLIN EXP NEPHROL, V13, P537, DOI 10.1007/s10157-009-0237-8; Chen YY, 2012, SCAND J CLIN LAB INV, V72, P281, DOI 10.3109/00365513.2012.661071; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dinneen SF, 1997, ARCH INTERN MED, V157, P1413, DOI 10.1001/archinte.157.13.1413; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Jensen JS, 2000, HYPERTENSION, V35, P898, DOI 10.1161/01.HYP.35.4.898; Konno S, 2013, J HYPERTENS, V31, P798, DOI 10.1097/HJH.0b013e32835e2146; Konta T, 2013, CLIN EXP NEPHROL, V17, P805, DOI 10.1007/s10157-013-0770-3; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; MOGENSEN CE, 1984, NEW ENGL J MED, V310, P356, DOI 10.1056/NEJM198402093100605; Munakata M, 2011, HYPERTENS RES, V34, P1135, DOI 10.1038/hr.2011.98; Navab M, 2011, NAT REV CARDIOL, V8, P222, DOI 10.1038/nrcardio.2010.222; Romundstad S, 2003, AM J KIDNEY DIS, V42, P466, DOI 10.1016/S0272-6386(03)00742-X; Wachtell K, 2003, ANN INTERN MED, V139, P901, DOI 10.7326/0003-4819-139-11-200312020-00008; Wang ZQ, 2005, KIDNEY INT, V68, P1289, DOI 10.1111/j.1523-1755.2005.00526.x; WHO MONICA Project, 1999, MONICA MAN 4 1; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yuyun MF, 2004, AM J EPIDEMIOL, V159, P284, DOI 10.1093/aje/kwh037	20	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123893	10.1371/journal.pone.0123893	http://dx.doi.org/10.1371/journal.pone.0123893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849735	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800259
J	Yang, XJ; Zhao, YW; Yang, XL; Kan, FWK				Yang, Xiaojing; Zhao, Yuewen; Yang, Xiaolong; Kan, Frederick W. K.			Recombinant Hamster Oviductin Is Biologically Active and Exerts Positive Effects on Sperm Functions and Sperm-Oocyte Binding	PLOS ONE			English	Article							BABOON PAPIO-ANUBIS; ESTROGEN-DEPENDENT GLYCOPROTEIN; ESTRUS-ASSOCIATED PROTEIN; IN-VITRO FERTILIZATION; ZONA-PELLUCIDA; GOLDEN-HAMSTER; MOLECULAR CHARACTERIZATION; TYROSINE PHOSPHORYLATION; IMMUNOCYTOCHEMICAL LOCALIZATION; ULTRASTRUCTURAL EVIDENCE	Studies carried out in several mammalian species suggest that oviductin, also known as oviduct-specific glycoprotein or OVGP1, plays a key role in sperm capacitation, fertilization, and development of early embryos. In the present study, we used recombinant DNA technology to produce, for the first time, recombinant hamster OVGP1 (rHamOVGP1) in human embryonic kidney 293 (HEK293) cells. rHamOVGP1 secreted in the culture medium was purified by affinity chromatography. The resulting protein migrated as a poly-dispersed band of 160-350 kDa on SDS-PAGE corresponding to the molecular mass of the native HamOVGP1. Subsequent mass spectrometric analysis of the purified rHamOVGP1 confirmed its identity as HamOVGP1. Immunocytochemistry demonstrated binding of rHamOVGP1 to the mid-piece and head of hamster sperm and to the zona pellucida (ZP) of ovarian oocytes. In vitro functional experiments showed that addition of rHamOVGP1 in the capacitation medium further enhanced tyrosine phosphorylation of two sperm proteins of approximately 75 kDa and 83 kDa in a time-dependent manner. After 3 hours of incubation in the presence of rHamOVGP1, a significant increase in acrosome reaction was measured. Pretreatment of either sperm or oocyte with 20 mu g/ml of rHamOVGP1 prior to sperm-egg binding assay significantly increased the number of sperm bound to the ZP. Addition of rHamOVGP1 in the medium during sperm-egg binding with either oocyte or sperm pretreated with rHamOVGP1 also saw an increase in the number of sperm bound to ZP. In all experimental conditions, the effect of rHamOVGP1 on sperm-oocyte binding was negated by the addition of monoclonal anti-HamOVGP1 antibody. The successful production and purification of a biologically active rHamOVGP1 will allow further exploration of the function of this glycoprotein in reproductive function.	[Yang, Xiaojing; Zhao, Yuewen; Kan, Frederick W. K.] Queens Univ, Fac Hlth Sci, Dept Biomed & Mol Sci, Kingston, ON, Canada; [Yang, Xiaolong] Queens Univ, Fac Hlth Sci, Dept Pathol & Mol Med, Kingston, ON, Canada	Queens University - Canada; McMaster University; Queens University - Canada	Kan, FWK (corresponding author), Queens Univ, Fac Hlth Sci, Dept Biomed & Mol Sci, Kingston, ON, Canada.	kanfwk@queensu.ca		Zhao, Yuewen/0000-0002-8765-1839	Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC)	Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC)	This work was supported by a Discover Grant from the Natural Sciences and Engineering Research Council of Canada (NSERC) to FWKK.	ABE H, 1990, J EXP ZOOL, V256, P210, DOI 10.1002/jez.1402560211; Aitken RJ, 2013, MOL HUM REPROD, V19, P785, DOI 10.1093/molehr/gat067; Araki Y, 2003, BIOCHEM J, V374, P551, DOI 10.1042/BJ20030466; ARAKI Y, 1987, J REPROD IMMUNOL, V11, P193, DOI 10.1016/0165-0378(87)90057-X; ARIAS EB, 1994, BIOL REPROD, V51, P685, DOI 10.1095/biolreprod51.4.685; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Aviles M, 2010, MOL HUM REPROD, V16, P896, DOI 10.1093/molehr/gaq056; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; BAVISTER BD, 1989, GAMETE RES, V23, P139, DOI 10.1002/mrd.1120230202; BOATMAN DE, 1995, BIOL REPROD, V52, P199, DOI 10.1095/biolreprod52.1.199; BOICE ML, 1990, BIOL REPROD, V43, P457, DOI 10.1095/biolreprod43.3.457; BUHI WC, 1990, BIOL REPROD, V43, P929, DOI 10.1095/biolreprod43.6.929; Buhi WC, 2002, REPRODUCTION, V123, P355, DOI 10.1530/rep.0.1230355; Buhi WC, 1996, BIOL REPROD, V55, P1305, DOI 10.1095/biolreprod55.6.1305; Buhi WC, 2000, CELLS TISSUES ORGANS, V166, P165, DOI 10.1159/000016731; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Chow A, 2010, INT J CANCER, V126, P2079, DOI 10.1002/ijc.24878; Coy P, 2012, REPRODUCTION, V144, P649, DOI 10.1530/REP-12-0279; Coy P, 2008, P NATL ACAD SCI USA, V105, P15809, DOI 10.1073/pnas.0804422105; DESOUZA MM, 1995, ENDOCRINOLOGY, V136, P2485, DOI 10.1210/en.136.6.2485; Fraser LR, 2010, MOL REPROD DEV, V77, P197, DOI 10.1002/mrd.21124; Jaffe RC, 1996, BIOL REPROD, V55, P421, DOI 10.1095/biolreprod55.2.421; Jha KN, 2002, MOL REPROD DEV, V61, P258, DOI 10.1002/mrd.1155; Kan FWK, 2006, MOL REPROD DEV, V73, P756, DOI 10.1002/mrd.20459; KAN FWK, 1989, BIOL REPROD, V40, P585, DOI 10.1095/biolreprod40.3.585; KAPUR RP, 1986, J EXP ZOOL, V238, P249, DOI 10.1002/jez.1402380215; KAPUR RP, 1988, ANAT REC, V221, P720, DOI 10.1002/ar.1092210307; Killian G, 2011, J ANIM SCI, V89, P1315, DOI 10.2527/jas.2010-3349; Killian GJ, 2004, ANIM REPROD SCI, V82-3, P141, DOI 10.1016/j.anireprosci.2004.04.028; KING RS, 1994, BIOL REPROD, V51, P34, DOI 10.1095/biolreprod51.1.34; KING RS, 1994, J ANDROL, V15, P468; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Lyng R, 2009, J CELL SCI, V122, P3894, DOI 10.1242/jcs.058776; MALETTE B, 1993, BIOCHEM J, V295, P437, DOI 10.1042/bj2950437; Mugnier S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-129; Naz Rajesh K, 2004, Reprod Biol Endocrinol, V2, P75, DOI 10.1186/1477-7827-2-75; ODayBowman MB, 1996, BIOL REPROD, V54, P60, DOI 10.1095/biolreprod54.1.60; OIKAWA T, 1988, GAMETE RES, V19, P113, DOI 10.1002/mrd.1120190202; OKO R, 1988, BIOL REPROD, V39, P169, DOI 10.1095/biolreprod39.1.169; OLIPHANT G, 1984, BIOL REPROD, V31, P165, DOI 10.1095/biolreprod31.1.165; PAQUETTE Y, 1995, MOL REPROD DEV, V42, P388, DOI 10.1002/mrd.1080420404; Pradeep MA, 2011, THERIOGENOLOGY, V75, P1005, DOI 10.1016/j.theriogenology.2010.11.007; ROBITAILLE G, 1988, BIOL REPROD, V38, P687, DOI 10.1095/biolreprod38.3.687; Saccary L, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109314; SENDAI Y, 1995, BIOL REPROD, V53, P285, DOI 10.1095/biolreprod53.2.285; SENDAI Y, 1994, BIOL REPROD, V50, P927, DOI 10.1095/biolreprod50.4.927; Si YM, 1999, BIOL REPROD, V61, P240, DOI 10.1095/biolreprod61.1.240; Siva AB, 2006, REPROD TOXICOL, V22, P702, DOI 10.1016/j.reprotox.2006.04.013; STJACQUES S, 1988, J REPROD IMMUNOL, V12, P247, DOI 10.1016/0165-0378(88)90011-3; SUZUKI K, 1995, BIOL REPROD, V53, P345, DOI 10.1095/biolreprod53.2.345; VERHAGE HG, 1988, ENDOCRINOLOGY, V122, P1639, DOI 10.1210/endo-122-4-1639; Verhage HG, 1997, BIOL REPROD, V57, P525, DOI 10.1095/biolreprod57.3.525; VERHAGE HG, 1989, ENDOCRINOLOGY, V124, P2464, DOI 10.1210/endo-124-5-2464; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129	55	27	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123003	10.1371/journal.pone.0123003	http://dx.doi.org/10.1371/journal.pone.0123003			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849110	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800192
J	Zhang, J; He, J; Zeng, XH; Ge, SJ; Huang, Y; Su, J; Ding, XM; Yang, JQ; Cao, YJ; Chen, H; Zhang, YH; Zhu, BS				Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Ge, Shi-Jun; Huang, Yu; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng			Genetic Heterogeneity of the beta-Globin Gene in Various Geographic Populations of Yunnan in Southwestern China	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGIC SURVEY; THALASSEMIA MUTATIONS; CHAIN VARIANTS; SOUTH CHINA; PROVINCE; SPECTRUM; HEMOGLOBINOPATHIES; HAPLOTYPES; MALARIA; REGION	Objectives The aim of this study was to investigate the geographic distribution of beta-globin gene mutations in different ethnic groups in Yunnan province. Methods From 2004 to 2014, 1,441 subjects with hemoglobin disorders, identified by PCR-reverse dot blot and DNA sequencing, were studied according to ethnicity and geographic origin. Haplotypes were examined among 41 unrelated thalassemia chromosomes. Results Eighteen beta-thalassemia mutations and seven hemoglobin variants were identified for 1,616 alleles in 22 different ethnic groups from all 16 prefecture-level divisions of Yunnan. The prevalence of beta-thalassemia was heterogeneous and regionally specific. CD 41-42 (-TCTT) was the most prevalent mutation in the populations of northeastern Yunnan. CD 17 (A > T) was the most common mutation in the populations of southeastern Yunnan, especially for the Zhuang minority, whereas Hb E (CD 26, G > A) was the most prevalent mutation in populations of southwestern Yunnan, especially for the Dai minority. Among the seven types of haplotypes identified, CD 17 (A > T) was mainly linked to haplotype VII (+ - - - - - +) and IVSII-654 (C > T) was only linked to haplotype I (+ - - - - + +). Conclusion Our data underline the heterogeneity of beta-globin gene mutations in Yunnan. This distribution of beta-globin mutations in the geographic regions and ethnic populations provided a detailed ethnic basis and evolutionary view of humans in southern China, which will be beneficial for genetic counseling and prevention strategies.	[Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng] First Peoples Hosp Yunnan Prov, Genet Diag Ctr, Yunnan Prov Key Lab Birth Defects & Genet Dis, Kunming, Peoples R China; [Zhang, Jie; He, Jing; Zeng, Xiao-Hong; Su, Jie; Ding, Xue-Mei; Yang, Ji-Qing; Cao, Yong-Jiu; Chen, Hong; Zhang, Ying-Hong; Zhu, Bao-Sheng] Kunming Univ Sci & Technol, Dept Genet, Kunming, Peoples R China; [Ge, Shi-Jun] Peoples Hosp Dehong Autonam Prefecture Dai & Jing, Dept Clin Lab, Mangshi, Peoples R China; [Huang, Yu] Maternal & Child Hlth Hosp Menghai, Dept Clin Lab, Menghai, Peoples R China	Kunming University of Science & Technology	Zhu, BS (corresponding author), First Peoples Hosp Yunnan Prov, Genet Diag Ctr, Yunnan Prov Key Lab Birth Defects & Genet Dis, Kunming, Peoples R China.	bszhu@aliyun.com	Ge, Shi-Jun/U-2499-2019		Fund of National Natural Science Foundation [81260415, 30760241]; key Natural Science Foundation of Yunnan Province [2011FB164]; Natural Science Foundation of Yunnan Province [2011FB224]	Fund of National Natural Science Foundation; key Natural Science Foundation of Yunnan Province; Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This study was conducted between the years 2012 and 2013 under the "the prevention and control programme of thalassemia in Yunnan". And this study was partially funded by the Fund of National Natural Science Foundation (81260415, 30760241), by key Natural Science Foundation of Yunnan Province (2011FB164), and by Natural Science Foundation of Yunnan Province (2011FB224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay A, 1999, HUM HERED, V49, P232, DOI 10.1159/000022880; Bi Y, 2013, AM J TROP MED HYG, V88, P526, DOI 10.4269/ajtmh.2012.12-0217; CHAN V, 1987, AM J HUM GENET, V41, P678; Edison ES, 2008, CLIN GENET, V73, P331, DOI 10.1111/j.1399-0004.2008.00973.x; Flatz G, 2004, HEMOGLOBIN, V28, P197, DOI 10.1081/HEM-120040334; GIRODON E, 1992, ANN HEMATOL, V65, P188, DOI 10.1007/BF01703113; Hu Hong, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P191; Huang SW, 2013, CLIN BIOCHEM, V46, P1865, DOI 10.1016/j.clinbiochem.2013.09.014; JANKOVIC L, 1990, HEMOGLOBIN, V14, P169, DOI 10.3109/03630269009046958; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; LAIG M, 1989, HUM GENET, V84, P47, DOI 10.1007/BF00210669; Lau EHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081846; LIEINJO LE, 1989, AM J HUM GENET, V45, P971; Lin M, 2013, HEMOGLOBIN, V37, P454, DOI 10.3109/03630269.2013.807285; Nicholas Tarling, 2008, THE EARLY KINGDOMS, P168; O'Donnell A, 2009, P NATL ACAD SCI USA, V106, P18716, DOI 10.1073/pnas.0910142106; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Pan HF, 2007, CLIN GENET, V71, P419, DOI 10.1111/j.1399-0004.2007.00791.x; Park SS, 2002, INT J HEMATOL, V76, P93, DOI 10.1007/BF03165096; Saetung R, 2013, SE ASIAN J TROP MED, V44, P1055; SICK K, 1967, BIOCHIM BIOPHYS ACTA, V140, P231, DOI 10.1016/0005-2795(67)90463-1; Svasti MLS, 2002, AM J HEMATOL, V71, P85, DOI 10.1002/ajh.10193; Than AM, 2005, INT J HEMATOL, V82, P119, DOI 10.1532/IJH97.05028; Tritipsombut J, 2012, HEMOGLOBIN, V36, P47, DOI 10.3109/03630269.2011.637149; Xiong F, 2010, CLIN GENET, V78, P139, DOI 10.1111/j.1399-0004.2010.01430.x; Yao HX, 2014, BLOOD CELL MOL DIS, V53, P16, DOI 10.1016/j.bcmd.2014.01.003; Yin AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089855; ZENG YT, 1987, J MED GENET, V24, P578, DOI 10.1136/jmg.24.10.578; Zhang J, 2012, HEMOGLOBIN, V36, P464, DOI 10.3109/03630269.2012.717327; ZHANG JZ, 1988, HUM GENET, V78, P37, DOI 10.1007/BF00291231	30	19	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122956	10.1371/journal.pone.0122956	http://dx.doi.org/10.1371/journal.pone.0122956			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849334	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800182
J	Mascali, D; DiNuzzo, M; Gili, T; Moraschi, M; Fratini, M; Maraviglia, B; Serra, L; Bozzali, M; Giove, F				Mascali, Daniele; DiNuzzo, Mauro; Gili, Tommaso; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Serra, Laura; Bozzali, Marco; Giove, Federico			Intrinsic Patterns of Coupling between Correlation and Amplitude of Low-Frequency fMRI Fluctuations Are Disrupted in Degenerative Dementia Mainly due to Functional Disconnection	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; DEFAULT-MODE NETWORK; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; BOLD SIGNAL; CONNECTIVITY	Low frequency fluctuations (LFFs) of the BOLD signal are a major discovery in the study of the resting brain with functional magnetic resonance imaging (fMRI). Two fMRI-based measures, functional connectivity (FC), a measure of signal synchronicity, and the amplitude of LFFs (ALFF), a measure of signal periodicity, have been proved to be sensitive to changes induced by several neurological diseases, including degenerative dementia. In spite of the increasing use of these measures, whether and how they are related to each other remains to be elucidated. In this work we used voxel-wise FC and ALFF computed in different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.073 Hz; and full-band: 0.01-0.073 Hz), in order to assess their relationship in healthy elderly as well as the relevant changes induced by Alzheimer's Disease (AD) and Mild Cognitive Impairment (MCI). We found that in healthy elderly subjects FC and ALFF are positively correlated in anterior and posterior cingulate cortex (full-band, slow-4 and slow-5), temporal cortex (full-band and slow-5), and in a set of subcortical regions (full-band and slow-4). These correlation patterns between FC and ALFF were absent in either AD or MCI patients. Notably, the loss of correlation between FC and ALFF in the AD group was primarily due to changes in FC rather than in ALFF. Our results indicate that degenerative dementia is characterized by a loss of global connection rather than by a decrease of fluctuation amplitude.	[Mascali, Daniele; DiNuzzo, Mauro; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Giove, Federico] Museo Stor Fis, Rome, Italy; [Mascali, Daniele; DiNuzzo, Mauro; Moraschi, Marta; Fratini, Michela; Maraviglia, Bruno; Giove, Federico] Ctr Studi & Ric Enrico Fermi, Rome, Italy; [Mascali, Daniele; DiNuzzo, Mauro] Univ Roma La Sapienza, Dipartimento Fis, I-00185 Rome, Italy; [Gili, Tommaso; Moraschi, Marta; Maraviglia, Bruno; Serra, Laura; Bozzali, Marco; Giove, Federico] Fdn Santa Lucia, IRCCS, Rome, Italy; [Fratini, Michela] Univ Roma Tre, Dipartimento Sci, Rome, Italy	Sapienza University Rome; IRCCS Santa Lucia; Roma Tre University	Giove, F (corresponding author), Museo Stor Fis, Rome, Italy.	federico.giove@roma1.infn.it	Fratini, Michela/AAC-1048-2019; Giove, Federico/C-3295-2008; Bozzali, Marco/AAC-1031-2022; DiNuzzo, Mauro/D-2494-2009; Serra, Laura/K-5637-2016; Mascali, Daniele/O-1936-2015; Mascali, Daniele/AAB-7591-2019	Fratini, Michela/0000-0003-3118-4335; Giove, Federico/0000-0002-6934-3146; DiNuzzo, Mauro/0000-0003-0181-5597; Serra, Laura/0000-0002-2717-1286; Mascali, Daniele/0000-0003-1269-6060; Mascali, Daniele/0000-0003-1269-6060; Maraviglia, Bruno/0000-0003-2354-8039; Gili, Tommaso/0000-0001-9154-1758; Moraschi, Marta/0000-0003-4789-6636; Bozzali, Marco/0000-0002-0568-2026				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2001, NEUROIMAGE, V14, P1238, DOI 10.1006/nimg.2001.0961; Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; Birn RM, 2006, NEUROIMAGE, V31, P1536, DOI 10.1016/j.neuroimage.2006.02.048; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Biswal BB, 2007, MAGN RESON IMAGING, V25, P1358, DOI 10.1016/j.mri.2007.03.022; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang C, 2009, NEUROIMAGE, V44, P857, DOI 10.1016/j.neuroimage.2008.09.029; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Deichmann R, 2004, NEUROIMAGE, V21, P757, DOI 10.1016/j.neuroimage.2003.09.062; Di Martino A, 2008, CEREB CORTEX, V18, P2735, DOI 10.1093/cercor/bhn041; Di X, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00118; Di X, 2013, CEREB CORTEX, V23, P255, DOI 10.1093/cercor/bhs001; DiNuzzo M, 2011, J NEUROPHYSIOL, V106, P3010, DOI 10.1152/jn.00416.2011; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; Gili T, 2011, J NEUROL NEUROSUR PS, V82, P58, DOI 10.1136/jnnp.2009.199935; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hiltunen T, 2014, J NEUROSCI, V34, P356, DOI 10.1523/JNEUROSCI.0276-13.2014; Laufs H, 2003, P NATL ACAD SCI USA, V100, P11053, DOI 10.1073/pnas.1831638100; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Liang PP, 2014, CURR ALZHEIMER RES, V11, P389, DOI 10.2174/1567205011666140331225335; Liang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032766; Liu XN, 2014, J ALZHEIMERS DIS, V40, P387, DOI 10.3233/JAD-131322; Luchinger R, 2012, NEUROIMAGE, V60, P1426, DOI 10.1016/j.neuroimage.2012.01.031; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Murphy K, 2013, NEUROIMAGE, V80, P349, DOI 10.1016/j.neuroimage.2013.04.001; Penttonen Markku, 2003, Thalamus & Related Systems, V2, P145, DOI 10.1016/S1472-9288(03)00007-4; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Scheeringa R, 2008, INT J PSYCHOPHYSIOL, V67, P242, DOI 10.1016/j.ijpsycho.2007.05.017; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Serra L, 2013, J ALZHEIMERS DIS, V33, P1157, DOI 10.3233/JAD-2012-121663; Song XP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086818; Sorg C, 2007, P NATL ACAD SCI USA, V104, P18760, DOI 10.1073/pnas.0708803104; Tomasi D, 2013, P NATL ACAD SCI USA, V110, P13642, DOI 10.1073/pnas.1303346110; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wee CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037828; Wei LQ, 2014, HUM BRAIN MAPP, V35, P331, DOI 10.1002/hbm.22176; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wise RG, 2004, NEUROIMAGE, V21, P1652, DOI 10.1016/j.neuroimage.2003.11.025; Xi Q, 2013, CHINESE MED J-PEKING, V126, P2912, DOI 10.3760/cma.j.issn.0366-6999.20130431; Xi Q, 2012, CHINESE MED J-PEKING, V125, P858, DOI 10.3760/cma.j.issn.0366-6999.2012.05.023; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Yu RJ, 2014, HUM BRAIN MAPP, V35, P627, DOI 10.1002/hbm.22203; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zhang HY, 2010, RADIOLOGY, V256, P598, DOI 10.1148/radiol.10091701; Zhang JQ, 2013, BEHAV BRAIN RES, V252, P18, DOI 10.1016/j.bbr.2013.05.039; Zhao ZL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/920902; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	64	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120988	10.1371/journal.pone.0120988	http://dx.doi.org/10.1371/journal.pone.0120988			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844531	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700004
J	Cruet-Hennequart, S; Drougard, C; Shaw, G; Legendre, F; Demoor, M; Barry, F; Lefaix, JL; Galera, P				Cruet-Hennequart, Severine; Drougard, Carole; Shaw, Georgina; Legendre, Florence; Demoor, Magali; Barry, Frank; Lefaix, Jean-Louis; Galera, Philippe			Radiation-Induced Alterations of Osteogenic and Chondrogenic Differentiation of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; IONIZING-RADIATION; STROMAL CELLS; CARTILAGE REPAIR; MATRIX SYNTHESIS; MARROW; HYPOXIA; BREAKS; RECRUITMENT; EXPRESSION	While human mesenchymal stem cells (hMSCs), either in the bone marrow or in tumour microenvironment could be targeted by radiotherapy, their response is poorly understood. The oxic effects on radiosensitivity, cell cycle progression are largely unknown, and the radiation effects on hMSCs differentiation capacities remained unexplored. Here we analysed hMSCs viability and cell cycle progression in 21% O-2 and 3% O-2 conditions after medical Xrays irradiation. Differentiation towards osteogenesis and chondrogenesis after irradiation was evaluated through an analysis of differentiation specific genes. Finally, a 3D culture model in hypoxia was used to evaluate chondrogenesis in conditions mimicking the natural hMSCs microenvironment. The hMSCs radiosensitivity was not affected by O-2 tension. A decreased number of cells in S phase and an increase in G2/M were observed in both O-2 tensions after 16 hours but hMSCs released from the G2/M arrest and proliferated at day 7. Osteogenesis was increased after irradiation with an enhancement of mRNA expression of specific osteogenic genes (alkaline phosphatase, osteopontin). Osteoblastic differentiation was altered since matrix deposition was impaired with a decreased expression of collagen I, probably through an increase of its degradation by MMP-3. After induction in monolayers, chondrogenesis was altered after irradiation with an increase in COL1A1 and a decrease in both SOX9 and ACAN mRNA expression. After induction in a 3D culture in hypoxia, chondrogenesis was altered after irradiation with a decrease in COL2A1, ACAN and SOX9 mRNA amounts associated with a RUNX2 increase. Together with collagens I and II proteins decrease, associated to a MMP-13 expression increase, these data show a radiation-induced impairment of chondrogenesis. Finally, a radiation-induced impairment of both osteogenesis and chondrogenesis was characterised by a matrix composition alteration, through inhibition of synthesis and/or increased degradation. Alteration of osteogenesis and chondrogenesis in hMSCs could potentially explain bone/joints defects observed after radiotherapy.	[Cruet-Hennequart, Severine; Drougard, Carole; Legendre, Florence; Demoor, Magali; Galera, Philippe] Normandy Univ, Caen, France; [Cruet-Hennequart, Severine; Drougard, Carole; Legendre, Florence; Demoor, Magali; Galera, Philippe] UNICAEN, Lab Microenvironm Cellulaire & Pathol MILPAT, Caen, France; [Cruet-Hennequart, Severine; Lefaix, Jean-Louis] CEA, DSV, IRCM, LARIA, Caen 5, France; [Cruet-Hennequart, Severine; Shaw, Georgina; Barry, Frank] Natl Univ Ireland Galway, Regenerat Med Inst REMEDI, Galway, Ireland	Universite de Caen Normandie; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); Ollscoil na Gaillimhe-University of Galway	Galera, P (corresponding author), Normandy Univ, Caen, France.	philippe.galera@unicaen.fr		Barry, Frank/0000-0002-5535-002X; Drougard, Carole/0000-0001-6526-104X; legendre, florence/0000-0002-9951-1585	Regional Council of Lower-Normandy (France); French Ministry of Research; French National Agency of Research (ANR, PROMOCART grant)	Regional Council of Lower-Normandy (France)(Region Normandie); French Ministry of Research(Ministry of Research, FranceEuropean Commission); French National Agency of Research (ANR, PROMOCART grant)(French National Research Agency (ANR))	This project was funded by the Regional Council of Lower-Normandy (France, Programme Emergence to SCH), another Programme Emergence to Christophe Denoyelle (BioTICLA, Caen, France) and PG, the French Ministry of Research and the French National Agency of Research (ANR, PROMOCART grant) to PG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio N, 2013, CELL MOL LIFE SCI, V70, P1637, DOI 10.1007/s00018-012-1224-x; Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278; Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001; Basciano L, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-12; Baxter NN, 2005, JAMA-J AM MED ASSOC, V294, P2587, DOI 10.1001/jama.294.20.2587; Chen MF, 2006, INT J RADIAT ONCOL, V66, P244, DOI 10.1016/j.ijrobp.2006.03.062; Claus S, 2010, J CELL BIOCHEM, V111, P1642, DOI 10.1002/jcb.22897; Cmielova J, 2013, INT J RADIAT BIOL, V89, P501, DOI 10.3109/09553002.2013.775530; Cruet-Hennequart S, 2010, CURR CANCER DRUG TAR, V10, P411, DOI 10.2174/156800910791208553; Damour O., 2012, Patent No. [WO 2012/ 038668, 2012038668, 2012/038668]; Delanian S, 2007, SEMIN RADIAT ONCOL, V17, P99, DOI 10.1016/j.semradonc.2006.11.006; Delanian S, 2011, INT J RADIAT ONCOL, V80, P832, DOI 10.1016/j.ijrobp.2010.03.029; Demoor M, 2012, PATHOL BIOL, V60, P199, DOI 10.1016/j.patbio.2012.03.003; Dikomey E, 2000, INT J RADIAT BIOL, V76, P773, DOI 10.1080/09553000050028922; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fakhry Maya, 2013, World J Stem Cells, V5, P136, DOI 10.4252/wjsc.v5.i4.136; Forlino A, 2011, NAT REV ENDOCRINOL, V7, P540, DOI 10.1038/nrendo.2011.81; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Freyria AM, 2009, TISSUE ENG PT A, V15, P1233, DOI 10.1089/ten.tea.2008.0114; Galera P, 2010, Brevet francais, Patent No. [FR 2965278 du 23/ 09/ 2010, 2965278]; Gelderblom H, 2008, ONCOLOGIST, V13, P320, DOI 10.1634/theoncologist.2007-0237; Gilbert S.F., 2000, DEV BIOL; Gupta PK, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt116; Habrand J L, 1997, Cancer Radiother, V1, P810, DOI 10.1016/S1278-3218(97)82962-9; Hall EJ, 2006, RADIOBIOLOGY RADIOBI, V6th; Harada H, 2011, J RADIAT RES, V52, P545, DOI 10.1269/jrr.11056; Harfouche G, 2010, MUTAT RES-REV MUTAT, V704, P167, DOI 10.1016/j.mrrev.2010.01.007; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Hollander AP, 2010, STEM CELLS, V28, P1992, DOI 10.1002/stem.534; Hou J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.338; Kim YH, 2012, STEM CELLS DEV, V21, P2958, DOI 10.1089/scd.2011.0349; Kurpinski K, 2009, INT J RADIAT ONCOL, V73, P869, DOI 10.1016/j.ijrobp.2008.10.002; Laurent C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085158; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; Li J, 2007, PEDIATR TRANSPLANT, V11, P379, DOI 10.1111/j.1399-3046.2006.00663.x; Liao JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089025; Logovskaya LV, 2013, B EXP BIOL MED+, V155, P145, DOI 10.1007/s10517-013-2100-x; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moussavi-Harami F, 2006, BIOCHEM BIOPH RES CO, V346, P379, DOI 10.1016/j.bbrc.2006.05.158; Mutsaers A.J., 2014, BONE; Nicolay NH, 2013, INT J RADIAT ONCOL, V87, P1171, DOI 10.1016/j.ijrobp.2013.09.003; Nyman JS, 2005, MICRON, V36, P566, DOI 10.1016/j.micron.2005.07.004; Oliver L, 2013, STEM CELLS, V31, P800, DOI 10.1002/stem.1336; Oliver L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019820; Ollitrault D, 2014, TISSUE ENG C; Palomaki S, 2013, STEM CELLS, V31, P1902, DOI 10.1002/stem.1435; Paulino AC, 2004, INT J RADIAT ONCOL, V60, P265, DOI 10.1016/j.ijrobp.2004.02.001; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prendergast AM, 2011, CELL CYCLE, V10, P3768, DOI 10.4161/cc.10.21.17972; Prockop Darwin J, 2008, Methods Mol Biol, V449, pv; Rodriguez R, 2012, CELL RES, V22, P62, DOI 10.1038/cr.2011.157; Sokolnikov ME, 2008, INT J CANCER, V123, P905, DOI 10.1002/ijc.23581; Sokolov M, 2013, INT J MOL SCI, V14, P15695, DOI 10.3390/ijms140815695; Thompson LH, 2012, MUTAT RES-REV MUTAT, V751, P158, DOI 10.1016/j.mrrev.2012.06.002; Titorencu I, 2007, CYTOTHERAPY, V9, P682, DOI 10.1080/14653240701561329; Titorencu I, 2014, CELL TISSUE RES, V355, P23, DOI 10.1007/s00441-013-1750-3; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Wang DJ, 2009, CANCER RES, V69, P8200, DOI 10.1158/0008-5472.CAN-09-1976; Willey JS, 2013, INT J RADIAT BIOL, V89, P268, DOI 10.3109/09553002.2013.747015; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064	61	17	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119334	10.1371/journal.pone.0119334	http://dx.doi.org/10.1371/journal.pone.0119334			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837977	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000008
J	Lim, N; Lidofsky, SD				Lim, Nicholas; Lidofsky, Steven D.			Impact of Physician Specialty on Quality Care for Patients Hospitalized with Decompensated Cirrhosis	PLOS ONE			English	Article							OF-CARE; AMERICAN ASSOCIATION; VARICEAL HEMORRHAGE; PRACTICE GUIDELINE; LIVER-DISEASES; ADULT PATIENTS; ORDER SET; MANAGEMENT; MORTALITY; OUTCOMES	Background Decompensated cirrhosis is a common precipitant for hospitalization, and there is limited information concerning factors that influence the delivery of quality care in cirrhotic inpatients. We sought to determine the relation between physician specialty and inpatient quality care for decompensated cirrhosis. Design We reviewed 247 hospital admissions for decompensated cirrhosis, managed by hospitalists or intensivists, between 2009 and 2013. The primary outcome was quality care delivery, defined as adherence to all evidence-based specialty society practice guidelines pertaining to each specific complication of cirrhosis. Secondary outcomes included new complications, length-of-stay, and in-hospital death. Results Overall, 147 admissions (59.5%) received quality care. Quality care was given more commonly by intensivists, compared with hospitalists (71.7% vs. 53.1%, P = .006), and specifically for gastrointestinal bleeding (72% vs. 45.8%, P = .03) and hepatic encephalopathy (100% vs. 63%, P = .005). Involvement of gastroenterology consultation was also more common in admissions in which quality care was administered (68.7% vs. 54.0%, P = .023). Timely diagnostic paracentesis was associated with reduced new complications in admissions for refractory ascites (9.5% vs. 46.6%, P = .02), and reduced length-of-stay in admissions for spontaneous bacterial peritonitis (5 days vs. 13 days, P = .02). Conclusions Adherence to quality indicators for decompensated cirrhosis is suboptimal among hospitalized patients. Although quality care adherence appears to be higher among cirrhotic patients managed by intensivists than by hospitalists, opportunities for improvement exist in both groups. Rational and cost-effective strategies should be sought to achieve this end.	[Lim, Nicholas; Lidofsky, Steven D.] Univ Vermont, Coll Med, Div Gastroenterol & Hepatol, Burlington, VT 05405 USA; [Lim, Nicholas; Lidofsky, Steven D.] Univ Vermont, Coll Med, Burlington, VT USA	University of Vermont; University of Vermont	Lidofsky, SD (corresponding author), Univ Vermont, Coll Med, Div Gastroenterol & Hepatol, Burlington, VT 05405 USA.	steven.lidofsky@uvm.edu		Lim, Nicholas/0000-0001-9740-8923				Bini EJ, 2001, HEPATOLOGY, V34, P1089, DOI 10.1053/jhep.2001.29204; Blei AT, 2001, AM J GASTROENTEROL, V96, P1968, DOI 10.1016/S0002-9270(01)02527-8; Buchanan PM, 2014, AM J GASTROENTEROL, V109, P934, DOI 10.1038/ajg.2013.487; Carretta HJ, 2013, AM J MED QUAL, V28, P46, DOI 10.1177/1062860612444459; Desai AP, 2014, J CLIN GASTROENTEROL, V48, pE30, DOI 10.1097/MCG.0b013e3182a87f70; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Garcia-Tsao G, 2007, HEPATOLOGY, V46, P922, DOI 10.1002/hep.21907; Ghaoui R, 2014, LIVER INT, V34, P204, DOI 10.1111/liv.12225; Gupta R, 2013, J CRIT CARE, V28, P1042, DOI 10.1016/j.jcrc.2013.06.010; Jairath V, 2014, DIGEST LIVER DIS, V46, P419, DOI 10.1016/j.dld.2013.12.010; Jungerwirth R, 2014, J HOSP MED, V9, P1, DOI 10.1002/jhm.2118; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Kanwal F, 2012, GASTROENTEROLOGY, V143, P70, DOI 10.1053/j.gastro.2012.03.038; Kanwal F, 2011, GASTROENTEROLOGY, V140, P1182, DOI 10.1053/j.gastro.2010.12.032; Kanwal F, 2010, CLIN GASTROENTEROL H, V8, P709, DOI 10.1016/j.cgh.2010.03.028; Mayorga CA, 2013, CLIN GASTROENTEROL H, V11, P1342, DOI 10.1016/j.cgh.2013.04.021; Orman ES, 2014, CLIN GASTROENTEROL H, V12, P496, DOI 10.1016/j.cgh.2013.08.025; Panzer RJ, 2013, JAMA-J AM MED ASSOC, V310, P1971, DOI 10.1001/jama.2013.282047; Pastores SM, 2014, CRIT CARE MED, V42, P1272, DOI 10.1097/CCM.0000000000000250; Runyon BA, 2013, HEPATOLOGY, V57, P1651, DOI 10.1002/hep.26359; Runyon BA, 2009, HEPATOLOGY, V49, P2087, DOI 10.1002/hep.22853; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Siegal EM, 2012, CRIT CARE MED, V40, P1952, DOI 10.1097/CCM.0b013e318258eef7; Thiel SW, 2009, CRIT CARE MED, V37, P819, DOI 10.1097/CCM.0b013e318196206b; Vilstrup H, 2014, HEPATOLOGY, V60, P715, DOI 10.1002/hep.27210; Volk ML, 2012, AM J GASTROENTEROL, V107, P247, DOI 10.1038/ajg.2011.314; Wilcox ME, 2013, CRIT CARE MED, V41, P2253, DOI 10.1097/CCM.0b013e318292313a; Wise KR, 2012, J HOSP MED, V7, P183, DOI 10.1002/jhm.972	28	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123490	10.1371/journal.pone.0123490	http://dx.doi.org/10.1371/journal.pone.0123490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837700	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000146
J	Tirodkar, TS; Lu, P; Bai, AP; Scheffel, MJ; Gencer, S; Garrett-Mayer, E; Bielawska, A; Ogretmen, B; Voelkel-Johnson, C				Tirodkar, Tejas S.; Lu, Ping; Bai, Aiping; Scheffel, Matthew J.; Gencer, Salih; Garrett-Mayer, Elizabeth; Bielawska, Alicja; Ogretmen, Besim; Voelkel-Johnson, Christina			Expression of Ceramide Synthase 6 Transcriptionally Activates Acid Ceramidase in a c-Jun N-terminal Kinase (JNK)-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLON-CANCER CELLS; SPHINGOLIPID METABOLISM; INDUCED APOPTOSIS; CARCINOMA-CELLS; TUMOR-CELLS; INDUCTION; STRESS; AUTOPHAGY; LIVER; SUPPRESSION	A family of six ceramide synthases with distinct but overlapping substrate specificities is responsible for generation of ceramides with acyl chains ranging from similar to 14-26 carbons. Ceramide synthase 6 (CerS6) preferentially generates C-14- and C-16-ceramides, and we have previously shown that down-regulation of this enzyme decreases apoptotic susceptibility. In this study, we further evaluated how increased CerS6 expression impacts sphingolipid composition and metabolism. Overexpression of CerS6 in HT29 colon cancer cells resulted in increased apoptotic susceptibility and preferential generation of C-16-ceramide, which occurred at the expense of very long chain, saturated ceramides. These changes were also reflected in sphingomyelin composition. HT-CerS6 cells had increased intracellular levels of sphingosine, which is generated by ceramidases upon hydrolysis of ceramide. qRT-PCR analysis revealed that only expression of acid ceramidase (ASAH1) was increased. The increase in acid ceramidase was confirmed by expression and activity analyses. Pharmacological inhibition of JNK (SP600125) or curcumin reduced transcriptional up-regulation of acid ceramidase. Using an acid ceramidase promoter driven luciferase reporter plasmid, we demonstrated that CerS1 has no effect on transcriptional activation of acid ceramidase and that CerS2 slightly but significantly decreased the luciferase signal. Similar to CerS6, overexpression of CerS3-5 resulted in an similar to 2-fold increase in luciferase reporter gene activity. Exogenous ceramide failed to induce reporter activity, while a CerS inhibitor and a catalytically inactive mutant of CerS6 failed to reduce it. Taken together, these results suggest that increased expression of CerS6 can mediate transcriptional activation of acid ceramidase in a JNK-dependent manner that is independent of CerS6 activity.	[Tirodkar, Tejas S.; Lu, Ping; Scheffel, Matthew J.; Voelkel-Johnson, Christina] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Bai, Aiping; Gencer, Salih; Bielawska, Alicja; Ogretmen, Besim] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Garrett-Mayer, Elizabeth] Med Univ S Carolina, Dept Publ Hlth, Charleston, SC 29425 USA; [Gencer, Salih] Dept Mol Biol & Genet, TR-34662 Istanbul, Turkey	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Voelkel-Johnson, C (corresponding author), Med Univ S Carolina, Dept Microbiol & Immunol, 173 Ashley Ave, Charleston, SC 29425 USA.	johnsocv@musc.edu	Regan, Clinton/E-6250-2012; Gencer, Salih/AAL-5502-2020; Gencer, Salih/B-6436-2012	Garrett-Mayer, Elizabeth/0000-0003-4709-0333	MUSC; Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC [P30 CA138313]; National Institutes of Health [P01 CA154778];  [CA88032];  [CA173687];  [DE016572]; NATIONAL CANCER INSTITUTE [R01CA173687, P01CA154778, P30CA138313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016572] Funding Source: NIH RePORTER	MUSC; Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This project was supported by MUSC intramural funds (to C. V. J.) and in part by the Lipidomics and Flow Cytometry Shared Resources, Hollings Cancer Center, MUSC (P30 CA138313).; Supported by CA88032, CA173687, and DE016572.; Supported by National Institutes of Health Grant P01 CA154778.	Alexaki A, 2014, J LIPID RES, V55, P2521, DOI 10.1194/jlr.M051862; Bai AP, 2014, BIOORGAN MED CHEM, V22, P6933, DOI 10.1016/j.bmc.2014.10.025; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Gault CR, 2010, ADV EXP MED BIOL, V688, P1; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Hanker LC, 2013, INT J GYNECOL PATHOL, V32, P249, DOI 10.1097/PGP.0b013e3182673982; Hartmann D., INT J BIOCH CELL BIO, V44, P620; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jensen SA, 2014, P NATL ACAD SCI USA, V111, P5682, DOI 10.1073/pnas.1316700111; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2012, J BIOL CHEM, V287, P21025, DOI 10.1074/jbc.M112.363580; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Lucki N, 2009, BBA-MOL CELL BIOL L, V1791, P706, DOI 10.1016/j.bbalip.2009.03.005; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Meixner M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-22; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Park JW, 2014, BBA-MOL CELL BIOL L, V1841, P671, DOI 10.1016/j.bbalip.2013.08.019; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Park MA, 2009, MOL CANCER THER, V8, P1280, DOI 10.1158/1535-7163.MCT-09-0073; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10911, DOI 10.1074/jbc.M109.077610; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Sanger N, 2015, MOL ONCOL, V9, P58, DOI 10.1016/j.molonc.2014.07.016; Schiffmann S, 2012, J IMMUNOL, V188, P5723, DOI 10.4049/jimmunol.1103109; Schiffmann S, 2010, BIOCHEM PHARMACOL, V80, P1632, DOI 10.1016/j.bcp.2010.08.012; Sehgal Vasudha, 2013, Genes Cancer, V4, P409, DOI 10.1177/1947601913507577; Senkal CE, 2011, J BIOL CHEM, V286, P42446, DOI 10.1074/jbc.M111.287383; Senkal CE, 2010, FASEB J, V24, P296, DOI 10.1096/fj.09-135087; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Separovic D, 2012, ANTICANCER RES, V32, P753; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Spassieva S, 2007, METHOD ENZYMOL, V434, P233, DOI 10.1016/S0076-6879(07)34012-3; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Tang HW, 2013, DEV CELL, V27, P489, DOI 10.1016/j.devcel.2013.10.017; Tirodkar T. S., 2012, Experimental Oncology, V34, P231; Turner LS, 2011, PROSTATE CANCER P D, V14, P30, DOI 10.1038/pcan.2010.47; VANVELDHOVEN PP, 1988, BIOCHIM BIOPHYS ACTA, V959, P185, DOI 10.1016/0005-2760(88)90030-6; Verheij M, 1996, NATURE, V380, P75, DOI 10.1038/380075a0; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; Walker T, 2010, MOL CANCER THER, V9, P1378, DOI 10.1158/1535-7163.MCT-09-1131; Walker T, 2009, MOL PHARMACOL, V76, P342, DOI 10.1124/mol.109.056523; WESTWICK JK, 1995, J BIOL CHEM, V270, P22689, DOI 10.1074/jbc.270.39.22689; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701	50	27	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13157	13167		10.1074/jbc.M114.631325	http://dx.doi.org/10.1074/jbc.M114.631325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25839235	Green Published, hybrid			2022-12-26	WOS:000354975700018
J	Weerakoon, H; Navaratne, A; Ranasinghe, S; Sivakanesan, R; Galketiya, KB; Rosairo, S				Weerakoon, Harshi; Navaratne, Ayanthi; Ranasinghe, Shirani; Sivakanesan, Ramaiah; Galketiya, Kuda Banda; Rosairo, Shanthini			Chemical Characterization of Gallstones: An Approach to Explore the Aetiopathogenesis of Gallstone Disease in Sri Lanka	PLOS ONE			English	Article							X-RAY DIFFRACTION; PIGMENT GALLSTONES; CHOLESTEROL; BILE; CHOLELITHIASIS; SPECTROSCOPY; EPIDEMIOLOGY; CALCIUM	Introduction Records on gallstones and associated ailments in Sri Lankan community are scarce, despite frequent detection of gallstone disease. Identification of the chemical composition of gallstones in the local setting is important in defining aetiopathogenic factors which in turn are useful in implementing therapeutic and preventive strategies. This study aimed to describe the chemical composition of gallstones and the socio-demographic factors of a cohort of Sri Lankan patients with gallstone disease. Materials and Methods Data on clinical and socio-demographic factors, and gallstones removed at surgery were collected from patients with cholelithiasis admitted to Teaching Hospital, Peradeniya, Sri Lanka from May 2011 to December 2012. External and cross sectional morphological features of gallstones were recorded by naked eye observation. Compositional analysis was carried out by Fourier Transform Infrared Spectroscopy, X - ray Powder Diffraction, and Atomic Absorption Spectrophotometry. Scanning Electron Microscopy was used to identify the microstructure of gallstones. Results Data of 102 patients were analyzed. Of them majority (n = 77, 76%) were females with a female: male ratio of 3:1. Mean age of the study group was 46.1 +/- 11.6 years. All the patients had primary gallbladder stones. According to the physical and chemical analysis, majority (n = 54, 53%) were pigment gallstones followed by mixed cholesterol gallstones (n = 38, 37%). Only 10 (9%) had pure cholesterol gallstones. Calcium bilirubinate, calcium carbonate and calcium phosphate were the commonest calcium salts identified in pigment gallstones and core of mixed cholesterol gallstones. Conclusion Presence of a pigment nidus in gallstones is a common feature in majority of Sri Lankan patients denoting the possible role of elevated unconjugated bilirubin in bile on the pathogenesis of GS. Hence it is imperative to explore this further to understand the aetiopathogenesis of GS among Sri Lankans.	[Weerakoon, Harshi] Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka; [Navaratne, Ayanthi] Univ Peradeniya, Fac Sci, Dept Chem, Peradeniya, Sri Lanka; [Ranasinghe, Shirani; Sivakanesan, Ramaiah] Univ Peradeniya, Fac Med, Dept Biochem, Peradeniya, Sri Lanka; [Galketiya, Kuda Banda] Univ Peradeniya, Fac Med, Dept Surg, Peradeniya, Sri Lanka; [Rosairo, Shanthini] Univ Peradeniya, Fac Med, Dept Radiol, Peradeniya, Sri Lanka; [Weerakoon, Harshi; Navaratne, Ayanthi; Ranasinghe, Shirani; Sivakanesan, Ramaiah] Univ Peradeniya, Post Grad Inst Sci, Peradeniya, Sri Lanka	Rajarata University of Sri Lanka; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya; University of Peradeniya	Weerakoon, H (corresponding author), Rajarata Univ Sri Lanka, Fac Med & Allied Sci, Dept Biochem, Saliyapura, Sri Lanka.	harshitw83@yahoo.com	Sivakanesan, Ramiah/AAK-6486-2020; Rosairo, Shanthini/V-5453-2019	Sivakanesan, Ramiah/0000-0001-9401-7337; Weerakoon, Harshi/0000-0002-8699-133X	Rajarata University of Sri Lanka, Mihintale, Sri Lanka [RJT/RP & HDC/2011/Med. Alli./R/07, RJT/RP & HDC/2013/Med. Alli./R/07]	Rajarata University of Sri Lanka, Mihintale, Sri Lanka	HW received a grant from Rajarata University of Sri Lanka, Mihintale, Sri Lanka (http://www.rjt.ac.lk/page.php); grants no: RJT/RP & HDC/2011/Med. & Alli./R/07 and RJT/RP & HDC/2013/Med. & Alli./R/07. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysuriya V, 2008, HEPATOB PANCREAT DIS, V7, P633; Alatise OI, 2010, BIOL TRACE ELEM RES, V134, P13, DOI 10.1007/s12011-009-8453-3; Athanasiadou D, 2013, J TRACE ELEM MED BIO, V27, P79, DOI 10.1016/j.jtemb.2012.08.004; Berzina-Cimdina L, 2012, INFRARED SPECTROSCOPY - MATERIALS SCIENCE, ENGINEERING AND TECHNOLOGY, P123; CAREY MC, 1978, J CLIN INVEST, V61, P998, DOI 10.1172/JCI109025; Chandran P, 2007, INDIAN J CLIN BIOCHE, V22, P145, DOI 10.1007/BF02913334; CIKRT M, 1972, BRIT J IND MED, V29, P74; HENICHART JP, 1982, CLIN CHIM ACTA, V118, P279, DOI 10.1016/0009-8981(82)90014-6; Jayanthi V, 2005, Indian J Gastroenterol, V24, P97; JUNIPER K, 1956, AM J MED, V20, P383, DOI 10.1016/0002-9343(56)90123-1; Kim IS, 2003, YONSEI MED J, V44, P561, DOI 10.3349/ymj.2003.44.4.561; Kleiner Oleg, 2002, BMC Gastroenterol, V2, P3, DOI 10.1186/1471-230X-2-3; Marth E, 2001, Int J Occup Med Environ Health, V14, P375; Omer LS., 2011, INT J CHEM, V3, P105; Pradhan Sailesh B, 2009, Kathmandu Univ Med J (KUMJ), V7, P268; Qiao T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074887; Rautray TR, 2007, NUCL INSTRUM METH B, V255, P409, DOI 10.1016/j.nimb.2006.12.147; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Shaffer EA, 2006, BEST PRACT RES CL GA, V20, P981, DOI 10.1016/j.bpg.2006.05.004; Shaffer Eldon A, 2005, Curr Gastroenterol Rep, V7, P132; Stinton LM, 2012, GUT LIVER, V6, P172, DOI 10.5009/gnl.2012.6.2.172; SUTOR DJ, 1969, GUT, V10, P681, DOI 10.1136/gut.10.8.681; SUTOR DJ, 1973, GUT, V14, P215, DOI 10.1136/gut.14.3.215; SUZUKI N, 1975, TOHOKU J EXP MED, V116, P259, DOI 10.1620/tjem.116.259; Toscano RA, 2004, THERMOCHIM ACTA, V410, P125, DOI 10.1016/j.tca.2003.07.002; TROTMAN BW, 1982, HEPATOLOGY, V2, P879, DOI 10.1002/hep.1840020624; Vitek L, 2012, CLIN RES HEPATOL GAS, V36, P122, DOI 10.1016/j.clinre.2011.08.010; Weerakoon HTW, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-88; WOSIEWITZ U, 1983, SCAN ELECTRON MICROS, P419	29	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121537	10.1371/journal.pone.0121537	http://dx.doi.org/10.1371/journal.pone.0121537			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853583	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400043
J	Cao, PB; Azar, S; SanClemente, H; Mounet, F; Dunand, C; Marque, G; Marque, C; Teulieres, C				Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.			Genome-Wide Analysis of the AP2/ERF Family in Eucalyptus grandis: An Intriguing Over-Representation of Stress-Responsive DREB1/CBF Genes	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; DNA-BINDING PROTEINS; APETALA2-LIKE GENE; REGULATORY GENES; AP2 DOMAIN; EXPRESSION; ARABIDOPSIS; TOLERANCE; SUPERFAMILY; ANNOTATION	Background The AP2/ERF family includes a large number of developmentally and physiologically important transcription factors sharing an AP2 DNA-binding domain. Among them DREB1/CBF and DREB2 factors are known as master regulators respectively of cold and heat/osmotic stress responses. Experimental Approaches The manual annotation of AP2/ERF family from Eucalyptus grandis, Malus, Populus and Vitis genomes allowed a complete phylogenetic study for comparing the structure of this family in woody species and the model Arabidopsis thaliana. Expression profiles of the whole groups of EgrDREB1 and EgrDREB2 were investigated through RNAseq database survey and RT-qPCR analyses. Results The structure and the size of the AP2/ERF family show a global conservation for the plant species under comparison. In addition to an expansion of the ERF subfamily, the tree genomes mainly differ with respect to the group representation within the subfamilies. With regard to the E. grandis DREB subfamily, an obvious feature is the presence of 17 DREB1/CBF genes, the maximum reported to date for dicotyledons. In contrast, only six DREB2 have been identified, which is similar to the other plants species under study, except for Malus. All the DREB1/CBF and DREB2 genes from E. grandis are expressed in at least one condition and all are heat-responsive. Regulation by cold and drought depends on the genes but is not specific of one group; DREB1/CBF group is more cold-inducible than DREB2 which is mainly drought responsive. Conclusion These features suggest that the dramatic expansion of the DREB1/CBF group might be related to the adaptation of this evergreen tree to climate changes when it expanded in Australia.	[Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.] Univ Toulouse, UPS, LRSV, UMR 5546, F-31326 Castanet Tolosan, France; [Cao, P. B.; Azar, S.; SanClemente, H.; Mounet, F.; Dunand, C.; Marque, G.; Marque, C.; Teulieres, C.] CNRS, LRSV, UMR 5546, F-31326 Castanet Tolosan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Teulieres, C (corresponding author), Univ Toulouse, UPS, LRSV, UMR 5546, 24 Chemin Borde Rouge,BP 42617, F-31326 Castanet Tolosan, France.	teulieres@lrsv.ups-tlse.fr	Dunand, Christophe/I-6424-2012; Mounet, Fabien/F-3614-2011; CAO, Phi Bang/A-7688-2016	Dunand, Christophe/0000-0003-1637-4042; Mounet, Fabien/0000-0001-6632-3070; CAO, Phi Bang/0000-0001-9374-3839	Fibre Excellence (31 St Gaudens, France); French Ministry for Scientific Research (University Toulouse III (UPS); CNRS; Labex Tulip [ANR-10-LABX-41]; Vietnamese Government; Midi Pyrenees Regional Council (France)	Fibre Excellence (31 St Gaudens, France); French Ministry for Scientific Research (University Toulouse III (UPS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Labex Tulip; Vietnamese Government; Midi Pyrenees Regional Council (France)(Region Occitanie)	This work was funded by Fibre Excellence (31, St Gaudens, France) associated with the Midi Pyrenees Regional Council (France) and also supported by the French Ministry for Scientific Research (University Toulouse III (UPS), CNRS and Labex Tulip (ANR-10-LABX-41); the Vietnamese Government provided the PBC grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal PK, 2010, BIOL PLANTARUM, V54, P201, DOI 10.1007/s10535-010-0038-7; Alonso JM, 2003, P NATL ACAD SCI USA, V100, P2992, DOI 10.1073/pnas.0438070100; [Anonymous], BMC P; Artlip TS, 2013, TREE PHYSIOL, V33, P866, DOI 10.1093/treephys/tpt056; Boutilier K, 2002, PLANT CELL, V14, P1737, DOI 10.1105/tpc.001941; Bowman D.M., 2000, AUSTR RAINFORESTS IS; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen YL, 2013, SCI WORLD J, DOI 10.1155/2013/954640; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; Dietz KJ, 2010, PROTOPLASMA, V245, P3, DOI 10.1007/s00709-010-0142-8; Duarte JM, 2006, MOL BIOL EVOL, V23, P469, DOI 10.1093/molbev/msj051; El Kayal W, 2006, J EXP BOT, V57, P2455, DOI 10.1093/jxb/erl019; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; FAO, 2007, STAT WORLDS FOR 2007; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Feng JX, 2005, PLANT MOL BIOL, V59, P853, DOI 10.1007/s11103-005-1511-0; Florence R.G, 1996, ECOLOGY SILVICULTURE; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Girardi CL, 2013, SCI HORTIC-AMSTERDAM, V151, P112, DOI 10.1016/j.scienta.2012.12.017; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; Guo AY, 2005, BIOINFORMATICS, V21, P2568, DOI 10.1093/bioinformatics/bti334; Haake V, 2002, PLANT PHYSIOL, V130, P639, DOI 10.1104/pp.006478; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hefer C, 2011, BMC P; Hinchee M., 2011, BMC P, V5, P124, DOI DOI 10.1186/1753-6561-5-S7-I24; Hu YX, 2004, CELL RES, V14, P8, DOI 10.1038/sj.cr.7290197; Jaglo KR, 2001, PLANT PHYSIOL, V127, P910, DOI 10.1104/pp.010548; JONES JDG, 1985, EMBO J, V4, P2411, DOI 10.1002/j.1460-2075.1985.tb03949.x; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keller G, 2013, TREES-STRUCT FUNCT, V27, P1713, DOI 10.1007/s00468-013-0918-5; Knox AK, 2010, THEOR APPL GENET, V121, P21, DOI 10.1007/s00122-010-1288-7; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Lawton-Rauh A, 2003, MOL PHYLOGENET EVOL, V29, P396, DOI 10.1016/j.ympev.2003.07.004; Lee SJ, 2010, PLANT PHYSIOL, V153, P716, DOI 10.1104/pp.110.154617; Lee SJ, 2009, MOL CELLS, V27, P409, DOI 10.1007/s10059-009-0058-3; Licausi F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-719; Lin HN, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r41; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin HA, 2006, J ARID ENVIRON, V66, P533, DOI 10.1016/j.jaridenv.2006.01.009; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Medina J, 2011, PLANT SCI, V180, P3, DOI 10.1016/j.plantsci.2010.06.019; Mizoi J, 2012, BBA-GENE REGUL MECH, V1819, P86, DOI 10.1016/j.bbagrm.2011.08.004; Moss PT, 2000, PALAEOGEOGR PALAEOCL, V155, P155, DOI 10.1016/S0031-0182(99)00099-1; Myburg AA, 2003, THEOR APPL GENET, V107, P1028, DOI 10.1007/s00122-003-1347-4; Myburg AA, 2014, NATURE, V510, P356, DOI 10.1038/nature13308; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Navarro M, 2009, J EXP BOT, V60, P2713, DOI 10.1093/jxb/erp129; Navarro M, 2011, PLANT BIOTECHNOL J, V9, P50, DOI 10.1111/j.1467-7652.2010.00530.x; Odronitz Florian, 2008, BMC Genomics, V9, P422, DOI 10.1186/1471-2164-9-422; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sandve SR, 2010, MOL ECOL, V19, P2075, DOI 10.1111/j.1365-294X.2010.04629.x; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Sohn KH, 2006, PLANT MOL BIOL, V61, P897, DOI 10.1007/s11103-006-0057-0; Song J, 2013, GENE, V513, P118, DOI 10.1016/j.gene.2012.10.058; Song YP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-111; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tayeh N, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-814; Tong Z, 2009, PLANT MOL BIOL, V71, P115, DOI 10.1007/s11103-009-9513-y; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Xiao H, 2008, PLANT CELL ENVIRON, V31, P1, DOI 10.1111/j.1365-3040.2007.01741.x; Xu W, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-785; Xu ZS, 2008, BOTANY, V86, P969, DOI 10.1139/B08-041; Zhang W, 2011, PLANT BIOLOGY, V13, P343, DOI 10.1111/j.1438-8677.2010.00375.x; Zhao T, 2012, MOL GENET GENOMICS, V287, P423, DOI 10.1007/s00438-012-0687-7; Zhou M-L, 2013, BIOINFORMATICS, V7, DOI [10.2174/157489312802460776, DOI 10.2174/157489312802]; Zhou ML, 2012, CURR BIOINFORM, V7, P324, DOI 10.2174/157489312802460776; Zhuang J, 2008, BIOCHEM BIOPH RES CO, V371, P468, DOI 10.1016/j.bbrc.2008.04.087; Zhuang J, 2011, MOL BIOL REP, V38, P745, DOI 10.1007/s11033-010-0162-7; Zhuang J, 2009, SCI HORTIC-AMSTERDAM, V123, P73, DOI 10.1016/j.scienta.2009.08.002	73	31	35	5	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121041	10.1371/journal.pone.0121041	http://dx.doi.org/10.1371/journal.pone.0121041			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849589	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800042
J	Dong, YJ; Dai, MF; Ye, DD				Dong, Yujuan; Dai, Meifeng; Ye, Dandan			Non-Homogeneous Fractal Hierarchical Weighted Networks	PLOS ONE			English	Article								A model of fractal hierarchical structures that share the property of non-homogeneous weighted networks is introduced. These networks can be completely and analytically characterized in terms of the involved parameters, i.e., the size of the original graph Nk and the non-homogeneous weight scaling factors r(1), r(2),..., r(M). We also study the average weighted shortest path (AWSP), the average degree and the average node strength, taking place on the non-homogeneous hierarchical weighted networks. Moreover the AWSP is scrupulously calculated. We show that the AWSP depends on the number of copies and the sum of all non-homogeneous weight scaling factors in the infinite network order limit.	[Dong, Yujuan; Dai, Meifeng; Ye, Dandan] Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China	Jiangsu University	Dai, MF (corresponding author), Jiangsu Univ, Fac Sci, Zhenjiang 212013, Jiangsu, Peoples R China.	daimf@mail.ujs.edu.cn	DAI, M/GPS-8291-2022		National Science Foundation of China [11071224]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This research is supported by the National Science Foundation of China (11071224) and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barnsley M, 1993, FRACTALS EVERYWHERE; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barrat A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066149; Barrat A., 2007, LARGE SCALE STRUCTUR; Barthelemy M, 2005, PHYSICA A, V346, P34, DOI 10.1016/j.physa.2004.08.047; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Carletti T, 2010, PHYSICA A, V389, P2134, DOI 10.1016/j.physa.2010.01.019; Dai MF, 2012, PHYSICA A, V391, P6165, DOI 10.1016/j.physa.2012.06.066; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Edgar G. A, 1990, MEASURE TOPOLOGY FRA; Li GL, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045103; Ravasz E, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026112; Song CM, 2006, NAT PHYS, V2, P275, DOI 10.1038/nphys266; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Zhang ZZ, 2008, EUR PHYS J B, V65, P141, DOI 10.1140/epjb/e2008-00305-8; Zhang ZZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051120; Zhang ZZ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.061113	18	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121946	10.1371/journal.pone.0121946	http://dx.doi.org/10.1371/journal.pone.0121946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849619	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800090
J	Eguchi, A; Mulya, A; Lazic, M; Radhakrishnan, D; Berk, MP; Povero, D; Gornicka, A; Feldstein, AE				Eguchi, Akiko; Mulya, Anny; Lazic, Milos; Radhakrishnan, Deepa; Berk, Michael P.; Povero, Davide; Gornicka, Agnieszka; Feldstein, Ariel E.			Microparticles Release by Adipocytes Act as "Find-Me" Signals to Promote Macrophage Migration	PLOS ONE			English	Article							ADIPOSE-TISSUE; INSULIN-RESISTANCE; APOPTOTIC CELLS; HEPATIC STEATOSIS; METABOLIC SYNDROME; OBESITY; INFLAMMATION; CLEARANCE; FAT; DEATH	Macrophage infiltration of adipose tissue during weight gain is a central event leading to the metabolic complications of obesity. However, what are the mechanisms attracting professional phagocytes to obese adipose tissue remains poorly understood. Here, we demonstrate that adipocyte-derived microparticles (MPs) are critical "find-me" signals for recruitment of monocytes and macrophages. Supernatants from stressed adipocytes stimulated the attraction of monocyte cells and primary macrophages. The activation of caspase 3 was required for release of these signals. Adipocytes exposed to saturated fatty acids showed marked release of MPs into the supernatant while common genetic mouse models of obesity demonstrate high levels of circulating adipocyte-derived MPs. The release of MPs was highly regulated and dependent on caspase 3 and Rho-associated kinase. Further analysis identified these MPs as a central chemoattractant in vitro and in vivo. In addition, intravenously transplanting circulating MPs from the ob/ob mice lead to activation of monocytes in circulation and adipose tissue of the wild type mice. These data identify adipocyte-derived MPs as novel "find me" signals that contributes to macrophage infiltration associated with obesity.	[Eguchi, Akiko; Lazic, Milos; Povero, Davide; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Mulya, Anny; Radhakrishnan, Deepa; Berk, Michael P.; Gornicka, Agnieszka; Feldstein, Ariel E.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA	University of California System; University of California San Diego; Cleveland Clinic Foundation	Feldstein, AE (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	afeldstein@ucsd.edu	Berk, Michael/M-3585-2019; Berk, Michael/M-7891-2013	Berk, Michael/0000-0002-5554-6946; Berk, Michael/0000-0002-5554-6946	NIH grant [U01 AA022489, DK082451]; Gilead research scholars program in liver disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA022489] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead research scholars program in liver disease; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by NIH grant (U01 AA022489) and (DK082451) to AEF, and Gilead research scholars program in liver disease to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Deaglio S, 2011, ADV PHARMACOL, V61, P301, DOI 10.1016/B978-0-12-385526-8.00010-2; Diehl Anna Mae, 2003, Endocr Pract, V9 Suppl 2, P93; Dinkla S, 2013, NANOMEDICINE-UK, V8, P1657, DOI [10.2217/NNM.13.149, 10.2217/nnm.13.149]; Eguchi A, 2013, ADIPOCYTE, V2, P170, DOI 10.4161/adip.24144; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fujimoto T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004838; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gornicka A, 2012, AM J PHYSIOL-ENDOC M, V303, pE597, DOI 10.1152/ajpendo.00022.2012; Gregory C, 2009, NATURE, V461, P181, DOI 10.1038/461181a; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hevener AL, 2007, J CLIN INVEST, V117, P1658, DOI 10.1172/JCI31561; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Krysko DV, 2006, APOPTOSIS, V11, P1709, DOI 10.1007/s10495-006-9527-8; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Nagaosa K, 2003, DEV GROWTH DIFFER, V45, P351; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Pang C, 2008, AM J PHYSIOL-ENDOC M, V295, pE313, DOI 10.1152/ajpendo.90296.2008; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Ravichandran KS, 2010, J EXP MED, V207, P1807, DOI 10.1084/jem.20101157; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Shet AS, 2003, BLOOD, V102, P2678, DOI 10.1182/blood-2003-03-0693; Staels B, 2006, NAT MED, V12, P54, DOI 10.1038/nm0106-54; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tilg H, 2008, MOL MED, V14, P222, DOI 10.2119/2007-00119.Tilg; Tilg H, 2008, TRENDS ENDOCRIN MET, V19, P371, DOI 10.1016/j.tem.2008.08.005; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08	43	60	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123110	10.1371/journal.pone.0123110	http://dx.doi.org/10.1371/journal.pone.0123110			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849214	Green Published, gold			2022-12-26	WOS:000352477800205
J	Farrell, B; Tsang, C; Raman-Wilms, L; Irving, H; Conklin, J; Pottie, K				Farrell, Barbara; Tsang, Corey; Raman-Wilms, Lalitha; Irving, Hannah; Conklin, James; Pottie, Kevin			What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process	PLOS ONE			English	Article							BENZODIAZEPINE USE; OLDER-ADULTS; POLYPHARMACY; MEDICATIONS; APPROPRIATENESS; OVERDIAGNOSIS; THERAPY; HEALTH; IMPACT; TRIALS	Polypharmacy and inappropriate medication use among older adults contribute to adverse drug reactions, falls, cognitive impairment, noncompliance, hospitalization and mortality. While deprescribing - tapering, reducing or stopping a medication - is feasible and relatively safe, clinicians find it difficult to carry out. Deprescribing guidelines would facilitate this process. The aim of this paper is to identify and prioritize medication classes where evidence-based deprescribing guidelines would be of benefit to clinicians. A modified Delphi approach included a literature review to identify potentially inappropriate medications for the elderly, an expert panel to develop survey content and three survey rounds to seek consensus on priorities. Panel participants included three pharmacists, two family physicians and one social scientist. Sixty-five Canadian geriatrics experts (36 pharmacists, 19 physicians and 10 nurse practitioners) participated in the survey. Twenty-nine drugs/drug classes were included in the first survey with 14 reaching the required (>= 70%) level of consensus, and 2 new drug classes added from qualitative comments. Fifty-three participants completed round two, and 47 participants completed round three. The final five priorities were benzodiazepines, atypical antipsychotics, statins, tricyclic antidepressants, and proton pump inhibitors; nine other drug classes were also identified as being in need of evidence-based deprescribing guidelines. The Delphi consensus process identified five priority drug classes for which expert clinicians felt guidance is needed for deprescribing. The classes of drugs that emerged strongly from the rankings dealt with mental health, cardiovascular, gastroenterological, and neurological conditions. The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based deprescribing guidelines are a priority in the care of the elderly.	[Farrell, Barbara; Tsang, Corey; Irving, Hannah; Conklin, James; Pottie, Kevin] Bruyere Res Inst, Ottawa, ON, Canada; [Farrell, Barbara; Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Farrell, Barbara; Tsang, Corey] Univ Waterloo, Sch Pharm, Waterloo, ON N2L 3G1, Canada; [Raman-Wilms, Lalitha] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON, Canada; [Conklin, James] Concordia Univ, Dept Appl Human Sci, Montreal, PQ, Canada	University of Ottawa; University of Ottawa; University of Waterloo; University of Toronto; Concordia University - Canada	Farrell, B (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.	bfarrell@bruyere.org	Pottie, Kevin/ABC-4385-2020	Tsang, Corey/0000-0002-2087-1888	Ontario Ministry of Health and Long-Term Care	Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was funded by the Ontario Ministry of Health and Long-Term Care (http://www.health.gov.on.ca/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. BF is the principal investigator; JC is the co-principal investigator.	American Geriatrics Society, 2012, AGS UPD BEERS CRIT P; [Anonymous], 2010, DELPHI TECHNIQUE NUR; [Anonymous], 2007, PRACTICAL ASSESSMENT, DOI [DOI 10.1576/T0AG.7.2.120.27071, DOI 10.7275/PDZ9-TH90]; Anthierens S, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-65; Bain KT, 2008, J AM GERIATR SOC, V56, P1946, DOI 10.1111/j.1532-5415.2008.01916.x; Bierman Arlene S, 2007, Am J Geriatr Pharmacother, V5, P147, DOI 10.1016/j.amjopharm.2007.06.005; Borghesani PR, 2011, J AM GERIATR SOC, V59, P376, DOI 10.1111/j.1532-5415.2011.03252.x; bpacnz, 2010, BEST PRACTICE J, V27; Brouwers MC, 2010, CAN MED ASSOC J, V182, pE839, DOI 10.1503/cmaj.090449; Daniel SB, 2011, NEW ENGL J MED, V365, P2002, DOI 10.1056/NEJMsa1103053; Byatt Kit, 2014, Evid Based Med, V19, P121, DOI 10.1136/eb-2013-101646; Canadian Institute for Health Information, 2007, DRUG CLAIMS SEN AN F; Canadian Institute for Health Information, 2012, US SEL PSYCH DRUGS S; Canadian Institute for Health Information (CIHI), 2013, ADVERSE DRUG REACT T; Chokshi NP, 2012, AM J CARDIOL, V110, P1477, DOI 10.1016/j.amjcard.2012.06.058; Declercq T, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007726.pub2; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Field A., 2009, DISCOVERING STAT USI, P539, DOI DOI 10.1111/J.1365-2648.2007.04270_1.X; Garfinkel D, 2007, ISR MED ASSOC J, V9, P430; Garfinkel D, 2010, ARCH INTERN MED, V170, P1648, DOI 10.1001/archinternmed.2010.355; Gnjidic D, 2012, CLIN GERIATR MED, V28, P237, DOI 10.1016/j.cger.2012.01.006; Godlee F., 2012, BMJ-BRIT MED J, V344, pe3783, DOI [10.1136/bmj.e3783, DOI 10.1136/BMJ.E3783]; Gokula M, 2012, CLIN GERIATR MED, V28, P323, DOI 10.1016/j.cger.2012.01.011; Gould RL, 2014, BRIT J PSYCHIAT, V204, P98, DOI 10.1192/bjp.bp.113.126003; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hajjar Emily R, 2007, Am J Geriatr Pharmacother, V5, P345, DOI 10.1016/j.amjopharm.2007.12.002; Hamilton Hilary J, 2009, BMC Geriatr, V9, P5, DOI 10.1186/1471-2318-9-5; Hardy James E., 2011, Journal of Pharmacy Practice and Research, V41, P146; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; Heath I, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6361; Heidelbaugh JJ, 2010, AM J MANAG CARE, V16, pE228; Heidelbaugh JJ, 2009, AM J GASTROENTEROL, V104, pS27, DOI 10.1038/ajg.2009.49; Holey EA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-52; Holmes HM, 2006, ARCH INTERN MED, V166, P605, DOI 10.1001/archinte.166.6.605; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Huang AR, 2012, DRUG AGING, V29, P359, DOI 10.2165/11599460-000000000-00000; Iyer S, 2008, DRUG AGING, V25, P1021, DOI 10.2165/0002512-200825120-00004; Jyrkka J, 2009, DRUG AGING, V26, P1039, DOI 10.2165/11319530-000000000-00000; Lane CJ, 2004, J AM GERIATR SOC, V52, P861, DOI 10.1111/j.1532-5415.2004.52250.x; Le Couteur D, 2011, AUST PRESCR, V34, P182; Mottram P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003491.pub2; Moynihan R, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3502; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Ontario Drug Benefit Program, 2012, 2010 11 REP CARD ONT; Ott SM, 2011, CLEV CLIN J MED, V78, P619, DOI 10.3949/ccjm.78a.11022; Pare G, 2013, INFORM MANAGE-AMSTER, V50, P207, DOI 10.1016/j.im.2013.03.003; Patton M. Q, 2002, QUALITATIVE RES EVAL, P431; Reason B, 2012, FAM PRACT, V29, P427, DOI 10.1093/fampra/cmr124; Reeve E, 2013, DRUG AGING, V30, P793, DOI 10.1007/s40266-013-0106-8; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Schunemann HJ, 2014, CAN MED ASSOC J, V186, pE123, DOI 10.1503/cmaj.131237; Sergi G, 2011, DRUG AGING, V28, P509, DOI 10.2165/11592010-000000000-00000; Sithamparanathan K., 2012, ASIAN J GERONTOL GER, V7, P107; Spijker-Huiges Antje, 2006, Eur J Gen Pract, V12, P10, DOI 10.1080/13814780600757120; Steinman MA, 2010, JAMA-J AM MED ASSOC, V304, P1592, DOI 10.1001/jama.2010.1482; Swinkels H, 2011, CAN MED ASSOC J, V183, pE928, DOI 10.1503/cmaj.090290; Sykes L, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005398.pub3; Voshaar RCO, 2006, BRIT J PSYCHIAT, V189, P213, DOI 10.1192/bjp.189.3.213; Welch GH, 2011, OVER DIAGNOSED MAKIN; Woodward MC., 2003, J PHARM PRACT RES, V33, P323, DOI [10.1002/jppr2003334323, DOI 10.1002/JPPR2003334323]; Wu C, 2012, DRUG SAFETY, V35, P769, DOI 10.2165/11599540-000000000-00000; Ziere G, 2006, BRIT J CLIN PHARMACO, V61, P218, DOI 10.1111/j.1365-2125.2005.02543.x; Zulman DM, 2011, J GEN INTERN MED, V26, P783, DOI 10.1007/s11606-010-1629-x	63	108	112	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122246	10.1371/journal.pone.0122246	http://dx.doi.org/10.1371/journal.pone.0122246			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849568	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800112
J	Gonzalez-Blanch, C; Gleeson, JF; Koval, P; Cotton, SM; McGorry, PD; Alvarez-Jimenez, M				Gonzalez-Blanch, Cesar; Gleeson, John F.; Koval, Peter; Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario			Social Functioning Trajectories of Young First-Episode Psychosis Patients with and without Cannabis Misuse: A 30-Month Follow-Up Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; RELAPSE PREVENTION THERAPY; SCREENING-TEST ASSIST; SUBSTANCE USE; MENTAL-ILLNESS; USE DISORDERS; DRUG-ABUSE; SCHIZOPHRENIA; ALCOHOL; PEOPLE	The aim of the study was to investigate trajectories of social functioning in young people with first-episode psychosis (FEP) with and without cannabis misuse using a secondary analysis of data from the Episode-II trial. Forty-two young people with FEP and comorbid cannabis use disorder were compared with 39 young people with FEP but without a cannabis use disorder. Social functioning was assessed every 6 months during a 30-month follow-up. Multilevel linear growth curve modeling was used to compare the social functioning trajectories over time for those with and without cannabis misuse. Cannabis misuse was not associated with social functioning at baseline assessment. Over a 30-month follow-up, FEP patients without cannabis disorder showed significant improvements in their social functioning, whereas patients with cannabis misuse at baseline displayed no such improvement. Patients with and without cannabis misuse differed significantly in their levels of social functioning after 24 months. Similar results were obtained after adjusting for potential confounders (i.e., age, gender, negative symptoms, premorbid functioning, DSM-IV diagnoses, baseline social functioning and other substance use). In the context of a specialized early intervention service, patients with cannabis misuse at baseline did not attain the improvements in social outcomes observed in their counterparts without cannabis misuse. There is a need to develop effective interventions to reduce cannabis misuse to ultimately improve social outcomes in young people with psychosis.	[Gonzalez-Blanch, Cesar] Univ Hosp Marques de Valdecilla, Mental Hlth Ctr, Santander, Spain; [Gleeson, John F.; Koval, Peter] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Koval, Peter] Katholieke Univ Leuven, Fac Psychol & Educ Sci, Leuven, Belgium; [Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Cotton, Sue M.; McGorry, Patrick D.; Alvarez-Jimenez, Mario] Orygen Youth Hlth Res Ctr, Melbourne, Vic, Australia	Hospital Universitario Marques de Valdecilla (HUMV); Australian Catholic University; KU Leuven; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Orygen, The National Centre of Excellence in Youth Mental Health	Gonzalez-Blanch, C (corresponding author), Univ Hosp Marques de Valdecilla, Mental Hlth Ctr, Santander, Spain.	cesar.gonzalezblanch@scsalud.es	McGorry, Patrick/O-4115-2019; Alvarez-Jimenez, Mario/G-4691-2013; Gonzalez-Blanch, Cesar/AAA-6065-2019; Gleeson, John F/I-1977-2018; Koval, Peter/ABB-9116-2020	Alvarez-Jimenez, Mario/0000-0002-3535-9086; Gleeson, John F/0000-0001-7969-492X; Koval, Peter/0000-0003-2460-0943; McGorry, Patrick/0000-0002-3789-6168; Gonzalez-Blanch, Cesar/0000-0002-3181-4731; Cotton, Sue/0000-0002-9386-8348	Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium; Colonial Foundation; National Health and Medical Research Council of Australia [350241]; Alicia Koplowitz Foundation; CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne; NHMRC Career Development Fellowship [APP1061998]	Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium(Eli Lilly); Colonial Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Alicia Koplowitz Foundation; CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by an unrestricted grant from Eli Lilly via the Lilly Melbourne Academic Psychiatry Consortium. In addition, the study was supported by the Colonial Foundation and a Program grant from the National Health and Medical Research Council of Australia (350241). This study was further supported by a grant from the Alicia Koplowitz Foundation to Dr. Gonzalez-Blanch. Dr. Alvarez-Jimenez is supported by the CR Roper Fellowship, Faculty of Medicine, Dentistry, and Health Science, the University of Melbourne. A/Prof Sue Cotton is supported by a NHMRC Career Development Fellowship (APP1061998). No funding body had any involvement in any aspect of the study or	Addington J, 2007, ACTA PSYCHIAT SCAND, V115, P304, DOI 10.1111/j.1600-0447.2006.00900.x; Ali R, 2002, ADDICTION, V97, P1183; Alvarez-Jimenez M, 2009, CAN J PSYCHIAT, V54, P710, DOI 10.1177/070674370905401008; Andreasen N.C, 1984, SCALE FOR THE ASSESS; APA APA, 1994, DIAGNOSTIC AND STATI; Bahorik AL, 2013, ADDICTION, V108, P1259, DOI 10.1111/add.12153; Barrowclough C, 2013, SCHIZOPHRENIA BULL, V39, P339, DOI 10.1093/schbul/sbr152; Bellack AS, 2006, ARCH GEN PSYCHIAT, V63, P426, DOI 10.1001/archpsyc.63.4.426; Birchwood M, 1998, BRIT J PSYCHIAT, V172, P53, DOI 10.1192/S0007125000297663; Bolger N, 2013, INTENSIVE LONGITUDIN; CANNONSPOOR HE, 1982, SCHIZOPHRENIA BULL, V8, P470, DOI 10.1093/schbul/8.3.470; Cassidy CM, 2010, SCHIZOPHRENIA BULL, V36, P1001, DOI 10.1093/schbul/sbp007; Clausen L, 2014, PSYCHOL MED, V44, P117, DOI 10.1017/S0033291713000433; Edwards J, 2006, ACTA PSYCHIAT SCAND, V114, P109, DOI 10.1111/j.1600-0447.2006.00783.x; Faber G, 2012, J CLIN PSYCHIAT, V73, P632, DOI 10.4088/JCP.11m07069; First M., 1997, STRUCTURED CLIN INTE; Foti DJ, 2010, AM J PSYCHIAT, V167, P987, DOI 10.1176/appi.ajp.2010.09020189; Ginsberg J., 2003, APPL NEUROPSYCHOL, V10, P182, DOI DOI 10.1207/S15324826AN1003_08; Gleeson JFM, 2013, SCHIZOPHRENIA BULL, V39, P436, DOI 10.1093/schbul/sbr165; Gleeson JFM, 2010, J CLIN PSYCHIAT, V71, P475, DOI 10.4088/JCP.08m04672yel; Gleeson JFM, 2009, J CLIN PSYCHIAT, V70, P477, DOI 10.4088/JCP.08m04407; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gonzalez-Blanch C, 2015, EUR PSYCHIAT, V30, DOI 10.1016/j.eurpsy.2014.07.002; Gonzalez-Blanch C, 2010, PSYCHOL MED, V40, P935, DOI 10.1017/S0033291709991267; Gonzalez-Pinto A, 2011, SCHIZOPHRENIA BULL, V37, P631, DOI 10.1093/schbul/sbp126; Hides L, 2009, ADDICT BEHAV, V34, P821, DOI 10.1016/j.addbeh.2009.03.001; Hjorthoj CR, 2014, CURR PHARM DESIGN, V20, P2205, DOI 10.2174/13816128113199990431; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; Koskinen J, 2010, SCHIZOPHRENIA BULL, V36, P1115, DOI 10.1093/schbul/sbp031; LUKOFF D, 1986, SCHIZOPHRENIA BULL, V12, P578, DOI 10.1093/schbul/12.4.578; Lynskey M, 2000, ADDICTION, V95, P1621, DOI 10.1046/j.1360-0443.2000.951116213.x; MONTGOMERY SM, 1979, PROG NEURO-PSYCHOPHA, V3, P429, DOI 10.1016/0364-7722(79)90058-4; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Nakagami E, 2008, SCHIZOPHR RES, V105, P95, DOI 10.1016/j.schres.2008.06.015; Newcombe DAL, 2005, DRUG ALCOHOL REV, V24, P217, DOI 10.1080/09595230500170266; Pencer A, 2005, PSYCHIAT RES, V133, P35, DOI 10.1016/j.psychres.2004.10.004; Portney L. G., 2000, FOUNDATIONS OF CLINI; Rabin RA, 2011, SCHIZOPHR RES, V128, P111, DOI 10.1016/j.schres.2011.02.017; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rey JM, 2004, J AM ACAD CHILD PSY, V43, P1194, DOI 10.1097/01.chi.0000135623.12843.60; Schimmelmann BG, 2012, EUR PSYCHIAT, V27, P463, DOI 10.1016/j.eurpsy.2011.03.001; United Nations Office on Drugs and Crime, 2013, WORLD DRUG REPORT 20; Wisdom JP, 2011, PSYCHIAT SERV, V62, P1007, DOI 10.1176/appi.ps.62.9.1007; Yucel M, 2012, SCHIZOPHRENIA BULL, V38, P316, DOI 10.1093/schbul/sbq079; Zammit S, 2008, BRIT J PSYCHIAT, V193, P357, DOI 10.1192/bjp.bp.107.046375	45	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122404	10.1371/journal.pone.0122404	http://dx.doi.org/10.1371/journal.pone.0122404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849623	Green Published, gold			2022-12-26	WOS:000352477800127
J	Han, Y; Zhu, QG; Zhang, ZK; Meng, K; Hou, YL; Ban, QY; Suo, JT; Rao, JP				Han, Ye; Zhu, Qinggang; Zhang, Zhengke; Meng, Kun; Hou, Yali; Ban, Qiuyan; Suo, Jiangtao; Rao, Jingping			Analysis of Xyloglucan Endotransglycosylase/Hydrolase (XTH) Genes and Diverse Roles of Isoenzymes during Persimmon Fruit Development and Postharvest Softening	PLOS ONE			English	Article							WALL-MODIFYING ENZYMES; ENDOTRANSGLUCOSYLASE/HYDROLASE XTH; TOMATO FRUIT; CELL-WALLS; ENDO-TRANSGLYCOSYLASES; GIBBERELLIC-ACID; EXPRESSION; ETHYLENE; METABOLISM; CLONING	Xyloglucan endotransglycosylase/hydrolase (XTH) enzymes have played a role in the remodeling of cell wall hemicelluloses. To investigate the function of XTHs in persimmon (Diospyros kaki L.) fruit development and postharvest softening, five cDNAs (DkXTH1 to DkXTH5), whose putative proteins contained the conserved DEIDFEFLG motif of XTH, were cloned. Real time quantitative PCR analysis revealed that DkXTH1, DkXTH4, and DkXTH5 peaked in immature expanding fruit, and their higher expression was observed along with higher fruit firmness in cold-treated fruit or firmer cultivar fruit during storage. The opposite gene expression patterns were observed in DkXTH2 and DkXTH3, which reached maxima concomitance with pronounced fruit softening. Meanwhile, the xyloglucan endotransglycosylase (XET) enzymes play important roles in both the rapid growth and ripening of persimmon fruit. Furthermore, the recombined DkXTH1 and DkXTH2 proteins showed significant XET activity without any detected XEH activity. However, the XET activity of recombined DkXTH2 protein had a higher affinity for small acceptor molecules than that of recombined DkXTH1 protein. The former might prefer to participate in cell wall restructuring, and the latter is more inclined to participate in cell wall assembly. Besides, DKXTH proteins could function by targeting to the cell wall under regulation of a signal peptide. The data suggested that individual DKXTHs could exhibit different patterns of expression, and the encoded products possessed specific enzymatic properties conferring on their respective functions in growth and postharvest softening of persimmon fruit.	[Han, Ye; Zhu, Qinggang; Meng, Kun; Hou, Yali; Ban, Qiuyan; Suo, Jiangtao; Rao, Jingping] Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China; [Zhang, Zhengke] Hainan Univ, Coll Food Sci & Technol, Haikou, Peoples R China	Northwest A&F University - China; Hainan University	Rao, JP (corresponding author), Northwest A&F Univ, Coll Hort, Yangling, Shaanxi, Peoples R China.	raojingpingxn@163.com		Zhu, Qinggang/0000-0002-8786-2169				Akaura Kazuyuki, 2008, Horticultural Research (Japan), V7, P111, DOI 10.2503/hrj.7.111; Atkinson RG, 2009, POSTHARVEST BIOL TEC, V51, P149, DOI 10.1016/j.postharvbio.2008.06.014; Baumann MJ, 2007, PLANT CELL, V19, P1947, DOI 10.1105/tpc.107.051391; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brummell DA, 2001, PLANT MOL BIOL, V47, P311, DOI 10.1023/A:1010656104304; Campbell P, 1999, TRENDS PLANT SCI, V4, P361, DOI 10.1016/S1360-1385(99)01468-5; Catala C, 2000, PLANT PHYSIOL, V122, P527, DOI 10.1104/pp.122.2.527; Catala C, 2001, PLANT PHYSIOL, V127, P1180, DOI 10.1104/pp.010481; Chanliaud E, 2004, PLANT J, V38, P27, DOI 10.1111/j.1365-313X.2004.02018.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Cosgrove DJ, 1997, PLANT CELL, V9, P1031, DOI 10.1105/tpc.9.7.1031; CUTILLASITURRALDE A, 1994, PHYSIOL PLANTARUM, V91, P169, DOI [10.1111/j.1399-3054.1994.tb00415.x, 10.1034/j.1399-3054.1994.910206.x]; DESILVA J, 1994, J EXP BOT, V45, P1693, DOI 10.1093/jxb/45.Special_Issue.1693; Eklof JM, 2010, PLANT PHYSIOL, V153, P456, DOI 10.1104/pp.110.156844; Figueroa CR, 2008, POSTHARVEST BIOL TEC, V49, P210, DOI 10.1016/j.postharvbio.2008.01.018; Figueroa CR, 2009, POSTHARVEST BIOL TEC, V53, P51, DOI 10.1016/j.postharvbio.2009.02.005; Fonseca S, 2005, J EXP BOT, V56, P2029, DOI 10.1093/jxb/eri201; Fry SC, 2004, NEW PHYTOL, V161, P641, DOI 10.1111/j.1469-8137.2004.00980.x; Fry SC, 1998, BIOCHEM J, V332, P507, DOI 10.1042/bj3320507; Genovesi V, 2008, J EXP BOT, V59, P875, DOI 10.1093/jxb/ern013; Goulao LF, 2008, POSTHARVEST BIOL TEC, V48, P37, DOI 10.1016/j.postharvbio.2007.09.022; Harada T, 2000, THEOR APPL GENET, V101, P742, DOI 10.1007/s001220051539; Harima S, 2003, POSTHARVEST BIOL TEC, V29, P319, DOI 10.1016/S0925-5214(03)00058-9; Henriksson H, 2003, BIOCHEM J, V375, P61, DOI 10.1042/BJ20030485; Hiwasa K, 2004, J EXP BOT, V55, P2281, DOI 10.1093/jxb/erh250; Jamet E, 2006, TRENDS PLANT SCI, V11, P33, DOI 10.1016/j.tplants.2005.11.006; Johansson P, 2004, PLANT CELL, V16, P874, DOI 10.1105/tpc.020065; Kallas AM, 2005, BIOCHEM J, V390, P105, DOI 10.1042/BJ20041749; Li CR, 2009, POSTHARVEST BIOL TEC, V52, P254, DOI 10.1016/j.postharvbio.2008.12.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu W, 2006, PLANT PHYSIOL BIOCH, V44, P707, DOI 10.1016/j.plaphy.2006.09.020; Lv JY, 2014, POSTHARVEST BIOL TEC, V92, P54, DOI 10.1016/j.postharvbio.2014.01.015; MACLACHLAN G, 1994, PLANT PHYSIOL, V105, P965, DOI 10.1104/pp.105.3.965; Mark P, 2009, PROTEINS, V75, P820, DOI 10.1002/prot.22291; Miedes E, 2010, J AGR FOOD CHEM, V58, P5708, DOI 10.1021/jf100242z; Miedes E, 2009, J PLANT PHYSIOL, V166, P489, DOI 10.1016/j.jplph.2008.07.003; Munoz-Bertomeu J, 2013, J PLANT PHYSIOL, V170, P1194, DOI 10.1016/j.jplph.2013.03.015; Mworia EG, 2010, POSTHARVEST BIOL TEC, V55, P108, DOI 10.1016/j.postharvbio.2009.08.007; Nardi CF, 2014, SCI HORTIC-AMSTERDAM, V165, P111, DOI 10.1016/j.scienta.2013.10.035; NISHITANI K, 1992, J BIOL CHEM, V267, P21058; NISHITANI K, 1995, J PLANT RES, V108, P137, DOI 10.1007/BF02344317; Nishiyama K, 2007, J EXP BOT, V58, P1281, DOI 10.1093/jxb/erl283; Ohba T, 2011, PLANT BIOTECHNOL-NAR, V28, P25, DOI 10.5511/plantbiotechnology.10.0922a; Opazo MC, 2013, POSTHARVEST BIOL TEC, V77, P28, DOI 10.1016/j.postharvbio.2012.11.007; Percy AE, 1996, PHYSIOL PLANTARUM, V96, P43, DOI [10.1111/j.1399-3054.1996.tb00181.x, 10.1034/j.1399-3054.1996.960107.x]; Rose JKC, 2002, PLANT CELL PHYSIOL, V43, P1421, DOI 10.1093/pcp/pcf171; Saladie M, 2006, PLANT J, V47, P282, DOI 10.1111/j.1365-313X.2006.02784.x; Schroder R, 1998, PLANTA, V204, P242, DOI 10.1007/s004250050253; Steele NM, 2000, PHYTOCHEMISTRY, V54, P667, DOI 10.1016/S0031-9422(00)00203-X; Steele NM, 2001, BIOCHEM J, V355, P671, DOI 10.1042/bj3550671; Sulova Z, 2003, PLANT PHYSIOL BIOCH, V41, P431, DOI 10.1016/S0981-9428(03)00050-0; SULOVA Z, 1995, ANAL BIOCHEM, V229, P80, DOI 10.1006/abio.1995.1381; Tabuchi A, 1997, PLANT CELL PHYSIOL, V38, P653, DOI 10.1093/oxfordjournals.pcp.a029217; Thompson JE, 1997, BIOCHEM J, V327, P699; Thompson JE, 2001, PLANT J, V26, P23, DOI 10.1046/j.1365-313x.2001.01005.x; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Zhang ZK, 2012, HORTSCIENCE, V47, P378, DOI 10.21273/HORTSCI.47.3.378; Zhu QG, 2013, FOOD CHEM, V138, P471, DOI 10.1016/j.foodchem.2012.09.141	58	32	36	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123668	10.1371/journal.pone.0123668	http://dx.doi.org/10.1371/journal.pone.0123668			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849978	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800249
J	Maruyama, T; Akutsu, Y; Suganami, A; Tamura, Y; Fujito, H; Ouchi, T; Akanuma, N; Isozaki, Y; Takeshita, N; Hoshino, I; Uesato, M; Toyota, T; Hayashi, H; Matsubara, H				Maruyama, Tetsuro; Akutsu, Yasunori; Suganami, Akiko; Tamura, Yutaka; Fujito, Hiromichi; Ouchi, Tomoki; Akanuma, Naoki; Isozaki, Yuka; Takeshita, Nobuyoshi; Hoshino, Isamu; Uesato, Masaya; Toyota, Taro; Hayashi, Hideki; Matsubara, Hisahiro			Treatment of Near-Infrared Photodynamic Therapy Using a Liposomally Formulated Indocyanine Green Derivative for Squamous Cell Carcinoma	PLOS ONE			English	Article							CANCER-CELLS; NANOPARTICLES; MECHANISMS; DRUG	Introduction Photodynamic therapy (PDT) is a less invasive option for cancer treatment that has evolved through recent developments in nanotechnology. We have designed and synthesized a novel liposome system that includes an indocyanine green (ICG) derivative, ICG-C18, in its bilayer. In addition to its use as an optical imager to visualize blood, lymphatic, and bile flow, ICG has also been used as an optical sensitizer. In the present report, we evaluate the use of our novel liposome system, LP-ICG-C18, in PDT for squamous cell carcinoma in an autologous murine model. Materials and Methods An excitation pulse beam (300 mu J/pulse) of a single band (800 nm) was used for sensitization. The cytotoxicity of the photodynamic therapy was evaluated in terms of cellular morphology changes, methyl thiazolyl tetrazolium (MTT) assay results, and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate-biotin nick end labeling (TUNEL) staining. We tested the enhanced permeability and retention effect of LP-ICG-C18 in tumor-bearing C3H/He mice using a near-infrared fluorescence imaging system and fluorescence microscopy. We also examined the antitumor effect of PDT by measuring tumor volume in tumor-bearing mice. Results Cell death and apoptosis were only observed in the PDT group receiving LP-ICG-C18. LPICG-C18 itself had no cytotoxic activity and showed good biocompatibility. LP-ICG-C18 accumulated on the tumor 24 hours after injection and was retained for approximately 3 weeks. Tumor cell apoptosis following PDT with LP-ICG-C18 was also observed under optical microscopy, MTT assay, and TUNEL staining. Conclusion These findings suggest that LP-ICG-C18 may be an effective intervening material in PDT for malignant disease.	[Maruyama, Tetsuro; Akutsu, Yasunori; Akanuma, Naoki; Isozaki, Yuka; Takeshita, Nobuyoshi; Hoshino, Isamu; Uesato, Masaya; Matsubara, Hisahiro] Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan; [Suganami, Akiko; Tamura, Yutaka] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba, Japan; [Fujito, Hiromichi] Chiba Univ, Fac Engn, Dept Med Syst Engn, Chiba 260, Japan; [Ouchi, Tomoki] Chiba Univ, Grad Sch Adv Integrat Sci, Div Neurosci, Chiba, Japan; [Toyota, Taro] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo, Japan; [Hayashi, Hideki] Chiba Univ, Ctr Frontier Med Engn, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; University of Tokyo; Chiba University	Akutsu, Y (corresponding author), Chiba Univ, Grad Sch Med, Dept Frontier Surg, Chiba, Japan.	yakutsu@faculty.chiba-u.jp			Nakayama Cancer Research Institute Gastrointestinal Project grant	Nakayama Cancer Research Institute Gastrointestinal Project grant	Nakayama Cancer Research Institute Gastrointestinal Project grant (http://ncri.or.jp/prize/prize.html) TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bareford LA, 2007, ADV DRUG DELIVER REV, V59, P748, DOI 10.1016/j.addr.2007.06.008; Barth BM, 2011, ACS NANO, V5, P5325, DOI 10.1021/nn2005766; Baumler W, 1999, BRIT J CANCER, V80, P360, DOI 10.1038/sj.bjc.6690363; Cheng Y, 2011, J AM CHEM SOC, V133, P2583, DOI 10.1021/ja108846h; Cui SS, 2013, ACS NANO, V7, P676, DOI 10.1021/nn304872n; Douillard S, 2013, PHOTODIAGN PHOTODYN, V10, P62, DOI 10.1016/j.pdpdt.2012.05.004; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Fickweiler S, 1997, J PHOTOCH PHOTOBIO B, V38, P178, DOI 10.1016/S1011-1344(96)07453-2; Hirano T, 2007, J JPN SOC LASER SURG, V28, P122, DOI DOI 10.2530/jslsm.28.122; Hocine O, 2010, INT J PHARMACEUT, V402, P221, DOI 10.1016/j.ijpharm.2010.10.004; HOPEROSS M, 1994, OPHTHALMOLOGY, V101, P529; Huang CJ, 2013, NANO LETT, V13, P1611, DOI 10.1021/nl400033h; Hulchanskyy TY, 2007, NANO LETT, V7, P2835, DOI 10.1021/nl0714637; Karakullukcu B, 2013, EUR ARCH OTO-RHINO-L, V270, P1093, DOI 10.1007/s00405-012-2104-6; Lee SJ, 2011, J CONTROL RELEASE, V152, P21, DOI 10.1016/j.jconrel.2011.03.027; Lee YEK, 2011, METHODS MOL BIOL, V726, P151, DOI 10.1007/978-1-61779-052-2_11; MAC E., 2003, PHOTODYNAMIC THERAPY; Panyam J, 2002, FASEB J, V16, DOI 10.1096/fj.02-0088com; Paszko E, 2013, EUR J PHARM SCI, V48, P202, DOI 10.1016/j.ejps.2012.10.018; Proulx ST, 2010, CANCER RES, V70, P7053, DOI 10.1158/0008-5472.CAN-10-0271; Qin M, 2011, PHOTOCH PHOTOBIO SCI, V10, P832, DOI 10.1039/c1pp05022b; Qumseya BJ, 2013, CLIN ENDOSC, V46, P30, DOI 10.5946/ce.2013.46.1.30; Radzi R, 2012, J VET MED SCI, V74, P545, DOI 10.1292/jvms.11-0464; Reddy GR, 2006, CLIN CANCER RES, V12, P6677, DOI 10.1158/1078-0432.CCR-06-0946; Rungta P, 2011, MACROMOL BIOSCI, V11, P927, DOI 10.1002/mabi.201100043; Sahay G, 2010, J CONTROL RELEASE, V145, P182, DOI 10.1016/j.jconrel.2010.01.036; Sakagami H, 2006, IN VIVO, V20, P499; SHIBAMOTO Y, 1991, CANCER RES, V51, P5134; Suganami A, 2012, BIOORG MED CHEM LETT, V22, P7481, DOI 10.1016/j.bmcl.2012.10.044; Toyota T, 2013, BIOORGANIC MEDICINAL, V22, P721; Urbanska K, 2002, ACTA BIOCHIM POL, V49, P387; Vranic S, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-2; Yano T, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-113; Yoon HY, 2012, KOREAN J INTERN MED, V27, P278, DOI 10.3904/kjim.2012.27.3.278; Zhao BZ, 2010, EXPERT REV ANTICANC, V10, P1797, DOI [10.1586/era.10.154, 10.1586/ERA.10.154]	35	11	11	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122849	10.1371/journal.pone.0122849	http://dx.doi.org/10.1371/journal.pone.0122849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850029	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800165
J	Xing, K; Zhu, F; Zhai, LW; Liu, HJ; Wang, Y; Wang, ZJ; Chen, SK; Hou, ZC; Wang, CD				Xing, Kai; Zhu, Feng; Zhai, Liwei; Liu, Huijie; Wang, Yuan; Wang, Zhijun; Chen, Shaokang; Hou, Zhuocheng; Wang, Chuduan			Integration of Transcriptome and Whole Genomic Resequencing Data to Identify Key Genes Affecting Swine Fat Deposition	PLOS ONE			English	Article							PORCINE ADIPOSE-TISSUE; DIFFERENTIAL EXPRESSION; ACID SYNTHESIS; RETINOID METABOLISM; EXTREME PHENOTYPES; BACKFAT THICKNESS; NUCLEAR RECEPTORS; NATIVE PIG; MUSCLE; LIVER	Fat deposition is highly correlated with the growth, meat quality, reproductive performance and immunity of pigs. Fatty acid synthesis takes place mainly in the adipose tissue of pigs; therefore, in this study, a high-throughput massively parallel sequencing approach was used to generate adipose tissue transcriptomes from two groups of Songliao black pigs that had opposite backfat thickness phenotypes. The total number of paired-end reads produced for each sample was in the range of 39.29-49.36 millions. Approximately 188 genes were differentially expressed in adipose tissue and were enriched for metabolic processes, such as fatty acid biosynthesis, lipid synthesis, metabolism of fatty acids, etinol, caffeine and arachidonic acid and immunity. Additionally, many genetic variations were detected between the two groups through pooled whole-genome resequencing. Integration of transcriptome and whole-genome resequencing data revealed important genomic variations among the differentially expressed genes for fat deposition, for example, the lipogenic genes. Further studies are required to investigate the roles of candidate genes in fat deposition to improve pig breeding programs.	[Xing, Kai; Zhu, Feng; Zhai, Liwei; Liu, Huijie; Wang, Yuan; Hou, Zhuocheng; Wang, Chuduan] China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China; [Wang, Zhijun] China Agr Univ, Dept Anim Genet & Breeding, MOA Key Lab Anim Genet & Breeding, Beijing 100193, Peoples R China; [Wang, Zhijun] Tianjin Ninghe Primary Pig Breeding Farm, Tianjin 301500, Peoples R China; [Chen, Shaokang] Anim Husb & Vet Stn Beijing, Beijing 100125, Peoples R China	China Agricultural University; China Agricultural University	Hou, ZC (corresponding author), China Agr Univ, Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	zchou@cau.edu.cn; cdwang@cau.edu.cn		Xing, Kai/0000-0002-2556-6946	Beijing team of the Pig Industry Technology System Innovation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China [2011BAD28B01]; Tianjin Ninghe primary pig breeding farm	Beijing team of the Pig Industry Technology System Innovation; National Key Technology Research and Development Program of the Ministry of Science and Technology of China(National Key Technology R&D Program); Tianjin Ninghe primary pig breeding farm	This research was financially supported by the Beijing team of the Pig Industry Technology System Innovation and National Key Technology Research and Development Program of the Ministry of Science and Technology of China (2011BAD28B01). Tianjin Ninghe primary pig breeding farm provided support in the form of a salary for author ZW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the author contributions' section.	Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Calder PC, 2008, PROSTAG LEUKOTR ESS, V79, P101, DOI 10.1016/j.plefa.2008.09.016; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Choi KM, 2008, ASIAN AUSTRAL J ANIM, V21, P967, DOI 10.5713/ajas.2008.80059; Colbert CL, 2010, P NATL ACAD SCI USA, V107, P18820, DOI 10.1073/pnas.1012736107; Corominas J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-843; Corominas J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053687; Dieguez C, 2011, NEUROENDOCRINOLOGY, V94, P1, DOI 10.1159/000328122; Doran O, 2006, BRIT J NUTR, V95, P609, DOI 10.1079/BJN20051526; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fam BC, 2012, ADIPOCYTE, V1, P259, DOI 10.4161/adip.21448; Fan WL, 2013, GENOME BIOL EVOL, V5, P1376, DOI 10.1093/gbe/evt097; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HOUPT KA, 1979, YALE J BIOL MED, V52, P307; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; KELLER H, 1993, P NATL ACAD SCI USA, V90, P2160, DOI 10.1073/pnas.90.6.2160; Kopecky J, 2004, PHYSIOL RES, V53, pS225; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XJ, 2012, ANIM GENET, V43, P144, DOI 10.1111/j.1365-2052.2011.02240.x; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moon JK, 2009, ANIM GENET, V40, P115, DOI 10.1111/j.1365-2052.2008.01798.x; Nguyen P, 2008, J ANIM PHYSIOL AN N, V92, P272, DOI 10.1111/j.1439-0396.2007.00752.x; OHEA EK, 1969, J NUTR, V99, P338, DOI 10.1093/jn/99.3.338; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Ren ZQ, 2008, GENET SEL EVOL, V40, P625, DOI 10.1051/gse:2008024; Roman J, 2008, J INVEST MED, V56, P528, DOI 10.2310/JIM.0b013e3181659932; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Sodhi SS, 2014, MOL BIOL REP, V41, P6305, DOI 10.1007/s11033-014-3513-y; Stachowiak M, 2013, MEAT SCI, V95, P64, DOI 10.1016/j.meatsci.2013.04.021; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Suzuki K, 2009, J ANIM SCI, V87, P2209, DOI 10.2527/jas.2008-0866; Taniguchi M, 2008, COMP BIOCHEM PHYS D, V3, P251, DOI 10.1016/j.cbd.2008.06.002; Tarazona S, 2013, NOISEQ DIFFERENTIAL; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tummaruk P, 2009, ANIM REPROD SCI, V110, P108, DOI 10.1016/j.anireprosci.2008.01.004; Vidal O, 2006, ANIM GENET, V37, P28, DOI 10.1111/j.1365-2052.2005.01366.x; WAKIL SJ, 1960, BIOCHIM BIOPHYS ACTA, V41, P122, DOI 10.1016/0006-3002(60)90377-2; WAKIL SJ, 1989, BIOCHEMISTRY-US, V28, P4523, DOI 10.1021/bi00437a001; Wang T, 2013, INT J BIOL SCI, V9, P550, DOI 10.7150/ijbs.6257; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; WISE EM, 1964, P NATL ACAD SCI USA, V52, P1255, DOI 10.1073/pnas.52.5.1255; Xing K, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-32; Zempleni J, 2012, ADV NUTR, V3, P213, DOI 10.3945/an.111.001305; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhou SL, 2012, GENET MOL RES, V11, P1254, DOI 10.4238/2012.May.9.4; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	58	14	15	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122396	10.1371/journal.pone.0122396	http://dx.doi.org/10.1371/journal.pone.0122396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849573	gold, Green Submitted, Green Published			2022-12-26	WOS:000352477800126
J	Yan, W; Hu, ZM; Zhao, YP; Zhang, XZ; Fan, YZ; Shi, PL; He, YT; Yu, GR; Li, YN				Yan, Wei; Hu, Zhongmin; Zhao, Yuping; Zhang, Xianzhou; Fan, Yuzhi; Shi, Peili; He, Yongtao; Yu, Guirui; Li, Yingnian			Modeling Net Ecosystem Carbon Exchange of Alpine Grasslands with a Satellite-Driven Model	PLOS ONE			English	Article							GROSS PRIMARY PRODUCTION; USE EFFICIENCY MODEL; TEMPERATURE-DEPENDENCE; VEGETATION INDEXES; INTEGRATING MODIS; FLUX MEASUREMENTS; DIOXIDE EXCHANGE; UNITED-STATES; CO2 EXCHANGE; RESPIRATION	Estimate of net ecosystem carbon exchange (NEE) between the atmosphere and terrestrial ecosystems, the balance of gross primary productivity (GPP) and ecosystem respiration (Reco) has significant importance for studying the regional and global carbon cycles. Using models driven by satellite data and climatic data is a promising approach to estimate NEE at regional scales. For this purpose, we proposed a semi-empirical model to estimate NEE in this study. In our model, the component GPP was estimated with a light response curve of a rectangular hyperbola. The component Reco was estimated with an exponential function of soil temperature. To test the feasibility of applying our model at regional scales, the temporal variations in the model parameters derived from NEE observations in an alpine grassland ecosystem on Tibetan Plateau were investigated. The results indicated that all the inverted parameters exhibit apparent seasonality, which is in accordance with air temperature and canopy phenology. In addition, all the parameters have significant correlations with the remote sensed vegetation indexes or environment temperature. With parameters estimated with these correlations, the model illustrated fair accuracy both in the validation years and at another alpine grassland ecosystem on Tibetan Plateau. Our results also indicated that the model prediction was less accurate in drought years, implying that soil moisture is an important factor affecting the model performance. Incorporating soil water content into the model would be a critical step for the improvement of the model.	[Yan, Wei; Zhao, Yuping; Zhang, Xianzhou; Fan, Yuzhi; Shi, Peili; He, Yongtao] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Lhasa Plateau Ecosyst Res Stn, Beijing 100101, Peoples R China; [Yan, Wei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Yan, Wei] Beijing Meteorol Bur, Beijing 100089, Peoples R China; [Hu, Zhongmin; Yu, Guirui] Chinese Acad Sci, Key Lab Ecosyst Network Observat & Modeling, Inst Geog Sci & Nat Resources Res, Beijing 100101, Peoples R China; [Li, Yingnian] Chinese Acad Sci, Northwest Inst Plateau Biol, Xining 810001, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences	Zhang, XZ (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Lhasa Plateau Ecosyst Res Stn, Beijing 100101, Peoples R China.	zhangxz@igsnrr.ac.cn	于, 贵瑞/C-1768-2014; zhang, xian/GYA-0290-2022; Peili, SHi/AAT-6450-2021	于, 贵瑞/0000-0002-1859-8966; shi, pei li/0000-0002-1120-0003	National Natural Science Foundation of China [41301043, 41171044]; National Key Technology RD Program [2011BAC09B03]; CAS action-plan for West Development [KZCX2-XB3-08]; Foundation for young scholars of IGSNRR [2013RC203]; CAS [XDB03030401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); CAS action-plan for West Development; Foundation for young scholars of IGSNRR; CAS(Chinese Academy of Sciences)	This research was jointly funded by National Natural Science Foundation of China (Grant No. 41301043, 41171044), National Key Technology R&D Program (2011BAC09B03), CAS action-plan for West Development (No. KZCX2-XB3-08), Foundation for young scholars of IGSNRR (2013RC203), and the special fund for the Tibet of CAS (XDB03030401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldocchi DD, 2003, GLOBAL CHANGE BIOL, V9, P479, DOI 10.1046/j.1365-2486.2003.00629.x; BROOKS A, 1985, PLANTA, V165, P397, DOI 10.1007/BF00392238; Carter GA, 1998, REMOTE SENS ENVIRON, V63, P61, DOI 10.1016/S0034-4257(97)00110-7; Choudhury BJ, 2001, REMOTE SENS ENVIRON, V75, P1, DOI 10.1016/S0034-4257(00)00151-6; Dobrowski SZ, 2005, REMOTE SENS ENVIRON, V97, P403, DOI 10.1016/j.rse.2005.05.006; Falge E, 2001, AGR FOREST METEOROL, V107, P43, DOI 10.1016/S0168-1923(00)00225-2; Fang C, 2001, SOIL BIOL BIOCHEM, V33, P155, DOI 10.1016/S0038-0717(00)00125-5; Fu YL, 2006, AGR FOREST METEOROL, V137, P234, DOI 10.1016/j.agrformet.2006.02.009; Gamon JA, 1999, NEW PHYTOL, V143, P105, DOI 10.1046/j.1469-8137.1999.00424.x; GAMON JA, 1995, ECOL APPL, V5, P28, DOI 10.2307/1942049; Gilmanov TG, 2005, GLOBAL ECOL BIOGEOGR, V14, P271, DOI 10.1111/j.1466-822x.2005.00151.x; Gitelson AA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045003; Gockede M, 2008, BIOGEOSCIENCES, V5, P433; Goetz SJ, 1999, ECOL MODEL, V122, P239, DOI 10.1016/S0304-3800(99)00140-4; Goudriaan J., 1985, NATO ASI SERIES A, V86, P107; He MZ, 2013, AGR FOREST METEOROL, V173, P28, DOI 10.1016/j.agrformet.2013.01.003; Hirose T, 1997, ECOLOGY, V78, P2339; Hollinger DY, 1999, GLOB CHANGE BIOL, V5, P891, DOI 10.1046/j.1365-2486.1999.00281.x; Hu ZM, 2008, GLOBAL CHANGE BIOL, V14, P1609, DOI 10.1111/j.1365-2486.2008.01582.x; Ide R, 2010, AGR FOREST METEOROL, V150, P389, DOI 10.1016/j.agrformet.2009.12.009; Inoue Y, 2008, REMOTE SENS ENVIRON, V112, P156, DOI 10.1016/j.rse.2007.04.011; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Migliavacca M, 2014, GLOBAL CHANGE BIOL; POTTER CS, 1993, GLOBAL BIOGEOCHEM CY, V7, P811, DOI 10.1029/93GB02725; Prince SD, 1995, J BIOGEOGR, V22, P815, DOI 10.2307/2845983; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Richardson AD, 2006, AGR FOREST METEOROL, V141, P219, DOI 10.1016/j.agrformet.2006.10.010; Running S. W., 1999, MODIS DAILY PHOTOSYN; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Shi PL, 2006, SCI CHINA SER D, V49, P207, DOI 10.1007/s11430-006-8207-4; Smith ML, 2002, ECOL APPL, V12, P1286; Tang XG, 2012, AGR FOREST METEOROL, V156, P75, DOI 10.1016/j.agrformet.2012.01.003; Tang XG, 2011, ECOL ENG, V37, P1567, DOI 10.1016/j.ecoleng.2011.03.030; WEBB EK, 1980, Q J ROY METEOR SOC, V106, P85, DOI 10.1002/qj.49710644707; Wen XF, 2006, AGR FOREST METEOROL, V137, P166, DOI 10.1016/j.agrformet.2006.02.005; Wilczak JM, 2001, BOUND-LAY METEOROL, V99, P127, DOI 10.1023/A:1018966204465; Xiao JF, 2011, AGR FOREST METEOROL, V151, P60, DOI 10.1016/j.agrformet.2010.09.002; Xiao JF, 2010, REMOTE SENS ENVIRON, V114, P576, DOI 10.1016/j.rse.2009.10.013; Xiao JF, 2008, AGR FOREST METEOROL, V148, P1827, DOI 10.1016/j.agrformet.2008.06.015; Xiao XM, 2004, REMOTE SENS ENVIRON, V91, P256, DOI 10.1016/j.rse.2004.03.010; Xiao XM, 2004, REMOTE SENS ENVIRON, V89, P519, DOI 10.1016/j.rse.2003.11.008; Xiao XM, 2003, REMOTE SENS ENVIRON, V84, P385, DOI 10.1016/S0034-4257(02)00129-3; Xu LL, 2007, ECOL MODEL, V208, P129, DOI 10.1016/j.ecolmodel.2007.05.013; Xu LK, 2004, AGR FOREST METEOROL, V123, P79, DOI 10.1016/j.agrformet.2003.10.004; Yuan WP, 2007, AGR FOREST METEOROL, V143, P189, DOI 10.1016/j.agrformet.2006.12.001; [张东秋 ZHANG Dongqiu], 2006, [自然资源学报, Journal of Natural Resources], V21, P458; Zhang LM, 2006, AGR FOREST METEOROL, V137, P176, DOI 10.1016/j.agrformet.2006.02.006; Zhang LX, 2015, ECOL MODEL, V300, P30, DOI 10.1016/j.ecolmodel.2015.01.001; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590; Zhou Y, 2014, TELLUS B, P66	51	7	8	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122486	10.1371/journal.pone.0122486	http://dx.doi.org/10.1371/journal.pone.0122486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849325	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800134
J	Zhang, L; Fang, Y; Lian, YJ; Chen, Y; Wu, TW; Zheng, YK; Zong, HL; Sun, LM; Zhang, RF; Wang, ZH; Xu, YM				Zhang, Lu; Fang, Yu; Lian, Yajun; Chen, Yuan; Wu, Tianwen; Zheng, Yake; Zong, Huili; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua; Xu, Yuming			Brain-Derived Neurotrophic Factor Ameliorates Learning Deficits in a Rat Model of Alzheimer's Disease Induced by A beta 1-42	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; BDNF MESSENGER-RNA; SYNAPTIC PLASTICITY; SIGNALING PATHWAY; ADULT HIPPOCAMPUS; MEMORY DEFICITS; GENE-EXPRESSION; WORKING-MEMORY; MICE; NEURONS	An emerging body of data suggests that the early onset of Alzheimer's disease (AD) is associated with decreased brain-derived neurotrophic factor (BDNF). Because BDNF plays a critical role in the regulation of high-frequency synaptic transmission and long-term potentiation in the hippocampus, the up-regulation of BDNF may rescue cognitive impairments and learning deficits in AD. In the present study, we investigated the effects of hippocampal BDNF in a rat model of AD produced by a ventricle injection of amyloid-beta 1-42 (A beta 1-42). We found that a ventricle injection of A beta 1-42 caused learning deficits in rats subjected to the Morris water maze and decreased BDNF expression in the hippocampus. Chronic intra-hippocampal BDNF administration rescued learning deficits in the water maze, whereas infusions of NGF and NT-3 did not influence the behavioral performance of rats injected with A beta 1-42. Furthermore, the BDNF-related improvement in learning was ERK-dependent because the inhibition of ERK, but not JNK or p38, blocked the effects of BDNF on cognitive improvement in rats injected with A beta 1-42. Together, our data suggest that the up-regulation of BDNF in the hippocampus via activation of the ERK signaling pathway can ameliorate A beta 1-42-induced learning deficits, thus identifying a novel pathway through which BDNF protects against AD-related cognitive impairments. The results of this research may shed light on a feasible therapeutic approach to control the progression of AD.	[Zhang, Lu; Fang, Yu; Xu, Yuming] Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China; [Zhang, Lu; Lian, Yajun; Chen, Yuan; Wu, Tianwen; Zheng, Yake; Xu, Yuming] Zhengzhou Univ, Affiliated Hosp 1, Dept Neurol, Zhengzhou 450052, Henan, Peoples R China; [Fang, Yu; Zong, Huili; Sun, Limin; Zhang, Ruifang; Wang, Zhenhua] Zhengzhou Univ, Affiliated Hosp 1, Dept Intens Care Unit, Zhengzhou 450052, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Xu, YM (corresponding author), Key Disciplines Lab Clin Med Henan, Zhengzhou, Henan, Peoples R China.	zhangluys@163.com	Zhang, Rui/GXN-3801-2022		Zhengzhou Science & Technology Basic Research Program [340600531794]; Henan Science & Technology Basic Research Program [122300410365]	Zhengzhou Science & Technology Basic Research Program; Henan Science & Technology Basic Research Program	This work was supported by Zhengzhou Science & Technology Basic Research Program (No. 340600531794) and by Henan Science & Technology Basic Research Program (No. 122300410365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta D, 2009, ALZHEIMERS DIS INT W, P1; Aicardi G, 2004, P NATL ACAD SCI USA, V101, P15788, DOI 10.1073/pnas.0406960101; Barco A, 2005, NEURON, V48, P123, DOI 10.1016/j.neuron.2005.09.005; Bekinschtein P, 2014, NEUROPHARMACOLOGY, V76, P677, DOI 10.1016/j.neuropharm.2013.04.024; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CARLESIMO GA, 1992, NEUROPSYCHOL REV, V3, P119, DOI 10.1007/BF01108841; Connor B, 1997, MOL BRAIN RES, V49, P71, DOI 10.1016/S0169-328X(97)00125-3; Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6; Fahnestock M, 2002, J NEURAL TRANSM-SUPP, P241; Ferrer I, 1999, J NEUROPATH EXP NEUR, V58, P729, DOI 10.1097/00005072-199907000-00007; Ferri C.P., 2009, ALZHEIMERS DIS INT W; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; Gartner AG, 2002, P NATL ACAD SCI USA, V99, P6386, DOI 10.1073/pnas.092129699; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gil-Bea FJ, 2011, HIPPOCAMPUS, V21, P999, DOI 10.1002/hipo.20812; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hock C, 2000, ARCH NEUROL-CHICAGO, V57, P846, DOI 10.1001/archneur.57.6.846; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hu YH, 2008, J NEUROCHEM, V105, P1, DOI 10.1111/j.1471-4159.2008.05237.x; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Jeronimo-Santos A., 2014, CEREB CORTEX; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kinoshita S, 1999, J NEUROSCI, V19, P2122; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Ma YL, 1999, CHINESE J PHYSIOL, V42, P73; Masliah E, 2001, NEUROLOGY, V56, P127, DOI 10.1212/WNL.56.1.127; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MERLIO JP, 1993, NEURON, V10, P151, DOI 10.1016/0896-6273(93)90307-D; Miettinen R, 2012, J NEUROSCI METH, V205, P130, DOI 10.1016/j.jneumeth.2011.12.017; Murer MG, 2001, PROG NEUROBIOL, V63, P71, DOI 10.1016/S0301-0082(00)00014-9; Nagahara AH, 2013, J NEUROSCI, V33, P15596, DOI 10.1523/JNEUROSCI.5195-12.2013; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Papaleo F, 2011, LEARN MEMORY, V18, P534, DOI 10.1101/lm.2213711; PHILLIPS HS, 1991, NEURON, V7, P695, DOI 10.1016/0896-6273(91)90273-3; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Schinder AF, 2000, TRENDS NEUROSCI, V23, P639, DOI 10.1016/S0166-2236(00)01672-6; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tong LQ, 2004, J NEUROSCI, V24, P6799, DOI 10.1523/JNEUROSCI.5463-03.2004; Ueyama T, 1997, NEUROSCI RES, V28, P103, DOI 10.1016/S0168-0102(97)00030-8; Xing B, 2012, BEHAV BRAIN RES, V235, P36, DOI 10.1016/j.bbr.2012.06.035; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yamada K, 2002, LIFE SCI, V70, P735, DOI 10.1016/S0024-3205(01)01461-8; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	50	145	156	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122415	10.1371/journal.pone.0122415	http://dx.doi.org/10.1371/journal.pone.0122415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849905	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800129
J	van der Meij, L; Klauke, F; Moore, HL; Ludwig, YS; Almela, M; van Lange, PAM				van der Meij, Leander; Klauke, Fabian; Moore, Hannah L.; Ludwig, Yannick S.; Almela, Mercedes; van Lange, Paul A. M.			Football Fan Aggression: The Importance of Low Basal Cortisol and a Fair Referee	PLOS ONE			English	Article							SALIVARY CORTISOL; HOT SAUCE; VIOLENCE; PERSONALITY; BEHAVIOR; BOYS; TESTOSTERONE; BONFERRONI; IDENTITY; MODEL	Fan aggression in football (soccer) is a societal problem that affects many countries worldwide. However, to date, most studies use an epidemiological or survey approach to explain football fan aggression. This study used a controlled laboratory study to advance a model of predictors for fan aggression. To do so, football fans (n = 74) saw a match summary in which their favorite team lost against their most important rival. Next, we measured levels of aggression with the hot sauce paradigm, in which fans were given the opportunity to administer a sample of hot sauce that a rival football supporter had to consume. To investigate if media exposure had the ability to reduce aggression, before the match fans saw a video in which fans of the rival team commented in a neutral, negative, or positive manner on their favorite team. Results showed that the media exposure did not affect aggression. However, participants displayed high levels of aggression and anger after having watched the match. Also, aggression was higher in fans with lower basal cortisol levels, which suggests that part of the aggression displayed was proactive and related to anti-social behavior. Furthermore, aggression was higher when the referee was blamed and aggression was lower when the performance of the participants' favorite team was blamed for the match result. These results indicate that aggression increased when the match result was perceived as unfair. Interventions that aim to reduce football fan aggression should give special attention to the perceived fairness of the match result.	[van der Meij, Leander; Klauke, Fabian; Moore, Hannah L.; Ludwig, Yannick S.; van Lange, Paul A. M.] Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands; [Almela, Mercedes] Univ Valencia, Dept Psychobiol, Lab Social Cognit Neurosci, Valencia, Spain	Vrije Universiteit Amsterdam; University of Valencia	van der Meij, L (corresponding author), Vrije Univ Amsterdam, Dept Social & Org Psychol, Amsterdam, Netherlands.	L.van.der.Meij@vu.nl	Almela, Mercedes/AAE-4481-2021; van der Meij, Leander/AAC-8945-2019	van der Meij, Leander/0000-0001-6394-3071; Almela, Mercedes/0000-0002-8930-0717				ARCHER J, 1991, BRIT J PSYCHOL, V82, P1, DOI 10.1111/j.2044-8295.1991.tb02379.x; BERKOWITZ L, 1989, PSYCHOL BULL, V106, P59, DOI 10.1037/0033-2909.106.1.59; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; Bettencourt BA, 2006, PSYCHOL BULL, V132, P751, DOI 10.1037/0033-2909.132.5.751; Braun R, 2008, INT SOCIOL, V23, P796, DOI 10.1177/0268580908095909; Bryant FB, 2001, J RES PERS, V35, P138, DOI 10.1006/jrpe.2000.2302; Card D, 2011, Q J ECON, V126, P103, DOI 10.1093/qje/qjr001; Chory-Assad RM., 2004, COMMUN EDUC, V53, P253, DOI [DOI 10.1080/0363452042000265189, 10.1080/0363452042000265189]; Chory-Assad RM., 2002, COMMUN Q, V50, P58, DOI [10.1080/01463370209385646, DOI 10.1080/01463370209385646]; DeWall CN, 2011, PSYCHOL VIOLENCE, V1, P245, DOI 10.1037/a0023842; Dickson A, 2013, DOMESTIC VIOLENCE AN; Dunning E., 2000, EUROPEAN J CRIMINAL, V8, P141, DOI [DOI 10.1023/A:1008773923878, https://doi.org/10.1023/A:1008773923878]; FoxSports, SAMENVATTING FEYENOO; Granger DA, 2009, PSYCHONEUROENDOCRINO, V34, P1437, DOI 10.1016/j.psyneuen.2009.06.017; HaaglandenVoetbalTV, CLUB IN BEELD DEEL 2; Harmon-Jones E, 2001, J PERS SOC PSYCHOL, V80, P797, DOI 10.1037/0022-3514.80.5.797; Kirby S, 2014, J RES CRIME DELINQ, V51, P259, DOI 10.1177/0022427813494843; Lieberman JD, 1999, AGGRESSIVE BEHAV, V25, P331, DOI 10.1002/(SICI)1098-2337(1999)25:5<331::AID-AB2>3.0.CO;2-1; McBurnett K, 2000, ARCH GEN PSYCHIAT, V57, P38, DOI 10.1001/archpsyc.57.1.38; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oosterlaan J, 2005, PSYCHIAT RES, V134, P1, DOI 10.1016/j.psychres.2004.12.005; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Pfattheicher S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085691; Poutvaara P, 2009, J PUBLIC ECON, V93, P403, DOI 10.1016/j.jpubeco.2008.10.004; Priks M, 2010, KYKLOS, V63, P450, DOI 10.1111/j.1467-6435.2010.00482.x; Ritter D, 2005, AGGRESSIVE BEHAV, V31, P407, DOI 10.1002/ab.20066; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roversi A., 1991, International Review for the Sociology of Sport, V26, P311, DOI 10.1177/101269029102600406; RUSSELL GW, 1995, SOC BEHAV PERSONAL, V23, P199, DOI 10.2224/sbp.1995.23.2.199; Russell GW, 2004, AGGRESS VIOLENT BEH, V9, P353, DOI 10.1016/S1359-1789(03)00031-4; Semyonov M., 1989, Sociology of Sport Journal, V6, P50; Shoal GD, 2003, J AM ACAD CHILD PSY, V42, P1101, DOI 10.1097/01.CHI.0000070246.24125.6D; Skarlicki DP, 1997, J APPL PSYCHOL, V82, P434, DOI 10.1037/0021-9010.82.3.434; Spaaij R, 2008, J SPORT SOC ISSUES, V32, P369, DOI 10.1177/0193723508324082; Steinberg L, 2008, DEV PSYCHOL, V44, P1764, DOI 10.1037/a0012955; Tyler TR, 2005, LEADERSHIP QUART, V16, P529, DOI 10.1016/j.leaqua.2005.06.001; van Bokhoven I, 2005, J NEURAL TRANSM, V112, P1083, DOI 10.1007/s00702-004-0253-5; van den Bos K, 2002, ADV EXP SOC PSYCHOL, V34, P1, DOI 10.1016/S0065-2601(02)80003-X; van der Meij L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034814; Van Hiel A, 2007, J COMMUNITY APPL SOC, V17, P169, DOI 10.1002/casp.902; VANLIMBERGEN K, 1989, CURR PSYCHOL RES REV, V8, P4, DOI 10.1007/BF02686733; Wann DL, 1999, PERCEPT MOTOR SKILL, V88, P1296, DOI 10.2466/PMS.88.3.1296-1298; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; ZANI B, 1991, J COMMUNITY APPL SOC, V1, P5, DOI 10.1002/casp.2450010103	44	17	17	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120103	10.1371/journal.pone.0120103	http://dx.doi.org/10.1371/journal.pone.0120103			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844939	Green Published, gold			2022-12-26	WOS:000352475700003
J	Altekruse, SF; Petrick, JL; Rolin, AI; Cuccinelli, JE; Zou, ZH; Tatalovich, Z; McGlynn, KA				Altekruse, Sean F.; Petrick, Jessica L.; Rolin, Alicia I.; Cuccinelli, James E.; Zou, Zhaohui; Tatalovich, Zaria; McGlynn, Katherine A.			Geographic Variation of Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma, and Hepatocellular Carcinoma in the United States	PLOS ONE			English	Article							LIVER-CANCER; RISK-FACTORS; C VIRUS; HEPATITIS-B; MORTALITY; CLASSIFICATION; EPIDEMIOLOGY; TRENDS	Background Intrahepatic (ICC) and extrahepatic cholangiocarcinomas (ECC) are tumors that arise from cholangiocytes in the bile duct, but ICCs are coded as primary liver cancers while ECCs are coded as biliary tract cancers. The etiology of these tumors is not well understood. It has been suggested that the etiology of ICC is more similar to that of another type of liver cancer, hepatocellular carcinoma (HCC), than to the etiology of ECC. If this is true, geographic incidence patterns and trends in ICC incidence should be more similar to that of HCC than ECC. Methods To examine this hypothesis, data from the North American Association of Central Cancer Registries Cancer in North America data file were analyzed. Incidence rates and joinpoint trends were calculated by demographic subgroup. County-level incidence rates were mapped. Results Overall incidence rates, racial distribution, male: female ratio, and peak ages were more similar between ICC and ECC than with HCC. During 2000-2009, average annual incidence rates of ECC increased. During 2005-2009, average annual ICC incidence rates also increased. High rates for all three cancer sites were found in the Pacific region, particularly Hawaii and Alaska. Rates of ICC and ECC were also high in the Northeast and the upper Midwest, while rates of HCC were high in the South. Conclusions Demographic patterns and geographical variation were more closely related between ICC and ECC than HCC, suggesting that the etiology of ICC and ECC may be similar. Increasing rates of both tumors suggest that further etiology studies are warranted.	[Altekruse, Sean F.; Rolin, Alicia I.; Tatalovich, Zaria] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Petrick, Jessica L.; McGlynn, Katherine A.] NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA; [Cuccinelli, James E.; Zou, Zhaohui] Informat Management Serv Inc, Calverton, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.	Petrick, JL (corresponding author), NCI, Div Canc Epidemiol & Genet, Rockville, MD 20850 USA.	jessica.petrick@nih.gov	Petrick, Jessica/P-1678-2017; Petrick, Jessica/AAA-9079-2020	Petrick, Jessica/0000-0001-6580-450X; Rolin, Alicia/0000-0001-8191-248X	National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Information Management Services, Inc.; NATIONAL CANCER INSTITUTE [ZIACP010158] Funding Source: NIH RePORTER	National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Control & Population Sciences); Division of Cancer Epidemiology and Genetics, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); Information Management Services, Inc.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Cancer Institute's Surveillance, Epidemiology, and End Results Contracts; North American Association of Central Cancer Registries Cancer in North America project; Division of Cancer Control and Population Sciences; and the Division of Cancer Epidemiology and Genetics, National Cancer Institute. Information Management Services, Inc. provided support in the form of salaries for authors [JEC and ZZ], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; [Anonymous], CENS 2000 SUMM FIL 1; [Anonymous], CENS 2000 SUMM FIL 3; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Chapman RW, 1999, ANN ONCOL, V10, P308, DOI 10.1023/A:1008313809752; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fritz A, 2000, INT CLASSIFICATION D; Horner MJ, 2011, CANCER EPIDEM BIOMAR, V20, P591, DOI 10.1158/1055-9965.EPI-10-1183; Jenks G.F., 1967, INT YB CARTOGR, V7, P186; Khan SA, 2012, J HEPATOL, V56, P848, DOI 10.1016/j.jhep.2011.11.015; Kobayashi M, 2000, CANCER, V88, P2471, DOI 10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T; Li M, 2012, J GASTROEN HEPATOL, V27, P1561, DOI 10.1111/j.1440-1746.2012.07207.x; McLean L, 2006, LIVER INT, V26, P1047, DOI 10.1111/j.1478-3231.2006.01350.x; National Center for Healthcare Statistics, PUBL US DAT FIL DOC; Pickle LW, 2007, CA-CANCER J CLIN, V57, P30, DOI 10.3322/canjclin.57.1.30; PICKLE LW, 2001, P BIOM SECT 2000 ANN, P45; Schottenfeld D., 2006, CANC EPIDEMIOLOGY PR, pxviii; Shaib YH, 2007, AM J GASTROENTEROL, V102, P1016, DOI 10.1111/j.1572-0241.2007.01104.x; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; Surveillance Epidemiology and End Results (SEER) Program, 2012, SEER STAT DAT N AM A; TOMIMATSU M, 1993, CANCER, V72, P683, DOI 10.1002/1097-0142(19930801)72:3<683::AID-CNCR2820720310>3.0.CO;2-C; U.S. Census Bureau, CENS HISP OR; U.S. Department of Agriculture, RUR URB CONT COD; *US DEP HHS, AR RES FIL 2006; Welzel TM, 2006, J NATL CANCER I, V98, P873, DOI 10.1093/jnci/djj234; Welzel TM, 2007, CLIN GASTROENTEROL H, V5, P1221, DOI 10.1016/j.cgh.2007.05.020	27	49	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120574	10.1371/journal.pone.0120574	http://dx.doi.org/10.1371/journal.pone.0120574			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837669	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000025
J	Burelle, Y; Bemeur, C; Rivard, ME; Legault, JT; Boucher, G; Morin, C; Coderre, L; Des Rosiers, C				Burelle, Yan; Bemeur, Chantal; Rivard, Marie-Eve; Legault, Julie Thompson; Boucher, Gabrielle; Morin, Charles; Coderre, Lise; Des Rosiers, Christine		LSFC Consortium	Mitochondrial Vulnerability and Increased Susceptibility to Nutrient-Induced Cytotoxicity in Fibroblasts from Leigh Syndrome French Canadian Patients	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; PERMEABILITY TRANSITION PORE; PROPIONYL-L-CARNITINE; COMPLEX-I ACTIVITY; FREE FATTY-ACIDS; OXIDATIVE STRESS; CELL-DEATH; KETOGENIC DIET; DEFICIENCY; LRPPRC	Mutations in LRPPRC are responsible for the French Canadian variant of Leigh Syndrome (LSFC), a severe disorder characterized biochemically by a tissue-specific deficiency of cytochrome c oxidase (COX) and clinically by the occurrence of severe and deadly acidotic crises. Factors that precipitate these crises remain unclear. To better understand the physiopathology and identify potential treatments, we performed a comprehensive analysis of mitochondrial function in LSFC and control fibroblasts. Furthermore, we have used this cell-based model to screen for conditions that promote premature cell death in LSFC cells and test the protective effect of ten interventions targeting well-defined aspects of mitochondrial function. We show that, despite maintaining normal ATP levels, LSFC fibroblasts present several mitochondrial functional abnormalities under normal baseline conditions, which likely impair their capacity to respond to stress. This includes mitochondrial network fragmentation, impaired oxidative phosphorylation capacity, lower membrane potential, increased sensitivity to Ca2+-induced permeability transition, but no changes in reactive oxygen species production. We also show that LSFC fibroblasts display enhanced susceptibility to cell death when exposed to palmitate, an effect that is potentiated by high lactate, while high glucose or acidosis alone or in combination were neutral. Furthermore, we demonstrate that compounds that are known to promote flux through the electron transport chain independent of phosphorylation (methylene blue, dinitrophenol), or modulate fatty acid (L-carnitine) or Krebs cycle metabolism (propionate) are protective, while antioxidants (idebenone, N-acetyl cysteine, resveratrol) exacerbate palmitate plus lactate-induced cell death. Collectively, beyond highlighting multiple alterations in mitochondrial function and increased susceptibility to nutrient-induced cytotoxicity in LSFC fibroblasts, these results raise questions about the nature of the diets, particularly excess fat intake, as well as on the use of antioxidants in patients with LSFC and, possibly, other COX defects.	[Burelle, Yan; Bemeur, Chantal] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Rivard, Marie-Eve; Legault, Julie Thompson; Boucher, Gabrielle; Coderre, Lise; Des Rosiers, Christine] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; [Rivard, Marie-Eve; Legault, Julie Thompson; Coderre, Lise; Des Rosiers, Christine] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Morin, Charles] Complexe Hosp Sagamie, Dept Pediat, Chicoutimi, PQ, Canada; [Morin, Charles] Complexe Hosp Sagamie, Clin Res Unit, Chicoutimi, PQ, Canada; [Coderre, Lise] Univ Montreal, Fac Med, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Des Rosiers, C (corresponding author), Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada.	christine.des.rosiers@umontreal.ca	Burelle, Yan/AAF-8104-2021	Burelle, Yan/0000-0001-9379-146X; Bemeur, Chantal/0000-0003-2757-5958; Laprise, Catherine/0000-0001-5526-9945	Canadian Institutes of Health Research (CIHR) [102168]; Lactic Acidosis Association	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lactic Acidosis Association	This work was supported by the Canadian Institutes of Health Research (CIHR; Grant #102168 to the CIHR Emerging team in the Leigh Syndrome French Canadian Type (LSFC): Translating LSFC gene discovery into treatments for patients (awarded to CDR, YB, LC, CM)) and by the Lactic Acidosis Association.(http://www.cihr-irsc.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Ascah A, 2011, AM J PHYSIOL-HEART C, V300, pH144, DOI 10.1152/ajpheart.00522.2010; Atamna H, 2012, BIOFACTORS, V38, P158, DOI 10.1002/biof.197; Aure K, 2007, NEUROMUSCULAR DISORD, V17, P368, DOI 10.1016/j.nmd.2007.01.019; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Brand MD, 2010, EXP GERONTOL, V45, P466, DOI 10.1016/j.exger.2010.01.003; Brunengraber H, 2006, J INHERIT METAB DIS, V29, P327, DOI 10.1007/s10545-006-0320-1; Burelle Y, 2010, J MOL CELL CARDIOL, V48, P310, DOI 10.1016/j.yjmcc.2009.09.004; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Das A, 2005, J BIOL CHEM, V280, P12944, DOI 10.1074/jbc.M404706200; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Debray FG, 2011, J MED GENET, V48, P183, DOI 10.1136/jmg.2010.081976; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Diaz F, 2012, HUM MOL GENET, V21, P5066, DOI 10.1093/hmg/dds350; DiMauro S, 2006, MUSCLE NERVE, V34, P265, DOI 10.1002/mus.20598; Distelmaier F, 2009, J MOL MED, V87, P515, DOI 10.1007/s00109-009-0452-5; Distelmaier F, 2009, BRAIN, V132, P833, DOI 10.1093/brain/awp058; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Ferrari R, 2004, ANN NY ACAD SCI, V1033, P79, DOI 10.1196/annals.1320.007; Freeman JM, 2007, PEDIATRICS, V119, P535, DOI 10.1542/peds.2006-2447; Galluzzi L, 2012, CIRC RES, V111, P1198, DOI 10.1161/CIRCRESAHA.112.268946; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jonckheere AI, 2011, MITOCHONDRION, V11, P954, DOI 10.1016/j.mito.2011.08.012; Kang HC, 2007, EPILEPSIA, V48, P82, DOI 10.1111/j.1528-1167.2006.00906.x; Koene S, 2011, J INHERIT METAB DIS, V34, P293, DOI 10.1007/s10545-009-9005-x; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kong JY, 2003, ARCH BIOCHEM BIOPHYS, V412, P196, DOI 10.1016/S0003-9861(03)00008-0; Koopman WJH, 2006, CYTOM PART A, V69A, P1, DOI 10.1002/cyto.a.20198; Koopman WJH, 2005, AM J PHYSIOL-CELL PH, V289, pC881, DOI 10.1152/ajpcell.00104.2005; Kumar S, 2009, LIFE SCI, V84, P328, DOI 10.1016/j.lfs.2008.12.016; Liu LJ, 2011, J BIOL CHEM, V286, P41253, DOI 10.1074/jbc.M111.276121; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Marcil M, 2006, J MOL CELL CARDIOL, V41, P998, DOI 10.1016/j.yjmcc.2006.08.117; Mattson MP, 2003, TRENDS MOL MED, V9, P196, DOI 10.1016/S1471-4914(03)00046-7; MERANTE F, 1993, AM J HUM GENET, V53, P481; Minners J, 2000, CARDIOVASC RES, V47, P68, DOI 10.1016/S0008-6363(00)00069-9; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; Moran M, 2010, BBA-MOL BASIS DIS, V1802, P443, DOI 10.1016/j.bbadis.2010.02.001; MORIN C, 1993, AM J HUM GENET, V53, P488; Mutomba MC, 2000, FEBS LETT, V478, P19, DOI 10.1016/S0014-5793(00)01817-2; Naviaux RK, 2012, J PHARMACOL EXP THER, V342, P608, DOI 10.1124/jpet.112.192120; Nicholls DG, 2009, BBA-BIOENERGETICS, V1787, P1416, DOI 10.1016/j.bbabio.2009.03.010; Nicholls DG, 2004, AGING CELL, V3, P35, DOI 10.1111/j.1474-9728.2003.00079.x; Parikh S, 2009, CURR TREAT OPTION N, V11, P414, DOI 10.1007/s11940-009-0046-0; Pecina P, 2003, BBA-MOL BASIS DIS, V1639, P53, DOI 10.1016/S0925-4439(03)00127-3; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Pfeffer G, 2013, NAT REV NEUROL, V9, P474, DOI 10.1038/nrneurol.2013.129; Picard M, 2013, AM J PHYSIOL-REG I, V304, pR393, DOI 10.1152/ajpregu.00584.2012; Rabkin SW, 2008, PROSTAG LEUKOTR ESS, V78, P147, DOI 10.1016/j.plefa.2007.09.003; RUSSELL RR, 1995, AM J PHYSIOL-HEART C, V268, pH441, DOI 10.1152/ajpheart.1995.268.1.H441; Sasarman F, 2015, HUM MOL GENET, V24, P480, DOI 10.1093/hmg/ddu468; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; Schiff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028823; Skulachev VP, 2012, PRINCIPLES OF BIOENE; Teodoro JS, 2013, TOXICOL MECH METHOD, V23, P297, DOI 10.3109/15376516.2012.759305; Trudeau K, 2010, AM J PATHOL, V177, P447, DOI 10.2353/ajpath.2010.091029; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valsecchi F, 2013, MITOCHONDRION, V13, P436, DOI 10.1016/j.mito.2012.12.001; Verkaart S, 2007, BBA-MOL BASIS DIS, V1772, P373, DOI 10.1016/j.bbadis.2006.12.009; Voloboueva LA, 2007, FASEB J, V21, P4077, DOI 10.1096/fj.07-8396com; Willems PHGM, 2009, INT J BIOCHEM CELL B, V41, P1773, DOI 10.1016/j.biocel.2009.01.012; Wojtczak L, 1999, J BIOENERG BIOMEMBR, V31, P447, DOI 10.1023/A:1005444322823; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; Yao JB, 1999, HUM MOL GENET, V8, P2541, DOI 10.1093/hmg/8.13.2541; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zou J, 2013, BIOCHEM J, V454, P447, DOI 10.1042/BJ20130306	69	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120767	10.1371/journal.pone.0120767	http://dx.doi.org/10.1371/journal.pone.0120767			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835550	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000033
J	Kim, HC; Jo, YJ; Kim, NH; Namgoong, S				Kim, Hak-Cheol; Jo, Yu-Jin; Kim, Nam-Hyung; Namgoong, Suk			Small Molecule Inhibitor of Formin Homology 2 Domains (SMIFH2) Reveals the Roles of the Formin Family of Proteins in Spindle Assembly and Asymmetric Division in Mouse Oocytes	PLOS ONE			English	Article							POLAR BODY EXTRUSION; MEIOTIC SPINDLE; ACTIN; CYTOKINESIS; MDIA1; GENE; RHO; ORGANIZATION; CYTOSKELETON; MAINTENANCE	Dynamic actin reorganization is the main driving force for spindle migration and asymmetric cell division in mammalian oocytes. It has been reported that various actin nucleators including Formin-2 are involved in the polarization of the spindle and in asymmetric cell division. In mammals, the formin family is comprised of 15 proteins. However, their individual roles in spindle migration and/or asymmetric division have not been elucidated yet. In this study, we employed a newly developed inhibitor for formin family proteins, small molecule inhibitor of formin homology 2 domains (SMIFH2), to assess the functions of the formin family in mouse oocyte maturation. Treatment with SMIFH2 during in vitro maturation of mouse oocytes inhibited maturation by decreasing cytoplasmic and cortical actin levels. In addition, treatment with SMIFH2, especially at higher concentrations (500 mu M), impaired the proper formation of meiotic spindles, indicating that formins play a role in meiotic spindle formation. Knockdown of the mDia2 formins caused a similar decrease in oocyte maturation and abnormal spindle morphology, mimicking the phenotype of SMIFH2-treated cells. Collectively, these results suggested that besides Formin-2, the other proteins of the formin, including mDia family play a role in asymmetric division and meiotic spindle formation in mammalian oocytes.	[Kim, Hak-Cheol; Jo, Yu-Jin; Kim, Nam-Hyung; Namgoong, Suk] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea	Chungbuk National University	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, Chungbuk, South Korea.	nhkim@chungbuk.ac.kr; suknamgoong@chungbuk.ac.kr			Next-Generation BioGreen 21 Program [PJ011206, PJ011126]; Rural Development Administration, Republic of Korea	Next-Generation BioGreen 21 Program(Rural Development Administration (RDA), Republic of Korea); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea)	Supported by grants from the Next-Generation BioGreen 21 Program (PJ011206 and PJ011126, Rural Development Administration, Republic of Korea. http://www.rda.go.kr/foreign/eng/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2011, DEVELOPMENT, V138, P2903, DOI 10.1242/dev.060269; Bartolini F, 2010, BBA-MOL CELL RES, V1803, P164, DOI 10.1016/j.bbamcr.2009.07.006; Bartolini F, 2008, J CELL BIOL, V181, P523, DOI 10.1083/jcb.200709029; Bovellan M, 2014, CURR BIOL, V24, P1628, DOI 10.1016/j.cub.2014.05.069; CASTRILLON DH, 1994, DEVELOPMENT, V120, P3367; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2014, M S-MED SCI, V30, P18, DOI 10.1051/medsci/20143001005; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Jang WI, 2014, CELL CYCLE, V13, P2359, DOI 10.4161/cc.29333; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Kwon S, 2011, MOL HUM REPROD, V17, P317, DOI 10.1093/molehr/gaq088; Leader B, 2000, MECH DEVELOP, V93, P221, DOI 10.1016/S0925-4773(00)00276-8; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Li YH, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109850; LIN JJC, 1985, HYBRIDOMA, V4, P223, DOI 10.1089/hyb.1985.4.223; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LONGO FJ, 1985, DEV BIOL, V107, P382, DOI 10.1016/0012-1606(85)90320-3; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Peng J, 2003, CURR BIOL, V13, P534, DOI 10.1016/S0960-9822(03)00170-2; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Rosero A, 2013, J EXP BOT, V64, P585, DOI 10.1093/jxb/ers351; Ryley DA, 2005, FERTIL STERIL, V83, P1363, DOI 10.1016/j.fertnstert.2004.10.051; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Schuh M, 2011, NAT CELL BIOL, V13, P1431, DOI 10.1038/ncb2353; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Song Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0081330, 10.1371/journal.pone.0075729]; Sun QY, 2006, REPRODUCTION, V131, P193, DOI 10.1530/rep.1.00847; Sun SC, 2011, CELL CYCLE, V10, P1853, DOI 10.4161/cc.10.11.15796; Sun SC, 2011, MOL HUM REPROD, V17, P296, DOI 10.1093/molehr/gar006; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Ucar H, 2013, J CELL SCI, V126, P5153, DOI 10.1242/jcs.130476; Wang F, 2014, SCI REP-UK, V4, DOI 10.1038/srep05596; Watanabe S, 2013, CELL REP, V5, P926, DOI 10.1016/j.celrep.2013.10.021; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Yi KX, 2012, CYTOSKELETON, V69, P727, DOI 10.1002/cm.21048; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang Y, 2015, BBA-MOL CELL RES, V1853, P317, DOI 10.1016/j.bbamcr.2014.11.005	54	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123438	10.1371/journal.pone.0123438	http://dx.doi.org/10.1371/journal.pone.0123438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837661	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000144
J	Liu, JL; Chen, XY; Zeng, XN				Liu, Jia Li; Chen, Xiao Yan; Zeng, Xin Nian			Classical Olfactory Conditioning in the Oriental Fruit Fly, Bactrocera dorsalis	PLOS ONE			English	Article							HONEYBEES APIS-MELLIFERA; PROBOSCIS EXTENSION; MALE ANNIHILATION; METHYL EUGENOL; MEMORY; FLIES; TEPHRITIDAE; INTENSITY; INSECTS; DIPTERA	The oriental fruit fly, Bactrocera dorsalis, is a serious pest of fruits and vegetables. Methyl eugenol (ME), a male attractant, is used to against this fly by mass trapping. Control effect may be influenced by learning, which could modify the olfactory response of the fly to this attractant. To collect the behavioral evidence, studies on the capability of this fly for olfactory learning are necessary. We investigated olfactory learning in male flies with a classical olfactory conditioning procedure using restrained individuals under laboratory conditions. The acquisition of the proboscis extension reflex was used as the criterion for conditioning. A high conditioned response level was found in oriental fruit flies when an odor was presented in paired association with a sucrose reward but not when the odor and sucrose were presented unpaired. We also found that the conditioning performance was influenced by the odor concentration, intertrial interval, and starvation time. A slight sensitization elicited by imbibing sucrose was observed. These results indicate that oriental fruit flies have a high capacity to form an olfactory memory as a result of classical conditioning.	[Liu, Jia Li; Chen, Xiao Yan; Zeng, Xin Nian] South China Agr Univ, Coll Nat Resources & Environm, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China	South China Agricultural University	Zeng, XN (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Minist Educ, Key Lab Nat Pesticide & Chem Biol, Guangzhou, Guangdong, Peoples R China.	zengxn@scau.edu.cn			National Natural Science Foundation of China [31401800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31401800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; Bhagavan S, 1997, PHYSIOL BEHAV, V61, P107, DOI 10.1016/S0031-9384(96)00357-5; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Chabaud MA, 2006, J COMP PHYSIOL A, V192, P1335, DOI 10.1007/s00359-006-0160-3; Gerber B, 1996, ANIM BEHAV, V52, P1079, DOI 10.1006/anbe.1996.0255; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hartlieb E, 1996, NATURWISSENSCHAFTEN, V83, P87, DOI 10.1007/s001140050253; ITO Y, 1974, STERILE INSECT TECHN, P45; Kunin W, 1996, THEOR POPUL BIOL, V49, P232, DOI 10.1006/tpbi.1996.0013; Laloi D, 1999, ENTOMOL EXP APPL, V90, P123, DOI 10.1023/A:1003598301272; Liu JL, 2013, APPL ENTOMOL ZOOL, V48, P387, DOI 10.1007/s13355-013-0199-x; MENZEL R, 1991, BEHAVIOUR AND PHYSIOLOGY OF BEES, P323; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 1990, COMPAR COGN, P237; Metcalf R. L., 1992, PLANT KAIROMONES INS, P109; METCALF RL, 1990, ANN ENTOMOL SOC AM, V83, P1017, DOI 10.1093/aesa/83.6.1017; Papaj Daniel R., 1993, P243; PAPAJ DR, 1989, ANNU REV ENTOMOL, V34, P315, DOI 10.1146/annurev.en.34.010189.001531; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; PAPAJ DR, 1986, J CHEM ECOL, V12, P1125, DOI 10.1007/BF01639000; Pelz C, 1997, J EXP BIOL, V200, P837; PROKOPY R J, 1988, Journal of Insect Behavior, V1, P67, DOI 10.1007/BF01052504; PROKOPY R J, 1989, Proceedings of the Hawaiian Entomological Society, V29, P97; PROKOPY RJ, 1990, J INSECT BEHAV, V3, P663, DOI 10.1007/BF01052335; PROKOPY RJ, 1989, ENTOMOL EXP APPL, V53, P65, DOI 10.1007/BF00369233; RESCORLA RA, 1988, ANNU REV NEUROSCI, V11, P329, DOI 10.1146/annurev.ne.11.030188.001553; SHELLY TE, 1994, FLA ENTOMOL, V77, P201, DOI 10.2307/3495505; Shelly T, 2010, APPL ENTOMOL ZOOL, V45, P349, DOI 10.1303/aez.2010.349; Simoes P, 2011, J EXP BIOL, V214, P2495, DOI 10.1242/jeb.055806; STEINER LF, 1965, J ECON ENTOMOL, V58, P961, DOI 10.1093/jee/58.5.961; Tan KH, 2002, J CHEM ECOL, V28, P1161, DOI 10.1023/A:1016277500007; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Vargas RI, 2010, J ECON ENTOMOL, V103, P409, DOI 10.1603/EC09299; VET LEM, 1990, J CHEM ECOL, V16, P3119, DOI 10.1007/BF00979615; Watanabe H, 2003, ZOOL SCI, V20, P1447, DOI 10.2108/zsj.20.1447; Wen-Hui Yu, 2013, THESIS SW U; Wright GA, 2005, J COMP PHYSIOL A, V191, P105, DOI 10.1007/s00359-004-0576-6; Wright GA, 2002, J CHEM ECOL, V28, P721, DOI 10.1023/A:1015232608858	41	11	11	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122155	10.1371/journal.pone.0122155	http://dx.doi.org/10.1371/journal.pone.0122155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837420	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000081
J	Gherbi, K; May, LT; Baker, JG; Briddon, SJ; Hill, SJ				Gherbi, Karolina; May, Lauren T.; Baker, Jillian G.; Briddon, Stephen J.; Hill, Stephen J.			Negative cooperativity across beta(1)-adrenoceptor homodimers provides insights into the nature of the secondary low-affinity CGP 12177 beta(1)-adrenoceptor binding conformation	FASEB JOURNAL			English	Article						dissociation; receptor dimerization; GPCR; allosterism	PROTEIN-COUPLED RECEPTORS; BETA-BLOCKERS; IN-VIVO; AGONIST; SITE; VISUALIZATION; DIMERIZATION; RADIOLIGAND; RESIDUES; STATES	At the beta(1)-adrenoceptor, CGP 12177 potently antagonizes agonist responses at the primary high-affinity catecholamine conformation while also exerting agonist effects of its own through a secondary low-affinity conformation. A recent mutagenesis study identified transmembrane region (TM) 4 of the beta(1)-adrenoceptor as key for this low-affinity conformation. Others suggested that TM4 has a role in beta(1)-adrenoceptor oligomerization. Here, assessment of the dissociation rate of a fluorescent analog of CGP 12177 [bordifluoropyrromethane-tetramethylrhodamine-(+/-) CGP 12177 (BODIPY-TMR-CGP)] at the human beta(1)-adrenoceptor expressed in Chinese hamster ovary cells revealed negative cooperative interactions between 2 distinct beta(1)-adrenoceptor conformations. The dissociation rate of 3 nM BODIPY-TMR-CGP was 0.09 +/- 0.01 min(-1) in the absence of competitor ligands, and this was enhanced 2.2- and 2.1-fold in the presence of 1 mu M CGP 12177 and 1 mu M propranolol, respectively. These effects on the BODIPY-TMR-CGP dissociation rate were markedly enhanced in beta(1)-adrenoceptor homodimers constrained by bimolecular fluorescence complementation (9.8- and 9.9-fold for 1 mu M CGP 12177 and 1 mu M propranolol, respectively) and abolished in beta(1)-adrenoceptors containing TM4 mutations vital for the second conformation pharmacology. This study suggests that negative cooperativity across a beta(1)-adrenoceptor homodimer may be responsible for generating the low-affinity pharmacology of the secondary beta(1)-adrenoceptor conformation.	[Gherbi, Karolina; May, Lauren T.; Baker, Jillian G.; Briddon, Stephen J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Cell Signalling Res Grp, Nottingham NG7 2UH, England	University of Nottingham	Hill, SJ (corresponding author), Univ Nottingham, Sch Med, Queens Med Ctr, Cell Signalling Res Grp, C Floor, Nottingham NG7 2UH, England.	stephen.hill@nottingham.ac.uk	Hill, Stephen J/M-6243-2018; Hill, Stephen/N-6753-2013	Hill, Stephen J/0000-0002-4424-239X; Hill, Stephen/0000-0002-4424-239X; May, Lauren/0000-0002-4412-1707; Briddon, Stephen/0000-0001-8514-0827; Gherbi, Karolina/0000-0002-2280-6852	Medical Research Council [G0800006]; MRC [G0800006] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank the Medical Research Council for financial support (G0800006).	Baker JG, 2003, MOL PHARMACOL, V63, P1312, DOI 10.1124/mol.63.6.1312; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2008, MOL PHARMACOL, V74, P1246, DOI 10.1124/mol.108.048371; Baker JG, 2014, MOL PHARMACOL, V85, P811, DOI 10.1124/mol.114.091587; Baker JG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077582; Calebiro D, 2013, P NATL ACAD SCI USA, V110, P743, DOI 10.1073/pnas.1205798110; Christopoulos A, 2002, PHARMACOL REV, V54, P323, DOI 10.1124/pr.54.2.323; Corriden R, 2014, FASEB J, V28, P4211, DOI 10.1096/fj.13-247270; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Gherbi K, 2014, BRIT J PHARMACOL, V171, P5431, DOI 10.1111/bph.12858; Granneman JG, 2001, AM J PHYSIOL-ENDOC M, V280, pE199, DOI 10.1152/ajpendo.2001.280.2.E199; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Huang JY, 2013, NAT STRUCT MOL BIOL, V20, P419, DOI 10.1038/nsmb.2504; Johnston JM, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002649; Joseph SS, 2004, N-S ARCH PHARMACOL, V369, P525, DOI 10.1007/s00210-004-0884-y; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; KAUMANN AJ, 1989, TRENDS PHARMACOL SCI, V10, P316, DOI 10.1016/0165-6147(89)90065-5; Kaumann AJ, 2001, N-S ARCH PHARMACOL, V363, P87, DOI 10.1007/s002100000336; Kaumann AJ, 2008, PHARMACOL THERAPEUT, V118, P303, DOI 10.1016/j.pharmthera.2008.03.009; Kerppola TK, 2008, METHOD CELL BIOL, V85, P431, DOI 10.1016/S0091-679X(08)85019-4; Konkar AA, 2000, J PHARMACOL EXP THER, V294, P923; Lowe MD, 2002, BRIT J PHARMACOL, V135, P451, DOI 10.1038/sj.bjp.0704450; May LT, 2010, MOL PHARMACOL, V77, P678, DOI 10.1124/mol.109.063065; May LT, 2007, ANNU REV PHARMACOL, V47, P1, DOI 10.1146/annurev.pharmtox.47.120505.105159; May LT, 2011, FASEB J, V25, P3465, DOI 10.1096/fj.11-186296; May LT, 2010, MOL PHARMACOL, V78, P511, DOI 10.1124/mol.110.064493; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2009, BRIT J PHARMACOL, V158, P5, DOI 10.1111/j.1476-5381.2009.00169.x; Molenaar P, 2007, CLIN EXP PHARMACOL P, V34, P1020, DOI 10.1111/j.1440-1681.2007.04730.x; Pak MD, 1996, J RECEPT SIGNAL TR R, V16, P1, DOI 10.3109/10799899609039938; Rose RH, 2010, BRIT J PHARMACOL, V159, P738, DOI 10.1111/j.1476-5381.2009.00480.x; Sarsero D, 1998, BRIT J PHARMACOL, V123, P371, DOI 10.1038/sj.bjp.0701609; Sarsero D, 2003, N-S ARCH PHARMACOL, V367, P10, DOI 10.1007/s00210-002-0652-9; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; Vauquelin G, 2010, EXPERT OPIN DRUG DIS, V5, P927, DOI 10.1517/17460441.2010.512037; Vauquelin G, 2010, BRIT J PHARMACOL, V161, P488, DOI 10.1111/j.1476-5381.2010.00936.x	36	29	29	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2859	2871		10.1096/fj.14-265199	http://dx.doi.org/10.1096/fj.14-265199			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837585	Green Published, hybrid			2022-12-26	WOS:000356859100016
J	Migliori, M; Cantaluppi, V; Mannari, C; Bertelli, AAE; Medica, D; Quercia, AD; Navarro, V; Scatena, A; Giovannini, L; Biancone, L; Panichi, V				Migliori, Massimiliano; Cantaluppi, Vincenzo; Mannari, Claudio; Bertelli, Alberto A. E.; Medica, Davide; Quercia, Alessandro Domenico; Navarro, Victor; Scatena, Alessia; Giovannini, Luca; Biancone, Luigi; Panichi, Vincenzo			Caffeic Acid, a Phenol Found in White Wine, Modulates Endothelial Nitric Oxide Production and Protects from Oxidative Stress-Associated Endothelial Cell Injury	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; ISCHEMIA-REPERFUSION INJURY; RED WINE; OLIVE OIL; MEDITERRANEAN DIET; FRENCH PARADOX; BLOOD-FLOW; ATHEROSCLEROSIS; DYSFUNCTION; SURVIVAL	Introduction Several studies demonstrated that endothelium dependent vasodilatation is impaired in cardiovascular and chronic kidney diseases because of oxidant stress-induced nitric oxide availability reduction. The Mediterranean diet, which is characterized by food containing phenols, was correlated with a reduced incidence of cardiovascular diseases and delayed progression toward end stage chronic renal failure. Previous studies demonstrated that both red and white wine exert cardioprotective effects. In particular, wine contains Caffeic acid (CAF), an active component with known antioxidant activities. Aim of the study The aim of the present study was to investigate the protective effect of low doses of CAF on oxidative stress-induced endothelial injury. Results CAF increased basal as well as acetylcholine-induced NO release by a mechanism independent from eNOS expression and phosphorylation. In addition, low doses of CAF (100 nM and 1 mu M) increased proliferation and angiogenesis and inhibited leukocyte adhesion and endothelial cell apoptosis induced by hypoxia or by the uremic toxins ADMA, pcresyl sulfate and indoxyl sulfate. The biological effects exerted by CAF on endothelial cells may be at least in part ascribed to modulation of NO release and by decreased ROS production. In an experimental model of kidney ischemia-reperfusion injury in mice, CAF significantly decreased tubular cell apoptosis, intraluminal cast deposition and leukocyte infiltration. Conclusion The results of the present study suggest that CAF, at very low dosages similar to those observed after moderate white wine consumption, may exert a protective effect on endothelial cell function by modulating NO release independently from eNOS expression and phosphorylation. CAF-induced NO modulation may limit cardiovascular and kidney disease progression associated with oxidative stress-mediated endothelial injury.	[Migliori, Massimiliano; Scatena, Alessia; Panichi, Vincenzo] Versilia Hosp, Nephrol & Dialysis Unit, Lido Di Camaiore, Italy; [Cantaluppi, Vincenzo; Medica, Davide; Quercia, Alessandro Domenico; Navarro, Victor; Biancone, Luigi] Univ Turin, Dept Med Sci, Nephrol Dialysis & Kidney Transplantat Unit, Turin, Italy; [Mannari, Claudio; Giovannini, Luca] Univ Pisa, Dept Translat Res & New Technol Med, Pisa, Italy; [Bertelli, Alberto A. E.] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	Ospedale Versilia; University of Turin; University of Pisa; University of Milan	Migliori, M (corresponding author), Versilia Hosp, Nephrol & Dialysis Unit, Lido Di Camaiore, Italy.	m.migliori@usl12.toscana.it	Migliori, Massimiliano/GRF-4854-2022; Cantaluppi, Vincenzo/K-8531-2016; Medica, Davide/AAM-7691-2021	Migliori, Massimiliano/0000-0001-8050-2120; Cantaluppi, Vincenzo/0000-0002-4120-3555; Medica, Davide/0000-0002-6171-8919; BIANCONE, Luigi/0000-0002-7700-6350; Navarro Tableros, Victor Manuel/0000-0001-7629-1199; panichi, vincenzo/0000-0002-5003-3172	Fondazione Cassa di Risparmio di Lucca	Fondazione Cassa di Risparmio di Lucca	This work was supported by a grant of Fondazione Cassa di Risparmio di Lucca (www.fondazionecarilucca.it). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksu U, 2011, CONTRIB NEPHROL, V174, P119, DOI 10.1159/000329249; Altug ME, 2008, BRAIN RES, V1201, P135, DOI 10.1016/j.brainres.2008.01.053; Anselm E, 2007, CARDIOVASC RES, V73, P404, DOI 10.1016/j.cardiores.2006.08.004; Antoniades C, 2011, HYPERTENSION, V58, P93, DOI 10.1161/HYPERTENSIONAHA.110.168245; Barbacanne MA, 2000, FREE RADICAL BIO MED, V29, P388, DOI 10.1016/S0891-5849(00)00336-1; Bertelli A, 2002, DRUG EXP CLIN RES, V28, P11; Bertelli AAE, 2002, ANN NY ACAD SCI, V957, P295, DOI 10.1111/j.1749-6632.2002.tb02929.x; Bertelli AAE, 2007, ATHEROSCLEROSIS, V195, P242, DOI 10.1016/j.atherosclerosis.2007.04.006; Bolati D, 2011, AM J NEPHROL, V34, P318, DOI 10.1159/000330852; Boto-Ordonez M, 2013, J AGR FOOD CHEM, V61, P9166, DOI 10.1021/jf402394c; Brunet P, 2011, KIDNEY BLOOD PRESS R, V34, P284, DOI 10.1159/000327131; Bussolati B, 2002, KIDNEY INT, V62, P1322; Buttiglieri S, 2003, BIOMATERIALS, V24, P2731, DOI 10.1016/S0142-9612(03)00088-7; Cantaluppi V, 2001, AIDS RES HUM RETROV, V17, P965, DOI 10.1089/088922201750290087; Cantaluppi V, 2012, CELL TRANSPLANT, V21, P1305, DOI 10.3727/096368911X627534; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Carrero JJ, 2012, CLIN J AM SOC NEPHRO, V7, P207, DOI 10.2215/CJN.06840711; Cicala C, 2003, LIFE SCI, V73, P73, DOI 10.1016/S0024-3205(03)00235-2; Cui JH, 2002, ANN NY ACAD SCI, V957, P308, DOI 10.1111/j.1749-6632.2002.tb02931.x; Diebolt M, 2001, HYPERTENSION, V38, P159, DOI 10.1161/01.HYP.38.2.159; Dudley JI, 2008, J AGR FOOD CHEM, V56, P9362, DOI 10.1021/jf801791d; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Fito M, 2007, MOL NUTR FOOD RES, V51, P1215, DOI 10.1002/mnfr.200600308; Fliser D, 2010, J NEPHROL, V23, P369; FREIMAN PC, 1986, CIRC RES, V58, P783, DOI 10.1161/01.RES.58.6.783; Furchgott RF, 1996, JAMA-J AM MED ASSOC, V276, P1186, DOI 10.1001/jama.276.14.1186; Ghosh D, 2009, MOL NUTR FOOD RES, V53, P322, DOI 10.1002/mnfr.200800182; GOLINO P, 1991, NEW ENGL J MED, V324, P641, DOI 10.1056/NEJM199103073241001; Huang XY, 2013, CLIN J AM SOC NEPHRO, V8, P1548, DOI 10.2215/CJN.01780213; Ito S, 2010, J BIOL CHEM, V285, P38869, DOI 10.1074/jbc.M110.166686; Jourde-Chiche N, 2011, SEMIN DIALYSIS, V24, P327, DOI 10.1111/j.1525-139X.2011.00925.x; Khan AQ, 2012, FOOD CHEM TOXICOL, V50, P175, DOI 10.1016/j.fct.2011.10.043; Kok FJ, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-1102-x; Leikert JF, 2002, CIRCULATION, V106, P1614, DOI 10.1161/01.CIR.0000034445.31543.43; Leone AM, 1996, BIOCHEM BIOPH RES CO, V221, P37, DOI 10.1006/bbrc.1996.0557; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Malyszko J, 2010, CLIN CHIM ACTA, V411, P1412, DOI 10.1016/j.cca.2010.06.019; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Moon MK, 2009, BIOL PHARM BULL, V32, P1371, DOI 10.1248/bpb.32.1371; Niwa T, 2010, NAGOYA J MED SCI, V72, P1; Prasad NR, 2009, J PHOTOCH PHOTOBIO B, V95, P196, DOI 10.1016/j.jphotobiol.2009.03.007; RENAUD S, 1992, LANCET, V339, P1523, DOI 10.1016/0140-6736(92)91277-F; Rietjens SJ, 2007, AM J PHYSIOL-HEART C, V292, pH1931, DOI 10.1152/ajpheart.00755.2006; Samuel SM, 2008, J AGR FOOD CHEM, V56, P9692, DOI 10.1021/jf802050h; Schepers E, 2010, BLOOD PURIFICAT, V30, P277, DOI 10.1159/000320765; Shoji K, 2014, CURR OPIN NEPHROL HY, V23, P161, DOI 10.1097/01.mnh.0000441049.98664.6c; Simonetti P, 2001, METHOD ENZYMOL, V335, P122; Simonetti P, 2001, J AGR FOOD CHEM, V49, P5964, DOI 10.1021/jf010546k; Sun CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034026; Thirunavukkarasu M, 2008, J AGR FOOD CHEM, V56, P6733, DOI 10.1021/jf801473v; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; van de Wiel A, 2001, Eur J Intern Med, V12, P484, DOI 10.1016/S0953-6205(01)00170-4; Visioli F, 2005, EUR J NUTR, V44, P121, DOI 10.1007/s00394-004-0504-0; Vissers MN, 2004, EUR J CLIN NUTR, V58, P955, DOI 10.1038/sj.ejcn.1601917; Wallerath T, 2005, NITRIC OXIDE-BIOL CH, V12, P97, DOI 10.1016/j.niox.2004.12.004; Wiklund NP, 1999, ACTA PHYSIOL SCAND, V167, P161; Wollin SD, 2001, J NUTR, V131, P1401, DOI 10.1093/jn/131.5.1401; Yu M, 2011, CLIN J AM SOC NEPHRO, V6, P30, DOI 10.2215/CJN.05340610; ZEIHER AM, 1993, J CLIN INVEST, V92, P652, DOI 10.1172/JCI116634; Zhang JL, 2006, MOL NUTR FOOD RES, V50, P996, DOI 10.1002/mnfr.200600072	61	37	39	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0117530	10.1371/journal.pone.0117530	http://dx.doi.org/10.1371/journal.pone.0117530			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853700	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400001
J	Tung, YC; Chang, CH; Chen, YC; Chu, PH				Tung, Ying-Chang; Chang, Chih-Hsiang; Chen, Yung-Chang; Chu, Pao-Hsien			Combined Biomarker Analysis for Risk of Acute Kidney Injury in Patients with ST-Segment Elevation Myocardial Infarction	PLOS ONE			English	Article							RECEPTOR FAMILY-MEMBER; GELATINASE-ASSOCIATED LIPOCALIN; NATRIURETIC PEPTIDE LEVELS; WORSENING RENAL-FUNCTION; ACUTE CORONARY SYNDROMES; SERUM-SOLUBLE ST2; HEART-FAILURE; CARDIORENAL SYNDROME; CARDIAC-SURGERY; CYSTATIN-C	Background Acute kidney injury (AKI) complicating ST-segment elevation myocardial infarction (STEMI) increases subsequent morbidity and mortality. We combined the biomarkers of heart failure (HF; B-type natriuretic peptide [BNP] and soluble ST2 [sST2]) and renal injury (NGAL [neutrophil gelatinase-associated lipocalin] and cystatin C) in predicting the development of AKI in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods and Results From March 2010 to September 2013, 189 STEMI patients were sequentially enrolled and serum samples were collected at presentation for BNP, sST2, NGAL and cystatin C analysis. 37 patients (19.6%) developed AKI of varying severity within 48 hours of presentation. Univariate analysis showed age, Killip class >= 2, hypertension, white blood cell counts, hemoglobin, estimated glomerular filtration rate, blood urea nitrogen, creatinine, and all the four biomarkers were predictive of AKI. Serum levels of the biomarkers were correlated with risk of AKI and the Acute Kidney Injury Network (AKIN) stage and all significantly discriminated AKI (area under the receiver operating characteristic [ROC] curve: BNP: 0.86, sST2: 0.74, NGAL: 0.75, cystatin C: 0.73; all P < 0.05). Elevation of >= 2 of the biomarkers higher than the cutoff values derived from the ROC analysis improved AKI risk stratification, regardless of the creatine level (creatinine < 1.24 mg/dL: odds ratio [OR] 11.25, 95% confidence interval [CI] 1.63-77.92, P = 0.014; creatinine >= 1.24: OR 15.0, 95% CI 1.23-183.6, P = 0.034). Conclusions In this study of STEMI patients undergoing primary PCI, the biomarkers of heart failure (BNP and sST2) and renal injury (NGAL and cystatin C) at presentation were predictive of AKI. High serum levels of the biomarkers were associated with an elevated risk and more advanced stage of AKI. Regardless of the creatinine level, elevation of >= 2 of the biomarkers higher than the cutoff values indicated a further rise in AKI risk. Combined biomarker approach may assist in risk stratification of AKI in patients with STEMI.	[Tung, Ying-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Dept Cardiol, Taipei 10591, Taiwan; [Chang, Chih-Hsiang; Chen, Yung-Chang; Chu, Pao-Hsien] Chang Gung Mem Hosp, Div Nephrol, Taipei 10591, Taiwan; [Chu, Pao-Hsien] Chang Gung Mem Hosp, Healthcare Ctr, Taipei 10591, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chu, PH (corresponding author), Chang Gung Mem Hosp, Dept Cardiol, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/G-3685-2010; Chu, Pao-Hsien/P-5249-2019; Chang, Jason Chih-Hsiang/P-8662-2017	Chu, Pao-Hsien/0000-0003-0361-6348; Chang, Jason Chih-Hsiang/0000-0002-7342-335X	Chang Gung Memorial Hospital, Taiwan [CMRPG391091, CMRPG1B0581, CMRPG 3B0821]	Chang Gung Memorial Hospital, Taiwan(Chang Gung Memorial Hospital)	This work was supported by research grants from Chang Gung Memorial Hospital, Taiwan (CMRPG391091, CMRPG1B0581, and CMRPG 3B0821). The authors declare that no author has any conflicts of financial or non-financial competing interests to disclose.	Aghel A, 2010, J CARD FAIL, V16, P49, DOI 10.1016/j.cardfail.2009.07.003; Akgul O, 2014, HERZ, V39, P507, DOI 10.1007/s00059-013-3853-8; Amin AP, 2010, AM HEART J, V160, P1065, DOI 10.1016/j.ahj.2010.08.007; Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365; Apple FS, 2002, CIRCULATION, V106, P2941, DOI 10.1161/01.CIR.0000041254.30637.34; Austin WJ, 2006, AM J CLIN PATHOL, V126, P506, DOI 10.1309/M7AAXA0J1THMNCDF; Aviles RJ, 2002, NEW ENGL J MED, V346, P2047, DOI 10.1056/NEJMoa013456; Bayes-Genis A, 2013, J CARD FAIL, V19, P768, DOI 10.1016/j.cardfail.2013.09.005; Broch K, 2012, EUR J HEART FAIL, V14, P268, DOI 10.1093/eurjhf/hfs006; Bruetto RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035496; Chen TH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032328; Coglianese EE, 2012, CLIN CHEM, V58, P1673, DOI 10.1373/clinchem.2012.192153; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; De Berardinis B, 2015, CLIN CHEM LAB MED, V53, P613, DOI 10.1515/cclm-2014-0191; de Lemos JA, 2003, LANCET, V362, P316, DOI 10.1016/S0140-6736(03)13976-1; de Lemos JA, 2001, NEW ENGL J MED, V345, P1014, DOI 10.1056/NEJMoa011053; Dhillon OS, 2011, AM HEART J, V161, P1163, DOI 10.1016/j.ahj.2011.03.025; Eggers KM, 2010, AM HEART J, V159, P788, DOI 10.1016/j.ahj.2010.02.022; Fouad Mohamed, 2013, Arab J Nephrol Transplant, V6, P21; Fox CS, 2012, CIRCULATION, V125, P497, DOI 10.1161/CIRCULATIONAHA.111.039909; Freda BJ, 2002, J AM COLL CARDIOL, V40, P2065, DOI 10.1016/S0735-1097(02)02608-6; Gnanaraj JF, 2013, KIDNEY INT, V83, P384, DOI 10.1038/ki.2012.406; Goldberg A, 2005, AM HEART J, V150, P330, DOI 10.1016/j.ahj.2004.09.055; Guerchicoff A, 2015, CATHETER CARDIO INTE, V85, P335, DOI 10.1002/ccd.25620; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Hata N, 2010, EUR J HEART FAIL, V12, P32, DOI 10.1093/eurjhf/hfp169; Hsiao PG, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.05.003; Ismail Y, 2012, SEMIN NEPHROL, V32, P18, DOI 10.1016/j.semnephrol.2011.11.003; Januzzi JL, 2007, J AM COLL CARDIOL, V50, P607, DOI 10.1016/j.jacc.2007.05.014; Januzzi JL, 2013, J CARDIOVASC TRANSL, V6, P493, DOI 10.1007/s12265-013-9459-y; Januzzi JL, 2005, AM J CARDIOL, V95, P948, DOI 10.1016/j.amjcard.2004.12.032; Kakkar R, 2008, NAT REV DRUG DISCOV, V7, P827, DOI 10.1038/nrd2660; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P2174, DOI 10.1001/jama.290.16.2174; Kiessling AH, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-10; Ko B, 2012, EUR HEART J, V33, P2065, DOI 10.1093/eurheartj/ehr493; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; LABOVITZ AJ, 1987, J AM COLL CARDIOL, V10, P748, DOI 10.1016/S0735-1097(87)80266-8; Lassus JPE, 2010, EUR HEART J, V31, P2791, DOI 10.1093/eurheartj/ehq293; Latchamsetty R, 2007, AM J CARDIOL, V99, P939, DOI 10.1016/j.amjcard.2006.10.058; Leblanc M, 2005, CURR OPIN CRIT CARE, V11, P533, DOI 10.1097/01.ccx.0000183666.54717.3d; Legrand M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112313; Levin ER, 1998, NEW ENGL J MED, V339, P321; Lindberg S, 2012, J AM COLL CARDIOL, V60, P339, DOI 10.1016/j.jacc.2012.04.017; LJUNGMAN S, 1990, DRUGS, V39, P10, DOI 10.2165/00003495-199000394-00004; Ma YC, 2006, J AM SOC NEPHROL, V17, P2937, DOI 10.1681/ASN.2006040368; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Marenzi G, 2010, CRIT CARE MED, V38, P438, DOI 10.1097/CCM.0b013e3181b9eb3b; McCullough PA, 2008, J AM COLL CARDIOL, V51, P1419, DOI 10.1016/j.jacc.2007.12.035; McCullough PA, 2013, CONTRIB NEPHROL, V182, P82, DOI [10.1159/000349966, 10.1159/000361059]; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mishra J, 2005, LANCET, V365, P1231, DOI 10.1016/s0140-6736(05)74811-x; Mueller T, 2008, CLIN CHEM, V54, P752, DOI 10.1373/clinchem.2007.096560; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; Newsome BB, 2008, ARCH INTERN MED, V168, P609, DOI 10.1001/archinte.168.6.609; Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267; Palazzuoli A, 2014, HEART FAIL REV, V19, P267, DOI 10.1007/s10741-013-9391-x; Palomba H, 2007, KIDNEY INT, V72, P624, DOI 10.1038/sj.ki.5002419; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Pfister R, 2008, EUR J HEART FAIL, V10, P315, DOI 10.1016/j.ejheart.2008.01.009; Poniatowski B, 2009, KIDNEY BLOOD PRESS R, V32, P77, DOI 10.1159/000208989; Prabhu A, 2010, ANN VASC SURG, V24, P525, DOI 10.1016/j.avsg.2010.01.001; Ronco C, 2012, J AM COLL CARDIOL, V60, P1031, DOI 10.1016/j.jacc.2012.01.077; Ronco C, 2010, CONTRIB NEPHROL, V165, P54, DOI 10.1159/000313745; Ronco C, 2010, EUR HEART J, V31, P703, DOI 10.1093/eurheartj/ehp507; Sabatine MS, 2008, CIRCULATION, V117, P1936, DOI 10.1161/CIRCULATIONAHA.107.728022; Sabatine MS, 2004, J AM COLL CARDIOL, V44, P1988, DOI 10.1016/j.jacc.2004.07.057; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Shah RV, 2009, CIRC-HEART FAIL, V2, P311, DOI 10.1161/CIRCHEARTFAILURE.108.833707; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Silva D, 2012, AM J CARDIOL, V109, P1431, DOI 10.1016/j.amjcard.2012.01.356; Tang WHW, 2010, HEART, V96, P255, DOI 10.1136/hrt.2009.166256; Tsai HS, 2014, ACTA CARDIOL SIN, V30, P93; Tung YC, 2014, ACTA CARDIOL SIN, V30, P501; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Wald R, 2010, CLIN J AM SOC NEPHRO, V5, P1373, DOI 10.2215/CJN.06350909; Weinberg EO, 2002, CIRCULATION, V106, P2961, DOI 10.1161/01.CIR.0000038705.69871.D9; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; Weir RAP, 2010, J AM COLL CARDIOL, V55, P243, DOI 10.1016/j.jacc.2009.08.047; Winton FR, 1931, J PHYSIOL-LONDON, V72, P49, DOI 10.1113/jphysiol.1931.sp002761; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064; Zhu JQ, 2006, CLIN CHIM ACTA, V374, P116, DOI 10.1016/j.cca.2006.06.001	84	25	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0125282	10.1371/journal.pone.0125282	http://dx.doi.org/10.1371/journal.pone.0125282			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853556	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400151
J	Campa, VM; Capilla, A; Varela, MJ; de la Rocha, AMA; Fernandez-Troyano, JC; Barreiro, RB; Lopez-Gimenez, JF				Campa, Vctor M.; Capilla, Almudena; Varela, Mara J.; Acanda de la Rocha, Arlet M.; Fernandez-Troyano, Juan C.; Belen Barreiro, R.; Lopez-Gimenez, Juan F.			Endocytosis as a Biological Response in Receptor Pharmacology: Evaluation by Fluorescence Microscopy	PLOS ONE			English	Article							PROTEIN-COUPLED-RECEPTOR; MU-OPIOID RECEPTOR; SINGLE-PARTICLE TRACKING; FUNCTIONAL SELECTIVITY; INTERNALIZATION; TOLERANCE; DESENSITIZATION; QUANTIFICATION; TRAFFICKING; DEPENDENCE	The activation of G-protein coupled receptors by agonist compounds results in diverse biological responses in cells, such as the endocytosis process consisting in the translocation of receptors from the plasma membrane to the cytoplasm within internalizing vesicles or endosomes. In order to functionally evaluate endocytosis events resulted from pharmacological responses, we have developed an image analysis method - the Q-Endosomes algorithm-that specifically discriminates the fluorescent signal originated at endosomes from that one observed at the plasma membrane in images obtained from living cells by fluorescence microscopy. Mu opioid (MOP) receptor tagged at the carboxy-terminus with yellow fluorescent protein (YFP) and permanently expressed in HEK293 cells was used as experimental model to validate this methodology. Time-course experiments performed with several agonists resulted in different sigmoid curves depending on the drug used to initiate MOP receptor endocytosis. Thus, endocytosis resulting from the simultaneous activation of co-expressed MOP and serotonin 5-HT2C receptors by morphine plus serotonin was significantly different, in kinetics as well as in maximal response parameters, from the one caused by DAMGO, sufentanyl or methadone. Therefore, this analytical tool permits the pharmacological characterization of receptor endocytosis in living cells with functional and temporal resolution.	[Campa, Vctor M.; Acanda de la Rocha, Arlet M.; Fernandez-Troyano, Juan C.; Lopez-Gimenez, Juan F.] UC, CSIC, IBBTEC, Santander, Spain; [Capilla, Almudena] UAM, Dept Biol & Hlth Psychol, Madrid, Spain; [Varela, Mara J.] USC, Ctr Res Mol Med & Chron Dis CIMUS, Santiago De Compostela, Spain; [Belen Barreiro, R.] UC, CSIC, IFCA, Inst Phys Cantabria, Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC); Autonomous University of Madrid; Universidade de Santiago de Compostela; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Fisica de Cantabria (IFCA)	Lopez-Gimenez, JF (corresponding author), UC, CSIC, IBBTEC, Santander, Spain.	jf.lopez.gimenez@csic.es	Capilla, Almudena/B-9387-2011; Lopez-Gimenez, Juan/K-5823-2014; Barreiro, Rita Belen/N-5442-2014; Campa, Victor M/K-5050-2014	Capilla, Almudena/0000-0002-4181-4284; Lopez-Gimenez, Juan/0000-0003-3021-6200; Barreiro, Rita Belen/0000-0002-6139-4272; Campa, Victor M/0000-0002-3842-1359	Spanish Government (MINECO) [SAF2010-15663]	Spanish Government (MINECO)	This work was supported by the SAF2010-15663 grant from the Spanish Government (MINECO) (http://www.idi.mineco.gob.es/portal/site/MICINN?lang choosen=en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger AC, 2010, ANN NEUROL, V67, P559, DOI 10.1002/ana.22002; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Conway BR, 1999, J BIOMOL SCREEN, V4, P75, DOI 10.1177/108705719900400207; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Fukunaga S, 2006, LIFE SCI, V80, P17, DOI 10.1016/j.lfs.2006.08.022; Ghosh RN, 2000, BIOTECHNIQUES, V29, P170, DOI 10.2144/00291pf01; Haasen D, 2006, METHOD ENZYMOL, V414, P121, DOI 10.1016/S0076-6879(06)14008-2; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jaqaman K, 2008, NAT METHODS, V5, P695, DOI 10.1038/nmeth.1237; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Leysen JE, 2004, CNS NEUROL DISORD-DR, V3, P11, DOI 10.2174/1568007043482598; Lopez-Gimenez JF, 2008, MOL PHARMACOL, V74, P1278, DOI 10.1124/mol.108.048272; Lopez-Gimenez JF, 2010, CNS NEUROL DISORD-DR, V9, P616; Magalhaes AC, 2012, BRIT J PHARMACOL, V165, P1717, DOI 10.1111/j.1476-5381.2011.01552.x; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Ruthardt N, 2011, MOL THER, V19, P1199, DOI 10.1038/mt.2011.102; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; STEPHENSON RP, 1956, BRIT J PHARM CHEMOTH, V11, P379, DOI 10.1111/j.1476-5381.1956.tb00006.x; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Ward RJ, 2011, METHODS MOL BIOL, V746, P21, DOI 10.1007/978-1-61779-126-0_2; Whistler JL, 2012, DRUG ALCOHOL DEPEN, V121, P189, DOI 10.1016/j.drugalcdep.2011.10.031; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942	25	6	6	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122604	10.1371/journal.pone.0122604	http://dx.doi.org/10.1371/journal.pone.0122604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849355	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800146
J	Conti, HR; Whibley, N; Coleman, BM; Garg, AV; Jaycox, JR; Gaffen, SL				Conti, Heather R.; Whibley, Natasha; Coleman, Bianca M.; Garg, Abhishek V.; Jaycox, Jillian R.; Gaffen, Sarah L.			Signaling through IL-17C/IL-17RE Is Dispensable for Immunity to Systemic, Oral and Cutaneous Candidiasis	PLOS ONE			English	Article							CHRONIC MUCOCUTANEOUS CANDIDIASIS; INNATE LYMPHOID-CELLS; HOST-DEFENSE; CUTTING EDGE; TH17 CELLS; IL-17 PATHWAY; T-CELLS; INTERLEUKIN-17; RECEPTOR; RESPONSES	Candida albicans is a commensal fungal microbe of the human orogastrointestinal tract and skin. C. albicans causes multiple forms of disease in immunocompromised patients, including oral, vaginal, dermal and disseminated candidiasis. The cytokine IL-17 ( IL-17A) and its receptor subunits, IL-17RA and IL-17RC, are required for protection to most forms of candidiasis. The importance of the IL-17R pathway has been observed not only in knockout mouse models, but also in humans with rare genetic mutations that impact generation of Th17 cells or the IL-17 signaling pathway, including Hyper-IgE Syndrome (STAT3 or TYK2 mutations) or IL17RA or ACT1 gene deficiency. The IL-17 family of cytokines is a distinct subclass of cytokines with unique structural and signaling properties. IL-17A is the bestcharacterized member of the IL-17 family to date, but far less is known about other IL-17related cytokines. In this study, we sought to determine the role of a related IL-17 cytokine, IL-17C, in protection against oral, dermal and disseminated forms of C. albicans infection. IL-17C signals through a heterodimeric receptor composed of the IL-17RA and IL-17RE subunits. We observed that IL-17C mRNA was induced following oral C. albicans infection. However, mice lacking IL-17C or IL-17RE cleared C. albicans infections in the oral mucosa, skin and bloodstream at rates similar to WT littermate controls. Moreover, these mice demonstrated similar gene transcription profiles and recovery kinetics as WT animals. These findings indicate that IL-17C and IL-17RE are dispensable for immunity to the forms of candidiasis evaluated, and illustrate a surprisingly limited specificity of the IL-17 family of cytokines with respect to systemic, oral and cutaneous Candida infections.	[Conti, Heather R.; Whibley, Natasha; Coleman, Bianca M.; Garg, Abhishek V.; Gaffen, Sarah L.] Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA; [Jaycox, Jillian R.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Gaffen, SL (corresponding author), Univ Pittsburgh, Dept Med, Div Rheumatol & Clin Immunol, Pittsburgh, PA 15260 USA.	sarah.gaffen@pitt.edu			National Institutes of Health [R01-AI107825, R01-DE022550, R01-DE023815];  [F32-E023293]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI107825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE023293, R01DE023815, R01DE022550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	SLG was supported the by the National Institutes of Health (R01-AI107825, R01-DE022550, R01-DE023815). HRC was supported by F32-E023293. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Bar E, 2012, J IMMUNOL, V188, P5636, DOI 10.4049/jimmunol.1200594; Bishu S, 2014, INFECT IMMUN, V82, P1173, DOI 10.1128/IAI.01335-13; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Conti HR, 2014, J EXP MED, V211, P2075, DOI 10.1084/jem.20130877; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Conti HR, 2014, CURRENT PROTOCOLS IM, V105, P61; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Ferreira MC, 2014, INFECT IMMUN, V82, P1030, DOI 10.1128/IAI.01389-13; Fidel P L Jr, 2011, Adv Dent Res, V23, P45, DOI 10.1177/0022034511399284; Friedrich M, 2014, INFLAMM BOWEL DIS, V20, P1891, DOI 10.1097/MIB.0000000000000198; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gladiator A, 2013, J IMMUNOL, V190, P521, DOI 10.4049/jimmunol.1202924; Glocker E, 2010, CURR OPIN ALLERGY CL, V10, P542, DOI 10.1097/ACI.0b013e32833fd74f; Golden JB, 2013, CYTOKINE, V62, P195, DOI 10.1016/j.cyto.2013.03.013; Hernandez-Santos N, 2013, MUCOSAL IMMUNOL, V6, P900, DOI 10.1038/mi.2012.128; Hernandez-Santos N, 2012, CELL HOST MICROBE, V11, P425, DOI 10.1016/j.chom.2012.04.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Huang WT, 2004, J INFECT DIS, V190, P624, DOI 10.1086/422329; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Huppler AR, 2014, J IMMUNOL, V192, P1745, DOI 10.4049/jimmunol.1302265; Huppler AR, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3893; Igyarto BZ, 2011, IMMUNITY, V35, P260, DOI 10.1016/j.immuni.2011.06.005; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Johnston A, 2013, J IMMUNOL, V190, P2252, DOI 10.4049/jimmunol.1201505; Kagami S, 2010, J IMMUNOL, V185, P5453, DOI 10.4049/jimmunol.1001153; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; Li HZ, 2000, P NATL ACAD SCI USA, V97, P773, DOI 10.1073/pnas.97.2.773; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Milner JD, 2013, NAT REV IMMUNOL, V13, P635, DOI 10.1038/nri3493; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Pietrella D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022770; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Puel A, 2010, J EXP MED, V207, P291, DOI 10.1084/jem.20091983; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; van de Veerdonk FL, 2010, SHOCK, V34, P407, DOI 10.1097/SHK.0b013e3181d67041; Whibley N, 2014, EUR J IMMUNOL, V44, P1069, DOI 10.1002/eji.201343604; Yamaguchi Y, 2007, J IMMUNOL, V179, P7128, DOI 10.4049/jimmunol.179.10.7128; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yano J, 2012, CYTOKINE, V58, P118, DOI 10.1016/j.cyto.2011.11.021; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	59	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122807	10.1371/journal.pone.0122807	http://dx.doi.org/10.1371/journal.pone.0122807			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849644	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000352477800162
J	Deng, ML; Ji, SK; Fei, WT; Raza, S; He, CF; Chen, YY; Chen, HC; Guo, AZ				Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Yingyu; Chen, Huanchun; Guo, Aizhen			Prevalence Study and Genetic Typing of Bovine Viral Diarrhea Virus (BVDV) in Four Bovine Species in China	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; RESPIRATORY-DISEASE; IDENTIFICATION; DIVERSITY; CATTLE; INFECTIONS; GENOTYPE-1; SUBTYPES; 1D	To determine the nationwide status of persistent BVDV infection in different bovine species in China and compare different test methods, a total of 1379 serum samples from clinical healthy dairy cattle, beef cattle, yaks (Bos grunniens), and water buffalo (Bubalus bubalis) were collected in eight provinces of China from 2010 to 2013. The samples were analyzed using commercial antibody (Ab) and antigen (Ag) detection kits, and RT-PCR based on the 5'-UTR and Npro gene sequencing. Results showed that the overall positive rates for BVDV Ab, Ag and RT-PCR detection were 58.09% (801/1379), 1.39% (14/1010), and 22.64% (146/645), respectively, while the individual positive rates varied among regions, species, and farms. The average Ab-positive rates for dairy cattle, beef cattle, yaks, and water buffalo were 89.49% (298/333), 63.27% (248/392), 45.38% (236/520), and 14.18% (19/134), respectively, while the Ag-positive rates were 0.00% (0/116), 0.77%(3/392), 0.82% (3/368), and 5.97% (8/134), respectively, and the nucleic acid-positive rates detected by RT-PCR were 32.06% (42/131), 13.00% (26/200), 28.89% (52/180), and 19.40% (26/134), respectively. In addition, the RT-PCR products were sequenced and 124 5'-UTR sequences were obtained. Phylogenetic analysis of the 5'-UTR sequences indicated that all of the 124 BVDV-positive samples were BVDV-1 and subtyped into either BVDV-1b (33.06%), BVDV-1m (49.19%), or a new cluster, designated as BVDV-1u (17.74%). Phylogenetic analysis based on Npro sequences confirmed this novel subtype. In conclusion, this study revealed the prevalence of BVDV-1 in bovine species in China and the dominant subtypes. The high proportion of bovines with detectable viral nucleic acids in the sera, even in the presence of high Ab levels, revealed a serious threat to bovine health.	[Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Yingyu; Chen, Huanchun; Guo, Aizhen] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China; [Deng, Mingliang; Ji, Sukun; Fei, Wentao; Raza, Sohail; He, Chenfei; Chen, Huanchun; Guo, Aizhen] Huazhong Agr Univ, Coll Vet Med, Wuhan 430070, Peoples R China; [He, Chenfei] Huazhong Agr Univ, Coll Anim Sci, Wuhan 430070, Peoples R China; [Guo, Aizhen] Minist Agr, Key Lab Dev Vet Diagnost Prod, Wuhan 430070, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs	Guo, AZ (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Peoples R China.	aizhen@mail.hzau.edu.cn	chen, ying/HHS-8254-2022; Raza, Sohail/AAU-7779-2020	Raza, Sohail/0000-0002-7943-9395	special fund for Agro-Scientific Research in the Public Interest [201003060]; Ning Xia Key S&T Special Project [2012ZDN0903]; Special Fund for China Agriculture Research System (Beef/Yak Cattle) [CARS-38]	special fund for Agro-Scientific Research in the Public Interest; Ning Xia Key S&T Special Project; Special Fund for China Agriculture Research System (Beef/Yak Cattle)	This work was funded by a special fund for Agro-Scientific Research in the Public Interest (#201003060), Ning Xia Key S&T Special Project (#2012ZDN0903) and Special Fund for China Agriculture Research System (Beef/Yak Cattle) (#CARS-38).	BAKER JC, 1995, VET CLIN N AM-FOOD A, V11, P425, DOI 10.1016/S0749-0720(15)30460-6; Becher P, 1997, J GEN VIROL, V78, P1357, DOI 10.1099/0022-1317-78-6-1357; BOLIN SR, 1985, AM J VET RES, V46, P2467; Brock KV, 2003, BIOLOGICALS, V31, P133, DOI 10.1016/S1045-1056(03)00029-0; BROWNLIE J, 1984, VET REC, V114, P535, DOI 10.1136/vr.114.22.535; CORIA MF, 1978, J AM VET MED ASSOC, V172, P449; Deng Y, 2012, VET MICROBIOL, V159, P490, DOI 10.1016/j.vetmic.2012.04.023; Flores EF, 2002, VIRUS RES, V87, P51, DOI 10.1016/S0168-1702(02)00080-1; Fulton RW, 2000, CAN J VET RES, V64, P151; Gao JF, 2013, TROP ANIM HEALTH PRO, V45, P791, DOI 10.1007/s11250-012-0290-2; Giammarioli M, 2014, VIRUS GENES, V28; Gong XW, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-30; Gong XW, 2013, VIRUS GENES, V46, P375, DOI 10.1007/s11262-012-0861-3; Houe H, 1999, VET MICROBIOL, V64, P89, DOI 10.1016/S0378-1135(98)00262-4; Jackova A, 2008, VET RES COMMUN, V32, P7, DOI 10.1007/s11259-007-9012-z; Kuta A, 2013, VET MICROBIOL, V166, P639, DOI 10.1016/j.vetmic.2013.07.002; LEE KM, 1957, AM J VET RES, V18, P952; Liu LH, 2009, VET MICROBIOL, V138, P62, DOI 10.1016/j.vetmic.2009.03.006; Luzzago C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/147145; Mahony TJ, 2005, VET MICROBIOL, V106, P1, DOI 10.1016/j.vetmic.2004.10.024; Mishra N, 2008, VET MICROBIOL, V130, P88, DOI 10.1016/j.vetmic.2008.01.005; Nagai M, 2008, VIRUS GENES, V36, P135, DOI 10.1007/s11262-007-0190-0; Oem JK, 2010, J VET DIAGN INVEST, V22, P518, DOI 10.1177/104063871002200404; Peletto S, 2012, RES VET SCI, V92, P147, DOI 10.1016/j.rvsc.2010.10.015; PELLERIN C, 1994, VIROLOGY, V203, P260, DOI 10.1006/viro.1994.1483; Qiu Changqing, 2000, CHINESE J PREVENTIVE, V22, P453; RICHER L, 1988, CAN VET J, V29, P713; Ridpath JF, 2000, VET MICROBIOL, V77, P145, DOI 10.1016/S0378-1135(00)00271-6; Strong R, 2013, VET MICROBIOL, V162, P315, DOI 10.1016/j.vetmic.2012.09.006; Sun K, 2012, THESIS SW U NATL CHI; Toplak I, 2004, VET MICROBIOL, V99, P175, DOI 10.1016/j.vetmic.2003.12.004; Vilcek S, 2001, ARCH VIROL, V146, P99, DOI 10.1007/s007050170194; Vilcek S, 2004, VET RES, V35, P609, DOI 10.1051/vetres:2004036; Wang Jintao, 2012, HEILONGJIANG ANIMAL, V24, P91; Xue F, 2010, VET MICROBIOL, V143, P379, DOI 10.1016/j.vetmic.2009.11.010; Yang De-Sheng, 2007, PROGR VET MED, V28, P4; Yesilbag K, 2014, VET MICROBIOL, V169, P42, DOI 10.1016/j.vetmic.2013.12.005; Zhong FG, 2011, VIRUS GENES, V42, P204, DOI 10.1007/s11262-010-0558-4; Zhu Liqian, 2011, CHINESE J ANIMAL INF, V19, P83	39	52	66	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121718	10.1371/journal.pone.0121718	http://dx.doi.org/10.1371/journal.pone.0121718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849315	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800074
J	Gao, K; Ma, HS; Cui, Y; Chen, XZ; Ma, J; Dai, JP				Gao, Kun; Ma, Housheng; Cui, Yong; Chen, Xuzhu; Ma, Jun; Dai, Jianping			Meningiomas of the Cerebellopontine Angle: Radiological Differences in Tumors with Internal Auditory Canal Involvement and Their Influence on Surgical Outcome	PLOS ONE			English	Article							INTRACANALICULAR MENINGIOMA; INTRACRANIAL MENINGIOMAS; CLASSIFICATION	This study explored the clinical, radiological, and pathological characteristics of cerebellopontine angle (CPA) meningiomas with internal auditory canal (IAC) involvement. The pre- and postoperative MR images of 193 consecutive patients with pathologically diagnosed meningioma centered around the IAC were analyzed, focusing on changes in the IAC, maximal axial tumor volume, peritumoral brain edema, and postoperative residual tumor. Patient age, sex, tumor volume, postoperative residual tumor, and pathological subtype were compared in patients with and without IAC involvement by the tumor and among the different types of IAC involvement. The results showed that the 71 patients (36.8%) with IAC involvement had a higher ratio of peritumoral edema (chi(2) = 5.922, P = 0.015), postoperative residual tumor (chi(2) = 22.183, P < 0.001), and a predominance of the meningothelial subtype (chi(2) = 5.89, P = 0.015). Peritumoral edema was a risk factor for IAC involvement (P = 0.016, OR = 2.186). Radiologically, IAC involvement could be distinguished as intruding (31%, 22/71), filled (29.6%, 21/71), and dilated (39.4%, 28/71). Patients with intruding IAC were significantly older (54.5 +/- 9.54 years, P = 0.021) and had the lowest postoperative residual tumor values (42%, chi(2) = 7.865, P = 0.005), while those with filled IAC were more likely to be female (95%,chi(2) = 9.404, P = 0.009). Our observations provide the basis for a morphological classification of IAC involvement by CPA meningiomas and further insight into the clinical features of these tumors.	[Gao, Kun] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Radiol, Beijing, Peoples R China; [Ma, Housheng] Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China; [Cui, Yong] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurosurg, Beijing, Peoples R China; [Chen, Xuzhu; Ma, Jun; Dai, Jianping] Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Capital Medical University	Ma, J (corresponding author), Capital Med Univ, Beijing Tiantan Hosp, Dept Neuroradiol, Beijing, Peoples R China.	radiology888@aliyun.com			National Natural Science Foundation of China [81271541]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by National Natural Science Foundation of China (81271541 to J. P. Dai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2009, J NEUROSURG, V111, P1053, DOI 10.3171/2007.11.17446; Seco AA, 2010, ACTA OTORRINOLAR ESP, V61, P387, DOI 10.1016/j.otorri.2009.09.001; Asaoka K, 2002, AM J NEURORADIOL, V23, P1493; Bacciu A, 2007, OTOL NEUROTOL, V28, P391, DOI 10.1097/MAO.0b013e31803261b4; Carney AS, 1999, SKULL BASE SURG, V9, P87, DOI 10.1055/s-2008-1058154; Desgeorges M, 1992, ACOUSTIC NEUROMA; Fathi AR, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0337-4; Hamilton BE, 2006, AM J NEURORADIOL, V27, P2204; He SH, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.10.FOCUS13360; Domingues PH, 2014, NEURO-ONCOLOGY, V16, P735, DOI 10.1093/neuonc/not325; Hou J, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13301; Ibebuike K, 2013, AFR HEALTH SCI, V13, P118, DOI 10.4314/ahs.v13i1.16; Ishikawa T, 2011, NEUROL MED-CHIR, V51, P233, DOI 10.2176/nmc.51.233; Kane AJ, 2011, J CLIN NEUROSCI, V18, P755, DOI 10.1016/j.jocn.2010.09.023; Kaur G, 2014, NEURO-ONCOLOGY, V16, P628, DOI 10.1093/neuonc/nou025; Kunii N, 2011, WORLD NEUROSURG, V75, P114, DOI 10.1016/j.wneu.2010.09.020; Nassehi D, 2013, DAN MED J, V60; Pollock BE, 2004, STEREOT FUNCT NEUROS, V82, P98, DOI 10.1159/000077659; Raper DMS, 2014, AM J NEURORADIOL, V35, P1798, DOI 10.3174/ajnr.A3919; Roser F, 2005, J NEUROSURG, V102, P17, DOI 10.3171/jns.2005.102.1.0017; Rousseau A, 2008, CURR OPIN NEUROL, V21, P720, DOI 10.1097/WCO.0b013e328312c3a7; Salehi F, 2013, ACTA NEUROCHIR, V155, P421, DOI 10.1007/s00701-012-1577-9; Tomogane Y, 2013, NEUROL MED-CHIR, V53, P482; von Eckardstein KL, 2010, NEUROSURGERY, V67, P1236, DOI 10.1227/NEU.0b013e3181efe412; Voss NF, 2000, SURG NEUROL, V53, P439, DOI 10.1016/S0090-3019(00)00195-6; Wang DJ, 2013, CHINESE MED J-PEKING, V126, P488, DOI 10.3760/cma.j.issn.0366-6999.20122874; Zielinski G, 2013, NEUROENDOCRINOL LETT, V34, P111	27	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122949	10.1371/journal.pone.0122949	http://dx.doi.org/10.1371/journal.pone.0122949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849220	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800181
J	Kim, JS; Lee, IK; Yun, BS				Kim, Jong Shik; Lee, In Kyoung; Yun, Bong Sik			A Novel Biosurfactant Produced by Aureobasidium pullulans L3-GPY from a Tiger Lily Wild Flower, Lilium lancifolium Thunb	PLOS ONE			English	Article							POLY(BETA-L-MALIC ACID); LIPID-COMPOSITION; POLYMALIC ACID; MALIC-ACID; MICROBIOLOGY; SURFACTANTS	Yeast biosurfactants are important biotechnological products in the food industry, and they have medical and cosmeceutical applications owing to their specific modes of action, low toxicity, and applicability. Thus, we have isolated and examined biosurfactant-producing yeast for various industrial and medical applications. A rapid and simple method was developed to screen biosurfactant-producing yeasts for high production of eco-friendly biosurfactants. Using this method, several potential niches of biosurfactant-producing yeasts, such as wild flowers, were investigated. We successfully selected a yeast strain, L3-GPY, with potent surfactant activity from a tiger lily, Lilium lancifolium Thunb. Here, we report the first identification of strain L3-GPY as the black yeast Aureobasidium pullulans. In addition, we isolated a new low-surface-tension chemical, designated glycerol-liamocin, from the culture supernatant of strain L3-GPY through consecutive chromatography steps, involving an ODS column, solvent partition, silica gel, Sephadex LH-20, and an ODS Sep-Pak cartridge column. The chemical structure of glycerol-liamocin, determined by mass spectrometry and nuclear magnetic resonance spectroscopy, indicates that it is a novel compound with the molecular formula C33H62O12. Furthermore, glycerol-liamocin exhibited potent biosurfactant activity (31 mN/m). These results suggest that glycerol-liamocin is a potential novel biosurfactantfor use in various industrial applications.	[Kim, Jong Shik] Gyeongbuk Inst Marine Bioind, Uljin 767813, Gyeongbuk, South Korea; [Lee, In Kyoung; Yun, Bong Sik] Chonbuk Natl Univ, Div Biotechnol, Iksan 570752, Chonbuk, South Korea; [Lee, In Kyoung; Yun, Bong Sik] Chonbuk Natl Univ, Adv Inst Environm & Biosci, Iksan 570752, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, JS (corresponding author), Gyeongbuk Inst Marine Bioind, 22 Haeyanggwahak Gil, Uljin 767813, Gyeongbuk, South Korea.	jskim@gimb.or.kr; bsyun@jbnu.ac.kr		Kim, Jong-Shik/0000-0002-8181-1707	research program of Gyeongsangbuk-Do; National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP) [NRF-2014R1A2A1A11052888]	research program of Gyeongsangbuk-Do; National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP)	This work was supported by the research program of Gyeongsangbuk-Do and the National Research Foundation of Korea (NRF), via a grant from the Korean government (MSIP) (no. NRF-2014R1A2A1A11052888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PFF, 2010, ADV EXP MED BIOL, V672, P236; Campos-Takaki GM, 2010, ADV EXP MED BIOL, V672, P250; Cao WF, 2013, J CHEM TECHNOL BIOT, V88, P808, DOI 10.1002/jctb.3905; Certik M, 2005, INT BIODETER BIODEGR, V55, P195, DOI 10.1016/j.ibiod.2004.11.005; Cheng KC, 2011, APPL MICROBIOL BIOT, V92, P29, DOI 10.1007/s00253-011-3477-y; Desai JD, 1997, MICROBIOL MOL BIOL R, V61, P47, DOI 10.1128/.61.1.47-64.1997; DESHPANDE MS, 1992, ENZYME MICROB TECH, V14, P514, DOI 10.1016/0141-0229(92)90122-5; Doshida J, 1996, J ANTIBIOT, V49, P1105, DOI 10.7164/antibiotics.49.1105; Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235; Gunde-Cimerman N, 2003, PHYS CHEM EARTH, V28, P1273, DOI 10.1016/j.pce.2003.08.056; Hewald S, 2005, APPL ENVIRON MICROB, V71, P3033, DOI 10.1128/AEM.71.6.3033-3040.2005; Kitamoto D, 2002, J BIOSCI BIOENG, V94, P187, DOI 10.1263/jbb.94.187; Kuiper I, 2004, MOL MICROBIOL, V51, P97, DOI 10.1046/j.1365-2958.2003.03751.x; Leathers, 2011, RANGSIT J ARTS SCI, V1, P41; Leathers TD, 2013, BIOTECHNOL LETT, V35, P1701, DOI 10.1007/s10529-013-1268-5; Leathers TD, 2013, BIOTECHNOL LETT, V35, P83, DOI 10.1007/s10529-012-1045-x; Liu S, 1996, APPL MICROBIOL BIOT, V46, P273, DOI 10.1007/s002530050816; Ma ZC, 2012, PROCESS BIOCHEM, V47, P1807, DOI 10.1016/j.procbio.2012.06.024; Manitchotpisit P, 2012, J IND MICROBIOL BIOT, V39, P125, DOI 10.1007/s10295-011-1007-7; Manitchotpisit P, 2011, BIOTECHNOL LETT, V33, P1151, DOI 10.1007/s10529-011-0548-1; Mari M, 2012, POSTHARVEST BIOL TEC, V73, P56, DOI 10.1016/j.postharvbio.2012.05.014; Morita T, 2006, APPL MICROBIOL BIOT, V73, P305, DOI 10.1007/s00253-006-0466-7; Muramatsu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041399; Myers D, 2006, SURFACTANT SCIENCE AND TECHNOLOGY, 3RD EDITION, P1; NAGATA N, 1993, BIOSCI BIOTECH BIOCH, V57, P638, DOI 10.1271/bbb.57.638; Prasongsuk S, 2013, APPL MICROBIOL BIOT, V97, P7821, DOI 10.1007/s00253-013-5069-5; Price NPJ, 2013, CARBOHYD RES, V370, P24, DOI 10.1016/j.carres.2013.01.014; Rodrigues L, 2006, J ANTIMICROB CHEMOTH, V57, P609, DOI 10.1093/jac/dkl024; Ron EZ, 2001, ENVIRON MICROBIOL, V3, P229, DOI 10.1046/j.1462-2920.2001.00190.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Singh A, 2007, BIOTECHNOL ADV, V25, P99, DOI 10.1016/j.biotechadv.2006.10.004; Singh RS, 2008, CARBOHYD POLYM, V73, P515, DOI 10.1016/j.carbpol.2008.01.003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Turk M, 2004, EXTREMOPHILES, V8, P53, DOI 10.1007/s00792-003-0360-5; Van Hamme JD, 2006, BIOTECHNOL ADV, V24, P604, DOI 10.1016/j.biotechadv.2006.08.001; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yurlova NA, 1997, ANTON LEEUW INT J G, V72, P141, DOI 10.1023/A:1000212003810; Zalar P, 2008, STUD MYCOL, P21, DOI 10.3114/sim.2008.61.02; Zan ZQ, 2013, J CHEM TECHNOL BIOT, V88, P1822, DOI 10.1002/jctb.4033; Zou X, 2013, BIOTECHNOL BIOENG, V110, P2105, DOI 10.1002/bit.24876	40	27	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122917	10.1371/journal.pone.0122917	http://dx.doi.org/10.1371/journal.pone.0122917			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849549	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800173
J	Rozanov, D; Spellman, P; Savinov, A; Strongin, AY				Rozanov, Dmitri; Spellman, Paul; Savinov, Alexei; Strongin, Alex Y.			A Humanized Leucine Zipper-TRAIL Hybrid Induces Apoptosis of Tumors both In Vitro and In Vivo	PLOS ONE			English	Article							CELL-DEATH; CANCER-CELLS; TNF-FAMILY; LIGAND; INDUCTION; MEMBER; IDENTIFICATION; RECEPTORS; MOLECULES; PATHWAY	Evidence suggests that stimulating apoptosis in malignant cells without inflicting collateral damage to the host's normal tissues is a promising cancer therapy. Chemo-and radiation therapies that, especially if combined, induce apoptosis in tumor cells have been used for treating cancer patients for decades. These treatments, however, are limited in their ability to discriminate between malignant and non-malignant cells and, therefore, produce substantial healthy tissue damage and subsequent toxic side-effects. In addition, as a result of these therapies, many tumor types acquire an apoptosis-resistant phenotype and become more aggressive and metastatic. Tumor necrosis factor-Related Apoptosis-Inducing Ligand (TRAIL) has been considered a promising and reliable selective inducer of apoptosis in cancerous cells. TRAIL, however, is not uniformly effective in cancer and multiple cancer cell types are considered resistant to natural TRAIL. To overcome this deficiency of TRAIL, we have earlier constructed a yeast-human hybrid leucine zipper-TRAIL in which the yeast GCN4-pII leucine zipper was fused to human TRAIL (GCN4-TRAIL). This construct exhibited a significantly improved anti-tumor apoptotic activity and safety, but is potentially immunogenic in humans. Here, we report a novel, potent, and fully human ATF7 leucine zipperTRAIL (ATF7-TRAIL) fusion construct that is expected to have substantially lower immunogenicity. In solution, ATF7-TRAIL exists solely as a trimer with a Tm of 80 degrees C and is active against cancer cells both in vitro and in vivo, in a mouse tumor xenograft model. Our data suggest that our re-engineered TRAIL is a promising candidate for further evaluation as an antitumor agent.	[Rozanov, Dmitri; Spellman, Paul] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA; [Savinov, Alexei] Sanford Res, Sioux Falls, SD USA; [Strongin, Alex Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Oregon Health & Science University; Sanford Health; Sanford Burnham Prebys Medical Discovery Institute	Rozanov, D (corresponding author), Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA.	rozanov@ohsu.edu	Strongin, Alex/R-6609-2019	Strongin, Alex/0000-0003-3765-3016	Department of Defense [W81XWH-09-1-0601]; NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Department of Defense, Concept award W81XWH-09-1-0601, http://www.usamraa.army.mil/DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroui S, 2009, APOPTOSIS, V14, P1352, DOI 10.1007/s10495-009-0397-8; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Ashkenazi A, 2008, CYTOKINE GROWTH F R, V19, P325, DOI 10.1016/j.cytogfr.2008.04.001; Badran A, 2010, INT J ONCOL, V36, P1229, DOI 10.3892/ijo_00000606; Bodmer JL, 2000, J BIOL CHEM, V275, P20632, DOI 10.1074/jbc.M909721199; CHATTON B, 1994, ONCOGENE, V9, P375; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; De Graeve F, 1999, ONCOGENE, V18, P3491, DOI 10.1038/sj.onc.1202723; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fong JH, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r11; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Fulda S, 2006, ONCOGENE, V25, P4798, DOI 10.1038/sj.onc.1209608; Hamard PJ, 2005, ONCOGENE, V24, P3472, DOI 10.1038/sj.onc.1208565; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Hartung F, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-109; Hymowitz SG, 1999, MOL CELL, V4, P563, DOI 10.1016/S1097-2765(00)80207-5; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kandasamy K, 2003, CANCER RES, V63, P1712; Kelley SK, 2001, J PHARMACOL EXP THER, V299, P31; Lacroix E, 1998, J MOL BIOL, V284, P173, DOI 10.1006/jmbi.1998.2145; Lemke J, 2014, CELL DEATH DIFFER, V21, P1350, DOI 10.1038/cdd.2014.81; Mitchell MJ, 2014, P NATL ACAD SCI USA, V111, P930, DOI 10.1073/pnas.1316312111; Park C, 2008, ACTA PHARMACOL SIN, V29, P341, DOI 10.1111/j.1745-7254.2008.00761.x; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Reichert JM, 2012, MABS-AUSTIN, V4, P413, DOI 10.4161/mabs.19931; Rozanov DV, 2009, MOL CANCER THER, V8, P1515, DOI 10.1158/1535-7163.MCT-09-0202; Schimmer AD, 2006, CANCER RES, V66, P2367, DOI 10.1158/0008-5472.CAN-05-1061; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Song JH, 2003, BRAIN PATHOL, V13, P539; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang S, 2008, ONCOGENE, V27, P6207, DOI 10.1038/onc.2008.298; Wang SL, 2003, ONCOGENE, V22, P8628, DOI 10.1038/sj.onc.1207232; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Zhang YQ, 2008, MOL CANCER RES, V6, P1861, DOI 10.1158/1541-7786.MCR-08-0313	38	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122980	10.1371/journal.pone.0122980	http://dx.doi.org/10.1371/journal.pone.0122980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849628	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800187
J	Seneviratne, S; Lawrenson, R; Scott, N; Kim, B; Shirley, R; Campbell, I				Seneviratne, Sanjeewa; Lawrenson, Ross; Scott, Nina; Kim, Boa; Shirley, Rachel; Campbell, Ian			Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study	PLOS ONE			English	Article							HORMONE-RECEPTOR STATUS; PROGNOSTIC-FACTORS; SURVIVAL; RACE; WOMEN; INEQUALITIES; DEPRIVATION; SUBTYPES; THERAPY; TRENDS	Introduction Indigenous Maori women have a 60% higher breast cancer mortality rate compared with European women in New Zealand. We investigated differences in cancer biological characteristics and their impact on breast cancer mortality disparity between Maori and NZ European women. Materials and Methods Data on 2849 women with primary invasive breast cancers diagnosed between 1999 and 2012 were extracted from the Waikato Breast Cancer Register. Differences in distribution of cancer biological characteristics between Maori and NZ European women were explored adjusting for age and socioeconomic deprivation in logistic regression models. Impacts of socioeconomic deprivation, stage and cancer biological characteristics on breast cancer mortality disparity between Maori and NZ European women were explored in Cox regression models. Results Compared with NZ European women (n=2304), Maori women (n=429) had significantly higher rates of advanced and higher grade cancers. Maori women also had non-significantly higher rates of ER/PR negative and HER-2 positive breast cancers. Higher odds of advanced stage and higher grade remained significant for Maori after adjusting for age and deprivation. Maori women had almost a 100% higher age and deprivation adjusted breast cancer mortality hazard compared with NZ European women (HR=1.98, 1.55-2.54). Advanced stage and lower proportion of screen detected cancer in Maori explained a greater portion of the excess breast cancer mortality (HR reduction from 1.98 to 1.38), while the additional contribution through biological differences were minimal (HR reduction from 1.38 to 1.35). Conclusions More advanced cancer stage at diagnosis has the greatest impact while differences in biological characteristics appear to be a minor contributor for inequities in breast cancer mortality between Maori and NZ European women. Strategies aimed at reducing breast cancer mortality in Maori should focus on earlier diagnosis, which will likely have a greater impact on reducing breast cancer mortality inequity between Maori and NZ European women.	[Seneviratne, Sanjeewa; Lawrenson, Ross; Campbell, Ian] Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand; [Scott, Nina] Waikato Dist Hlth Board, Maori Hlth Serv, Hamilton, New Zealand; [Kim, Boa; Shirley, Rachel] Waikato Hosp, Waikato Breast Canc Trust, Hamilton, New Zealand	University of Auckland; Waikato Hospital	Seneviratne, S (corresponding author), Univ Auckland, Waikato Clin Sch, Hamilton, New Zealand.	Sanjeewa.Seneviratne@waikatodhb.health.nz	Seneviratne, Sanjeewa/V-5764-2019	Seneviratne, Sanjeewa/0000-0003-0310-1387	Waikato Breast Cancer Trust; Cancer Society of New Zealand; New Zealand Breast Cancer Foundation; Lion Foundation; WEL Energy Trust	Waikato Breast Cancer Trust; Cancer Society of New Zealand; New Zealand Breast Cancer Foundation; Lion Foundation; WEL Energy Trust	The authors acknowledge funding support received from the Waikato Breast Cancer Trust, Cancer Society of New Zealand, New Zealand Breast Cancer Foundation, Lion Foundation and the WEL Energy Trust towards the WBCR and for additional data collection included for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajwani S., 2003, DECADES DISPARITY ET; Allred DC, 2008, ONCOLOGIST, V13, P1134, DOI 10.1634/theoncologist.2008-0184; Althuis MD, 2005, INT J EPIDEMIOL, V34, P405, DOI 10.1093/ije/dyh414; American Joint Committee on Cancer, 2010, AM JOINT COMMITTEE C, V7th; [Anonymous], 2004, ETHN DAT PROT HLTH D; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cunningham R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-674; Dachs GU, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-543; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Haynes R, 2008, SOC SCI MED, V67, P928, DOI 10.1016/j.socscimed.2008.05.005; Jack RH, 2013, EUR J CANCER, V49, P696, DOI 10.1016/j.ejca.2012.09.012; Jeffreys M, 2005, AM J PUBLIC HEALTH, V95, P834, DOI 10.2105/AJPH.2004.053678; Li CI, 2002, CANCER EPIDEM BIOMAR, V11, P601; McKenzie F, 2008, CANCER CAUSE CONTROL, V19, P403, DOI 10.1007/s10552-007-9099-0; O'Brien KM, 2010, CLIN CANCER RES, V16, P6100, DOI 10.1158/1078-0432.CCR-10-1533; Pauletti G, 1996, ONCOGENE, V13, P63; Robson B, 2010, UNEQUAL IMPACT; Rosenberg J, 2005, BREAST CANCER RES TR, V89, P47, DOI 10.1007/s10549-004-1470-1; Salmond C., 2007, NZDEP2006 INDEX DEPR; Salmond CE, 2012, CAN J PUBLIC HEALTH, V103, pS7; Seneviratne S, 2015, BREAST, V24, P62, DOI 10.1016/j.breast.2014.11.011; Seneviratne S, 2015, ETHNIC HEALTH, V20, P178, DOI 10.1080/13557858.2014.895976; Seneviratne S, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-839; Seneviratne S, 2014, CANCER EPIDEMIOL, V38, P638, DOI 10.1016/j.canep.2014.06.008; Taylor A, 2003, J PUBLIC HEALTH MED, V25, P228, DOI 10.1093/pubmed/fdg072; Vona-Davis L, 2009, J WOMENS HEALTH, V18, P883, DOI 10.1089/jwh.2008.1127; Weston MK, 2008, BREAST CANCER RES TR, V111, P555, DOI 10.1007/s10549-007-9813-3	29	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123523	10.1371/journal.pone.0123523	http://dx.doi.org/10.1371/journal.pone.0123523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849101	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800240
J	Walker, AW; Smith, CM; Chua, BE; Krstew, EV; Zhang, C; Gundlach, AL; Lawrence, AJ				Walker, Andrew W.; Smith, Craig M.; Chua, Berenice E.; Krstew, Elena V.; Zhang, Cary; Gundlach, Andrew L.; Lawrence, Andrew J.			Relaxin-3 Receptor (RXFP3) Signalling Mediates Stress-Related Alcohol Preference in Mice	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; CHRONIC SWIM STRESS; NUCLEUS-INCERTUS; STRIA TERMINALIS; MESSENGER-RNA; BED NUCLEUS; MATERNAL SEPARATION; ETHANOL-CONSUMPTION; BRAIN; ANXIETY	Stressful life events are causally linked with alcohol use disorders (AUDs), providing support for a hypothesis that alcohol consumption is aimed at stress reduction. We have previously shown that expression of relaxin-3 mRNA in rat brain correlates with alcohol intake and that central antagonism of relaxin-3 receptors (RXFP3) prevents stress-induced reinstatement of alcohol-seeking. Therefore the objectives of these studies were to investigate the impact of Rxfp3 gene deletion in C57BL/6J mice on baseline and stress-related alcohol consumption. Male wild-type (WT) and Rxfp3 knockout (KO) (C57/B6J(RXFP3TM1/DGen)) littermate mice were tested for baseline saccharin and alcohol consumption and preference over water in a continuous access two-bottle free-choice paradigm. Another cohort of mice was subjected to repeated restraint followed by swim stress to examine stress-related alcohol preference. Hepatic alcohol and aldehyde dehydrogenase activity was assessed in mice following chronic alcohol intake and in naive controls. WT and Rxfp3 KO mice had similar baseline saccharin and alcohol preference, and hepatic alcohol processing. However, Rxfp3 KO mice displayed a stress-induced reduction in alcohol preference that was not observed in WT littermates. Notably, this phenotype, once established, persisted for at least six weeks after cessation of stress exposure. These findings suggest that in mice, relaxin-3/RXFP3 signalling is involved in maintaining high alcohol preference during and after stress, but does not appear to strongly regulate the primary reinforcing effects of alcohol.	[Walker, Andrew W.; Smith, Craig M.; Chua, Berenice E.; Zhang, Cary; Gundlach, Andrew L.] Florey Inst Neurosci & Mental Hlth, Neuropeptides Div, Melbourne, Vic, Australia; [Walker, Andrew W.; Smith, Craig M.; Krstew, Elena V.; Lawrence, Andrew J.] Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Melbourne, Vic, Australia; [Walker, Andrew W.; Smith, Craig M.; Zhang, Cary; Gundlach, Andrew L.; Lawrence, Andrew J.] Univ Melbourne, Florey Dept Neurosci & Mental Hlth, Melbourne, Vic, Australia; [Gundlach, Andrew L.] Univ Melbourne, Dept Anat & Neurosci, Melbourne, Vic, Australia	Florey Institute of Neuroscience & Mental Health; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Lawrence, AJ (corresponding author), Florey Inst Neurosci & Mental Hlth, Behav Neurosci Div, Melbourne, Vic, Australia.	andrew.lawrence@florey.edu.au	Gundlach, Andrew L/X-6421-2018	Gundlach, Andrew L/0000-0002-6066-9692	National Health and Medical Research Council (NHMRC) of Australia project grant [1021227]; NHMRC (Australia) [1005985, 1020737]; Pratt Foundation; Besen Foundation; Victorian Government's Operational Infrastructure Support Program; University of Melbourne International Postgraduate Research Scholarship (IPRS)	National Health and Medical Research Council (NHMRC) of Australia project grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Besen Foundation; Victorian Government's Operational Infrastructure Support Program; University of Melbourne International Postgraduate Research Scholarship (IPRS)	This research was supported by a National Health and Medical Research Council (NHMRC) of Australia project grant (1021227 to ALG and AJL) and NHMRC (Australia) Research Fellowships (1005985 and 1020737) to ALG and AJL; a grant from the Pratt and Besen Foundations (ALG and AJL); and the Victorian Government's Operational Infrastructure Support Program. AWW was the recipient of a University of Melbourne International Postgraduate Research Scholarship (IPRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Banerjee A, 2010, NEUROPHARMACOLOGY, V58, P145, DOI 10.1016/j.neuropharm.2009.06.019; Bathgate RA, 2006, PHARMACOL REV, V58, P7, DOI 10.1124/pr.58.1.9; Bathgate RAD, 2002, J BIOL CHEM, V277, P1148, DOI 10.1074/jbc.M107882200; Bathgate Ross A D, 2013, Front Endocrinol (Lausanne), V4, P13, DOI 10.3389/fendo.2013.00013; Becker HC, 2011, PSYCHOPHARMACOLOGY, V218, P131, DOI 10.1007/s00213-011-2443-9; Bird MK, 2008, INT J NEUROPSYCHOPH, V11, P765, DOI 10.1017/S1461145708008572; Boyce-Rustay JM, 2008, BEHAV BRAIN RES, V186, P133, DOI 10.1016/j.bbr.2007.07.031; Boyce-Rustay JM, 2007, PHYSIOL BEHAV, V91, P77, DOI 10.1016/j.physbeh.2007.01.024; Burazin TCD, 2002, J NEUROCHEM, V82, P1553, DOI 10.1046/j.1471-4159.2002.01114.x; Choi DC, 2007, J NEUROSCI, V27, P2025, DOI 10.1523/JNEUROSCI.4301-06.2007; Correia D, 2009, PROG NEURO-PSYCHOPH, V33, P880, DOI 10.1016/j.pnpbp.2009.04.015; Crestani CC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-30; Cruz FC, 2008, PSYCHOPHARMACOLOGY, V201, P459, DOI 10.1007/s00213-008-1307-4; Dahlhoff M, 2013, EXP CELL RES, V319, P529, DOI 10.1016/j.yexcr.2012.11.001; Dayas CV, 2001, EUR J NEUROSCI, V14, P1143, DOI 10.1046/j.0953-816x.2001.01733.x; Donizetti A, 2008, DEV DYNAM, V237, P3864, DOI 10.1002/dvdy.21786; Funk CK, 2006, J NEUROSCI, V26, P11324, DOI 10.1523/JNEUROSCI.3096-06.2006; Hosken IT, 2015, BEHAV BRAIN RES, V278, P167, DOI 10.1016/j.bbr.2014.09.028; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Huot RL, 2001, PSYCHOPHARMACOLOGY, V158, P366, DOI 10.1007/s002130100701; Jupp B, 2011, BRIT J PHARMACOL, V162, P880, DOI 10.1111/j.1476-5381.2010.01088.x; Jupp B, 2011, BRAIN RES, V1391, P54, DOI 10.1016/j.brainres.2011.03.045; Koob GF, 2003, ALCOHOL CLIN EXP RES, V27, P232, DOI 10.1097/01.ALC.0000057122.36127.C2; Lawrence AJ, 2006, BRIT J PHARMACOL, V148, P752, DOI 10.1038/sj.bjp.0706789; Liu CL, 2003, J BIOL CHEM, V278, P50754, DOI 10.1074/jbc.M308995200; Lodge DJ, 2003, NEUROSCIENCE, V117, P243, DOI 10.1016/S0306-4522(02)00793-5; Lopez MF, 2011, ALCOHOL, V45, P355, DOI 10.1016/j.alcohol.2010.08.017; Ma S, 2007, NEUROSCIENCE, V144, P165, DOI 10.1016/j.neuroscience.2006.08.072; Ma S, 2013, J PHYSIOL-LONDON, V591, P3981, DOI 10.1113/jphysiol.2013.254300; Ma S, 2009, J COMP NEUROL, V517, P856, DOI 10.1002/cne.22197; Ma SR, 2009, ANN NY ACAD SCI, V1160, P256, DOI 10.1111/j.1749-6632.2009.03954.x; McFarlane AC, 1998, ADDICT BEHAV, V23, P813, DOI 10.1016/S0306-4603(98)00098-7; Mercier S, 2003, BEHAV BRAIN RES, V139, P167, DOI 10.1016/S0166-4328(02)00265-6; Misawa H, 2001, J BIOL CHEM, V276, P9264, DOI 10.1074/jbc.M009334200; Molander A, 2012, NEUROPSYCHOPHARMACOL, V37, P1047, DOI 10.1038/npp.2011.297; Moorman DE, 2009, ALCOHOL, V43, P379, DOI 10.1016/j.alcohol.2009.07.002; Olive MF, 2002, PHARMACOL BIOCHEM BE, V72, P213, DOI 10.1016/S0091-3057(01)00748-1; Ostrander MM, 2009, STRESS, V12, P469, DOI 10.3109/10253890802641966; Ray LA, 2009, ALCOHOL CLIN EXP RES, V33, P2154, DOI 10.1111/j.1530-0277.2009.01053.x; Richards JK, 2008, PSYCHOPHARMACOLOGY, V199, P109, DOI 10.1007/s00213-008-1136-5; Richardson HN, 2008, PHARMACOL BIOCHEM BE, V88, P497, DOI 10.1016/j.pbb.2007.10.008; RITZ MC, 1989, ALCOHOL, V6, P227, DOI 10.1016/0741-8329(89)90023-2; Ryan PJ, 2014, DRUG ALCOHOL DEPEN, V140, P8, DOI 10.1016/j.drugalcdep.2014.04.017; Ryan Philip J, 2013, Proc Natl Acad Sci U S A, V110, P20789, DOI 10.1073/pnas.1317807110; Ryan PJ, 2013, BEHAV BRAIN RES, V244, P142, DOI 10.1016/j.bbr.2013.01.034; Ryan PJ, 2011, NEUROSCI BIOBEHAV R, V35, P1326, DOI 10.1016/j.neubiorev.2011.02.004; Sakharkar AJ, 2014, INT J NEUROPSYCHOPH, V17, P2057, DOI 10.1017/S1461145714001047; Sillaber I, 2002, SCIENCE, V296, P931, DOI 10.1126/science.1069836; Skelly MJ, 2014, BRAIN BEHAV, V4, P468, DOI 10.1002/brb3.230; Slopen N, 2011, SOC SCI MED, V73, P615, DOI 10.1016/j.socscimed.2011.06.022; Smith CM, 2010, J COMP NEUROL, V518, P4016, DOI 10.1002/cne.22442; Tanaka M, 2005, EUR J NEUROSCI, V21, P1659, DOI 10.1111/j.1460-9568.2005.03980.x; Thomas SE, 2011, PSYCHOPHARMACOLOGY, V218, P19, DOI 10.1007/s00213-010-2163-6; Van Pett K, 2000, J COMP NEUROL, V428, P191, DOI 10.1002/1096-9861(20001211)428:2<191::AID-CNE1>3.0.CO;2-U; Verheul R, 1999, ALCOHOL ALCOHOLISM, V34, P197, DOI 10.1093/alcalc/34.2.197; Watanabe Y, 2011, J MOL NEUROSCI, V43, P169, DOI 10.1007/s12031-010-9468-0; Wilkinson TN, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-14	58	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122504	10.1371/journal.pone.0122504	http://dx.doi.org/10.1371/journal.pone.0122504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849482	Green Published, gold			2022-12-26	WOS:000352477800136
J	Ye, JQ; Fan, ZL; Shang, JJ; Tian, XY; Yang, JL; Chen, HJ; Shao, HX; Qin, AJ				Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Yang, Jialiang; Chen, Hongjun; Shao, Hongxia; Qin, Aijian			ALV-J GP37 Molecular Analysis Reveals Novel Virus-Adapted Sites and Three Tyrosine-Based Env Species	PLOS ONE			English	Article							AVIAN-LEUKOSIS VIRUS; SUBGROUP-J; PHYLOGENETIC ANALYSIS; GLYCOPROTEIN GP85; GENETIC DIVERSITY; PROTEIN; ITAM; TRANSFORMATION; CHICKENS; HPRS-103	Compared to other avian leukosis viruses (ALV), ALV-J primarily induces myeloid leukemia and hemangioma and causes significant economic loss for the poultry industry. The ALV-J Env protein is hypothesized to be related to its unique pathogenesis. However, the molecular determinants of Env for ALV-J pathogenesis are unclear. In this study, we compared and analyzed GP37 of ALV-J Env and the EAV-HP sequence, which has high homology to that of ALV-J Env. Phylogenetic analysis revealed five groups of ALV-J GP37 and two novel ALV-J Envs with endemic GP85 and EAV-HP-like GP37. Furthermore, at least 15 virus-adapted mutations were detected in GP37 compared to the EAV-HP sequence. Further analysis demonstrated that three tyrosine-based motifs (YxxM, ITIM (immune tyrosine-based inhibitory motif) and ITAM-like (immune tyrosine-based active motif like)) associated with immune disease and oncogenesis were found in the cytoplasmic tail of GP37. Based on the potential function and distribution of these motifs in GP37, ALV-J Env was grouped into three species, inhibitory Env, bifunctional Env and active Env. Accordingly, 36.91%, 61.74% and 1.34% of ALV-J Env sequences from GenBank are classified as inhibitory, bifunctional and active Env, respectively. Additionally, the Env of the ALV-J prototype strain, HPRS-103, and 17 of 18 EAV-HP sequences belong to the inhibitory Env. And models for signal transduction of the three ALV-J Env species were predicted. Our findings and models provide novel insights for identifying the roles and molecular mechanism of ALV-J Env in the unique pathogenesis of ALV-J.	[Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Yangzhou Univ, Key Lab Jiangsu Prevent Vet Med, Yangzhou 225009, Jiangsu, Peoples R China; [Ye, Jianqiang; Fan, Zhonglei; Shang, Jianjun; Tian, Xiaoyan; Shao, Hongxia; Qin, Aijian] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China; [Yang, Jialiang] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Chen, Hongjun] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Shanghai, Peoples R China	Yangzhou University; Yangzhou University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Ye, JQ (corresponding author), Yangzhou Univ, Minist Educ, Key Lab Avian Prevent Med, Yangzhou 225009, Jiangsu, Peoples R China.	jqye@yzu.edu.cn; aijian@yzu.edu.cn	ye, jianqiang/ABH-8988-2020		National Natural Science Foundation of China [31472171]; Key University Science Research Project of Jiangsu Province [14KJA230002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key University Science Research Project of Jiangsu Province; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This project was partially funded by National Natural Science Foundation of China (31472171), Key University Science Research Project of Jiangsu Province (14KJA230002) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	BAI J, 1995, J VIROL, V69, P779, DOI 10.1128/JVI.69.2.779-784.1995; Barrow AD, 2006, EUR J IMMUNOL, V36, P1646, DOI 10.1002/eji.200636195; Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; BROWN DW, 1988, J VIROL, V62, P4828, DOI 10.1128/JVI.62.12.4828-4831.1988; Chesters PM, 2002, J GEN VIROL, V83, P2553, DOI 10.1099/0022-1317-83-10-2553; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cui ZZ, 2003, AVIAN DIS, V47, P1321, DOI 10.1637/6085; Gao YL, 2010, EMERG INFECT DIS, V16, P1637, DOI 10.3201/eid1610.100780; Humphrey MB, 2005, IMMUNOL REV, V208, P50, DOI 10.1111/j.0105-2896.2005.00325.x; Jiang LL, 2014, ARCH VIROL, V159, P1821, DOI 10.1007/s00705-014-2004-8; Katz E, 2005, J EXP MED, V201, P431, DOI 10.1084/jem.20041471; Lagunoff M, 2001, J VIROL, V75, P5891, DOI 10.1128/JVI.75.13.5891-5898.2001; Lanier LL, 2006, TRENDS CELL BIOL, V16, P388, DOI 10.1016/j.tcb.2006.06.004; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Pan W, 2012, VET MICROBIOL, V156, P205, DOI 10.1016/j.vetmic.2011.10.019; Payne LN, 2012, AVIAN PATHOL, V41, P11, DOI 10.1080/03079457.2011.646237; PAYNE LN, 1991, J GEN VIROL, V72, P801, DOI 10.1099/0022-1317-72-4-801; PAYNE LN, 1992, J GEN VIROL, V73, P2995, DOI 10.1099/0022-1317-73-11-2995; Qin AJ, 2001, AVIAN DIS, V45, P938, DOI 10.2307/1592872; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thu WL, 2003, J VET MED SCI, V65, P325, DOI 10.1292/jvms.65.325; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Wang ZF, 2006, SCI CHINA SER C, V49, P227, DOI 10.1007/s11427-006-0227-y; WILLEMS L, 1995, J VIROL, V69, P4137, DOI 10.1128/JVI.69.7.4137-4141.1995; Wootton SK, 2005, NATURE, V434, P904, DOI 10.1038/nature03492; Wu XP, 2010, VET RES COMMUN, V34, P619, DOI 10.1007/s11259-010-9436-8; Yan Du ZC, 1999, CHINA POULTRY, V3, P1	28	6	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122887	10.1371/journal.pone.0122887	http://dx.doi.org/10.1371/journal.pone.0122887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849207	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800169
J	Brown, AE; Jones, DE; Walker, M; Newton, JL				Brown, Audrey E.; Jones, David E.; Walker, Mark; Newton, Julia L.			Abnormalities of AMPK Activation and Glucose Uptake in Cultured Skeletal Muscle Cells from Individuals with Chronic Fatigue Syndrome	PLOS ONE			English	Article							PROTEIN-KINASE; ENGINEERED MUSCLE; PERIPHERAL MUSCLE; IN-VIVO; EXERCISE; INTERLEUKIN-6; DIFFERENTIATION; MATURATION; IL-6; METABOLISM	Background Post exertional muscle fatigue is a key feature in Chronic Fatigue Syndrome (CFS). Abnormalities of skeletal muscle function have been identified in some but not all patients with CFS. To try to limit potential confounders that might contribute to this clinical heterogeneity, we developed a novel in vitro system that allows comparison of AMP kinase (AMPK) activation and metabolic responses to exercise in cultured skeletal muscle cells from CFS patients and control subjects. Methods Skeletal muscle cell cultures were established from 10 subjects with CFS and 7 age-matched controls, subjected to electrical pulse stimulation (EPS) for up to 24h and examined for changes associated with exercise. Results In the basal state, CFS cultures showed increased myogenin expression but decreased IL6 secretion during differentiation compared with control cultures. Control cultures subjected to 16h EPS showed a significant increase in both AMPK phosphorylation and glucose uptake compared with unstimulated cells. In contrast, CFS cultures showed no increase in AMPK phosphorylation or glucose uptake after 16h EPS. However, glucose uptake remained responsive to insulin in the CFS cells pointing to an exercise-related defect. IL6 secretion in response to EPS was significantly reduced in CFS compared with control cultures at all time points measured. Conclusion EPS is an effective model for eliciting muscle contraction and the metabolic changes associated with exercise in cultured skeletal muscle cells. We found four main differences in cultured skeletal muscle cells from subjects with CFS; increased myogenin expression in the basal state, impaired activation of AMPK, impaired stimulation of glucose uptake and diminished release of IL6. The retention of these differences in cultured muscle cells from CFS subjects points to a genetic/epigenetic mechanism, and provides a system to identify novel therapeutic targets.	[Brown, Audrey E.; Jones, David E.; Walker, Mark] Newcastle Univ, Sch Med, Inst Cellular Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jones, David E.; Walker, Mark; Newton, Julia L.] NHS Fdn Trust, Newcastle Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [Newton, Julia L.] Newcastle Univ, Inst Ageing & Hlth, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Newton, JL (corresponding author), NHS Fdn Trust, Newcastle Hosp, Newcastle Upon Tyne, Tyne & Wear, England.	julia.newton@ncl.ac.uk		Brown, Audrey/0000-0002-0222-4214; Newton, Julia/0000-0002-1249-5253	ME Research UK; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University	ME Research UK; National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University	This research was supported by ME Research UK and by the National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre based at Newcastle upon Tyne Hospitals NHS Foundation Trust and Newcastle University. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.	Abbott MJ, 2009, AM J PHYSIOL-REG I, V297, pR1724, DOI 10.1152/ajpregu.00179.2009; Al-Shanti N, 2008, GROWTH FACTORS, V26, P61, DOI 10.1080/08977190802025024; [Anonymous], 2007, CHRON FAT SYNDR MYAL, V7; Baeza-Raja B, 2004, MOL BIOL CELL, V15, P2013, DOI 10.1091/mbc.E03-08-0585; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; Flynn JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013535; Fujita H, 2007, EXP CELL RES, V313, P1853, DOI 10.1016/j.yexcr.2007.03.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Glund S, 2009, ENDOCRINOLOGY, V150, P600, DOI 10.1210/en.2008-1204; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hoene M, 2013, AM J PHYSIOL-CELL PH, V304, pC128, DOI 10.1152/ajpcell.00025.2012; Hollingsworth KG, 2008, CLIN GASTROENTEROL H, V6, P1041, DOI 10.1016/j.cgh.2008.04.013; Huang YC, 2005, J APPL PHYSIOL, V98, P706, DOI 10.1152/japplphysiol.00273.2004; Hughes SM, 1999, J CELL BIOL, V145, P633, DOI 10.1083/jcb.145.3.633; Jones DEJ, 2010, J INTERN MED, V267, P394, DOI 10.1111/j.1365-2796.2009.02160.x; Jones DEJ, 2012, EUR J CLIN INVEST, V42, P186, DOI 10.1111/j.1365-2362.2011.02567.x; Juhas M, 2014, BIOMATERIALS, V35, P9438, DOI 10.1016/j.biomaterials.2014.07.035; Juhas M, 2014, P NATL ACAD SCI USA, V111, P5508, DOI 10.1073/pnas.1402723111; Kelly M, 2004, BIOCHEM BIOPH RES CO, V320, P449, DOI 10.1016/j.bbrc.2004.05.188; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Lambernd S, 2012, DIABETOLOGIA, V55, P1128, DOI 10.1007/s00125-012-2454-z; MacDonald C, 2003, J APPL PHYSIOL, V95, P2273, DOI 10.1152/japplphysiol.00242.2003; Martin NRW, 2013, BIOMATERIALS, V34, P5759, DOI 10.1016/j.biomaterials.2013.04.002; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; Nikolic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033203; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Player DJ, 2014, BIOTECHNOL LETT, V36, P1113, DOI 10.1007/s10529-014-1464-y; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Robinson M, 2010, SCAND J MED SCI SPOR, V20, P282, DOI 10.1111/j.1600-0838.2009.00895.x; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sharples AP, 2012, AGING CELL, V11, P986, DOI 10.1111/j.1474-9726.2012.00869.x; Sorensen B, 2003, J ALLERGY CLIN IMMUN, V112, P397, DOI 10.1067/mai.2003.1615; VANDERVEN PFM, 1992, CELL TISSUE RES, V270, P189, DOI 10.1007/BF00381893; Wang CZ, 2010, J APPL PHYSIOL, V109, P840, DOI 10.1152/japplphysiol.00115.2010; White PD, 2011, LANCET, V377, P823, DOI 10.1016/S0140-6736(11)60096-2; Winder WW, 1996, AM J PHYSIOL-ENDOC M, V270, pE299, DOI 10.1152/ajpendo.1996.270.2.E299	38	51	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122982	10.1371/journal.pone.0122982	http://dx.doi.org/10.1371/journal.pone.0122982			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836975	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000119
J	Chu, C; Lagercrantz, H; Forssberg, H; Nagy, Z				Chu, Carlton; Lagercrantz, Hugo; Forssberg, Hans; Nagy, Zoltan			Investigating the Use of Support Vector Machine Classification on Structural Brain Images of Preterm-Born Teenagers as a Biological Marker	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; BIRTH-WEIGHT; BEHAVIORAL OUTCOMES; ADOLESCENTS; TERM; AGE; CHILDREN; INFANTS; MATURATION; PATTERNS	Preterm birth has been shown to induce an altered developmental trajectory of brain structure and function. With the aid support vector machine (SVM) classification methods we aimed to investigate whether MRI data, collected in adolescence, could be used to predict whether an individual had been born preterm or at term. To this end we collected T1-weighted anatomical MRI data from 143 individuals (69 controls, mean age 14.6y). The inclusion criteria for those born preterm were birth weight <= 1500g and gestational age < 37w. A linear SVM was trained on the grey matter segment of MR images in two different ways. First, all the individuals were used for training and classification was performed by the leave-one-out method, yielding 93% correct classification (sensitivity = 0.905, specificity = 0.942). Separately, a random half of the available data were used for training twice and each time the other, unseen, half of the data was classified, resulting 86% and 91% accurate classifications. Both gestational age (R = -0.24, p < 0.04) and birth weight (R = -0.51, p < 0.001) correlated with the distance to decision boundary within the group of individuals born preterm. Statistically significant correlations were also found between IQ (R = -0.30, p < 0.001) and the distance to decision boundary. Those born small for gestational age did not form a separate subgroup in these analyses. The high rate of correct classification by the SVM motivates further investigation. The long-term goal is to automatically and non-invasively predict the outcome of preterm-born individuals on an individual basis using as early a scan as possible.	[Chu, Carlton] DeepMind Technol Ltd, London, England; [Lagercrantz, Hugo; Forssberg, Hans] Karolinska Inst, Lab Social & Neural Syst Res, Stockholm, Sweden; [Nagy, Zoltan] Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland; [Nagy, Zoltan] UCL Inst Neurol, Wellcome Trust Ctr Neuroimaging, London, England	Karolinska Institutet; University of Zurich; University of London; University College London	Nagy, Z (corresponding author), Univ Zurich, Lab Social & Neural Syst Res, Zurich, Switzerland.	zoltan.nagy@uz.ch	Forssberg, Hans/A-2944-2009; Nagy, Zoltan/AAI-2485-2019	Nagy, Zoltan/0000-0001-6611-6362; Forssberg, Hans/0000-0003-2069-6618	Sallskapet Barnavard (Sweden); Swedish Research Council, the Bank of Sweden Tercentenary Foundation; Wellcome Trust [079866/Z/06/Z]	Sallskapet Barnavard (Sweden); Swedish Research Council, the Bank of Sweden Tercentenary Foundation; Wellcome Trust(Wellcome TrustEuropean Commission)	Funding support was provided by Sallskapet Barnavard (Sweden), the Swedish Research Council, the Bank of Sweden Tercentenary Foundation and the Wellcome Trust (079866/Z/06/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. DeepMind Technologies Ltd., provided support in the form of salary for author Carlton Chu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Ameye L, 2005, C P IEEE ENG MED BIO, P54622; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Chu C, 2011, NEUROIMAGE, V56, P662, DOI 10.1016/j.neuroimage.2010.03.058; Counsell SJ, 2006, PEDIATRICS, V117, P376, DOI 10.1542/peds.2005-0820; Cristianini N, 2000, INTRO SUPPORT VECTOR; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Erus G., 2014, CEREB CORTEX; Fan Y, 2007, IEEE T MED IMAGING, V26, P93, DOI 10.1109/TMI.2006.886812; Fenton TR, 2003, BMC PEDIATR, P313; Franke K, 2012, NEUROIMAGE, V63, P1305, DOI 10.1016/j.neuroimage.2012.08.001; Gaonkar B, 2013, NEUROIMAGE, V78, P270, DOI 10.1016/j.neuroimage.2013.03.066; Gressens P, 2002, J PEDIATR-US, V140, P646, DOI 10.1067/mpd.2002.123214; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Huppi PS, 1998, PEDIATR RES, V44, P584; Huppi PS, 2001, PEDIATRICS, V107, P455, DOI 10.1542/peds.107.3.455; Inder TE, 2005, PEDIATRICS, V115, P286, DOI 10.1542/peds.2004-0326; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; KATZSALAMON M, 1997, ACTA PAEDIAT S419, V86, P1; Kawasaki Y, 2007, NEUROIMAGE, V34, P235, DOI 10.1016/j.neuroimage.2006.08.018; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Krishnan ML, 2007, PEDIATRICS, V120, pE604, DOI 10.1542/peds.2006-3054; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Murphy BP, 2001, PEDIATRICS, V107, P217, DOI 10.1542/peds.107.2.217; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Nosarti C, 2008, BRAIN, V131, P205, DOI 10.1093/brain/awm282; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; Precup D, 2012, IEEE ENG MED BIO, P5630, DOI 10.1109/EMBC.2012.6347271; Skiold B, 2012, J PEDIATR-US, V160, P559, DOI 10.1016/j.jpeds.2011.09.053; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; Ullman H, 2014, J NEUROSCI, V34, P1592, DOI 10.1523/JNEUROSCI.0842-13.2014; Van Reempts P, 2007, PEDIATRICS, V120, pe815, DOI 10.1542/peds.2006-3122; Vapnik V.N., 1995, NATURE STAT LEARNING; Yung A, 2007, PEDIATR RES, V61, P732, DOI 10.1203/pdr.0b013e31805365db	41	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123108	10.1371/journal.pone.0123108	http://dx.doi.org/10.1371/journal.pone.0123108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837791	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000127
J	Forleo, C; Carmosino, M; Resta, N; Rampazzo, A; Valecce, R; Sorrentino, S; Iacoviello, M; Pisani, F; Procino, G; Gerbino, A; Scardapane, A; Simone, C; Calore, M; Torretta, S; Svelto, M; Favale, S				Forleo, Cinzia; Carmosino, Monica; Resta, Nicoletta; Rampazzo, Alessandra; Valecce, Rosanna; Sorrentino, Sandro; Iacoviello, Massimo; Pisani, Francesco; Procino, Giuseppe; Gerbino, Andrea; Scardapane, Arnaldo; Simone, Cristiano; Calore, Martina; Torretta, Silvia; Svelto, Maria; Favale, Stefano			Clinical and Functional Characterization of a Novel Mutation in Lamin A/C Gene in a Multigenerational Family with Arrhythmogenic Cardiac Laminopathy	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; SUDDEN-DEATH; ATRIOVENTRICULAR-BLOCK; LMNA GENE; APOPTOSIS; DISEASE; CARDIOMYOCYTES; ARRHYTHMIAS; PHENOTYPE	Mutations in the lamin A/C gene (LMNA) were associated with dilated cardiomyopathy (DCM) and, recently, were related to severe forms of arrhythmogenic right ventricular cardiomyopathy (ARVC). Both genetic and phenotypic overlap between DCM and ARVC was observed; molecular pathomechanisms leading to the cardiac phenotypes caused by LMNA mutations are not yet fully elucidated. This study involved a large Italian family, spanning 4 generations, with arrhythmogenic cardiomyopathy of different phenotypes, including ARVC, DCM, system conduction defects, ventricular arrhythmias, and sudden cardiac death. Mutation screening of LMNA and ARVC-related genes PKP2, DSP, DSG2, DSC2, JUP, and CTNNA3 was performed. We identified a novel heterozygous mutation (c.418_438dup) in LMNA gene exon 2, occurring in a highly conserved protein domain across several species. This newly identified variant was not found in 250 ethnically-matched control subjects. Genotype-phenotype correlation studies suggested a co-segregation of the LMNA mutation with the disease phenotype and an incomplete and age-related penetrance. Based on clinical, pedigree, and molecular genetic data, this mutation was considered likely disease-causing. To clarify its potential pathophysiologic impact, functional characterization of this LMNA mutant was performed in cultured cardiomyocytes expressing EGFP-tagged wild-type and mutated LMNA constructs, and indicated an increased nuclear envelope fragility, leading to stress-induced apoptosis as the main pathogenetic mechanism. This study further expands the role of the LMNA gene in the pathogenesis of cardiac laminopathies, suggesting that LMNA should be included in mutation screening of patients with suspected arrhythmogenic cardiomyopathy, particularly when they have ECG evidence for conduction defects. The combination of clinical, genetic, and functional data contribute insights into the pathogenesis of this form of life-threatening arrhythmogenic cardiac laminopathy.	[Forleo, Cinzia; Valecce, Rosanna; Sorrentino, Sandro; Iacoviello, Massimo; Favale, Stefano] Univ Bari, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy; [Carmosino, Monica; Pisani, Francesco; Procino, Giuseppe; Gerbino, Andrea; Torretta, Silvia; Svelto, Maria] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Resta, Nicoletta; Simone, Cristiano] Univ Bari, Dept Biomed Sci & Human Oncol, Med Genet Sect, Bari, Italy; [Rampazzo, Alessandra; Calore, Martina] Univ Padua, Dept Biol, Padua, Italy; [Scardapane, Arnaldo] Univ Bari, Interdisciplinary Dept Med, Sect Radiol, Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Padua; Universita degli Studi di Bari Aldo Moro	Forleo, C (corresponding author), Univ Bari, Dept Emergency & Organ Transplantat, Cardiol Unit, Bari, Italy.	cinzia.forleo@uniba.it; monica.carmosino@uniba.it	PISANI, Francesco/AAC-1749-2019; Rampazzo, Alessandra/AAD-5936-2022; Resta, Nicoletta/I-8424-2018; Calore, Martina/B-3602-2018; Simone, Cristiano/K-3452-2018; Iacoviello, Massimo/AAW-4962-2021; Gerbino, Andrea/Y-6526-2018; Carmosino, Monica/O-2594-2014	PISANI, Francesco/0000-0001-8511-117X; Resta, Nicoletta/0000-0001-8640-5532; Calore, Martina/0000-0003-4751-1476; Simone, Cristiano/0000-0002-2628-7658; Iacoviello, Massimo/0000-0001-9613-5062; Gerbino, Andrea/0000-0002-2839-0130; Carmosino, Monica/0000-0001-7600-8816; Svelto, Maria/0000-0002-5584-9541; Torretta, Silvia/0000-0002-9060-7628; favale, stefano/0000-0002-9833-9576; Forleo, Cinzia/0000-0002-9452-4037; Procino, Giuseppe/0000-0002-0043-7523	Italian Ministry of University, Scientific and Technical Research [ORBA1085M0]; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica [RBRN07BMCT_009]	Italian Ministry of University, Scientific and Technical Research; Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This work was supported by the Italian Ministry of University, Scientific and Technical Research (grant number ORBA1085M0 to SF), and by Fondo per gli Investimenti della Ricerca di Base-Rete Nazionale di Proteomica (grant number RBRN07BMCT_009 to MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselme F, 2013, HEART RHYTHM, V10, P1492, DOI [10.1016/j.hrthm.2013.06.020, 10.1016/j.hrthm.2013.06020]; Arbustini E, 2002, J AM COLL CARDIOL, V39, P981, DOI 10.1016/S0735-1097(02)01724-2; Arbustini E, 2013, J AM COLL CARDIOL, V62, P2046, DOI 10.1016/j.jacc.2013.08.1644; Basso C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P1233, DOI 10.1161/CIRCEP.111.962035; Basso C, 2012, NAT REV CARDIOL, V9, P223, DOI 10.1038/nrcardio.2011.173; Bauce B, 2010, HEART RHYTHM, V7, P22, DOI 10.1016/j.hrthm.2009.09.070; Bertrand AT, 2011, BIOCHEM SOC T, V39, P1687, DOI 10.1042/BST20110670; Carmosino M, 2014, BIOL CELL, V106, P346, DOI 10.1111/boc.201400033; Cattin ME, 2013, CURR OPIN CARDIOL, V28, P297, DOI 10.1097/HCO.0b013e32835f0c79; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Charron P, 2010, EUR HEART J, V31, P2715, DOI 10.1093/eurheartj/ehq271; Davidson PM, 2014, TRENDS CELL BIOL, V24, P247, DOI 10.1016/j.tcb.2013.11.004; De Backer J, 2010, INT J CARDIOL, V138, P97, DOI 10.1016/j.ijcard.2008.06.008; Duranteau J, 1998, J BIOL CHEM, V273, P11619, DOI 10.1074/jbc.273.19.11619; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fernandez X, 2008, INT J CARDIOL, V126, P136, DOI 10.1016/j.ijcard.2007.01.072; Forissier JF, 2003, EUR J HEART FAIL, V5, P821, DOI 10.1016/S1388-9842(03)00149-1; Hasselberg NE, 2014, EUROPACE, V16, P563, DOI 10.1093/europace/eut291; Hermida-Prieto M, 2004, AM J CARDIOL, V94, P50, DOI 10.1016/j.amjcard.2004.03.029; Holmstrom M, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-30; JAMES TN, 1994, CIRCULATION, V90, P556, DOI 10.1161/01.CIR.90.1.556; Jovanovic S, 2006, BIOCHEM BIOPH RES CO, V341, P57, DOI 10.1016/j.bbrc.2005.12.147; Mallat Z, 1996, NEW ENGL J MED, V335, P1190, DOI 10.1056/NEJM199610173351604; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Marinho HS, 2014, REDOX BIOL, V2, P535, DOI 10.1016/j.redox.2014.02.006; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Millat G, 2011, EUR J MED GENET, V54, pE570, DOI 10.1016/j.ejmg.2011.07.005; Millat G, 2009, CLIN BIOCHEM, V42, P892, DOI 10.1016/j.clinbiochem.2009.01.016; Nerheim Pamela, 2001, Cardiology Clinics, V19, P155, DOI 10.1016/S0733-8651(05)70201-0; Quarta G, 2012, EUR HEART J, V33, P1128, DOI 10.1093/eurheartj/ehr451; Sen-Chowdhry S, 2012, CIRCULATION, V125, P1563, DOI 10.1161/CIRCULATIONAHA.111.025528; Taylor M, 2011, CIRCULATION, V124, P876, DOI 10.1161/CIRCULATIONAHA.110.005405; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Tesson F, 2014, CARDIOL J, V21, P331, DOI 10.5603/CJ.a2014.0037; Tilgner K, 2009, J CELL SCI, V122, P401, DOI 10.1242/jcs.026179; Valente M, 1998, AM J PATHOL, V152, P479; Valtuille L, 2013, INT J CARDIOL, V168, P4325, DOI 10.1016/j.ijcard.2013.04.177; van Berlo JH, 2005, J MOL MED, V83, P79, DOI 10.1007/s00109-004-0589-1; van der Zwaag PA, 2012, EUR J HEART FAIL, V14, P1199, DOI 10.1093/eurjhf/hfs119; van Hengel J, 2013, EUR HEART J, V34, P201, DOI 10.1093/eurheartj/ehs373; van Tintelen JP, 2007, J AM COLL CARDIOL, V49, P2430, DOI 10.1016/j.jacc.2007.02.063; Worman HJ, 2012, J PATHOL, V226, P316, DOI 10.1002/path.2999; Wright AR, 1998, PHARMACOL THERAPEUT, V80, P89, DOI 10.1016/S0163-7258(98)00025-4; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	45	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121723	10.1371/journal.pone.0121723	http://dx.doi.org/10.1371/journal.pone.0121723			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837155	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000059
J	Han, YQ; Lei, WB; Wen, LZ; Hou, ML				Han, Yongqiang; Lei, Wenbin; Wen, Lizhang; Hou, Maolin			Silicon-Mediated Resistance in a Susceptible Rice Variety to the Rice Leaf Folder, Cnaphalocrocis medinalis Guenee (Lepidoptera: Pyralidae)	PLOS ONE			English	Article							BORER ELDANA-SACCHARINA; ENHANCES RESISTANCE; WALKER LEPIDOPTERA; LEAFFOLDER; SUGARCANE; MECHANISMS; RESPONSES; ACCUMULATION; PHYTOALEXINS; PERFORMANCE	The rice leaf folder, Cnaphalocrocis medinalis (Guenee), is one of the most destructive rice pests in Asian countries. Rice varieties resistant to the rice leaf folder are generally characterized by high silicon content. In this study, silicon amendment, at 0.16 and 0.32 g Si/kg soil, enhanced resistance of a susceptible rice variety to the rice leaf folder. Silicon addition to rice plants at both the low and high rates significantly extended larval development and reduced larval survival rate and pupation rate in the rice leaf folder. When applied at the high rate, silicon amendment reduced third-instars' weight gain and pupal weight. Altogether, intrinsic rate of increase, finite rate of increase and net reproduction rate of the rice leaf folder population were all reduced at both the low and high silicon addition rates. Although the third instars consumed more in silicon-amended treatments, C:N ratio in rice leaves was significantly increased and food conversion efficiencies were reduced due to increased silicon concentration in rice leaves. Our results indicate that reduced food quality and food conversion efficiencies resulted from silicon addition account for the enhanced resistance in the susceptible rice variety to the rice leaf folder.	[Han, Yongqiang; Wen, Lizhang] Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China; [Han, Yongqiang; Lei, Wenbin; Hou, Maolin] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wen, LZ (corresponding author), Hunan Agr Univ, Coll Plant Protect, Changsha, Hunan, Peoples R China.	weninsect123@yahoo.com.cn; mlhou@ippcaas.cn			National Natural Science Foundation of China [31371951]; Ministry of Science and Technology of China [2012BAD19B03]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was financially supported by National Natural Science Foundation of China (31371951) and a grant from Ministry of Science and Technology of China (2012BAD19B03) to MLH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez J, 2001, CROP PROT, V20, P43, DOI 10.1016/S0261-2194(00)00051-X; Bezemer TM, 1998, OIKOS, V82, P212, DOI 10.2307/3546961; Brunings AM, 2009, ANN APPL BIOL, V155, P161, DOI 10.1111/j.1744-7348.2009.00347.x; Cai KZ, 2008, PHYSIOL PLANTARUM, V134, P324, DOI 10.1111/j.1399-3054.2008.01140.x; Chi H, 1997, COMPUTER PROGRAM FOR; Dai WM, 2005, CROP SCI, V45, P1345, DOI 10.2135/cropsci2004.0505; Dallagnol LJ, 2013, PLANT PATHOL, V62, P120, DOI 10.1111/j.1365-3059.2012.02606.x; DJAMIN A, 1967, J ECON ENTOMOL, V60, P347, DOI 10.1093/jee/60.2.347; Epstein E, 1999, ANNU REV PLANT PHYS, V50, P641, DOI 10.1146/annurev.arplant.50.1.641; Fauteux F, 2006, P NATL ACAD SCI USA, V103, P17554, DOI 10.1073/pnas.0606330103; Fawe A, 1998, PHYTOPATHOLOGY, V88, P396, DOI 10.1094/PHYTO.1998.88.5.396; [韩永强 Han Yongqiang], 2010, [生态学报, Acta Ecologica Sinica], V30, P5967; HANIFA AM, 1974, INDIAN J EXP BIOL, V12, P463; [郝丽霞 HAO LiXia], 2008, [生态学报, Acta Ecologica Sinica], V28, P5987; Heong KL, 1993, P INT WORKSH EC THRE, P8; Hou ML, 2010, J ECON ENTOMOL, V103, P1412, DOI 10.1603/EC09341; Islam Z, 1997, CROP PROT, V16, P215, DOI 10.1016/S0261-2194(96)00101-9; Keeping MG, 2002, AGR FOREST ENTOMOL, V4, P265, DOI 10.1046/j.1461-9563.2002.00150.x; Keeping MG, 2006, J APPL ENTOMOL, V130, P410, DOI 10.1111/j.1439-0418.2006.01081.x; KHAN ZR, 1989, ENTOMOL EXP APPL, V52, P7, DOI 10.1007/BF00163936; KHAN ZR, 1988, INSECT SCI APPL, V9, P129, DOI 10.1017/S1742758400005919; Kvedaras OL, 2007, B ENTOMOL RES, V97, P175, DOI 10.1017/S0007485307004853; Kvedaras OL, 2007, ENTOMOL EXP APPL, V125, P103, DOI 10.1111/j.1570-7458.2007.00604.x; Kvedaras OL, 2010, B ENTOMOL RES, V100, P367, DOI 10.1017/S0007485309990265; Laing M, 2005, P 3 SIL AGR C FED U, P41; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li Xia, 2013, Acta Ecologica Sinica, V33, P4370; Liang YC, 2003, J PLANT PHYSIOL, V160, P1157, DOI 10.1078/0176-1617-01065; Ma J.F, 2001, SILICON AGR, V8, P17, DOI 10.1016/S0928-3420(01)80006-9; Ma JF, 2006, NATURE, V440, P688, DOI 10.1038/nature04590; Ma JF, 2004, SOIL SCI PLANT NUTR, V50, P11, DOI 10.1080/00380768.2004.10408447; Ma JF, 2002, SOIL FERTILIZER AND; Ma TS, 1997, CHINESE J SOIL SCI, V28, P169; Massey FP, 2009, J ANIM ECOL, V78, P281, DOI 10.1111/j.1365-2656.2008.01472.x; Massey FP, 2006, J ANIM ECOL, V75, P595, DOI 10.1111/j.1365-2656.2006.01082.x; Mishra N. C., 1992, Indian Journal of Entomology, V54, P190; NAKANO K., 1961, Japanese Journal of Applied Entomology and Zoology, V5, P17, DOI 10.1303/jjaez.5.17; Padmavathi C, 2013, J APPL ENTOMOL, V137, P249, DOI 10.1111/j.1439-0418.2012.01741.x; Panzuto M, 2002, J CHEM ECOL, V28, P145, DOI 10.1023/A:1013571020783; PETERSON SS, 1988, J KANSAS ENTOMOL SOC, V61, P169; RAMACHANDRAN R, 1991, J CHEM ECOL, V17, P41, DOI 10.1007/BF00994421; Remus-Borel W, 2005, PHYSIOL MOL PLANT P, V66, P108, DOI 10.1016/j.pmpp.2005.05.006; Rodrigues FA, 2004, PHYTOPATHOLOGY, V94, P177, DOI 10.1094/PHYTO.2004.94.2.177; SALIM M, 1992, CROP SCI, V32, P212, DOI 10.2135/cropsci1992.0011183X003200010044x; Sangster A. G., 2001, SILICON AGR, V8, P85, DOI DOI 10.1016/S0928-3420(01)80009-4; Savant NK, 1997, ADV AGRON, V58, P151; Sidhu JK, 2013, B ENTOMOL RES, V103, P656, DOI 10.1017/S0007485313000369; Snyder GH., 2001, STUD PLANT SCI, P185, DOI [10.1016/S0928-3420(01)80015-X, DOI 10.1016/S0928-3420(01)80015-X]; SPSS Inc, 2004, SPSS 13 0 FOR WINDOW; Sudhakar GK, 1991, J ENTOMOL RES, V152, P79; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1; Wang Feng-ying, 2009, Zhongguo Shuidao Kexue, V23, P537, DOI 10.3969/j.issn.1001-7216.2009.05.14; Wang Qi-Xiang, 2008, Acta Entomologica Sinica, V51, P1265; Wang XZ, 2002, PRINCIPLES AND METHO; Xu HongXing, 2006, Acta Phytophylacica Sinica, V33, P241; Xu J, 2010, J ECON ENTOMOL, V103, P1166, DOI 10.1603/EC09265; Ye M, 2013, P NATL ACAD SCI USA, V110, pE3631, DOI 10.1073/pnas.1305848110; Zhang Guo-Liang, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P600	58	68	84	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120557	10.1371/journal.pone.0120557	http://dx.doi.org/10.1371/journal.pone.0120557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837635	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000024
J	Lobo, JM; Dicker, AP; Buerki, C; Daviconi, E; Karnes, RJ; Jenkins, RB; Patel, N; Den, RB; Showalter, TN				Lobo, Jennifer Mason; Dicker, Adam P.; Buerki, Christine; Daviconi, Elai; Karnes, R. Jeffrey; Jenkins, Robert B.; Patel, Nirav; Den, Robert B.; Showalter, Timothy N.			Evaluating the Clinical Impact of a Genomic Classifier in Prostate Cancer Using Individualized Decision Analysis	PLOS ONE			English	Article							POSTPROSTATECTOMY RADIATION-THERAPY; RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; COST-EFFECTIVENESS; POSTOPERATIVE RADIOTHERAPY; SALVAGE RADIOTHERAPY; BREAST-CANCER; RISK; TRIAL; MEN	Background Currently there is controversy surrounding the optimal way to treat patients with prostate cancer in the post-prostatectomy setting. Adjuvant therapies carry possible benefits of improved curative results, but there is uncertainty in which patients should receive adjuvant therapy. There are concerns about giving toxicity to a whole population for the benefit of only a subset. We hypothesized that making post-prostatectomy treatment decisions using genomics-based risk prediction estimates would improve cancer and quality of life outcomes. Methods We developed a state-transition model to simulate outcomes over a 10 year horizon for a cohort of post-prostatectomy patients. Outcomes included cancer progression rates at 5 and 10 years, overall survival, and quality-adjusted survival with reductions for treatment, side effects, and cancer stage. We compared outcomes using population-level versus individual-level risk of cancer progression, and for genomics-based care versus usual care treatment recommendations. Results Cancer progression outcomes, expected life-years (LYs), and expected quality-adjusted life-years (QALYs) were significantly different when individual genomics-based cancer progression risk estimates were used in place of population-level risk estimates. Use of the genomic classifier to guide treatment decisions provided small, but statistically significant, improvements in model outcomes. We observed an additional 0.03 LYs and 0.07 QALYs, a 12% relative increase in the 5-year recurrence-free survival probability, and a 4% relative reduction in the 5-year probability of metastatic disease or death. Conclusions The use of genomics-based risk prediction to guide treatment decisions may improve outcomes for prostate cancer patients. This study offers a framework for individualized decision analysis, and can be extended to incorporate a wide range of personal attributes to enable delivery of patient-centered tools for informed decision-making.	[Lobo, Jennifer Mason] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Dicker, Adam P.; Den, Robert B.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Dicker, Adam P.; Den, Robert B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Buerki, Christine; Daviconi, Elai] GenomeDx Biosci, Vancouver, BC, Canada; [Karnes, R. Jeffrey] Mayo Clin, Dept Urol, Rochester, MN USA; [Jenkins, Robert B.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Patel, Nirav; Showalter, Timothy N.] Univ Virginia, Sch Med, Dept Radiat Oncol, Charlottesville, VA 22908 USA	University of Virginia; Jefferson University; Jefferson University; GenomeDx Biosciences; Mayo Clinic; Mayo Clinic; University of Virginia	Lobo, JM (corresponding author), Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA.	jem4yb@virginia.edu	Lobo, Jennifer/AAK-6713-2021	Den, Robert/0000-0002-8653-1763; Dicker, Adam/0000-0003-0733-3337; Showalter, Timothy/0000-0003-1373-8496	GenomeDx Biosciences; Prostate Cancer Foundation Young Investigator Award; American Society for Radiation Oncology Comparative Effectiveness Research Award	GenomeDx Biosciences; Prostate Cancer Foundation Young Investigator Award; American Society for Radiation Oncology Comparative Effectiveness Research Award	This work was supported by a research grant from GenomeDx Biosciences (genomedx.com/), as well as by a 2011 Prostate Cancer Foundation Young Investigator Award (T.N.S.; www.pcf.org/) and an American Society for Radiation Oncology Comparative Effectiveness Research Award (T.N.S.; www.astro.org). GenomeDx Biosciences provided support in the form of salaries for authors CB and ED, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Badani K, 2013, ONCOTARGET, V4, P600, DOI 10.18632/oncotarget.918; Barlow WE, 1999, J CLIN EPIDEMIOL, V52, P1165, DOI 10.1016/S0895-4356(99)00102-X; Basu A, 2007, MED DECIS MAKING, V27, P112, DOI 10.1177/0272989X06297393; Basu A, 2009, MED DECIS MAKING, V29, pNP9, DOI 10.1177/0272989X09351586; Blohmer J U, 2013, J Med Econ, V16, P30, DOI 10.3111/13696998.2012.722572; Bolla M, 2005, LANCET, V366, P572, DOI 10.1016/S0140-6736(05)67101-2; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Boorjian SA, 2012, J UROLOGY, V188, P1761, DOI 10.1016/j.juro.2012.07.037; Cowen ME, 1998, MED DECIS MAKING, V18, P376, DOI 10.1177/0272989X9801800404; Crawford ED, 2014, ONCOLOGY-NY, V28, P135; Den RB, 2014, INT J RADIAT ONCOL, V89, P1038, DOI 10.1016/j.ijrobp.2014.04.052; Efstathiou JA, 2012, LANCET, V380, P1974, DOI 10.1016/S0140-6736(12)61608-0; Elkin EB, 2004, MED DECIS MAKING, V24, P504, DOI 10.1177/0272989X04268954; Elliott SP, 2011, PROSTATE CANCER P D, V14, P270, DOI 10.1038/pcan.2011.27; Erho N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066855; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Garraway LA, 2013, J CLIN ONCOL, V31, P1803, DOI 10.1200/JCO.2013.49.4799; Ghia AJ, 2010, UROLOGY, V76, P1169, DOI 10.1016/j.urology.2010.04.047; Goddard KAB, 2012, GENET MED, V14, P633, DOI 10.1038/gim.2012.16; Grossfeld GD, 1998, J UROLOGY, V160, P1398, DOI 10.1016/S0022-5347(01)62548-5; Hall PS, 2012, JNCI-J NATL CANCER I, V104, P56, DOI 10.1093/jnci/djr484; Hayes JH, 2010, JAMA-J AM MED ASSOC, V304, P2373, DOI 10.1001/jama.2010.1720; Hoffman KE, 2011, J UROLOGY, V185, P116, DOI 10.1016/j.juro.2010.08.086; Hornberger J, 2012, VALUE HEALTH, V15, P1014, DOI 10.1016/j.jval.2012.07.012; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Konety BR, 2008, J UROLOGY, V179, P1797, DOI 10.1016/j.juro.2008.01.044; Konski A, 2006, INT J RADIAT ONCOL, V66, P408, DOI 10.1016/j.ijrobp.2006.04.049; Krupski TL, 2007, J UROLOGY, V178, P1423, DOI 10.1016/j.juro.2007.05.135; Mishra MV, 2011, FUTURE ONCOL, V7, P1429, DOI [10.2217/FON.11.120, 10.2217/fon.11.120]; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Nielsen ME, 2010, J NATL COMPR CANC NE, V8, P228, DOI 10.6004/jnccn.2010.0015; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; Showalter TN, 2011, INT J RAD ONCOL BIOL; Simonds NI, 2013, JNCI-J NATL CANCER I, V105, P929, DOI 10.1093/jnci/djt108; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stephenson AJ, 2004, JAMA-J AM MED ASSOC, V291, P1325, DOI 10.1001/jama.291.11.1325; Stewart ST, 2005, MED CARE, V43, P347, DOI 10.1097/01.mlr.0000156862.33341.45; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Thompson IM, 2006, JAMA-J AM MED ASSOC, V296, P2329, DOI 10.1001/jama.296.19.2329; Valicenti RK, 2013, INT J RADIAT ONCOL, V86, P822, DOI 10.1016/j.ijrobp.2013.05.029; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x; Wiegel T, 2009, J CLIN ONCOL, V27, P2924, DOI 10.1200/JCO.2008.18.9563	42	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0116866	10.1371/journal.pone.0116866	http://dx.doi.org/10.1371/journal.pone.0116866			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837660	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000003
J	Renna, C; Salaroli, R; Cocchi, C; Cenacchi, G				Renna, Cristiano; Salaroli, Roberta; Cocchi, Claudia; Cenacchi, Giovanna			XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; ADP-RIBOSE POLYMERASE; NEUTRAL COMET ASSAY; BRAIN-TUMORS; THERAPEUTIC TARGET; MEDULLOBLASTOMA; RADIATION; TANKYRASE; RADIOSENSITIVITY; SURVIVORS	Diphtheria toxin-like ADP-ribosyltransferases 1 and 5 (ARTD-1, ARTD-5) are poly ADP-ribose enzymes (PARP) involved in non-homologous end-joining (NHEJ), which is the major pathway of double-strand break (DSB) repair. In addition, ARTD-5, or Tankyrase (TNKS), is a positive regulator of the WNT signaling implicated in the development and biological behavior of many neoplasms, such as Medulloblastoma (MB), in which radiotherapy is an essential part of the treatment. The use of radiosensitizing agents may improve the therapeutic index in MB patients by increasing the efficacy of radiotherapy, while reducing toxicity to the neuroaxis. ARTD-5 seems to be a good molecular target for improving the current treatment of MB. In this study, we used the small molecule XAV939, a potent ARTD-5 inhibitor with a slight affinity for ARTD-1, in different human MB cell lines. XAV939 inhibited the WNT pathway and DNA-PKcs in our MB cells, with many biological consequences. The co-administration of XAV939 and ionizing radiations (IR) inhibited MB cells proliferation and clonogenic capacity, decreased their efficacy in repairing DNA damage, and increased IR-induced cell mortality. In conclusion, our in vitro data show that XAV939 could be a very promising small molecule in MB treatment, and these results lay the basis for further in vivo studies with the aim of improving the current therapy available for MB patients.	[Renna, Cristiano; Salaroli, Roberta; Cocchi, Claudia; Cenacchi, Giovanna] Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy	University of Bologna	Cenacchi, G (corresponding author), Alma Mater Studiorum Univ Bologna, Dept Biomed & Neuromotor Sci, Bologna, Italy.	giovanna.cenacchi@unibo.it	Cocchi, Claudia/AAB-8902-2021	Cocchi, Claudia/0000-0002-7736-9039; CENACCHI, GIOVANNA/0000-0001-5824-3118	Bologna University RFO funds; Fondazione del Monte di Bologna e Ravenna, Italy	Bologna University RFO funds; Fondazione del Monte di Bologna e Ravenna, Italy	The work was supported by Bologna University RFO funds and Fondazione del Monte di Bologna e Ravenna (www.fondazionedelmonte.it), Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afanasieva K, 2010, ELECTROPHORESIS, V31, P512, DOI 10.1002/elps.200900421; Annunziata CM, 2010, CLIN CANCER RES, V16, P4517, DOI 10.1158/1078-0432.CCR-10-0526; [Anonymous], 2011, CURR PROB CANCER, V35, P7, DOI 10.1016/j.currproblcancer.2010.12.002; Banath JP, 1998, INT J RADIAT BIOL, V73, P649, DOI 10.1080/095530098141906; Baryawno N, 2010, CANCER RES, V70, P2138, DOI 10.1158/0008-5472.CAN-10-0016; Chanet F, 2010, TARGETING POLY ADP R; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Cimmino F, 2012, J NEURO-ONCOL, V106, P59, DOI 10.1007/s11060-011-0645-y; Cook BD, 2002, MOL CELL BIOL, V22, P332, DOI 10.1128/MCB.22.1.332-342.2002; Dregalla RC, 2010, AGING-US, V2, P691, DOI 10.18632/aging.100210; Eastham AM, 1999, BRIT J CANCER, V79, P1366, DOI 10.1038/sj.bjc.6690219; Fancy SPJ, 2011, NAT NEUROSCI, V14, P1009, DOI 10.1038/nn.2855; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerber NU, 2008, ARCH DIS CHILD, V93, P582, DOI 10.1136/adc.2007.116202; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Grill J, 1999, INT J RADIAT ONCOL, V45, P137, DOI 10.1016/S0360-3016(99)00177-7; Guessous F, 2008, J CELL PHYSIOL, V217, P577, DOI 10.1002/jcp.21542; Holthouse DJ, 2009, NEUROPATHOLOGY, V29, P398, DOI 10.1111/j.1440-1789.2008.00989.x; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; JACOBSEN PF, 1985, J NEUROPATH EXP NEUR, V44, P472, DOI 10.1097/00005072-198509000-00003; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Krukenberg KA, 2014, CELL REP, V8, P1808, DOI 10.1016/j.celrep.2014.08.009; Kuimov AN, 2001, GENES IMMUN, V2, P52, DOI 10.1038/sj.gene.6363722; Luttjeboer M, 2010, INT J RADIAT BIOL, V86, P458, DOI 10.3109/09553000903568019; Merchant TE, 2010, SEMIN RADIAT ONCOL, V20, P58, DOI 10.1016/j.semradonc.2009.09.005; Mulhern RK, 2004, LANCET ONCOL, V5, P399, DOI 10.1016/S1470-2045(04)01507-4; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; O'Shaughnessy J, 2011, NEW ENGL J MED, V364, P205, DOI 10.1056/NEJMoa1011418; OBE G, 1992, MUTAGENESIS, V7, P3, DOI 10.1093/mutage/7.1.3; OLIVE PL, 1993, INT J RADIAT BIOL, V64, P349, DOI 10.1080/09553009314551531; OLIVE PL, 1995, RADIAT RES, V142, P144, DOI 10.2307/3579022; OLIVE PL, 1991, CANCER RES, V51, P4671; Olive PL, 2006, COMET ASSAY METHOD M, P675; Ratnam K, 2007, CLIN CANCER RES, V13, P1383, DOI 10.1158/1078-0432.CCR-06-2260; Rich T, 2000, NATURE, V407, P777, DOI 10.1038/35037717; Rydberg B, 2000, RADIAT RES, V153, P805, DOI 10.1667/0033-7587(2000)153[0805:RIHLST]2.0.CO;2; Salaroli R, 2008, J NEURO-ONCOL, V90, P243, DOI 10.1007/s11060-008-9659-5; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; van Vuurden DG, 2011, ONCOTARGET, V2, P984, DOI 10.18632/oncotarget.362; Vinchon M, 2011, CHILD NERV SYST, V27, P697, DOI 10.1007/s00381-010-1385-6; Wada S, 2003, J VET MED SCI, V65, P471, DOI 10.1292/jvms.65.471; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Wang Q, 2008, NEUROSCI LETT, V438, P168, DOI 10.1016/j.neulet.2008.04.012; Wojewodzka M, 2002, NUKLEONIKA, V47, P1; Wojewodzka M, 2002, MUTAT RES-GEN TOX EN, V518, P9, DOI 10.1016/S1383-5718(02)00070-0; Yamada M, 1989, No To Shinkei, V41, P695; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; ZAFFARONI N, 1994, INT J RADIAT BIOL, V66, P279, DOI 10.1080/09553009414551211	48	9	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0124149	10.1371/journal.pone.0124149	http://dx.doi.org/10.1371/journal.pone.0124149			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835728	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000154
J	Ruggeberg, M; Burgert, I				Rueggeberg, Markus; Burgert, Ingo			Bio-Inspired Wooden Actuators for Large Scale Applications	PLOS ONE			English	Article							DYNAMIC SORPTION; PINE-CONES; BILAYER; HYGROEXPANSION; HUMIDITY	Implementing programmable actuation into materials and structures is a major topic in the field of smart materials. In particular the bilayer principle has been employed to develop actuators that respond to various kinds of stimuli. A multitude of small scale applications down to micrometer size have been developed, but up-scaling remains challenging due to either limitations in mechanical stiffness of the material or in the manufacturing processes. Here, we demonstrate the actuation of wooden bilayers in response to changes in relative humidity, making use of the high material stiffness and a good machinability to reach large scale actuation and application. Amplitude and response time of the actuation were measured and can be predicted and controlled by adapting the geometry and the constitution of the bilayers. Field tests in full weathering conditions revealed long-term stability of the actuation. The potential of the concept is shown by a first demonstrator. With the sensor and actuator intrinsically incorporated in the wooden bilayers, the daily change in relative humidity is exploited for an autonomous and solar powered movement of a tracker for solar modules.	[Rueggeberg, Markus; Burgert, Ingo] ETH, Swiss Fed Inst Technol Zurich, Inst Bldg Mat, Zurich, Switzerland; [Rueggeberg, Markus; Burgert, Ingo] Swiss Fed Las Mat Sci & Technol EMPA, Appl Wood Mat, Dubendorf, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Ruggeberg, M (corresponding author), ETH, Swiss Fed Inst Technol Zurich, Inst Bldg Mat, Zurich, Switzerland.	mrueggeberg@ethz.ch			Empa/Marie-Curie COFUND Program; BTA flagship project of the Climate-KIC program; Wood Materials Science group at ETH Zurich; Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland; Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator)	Empa/Marie-Curie COFUND Program; BTA flagship project of the Climate-KIC program; Wood Materials Science group at ETH Zurich; Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland; Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator)	MR was funded by the Empa/Marie-Curie COFUND Program and within the framework of the BTA flagship project of the Climate-KIC program. IB receives supportive funding of the Wood Materials Science group at ETH Zurich and Empa by BAFU (Bundesamt fur Umwelt) and Lignum, Switzerland. The work also received funding from Climate-KIC in the framework of the flagship project BTA (Building Technology Accelerator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armon S, 2011, SCIENCE, V333, P1726, DOI 10.1126/science.1203874; Bassik N, 2010, POLYMER, V51, P6093, DOI 10.1016/j.polymer.2010.10.035; Bi HC, 2013, NANOSCALE, V5, P9123, DOI 10.1039/c3nr01988h; CHOMCHARN A, 1983, WOOD SCI TECHNOL, V17, P259, DOI 10.1007/BF00349914; Cianchetti M, 2014, ACTUATORS, V3, P226, DOI 10.3390/act3030226; Dawson J, 1997, NATURE, V390, P668, DOI 10.1038/37745; Elbaum R, 2007, SCIENCE, V316, P884, DOI 10.1126/science.1140097; Erb RM, 2013, NATURE COMMUNICATION, P4; Hering S, 2012, WOOD SCI TECHNOL, V46, P927, DOI 10.1007/s00226-011-0449-4; Ma E, 2010, WOOD FIBER SCI, V42, P229; Menges A, 2012, ARCHIT DESIGN, V82, P52, DOI 10.1002/ad.1379; Ozyhar T, 2013, HOLZFORSCHUNG, V67, P395, DOI 10.1515/hf-2012-0089; Reyssat E, 2009, J R SOC INTERFACE, V6, P951, DOI 10.1098/rsif.2009.0184; Skaar C., 1988, WOOD WATER RELATION; Sreekumar M, 2007, IND ROBOT, V34, P285, DOI 10.1108/01439910710749609; Steiger R, 2009, WOOD SCI TECHNOL, V43, P259, DOI 10.1007/s00226-008-0221-6; Techawanitchai P, 2012, SOFT MATTER, V8, P2844, DOI 10.1039/c2sm07277g; Timoshenko S, 1925, J OPT SOC AM REV SCI, V11, P233, DOI 10.1364/JOSA.11.000233; Tzou HS, 2004, MECH ADV MATER STRUC, V11, P367, DOI 10.1080/15376490490451552; Viola EA, 2010, J PHYS CHEM C, V114, P20258, DOI 10.1021/jp106653c; Zhao Q, 2013, SOFT MATTER, V9, P1744, DOI 10.1039/c2sm27077c	21	232	255	11	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120718	10.1371/journal.pone.0120718	http://dx.doi.org/10.1371/journal.pone.0120718			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835386	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000031
J	Ryan, JM; Hensey, O; McLoughlin, B; Lyons, A; Gormley, J				Ryan, Jennifer M.; Hensey, Owen; McLoughlin, Brenda; Lyons, Alan; Gormley, John			Associations of Sedentary Behaviour, Physical Activity, Blood Pressure and Anthropometric Measures with Cardiorespiratory Fitness in Children with Cerebral Palsy	PLOS ONE			English	Article							METABOLIC SYNDROME; CARDIOMETABOLIC RISK; ACTIVITY INTENSITY; RT3 ACCELEROMETER; ACTIVITY LEVEL; FAT MASS; ADULTS; ADOLESCENTS; WALKING; CHILDHOOD	Background Children with cerebral palsy (CP) have poor cardiorespiratory fitness in comparison to their peers with typical development, which may be due to low levels of physical activity. Poor cardiorespiratory fitness may contribute to increased cardiometabolic risk. Purpose The aim of this study was to determine the association between sedentary behaviour, physical activity and cardiorespiratory fitness in children with CP. An objective was to determine the association between cardiorespiratory fitness, anthropometric measures and blood pressure in children with CP. Methods This study included 55 ambulatory children with CP [mean (SD) age 11.3 (0.2) yr, range 6-17 yr; Gross Motor Function Classification System (GMFCS) levels I and II]. Anthropometric measures (BMI, waist circumference and waist-height ratio) and blood pressure were taken. Cardiorespiratory fitness was measured using a 10 m shuttle run test. Children were classified as low, middle and high fitness according to level achieved on the test using reference curves. Physical activity was measured by accelerometry over 7 days. In addition to total activity, time in sedentary behaviour and light, moderate, vigorous, and sustained moderate-to-vigorous activity (>= 10 min bouts) were calculated. Results Multiple regression analyses revealed that vigorous activity (beta = 0.339, p < 0.01), sustained moderate-to-vigorous activity (beta = 0.250, p < 0.05) and total activity (beta = 0.238, p < 0.05) were associated with level achieved on the shuttle run test after adjustment for age, sex and GMFCS level. Children with high fitness spent more time in vigorous activity than children with middle fitness (p < 0.05). Shuttle run test level was negatively associated with BMI (r(2) = -0.451, p < 0.01), waist circumference (r(2) = -0.560, p < 0.001), waist-height ratio (r(2) = -0.560, p < 0.001) and systolic blood pressure (r(2) = -0.306, p < 0.05) after adjustment for age, sex and GMFCS level. Conclusions Participation in physical activity, particularly at a vigorous intensity, is associated with high cardiorespiratory fitness in children with CP. Low cardiorespiratory fitness is associated with increased cardiometabolic risk.	[Ryan, Jennifer M.; Gormley, John] Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland; [Ryan, Jennifer M.] Brunel Univ London, Inst Environm Hlth & Soc, London, England; [Hensey, Owen; McLoughlin, Brenda] Cent Remedial Clin, Dublin, Ireland; [Lyons, Alan] Enable Ireland, Dept Physiotherapy, Cork, Ireland	Trinity College Dublin; Brunel University	Ryan, JM (corresponding author), Univ Dublin Trinity Coll, Sch Med, Dublin 2, Ireland.	Jennifer.Ryan@brunel.ac.uk		Gormley, John/0000-0003-4176-4122; Ryan, Jennifer/0000-0003-3768-2132				Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Capio CM, 2012, RES DEV DISABIL, V33, P1235, DOI 10.1016/j.ridd.2012.02.020; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dallmeijer AJ, 2011, DISABIL REHABIL, V33, P1351, DOI 10.3109/09638288.2010.531374; Dencker M, 2008, SCAND J MED SCI SPOR, V18, P728, DOI 10.1111/j.1600-0838.2007.00741.x; Denton SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061073; Fowler EG, 2007, PHYS THER, V87, P1495, DOI 10.2522/ptj.20060116; Hay J, 2012, ARCH PEDIAT ADOL MED, V166, P1022, DOI 10.1001/archpediatrics.2012.1028; Imms C, 2008, DEV MED CHILD NEUROL, V50, P363, DOI 10.1111/j.1469-8749.2008.02051.x; Jackson LV, 2007, ARCH DIS CHILD, V92, P298, DOI 10.1136/adc.2005.081216; Janssen I, 2007, DIABETES CARE, V30, P2143, DOI 10.2337/dc07-0734; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Klasson-Heggebo L, 2006, BRIT J SPORT MED, V40, P25, DOI 10.1136/bjsm.2004.016113; Kulinski JP, 2014, MAYO CLIN PROC, V89, P1063, DOI 10.1016/j.mayocp.2014.04.019; Kwon JH, 2011, YONSEI MED J, V52, P39, DOI 10.3349/ymj.2011.52.1.39; Maltais DB, 2005, MED SCI SPORT EXER, V37, P347, DOI 10.1249/01.MSS.0000155437.45937.82; Mc Manus V, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-50; Morrison JA, 2012, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2012-6; Myers R., 1990, CLASSICAL MODERN REG; Nieuwenhuijsen C, 2011, SCAND J MED SCI SPOR, V21, P535, DOI 10.1111/j.1600-0838.2009.01086.x; Opheim A, 2009, DEV MED CHILD NEUROL, V51, P381, DOI 10.1111/j.1469-8749.2008.03250.x; Palisano RJ, 2008, DEV MED CHILD NEUROL, V50, P744, DOI 10.1111/j.1469-8749.2008.03089.x; Pan H, 2007, LMSGROWTH PROGRAM VE; Peterson MD, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-22; Peterson MD, 2012, ARCH PHYS MED REHAB, V93, P816, DOI 10.1016/j.apmr.2011.12.024; Ryan J, 2014, ADAPT PHYS ACT Q, V31, P310, DOI 10.1123/apaq.2013-0088; Ryan JM, 2014, PHYS THER, V94, P1144, DOI 10.2522/ptj.20130499; Ryan JM, 2014, ARCH PHYS MED REHAB, V95, P1540, DOI 10.1016/j.apmr.2014.03.029; Slaman J, 2013, ARCH PHYS MED REHAB, V94, P896, DOI 10.1016/j.apmr.2012.11.005; Stergiou GS, 2006, BLOOD PRESS MONIT, V11, P229, DOI 10.1097/01.mbp.0000209074.38331.16; Stevens SL, 2010, ARCH PHYS MED REHAB, V91, P1891, DOI 10.1016/j.apmr.2010.08.015; Taylor RW, 2000, AM J CLIN NUTR, V72, P490; Unnithan VB, 1998, SPORTS MED, V26, P239, DOI 10.2165/00007256-199826040-00003; Van den Berg-Emons RJ, 1998, INT J REHABIL RES, V21, P179, DOI 10.1097/00004356-199806000-00006; Vanhelst J, 2010, J SPORT SCI, V28, P381, DOI 10.1080/02640410903508821; Verschuren O, 2007, ARCH PEDIAT ADOL MED, V161, P1075, DOI 10.1001/archpedi.161.11.1075; Verschuren O, 2006, PHYS THER, V86, P1107, DOI 10.1093/ptj/86.8.1107; Verschuren O, 2012, J PEDIATR-US, V161, P488, DOI 10.1016/j.jpeds.2012.02.042; Verschuren O, 2010, RES DEV DISABIL, V31, P1352, DOI 10.1016/j.ridd.2010.07.005; Verschuren O, 2010, PHYS THER, V90, P1148, DOI 10.2522/ptj.20090318; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15; World Health Organization, 2000, WHO TECH REP SER, V894, p[i, 1]	42	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123267	10.1371/journal.pone.0123267	http://dx.doi.org/10.1371/journal.pone.0123267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835955	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000135
J	Rahman, MA; Sobia, P; Dwivedi, VP; Bhawsar, A; Singh, DK; Sharma, P; Moodley, P; Van Kaer, L; Bishai, WR; Das, G				Rahman, Md. Aejazur; Sobia, Parveen; Dwivedi, Ved Prakash; Bhawsar, Aakansha; Singh, Dhiraj Kumar; Sharma, Pawan; Moodley, Prashini; Van Kaer, Luc; Bishai, William R.; Das, Gobardhan			Mycobacterium tuberculosis TlyA Protein Negatively Regulates T Helper (Th) 1 and Th17 Differentiation and Promotes Tuberculosis Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETED ANTIGENIC TARGET; PHAGOSOME MATURATION; INTERFERON-GAMMA; IN-VITRO; INFECTION; AUTOPHAGY; HOST; IMMUNITY; DEFENSE; VACCINE	Mycobacterium tuberculosis, the causative agent of tuberculosis, is an ancient pathogen and a major cause of death world-wide. Although various virulence factors of M. tuberculosis have been identified, its pathogenesis remains incompletely understood. TlyA is a virulence factor in several bacterial infections and is evolutionarily conserved in many Gram-positive bacteria, but its function in M. tuberculosis pathogenesis has not been elucidated. Here, we report that TlyA significantly contributes to the pathogenesis of M. tuberculosis. We show that a TlyA mutant M. tuberculosis strain induces increased IL-12 and reduced IL-1 beta and IL-10 cytokine responses, which sharply contrasts with theimmuneresponses induced by wild type M. tuberculosis. Furthermore, compared with wild type M. tuberculosis, TlyA-deficient M. tuberculosis bacteria are more susceptible to autophagy in macrophages. Consequently, animals infected with the TlyA mutant M. tuberculosis organisms exhibited increased host-protective immune responses, reduced bacillary load, and increased survival compared with animals infected with wild type M. tuberculosis. Thus, M. tuberculosis employs TlyA as a host evasion factor, thereby contributing to its virulence.	[Rahman, Md. Aejazur; Sobia, Parveen; Dwivedi, Ved Prakash; Moodley, Prashini; Das, Gobardhan] Univ KwaZulu Natal, Sch Lab Med & Med Sci, ZA-4001 Durban, South Africa; [Sharma, Pawan] North Eastern Reg Biotechnol Programme Management, New Delhi, India; [Van Kaer, Luc] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Bishai, William R.] Johns Hopkins Sch Med, Ctr TB Res, Dept Med, Div Infect Dis, Baltimore, MD 21231 USA; [Bhawsar, Aakansha; Singh, Dhiraj Kumar; Das, Gobardhan] Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India	University of Kwazulu Natal; Vanderbilt University; Johns Hopkins University; Johns Hopkins Medicine; Jawaharlal Nehru University, New Delhi	Das, G (corresponding author), Jawaharlal Nehru Univ, Special Ctr Mol Med, New Delhi 110067, India.	gobardhan.das07@gmail.com	Sharma, Pawan/F-7806-2010; Van Kaer, Luc/H-1033-2015; Rhaman, Aejazur/AAC-5104-2019	Sharma, Pawan/0000-0002-2525-5451; Van Kaer, Luc/0000-0001-5275-2309; Rhaman, Aejazur/0000-0002-2616-3372; Dwivedi, Ved Prakash/0000-0003-4321-2567; Singh, Dhiraj/0000-0001-5507-1197				Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Arend SM, 2000, J INFECT DIS, V181, P1850, DOI 10.1086/315448; Bhattacharya D, 2014, J BIOL CHEM, V289, P16508, DOI 10.1074/jbc.M114.558098; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bradfute SB, 2013, CURR OPIN MICROBIOL, V16, P355, DOI 10.1016/j.mib.2013.05.003; Butt AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043080; Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9; Chatterjee S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002378; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Corcelle E, 2007, AUTOPHAGY, V3, P57, DOI 10.4161/auto.3424; Deretic V, 2009, CURR TOP MICROBIOL, V335, P169, DOI 10.1007/978-3-642-00302-8_8; Dwivedi VP, 2012, J BIOL CHEM, V287, P33656, DOI 10.1074/jbc.M112.375154; Dye C, 2006, LANCET, V367, P938, DOI 10.1016/S0140-6736(06)68384-0; Ehrt S, 2009, CELL MICROBIOL, V11, P1170, DOI 10.1111/j.1462-5822.2009.01335.x; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2003, J BIOL CHEM, V278, P46961, DOI 10.1074/jbc.M305225200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hall BS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004061; Jo EK, 2013, PATHOG DIS, V67, P108, DOI 10.1111/2049-632X.12023; Kumar P, 2012, IMMUNOL CELL BIOL, V90, P411, DOI 10.1038/icb.2011.54; Li N, 2012, MOL BIOL REP, V39, P4655, DOI 10.1007/s11033-011-1257-5; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Lin PL, 2006, INFECT IMMUN, V74, P3790, DOI 10.1128/IAI.00064-06; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713; Martino MC, 2001, INFECT IMMUN, V69, P1697, DOI 10.1128/IAI.69.3.1697-1703.2001; McCluskey J, 2002, INFECT IMMUN, V70, P2899, DOI 10.1128/IAI.70.6.2899-2907.2002; Monshupanee T, 2012, MOL MICROBIOL, V85, P1194, DOI 10.1111/j.1365-2958.2012.08168.x; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Pathak SK, 2007, NAT IMMUNOL, V8, P610, DOI 10.1038/ni1468; Peng H, 2011, J BIOL CHEM, V286, P24508, DOI 10.1074/jbc.M111.234062; Petersen HJ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00120; Prados-Rosales R, 2011, J CLIN INVEST, V121, P1471, DOI 10.1172/JCI44261; Raghuvanshi S, 2010, P NATL ACAD SCI USA, V107, P21653, DOI 10.1073/pnas.1007967107; Rahman A, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-35; Rahman MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086886; Rook GAW, 2004, TRENDS IMMUNOL, V25, P483, DOI 10.1016/j.it.2004.06.005; Rosenzweig SD, 2005, IMMUNOL REV, V203, P38, DOI 10.1111/j.0105-2896.2005.00227.x; SAHA B, 1994, EUR J IMMUNOL, V24, P2618, DOI 10.1002/eji.1830241108; Sakamoto K, 2012, VET PATHOL, V49, P423, DOI 10.1177/0300985811429313; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Singh PP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018564; Sklar JG, 2010, MOL MICROBIOL, V77, P605, DOI 10.1111/j.1365-2958.2010.07232.x; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sweeney KA, 2011, NAT MED, V17, P1261, DOI 10.1038/nm.2420; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Venugopal A, 2011, CELL HOST MICROBE, V9, P21, DOI 10.1016/j.chom.2010.12.004; Wang QL, 2001, INFECT IMMUN, V69, P2270, DOI 10.1128/IAI.69.4.2270-2276.2001; Yamada H, 2000, LAB INVEST, V80, P759, DOI 10.1038/labinvest.3780079; Yuk JM, 2014, CLIN EXP VACCINE RES, V3, P155, DOI 10.7774/cevr.2014.3.2.155; Zhang XQ, 2010, CANCER GENE THER, V17, P579, DOI 10.1038/cgt.2010.14	56	23	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14407	14417		10.1074/jbc.M115.653600	http://dx.doi.org/10.1074/jbc.M115.653600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847237	Green Published, hybrid			2022-12-26	WOS:000355754600012
J	Dunschede, B; Trager, C; Schoder, CV; Ziehe, D; Walter, B; Funke, S; Hofmann, E; Schunemann, D				Duenschede, Beatrix; Traeger, Chantal; Schoeder, Christine Vera; Ziehe, Dominik; Walter, Bjoern; Funke, Silke; Hofmann, Eckhard; Schuenemann, Danja			Chloroplast SRP54 Was Recruited for Posttranslational Protein Transport via Complex Formation with Chloroplast SRP43 during Land Plant Evolution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; ALGA CHLAMYDOMONAS-REINHARDTII; THYLAKOID MEMBRANE-PROTEIN; CHLOROPHYLL ANTENNA; BINDING PROTEIN; 54-KDA SUBUNIT; COMPONENTS; HOMOLOG; CPSRP43; GENE	In bacteria, membrane proteins are targeted cotranslationally via a signal recognition particle (SRP). During the evolution of higher plant chloroplasts from cyanobacteria, the SRP pathway underwent striking adaptations that enable the posttranslational transport of the abundant light-harvesting chlorophyll-a/b-binding proteins (LHCPs). The conserved 54-kDa SRP subunit in higher plant chloroplasts (cpSRP54) is not bound to an SRP RNA, an essential SRP component in bacteria, but forms a stable heterodimer with the chloroplast-specific cpSRP43. This heterodimeric cpSRP recognizes LHCP and delivers it to the thylakoid membrane whereby cpSRP43 plays a central role. This study shows that the cpSRP system in the green alga Chlamydomonas reinhardtii differs significantly from that of higher plants as cpSRP43 is not complexed to cpSRP54 in Chlamydomonas and cpSRP54 is not involved in LHCP recognition. This divergence is attributed to altered residues within the cpSRP54 tail and the second chromodomain of cpSRP43 that are crucial for the formation of the binding interface in Arabidopsis. These changes are highly conserved among chlorophytes, whereas all land plants contain cpSRP proteins with typical interaction motifs. These data demonstrate that the coevolution of LHCPs and cpSRP43 occurred independently of complex formation with cpSRP54 and that the interaction between cpSRP54 and cpSRP43 evolved later during the transition from chlorophytes to land plants. Furthermore, our data show that in higher plants a heterodimeric form of cpSRP is required for the formation of a low molecular weight transit complex with LHCP.	[Duenschede, Beatrix; Traeger, Chantal; Schoeder, Christine Vera; Ziehe, Dominik; Walter, Bjoern; Funke, Silke; Schuenemann, Danja] Ruhr Univ Bochum, Mol Biol Plant Organelles, D-44780 Bochum, Germany; [Hofmann, Eckhard] Ruhr Univ Bochum, Prot Crystallog, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Schunemann, D (corresponding author), Ruhr Univ Bochum, Fac Biol & Biotechnol, Mol Biol Plant Organelles, D-44780 Bochum, Germany.	Danja.Schuenemann@rub.de	Hofmann, Eckhard/GPF-5024-2022	Schuenemann, Danja/0000-0001-8894-7685; Hofmann, Eckhard/0000-0003-4874-372X	Deutsche Forschungsgemeinschaft (DFG) [SFB 642, SCHU 1163/5-1]; Ruhr University Research School - Germany's Excellence Initiative (DFG) [GSC 98/1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ruhr University Research School - Germany's Excellence Initiative (DFG)	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB 642 and SCHU 1163/5-1 and by the Ruhr University Research School funded by Germany's Excellence Initiative (DFG Grant GSC 98/1).	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Bals T, 2010, FEBS LETT, V584, P4138, DOI 10.1016/j.febslet.2010.08.053; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; FRANKLIN AE, 1993, J BIOL CHEM, V268, P22175; Funke S, 2005, J BIOL CHEM, V280, P8912, DOI 10.1074/jbc.M409992200; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Groves MR, 2001, J BIOL CHEM, V276, P27778, DOI 10.1074/jbc.M103470200; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Harris E. H, 1989, CHLAMYDOMONAS SOURCE, P242; Hermkes R, 2006, FEBS LETT, V580, P3107, DOI 10.1016/j.febslet.2006.04.055; Holdermann I, 2012, NAT STRUCT MOL BIOL, V19, P260, DOI 10.1038/nsmb.2196; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kirst H, 2012, PLANT PHYSIOL, V160, P2251, DOI 10.1104/pp.112.206672; Kirst H, 2012, PLANT PHYSIOL, V158, P930, DOI 10.1104/pp.111.189910; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kogata N, 1999, FEBS LETT, V447, P329, DOI 10.1016/S0014-5793(99)00305-1; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; Mason CB, 2006, NAT PROTOC, V1, P2227, DOI 10.1038/nprot.2006.348; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Neilson JAD, 2010, PHOTOSYNTH RES, V106, P57, DOI 10.1007/s11120-010-9576-2; Nilsson R, 2002, FEBS LETT, V524, P127, DOI 10.1016/S0014-5793(02)03016-8; Nilsson R, 1999, EMBO J, V18, P733, DOI 10.1093/emboj/18.3.733; Nussaume L, 2008, NAT CHEM BIOL, V4, P529, DOI 10.1038/nchembio0908-529; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; PAYAN LA, 1991, J CELL BIOL, V112, P603, DOI 10.1083/jcb.112.4.603; Richter CV, 2010, EUR J CELL BIOL, V89, P965, DOI 10.1016/j.ejcb.2010.06.020; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Trager C, 2012, PLANT CELL, V24, P4819, DOI 10.1105/tpc.112.102996; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200	36	24	25	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13104	13114		10.1074/jbc.M114.597922	http://dx.doi.org/10.1074/jbc.M114.597922			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833951	Green Published, hybrid			2022-12-26	WOS:000354975700014
J	Vigliarolo, T; Guida, L; Millo, E; Fresia, C; Turco, E; De Flora, A; Zocchi, E				Vigliarolo, Tiziana; Guida, Lucrezia; Millo, Enrico; Fresia, Chiara; Turco, Emilia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Transport in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; MOLECULAR CHARACTERIZATION; HUMAN GRANULOCYTES; PLASMA-MEMBRANE; ANION-EXCHANGE; PROTEIN; CELL; 2ND-MESSENGER; BINDING; IDENTIFICATION	Abscisic acid (ABA) is a plant hormone involved in the response to environmental stress. Recently, ABA has been shown to be present and active also in mammals, where it stimulates the functional activity of innate immune cells, of mesenchymal and hemopoietic stem cells, and insulin-releasing pancreatic beta-cells. LANCL2, the ABA receptor in mammalian cells, is a peripheral membrane protein that localizes at the intracellular side of the plasma membrane. Here we investigated the mechanism enabling ABA transport across the plasmamembrane of human red blood cells (RBC). Both influx and efflux of [H-3] ABA occur across intact RBC, as detected by radiometric and chromatographic methods. ABA binds specifically to Band 3 (the RBC anion transporter), as determined by labeling of RBC membranes with biotinylated ABA. Proteoliposomes reconstituted with human purified Band 3 transport [H-3] ABA and [S-35] sulfate, and ABA transport is sensitive to the specific Band 3 inhibitor 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid. Once inside RBC, ABA stimulates ATP release through the LANCL2-mediated activation of adenylate cyclase. As ATP released from RBC is known to exert a vasodilator response, these results suggest a role for plasma ABA in the regulation of vascular tone.	[Vigliarolo, Tiziana; Guida, Lucrezia; Fresia, Chiara; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Millo, Enrico] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Turco, Emilia] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	University of Genoa; University of Genoa; University of Turin	Vigliarolo, T (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15 1, I-16132 Genoa, Italy.	tiziana.vigliarolo@edu.unige.it	Millo, Enrico/K-3218-2018	Millo, Enrico/0000-0002-4019-0051; FRESIA, CHIARA MARTA/0000-0002-9177-4655	Italian Ministry of Education, University and Scientific Research [PRIN 2007BZ4RX3_005]; Fondazione CARIGE; Compagnia di S. Paolo di Torino [ROL 316]	Italian Ministry of Education, University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); Fondazione CARIGE(Fondazione Carige); Compagnia di S. Paolo di Torino(Compagnia di San Paolo)	This work was supported in part by the Italian Ministry of Education, University and Scientific Research Grant PRIN 2007BZ4RX3_005, the Fondazione CARIGE, and the Compagnia di S. Paolo di Torino (ID ROL 316).	Badrnya S, 2014, ARTERIOSCL THROM VAS, V34, P571, DOI 10.1161/ATVBAHA.113.302919; Bodrato N, 2009, J BIOL CHEM, V284, P14777, DOI 10.1074/jbc.M802604200; Boursiac Y, 2013, TRENDS PLANT SCI, V18, P325, DOI 10.1016/j.tplants.2013.01.007; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2001, FASEB J, V15, P10; Bruzzone S., 2012, MESSENGER, V1, P141; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Bruzzone S, 2012, FASEB J, V26, P1251, DOI 10.1096/fj.11-190140; De Flora A., 2014, MESSENGER, V3, P1; Ellsworth ML, 2012, J PHYSIOL-LONDON, V590, P4985, DOI 10.1113/jphysiol.2012.233106; EY PL, 1978, IMMUNOCHEMISTRY, V15, P429, DOI 10.1016/0161-5890(78)90070-6; FALKE JJ, 1984, J BIOL CHEM, V259, P6472; Franco L, 1998, FASEB J, V12, P1507; Gatto C, 1997, ARCH BIOCHEM BIOPHYS, V340, P90, DOI 10.1006/abbi.1997.9879; Grozio A, 2013, NUCLEIC ACID THER, V23, P322, DOI 10.1089/nat.2013.0418; Grozio A, 2011, BIOCHEM BIOPH RES CO, V415, P696, DOI 10.1016/j.bbrc.2011.10.143; Guo JJ, 2011, J INTEGR PLANT BIOL, V53, P469, DOI 10.1111/j.1744-7909.2011.01044.x; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; JENNINGS ML, 1984, BIOCHEMISTRY-US, V23, P6432, DOI 10.1021/bi00321a024; Jennings ML, 2005, BIOPHYS J, V88, P2681, DOI 10.1529/biophysj.104.056812; JENNINGS ML, 1976, J MEMBRANE BIOL, V28, P187, DOI 10.1007/BF01869697; Joshi-Saha A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002164; Kang J, 2010, P NATL ACAD SCI USA, V107, P2355, DOI 10.1073/pnas.0909222107; Kanno Y, 2012, P NATL ACAD SCI USA, V109, P9653, DOI 10.1073/pnas.1203567109; Kawaguchi Y, 2013, BIOORG MED CHEM LETT, V23, P3738, DOI 10.1016/j.bmcl.2013.05.008; Kuromori T, 2010, PLANT SIGNAL BEHAV, V5, P1124, DOI 10.4161/psb.5.9.12566; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Li HH, 2011, BIOCHEM PHARMACOL, V82, P701, DOI 10.1016/j.bcp.2011.06.042; Liu DS, 1996, BIOCHEMISTRY-US, V35, P15228, DOI 10.1021/bi961443b; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu PY, 2011, J MOL MODEL, V17, P543, DOI 10.1007/s00894-010-0748-y; Magnone M, 2009, J BIOL CHEM, V284, P17808, DOI 10.1074/jbc.M809546200; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1399, P51, DOI 10.1016/S0167-4781(98)00091-8; Mizutani M, 2013, FEBS LETT, V587, P23, DOI 10.1016/j.febslet.2012.11.009; Montalbetti N, 2011, J BIOL CHEM, V286, P38397, DOI 10.1074/jbc.M111.221713; Moriya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078235; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; NIGGLI V, 1982, FEBS LETT, V138, P164, DOI 10.1016/0014-5793(82)80432-8; PEDEMONTE CH, 1988, BIOCHEMISTRY-US, V27, P7966, DOI 10.1021/bi00420a056; POOLE RC, 1991, BIOCHEM J, V275, P307, DOI 10.1042/bj2750307; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; RUETZ S, 1988, P NATL ACAD SCI USA, V85, P6147, DOI 10.1073/pnas.85.16.6147; Scarfi S, 2009, STEM CELLS, V27, P2469, DOI 10.1002/stem.173; Scarfi S, 2008, STEM CELLS, V26, P2855, DOI 10.1634/stemcells.2008-0488; Schubert K, 2011, EUR J IMMUNOL, V41, P645, DOI 10.1002/eji.201041117; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; WERNER PK, 1985, BIOCHEMISTRY-US, V24, P6375, DOI 10.1021/bi00344a009; Wu Zhong-Yi, 1996, Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai), V28, P694; Xue-Xuan X, 2010, CRIT REV BIOTECHNOL, V30, P222, DOI 10.3109/07388551.2010.487186; Yamazaki D, 2003, PLANT J, V35, P129, DOI 10.1046/j.1365-313X.2003.01782.x; Zhang HW, 2014, MOL PLANT, V7, P1522, DOI 10.1093/mp/ssu063	55	15	16	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13042	13052		10.1074/jbc.M114.629501	http://dx.doi.org/10.1074/jbc.M114.629501			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847240	Green Published, hybrid			2022-12-26	WOS:000354975700009
J	Ho, CCM; Guo, N; Sockolosky, JT; Ring, AM; Weiskopf, K; Ozkan, E; Mori, Y; Weissman, IL; Garcia, KC				Ho, Chia Chi M.; Guo, Nan; Sockolosky, Jonathan T.; Ring, Aaron M.; Weiskopf, Kipp; Oezkan, Engin; Mori, Yasuo; Weissman, Irving L.; Garcia, K. Christopher			"Velcro" Engineering of High Affinity CD47 Ectodomain as Signal Regulatory Protein alpha(SIRP alpha) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA SIRP-ALPHA; YEAST SURFACE DISPLAY; CELLS; MACROPHAGES; TRANSPORT; BINDING; 5-OXOPROLINE; SPECIFICITY; ENGRAFTMENT; EXPRESSION	CD47 is a cell surface protein that transmits an anti-phagocytic signal, known as the "don't-eat-me" signal, to macrophages upon engaging its receptor signal regulatory protein alpha (SIRP alpha). Molecules that antagonize the CD47-SIRP alpha interaction by binding to CD47, such as anti-CD47 antibodies and the engineered SIRP alpha variant CV1, have been shown to facilitate macrophage-mediated anti-tumor responses. However, these strategies targeting CD47 are handicapped by large antigen sinks in vivo and indiscriminate cell binding due to ubiquitous expression of CD47. These factors reduce bioavailability and increase the risk of toxicity. Here, we present an alternative strategy to antagonize the CD47-SIRP alpha pathway by engineering high affinity CD47 variants that target SIRP alpha, which has restricted tissue expression. CD47 proved to be refractive to conventional affinity maturation techniques targeting its binding interface with SIRP alpha. Therefore, we developed a novel engineering approach, whereby we augmented the existing contact interface via N-terminal peptide extension, coined "Velcro" engineering. The high affinity variant (Velcro-CD47) bound to the two most prominent human SIRP alpha alleles with greatly increased affinity relative to wild-type CD47 and potently antagonized CD47 binding to SIRP alpha on human macrophages. Velcro-CD47 synergizes with tumor-specific monoclonal antibodies to enhance macrophage phagocytosis of tumor cells in vitro, with similar potency as CV1. Finally, Velcro-CD47 interacts specifically with a subset of myeloid-derived cells in human blood, whereas CV1 binds all myeloid, lymphoid, and erythroid populations interrogated. This is consistent with the restricted expression of SIRP alpha compared with CD47. Herein, we have demonstrated that "Velcro" engineering is a powerful protein-engineering tool with potential applications to other systems and that Velcro-CD47 could be an alternative adjuvant to CD47-targeting agents for cancer immunotherapy.	[Ho, Chia Chi M.] Stanford Univ, Sch Engn, Dept Bioengn, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Sockolosky, Jonathan T.; Ring, Aaron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Guo, Nan; Weiskopf, Kipp; Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Sockolosky, Jonathan T.; Ring, Aaron M.; Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; [Oezkan, Engin; Garcia, K. Christopher] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ho, Chia Chi M.; Guo, Nan; Weiskopf, Kipp; Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Ludwig Ctr Canc Stem Cell Res & Med, Stanford, CA 94305 USA; [Mori, Yasuo; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Beckman B171B,279 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu	Regan, Clinton/E-6250-2012	Ring, Aaron/0000-0003-3699-2446; Ozkan, Engin/0000-0002-0263-6729	National Institutes of Health [R01CA177684]; Siebel Stem Cell Institute; Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant [5T32 AI072905]; Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA177684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R43AI072905] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Siebel Stem Cell Institute; Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant; Virginia and D. K. Ludwig Fund for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01CA177684 (to K. C. G.). This work was also supported by Siebel Stem Cell Institute (to C. H.), by Stanford Molecular and Cellular Immunobiology National Institutes of Health Training Grant 5T32 AI072905 (to J. T. S.), and by the Virginia and D. K. Ludwig Fund for Cancer Research (to I. L. W.).	Adams S, 1998, J IMMUNOL, V161, P1853; Baba N, 2013, J EXP MED, V210, P1251, DOI 10.1084/jem.20122037; Bain CC, 2011, EUR J IMMUNOL, V41, P2494, DOI 10.1002/eji.201141714; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Beatty GL, 2011, SCIENCE, V331, P1612, DOI 10.1126/science.1198443; Bhargava P, 2012, BIOCHEM J, V442, P253, DOI 10.1042/BJ20111708; Birnbaum ME, 2014, CELL, V157, P1073, DOI 10.1016/j.cell.2014.03.047; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caoili Salvador Eugenio C., 2012, Advances in Bioinformatics, V2012, P346765, DOI 10.1155/2012/346765; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; Chao MP, 2011, BLOOD, V118, P4890, DOI 10.1182/blood-2011-02-338020; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Chao MP, 2010, CELL, V142, P699, DOI 10.1016/j.cell.2010.07.044; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; Desai N, 2012, AAPS J, V14, P282, DOI 10.1208/s12248-012-9339-4; Edris B, 2012, P NATL ACAD SCI USA, V109, P6656, DOI 10.1073/pnas.1121629109; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Foote J, 2000, P NATL ACAD SCI USA, V97, P10679, DOI 10.1073/pnas.97.20.10679; GANAPATHY V, 1983, J BIOL CHEM, V258, P2266; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Hatherley D, 2014, J BIOL CHEM, V289, P10024, DOI 10.1074/jbc.M114.550558; Houot R, 2011, TRENDS IMMUNOL, V32, P510, DOI 10.1016/j.it.2011.07.003; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Junttila IS, 2012, NAT CHEM BIOL, V8, P990, DOI [10.1038/NCHEMBIO.1096, 10.1038/nchembio.1096]; Lamminmaki U, 1999, J MOL BIOL, V291, P589, DOI 10.1006/jmbi.1999.2981; Lee CV, 2004, J MOL BIOL, V340, P1073, DOI 10.1016/j.jmb.2004.05.051; Levin AM, 2012, NATURE, V484, P529, DOI 10.1038/nature10975; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Liu Y, 2007, J MOL BIOL, V365, P680, DOI 10.1016/j.jmb.2006.09.079; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MAACK T, 1979, KIDNEY INT, V16, P251, DOI 10.1038/ki.1979.128; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Miyauchi S, 2010, BBA-BIOMEMBRANES, V1798, P1164, DOI 10.1016/j.bbamem.2010.03.002; Momtaz P, 2014, PHARMACOGEN PERS MED, V7, P357, DOI 10.2147/PGPM.S53163; Mori Y, 2009, J EXP MED, V206, P183, DOI 10.1084/jem.20081756; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Peggs KS, 2006, CURR OPIN IMMUNOL, V18, P206, DOI 10.1016/j.coi.2006.01.011; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Poulsen TR, 2011, J IMMUNOL, V187, P4229, DOI 10.4049/jimmunol.1000928; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Shin DS, 2015, CURR OPIN IMMUNOL, V33, P23, DOI 10.1016/j.coi.2015.01.006; Strowig T, 2011, P NATL ACAD SCI USA, V108, P13218, DOI 10.1073/pnas.1109769108; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; Tsai RK, 2008, J CELL BIOL, V180, P989, DOI 10.1083/jcb.200708043; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Veillette A, 1998, J BIOL CHEM, V273, P22719, DOI 10.1074/jbc.273.35.22719; Wang H, 2007, BLOOD, V109, P836, DOI 10.1182/blood-2006-04-019794; Weiskopf K, 2013, SCIENCE, V341, P88, DOI 10.1126/science.1238856; Weissleder R, 2014, NAT MATER, V13, P125, DOI [10.1038/nmat3780, 10.1038/NMAT3780]; Willingham SB, 2012, P NATL ACAD SCI USA, V109, P6662, DOI 10.1073/pnas.1121623109; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zhao XW, 2011, P NATL ACAD SCI USA, V108, P18342, DOI 10.1073/pnas.1106550108	59	62	78	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12650	12663		10.1074/jbc.M115.648220	http://dx.doi.org/10.1074/jbc.M115.648220			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837251	hybrid, Green Published			2022-12-26	WOS:000354569000019
J	Petherick, KJ; Conway, OJL; Mpamhanga, C; Osborne, SA; Kamal, A; Saxty, B; Ganley, IG				Petherick, Katy J.; Conway, Owen J. L.; Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara; Ganley, Ian G.			Pharmacological Inhibition of ULK1 Kinase Blocks Mammalian Target of Rapamycin (mTOR)-dependent Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADVANCED SOLID TUMORS; PHASE-I TRIAL; PROTEIN-KINASE; CROSS-TALK; COMPLEX; HYDROXYCHLOROQUINE; PHOSPHORYLATION; VPS34; AMPK; MTOR	Autophagy is a cell-protective and degradative process that recycles damaged and long-lived cellular components. Cancer cells are thought to take advantage of autophagy to help them to cope with the stress of tumorigenesis; thus targeting autophagy is an attractive therapeutic approach. However, there are currently no specific inhibitors of autophagy. ULK1, a serine/threonine protein kinase, is essential for the initial stages of autophagy, and here we report that two compounds, MRT67307 and MRT68921, potently inhibit ULK1 and ULK2 in vitro and block autophagy in cells. Using a drug-resistant ULK1 mutant, we show that the autophagy-inhibiting capacity of the compounds is specifically through ULK1. ULK1 inhibition results in accumulation of stalled early autophagosomal structures, indicating a role for ULK1 in the maturation of autophagosomes as well as initiation.	[Petherick, Katy J.; Conway, Owen J. L.; Ganley, Ian G.] Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland; [Mpamhanga, Chido; Osborne, Simon A.; Kamal, Ahmad; Saxty, Barbara] MRC, Technol Ctr Therapeut Discovery, London NW7 1AD, England	University of Dundee	Ganley, IG (corresponding author), Univ Dundee, MRC, Prot Phosphorylat & Ubiquitylat Unit, Coll Life Sci, Dundee DD1 5EH, Scotland.	i.ganley@dundee.ac.uk		Ganley, Ian/0000-0003-1481-9407; Conway, Owen/0000-0002-0640-1038	Medical Research Council; Division of Signal Transduction Therapy Unit; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck KGaA; Janssen Pharmaceutica; Pfizer; Medical Research Council [MC_UP_A500_1019, MC_UU_12016/4] Funding Source: Medline; MRC [MC_UU_12016/4] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Division of Signal Transduction Therapy Unit; AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck KGaA; Janssen Pharmaceutica(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Pfizer(Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council and by the Division of Signal Transduction Therapy Unit (including AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck KGaA, Janssen Pharmaceutica, and Pfizer).	Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Barnard RA, 2014, AUTOPHAGY, V10, P1415, DOI 10.4161/auto.29165; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Cheong H, 2008, MOL BIOL CELL, V19, P668, DOI 10.1091/mbc.E07-08-0826; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Chresta CM, 2010, CANCER RES, V70, P288, DOI 10.1158/0008-5472.CAN-09-1751; Clark K, 2012, P NATL ACAD SCI USA, V109, P16986, DOI 10.1073/pnas.1215450109; Clark K, 2011, P NATL ACAD SCI USA, V108, P17093, DOI 10.1073/pnas.1114194108; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dowdle WE, 2014, NAT CELL BIOL, V16, P1069, DOI 10.1038/ncb3053; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Ganley IG, 2004, MOL BIOL CELL, V15, P5420, DOI 10.1091/mbc.E04-08-0747; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; Hardie DG, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-36; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Joo JH, 2011, MOL CELL, V43, P572, DOI 10.1016/j.molcel.2011.06.018; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Karanasios E, 2013, J CELL SCI, V126, P5224, DOI 10.1242/jcs.132415; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Mack HID, 2012, AUTOPHAGY, V8, P1197, DOI 10.4161/auto.20586; Mahalingam D, 2014, AUTOPHAGY, V10, P1403, DOI 10.4161/auto.29231; McIver EG, 2012, BIOORG MED CHEM LETT, V22, P7169, DOI 10.1016/j.bmcl.2012.09.063; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Newman AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050672; Poklepovic A, 2014, AUTOPHAGY, V10, P1478, DOI 10.4161/auto.29428; Rangwala R, 2014, AUTOPHAGY, V10, P1391, DOI 10.4161/auto.29119; Rangwala R, 2014, AUTOPHAGY, V10, P1369, DOI 10.4161/auto.29118; Ronan B, 2014, NAT CHEM BIOL, V10, P1013, DOI 10.1038/nchembio.1681; Rosenfeld MR, 2014, AUTOPHAGY, V10, P1359, DOI 10.4161/auto.28984; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Russell RC, 2013, NAT CELL BIOL, V15, P741, DOI 10.1038/ncb2757; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Thorburn A, 2014, MOL PHARMACOL, V85, P830, DOI 10.1124/mol.114.091850; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Vogl DT, 2014, AUTOPHAGY, V10, P1380, DOI 10.4161/auto.29264; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wong PM, 2013, AUTOPHAGY, V9, P124, DOI 10.4161/auto.23323	47	207	217	4	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2015	290	18					11376	11383		10.1074/jbc.C114.627778	http://dx.doi.org/10.1074/jbc.C114.627778			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CH0OA	25833948	Green Published, hybrid			2022-12-26	WOS:000353719400014
J	Buric, M; Blahovec, J; Kouril, J				Buric, Milos; Blahovec, Josef; Kouril, Jan			Back to the Roots: The Integration of a Constructed Wetland into a Recirculating Hatchery - A Case Study	PLOS ONE			English	Article							TROUT ONCORHYNCHUS-MYKISS; VEGETATED DRAINAGE DITCHES; SALMON SALMO-SALAR; LOW-GRADE WEIRS; AQUACULTURE SYSTEMS; WATER-QUALITY; WASTE-WATER; FISH PRODUCTION; PERFORMANCE; EFFLUENT	Aquaculture is currently one of the fastest growing food-producing sectors, accounting for around 50% of the world's food fish. Limited resources, together with climatic change, have stimulated the search for solutions to support and sustain the production of fish as a nutritious food. The integration of a constructed wetland (CW) into a recirculating hatchery (RHS) was evaluated with respect to its economic feasibility and environmental impact. The outcome of eight production cycles showed the potential of CW integration for expanded production without increased operation costs or environmental load. Concretely, the use of constructed wetland allows the rearing about 40% more fish biomass, resulting in higher production and profitability. The low requirements for space, fresh water, and energy enable the establishment of such systems almost anywhere. Constructed wetlands could enhance the productivity of existing small scale facilities, as well as larger systems, to address economic and environmental issues in aquaculture. Such systems have potential to be sustainable in the context of possible future climate change and resource limitations.	[Buric, Milos; Kouril, Jan] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic; [Blahovec, Josef] Trout Farm Mlyny, Stachy, Czech Republic	University of South Bohemia Ceske Budejovice	Buric, M (corresponding author), Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Vodnany, Czech Republic.	buric@frov.jcu.cz	Buric, Milos/F-8114-2015	Buric, Milos/0000-0003-2220-5579	Ministry of Education, Youth and Sports of the Czech Republic [CZ.1.05/2.1.00/01.0024, LO1205]; Ministry of Agriculture of the Czech Republic [NAZV QJ1210013]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	The study was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/?lang=2) - projects "CENAKVA" (No. CZ.1.05/2.1.00/01.0024), "CENAKVA II" (No. LO1205 under the NPU I program) and by the Ministry of Agriculture of the Czech Republic (http://eagri.cz/public/web/en/mze/) (project No. NAZV QJ1210013). Trout farm Mlyny provided support in the form of salaries for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adarme-Vega TC, 2014, CURR OPIN BIOTECH, V26, P14, DOI 10.1016/j.copbio.2013.08.003; Arismendi I, 2009, FRESHWATER BIOL, V54, P1135, DOI 10.1111/j.1365-2427.2008.02157.x; Barnes ME, 2013, N AM J AQUACULT, V75, P244, DOI 10.1080/15222055.2013.768573; Blanchet C, 2005, LIPIDS, V40, P529, DOI 10.1007/s11745-005-1414-0; Bostock J, 2010, PHILOS T R SOC B, V365, P2897, DOI 10.1098/rstb.2010.0170; Boyd CE, 2003, AQUACULTURE, V226, P101, DOI 10.1016/S0044-8486(03)00471-X; Bunting SW, 2009, AQUACULTURE, V294, P43, DOI 10.1016/j.aquaculture.2009.04.017; Buric M., 2014, Journal of Aquaculture Research and Development, V5, P271; Buric M, 2016, AQUAC RES, V47, P1156, DOI 10.1111/are.12572; Cole DW, 2009, INT J HYG ENVIR HEAL, V212, P369, DOI 10.1016/j.ijheh.2008.08.003; d'Orbcastel ER, 2009, AQUACULT ENG, V40, P113, DOI 10.1016/j.aquaeng.2008.12.002; Davidson J, 2014, AQUACULT ENG, V59, P30, DOI 10.1016/j.aquaeng.2014.01.003; Davidson J, 2011, AQUACULT ENG, V44, P80, DOI 10.1016/j.aquaeng.2011.04.001; Dewailly E, 2007, FOOD CHEM TOXICOL, V45, P1343, DOI 10.1016/j.fct.2007.01.010; Endut A, 2009, DESALIN WATER TREAT, V5, P19, DOI 10.5004/dwt.2009.559; Flora C, 2014, AQUACULT ENG, V60, P68, DOI 10.1016/j.aquaeng.2014.04.007; Flora C, 2014, AQUACULT ENG, V60, P56, DOI 10.1016/j.aquaeng.2014.04.006; Food and Agriculture Organization of United Nations, 2013, FAO YB, P105; Godfray HCJ, 2010, PHILOS T R SOC B, V365, P2769, DOI 10.1098/rstb.2010.0180; Good C, 2011, AQUACULT ENG, V44, P97, DOI 10.1016/j.aquaeng.2011.04.003; Graber A, 2009, DESALINATION, V246, P147, DOI 10.1016/j.desal.2008.03.048; Hagopian DS, 1998, AQUACULT ENG, V18, P223, DOI 10.1016/S0144-8609(98)00032-6; Hastein I, 2008, REV SCI TECH OIE, V27, P125, DOI 10.20506/rst.27.1.1798; Idris S, 2012, ENVIRON SCI POLLUT R, V19, P1159, DOI 10.1007/s11356-011-0642-x; Jesus JM, 2014, INT J PHYTOREMEDIAT, V16, P334, DOI 10.1080/15226514.2013.773284; Klinger D, 2012, ANNU REV ENV RESOUR, V37, P247, DOI 10.1146/annurev-environ-021111-161531; Kozak P, 2011, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2011014; Kroupova H, 2005, VET MED-CZECH, V50, P461, DOI 10.17221/5650-VETMED; Laursen DC, 2013, APPL ANIM BEHAV SCI, V144, P163, DOI 10.1016/j.applanim.2013.01.010; Lin YF, 2003, ENVIRON POLLUT, V123, P107, DOI 10.1016/S0269-7491(02)00338-X; Malone RF, 2000, AQUACULT ENG, V22, P57, DOI 10.1016/S0144-8609(00)00032-7; Manley CB, 2014, AQUACULTURE, V420, P89, DOI 10.1016/j.aquaculture.2013.10.040; Martins CIM, 2010, AQUACULT ENG, V43, P83, DOI 10.1016/j.aquaeng.2010.09.002; Midilli A, 2012, ENVIRON PROG SUSTAIN, V31, P604, DOI 10.1002/ep.10580; Muir J, 2005, PHILOS T R SOC B, V360, P191, DOI 10.1098/rstb.2004.1572; National Intelligence Council, 2012, GLOB TRENDS 2030 ALT, P160; Pedersen LF, 2012, AQUACULTURE, V338, P237, DOI 10.1016/j.aquaculture.2012.01.035; Salama NKG, 2011, AQUACULT ENV INTERAC, V2, P61, DOI 10.3354/aei00030; Sharrer M, 2010, BIORESOURCE TECHNOL, V101, P6630, DOI 10.1016/j.biortech.2010.03.101; Shi YH, 2011, BIORESOURCE TECHNOL, V102, P9416, DOI 10.1016/j.biortech.2011.07.058; Sindilariu PD, 2008, AQUACULTURE, V277, P179, DOI 10.1016/j.aquaculture.2008.02.026; Sindilariu PD, 2009, ECOL ENG, V35, P711, DOI 10.1016/j.ecoleng.2008.11.007; Skaala O, 2014, MAR BIOL RES, V10, P308, DOI 10.1080/17451000.2013.810758; Snow A, 2012, ENVIRON REV, V20, P54, DOI [10.1139/A11-023, 10.1139/a11-023]; Suhr KI, 2010, AQUACULT ENG, V42, P31, DOI 10.1016/j.aquaeng.2009.10.001; Svendsen LM, 2010, FARMING FRESHWATER R; Svobodova Z, 2005, ACTA VET BRNO, V74, P129, DOI 10.2754/avb200574010129; Tello A, 2010, ENVIRON POLLUT, V158, P1147, DOI 10.1016/j.envpol.2009.11.029; Terjesen BF, 2013, AQUACULT ENG, V54, P49, DOI 10.1016/j.aquaeng.2012.11.002; Turcios AE, 2014, SUSTAINABILITY-BASEL, V6, P836, DOI 10.3390/su6020836; van Rijn J, 2013, AQUACULT ENG, V53, P49, DOI 10.1016/j.aquaeng.2012.11.010; Vymazal J, 2011, HYDROBIOLOGIA, V674, P133, DOI 10.1007/s10750-011-0738-9; Wang XX, 2012, AQUACULT ENV INTERAC, V2, P267, DOI 10.3354/aei00044; Weaver KL, 2008, J AM DIET ASSOC, V108, P1178, DOI 10.1016/j.jada.2008.04.023; Webb JA, 2012, AQUACULT ENV INTERAC, V3, P23, DOI 10.3354/aei00048; Wilfart A, 2013, J ENVIRON MANAGE, V121, P96, DOI 10.1016/j.jenvman.2013.01.031; Zachritz WH, 2008, AQUACULT ENG, V39, P16, DOI 10.1016/j.aquaeng.2008.05.001; Zhang SY, 2011, AQUACULT ENG, V45, P93, DOI 10.1016/j.aquaeng.2011.08.001; Zhong F, 2011, J ENVIRON SCI HEAL A, V46, P789, DOI 10.1080/10934529.2011.571974	59	5	5	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123577	10.1371/journal.pone.0123577	http://dx.doi.org/10.1371/journal.pone.0123577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853416	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400104
J	Cornez, G; ter Haar, SM; Cornil, CA; Balthazart, J				Cornez, Gilles; ter Haar, Sita M.; Cornil, Charlotte A.; Balthazart, Jacques			Anatomically Discrete Sex Differences in Neuroplasticity in Zebra Finches as Reflected by Perineuronal Nets	PLOS ONE			English	Article							VOCAL CONTROL NUCLEI; SONG CONTROL PATHWAY; NEURAL MECHANISMS; FUNCTIONAL RECOVERY; PROJECTION NEURONS; ADULT MALE; BRAIN; FEMALE; PARVALBUMIN; AROMATASE	Large morphological sex differences in the vertebrate brain were initially identified in song control nuclei of oscines. Besides gross differences between volumes of nuclei in males and females, sex differences also concern the size and dendritic arborization of neurons and various neurochemical markers, such as the calcium-binding protein parvalbumin (PV). Perineuronal nets (PNN) of the extracellular matrix are aggregates of different compounds, mainly chondroitin sulfate proteoglycans, that surround subsets of neurons, often expressing PV. PNN develop in zebra finches song control nuclei around the end of the sensitive period for song learning and tutor deprivation, known to delay the end of the song learning sensitive period, decreases the numbers of PNN in HVC. We demonstrate here the existence in zebra finches of a major sex difference (males > females) affecting the number of PNN (especially those surrounding PV-positive cells) in HVC and to a smaller extent the robust nucleus of the arcopallium, RA, the two main nuclei controlling song production. These differences were not present in Area X and LMAN, the lateral magnocellular nucleus of the anterior nidopallium. A dense expression of material immunoreactive for chondroitin sulfate was also detected in several nuclei of the auditory and visual pathways. This material was often organized in perineuronal rings but quantification of these PNN did not reveal any sex difference with the exception that the percentage of PNN surrounding PV-ir cells in the dorsal lateral mesencephalic nucleus, MLd, was larger in females than in males, a sex difference in the opposite direction compared to what is seen in HVC and RA. These data confirm and extend previous studies demonstrating the sex difference affecting PNN in HVC-RA by showing that this sex difference is anatomically specific and does not concern visual or auditory pathways.	[Cornez, Gilles; ter Haar, Sita M.; Cornil, Charlotte A.; Balthazart, Jacques] Univ Liege, GIGA Neurosci, Res Grp Behav Neuroendocrinol, Liege, Belgium	University of Liege	Balthazart, J (corresponding author), Univ Liege, GIGA Neurosci, Res Grp Behav Neuroendocrinol, Liege, Belgium.	jbalthazart@ulg.ac.be	Cornil, Charlotte Anne/J-2462-2019	Cornil, Charlotte Anne/0000-0002-5536-7753	Belgian Science Policy [BELSPO: SSTC PAI P7/17]; Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS)	Belgian Science Policy(Belgian Federal Science Policy Office); Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS)(Fonds de la Recherche Scientifique - FNRS)	Funding for this work was provided by a grant from the Belgian Science Policy (BELSPO: SSTC PAI P7/17; url: https://www.belspo.be/belspo/index_en.stm) to JB and CAC. CAC is Research Associate of the Fonds National de la Recherche Scientifique (F.R.S.-FNRS; url: http://www.fnrs.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD AP, 1975, J EXP ZOOL, V191, P309, DOI 10.1002/jez.1401910302; Ball GF, 2001, MICROSC RES TECHNIQ, V54, P327, DOI 10.1002/jemt.1146; Balmer TS, 2009, J NEUROSCI, V29, P12878, DOI 10.1523/JNEUROSCI.2974-09.2009; Benton S, 1998, BEHAV BRAIN RES, V96, P135, DOI 10.1016/S0166-4328(98)00011-4; Best BJ, 2012, ABST SOC NEUR, V30318; Bolhuis JJ, 2006, NAT REV NEUROSCI, V7, P347, DOI 10.1038/nrn1904; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; BRAUN K, 1991, NEUROSCIENCE, V40, P853, DOI 10.1016/0306-4522(91)90017-I; Burt JM, 2000, J NEUROBIOL, V42, P1, DOI 10.1002/(SICI)1097-4695(200001)42:1<1::AID-NEU1>3.0.CO;2-6; Celio MR, 1998, TRENDS NEUROSCI, V21, P510, DOI 10.1016/S0166-2236(98)01298-3; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; De Groof G, 2008, EUR J NEUROSCI, V28, P2475, DOI 10.1111/j.1460-9568.2008.06545.x; Del Negro C, 1998, BEHAV BRAIN RES, V96, P151, DOI 10.1016/S0166-4328(98)00009-6; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Doupe AJ, 2005, TRENDS NEUROSCI, V28, P353, DOI 10.1016/j.tins.2005.05.005; Eens M, 1997, ADV STUD BEHAV, V26, P355, DOI 10.1016/S0065-3454(08)60384-8; Evrard HC, 2004, J COMP NEUROL, V473, P194, DOI 10.1002/cne.20068; Fortune ES, 2011, SCIENCE, V334, P666, DOI 10.1126/science.1209867; Gall MD, 2012, J COMP PHYSIOL A, V198, P61, DOI 10.1007/s00359-011-0687-9; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Gati G, 2010, J CHEM NEUROANAT, V40, P243, DOI 10.1016/j.jchemneu.2010.07.002; GERLACH JL, 1983, DEV BRAIN RES, V11, P7, DOI 10.1016/0165-3806(83)90197-9; Handa R., 2014, CURR EYE RES, V40, P1; Hara E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029457; Hernandez AM, 2004, J NEUROBIOL, V59, P247, DOI 10.1002/neu.10312; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Horvath TL, 1999, J NEUROENDOCRINOL, V11, P77; JURASKA JM, 1991, PSYCHONEUROENDOCRINO, V16, P105, DOI 10.1016/0306-4530(91)90073-3; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Karetko M, 2009, ACTA NEUROBIOL EXP, V69, P564; KIRN JR, 1993, J NEUROSCI, V13, P1654; Lucas JR, 2007, J COMP PHYSIOL A, V193, P201, DOI 10.1007/s00359-006-0180-z; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; MACLUSKY NJ, 1979, BRAIN RES, V178, P143, DOI 10.1016/0006-8993(79)90094-5; MacLusky NJ, 1989, ABST SOC NEUR, V3911; Madison F.N., 2014, GEN COMP ENDOCRINOL; Maguire SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063239; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; McRae PA, 2007, J NEUROSCI, V27, P5405, DOI 10.1523/JNEUROSCI.5425-06.2007; Meyer CE, 2014, BASAL GANGLIA, V3, P229, DOI 10.1016/j.baga.2013.10.002; Miller-Sims VC, 2012, J NEUROPHYSIOL, V107, P1142, DOI 10.1152/jn.00614.2011; Mooney R, 2009, CURR OPIN NEUROBIOL, V19, P654, DOI 10.1016/j.conb.2009.10.004; Mooney R, 2009, LEARN MEMORY, V16, P655, DOI 10.1101/lm.1065209; NIXDORF BE, 1989, J COMP NEUROL, V284, P337, DOI 10.1002/cne.902840302; Noirot IC, 2007, ASBT SOC NEUR, V672; Noirot IC, 2009, HEARING RES, V252, P49, DOI 10.1016/j.heares.2009.04.012; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1981, SCIENCE, V214, P1368, DOI 10.1126/science.7313697; NOTTEBOHM F, 1980, BRAIN RES, V189, P429, DOI 10.1016/0006-8993(80)90102-X; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Nowicka D, 2009, EUR J NEUROSCI, V30, P2053, DOI 10.1111/j.1460-9568.2009.06996.x; Peterson RS, 2005, P ROY SOC B-BIOL SCI, V272, P2089, DOI 10.1098/rspb.2005.3181; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Prbve E., 1974, J ORNITHOL, V115, P338; Reiner A, 2004, J COMP NEUROL, V473, P377, DOI 10.1002/cne.20118; Rohmann KN, 2005, HORM BEHAV, V48, P125; SHERIDAN PJ, 1979, BRAIN RES, V178, P201, DOI 10.1016/0006-8993(79)90101-X; Sun LN, 2010, NEUROSCI RES, V68, P22, DOI 10.1016/j.neures.2010.05.003; Terpstra NJ, 2006, J COMP NEUROL, V494, P784, DOI 10.1002/cne.20831; Van Meir V, 2005, NEUROIMAGE, V25, P1242, DOI 10.1016/j.neuroimage.2004.12.058; Wang DF, 2012, CELL TISSUE RES, V349, P147, DOI 10.1007/s00441-012-1375-y; Wilbrecht L, 2003, MENT RETARD DEV D R, V9, P135, DOI 10.1002/mrdd.10073; Wild JM, 2001, BRAIN RES, V917, P235	68	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123199	10.1371/journal.pone.0123199	http://dx.doi.org/10.1371/journal.pone.0123199			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848776	Green Published, gold			2022-12-26	WOS:000352477800214
J	de Seny, D; Cobraiville, G; Charlier, E; Neuville, S; Lutteri, L; Le Goff, C; Malaise, D; Malaise, O; Chapelle, JP; Relic, B; Malaise, MG				de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Lutteri, Laurence; Le Goff, Caroline; Malaise, Denis; Malaise, Olivier; Chapelle, Jean-Paul; Relic, Biserka; Malaise, Michel G.			Apolipoprotein-A1 as a Damage-Associated Molecular Patterns Protein in Osteoarthritis: Ex Vivo and In Vitro Pro-Inflammatory Properties	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; A-I; RHEUMATOID-ARTHRITIS; THERAPEUTIC TARGET; SYNOVIAL-FLUID; CHOLESTEROL; SERUM; DISEASE; OBESITY; RISK	Osteoarthritis (OA) is associated with a local inflammatory process. Dyslipidemia is known to be an underlying cause for the development of OA. Therefore, lipid and inflammatory levels were quantified ex vivo in blood and synovial fluid of OA patients (n=29) and compared to those of rheumatoid arthritis (RA) patients (n=27) or healthy volunteers (HV) (n=35). The role of apolipoprotein A-I (ApoA1) was investigated in vitro on inflammatory parameters using human joint cells isolated from cartilage and synovial membrane obtained from OA patients after joint replacement. Cells were stimulated with ApoA1 in the presence or not of serum amyloid A (SAA) protein and/or lipoproteins (LDL and HDL) at physiological concentration observed in OA synovial fluid. In our ex vivo study, ApoA1, LDL-C and total cholesterol levels were strongly correlated to each other inside the OA joint cavity whereas same levels were not or weakly correlated to their corresponding serum levels. In OA synovial fluid, ApoA1 was not as strongly correlated to HDL as observed in OA serum or in RA synovial fluid, suggesting a dissociative level between ApoA1 and HDL in OA synovial fluid. In vitro, ApoA1 induced IL-6, MMP-1 and MMP-3 expression by primary chondrocytes and fibroblast-like synoviocytes through TLR4 receptor. HDL and LDL attenuated joint inflammatory response induced by ApoA1 and SAA in a ratio dependent manner. In conclusion, a dysregulated lipidic profile in the synovial fluid of OA patients was observed and was correlated with inflammatory parameters in the OA joint cavity. Pro-inflammatory properties of ApoA1 were confirmed in vitro.	[de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Relic, Biserka; Malaise, Michel G.] Univ Liege, GIGA Res, Lab Rheumatol, B-4000 Liege, Belgium; [de Seny, Dominique; Cobraiville, Gael; Charlier, Edith; Neuville, Sophie; Malaise, Denis; Malaise, Olivier; Relic, Biserka; Malaise, Michel G.] CHU Hosp Liege, B-4000 Liege, Belgium; [Le Goff, Caroline; Malaise, Denis; Chapelle, Jean-Paul] CHU Hosp Liege, Clin Chem Lab, B-4000 Liege, Belgium	University of Liege	de Seny, D (corresponding author), Univ Liege, GIGA Res, Lab Rheumatol, B-4000 Liege, Belgium.	ddeseny@chu.ulg.ac.be	Le Goff, Caroline/AAE-8177-2021	Malaise, Denis/0000-0001-7454-819X	"Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium)	"Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium)	This study was supported by the "Fond d'Investissement pour la Recherche Scientifique" (FIRS) of the authors' Institution (CHU Liege, Belgium) for the entire group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman-Farinelli MA, 2008, MED J AUSTRALIA, V188, P317, DOI 10.5694/j.1326-5377.2008.tb01634.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Annema W, 2010, J LIPID RES, V51, P743, DOI 10.1194/jlr.M000323; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Beck WHJ, 2013, BBA-BIOMEMBRANES, V1828, P1503, DOI 10.1016/j.bbamem.2013.02.009; Busso N, 2001, AM J PATHOL, V159, P1445, DOI 10.1016/S0002-9440(10)62531-X; Chiang SL, 2014, SCAND J RHEUMATOL, V2014, P1, DOI [10. 3109/ 03009742. 2013. 805242 PMID: 25521915, DOI 10.3109/03009742.2013.805242]; Chiba T, 2011, ARTERIOSCL THROM VAS, V31, P1326, DOI 10.1161/ATVBAHA.111.226159; Conde J, 2011, ANN RHEUM DIS, V70, P551, DOI 10.1136/ard.2010.132399; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davies-Tuck ML, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2873; de Seny D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066769; Erb N, 2004, SCAND J RHEUMATOL, V33, P293, DOI 10.1080/03009740410006899; Farbstein D, 2012, EXPERT REV CARDIOVAS, V10, P353, DOI [10.1586/erc.11.182, 10.1586/ERC.11.182]; Gkretsi V, 2011, PROG LIPID RES, V50, P133, DOI 10.1016/j.plipres.2010.11.001; Katz JD, 2010, CURR OPIN RHEUMATOL, V22, P512, DOI 10.1097/BOR.0b013e32833bfb4b; Kontush A, 2006, PHARMACOL REV, V58, P342, DOI 10.1124/pr.58.3.1; Luscher TF, 2014, CIRC RES, V114, P171, DOI 10.1161/CIRCRESAHA.114.300935; MALLE E, 1993, ATHEROSCLEROSIS, V102, P131, DOI 10.1016/0021-9150(93)90155-N; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Moya MD, 2012, ATHEROSCLEROSIS, V222, P390, DOI 10.1016/j.atherosclerosis.2012.02.032; Ogasawara K, 2008, CLIN CHIM ACTA, V397, P42, DOI 10.1016/j.cca.2008.07.014; Oliviero F, 2012, CLIN CHIM ACTA, V413, P303, DOI 10.1016/j.cca.2011.10.019; Oliviero F, 2009, CLIN EXP RHEUMATOL, V27, P79; Onat A, 2010, INT J CARDIOL, V142, P72, DOI 10.1016/j.ijcard.2008.12.066; Onat A, 2013, EUR J CLIN INVEST, V43, P1129, DOI 10.1111/eci.12150; Onat A, 2013, ANADOLU KARDIYOL DER, V13, P306, DOI 10.5152/akd.2013.106; Onat A, 2009, METABOLISM, V58, P1393, DOI 10.1016/j.metabol.2009.05.004; Oram JF, 1996, J LIPID RES, V37, P2473; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Relic B, 2002, LAB INVEST, V82, P1661, DOI 10.1097/01.LAB.0000041714.05322.C0; Relic B, 2006, J BIOL CHEM, V281, P22597, DOI 10.1074/jbc.M512807200; Relic B, 2009, LAB INVEST, V89, P811, DOI 10.1038/labinvest.2009.41; Rosenson RS, 2013, CIRCULATION, V128, P1256, DOI 10.1161/CIRCULATIONAHA.113.000962; Santos-Gallego CG, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0512-5; Singh G, 2002, AM J MANAG CARE, V8, pS383; Solomon A, 2006, ARTHRITIS RHEUM, V54, P3545, DOI 10.1002/art.22201; Sowers MR, 2010, CURR OPIN RHEUMATOL, V22, P533, DOI 10.1097/BOR.0b013e32833b4682; Tsezou A, 2010, J ORTHOP RES, V28, P1033, DOI 10.1002/jor.21084; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Zamanian-Daryoush M, 2013, J BIOL CHEM, V288, P21237, DOI 10.1074/jbc.M113.468967	41	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122904	10.1371/journal.pone.0122904	http://dx.doi.org/10.1371/journal.pone.0122904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849372	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800171
J	Desch, KC; Kretz, C; Yee, A; Gildersleeve, R; Metzger, K; Agrawal, N; Cheng, J; Ginsburg, D				Desch, Karl C.; Kretz, Colin; Yee, Andrew; Gildersleeve, Robert; Metzger, Kristin; Agrawal, Nidhi; Cheng, Jane; Ginsburg, David			Probing ADAMTS13 Substrate Specificity using Phage Display	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; FACTOR-VIII; PLASMINOGEN-ACTIVATOR; SCISSILE BOND; DOMAIN A2; CLEAVAGE; LOCALIZATION; CONSTRUCTION; SUFFICIENT; CONTRIBUTE	Von Willebrand factor (VWF) is a large, multimeric protein that regulates hemostasis by tethering platelets to the subendothelial matrix at sites of vascular damage. The procoagulant activity of plasma VWF correlates with the length of VWF multimers, which is proteolytically controlled by the metalloprotease ADAMTS13. To probe ADAMTS13 substrate specificity, we created phage display libraries containing randomly mutated residues of a minimal ADAMTS13 substrate fragment of VWF, termed VWF73. The libraries were screened for phage particles displaying VWF73 mutant peptides that were resistant to proteolysis by ADAMTS13. These peptides exhibited the greatest mutation frequency near the ADAMTS13 scissile residues. Kinetic assays using mutant and wild-type substrates demonstrated excellent agreement between rates of cleavage for mutant phage particles and the corresponding mutant peptides. Cleavage resistance of selected mutations was tested in vivo using hydrodynamic injection of corresponding full-length expression plasmids into VWF-deficient mice. These studies confirmed the resistance to cleavage resulting from select amino acid substitutions and uncovered evidence of alternate cleavage sites and recognition by other proteases in the circulation of ADAMTS13 deficient mice. Taken together, these studies demonstrate the key role of specific amino acids residues including P3-P2' and P11', for substrate specificity and emphasize the importance in flowing blood of other ADAMTS13-VWF exosite interactions outside of VWF73.	[Desch, Karl C.] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Kretz, Colin; Yee, Andrew; Gildersleeve, Robert; Metzger, Kristin; Agrawal, Nidhi; Cheng, Jane] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Ginsburg, David] Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Ginsburg, David] Univ Michigan, Dept Internal Med & Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Ginsburg, D (corresponding author), Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.	ginsburg@umich.edu	Kretz, Colin/L-1178-2016	Kretz, Colin/0000-0001-7979-7603; Ginsburg, David/0000-0002-6436-8942	National Institute of Health (US); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL057346, R01HL039693] Funding Source: NIH RePORTER	National Institute of Health (US)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by grants from the National Institute of Health (US). DG is a Howard Hughes Investigator.	Akiyama M, 2009, P NATL ACAD SCI USA, V106, P19274, DOI 10.1073/pnas.0909755106; Akiyama M, 2009, ACTA CRYSTALLOGR F, V65, P739, DOI 10.1107/S1744309109023410; Banno F, 2004, J BIOL CHEM, V279, P30896, DOI 10.1074/jbc.M314184200; Barbas C. F., 2001, PHAGE DISPLAY LAB MA; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cao WJ, 2012, J BIOL CHEM, V287, P32459, DOI 10.1074/jbc.M112.390690; Chen JC, 2008, NAT BIOTECHNOL, V26, P114, DOI 10.1038/nbt1373; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gao WQ, 2006, P NATL ACAD SCI USA, V103, P19099, DOI 10.1073/pnas.0607264104; GINSBURG D, 1985, SCIENCE, V228, P1401, DOI 10.1126/science.3874428; Ke SH, 1997, J BIOL CHEM, V272, P16603, DOI 10.1074/jbc.272.26.16603; Kokame K, 2004, BLOOD, V103, P607, DOI 10.1182/blood-2003-08-2861; LAWRENCE DA, 1994, J BIOL CHEM, V269, P15223; Levy GG, 2005, BLOOD, V106, P11, DOI 10.1182/blood-2004-10-4097; Levy GG, 2001, NATURE, V413, P488, DOI 10.1038/35097008; LYONS LB, 1972, VIROLOGY, V49, P45, DOI 10.1016/S0042-6822(72)80006-0; LYONS SE, 1992, J BIOL CHEM, V267, P4424; McKinnon TAJ, 2008, BLOOD, V111, P3042, DOI 10.1182/blood-2007-06-095042; MEISSNER PS, 1987, P NATL ACAD SCI USA, V84, P4171, DOI 10.1073/pnas.84.12.4171; MOAKE JL, 1982, NEW ENGL J MED, V307, P1432, DOI 10.1056/NEJM198212023072306; Muia J, 2014, P NATL ACAD SCI USA, V111, P18584, DOI 10.1073/pnas.1413282112; Nishio K, 2004, P NATL ACAD SCI USA, V101, P10578, DOI 10.1073/pnas.0402041101; Perkin-Elmer, 2014, ALPHALISA ALPHASCREE; Pruss CM, 2012, J THROMB HAEMOST, V10, P940, DOI 10.1111/j.1538-7836.2012.04675.x; Sadler JE, 2008, BLOOD, V112, P11, DOI 10.1182/blood-2008-02-078170; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; TSAI HM, 1994, BLOOD, V83, P2171; Uemura M, 2005, BLOOD, V106, P922, DOI 10.1182/blood-2005-01-0152; WAY JC, 1984, GENE, V32, P369, DOI 10.1016/0378-1119(84)90012-X; Xiang YZ, 2011, P NATL ACAD SCI USA, V108, P11602, DOI 10.1073/pnas.1018559108; Xu AJ, 2013, J BIOL CHEM, V288, P6317, DOI 10.1074/jbc.M112.422618; Yee A, 2014, BLOOD, V124, P445, DOI 10.1182/blood-2013-11-540534; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zheng XL, 2001, J BIOL CHEM, V276, P41059, DOI 10.1074/jbc.C100515200; Zhou WH, 2007, BLOOD, V110, P886, DOI 10.1182/blood-2007-01-070953; Zhou WH, 2005, LAB INVEST, V85, P780, DOI 10.1038/labinvest.3700275	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122931	10.1371/journal.pone.0122931	http://dx.doi.org/10.1371/journal.pone.0122931			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849793	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800176
J	Dopheide, A; Lear, G; He, ZL; Zhou, JZ; Lewis, GD				Dopheide, Andrew; Lear, Gavin; He, Zhili; Zhou, Jizhong; Lewis, Gillian D.			Functional Gene Composition, Diversity and Redundancy in Microbial Stream Biofilm Communities	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; BACTERIAL COMMUNITIES; BENTHIC INVERTEBRATES; NUTRIENT-UPTAKE; NEW-ZEALAND; LITTER; GEOCHIP; COPPER; BIOGEOGRAPHY; CONTAMINANTS	We surveyed the functional gene composition and diversity of microbial biofilm communities in 18 New Zealand streams affected by different types of catchment land use, using a comprehensive functional gene array, GeoChip 3.0. A total of 5,371 nutrient cycling and energy metabolism genes within 65 gene families were detected among all samples (342 to 2,666 genes per stream). Carbon cycling genes were most common, followed by nitrogen cycling genes, with smaller proportions of sulphur, phosphorus cycling and energy metabolism genes. Samples from urban and native forest streams had the most similar functional gene composition, while samples from exotic forest and rural streams exhibited the most variation. There were significant differences between nitrogen and sulphur cycling genes detected in native forest and urban samples compared to exotic forest and rural samples, attributed to contrasting proportions of nitrogen fixation, denitrification, and sulphur reduction genes. Most genes were detected only in one or a few samples, with only a small minority occurring in all samples. Nonetheless, 42 of 65 gene families occurred in every sample and overall proportions of gene families were similar among samples from contrasting streams. This suggests the existence of functional gene redundancy among different stream biofilm communities despite contrasting taxonomic composition.	[Dopheide, Andrew; Lear, Gavin; Lewis, Gillian D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Inst Environm Genom, Norman, OK 73019 USA; [He, Zhili; Zhou, Jizhong] Univ Oklahoma, Dept Microbiol & Plant Biol, Norman, OK 73019 USA	University of Auckland; University of Oklahoma System; University of Oklahoma - Norman; University of Oklahoma System; University of Oklahoma - Norman	Lewis, GD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.	gd.lewis@auckland.ac.nz	Lewis, Gillian/P-5538-2016; He, Zhili/C-2879-2012; Dopheide, Andrew/ABE-4778-2020; 吴, 昊/AAB-1620-2020; Lear, Gavin/AGI-4146-2022; Lear, Gavin/AHD-1751-2022	Lewis, Gillian/0000-0003-2904-7956; He, Zhili/0000-0001-8225-7333; Dopheide, Andrew/0000-0003-1554-9832; Lear, Gavin/0000-0001-5083-4773	New Zealand Foundation for Research, Science and Technology [UOAx306]; Royal Society of New Zealand Marsden Fund [LIU0901]	New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This study was supported by the New Zealand Foundation for Research, Science and Technology UOAx306 (GDL) (http://www.msi.govt.nz/) and the Royal Society of New Zealand Marsden Fund LIU0901 (GL) (http://www.royalsociety.org.nz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105; Ancion P, 2010, THESIS U AUCKLAND NZ; Ancion PY, 2010, ENVIRON POLLUT, V158, P2738, DOI 10.1016/j.envpol.2010.04.013; [Anonymous], 2010, R LANG ENV STAT COMP; Battin TJ, 2003, NATURE, V426, P439, DOI 10.1038/nature02152; Bernot MJ, 2006, FRESHWATER BIOL, V51, P499, DOI 10.1111/j.1365-2427.2006.01508.x; De la Iglesia R, 2012, FEMS MICROBIOL ECOL, V79, P720, DOI 10.1111/j.1574-6941.2011.01254.x; Dopheide A, 2009, APPL ENV MICROBIOL, V75; Fierer N, 2007, ECOLOGY, V88, P2162, DOI 10.1890/06-1746.1; Findlay S, 1997, NEW ZEAL J MAR FRESH, V31, P701, DOI 10.1080/00288330.1997.9516800; Findlay S, 2010, J N AM BENTHOL SOC, V29, P170, DOI 10.1899/09-023.1; Frossard A, 2012, ISME J, V6, P680, DOI 10.1038/ismej.2011.134; GEESEY GG, 1978, LIMNOL OCEANOGR, V23, P1214, DOI 10.4319/lo.1978.23.6.1214; Hagen EM, 2010, HYDROBIOLOGIA, V655, P61, DOI 10.1007/s10750-010-0404-7; Harding JS, 1998, P NATL ACAD SCI USA, V95, P14843, DOI 10.1073/pnas.95.25.14843; He ZL, 2007, ISME J, V1, P67, DOI 10.1038/ismej.2007.2; He ZL, 2010, ISME J, V4, P1167, DOI 10.1038/ismej.2010.46; He ZL, 2010, ECOL LETT, V13, P564, DOI 10.1111/j.1461-0248.2010.01453.x; He ZL, 2005, APPL ENVIRON MICROB, V71, P3753, DOI 10.1128/AEM.71.7.3753-3760.2005; Headley JV, 1998, ENVIRON SCI TECHNOL, V32, P3968, DOI 10.1021/es980499l; Hoover TM, 2011, CAN J FOREST RES, V41, P1394, DOI [10.1139/x11-067, 10.1139/X11-067]; JONES SE, 1993, HYDROBIOLOGIA, V257, P1, DOI 10.1007/BF00013991; Kimes NE, 2010, ENVIRON MICROBIOL, V12, P541, DOI 10.1111/j.1462-2920.2009.02113.x; Kirchman DL, 2010, ENVIRON MICROBIOL, V12, P1132, DOI 10.1111/j.1462-2920.2010.02154.x; Langenheder S, 2006, APPL ENVIRON MICROB, V72, P212, DOI 10.1128/AEM.72.1.212-220.2006; Lear G, 2009, ECOL INDIC, V9, P848, DOI 10.1016/j.ecolind.2008.10.001; Lear G, 2009, FRESHWATER BIOL, V54, P1532, DOI 10.1111/j.1365-2427.2009.02190.x; Lear G, 2013, GLOBAL ECOL BIOGEOGR, V22, P544, DOI 10.1111/geb.12046; Lear G, 2011, AQUAT ECOL, V45, P517, DOI 10.1007/s10452-011-9372-x; Lear G, 2009, APPL ENVIRON MICROB, V75, P3455, DOI 10.1128/AEM.00274-09; Magalhaes CM, 2011, FEMS MICROBIOL ECOL, V77, P274, DOI 10.1111/j.1574-6941.2011.01107.x; Neale MW, 2010, 2010016 AUCKL REG CO; Neale MW, 2009, 2009102 AUCKL REG CO; Paerl HW, 1996, MICROB ECOL, V31, P225; Peter H, 2011, ISME J, V5, P351, DOI 10.1038/ismej.2010.119; Quinn JM, 1997, NEW ZEAL J MAR FRESH, V31, P579, DOI 10.1080/00288330.1997.9516791; Quinn JM, 2000, NEW ZEAL J MAR FRESH, V34, P253, DOI 10.1080/00288330.2000.9516931; Reed HE, 2007, FEMS MICROBIOL ECOL, V62, P161, DOI 10.1111/j.1574-6941.2007.00386.x; Rice D.A., 2010, BIG THOMPSON RIVER W, P80523; Romani AM, 2004, MICROB ECOL, V47, P316, DOI 10.1007/s00248-003-2019-2; Scarsbrook MR, 2001, NEW ZEAL J MAR FRESH, V35, P751, DOI 10.1080/00288330.2001.9517040; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; Tu Qichao, 2014, Mol Ecol Resour, V14, P914, DOI 10.1111/1755-0998.12239; VAN HULLEBUSCH E. D., 2003, REV ENVIRON SCI BIO, V2, P9, DOI DOI 10.1023/B:RESB.0000022995.48330.55; Van Nostrand JD, 2009, ENVIRON MICROBIOL, V11, P2611, DOI 10.1111/j.1462-2920.2009.01986.x; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Wang LT, 2007, INT J SYST EVOL MICR, V57, P1846, DOI 10.1099/ijs.0.64685-0; Whiles MR, 1997, HYDROBIOLOGIA, V353, P107, DOI 10.1023/A:1003054827248; WRIGHT AC, 1981, NEW ZEAL J GEOL GEOP, V24, P155, DOI 10.1080/00288306.1981.10422711; Wu LY, 2006, APPL ENVIRON MICROB, V72, P4931, DOI 10.1128/AEM.02738-05; Xie JP, 2011, APPL ENVIRON MICROB, V77, P991, DOI 10.1128/AEM.01798-10; Yin HQ, 2008, ARCH MICROBIOL, V189, P101, DOI 10.1007/s00203-007-0298-6; Zak DR, 2006, TRENDS ECOL EVOL, V21, P288, DOI 10.1016/j.tree.2006.04.003; Zhang GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023059; Zhou JZ, 1996, APPL ENVIRON MICROB, V62, P316, DOI 10.1128/AEM.62.2.316-322.1996	56	36	37	4	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123179	10.1371/journal.pone.0123179	http://dx.doi.org/10.1371/journal.pone.0123179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849814	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800212
J	Infurna, FJ; Rivers, CT; Reich, J; Zautra, AJ				Infurna, Frank J.; Rivers, Crystal T.; Reich, John; Zautra, Alex J.			Childhood Trauma and Personal Mastery: Their Influence on Emotional Reactivity to Everyday Events in a Community Sample of Middle-Aged Adults	PLOS ONE			English	Article							DAILY STRESSORS; PHYSICAL HEALTH; LIFE STRESS; PERCEIVED CONTROL; POSITIVE AFFECT; RISK; EXPERIENCES; RESILIENCE; ORIGINS; ABUSE	Childhood trauma is associated with premature declines in health in midlife and old age. Pathways that have been implicated, but less studied include social-emotional regulation, biological programming, and habitual patterns of thought and action. In this study we focused on childhood trauma's influence via alterations in social-emotional regulation to everyday life events, a pathway that has been linked to subsequent health effects. Data from a 30-day daily diary of community residents who participated in a study of resilience in Midlife (n = 191, M-age = 54, SD = 7.50, 54% women) was used to examine whether self-reports of childhood trauma were associated with daily well-being, as well as reported and emotional reactivity to daily negative and positive events. Childhood trauma reports were associated with reporting lower overall levels of and greater variability in daily well-being. Childhood trauma was linked to greater reports of daily negative events, but not to positive events. Focusing on emotional reactivity to daily events, residents who reported higher levels of childhood trauma showed stronger decreases in well-being when experiencing negative events and also stronger increases in well-being with positive events. For those reporting childhood trauma, higher levels of mastery were associated with stronger decreases in well-being with negative events and stronger increases in well-being with positive events, suggesting that mastery increases sensitivity to daily negative and positive events. Our results suggest that childhood trauma may lead to poorer health in midlife through disturbances in the patterns of everyday life events and responses to those events. Further, our findings indicate that mastery may have a different meaning for those who experienced childhood trauma. We discuss social-emotional regulation as one pathway linking childhood trauma to health, and psychosocial resources to consider when building resilience-promoting interventions for mitigating the detrimental health effects of childhood trauma.	[Infurna, Frank J.; Rivers, Crystal T.; Reich, John; Zautra, Alex J.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Infurna, FJ (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	Frank.Infurna@asu.edu			National Institute on Aging [R01 AG26006]; NATIONAL INSTITUTE ON AGING [R01AG026006] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by the National Institute on Aging R01 AG26006. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Almeida DM, 2010, HDB PSYCHOL AGING, P191; [Anonymous], 2006, SAS MIXED MODELS; BALTES PB, 1987, DEV PSYCHOL, V23, P611, DOI 10.1037/0012-1649.23.5.611; BANDURA A, 1989, AM PSYCHOL, V44, P1175, DOI 10.1037/0003-066X.44.9.1175; Bandura A, 1997, SELF EFFICACY THE EX; Bernstein DP, 2003, CHILD ABUSE NEGLECT, V27, P169, DOI 10.1016/S0145-2134(02)00541-0; Blackertz L, 1998, AMERICAN JOURNAL OF, V19, P307; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Boyce WT, 2005, DEV PSYCHOPATHOL, V17, P271, DOI 10.1017/S0954579405050145; Bradbum N. M., 1969, THE STRUCTURE OF PSY; Carstensen LL, 2011, PSYCHOL AGING, V26, P21, DOI 10.1037/a0021285; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Cassidy J., 2008, HANDBOOK OF ATTACHME; Charles ST, 2013, PSYCHOL SCI, V24, P733, DOI 10.1177/0956797612462222; Cloitre M, 2005, BEHAV THER, V36, P119, DOI 10.1016/S0005-7894(05)80060-7; Cook T. D., 1979, QUASIEXPERIMENTATION, P19; Davis MC, 2000, PSYCHOSOM MED, V62, P17, DOI 10.1097/00006842-200001000-00003; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Diehl M, 2010, DEV PSYCHOL, V46, P1132, DOI 10.1037/a0019937; Division of Behavioral and Social Research National Institute on Aging, 2013, NETWORK ON REVERSIBI; Fagundes CP, 2013, BRAIN BEHAV IMMUN, V27, P8, DOI 10.1016/j.bbi.2012.06.014; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Ferraro KF, 2009, GERONTOLOGIST, V49, P333, DOI 10.1093/geront/gnp034; Glaser JP, 2006, J PSYCHOSOM RES, V61, P229, DOI 10.1016/j.jpsychores.2006.04.014; Goleman D., 2006, WORKING EMOTIONAL IN; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Hay EL, 2010, PSYCHOL AGING, V25, P118, DOI 10.1037/a0018747; Hostinar CE, 2013, CURR DIR PSYCHOL SCI, V22, P400, DOI 10.1177/0963721413488889; Infurna FJ, 2013, DEV PSYCHOL, V49, P1833, DOI 10.1037/a0031041; JAMES SA, 1983, J BEHAV MED, V6, P259, DOI 10.1007/BF01315113; Kahn RL, 1978, CLIN PSYCHOL AGING, P43; Kok BE, 2013, PSYCHOL SCI, V24, P1123, DOI 10.1177/0956797612470827; Lachman ME, 2006, CURR DIR PSYCHOL SCI, V15, P282, DOI 10.1111/j.1467-8721.2006.00453.x; Lieberman MD, 2013, SOCIAL WHY ARE BRAIN; Little R. J. A., 1987, STATISTICAL ANALYSIS; Luecken LJ, 2004, CLIN PSYCHOL REV, V24, P171, DOI 10.1016/j.cpr.2004.01.003; Luthar SS, 2000, CHILD DEV, V71, P543, DOI 10.1111/1467-8624.00164; Mallers MH, 2010, DEV PSYCHOL, V46, P1651, DOI 10.1037/a0021020; Masi CM, 2011, PERS SOC PSYCHOL REV, V15, P219, DOI 10.1177/1088868310377394; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Mroczek DK, JOURNALS OF GERONTOL; Neupert SD, 2007, J GERONTOL B-PSYCHOL, V62, pP216, DOI 10.1093/geronb/62.4.P216; O'Rand AM, 2005, J GERONTOL B-PSYCHOL, V60, P117, DOI 10.1093/geronb/60.Special_Issue_2.S117; Ong AD, 2013, ANN BEHAV MED, V46, P52, DOI 10.1007/s12160-013-9484-8; Pearlin LI, 2007, J HEALTH SOC BEHAV, V48, P164, DOI 10.1177/002214650704800205; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Piazza JR, 2013, ANN BEHAV MED, V45, P110, DOI 10.1007/s12160-012-9423-0; Piazza JR, 2010, J GERONTOL B-PSYCHOL, V65, P513, DOI 10.1093/geronb/gbq049; Pluess M, 2013, PSYCHOL BULL, V139, P901, DOI 10.1037/a0030196; Porter CA, 1999, J CHILD SEX ABUS, V8, P3, DOI DOI 10.1300/J070V08N01_02; Power C, 2005, INT J EPIDEMIOL, V34, P335, DOI 10.1093/ije/dyh394; Power C, 2013, ANNU REV PUBL HEALTH, V34, P7, DOI 10.1146/annurev-publhealth-031912-114423; Pressman SD, 2005, PSYCHOL BULL, V131, P925, DOI 10.1037/0033-2909.131.6.925; Raposa EB, PSYCHOLOGICAL SCIENC; REICH JW, 1984, J COMMUNITY PSYCHOL, V12, P312, DOI 10.1002/1520-6629(198410)12:4<312::AID-JCOP2290120404>3.0.CO;2-B; Reich JW, 1981, J PERS SOC PSYCHOL, V41, P1082; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Rivers C, THE ENCYCLO PEDIA OF; RODIN J, 1986, SCIENCE, V233, P1271, DOI 10.1126/science.3749877; RYFF CD, 1989, J PERS SOC PSYCHOL, V57, P1069, DOI 10.1037/0022-3514.57.6.1069; Schafer MH, 2012, GERONTOLOGIST, V52, P111, DOI 10.1093/geront/gnr071; Schafer MH, CHILD ABUSE NEGLECT; Shields A, 1998, J CLIN CHILD PSYCHOL, V27, P381, DOI 10.1207/s15374424jccp2704_2; Singer JD., 2003, APPL LONGITUDINAL AN; Skinner E. A., 1995, PERCEIVED CONTROL MO, V8; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Strand EB, 2007, COGNITIVE THER RES, V31, P503, DOI 10.1007/s10608-006-9028-7; TAYLOR SE, 1983, AM PSYCHOL, V38, P1161, DOI 10.1037/0003-066X.38.11.1161; Thombs BD, 2006, ARCH INTERN MED, V166, P2020, DOI 10.1001/archinte.166.18.2020; Thorndike E.L., 1920, HARPERS MAGAZINE, V140, P227, DOI DOI 10.1234/12345678; van IJzendoorn MH, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.73; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wegman HL, 2009, PSYCHOSOM MED, V71, P805, DOI 10.1097/PSY.0b013e3181bb2b46; Whitelock CF, 2013, CLIN PSYCHOL SCI, V1, P351, DOI 10.1177/2167702613480136; Zautra A., 2013, RESILIENCE HDB APPRO, P185; Zautra AJ, 2005, J PERS, V73, P1511, DOI 10.1111/j.0022-3506.2005.00357.x; Zautra AJ, NEW DEV EMOTIONAL AG; Zautra AJ, 2012, J PSYCHOTHER INTEGR, V22, P206, DOI 10.1037/a0029573	82	42	42	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121840	10.1371/journal.pone.0121840	http://dx.doi.org/10.1371/journal.pone.0121840			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849572	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800078
J	Techa, S; Chung, JS				Techa, Sirinart; Chung, J. Sook			Ecdysteroids Regulate the Levels of Molt-Inhibiting Hormone (MIH) Expression in the Blue Crab, Callinectes sapidus	PLOS ONE			English	Article							RETINOID-X-RECEPTOR; CRUSTACEAN HYPERGLYCEMIC HORMONE; Y-ORGANS INVITRO; CARCINUS-MAENAS; MANDUCA-SEXTA; FIDDLER-CRAB; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; UCA-PUGILATOR; PROCAMBARUS-CLARKII	Arthropod molt is coordinated through the interplay between ecdysteroids and neuropeptide hormones. In crustaceans, changes in the activity of Y-organs during the molt cycle have been regulated by molt-inhibiting hormone (MIH) and crustacean hyperglycemic hormone (CHH). Little has been known of the mode of direct effects of ecdysteroids on the levels of MIH and CHH in the eyestalk ganglia during the molt cycle. This study focused on a putative feedback of ecdysteroids on the expression levels of MIH transcripts using in vitro incubation study with ecdysteroids and in vivo RNAi in the blue crab, Callinectes sapidus. Our results show a specific expression of ecdysone receptor (EcR) in which EcR1 is the major isoform in eyestalk ganglia. The initial elevation of MIH expression at the early premolt stages is replicated by in vitro incubations of eyestalk ganglia with ecdysteroids that mimic the intrinsic conditions of D-0 stage: the concentration (75 ng/ml) and composition (ponasterone A and 20-hydroxyecdysone at a 3:1 (w:w) ratio). Additionally, multiple injections of EcR1-dsRNA reduce MIH expression by 67%, compared to the controls. Our data provide evidence on a putative feedback mechanism of hormonal regulation during molting cycle, specifically how the molt cycle is repeated during the life cycle of crustaceans. The elevated concentrations of ecdysteroids at early premolt stage may act positively on the levels of MIH expression in the eyestalk ganglia. Subsequently, the increased MIH titers in the hemolymph at postmolt would inhibit the synthesis and release of ecdysteroids by Y-organs, resulting in re-setting the subsequent molt cycle.	[Techa, Sirinart; Chung, J. Sook] Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Columbus Ctr, Baltimore, MD 21202 USA	University System of Maryland; University of Maryland Baltimore; University of Maryland Center for Environmental Science; Institute of Marine & Environmental Technology	Chung, JS (corresponding author), Univ Maryland, Ctr Environm Sci, Inst Marine & Environm Technol, Columbus Ctr, 701 E Pratt St, Baltimore, MD 21202 USA.	chung@umces.edu	Chung, J.Sook/D-3832-2012	Chung, J.Sook/0000-0002-9318-304X	United States-Israel Binational Agricultural Research and Development (BARD) fund [MB-8714-08]; Thai government scholarship (National Science and Technology Development Agency, NSTDA)	United States-Israel Binational Agricultural Research and Development (BARD) fund; Thai government scholarship (National Science and Technology Development Agency, NSTDA)	This work was supported by Research Grant MB-8714-08 from the United States-Israel Binational Agricultural Research and Development (BARD) fund. ST was supported by a Thai government scholarship (National Science and Technology Development Agency, NSTDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGER K, 1987, MAR BIOL, V94, P367, DOI 10.1007/BF00428242; Antoniewski C, 1996, MOL CELL BIOL, V16, P2977; Asazuma H, 2007, COMP BIOCHEM PHYS B, V148, P139, DOI 10.1016/j.cbpb.2007.05.002; BEYDON P, 1983, J INSECT PHYSIOL, V29, P529, DOI 10.1016/0022-1910(83)90084-7; BIDMON HJ, 1992, EXPERIENTIA, V48, P42, DOI 10.1007/BF01923604; Chan SM, 2003, GEN COMP ENDOCR, V134, P214, DOI 10.1016/S0016-6480(03)00263-6; Chan SM, 1998, GENE, V224, P23, DOI 10.1016/S0378-1119(98)00517-4; Chang ES, 2011, GEN COMP ENDOCR, V172, P323, DOI 10.1016/j.ygcen.2011.04.003; Chang ES, 2001, AM ZOOL, V41, P1090, DOI 10.1668/0003-1569(2001)041[1090:HITLOC]2.0.CO;2; Chung ACK, 1998, GEN COMP ENDOCR, V109, P375, DOI 10.1006/gcen.1997.7046; Chung ACK, 1998, MOL CELL ENDOCRINOL, V139, P209, DOI 10.1016/S0303-7207(98)00056-2; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; Chung JS, 2010, ARCH INSECT BIOCHEM, V73, P1, DOI 10.1002/arch.20327; Chung JS, 2010, GEN COMP ENDOCR, V166, P447, DOI 10.1016/j.ygcen.2009.12.011; Chung J Sook, 2008, Saline Syst, V4, P18, DOI 10.1186/1746-1448-4-18; Chung JS, 2005, ENDOCRINOLOGY, V146, P5545, DOI 10.1210/en.2005-0859; Chung JS, 2003, EUR J BIOCHEM, V270, P3280, DOI 10.1046/j.1432-1033.2003.03720.x; Chung JS, 1999, P NATL ACAD SCI USA, V96, P13103, DOI 10.1073/pnas.96.23.13103; Dell S, 1999, ARCH INSECT BIOCHEM, V41, P148, DOI 10.1002/(SICI)1520-6327(1999)41:3&lt;148::AID-ARCH6&gt;3.0.CO;2-U; Diederen JHB, 2002, MICROSC RES TECHNIQ, V56, P227, DOI 10.1002/jemt.10026; DRACH P, 1967, VIE MILIEU A BIOL MA, V18, P595; Durica DS, 2006, INTEGR COMP BIOL, V46, P948, DOI 10.1093/icb/icl005; Durica DS, 2002, MOL CELL ENDOCRINOL, V189, P59, DOI 10.1016/S0303-7207(01)00740-7; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Ghbeish N, 2001, P NATL ACAD SCI USA, V98, P3867, DOI 10.1073/pnas.061437798; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; Gu PL, 1998, FEBS LETT, V441, P397, DOI 10.1016/S0014-5793(98)01573-7; Holen T, 2002, NUCLEIC ACIDS RES, V30, P1757, DOI 10.1093/nar/30.8.1757; HOPKINS PM, 1986, GEN COMP ENDOCR, V63, P362, DOI 10.1016/0016-6480(86)90135-8; HOPKINS PM, 1992, AM ZOOL, V32, P450; KARIM FD, 1992, EMBO J, V11, P4083, DOI 10.1002/j.1460-2075.1992.tb05501.x; Kozlova T, 2000, TRENDS ENDOCRIN MET, V11, P276, DOI 10.1016/S1043-2760(00)00282-4; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Lachaise A., 1993, J CRUSTACEAN BIOL, V13, P198; LACHAISE F, 1984, STEROIDS, V43, P243, DOI 10.1016/0039-128X(84)90043-6; LACHAISE F, 1989, J EXP ZOOL, V252, P283, DOI 10.1002/jez.1402520311; Lu WQ, 2000, GENE, V253, P197, DOI 10.1016/S0378-1119(00)00282-1; Luo KQ, 2004, BIOCHEM BIOPH RES CO, V318, P303, DOI 10.1016/j.bbrc.2004.04.027; Martin-Creuzburg D, 2007, GEN COMP ENDOCR, V151, P66, DOI 10.1016/j.ygcen.2006.11.015; MATTSON MP, 1986, BIOL BULL, V171, P264, DOI 10.2307/1541922; MATTSON MP, 1986, GEN COMP ENDOCR, V63, P414, DOI 10.1016/0016-6480(86)90141-3; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nagaraju GPC, 2011, J ENDOCRINOL, V210, P379, DOI 10.1530/JOE-11-0154; Nakatsuji T, 2004, GEN COMP ENDOCR, V135, P358, DOI 10.1016/j.ygcen.2003.11.001; Nakatsuji T, 2006, MOL CELL ENDOCRINOL, V253, P76, DOI 10.1016/j.mce.2006.05.001; Nimitkul S, 2010, SICB M, V129; Oates AC, 2000, DEV BIOL, V224, P20, DOI 10.1006/dbio.2000.9761; REES HH, 1995, EUR J ENTOMOL, V92, P9; SAKURAI S, 1989, GEN COMP ENDOCR, V75, P204, DOI 10.1016/0016-6480(89)90072-5; Seinen E, 2011, BRIEF FUNCT GENOMICS, V10, P206, DOI 10.1093/bfgp/elr017; SNYDER MJ, 1991, GEN COMP ENDOCR, V81, P133, DOI 10.1016/0016-6480(91)90133-Q; SODERHALL K, 1983, DEV COMP IMMUNOL, V7, P229, DOI 10.1016/0145-305X(83)90004-6; SPAZIANI E, 1993, MOL CELL ENDOCRINOL, V95, P111, DOI 10.1016/0303-7207(93)90035-I; Styrishave B, 2008, J MAR BIOL ASSOC UK, V88, P575, DOI [10.1017/S0025315408000878, 10.1017/S0025315408000879]; Suganthi AS, 1999, ZOOL STUD, V38, P314; Takaki K, 2003, INSECT BIOCHEM MOLEC, V33, P1189, DOI 10.1016/j.ibmb.2003.06.006; TAMONE SL, 1993, GEN COMP ENDOCR, V89, P425, DOI 10.1006/gcen.1993.1050; Tarrant AM, 2011, GEN COMP ENDOCR, V173, P346, DOI 10.1016/j.ygcen.2011.06.010; Techa S, 2013, GENE, V527, P139, DOI 10.1016/j.gene.2013.05.035; Thomton JD, 2006, J CRUSTACEAN BIOL, V26, P176, DOI 10.1651/C-2625.1; TRAVIS DF, 1955, BIOL BULL, V109, P484, DOI 10.2307/1539178; Truman JW, 1996, SCIENCE, V271, P40, DOI 10.1126/science.271.5245.40; Van der Horst DJ, 2003, COMP BIOCHEM PHYS B, V136, P217, DOI 10.1016/S1096-4959(03)00151-9; Verhaegen Y, 2011, GEN COMP ENDOCR, V172, P158, DOI 10.1016/j.ygcen.2011.02.019; Wang WL, 2000, J EXP ZOOL, V286, P725, DOI 10.1002/(SICI)1097-010X(20000601)286:7<725::AID-JEZ7>3.0.CO;2-N; Wang YH, 2009, MOL CELL ENDOCRINOL, V309, P109, DOI 10.1016/j.mce.2009.05.016; WATSON RD, 1986, INSECT BIOCHEM, V16, P149, DOI 10.1016/0020-1790(86)90089-2; WEBSTER SG, 1986, GEN COMP ENDOCR, V61, P237, DOI 10.1016/0016-6480(86)90201-7; WEBSTER SG, 1986, J COMP PHYSIOL B, V156, P617, DOI 10.1007/BF00692738; Webster SG, 2012, GEN COMP ENDOCR, V175, P217, DOI 10.1016/j.ygcen.2011.11.035; WHISENTON LR, 1987, GEN COMP ENDOCR, V66, P62, DOI 10.1016/0016-6480(87)90350-9; WHISENTON LR, 1987, MOL CELL ENDOCRINOL, V54, P171, DOI 10.1016/0303-7207(87)90154-7; Zmora N, 2014, ENDOCRINOLOGY, V155, P230, DOI 10.1210/en.2013-1603; Zmora Nilli, 2009, Saline Syst, V5, P6, DOI 10.1186/1746-1448-5-6; Zmora Nilli, 2009, Saline Syst, V5, P7, DOI 10.1186/1746-1448-5-7	75	44	45	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0117278	10.1371/journal.pone.0117278	http://dx.doi.org/10.1371/journal.pone.0117278			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849453	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800003
J	Yang, XJ; Wang, X; Wang, K; Su, LX; Li, HM; Li, R; Shen, QR				Yang, Xiujuan; Wang, Xuan; Wang, Kang; Su, Lanxi; Li, Hongmei; Li, Rong; Shen, Qirong			The Nematicidal Effect of Camellia Seed Cake on Root-Knot Nematode Meloidogyne javanica of Banana	PLOS ONE			English	Article							CHROMATOGRAPHY-MASS SPECTROMETRY; SOLID-PHASE MICROEXTRACTION; PLANT-PARASITIC NEMATODES; TRITERPENOID SAPONINS; PANAX-NOTOGINSENG; IDENTIFICATION; STRATEGIES; INCOGNITA; EXTRACTS; SYSTEMS	Suppression of root-knot nematodes is crucially important for maintaining the worldwide development of the banana industry. Growing concerns about human and environmental safety have led to the withdrawal of commonly used nematicides and soil fumigants, thus motivating the development of alternative nematode management strategies. In this study, Meloidogyne javanica was isolated, and the nematicidal effect of Camellia seed cake on this pest was investigated. The results showed that in dish experiments, Camellia seed cake extracts under low concentration (2 g/L) showed a strong nematicidal effect. After treatment for 72 h, the eggs of M. javanica were gradually dissolved, and the intestine of the juveniles gradually became indistinct. Nematicidal compounds, including saponins identified by HPLC-ESI-MS and 8 types of volatile compounds identified by GC-MS, exhibited effective nematicidal activities, especially 4-methylphenol. The pot experiments demonstrated that the application of Camellia seed cake suppressed M. javanica, and promoted the banana plant growth. This study explored an effective nematicidal agent for application in soil and revealed its potential mechanism of nematode suppression.	[Yang, Xiujuan; Wang, Kang; Su, Lanxi; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China; [Yang, Xiujuan; Wang, Kang; Su, Lanxi; Li, Rong; Shen, Qirong] Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Engn Ctr Solid Organ Waste Utilizat, Nanjing, Jiangsu, Peoples R China; [Wang, Xuan; Li, Hongmei] Nanjing Agr Univ, Dept Plant Pathol, Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University; Nanjing Agricultural University	Li, R (corresponding author), Nanjing Agr Univ, Jiangsu Collaborat Innovat Ctr Solid Organ Waste, Natl Engn Res Ctr Organ Based Fertilizers, Jiangsu Key Lab, Nanjing, Jiangsu, Peoples R China.	lirong@njau.edu.cn	Shen, Qirong/AAB-6531-2020; Yang, Xiujuan/HHC-5802-2022	Yang, Xiujuan/0000-0002-1923-0629	National Key Basic Research Program of China [2015CB150506]; National Natural Science Foundation of China [31372142]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project [B12009]; National Key Technology R&D Program of the Ministry of Science and Technology [2011BAD11B03]; Innovative Research Team Development Plan of the Ministry of Education of China [IRT1256]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); 111 project(Ministry of Education, China - 111 Project); National Key Technology R&D Program of the Ministry of Science and Technology(National Key Technology R&D Program); Innovative Research Team Development Plan of the Ministry of Education of China	This work was supported by the National Key Basic Research Program of China (2015CB150506), the National Natural Science Foundation of China (31372142), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), 111 project (B12009), the National Key Technology R&D Program of the Ministry of Science and Technology (2011BAD11B03), and the Innovative Research Team Development Plan of the Ministry of Education of China (IRT1256). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MAM, 2007, PLANT PATHOL, V56, P190, DOI 10.1111/j.1365-3059.2006.01455.x; BYBD DW, 1983, J NEMATOL, V15, P142; Chen RS, 2012, PADDY WATER ENVIRON, V10, P291, DOI 10.1007/s10333-011-0280-4; Chitwood DJ, 2002, ANNU REV PHYTOPATHOL, V40, P221, DOI 10.1146/annurev.phyto.40.032602.130045; D'Addabbo T, 2011, PHYTOCHEM REV, V10, P503, DOI 10.1007/s11101-010-9180-2; Dawar S, 2007, PAK J BOT, V39, P2209; Dinda B, 2010, CHEM BIODIVERS, V7, P2327, DOI 10.1002/cbdv.200800070; El-Rokiek Kowthar Gad, 2011, Journal of Plant Protection Research, V51, P121, DOI 10.2478/v10045-011-0021-0; Farag MA, 2006, PHYTOCHEMISTRY, V67, P2262, DOI 10.1016/j.phytochem.2006.07.021; Gonzalez JM, 1999, APPL ENVIRON MICROB, V65, P1463; Gowen S., 1990, P431; [贺国文 He Guowen], 2008, [理化检验. B, 化学分册, Physical Testing and Chemical Analysis], V44, P1169; Huang Yong, 2013, Journal of Southwest Forestry University, V33, P1; Hussain MA, 2011, PAK J BOT, V43, P197; Irshad U, 2011, SOIL BIOL BIOCHEM, V43, P2121, DOI 10.1016/j.soilbio.2011.06.015; Jabeen S., 1996, Proceedings of Parasitology, P11; JaizmeVega MC, 1997, PLANT SOIL, V196, P27, DOI 10.1023/A:1004236310644; Jiang Y, 2012, EUR J SOIL BIOL, V52, P20, DOI 10.1016/j.ejsobi.2012.05.003; Lee CP, 2006, J AGR FOOD CHEM, V54, P779, DOI 10.1021/jf052325a; Li G, 2013, Patent No. [CN103439426A, 103439426]; Li H, 2008, NEMATOLOGY, V10, P335, DOI 10.1163/156854108783900294; Long J, 2010, N CHINA HORTICULTURE, V22, P148; Mansoor F, 2007, PAK J BOT, V39, P2113; MOJTAHEDI H, 1991, J NEMATOL, V23, P170; Njuguna D. G., 2013, International Journal of Research in Chemistry and Environment (IJRCE), V3, P253; Oka Y, 2000, PEST MANAG SCI, V56, P983, DOI 10.1002/1526-4998(200011)56:11<983::AID-PS233>3.0.CO;2-X; Oka Y, 2013, PEST MANAG SCI, V69, P1225, DOI 10.1002/ps.3487; Pradhan M. A. A., 2012, Bangladesh Journal of Agricultural Research, V37, P271, DOI 10.3329/bjar.v37i2.11230; Queneherve P, 2009, EUPHYTICA, V165, P123, DOI 10.1007/s10681-008-9773-7; Remen C, 2010, SOIL BIOL BIOCHEM, V42, P978, DOI 10.1016/j.soilbio.2010.02.017; Rumbos CI, 2011, AUST J CROP SCI, V5, P1388; Shen ZZ, 2013, EUR J SOIL BIOL, V57, P1, DOI 10.1016/j.ejsobi.2013.03.006; Siddiqui MA, 2003, SOIL BIOL BIOCHEM, V35, P1615, DOI 10.1016/j.soilbio.2003.08.006; SIKORA RA, 1973, PLANT DIS REP, V57, P615; Silva CL, 2011, BRIT J CANCER, V105, P1894, DOI 10.1038/bjc.2011.437; Strobel GA, 2001, MICROBIOL-SGM, V147, P2943, DOI 10.1099/00221287-147-11-2943; Sun HX, 2005, VACCINE, V23, P5533, DOI 10.1016/j.vaccine.2005.07.036; Tian JK, 2006, CHEM PHARM BULL, V54, P567, DOI 10.1248/cpb.54.567; TOMASZEWSKI EK, 1994, J NEMATOL, V26, P436; Tranthim-Fryer DJ, 2001, J FORENSIC SCI, V46, P934; Vovlas N, 2005, PLANT PATHOL, V54, P657, DOI 10.1111/j.1365-3059.2005.01244.x; Wang BB, 2013, BIOL FERT SOILS, V49, P435, DOI 10.1007/s00374-012-0739-5; Wang KH, 2009, PLANT DIS, pPD; Wang LongPing, 2013, Journal of Anhui Agricultural University, V40, P642; Wardencki W, 2004, INT J FOOD SCI TECH, V39, P703, DOI 10.1111/j.1365-2621.2004.00839.x; Xiao TongJian, 2012, African Journal of Microbiology Research, V6, P2321; Yoshikawa M, 1997, CHEM PHARM BULL, V45, P1039, DOI 10.1248/cpb.45.1039	47	14	15	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119700	10.1371/journal.pone.0119700	http://dx.doi.org/10.1371/journal.pone.0119700			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849382	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800015
J	Yin, L; Ling, XY; Zhang, YF; Shen, H; Min, J; Xi, W; Wang, J; Wang, ZN				Yin, Liang; Ling, Xinyu; Zhang, Yufeng; Shen, Hua; Min, Jie; Xi, Wang; Wang, Jing; Wang, Zhinong			CHADS(2) and CHA(2)DS(2)-VASc Scoring Systems for Predicting Atrial Fibrillation following Cardiac Valve Surgery	PLOS ONE			English	Article							MANAGEMENT; GUIDELINES; PREVENTION; MORTALITY; OUTCOMES; UPDATE; RISKS	Objective Clinical use of CHADS(2) and CHA(2)DS(2)-VASc scoring systems for predicting AF following cardiac surgery have been reported in previous studies and demonstrated well-validated predictive value. We sought to investigate whether the two scoring systems are effective for predicting new-onset of AF following cardiac valve surgery and to demonstrate its potential utility of clinical assessment. Methods Medical records of all patients underwent cardiac valve surgeries during the period of January 2003 and December 2013 without preoperative AF at the cardiac center of our university were reviewed. The main outcome end point of our study was the early new-onset of AF following cardiac valve surgery. Results There were overall 518 patients involved in this study, with 234 (45.17%) developed POAF following valve surgery. Patients with POAF had older age (P = 0.23) and higher BMI (P = 0.013) than those without POAF. History of heart failure (P = 0.025), hypertension (P = 0.021), previous stroke or TIA (P = 0.032), coronary artery disease (P = 0.001), carotid artery disease (P = 0.024) and preoperative medication of statins (P = 0.021) were significantly more recorded in POAF group. Patients with POAF also had higher LAD (P = 0.013) and E/e' ratio (P < 0.001). The CHADS(2) and CHA(2)DS(2)-VASc scores were significantly higher in patients with POAF (P = 0.002; P < 0.001), and under univariate and multivariate regression analysis the CHADS(2) and CHA(2)DS(2)-VASc scores were significant predictors of POAF (P = 0.001; P < 0.001). Based on stratification of CHADS(2) and CHA(2)DS(2)-VASc scores, the Kaplan-Meier analysis obtained a higher POAF rate on patients with higher stratification of CHADS(2) and CHA(2)DS(2)-VASc scores (P < 0.001; P < 0.001). Conclusion In conclusion, CHADS(2) and CHA(2)DS(2)-VASc scores were directly associated with the incidence of POAF following valve surgery and a higher score was strongly predictive of POAF.	[Yin, Liang; Ling, Xinyu; Zhang, Yufeng; Shen, Hua; Min, Jie; Xi, Wang; Wang, Jing; Wang, Zhinong] Second Mil Med Univ, Dept Cardiothorac Surg, Changzheng Hosp, Shanghai 200003, Peoples R China	Naval Medical University	Wang, ZN (corresponding author), Second Mil Med Univ, Dept Cardiothorac Surg, Changzheng Hosp, Shanghai 200003, Peoples R China.	wangzn007@163.com	Zhang, Yufeng/GZL-1973-2022		National Nature Science Foundation of China [81170232, 81300102]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Nature Science Foundation of China (NO. 81170232 and 81300102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlsson A, 2014, SCANDINAVIAN CARDIOV; Anderson JL, 2013, CIRCULATION, V127, P1916, DOI 10.1161/CIR.0b013e318290826d; Andrikopoulos G, 2012, HELL J CARDIOL, V53, P407; Azemi T, 2012, J AM SOC ECHOCARDIOG, V25, P1327, DOI 10.1016/j.echo.2012.09.004; Benedetto U, 2013, J CARDIOVASC MED, V14, P104, DOI 10.2459/JCM.0b013e32834a13c1; Bhave PD, 2012, AM HEART J, V164, P918, DOI 10.1016/j.ahj.2012.09.004; Bramer S, 2011, ANN THORAC SURG, V92, P2091, DOI 10.1016/j.athoracsur.2011.06.079; Camm AJ, 2012, EUR HEART J, V33, P2719, DOI 10.1093/eurheartj/ehs253; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Carmo GAL, 2012, HEART RHYTHM, V9, pE12, DOI 10.1016/j.hrthm.2012.03.043; Chao TF, 2011, J AM COLL CARDIOL, V58, P2380, DOI 10.1016/j.jacc.2011.08.045; Chua SK, 2013, CIRCULATION J OFFICI, V78, P265; Chua SK, 2013, J THORAC CARDIOV SUR, V146, P919, DOI 10.1016/j.jtcvs.2013.03.040; Curtis AB, 2011, POSTGRAD MED, V123, P7, DOI 10.3810/pgm.2011.11.2491; Efird JT, 2014, EUR J CARDIO-THORAC, V45, pE20, DOI 10.1093/ejcts/ezt529; Erdil N, 2013, ANN THORACIC CARDIOV; Hashemzadeh K, 2013, J CARDIOVASC THORAC, V5, P101, DOI 10.5681/jcvtr.2013.022; Hogue CW, 2005, CHEST, V128, p9S, DOI 10.1378/chest.128.2_suppl.9S; Hung CY, 2013, AM J MED, V126, P133, DOI 10.1016/j.amjmed.2012.06.027; Kotowycz MA, 2011, CAN J CARDIOL, V27, P506, DOI 10.1016/j.cjca.2011.01.002; Lorenzo-Seva U, 2010, BEHAV RES METHODS, V42, P29, DOI 10.3758/BRM.42.1.29; Meiltz A, 2008, EUROPACE, V10, P674, DOI 10.1093/europace/eun086; Narducci ML, 2013, J CARDIOTHORACIC VAS; Omae T, 2012, J ANESTH, V26, P429, DOI 10.1007/s00540-012-1330-9; Yin L, 2010, HEART LUNG CIRC, V19, P579, DOI 10.1016/j.hlc.2010.06.664	25	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123858	10.1371/journal.pone.0123858	http://dx.doi.org/10.1371/journal.pone.0123858			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849563	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800257
J	Zhang, ML; Wen, ZB; Fritsch, PW; Sanderson, SC				Zhang, Ming-Li; Wen, Zhi-Bin; Fritsch, Peter W.; Sanderson, Stewart C.			Spatiotemporal Evolution of Calophaca (Fabaceae) Reveals Multiple Dispersals in Central Asian Mountains	PLOS ONE			English	Article							TIBETAN PLATEAU; LATE MIOCENE; MOLECULAR PHYLOGENY; VICARIANCE ANALYSIS; GLACIAL REFUGIA; UPLIFT; DIVERSIFICATION; BIOGEOGRAPHY; RADIATION; PATTERNS	Background The Central Asian flora plays a significant role in Eurasia and the Northern Hemisphere. Calophaca, a member of this flora, includes eight currently recognized species, and is centered in Central Asia, with some taxa extending into adjacent areas. A phylogenetic analysis of the genus utilizing nuclear ribosomal ITS and plastid trnS-trnG and rbcL sequences was carried out in order to confirm its taxonomic status and reconstruct its evolutionary history. Methodology/Principal Finding We employed BEAST Bayesian inference for dating, and S-DIVA and BBM for ancestral area reconstruction, to study its spatiotemporal evolution. Our results show that Calophacais monophyletic and nested within Caragana. The divergence time of Calophaca is estimated at ca. 8.0 Ma, most likely driven by global cooling and aridification, influenced by rapid uplift of the Qinghai Tibet Plateau margins. Conclusions/Significance According to ancestral area reconstructions, the genus most likely originated in the Pamir Mountains, a global biodiversity hotspot and hypothesized Tertiary refugium of many Central Asian plant lineages. Dispersals from this location are inferred to the western Tianshan Mountains, then northward to the Tarbagatai Range, eastward to East Asia, and westward to the Caucasus, Russia, and Europe. The spatiotemporal evolution of Calophaca provides a case contributing to an understanding of the flora and biodiversity of the Central Asian mountains and adjacent regions.	[Zhang, Ming-Li; Wen, Zhi-Bin] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China; [Zhang, Ming-Li] Chinese Acad Sci, Inst Bot, Beijing, Peoples R China; [Fritsch, Peter W.] Calif Acad Sci, Dept Bot, San Francisco, CA 94118 USA; [Sanderson, Stewart C.] US Forest Serv, Shrub Sci Lab, Intermt Res Stn, USDA, Provo, UT USA	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; California Academy of Sciences; United States Department of Agriculture (USDA); United States Forest Service	Zhang, ML (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Key Lab Biogeog & Bioresource Arid Land, Urumqi, Peoples R China.	zhangml@ibcas.ac.cn			China National Basic Research Special Program [2012FY111500]; Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China [KZCX2-YW-T09]; State International Science and Technology Cooperation Program of China [2010DFA92720]; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences	China National Basic Research Special Program; Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China; State International Science and Technology Cooperation Program of China; Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was funded by China National Basic Research Special Program (2012FY111500), Innovation Research Group Program of Chinese Academy of Sciences and State Administration of Foreign Experts Affairs of China (KZCX2-YW-T09), State International Science and Technology Cooperation Program of China (2010DFA92720), and Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGAKHANJANZ O, 1995, ECOL STUD-ANAL SYNTH, V113, P63; Ali SS, 2012, ANN BOT-LONDON, V109, P95, DOI 10.1093/aob/mcr274; Almeida EAB, 2012, J BIOGEOGR, V39, P526, DOI 10.1111/j.1365-2699.2011.02624.x; An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; [Anonymous], 1963, PLANTS CENTRAL ASIA, p[1, 1]; Borissova AG, 1945, FLORA USSR, V11, P327; CERLING TE, 1993, NATURE, V361, P344, DOI 10.1038/361344a0; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; [常朝阳 Chang Zhaoyang], 2004, [西北植物学报, Acta Botanica Boreali-Occidentalla Sinica], V24, P2312; Clayton JW, 2009, SYST BIOL, V58, P395, DOI 10.1093/sysbio/syp041; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Doyle J. J., 1987, PHYTOCHEM B, P11; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ducea MN, 2003, GEOLOGY, V31, P849, DOI 10.1130/G19707.1; Farris JS, 1995, CLADISTICS, V10, P315, DOI [DOI 10.1111/J.1096-0031.1994.TB00181.X, DOI 10.1111/J.1096-0031.1996.TB00196.X]; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gorbunova NN, 1987, SYSTEMATICS CARAGANA; Guo ZT, 2008, CLIM PAST, V4, P153, DOI 10.5194/cp-4-153-2008; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Jia DR, 2012, NEW PHYTOL, V194, P1123, DOI 10.1111/j.1469-8137.2012.04115.x; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Kadereit JW, 2008, PLANT ECOL DIVERS, V1, P171, DOI 10.1080/17550870802328751; Kreuter E, 1955, CHROMOSOME ATLAS FLO, P163; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Li S-F, 1998, ACTA BOT BOR OCCID S, V18, P58; Liu JQ, 2006, MOL PHYLOGENET EVOL, V38, P31, DOI 10.1016/j.ympev.2005.09.010; Liu XJ, 2012, QUAT GEOCHRONOL, V10, P37, DOI 10.1016/j.quageo.2012.01.016; Lock J.M., 2005, LEGUMES WORLD, P489; Ma Qian, 2012, Chinese Journal of Applied and Environmental Biology, V18, P391, DOI 10.3724/SP.J.1145.2012.00391; Magulaev A. Yu., 1980, Botanicheskii Zhurnal, V65, P836; Malyshev LI, 2008, CONTEMP PROBL ECOL+, V1, P440, DOI 10.1134/S1995425508040073; Mao KS, 2012, P NATL ACAD SCI USA, V109, P7793, DOI 10.1073/pnas.1114319109; Medail F, 1999, CONSERV BIOL, V13, P1510, DOI 10.1046/j.1523-1739.1999.98467.x; Medail F, 2009, J BIOGEOGR, V36, P1333, DOI 10.1111/j.1365-2699.2008.02051.x; Miao YF, 2012, EARTH-SCI REV, V112, P155, DOI 10.1016/j.earscirev.2012.02.003; Miao YF, 2011, QUATERN INT, V236, P3, DOI 10.1016/j.quaint.2010.08.014; Molnar P, 2005, PALAEONTOL ELECTRON, V8; MOLNAR P, 1993, REV GEOPHYS, V31, P357, DOI 10.1029/93RG02030; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Polhill R. M., 1981, Advances in legume systematics. Part 1 [Polhill, R.M.; Raven, P.H. (Editors)]., P1; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Pyankov VI, 2000, OECOLOGIA, V123, P15, DOI 10.1007/s004420050985; Qiu YX, 2011, MOL PHYLOGENET EVOL, V59, P225, DOI 10.1016/j.ympev.2011.01.012; QUADE J, 1995, PALAEOGEOGR PALAEOCL, V115, P91, DOI 10.1016/0031-0182(94)00108-K; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Schonswetter P, 2005, MOL ECOL, V14, P3547, DOI 10.1111/j.1365-294X.2005.02683.x; Stewart JR, 2010, P ROY SOC B-BIOL SCI, V277, P661, DOI 10.1098/rspb.2009.1272; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; Sun JM, 2009, GEOLOGY, V37, P1051, DOI 10.1130/G30278A.1; Sun JM, 2009, TECTONOPHYSICS, V463, P60, DOI 10.1016/j.tecto.2008.09.008; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Takhtajan A, 1969, FLOWERING PLANTS ORI; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang YJ, 2004, ACTA PHYTOTAXON SIN, V42, P481; Wang YJ, 2009, BIOL J LINN SOC, V97, P893, DOI 10.1111/j.1095-8312.2009.01225.x; Wojciechowski M.F., 2000, ADV LEGUME SYST, V9, P277; Wojciechowski MF, 2005, BRITTONIA, V57, P382, DOI 10.1663/0007-196X(2005)057[0382:AFAMPP]2.0.CO;2; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; Wulff E, 1944, HIST PLANT GEOGRAPHY; Xu L-R, 1992, ACTA BOT BOREAL OCCI, V12, P149; Yakovlev G.P., 1996, LEGUMES NO EURASIA C; Yu Y., 2011, RASP RECONSTRUCT ANC; Zachos F.E., 2011, BIODIVERSITY HOTSPOT; Zhang ML, 2010, PLANT SYST EVOL, V288, P191, DOI 10.1007/s00606-010-0324-z; Zhang ML, 2009, MOL PHYLOGENET EVOL, V50, P547, DOI 10.1016/j.ympev.2008.12.001; Zhang Z-W, 1993, FLORA CHINA, V42, P67; Zheng HB, 2000, GEOLOGY, V28, P715, DOI 10.1130/0091-7613(2000)028<0715:PUOTNT>2.3.CO;2; Zhu X-Y, 2010, FLORA CHINA, V10, P527	73	7	7	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123228	10.1371/journal.pone.0123228	http://dx.doi.org/10.1371/journal.pone.0123228			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849146	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800216
J	Xu, L; Cao, F; Xu, F; He, BC; Dong, Z				Xu, Lu; Cao, Fang; Xu, Feng; He, Baicheng; Dong, Zhi			Bexarotene Reduces Blood-Brain Barrier Permeability in Cerebral Ischemia-Reperfusion Injured Rats	PLOS ONE			English	Article							APOLIPOPROTEIN-E; MATRIX METALLOPROTEINASES; IN-VITRO; MICE; MODELS; ISCHEMIA/REPERFUSION; INTEGRITY; INFUSION; DISEASE; STROKE	Background Matrix metalloproteinase-9 (MMP-9) over-expression disrupts the blood-brain barrier (BBB) in the ischemic brain. The retinoid X receptor agonist bexarotene suppresses MMP-9 expression in endothelial cells and displays neuroprotective effects. Therefore, we hypothesized that bexarotene may have a beneficial effect on I/R-induced BBB dysfunction. Methods A total of 180 rats were randomized into three groups (n = 60 each): (i) a sham-operation group, (ii) a cerebral ischemia-reperfusion (I/R) group, and (iii) an I/R+bexarotene group. Brain water content was measured by the dry wet weight method. BBB permeability was analyzed by Evans Blue staining and the magnetic resonance imaging contrast agent Omniscan. MMP-9 mRNA expression, protein expression, and activity were assessed by reverse transcription polymerase chain reaction, Western blotting, and gelatin zymography, respectively. Apolipoprotein E (apoE), claudin-5, and occludin expression were analyzed by Western blotting. Results After 24 h, 48 h, and 72 h post-I/R, several effects were observed with bexarotene administration: (i) brain water content and BBB permeability were significantly reduced; (ii) MMP-9 mRNA and protein expression as well as activity were significantly decreased; (iii) claudin-5 and occludin expression were significantly increased; and (iv) apoE expression was significantly increased. Conclusions Bexarotene decreases BBB permeability in rats with cerebral I/R injury. This effect may be due in part to bexarotene's upregulation of apoE expression, which has been previously shown to reduce BBB permeability through suppressing MMP-9-mediated degradation of the tight junction proteins claudin-5 and occludin. This work offers insight to aid future development of therapeutic agents for cerebral I/R injury in human patients.	[Xu, Lu; Cao, Fang; Xu, Feng; He, Baicheng; Dong, Zhi] Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China	Chongqing Medical University	Dong, Z (corresponding author), Chongqing Med Univ, Coll Pharm, Chongqing Key Lab Biochem & Mol Pharmacol, Chongqing 400016, Peoples R China.	dongzhi8623@163.com			 [2010ZX09401-306-1-1]		This study was financially supported by the national major special fund(2010ZX09401-306-1-1) 2010-2013, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibhatla RM, 2008, CNS NEUROL DISORD-DR, V7, P243, DOI 10.2174/187152708784936608; Akamatsu Y, 2011, NEUROSCI LETT, V503, P110, DOI 10.1016/j.neulet.2011.08.018; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bomben V, 2014, NEUROBIOL AGING, V35, P2091, DOI 10.1016/j.neurobiolaging.2014.03.029; Chen F, 2009, HEPATOLOGY, V50, P1914, DOI 10.1002/hep.23203; Clark AW, 1997, NEUROSCI LETT, V238, P53, DOI 10.1016/S0304-3940(97)00859-8; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Fu JJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-227; Fullerton SM, 2001, EXP NEUROL, V169, P13, DOI 10.1006/exnr.2001.7631; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Horsburgh K, 2000, J CEREBR BLOOD F MET, V20, P458, DOI 10.1097/00004647-200003000-00003; Lerner V, 2013, J CLIN PSYCHIAT, V74, P1224, DOI 10.4088/JCP.12m08160; Liu Y, 2014, BRAIN RES, V1544, P45, DOI 10.1016/j.brainres.2013.11.031; Lomnitski L, 1999, BBA-MOL BASIS DIS, V1453, P359, DOI 10.1016/S0925-4439(99)00010-1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Lynch JR, 2002, ANN NEUROL, V51, P113, DOI 10.1002/ana.10098; Lynch JR, 2001, J NEUROIMMUNOL, V114, P107, DOI 10.1016/S0165-5728(00)00459-8; McFarland K, 2013, ACS CHEM NEUROSCI, V4, P1430, DOI 10.1021/cn400100f; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Shimbo D, 2014, BRAIN RES, V1554, P59, DOI 10.1016/j.brainres.2014.01.038; Ulrich JD, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-13; Vonderheid Eric C, 2003, Dermatol Ther, V16, P276, DOI 10.1111/j.1396-0296.2003.01638.x; Wu YJ, 2014, NEUROSCI LETT, V558, P26, DOI 10.1016/j.neulet.2013.09.005; Xin HL, 2012, NEURAL REGEN RES, V7, P2405, DOI 10.3969/j.issn.1673-5374.2012.31.001; Yamashita T, 2011, ACTA MED OKAYAMA, V65, P219; Zheng MH, 2014, J MOL NEUROSCI, V54, P282, DOI 10.1007/s12031-014-0291-x; Zhou S, 2013, FEBS LETT, V587, P254, DOI 10.1016/j.febslet.2012.12.003	30	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0122744	10.1371/journal.pone.0122744	http://dx.doi.org/10.1371/journal.pone.0122744			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844636	gold, Green Published, Green Submitted			2022-12-26	WOS:000352475700013
J	Boittin, FX; Denis, J; Mayol, JF; Martigne, P; Raffin, F; Coulon, D; Grenier, N; Drouet, M; Herodin, F				Boittin, Francois-Xavier; Denis, Josiane; Mayol, Jean-Francois; Martigne, Patrick; Raffin, Florent; Coulon, David; Grenier, Nancy; Drouet, Michel; Herodin, Francis			The Extent of Irradiation-Induced Long-Term Visceral Organ Damage Depends on Cranial/Brain Exposure	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; PITUITARY-ADRENAL AXIS; NECROSIS-FACTOR-ALPHA; IONIZING-RADIATION; BRAIN IRRADIATION; DRUG PHARMACOKINETICS; DYSFUNCTION SYNDROME; RAT-BRAIN; ADULT-RAT; MICE	In case of high-dose radiation exposure, mechanisms controlling late visceral organ damage are still not completely understood and may involve the central nervous system. To investigate the influence of cranial/brain irradiation on late visceral organ damage in case of high-dose exposure, Wistar rats were irradiated at 12 Gy, with either the head and fore limbs or the two hind limbs protected behind a lead wall (head-and hind limbs-protected respectively), which allows long-term survival thanks to bone marrow protection. Although hind limbs- and head-protected irradiated rats exhibited similar hematopoietic and spleen reconstitution, a late body weight loss was observed in hind limbs-protected rats only. Histological analysis performed at this time revealed that late damages to liver, kidney and ileum were attenuated in rats with head exposed when compared to animals whose head was protected. Plasma measurements of inflammation biomarkers (haptoglobin and the chemokine CXCL1) suggest that the attenuated organ damage in hind limbs-protected rats may be in part related to reduced acute and chronic inflammation. Altogether our results demonstrate the influence of cranial/brain exposure in the onset of organ damage.	[Boittin, Francois-Xavier; Denis, Josiane; Mayol, Jean-Francois; Martigne, Patrick; Raffin, Florent; Coulon, David; Grenier, Nancy; Drouet, Michel; Herodin, Francis] Inst Rech Biomed Armees, Dept Radiobiol, Bretigny Sur Orge, France		Boittin, FX (corresponding author), Inst Rech Biomed Armees, Dept Radiobiol, Bretigny Sur Orge, France.	francois-xavier.boittin@irba.fr			DGA (Direction Generale de l'Armement) [PDH2-NRBC4-NR404]	DGA (Direction Generale de l'Armement)	This work was supported by a grant from DGA (Direction Generale de l'Armement): Grant PDH2-NRBC4-NR404.	Booth C, 2012, HEALTH PHYS, V103, P400, DOI 10.1097/HP.0b013e31826530e2; Chiang CS, 1997, INT J RADIAT BIOL, V72, P45, DOI 10.1080/095530097143527; De la Cal C, 2012, OPEN DENT J, V6, P8, DOI 10.2174/1874210601206010008; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Fares RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053888; Fernandez R, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00489; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Gaugler M-H, 2005, BRIT J RADIOL, V78, P100, DOI [10.1259/bjr/24511652, DOI 10.1259/BJR/24511652]; GERACI JP, 1995, RADIAT RES, V143, P58, DOI 10.2307/3578926; GIRINSKY TA, 1994, RADIAT RES, V139, P360, DOI 10.2307/3578835; Gourmelon P., 2005, BR J RADIOL S, V78, P62; Groza P, 1975, Physiologie, V12, P53; Hellstraom NAK, 2009, STEM CELLS, V27, P634, DOI 10.1634/stemcells.2008-0732; HONG JH, 1995, INT J RADIAT ONCOL, V33, P619, DOI 10.1016/0360-3016(95)00279-8; Johnston CJ, 2010, RADIAT RES, V173, P522, DOI 10.1667/RR1882.1; Lebaron-Jacobs L, 2004, RADIAT RES, V161, P712, DOI 10.1667/RR3180; Linard C, 2005, J NEUROIMMUNOL, V168, P83, DOI 10.1016/j.jneuroim.2005.07.007; Ma SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056607; Magana E, 2003, SOUTH MED J, V96, P521, DOI 10.1097/01.SMJ.0000054502.81803.A3; MAGIC Z, 1995, RADIAT RES, V143, P187, DOI 10.2307/3579156; Marquette C, 2003, INT J RADIAT BIOL, V79, P777, DOI 10.1080/09553000310001610998; Merino-Sanjuan M, 2011, NUTR HOSP, V26, P1296, DOI [10.1590/S0212-16112011000600016, 10.3305/nh.2011.26.6.5403]; MICHALOWSKI AS, 1994, ACTA ONCOL, V33, P139, DOI 10.3109/02841869409098397; MINKOVA M I, 1988, Acta Physiologica et Pharmacologica Bulgarica, V14, P63; Mizock BA, 2009, DM-DIS MON, V55, P476, DOI 10.1016/j.disamonth.2009.04.002; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; MOULDER JE, 1990, INT J RADIAT ONCOL, V19, P1389, DOI 10.1016/0360-3016(90)90349-O; Olson TS, 2002, AM J PHYSIOL-REG I, V283, pR7, DOI 10.1152/ajpregu.00738.2001; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Rabbani ZN, 2007, INT J RADIAT ONCOL, V67, P573, DOI 10.1016/j.ijrobp.2006.09.053; Randall K, 1996, INT J RADIAT BIOL, V70, P351, DOI 10.1080/095530096145085; RAO KR, 1988, BRIT J RADIOL, V61, P839, DOI 10.1259/0007-1285-61-729-839; Robinson ICAF, 2001, J ENDOCRINOL, V169, P519, DOI 10.1677/joe.0.1690519; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Slamberova Romana, 2014, Prague Med Rep, V115, P43; Spitz DR, 2014, ANTIOXID REDOX SIGN, V20, P1407, DOI 10.1089/ars.2013.5769; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tonomura Y, 2009, HUM EXP TOXICOL, V28, P293, DOI 10.1177/0960327109105404; VANDYKE D, 1964, BLOOD, V24, P356, DOI 10.1182/blood.V24.4.356.356; Velickovic N, 2012, CELL MOL NEUROBIOL, V32, P1175, DOI 10.1007/s10571-012-9843-1; Weidenfeld J, 2013, NEUROIMMUNOMODULAT, V20, P57, DOI 10.1159/000342522; Williams JP, 2011, INT J RADIAT BIOL, V87, P851, DOI 10.3109/09553002.2011.560996; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9; Zeilstra LJW, 2000, INT J RADIAT BIOL, V76, P419, DOI 10.1080/095530000138763	44	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122900	10.1371/journal.pone.0122900	http://dx.doi.org/10.1371/journal.pone.0122900			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836679	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000118
J	Guo, TC; Gamil, AAA; Koenig, M; Evensen, O				Guo, Tz Chun; Gamil, Amr Ahmed Abdelrahim; Koenig, Melanie; Evensen, Oystein			Sequence Analysis and Identification of New Isoform of EP4 Receptors in Different Atlantic Salmon Tissues (Salmo salar L.) and Its Role in PGE2 Induced Immunomodulation In Vitro	PLOS ONE			English	Article							AGONIST-INDUCED DESENSITIZATION; PROSTANOID RECEPTORS; MESSENGER-RNA; PROSTAGLANDIN E-2; PHARMACOLOGICAL CHARACTERIZATION; TERMINAL DOMAINS; SUBTYPE; INFLAMMATION; MACROPHAGES; PROTEIN	PGE2 plays an important role in a broad spectrum of physiological and pathological processes mediated through a membrane-bound G protein-coupled receptor (GPCR) called EP receptor. In mammals, four subtypes of EP receptor (EP 1-4) are identified and each of them functions through different signal transduction pathways. Orthologous EP receptors have also been identified in other non-mammalian species, such as chicken and zebrafish. EP4 is the only identified PGE2 receptor to date in Atlantic salmon but its tissue distribution and function have not been studied in any detail. In this study, we first sequenced EP4 receptor in different tissues and found that the presence of the 3nt deletion in the 5' untranslated region was accompanied by silent mutation at nt 668. While attempting to amplify the same sequence in TO cells (an Atlantic salmon macrophage-like cell line), we failed to obtain the full-length product. Further investigation revealed different isoform of EP4 receptor in TO cells and we subsequently documented its presence in different Atlantic salmon tissues. These two isoforms of EP4 receptor share high homology in their first half of sequence but differ in the second half part with several deletion segments though the final length of coding sequence is the same for two isoforms. We further studied the immunomodulation effect of PGE2 in TO cells and found that PGE2 inhibited the induction of CXCL-10, CCL-4, IL-8 and IL-1 beta genes expression in a time dependent manner and without cAMP upregulation.	[Guo, Tz Chun; Gamil, Amr Ahmed Abdelrahim; Evensen, Oystein] Norwegian Univ Life Sci, Fac Vet Med & Biosci, Sea Lice Res Ctr, N-0033 Oslo, Norway; [Koenig, Melanie] Synapt Vesicle Dynam, European Neurosci Inst, D-37077 Gottingen, Germany	Norwegian University of Life Sciences	Evensen, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med & Biosci, Sea Lice Res Ctr, POB 8146 Dep, N-0033 Oslo, Norway.	oystein.evensen@nmbu.no	Evensen, Øystein/O-3011-2015	Evensen, Øystein/0000-0002-4856-3043; Gamil, Amr/0000-0001-9920-6487	Research Council of Norway, SFI-Sea Lice Research Centre [203513]	Research Council of Norway, SFI-Sea Lice Research Centre(Research Council of Norway)	The work was supported by Research Council of Norway, SFI-Sea Lice Research Centre, grant number 203513. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Bastepe M, 1997, MOL PHARMACOL, V51, P343, DOI 10.1124/mol.51.2.343; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Breyer RM, 2001, ANNU REV PHARMACOL, V41, P661, DOI 10.1146/annurev.pharmtox.41.1.661; Caughey GE, 2001, J IMMUNOL, V167, P2831, DOI 10.4049/jimmunol.167.5.2831; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Fabre JE, 2001, J CLIN INVEST, V107, P603, DOI 10.1172/JCI10881; Frolov A, 2013, PROSTAG LEUKOTR ESS, V89, P351, DOI 10.1016/j.plefa.2013.08.003; Froystad MK, 1998, DEV COMP IMMUNOL, V22, P533, DOI 10.1016/S0145-305X(98)00032-9; Fujino H, 2006, MOL PHARMACOL, V69, P13, DOI 10.1124/mol.105.017749; Fujino H, 2005, MOL PHARMACOL, V68, P251, DOI 10.1124/mol.105.011833; GEROZISSIS K, 1991, PROSTAG OTH LIPID M, V41, P345, DOI 10.1016/0090-6980(91)90004-Y; Goodson ML, 2005, J BIOL CHEM, V280, P7493, DOI 10.1074/jbc.M411514200; Hansson MC, 2004, AQUAT TOXICOL, V68, P219, DOI 10.1016/j.aquatox.2004.02.006; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; Hata AN, 2004, PHARMACOL THERAPEUT, V103, P147, DOI 10.1016/j.pharmthera.2004.06.003; Horseman ND, 2002, TRENDS ENDOCRIN MET, V13, P47, DOI 10.1016/S1043-2760(01)00558-6; Hubbard NE, 2001, PROSTAG LEUKOTR ESS, V65, P287, DOI 10.1054/plef.2001.0327; Iwasaki R, 2013, BIOCHEM BIOPH RES CO, V438, P353, DOI 10.1016/j.bbrc.2013.07.075; KATOH H, 1995, BBA-GEN SUBJECTS, V1244, P41, DOI 10.1016/0304-4165(94)00182-W; KOTANI M, 1995, MOL PHARMACOL, V48, P869; Kwok AHY, 2012, GEN COMP ENDOCR, V179, P88, DOI 10.1016/j.ygcen.2012.07.019; LANNAN CN, 1984, IN VITRO CELL DEV B, V20, P671, DOI 10.1007/BF02618871; Leong JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-279; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luschnig-Schratl P, 2011, CELL MOL LIFE SCI, V68, P3573, DOI 10.1007/s00018-011-0642-5; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NEGISHI M, 1993, J BIOL CHEM, V268, P9517; NOMURA T, 1976, BIOCHIM BIOPHYS ACTA, V431, P127; Plata G, 2014, NUCLEIC ACIDS RES, V42, P2405, DOI 10.1093/nar/gkt1200; RENZ H, 1988, J IMMUNOL, V141, P2388; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; SCHNEIDER WP, 1972, J AM CHEM SOC, V94, P2122, DOI 10.1021/ja00761a060; SUGIMOTO Y, 1993, J BIOL CHEM, V268, P2712; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sun L, 2012, ACTA PHARMACOL SIN, V33, P342, DOI 10.1038/aps.2011.200; Takayama K, 2002, J BIOL CHEM, V277, P44147, DOI 10.1074/jbc.M204810200; Tsuge K, 2013, BIOCHEM BIOPH RES CO, V436, P685, DOI 10.1016/j.bbrc.2013.06.017; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Warren IA, 2014, GENOME BIOL EVOL, V6, P1790, DOI 10.1093/gbe/evu131; Wergeland HI, 2001, DIS AQUAT ORGAN, V44, P183, DOI 10.3354/dao044183; WOLF K, 1962, SCIENCE, V135, P1065, DOI 10.1126/science.135.3508.1065; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Yokoyama U, 2013, PHARMACOL REV, V65, P1010, DOI 10.1124/pr.112.007195	45	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0120483	10.1371/journal.pone.0120483	http://dx.doi.org/10.1371/journal.pone.0120483			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837516	Green Published, Green Accepted, gold			2022-12-26	WOS:000352139000022
J	Gasser, A; Brogi, S; Urayama, K; Nishi, T; Kurose, H; Tafi, A; Ribeiro, N; Desaubry, L; Nebigil, CG				Gasser, Adeline; Brogi, Simone; Urayama, Kyoji; Nishi, Toshishide; Kurose, Hitoshi; Tafi, Andrea; Ribeiro, Nigel; Desaubry, Laurent; Nebigil, Canan G.			Discovery and Cardioprotective Effects of the First Non-Peptide Agonists of the G Protein-Coupled Prokineticin Receptor-1	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CRYSTAL-STRUCTURE; PHARMACOLOGICAL CHARACTERIZATION; IDENTIFICATION; ANTAGONISTS; ANGIOGENESIS; LIGANDS; CELLS; BV8; SURVIVAL	Prokineticins are angiogenic hormones that activate two G protein-coupled receptors: PKR1 and PKR2. PKR1 has emerged as a critical mediator of cardiovascular homeostasis and cardioprotection. Identification of non-peptide PKR1 agonists that contribute to myocardial repair and collateral vessel growth hold promises for treatment of heart diseases. Through a combination of in silico studies, medicinal chemistry, and pharmacological profiling approaches, we designed, synthesized, and characterized the first PKR1 agonists, demonstrating their cardioprotective activity against myocardial infarction (MI) in mice. Based on high throughput docking protocol, 250,000 compounds were computationally screened for putative PKR1 agonistic activity, using a homology model, and 10 virtual hits were pharmacologically evaluated. One hit internalizes PKR1, increases calcium release and activates ERK and Akt kinases. Among the 30 derivatives of the hit compound, the most potent derivative, IS20, was confirmed for its selectivity and specificity through genetic gain- and loss-of-function of PKR1. Importantly, IS20 prevented cardiac lesion formation and improved cardiac function after MI in mice, promoting proliferation of cardiac progenitor cells and neovasculogenesis. The preclinical investigation of the first PKR1 agonists provides a novel approach to promote cardiac neovasculogenesis after MI.	[Gasser, Adeline; Urayama, Kyoji; Nishi, Toshishide; Nebigil, Canan G.] Univ Strasbourg, CNRS, Biotechnol & Cell Signaling Lab, UMR 7242, Illkirch Graffenstaden, France; [Brogi, Simone] Univ Siena, European Res Ctr Drug Discovery & Dev NatSynDrugs, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Biotechnol, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Chem, I-53100 Siena, Italy; [Brogi, Simone; Tafi, Andrea] Univ Siena, Dept Pharm, I-53100 Siena, Italy; [Nishi, Toshishide; Kurose, Hitoshi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol & Toxicol, Fukuoka 8128582, Japan; [Ribeiro, Nigel; Desaubry, Laurent] Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Siena; University of Siena; University of Siena; University of Siena; Kyushu University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Desaubry, L (corresponding author), Univ Strasbourg, CNRS, Therapeut Innovat Lab, UMR7200, Illkirch Graffenstaden, France.	desaubry@unistra.fr; nebigil@unistra.fr	Brogi, Simone/AAP-4179-2020; Desaubry, Laurent G/R-5446-2017; Nebigil, Canan/AAK-7162-2021	Brogi, Simone/0000-0001-9375-6242; Desaubry, Laurent G/0000-0002-1192-2970; Nebigil, Canan/0000-0002-2035-5795; GASSER, Adeline/0000-0003-2678-327X	Centre National de la Recherche Scientifique (CNRS); Fondation pour la Recherche Medicale en France (FRM); Region Alsace; Laboratory of Excellence, Medalis	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale en France (FRM)(Fondation pour la Recherche Medicale); Region Alsace(Region Grand-Est); Laboratory of Excellence, Medalis	This work was supported by Centre National de la Recherche Scientifique (CNRS), Fondation pour la Recherche Medicale en France (FRM), Region Alsace, and Laboratory of Excellence, Medalis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CPHMODELS 3 2 SERV; Balboni G, 2008, J MED CHEM, V51, P7635, DOI 10.1021/jm800854e; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Bullock CM, 2004, MOL PHARMACOL, V65, P582, DOI 10.1124/mol.65.3.582; Cappelli A, 2013, EUR J MED CHEM, V63, P85, DOI 10.1016/j.ejmech.2013.01.044; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carroll C, 2013, United States patent, Patent No. [WO2013179024A1, US20130324576, 2013179024]; Chen JC, 2005, MOL PHARMACOL, V67, P2070, DOI 10.1124/mol.105.011619; Cheng H, 1999, BIOPHYS J, V76, P606, DOI 10.1016/S0006-3495(99)77229-2; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Congiu C, 2014, EUR J MED CHEM, V81, P334, DOI 10.1016/j.ejmech.2014.05.030; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Dai WM, 2011, J RECEPT SIG TRANSD, V31, P229, DOI 10.3109/10799893.2011.578141; DeVita RJ, 2007, CURR TOP MED CHEM, V7, P1433, DOI 10.2174/156802607782194789; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gemma S, 2014, RSC ADV, V4, P4769, DOI 10.1039/c3ra45933k; Giovani S, 2014, BIOORG MED CHEM LETT, V24, P3582, DOI 10.1016/j.bmcl.2014.05.044; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guazzi M, 2014, PROG CARDIOVASC DIS, V56, P508, DOI 10.1016/j.pcad.2013.11.003; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jones G, 1995, J COMPUT AID MOL DES, V9, P532, DOI 10.1007/BF00124324; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kisliouk T, 2005, ENDOCRINOLOGY, V146, P3950, DOI 10.1210/en.2005-0297; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kooistra AJ, 2013, METHOD ENZYMOL, V522, P279, DOI 10.1016/B978-0-12-407865-9.00015-7; LeCouter J, 2004, P NATL ACAD SCI USA, V101, P16813, DOI 10.1073/pnas.0407697101; LeCouter J, 2003, P NATL ACAD SCI USA, V100, P2685, DOI 10.1073/pnas.0337667100; LeCouter J, 2001, NATURE, V412, P877, DOI 10.1038/35091000; Levit A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027990; Li YY, 2010, CURR MED CHEM, V17, P1167, DOI 10.2174/092986710790827807; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Martin C, 2011, ENDOCR REV, V32, P225, DOI 10.1210/er.2010-0007; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Miserey-Lenkei S, 2002, J BIOL CHEM, V277, P5891, DOI 10.1074/jbc.M108398200; Nebigil CG, 2009, TRENDS CARDIOVAS MED, V19, P55, DOI 10.1016/j.tcm.2009.04.007; Nguyen TL, 2013, J DEV BIOL, V1, P20, DOI 10.3390/jdb1010020; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Urayama K, 2009, CARDIOVASC RES, V81, P28, DOI 10.1093/cvr/cvn251; Wang LY, 2009, J PHARMACOL EXP THER, V331, P340, DOI 10.1124/jpet.109.156380; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Zhou QY, 2014, United States patent, Patent No. [WO2010077976A3, US8722896B2, 2010077976]	48	45	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 1	2015	10	4							e0121027	10.1371/journal.pone.0121027	http://dx.doi.org/10.1371/journal.pone.0121027			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9AM	25831128	Green Published, Green Submitted, gold			2022-12-26	WOS:000352135600053
J	Kiriakidis, S; Henze, AT; Kruszynska-Ziaja, I; Skobridis, K; Theodorou, V; Paleolog, EM; Mazzone, M				Kiriakidis, Serafim; Henze, Anne-Theres; Kruszynska-Ziaja, Ilona; Skobridis, Konstantinos; Theodorou, Vassiliki; Paleolog, Ewa M.; Mazzone, Massimiliano			Factor-inhibiting HIF-1 (FIH-1) is required for human vascular endothelial cell survival	FASEB JOURNAL			English	Article						angiogenesis; Notch2; apoptosis	HYPOXIA-INDUCIBLE FACTOR; ANKYRIN REPEAT DOMAIN; TUMOR-SUPPRESSOR PROTEIN; ASPARAGINYL HYDROXYLASE; RHEUMATOID-ARTHRITIS; KAPPA-B; NOTCH; ANGIOGENESIS; GROWTH; CANCER	Factor-inhibiting hypoxia-inducible factor (HIF)-1 (FIH-1) is an asparaginyl beta-hydroxylase enzyme that was initially found to hydroxylate the HIF-alpha, preventing its transcriptional activity and leading to adaptive responses to hypoxia. More recently, other substrates, such as neurogenic locus notch homolog (Notch), have been found to be alternative FIH targets, but the biologic relevance of this regulation was never investigated. Given the key function of Notch in angiogenesis, we here investigate the role of FIH/Notch signaling in endothelial cells. We report that FIH-1 silencing in HUVECs results in reduced growth and increased apoptosis. The knockdown of FIH is associated with increased Notch2 activity, leading to enhanced expression of the Notch target hairy/enhancer-of-split related with YRPW motif protein 1 (Hey-1). Consistent with recent findings showing that Notch2 suppresses survivin (a key inhibitor of apoptosis), FIH targeting in HUVECs leads to selective repression of survivin in endothelial cells, thus promoting cell apoptosis and growth arrest. Our data support the concept that FIH-1 may interact with Notch2 and repress its activity, thereby playing a critical role in controlling the survival of vascular endothelial cells. These findings might pave the way toward novel, antiangiogenic strategies in disorders that are characterized by excessive vascular growth, such as cancer and rheumatoid arthritis.	[Kiriakidis, Serafim; Kruszynska-Ziaja, Ilona; Paleolog, Ewa M.] Univ Oxford, Kennedy Inst Rheumatol, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford OX3 7LD, England; [Henze, Anne-Theres; Mazzone, Massimiliano] Vlaams Inst Biotechnol, Vesalius Res Ctr, Lab Mol Oncol & Angiogenesis, Leuven, Belgium; [Henze, Anne-Theres; Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Lab Mol Oncol & Angiogenesis, Vesalius Res Ctr, Leuven, Belgium; [Skobridis, Konstantinos; Theodorou, Vassiliki] Univ Ioannina, Dept Chem, Sect Organ Chem & Biochem, GR-45110 Ioannina, Greece	University of Oxford; Flanders Institute for Biotechnology (VIB); KU Leuven; University of Ioannina	Kiriakidis, S (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Botnar Res Ctr, NDORMS, Windmill Rd, Oxford OX3 7LD, England.	serafim.kiriakidis@kennedy.ox.ac.uk; massimiliano.mazzone@vib-kuleuven.be		Mazzone, Massimiliano/0000-0001-8824-4015	Kennedy Institute of Rheumatology trustees; Arthritis Research UK; Research Foundation Flanders (FWO) [G.0718.10N]; Stichting tegen Kanker [2010-169]; FWO fellowship	Kennedy Institute of Rheumatology trustees; Arthritis Research UK(Versus Arthritis); Research Foundation Flanders (FWO)(FWO); Stichting tegen Kanker; FWO fellowship(FWO)	The authors (S.K., I.K.-Z., and E.M.P.) are grateful to the Kennedy Institute of Rheumatology trustees for funding the work and acknowledge the assistance of Sofia Konisti for Western blotting techniques and Parisa Amjadi for FACS analysis. The Kennedy Institute of Rheumatology is supported by Arthritis Research UK. This work was also supported by grants from Research Foundation Flanders (FWO; G.0718.10N) and Stichting tegen Kanker (2010-169) to M.M. A.-H.T. is supported by an FWO fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. S.K. dedicates this manuscript to his late mentor Dr. Hem Chandra Jha (Institute of Physiological Chemistry, University of Bonn, Germany), who sadly and unexpected passed away in September 2013. S.K., A.T.H., I.K-Z., K.S., and V.T. performed the experimental studies and data analysis. S.K., M.M., and E.M.P. oversaw the conception and design of the study. All authors contributed to the writing of the manuscript and have read and approved the final manuscript. The authors declare no conflicts of interest.	Altieri DC, 2013, CANCER LETT, V332, P225, DOI 10.1016/j.canlet.2012.03.005; Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Casazza A, 2014, ONCOGENE, V33, P1743, DOI 10.1038/onc.2013.121; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Coulon C, 2010, ARTERIOSCL THROM VAS, V30, P2331, DOI 10.1161/ATVBAHA.110.214106; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fulda S, 2012, NAT REV DRUG DISCOV, V11, P109, DOI 10.1038/nrd3627; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grosjean J, 2006, BIOCHEM BIOPH RES CO, V340, P984, DOI 10.1016/j.bbrc.2005.12.095; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hainaud P, 2006, CANCER RES, V66, P8501, DOI 10.1158/0008-5472.CAN-05-4226; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hon WC, 2002, NATURE, V417, P975, DOI 10.1038/nature00767; Khan MN, 2011, BRIT J CANCER, V104, P1151, DOI 10.1038/bjc.2011.73; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Kume T, 2009, VASC CELL, V1, DOI 10.1186/2040-2384-1-8; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Larsen H, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3934; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Mailhos C, 2001, DIFFERENTIATION, V69, P135, DOI 10.1046/j.1432-0436.2001.690207.x; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; McDonough MA, 2005, J AM CHEM SOC, V127, P7680, DOI 10.1021/ja050841b; Mesri M, 2001, AM J PATHOL, V158, P1757, DOI 10.1016/S0002-9440(10)64131-4; Muz B, 2012, ARTHRITIS RHEUM-US, V64, P2856, DOI 10.1002/art.34479; O'Connor DS, 2000, AM J PATHOL, V156, P393, DOI 10.1016/S0002-9440(10)64742-6; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Pelletier J, 2012, ONCOGENE, V31, P2989, DOI 10.1038/onc.2011.471; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Quillard T, 2010, BIOCHEM PHARMACOL, V80, P2032, DOI 10.1016/j.bcp.2010.07.010; Quillard T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008244; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Stolze IP, 2004, J BIOL CHEM, V279, P42719, DOI 10.1074/jbc.M406713200; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Tran J, 1999, BIOCHEM BIOPH RES CO, V264, P781, DOI 10.1006/bbrc.1999.1589; Wang MM, 2011, INT J BIOCHEM CELL B, V43, P1550, DOI 10.1016/j.biocel.2011.08.005; Wilkins SE, 2012, J BIOL CHEM, V287, P8769, DOI 10.1074/jbc.M111.294678; Wilkins SE, 2009, INT J BIOCHEM CELL B, V41, P1563, DOI 10.1016/j.biocel.2009.01.005; Zhang N, 2010, CELL METAB, V11, P364, DOI 10.1016/j.cmet.2010.03.001; Zheng X, 2008, P NATL ACAD SCI USA, V105, P3368, DOI 10.1073/pnas.0711591105; Zwerts F, 2007, BLOOD, V109, P4742, DOI 10.1182/blood-2006-06-028068	54	21	21	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2814	2827		10.1096/fj.14-252379	http://dx.doi.org/10.1096/fj.14-252379			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837583				2022-12-26	WOS:000356859100013
J	Slutzki, M; Reshef, D; Barak, Y; Haimovitz, R; Rotem-Bamberger, S; Lamed, R; Bayer, EA; Schueler-Furman, O				Slutzki, Michal; Reshef, Dan; Barak, Yoav; Haimovitz, Rachel; Rotem-Bamberger, Shahar; Lamed, Raphael; Bayer, Edward A.; Schueler-Furman, Ora			Crucial Roles of Single Residues in Binding Affinity, Specificity, and Promiscuity in the Cellulosomal Cohesin-Dockerin Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN DOCKING; CLOSTRIDIUM-THERMOCELLUM; COMPUTATIONAL DESIGN; DOMAIN; RECOGNITION; SURFACE; DEGRADATION; COMPONENTS; STABILITY; MECHANISM	Interactions between cohesin and dockerin modules play a crucial role in the assembly of multienzyme cellulosome complexes. Although intraspecies cohesin and dockerin modules bind in general with high affinity but indiscriminately, cross-species binding is rare. Here, we combined ELISA-based experiments with Rosetta-based computational design to evaluate the contribution of distinct residues at the Clostridium thermocellum cohesin-dockerin interface to binding affinity, specificity, and promiscuity. We found that single mutations can show distinct and significant effects on binding affinity and specificity. In particular, mutations at cohesin position Asn(37) show dramatic variability in their effect on dockerin binding affinity and specificity: the N37A mutant binds promiscuously both to cognate (C. thermocellum) as well as to non-cognate Clostridium cellulolyticum dockerin. N37L in turn switches binding specificity: compared with the wild-type C. thermocellum cohesin, this mutant shows significantly increased preference for C. cellulolyticum dockerin combined with strongly reduced binding to its cognate C. thermocellum dockerin. The observation that a single mutation can overcome the naturally observed specificity barrier provides insights into the evolutionary dynamics of this system that allows rapid modulation of binding specificity within a high affinity background.	[Slutzki, Michal; Barak, Yoav; Haimovitz, Rachel; Bayer, Edward A.] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Reshef, Dan; Rotem-Bamberger, Shahar; Schueler-Furman, Ora] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, Inst Med Res Israel Canada, IL-9112102 Jerusalem, Israel; [Lamed, Raphael] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-6997801 Ramat Aviv, Israel	Weizmann Institute of Science; Hebrew University of Jerusalem; Tel Aviv University	Schueler-Furman, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Microbiol & Mol Genet, IL-9112102 Jerusalem, Israel.	oraf@ekmd.huji.ac.il	Schueler-Furman, Ora/AAC-5932-2020	Schueler-Furman, Ora/0000-0002-1624-0362	Israel Science Foundation (ISF) - Israel Academy of Science and Humanities [306/06, 319/11, 1349/13, 24/11]; Israel Science Foundation (ISF) - Israel Academy of Science and Humanities (Sidney E. Frank Foundation through the ISF); United States-Israel Binational Science Foundation, Jerusalem, Israel [2009418, 2013284]; European Research Council [310873]; European Union [NMP.2013.1.1-2, 604530]; European Research Area-Industrial Biology Consortium [EIB.12.022]	Israel Science Foundation (ISF) - Israel Academy of Science and Humanities; Israel Science Foundation (ISF) - Israel Academy of Science and Humanities (Sidney E. Frank Foundation through the ISF); United States-Israel Binational Science Foundation, Jerusalem, Israel(US-Israel Binational Science Foundation); European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); European Research Area-Industrial Biology Consortium	This work was supported, in whole or in part, by the Israel Science Foundation (ISF) funded by the Israel Academy of Science and Humanities (Grants 306/06 and 319/11 to O. S.-F., 1349/13 to E. A. B., and 24/11 to R. L. by The Sidney E. Frank Foundation through the ISF); the United States-Israel Binational Science Foundation, Jerusalem, Israel (Grants 2009418 to O. S.-F. and 2013284 to E. A. B.); the European Research Council (Starting Grant 310873 to O. S.-F.); the European Union, Area NMP.2013.1.1-2: (Selfassembly of naturally occurring nanosystems: CellulosomePlus Project 604530 to E. A. B.), and a European Research Area-Industrial Biology Consortium (EIB.12.022, acronym FiberFuel, to E. A. B.).	Adams JJ, 2008, P NATL ACAD SCI USA, V105, P12194, DOI 10.1073/pnas.0803154105; Adams JJ, 2006, P NATL ACAD SCI USA, V103, P305, DOI 10.1073/pnas.0507109103; Akiva E, 2008, P NATL ACAD SCI USA, V105, P13292, DOI 10.1073/pnas.0801207105; Bahari L, 2011, J IND MICROBIOL BIOT, V38, P825, DOI 10.1007/s10295-010-0848-9; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barak Y, 2005, J MOL RECOGNIT, V18, P491, DOI 10.1002/jmr.749; Bayer EA, 2004, ANNU REV MICROBIOL, V58, P521, DOI 10.1146/annurev.micro.57.030502.091022; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Carvalho AL, 2003, P NATL ACAD SCI USA, V100, P13809, DOI 10.1073/pnas.1936124100; Carvalho AL, 2007, P NATL ACAD SCI USA, V104, P3089, DOI 10.1073/pnas.0611173104; Caspi J, 2008, J BIOTECHNOL, V135, P351, DOI 10.1016/j.jbiotec.2008.05.003; Caspi J, 2009, APPL ENVIRON MICROB, V75, P7335, DOI 10.1128/AEM.01241-09; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Fierobe HP, 2005, J BIOL CHEM, V280, P16325, DOI 10.1074/jbc.M414449200; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haimovitz R, 2008, PROTEOMICS, V8, P968, DOI 10.1002/pmic.200700486; Halperin I, 2006, PROTEINS, V63, P832, DOI 10.1002/prot.20933; Handelsman T, 2004, FEBS LETT, V572, P195, DOI 10.1016/j.febslet.2004.07.040; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kahel-Raifer H, 2010, FEMS MICROBIOL LETT, V308, P84, DOI 10.1111/j.1574-6968.2010.01997.x; Kaneko T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000796; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Kleanthous C, 2001, TRENDS BIOCHEM SCI, V26, P624, DOI 10.1016/S0968-0004(01)01941-7; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T., 2004, SCI STKE, V2004, ppl2, DOI [10.1126/stke.2192004pl2, DOI 10.1126/STKE.2192004PL2]; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; Lapidot A, 1996, J BIOTECHNOL, V51, P259, DOI 10.1016/S0168-1656(96)01604-5; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; Li W, 1998, BIOCHEMISTRY-US, V37, P11771, DOI 10.1021/bi9808621; Lytle BL, 2000, ARCH BIOCHEM BIOPHYS, V379, P237, DOI 10.1006/abbi.2000.1882; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Mechaly A, 2001, J BIOL CHEM, V276, P9883, DOI 10.1074/jbc.M009237200; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P7138, DOI 10.1128/AEM.01306-07; Mingardon F, 2007, APPL ENVIRON MICROB, V73, P3822, DOI 10.1128/AEM.00398-07; Miras I, 2002, BIOCHEMISTRY-US, V41, P2115, DOI 10.1021/bi011854e; Morais S, 2013, APPL ENVIRON MICROB, V79, P5242, DOI 10.1128/AEM.01211-13; Morais S, 2012, MBIO, V3, DOI 10.1128/mBio.00508-12; Morais S, 2011, MBIO, V2, DOI 10.1128/mBio.00233-11; Morais S, 2010, APPL ENVIRON MICROB, V76, P3787, DOI 10.1128/AEM.00266-10; Motulsky H, 2004, FITTING MODELS BIOL, P256; Nakar D, 2004, J BIOL CHEM, V279, P42881, DOI 10.1074/jbc.M407350200; Nataf Y, 2010, P NATL ACAD SCI USA, V107, P18646, DOI 10.1073/pnas.1012175107; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Pages S, 1997, PROTEINS, V29, P517, DOI 10.1002/(SICI)1097-0134(199712)29:4<517::AID-PROT11>3.3.CO;2-I; Pinheiro BA, 2008, J BIOL CHEM, V283, P18422, DOI 10.1074/jbc.M801533200; Potapov V, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-374; Potapov V, 2009, PROTEIN ENG DES SEL, V22, P553, DOI 10.1093/protein/gzp030; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Sakka K, 2011, FEMS MICROBIOL LETT, V314, P75, DOI 10.1111/j.1574-6968.2010.02146.x; Sakka K, 2009, FEMS MICROBIOL LETT, V300, P249, DOI 10.1111/j.1574-6968.2009.01788.x; Schreiber G, 2013, CURR OPIN STRUC BIOL, V23, P903, DOI 10.1016/j.sbi.2013.08.003; Schreiber G, 2011, CURR OPIN STRUC BIOL, V21, P50, DOI 10.1016/j.sbi.2010.10.002; Schueler-Furman O, 2005, PROTEINS, V60, P187, DOI 10.1002/prot.20556; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sharabi O, 2011, PROTEINS, V79, P1487, DOI 10.1002/prot.22977; Slutzki M, 2012, J MOL RECOGNIT, V25, P616, DOI 10.1002/jmr.2178; Slutzki M, 2012, METHOD ENZYMOL, V510, P417, DOI 10.1016/B978-0-12-415931-0.00022-7; Vazana Y, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-182; Vazana Y, 2010, APPL ENVIRON MICROB, V76, P3236, DOI 10.1128/AEM.00009-10; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Weichenberger CX, 2006, BIOINFORMATICS, V22, P1397, DOI 10.1093/bioinformatics/btl128; Weinstein JY, 2015, J MOL RECOGNIT, V28, P148, DOI 10.1002/jmr.2380; Xu JC, 2009, PROTEIN SCI, V18, P949, DOI 10.1002/pro.105	65	10	10	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13654	13666		10.1074/jbc.M115.651208	http://dx.doi.org/10.1074/jbc.M115.651208			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25833947	Green Published, hybrid			2022-12-26	WOS:000355313000003
J	Leone, P; Bebeacua, C; Opota, O; Kellenberger, C; Klaholz, B; Orlov, I; Cambillau, C; Lemaitre, B; Roussel, A				Leone, Philippe; Bebeacua, Cecilia; Opota, Onya; Kellenberger, Christine; Klaholz, Bruno; Orlov, Igor; Cambillau, Christian; Lemaitre, Bruno; Roussel, Alain			X-ray and Cryo-electron Microscopy Structures of Monalysin Pore-forming Toxin Reveal Multimerization of the Pro-form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPTAMERIC TRANSMEMBRANE PORE; CRYSTAL-STRUCTURE; PROTECTIVE ANTIGEN; ELECTRON-MICROSCOPY; CONFORMATIONAL-CHANGES; MAXIMUM-LIKELIHOOD; MEMBRANE-CHANNEL; AEROLYSIN; MECHANISM; HEMOLYSIN	beta-Barrel pore-forming toxins (beta-PFT), a large family of bacterial toxins, are generally secreted as water-soluble monomers and can form oligomeric pores in membranes following proteolytic cleavage and interaction with cell surface receptors. Monalysin has been recently identified as a beta-PFT that contributes to the virulence of Pseudomonas entomophila against Drosophila. It is secreted as a pro-protein that becomes active upon cleavage. Here we report the crystal and cryo-electron microscopy structure of the pro-form of Monalysin as well as the crystal structures of the cleaved form and of an inactive mutant lacking the membrane-spanning region. The overall structure of Monalysin displays an elongated shape, which resembles those of beta-poreforming toxins, such as Aerolysin, but is devoid of a receptorbinding domain. X-ray crystallography, cryo-electron microscopy, and light-scattering studies show that pro-Monalysin forms a stable doughnut-like 18-mer complex composed of two disk-shaped nonamers held together by N-terminal swapping of the pro-peptides. This observation is in contrast with the monomeric pro-form of the other beta-PFTs that are receptor-dependent for membrane interaction. The membrane-spanning region of pro-Monalysin is fully buried in the center of the doughnut, suggesting that upon cleavage of pro-peptides, the two disk-shaped nonamers can, and have to, dissociate to leave the transmembrane segments free to deploy and lead to pore formation. In contrast with other toxins, the delivery of 18 subunits at once, nearby the cell surface, may be used to bypass the requirement of receptor-dependent concentration to reach the threshold for oligomerization into the pore-forming complex.	[Leone, Philippe; Bebeacua, Cecilia; Kellenberger, Christine; Cambillau, Christian; Roussel, Alain] CNRS, AFMB, Unite Mixte Rech UMR 7257, F-13288 Marseille, France; [Leone, Philippe; Bebeacua, Cecilia; Kellenberger, Christine; Cambillau, Christian; Roussel, Alain] Aix Marseille Univ, Architecture & Fonct Macromol Biol, UMR 7257, F-13288 Marseille, France; [Opota, Onya; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Global Hlth Inst, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Klaholz, Bruno; Orlov, Igor] Univ Strasbourg, IGBMC Inst Genet & Mol & Cellular Biol, Dept Integrated Struct Biol, CNRS,UMR 7104,INSERM,U964,CBI, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Roussel, A (corresponding author), CNRS, AFMB, Unite Mixte Rech UMR 7257, F-13288 Marseille, France.	alain.roussel@afmb.univ-mrs.fr	Opota, Onya/K-5851-2017; kellenberger, christine/AAV-9304-2020; Lemaitre, Bruno/T-8146-2019	Opota, Onya/0000-0002-5421-0607; Lemaitre, Bruno/0000-0001-7970-1667	French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; European Strategy Forum on Research Infrastructures (ESFRI)	French Infrastructure for Integrated Structural Biology (FRISBI); European Strategy Forum on Research Infrastructures (ESFRI)	This work was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) Grant ANR-10-INSB-05-01 and by Instruct as part of the European Strategy Forum on Research Infrastructures (ESFRI).	Benson EL, 1998, BIOCHEMISTRY-US, V37, P3941, DOI 10.1021/bi972657b; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Blemont M, 2013, ACTA CRYSTALLOGR F, V69, P930, DOI 10.1107/S174430911301885X; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRUBER HJ, 1994, MOL MICROBIOL, V14, P1093, DOI 10.1111/j.1365-2958.1994.tb01341.x; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Iacovache I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002135; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kitadokoro K, 2011, J BIOL CHEM, V286, P19549, DOI 10.1074/jbc.M111.228478; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacy DB, 2004, P NATL ACAD SCI USA, V101, P13147, DOI 10.1073/pnas.0405405101; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Melton JA, 2004, J BIOL CHEM, V279, P14315, DOI 10.1074/jbc.M313758200; MILNE JC, 1994, J BIOL CHEM, V269, P20607; MOLLOY SS, 1992, J BIOL CHEM, V267, P16396; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Olson R, 1999, NAT STRUCT BIOL, V6, P134; Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259; Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; Roblin P, 2008, PROTEINS, V71, P485, DOI 10.1002/prot.21900; Roussel A, 1991, SILICON GRAPHICS GEO, P86; Scheres SHW, 2008, NAT PROTOC, V3, P977, DOI 10.1038/nprot.2008.62; Scheres SHW, 2010, METHOD ENZYMOL, V482, P295, DOI 10.1016/S0076-6879(10)82012-9; Shaikh TR, 2008, NAT PROTOC, V3, P1941, DOI 10.1038/nprot.2008.156; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; VANDERGOOT FG, 1994, J BIOL CHEM, V269, P30496; VANDERGOOT FG, 1993, J BIOL CHEM, V268, P18272; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wallace AJ, 2000, CELL, V100, P265, DOI 10.1016/S0092-8674(00)81564-0; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamashita K, 2011, P NATL ACAD SCI USA, V108, P17314, DOI 10.1073/pnas.1110402108	45	17	18	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13191	13201		10.1074/jbc.M115.646109	http://dx.doi.org/10.1074/jbc.M115.646109			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847242	Green Published, hybrid			2022-12-26	WOS:000354975700021
J	Li, J; Biss, M; Fu, Y; Xu, X; Moore, SA; Xiao, W				Li, Jia; Biss, Michael; Fu, Yu; Xu, Xin; Moore, Stanley A.; Xiao, Wei			Two Duplicated Genes DDI2 and DDI3 in Budding Yeast Encode a Cyanamide Hydratase and Are Induced by Cyanamide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; HD-DOMAIN; DNTP TRIPHOSPHOHYDROLASE; MYROTHECIUM-VERRUCARIA; NATURAL CYANAMIDE; ESCHERICHIA-COLI; DNA GLYCOSYLASE; EXPRESSION; SPECIFICITY; DISRUPTION	Two DNA damage-inducible genes in Saccharomyces cerevisiae, DDI2 and DDI3, are identical and encode putative HD domain-containing proteins, whose functions are currently unknown. Because Ddi2/3 also shows limited homology to a fungal cyanamide hydratase that converts cyanamide to urea, we tested the enzymatic activity of recombinant Ddi2. To this end, we developed a novel enzymatic assay and determined that the K-m value of the recombinant Ddi2/3 for cyanamide is 17.3 +/- 0.05 mM, and its activity requires conserved residues in the HD domain. Unlike most other DNA damage-inducible genes, DDI2/3 is only induced by a specific set of alkylating agents and surprisingly is strongly induced by cyanamide. To characterize the biological function of DDI2/3, we sequentially deleted both DDI genes and found that the double mutant was unable to metabolize cyanamide and became much more sensitive to growth inhibition by cyanamide, suggesting that the DDI2/3 genes protect host cells from cyanamide toxicity. Despite the physiological relevance of the cyanamide induction, DDI2/3 is not involved in its own transcriptional regulation. The significance of cyanamide hydratase activity and its induced expression is discussed.	[Li, Jia; Biss, Michael; Fu, Yu; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada; [Moore, Stanley A.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Xu, Xin; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing 100048, Peoples R China	University of Saskatchewan; University of Saskatchewan; Capital Normal University	Xiao, W (corresponding author), Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK S7N 5E5, Canada.	wei.xiao@usask.ca		Xiao, Wei/0000-0001-7568-0782	Natural Sciences and Engineering Research Council of Canada [RGPIN-2014-04580, SAM 262138-2011]; University of Saskatchewan	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada Discovery Grants RGPIN-2014-04580 and SAM 262138-2011 (to W. X.).; Supported by a graduate teaching fellowship from University of Saskatchewan.	Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; BERBEN G, 1991, YEAST, V7, P475, DOI 10.1002/yea.320070506; Briganti F, 1999, J BIOL INORG CHEM, V4, P528, DOI 10.1007/s007750050375; Brown PM, 2006, ACTA CRYSTALLOGR F, V62, P811, DOI 10.1107/S1744309106028144; Brownt PM, 2006, P NATL ACAD SCI USA, V103, P15032, DOI 10.1073/pnas.0605143103; CHEN J, 1989, P NATL ACAD SCI USA, V86, P7961, DOI 10.1073/pnas.86.20.7961; CHEN J, 1990, EMBO J, V9, P4569, DOI 10.1002/j.1460-2075.1990.tb07910.x; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Coissac E, 1997, MOL BIOL EVOL, V14, P1062, DOI 10.1093/oxfordjournals.molbev.a025712; DeMaster EG, 1998, BIOCHEM PHARMACOL, V55, P2007, DOI 10.1016/S0006-2952(98)00080-X; Fu Y., 2008, THESIS U SASKATCHEWA; Fu Y, 2008, FEMS MICROBIOL REV, V32, P908, DOI 10.1111/j.1574-6976.2008.00126.x; Fu Y, 2008, CELL, V133, P601, DOI 10.1016/j.cell.2008.02.050; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Gotz R, 1999, YEAST, V15, P855, DOI 10.1002/(SICI)1097-0061(199907)15:10A<855::AID-YEA425>3.0.CO;2-C; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Hulme R, 2008, TETRAHEDRON, V64, P3372, DOI 10.1016/j.tet.2008.01.087; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jia XM, 2002, MUTAT RES-GEN TOX EN, V519, P83, DOI 10.1016/S1383-5718(02)00129-8; Kamo T, 2003, J CHEM ECOL, V29, P275, DOI 10.1023/A:1022621709486; Kamo T, 2008, PHYTOCHEMISTRY, V69, P1166, DOI 10.1016/j.phytochem.2007.11.004; Kamo T, 2006, BIOSCI BIOTECH BIOCH, V70, P2310, DOI 10.1271/bbb.60171; Katla VR, 2013, CHEM PHARM BULL, V61, P25, DOI 10.1248/cpb.c12-00582; Ke SH, 1997, NUCLEIC ACIDS RES, V25, P3371, DOI 10.1093/nar/25.16.3371; Kondo N, 2004, J BIOCHEM, V136, P221, DOI 10.1093/jb/mvh115; Kondo N, 2007, ACTA CRYSTALLOGR D, V63, P230, DOI 10.1107/S0907444906049262; Liu Y, 1997, MOL GEN GENET, V255, P533, DOI 10.1007/s004380050526; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; MONDZAC A, 1965, J LAB CLIN MED, V66, P526; MYERS AM, 1986, GENE, V45, P299, DOI 10.1016/0378-1119(86)90028-4; Nagata M, 2008, J BIOL CHEM, V283, P2176, DOI 10.1074/jbc.M705309200; OLSON JA, 1953, J BIOL CHEM, V202, P841; Padilla PA, 1998, J BACTERIOL, V180, P5718, DOI 10.1128/JB.180.21.5718-5726.1998; Pastushok L, 2005, J BIOL CHEM, V280, P17891, DOI 10.1074/jbc.M410469200; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; QUIRK S, 1991, J BACTERIOL, V173, P6665, DOI 10.1128/jb.173.21.6665-6669.1991; Rao F, 2010, BIOCHEM BIOPH RES CO, V398, P500, DOI 10.1016/j.bbrc.2010.06.107; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sherman F., 1983, METHODS YEAST GENETI; STELLER WA, 1965, J AGR FOOD CHEM, V13, P329, DOI 10.1021/jf60140a011; STRANSKY H, 1973, Z PFLANZENPHYSIOL, V70, P74, DOI 10.1016/S0044-328X(73)80049-2; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Weeks JT, 2000, CROP SCI, V40, P1749, DOI 10.2135/cropsci2000.4061749x; White RE, 2011, FEBS LETT, V585, P139, DOI 10.1016/j.febslet.2010.11.026; Wightman R, 2003, MICROBIOL-SGM, V149, P1447, DOI 10.1099/mic.0.26194-0; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200; Zhang XH, 2005, J PLANT PHYSIOL, V162, P1064, DOI 10.1016/j.jplph.2004.11.013; Zhu Y, 2004, NUCLEIC ACIDS RES, V32, P5066, DOI 10.1093/nar/gkh838; Zhu Y, 1998, NUCLEIC ACIDS RES, V26, P5402, DOI 10.1093/nar/26.23.5402; Zimmerman MD, 2008, J MOL BIOL, V378, P215, DOI 10.1016/j.jmb.2008.02.036	52	10	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12664	12675		10.1074/jbc.M115.645408	http://dx.doi.org/10.1074/jbc.M115.645408			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847245	Green Published, hybrid			2022-12-26	WOS:000354569000020
J	Lekhanont, K; Nonpassopon, M; Wannarosapark, K; Chuckpaiwong, V				Lekhanont, Kaevalin; Nonpassopon, Manachai; Wannarosapark, Khemruetai; Chuckpaiwong, Varintorn			Agreement between Clinical History Method, Orbscan IIz, and Pentacam in Estimating Corneal Power after Myopic Excimer Laser Surgery	PLOS ONE			English	Article							INTRAOCULAR-LENS CALCULATION; REFRACTIVE SURGERY; EYES; REPEATABILITY; ACCURACY; TOPOGRAPHY; REPRODUCIBILITY; KERATOMETRY; CATARACT	The purpose of this study was to investigate the agreement between the clinical history method (CHM), Orbscan IIz, and Pentacam in estimating corneal power after myopic excimer laser surgery. Fifty five patients who had myopic LASIK/ PRK were recruited into this study. One eye of each patient was randomly selected by a computer-generated process. At 6 months after surgery, postoperative corneal power was calculated from the CHM, Orbscan IIz total optical power at the 3.0 and 4.0 mm zones, and Pentacam equivalent keratometric readings (EKRs) at 3.0, 4.0, and 4.5 mm. Statistical analyses included multilevel models, Pearson's correlation test, and Bland-Altman plots. The Orbscan IIz 3.0-mm and 4.0 mm total optical power, and Pentacam 3.0-mm, 4.0-mm, and 4.5-mm EKR values had strong linear positive correlations with the CHM values (r = 0.90-0.94, P = < 0.001, for all comparisons, Pearson's correlation). However, only Pentacam 3.0-mm EKR was not statistically different from CHM (P = 0.17, multilevel models). The mean 3.0-and 4.0-mm total optical powers of the Orbscan IIz were significantly flatter than the values derived from CHM, while the average EKRs of the Pentacam at 4.0 and 4.5 mm were significantly steeper. The mean Orbscan IIz 3.0-mm total optical power was the lowest keratometric reading compared to the other 5 values. Large 95% LoA was observed between each of these values, particularly EKRs, and those obtained with the CHM. The width of the 95% LoA was narrowest for Orbscan IIz 3.0-mm total optical power. In conclusion, the keratometric values extracted from these 3 methods were disparate, either because of a statistically significant difference in the mean values or moderate agreement between them. Therefore, they are not considered equivalent and cannot be used interchangeably.	[Lekhanont, Kaevalin; Nonpassopon, Manachai; Wannarosapark, Khemruetai; Chuckpaiwong, Varintorn] Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok 10700, Thailand	Mahidol University	Lekhanont, K (corresponding author), Mahidol Univ, Ramathibodi Hosp, Dept Ophthalmol, Bangkok 10700, Thailand.	lekhanont@yahoo.com			Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL [55058]; Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies)	Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL; Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies)	Supported by 1. A Research Grant number 55058 from the Faculty of Medicine, Ramathibodi Hospital, Mahidol University: KL, 2. Department of Ophthalmology, Ramathibodi Hospital (stationery and office supplies). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arce CG, 2009, J REFRACT SURG, V25, P1061, DOI 10.3928/1081597X-20091117-05; Argento C, 2003, J CATARACT REFR SURG, V29, P1346, DOI 10.1016/S0886-3350(03)00351-1; Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Cheng ACK, 2005, J REFRACT SURG, V21, P365; Crawford AZ, 2013, AM J OPHTHALMOL, V156, P53, DOI 10.1016/j.ajo.2013.01.029; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Feiz V, 2010, MIDDLE EAST AFR J OP, V17, P63, DOI 10.4103/0974-9233.61219; Geggel HS, 2009, OPHTHALMOLOGY, V116, P1057, DOI 10.1016/j.ophtha.2009.01.017; Gimbel HV, 2001, J CATARACT REFR SURG, V27, P571, DOI 10.1016/S0886-3350(00)00795-1; Holladay JT, 2009, J REFRACT SURG, V25, P862, DOI 10.3928/1081597X-20090917-07; Huang David, 2013, Trans Am Ophthalmol Soc, V111, P34; Jonna G, 2013, CURR OPIN OPHTHALMOL, V24, P275, DOI 10.1097/ICU.0b013e3283622955; Kalyani SD, 2008, CURR OPIN OPHTHALMOL, V19, P357, DOI 10.1097/ICU.0b013e3282fec43e; Kawamorita T, 2009, J CATARACT REFR SURG, V35, P127, DOI 10.1016/j.jcrs.2008.10.019; Kim EC, 2013, J CATARACT REFR SURG, V39, P1640, DOI 10.1016/j.jcrs.2013.04.045; Kim SW, 2009, J REFRACT SURG, V25, P285, DOI 10.3928/1081597X-20090301-08; Lackner B, 2005, OPTOMETRY VISION SCI, V82, P892, DOI 10.1097/01.opx.0000180817.46312.0a; Latkany RA, 2005, J CATARACT REFR SURG, V31, P562, DOI 10.1016/j.jcrs.2004.06.053; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659; Michaels DD, 1985, VISUAL OPTICS REFRAC; Oh JH, 2014, CORNEA, V33, P261, DOI 10.1097/ICO.0000000000000034; Qazi MA, 2007, J CATARACT REFR SURG, V33, P21, DOI 10.1016/j.jcrs.2006.08.026; Quisling S, 2006, OPHTHALMOLOGY, V113, P1629, DOI [10.1016/j.ophtha.2006.03.046, 10.1016/j.ophtha.2006.06.046]; Savini G, 2008, J CATARACT REFR SURG, V34, P809, DOI 10.1016/j.jcrs.2008.01.012; Savini G, 2006, OPHTHALMOLOGY, V113, P1271, DOI 10.1016/j.ophtha.2006.03.024; Savini G, 2013, J CATARACT REFR SURG, V39, P605, DOI 10.1016/j.jcrs.2012.12.031; Savini G, 2011, J CATARACT REFR SURG, V37, P302, DOI 10.1016/j.jcrs.2010.07.039; Seitz B, 2000, J REFRACT SURG, V16, P349; Shetty R, 2011, RECENT ADV OPHTHALMO, V10, P89; Sonego-Krone S, 2004, ARCH OPHTHALMOL-CHIC, V122, P159, DOI 10.1001/archopht.122.2.159; Srivannaboon S, 1999, J CATARACT REFR SURG, V25, P1596, DOI 10.1016/S0886-3350(99)00286-2; Tang QY, 2009, J CATARACT REFR SURG, V35, P1198, DOI 10.1016/j.jcrs.2009.02.030; Tay E, 2011, J CATARACT REFR SURG, V37, P1945, DOI 10.1016/j.jcrs.2011.05.025; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang L, 2010, J CATARACT REFR SURG, V36, P1466, DOI 10.1016/j.jcrs.2010.03.044	35	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123729	10.1371/journal.pone.0123729	http://dx.doi.org/10.1371/journal.pone.0123729			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853655	Green Published, Green Submitted, gold			2022-12-26	WOS:000352478400116
J	Zhao, JJ; Ji, GH; Qiang, Y; Han, XH; Pei, B; Shi, ZH				Zhao, Juanjuan; Ji, Guohua; Qiang, Yan; Han, Xiaohong; Pei, Bo; Shi, Zhenghao			A New Method of Detecting Pulmonary Nodules with PET/CT Based on an Improved Watershed Algorithm	PLOS ONE			English	Article							MULTIMODALITY IMAGE REGISTRATION; CT	Background Integrated F-18-fluorodeoxyglucose positron emission tomography/ computed tomography (F-18-FDG PET/CT) is widely performed for staging solitary pulmonary nodules (SPNs). However, the diagnostic efficacy of SPNs based on PET/CT is not optimal. Here, we propose a method of detection based on PET/CT that can differentiate malignant and benign SPNs with few false-positives. Method Our proposed method combines the features of positron-emission tomography (PET) and computed tomography (CT). A dynamic threshold segmentation method was used to identify lung parenchyma in CT images and suspicious areas in PET images. Then, an improved watershed method was used to mark suspicious areas on the CT image. Next, the support vector machine (SVM) method was used to classify SPNs based on textural features of CT images and metabolic features of PET images to validate the proposed method. Results Our proposed method was more efficient than traditional methods and methods based on the CT or PET features alone (sensitivity 95.6%; average of 2.9 false positives per scan).	[Zhao, Juanjuan; Ji, Guohua; Qiang, Yan; Han, Xiaohong; Pei, Bo] Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China; [Shi, Zhenghao] Xian Univ Technol, Coll Comp Sci & Engn, Xian 710048, Peoples R China	Taiyuan University of Technology; Xi'an University of Technology	Qiang, Y (corresponding author), Taiyuan Univ Technol, Coll Comp Sci & Technol, Taiyuan 030024, Peoples R China.	27420265@qq.com	han, xiao/HDN-9782-2022		National Natural Science Foundation of China [61202163, 61373100]; Science and Technique Project of Shanxi Province [20120313032-3]; Natural Science Foundation of Shanxi Province [2012011015-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technique Project of Shanxi Province; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province)	The work is supported by the fund of National Natural Science Foundation of China (61202163, 61373100), (http://www.nsfc.gov.cn/) the Science and Technique Project of Shanxi Province under Grant (20120313032-3), (http://www.sxinfo.gov.cn/) and the Natural Science Foundation of Shanxi Province (2012011015-1), (http://www.sxinfo.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Choi WJ, 2012, INFORM SCIENCES, V212, P57, DOI 10.1016/j.ins.2012.05.008; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Darmanayagam SE, 2013, J DIGIT IMAGING, V26, P496, DOI 10.1007/s10278-012-9539-6; Dehmeshki J, 2007, COMPUT MED IMAG GRAP, V31, P408, DOI 10.1016/j.compmedimag.2007.03.002; Du XG, 2013, 2013 THIRD INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEM DESIGN AND ENGINEERING APPLICATIONS (ISDEA), P274, DOI 10.1109/ISDEA.2012.68; Eichkitz CG, 2013, COMPUT GEOSCI-UK, V60, P176, DOI 10.1016/j.cageo.2013.07.006; FORREST S, 1993, FOUNDATIONS OF GENETIC ALGORITHMS 2, P109; Fraioli F, 2010, RADIOL MED, V115, P385, DOI 10.1007/s11547-010-0507-2; Gao ZY, 2008, IMAGE VISION COMPUT, V26, P164, DOI 10.1016/j.imavis.2006.08.002; Guo YH, 2013, MED PHYS, V40, DOI 10.1118/1.4812679; Suarez-Cuenca JJ, 2009, COMPUT BIOL MED, V39, P921, DOI 10.1016/j.compbiomed.2009.07.005; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Masoumi H, 2012, BIOMED SIGNAL PROCES, V7, P429, DOI 10.1016/j.bspc.2012.01.002; Messay T, 2010, MED IMAGE ANAL, V14, P390, DOI 10.1016/j.media.2010.02.004; Nandan M, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036001; Okada T, 2009, JPN J RADIOL, V27, P91, DOI 10.1007/s11604-008-0306-z; Opfer R, 2007, MED IMAGING INT SOC; Shi ZH, 2013, APPL MATH INFORM SCI, V7, P1165, DOI 10.12785/amis/070339; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takahashi Y, 2013, ACTA RADIOL, V54, P164, DOI 10.1258/ar.2012.120138; VIOLA P, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P16, DOI 10.1109/ICCV.1995.466930; Wei J, 2002, CARS 2002: COMPUTER ASSISTED RADIOLOGY AND SURGERY, PROCEEDINGS, P706; Wei Y, 2013, J APPL MATH, P1, DOI DOI 10.1109/GIT4NDM.2013.8; Yan J, 2009, SPIE MED IMAGING INT; Zhang J, 2010, P 2010 3 INT C BIOM	28	176	177	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123694	10.1371/journal.pone.0123694	http://dx.doi.org/10.1371/journal.pone.0123694			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853496	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400114
J	Bourque, CPA; Bayat, M				Bourque, Charles P. -A.; Bayat, Mahmoud			Landscape Variation in Tree Species Richness in Northern Iran Forests	PLOS ONE			English	Article							GROWTH; PATTERNS; ENVIRONMENTS; REGENERATION; MANAGEMENT; DIVERSITY	Mapping landscape variation in tree species richness (SR) is essential to the long term management and conservation of forest ecosystems. The current study examines the prospect of mapping field assessments of SR in a high-elevation, deciduous forest in northern Iran as a function of 16 biophysical variables representative of the area's unique physiography, including topography and coastal placement, biophysical environment, and forests. Basic to this study is the development of moderate-resolution biophysical surfaces and associated plot-estimates for 202 permanent sampling plots. The biophysical variables include: (i) three topographic variables generated directly from the area's digital terrain model; (ii) four ecophysiologically-relevant variables derived from process models or from first principles; and (iii) seven variables of Landsat-8-acquired surface reflectance and two, of surface radiance. With symbolic regression, it was shown that only four of the 16 variables were needed to explain 85% of observed plot-level variation in SR (i.e., wind velocity, surface reflectance of blue light, and topographic wetness indices representative of soil water content), yielding mean-absolute and root-mean-squared error of 0.50 and 0.78, respectively. Overall, localised calculations of wind velocity and surface reflectance of blue light explained about 63% of observed variation in SR, with wind velocity accounting for 51% of that variation. The remaining 22% was explained by linear combinations of soil-water-related topographic indices and associated thresholds. In general, SR and diversity tended to be greatest for plots dominated by Carpinus betulus (involving >= 33% of all trees in a plot), than by Fagus orientalis (median difference of one species). This study provides a significant step towards describing landscape variation in SR as a function of modelled and satellite-based information and symbolic regression. Methods in this study are sufficiently general to be applicable to the characterisation of SR in other forested regions of the world, providing plot-scale data are available for model generation.	[Bourque, Charles P. -A.] Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada; [Bayat, Mahmoud] Univ Tehran, Nat Resources Fac, Dept Forestry, Karaj, Iran	University of New Brunswick; University of Tehran	Bourque, CPA (corresponding author), Univ New Brunswick, Fac Forestry & Environm Management, Fredericton, NB E3B 5A3, Canada.	cbourque@unb.ca	Bayat, Mahmoud/AAA-9781-2019; Bayat, Mahmoud/S-1673-2016	Bayat, Mahmoud/0000-0002-2210-0710; Bayat, Mahmoud/0000-0003-4348-3228	University of Tehran, Karaj, Iran; Natural Sciences and Engineering Research Council of Canada	University of Tehran, Karaj, Iran; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The authors acknowledge the University of Tehran, Karaj, Iran, for the use of the Kheyrud Experimental Forest and for logistical and financial support to MB (http://www.ut.ac.ir); Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca) for funding portion of this research by way of a Discovery Grant to CPAB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashraf MI, 2015, MITIG ADAPT STRAT GL, V20, P159, DOI 10.1007/s11027-013-9484-9; Ashraf MI, 2012, HYDROL PROCESS, V26, P1119, DOI 10.1002/hyp.8195; Austin MP, 1996, AUST J ECOL, V21, P154, DOI 10.1111/j.1442-9993.1996.tb00596.x; Bang C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011061; Bassow SL, 1998, ECOLOGY, V79, P2660, DOI 10.1890/0012-9658(1998)079[2660:HECACL]2.0.CO;2; Bayat M, 2013, EUR J FOREST RES, V132, P851, DOI 10.1007/s10342-013-0714-1; Beven K, 1997, HYDROL PROCESS, V11, P1069; Bourque CPA, 2012, J HYDROL, V454, P141, DOI 10.1016/j.jhydrol.2012.06.008; Bourque CPA, 1998, CAN J SOIL SCI, V78, P409, DOI 10.4141/S97-089; Bourque CPA, 2000, CAN J FOREST RES, V30, P1179, DOI 10.1139/cjfr-30-8-1179; Byun JG, 2013, J PLANT ECOL, V6, P380, DOI 10.1093/jpe/rtt001; Campbell G.S., 1998, INTRO ENV BIOPHYSICS, Vsecond, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; CHAVEZ PS, 1988, REMOTE SENS ENVIRON, V24, P459, DOI 10.1016/0034-4257(88)90019-3; Detto M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076296; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Geiger R., 1965, CLIMATE NEAR GROUND; Goudriaan J., 1977, CROP MICROMETEOROLOG; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Gruber S, 2009, DEV SOIL SCI, V33, P171, DOI 10.1016/S0166-2481(08)00007-X; Heikkinen RK, 1997, BIODIVERS CONSERV, V6, P1181, DOI 10.1023/A:1018356823171; Heshmati GA, 2007, INT J PLANT PROD, V1, P215; Heyder JC, 1986, WALDBAU WANDEL SILVI; JARVIS A, 2005, THESIS KINGS COLL LO; Kerr JT, 2003, TRENDS ECOL EVOL, V18, P299, DOI 10.1016/S0169-5347(03)00071-5; Kimmins J.P., 1997, FOREST ECOLOGY FDN S, V3rd; Kopecky M, 2010, APPL VEG SCI, V13, P450, DOI 10.1111/j.1654-109X.2010.01083.x; Lebourgeois F, 2005, TREES-STRUCT FUNCT, V19, P385, DOI 10.1007/s00468-004-0397-9; Ledo A, 2013, J VEG SCI, V24, P1086, DOI 10.1111/jvs.12023; Lopes AMG, 2003, ENVIRON MODELL SOFTW, V18, P81, DOI 10.1016/S1364-8152(02)00024-5; Marvie-Mohadjer MR, 2012, SILVICULTURE; McVicar TR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042255; MERRIAM JB, 1992, GEOPHYS J INT, V109, P488, DOI 10.1111/j.1365-246X.1992.tb00112.x; Moeslund JE, 2013, BIODIVERS CONSERV, V22, P2151, DOI 10.1007/s10531-013-0442-3; Murphy PNC, 2011, ECOL MODEL, V222, P2314, DOI 10.1016/j.ecolmodel.2011.01.003; Nagendra H, 2001, INT J REMOTE SENS, V22, P2377, DOI 10.1080/01431160117096; Namiranian M, 2009, INTERNAL REPORT; Nilsen ET, 1996, FIELD CROP RES, P192; Oliver C.D., 1996, FOREST STAND DYNAMIC; Papaik MJ, 2006, J ECOL, V94, P1011, DOI 10.1111/j.1365-2745.2006.01153.x; Patry C, 2013, FOREST CHRON, V89, P525, DOI 10.5558/tfc2013-093; Pausas JG, 2003, J VEG SCI, V14, P661, DOI 10.1111/j.1654-1103.2003.tb02198.x; Pausas JG, 2001, J VEG SCI, V12, P153, DOI 10.2307/3236601; Peckham SD, 2009, DEV SOIL SCI, V33, P411, DOI 10.1016/S0166-2481(08)00018-4; Rao LE, 2011, PLANT ECOL, V212, P1079, DOI 10.1007/s11258-010-9888-5; Redowan M, 2013, J INDIAN SOC REMOTE, V41, P567, DOI 10.1007/s12524-012-0254-z; Renno CD, 2008, REMOTE SENS ENVIRON, V112, P3469, DOI 10.1016/j.rse.2008.03.018; RETUERTO R, 1992, OECOLOGIA, V92, P113, DOI 10.1007/BF00317271; Schietti J, 2014, PLANT ECOL DIVERS, V7, P241, DOI 10.1080/17550874.2013.783642; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Sefidi K, 2011, FOREST ECOL MANAG, V262, P1094, DOI 10.1016/j.foreco.2011.06.008; Skov F, 2003, FOREST ECOL MANAG, V180, P583, DOI 10.1016/S0378-1127(02)00646-1; Sprugel DG, 1982, SCI, V211, P390; Tabari M., 2007, Caspian Journal of Environmental Sciences, V5, P35; Tabari M, 2005, FORESTRY, V78, P443, DOI 10.1093/forestry/cpi032; WADSWORTH R. M., 1959, ANN BOT, V23, P195; Webb EL, 1999, J BIOGEOGR, V26, P887, DOI 10.1046/j.1365-2699.1999.00326.x	56	18	18	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121172	10.1371/journal.pone.0121172	http://dx.doi.org/10.1371/journal.pone.0121172			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849029	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800047
J	Chen, YY; Huang, XB; Xiao, Y; Jiang, Y; Shan, XW; Zhang, J; Cai, SX; Liu, JB				Chen, Yan-Yan; Huang, Xi-Bao; Xiao, Ying; Jiang, Yong; Shan, Xiao-wei; Zhang, Juan; Cai, Shun-Xiang; Liu, Jian-Bing			Spatial Analysis of Schistosomiasis in Hubei Province, China: A GIS-Based Analysis of Schistosomiasis from 2009 to 2013	PLOS ONE			English	Article							REPUBLIC-OF-CHINA; GEOGRAPHIC INFORMATION-SYSTEM; JAPONICUM INFECTION; INTERVENTION TRIAL; ENDEMIC AREAS; RISK-FACTORS; LAKE REGION; TRANSMISSION; IMPACT; AUTOCORRELATION	Background Schistosomiasis remains a major public health problem in China. The major endemic areas are located in the lake and marshland regions of southern China, particularly in areas along the middle and low reach of the Yangtze River. Spatial analytical techniques are often used in epidemiology to identify spatial clusters in disease regions. This study assesses the spatial distribution of schistosomiasis and explores high-risk regions in Hubei Province, China to provide guidance on schistosomiasis control in marshland regions. Methods In this study, spatial autocorrelation methodologies, including global Moran's I and local Getis-Ord statistics, were utilized to describe and map spatial clusters and areas where human Schistosoma japonicum infection is prevalent at the county level in Hubei province. In addition, linear logistic regression model was used to determine the characteristics of spatial autocorrelation with time. Results The infection rates of S. japonicum decreased from 2009 to 2013. The global autocorrelation analysis results on the infection rate of S. japonicum for five years showed statistical significance (Moran's I > 0, P < 0.01), which suggested that spatial clusters were present in the distribution of S. japonicum infection from 2009 to 2013. Local autocorrelation analysis results showed that the number of highly aggregated areas ranged from eight to eleven within the five-year analysis period. The highly aggregated areas were mainly distributed in eight counties. Conclusions The spatial distribution of human S. japonicum infections did not exhibit a temporal change at the county level in Hubei Province. The risk factors that influence human S. japonicum transmission may not have changed after achieving the national criterion of infection control. The findings indicated that spatial-temporal surveillance of S. japonicumtransmission plays a significant role on schistosomiasis control. Timely and integrated prevention should be continued, especially in the Yangtze River Basin of Jianghan Plain area.	[Chen, Yan-Yan; Huang, Xi-Bao; Xiao, Ying; Jiang, Yong; Shan, Xiao-wei; Zhang, Juan; Cai, Shun-Xiang; Liu, Jian-Bing] Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China		Cai, SX (corresponding author), Hubei Ctr Dis Control & Prevent, Wuhan, Peoples R China.	441711219@qq.com; hbcdcxf@126.com			Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China [XF2012-24, XF2012-26]	Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China	This study was funded by the Provinal Research of Schistosomiasis Prevention of Health Department of Hubei, China (XF2012-24, XF2012-26). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alias H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-186; Cai YC, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-138; Torres RMC, 2013, CIENC SAUDE COLETIVA, V18, P1441, DOI 10.1590/S1413-81232013000500029; Chaput EK, 2002, EMERG INFECT DIS, V8, P943, DOI 10.3201/eid0809.020103; CHEN YL, 2014, PLOS NEGLECT TROP D, V8, P89779, DOI DOI 10.1371/JOURNAL.PONE.0089779; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; Coulibaly D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-82; Estrada-Pena A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102905; Flahaut B, 2003, ACCIDENT ANAL PREV, V35, P991, DOI 10.1016/S0001-4575(02)00107-0; Gray DJ, 2007, AM J TROP MED HYG, V77, P866, DOI 10.4269/ajtmh.2007.77.866; Gray DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005900; Guimaraes RJPS, 2008, ACTA TROP, V108, P234, DOI 10.1016/j.actatropica.2008.07.001; Hong XC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002122; Hu Y, 2014, PARASITOL INT, V63, P500, DOI 10.1016/j.parint.2014.01.009; Hui FM, 2009, AM J TROP MED HYG, V81, P503; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Liu JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031876; Mattsson BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055097; McManus DP, 2010, CLIN MICROBIOL REV, V23, P442, DOI 10.1128/CMR.00044-09; Peng WX, 2010, PARASITOLOGY, V137, P1099, DOI 10.1017/S003118200999206X; Raso G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006947; Ross AGP, 2001, CLIN MICROBIOL REV, V14, P270, DOI 10.1128/CMR.14.2.270-295.2001; Seto EYW, 2008, ECOHEALTH, V5, P149, DOI 10.1007/s10393-008-0169-x; Shanghai WL, 2006, EPIDEMIC STATUS SCHI, P36; SHOUPAI M, 1982, AM J TROP MED HYG, V31, P92, DOI 10.4269/ajtmh.1982.31.92; Smith JL, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002359; Szonyi B, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-31; Tsai PJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-464; Utzinger J, 2005, ACTA TROP, V96, P69, DOI 10.1016/j.actatropica.2005.08.004; Viladomat J, 2014, BIOMETRICS, V70, P409, DOI 10.1111/biom.12139; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; Wang XH, 2006, INT J PARASITOL, V36, P895, DOI 10.1016/j.ijpara.2006.04.003; Wu JL, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-23; Yang GJ, 2005, ACTA TROP, V96, P117, DOI 10.1016/j.actatropica.2005.07.006; Yang GJ, 2005, INT J PARASITOL, V35, P155, DOI 10.1016/j.ijpara.2004.11.002; Yang H, 2010, CHIN J SCHISTO CONTR, V22, P521; Zhang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092700; Zhang ZJ, 2009, PARASITOLOGY, V136, P737, DOI 10.1017/S0031182009005885; Zhang ZJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001620; Zhou D, 1994, World Health Forum, V15, P387; Zhou XN, 2008, AM J TROP MED HYG, V78, P188, DOI 10.4269/ajtmh.2008.78.188; Zhou XN, 2007, EMERG INFECT DIS, V13, P1470, DOI 10.3201/eid1310.061423; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005; Zhou XN, 2001, ACTA TROP, V79, P97, DOI 10.1016/S0001-706X(01)00107-3; Zhou YY, 2013, BMC MED IMAGING, V13, DOI 10.1186/1471-2342-13-13; Zhou YB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-275; Zhu HQ, 2014, SE ASIAN J TROP MED, V45, P20; Zhu HM, 2008, ECOHEALTH, V5, P137, DOI 10.1007/s10393-008-0168-y; Zhu HuiGuo, 2008, Chinese Journal of Schistosomiasis Control, V20, P251; Zhu YC, 2005, ACTA TROP, V96, P130, DOI 10.1016/j.actatropica.2005.07.007	52	20	23	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0118362	10.1371/journal.pone.0118362	http://dx.doi.org/10.1371/journal.pone.0118362			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849567	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800005
J	Manalebh, A; Demissie, M; Mekonnen, D; Abera, B				Manalebh, Almaw; Demissie, Meaza; Mekonnen, Daniel; Abera, Bayeh			The Quality of Sputum Smear Microscopy in Public-Private Mix Directly Observed Treatment Laboratories in West Amhara Region, Ethiopia	PLOS ONE			English	Article							TUBERCULOSIS LABORATORIES; DIAGNOSIS; ASSURANCE; TB; RECHECKING; SYSTEM; GHANA; INDIA	Ethiopia adopted Public-Private Mix Directly Observed Treatment Short Course Chemotherapy (PPM-DOTS) strategy for tuberculosis (TB) control program. Quality of sputum smear microscopy has paramount importance for tuberculosis control program in resource-poor countries like Ethiopia. A cross-sectional study was conducted to assess the quality of sputum smear microscopy in 37 Public-Private Mix laboratories in West Amhara, Ethiopia. The three external quality assessment methods (onsite evaluation, panel testing and blind rechecking) were employed. Onsite assessment revealed that 67.6% of PPM-DOTS laboratories were below the standard physical space (5 X 6) m(2). The average monthly workload per laboratory technician was 19.5 (SD +/- 2.9) slides with 12.8% positivity rate. The quality of Acid Fast Bacilli (AFB) staining reagents was sub-standard. The overall agreement for blind rechecking of 1,123 AFB slides was 99.4% (Kappa = 0.97). Reading of 370 AFB panel slides showed 3.5% false reading (Kappa = 0.92). Moreover, the consistency of reading scanty bacilli slides was lower (93%) compared to 1+, 2+ and 3+ bacilli. Based on blind rechecking and panel testing results, PPM-DOTS site laboratories showed good agreement with the reference laboratory. Physical space and qualities of AFB reagents would be areas of intervention to sustain the quality of sputum smear microscopy. Therefore, regular external quality assessment and provision of basic laboratory supplies for TB diagnosis would be the way forward to improve the quality of sputum smear microscopy services in PPM-DOTS laboratories.	[Manalebh, Almaw] USAID Ethiopia, Private Hlth Sect Programme, Bahir Dar, Ethiopia; [Demissie, Meaza] Addis Continental Inst Publ Hlth, Gondar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Med Microbiol, Coll Med & Heath Sci, Bahir Dar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Parasitol, Coll Med & Heath Sci, Bahir Dar, Ethiopia; [Mekonnen, Daniel; Abera, Bayeh] Bahir Dar Univ, Dept Immunol, Coll Med & Heath Sci, Bahir Dar, Ethiopia	United States Agency for International Development (USAID); Addis Continental Institute of Public Health; Bahir Dar University; Bahir Dar University; Bahir Dar University	Abera, B (corresponding author), Bahir Dar Univ, Dept Med Microbiol, Coll Med & Heath Sci, Bahir Dar, Ethiopia.	bayeabera15@gmail.com	Abera, Bayeh/AAU-8754-2020		University of Gondar; Bahir Dar Regional Health Research Laboratory Center	University of Gondar; Bahir Dar Regional Health Research Laboratory Center	The authors would like to acknowledge the University of Gondar and Bahir Dar Regional Health Research Laboratory Center for supporting this study. We are also grateful for private laboratory personnel, heads and owners for their facilitation and cooperation in giving valid and relevant information for the study.	Addo KK, 2006, INT J TUBERC LUNG D, V10, P870; Addo KK, 2006, INT J TUBERC LUNG D, V10, P812; Ajaykumar T, 2006, NTI B, V42, P15; Aziz M, 2002, INT J TUBERC LUNG D, V6, P340; Basra D, 2006, East Afr Med J, V83, P306; Dave Paresh V, 2011, Indian J Tuberc, V58, P113; Federal Ministry of Health, 2012, TUB ANN B FMOH; Federal Ministry of Health (FMOH), 2013, GUID CLIN PROGR MAN, V5th; (FMOH) Federal Ministry of Health, 2006, PPM DOTS IMPL GUID; (FMOH) Federal Ministry of Health of Ethiopia, 2009, GUID QUAL ASS SMEAR; Hepple P, 2012, INT J TUBERC LUNG D, V16, P579, DOI 10.5588/ijtld.11.0617; Huong NT, 2006, INT J TUBERC LUNG D, V10, P277; Leon C. I., 1993, Boletin de la Oficina Sanitaria Panamericana, V115, P103; Malik S, 2011, SE ASIAN J TROP MED, V42, P342; Maloney SA, 2001, INT J TUBERC LUNG S1, V5, pS132; Martinez-Guarneros A, 2003, INT J TUBERC LUNG D, V7, P516; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; Paramasivan CN, 2003, INT J TUBERC LUNG D, V7, P522; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Private Sector Program, 2009, ETH INT TB HIV SERV; Shargie E. B., 2005, Ethiopian Journal of Health Development, V19, P104; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2014, WHOHTMTB201408; World Health Organization, 2003, QUAL ASS SPUT MICR D; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123749	10.1371/journal.pone.0123749	http://dx.doi.org/10.1371/journal.pone.0123749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849516	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800256
J	Sheng, M; Hosseinzadeh, A; Muralidharan, SV; Gaur, R; Selstam, E; Tuck, S				Sheng, Ming; Hosseinzadeh, Ava; Muralidharan, Somsundar Veppil; Gaur, Rahul; Selstam, Eva; Tuck, Simon			Aberrant Fat Metabolism in Caenorhabditis elegans Mutants with Defects in the Defecation Motor Program	PLOS ONE			English	Article							C-ELEGANS; RHYTHMIC BEHAVIOR; GENETICS; NEUROPEPTIDE; INSULIN; CONTRIBUTES; DISSECTION; INTESTINE; RECEPTOR; NEURONS	The molecular mechanisms by which dietary fatty acids are absorbed by the intestine, and the way in which the process is regulated are poorly understood. In a genetic screen for mutations affecting fat accumulation in the intestine of Caenorhabditis elegans, nematode worms, we have isolated mutations in the aex-5 gene, which encodes a Kex2/subtilisinfamily, Ca2+-sensitive proprotein convertase known to be required for maturation of certain neuropeptides, and for a discrete step in an ultradian rhythmic phenomenon called the defecation motor program. We demonstrate that aex-5 mutants have markedly lower steadystate levels of fat in the intestine, and that this defect is associated with a significant reduction in the rate at which labeled fatty acid derivatives are taken up from the intestinal lumen. Other mutations affecting the defecation motor program also affect steady-state levels of triglycerides, suggesting that the program is required per se for the proper accumulation of neutral lipids. Our results suggest that an important function of the defecation motor program in C. elegans is to promote the uptake of an important class of dietary nutrients. They also imply that modulation of the program might be one way in which worms adjust nutrient uptake in response to altered metabolic status.	[Sheng, Ming; Hosseinzadeh, Ava; Muralidharan, Somsundar Veppil; Gaur, Rahul; Tuck, Simon] Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden; [Selstam, Eva] Umea Univ, Dept Plant Physiol, SE-90187 Umea, Sweden	Umea University; Umea University	Tuck, S (corresponding author), Umea Univ, Umea Ctr Mol Med, SE-90187 Umea, Sweden.	Simon.Tuck@umu.se		hosseinzadeh, ava/0000-0003-3069-0295	Vetenskapsradet [K2012-67X-20441-63]; Cancerfonden [12 0534]	Vetenskapsradet(Swedish Research Council); Cancerfonden(Swedish Cancer Society)	Work in ST's laboratory is supported by grants from Vetenskapsradet (K2012-67X-20441-63) and Cancerfonden (12 0534). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ashrafi K, 2007, WORMBOOK; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1997, FEEDING DEFECATION; Beg AA, 2003, NAT NEUROSCI, V6, P1145, DOI 10.1038/nn1136; Beg AA, 2008, CELL, V132, P149, DOI 10.1016/j.cell.2007.10.058; Bender A, 2013, ACS CHEM BIOL, V8, P636, DOI 10.1021/cb300396j; Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; BRENNER S, 1974, GENETICS, V77, P71; CLOKEY GV, 1986, MECH AGEING DEV, V35, P79, DOI 10.1016/0047-6374(86)90068-0; Croll N, 1975, J ZOOL, V184, P507; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Espelt MV, 2005, J GEN PHYSIOL, V126, P379, DOI 10.1085/jgp.200509355; Graham TR, 2004, TRENDS CELL BIOL, V14, P670, DOI 10.1016/j.tcb.2004.10.008; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Husson SJ, 2006, J NEUROCHEM, V98, P1999, DOI 10.1111/j.1471-4159.2006.04014.x; Iwasaki K, 1997, TRENDS GENET, V13, P111, DOI 10.1016/S0168-9525(97)01059-7; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kemp BJ, 2012, CURR BIOL, V22, P2213, DOI 10.1016/j.cub.2012.09.047; Kniazeva M, 2003, GENETICS, V163, P159; LIU DWC, 1994, J NEUROSCI, V14, P1953; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Mahoney TR, 2008, P NATL ACAD SCI USA, V105, P16350, DOI 10.1073/pnas.0803617105; MCGHEE JD, 2007, WORMBOOK; Nassir N, 2009, MED CHEM, V9, P3; Nilsson L, 2011, TRAFFIC, V12, P1839, DOI 10.1111/j.1600-0854.2011.01271.x; O'Rourke EJ, 2009, CELL METAB, V10, P430, DOI 10.1016/j.cmet.2009.10.002; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Papaioannou Sylvana, 2008, Invertebrate Neuroscience, V8, P91, DOI 10.1007/s10158-008-0072-8; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Pfeiffer J, 2008, CURR BIOL, V18, P297, DOI 10.1016/j.cub.2008.01.054; Pino EC, 2013, JOVE; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; THOMAS JH, 1990, GENETICS, V124, P855; Wang H, 2013, CURR BIOL, V23, P746, DOI 10.1016/j.cub.2013.03.049; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Watts JL, 2003, GENETICS, V163, P581; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	44	8	14	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124515	10.1371/journal.pone.0124515	http://dx.doi.org/10.1371/journal.pone.0124515			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849533	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800268
J	Sun, TJ; Lu, Y; Narusaka, M; Shi, C; Yang, YB; Wu, JX; Zeng, HY; Narusaka, Y; Yao, N				Sun, Tie-Jun; Lu, Yun; Narusaka, Mari; Shi, Chao; Yang, Yu-Bing; Wu, Jian-Xin; Zeng, Hong-Yun; Narusaka, Yoshihiro; Yao, Nan			A Novel Pyrimidin-Like Plant Activator Stimulates Plant Disease Resistance and Promotes Growth	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; APOPLASTIC OXIDATIVE BURST; MONOOXYGENASE FMO1; GENE-EXPRESSION; INNATE IMMUNITY; SALICYLIC-ACID; CELL-DEATH; ARABIDOPSIS; BENZOTHIADIAZOLE; SIGNAL	Plant activators are chemicals that induce plant defense responses to a broad spectrum of pathogens. Here, we identified a new potential plant activator, 5-(cyclopropylmethyl)-6-methyl-2-(2-pyridyl)pyrimidin-4-ol, named PPA (pyrimidin-type plant activator). Compared with benzothiadiazole S-methyl ester (BTH), a functional analog of salicylic acid (SA), PPA was fully soluble in water and increased fresh weight of rice (Oryza sativa) and Arabidopsis plants at low concentrations. In addition, PPA also promoted lateral root development. Microarray data and real-time PCR revealed that PPA-treated leaves not challenged with pathogen showed up-regulation of genes related to reactive oxygen species (ROS), defenses and SA. During bacterial infection, Arabidopsis plants pretreated with PPA showed dramatically decreased disease symptoms and an earlier and stronger ROS burst, compared with plants pretreated with BTH. Microscopy revealed that H2O2 accumulated in the cytosol, plasma membrane and cell wall around intracellular bacteria, and also on the bacterial cell wall, indicating that H2O2 was directly involved in killing bacteria. The increase in ROS-related gene expression also supported this observation. Our results indicate that PPA enhances plant defenses against pathogen invasion through the plant redox system, and as a water-soluble compound that can promote plant growth, has broad potential applications in agriculture.	[Sun, Tie-Jun; Lu, Yun; Shi, Chao; Yang, Yu-Bing; Wu, Jian-Xin; Zeng, Hong-Yun; Yao, Nan] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Narusaka, Mari; Narusaka, Yoshihiro] Res Inst Biol Sci Okayama, Okayama, Japan	Sun Yat Sen University	Narusaka, Y (corresponding author), Res Inst Biol Sci Okayama, Okayama, Japan.	yo_narusaka@bio-ribs.com; yaonan@mail.sysu.edu.cn			National Key Basic Science 973 Program [2012CB114006]; National Natural Science Foundation of China [31170247]; Fundamental Research Funds for the Central Universities [13lgjc27]; Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan; JSPS KAKENHI [24580071]	National Key Basic Science 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the National Key Basic Science 973 Program (2012CB114006), National Natural Science Foundation of China (31170247), Fundamental Research Funds for the Central Universities (13lgjc27), Industrial Technology Research Grant Program in 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan and by JSPS KAKENHI Grant Number 24580071. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Bindschedler LV, 2006, PLANT J, V47, P851, DOI 10.1111/j.1365-313X.2006.02837.x; Boller T, 2009, SCIENCE, V324, P742, DOI 10.1126/science.1171647; Canet JV, 2010, PLANT BIOTECHNOL J, V8, P126, DOI 10.1111/j.1467-7652.2009.00468.x; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Casimiro I, 2003, TRENDS PLANT SCI, V8, P165, DOI 10.1016/S1360-1385(03)00051-7; Chanda B, 2011, NAT GENET, V43, P421, DOI 10.1038/ng.798; Chaturvedi R, 2012, PLANT J, V71, P161, DOI 10.1111/j.1365-313X.2012.04981.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Ford KA, 2010, P NATL ACAD SCI USA, V107, P17527, DOI 10.1073/pnas.1013020107; Friedrich L, 1996, PLANT J, V10, P61, DOI 10.1046/j.1365-313X.1996.10010061.x; Godard JF, 1999, CROP PROT, V18, P397, DOI 10.1016/S0261-2194(99)00040-X; Gorlach J, 1996, PLANT CELL, V8, P629, DOI 10.1105/tpc.8.4.629; Gozzo F, 2003, J AGR FOOD CHEM, V51, P4487, DOI 10.1021/jf030025s; Hamdoun S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083219; Heil M, 2000, J ECOL, V88, P645, DOI 10.1046/j.1365-2745.2000.00479.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jung HW, 2009, SCIENCE, V324, P89, DOI 10.1126/science.1170025; Kunz W, 1997, PESTIC SCI, V50, P275, DOI 10.1002/(SICI)1096-9063(199708)50:4&lt;275::AID-PS593&gt;3.0.CO;2-7; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luna E, 2012, PLANT PHYSIOL, V158, P844, DOI 10.1104/pp.111.187468; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; Mishina TE, 2006, PLANT PHYSIOL, V141, P1666, DOI 10.1104/pp.106.081257; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shen CX, 2010, AM J BOT, V97, P1602, DOI 10.3732/ajb.1000073; Skelly MJ, 2013, ANTIOXID REDOX SIGN, V19, P990, DOI 10.1089/ars.2013.5429; Slaughter A, 2012, PLANT PHYSIOL, V158, P835, DOI 10.1104/pp.111.191593; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Torres MA, 2006, PLANT PHYSIOL, V141, P373, DOI 10.1104/pp.106.079467; Uehara F, 2013, BIOORG MED CHEM LETT, V23, P6928, DOI 10.1016/j.bmcl.2013.09.021; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Yao N, 2006, PLANT CELL, V18, P397, DOI 10.1105/tpc.105.036251; Yao N, 2002, PLANT J, V30, P567, DOI 10.1046/j.1365-313X.2002.01314.x; Yoshioka H, 2003, PLANT CELL, V15, P706, DOI 10.1105/tpc.008680; Zipfel C, 2009, CURR OPIN PLANT BIOL, V12, P414, DOI 10.1016/j.pbi.2009.06.003	41	11	11	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123227	10.1371/journal.pone.0123227	http://dx.doi.org/10.1371/journal.pone.0123227			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849038	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800215
J	Wang, B; Roth, JA; Nguyen, H; Felber, E; Furnback, W; Garrison, LP				Wang, Bruce; Roth, Joshua A.; Nguyen, Hiep; Felber, Eugene; Furnback, Wes; Garrison, Louis P.			The Short-Term Cost-Effectiveness of Once-Daily Liraglutide Versus Once-Weekly Exenatide for the Treatment of Type 2 Diabetes Mellitus in the United States	PLOS ONE			English	Article							IMPROVED GLYCEMIC CONTROL; HEALTH-CARE COSTS; OPEN-LABEL; RANDOMIZED-TRIAL; METFORMIN; SITAGLIPTIN; EFFICACY; SAFETY; OUTCOMES; PIOGLITAZONE	Background Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease with substantial morbidity, mortality, and economic impacts. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as once-daily (QD) liraglutide and once-weekly (QW) exenatide, are FDA-approved treatment for T2DM. Head-to-head trials and meta-analyses comparing these agents have reported clinically meaningful improvements but small differences in glycemic control between both agents. In this study, we calculate and compare the cost-effectiveness implications of these alternative effectiveness outcomes. Methods We developed a decision model to evaluate the short-term cost-effectiveness of exenatide QW 2 mg versus liraglutide QD 1.8 mg in T2DM patients, with effectiveness measured as reduction in glycated hemoglobin (HbA1c). In the base case, the model tracks change in HbA1c and direct medical expenditure over a 6-month time horizon. We calculated and compared the cost per 1% reduction in HbA1c of models populated with clinical data from a head-to-head randomized, controlled trial (DURATION-6) and a network meta-analysis. Expenditure inputs were derived from wholesale acquisition costs and published sources. Results In the base case, 6-month expenditure for the liraglutide and exenatide strategies were $3,509 and $2,618, respectively. Using clinical data from DURATION-6 and the network meta-analysis, the liraglutide strategy had an incremental cost per 1% reduction in HbA1c of $4,773 and $27,179, respectively. The most influential model parameters were drug costs, magnitude of HbA1c reduction in patients on treatment for >1 month, and liraglutide gastrointestinal adverse event rate. In probabilistic sensitivity analyses (PSA) using DURATION- 6 data, the exenatide strategy was optimal at willingness-to-pay levels below $4,800 per 1% reduction in HbA1c. In a PSA using meta-analysis data, the exenatide strategy was dominant. Conclusions Our modeled results demonstrate that the effectiveness and cost-effectiveness of liraglutide QD 1.8 mg relative to exenatide QW 2 mg depend largely on the chosen source of the clinical data.	[Wang, Bruce; Furnback, Wes] Elysia Grp LLC, New York, NY 10018 USA; [Roth, Joshua A.; Garrison, Louis P.] Univ Washington, Dept Pharm, Seattle, WA 98195 USA; [Roth, Joshua A.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Nguyen, Hiep] AstraZeneca, Ft Washington, MD USA; [Felber, Eugene] Bristol Myers Squibb Co, New York, NY 10154 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; AstraZeneca; Bristol-Myers Squibb	Wang, B (corresponding author), Elysia Grp LLC, New York, NY 10018 USA.	bruce.wang@alscg.com		Roth, Joshua/0000-0001-6621-8342	Bristol-Myers Squibb Company	Bristol-Myers Squibb Company(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb Company. HN was an employee of Bristol-Myers Squibb Company during the study and was a contributor to the study design, decision to publish, and preparation of the manuscript.	Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Beckles GL, 2013, MMWR-MORBID MORTAL W, V62, P99; Bergenstal RM, 2013, DIABETES OBES METAB, V15, P264, DOI 10.1111/dom.12026; Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Boyle JP, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-29; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Buse JB, 2013, LANCET, V381, P117, DOI 10.1016/S0140-6736(12)61267-7; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeKoven M, 2014, ADV THER, V31, P202, DOI 10.1007/s12325-014-0098-8; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Gabriel SE, 2012, NEW ENGL J MED, V367, P787, DOI 10.1056/NEJMp1207437; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Green JB, 2013, AM HEART J, V166, P983, DOI 10.1016/j.ahj.2013.09.003; Langer J, 2013, J MANAGE CARE PHARM, V19, P237, DOI 10.18553/jmcp.2013.19.3.237; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; McBrien KA, 2013, DIABETES CARE, V36, P1172, DOI 10.2337/dc12-0862; Menzin J, 2010, J MANAGE CARE PHARM, V16, P264, DOI 10.18553/jmcp.2010.16.4.264; Narayan KMV, 2006, DIABETES CARE, V29, P2114, DOI 10.2337/dc06-1136; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Pelletier Elise M, 2012, J Med Econ, V15, P1039, DOI 10.3111/13696998.2012.688903; Qaseem A, 2012, ANN INTERN MED, V156, P218, DOI 10.7326/0003-4819-156-3-201202070-00011; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Russell-Jones D, 2012, DIABETES CARE, V35, P252, DOI 10.2337/dc11-1107; Saunders B, 2014, AM DIAB ASS ADA 74 S; Scott DA, 2013, DIABETES OBES METAB, V15, P213, DOI 10.1111/dom.12007; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Wagner EH, 2001, JAMA-J AM MED ASSOC, V285, P182, DOI 10.1001/jama.285.2.182; Wild Howard, 2012, Am J Manag Care, V18, pS43; Zhuo XH, 2012, HEALTH AFFAIR, V31, P50, DOI 10.1377/hlthaff.2011.1115; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	32	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121915	10.1371/journal.pone.0121915	http://dx.doi.org/10.1371/journal.pone.0121915			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849542	Green Submitted, gold, Green Published			2022-12-26	WOS:000352477800088
J	Estrabaud, E; Appourchaux, K; Bieche, I; Carrat, F; Lapalus, M; Lada, O; Martinot-Peignoux, M; Boyer, N; Marcellin, P; Vidaud, M; Asselah, T				Estrabaud, Emilie; Appourchaux, Kevin; Bieche, Ivan; Carrat, Fabrice; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Vidaud, Michel; Asselah, Tarik			IFI35, mir-99a and HCV Genotype to Predict Sustained Virological Response to Pegylated-Interferon Plus Ribavirin in Chronic Hepatitis C	PLOS ONE			English	Article							GENE-EXPRESSION SIGNATURE; DISEASE PROGRESSION; ISG EXPRESSION; FIBROSIS; THERAPY; INFECTION; MICRORNA-122; POLYMORPHISM; MODULATION; GROWTH	Although, the treatment of chronic hepatitis C (CHC) greatly improved with the use of direct antiviral agents, pegylated-interferon (PEG-IFN) plus ribavirin remains an option for many patients, worldwide. The intra-hepatic level of expression of interferon stimulated genes (ISGs) and the rs12979860 CC genotype located within IFNL3 have been associated with sustained virological response (SVR), in patients with CHC. The aim of the study was to identify micro-RNAs associated with SVR and to build an accurate signature to predict SVR. Pre-treatment liver biopsies from 111 patients, treated with PEG-IFN plus ribavirin, were studied. Fifty-seven patients had SVR, 36 non-response (NR) and 18 relapse (RR). The expression of 851 human miRNAs and 30 selected mRNAs, including ISGs, was assessed by RT-qPCR. In the first group of patients (screen), 20 miRNAs out of the 851 studied were deregulated between NRs and SVRs. From the 4 miRNAs validated (mir-23a, mir-181a*, mir-217 and mir-99a), in the second group of patients (validation), 3 (mir-23a, mir-181a* and mir-99a) were down-regulated in NRs as compared to SVRs. The ISGs, studied, were accumulated in SVRs and IFNL3 rs12979860 CT/TT carriers compared respectively to NRs and CC carriers. Combining, clinical data together with the expression of selected genes and micro-RNAs, we identified a signature (IFI35, mir-99a and HCV genotype) to predict SVR (AUC:0.876) with a positive predictive value of 86.54% with high sensibility (80%) and specificity (80.4%). This signature may help to characterize patients with low chance to respond to PEG-IFN/ribavirin and to elucidate mechanisms of NR.	[Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] INSERM, Team Viral Hepatitis, Ctr Rech Inflammat, UMR1149, Paris, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] Univ Paris 07, Paris, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] PMAD Hop Beaujon, Serv Hepatol, Clichy, France; [Estrabaud, Emilie; Appourchaux, Kevin; Lapalus, Martine; Lada, Olivier; Martinot-Peignoux, Michelle; Boyer, Nathalie; Marcellin, Patrick; Asselah, Tarik] PRES Paris Sorbonne Cite, Lab Excellence Labex INFLAMEX, Paris, France; [Bieche, Ivan; Vidaud, Michel] Univ Paris 05, Sorbonne Paris Cite, Fac Sci Pharmaceut & Biol, INSERM UMR745, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Carrat, Fabrice] Univ Paris 06, Paris, France; [Carrat, Fabrice] INSERM, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Estrabaud, E (corresponding author), INSERM, Team Viral Hepatitis, Ctr Rech Inflammat, UMR1149, BP 416, Paris, France.	emilie.estrabaud@inserm.fr	Bièche, Ivan/O-7399-2017; Carrat, Fabrice/AAU-8480-2020; Vidaud, Michel/O-7346-2017	Bièche, Ivan/0000-0002-2430-5429; Carrat, Fabrice/0000-0002-8672-7918; 	french national agency for research on AIDS and viral hepatitis (ANRS)	french national agency for research on AIDS and viral hepatitis (ANRS)(ANRSFrench National Research Agency (ANR))	EE fellowship was supported by the french national agency for research on AIDS and viral hepatitis (ANRS). The study was supported by fundings from the french national agency for research on AIDS and viral hepatitis (ANRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2011, J HEPATOL, V54, P1094, DOI 10.1016/j.jhep.2010.09.019; Akamatsu S, 2014, J INFECT; Asselah T, 2008, GUT, V57, P516, DOI 10.1136/gut.2007.128611; Asselah T, 2005, GASTROENTEROLOGY, V129, P2064, DOI 10.1053/j.gastro.2005.09.010; Asselah T, 2008, HEPATOLOGY, V48, P953, DOI 10.1002/hep.22411; Asselah T, 2014, J HEPATOL, V61, P193, DOI 10.1016/j.jhep.2014.03.006; Asselah T, 2014, LIVER INT, V34, P60, DOI 10.1111/liv.12424; Asselah T, 2012, J HEPATOL, V56, P527, DOI 10.1016/j.jhep.2011.09.008; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Craxi A, 2011, J HEPATOL, V55, P245, DOI 10.1016/j.jhep.2011.02.023; Das A, 2014, J VIROL, V88, P3103, DOI 10.1128/JVI.03202-13; de Yebenes VG, 2014, BLOOD, V124, P229, DOI 10.1182/blood-2013-12-543611; Dill MT, 2011, GASTROENTEROLOGY, V140, P1021, DOI 10.1053/j.gastro.2010.11.039; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Estrabaud E, 2012, J HEPATOL; Estrabaud E, 2014, J VIROL, V88, P6394, DOI 10.1128/JVI.00016-14; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gelley F, 2014, J GASTROEN HEPATOL, V29, P121, DOI 10.1111/jgh.12362; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Honda M, 2010, GASTROENTEROLOGY, V139, P499, DOI 10.1053/j.gastro.2010.04.049; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Marcellin P, 2002, HEPATOLOGY, V36, pS47, DOI 10.1053/jhep.2002.36993; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Murakami Y, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-48; Nattermann J, 2007, HEPATOLOGY, V46, P1016, DOI 10.1002/hep.21778; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Peng XX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-373; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Sarrazin C, 2011, J HEPATOL, V54, P415, DOI 10.1016/j.jhep.2010.07.041; Schinazi R, 2014, LIVER INT, V34, P69, DOI 10.1111/liv.12423; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Urban TJ, 2010, HEPATOLOGY, V52, P1888, DOI 10.1002/hep.23912; Wang B, 2012, HEPATOLOGY; Yang ZP, 2014, ACTA DIABETOL, V51, P823, DOI 10.1007/s00592-014-0617-8; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121395	10.1371/journal.pone.0121395	http://dx.doi.org/10.1371/journal.pone.0121395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844942	Green Published, Green Submitted, gold			2022-12-26	WOS:000352475700007
J	Manning, VA; Ciuffetti, LM				Manning, Viola A.; Ciuffetti, Lynda M.			Necrotrophic Effector Epistasis in the Pyrenophora tritici-repentis-Wheat Interaction	PLOS ONE			English	Article							HOST-SELECTIVE TOXINS; TAN SPOT; CAUSAL AGENT; PTR TOXA; RACE STRUCTURE; VIRULENCE; GENE; CULTIVARS; CHLOROSIS; DISEASE	Pyrenophora tritici-repentis, the causal agent of tan spot disease of wheat, mediates disease by the production of host-selective toxins (HST). The known toxins are recognized in an 'inverse' gene-for-gene manner, where each is perceived by the product of a unique locus in the host and recognition leads to disease susceptibility. Given the importance of HSTs in disease development, we would predict that the loss of any of these major pathogenicity factors would result in reduced virulence and disease development. However, after either deletion of the gene encoding the HST ToxA or, reciprocally, heterologous expression of ToxA in a race that does not normally produce the toxin followed by inoculation of ToxA-sensitive and insensitive wheat cultivars, we demonstrate that ToxA symptom development can be epistatic to other HST-induced symptoms. ToxA epistasis on certain ToxA-sensitive wheat cultivars leads to genotype-specific increases in total leaf area affected by disease. These data indicate a complex interplay between host responses to HSTs in some genotypes and underscore the challenge of identifying additional HSTs whose activity may be masked by other toxins. Also, through mycelial staining, we acquire preliminary evidence that ToxA may provide additional benefits to fungal growth in planta in the absence of its cognate recognition partner in the host.	[Manning, Viola A.; Ciuffetti, Lynda M.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA; [Ciuffetti, Lynda M.] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Ciuffetti, LM (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA.	ciuffetL@science.oregonstate.edu			Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2010-65108-20548]	Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2010-65108-20548 from the USDA National Institute of Food and Agriculture. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboukhaddour R, 2013, CAN J PLANT PATHOL, V35, P256, DOI 10.1080/07060661.2013.782470; Aboukhaddour R, 2012, MOL PLANT PATHOL, V13, P318, DOI 10.1111/j.1364-3703.2011.00748.x; Adhikari T., 2009, FUNGAL LEAF SPOT DIS; Ali S, 2003, PLANT DIS, V87, P418, DOI 10.1094/PDIS.2003.87.4.418; Amaike S, 2008, PLANT PATHOL, V57, P623, DOI 10.1111/j.1365-3059.2007.01821.x; Andrie RA, 2007, PHYTOPATHOLOGY, V97, P694, DOI 10.1094/PHYTO-97-6-0694; [Anonymous], TAN SPOT WHEAT ARGEN; Ayliffe M, 2011, MOL PLANT MICROBE IN, V24, P1143, DOI 10.1094/MPMI-04-11-0100; Bailey KL, 1996, CAN J PLANT PATHOL, V18, P159, DOI 10.1080/07060669609500641; BALLANCE GM, 1989, PHYSIOL MOL PLANT P, V35, P203, DOI 10.1016/0885-5765(89)90051-9; Benslimane H, 2011, PHYTOPATHOL MEDITERR, V50, P203; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Cho YR, 2006, MOL PLANT MICROBE IN, V19, P7, DOI 10.1094/MPMI-19-0007; Ciuffetti L.M., 2014, GENOMICS PLANT ASS F, P1, DOI [10.1007/978-3-662-44053-7_1, DOI 10.1007/978-3-662-44053-7_1]; Ciuffetti LM, 1997, PLANT CELL, V9, P135, DOI 10.1105/tpc.9.2.135; Ciuffetti LM, 2010, NEW PHYTOL, V187, P911, DOI 10.1111/j.1469-8137.2010.03362.x; Coll NS, 2011, CELL DEATH DIFFER, V18, P1247, DOI 10.1038/cdd.2011.37; De Wolf ED, 1998, CAN J PLANT PATHOL, V20, P349, DOI 10.1080/07060669809500404; Du Fall LA, 2013, NEW PHYTOL, V200, P185, DOI 10.1111/nph.12356; Dushnicky LG, 1998, CAN J PLANT PATHOL, V20, P19, DOI 10.1080/07060669809500441; Effertz RJ, 2002, PHYTOPATHOLOGY, V92, P527, DOI 10.1094/PHYTO.2002.92.5.527; Eitas TK, 2010, CURR OPIN PLANT BIOL, V13, P472, DOI 10.1016/j.pbi.2010.04.007; Faris J.D., 2013, THEOR APPL GENET, V29, P1; Faris JD, 2010, P NATL ACAD SCI USA, V107, P13544, DOI 10.1073/pnas.1004090107; FLING SP, 1986, ANAL BIOCHEM, V155, P83, DOI 10.1016/0003-2697(86)90228-9; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Friesen TL, 2002, PHYTOPATHOLOGY, V92, P38, DOI 10.1094/PHYTO.2002.92.1.38; Fu HT, 2013, FUNGAL BIOL-UK, V117, P673, DOI 10.1016/j.funbio.2013.07.003; Heath MC, 2000, PROGRAMMED CELL DEAT, P77, DOI DOI 10.1007/978-94-010-0934-8_6; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Lamari L, 2005, CAN J PLANT PATHOL, V27, P383; Lamari L, 2003, PHYTOPATHOLOGY, V93, P391, DOI 10.1094/PHYTO.2003.93.4.391; LAMARI L, 1991, PLANT DIS, V75, P121, DOI 10.1094/PD-75-0121; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P49, DOI 10.1080/07060668909501146; Lamari L, 1998, CAN J PLANT PATHOL, V20, P396, DOI 10.1080/07060669809500410; LAMARI L, 1989, CAN J PLANT PATHOL, V11, P284, DOI 10.1080/07060668909501114; Lamari L, 2010, CAN J PLANT PATHOL, V32, P4, DOI 10.1080/07060661003594117; LAREZ CR, 1986, PHYTOPATHOLOGY, V76, P931, DOI 10.1094/Phyto-76-931; Lorang J, 2012, SCIENCE, V338, P659, DOI 10.1126/science.1226743; LOUGHMAN R, 1986, PLANT PATHOL, V35, P443, DOI 10.1111/j.1365-3059.1986.tb02041.x; Manning VA, 2005, PLANT CELL, V17, P3203, DOI 10.1105/tpc.105.035063; Manning VA, 2013, G3-GENES GENOM GENET, V3, P41, DOI 10.1534/g3.112.004044; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Martinez JP, 2004, MOL PLANT MICROBE IN, V17, P467, DOI 10.1094/MPMI.2004.17.5.467; Meinhardt S, 2002, NEW RACE PYRENOPHORA, P117; Moffat CS, 2014, MOL PLANT PATHOL, V15, P918, DOI 10.1111/mpp.12154; Moreno MV, 2008, EUR J PLANT PATHOL, V122, P239, DOI 10.1007/s10658-008-9277-2; Morral R, 2014, SASKATOON SASKATCHWA, P1; Murray GM, 2009, AUSTRALAS PLANT PATH, V38, P558, DOI 10.1071/AP09053; OROLAZA NP, 1995, PHYTOPATHOLOGY, V85, P1282, DOI 10.1094/Phyto-85-1282; Pandelova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040240; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; Rodriguez RW, 1996, PLANT DIS, V80, P478, DOI 10.1094/PD-80-0478; SCHUH W, 1990, PHYTOPATHOLOGY, V80, P804, DOI 10.1094/Phyto-80-804; Singh PK, 2007, CAN J PLANT PATHOL, V29, P166, DOI 10.1080/07060660709507453; Strelkov SE, 2005, PHYSIOL MOL PLANT P, V67, P164, DOI 10.1016/j.pmpp.2005.12.004; Strelkov SE, 2003, CAN J PLANT PATHOL, V25, P339; Strelkov SE, 2002, CAN J PLANT PATHOL, V24, P29, DOI 10.1080/07060660109506967; Tai Y. S., 2007, Biotechnology, V6, P288; TOMAS A, 1990, MOL PLANT MICROBE IN, V3, P221, DOI 10.1094/MPMI-3-221; TUORI RP, 1995, MOL PLANT MICROBE IN, V8, P41, DOI 10.1094/MPMI-8-0041; Vincent D, 2012, MOL PLANT PATHOL, V13, P467, DOI 10.1111/j.1364-3703.2011.00763.x; Wolpert TJ, 2002, ANNU REV PHYTOPATHOL, V40, P251, DOI 10.1146/annurev.phyto.40.011402.114210	63	27	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0123548	10.1371/journal.pone.0123548	http://dx.doi.org/10.1371/journal.pone.0123548			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25845019	Green Published, Green Submitted, gold			2022-12-26	WOS:000352475700023
J	de Freitas, CT; Shepard, GH; Piedade, MTF				de Freitas, Carolina T.; Shepard, Glenn H., Jr.; Piedade, Maria T. F.			The Floating Forest: Traditional Knowledge and Use of Matupa Vegetation Islands by Riverine Peoples of the Central Amazon	PLOS ONE			English	Article							ECOLOGICAL KNOWLEDGE; INDIGENOUS KNOWLEDGE; CLASSIFICATION; CONSERVATION	Matupas are floating vegetation islands found in floodplain lakes of the central Brazilian Amazon. They form initially from the agglomeration of aquatic vegetation, and through time can accumulate a substrate of organic matter sufficient to grow forest patches of several hectares in area and up to 12 m in height. There is little published information on matupas despite their singular characteristics and importance to local fauna and people. In this study we document the traditional ecological knowledge of riverine populations who live near and interact with matupas. We expected that their knowledge, acquired through long term observations and use in different stages of the matupa life cycle, could help clarify various aspects about the ecology and natural history of these islands that field biologists may not have had the opportunity to observe. Research was carried out in five riverine communities of the Amana Sustainable Development Reserve (Brazil). Semistructured interviews were conducted with 45 inhabitants in order to register local understandings of how matupas are formed, biotic/abiotic factors related to their occurrence, the plants and animals that occur on them, their ecological relevance, and local uses. Local people elucidated several little-known aspects about matupa ecology, especially regarding the importance of seasonal dynamics of high/low water for matupas formation and the relevance of these islands for fish populations. Soil from matupas is especially fertile and is frequently gathered for use in vegetable gardens. In some cases, crops are planted directly onto matupas, representing an incipient agricultural experiment that was previously undocumented in the Amazon. Matupas are also considered a strategic habitat for fishing, mainly for arapaima (Arapaima gigas). The systematic study of traditional ecological knowledge proved to be an important tool for understanding this little-known Amazonian landscape.	[de Freitas, Carolina T.] Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil; [Shepard, Glenn H., Jr.] Museu Paraense Emilio Goeldi, Dept Anthropol, Belem, Para, Brazil; [Piedade, Maria T. F.] Inst Nacl de Pesquisas da Amazonia, Coordenacao Pesquisas Dinam Ambiental, Manaus, Amazonas, Brazil	Institute Nacional de Pesquisas da Amazonia; Museu Paraense Emilio Goeldi; Institute Nacional de Pesquisas da Amazonia	de Freitas, CT (corresponding author), Inst Nacl de Pesquisas da Amazonia, Programa Posgrad Ecol, Manaus, Amazonas, Brazil.	carol.tavares.freitas@gmail.com	Shepard, Glenn H./C-3667-2014; Piedade, Maria Teresa/C-5372-2013; Shepard, Glenn/AAS-4059-2021; Freitas, Carolina/D-3225-2019	Shepard, Glenn H./0000-0003-3195-8230; Piedade, Maria Teresa/0000-0002-7320-0498; Shepard, Glenn/0000-0003-3195-8230; Freitas, Carolina/0000-0002-2335-4229	Instituto de Desenvolvimento Sustentavel Mamiraua; National Geographic Society [9159-12]	Instituto de Desenvolvimento Sustentavel Mamiraua; National Geographic Society(National Geographic Society)	CTF received financial and logistical support from the Instituto de Desenvolvimento Sustentavel Mamiraua (http://www.mamiraua.org.br/) and also financial support from the National Geographic Society (Grant Number 9159-12; http://www.nationalgeographic.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraao MB, 2008, J BIOGEOGR, V35, P2237, DOI 10.1111/j.1365-2699.2008.01975.x; Agostinho AA, 2007, AQUAT ECOL, V41, P611, DOI 10.1007/s10452-007-9122-2; [Anonymous], 1998, ETHNOGRAPHERS TOOLKI; Balram S, 2004, BIODIVERS CONSERV, V13, P1195, DOI 10.1023/B:BIOC.0000018152.11643.9c; Banuri T., 1993, WHO WILL SAVE FOREST; Berkes F, 1999, SACRED ECOLOGY TRADI, P1; Berkes F., 1993, TRADITIONAL ECOLOGIC, P1; Bernard HR, 1994, RES METHODS ANTHR QU; Brook R, 2008, BIODIVERS CONSERV, V17, P3501, DOI 10.1007/s10531-008-9445-x; CASCUDO Luis da Camara, 2001, DICIONARIO FOLCLORE; Curtis JT, 1951, ECOLOGY, V31, P476; Fleck David W., 2000, Journal of Ethnobiology, V20, P1; GALVAO Eduardo, 1955, SANTOS VISAGENS ESTU; Halme KJ, 2007, BIODIVERS CONSERV, V16, P1785, DOI 10.1007/s10531-006-9071-4; Hoogmoed Marinus S., 1993, Monographiae Biologicae, V70, P199; Huntington HP, 2000, ECOL APPL, V10, P1270, DOI 10.1890/1051-0761(2000)010[1270:UTEKIS]2.0.CO;2; IDSM, 2014, AM RES DES SUST; Ingold T, 2006, ETHNOS, V71, P9, DOI 10.1080/00141840600603111; Johnson Leslie M., 2010, LANDSCAPE ETHNOECOLO; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W.J., 1983, P269; JUNK W.J., 1997, CENTRAL AMAZON FLOOD, P148, DOI DOI 10.1038/sdata.2017.122; Junk WJ, 1977, MACROFITAS AQUATICAS; Junk WJ, 2012, WETL ECOL MANAG, V20, P461, DOI 10.1007/s11273-012-9268-0; Junk WJ, 2011, WETLANDS, V31, P623, DOI 10.1007/s13157-011-0190-7; Monteiro MY, 2006, CRENDICES SUPERSTICO; NODA H, 1978, Acta Amazonica, V8, P107; Parker E. P., 1989, Advances in Economic Botany, V7, P249; Pereira M.N., 1944, B MINISTERIO AGR, V33, P21; Petr T, 2000, 396 FAO; POSEY DA, 1984, HUM ORGAN, V43, P95, DOI 10.17730/humo.43.2.908kp82611x0w860; Sanchez-Botero Jorge Ivan, 2001, Acta Amazonica, V31, P437; Sheil D, 2004, TRENDS ECOL EVOL, V19, P634, DOI 10.1016/j.tree.2004.09.019; Shepard G.H., 2004, ADV EC BOT, V15, P133; Shepard GH Jr, 2001, DEBATE AGRARIO, V33, P19; Shepard Junior Glenn H., 2001, Journal of Ethnobiology, V21, P1; Sillitoe P, 1998, CURR ANTHROPOL, V39, P223, DOI 10.1086/204722; Sutrop Urmas, 2001, FIELD METHOD, V13, P263; Toledo V., 1992, ETNOECOLOGICA, V1, P5; Ugarte JC., 2009, THESIS U NACL AGRARI; Villamarin F, 2011, BIOL CONSERV, V144, P913, DOI 10.1016/j.biocon.2010.12.012	41	7	8	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122542	10.1371/journal.pone.0122542	http://dx.doi.org/10.1371/journal.pone.0122542			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837281	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000100
J	deVries, MS; del Rio, CM; Tunstall, TS; Dawson, TE				deVries, Maya S.; del Rio, Carlos Martinez; Tunstall, Tate S.; Dawson, Todd E.			Isotopic Incorporation Rates and Discrimination Factors in Mantis Shrimp Crustaceans	PLOS ONE			English	Article							CARBON INCORPORATION RATES; STABLE-ISOTOPES; TISSUE-CARBON; FOOD-WEB; NITROGEN; TURNOVER; DIET; RATIOS; STOMATOPODS; SULFUR	Stable isotope analysis has provided insights into the trophic ecology of a wide diversity of animals. Knowledge about isotopic incorporation rates and isotopic discrimination between the consumer and its diet for different tissue types is essential for interpreting stable isotope data, but these parameters remain understudied in many animal taxa and particularly in aquatic invertebrates. We performed a 292-day diet shift experiment on 92 individuals of the predatory mantis shrimp, Neogonodactylus bredini, to quantify carbon and nitrogen incorporation rates and isotope discrimination factors in muscle and hemolymph tissues. Average isotopic discrimination factors between mantis shrimp muscle and the new diet were 3.0 +/- 0.6% and 0.9 +/- 0.3% for carbon and nitrogen, respectively, which is contrary to what is seen in many other animals (e.g. C and N discrimination is generally 0-1% and 3-4%, respectively). Surprisingly, the average residence time of nitrogen in hemolymph (28.9 +/- 8.3 days) was over 8 times longer than that of carbon (3.4 +/- 1.4 days). In muscle, the average residence times of carbon and nitrogen were of the same magnitude (89.3 +/- 44.4 and 72.8 +/- 18.8 days, respectively). We compared the mantis shrimps' incorporation rates, along with rates from four other invertebrate taxa from the literature, to those predicted by an allometric equation relating carbon incorporation rate to body mass that was developed for teleost fishes and sharks. The rate of carbon incorporation into muscle was consistent with rates predicted by this equation. Our findings provide new insight into isotopic discrimination factors and incorporation rates in invertebrates with the former showing a different trend than what is commonly observed in other animals.	[deVries, Maya S.; Tunstall, Tate S.; Dawson, Todd E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [del Rio, Carlos Martinez] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of California System; University of California Berkeley; University of Wyoming	deVries, MS (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	mdevries@ucsd.edu			American Museum of Natural History Lerner-Gray Fund; Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research; Society of Integrative and Comparative Biology Grants-In-Aid-of-Research; Smithsonian Tropical Research Institute's Short-Term Fellowship Award; UC Berkeley Department of Integrative Biology Endowment; UC Museum of Paleontology Graduate Student Research Award; National Science Foundation [IOS-1014573]; Berkeley Research Impact Initative (BRII) - UC Berkeley Library	American Museum of Natural History Lerner-Gray Fund; Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research; Society of Integrative and Comparative Biology Grants-In-Aid-of-Research; Smithsonian Tropical Research Institute's Short-Term Fellowship Award; UC Berkeley Department of Integrative Biology Endowment; UC Museum of Paleontology Graduate Student Research Award; National Science Foundation(National Science Foundation (NSF)); Berkeley Research Impact Initative (BRII) - UC Berkeley Library	This research was funded by the American Museum of Natural History Lerner-Gray Fund (http://www.amnh.org/our-research/richard-gilder-graduate-school/academics-and-research/fellowship-and-grant-opportunities/research-grants-and-student-exchange-fellowships), the Berkeley and National Sigma Xi Scientific Honors Society Grants-In-Aid-of-Research (https://www.sigmaxi.org/programs/grants-in-aid), the Society of Integrative and Comparative Biology Grants-In-Aid-of-Research (http://www.sicb.org/grants/researchgrant.php3), the Smithsonian Tropical Research Institute's Short-Term Fellowship Award (http://www.stri.si.edu/english/education_fellowships/fellowships/index.php), the UC Berkeley Department of Integrative Biology Endowment, the UC Museum of Paleontology Graduate Student Research Award (all awards to MSdV). Funding was also provided by the National Science Foundation (IOS-1014573 to S. N. Patek). Publication made possible in part by support from the Berkeley Research Impact Initative (BRII) sponsored by the UC Berkeley Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams TS, 2000, LIMNOL OCEANOGR, V45, P601, DOI 10.4319/lo.2000.45.3.0601; Arneson LS, 2006, CAN J ZOOL, V84, P992, DOI 10.1139/Z06-081; Ballestrazzi R, 1998, AQUACULTURE, V161, P55, DOI 10.1016/S0044-8486(97)00256-1; Bearhop S, 2004, J ANIM ECOL, V73, P1007, DOI 10.1111/j.0021-8790.2004.00861.x; Ben-David M, 2012, J MAMMAL, V93, P312, DOI 10.1644/11-MAMM-S-166.1; Blanchet-Aurigny A, 2012, J EXP MAR BIOL ECOL, V426, P68, DOI 10.1016/j.jembe.2012.05.013; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Bond AL, 2011, ECOL APPL, V21, P1017, DOI 10.1890/09-2409.1; BUNN SE, 1995, LIMNOL OCEANOGR, V40, P622, DOI 10.4319/lo.1995.40.3.0622; Caldwell R.L., 1989, Collana U.Z.I. Selected Symposia and Monographs, V3, P117; Caldwell RL, 1987, SHORT TERM ASSESMENT, P113; Carleton SA, 2005, OECOLOGIA, V144, P226, DOI 10.1007/s00442-005-0066-8; Carleton SA, 2008, RAPID COMMUN MASS SP, V22, P3008, DOI 10.1002/rcm.3691; Carleton SA, 2010, FUNCT ECOL, V24, P805, DOI 10.1111/j.1365-2435.2010.01700.x; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; Carter CG, 2014, CENT EUR J BIOL, V9, P1, DOI 10.2478/s11535-013-0134-0; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cerling TE, 2007, OECOLOGIA, V151, P175, DOI 10.1007/s00442-006-0571-4; Dattagupta S, 2004, LIMNOL OCEANOGR, V49, P1144, DOI 10.4319/lo.2004.49.4.1144; del Rio CM, 2008, OECOLOGIA, V156, P765, DOI 10.1007/s00442-008-1040-z; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; del Rio CM, 2005, PHYSIOLOGICAL ADAPTATIONS TO FEEDING INVERTEBRATES, P141; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; DINGLE H, 1978, BIOL BULL, V155, P134, DOI 10.2307/1540871; DOMINGUEZ JH, 1988, J EXP MAR BIOL ECOL, V117, P47, DOI 10.1016/0022-0981(88)90070-6; Dubois S, 2007, J EXP MAR BIOL ECOL, V351, P121, DOI 10.1016/j.jembe.2007.06.020; Fantle MS, 1999, OECOLOGIA, V120, P416, DOI 10.1007/s004420050874; Florin ST, 2011, FUNCT ECOL, V25, P519, DOI 10.1111/j.1365-2435.2010.01799.x; Frazer T, 1997, J EXP MAR BIOL ECOL, P212; Fry B., 2006, STABLE ISOTOPE ECOLO; FULL RJ, 1989, ETHOLOGY, V81, P134; Gamboa-Delgado J, 2011, J SHELLFISH RES, V30, P969, DOI 10.2983/035.030.0340; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Kaufman MR, 2008, OECOLOGIA, V158, P11, DOI 10.1007/s00442-008-1122-y; Kim SL, 2012, J EXP BIOL, V215, P2495, DOI 10.1242/jeb.070656; KUNZE JC, 1981, PHILOS T ROY SOC B, V292, P255, DOI 10.1098/rstb.1981.0032; Kurle CM, 2013, CONDOR, V115, P492, DOI 10.1525/cond.2013.120107; Leal JCM, 2008, MAR BIOL, V153, P673, DOI 10.1007/s00227-007-0841-7; Lecomte N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021357; Logan JM, 2008, J ANIM ECOL, V77, P838, DOI 10.1111/j.1365-2656.2008.01394.x; MacAvoy SE, 2001, CAN J FISH AQUAT SCI, V58, P923, DOI 10.1139/cjfas-58-5-923; Mateo MA, 2008, OECOLOGIA, V157, P105, DOI 10.1007/s00442-008-1052-8; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Murray IW, 2012, PHYSIOL BIOCHEM ZOOL, V85, P96, DOI 10.1086/663867; Parker PL., 1989, STABLE ISOTOPES ECOL, P288; Patek SN, 2005, J EXP BIOL, V208, P3655, DOI 10.1242/jeb.01831; Patek SN, 2004, NATURE, V428, P819, DOI 10.1038/428819a; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; REAKA ML, 1976, BIOL BULL, V150, P468, DOI 10.2307/1540686; STEGER R, 1987, ECOLOGY, V68, P1520, DOI 10.2307/1939236; Suring E, 2009, J EXP MAR BIOL ECOL, V370, P56, DOI 10.1016/j.jembe.2008.11.014; TIESZEN LL, 1983, OECOLOGIA, V57, P32, DOI 10.1007/BF00379558; Warne RW, 2010, PHYSIOL BIOCHEM ZOOL, V83, P608, DOI 10.1086/651585; Weidel BC, 2011, CAN J FISH AQUAT SCI, V68, P387, DOI 10.1139/F10-158; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115; Zarai Z, 2011, J SCI FOOD AGR, V91, P1265, DOI 10.1002/jsfa.4309; [No title captured]	59	33	35	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122334	10.1371/journal.pone.0122334	http://dx.doi.org/10.1371/journal.pone.0122334			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835953	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000095
J	Jamba, A; Kondo, S; Urushihara, M; Nagai, T; Kim-Kaneyama, J; Miyazaki, A; Kagami, S				Jamba, Ariunbold; Kondo, Shuji; Urushihara, Maki; Nagai, Takashi; Kim-Kaneyama, Joo-ri; Miyazaki, Akira; Kagami, Shoji			Hydrogen Peroxide-Inducible Clone-5 Regulates Mesangial Cell Proliferation in Proliferative Glomerulonephritis in Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; PDGF RECEPTOR; EXPRESSION; HIC-5; GENE; GLOMERULOSCLEROSIS; ACTIVATION; PROTEIN; BETA-1-INTEGRINS	Hydrogen peroxide-inducible clone-5 (Hic-5) is a transforming growth factor (TGF)-beta 1-in-ducible focal adhesion protein. We previously demonstrated that Hic-5 was localized in mesangial cells and its expression was associated with glomerular cell proliferation and matrix expansion in human and rat glomerulonephritis (GN). In the present study, we first assessed the role of Hic-5 in mesangioproliferative GN by injecting Habu venom into heminephrectomized wild type (Hic-5+/+) and Hic-5-deficient (Hic-5-/-) mice. Hic-5+/+ GN mice exhibited glomerular cell proliferation on day 7. Surprisingly, glomerular cell number and Ki-67-positive cells in Hic-5-/- GN mice were significantly greater than those in Hic-5+/+ GN mice on day 7, although the number of glomerular apoptotic cells and the expression of growth factors (platelet-derived growth factor-BB and TGF-beta 1) and their receptors were similarly increased in both Hic-5+/+ and Hic-5-/- GN mice. In culture experiments, proliferation assays showed that platelet-derived growth factor-BB and TGF-beta 1 enhanced the proliferation of Hic-5-/- mesangial cells compared with Hic-5+/+ mesangial cells. In addition, mitogenic regulation by Hic-5 was associated with altered and coordinated expression of cell cycle-related proteins including cyclin D1 and p21. The present results suggest that Hic-5 might regulate mesangial cell proliferation in proliferative GN in mice. In conclusion, modulation of Hic-5 expression might have a potential to prevent mesangial cell proliferation in the acute mitogenic phase of glomerulonephritis.	[Jamba, Ariunbold; Kondo, Shuji; Urushihara, Maki; Nagai, Takashi; Kagami, Shoji] Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima, Japan; [Kim-Kaneyama, Joo-ri; Miyazaki, Akira] Showa Univ, Sch Med, Dept Biochem, Tokyo 142, Japan	Tokushima University; Showa University	Kondo, S (corresponding author), Univ Tokushima, Grad Sch, Dept Pediat, Inst Hlth Biosci, Tokushima, Japan.	shuchann@tokushima-u.ac.jp			Morinaga Foundation for Health and Nutrition;  [23591570];  [23591571];  [26461613]; Grants-in-Aid for Scientific Research [26461613] Funding Source: KAKEN	Morinaga Foundation for Health and Nutrition; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research, number 23591570 to Shoji Kagami, and number 23591571 and 26461613 to Shuji Kondo, (http://www.jsps.go.jp/english/index.html) and by the Morinaga Foundation for Health and Nutrition to Shuji Kondo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abboud HE, 2012, EXP CELL RES, V318, P979, DOI 10.1016/j.yexcr.2012.02.025; ABBOUD HE, 1993, KIDNEY INT, V43, P252, DOI 10.1038/ki.1993.39; Amann K, 2012, NEPHROL DIAL TRANSPL, V27, P1755, DOI 10.1093/ndt/gfr603; [Anonymous], 2004, J CELL PHYSL; BARNES JL, 1993, AM J PATHOL, V143, P1366; Couser WG, 1998, NEPHROL DIAL TRANSPL, V13, P10, DOI 10.1093/ndt/13.suppl_1.10; Cove-Smith A, 2008, NEPHRON EXP NEPHROL, V108, pE74, DOI 10.1159/000127359; Dabiri G, 2008, J INVEST DERMATOL, V128, P280, DOI 10.1038/sj.jid.5700975; Deakin NO, 2011, MOL BIOL CELL, V22, P327, DOI 10.1091/mbc.E10-09-0790; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Hornigold N, 2010, KIDNEY INT, V77, P329, DOI 10.1038/ki.2009.417; IIDA H, 1991, P NATL ACAD SCI USA, V88, P6560, DOI 10.1073/pnas.88.15.6560; ISAKA Y, 1993, J CLIN INVEST, V92, P2597, DOI 10.1172/JCI116874; Kagami S, 1999, J AM SOC NEPHROL, V10, P779; KAGAMI S, 1993, LAB INVEST, V69, P68; Kagami S, 2000, KIDNEY INT, V58, P1088, DOI 10.1046/j.1523-1755.2000.00266.x; Kagami Shoji, 2004, Journal of Medical Investigation, V51, P1, DOI 10.2152/jmi.51.1; Kim-Kaneyama J, 2011, J MOL CELL CARDIOL, V50, P77, DOI 10.1016/j.yjmcc.2010.09.024; Kinoshita Y, 2011, TRANSL RES, V158, P235, DOI 10.1016/j.trsl.2011.05.003; Kitamura M, 1997, NEPHROL DIAL TRANSPL, V12, P669, DOI 10.1093/ndt/12.4.669; KLAHR S, 1988, NEW ENGL J MED, V318, P1657; Kondo S, 2004, BBA-MOL CELL RES, V1693, P91, DOI 10.1016/j.bbamcr.2004.05.005; Kondo S, 2006, J AM SOC NEPHROL, V17, P783, DOI 10.1681/ASN.2005050519; Kuhara T, 1997, J AM SOC NEPHROL, V8, P1679; Matsuda M, 1997, AM J NEPHROL, V17, P25, DOI 10.1159/000169067; Matsuura S, 2011, J HISTOCHEM CYTOCHEM, V59, P864, DOI 10.1369/0022155411413929; Morita T, 1998, AM J KIDNEY DIS, V31, P559, DOI 10.1053/ajkd.1998.v31.pm9531171; Morita T, 2011, NEPHROL DIAL TRANSPL, V26, P4023, DOI 10.1093/ndt/gfr176; NIEMIR ZI, 1995, KIDNEY INT, V48, P1530, DOI 10.1038/ki.1995.443; Sakai N, 2005, PATHOL INT, V55, P19, DOI 10.1111/j.1440-1827.2005.01781.x; Schocklmann HO, 1999, KIDNEY INT, V56, P1199, DOI 10.1046/j.1523-1755.1999.00710.x; Schocklmann HO, 2000, KIDNEY INT, V58, P1108, DOI 10.1046/j.1523-1755.2000.00268.x; Schoecklmann HO, 1997, KIDNEY INT, V51, P1228, DOI 10.1038/ki.1997.168; SHIBANUMA M, 1994, J BIOL CHEM, V269, P26767; Shibanuma M, 1998, INT J BIOCHEM CELL B, V30, P39, DOI 10.1016/S1357-2725(97)00155-6; Suga K, 2012, NEPHRON EXP NEPHROL, V120, pE59, DOI 10.1159/000335780; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Urushihara M, 2010, AM J PHYSIOL-RENAL, V298, pF167, DOI 10.1152/ajprenal.00124.2009; Watanabe T, 2002, J PATHOL, V198, P397, DOI 10.1002/path.1213; Yamamoto T, 1998, J AM SOC NEPHROL, V9, P2253	40	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122773	10.1371/journal.pone.0122773	http://dx.doi.org/10.1371/journal.pone.0122773			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835392	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000111
J	Li, FJ; Duggal, RN; Oliva, OM; Karki, S; Surolia, R; Wang, Z; Watson, RD; Thannickal, VJ; Powell, M; Watts, S; Kulkarni, T; Batra, H; Bolisetty, S; Agarwal, A; Antony, VB				Li, Fu Jun; Duggal, Ryan N.; Oliva, Octavio M.; Karki, Suman; Surolia, Ranu; Wang, Zheng; Watson, R. Douglas; Thannickal, Victor J.; Powell, Mickie; Watts, Stephen; Kulkarni, Tejaswini; Batra, Hitesh; Bolisetty, Subhashini; Agarwal, Anupam; Antony, Veena B.			Heme Oxygenase-1 Protects Corexit 9500A-Induced Respiratory Epithelial Injury across Species	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ENDOTHELIAL-CELL APOPTOSIS; DIOCTYL SODIUM SULFOSUCCINATE; HORIZON OIL-SPILL; GULF-OF-MEXICO; OXIDATIVE STRESS; E-CADHERIN; NADPH OXIDASE; PARACELLULAR PERMEABILITY; HYDROGEN-PEROXIDE	The effects of Corexit 9500A (CE) on respiratory epithelial surfaces of terrestrial mammals and marine animals are largely unknown. This study investigated the role of CE-induced heme oxygenase-1 (HO-1), a cytoprotective enzyme with anti-apoptotic and antioxidant activity, in human bronchial airway epithelium and the gills of exposed aquatic animals. We evaluated CE-mediated alterations in human airway epithelial cells, mice lungs and gills from zebrafish and blue crabs. Our results demonstrated that CE induced an increase in gill epithelial edema and human epithelial monolayer permeability, suggesting an acute injury caused by CE exposure. CE induced the expression of HO-1 as well as C-reactive protein (CRP) and NADPH oxidase 4 (NOX4), which are associated with ROS production. Importantly, CE induced caspase-3 activation and subsequent apoptosis of epithelial cells. The expression of the intercellular junctional proteins, such as tight junction proteins occludin, zonula occludens (ZO-1), ZO-2 and adherens junctional proteins E-cadherin and Focal Adhesion Kinase (FAK), were remarkably inhibited by CE, suggesting that these proteins are involved in CE-induced increased permeability and subsequent apoptosis. The cytoskeletal protein F-actin was also disrupted by CE. Treatment with carbon monoxide releasing molecule-2 (CORM-2) significantly inhibited CE-induced ROS production, while the addition of HO-1 inhibitor, significantly increased CE-induced ROS production and apoptosis, suggesting a protective role of HO-1 or its reaction product, CO, in CE-induced apoptosis. Using HO-1 knockoutmice, we further demonstrated that HO-1 protected against CE-induced inflammation and cellular apoptosis and corrected CE-mediated inhibition of E-cadherin and FAK. These observations suggest that CE activates CRP and NOX4-mediated ROS production, alters permeability by inhibition of junctional proteins, and leads to caspase-3 dependent apoptosis of epithelial cells, while HO-1 and its reaction products protect against oxidative stress and apoptosis.	[Li, Fu Jun; Duggal, Ryan N.; Oliva, Octavio M.; Karki, Suman; Surolia, Ranu; Wang, Zheng; Thannickal, Victor J.; Kulkarni, Tejaswini; Batra, Hitesh; Antony, Veena B.] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Watson, R. Douglas; Powell, Mickie; Watts, Stephen] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Bolisetty, Subhashini; Agarwal, Anupam] Univ Alabama Birmingham, Dept Med, Div Nephrol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Antony, VB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.	vantony@uab.edu	Bolisetty, Subhashini/F-6496-2011	Bolisetty, Subhashini/0000-0002-4650-3151; Surolia, Ranu/0000-0001-5389-3584	NIGMS [5R25GM086256]; BP/Gulf of Mexico Research Initiative (RDW); NIH/NHLBI [P01 HL114470]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336, T32DK007545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM086256] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BP/Gulf of Mexico Research Initiative (RDW); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a NIGMS Grant 5R25GM086256, which funds the UAB PREP Scholars Program (OMO); BP/Gulf of Mexico Research Initiative (RDW); and NIH/NHLBI (P01 HL114470, VBA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SE, 2011, J TOXICOL ENV HEAL A, V74, P1419, DOI 10.1080/15287394.2011.606797; Bolisetty S, 2013, AM J PHYSIOL-RENAL, V305, pF255, DOI 10.1152/ajprenal.00160.2013; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Buret AG, 2003, INT J PARASITOL, V33, P1363, DOI 10.1016/S0020-7519(03)00138-3; Castranova V, 2011, J TOXICOL ENV HEAL A, V74, P1367, DOI 10.1080/15287394.2011.606792; Chin AC, 2002, INFECT IMMUN, V70, P3673, DOI 10.1128/IAI.70.7.3673-3680.2002; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Dumont A, 1999, ONCOGENE, V18, P747, DOI 10.1038/sj.onc.1202325; Durante W, 2010, CURR DRUG TARGETS, V11, P1504, DOI 10.2174/1389450111009011504; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Fleury C, 2002, BIOCHIMIE, V84, P131, DOI 10.1016/S0300-9084(02)01369-X; Foresti R, 1997, J BIOL CHEM, V272, P18411, DOI 10.1074/jbc.272.29.18411; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; GIAEVER I, 1993, NATURE, V366, P591, DOI 10.1038/366591a0; Gray JL, 2014, CHEMOSPHERE, V95, P124, DOI 10.1016/j.chemosphere.2013.08.049; Griffith B, 2009, ANTIOXID REDOX SIGN, V11, P2505, DOI [10.1089/ars.2009.2599, 10.1089/ARS.2009.2599]; Guo X, 2003, AM J PHYSIOL-CELL PH, V285, pC1174, DOI 10.1152/ajpcell.00015.2003; Hayashi Y, 2012, BIOCHEM BIOPH RES CO, V417, P169, DOI 10.1016/j.bbrc.2011.11.078; Hirai K, 2007, INT J CANCER, V120, P500, DOI 10.1002/ijc.22287; Jarmi T, 2009, CURR HYPERTENS REP, V11, P56, DOI 10.1007/s11906-009-0011-z; Jonsson ME, 2009, AQUAT TOXICOL, V91, P62, DOI 10.1016/j.aquatox.2008.10.010; Kaizaki A, 2006, BRAIN RES, V1108, P39, DOI 10.1016/j.brainres.2006.06.011; Kantak SS, 1998, J BIOL CHEM, V273, P16953, DOI 10.1074/jbc.273.27.16953; Kim SJ, 2013, FREE RADICAL BIO MED, V65, P997, DOI 10.1016/j.freeradbiomed.2013.08.178; Kim Y, 2014, FEBS LETT, V588, P625, DOI 10.1016/j.febslet.2014.01.008; Kobayashi S, 2003, ARTERIOSCL THROM VAS, V23, P1398, DOI 10.1161/01.ATV.0000081637.36475.BC; Krajnak K, 2011, J TOXICOL ENV HEAL A, V74, P1397, DOI 10.1080/15287394.2011.606795; Kujawinski EB, 2011, ENVIRON SCI TECHNOL, V45, P1298, DOI 10.1021/es103838p; Li JZ, 2012, CAN J PHYSIOL PHARM, V90, P1569, DOI 10.1139/y2012-140; Liu B, 2006, CHEMOSPHERE, V62, P520, DOI 10.1016/j.chemosphere.2005.06.054; Liu GS, 2014, FREE RADICAL BIO MED, V70, P14, DOI 10.1016/j.freeradbiomed.2013.12.024; Lu Q, 2012, MICROVASC RES, V83, P56, DOI 10.1016/j.mvr.2011.05.003; Ma TY, 1999, AM J PHYSIOL-GASTR L, V276, pG965, DOI 10.1152/ajpgi.1999.276.4.G965; Man Y, 2000, AM J RESP CELL MOL, V23, P610, DOI 10.1165/ajrcmb.23.5.4046; Menard N, 2012, PHARM RES-DORDR, V29, P1882, DOI 10.1007/s11095-012-0714-8; Minamino T, 2001, P NATL ACAD SCI USA, V98, P8798, DOI 10.1073/pnas.161272598; MOFFATT RE, 1975, CAN J COMP MED, V39, P434; Motterlini R, 2000, FREE RADICAL BIO MED, V28, P1303, DOI 10.1016/S0891-5849(00)00294-X; Nabata A, 2008, ATHEROSCLEROSIS, V196, P129, DOI 10.1016/j.atherosclerosis.2007.03.003; Nakatsuji T, 2006, MOL CELL ENDOCRINOL, V253, P96, DOI 10.1016/j.mce.2006.05.004; Nawijn MC, 2011, TRENDS IMMUNOL, V32, P248, DOI 10.1016/j.it.2011.03.004; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Rao R. K., 2008, V447, P171, DOI 10.1007/978-1-59745-242-7_13; Reiter TA, 2005, FREE RADICAL BIO MED, V39, P1075, DOI 10.1016/j.freeradbiomed.2005.05.023; Rico-Martinez R, 2013, ENVIRON POLLUT, V173, P5, DOI 10.1016/j.envpol.2012.09.024; Ryu J, 2007, CARDIOVASC RES, V75, P555, DOI 10.1016/j.cardiores.2007.04.027; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schmeiser K, 1999, CELL DEATH DIFFER, V6, P377, DOI 10.1038/sj.cdd.4400504; Schmidt CW, 2010, ENVIRON HEALTH PERSP, V118, pA338, DOI 10.1289/ehp.118-a338; Shah A, 2013, J BIOL CHEM, V288, P6835, DOI 10.1074/jbc.M112.419101; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Shi YL, 2013, J TOXICOL ENV HEAL A, V76, P827, DOI 10.1080/15287394.2013.821396; Sriram K, 2011, J TOXICOL ENV HEAL A, V74, P1405, DOI 10.1080/15287394.2011.606796; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Wise James, 2011, Reviews on Environmental Health, V26, P281, DOI 10.1515/REVEH.2011.035; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038; Zhang H, 2014, FREE RADICAL BIO MED, V69, P219, DOI 10.1016/j.freeradbiomed.2014.01.025; Zheng MY, 2014, LIFE SCI, V95, P108, DOI 10.1016/j.lfs.2013.12.010; Zolfaghari-Baghbaderani A, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/981365	65	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122275	10.1371/journal.pone.0122275	http://dx.doi.org/10.1371/journal.pone.0122275			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835394	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000091
J	Wang, Q; Wu, XH; Zhao, B; Qin, J; Peng, TC				Wang, Quan; Wu, Xianhua; Zhao, Bin; Qin, Jie; Peng, Tingchun			Combined Multivariate Statistical Techniques, Water Pollution Index (WPI) and Daniel Trend Test Methods to Evaluate Temporal and Spatial Variations and Trends of Water Quality at Shanchong River in the Northwest Basin of Lake Fuxian, China	PLOS ONE			English	Article							LAND-USE; EUTROPHICATION; APPORTIONMENT; NITROGEN; INDIA	Understanding spatial and temporal variations in river water quality and quantitatively evaluating the trend of changes are important in order to study and efficiently manage water resources. In this study, an analysis of Water Pollution Index (WPI), Daniel Trend Test, Cluster Analysis and Discriminant Analysis are applied as an integrated approach to quantitatively explore the spatial and temporal variations and the latent sources of water pollution in the Shanchong River basin, Northwest Basin of Lake Fuxian, China. We group all field surveys into 2 clusters (dry season and rainy season). Moreover, 14 sampling sites have been grouped into 3 clusters for the rainy season (highly polluted, moderately polluted and less polluted sites) and 2 clusters for the dry season (highly polluted and less polluted sites) based on their similarities and the level of pollution during the two seasons. The results show that the main trend of pollution was aggravated during the transition from the dry to the rainy season. The Water Pollution Index of Total Nitrogen is the highest of all pollution parameters, whereas the Chemical Oxygen Demand (Chromium) is the lowest. Our results also show that the main sources of pollution are farming activities alongside the Shanchong River, soil erosion and fish culture at Shanchong River reservoir area and domestic sewage from scattered rural residential area. Our results suggest that strategies to prevent water pollutionat the Shanchong River basin need to focus on non-point pollution control by employing appropriate fertilizer formulas in farming, and take the measures of soil and water conservation at Shanchong reservoir area, and purifying sewage from scattered villages.	[Wang, Quan; Wu, Xianhua; Zhao, Bin; Qin, Jie; Peng, Tingchun] Yuxi Normal Univ, Yuxi Res Ctr Ecoenvironm Sci Plateau Lakes, Yuxi, Yunnan Province, Peoples R China	Yuxi Normal University	Wu, XH (corresponding author), Yuxi Normal Univ, Yuxi Res Ctr Ecoenvironm Sci Plateau Lakes, Yuxi, Yunnan Province, Peoples R China.	xhw105@163.com	wang, quan/GXG-6960-2022	Wang, Quan/0000-0002-3559-4932	National Basic Research Program of China [2014CB460607]; Yunnan Applied Basic Research Projects [2013FD051]	National Basic Research Program of China(National Basic Research Program of China); Yunnan Applied Basic Research Projects	This work was supported by grants from National Basic Research Program of China (No. 2014CB460607), Yunnan Applied Basic Research Projects (No. 2013FD051). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGSTROM L, 1986, PLANT SOIL, V93, P333, DOI 10.1007/BF02374284; BROOKES PC, 1997, LOSSES PHOSPHORUS DR, P253; Bu HM, 2010, ECOTOX ENVIRON SAFE, V73, P907, DOI 10.1016/j.ecoenv.2009.11.007; Chang NB, 2005, STOCH ENV RES RISK A, V19, P97, DOI 10.1007/s00477-004-0217-1; Chen JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102714; Freddy N., 2008, HARMONIZED WORLD SOI; Gao Wei, 2013, Hupo Kexue, V25, P635; Huang F, 2010, WATER RES, V44, P1562, DOI 10.1016/j.watres.2009.11.003; Keatley BE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015913; Kolovos A, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000743; Kowalkowski T, 2006, WATER RES, V40, P744, DOI 10.1016/j.watres.2005.11.042; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li SY, 2008, CATENA, V75, P216, DOI 10.1016/j.catena.2008.06.005; Li X, 2011, J ANHUI AGR SCI, V39, p[18112, 18169]; [黎小正 Li Xiaozheng], 2011, [广东农业科学, Guangdong Agricultural Sciences], V38, P121; Lin Wang, 2006, J YUXI TEACH COLL, V22, P64; Liu X, 2010, J ANHUI AGR SCI, V38, P16341; Ministry of Environmental Protection of the People's Republic of China, 2003, GB38382002 MIN ENV P; Ministry of Environmental Protection of the People's Republic of China, 2008, TECHN GUID SURF WAT; Parelho C, 2014, SCI TOTAL ENVIRON, V496, P241, DOI 10.1016/j.scitotenv.2014.07.053; RYTHER JH, 1971, SCIENCE, V171, P1008, DOI 10.1126/science.171.3975.1008; SCHINDLE.DW, 1971, J PHYCOL, V7, P321, DOI 10.1111/j.1529-8817.1971.tb01527.x; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Shrestha S, 2007, ENVIRON MODELL SOFTW, V22, P464, DOI 10.1016/j.envsoft.2006.02.001; Singh EJK, 2013, ENVIRON SCI POLLUT R, V20, P2421, DOI 10.1007/s11356-012-1127-2; Singh KP, 2005, ANAL CHIM ACTA, V538, P355, DOI 10.1016/j.aca.2005.02.006; State Environment Protection Bureau of China, 2002, WAT WAST AN METH; Statistical Bureau of Yunnan Province, 2013, YUNN STAT YB 2013; Su SL, 2011, PHYS CHEM EARTH, V36, P379, DOI 10.1016/j.pce.2010.03.021; Tao T, 2014, NATURE, V511, P527, DOI 10.1038/511527a; The tobacco industry Office of Yuxi Municipal People's Government, 2008, YUX TOB SOIL MAN FER; Wan L, 2008, ENV PROT SCI, V34, P53; Wang Q, 2013, J YUXI NORM U, V29, P9; Wang Quan, 2012, Environmental Science & Technology (China), V35, P191; Wang XZ, 2012, QUATERN INT, V282, P137, DOI 10.1016/j.quaint.2012.05.015; Wang Y, 2013, J HYDRO-ENVIRON RES, V7, P30, DOI 10.1016/j.jher.2012.10.003; Wu Bin, 2010, J YUXI NORM U, V26, P39; Xu HS, 2012, PROCEDIA ENVIRON SCI, V13, P1641, DOI 10.1016/j.proenv.2012.01.157; Yuxi Federation of social science circles, 2013, YUXI FEDERATION SOCI; Zhang Y, 2009, ENVIRON MONIT ASSESS, V152, P105, DOI 10.1007/s10661-008-0300-z; Zhao L, 2012, J ENVIRON SCI-CHINA, V24, P1355, DOI 10.1016/S1001-0742(11)60967-4; Zhou NQ, 2011, J HYDROL, V396, P267, DOI 10.1016/j.jhydrol.2010.11.019	42	27	29	2	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118590	10.1371/journal.pone.0118590	http://dx.doi.org/10.1371/journal.pone.0118590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837673	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000004
J	Xie, HS; Chung, JK; Mascelli, MA; McCauley, TG				Xie, Hongsheng; Chung, Jou-Ku; Mascelli, Mary Ann; McCauley, Thomas G.			Pharmacokinetics and Bioavailability of a Therapeutic Enzyme (Idursulfase) in Cynomolgus Monkeys after Intrathecal and Intravenous Administration	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; HUNTER-SYNDROME	Intravenous enzyme replacement therapy with iduronate-2-sulfatase is an approved treatment for Hunter syndrome, however, conventional intravenous delivery cannot treat the neurologic manifestations of the disease due to its limited central nervous system penetration. Intrathecal administration of iduronate-2-sulfatase for delivery to the central nervous system is currently under investigation. The objective of this study was to evaluate the pharmacokinetics of idursulfase in the central nervous system of cynomolgus monkeys (Macaca fasicularis) after intravenous and intrathecal administration. Twenty-seven monkeys, treatment-naive to enzyme replacement therapy, were placed into 4 groups according to body weight: Group 1 was administered 0.5 mg/kg idursulfase intravenously, Groups 2-4 were administered an intrathecal formulation (1-, 10-, and 30-mg doses). Blood samples and cerebrospinal fluid (sampled at the cisterna magna or lumbar level) were collected at the same time points for 72 hours post dosing. Following intravenous administration, a high maximum serum concentration and rapid distribution of iduronate-2-sulfatase out of the central compartment were observed (elimination half-life: 4.3 hours). Iduronate-2-sulfatase exposure in the cerebrospinal fluid was limited, suggesting intravenous administration provided minimal penetration of the blood-brain barrier. Following intrathecal administration, a high maximum observed concentration was immediately noted and elimination half-life ranged between 7.8-10 hours and 5.9-6.7 hours (cisterna magna and lumbar sampling, respectively). Cerebrospinal fluid pharmacokinetic profiles at different doses of iduronate-2-sulfatase were similar and the dose/exposure relationship was proportional. After intrathecal administration, movement of iduronate-2-sulfatase from cerebrospinal fluid to serum was observed (systemic bioavailability was 40-83%). The clear penetration of iduronate-2-sulfatase into the cerebrospinal fluid and the dose response suggest that intrathecal delivery of iduronate-2-sulfatase may be suitable for treating the central nervous system manifestations associated with Hunter syndrome.	[Xie, Hongsheng; Chung, Jou-Ku; Mascelli, Mary Ann; McCauley, Thomas G.] Shire, Lexington, MA 02421 USA	Shire Pharmaceuticals Limited	Chung, JK (corresponding author), Shire, Lexington, MA 02421 USA.	jchung@shire.com			Shire	Shire	This study was funded and conducted by Shire (http://www.shire.com/shireplc/en/home). Editorial assistance was provided by Robin Smith, PhD, of The Curry Rockefeller Group, LLC, Tarrytown, New York and this assistance was funded by Shire. The funders had a role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	ANDERSSON M, 1994, J NEUROL NEUROSUR PS, V57, P897, DOI 10.1136/jnnp.57.8.897; BACH G, 1973, P NATL ACAD SCI USA, V70, P2134, DOI 10.1073/pnas.70.7.2134; Bernards C, 1999, SPINAL DRUG DELIVERY, P634; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; GREENE HL, 1969, ARCH NEUROL-CHICAGO, V20, P147, DOI 10.1001/archneur.1969.00480080047005; Hemsley KM, 2009, INT J CLIN PHARM TH, V47, pS118; Kapoor KG, 2008, BRAIN RES BULL, V77, P327, DOI 10.1016/j.brainresbull.2008.08.009; Loth F, 2001, J BIOMECH ENG-T ASME, V123, P71, DOI 10.1115/1.1336144; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Muenzer J, 2006, GENET MED, V8, P465, DOI 10.1097/01.gim.0000232477.37660.fb; Nagaraja Tavarekere N, 2005, Cerebrospinal Fluid Res, V2, P5, DOI 10.1186/1743-8454-2-5; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Wraith JE, 2008, EUR J PEDIATR, V167, P267, DOI 10.1007/s00431-007-0635-4; Yoshida K, 2009, MAGN RESON MED SCI, V8, P91, DOI 10.2463/mrms.8.91	16	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122453	10.1371/journal.pone.0122453	http://dx.doi.org/10.1371/journal.pone.0122453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836678	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000098
J	Burke, SJ; May, AL; Noland, RC; Lu, DH; Brissova, M; Powers, AC; Sherrill, EM; Karlstad, MD; Campagna, SR; Stephens, JM; Colliera, JJ				Burke, Susan J.; May, Amanda L.; Noland, Robert C.; Lu, Danhong; Brissova, Marcela; Powers, Alvin C.; Sherrill, Elizabeth M.; Karlstad, Michael D.; Campagna, Shawn R.; Stephens, Jacqueline M.; Colliera, J. Jason			Thiobenzothiazole-modified Hydrocortisones Display Anti-inflammatory Activity with Reduced Impact on Islet beta-Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; GLUCOSE; TRANSPLANTATION; EXPRESSION; RAT; DYSFUNCTION; MECHANISMS; CYCLOOXYGENASE-2; GLUCOCORTICOIDS; PREDNISOLONE	Glucocorticoids signal through the glucocorticoid receptor (GR) and are administered clinically for a variety of situations, including inflammatory disorders, specific cancers, rheumatoid arthritis, and organ/tissue transplantation. However, glucocorticoid therapy is also associated with additional complications, including steroid-induced diabetes. We hypothesized that modification of the steroid backbone is one strategy to enhance the therapeutic potential of GR activation. Toward this goal, two commercially unavailable, thiobenzothiazole-containing derivatives of hydrocortisone (termed MS4 and MS6) were examined using 832/13 rat insulinoma cells as well as rodent and human islets. We found that MS4 had transrepression properties but lacked transactivation ability, whereas MS6 retained both transactivation and transrepression activities. In addition, MS4 and MS6 both displayed anti-inflammatory activity. Furthermore, MS4 displayed reduced impact on islet beta-cell function in both rodent and human islets. Similar to dexamethasone, MS6 promoted adipocyte development in vitro, whereas MS4 did not. Moreover, neither MS4 nor MS6 activated the Pck1 (Pepck) gene in primary rat hepatocytes. We conclude that modification of the functional groups attached to the D-ring of the hydrocortisone steroid molecule produces compounds with altered structure-function GR agonist activity with decreased impact on insulin secretion and reduced adipogenic potential but with preservation of anti-inflammatory activity.	[Burke, Susan J.; Colliera, J. Jason] Pennington Biomed Res Ctr, Lab Islet Biol & Inflammat, Baton Rouge, LA 70808 USA; [Noland, Robert C.] Pennington Biomed Res Ctr, Skeletal Muscle Metab Lab, Baton Rouge, LA 70808 USA; [Stephens, Jacqueline M.] Pennington Biomed Res Ctr, Adipocyte Biol Lab, Baton Rouge, LA 70808 USA; [Burke, Susan J.; Sherrill, Elizabeth M.; Colliera, J. Jason] Univ Tennessee, Dept Nutr, Knoxville, TN 37996 USA; [May, Amanda L.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA; [Lu, Danhong] Duke Univ, Sarah W Stedman Nutr & Metab Ctr, Sch Med, Durham, NC 27701 USA; [Brissova, Marcela; Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Med, Div Diabet Endocrinol & Metab, Nashville, TN 37232 USA; [Powers, Alvin C.] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Karlstad, Michael D.; Colliera, J. Jason] Univ Tennessee, Grad Sch Med, Med Ctr, Dept Surg, Knoxville, TN 37920 USA; [Powers, Alvin C.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37212 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville; Duke University; Vanderbilt University; Vanderbilt University; University of Tennessee System; University of Tennessee Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Colliera, JJ (corresponding author), Pennington Biomed Res Ctr, Lab Islet Biol & Inflammat, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.	Jason.collier@pbrc.edu	Karlstad, Michael/V-3212-2019; Stephens, Jacqueline M/R-5217-2018; Collier, Susan J/N-1959-2017; Noland, Robert/N-1982-2017	Karlstad, Michael/0000-0002-3190-8738; Collier, Susan J/0000-0003-2571-4416; Noland, Robert/0000-0001-5543-3450	COBRE [NIH8 P20-GM103528]; NORC center grants from the National Institutes of Health [1P30-DK072476]; Vanderbilt Diabetes Research and Training Center, National Institutes of Health [P30 DK020593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072476, U01DK089572, P30DK020593, R01DK103860, R01DK097829] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R44GM099207, P20GM103528] Funding Source: NIH RePORTER	COBRE; NORC center grants from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Diabetes Research and Training Center, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project used the PBRC Genomics Core Facilities that are supported in part by COBRE (Grant NIH8 P20-GM103528) and NORC (Grant 1P30-DK072476) center grants from the National Institutes of Health. Islet isolation and insulin secretion studies were performed in collaboration with the Vanderbilt Islet Procurement and Analysis Core (supported by the Vanderbilt Diabetes Research and Training Center, National Institutes of Health Grant P30 DK020593).	Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Biju P, 2011, BIOORG MED CHEM LETT, V21, P6343, DOI 10.1016/j.bmcl.2011.08.108; Blondeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030210; Burke S. J., 2014, IMMUNOME RES, V10, pe002, DOI DOI 10.4172/1745-7580.S2.E002; Burke SJ, 2014, AM J PHYSIOL-ENDOC M, V306, pE131, DOI 10.1152/ajpendo.00347.2013; Burke SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046986; Burke SJ, 2011, CELL IMMUNOL, V271, P379, DOI 10.1016/j.cellimm.2011.08.004; Cardozo AK, 2003, DIABETOLOGIA, V46, P255, DOI 10.1007/s00125-002-1017-0; Chanson P, 2010, NEUROENDOCRINOLOGY, V92, P96, DOI 10.1159/000314272; Clark AR, 2012, PHARMACOL THERAPEUT, V134, P54, DOI 10.1016/j.pharmthera.2011.12.004; Collier JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022485; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Collier JJ, 2004, MOL ENDOCRINOL, V18, P1051, DOI 10.1210/me.2003-0357; Colvin ES, 2013, ENDOCRINOLOGY, V154, P1039, DOI 10.1210/en.2012-1923; CORBETT JA, 1993, AUTOIMMUNITY, V15, P145, DOI 10.3109/08916939309043889; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Delaunay F, 1997, J CLIN INVEST, V100, P2094, DOI 10.1172/JCI119743; Gesina E, 2004, DIABETES, V53, P2322, DOI 10.2337/diabetes.53.9.2322; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Heitmeier MR, 2004, J BIOL CHEM, V279, P53145, DOI 10.1074/jbc.M410978200; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Lambillotte C, 1997, J CLIN INVEST, V99, P414, DOI 10.1172/JCI119175; Laskewitz AJ, 2010, ENDOCRINOLOGY, V151, P2171, DOI 10.1210/en.2009-1374; Lorenz MA, 2013, J BIOL CHEM, V288, P10923, DOI 10.1074/jbc.M112.414961; Lu DH, 2002, P NATL ACAD SCI USA, V99, P2708, DOI 10.1073/pnas.052005699; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Martin AP, 2008, DIABETES, V57, P3025, DOI 10.2337/db08-0625; Martin AP, 2008, DIABETES, V57, P387, DOI 10.2337/db07-1309; McCall M, 2012, AM J TRANSPLANT, V12, P322, DOI 10.1111/j.1600-6143.2011.03796.x; Melamud E, 2010, ANAL CHEM, V82, P9818, DOI 10.1021/ac1021166; MITCHELL J, 1994, MOL ENDOCRINOL, V8, P585, DOI 10.1210/me.8.5.585; Miyazaki Y, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-44; Monti P, 2008, J CLIN INVEST, V118, P1806, DOI 10.1172/JCI35197; NEWGARD CB, 1995, ANNU REV BIOCHEM, V64, P689, DOI 10.1146/annurev.biochem.64.1.689; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; OBrien RM, 1995, BBA-GENE STRUCT EXPR, V1264, P284, DOI 10.1016/0167-4781(95)00194-8; Oshima H, 2006, J BIOL CHEM, V281, P29330, DOI 10.1074/jbc.M602424200; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; Petersons CJ, 2013, DIABETES CARE, V36, P2822, DOI 10.2337/dc12-2617; Piemonti L, 2002, DIABETES, V51, P55, DOI 10.2337/diabetes.51.1.55; Prentki M, 2013, CELL METAB, V18, P162, DOI 10.1016/j.cmet.2013.05.018; Richard AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098897; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Rother KI, 2004, J CLIN INVEST, V114, P877, DOI 10.1172/JC1200423235; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Sarkar SA, 2012, DIABETES, V61, P436, DOI 10.2337/db11-0853; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; SCHARP DW, 1990, DIABETES, V39, P515, DOI 10.2337/diabetes.39.4.515; Schroppel B, 2005, J AM SOC NEPHROL, V16, P444, DOI 10.1681/ASN.2004090743; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Ullrich S, 2005, DIABETES, V54, P1090, DOI 10.2337/diabetes.54.4.1090; van Raalte DH, 2014, NETH J MED, V72, P62; van Raalte DH, 2013, METABOLISM, V62, P568, DOI 10.1016/j.metabol.2012.10.007; Vandevyver S, 2013, ENDOCRINOLOGY, V154, P993, DOI 10.1210/en.2012-2045; Wang YH, 2006, J NUTR, V136, P2953, DOI 10.1093/jn/136.12.2953; Yuan J, 2008, NAT PROTOC, V3, P1328, DOI 10.1038/nprot.2008.131; Zhang C, 2005, MOL CELL BIOL, V25, P4969, DOI 10.1128/MCB.25.12.4969-4976.2005	61	7	7	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13401	13416		10.1074/jbc.M114.632190	http://dx.doi.org/10.1074/jbc.M114.632190			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851902	Green Published, hybrid			2022-12-26	WOS:000354975700036
J	Tran, QK; VerMeer, M; Burgard, MA; Hassan, AB; Giles, J				Tran, Quang-Kim; VerMeer, Mark; Burgard, Michelle A.; Hassan, Ali B.; Giles, Jennifer			Hetero-oligomeric Complex between the G Protein-coupled Estrogen Receptor 1 and the Plasma Membrane Ca2+-ATPase 4b	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; NITRIC-OXIDE SYNTHASE; 30 GPR30; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; SMOOTH-MUSCLE; UP-REGULATION; 17-BETA-ESTRADIOL; ACTIVATION; CALMODULIN; ALPHA	The new G protein-coupled estrogen receptor 1 (GPER/GPR30) plays important roles in many organ systems. The plasma membrane Ca2+-ATPase (PMCA) is essential for removal of cytoplasmic Ca2+ and for shaping the time courses of Ca2+-dependent activities. Here, we show that PMCA and GPER/GPR30 physically interact and functionally influence each other. In primary endothelial cells, GPER/GPR30 agonist G-1 decreases PMCA-mediated Ca2+ extrusion by promoting PMCA tyrosine phosphorylation. GPER/GPR30 overexpression decreases PMCA activity, and G-1 further potentiates this effect. GPER/GPR30 knockdown increases PMCA activity, whereas PMCA knockdown substantially reduces GPER/GPR30-mediated phosphorylation of the extracellular signalrelated kinase (ERK1/2). GPER/GPR30 co-immunoprecipitates with PMCA with or without treatment with 17 beta-estradiol, thapsigargin, or G-1. Heterologously expressed GPER/GPR30 in HEK 293 cells co-localizes with PMCA4b, the main endothelial PMCA isoform. Endothelial cells robustly express the PDZ post-synaptic density protein (PSD)-95, whose knockdown reduces the association between GPER/GPR30 and PMCA. Additionally, the association between PMCA4b and GPER/GPR30 is substantially reduced by truncation of either or both of their C-terminal PDZ-binding motifs. Functionally, inhibition of PMCA activity is significantly reduced by truncation of GPER/GPR30's C-terminal PDZ-binding motif. These data strongly indicate that GPER/GPR30 and PMCA4b form a hetero-oligomeric complex in part via the anchoring action of PSD-95, in which they constitutively affect each other's function. Activation of GPER/GPR30 further inhibits PMCA activity through tyrosine phosphorylation of the pump. These interactions represent cross-talk between Ca2+ signaling and GPER/GPR30-mediated activities.	[Tran, Quang-Kim; VerMeer, Mark; Burgard, Michelle A.; Hassan, Ali B.; Giles, Jennifer] Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Des Moines, IA 50312 USA		Tran, QK (corresponding author), Des Moines Univ, Coll Osteopath Med, Dept Physiol & Pharmacol, Ryan Hall 258,3320 Grand Ave, Des Moines, IA 50312 USA.	kim.tran@dmu.edu	Regan, Clinton/E-6250-2012	Tran, Kim/0000-0003-1881-1357	National Institutes of Health [HL112184]; Mentored Research Program at Des Moines University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL112184] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mentored Research Program at Des Moines University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL112184 (to Q.-K. T.).; Supported by the Mentored Research Program at Des Moines University.	Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Albanito L, 2007, CANCER RES, V67, P1859, DOI 10.1158/0008-5472.CAN-06-2909; [Anonymous], 2014, ECONOMIST, V411, P30; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bozulic LD, 2007, J THROMB HAEMOST, V5, P1041, DOI 10.1111/j.1538-7836.2007.02508.x; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Brown C.S., 2007, PLATELETS, V18, P207; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Dean William L, 2010, World J Biol Chem, V1, P265, DOI 10.4331/wjbc.v1.i9.265; Dean WL, 1997, J BIOL CHEM, V272, P15113, DOI 10.1074/jbc.272.24.15113; Delbeck M, 2011, MOL MED REP, V4, P37, DOI 10.3892/mmr.2010.402; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Enyedi Agnes, 2011, Commun Integr Biol, V4, P340, DOI 10.4161/cib.4.3.15040; Evans NJ, 2008, CAN J PHYSIOL PHARM, V86, P526, DOI 10.1139/Y08-050; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Filardo E, 2007, ENDOCRINOLOGY, V148, P3236, DOI 10.1210/en.2006-1605; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Haas E, 2007, HYPERTENSION, V49, P1358, DOI 10.1161/HYPERTENSIONAHA.107.089995; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Hart D, 2014, STEROIDS, V81, P49, DOI 10.1016/j.steroids.2013.11.004; JARRETT HW, 1977, BIOCHEM BIOPH RES CO, V77, P1210, DOI 10.1016/S0006-291X(77)80108-3; Kanda N, 2003, J INVEST DERMATOL, V121, P1500, DOI 10.1111/j.1523-1747.2003.12617.x; Krapivinsky G, 2011, P NATL ACAD SCI USA, V108, P19234, DOI 10.1073/pnas.1117231108; Lenhart PM, 2013, J MOL ENDOCRINOL, V51, P191, DOI 10.1530/JME-13-0021; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Otto C, 2008, ENDOCRINOLOGY, V149, P4846, DOI 10.1210/en.2008-0269; Padanyi R, 2009, BBA-MOL CELL RES, V1793, P1023, DOI 10.1016/j.bbamcr.2008.11.007; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Prossnitz ER, 2011, NAT REV ENDOCRINOL, V7, P715, DOI 10.1038/nrendo.2011.122; Tran QK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089669; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rinaldi GJ, 2005, DIABETES METAB, V31, P487, DOI 10.1016/S1262-3636(07)70220-3; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Schuh K, 2003, J BIOL CHEM, V278, P41246, DOI 10.1074/jbc.M307606200; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sheng JZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1531, DOI 10.1152/ajpcell.00561.2007; Strehler EE, 2007, BIOCHEM SOC T, V35, P919, DOI 10.1042/BST0350919; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tran QK, 2005, CELL CALCIUM, V37, P541, DOI 10.1016/j.ceca.2005.02.001; Tran QK, 2003, J BIOL CHEM, V278, P24247, DOI 10.1074/jbc.C300165200; Tran QK, 2009, J BIOL CHEM, V284, P11892, DOI 10.1074/jbc.M806205200; Ullrich ND, 2008, AM J PHYSIOL-HEART C, V294, pH2421, DOI 10.1152/ajpheart.01225.2007; Vivacqua A, 2006, MOL PHARMACOL, V70, P1414, DOI 10.1124/mol.106.026344; Wan TC, 2003, THROMB HAEMOSTASIS, V89, P122; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Wang X, 2002, CELL CALCIUM, V31, P265, DOI 10.1016/S0143-4160(02)00075-1; Watanabe H, 1999, BIOCHEM BIOPH RES CO, V265, P697, DOI 10.1006/bbrc.1999.1755; Yates MA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-20	51	33	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13293	13307		10.1074/jbc.M114.628743	http://dx.doi.org/10.1074/jbc.M114.628743			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847233	Green Published, hybrid			2022-12-26	WOS:000354975700029
J	Bonsor, DA; Pham, KT; Beadenkopf, R; Diederichs, K; Haas, R; Beckett, D; Fischer, W; Sundberg, EJ				Bonsor, Daniel A.; Pham, Kieu T.; Beadenkopf, Robert; Diederichs, Kay; Haas, Rainer; Beckett, Dorothy; Fischer, Wolfgang; Sundberg, Eric J.			Integrin Engagement by the Helical RGD Motif of the Helicobacter pylori CagL Protein Is Regulated by pH-induced Displacement of a Neighboring Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATENT TGF-BETA; PATHOGENICITY ISLAND; IV SECRETION; 3-DIMENSIONAL STRUCTURE; EXTRACELLULAR-MATRIX; CELLS; STABILITY; INFECTION; ADHESION; BINDING	Arginine-aspartate-glycine (RGD) motifs are recognized by integrins to bridge cells to one another and the extracellular matrix. RGD motifs typically reside in exposed loop conformations. X-ray crystal structures of the Helicobacter pylori protein CagL revealed that RGD motifs can also exist in helical regions of proteins. Interactions between CagL and host gastric epithelial cell via integrins are required for the translocation of the bacterial oncoprotein CagA. Here, we have investigated the molecular basis of the CagL-host cell interactions using structural, biophysical, and functional analyses. We solved an x-ray crystal structure of CagL that revealed conformational changes induced by low pH not present in previous structures. Using analytical ultracentrifugation, we found that pH-induced conformational changes in CagL occur in solution and not just in the crystalline environment. By designing numerous CagL mutants based on all available crystal structures, we probed the functional roles of CagL conformational changes on cell surface integrin engagement. Together, our data indicate that the helical RGD motif in CagL is buried by a neighboring helix at lowpH to inhibit CagL binding to integrin, whereas at neutral pH the neighboring helix is displaced to allow integrin access to the CagL RGD motif. This novel molecular mechanism of regulating integrin-RGD motif interactions by changes in the chemical environment provides new insight to H. pylori-mediated oncogenesis.	[Bonsor, Daniel A.; Beadenkopf, Robert; Sundberg, Eric J.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Pham, Kieu T.; Haas, Rainer; Fischer, Wolfgang] Univ Munich, Max von Pettenkofer Inst, D-80336 Munich, Germany; [Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Haas, Rainer] Ludwig Maximilians Univ Munchen, German Ctr Infect Res DZIF, Munich, Germany; [Beckett, Dorothy] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Munich; University of Konstanz; German Center for Infection Research; University of Munich; University System of Maryland; University of Maryland College Park	Sundberg, EJ (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	esundberg@ihv.umaryland.edu		Sundberg, Eric/0000-0003-0478-3033	Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [HA2697/16-1, 17-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015899] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in part, by an Alexander von Humboldt Foundation Experienced Researcher Fellowship (to E. J. S.) and Research Grants HA2697/16-1 and 17-1 from the Deutsche Forschungsgemeinschaft (to R. H.).	Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Barden S, 2015, J MOL BIOL, V427, P1304, DOI 10.1016/j.jmb.2015.01.006; Barden S, 2014, ACTA CRYSTALLOGR D, V70, P1391, DOI 10.1107/S1399004714003150; Barden S, 2013, STRUCTURE, V21, P1931, DOI 10.1016/j.str.2013.08.018; BELANGER LF, 1946, ENDOCRINOLOGY, V39, P8, DOI 10.1210/endo-39-1-8; BLASER MJ, 1995, CANCER RES, V55, P2111; Censini S, 1996, P NATL ACAD SCI USA, V93, P14648, DOI 10.1073/pnas.93.25.14648; Choi IJ, 2007, CELL MICROBIOL, V9, P2457, DOI 10.1111/j.1462-5822.2007.00973.x; Conradi J, 2012, AMINO ACIDS, V43, P219, DOI 10.1007/s00726-011-1066-0; Davis GE, 2000, AM J PATHOL, V156, P1489, DOI 10.1016/S0002-9440(10)65020-1; DAVIS GE, 1992, BIOCHEM BIOPH RES CO, V182, P1025, DOI 10.1016/0006-291X(92)91834-D; Dombkowski AA, 2003, BIOINFORMATICS, V19, P1852, DOI 10.1093/bioinformatics/btg231; Dong XC, 2014, NAT STRUCT MOL BIOL, V21, P1091, DOI 10.1038/nsmb.2905; Dupeux F, 2011, ACTA CRYSTALLOGR D, V67, P915, DOI 10.1107/S0907444911036225; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gorrell RJ, 2013, CELL MICROBIOL, V15, P554, DOI 10.1111/cmi.12055; HOUMARD J, 1972, P NATL ACAD SCI USA, V69, P3506, DOI 10.1073/pnas.69.12.3506; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; JOHNSON ML, 1981, BIOPHYS J, V36, P575, DOI 10.1016/S0006-3495(81)84753-4; Pham KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035341; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; MASON PW, 1994, P NATL ACAD SCI USA, V91, P1932, DOI 10.1073/pnas.91.5.1932; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Odenbreit S, 2001, CELL MICROBIOL, V3, P21, DOI 10.1046/j.1462-5822.2001.00088.x; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pang SS, 2014, J BIOL CHEM, V289, P6332, DOI 10.1074/jbc.M113.513135; Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Philo JS, 2006, ANAL BIOCHEM, V354, P238, DOI 10.1016/j.ab.2006.04.053; Schurpf T, 2012, FASEB J, V26, P3412, DOI 10.1096/fj.11-202036; Shaffer CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002237; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; STACHURA J, 1993, J CLIN GASTROENTEROL, V17, pS70, DOI 10.1097/00004836-199312001-00015; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stockbauer KE, 1999, P NATL ACAD SCI USA, V96, P242, DOI 10.1073/pnas.96.1.242; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tegtmeyer N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097782; Wiedemann T, 2012, GUT, V61, P986, DOI 10.1136/gutjnl-2011-300525; Yeh YC, 2011, MOL CARCINOGEN, V50, P751, DOI 10.1002/mc.20753; Zhang YA, 2009, MICROBIOL RES, V164, P180, DOI 10.1016/j.micres.2006.10.010	46	22	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12929	12940		10.1074/jbc.M115.641829	http://dx.doi.org/10.1074/jbc.M115.641829			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25837254	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000354569000042
J	Hansen, EL; Sozer, EB; Romeo, S; Frandsen, SK; Vernier, PT; Gehl, J				Hansen, Emilie Louise; Sozer, Esin Bengisu; Romeo, Stefania; Frandsen, Stine Krog; Vernier, P. Thomas; Gehl, Julie			Dose-Dependent ATP Depletion and Cancer Cell Death following Calcium Electroporation, Relative Effect of Calcium Concentration and Electric Field Strength	PLOS ONE			English	Article							IRREVERSIBLE ELECTROPORATION; BLADDER-CANCER; IN-VITRO; ELECTROCHEMOTHERAPY; NECROPTOSIS; ABLATION; TUMORS; ELECTROPERMEABILIZATION; CYTOTOXICITY; MITOCHONDRIA	Background Electroporation, a method for increasing the permeability of membranes to ions and small molecules, is used in the clinic with chemotherapeutic drugs for cancer treatment (electrochemotherapy). Electroporation with calcium causes ATP (adenosine triphosphate) depletion and cancer cell death and could be a novel cancer treatment. This study aims at understanding the relationship between applied electric field, calcium concentration, ATP depletion and efficacy. Methods In three human cell lines-H69 (small-cell lung cancer), SW780 (bladder cancer), and U937 (leukaemia), viability was determined after treatment with 1, 3, or 5 mM calcium and eight 99 mu s pulses with 0.8, 1.0, 1.2, 1.4 or 1.6 kV/cm. Fitting analysis was applied to quantify the cell-killing efficacy in presence of calcium. Post-treatment intracellular ATP was measured in H69 and SW780 cells. Post-treatment intracellular ATP was observed with fluorescence confocal microscopy of quinacrine-labelled U937 cells. Results Both H69 and SW780 cells showed dose-dependent (calcium concentration and electric field) decrease in intracellular ATP (p<0.05) and reduced viability. The 50% effective cell kill was found at 3.71 kV/cm (H69) and 3.28 kV/cm (SW780), reduced to 1.40 and 1.15 kV/cm (respectively) with 1 mM calcium (lower EC50 for higher calcium concentrations). Quinacrine fluorescence intensity of calcium-electroporated U937 cells was one third lower than in controls (p<0.0001). Conclusions Calcium electroporation dose-dependently reduced cell survival and intracellular ATP. Increasing extracellular calcium allows the use of a lower electric field. General Significance This study supports the use of calcium electroporation for treatment of cancer and possibly lowering the applied electric field in future trials.	[Hansen, Emilie Louise; Frandsen, Stine Krog; Gehl, Julie] Univ Copenhagen, Herlev Hosp, Ctr Expt Drug & Gene Electrotransfer, Dept Oncol, Copenhagen, Denmark; [Sozer, Esin Bengisu; Vernier, P. Thomas] Old Dominion Univ, Frank Reidy Res Ctr Bioelect, Norfolk, VA USA; [Romeo, Stefania] Italian Natl Res Council, Inst Elect Sensing Environm IREA, Naples, Italy	University of Copenhagen; Herlev & Gentofte Hospital; Old Dominion University; Consiglio Nazionale delle Ricerche (CNR); Istituto Per Il Rilevamento Elettromagnetico Dell'Ambiente (IREA-CNR)	Gehl, J (corresponding author), Univ Copenhagen, Herlev Hosp, Ctr Expt Drug & Gene Electrotransfer, Dept Oncol, Copenhagen, Denmark.	Karen.Julie.Gehl@RegionH.dk	Sozer, Esin B/AAA-5318-2020; Romeo, Stefania/I-6664-2019; Vernier, P. Thomas/D-7926-2016	Romeo, Stefania/0000-0002-9849-3637; Vernier, P. Thomas/0000-0003-2335-1500; Frandsen, Stine/0000-0002-3133-5351; Vissing, Mille/0000-0002-7823-5139; Sozer, Esin/0000-0002-6244-3670; Gehl, Julie/0000-0003-3829-0210	Danish Cancer Society [R81-A5208-13-S7]; COST Action "European Network for the Development of Electroporation-based Technologies and Treatments" [TD1104-010414-042351]; COST Action [TD1104-040514-041263]; Acta Oncologica Foundation; The Danish Cancer Society [R81-A5208, R110-A6996] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); COST Action "European Network for the Development of Electroporation-based Technologies and Treatments"; COST Action(European Cooperation in Science and Technology (COST)); Acta Oncologica Foundation; The Danish Cancer Society(Danish Cancer Society)	ELH was supported by a scholarship from the Danish Cancer Society (R81-A5208-13-S7) and by a grant from the COST Action "European Network for the Development of Electroporation-based Technologies and Treatments" (TD1104-010414-042351). SR was supported by a grant from the COST Action (TD1104-040514-041263). JG was a Royal Swedish Academy of Sciences Research Fellow supported by a grant from the Acta Oncologica Foundation (2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; BELEHRADEK M, 1993, CANCER-AM CANCER SOC, V72, P3694, DOI 10.1002/1097-0142(19931215)72:12<3694::AID-CNCR2820721222>3.0.CO;2-2; Bergner A, 2008, ANTI-CANCER AGENT ME, V8, P705, DOI 10.2174/187152008785914734; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bower M, 2011, J SURG ONCOL, V104, P22, DOI 10.1002/jso.21899; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Davalos RV, 2005, ANN BIOMED ENG, V33, P223, DOI 10.1007/s10439-005-8981-8; Ellis TL, 2011, J NEUROSURG, V114, P681, DOI 10.3171/2010.5.JNS091448; Frandsen SK, 2014, BBA-GEN SUBJECTS, V1840, P1204, DOI 10.1016/j.bbagen.2013.12.003; Frandsen SK, 2012, CANCER RES, V72, P1336, DOI 10.1158/0008-5472.CAN-11-3782; Gehl J, 2003, ACTA PHYSIOL SCAND, V177, P437, DOI 10.1046/j.1365-201X.2003.01093.x; Gehl J, 1998, ANTI-CANCER DRUG, V9, P319, DOI 10.1097/00001813-199804000-00005; Giorgi C, 2008, CURR MOL MED, V8, P119; Gjetting T, 2010, INT J NANOMED, V5, P371; Heller R, 1998, CANCER-AM CANCER SOC, V83, P148, DOI 10.1002/(SICI)1097-0142(19980701)83:1<148::AID-CNCR20>3.0.CO;2-W; Herbsleb M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-31; Jaroszeski MJ, 2000, ANTI-CANCER DRUG, V11, P201, DOI 10.1097/00001813-200003000-00008; Jouan-Lanhouet S, 2012, CELL DEATH DIFFER, V19, P2003, DOI 10.1038/cdd.2012.90; Kingham TP, 2012, J AM COLL SURGEONS, V215, P379, DOI 10.1016/j.jamcollsurg.2012.04.029; Mahmood F, 2011, BIOELECTROCHEMISTRY, V81, P10, DOI 10.1016/j.bioelechem.2010.12.002; Marty M, 2006, EJC SUPPL, V4, P3, DOI 10.1016/j.ejcsup.2006.08.002; Matthiessen LW, 2011, ACTA ONCOL, V50, P621, DOI 10.3109/0284186X.2011.573626; Miklavcic D, 2012, MED BIOL ENG COMPUT, V50, P1213, DOI 10.1007/s11517-012-0991-8; Mitchell CH, 1998, P NATL ACAD SCI USA, V95, P7174, DOI 10.1073/pnas.95.12.7174; Movahed S, 2011, MICROFLUID NANOFLUID, V10, P703, DOI 10.1007/s10404-010-0716-y; Neal RE, 2014, PROSTATE, V74, P458, DOI 10.1002/pros.22760; Pakhomova ON, 2013, J CELL MOL MED, V17, P154, DOI 10.1111/j.1582-4934.2012.01658.x; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; ROLS MP, 1990, BIOPHYS J, V58, P1089, DOI 10.1016/S0006-3495(90)82451-6; Sorensen CE, 2001, J BIOL CHEM, V276, P32925, DOI 10.1074/jbc.M103313200; Tracy CR, 2011, BJU INT, V107, P1982, DOI 10.1111/j.1464-410X.2010.09797.x; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vasquez JL, 2014, J UROL IN PRESS; Vasquez JL, 2012, BIOELECTROCHEMISTRY, V88, P127, DOI 10.1016/j.bioelechem.2012.08.001; Weaver J C, 1995, Methods Mol Biol, V48, P3; WHITE PN, 1995, HEARING RES, V90, P97, DOI 10.1016/0378-5955(95)00151-1; Wu W, 2012, CRIT REV ONCOL HEMAT, V82, P249, DOI 10.1016/j.critrevonc.2011.08.004; Yegutkin GG, 2006, MOL BIOL CELL, V17, P3378, DOI 10.1091/mbc.E05-10-0993	38	44	45	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122973	10.1371/journal.pone.0122973	http://dx.doi.org/10.1371/journal.pone.0122973			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853661	gold, Green Published			2022-12-26	WOS:000352478400089
J	Kumar, K; Muthamilarasan, M; Bonthala, VS; Roy, R; Prasad, M				Kumar, Karunesh; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Roy, Riti; Prasad, Manoj			Unraveling 14-3-3 Proteins in C-4 Panicoids with Emphasis on Model Plant Setaria italica Reveals Phosphorylation-Dependent Subcellular Localization of RS Splicing Factor	PLOS ONE			English	Article							FOXTAIL MILLET; ADAPTER PROTEINS; MESSENGER-RNA; ARABIDOPSIS; FAMILY; ISOFORMS; BINDING; IDENTIFICATION; EVOLUTION; SEQUENCE	14-3-3 proteins are a large multigenic family of regulatory proteins ubiquitously found in eukaryotes. In plants, 14-3-3 proteins are reported to play significant role in both development and response to stress stimuli. Therefore, considering their importance, genome-wide analyses have been performed in many plants including Arabidopsis, rice and soybean. But, till date, no comprehensive investigation has been conducted in any C-4 panicoid crops. In view of this, the present study was performed to identify 8, 5 and 26 potential 14-3-3 gene family members in foxtail millet (Si14-3-3), sorghum (Sb14-3-3) and maize (Zm14-3-3), respectively. In silico characterization revealed large variations in their gene structures; segmental and tandem duplications have played a major role in expansion of these genes in foxtail millet and maize. Gene ontology annotation showed the participation of 14-3-3 proteins in diverse biological processes and molecular functions, and in silico expression profiling indicated their higher expression in all the investigated tissues. Comparative mapping was performed to derive the orthologous relationships between 14-3-3 genes of foxtail millet and other Poaceae members, which showed a higher, as well as similar percentage of orthology among these crops. Expression profiling of Si14-3-3genes during different timepoints of abiotic stress and hormonal treatments showed a differential expression pattern of these genes, and sub-cellular localization studies revealed the site of action of Si14-3-3 proteins within the cells. Further downstream characterization indicated the interaction of Si14-3-3 with a nucleocytoplasmic shuttling phosphoprotein (SiRSZ21A) in a phosphorylationdependent manner, and this demonstrates that Si14-3-3 might regulate the splicing events by binding with phosphorylated SiRSZ21A. Taken together, the present study is a comprehensive analysis of 14-3-3 gene family members in foxtail millet, sorghum and maize, which provides interesting information on their gene structure, protein domains, phylogenetic and evolutionary relationships, and expression patterns during abiotic stresses and hormonal treatments, which could be useful in choosing candidate members for further functional characterization. In addition, demonstration of interaction between Si14-3-3 and SiRSZ21A provides novel clues on the involvement of 14-3-3 proteins in the splicing events.	[Kumar, Karunesh; Muthamilarasan, Mehanathan; Bonthala, Venkata Suresh; Roy, Riti; Prasad, Manoj] NIPGR, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Prasad, M (corresponding author), NIPGR, New Delhi, India.	manoj_prasad@nipgr.ac.in	Muthamilarasan, Mehanathan/H-9340-2017; Bonthala, Venkata Suresh/G-9852-2013; Prasad, Manoj/AAE-8540-2019	Muthamilarasan, Mehanathan/0000-0001-7589-6372; Bonthala, Venkata Suresh/0000-0001-6550-1648; Prasad, Manoj/0000-0003-0691-0163	National Institute of Plant Genome Research, New Delhi, India; Council of Scientific and Industrial Research, New Delhi; University Grants Commission, New Delhi	National Institute of Plant Genome Research, New Delhi, India; Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission, New Delhi(University Grants Commission, India)	This work was financially supported by the core grant of National Institute of Plant Genome Research, New Delhi, India. KK and MM are the recipients of research fellowships from Council of Scientific and Industrial Research, New Delhi and University Grants Commission, New Delhi, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsterfjord M, 2004, PLANT CELL PHYSIOL, V45, P1202, DOI 10.1093/pcp/pch136; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; Bihn EA, 1997, PLANT J, V12, P1439, DOI 10.1046/j.1365-313x.1997.12061439.x; Breton G, 2003, PLANT PHYSIOL, V132, P64, DOI 10.1104/pp.102.015255; Carlberg I, 2003, P NATL ACAD SCI USA, V100, P757, DOI 10.1073/pnas.0235452100; Cazalla D, 2002, MOL CELL BIOL, V22, P6871, DOI 10.1128/MCB.22.19.6871-6882.2002; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Colwill K, 1996, EMBO J, V15, P265, DOI 10.1002/j.1460-2075.1996.tb00357.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; de Boer AH, 2013, PROTOPLASMA, V250, P425, DOI 10.1007/s00709-012-0437-z; DeLille JM, 2001, PLANT PHYSIOL, V126, P35, DOI 10.1104/pp.126.1.35; Denison FC, 2011, SEMIN CELL DEV BIOL, V22, P720, DOI 10.1016/j.semcdb.2011.08.006; Diaz C, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-192; Doust AN, 2009, PLANT PHYSIOL, V149, P137, DOI 10.1104/pp.108.129627; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Jogl G, 2003, P NATL ACAD SCI USA, V100, P50, DOI 10.1073/pnas.0233793100; Konagaya Ken-ichi, 2004, Journal of General Plant Pathology, V70, P221, DOI 10.1007/s10327-003-0113-4; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Lata C, 2010, BIOCHEM BIOPH RES CO, V393, P720, DOI 10.1016/j.bbrc.2010.02.068; Li XY, 2011, PLANTA, V233, P569, DOI 10.1007/s00425-010-1315-6; Lopato S, 1999, PLANT MOL BIOL, V39, P761, DOI 10.1023/A:1006129615846; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MICHALAK M, 1992, BIOCHEM J, V285, P681, DOI 10.1042/bj2850681; Mishra AM, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095280, 10.1371/journal.pone.0086852]; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109920; Muthamilarasan M, 2014, FUNCT INTEGR GENOMIC, V14, P531, DOI 10.1007/s10142-014-0383-2; Puranik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064594; Rausin G, 2010, PLANT PHYSIOL, V153, P273, DOI 10.1104/pp.110.154740; Roberts MR, 2003, TRENDS PLANT SCI, V8, P218, DOI 10.1016/S1360-1385(03)00056-6; Rosenquist M, 2000, J MOL EVOL, V51, P446, DOI 10.1007/s002390010107; SanMiguel P, 1998, NAT GENET, V20, P43, DOI 10.1038/1695; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Sehnke PC, 2000, PLANT PHYSIOL, V122, P235, DOI 10.1104/pp.122.1.235; Sehnke PC, 2001, P NATL ACAD SCI USA, V98, P765, DOI 10.1073/pnas.021304198; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sottocornola B, 2008, PLANT BIOLOGY, V10, P231, DOI 10.1111/j.1438-8677.2007.00028.x; Sun GL, 2011, FUNCT INTEGR GENOMIC, V11, P627, DOI 10.1007/s10142-011-0242-3; Swartz JE, 2007, J BIOL CHEM, V282, P19844, DOI 10.1074/jbc.M701660200; Xu SH, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002159; Yadav CB, 2015, PLANT MOL BIOL REP, V33, P43, DOI 10.1007/s11105-014-0736-y; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yao Y, 2007, J BIOCHEM MOL BIOL, V40, P349; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zhang ZT, 2010, J EXP BOT, V61, P3331, DOI 10.1093/jxb/erq155	50	19	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123236	10.1371/journal.pone.0123236	http://dx.doi.org/10.1371/journal.pone.0123236			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849294	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800217
J	Lee, SJ; Kang, JH; Iqbal, W; Kwon, OS				Lee, Su Jin; Kang, Jeong Han; Iqbal, Waqas; Kwon, Oh-Shin			Proteomic Analysis of Mice Fed Methionine and Choline Deficient Diet Reveals Marker Proteins Associated with Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; ACUTE ETHANOL INTOXICATION; INDUCED OXIDATIVE STRESS; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; MEDIATED APOPTOSIS; RAT MODEL; CURCUMIN; CELLS; GLUTATHIONE	The mechanisms underlying the progression of simple steatosis to steatohepatitis are yet to be elucidated. To identify the proteins involved in the development of liver tissue inflammation, we performed comparative proteomic analysis of non-alcoholic steatohepatitis (NASH). Mice fed a methionine and choline deficient diet (MCD) developed hepatic steatosis characterized by increased free fatty acid (FFA) and triglyceride levels as well as alpha-SMA. Two-dimensional proteomic analysis revealed that the change from the normal diet to the MCD diet affected the expressions of 50 proteins. The most-pronounced changes were observed in the expression of proteins involved in Met metabolism and oxidative stress, most of which were significantly downregulated in NASH model animals. Peroxiredoxin (Prx) is the most interesting among the modulated proteins identified in this study. In particular, cross-regulated Prx1 and Prx6 are likely to participate in cellular defense against the development of hepatitis. Thus, these Prx isoforms may be a useful new marker for early stage steatohepatitis. Moreover, curcumin treatment results in alleviation of the severity of hepatic inflammation in steatohepatitis. Notably, curcumin administration in MCD-fed mice dramatically reduced CYP2E1 as well as Prx1 expression, while upregulating Prx6 expression. These findings suggest that curcumin may have a protective role against MCD fed-induced oxidative stress.	[Lee, Su Jin; Iqbal, Waqas; Kwon, Oh-Shin] Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu 702701, South Korea; [Kang, Jeong Han] Mayo Clin, Thorac Dis Res Unit, Dept Biochem & Mol Biol, Coll Med, Rochester, MN USA; [Kang, Jeong Han] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA	Kyungpook National University; Mayo Clinic; Mayo Clinic	Kwon, OS (corresponding author), Kyungpook Natl Univ, Coll Nat Sci, Sch Life Sci, Taegu 702701, South Korea.	oskwon@knu.ac.kr	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology [2011-0014420]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Korean Ministry of Education, Science and Technology	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Korean Ministry of Education, Science and Technology (2011-0014420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMON HPT, 1991, PLANTA MED, V57, P1, DOI 10.1055/s-2006-960004; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bae SH, 2011, HEPATOLOGY, V53, P945, DOI 10.1002/hep.24104; Banerjee A, 2008, PROTEOMICS, V8, P4327, DOI 10.1002/pmic.200700368; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Chan WH, 2003, J CELL BIOCHEM, V90, P327, DOI 10.1002/jcb.10638; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dickinson DA, 2003, BIOL CHEM, V384, P527, DOI 10.1515/BC.2003.061; Diehl AM, 2005, GUT, V54, P303, DOI 10.1136/gut.2003.024935; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Friedman SL, 2004, NAT CLIN PRACT GASTR, V1, P98, DOI 10.1038/ncpgasthep0055; Gao S, 2013, FOOD CHEM TOXICOL, V59, P739, DOI 10.1016/j.fct.2013.07.032; George J, 2003, J HEPATOL, V39, P756, DOI 10.1016/S0168-8278(03)00376-3; Gomez-Quiroz LE, 2008, J BIOL CHEM, V283, P14581, DOI 10.1074/jbc.M707733200; Hansen JM, 2007, FREE RADICAL BIO MED, V43, P282, DOI 10.1016/j.freeradbiomed.2007.04.029; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Holley SL, 2007, CARCINOGENESIS, V28, P2268, DOI 10.1093/carcin/bgm135; Hsuuw YD, 2005, J CELL PHYSIOL, V205, P379, DOI 10.1002/jcp.20408; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Kang JH, 2009, BBA-PROTEINS PROTEOM, V1794, P446, DOI 10.1016/j.bbapap.2008.11.015; Kang JH, 2009, PROTEOMICS, V9, P4445, DOI 10.1002/pmic.200800941; Kim K, 2010, FEBS LETT, V584, P707, DOI 10.1016/j.febslet.2009.12.019; KORPELA H, 1985, AM J CLIN NUTR, V42, P147, DOI 10.1093/ajcn/42.1.147; Kuo ML, 1996, BBA-MOL BASIS DIS, V1317, P95, DOI 10.1016/S0925-4439(96)00032-4; Kurose I, 1997, HEPATOLOGY, V25, P368; Leclercq IA, 2004, J HEPATOL, V41, P926, DOI 10.1016/j.jhep.2004.08.010; Leclercq IA, 2000, J CLIN INVEST, V105, P1067, DOI 10.1172/JCI8814; Leung TM, 2013, J HEPATOL, V58, P395, DOI 10.1016/j.jhep.2012.08.018; LINDAHL R, 1992, CRIT REV BIOCHEM MOL, V27, P283, DOI 10.3109/10409239209082565; Luckey SW, 2001, ARCH BIOCHEM BIOPHYS, V389, P77, DOI 10.1006/abbi.2001.2307; MASINI A, 1994, BIOCHEM PHARMACOL, V47, P217, DOI 10.1016/0006-2952(94)90009-4; Miyazaki H, 2014, J CLIN BIOCHEM NUTR, V54, P190, DOI 10.3164/jcbn.13-74; Newton BW, 2009, J PROTEOME RES, V8, P1663, DOI 10.1021/pr800905w; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Rivera-Espinoza Y, 2009, LIVER INT, V29, P1457, DOI 10.1111/j.1478-3231.2009.02086.x; Rodriguez-Suarez E, 2010, PROTEOM CLIN APPL, V4, P362, DOI 10.1002/prca.200900119; RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784; Wang XS, 2003, J BIOL CHEM, V278, P25179, DOI 10.1074/jbc.M302706200; WIELAND P, 1995, BIOCHEM BIOPH RES CO, V213, P815, DOI 10.1006/bbrc.1995.2202	45	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120577	10.1371/journal.pone.0120577	http://dx.doi.org/10.1371/journal.pone.0120577			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849376	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800027
J	Shah, I; Adnan, R; Ngah, WSW; Mohamed, N				Shah, Irfan; Adnan, Rohana; Ngah, Wan Saime Wan; Mohamed, Norita			Iron Impregnated Activated Carbon as an Efficient Adsorbent for the Removal of Methylene Blue: Regeneration and Kinetics Studies	PLOS ONE			English	Article							AQUEOUS-SOLUTION; ADSORPTION CHARACTERISTICS; ENHANCED ADSORPTION; MALACHITE-GREEN; WASTE-WATER; DYE; THERMODYNAMICS; EQUILIBRIUM; DEGRADATION; OXIDATION	In this study, iron impregnated activated carbon (FeAC) was synthesized following an oxidation and iron impregnation of activated carbon (AC). Both the AC and FeAC were characterized by pHZPC and FTIR spectroscopy. The removal of Methylene Blue (MB) by AC and FeAC was examined under various experimental conditions. The FeAC showed up to 95% (higher than AC) MB removal in the pH range of 7-10. Although the reaction kinetics was pseudo-second order, the overall rate was controlled by a number of processes such as film diffusion, pore diffusion and intraparticle diffusion. The activation energy values for the MB uptake by AC and FeAC (21.79 and 14.82 kJ/mol, respectively) revealed a physisorption process. In the regeneration study, FeAC has shown consistently >= 90% MB removal even up to 10 repeated cycles. The reusable characteristic of the spent FeAC improved the practical use of activated carbon and can be a breakthrough for continuous flow system applications where it can work effectively without any significant reduction in its performance.	[Shah, Irfan; Adnan, Rohana; Ngah, Wan Saime Wan; Mohamed, Norita] Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Malaysia	Universiti Sains Malaysia	Adnan, R (corresponding author), Univ Sains Malaysia, Sch Chem Sci, George Town 11800, Malaysia.	r_adnan@usm.my	Adnan, Rohana/E-5342-2012; Ngah, Wan Saime Wan/AAP-2305-2020; Ngah, Wan Saime Wan/A-3557-2009	Ngah, Wan Saime Wan/0000-0001-7675-2450; Adnan, Rohana/0000-0002-7628-7656	USM RUI Grant [1001/PKIMIA/815099]; The World Academy of Science (TWAS); Universiti Sains Malaysia (USM)	USM RUI Grant; The World Academy of Science (TWAS); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	The authors gratefully acknowledge the USM RUI Grant No. 1001/PKIMIA/815099 for the current work. IS also acknowledges the support from The World Academy of Science (TWAS) and Universiti Sains Malaysia (USM) for awarding TWAS-USM Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHARONI C, 1979, J CHEM TECHNOL BIOT, V29, P404; [Anonymous], 2010, J CHEM PHARM RES; Auta M, 2014, CHEM ENG J, V237, P352, DOI 10.1016/j.cej.2013.09.066; Baig SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100704; Bakheet B, 2013, WATER RES, V47, P6234, DOI 10.1016/j.watres.2013.07.042; Benaissa H, 2010, J TAIBAH UNIV SCI, V4, P31, DOI 10.1016/S1658-3655(12)60024-7; Borah D, 2008, J COLLOID INTERF SCI, V319, P53, DOI 10.1016/j.jcis.2007.11.019; Chang MY, 2005, COLLOID SURFACE A, V269, P35, DOI 10.1016/j.colsurfa.2005.06.064; Chien H.-A., 2014, DESALIN WATER TREAT, P1; CHIEN SH, 1980, SOIL SCI SOC AM J, V44, P265, DOI 10.2136/sssaj1980.03615995004400020013x; Cottet L, 2014, APPL CLAY SCI, V95, P25, DOI 10.1016/j.clay.2014.03.023; Crini G, 2007, SEP PURIF TECHNOL, V53, P97, DOI 10.1016/j.seppur.2006.06.018; El Saliby I, 2013, WATER RES, V47, P4115, DOI 10.1016/j.watres.2012.12.045; Garcia-Vaquero N, 2014, DESALINATION, V347, P94, DOI 10.1016/j.desal.2014.05.036; Garg VK, 2004, DYES PIGMENTS, V62, P1, DOI 10.1016/j.dyepig.2003.10.016; Ghasemi J, 2007, J CHEM THERMODYN, V39, P967, DOI 10.1016/j.jct.2006.10.018; Gupta VK, 2011, WATER RES, V45, P4047, DOI 10.1016/j.watres.2011.05.016; He Y, 2008, J MEMBRANE SCI, V321, P183, DOI 10.1016/j.memsci.2008.04.056; Huang W, 2014, DESALINATION, V340, P67, DOI 10.1016/j.desal.2014.02.012; Jadhav AH, 2015, CHEM ENG J, V259, P348, DOI 10.1016/j.cej.2014.07.127; Kannan C, 2013, J HAZARD MATER, V244, P10, DOI 10.1016/j.jhazmat.2012.11.016; Kertesz S, 2014, DESALINATION, V343, P106, DOI 10.1016/j.desal.2013.11.013; Kim TH, 2004, J HAZARD MATER, V112, P95, DOI 10.1016/j.jhazmat.2004.04.008; Labanda J, 2011, CHEM ENG J, V166, P536, DOI 10.1016/j.cej.2010.11.013; Li XY, 2015, CHEM ENG J, V260, P28, DOI 10.1016/j.cej.2014.08.042; Lim L. B. L., 2013, DESALIN WATER TREAT, P1, DOI [10.1080/19443994.2013.852136, DOI 10.1080/19443994.2013.852136]; Liu JY, 2014, DESALINATION, V344, P446, DOI 10.1016/j.desal.2014.04.015; Liu Y, 2014, CHEM ENG J, V237, P403, DOI 10.1016/j.cej.2013.10.048; Liu Y, 2010, J ENVIRON SCI, V22, P486, DOI 10.1016/S1001-0742(09)60134-0; Lu XC, 2012, APPL SURF SCI, V258, P8247, DOI 10.1016/j.apsusc.2012.05.029; Sotelo JL, 2013, CHEM ENG J, V228, P102, DOI 10.1016/j.cej.2013.04.088; Nandi BK, 2009, J HAZARD MATER, V161, P387, DOI 10.1016/j.jhazmat.2008.03.110; Ofomaja AE, 2008, BIORESOURCE TECHNOL, V99, P5411, DOI 10.1016/j.biortech.2007.11.018; Onal Y, 2006, J HAZARD MATER, V137, P1719, DOI 10.1016/j.jhazmat.2006.05.036; Riera-Torres M, 2010, DESALINATION, V252, P53, DOI 10.1016/j.desal.2009.11.002; Romanos J, 2013, CARBON, V54, P208, DOI 10.1016/j.carbon.2012.11.031; Sen TK, 2011, WATER AIR SOIL POLL, V218, P499, DOI 10.1007/s11270-010-0663-y; Shah I, 2014, BIORESOURCE TECHNOL, V160, P52, DOI 10.1016/j.biortech.2014.02.047; Shan C, 2013, WATER RES, V47, P3411, DOI 10.1016/j.watres.2013.03.035; Tseng RL, 2003, CARBON, V41, P487, DOI 10.1016/S0008-6223(02)00367-6; Tseng RL, 2006, J COLLOID INTERF SCI, V303, P494, DOI 10.1016/j.jcis.2006.08.024; Tseng RL, 2006, J HAZARD MATER, V136, P671, DOI 10.1016/j.jhazmat.2005.12.048; Wang PF, 2014, APPL SURF SCI, V290, P116, DOI 10.1016/j.apsusc.2013.11.010; Weber W.J., 1963, J SANIT ENG DIV, V89, P31, DOI [10.1061/JSEDAI.0000430, DOI 10.1061/JSEDAI.0000430]; Weng CH, 2006, COLLOID SURFACE A, V274, P154, DOI 10.1016/j.colsurfa.2005.08.044; Wu FC, 2006, J COLLOID INTERF SCI, V294, P21, DOI 10.1016/j.jcis.2005.06.084; Wu FC, 2009, CHEM ENG J, V150, P366, DOI 10.1016/j.cej.2009.01.014; Yan H, 2014, J HAZARD MATER, V268, P191, DOI 10.1016/j.jhazmat.2014.01.015; Yang GX, 2014, WATER RES, V48, P396, DOI 10.1016/j.watres.2013.09.050; Zelmanov G, 2014, DESALINATION, V333, P107, DOI 10.1016/j.desal.2013.11.027	50	82	85	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122603	10.1371/journal.pone.0122603	http://dx.doi.org/10.1371/journal.pone.0122603			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849291	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800145
J	Shen, B; Wong, CO; Lau, OC; Woo, T; Bai, SW; Huang, Y; Yao, XQ				Shen, Bing; Wong, Ching-On; Lau, On-Chai; Woo, Theodosia; Bai, Suwen; Huang, Yu; Yao, Xiaoqiang			Plasma Membrane Mechanical Stress Activates TRPC5 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; CATION CHANNEL; ION CHANNELS; MECHANOSENSITIVE CHANNELS; LATERAL PRESSURE; TOUCH SENSATION; CALCIUM-CHANNEL; SMOOTH-MUSCLE; NEURONS; PROTEIN	Mechanical forces exerted on cells impose stress on the plasma membrane. Cells sense this stress and elicit a mechanoelectric transduction cascade that initiates compensatory mechanisms. Mechanosensitive ion channels in the plasma membrane are responsible for transducing the mechanical signals to electrical signals. However, the mechanisms underlying channel activation in response to mechanical stress remain incompletely understood. Transient Receptor Potential (TRP) channels serve essential functions in several sensory modalities. These channels can also participate in mechanotransduction by either being autonomously sensitive to mechanical perturbation or by coupling to other mechanosensory components of the cell. Here, we investigated the response of a TRP family member, TRPC5, to mechanical stress. Hypoosmolarity triggers Ca2+ influx and cationic conductance through TRPC5. Importantly, for the first time we were able to record the stretch-activated TRPC5 current at single-channel level. The activation threshold for TRPC5 was found to be 240 mOsm for hypoosmotic stress and between -20 and -40 mmHg for pressure applied to membrane patch. In addition, we found that disruption of actin filaments suppresses TRPC5 response to hypoosmotic stress and patch pipette pressure, but does not prevent the activation of TRPC5 by stretch-independent mechanisms, indicating that actin cytoskeleton is an essential transduction component that confers mechanosensitivity to TRPC5. In summary, our findings establish that TRPC5 can be activated at the single-channel level when mechanical stress on the cell reaches a certain threshold.	[Shen, Bing; Wong, Ching-On; Lau, On-Chai; Woo, Theodosia; Huang, Yu; Yao, Xiaoqiang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China; [Shen, Bing; Bai, Suwen] Anhui Med Univ, Dept Physiol, Hefei, Peoples R China	Chinese University of Hong Kong; Anhui Medical University	Wong, CO (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77025 USA.	ching.o.wong@uth.tmc.edu; yao2068@cuhk.edu.hk	Yao, Xiaoqiang/I-5413-2016; Huang, Yu/K-2866-2017	Yao, Xiaoqiang/0000-0002-0687-8186; Huang, Yu/0000-0002-1277-6784; Wong, Ching On/0000-0002-8602-2125; Lau, Eva On-Chai/0000-0001-7998-0061; suwen, bai/0000-0001-9359-014X	Hong Kong RGC [CUHK478710, CUHK478011, T13-706/11, AoE/M-05/12, CUHK2/CRF/11G]; Natural Science Foundation of China [81371284]; third installment of Anhui Provincial Science and Technology Plan [1301043020]	Hong Kong RGC(Hong Kong Research Grants Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); third installment of Anhui Provincial Science and Technology Plan	This work was supported by CUHK478710, CUHK478011, T13-706/11, AoE/M-05/12 and CUHK2/CRF/11G from the Hong Kong RGC, Grant 81371284 from Natural Science Foundation of China, and Grant 1301043020 from the third installment of Anhui Provincial Science and Technology Plan 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander SPH, 2011, BRIT J PHARMACOL, V164, pS1, DOI 10.1111/j.1476-5381.2011.01649_1.x; ANDRESEN MC, 1992, AM J PHYSIOL, V262, pH1415, DOI 10.1152/ajpheart.1992.262.5.H1415; Arnadottir J, 2011, J NEUROSCI, V31, P12695, DOI 10.1523/JNEUROSCI.4580-10.2011; Arnadottir J, 2010, ANNU REV BIOPHYS, V39, P111, DOI 10.1146/annurev.biophys.37.032807.125836; AUERBACH A, 1991, BIOPHYS J, V60, P660, DOI 10.1016/S0006-3495(91)82095-1; Beech DJ, 2007, BIOCHEM SOC T, V35, P101, DOI 10.1042/BST0350101; Berrier C, 1996, J MEMBRANE BIOL, V151, P175, DOI 10.1007/s002329900068; Birder LA, 2002, NAT NEUROSCI, V5, P856, DOI 10.1038/nn902; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Bush EW, 2006, J BIOL CHEM, V281, P33487, DOI 10.1074/jbc.M605536200; Cantor RS, 1997, BIOCHEMISTRY-US, V36, P2339, DOI 10.1021/bi9627323; Carr MJ, 2001, BRIT J PHARMACOL, V133, P1255, DOI 10.1038/sj.bjp.0704197; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Coste B, 2012, NATURE, V483, P176, DOI 10.1038/nature10812; Dai JW, 1998, J NEUROSCI, V18, P6681; Dedman A, 2009, EUR BIOPHYS J BIOPHY, V38, P293, DOI 10.1007/s00249-008-0318-8; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Ermakov YA, 2010, BIOPHYS J, V98, P1018, DOI 10.1016/j.bpj.2009.11.044; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; Garrison SR, 2012, J NEUROPHYSIOL, V107, P913, DOI 10.1152/jn.00658.2011; Glazebrook PA, 2005, PFLUG ARCH EUR J PHY, V451, P125, DOI 10.1007/s00424-005-1468-5; Gomis A, 2008, J PHYSIOL-LONDON, V586, P5633, DOI 10.1113/jphysiol.2008.161257; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Jemal I, 2014, PFLUG ARCH EUR J PHY, V466, P1635, DOI 10.1007/s00424-013-1392-z; Jeon JP, 2012, J BIOL CHEM, V287, P17029, DOI 10.1074/jbc.M111.326553; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kim SE, 2012, NATURE, V483, P209, DOI 10.1038/nature10801; Kung C, 2005, NATURE, V436, P647, DOI 10.1038/nature03896; Kwan KY, 2006, NEURON, V50, P277, DOI 10.1016/j.neuron.2006.03.042; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Lin YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004293; Maroto R, 2005, NAT CELL BIOL, V7, P179, DOI 10.1038/ncb1218; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mihara H, 2013, AM J PHYSIOL-GASTR L, V304, pG235, DOI 10.1152/ajpgi.00256.2012; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Obukhov AG, 2004, J CELL PHYSIOL, V201, P227, DOI 10.1002/jcp.20057; Ohya Y, 1998, HYPERTENSION, V31, P254, DOI 10.1161/01.HYP.31.1.254; OPSAHL LR, 1994, BIOPHYS J, V66, P75, DOI 10.1016/S0006-3495(94)80752-0; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Raghunathan M, 2012, J PHYS CHEM B, V116, P3918, DOI 10.1021/jp211904j; Riccio A, 2009, CELL, V137, P761, DOI 10.1016/j.cell.2009.03.039; Schaefer M, 2000, J BIOL CHEM, V275, P17517, DOI 10.1074/jbc.275.23.17517; Son AR, 2009, J DENT RES, V88, P1014, DOI 10.1177/0022034509343413; Storch U, 2012, AM J PHYSIOL-HEART C, V302, pH1241, DOI 10.1152/ajpheart.00818.2011; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sukharev S, 2012, J CELL SCI, V125, P3075, DOI 10.1242/jcs.092353; Tang Y, 2000, J BIOL CHEM, V275, P37559, DOI 10.1074/jbc.M006635200; Trebak M., 2007, V179, P593; Ursell T, 2011, BIOPHYS J, V101, P1913, DOI 10.1016/j.bpj.2011.08.057; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Welsh DG, 2002, CIRC RES, V90, P248, DOI 10.1161/hh0302.105662; Wong CO, 2010, BRIT J PHARMACOL, V159, P1486, DOI 10.1111/j.1476-5381.2010.00636.x; Xu SZ, 2005, NAT BIOTECHNOL, V23, P1289, DOI 10.1038/nbt1148; Xu SZ, 2005, BRIT J PHARMACOL, V145, P405, DOI 10.1038/sj.bjp.0706197; Yan ZQ, 2013, NATURE, V493, P221, DOI 10.1038/nature11685; Yip H, 2004, HISTOCHEM CELL BIOL, V122, P553, DOI 10.1007/s00418-004-0720-y; Yoshimura K, 2010, J R SOC INTERFACE, V7, pS307, DOI 10.1098/rsif.2010.0095.focus; Zimmermann K, 2011, P NATL ACAD SCI USA, V108, P18114, DOI 10.1073/pnas.1115387108	61	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122227	10.1371/journal.pone.0122227	http://dx.doi.org/10.1371/journal.pone.0122227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849346	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800109
J	Teixeira, AF; de Morais, ZM; Kirchgatter, K; Romero, EC; Vasconcellos, SA; Nascimento, ALTO				Teixeira, Aline F.; de Morais, Zenaide M.; Kirchgatter, Karin; Romero, Eliete C.; Vasconcellos, Silvio A.; Nascimento, Ana Lucia T. O.			Features of Two New Proteins with OmpA-Like Domains Identified in the Genome Sequences of Leptospira interrogans	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX PROTEINS; IMMUNOGLOBULIN-LIKE PROTEINS; BINDING PROTEIN; PATHOGENIC LEPTOSPIRA; INTERACTING-PROTEIN; HUMAN PLASMINOGEN; SURFACE; LIPOPROTEIN; SEROVAR; FIBRONECTIN	Leptospirosis is an acute febrile disease caused by pathogenic spirochetes of the genus Leptospira. It is considered an important re-emerging infectious disease that affects humans worldwide. The knowledge about the mechanisms by which pathogenic leptospires invade and colonize the host remains limited since very few virulence factors contributing to the pathogenesis of the disease have been identified. Here, we report the identification and characterization of two new leptospiral proteins with OmpA-like domains. The recombinant proteins, which exhibit extracellular matrix-binding properties, are called Lsa46 -LIC13479 and Lsa77 -LIC10050 (Leptospiral surface adhesins of 46 and 77 kDa, respectively). Attachment of Lsa46 and Lsa77 to laminin was specific, dose dependent and saturable, with K-D values of 24.3 +/- 17.0 and 53.0 +/- 17.5 nM, respectively. Lsa46 and Lsa77 also bind plasma fibronectin, and both adhesins are plasminogen (PLG)-interacting proteins, capable of generating plasmin (PLA) and as such, increase the proteolytic ability of leptospires. The proteins corresponding to Lsa46 and Lsa77 are present in virulent L. interrogans L1-130 and in saprophyte L. biflexa Patoc 1 strains, as detected by immunofluorescence. The adhesins are recognized by human leptospirosis serum samples at the onset and convalescent phases of the disease, suggesting that they are expressed during infection. Taken together, our data could offer valuable information to the understanding of leptospiral pathogenesis.	[Teixeira, Aline F.; Nascimento, Ana Lucia T. O.] Inst Butantan, Ctr Biotechnol, Sao Paulo, SP, Brazil; [Teixeira, Aline F.; Nascimento, Ana Lucia T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Interunidades Biotecnol, Sao Paulo, SP, Brazil; [de Morais, Zenaide M.; Vasconcellos, Silvio A.] Univ Sao Paulo, Fac Med Vet & Zootecnia, Lab Zoonoses Bacterianas, Sao Paulo, SP, Brazil; [Kirchgatter, Karin] Univ Sao Paulo, Superintendencia Controle Endemias Inst Med, Nucl Estudos Malaria, Sao Paulo, SP, Brazil; [Romero, Eliete C.] Adolfo Lutz Inst, Ctr Bacteriol, Sao Paulo, Brazil	Instituto Butantan; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Adolfo Lutz	Nascimento, ALTO (corresponding author), Inst Butantan, Ctr Biotechnol, Sao Paulo, SP, Brazil.	ana.nascimento@butantan.gov.br	Nascimento, Ana L. T. O./E-8488-2012; Romero, Eliete C/H-6976-2012; Kirchgatter, Karin/D-8376-2013	Nascimento, Ana L. T. O./0000-0003-4851-0870; Romero, Eliete C/0000-0002-8635-439X; Kirchgatter, Karin/0000-0002-2449-2316; Teixeira, Aline/0000-0002-1171-8312	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/23913-9]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [302758/2013-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant number 2012/23913-9 and Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) grant number 302758/2013-5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adindla S, 2004, COMP FUNCT GENOM, V5, P2, DOI 10.1002/cfg.358; Atzingen MV, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-70; Atzingen MV, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/564285; Atzingen MV, 2009, J INFECTION, V59, P264, DOI 10.1016/j.jinf.2009.07.010; Bajani MD, 2003, J CLIN MICROBIOL, V41, P803, DOI 10.1128/JCM.41.2.803-809.2003; Barbosa AS, 2006, INFECT IMMUN, V74, P6356, DOI 10.1128/IAI.00460-06; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Carvalho E, 2009, FEBS LETT, V583, P1381, DOI 10.1016/j.febslet.2009.03.050; Cascales E, 2002, J BACTERIOL, V184, P754, DOI 10.1128/JB.184.3.754-759.2002; Chou LF, 2012, GENE, V511, P364, DOI 10.1016/j.gene.2012.09.074; Choy HA, 2007, INFECT IMMUN, V75, P2441, DOI 10.1128/IAI.01635-06; COLEMAN JL, 1995, INFECT IMMUN, V63, P2478, DOI 10.1128/IAI.63.7.2478-2484.1995; Croda J, 2007, J CLIN MICROBIOL, V45, P1528, DOI 10.1128/JCM.02344-06; Cullen PA, 2003, INFECT IMMUN, V71, P2414, DOI 10.1128/IAI.71.5.2414-2421.2003; Domingos RF, 2015, MICROBIOL-SGM, V161, P851, DOI 10.1099/mic.0.000041; Domingos RF, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-50; Faine S, 1999, LEPTOSPIRA LEPTOSPIR, V2nd; Fenno JC, 2000, INFECT IMMUN, V68, P1884, DOI 10.1128/IAI.68.4.1884-1892.2000; Fernandes LG., 2014, MICROBIOLOGY; Fernandes LGV, 2012, INFECT IMMUN, V80, P3679, DOI 10.1128/IAI.00474-12; Fink DL, 2002, INFECT IMMUN, V70, P4902, DOI 10.1128/IAI.70.9.4902-4907.2002; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLUGEL A, 1994, J BIOL CHEM, V269, P29732; Fraga TR, 2010, J BIOTECHNOL, V148, P156, DOI 10.1016/j.jbiotec.2010.04.007; Gamberini M, 2005, FEMS MICROBIOL LETT, V244, P305, DOI 10.1016/j.femsle.2005.02.004; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Grizot S, 2004, MOL MICROBIOL, V51, P1027, DOI 10.1111/j.1365-2958.2003.03903.x; Hauk P, 2008, INFECT IMMUN, V76, P2642, DOI 10.1128/IAI.01639-07; Hoke DE, 2008, INFECT IMMUN, V76, P2063, DOI 10.1128/IAI.01643-07; Hsieh WJ, 2005, FEMS MICROBIOL LETT, V243, P339, DOI 10.1016/j.femsle.2004.12.021; Hull-Jackson C, 2006, J CLIN MICROBIOL, V44, P1853, DOI 10.1128/JCM.44.5.1853-1855.2006; Hussain M, 2001, MICROB PATHOGENESIS, V31, P261, DOI 10.1006/mpat.2001.0469; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Koizumi N, 2003, FEMS MICROBIOL LETT, V226, P215, DOI 10.1016/S0378-1097(03)00619-0; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Levett PN, 2003, CLIN INFECT DIS, V36, P447, DOI 10.1086/346208; Lin YP, 2009, J BIOL CHEM, V284, P19380, DOI 10.1074/jbc.M109.004531; Longhi MT, 2009, J MED MICROBIOL, V58, P1275, DOI 10.1099/jmm.0.011916-0; Malmstrom J, 2009, NATURE, V460, P762, DOI 10.1038/nature08184; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Mendes RS, 2011, INFECT IMMUN, V79, P4657, DOI 10.1128/IAI.05583-11; Merien F, 2000, FEMS MICROBIOL LETT, V185, P17, DOI 10.1111/j.1574-6968.2000.tb09034.x; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nascimento ALTO, 2004, BRAZ J MED BIOL RES, V37, P459, DOI 10.1590/S0100-879X2004000400003; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Oliveira R, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002396; Oliveira R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021962; Oliveira TR, 2010, MICROBES INFECT, V12, P207, DOI 10.1016/j.micinf.2009.12.004; Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i; Picardeau M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001607; Pinne M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000815; Ramos CRR, 2004, BRAZ J MED BIOL RES, V37, P1103, DOI 10.1590/S0100-879X2004000800001; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Ricaldi JN, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001853; Ristow P, 2007, PLOS PATHOG, V3, P894, DOI 10.1371/journal.ppat.0030097; Rojas M, 2008, ACTA TROP, V107, P54, DOI 10.1016/j.actatropica.2008.04.013; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Siqueira G.H., 2013, AM J TROP MED HYG; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Souza NM, 2012, MICROB PATHOGENESIS, V53, P125, DOI 10.1016/j.micpath.2012.06.001; Stevenson B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001188; Sun MZ, 2006, BBA-PROTEINS PROTEOM, V1764, P1340, DOI 10.1016/j.bbapap.2006.06.003; TURNER LH, 1970, T ROY SOC TROP MED H, V64, P623, DOI 10.1016/0035-9203(70)90087-8; Verma A, 2006, INFECT IMMUN, V74, P2659, DOI 10.1128/IAI.74.5.2659-2666.2006; Verma A, 2010, INFECT IMMUN, V78, P2053, DOI 10.1128/IAI.01282-09; Vieira ML, 2015, CRITICAL RE IN PRESS, DOI [10.3109/1040841X.2013.804031, DOI 10.3109/1040841X.2013.804031]; Vieira ML, 2013, MICROB PATHOG, V51, P360; Vieira ML, 2014, FEMS MICROBIOL LETT, V352, P129, DOI 10.1111/1574-6968.12349; Vieira ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011259; Vieira ML, 2010, J INFECTION, V60, P52, DOI 10.1016/j.jinf.2009.10.047; Vieira ML, 2009, INFECT IMMUN, V77, P4092, DOI 10.1128/IAI.00353-09; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Yu CS, 2004, PROTEIN SCI, V13, P1402, DOI 10.1110/ps.03479604	79	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122762	10.1371/journal.pone.0122762	http://dx.doi.org/10.1371/journal.pone.0122762			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849456	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800159
J	Grunseit, AC; O'Hara, BJ; Chau, JY; Briggs, M; Bauman, AE				Grunseit, Anne C.; O'Hara, Blythe J.; Chau, Josephine Y.; Briggs, Megan; Bauman, Adrian E.			Getting the Message Across: Outcomes and Risk Profiles by Awareness Levels of the "Measure-Up" Obesity Prevention Campaign in Australia	PLOS ONE			English	Article							MASS-MEDIA CAMPAIGNS; PHYSICAL-ACTIVITY; VERB(TM) CAMPAIGN; HELP-SEEKING; POPULATION; PREVALENCE; BEHAVIORS; MORTALITY; IMPACT; ADULTS	Background Obesity campaign evaluations have used campaign awareness to assess impact, yet have not compared unprompted campaign recallers, with prompted recallers and those with no campaign recall. Using data from an Australian mass-media obesity prevention campaign linking waist circumference and chronic disease we examined whether those with different degrees of campaign recall are distinct groups demographically and for subsequent campaign effects. Methods A national cross-sectional telephone survey of randomly selected adults aged 18 to 65 years was conducted post-campaign (n = 2812) covering campaign recall, self-reported diet and physical activity (PA) and waist-measuring knowledge, behaviours and intentions to make lifestyle changes. Respondents were divided into three groups indicating campaign recall: Unprompted Recallers (n=1154); Prompted Recallers (n=1284); and No Recallers (n=374) and compared on demographic, knowledge, and behavioural risk factors for obesity/chronic disease. Results Unprompted Recallers were more likely to speak English at home (p<.001), be in the primary campaign target group (25-45 years with children) (p<0.001) than the other two groups and to be university educated and female than the Prompted Recall group only (p=0.001). Unprompted Recallers had better knowledge about recommended waist circumference (p<.001), fruit (p=0.004), vegetable (p<0.001) and PA guidelines (p<0.001) than both the other groups. The No Recall group was less likely than the other two to be overweight/obese (46% vs 55%, p=0.020 and 54%, p=0.037), comparable on meeting fruit consumption and PA guidelines but more likely to meet vegetable intake recommendations (than Unprompted Recallers only). Conclusions Unprompted recallers were more knowledgeable about campaign messages; behaviour change and intentions to change were stronger for the two recall groups compared with the No Recall group but not different between them. The current analysis revealed subtle differences in campaign exposure and/or attendance by different demographic subgroups that would not be apparent in a simple aware/unaware dichotomy.	[Grunseit, Anne C.; O'Hara, Blythe J.; Chau, Josephine Y.; Bauman, Adrian E.] Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia; [Briggs, Megan] Dept Hlth, People Capabil & Commun Div, Hlth Mkt Unit, Canberra, ACT, Australia	University of Sydney	Grunseit, AC (corresponding author), Univ Sydney, Sch Publ Hlth, Prevent Res Collaborat, Camperdown, NSW, Australia.	anne.grunseit@sydney.edu.au	Grunseit, Anne/AAF-2675-2020	Chau, Josephine/0000-0001-6261-2545; Grunseit, Anne/0000-0003-1250-3265				Australian Bureau of Statistics, 2009, 43640 AUSTR BUR STAT; Australian Bureau of Statistics, 2010, 32010 AUSTR BUR STAT; Australian Bureau of Statistics, 2012, 14364055001 AUSTR BU; Australian Bureau of Statistics, 2012, 62270 AUSTR BUR STAT; Australian Bureau of Statistics, 2009, 41020 AUSTR BUR STAT; Australian Bureau of Statistics, 2011, HOUS INC INC DISTR A; Australian Communications and Media Authority, 2010, CONV COMM REP 2 AUST; Australian Institute of Health and Welfare, 2006, CHRON DIS ASS RISK F; Australian Institute of Health and Welfare (AIHW), 2003, ACT AUSTR SURV GUID; Bauman A, 2008, AM J PREV MED, V34, pS249, DOI 10.1016/j.amepre.2008.03.015; Bauman A, 2006, EVAL PROGRAM PLANN, V29, P312, DOI 10.1016/j.evalprogplan.2005.12.004; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS196, DOI 10.1123/jpah.6.s2.s196; Brown WJ., 2005, CHOOSE HLTH BE ACTIV; Commonwealth Department of Health and Aged Care, 1998, AUSTR GUID HLTH EAT; Croker H, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-404; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dixon J, 2000, Aust J Rural Health, V8, P254, DOI 10.1046/j.1440-1584.2000.00327.x; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Galdas PM, 2005, J ADV NURS, V49, P616, DOI 10.1111/j.1365-2648.2004.03331.x; GfK Blue Moon Research and Planning, 2009, AUSTR BETT HLTH IN P, DOI [10.4066/AMJ.2011693, DOI 10.4066/AMJ.2011693]; GfK Blue Moon Research and Planning, 2010, MEAS PHAS 2 QUAL FOR; GfK Blue Moon Research and Planning, 2007, RES REPORT; Huhman M, 2008, AM J PREV MED, V34, pS241, DOI 10.1016/j.amepre.2008.03.006; James N, 2011, J SCI MED SPORT S1, V14, pe24, DOI [10.1016/j.jsams.2011.11.049, DOI 10.1016/J.JSAMS.2011.11.049]; King EL, 2013, HEALTH EDUC RES, V28, P1029, DOI 10.1093/her/cyt084; Leavy J, 2011, J SCI MED SPORT S11, V14; Leavy JE, 2011, HEALTH EDUC RES, V26, P1060, DOI 10.1093/her/cyr069; Mealing NM, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-26; Morley B, 2009, HEALTH EDUC RES, V24, P1069, DOI 10.1093/her/cyp034; National Health and Medical Research Council, 2001, CLIN PRACT GUID MAN; Noble G, 2005, PRISM, V3, P1; Nutbeam D, 2008, SOC SCI MED, V67, P2072, DOI 10.1016/j.socscimed.2008.09.050; O'Hara BJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-762; Pennay DW, 2010, ACSPRI SOC SCI METH; Pollard C, 2009, AM J PUBLIC HEALTH, V99, P355, DOI 10.2105/AJPH.2007.131367; Smith JA, 2006, MED J AUSTRALIA, V184, P81, DOI 10.5694/j.1326-5377.2006.tb00124.x; StataCorp, 2013, STAT STAT SOFTW REL; The Social Research Centre, 2010, EV AUSTR BETT HLTH I; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; US Department of Health and Human Services, 2008, PHYS ACT GUID AM; Valente T, 2013, PUBLIC COMMUNICATION, P105; van der Feen de Lille J C, 1998, Nutr Health, V12, P107; van Wechem Sigrid N., 1998, Nutrition and Health (Bicester), V12, P119; Verheijden MW, 2012, FAM PRACT, V29, pi75, DOI 10.1093/fampra/cmr133; Wakefield MA, 2008, AM J PUBLIC HEALTH, V98, P1443, DOI 10.2105/AJPH.2007.128991; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wammes B, 2007, OBESITY, V15, P2780, DOI 10.1038/oby.2007.330; Wardle J, 2001, HEALTH EDUC RES, V16, P343, DOI 10.1093/her/16.3.343; Waters A-M, 2003, GROWING PROBLEM TREN; WHO, 2000, OB PREV MAN GLOB EP; World Health Organization, 2003, OB OV WHO GLOB STRAT; Xingjin W, 2003, EFFECT DESORPTION TI	53	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0121387	10.1371/journal.pone.0121387	http://dx.doi.org/10.1371/journal.pone.0121387			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VA	25844811	Green Published, gold, Green Submitted			2022-12-26	WOS:000352475700006
J	Schmitz, K; Koeppen, H; Binot, E; Fassunke, J; Kunstlinger, H; Ihle, MA; Heydt, C; Wardelmann, E; Buttner, R; Merkelbach-Bruse, S; Ruschoff, J; Schildhaus, HU				Schmitz, Katja; Koeppen, Hartmut; Binot, Elke; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela A.; Heydt, Carina; Wardelmann, Eva; Buettner, Reinhard; Merkelbach-Bruse, Sabine; Rueschoff, Josef; Schildhaus, Hans-Ulrich			MET Gene Copy Number Alterations and Expression of MET and Hepatocyte Growth Factor Are Potential Biomarkers in Angiosarcomas and Undifferentiated Pleomorphic Sarcomas	PLOS ONE			English	Article							C-MET; SCATTER FACTOR; SIGNALING PATHWAY; FACTOR RECEPTOR; CELL; AMPLIFICATION; OVEREXPRESSION; ASSAY; RECOMMENDATIONS; RADIOTHERAPY	Soft tissue sarcomas are a heterogeneous group of tumors with many different subtypes. In 2014 an estimated 12,020 newly diagnosed cases and 4,740 soft tissue sarcoma related deaths can be expected in the United States. Many soft tissue sarcomas are associated with poor prognosis and therapeutic options are often limited. The evolution of precision medicine has not yet fully reached the clinical treatment of sarcomas since therapeutically tractable genetic changes have not been comprehensively studied so far. We analyzed a total of 484 adult-type malignant mesenchymal tumors by MET fluorescence in situ hybridization and MET and hepatocyte growth factor immunohistochemistry. Eleven different entities were included, among them the most common and clinically relevant subtypes and tumors with specific translocations or complex genetic changes. MET protein expression was observed in 2.6% of the cases, all of which were either undifferentiated pleomorphic sarcomas or angiosarcomas, showing positivity rates of 14% and 17%, respectively. 6% of the tumors showed hepatocyte growth factor overexpression, mainly seen in undifferentiated pleomorphic sarcomas and angiosarcomas, but also in clear cell sarcomas, malignant peripheral nerve sheath tumors, leiomyosarcomas and gastrointestinal stromal tumors. MET and hepatocyte growth factor overexpression were significantly correlated and may suggest an autocrine activation in these tumors. MET FISH amplification and copy number gain were present in 4% of the tumors (15/413). Two samples, both undifferentiated pleomorphic sarcomas, fulfilled the criteria for high level amplification of MET, one undifferentiated pleomorphic sarcoma reached an intermediate level copy number gain, and 12 samples of different subtypes were categorized as low level copy number gains for MET. Our findings indicate that angiosarcomas and undifferentiated pleomorphic sarcomas rather than other frequent adult-type sarcomas should be enrolled in screening programs for clinical trials with MET inhibitors. The screening methods should include both in situ hybridization and immunohistochemistry.	[Schmitz, Katja; Binot, Elke; Fassunke, Jana; Kuenstlinger, Helen; Ihle, Michaela A.; Heydt, Carina; Wardelmann, Eva; Buettner, Reinhard; Merkelbach-Bruse, Sabine; Schildhaus, Hans-Ulrich] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Schmitz, Katja; Schildhaus, Hans-Ulrich] Univ Hosp Gottingen, Inst Pathol, Gottingen, Germany; [Koeppen, Hartmut] Genentech Inc, San Francisco, CA 94080 USA; [Wardelmann, Eva] Univ Hosp Munster, Gerhard Domagk Inst Pathol, Munster, Germany; [Rueschoff, Josef] Targos Mol Pathol GmbH, Kassel, Germany	University of Cologne; University of Gottingen; Roche Holding; Genentech; University of Munster; Targos Molecular Pathology GmbH	Schildhaus, HU (corresponding author), Univ Hosp Cologne, Inst Pathol, Cologne, Germany.	hans-ulrich.schildhaus@med.uni-goettingen.de			German Cancer Aid (Deutsche Krebshilfe)	German Cancer Aid (Deutsche Krebshilfe)(Deutsche Krebshilfe)	The German Cancer Aid (Deutsche Krebshilfe) supported the creation of the TMAs used here. The German Cancer Aid had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appleman LJ, 2011, J CLIN ONCOL, V29, P4837, DOI 10.1200/JCO.2011.37.7929; Bramwell VHC, 2005, CANCER BIOL THER, V4, P1336, DOI 10.4161/cbt.4.12.2166; Camidge DR, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.8001; Casali PG, 2009, ANN ONCOL, V20, P132, DOI 10.1093/annonc/mdp153; Davis IJ, 2010, CANCER RES, V70, P639, DOI 10.1158/0008-5472.CAN-09-1121; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; Fletcher CDM BJ, 2013, PATHOLOGY GENETICS T; Gao CF, 2009, MOL CANCER THER, V8, P2803, DOI 10.1158/1535-7163.MCT-09-0125; Hou JX, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-64; Koeppen H, 2012, MODERN PATHOL, V25, p480A; Koeppen H, 2014, J CLIN ONCOL SUPPL, V32, p5s; Lee HJ, 2011, RADIAT ONCOL J, V29, P260, DOI 10.3857/roj.2011.29.4.260; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lee J, 2012, RADIAT ONCOL J, V30, P62, DOI 10.3857/roj.2012.30.2.62; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Maier JAM, 1996, INT J CANCER, V65, P168, DOI 10.1002/(SICI)1097-0215(19960117)65:2<168::AID-IJC7>3.0.CO;2-X; Maulik G, 2002, CYTOKINE GROWTH F R, V13, P41, DOI 10.1016/S1359-6101(01)00029-6; Mentzel T, 2012, MODERN PATHOL, V25, P75, DOI 10.1038/modpathol.2011.134; Miyamoto M, 2011, BRIT J CANCER, V105, P131, DOI 10.1038/bjc.2011.199; Movva S, 2014, J CLIN ONCOL SUPPL, V32, p5s; NALDINI L, 1991, EMBO J, V10, P2867, DOI 10.1002/j.1460-2075.1991.tb07836.x; Negri T, 2010, CLIN CANCER RES, V16, P3581, DOI 10.1158/1078-0432.CCR-09-2912; Neklason DW, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-424; Rao UNM, 1997, HUM PATHOL, V28, P1066, DOI 10.1016/S0046-8177(97)90060-5; RONG S, 1993, CANCER RES, V53, P5355; ROSEN EM, 1989, IN VITRO CELL DEV B, V25, P163; ROSEN EM, 1990, EXP CELL RES, V186, P22, DOI 10.1016/0014-4827(90)90205-O; Rosen EM, 1996, INT J CANCER, V67, P248, DOI 10.1002/(SICI)1097-0215(19960717)67:2<248::AID-IJC16>3.0.CO;2-7; ROSEN EM, 1994, INT J CANCER, V57, P706, DOI 10.1002/ijc.2910570517; Rosen LS, 2011, CLIN CANCER RES, V17, P7754, DOI 10.1158/1078-0432.CCR-11-1002; Schildhaus HU, 2015, CLIN CANCER RES, V21, P907, DOI 10.1158/1078-0432.CCR-14-0450; Schildhaus HU, 2012, MODERN PATHOL, V25, P1473, DOI 10.1038/modpathol.2012.102; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Spigel DR, 2012, CLIN LUNG CANCER, V13, P500, DOI 10.1016/j.cllc.2012.05.009; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Torres KE, 2011, CLIN CANCER RES, V17, P3943, DOI 10.1158/1078-0432.CCR-11-0193; Tsuda M, 2007, CANCER RES, V67, P919, DOI 10.1158/0008-5472.CAN-06-2855; Vance GH, 2009, ARCH PATHOL LAB MED, V133, P611, DOI 10.1043/1543-2165-133.4.611; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Wallenius V, 2000, AM J PATHOL, V156, P821, DOI 10.1016/S0002-9440(10)64950-4; Weiss SW, 2001, ENZINGER AND WEISSS; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70	45	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 6	2015	10	4							e0120079	10.1371/journal.pone.0120079	http://dx.doi.org/10.1371/journal.pone.0120079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VA	25844809	Green Submitted, Green Published, gold			2022-12-26	WOS:000352475700002
J	Bernard, MC; Barban, V; Pradezynski, F; de Montfort, A; Ryall, R; Caillet, C; Londono-Hayes, P				Bernard, Marie-Clotilde; Barban, Veronique; Pradezynski, Fabrine; de Montfort, Aymeric; Ryall, Robert; Caillet, Catherine; Londono-Hayes, Patricia			Immunogenicity, Protective Efficacy, and Non-Replicative Status of the HSV-2 Vaccine Candidate HSV529 in Mice and Guinea Pigs	PLOS ONE			English	Article							SIMPLEX-VIRUS 2; GENITAL HERPES; DELETION MUTANT; INFECTION; GLYCOPROTEIN; METAANALYSIS	HSV-2 vaccine is needed to prevent genital disease, latent infection, and virus transmission. A replication-deficient mutant virus (dl5-29) has demonstrated promising efficacy in animal models of genital herpes. However, the immunogenicity, protective efficacy, and non-replicative status of the highly purified clinical vaccine candidate (HSV529) derived from dl5-29 have not been evaluated. Humoral and cellular immune responses were measured in mice and guinea pigs immunized with HSV529. Protection against acute and recurrent genital herpes, mortality, latent infection, and viral shedding after vaginal HSV-2 infection was determined in mice or in naive and HSV-1 seropositive guinea pigs. HSV529 replication and pathogenicity were investigated in three sensitive models of virus replication: severe combined immunodeficient (SCID/Beige) mice inoculated by the intramuscular route, suckling mice inoculated by the intracranial route, and vaginally-inoculated guinea pigs. HSV529 immunization induced HSV-2-neutralizing antibody production in mice and guinea pigs. In mice, it induced production of specific HSV-2 antibodies and splenocytes secreting IFN. or IL-5. Immunization effectively prevented HSV-2 infection in all three animal models by reducing mortality, acute genital disease severity and frequency, and viral shedding. It also reduced ganglionic viral latency and recurrent disease in naive and HSV-1 seropositive guinea pigs. HSV529 replication/propagation was not detected in the muscles of SCID/Beige mice, in the brains of suckling mice, or in vaginal secretions of inoculated guinea pigs. These results confirm the non-replicative status, as well as its immunogenicity and efficacy in mice and guinea pigs, including HSV-1 seropositive guinea pigs. In mice, HSV529 produced Th1/Th2 characteristic immune response thought to be necessary for an effective vaccine. These results further support the clinical investigation of HSV529 in human subjects as a prophylactic vaccine.	[Bernard, Marie-Clotilde; Barban, Veronique; Pradezynski, Fabrine; de Montfort, Aymeric; Caillet, Catherine; Londono-Hayes, Patricia] Sanofi Pasteur, Res & Dev, Marcy Letoile, France; [Ryall, Robert] Sanofi Pasteur, Res & Dev, Swiftwater, PA USA	Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Bernard, MC (corresponding author), Sanofi Pasteur, Res & Dev, Marcy Letoile, France.	marie-clotilde.bernard@sanofipasteur.com						Awasthi S, 2012, J VIROL, V86, P4586, DOI 10.1128/JVI.07203-11; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Da Costa X, 2000, J VIROL, V74, P7963, DOI 10.1128/JVI.74.17.7963-7971.2000; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P6994, DOI 10.1073/pnas.96.12.6994; Delagrave S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046714; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Hofstetter AM, 2014, CURR OPIN INFECT DIS, V27, P75, DOI 10.1097/QCO.0000000000000029; Hoshino Y, 2005, J VIROL, V79, P410, DOI 10.1128/JVI.79.1.410-418.2005; Hoshino Y, 2008, VACCINE, V26, P4034, DOI 10.1016/j.vaccine.2008.05.022; Hoshino Y, 2009, J INFECT DIS, V200, P1088, DOI 10.1086/605645; Johnston C, 2012, LANCET, V379, P641, DOI 10.1016/S0140-6736(11)61750-9; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Mundle ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057224; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Wald A, 2002, J INFECT DIS, V185, P45, DOI 10.1086/338231	15	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121518	10.1371/journal.pone.0121518	http://dx.doi.org/10.1371/journal.pone.0121518			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837802	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000047
J	McHugh, MJ; Broadhurst, MK; Sterling, DJ; Millar, RB				McHugh, Matthew J.; Broadhurst, Matt K.; Sterling, David J.; Millar, Russell B.			A 'Simple Anterior Fish Excluder' (SAFE) for Mitigating Penaeid-Trawl Bycatch	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; VISUAL-STIMULUS; BEHAVIOR; DESIGN; CATCH; GEAR	Various plastic strips and sheets (termed 'simple anterior fish excluders'-SAFEs) were positioned across the openings of penaeid trawls in attempts at reducing the unwanted bycatches of small teleosts. Initially, three SAFEs (a single wire without, and with small and large plastic panels) were compared against a control (no SAFE) on paired beam trawls. All SAFEs maintained targeted Metapenaeus macleayi catches, while the largest plastic SAFE significantly reduced total bycatch by 51% and the numbers of Pomatomus saltatrix, Mugil cephalus and Herklotsichthys castelnaui by up to 58%. A redesigned SAFE ('continuous plastic') was subsequently tested (against a control) on paired otter trawls, significantly reducing total bycatch by 28% and Pomatomus saltatrix and Herklotsichthys castelnaui by up to 42%. The continuous-plastic SAFE also significantly reduced Metapenaeus macleayi catches by similar to 7%, but this was explained by similar to 5% less wing-end spread, and could be simply negated through otter-board refinement. Further work is required to refine the tested SAFEs, and to quantify species-specific escape mechanisms. Nevertheless, the SAFE concept might represent an effective approach for improving penaeid-trawl selectivity.	[McHugh, Matthew J.; Broadhurst, Matt K.] Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia; [Broadhurst, Matt K.] NSW Dept Primary Ind, Fisheries Conservat Technol Unit, Coffs Harbour, NSW, Australia; [Sterling, David J.] Sterling Trawl Gear Serv, Manly, Qld, Australia; [Millar, Russell B.] Univ Auckland, Dept Stat, Auckland 1, New Zealand	University of Queensland; NSW Department of Primary Industries; University of Auckland	McHugh, MJ (corresponding author), Univ Queensland, Sch Biol Sci, Marine & Estuarine Ecol Unit, Brisbane, Qld, Australia.	matthew.mchugh@uq.net.au	Broadhurst, Matt K/I-6783-2015; McHugh, Matthew/AAC-3288-2020	Broadhurst, Matt K/0000-0003-0184-7249; McHugh, Matthew/0000-0001-6210-0689				Alverson DL, 1996, REV FISH BIOL FISHER, V6, P443, DOI 10.1007/BF00164325; Bayse SM, 2014, FISH RES, V152, P55, DOI 10.1016/j.fishres.2013.03.018; Benjamini Y, 2001, ANN STAT, V29, P1165; Brewer D, 1998, FISH RES, V36, P195, DOI 10.1016/S0165-7836(98)00096-4; Broadhurst Matt K., 2007, V7, P1; Broadhurst MK, 2006, FISH FISH, V7, P180, DOI 10.1111/j.1467-2979.2006.00213.x; Broadhurst MK, 2014, FISH RES, V153, P24, DOI 10.1016/j.fishres.2013.12.018; Broadhurst MK, 2012, FISH RES, V131, P67, DOI 10.1016/j.fishres.2012.07.015; Broadhurst MK, 2000, REV FISH BIOL FISHER, V10, P27, DOI 10.1023/A:1008936820089; Crowder LB, 1998, FISHERIES, V23, P8, DOI 10.1577/1548-8446(1998)023&lt;0008:FBIFM&gt;2.0.CO;2; Davis MW, 2002, CAN J FISH AQUAT SCI, V59, P1834, DOI 10.1139/F02-139; Eayrs S, 2007, GUIDE BYCATCH REDUCT; Food and Agriculture Organization (FAO), 2012, STAT WORLD FISH AQ 2; GLASS CW, 1989, FISH RES, V7, P249, DOI 10.1016/0165-7836(89)90059-3; Hall MA, 2000, MAR POLLUT BULL, V41, P204, DOI 10.1016/S0025-326X(00)00111-9; Hooper J, 2005, CCAMLR SCI, V12, P195; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Kelleher Kieran, 2005, FAO FISHERIES TECHNI; Kim YH, 1998, FISH RES, V34, P151, DOI 10.1016/S0165-7836(97)00087-8; Kim YH, 1998, FISH RES, V34, P165, DOI 10.1016/S0165-7836(97)00089-1; Main J., 1981, SCOT FISH RES REP, V23, P1; McHugh MJ, 2014, FISHERIES MANAG ECOL, V21, P299, DOI 10.1111/fme.12079; Ryer CH, 2008, FISH RES, V90, P138, DOI 10.1016/j.fishres.2007.10.005; SEIDEL WR, 1978, MAR FISH REV, V40, P21; Sterling D, 2000, PHYS PERFORMANCE PRA; Walsh SJ, 2003, FISH RES, V63, P289, DOI 10.1016/S0165-7836(03)00130-9; Winger Paul D., 2010, P67	27	7	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123124	10.1371/journal.pone.0123124	http://dx.doi.org/10.1371/journal.pone.0123124			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837892	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000128
J	Qi, JL; Zhang, DP; Fu, XJ; Li, CM; Meng, SN; Dai, M; Liu, H; Sun, JP				Qi, Jinlei; Zhang, Dapeng; Fu, Xiaojing; Li, Chengmei; Meng, Sining; Dai, Min; Liu, Hui; Sun, Jiangping			High Risks of HIV Transmission for Men Who Have Sex with Men - A Comparison of Risk Factors of HIV Infection among MSM Associated with Recruitment Channels in 15 Cities of China	PLOS ONE			English	Article							ONLINE; INTERNET; PREVALENCE; EPIDEMIC; BEHAVIOR	Objective While the HIV epidemic varies greatly by region and population group throughout China, the HIV incidence among men who have sex with men (MSM) continues to rise at an alarmingly fast pace. We seek to analyze the risk factors associated with HIV infection among MSM recruited from different channels in large urban centers across China, in an attempt to shed light on the design of future targeted intervention strategies. Methods A total of 33,684 MSM from 14 cities and one province were recruited from July to December 2011. Demographic (e.g. age, marital status, education) and behavioral (e.g. condom use, HIV testing history) data were collected using information collection cards. Blood samples were also collected to test for HIV and Syphilis. Results Participants were recruited from five different channels, and all demonstrated distinct characteristics. The overall rate of positive HIV screening was 6.27% and the rate of syphilis infection was 6.50%. Participants recruited from bathhouses had the highest HIV (11.80%) and syphilis infection rates (11.20%). Participants who were infected with syphilis had the highest HIV-positive screening rate (13.75%; 95% CI OR, 2.33-3.06). living in the southwest region of the country (11.64%; OR=2.76, 95% CI OR 2.19-3.47), Being >20 years of age (P<0.001), living in the southwest region of the country (OR=2.76, 95% CI 2.19-3.47), not having sex with female over the previous 3 months (OR=1.27, 95% CI 1.09-1.48), no condom use during the last anal intercourse (OR=1.54, 95% CI 1.39-1.70) and other factors were all associated with a higher probability of having an HIV-positive test result. Conclusion Depending on the way they are recruited, more targeted interventions are required to prevent the spread of HIV/AIDS among MSM with different characteristics and behaviors. Results from this study could provide evidence for researchers to conduct further studies and policy-makers to establish more effective and strategic interventions for MSM in China.	[Qi, Jinlei; Zhang, Dapeng; Fu, Xiaojing; Li, Chengmei; Meng, Sining; Liu, Hui; Sun, Jiangping] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China; [Dai, Min] Bill & Melinda Gates Fdn China Off, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Sun, JP (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China.	jpsun@chinaaids.cn	DAI, M/GPS-8291-2022		China-Gates Foundation HIV Cooperation Program [Opp 49277]	China-Gates Foundation HIV Cooperation Program	This program was funded by the China-Gates Foundation HIV Cooperation Program (Opp 49277). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyrer C, 2012, LANCET, V380, P367, DOI 10.1016/S0140-6736(12)60821-6; Bingham TA, 2008, SEX TRANSM DIS, V35, P631, DOI 10.1097/OLQ.0b013e31816b475a; Bolding G, 2004, AIDS CARE, V16, P993, DOI 10.1080/09540120412331292453; *CDCP, 2001, MMWR-MORBID MORTAL W, V50, P440; Feng LG, 2009, JAIDS-J ACQ IMM DEF, V52, P79, DOI 10.1097/QAI.0b013e3181a4f53e; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Glick SN, 2012, J ACQ IMMUN DEF SYND, V60, P8; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Han Mei, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P878; He Q, 2011, SEXUALLY TRANSMITTED, V88, P5; Hooper S, 2008, AIDS BEHAV, V12, P867, DOI 10.1007/s10461-008-9373-5; Horvath KJ, 2008, J URBAN HEALTH, V85, P744, DOI 10.1007/s11524-008-9299-2; Hospers HJ, 2005, AIDS, V19, P1097, DOI 10.1097/01.aids.0000174457.08992.62; Huebner DM, 2012, INT J STD AIDS, V23, P182, DOI 10.1258/ijsa.2009.009318; Huebner DM, 2006, JAIDS-J ACQ IMM DEF, V43, P239, DOI 10.1097/01.qai.0000242464.50947.16; Ko NY, 2011, AIDS BEHAV, V15, P292, DOI 10.1007/s10461-010-9748-2; Lewnard JA, 2014, SEXUALLY TRANSMITTED, V90, P7; LI H, 2011, PLOS GENET, V7, P23431, DOI DOI 10.1371/JOURNAL.PONE.0023431; Liau A, 2006, SEX TRANSM DIS, V33, P576, DOI 10.1097/01.olq.0000204710.35332.c5; Macdonald DS, 1996, SOC SCI MED, V42, P1325, DOI 10.1016/0277-9536(95)00223-5; Macdonald N, 2007, SEX TRANSM INFECT, V84, P8, DOI 10.1136/sti.2007.027946; Purcell David W, 2012, Open AIDS J, V6, P98, DOI 10.2174/1874613601206010098; Van Beneden CA, 2002, J ACQ IMMUN DEF SYND, V30, P522, DOI 10.1097/00126334-200208150-00008; van Griensven F, 2009, CURR OPIN HIV AIDS, V4, P300, DOI 10.1097/COH.0b013e32832c3bb3; Wohlfeiler D, 2005, SEX TRANSM DIS, V32, pS48, DOI 10.1097/01.olq.0000175394.81945.68; Woods WJ, 2007, JAIDS-J ACQ IMM DEF, V45, P231, DOI 10.1097/QAI.0b013e318055601e; Woods WJ, 2003, J HOMOSEXUAL, V44, P1, DOI 10.1300/J082v44n03_01; Wu Z, 2006, SCIENCE, V312, P2; Wu ZY, 2013, CLIN INFECT DIS, V57, P298, DOI 10.1093/cid/cit210; Xu JJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-3; Ybarra Michele L, 2007, Curr HIV/AIDS Rep, V4, P201, DOI 10.1007/s11904-007-0029-2; Zhang B, 2002, J CHINA AIDS STD PRE, V8, P3; Zhang D, 2011, INT J STD AIDS; Zhang Da-peng, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P431	34	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121267	10.1371/journal.pone.0121267	http://dx.doi.org/10.1371/journal.pone.0121267			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837667	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000044
J	Xu, HY; Wang, ZY; Chen, JF; Wang, TY; Wang, LL; Tang, LL; Lin, XY; Zhang, CW; Chen, BC				Xu, Hui Ying; Wang, Zhang Yang; Chen, Jing Feng; Wang, Tian Yang; Wang, Ling Ling; Tang, Li Li; Lin, Xian-yang; Zhang, Chun-wu; Chen, Bi-cheng			Association between Ankylosing Spondylitis and the miR-146a and miR-499 Polymorphisms	PLOS ONE			English	Article							NF-KAPPA-B; PERIPHERAL-BLOOD; FUNCTIONAL POLYMORPHISM; TNF-ALPHA; MICRORNA; EXPRESSION; TOLL-LIKE-RECEPTOR-4; INFLAMMATION; BIOMARKERS; ARTHRITIS	miRNAs are small, non-coding RNAs that regulate the expression of multiple target genes at the post-transcriptional level. Single-nucleotide polymorphisms (SNPs) in miRNA sequences may alter miRNA expression and have been implicated in the pathogenesis of multiple forms of arthritis, including rheumatoid arthritis (RA) and osteoarthritis. The present study explored the association between ankylosing spondylitis (AS) and two single nucleotide polymorphisms (SNPs), miR-146a rs2910164G>C and miR-499 rs3746444T>C, in a Han Chinese population. A case-control study consisting of 102 subjects with AS and 105 healthy controls was designed. The two miRNA SNPs were identified by direct sequencing. Subsequently, their gene and genotype frequencies were compared with healthy controls. A significant difference was observed in the miR-146a rs2910164G>C SNP. The frequency of the G allele was markedly higher in the AS patients than in the healthy controls (P = 0.005, Pc = 0.01, OR = 1.787), and the frequency of the GG genotype was higher in AS patients than in controls (P = 0.014, Pc = 0.042, OR = 2.516). However, no significant association was found between the miR-499 rs3746444T>C variant and susceptibility to AS. This is the first study to address the association between the miR-146a rs2910164G>C and miR-499 rs3746444T>C polymorphisms and AS, and it suggests a potential pathogenic factor for AS. Further studies are needed to validate our findings in a larger series, as well as in other ethnic backgrounds.	[Xu, Hui Ying; Wang, Zhang Yang; Wang, Ling Ling; Tang, Li Li; Chen, Bi-cheng] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Surg, Wenzhou 325000, Peoples R China; [Chen, Jing Feng; Wang, Tian Yang] Wenzhou Med Univ, Affiliated Hosp 1, Dept Surg, Wenzhou 325000, Peoples R China; [Lin, Xian-yang; Zhang, Chun-wu] Wenzhou Med Univ, Affiliated Hosp 1, Injury Orthopaed Tradit Chinese Med, Wenzhou 325000, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, CW (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Injury Orthopaed Tradit Chinese Med, Wenzhou 325000, Peoples R China.	bisonch@163.com	Kumar, Sushmitha Vijaya/AAU-4235-2021; XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276	Technology Foundation of Zhejiang Province [2013C33173]; Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project; Fresh Talent Program [2014R413014]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	Technology Foundation of Zhejiang Province; Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project; Fresh Talent Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from Technology Foundation of Zhejiang Province [grant number No. 2013C33173].(URLs: http://www.zjkjt.gov.cn/) and the Zhejiang Provincial Undergraduate Scientific and Technological Innovation Project and the Fresh Talent Program (grant number: 2014R413014) (URLs: http://www.zjkjt.gov.cn/html/node18/detail0104/2011/0104_22730.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiz H, 2011, ASIAN PAC J CANCER P, V12, P3107; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Ciccacci C, 2014, ACTA DIABETOL, V51, P663, DOI 10.1007/s00592-014-0582-2; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Rycke L, 2005, ARTHRITIS RHEUM-US, V52, P2146, DOI 10.1002/art.21155; DiDonato JA, 2012, IMMUNOL REV, V246, P379, DOI 10.1111/j.1600-065X.2012.01099.x; Eggert M, 2007, RHEUMATOL INT, V27, P841, DOI 10.1007/s00296-007-0303-z; Green MJ, 2013, MOL PSYCHIATR, V18, P774, DOI 10.1038/mp.2012.84; Hasani SS, 2014, TUMOR BIOL, V35, P219, DOI 10.1007/s13277-013-1027-1; Iyer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044789; Ji W, 2014, BIOMED REP, V2, P517, DOI 10.3892/br.2014.262; Jones SW, 2009, OSTEOARTHR CARTILAGE, V17, P464, DOI 10.1016/j.joca.2008.09.012; Li S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073563, 10.1371/journal.pone.0053163, 10.1371/journal.pone.0081438]; Li YT, 2012, ARTHRITIS RHEUM-US, V64, P3240, DOI 10.1002/art.34550; Liang YL, 2012, MOL BIOL REP, V39, P8873, DOI 10.1007/s11033-012-1754-1; Lu LF, 2010, CELL, V142, P914, DOI 10.1016/j.cell.2010.08.012; Ma XP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079584; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Qipshidze-Kelm N, 2014, REDOX BIOL, V2, P1, DOI 10.1016/j.redox.2013.10.009; Rusca Nicole, 2011, Mol Biol Int, V2011, P437301, DOI 10.4061/2011/437301; Rusca N, 2012, MOL CELL BIOL, V32, P4432, DOI 10.1128/MCB.00824-12; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Shao YM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/916202; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Stanczyk J, 2008, ARTHRITIS RHEUM, V58, P1001, DOI 10.1002/art.23386; Szanto S, 2008, J RHEUMATOL, V35, P2372, DOI 10.3899/jrheum.070839; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; van Gaalen FA, 2004, ARTHRITIS RHEUM, V50, P2113, DOI 10.1002/art.20316; Wang JH, 2013, OSTEOARTHR CARTILAGE, V21, P1987, DOI 10.1016/j.joca.2013.09.008; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xiao JJ, 2014, INT J CLIN EXP MED, V7, P136; Yamashita J, 2013, MELANOMA RES, V23, P13, DOI 10.1097/CMR.0b013e32835c5b30; Yang B, 2012, HUM IMMUNOL, V73, P101, DOI 10.1016/j.humimm.2011.10.005; Yang B, 2011, MOL BIOL REP, V38, P4913, DOI 10.1007/s11033-010-0633-x; Yang LL, 2012, J EXP MED, V209, P1655, DOI 10.1084/jem.20112218; Yang ZX, 2007, CLIN EXP IMMUNOL, V149, P48, DOI 10.1111/j.1365-2249.2007.03396.x; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhao HF, 2014, AUTOIMMUNITY, V47, P173, DOI 10.3109/08916934.2014.883503; Zhu S, 2012, NAT MED, V18, P1077, DOI 10.1038/nm.2815	39	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122055	10.1371/journal.pone.0122055	http://dx.doi.org/10.1371/journal.pone.0122055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836258	gold, Green Published, Green Submitted			2022-12-26	WOS:000352139000076
J	Xu, H; Arnold, MG; Kumar, SV				Xu, Hao; Arnold, Matthew Grant; Kumar, Sushmitha Vijay			Differential Effects of Munc18s on Multiple Degranulation-Relevant Trans-SNARE Complexes	PLOS ONE			English	Article							MEMBRANE-FUSION; MAST-CELLS; COMPOUND EXOCYTOSIS; N-PEPTIDE; SYNTAXIN; RELEASE; IDENTIFICATION; SNAP-23; DOCKING; NSF	Mast cell exocytosis, which includes compound degranulation and vesicle-associated piecemeal degranulation, requires multiple Q-and R-SNAREs. It is not clear how these SNAREs pair to form functional trans-SNARE complexes and how these trans-SNARE complexes are selectively regulated for fusion. Here we undertake a comprehensive examination of the capacity of two Q-SNARE subcomplexes (syntaxin3/SNAP-23 and syntaxin4/SNAP-23) to form fusogenic trans-SNARE complexes with each of the four granule-borne R-SNAREs (VAMP2, 3, 7, 8). We report the identification of at least six distinct trans-SNARE complexes under enhanced tethering conditions: i) VAMP2/syntaxin3/SNAP-23, ii) VAMP2/syntaxin4/SNAP-23, iii) VAMP3/syntaxin3/SNAP-23, iv) VAMP3/syntaxin4/SNAP23, v) VAMP8/syntaxin3/SNAP-23, and vi) VAMP8/syntaxin4/SNAP-23. We show for the first time that Munc18a operates synergistically with SNAP-23-based non-neuronal SNARE complexes (i to iv) in lipid mixing, in contrast to Munc18b and c, which exhibit no positive effect on any SNARE combination tested. Pre-incubation with Munc18a renders the SNARE-dependent fusion reactions insensitive to the otherwise inhibitory R-SNARE cytoplasmic domains, suggesting a protective role of Munc18a for its cognate SNAREs. Our findings substantiate the recently discovered but unexpected requirement for Munc18a in mast cell exocytosis, and implicate post-translational modifications in Munc18b/c activation.	[Xu, Hao; Arnold, Matthew Grant; Kumar, Sushmitha Vijay] Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Xu, H (corresponding author), Univ So Mississippi, Dept Biol Sci, Hattiesburg, MS 39406 USA.	hao.xu@usm.edu	Kumar, Sushmitha Vijaya/AAU-4235-2021; XU, HAO/B-3194-2011	XU, HAO/0000-0002-5776-0276	University of Southern Mississippi Development Grant [DE01475]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	University of Southern Mississippi Development Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HX received The University of Southern Mississippi (http://www.usm.edu/) Development Grant DE01475 for the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2002, P NATL ACAD SCI USA, V99, P13867, DOI 10.1073/pnas.202335999; Bin NR, 2013, P NATL ACAD SCI USA, V110, P4610, DOI 10.1073/pnas.1214887110; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Brochetta C, 2014, J IMMUNOL, V192, P41, DOI 10.4049/jimmunol.1301277; Burgo A, 2013, J BIOL CHEM, V288, P11960, DOI 10.1074/jbc.M112.415075; CHAKRAVARTY N, 1990, EXP CELL RES, V186, P245, DOI 10.1016/0014-4827(90)90302-Q; Crivellato E, 2010, ANAT REC, V293, P1115, DOI 10.1002/ar.21146; Dennison SM, 2006, BIOPHYS J, V90, P1661, DOI 10.1529/biophysj.105.069617; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Frank SPC, 2011, MOL IMMUNOL, V49, P353, DOI 10.1016/j.molimm.2011.09.011; Furukawa N, 2014, SCI REP-UK, V4, DOI 10.1038/srep04277; Genc O, 2014, ELIFE, V3, DOI 10.7554/eLife.01715; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hibi T, 2000, BIOCHEM BIOPH RES CO, V271, P36, DOI 10.1006/bbrc.2000.2591; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hu SH, 2007, P NATL ACAD SCI USA, V104, P8773, DOI 10.1073/pnas.0701124104; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kanda H, 2005, J CLIN INVEST, V115, P291, DOI 10.1172/JCI200522681; Kioumourtzoglou D, 2014, MOL CELL BIOL, V34, P1271, DOI 10.1128/MCB.01203-13; KOOPMANN WR, 1990, BIOCHEM J, V265, P365, DOI 10.1042/bj2650365; Lippert U, 2007, FEBS LETT, V581, P3479, DOI 10.1016/j.febslet.2007.06.057; Liu Y, 2007, FEBS LETT, V581, P4318, DOI 10.1016/j.febslet.2007.07.083; Liu YT, 2002, MOL BIOL CELL, V13, P3314, DOI 10.1091/mbc.E02-04-0204; Lorentz A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00143; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Munson Mary, 2009, Biochem J, V418, pe1, DOI 10.1042/BJ20082389; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Peng RW, 2010, BIOCHEM J, V431, P353, DOI 10.1042/BJ20100145; Pernas-Sueiras O, 2006, J CELL BIOCHEM, V99, P1651, DOI 10.1002/jcb.21009; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Pombo I, 2003, FEBS LETT, V550, P144, DOI 10.1016/S0014-5793(03)00864-0; Puri N, 2003, J IMMUNOL, V171, P5345, DOI 10.4049/jimmunol.171.10.5345; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Sakiyama H, 2009, INFLAMM RES, V58, P139, DOI 10.1007/s00011-008-7173-z; Sander LE, 2008, EUR J IMMUNOL, V38, P855, DOI 10.1002/eji.200737634; Schraw TD, 2003, BIOCHEM J, V374, P207, DOI 10.1042/BJ20030610; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suzuki K, 2008, CELL, V134, P485, DOI 10.1016/j.cell.2008.05.050; Tadokoro S, 2007, MOL IMMUNOL, V44, P3427, DOI 10.1016/j.molimm.2007.02.013; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; THEOHARIDES TC, 1985, BIOCHEM PHARMACOL, V34, P1389, DOI 10.1016/0006-2952(85)90675-6; Thorngren N, 2004, EMBO J, V23, P2765, DOI 10.1038/sj.emboj.7600286; Thurmond DC, 2000, MOL CELL BIOL, V20, P379, DOI 10.1128/MCB.20.1.379-388.2000; Tiwari N, 2009, Inflamm Res, V58 Suppl 1, P13, DOI 10.1007/s00011-009-0645-y; Tiwari N, 2008, BLOOD, V111, P3665, DOI 10.1182/blood-2007-07-103309; Wang L, 2000, J BIOL CHEM, V275, P22862, DOI 10.1074/jbc.M001447200; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Woodman PG, 1997, BBA-MOL CELL RES, V1357, P155, DOI 10.1016/S0167-4889(97)00039-6; Woska JR, 2011, SCAND J IMMUNOL, V73, P8, DOI 10.1111/j.1365-3083.2010.02471.x; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yang Y, 2013, BIOCHEM J, V450, P537, DOI 10.1042/BJ20121256; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200	63	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2015	10	9							e0138683	10.1371/journal.pone.0138683	http://dx.doi.org/10.1371/journal.pone.0138683			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CS0ZE	25836258	Green Submitted, Green Published, gold			2022-12-26	WOS:000361790200147
J	Suwa, Y; Gu, JY; Baranovskiy, AG; Babayeva, ND; Pavlov, YI; Tahirov, TH				Suwa, Yoshiaki; Gu, Jianyou; Baranovskiy, Andrey G.; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.			Crystal Structure of the Human Pol alpha B Subunit in Complex with the C-terminal Domain of the Catalytic Subunit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; CYCLE-DEPENDENT PHOSPHORYLATION; ACCESSORY SUBUNITS; ZINC-FINGER; PRIMASE; REPLICATION; DELTA; ZETA; EPSILON; HELICASE	In eukaryoticDNAreplication, shortRNA-DNAhybrid primers synthesized by primase-DNA polymerase alpha (Prim-Pol alpha) are needed to start DNA replication by the replicative DNA poly-merases, Pol delta and Pol epsilon. The C terminus of the Pol alpha catalytic subunit (p180(C)) in complex with the B subunit (p70) regulates the RNA priming and DNA polymerizing activities of Prim-Pol alpha. It tethers Pol alpha and primase, facilitating RNA primer handover from primase to Pol alpha. To understand these regulatory mechanisms and to reveal the details of human Pol alpha organization, we determined the crystal structure of p70 in complex with p180(C). The structured portion of p70 includes a phosphodiesterase (PDE) domain and an oligonucleotide/oligosaccharide binding (OB) domain. The N-terminal domain and the linker connecting it to the PDE domain are disordered in the reported crystal structure. The p180(C) adopts an elongated asymmetric saddle shape, with a three-helix bundle in the middle and zinc-binding modules (Zn1 and Zn2) on each side. The extensive p180(C)-p70 interactions involve 20 hydrogen bonds and a number of hydrophobic interactions resulting in an extended buried surface of 4080 angstrom(2). Importantly, in the structure of the p180(C)-p70 complex with full-length p70, the residues from the N-terminal to the OB domain contribute to interactions with p180(C). The comparative structural analysis revealed both the conserved features and the differences between the human and yeast Pol alpha complexes.	[Suwa, Yoshiaki; Gu, Jianyou; Baranovskiy, Andrey G.; Babayeva, Nigar D.; Pavlov, Youri I.; Tahirov, Tahir H.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA; [Pavlov, Youri I.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Tahirov, TH (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA.	ttahirov@unmc.edu	Regan, Clinton/E-6250-2012; Pavlov, Youri/T-7532-2017	Pavlov, Youri/0000-0003-1179-5796; Tahirov, Tahir/0000-0002-1238-0069	National Institutes of Health [R01 GM101167, P41 GM103403]; National Cancer Institute Cancer Center [P30 CA036727]; U.S. Department of Energy [DE-AC0206CH11357]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101167, P41GM103403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM101167 (to T. H. T.) and P41 GM103403 and National Cancer Institute Cancer Center Support Grant P30 CA036727. This work was also supported in part by U.S. Department of Energy under Contract DE-AC0206CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARAKI H, 1991, P NATL ACAD SCI USA, V88, P4601, DOI 10.1073/pnas.88.11.4601; Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Baranovskiy AG, 2008, CELL CYCLE, V7, P3026, DOI 10.4161/cc.7.19.6720; Baranovskiy AG, 2015, J BIOL CHEM, V290, P5635, DOI 10.1074/jbc.M114.624742; Baranovskiy AG, 2014, NUCLEIC ACIDS RES, V42, P14013, DOI 10.1093/nar/gku1209; Baranovskiy AG, 2012, J BIOL CHEM, V287, P17281, DOI 10.1074/jbc.M112.351122; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dua R, 1998, J BIOL CHEM, V273, P30046, DOI 10.1074/jbc.273.45.30046; Dua R, 1999, J BIOL CHEM, V274, P22283, DOI 10.1074/jbc.274.32.22283; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FOIANI M, 1995, MOL CELL BIOL, V15, P883; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia JS, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-82; Garcia JS, 2004, NUCLEIC ACIDS RES, V32, P3005, DOI 10.1093/nar/gkh623; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Giot L, 1997, GENETICS, V146, P1239; Grossi S, 2004, GENE DEV, V18, P992, DOI 10.1101/gad.300004; Heitzer E, 2014, CURR OPIN GENET DEV, V24, P107, DOI 10.1016/j.gde.2013.12.005; Huang H, 2010, J BIOL CHEM, V285, P33475, DOI 10.1074/jbc.M110.156240; Huang H, 2010, J BIOL CHEM, V285, P17112, DOI 10.1074/jbc.M110.116830; Johansson E, 2010, TRENDS BIOCHEM SCI, V35, P339, DOI 10.1016/j.tibs.2010.01.004; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Kilkenny ML, 2012, J BIOL CHEM, V287, P23740, DOI 10.1074/jbc.M112.368951; Kilkenny ML, 2013, P NATL ACAD SCI USA, V110, P15961, DOI 10.1073/pnas.1311185110; Klinge S, 2009, EMBO J, V28, P1978, DOI 10.1038/emboj.2009.150; Kunkel TA, 2014, NAT STRUCT MOL BIOL, V21, P649, DOI 10.1038/nsmb.2852; Langston LD, 2014, P NATL ACAD SCI USA, V111, P15390, DOI 10.1073/pnas.1418334111; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lee YS, 2014, P NATL ACAD SCI USA, V111, P2954, DOI 10.1073/pnas.1324001111; Loeb LA, 2008, NAT REV GENET, V9, P594, DOI 10.1038/nrg2345; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; NASHEUER HP, 1991, J BIOL CHEM, V266, P7893; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Northam MR, 2014, NUCLEIC ACIDS RES, V42, P290, DOI 10.1093/nar/gkt830; Northam MR, 2010, GENETICS, V184, P27, DOI 10.1534/genetics.109.107482; Nuutinen T, 2008, NUCLEIC ACIDS RES, V36, P5102, DOI 10.1093/nar/gkn497; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Pavlov YI, 2010, MUTAT RES-FUND MOL M, V685, P45, DOI 10.1016/j.mrfmmm.2009.08.002; Pellegrini Luca, 2012, Subcell Biochem, V62, P157, DOI 10.1007/978-94-007-4572-8_9; Preston BD, 2010, SEMIN CANCER BIOL, V20, P281, DOI 10.1016/j.semcancer.2010.10.009; Reijns MAM, 2015, NATURE, V518, P502, DOI 10.1038/nature14183; Sengupta S, 2013, CURR BIOL, V23, P543, DOI 10.1016/j.cub.2013.02.011; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Tahirov TH, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-11; Uchiyama M, 2004, MOL CELL BIOL, V24, P7419, DOI 10.1128/MCB.24.17.7419-7434.2004; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Weeks SD, 2007, PROTEIN EXPRES PURIF, V53, P40, DOI 10.1016/j.pep.2006.12.006; Zhang YB, 2014, J BIOL CHEM, V289, P22021, DOI 10.1074/jbc.M114.570333; Zhou B, 2012, J BIOL CHEM, V287, P26854, DOI 10.1074/jbc.M112.363655; Zhou JQ, 1997, NUCLEIC ACIDS RES, V25, P1094, DOI 10.1093/nar/25.6.1094	57	26	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2015	290	23					14328	14337		10.1074/jbc.M115.649954	http://dx.doi.org/10.1074/jbc.M115.649954			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ8MC	25847248	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000355754600006
J	Trakhtenberg, EF; Morkin, MI; Patel, KH; Fernandez, SG; Sang, A; Shaw, P; Liu, XF; Wang, Y; Mlacker, GM; Gao, H; Velmeshev, D; Dombrowski, SM; Vitek, MP; Goldberg, JL				Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Sang, Alan; Shaw, Peter; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Gao, Han; Velmeshev, Dmitry; Dombrowski, Susan M.; Vitek, Michael P.; Goldberg, Jeffrey L.			The N-terminal Set-beta Protein Isoform Induces Neuronal Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING FACTOR-I; PHOSPHATASE 2A; MYELOID LEUKEMOGENESIS; PUTATIVE ONCOGENE; ALZHEIMER-DISEASE; AXON GROWTH; CELL-DEATH; INHIBITOR; LOCALIZATION; ONCOPROTEIN	Set-beta protein plays different roles in neurons, but the diversity of Set-beta neuronal isoforms and their functions have not been characterized. The expression and subcellular localization of Set-beta are altered in Alzheimer disease, cleavage of Set-beta leads to neuronal death after stroke, and the full-length Set-beta regulates retinal ganglion cell (RGC) and hippocampal neuron axon growth and regeneration in a subcellular localization-dependent manner. Here we used various biochemical approaches to investigate Set-beta isoforms and their role in the CNS, using the same type of neurons, RGCs, across studies. We found multiple alternatively spliced isoforms expressed from the Set locus in purified RGCs. Set transcripts containing the Set-beta-specific exon were the most highly expressed isoforms. We also identified a novel, alternatively spliced Set-beta transcript lacking the nuclear localization signal and demonstrated that the full-length (similar to 39-kDa) Set-beta is localized predominantly in the nucleus, whereas a shorter (similar to 25-kDa) Set-beta isoform is localized predominantly in the cytoplasm. Finally, we show that an N-terminal Set-beta cleavage product can induce neuronal death.	[Trakhtenberg, Ephraim F.; Gao, Han; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Trakhtenberg, Ephraim F.; Morkin, Melina I.; Patel, Karan H.; Fernandez, Stephanie G.; Liu, Xiongfei; Wang, Yan; Mlacker, Gregory M.; Goldberg, Jeffrey L.] Univ Miami, Miller Sch Med, Interdisciplinary Stem Cell Inst, Miami, FL 33136 USA; [Velmeshev, Dmitry] Univ Miami, Miller Sch Med, Mol & Cellular Pharmacol Program, Miami, FL 33136 USA; [Dombrowski, Susan M.] Genomatix Software, Ann Arbor, MI 48108 USA; [Dombrowski, Susan M.] Wayne State Univ, Dept Obstet & Gynecol, Sch Med, Detroit, MI 48201 USA; [Morkin, Melina I.; Sang, Alan; Shaw, Peter; Wang, Yan; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Vitek, Michael P.] Oncotide Pharmaceut Inc, Durham, NC 27709 USA; [Vitek, Michael P.] Duke Univ, Dept Neurol, Med Ctr, Durham, NC 27708 USA	University of Miami; Bascom Palmer Eye Institute; University of Miami; University of Miami; University of Miami; Wayne State University; University of California System; University of California San Diego; Duke University	Trakhtenberg, EF (corresponding author), Univ Miami, Miller Sch Med, Neurosci Program, Miami, FL 33136 USA.	Ephraim.Trakhtenberg@childrens.harvard.edu; JLGoldberg@ucsd.edu		Gao, Han/0000-0002-6021-2764; Vitek, Michael/0000-0001-8140-8048; Velmeshev, Dmitry/0000-0002-6491-7307; Goldberg, Jeffrey/0000-0002-1390-7360	NEI/National Institutes of Health [EY020913, P30-EY022589, P30 EY014801]; NINDS/National Institutes of Health [T32NS007492]; American Heart Association [11PRE7310069]; Walter G. Ross Distinguished Chair in Ophthalmic Research; Research to Prevent Blindness, Inc.; Lois Pope LIFE fellowship; summer research scholarship; CAS Summer Research Program for Underrepresented Minorities and Women; NATIONAL EYE INSTITUTE [P30EY014801, R01EY020913, P30EY022589] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007492] Funding Source: NIH RePORTER	NEI/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); Walter G. Ross Distinguished Chair in Ophthalmic Research; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Lois Pope LIFE fellowship; summer research scholarship; CAS Summer Research Program for Underrepresented Minorities and Women; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by NEI/National Institutes of Health Grants EY020913 (to J. L. G.), P30-EY022589 (to the Shiley Eye Center, University of California San Diego), and P30 EY014801 (to the University of Miami) and NINDS/National Institutes of Health Grant T32NS007492 (to E. F. T.). This work was also supported by American Heart Association Grant 11PRE7310069 (to E. F. T.), by the Walter G. Ross Distinguished Chair in Ophthalmic Research (to J. L. G.), by an unrestricted grant from Research to Prevent Blindness, Inc., by the Lois Pope LIFE fellowship and research awards (to E. F. T.), and by a summer research scholarship and the CAS Summer Research Program for Underrepresented Minorities and Women (to S. G. F.). M. P. V. is an employee and stockholder in Oncotide Pharmaceuticals, Inc. and an employee of Duke University Medical Center.	ADACHI Y, 1994, J BIOL CHEM, V269, P2258; Beresford PJ, 2001, J BIOL CHEM, V276, P43285, DOI 10.1074/jbc.M108137200; Briand S, 2011, NEUROBIOL AGING, V32, P1099, DOI 10.1016/j.neurobiolaging.2009.05.021; Carmona-Mora P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045155; Cervoni N, 2002, J BIOL CHEM, V277, P25026, DOI 10.1074/jbc.M202256200; Chohan MO, 2006, FEBS LETT, V580, P3973, DOI 10.1016/j.febslet.2006.06.021; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Christensen DJ, 2011, J IMMUNOL, V186, P2535, DOI 10.4049/jimmunol.1002847; Corredor RG, 2012, J NEUROSCI, V32, P7734, DOI 10.1523/JNEUROSCI.5288-11.2012; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Fan ZS, 2003, CELL, V112, P659, DOI 10.1016/S0092-8674(03)00150-8; Gamble MJ, 2007, NAT STRUCT MOL BIOL, V14, P548, DOI 10.1038/nsmb1248; Lam BD, 2013, FEBS LETT, V587, P111, DOI 10.1016/j.febslet.2012.11.013; Le Guelte A, 2012, J CELL SCI, V125, P4137, DOI 10.1242/jcs.108282; LI M, 1995, BIOCHEMISTRY-US, V34, P1988, DOI 10.1021/bi00006a020; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Liu ZX, 2008, MOL CELL, V29, P665, DOI 10.1016/j.molcel.2008.02.017; Merrick SE, 1997, J NEUROSCI, V17, P5726; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Nagata K, 1998, EXP CELL RES, V240, P274, DOI 10.1006/excr.1997.3930; NAGATA K, 1995, P NATL ACAD SCI USA, V92, P4279, DOI 10.1073/pnas.92.10.4279; Nunbhakdi-Craig V, 2007, J NEUROCHEM, V101, P959, DOI 10.1111/j.1471-4159.2007.04503.x; Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Saito S, 1999, BIOCHEM BIOPH RES CO, V259, P471, DOI 10.1006/bbrc.1999.0790; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sontag E, 2007, J NEUROSCI, V27, P2751, DOI 10.1523/JNEUROSCI.3316-06.2007; Switzer CH, 2011, ONCOGENE, V30, P2504, DOI 10.1038/onc.2010.622; Tanimukai H, 2005, AM J PATHOL, V166, P1761, DOI 10.1016/S0002-9440(10)62486-8; ten Klooster JP, 2007, EMBO J, V26, P336, DOI 10.1038/sj.emboj.7601518; Trakhtenberg EF, 2014, J NEUROSCI, V34, P7361, DOI 10.1523/JNEUROSCI.3658-13.2014; VAESEN M, 1994, BIOL CHEM H-S, V375, P113, DOI 10.1515/bchm3.1994.375.2.113; Vasudevan NT, 2011, MOL CELL, V41, P636, DOI 10.1016/j.molcel.2011.02.025; VONLINDERN M, 1992, MOL CELL BIOL, V12, P3346, DOI 10.1128/MCB.12.8.3346; Wang XC, 2010, FASEB J, V24, P4420, DOI 10.1096/fj.10-158477; Yu G, 2013, NEUROBIOL AGING, V34, P1748, DOI 10.1016/j.neurobiolaging.2012.12.025	36	8	8	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13417	13426		10.1074/jbc.M114.633883	http://dx.doi.org/10.1074/jbc.M114.633883			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25833944	hybrid, Green Published			2022-12-26	WOS:000354975700037
J	Ji, YR; Kim, HJ; Bae, KB; Lee, S; Kim, MO; Ryoo, ZY				Ji, Young Rae; Kim, Hei Jung; Bae, Ki Beom; Lee, Sanggyu; Kim, Myoung Ok; Ryoo, Zae Young			Hepatic Serum Amyloid A1 Aggravates T Cell-mediated Hepatitis by Inducing Chemokines via Toll-like Receptor 2 in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-REACTIVE PROTEIN; CONCANAVALIN-A; LIVER-DISEASE; VIRUS-INFECTION; TH17 CELLS; EXPRESSION; INFLAMMATION; ACTIVATION; INDUCTION; MIGRATION	Serum amyloid A is a proinflammatory molecule that induces leukocyte infiltration and promotes neutrophil adhesion to endothelial cells under inflammatory conditions. The aim of this study was to examine whether Saa1 aggravates T cell-mediated hepatitis by inducing chemokines in a liver-specific, Saa1-overexpressing, transgenic (TG) mouse model. We generated TG mice in which Saa1 was overexpressed specifically in liver tissue. The chemokines monocyte chemotactic protein 1 (MCP1), MIP1 alpha, MIP1 beta, interferon gamma-induced protein 10 (IP-10), and eotaxin were induced in Saa1 TG mice. After concanavalin A treatment, Saa1 expression was higher in Saa1 TG mice than in WT mice. More severe liver injury, increased hepatocyte apoptosis, and higher levels of hepatic enzymes were observed in Saa1 TG mice than in WT mice. Liver infiltration of CD4(+) T cells and macrophages increased after inducing hepatitis. Activation of T cells was higher in Saa1 TG mice than in WT mice, and the populations of Th17 cells and regulatory T cells were altered by overexpressing Saa1 in TG mice. Secretion of various cytokines, such as interferon gamma, tumor necrosis factor alpha, and interleukin 6, increased in Saa1 TG mice. Injecting a Toll-like receptor 2 (TLR2) antagonist in vivo inhibited chemokine expression and I kappa B alpha phosphorylation and showed that the induction of chemokines by Saa1 was dependent on TLR2. Hepatic Saa1 accelerated T cell-mediated hepatitis by inducing chemokine production and activating T cells by TLR2. Therefore, Saa1 might be a novel inflammatory factor that acts as a chemokine modulator in hepatitis.	[Ji, Young Rae; Kim, Hei Jung; Bae, Ki Beom; Lee, Sanggyu; Ryoo, Zae Young] Kyungpook Natl Univ, Sch Life Sci, KNU Creat BioRes Grp, Plus Project BK21, Taegu 702701, South Korea; [Kim, Myoung Ok] Kyungpook Natl Univ, Dept Anim Sci, Sangju 742711, South Korea	Kyungpook National University; Kyungpook National University	Ryoo, ZY (corresponding author), Kyungpook Natl Univ, Sch Life Sci & Biotechnol, 1370 Sankyuk Dong, Taegu, South Korea.	jaewoong64@hanmail.net	Ji, Youngrae/AAK-9711-2021; Ji, Youngrae/AAK-9724-2021; RYOO, ZAEYOUNG/AAQ-1573-2020	Ji, Youngrae/0000-0002-8825-9783; 	Next Generation BioGreen21 Program [PJ 009573]; National Research Foundation of Korea - Korean government (MSIP) [2008-0062618]	Next Generation BioGreen21 Program(Rural Development Administration (RDA), Republic of Korea); National Research Foundation of Korea - Korean government (MSIP)	This research was supported by Next Generation BioGreen21 Program Grant PJ 009573 and National Research Foundation of Korea grant 2008-0062618 funded by the Korean government (MSIP).	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; BADOLATO R, 1994, J EXP MED, V180, P203, DOI 10.1084/jem.180.1.203; Baranova IN, 2005, J BIOL CHEM, V280, P8031, DOI 10.1074/jbc.M405009200; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Cai ZH, 2007, J VIROL, V81, P6128, DOI 10.1128/JVI.02627-06; Cheng K, 2012, ANGEW CHEM INT EDIT, V51, P12246, DOI 10.1002/anie.201204910; Cheng N, 2008, J IMMUNOL, V181, P22, DOI 10.4049/jimmunol.181.1.22; EGGINK HF, 1982, CLIN EXP IMMUNOL, V50, P17; Erhardt A, 2011, J IMMUNOL, V186, P5284, DOI 10.4049/jimmunol.1003750; Furlaneto CJ, 2000, BIOCHEM BIOPH RES CO, V268, P405, DOI 10.1006/bbrc.2000.2143; GANAPATHI MK, 1991, J IMMUNOL, V147, P1261; Hanidziar D, 2010, CURR OPIN ORGAN TRAN, V15, P411, DOI 10.1097/MOT.0b013e32833b7929; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; He R, 2003, BLOOD, V101, P1572, DOI 10.1182/blood-2002-05-1431; Hogan B, 1994, MANIPULATING MOUSE E; Ito A, 1999, J IMMUNOL, V162, P4260; Kanellopoulos PN, 1996, J STRUCT BIOL, V116, P345, DOI 10.1006/jsbi.1996.0052; Kim SR, 2014, HEPATOL RES, V44, P584, DOI 10.1111/hepr.12145; Knolle PA, 1996, HEPATOLOGY, V24, P824, DOI 10.1002/hep.510240413; Lannergard A, 2003, SCAND J CLIN LAB INV, V63, P267, DOI 10.1080/00365510310001636; Lavie M, 2006, HEPATOLOGY, V44, P1626, DOI 10.1002/hep.21406; Lee HY, 2005, BIOCHEM BIOPH RES CO, V330, P989, DOI 10.1016/j.bbrc.2005.03.069; Leow KY, 2012, INFLAMM RES, V61, P391, DOI 10.1007/s00011-011-0424-4; Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; Ray A, 1999, J BIOL CHEM, V274, P4300, DOI 10.1074/jbc.274.7.4300; Saha A, 2011, NEPHROL DIAL TRANSPL, V26, P2407, DOI 10.1093/ndt/gfr224; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Sandri S, 2008, J LEUKOCYTE BIOL, V83, P1174, DOI 10.1189/jlb.0407203; Shim JW, 2009, EXP MOL MED, V41, P584, DOI 10.3858/emm.2009.41.8.064; Simpson KJ, 2003, CLIN SCI, V104, P47, DOI 10.1042/CS20020137; Su ZJ, 2013, DIAGN MICR INFEC DIS, V76, P437, DOI 10.1016/j.diagmicrobio.2013.04.026; Tilg H, 2006, LIVER INT, V26, P1029, DOI 10.1111/j.1478-3231.2006.01339.x; Tsui TY, 2007, SHOCK, V27, P165, DOI 10.1097/01.shk.0000239781.71516.61; Weber SN, 2010, BEST PRACT RES CL GA, V24, P635, DOI 10.1016/j.bpg.2010.07.013; XU LL, 1995, J IMMUNOL, V155, P1184; Zeremski M, 2008, HEPATOLOGY, V48, P1440, DOI 10.1002/hep.22500; Zeremski M, 2011, J HEPATOL, V55, P545, DOI 10.1016/j.jhep.2010.12.033; Zhou ML, 2014, INT IMMUNOPHARMACOL, V21, P241, DOI 10.1016/j.intimp.2014.04.027	41	30	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12804	12811		10.1074/jbc.M114.635763	http://dx.doi.org/10.1074/jbc.M114.635763			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25847238	hybrid, Green Published			2022-12-26	WOS:000354569000031
J	Scialpi, F; Mellis, D; Ditzel, M				Scialpi, Flavia; Mellis, David; Ditzel, Mark			EDD, a Ubiquitin-protein Ligase of the N-end Rule Pathway, Associates with Spindle Assembly Checkpoint Components and Regulates the Mitotic Response to Nocodazole	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; DROSOPHILA-MELANOGASTER; E3 LIGASE; CENP-E; CELLS; BUBR1; KINETOCHORES; EXPRESSION; MITOSIS; KINASE	In this work, we identify physical and genetic interactions that implicate E3 identified by differential display (EDD) in promoting spindle assembly checkpoint (SAC) function. During mitosis, the SAC initiates a mitotic checkpoint in response to chromosomes with kinetochores unattached to spindle pole microtubules. Similar to Budding uninhibited by benzimidazoles-related 1 (BUBR1) siRNA, a bona fide SAC component, EDD siRNA abrogated G(2)/M accumulation in response to the mitotic destabilizing agent nocodazole. Furthermore, EDD siRNA reduced mitotic cell viability and, in nocodazole-treated cells, increased expression of the promitotic progression protein cell division cycle 20 (CDC20). Copurification studies also identified physical interactions with CDC20, BUBR1, and other components of the SAC. Taken together, these observations highlight the potential role of EDD in regulating mitotic progression and the cellular response to perturbed mitosis.	[Scialpi, Flavia; Mellis, David; Ditzel, Mark] Western Gen Hosp, MRC Inst Genet & Mol Med, Edinburgh EH4 2XR, Midlothian, Scotland	University of Edinburgh	Ditzel, M (corresponding author), Western Gen Hosp, Edinburgh CRUK Canc Res Ctr, MRC Inst Genet & Mol Med, Crewe Rd S, Edinburgh EH4 2XR, Midlothian, Scotland.	mark.ditzel@ed.ac.uk			Biotechnology and Biological Sciences Research Council New Investigator Award [BB/H012869/1]; Cancer Research UK; BBSRC [BB/H012869/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H012869/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by Biotechnology and Biological Sciences Research Council New Investigator Award (BB/H012869/1 (to M. D. and F. S.) and by Cancer Research UK.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Choi E, 2009, EMBO J, V28, P2077, DOI 10.1038/emboj.2009.123; DEBRABANDER M, 1977, CELL BIOL INT REP, V1, P177, DOI 10.1016/0309-1651(77)90038-8; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Fuja TJ, 2004, CANCER RES, V64, P942, DOI 10.1158/0008-5472.CAN-03-2100; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Hay-Koren A, 2011, MOL BIOL CELL, V22, P399, DOI 10.1091/mbc.E10-05-0440; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Hayashi MT, 2012, NAT STRUCT MOL BIOL, V19, P387, DOI 10.1038/nsmb.2245; Henderson MJ, 2006, J BIOL CHEM, V281, P39990, DOI 10.1074/jbc.M602818200; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hu GQ, 2010, J BIOL CHEM, V285, P11800, DOI 10.1074/jbc.M109.079384; Huang HM, 2007, J CELL BIOL, V177, P413, DOI 10.1083/jcb.200701122; Huang Xuan, 2006, Methods Mol Biol, V314, P73; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kim EM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000015; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lee JD, 2002, DEVELOPMENT, V129, P5697, DOI 10.1242/dev.00159; Ling SY, 2011, J BIOL CHEM, V286, P14972, DOI 10.1074/jbc.M110.182527; Ma HT, 2011, METHODS MOL BIOL, V761, P151, DOI 10.1007/978-1-61779-182-6_10; MacPhail SH, 2003, RADIAT RES, V159, P759, DOI 10.1667/RR3003; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; MANSFIELD E, 1994, DEV BIOL, V165, P507, DOI 10.1006/dbio.1994.1271; MARTIN P, 1977, DEV BIOL, V55, P213, DOI 10.1016/0012-1606(77)90168-3; Meissner B, 2013, BLOOD, V121, P3161, DOI 10.1182/blood-2013-01-478834; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Munoz MA, 2007, CELL CYCLE, V6, P3070, DOI 10.4161/cc.6.24.5021; Musacchio A, 2011, PHILOS T R SOC B, V366, P3595, DOI 10.1098/rstb.2011.0072; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Okamoto K, 2013, NATURE, V494, P502, DOI 10.1038/nature11873; Patra D, 1998, GENE DEV, V12, P2549, DOI 10.1101/gad.12.16.2549; Saunders DN, 2004, MOL CELL BIOL, V24, P7225, DOI 10.1128/MCB.24.16.7225-7234.2004; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Smits VAJ, 2012, CELL CYCLE, V11, P715, DOI 10.4161/cc.11.4.19154; Sriram SM, 2011, NAT REV MOL CELL BIO, V12, P735, DOI 10.1038/nrm3217; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Zhang TY, 2014, P NATL ACAD SCI USA, V111, P12091, DOI 10.1073/pnas.1400230111	46	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2015	290	20					12585	12594		10.1074/jbc.M114.625673	http://dx.doi.org/10.1074/jbc.M114.625673			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI2IF	25833949	Green Published, hybrid			2022-12-26	WOS:000354569000014
J	Fortuny, J; Marce-Nogue, J; Heiss, E; Sanchez, M; Gil, L; Galobart, A				Fortuny, Josep; Marce-Nogue, Jordi; Heiss, Egon; Sanchez, Montserrat; Gil, Lluis; Galobart, Angel			3D Bite Modeling and Feeding Mechanics of the Largest Living Amphibian, the Chinese Giant Salamander Andrias davidianus (Amphibia:Urodela)	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; PREY-CAPTURE; IN-VIVO; PERFORMANCE; MORPHOLOGY; SKULL; EVOLUTION; BEHAVIOR; RECONSTRUCTION; BIOMECHANICS	Biting is an integral feature of the feeding mechanism for aquatic and terrestrial salamanders to capture, fix or immobilize elusive or struggling prey. However, little information is available on how it works and the functional implications of this biting system in amphibians although such approaches might be essential to understand feeding systems performed by early tetrapods. Herein, the skull biomechanics of the Chinese giant salamander, Andrias davidianus is investigated using 3D finite element analysis. The results reveal that the prey contact position is crucial for the structural performance of the skull, which is probably related to the lack of a bony bridge between the posterior end of the maxilla and the anterior quadrato-squamosal region. Giant salamanders perform asymmetrical strikes. These strikes are unusual and specialized behavior but might indeed be beneficial in such sit-and-wait or ambush-predators to capture laterally approaching prey. However, once captured by an asymmetrical strike, large, elusive and struggling prey have to be brought to the anterior jaw region to be subdued by a strong bite. Given their basal position within extant salamanders and their "conservative" morphology, cryptobranchids may be useful models to reconstruct the feeding ecology and biomechanics of different members of early tetrapods and amphibians, with similar osteological and myological constraints.	[Fortuny, Josep; Marce-Nogue, Jordi; Galobart, Angel] Inst Catala Paleontol Miquel Crusafont, Sabadell, Spain; [Fortuny, Josep; Marce-Nogue, Jordi; Sanchez, Montserrat; Gil, Lluis] Univ Politecn Cataluna, BarcelonaTech, Terrassa, Spain; [Heiss, Egon] Univ Vienna, Dept Integrat Zool, Vienna, Austria; [Heiss, Egon] Univ Jena, Inst Systemat Zool & Evolutionary Biol, Jena, Germany	Institut Catala de Paleontologia Miquel Crusafont (ICP); Universitat Politecnica de Catalunya; University of Vienna; Friedrich Schiller University of Jena	Fortuny, J (corresponding author), Inst Catala Paleontol Miquel Crusafont, Sabadell, Spain.	Josep.Fortuny@icp.cat	Galobart, Àngel À/H-5024-2011; Fortuny, Josep/L-2523-2014; Marcé-Nogué, Jordi/B-3933-2012; Gil, Lluís/K-9157-2013	Galobart, Àngel À/0000-0003-1508-4561; Fortuny, Josep/0000-0003-4282-1619; Marcé-Nogué, Jordi/0000-0001-9852-7027; Gil, Lluís/0000-0002-2007-4846; Heiss, Egon/0000-0002-5257-8889	Spanish Ministry of Economy and Competitiveness [CGL 2011-30069-C02-01]; Austrian Science Fund FWF [J3186-B17]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Austrian Science Fund FWF(Austrian Science Fund (FWF))	This work was supported by the Spanish Ministry of Economy and Competitiveness (Project number: CGL 2011-30069-C02-01. 2012-2014) and the Austrian Science Fund FWF (Project number: J3186-B17). Both funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R., 1992, EXPLORING BIOMECHANI; Anderson JS, 2008, NATURE, V453, P515, DOI 10.1038/nature06865; Anderson PSL, 2012, BIOL LETTERS, V8, P119, DOI 10.1098/rsbl.2011.0674; Anderson RA, 2008, BIOL J LINN SOC, V93, P709, DOI 10.1111/j.1095-8312.2007.00905.x; Attard MRG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093088; Bright JA, 2014, J PALEONTOL, V88, P760, DOI 10.1666/13-090; CARROLL RL, 1980, ZOOL J LINN SOC-LOND, V68, P1, DOI 10.1111/j.1096-3642.1980.tb01916.x; Carroll RL, 2009, THE RISE OF AMPHIBIA; CUNDALL D, 1987, EXPERIENTIA, V43, P1229, DOI 10.1007/BF01945537; CURREY JD, 1987, J BIOMECH, V20, P1035, DOI 10.1016/0021-9290(87)90021-2; Curtis N, 2010, J BIOMECH, V43, P2804, DOI 10.1016/j.jbiomech.2010.05.037; Deban SM, 2003, EXPTL BIOL REV, P161; Deban Stephen M., 2000, P65, DOI 10.1016/B978-012632590-4/50004-6; Doblare M, 2004, ENG FRACT MECH, V71, P1809, DOI 10.1016/j.engfracmech.2003.08.003; Duellman WE, 1994, BIOLOGY OF AMPHIBIAN; Dumont ER, 2009, J THEOR BIOL, V256, P96, DOI 10.1016/j.jtbi.2008.08.017; Eaton TH, 1936, J MORPHOL, V37, P31, DOI 10.1002/jmor.1050600104; ELWOOD JRL, 1994, J MORPHOL, V220, P47, DOI 10.1002/jmor.1052200106; Erickson GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031781; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Fortuny J, 2012, ANAT REC, V295, P1134, DOI 10.1002/ar.22486; Gao KQ, 2003, NATURE, V422, P424, DOI 10.1038/nature01491; Heiss E, 2013, J EXP BIOL, V216, P4426, DOI 10.1242/jeb.091991; Heiss E, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1028; Herrel A, 2012, ELS, P1; Hyrtl J, 1865, CRYPTOBRANCHUS JAPON; Kathe W, 1999, ZOOL J LINN SOC-LOND, V126, P1; Kathe W, 1995, GEOBIOS-LYON, V28, P255, DOI DOI 10.1016/S0016-6995(95)80123-5; Lanyon L.E., 1985, P1; LARSEN JH, 1975, J MORPHOL, V147, P137, DOI 10.1002/jmor.1051470203; Lauder G.V., 1985, P210; LAUDER GV, 1986, ZOOL J LINN SOC-LOND, V88, P277, DOI 10.1111/j.1096-3642.1986.tb01191.x; LAUDER GV, 1985, J MORPHOL, V185, P297, DOI 10.1002/jmor.1051850304; Lintner M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046344; Marce-Nogue J, 2011, PROC 13TH INT CONF O, P237; Marce-Nogue J, SPANISH JOURNAL OF P; Marce-Nogue J, 2013, PALAEONTOL ELECTRON, V16; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; Mase GE, 1999, CONTINUUM MECHANICS; Meers, 2003, HIST BIOL, V16, P1, DOI DOI 10.1080/0891296021000050755; MILLER BT, 1990, J EXP ZOOL, V256, P135, DOI 10.1002/jez.1402560204; Pardo J, 2013, ANAT REC, V296, P243; Parr WCH, 2012, J THEOR BIOL, V301, P1, DOI 10.1016/j.jtbi.2012.01.030; Rafferty KL, 1999, J MORPHOL, V242, P167, DOI 10.1002/(SICI)1097-4687(199911)242:2<167::AID-JMOR8>3.3.CO;2-T; Rayfield EJ, 2007, ANNU REV EARTH PL SC, V35, P541, DOI 10.1146/annurev.earth.35.031306.140104; Ruta M, 2007, J SYST PALAEONTOL, V5, P69, DOI 10.1017/S1477201906002008; Schoch RR, 2014, J EXP ZOOL PART B, V322, P619, DOI [10.1002/jez.b.22599, 10.1002/.22599]; Schoch RR, 2000, ENCYCLOPEDIA OF PALE; Schumacher G. H., 1958, Anatomischer Anzeiger, V105, P361; Schumacher G. H., 1959, Anatomischer Anzeiger, V107, P266; Schwenk Kurt, 2000, P21, DOI 10.1016/B978-012632590-4/50003-4; Skutschas P, 2011, ZOOL J LINN SOC-LOND, V161, P816, DOI 10.1111/j.1096-3642.2010.00663.x; Strait DS, 2005, ANAT REC PART A, V283A, P275, DOI 10.1002/ar.a.20172; Wake David B., 2000, P95, DOI 10.1016/B978-012632590-4/50005-8; Walmsley CW, 2013, PEERJ, V1, DOI 10.7717/peerj.204; Wiens JJ, 2005, SYST BIOL, V54, P91, DOI 10.1080/10635150590906037; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; Witzmann F, 2013, J MORPHOL, V274, P525, DOI 10.1002/jmor.20113; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Zhang P, 2009, MOL PHYLOGENET EVOL, V53, P492, DOI 10.1016/j.ympev.2009.07.010	61	33	33	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121885	10.1371/journal.pone.0121885	http://dx.doi.org/10.1371/journal.pone.0121885			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853557	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400052
J	Hoyt, JR; Cheng, TL; Langwig, KE; Hee, MM; Frick, WF; Kilpatrick, AM				Hoyt, Joseph R.; Cheng, Tina L.; Langwig, Kate E.; Hee, Mallory M.; Frick, Winifred F.; Kilpatrick, A. Marm			Bacteria Isolated from Bats Inhibit the Growth of Pseudogymnoascus destructans, the Causative Agent of White-Nose Syndrome	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS; GEOMYCES-DESTRUCTANS; CUTANEOUS BACTERIA; SKIN; IDENTIFICATION; PATHOGEN; DISEASE; 2,4-DIACETYLPHLOROGLUCINOL; CHYTRIDIOMYCOSIS; PERSISTENCE	Emerging infectious diseases are a key threat to wildlife. Several fungal skin pathogens have recently emerged and caused widespread mortality in several vertebrate groups, including amphibians, bats, rattlesnakes and humans. White-nose syndrome, caused by the fungal skin pathogen Pseudogymnoascus destructans, threatens several hibernating bat species with extinction and there are few effective treatment strategies. The skin microbiome is increasingly understood to play a large role in determining disease outcome. We isolated bacteria from the skin of four bat species, and co-cultured these isolates with P. destructans to identify bacteria that might inhibit or kill P. destructans. We then conducted two reciprocal challenge experiments in vitro with six bacterial isolates (all in the genus Pseudomonas) to quantify the effect of these bacteria on the growth of P. destructans. All six Pseudomonas isolates significantly inhibited growth of P. destructans compared to non-inhibitory control bacteria, and two isolates performed significantly better than others in suppressing P. destructans growth for at least 35 days. In both challenge experiments, the extent of suppression of P. destructans growth was dependent on the initial concentration of P. destructans and the initial concentration of the bacterial isolate. These results show that bacteria found naturally occurring on bats can inhibit the growth of P. destructans in vitro and should be studied further as a possible probiotic to protect bats from white-nose syndrome. In addition, the presence of these bacteria may influence disease outcomes among individuals, populations, and species.	[Hoyt, Joseph R.; Cheng, Tina L.; Langwig, Kate E.; Hee, Mallory M.; Frick, Winifred F.; Kilpatrick, A. Marm] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Hoyt, JR (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	jrhoyt@ucsc.edu	Frick, Winifred/ABA-3519-2020	Frick, Winifred/0000-0002-9469-1839	United States Fish and Wildlife Service [F12AP01081]; National Science Foundation [DEB-1115895]; Bat Conservation International Student Scholarship	United States Fish and Wildlife Service(US Fish & Wildlife Service); National Science Foundation(National Science Foundation (NSF)); Bat Conservation International Student Scholarship	This work was supported by United States Fish and Wildlife Service (F12AP01081) to WFF; National Science Foundation (DEB-1115895) to AMK; and Bat Conservation International Student Scholarship to JRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson DR, 2002, J WILDLIFE MANAGE, V66, P912, DOI 10.2307/3803155; Bangera MG, 1999, J BACTERIOL, V181, P3155, DOI 10.1128/JB.181.10.3155-3163.1999; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Brucker RM, 2008, J CHEM ECOL, V34, P39, DOI 10.1007/s10886-007-9352-8; Clinical and Laboratory Standards Institute (CLSI), 2006, PERFORMANCE STANDARD; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Cornelison CT, 2014, MYCOPATHOLOGIA, V177, P1, DOI 10.1007/s11046-013-9716-2; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Culp CE, 2007, HERPETOLOGICA, V63, P66, DOI 10.1655/0018-0831(2007)63[66:IOTNBM]2.0.CO;2; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Diby P, 2005, ANN MICROBIOL, V55, P129; EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843; Frick WF, 2015, GLOBAL ECOL BIOGEOGR, V24, P741, DOI 10.1111/geb.12290; Gram L, 1999, APPL ENVIRON MICROB, V65, P969; Grice EA, 2008, GENOME RES, V18, P1043, DOI 10.1101/gr.075549.107; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Harris RN, 2006, ECOHEALTH, V3, P53, DOI 10.1007/s10393-005-0009-1; Harris RN, 2009, ISME J, V3, P818, DOI 10.1038/ismej.2009.27; Hoyt JR, 2015, ECOHEALTH, V12, P330, DOI 10.1007/s10393-014-0981-4; Irianto A., 2002, J FISH DIS, V25, P1, DOI DOI 10.1046/J.1365-2761.2002.00375.X; Johnson KB, 1998, ANNU REV PHYTOPATHOL, V36, P227, DOI 10.1146/annurev.phyto.36.1.227; Kilpatrick AM, 2006, BIOL CONSERV, V128, P475, DOI 10.1016/j.biocon.2005.10.014; Knight SC, 1997, ANNU REV PHYTOPATHOL, V35, P349, DOI 10.1146/annurev.phyto.35.1.349; Langwig KE, 2015, FRONT ECOL ENVIRON, V13, P195, DOI 10.1890/140241; Langwig KE, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2335; Langwig KE, 2012, ECOL LETT, V15, P1050, DOI 10.1111/j.1461-0248.2012.01829.x; Lindow SE, 1985, BIOL CONTROL PHYLLOP; Lorch JM, 2013, APPL ENVIRON MICROB, V79, P1293, DOI 10.1128/AEM.02939-12; McCallum H, 2012, PHILOS T R SOC B, V367, P2828, DOI 10.1098/rstb.2012.0224; Meteyer CU, 2011, J WILDLIFE DIS, V47, P618, DOI 10.7589/0090-3558-47.3.618; R Development Core Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Robbins A, 2011, WHITE NOSE SYNDROME, P24; Roelle J, 2006, USGS SCIENTIFIC INVE, P288; ROTH RR, 1988, ANNU REV MICROBIOL, V42, P441, DOI 10.1146/annurev.mi.42.100188.002301; Schrezenmeir J, 2001, AM J CLIN NUTR, V73, p361S, DOI 10.1093/ajcn/73.2.361s; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Storm JJ, 2011, ACTA THERIOL, V56, P123, DOI 10.1007/s13364-010-0018-5; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Verant ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046280; Warmink JA, 2011, SOIL BIOL BIOCHEM, V43, P760, DOI 10.1016/j.soilbio.2010.12.009; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; ZANOWIAK DJ, 1993, SOUTHWEST NAT, V38, P73, DOI 10.2307/3671650	48	92	93	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121329	10.1371/journal.pone.0121329	http://dx.doi.org/10.1371/journal.pone.0121329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853558	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400034
J	Li, J; Veltri, RW; Yuan, Z; Christudass, CS; Mandecki, W				Li, Ji; Veltri, Robert W.; Yuan, Zhen; Christudass, Christhunesa S.; Mandecki, Wlodek			Macrophage Inhibitory Cytokine 1 Biomarker Serum Immunoassay in Combination with PSA Is a More Specific Diagnostic Tool for Detection of Prostate Cancer	PLOS ONE			English	Article							ACTIVE SURVEILLANCE; UNITED-STATES; ANTIGEN; EXPRESSION; OVERDIAGNOSIS; FLUORESCENCE; MORTALITY; GROWTH; TISSUE; CHIPS	Background Prostate cancer (PCa) is the most common malignancy among men in the United States. Though highly sensitive, the often-used prostate-specific antigen (PSA) test has low specificity which leads to overdiagnosis and overtreatment of PCa. This paper presents results of a retrospective study that indicates that testing for macrophage inhibitory cytokine 1 (MIC-1) concentration along with the PSA assay could provide much improved specificity to the assay. Methods The MIC-1 serum level was determined by a novel p-Chip-based immunoassay run on 70 retrospective samples. The assay was configured on p-Chips, small integrated circuits (IC) capable of storing in their electronic memories a serial number to identify the molecular probe immobilized on its surface. The distribution of MIC-1 and pre-determined PSA concentrations were displayed in a 2D plot and the predictive power of the dual MIC-1/PSA assay was analyzed. Results MIC-1 concentration in serum was elevated in PCa patients (1.44 ng/ml) compared to normal and biopsy-negative individuals (0.93 ng/ml and 0.88 ng/ml, respectively). In addition, the MIC-1 level was correlated with the progression of PCa. The area under the receiver operator curve (AUC-ROC) was 0.81 providing an assay sensitivity of 83.3% and specificity of 60.7% by using a cutoff of 0.494 for the logistic regression value of MIC-1 and PSA. Another approach, by defining high-frequency PCa zones in a two-dimensional plot, resulted in assay sensitivity of 78.6% and specificity of 89.3%. Conclusions The analysis based on correlation of MIC-1 and PSA concentrations in serum with the patient PCa status improved the specificity of PCa diagnosis without compromising the high sensitivity of the PSA test alone and has potential for PCa prognosis for patient therapy strategies.	[Li, Ji; Yuan, Zhen; Mandecki, Wlodek] PharmaSeq Inc, Monmouth Jct, NJ 08852 USA; [Veltri, Robert W.; Christudass, Christhunesa S.] Johns Hopkins Univ, Sch Med, JHUSOM, Baltimore, MD USA	Johns Hopkins University	Mandecki, W (corresponding author), PharmaSeq Inc, Monmouth Jct, NJ 08852 USA.	mandecki@pharmaseq.com			National Cancer Institute [HSSN261201200069C]; PharmaSeq, Inc.	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PharmaSeq, Inc.	The study design, data collection and analysis were supported by a grant/contract from the National Cancer Institute (HSSN261201200069C to WM) (http://www.cancer.gov). JL, ZY and WM are employed by PharmaSeq, Inc. PharmaSeq, Inc. provided support in the form of salaries for authors JL, ZY and WM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Bastian PJ, 2009, EUR UROL, V55, P1321, DOI 10.1016/j.eururo.2009.02.028; Bauskin AR, 2006, CANCER RES, V66, P4983, DOI 10.1158/0008-5472.CAN-05-4067; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2006, CLIN CANCER RES, V12, P89, DOI 10.1158/1078-0432.CCR-05-1331; Brown DA, 2009, CLIN CANCER RES, V15, P6658, DOI 10.1158/1078-0432.CCR-08-3126; Carter HB, 2013, J UROLOGY, V190, P419, DOI 10.1016/j.juro.2013.04.119; Cheung PK, 2004, CANCER RES, V64, P5929, DOI 10.1158/0008-5472.CAN-04-1216; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Draisma G, 2003, J NATL CANCER I, V95, P868, DOI 10.1093/jnci/95.12.868; Etzioni R, 2002, J NATL CANCER I, V94, P981; Etzioni R, 2008, CANCER CAUSE CONTROL, V19, P175, DOI 10.1007/s10552-007-9083-8; Gruda MC, 2010, J AM ASSOC LAB ANIM, V49, P826; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kakehi Y, 2004, PROSTATE, V59, P351, DOI 10.1002/pros.10365; Karan D, 2003, BIOCHEM BIOPH RES CO, V305, P598, DOI 10.1016/S0006-291X(03)00823-4; Khan MA, 2003, J UROLOGY, V170, P723, DOI 10.1097/01.ju.0000086940.10392.93; Klotz L, 2013, CURR OPIN ENDOCRINOL, V20, P204, DOI 10.1097/MED.0b013e328360332a; Li J, 2010, ANAL BIOANAL CHEM, V398, P1993, DOI 10.1007/s00216-010-4108-7; Lin X, 2007, CLIN CHEM, V53, P1372, DOI 10.1373/clinchem.2006.081810; Mandecki W, 2006, CYTOM PART A, V69A, P1097, DOI 10.1002/cyto.a.20344; Mikolajczyk Stephen D., 2003, Keio Journal of Medicine, V52, P86; Miller MC, 2001, UROLOGY, V57, P1105, DOI 10.1016/S0090-4295(01)00953-0; Nakamura T, 2003, BRIT J CANCER, V88, P1101, DOI 10.1038/sj.bjc.6600869; Partin AW, 2013, J UROLOGY, V190, P427, DOI 10.1016/j.juro.2013.05.030; Presti Joseph C, 2007, Rev Urol, V9, P93; Rasiah KK, 2006, CANCER EPIDEM BIOMAR, V15, P711, DOI 10.1158/1055-9965.EPI-05-0752; Rich R, 2012, ANAL BIOANAL CHEM, V404, P2223, DOI 10.1007/s00216-012-6369-9; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; Sokoll LJ, 2010, CANCER EPIDEM BIOMAR, V19, P1193, DOI 10.1158/1055-9965.EPI-10-0007; STENMAN UH, 1991, CANCER RES, V51, P222; Stephan C, 2006, PROSTATE, V66, P651, DOI 10.1002/pros.20381; Tosoian JJ, 2011, J CLIN ONCOL, V29, P2185, DOI 10.1200/JCO.2010.32.8112; Welch HG, 2005, J NATL CANCER I, V97, P1132, DOI 10.1093/jnci/dji205; Welsh JB, 2003, P NATL ACAD SCI USA, V100, P3410, DOI 10.1073/pnas.0530278100; Yang MH, 2014, LIFE SCI, V100, P75, DOI 10.1016/j.lfs.2014.01.075	37	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122249	10.1371/journal.pone.0122249	http://dx.doi.org/10.1371/journal.pone.0122249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853582	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400061
J	Lutz, HL; Hochachka, WM; Engel, JI; Bell, JA; Tkach, VV; Bates, JM; Hackett, SJ; Weckstein, JD				Lutz, Holly L.; Hochachka, Wesley M.; Engel, Joshua I.; Bell, Jeffrey A.; Tkach, Vasyl V.; Bates, John M.; Hackett, Shannon J.; Weckstein, Jason D.			Parasite Prevalence Corresponds to Host Life History in a Diverse Assemblage of Afrotropical Birds and Haemosporidian Parasites	PLOS ONE			English	Article							AVIAN MALARIA PARASITES; BLOOD PARASITES; HAEMOPROTEUS HAEMOSPORIDA; NEOTROPICAL SAVANNA; SEXUAL SELECTION; FEEDING SUCCESS; AEDES-AEGYPTI; FOREST BIRDS; PLASMODIUM; HEMATOZOA	Avian host life history traits have been hypothesized to predict rates of infection by haemosporidian parasites. Using molecular techniques, we tested this hypothesis for parasites from three haemosporidian genera (Plasmodium, Haemoproteus, and Leucocytozoon) collected from a diverse sampling of birds in northern Malawi. We found that host life history traits were significantly associated with parasitism rates by all three parasite genera. Nest type and nest location predicted infection probability for all three parasite genera, whereas flocking behavior is an important predictor of Plasmodium and Haemoproteus infection and habitat is an important predictor of Leucocytozoon infection. Parasite prevalence was 79.1% across all individuals sampled, higher than that reported for comparable studies from any other region of the world. Parasite diversity was also exceptionally high, with 248 parasite cytochrome b lineages identified from 152 host species. A large proportion of Plasmodium, Haemoproteus, and Leucocytozoon parasite DNA sequences identified in this study represent new, previously undocumented lineages (n = 201; 81% of total identified) based on BLAST queries against the avian malaria database, MalAvi.	[Lutz, Holly L.] Cornell Univ, Coll Agr & Life Sci, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Lutz, Holly L.] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA; [Lutz, Holly L.; Hochachka, Wesley M.] Cornell Univ, Cornell Lab Ornithol, Ithaca, NY 14853 USA; [Engel, Joshua I.; Bates, John M.; Hackett, Shannon J.] Field Museum Nat Hist, Dept Zool, Chicago, IL 60605 USA; [Bell, Jeffrey A.; Tkach, Vasyl V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58201 USA; [Weckstein, Jason D.] Drexel Univ, Acad Nat Sci, Dept Ornithol, Philadelphia, PA 19104 USA; [Weckstein, Jason D.] Dept Biodivers Earth & Environm Sci, Philadelphia, PA 19104 USA	Cornell University; Cornell University; Cornell University; Field Museum of Natural History (Chicago); University of North Dakota Grand Forks; Drexel University	Lutz, HL (corresponding author), Cornell Univ, Coll Agr & Life Sci, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.	hll47@cornell.edu	Hochachka, Wesley M./J-9768-2012; Bell, Jeffrey Andrew/Q-5057-2019	Hochachka, Wesley M./0000-0002-0595-7827; Bell, Jeffrey Andrew/0000-0001-9146-4318; Weckstein, Jason/0000-0001-7941-5724; Tkach, Vasyl/0000-0001-5084-7566; Lutz, Holly/0000-0001-6454-809X	Field Museum of Natural History's Emerging Pathogens Project - Davee Foundation; Dr. Ralph and Mariam Faulk Medical Research Trust; Division Of Environmental Biology [1120734] Funding Source: National Science Foundation	Field Museum of Natural History's Emerging Pathogens Project - Davee Foundation; Dr. Ralph and Mariam Faulk Medical Research Trust; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by the Field Museum of Natural History's Emerging Pathogens Project, funded by the Davee Foundation and Dr. Ralph and Mariam Faulk Medical Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson CT, 1991, BIRD PARASITE INTERA, P19; Bates D., 2012, IME4 LINEAR MIXED EF; Beadell JS, 2009, INT J PARASITOL, V39, P257, DOI 10.1016/j.ijpara.2008.06.005; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Belo NO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017654; BENNETT G. F., 1960, CANADIAN JOUR ZOOL, V38, P261, DOI 10.1139/z60-033; BENNETT GF, 1991, J PARASITOL, V77, P207, DOI 10.2307/3283083; BENNETT GORDON F., 1960, CANADIAN JOUR ZOOL, V38, P377, DOI 10.1139/z60-042; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1111/j.0014-3820.2004.tb01742.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Bernier UR, 1999, ANAL CHEM, V71, P1, DOI 10.1021/ac980990v; BIDLINGMAYER WL, 1994, J AM MOSQUITO CONTR, V10, P272; Bishop AL, 2002, RESPONSE CULICOIDES; Bishop AL, 2008, AUST J ENTOMOL, V47, P121, DOI 10.1111/j.1440-6055.2008.00637.x; BLACKMORE JOHN S., 1958, MOSQUITO NEWS, V18, P15; Brown LH, 1982, BIRDS AFRICA, VI; Burkett-Cadena ND, 2010, AM J TROP MED HYG, V83, P395, DOI 10.4269/ajtmh.2010.10-0048; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Caillouet KA, 2013, J MED ENTOMOL, V50, P462, DOI 10.1603/ME12183; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Combes C, 1997, INT J PARASITOL, V27, P1, DOI 10.1016/S0020-7519(96)00168-3; Day JF, 1999, J MED ENTOMOL, V36, P614, DOI 10.1093/jmedent/36.5.614; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dowsett-Lemaire F, 2006, THE BIRDS OF MALAWI; Durrant KL, 2006, ORNITHOL MONOGR, P98; EDMAN JD, 1987, INSECT SCI APPL, V8, P617, DOI 10.1017/S1742758400022694; EDMAN JD, 1971, ANN ENTOMOL SOC AM, V64, P513, DOI 10.1093/aesa/64.2.513; Engel Joshua I., 2013, Journal of East African Natural History, V101, P223; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Ewen JG, 2012, ECOL LETT, V15, P1112, DOI 10.1111/j.1461-0248.2012.01833.x; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, J PARASITOL, V89, P1044, DOI 10.1645/GE-3157; Fecchio A, 2013, PARASITOLOGY, V140, P181, DOI 10.1017/S0031182012001412; Fecchio A, 2011, EMU, V111, P132, DOI 10.1071/MU10063; Freed LA, 2006, CONDOR, V108, P459, DOI 10.1650/0010-5422(2006)108[459:DQAAOA]2.0.CO;2; Fry C.H., 2004, BIRDS AFRICA, V7; Fry C. H., 2002, BIRDS AFRICA, VVI; Fry CH., 1988, BIRDS AFRICA, V3; Garvin MC, 1997, AUK, V114, P179, DOI 10.2307/4089159; Giardina AR, 2000, CAN J ZOOL, V78, P2184, DOI 10.1139/cjz-78-12-2184; Gilbert KL, 2012, THESIS E KENTUCKY U; Gonzalez AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100695; GREINER EC, 1975, CAN J ZOOL, V53, P1762, DOI 10.1139/z75-211; HAMILTON WD, 1982, SCIENCE, V218, P384, DOI 10.1126/science.7123238; HAYES RO, 1967, AM J TROP MED HYG, V16, P675, DOI 10.4269/ajtmh.1967.16.675; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Hellgren O, 2007, J PARASITOL, V93, P889, DOI 10.1645/GE-1051R1.1; Ishtiaq F, 2007, J WILDLIFE DIS, V43, P382, DOI 10.7589/0090-3558-43.3.382; Ishtiaq F, 2012, PARASITOLOGY, V139, P221, DOI 10.1017/S0031182011001831; Janousek WM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-399; Jasinskiene N, 2007, AM J TROP MED HYG, V76, P1072, DOI 10.4269/ajtmh.2007.76.1072; KALE HW, 1972, MOSQ NEWS, V32, P343; Keith S., 1992, BIRDS AFRICA, V4; Khan AA, 1977, CHEM CONTROL INSECT, P91; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kuznetsova Alexandra, 2013, LMERTEST TESTS LINEA; Lacorte GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057770; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Logan JG, 2010, ECOL CONT VECTOR-BOR, V2, P217; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Londono A, 2007, CARIBB J SCI, V43, P87; Mahmood F, 2004, J MED ENTOMOL, V41, P965, DOI 10.1603/0022-2585-41.5.965; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; Medeiros MCI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2947; Merino S, 2008, AUSTRAL ECOL, V33, P329, DOI 10.1111/j.1442-9993.2008.01820.x; Mijares A, 2012, AVIAN DIS, V56, P583, DOI 10.1637/10058-011312-ResNote.1; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; MUIR LE, 1992, J MED ENTOMOL, V29, P278, DOI 10.1093/jmedent/29.2.278; Muller M, 1991, REPORT BLUETONGUE RE; Ogden NH, 2008, APPL ENVIRON MICROB, V74, P1780, DOI 10.1128/AEM.01982-07; Poulin R., 2007, EVOL ECOL, V2; PRUETTJONES SG, 1991, CURR ORNITHOL, V8, P213; READ AF, 1991, AM NAT, V138, P434, DOI 10.1086/285225; READ AF, 1988, TRENDS ECOL EVOL, V3, P97, DOI 10.1016/0169-5347(88)90115-2; Ribeiro SF, 2005, PARASITOLOGY, V130, P261, DOI 10.1017/S0031182004006596; Richard FA, 2002, J PARASITOL, V88, P819, DOI 10.1645/0022-3395(2002)088[0819:ACAOPB]2.0.CO;2; Ricklefs RE, 2005, ECOL MONOGR, V75, P543, DOI 10.1890/04-1820; RICKLEFS RE, 1992, P NATL ACAD SCI USA, V89, P4722, DOI 10.1073/pnas.89.10.4722; Rodríguez Oscar A., 2009, Hornero, V24, P1; Savage AF, 2009, J WILDLIFE DIS, V45, P907, DOI 10.7589/0090-3558-45.4.907; Scheuerlein A, 2004, P ROY SOC B-BIOL SCI, V271, P1363, DOI 10.1098/rspb.2004.2726; Scott T.W., 1991, Oxford Ornithology Series, P179; SCOTT TW, 1990, J MED ENTOMOL, V27, P856, DOI 10.1093/jmedent/27.5.856; Sehgal RNM, 2011, P ROY SOC B, V10, P1025; SOUSA OE, 1982, J WILDLIFE DIS, V18, P205, DOI 10.7589/0090-3558-18.2.205; Svensson-Coelho M, 2013, ORNITHOL MONOGR; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; Unnasch RS, 2006, ECOL MODEL, V192, P425, DOI 10.1016/j.ecolmodel.2005.07.011; Urban E.K., 1986, BIRDS AFRICA, V2; Urban EK, 1997, BIRDS AFRICA, V5; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2008, PARASITOL RES, V102, P1185, DOI 10.1007/s00436-008-0892-9; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; WICKLER SJ, 1981, PHYSIOL ZOOL, V54, P132, DOI 10.1086/physzool.54.1.30155811; WITHERS PC, 1978, AM NAT, V112, P1101, DOI 10.1086/283349; YOUNG BE, 1993, J WILDLIFE DIS, V29, P555, DOI 10.7589/0090-3558-29.4.555	99	80	81	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121254	10.1371/journal.pone.0121254	http://dx.doi.org/10.1371/journal.pone.0121254			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853491	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400033
J	Melton, JT; Leliaert, F; Tronholm, A; Lopez-Bautista, JM				Melton, James T., III; Leliaert, Frederik; Tronholm, Ana; Lopez-Bautista, Juan M.			The Complete Chloroplast and Mitochondrial Genomes of the Green Macroalga Ulva sp UNA00071828 (Ulvophyceae, Chlorophyta)	PLOS ONE			English	Article							ALGA OLTMANNSIELLOPSIS-VIRIDIS; DNA-SEQUENCE; PHYLOGENETIC ANALYSES; EVOLUTIONARY TRENDS; DIVERSITY; REVEALS; VIRIDIPLANTAE; ARCHITECTURE; ALIGNMENT; INSIGHTS	Sequencing mitochondrial and chloroplast genomes has become an integral part in understanding the genomic machinery and the phylogenetic histories of green algae. Previously, only three chloroplast genomes (Oltmannsiellopsis viridis, Pseudendoclonium akinetum, and Bryopsis hypnoides) and two mitochondrial genomes (O. viridis and P. akinetum) from the class Ulvophyceae have been published. Here, we present the first chloroplast and mitochondrial genomes from the ecologically and economically important marine, green algal genus Ulva. The chloroplast genome of Ulva sp. was 99,983 bp in a circular-mapping molecule that lacked inverted repeats, and thus far, was the smallest ulvophycean plastid genome. This cpDNA was a highly compact, AT-rich genome that contained a total of 102 identified genes (71 protein-coding genes, 28 tRNA genes, and three ribosomal RNA genes). Additionally, five introns were annotated in four genes: atpA (1), petB (1), psbB (2), and rrl (1). The circular-mapping mitochondrial genome of Ulva sp. was 73,493 bp and follows the expanded pattern also seen in other ulvophyceans and trebouxiophyceans. The Ulva sp. mtDNA contained 29 protein-coding genes, 25 tRNA genes, and two rRNA genes for a total of 56 identifiable genes. Ten introns were annotated in this mtDNA: cox1 (4), atp1 (1), nad3 (1), nad5 (1), and rrs (3). Double-cut-and-join (DCJ) values showed that organellar genomes across Chlorophyta are highly rearranged, in contrast to the highly conserved organellar genomes of the red algae (Rhodophyta). A phylogenomic investigation of 51 plastid protein-coding genes showed that Ulvophyceae is not monophyletic, and also placed Oltmannsiellopsis (Oltmannsiellopsidales) and Tetraselmis (Chlorodendrophyceae) closely to Ulva (Ulvales) and Pseudendoclonium (Ulothrichales).	[Melton, James T., III; Leliaert, Frederik; Tronholm, Ana; Lopez-Bautista, Juan M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA; [Leliaert, Frederik] Univ Ghent, Dept Biol, Marine Biol Res Grp, B-9000 Ghent, Belgium; [Tronholm, Ana] Smithsonian Marine Stn Ft Pierce, Ft Pierce, FL 34949 USA	University of Alabama System; University of Alabama Tuscaloosa; Ghent University; Smithsonian Institution; Smithsonian National Museum of Natural History	Melton, JT (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL 35487 USA.	melto006@crimson.ua.edu	Leliaert, Frederik/A-9162-2009	Leliaert, Frederik/0000-0002-4627-7318; Tronholm, Ana/0000-0002-0151-2804	National Science Foundation under the ATOL Program [DEB 1036495, 0937978]; College of Arts and Sciences (CARSCA Program); Office for Research (Research Stimulation Program); Department of Biological Sciences	National Science Foundation under the ATOL Program; College of Arts and Sciences (CARSCA Program); Office for Research (Research Stimulation Program); Department of Biological Sciences	This study was funded by The National Science Foundation under the ATOL Program, through grants DEB 1036495 and 0937978 to JMLB. Additional support was provided by the College of Arts and Sciences (CARSCA Program) and the Office for Research (Research Stimulation Program) at UA to JMLB, and the Department of Biological Sciences (research and travel awards) to JTM.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Bergeron A, 2006, LECT NOTES COMPUT SC, V4175, P163; Braga MDV, 2011, J COMPUT BIOL, V18, P1167, DOI 10.1089/cmb.2011.0118; Brouard JS, 2010, GENOME BIOL EVOL, V2, P240, DOI 10.1093/gbe/evq014; Burger G, 2012, ADV PHOTOSYNTHESIS R, V35, P125, DOI DOI 10.1007/S11120-013-9921-3; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charlier Roger H., 2007, Environmental Research, Engineering and Management, V41, P52; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Koning AP, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-12; DePriest MS, 2014, BIOL BULL-US, V227, P191, DOI 10.1086/BBLv227n2p191; DePriest MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068246; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fucikova K, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00063; Guidone M, 2013, J PHYCOL, V49, P979, DOI 10.1111/jpy.12108; Guiry MD, 2014, ALGAEBASE; Hayden HS, 2003, EUR J PHYCOL, V38, P277, DOI 10.1080/1364253031000136321; Heesch S, 2009, EUR J PHYCOL, V44, P143, DOI 10.1080/09670260802422477; Hilker R, 2012, BIOINFORMATICS, V28, P2509, DOI 10.1093/bioinformatics/bts440; Hofmann LC, 2010, EUR J PHYCOL, V45, P230, DOI 10.1080/09670261003746201; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkendale L, 2013, J PHYCOL, V49, P69, DOI 10.1111/jpy.12016; Knoop V, 2012, GENOMICS CHLOROPLAST, V35, P175, DOI DOI 10.1007/978-94-007-2920-9_; Kraft LGK, 2010, J PHYCOL, V46, P1257, DOI 10.1111/j.1529-8817.2010.00909.x; Lang B.F., 2012, ADV PHOTOSYNTHESIS R, P59, DOI DOI 10.1007/S11120-013-9921-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lawton RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077344; Lehman RL, 1997, J PHYCOL, V33, P1055, DOI 10.1111/j.0022-3646.1997.01055.x; Leliaert F, 2012, CRIT REV PLANT SCI, V31, P1, DOI 10.1080/07352689.2011.615705; Leliaert F, 2009, PHYCOL RES, V57, P147, DOI 10.1111/j.1440-1835.2009.00532.x; Lemieux C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-857; Lemieux C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0211-2; Lewis LA, 2004, AM J BOT, V91, P1535, DOI 10.3732/ajb.91.10.1535; Liu Y, 2012, GENOMICS CHLOROPLAST, P159, DOI [10.1007/s11120-013-9921-3, DOI 10.1007/S11120-013-9921-3]; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014663; MANHART JR, 1989, MOL GEN GENET, V216, P417, DOI 10.1007/BF00334385; Marin B, 2012, PROTIST, V163, P778, DOI 10.1016/j.protis.2011.11.004; Norris JN, 2010, MARINE ALGAE NO GULF, P31; O'Kelly CJ, 2010, J PHYCOL, V46, P728, DOI 10.1111/j.1529-8817.2010.00860.x; PADMANABHAN U, 1978, BIOCHIM BIOPHYS ACTA, V521, P67, DOI 10.1016/0005-2787(78)90249-6; Pombert J-F, 2010, PLOS ONE, DOI [10.1371/journal.pone.0008954, DOI 10.1371/J0URNAL.P0NE.0008954]; Pombert JF, 2006, CURR GENET, V50, P137, DOI 10.1007/s00294-006-0076-z; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Pombert JF, 2005, MOL BIOL EVOL, V22, P1903, DOI 10.1093/molbev/msi182; Pombert JF, 2004, MOL BIOL EVOL, V21, P922, DOI 10.1093/molbev/msh099; Rambaut A., 2007, TRACER V1 4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Servin-Garciduenas LE, 2012, EUKARYOT CELL, V11, P1417, DOI 10.1128/EC.00244-12; Skaloud P, 2013, POLAR BIOL, V36, P1281, DOI 10.1007/s00300-013-1347-z; Smith DR, 2008, MOL BIOL EVOL, V25, P487, DOI 10.1093/molbev/msm245; Smith DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023624; Smith DR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-132; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turmel M, 2007, BMC GENOMICS, V12, P1; WOLFF G, 1994, J MOL BIOL, V237, P75, DOI 10.1006/jmbi.1994.1210; XU JN, 2012, PLOS GENET, V8, DOI DOI 10.1371/JOURNAL.PONE.0037438; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang XW, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-565; Zuccarello GC, 2009, J PHYCOL, V45, P1206, DOI 10.1111/j.1529-8817.2009.00731.x	67	53	53	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121020	10.1371/journal.pone.0121020	http://dx.doi.org/10.1371/journal.pone.0121020			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849557	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800041
J	Wang, ZJ; Gong, HL; Zhang, J				Wang, Zhengjun; Gong, Huili; Zhang, Jing			Receding Water Line and Interspecific Competition Determines Plant Community Composition and Diversity in Wetlands in Beijing	PLOS ONE			English	Article							LONG-TERM; SUCCESSION PROCESS; SPECIES RICHNESS; RAIN-FORESTS; BIODIVERSITY; LITTER; REGENERATION; RESTORATION; GRASSLAND; DYNAMICS	Climate and human-induced wetland degradation has accelerated in recent years, not only resulting in reduced ecosystem services but also greatly affecting the composition and diversity of wetland plant communities. To date, the knowledge of the differences in community parameters and their successional trends in degraded wetlands remains scarce. Here based on remote sensing images, geographic information system technology, and statistical methods, we produced a successional gradient map of the Yeyahu Wetland Nature Reserve in Beijing, which has experienced a steady decline in water level in recent decades. In addition, we analyzed community composition and diversity along with each identified gradient. The results showed that community diversity decreases while dominance increases with the progress of succession, with the highest diversity occurring during the early stage of succession. Moreover, the community demonstrates greater similarity among subareas during later successional stages, and the similarity coefficients calculated from the important value (IV) of each species are more accurate. Correlation analysis showed that the impact of soil factors on diversity was not significant at a subarea scale, although these nutrients showed an increasing trend with the community succession. Furthermore, the IVs of the dominant species had a particularly significant impact on diversity, showing a significantly negative correlation with diversity indices and a significantly positive correlation with dominance indices. Further analysis showed that the retreat of water level resulted from sustained drought and local human activities was a major extrinsic driving force resulting in observed differences in the community successional stages, which resulted in differences in community composition and diversity. On the other hand, interspecific competition was the main intrinsic mechanism, which significantly influenced the IVs of the dominant species and community diversity. The results of this study could aid in improving the understanding of community composition, diversity, and its successional trends in degraded wetlands.	[Wang, Zhengjun; Zhang, Jing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Gong, Huili] Capital Normal Univ, Coll Resources Environm & Tourism, Beijing, Peoples R China	Capital Normal University; Capital Normal University	Gong, HL (corresponding author), Capital Normal Univ, Coll Resources Environm & Tourism, Beijing, Peoples R China.	bjcnu@126.com		Gong, Huili/0000-0001-8691-0264	National Natural Science Foundation of China [01111210010046, 0111121010076]; International Science & Technology Cooperation Program of China [2010DFA92400]; Beijing Educational Committee [KM200810028014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Beijing Educational Committee	This research was financially supported by grants from the National Natural Science Foundation of China (01111210010046 and 0111121010076, HG received the funding, and the website of funder is: http://www.nsfc.gov.cn/), the International Science & Technology Cooperation Program of China (2010DFA92400, HG received the funding, and the website of funder is: http://www.most.gov.cn/) and the Beijing Educational Committee (KM200810028014, ZW received the funding, and the website of funder is: http://www.bjedu.gov.cn/publish/portal0/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gonzalez-Oreja JA, 2010, BIODIVERS CONSERV, V19, P1417, DOI 10.1007/s10531-009-9770-8; BERTNESS MD, 1994, TRENDS ECOL EVOL, V9, P191, DOI 10.1016/0169-5347(94)90088-4; Brooker RW, 2012, ACTA OECOL, V45, P8, DOI 10.1016/j.actao.2012.08.002; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; Chazdon RL, 1998, MAN BIOSPH, V20, P285; [陈利云 Chen Liyun], 2014, [干旱区资源与环境, Journal of Arid Land Resources and Environment], V28, P148; Chen Y.Y., 2003, WETLAND SCI, V1, P7, DOI DOI 10.13248/J.CNKI.WETLANDSCI.2003.01.003; CLIFFORD H T, 1975, P229; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; [崔丽娟 Cui Lijuan], 2013, [生态环境学报, Ecology and Environmental Sciences], V22, P1749; Czerepko J, 2008, FOREST ECOL MANAG, V255, P630, DOI 10.1016/j.foreco.2007.09.039; Ding Y, 2012, BIOL CONSERV, V145, P225, DOI 10.1016/j.biocon.2011.11.009; Dole-Olivier MJ, 2009, FRESHWATER BIOL, V54, P777, DOI 10.1111/j.1365-2427.2008.02133.x; FACELLI JM, 1993, OECOLOGIA, V95, P277, DOI 10.1007/BF00323500; Foster BL, 2000, PLANT ECOL, V146, P1, DOI 10.1023/A:1009895103017; Gao D, 2009, J CAPITAL NORMAL U N, V30, P34; Gimaret-Carpentier C, 1998, J VEG SCI, V9, P161, DOI 10.2307/3237115; Goldblum D, 1999, J TORREY BOT SOC, V126, P335, DOI 10.2307/2997317; Gomez-Aparicio L, 2009, J ECOL, V97, P1202, DOI 10.1111/j.1365-2745.2009.01573.x; Gong ZN, 2007, ECOLOGICAL EVOLUTION; Guan X, 2007, J CAPITAL NORMAL U N, V28, P44; Hartter J, 2009, LANDSCAPE ECOL, V24, P643, DOI 10.1007/s10980-009-9339-7; Hovstad KA, 2008, PLANT ECOL, V196, P251, DOI 10.1007/s11258-007-9349-y; Hu HX, 2004, FOREST HUMANKIND, V7, P22; [胡振鹏 Hu Zhenpeng], 2010, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V19, P597; Jing ZB, 2013, ECOL ENG, V57, P162, DOI 10.1016/j.ecoleng.2013.04.035; KENKEL NC, 1991, J VEG SCI, V2, P539, DOI 10.2307/3236036; Krebs CJ, 1999, ECOLOGICAL METHODOLO, P377; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Lande R, 2000, OIKOS, V89, P601, DOI 10.1034/j.1600-0706.2000.890320.x; LEPS J, 1988, FOLIA GEOBOT PHYTOTX, V23, P79, DOI 10.1007/BF02853297; [廖玉静 LIAO Yu-jing], 2009, [土壤通报, Journal of Soil Science], V40, P1199; Lu BM, 2010, J BEIJING FORESTRY U, V32, P36; Luan SS, 2010, J CAPITAL NORMAL U N, V31, P39; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Matuszkiewicz JM, 2013, FOREST ECOL MANAG, V310, P567, DOI 10.1016/j.foreco.2013.08.060; PAPANASTASIS VP, 1977, J RANGE MANAGE, V30, P446, DOI 10.2307/3897808; PIELOU E C, 1969, P286; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Prach K, 2011, TRENDS ECOL EVOL, V26, P119, DOI 10.1016/j.tree.2010.12.007; [秦伟 QIN Wei], 2008, [干旱区研究, Arid Zone Research], V25, P507; SALE PF, 1974, OECOLOGIA, V17, P245, DOI 10.1007/BF00344924; SCHOENER TW, 1983, AM NAT, V122, P240, DOI 10.1086/284133; Shannon C.E, 1949, MATH THEORY COMMUNIC, V1st; [邵新庆 SHAO XinQing], 2008, [生态学报, Acta Ecologica Sinica], V28, P855; [沈蕊 Shen Rui], 2010, [生态环境学报, Ecology and Environmental Sciences], V19, P2821; Siles G, 2008, J APPL ECOL, V45, P1790, DOI 10.1111/j.1365-2664.2008.01574.x; Spehn EM, 2005, ECOL MONOGR, V75, P37, DOI 10.1890/03-4101; Tang CQ, 2013, FOREST ECOL MANAG, V294, P188, DOI 10.1016/j.foreco.2012.07.019; TILMAN D, 1985, AM NAT, V125, P827, DOI 10.1086/284382; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; Wang B, 1987, PHYTOCOENOLOGY; [王慧亮 Wang Huiliang], 2010, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V19, P653; Wang Shi-xiong, 2013, Shengtaixue Zazhi, V32, P1135; [王颖 Wang Ying], 2005, [地理学报, Acta Geographica Sinica], V60, P656; Wang Zhouping, 2003, Yingyong Shengtai Xuebao, V14, P7; Wardle DA, 1999, ECOL MONOGR, V69, P535, DOI 10.1890/0012-9615(1999)069[0535:PRIPGV]2.0.CO;2; WILLIAMSLINERA G, 1990, J ECOL, V78, P356, DOI 10.2307/2261117; WOLDA H, 1983, OECOLOGIA, V58, P290, DOI 10.1007/BF00385226; Xiong ZB, 2010, GUIZHOU SCI, V28, P60; Ye D, 2006, SCI TECHNOLOGY ENG, V6, P2858; Ye D, 2006, SCI TECHNOLOGY ENG, V6, P2867; Zhang YB, 2011, FOREST ECOL MANAG, V262, P361, DOI 10.1016/j.foreco.2011.03.042; [张志鹏 Zhang Zhipeng], 2013, [灌溉排水学报, Journal of Irrigation and Drainage], V32, P46; [左小安 ZUO Xiao-an], 2009, [草业学报, Acta Prataculturae Sinica], V18, P9	65	4	4	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124156	10.1371/journal.pone.0124156	http://dx.doi.org/10.1371/journal.pone.0124156			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848799	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800262
J	Amissah, L; Mohren, GMJ; Kyereh, B; Poorter, L				Amissah, Lucy; Mohren, Godefridus M. J.; Kyereh, Boateng; Poorter, Lourens			The Effects of Drought and Shade on the Performance, Morphology and Physiology of Ghanaian Tree Species	PLOS ONE			English	Article							WATER RELATIONS; SEEDLING ESTABLISHMENT; DESICCATION-TOLERANCE; TRADE-OFFS; PHOTOSYNTHETIC ACCLIMATION; RELATIVE IMPORTANCE; BIOMASS ALLOCATION; ROOT MORPHOLOGY; LIGHT GRADIENT; CARBON BALANCE	In tropical forests light and water availability are the most important factors for seedling growth and survival but an increasing frequency of drought may affect tree regeneration. One central question is whether drought and shade have interactive effects on seedling growth and survival. Here, we present results of a greenhouse experiment, in which seedlings of 10 Ghanaian tree species were exposed to combinations of strong seasonal drought (continuous watering versus withholding water for nine weeks) and shade (5% irradiance versus 20% irradiance). We evaluated the effects of drought and shade on seedling survival and growth and plasticity of 11 underlying traits related to biomass allocation, morphology and physiology. Seedling survival under dry conditions was higher in shade than in high light, thus providing support for the "facilitation hypothesis" that shade enhances plant performance through improved microclimatic conditions, and rejecting the trade-off hypothesis that drought should have stronger impact in shade because of reduced root investment. Shaded plants had low biomass fraction in roots, in line with the trade-off hypothesis, but they compensated for this with a higher specific root length (i.e., root length per unit root mass), resulting in a similar root length per plant mass and, hence, similar water uptake capacity as high-light plants. The majority (60%) of traits studied responded independently to drought and shade, indicating that within species shade-and drought tolerances are not in trade-off, but largely uncoupled. When individual species responses were analysed, then for most of the traits only one to three species showed significant interactive effects between drought and shade. The uncoupled response of most species to drought and shade should provide ample opportunity for niche differentiation and species coexistence under a range of water and light conditions. Overall our greenhouse results suggest that, in the absence of root competition shaded tropical forest tree seedlings may be able to survive prolonged drought.	[Amissah, Lucy] KNUST, Council Sci & Ind Research, Forestry Res Inst Ghana, Kumasi, Ghana; [Amissah, Lucy; Mohren, Godefridus M. J.] Wageningen Univ, Forest Ecol & Forest Management Grp, NL-6700 AP Wageningen, Netherlands; [Kyereh, Boateng; Poorter, Lourens] Kwame Nkrumah Univ Sci & Technol, Coll Agr & Nat Resources, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Wageningen University & Research; Kwame Nkrumah University Science & Technology	Amissah, L (corresponding author), KNUST, Council Sci & Ind Research, Forestry Res Inst Ghana, Kumasi, Ghana.	ewurakua.amissah@gmail.com	Poorter, Lourens/AAL-1709-2021; Mohren, Godefridus M.J./C-5608-2015	Mohren, Godefridus M.J./0000-0002-7004-4602; Poorter, Lourens/0000-0003-1391-4875	Netherlands Fellowship Programme (NFP) [CF7428/2011]; Wageningen University Sandwich Fellowship; Council for Scientific and Industrial Research-Forestry Research Institute of Ghana	Netherlands Fellowship Programme (NFP); Wageningen University Sandwich Fellowship; Council for Scientific and Industrial Research-Forestry Research Institute of Ghana	LA was supported by the Netherlands Fellowship Programme (NFP); grant number CF7428/2011 (http://www.nuffic.nl/en/scholarships/netherlands-fellowship-programmes-nfp), Wageningen University Sandwich Fellowship (http://www.wageningenur.nl/en/wageningen-university.htm) and the Council for Scientific and Industrial Research-Forestry Research Institute of Ghana (www.csir-forig.org.gh). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Agyeman VK, 1999, J ECOL, V87, P815, DOI 10.1046/j.1365-2745.1999.00400.x; Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Amissah L, 2014, J TROP ECOL, V30, P435, DOI 10.1017/S026646741400025X; Apetorgbor MM, 2007, PROTA, V1, P704; Aranda I, 2005, FOREST ECOL MANAG, V210, P117, DOI 10.1016/j.foreco.2005.02.012; Baltzer JL, 2008, FUNCT ECOL, V22, P221, DOI 10.1111/j.1365-2435.2007.01374.x; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Brodribb TJ, 2014, P NATL ACAD SCI USA, V111, P14489, DOI 10.1073/pnas.1407930111; BROUWER R., 1963, Jaarboek. Instituut voor biologisch en scheikundig Onderzoek van Landbouwgewassen 1963, P31; Burslem DFRP, 1996, MAN BIOSPHERE SERIES, V17; Cao KF, 2000, J TROP ECOL, V16, P101, DOI 10.1017/S0266467400001292; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Condit R, 1998, CLIMATIC CHANGE, V39, P413, DOI 10.1023/A:1005395806800; Coomes DA, 2000, ECOL MONOGR, V70, P171, DOI 10.1890/0012-9615(2000)070[0171:IORCIF]2.0.CO;2; Cox PM, 2008, NATURE, V453, P212, DOI 10.1038/nature06960; De Smedt S, 2012, THESIS U ANTWERPEN B; Deines JM, 2011, AUST J BOT, V59, P620, DOI 10.1071/BT10321; DEKA RN, 1995, EUR J SOIL SCI, V46, P233, DOI 10.1111/j.1365-2389.1995.tb01831.x; Duclos V, 2013, BIOTROPICA, V45, P419, DOI 10.1111/btp.12039; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Evans JR, 2001, PLANT CELL ENVIRON, V24, P755, DOI 10.1046/j.1365-3040.2001.00724.x; Fauset S, 2012, ECOL LETT, V15, P1120, DOI 10.1111/j.1461-0248.2012.01834.x; FISHER BL, 1991, OECOLOGIA, V86, P292, DOI 10.1007/BF00317543; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63, DOI 10.1071/PP9880063; Gommers CMM, 2013, TRENDS PLANT SCI, V18, P65, DOI 10.1016/j.tplants.2012.09.008; Gyakari, 2006, PHOTO GUIDE FOREST T; Hall J.B., 1981, DISTRIBUTION ECOLOGY, DOI 10.1007/978-94-009-8650-3; Hawthorne W. D., 1995, Tropical Forestry Papers; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Hoffmann WA, 2002, ANN BOT-LONDON, V90, P37, DOI 10.1093/aob/mcf140; Holmgren M, 2000, PLANT ECOL, V147, P49, DOI 10.1023/A:1009804726307; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Jiofack Tafokou R. B., 2008, PROTA; Kursar TA, 2009, FUNCT ECOL, V23, P93, DOI 10.1111/j.1365-2435.2008.01483.x; Kyereh B, 1994, THESIS U ABERDEEN; Lemmens RHMJ, 2007, PROTA, P704; Lewis SL, 2011, SCIENCE, V331, P554, DOI 10.1126/science.1200807; Malhi Y, 2004, PHILOS T R SOC B, V359, P311, DOI 10.1098/rstb.2003.1433; Malhi Y, 2009, P NATL ACAD SCI USA, V106, P20610, DOI 10.1073/pnas.0804619106; Markesteijn L, 2009, J ECOL, V97, P311, DOI 10.1111/j.1365-2745.2008.01466.x; Marod D, 2002, PLANT ECOL, V161, P41, DOI 10.1023/A:1020372401313; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; MORENO JM, 1992, OECOLOGIA, V90, P50, DOI 10.1007/BF00317808; Nepstad D., 2004, Global Change Biology, V10, P704, DOI 10.1111/j.1529-8817.2003.00772.x; NEWMAN EI, 1966, J APPL ECOL, V3, P139, DOI 10.2307/2401670; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; Owusu FW, 2008, PROTA, V1, P704; Poorter H, 2000, AUST J PLANT PHYSIOL, V27, P1191, DOI 10.1071/PP99173; Poorter L, 1999, FUNCT ECOL, V13, P396, DOI 10.1046/j.1365-2435.1999.00332.x; Poorter L, 2000, J TROP ECOL, V16, P481, DOI 10.1017/S026646740000153X; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Poorter Lourens, 2005, P35, DOI 10.1017/CBO9780511541971.003; Quero JL, 2008, FUNCT PLANT BIOL, V35, P725, DOI 10.1071/FP08149; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Saatchi S, 2013, P NATL ACAD SCI USA, V110, P565, DOI 10.1073/pnas.1204651110; Sack L, 2004, OIKOS, V107, P110, DOI 10.1111/j.0030-1299.2004.13184.x; Sack L, 2003, PLANT ECOL, V168, P139, DOI 10.1023/A:1024423820136; Sack L, 2002, OECOLOGIA, V131, P175, DOI 10.1007/s00442-002-0873-0; Saldana A, 2005, Oecologia, V145, P252, DOI 10.1007/s00442-005-0116-2; Sanchez-Gomez D, 2006, NEW PHYTOL, V170, P795, DOI 10.1111/j.1469-8137.2006.01711.x; Sanchez-Gomez D, 2008, ANN FOREST SCI, V65, DOI 10.1051/forest:2008040; Schiotz M, 2006, FOREST ECOL MANAG, V225, P306, DOI 10.1016/j.foreco.2006.01.007; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; SIMS DA, 1994, PLANT CELL ENVIRON, V17, P881, DOI 10.1111/j.1365-3040.1994.tb00317.x; Slot M, 2007, BIOTROPICA, V39, P683, DOI 10.1111/j.1744-7429.2007.00328.x; SMITH T, 1989, VEGETATIO, V83, P49, DOI 10.1007/BF00031680; Sterck F, 2014, ECOLOGY, V95, P2514, DOI 10.1890/13-2377.1; Sterck F, 2011, TREE PHYSIOL, V31, P1024, DOI 10.1093/treephys/tpr065; Tchinda A.T., 2008, PROTA 7 1 TIMBERS BO; THOMAS CM, 1989, OECOLOGIA, V80, P309, DOI 10.1007/BF00379032; Tyree MT, 2002, J EXP BOT, V53, P2239, DOI 10.1093/jxb/erf078; Tyree MT, 2003, PLANT PHYSIOL, V132, P1439, DOI 10.1104/pp.102.018937; TYREE MT, 1972, J EXP BOT, V23, P267, DOI 10.1093/jxb/23.1.267; Valladares F, 2000, ECOLOGY, V81, P1925, DOI 10.1890/0012-9658(2000)081[1925:PPRTLO]2.0.CO;2; Valladares F, 2003, PROG BOT, V64, P439; Valladares F, 2002, PLANT CELL ENVIRON, V25, P749, DOI 10.1046/j.1365-3040.2002.00856.x; Valladares F, 2007, NEW PHYTOL, V176, P749, DOI 10.1111/j.1469-8137.2007.02275.x; Veenendaal EM, 1996, J ECOL, V84, P83, DOI 10.2307/2261702; Walters MB, 1999, NEW PHYTOL, V143, P143, DOI 10.1046/j.1469-8137.1999.00425.x; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; WRIGHT SJ, 1992, OECOLOGIA, V89, P457, DOI 10.1007/BF00317149	85	26	28	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121004	10.1371/journal.pone.0121004	http://dx.doi.org/10.1371/journal.pone.0121004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836337	gold, Green Submitted, Green Published			2022-12-26	WOS:000352139000036
J	Menzel, C; Hayn-Leichsenring, GU; Langner, O; Wiese, H; Redies, C				Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Langner, Oliver; Wiese, Holger; Redies, Christoph			Fourier Power Spectrum Characteristics of Face Photographs: Attractiveness Perception Depends on Low-Level Image Properties	PLOS ONE			English	Article							FACIAL ATTRACTIVENESS; SPATIAL-FREQUENCY; VISUAL-PERCEPTION; COLOR HOMOGENEITY; NATURAL IMAGES; AGE; BEAUTY; STATISTICS; HEALTH; EYE	We investigated whether low-level processed image properties that are shared by natural scenes and artworks - but not veridical face photographs - affect the perception of facial attractiveness and age. Specifically, we considered the slope of the radially averaged Fourier power spectrum in a log-log plot. This slope is a measure of the distribution of special frequency power in an image. Images of natural scenes and artworks possess - compared to face images - a relatively shallow slope (i.e., increased high spatial frequency power). Since aesthetic perception might be based on the efficient processing of images with natural scene statistics, we assumed that the perception of facial attractiveness might also be affected by these properties. We calculated Fourier slope and other beauty-associated measurements in face images and correlated them with ratings of attractiveness and age of the depicted persons (Study 1). We found that Fourier slope - in contrast to the other tested image properties - did not predict attractiveness ratings when we controlled for age. In Study 2A, we overlaid face images with random-phase patterns with different statistics. Patterns with a slope similar to those in natural scenes and artworks resulted in lower attractiveness and higher age ratings. In Studies 2B and 2C, we directly manipulated the Fourier slope of face images and found that images with shallower slopes were rated as more attractive. Additionally, attractiveness of unaltered faces was affected by the Fourier slope of a random-phase background (Study 3). Faces in front of backgrounds with statistics similar to natural scenes and faces were rated as more attractive. We conclude that facial attractiveness ratings are affected by specific image properties. An explanation might be the efficient coding hypothesis.	[Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Langner, Oliver; Wiese, Holger; Redies, Christoph] Univ Jena, Person Percept Res Unit, Jena, Germany; [Menzel, Claudia; Hayn-Leichsenring, Gregor U.; Redies, Christoph] Univ Jena, Jena Univ Hosp, Inst Anat 1, Expt Aesthet Grp, Jena, Germany; [Langner, Oliver] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Wiese, Holger] Univ Durham, Dept Psychol, Durham DH1 3LE, England	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; University of Lubeck; Durham University	Hayn-Leichsenring, GU (corresponding author), Univ Jena, Person Percept Res Unit, Jena, Germany.	gregorhaynleichsenring@googlemail.com	Wiese, Holger/M-5281-2014; Menzel, Claudia/AAE-8084-2020	Wiese, Holger/0000-0003-4928-0771; Menzel, Claudia/0000-0003-1156-5392	German Research Council [RE616/7-1]	German Research Council(German Research Foundation (DFG))	This work has been funded by the German Research Council, grant number RE616/7-1 (to CR and GUHL); www.dfg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado L, 2010, SPAN J PSYCHOL, V13, P525, DOI 10.1017/S1138741600002225; Albert AM, 2007, FORENSIC SCI INT, V172, P1, DOI 10.1016/j.forsciint.2007.03.015; Amirshahi SA, 2012, P SPIE HUMAN VISION, V8291; Arce-Lopera C, 2013, SKIN RES TECHNOL, V19, pE273, DOI 10.1111/j.1600-0846.2012.00638.x; Baudouin JY, 2004, ACTA PSYCHOL, V117, P313, DOI 10.1016/j.actpsy.2004.07.002; Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Berlyne D. E., 1971, AESTHETICS PSYCHOBIO; Blickhan M, 2011, BIOL PSYCHOL, V88, P204, DOI 10.1016/j.biopsycho.2011.08.003; Bosch A., 2007, P 6 ACM INT C IM VID, V5, P401, DOI [10.1145/1282280.1282340, DOI 10.1145/1282280, DOI 10.1145/1282280.1282340]; Braun J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00808; Burton AM, 2010, BEHAV RES METHODS, V42, P286, DOI 10.3758/BRM.42.1.286; BURTON GJ, 1987, APPL OPTICS, V26, P157, DOI 10.1364/AO.26.000157; Chase C, 2009, OPTOMETRY VISION SCI, V86, P883, DOI 10.1097/OPX.0b013e3181ae1b7c; Cheung OS, 2008, J EXP PSYCHOL HUMAN, V34, P1327, DOI 10.1037/a0011752; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Dakin S., 2009, J VISION, V9; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; de Tommaso M, 2008, CONSCIOUS COGN, V17, P1152, DOI 10.1016/j.concog.2008.07.002; Dixson BJ, 2013, EVOL HUM BEHAV, V34, P236, DOI 10.1016/j.evolhumbehav.2013.02.003; EAGLY AH, 1991, PSYCHOL BULL, V110, P109, DOI 10.1037/0033-2909.110.1.109; Ebner NC, 2008, BEHAV RES METHODS, V40, P130, DOI [10.3758/BRM.40.1.130, 10.3738/BRM.40.1.130]; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Fechner G.T., 1876, VORSCHULE STHETIK; Fernandez D, 2008, PERCEPTION, V37, P1098, DOI 10.1068/p5814; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2012, J EUR ACAD DERMATOL, V26, P1486, DOI 10.1111/j.1468-3083.2011.04316.x; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Foos PW, 2011, J GENET PSYCHOL, V172, P162, DOI 10.1080/00221325.2010.526154; Goffaux V, 2005, PERCEPTION, V34, P77, DOI 10.1068/p5370; Goffaux V, 2006, J EXP PSYCHOL HUMAN, V32, P1023, DOI 10.1037/0096-1523.32.4.1023; Goffaux V, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00143; Graham DJ, 2010, VISION RES, V50, P1503, DOI 10.1016/j.visres.2010.05.002; Graham DJ, 2008, SPATIAL VISION, V21, P149, DOI 10.1163/156856808782713771; Grammer K, 2003, BIOL REV, V78, P385, DOI 10.1017/S1464793102006085; HENSS R, 1991, J APPL SOC PSYCHOL, V21, P933, DOI 10.1111/j.1559-1816.1991.tb00451.x; Honekopp J, 2006, J EXP PSYCHOL HUMAN, V32, P199, DOI 10.1037/0096-1523.32.2.199; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Juricevic I, 2010, PERCEPTION, V39, P884, DOI 10.1068/p6656; Keil MS, 2008, P ROY SOC B-BIOL SCI, V275, P2095, DOI 10.1098/rspb.2008.0486; Koch M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012268; KORTHASE KM, 1982, PERCEPT MOTOR SKILL, V54, P1251, DOI 10.2466/pms.1982.54.3c.1251; Kwart DG, 2012, PERCEPTION, V41, P925, DOI 10.1068/p7136; Langlois JH, 2000, PSYCHOL BULL, V126, P390, DOI 10.1037/0033-2909.126.3.390; Little A, 2002, PSYCHOLOGIST, V15, P28; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; McKimmie B, 2002, A FACE ACAD FACIAL A; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Nadal M., 2007, THESIS U ILLES BALEA; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; O'Hare L, 2013, J VISION, V13, DOI 10.1167/13.5.7; O'Hare L, 2011, VISION RES, V51, P1767, DOI 10.1016/j.visres.2011.06.002; Pachai MV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00074; Parraga CA, CURRENT BIOL, V10, P35; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Phillips PJ, 1998, IMAGE VISION COMPUT, V16, P295, DOI 10.1016/S0262-8856(97)00070-X; Porcheron A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057985; Puccetti G, 2011, SKIN RES TECHNOL, V17, P129, DOI 10.1111/j.1600-0846.2010.00480.x; Reber R, 2004, PERS SOC PSYCHOL REV, V8, P364, DOI 10.1207/s15327957pspr0804_3; Redies C, 2007, NETWORK-COMP NEURAL, V18, P235, DOI 10.1080/09548980701574496; Redies C, 2012, LECT NOTES COMPUT SC, V7583, P522, DOI 10.1007/978-3-642-33863-2_54; Redies C, 2008, SPATIAL VISION, V21, P97, DOI 10.1163/156856808782713780; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes MG, 2009, APPL COGNITIVE PSYCH, V23, P1, DOI 10.1002/acp.1442; Rotshtein P, 2007, CEREB CORTEX, V17, P2713, DOI 10.1093/cercor/bhl180; Ruiz-Soler M, 2006, PSYCHOL RES-PSYCH FO, V70, P273, DOI 10.1007/s00426-005-0215-z; Russell R, 2003, PERCEPTION, V32, P1093, DOI 10.1068/p5101; Samson N, 2010, J COSMET DERMATOL-US, V9, P79, DOI 10.1111/j.1473-2165.2010.00489.x; Stephen ID, 2012, EVOL PSYCHOL-US, V10, P562; TADMOR Y, 1994, VISION RES, V34, P541, DOI 10.1016/0042-6989(94)90167-8; Thornhill R, 1999, TRENDS COGN SCI, V3, P452, DOI 10.1016/S1364-6613(99)01403-5; TOLHURST DJ, 1992, OPHTHAL PHYSL OPT, V12, P229, DOI 10.1111/j.1475-1313.1992.tb00296.x; Voelkle MC, 2012, PSYCHOL AGING, V27, P265, DOI 10.1037/a0025065; Wolff N, 2012, PSYCHOL AGING, V27, P1066, DOI 10.1037/a0029112	76	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122801	10.1371/journal.pone.0122801	http://dx.doi.org/10.1371/journal.pone.0122801			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25835539	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000352139000113
J	Moghimi, S; Schudlo, L; Chau, T; Guerguerian, AM				Moghimi, Saba; Schudlo, Larissa; Chau, Tom; Guerguerian, Anne-Marie			Variability in Prefrontal Hemodynamic Response during Exposure to Repeated SelfSelected Music Excerpts, a Near-Infrared Spectroscopy Study	PLOS ONE			English	Article							PATIENT; ANXIETY; CORTEX; RECOGNITION; CORRELATE; PLEASANT	Music-induced brain activity modulations in areas involved in emotion regulation may be useful in achieving therapeutic outcomes. Clinical applications of music may involve prolonged or repeated exposures to music. However, the variability of the observed brain activity patterns in repeated exposures to music is not well understood. We hypothesized that multiple exposures to the same music would elicit more consistent activity patterns than exposure to different music. In this study, the temporal and spatial variability of cerebral prefrontal hemodynamic response was investigated across multiple exposures to self-selected musical excerpts in 10 healthy adults. The hemodynamic changes were measured using prefrontal cortex near infrared spectroscopy and represented by instantaneous phase values. Based on spatial and temporal characteristics of these observed hemodynamic changes, we defined a consistency index to represent variability across these domains. The consistency index across repeated exposures to the same piece of music was compared to the consistency index corresponding to prefrontal activity from randomly matched non-identical musical excerpts. Consistency indexes were significantly different for identical versus non-identical musical excerpts when comparing a subset of repetitions. When all four exposures were compared, no significant difference was observed between the consistency indexes of randomly matched non-identical musical excerpts and the consistency index corresponding to repetitions of the same musical excerpts. This observation suggests the existence of only partial consistency between repeated exposures to the same musical excerpt, which may stem from the role of the prefrontal cortex in regulating other cognitive and emotional processes.	[Moghimi, Saba; Schudlo, Larissa; Chau, Tom; Guerguerian, Anne-Marie] Univ Toronto, Toronto, ON, Canada; [Moghimi, Saba; Guerguerian, Anne-Marie] Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Schudlo, Larissa; Chau, Tom] Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Schudlo, Larissa; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital	Guerguerian, AM (corresponding author), Univ Toronto, Toronto, ON, Canada.	anne-marie.guerguerian@sickkids.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316	Natural Sciences and Engineering Research Council of Canada [227451]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This study was funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp), Grant no. 227451, Title: Intelligent systems for pediatric rehabilitation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya J, 2001, INT J PSYCHOPHYSIOL, V42, P287, DOI 10.1016/S0167-8760(01)00153-2; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Brattico E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00308; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Chan MF, 2012, J CLIN NURS, V21, P776, DOI 10.1111/j.1365-2702.2011.03954.x; Chan MF, 2011, COMPLEMENT THER MED, V19, P332, DOI 10.1016/j.ctim.2011.08.003; Chanda ML, 2013, TRENDS COGN SCI, V17, P179, DOI 10.1016/j.tics.2013.02.007; Chlan LL, 2013, JAMA-J AM MED ASSOC, V309, P2335, DOI 10.1001/jama.2013.5670; Cope M., 1992, APPL NEAR INFRARED S, P214; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Davis T, 2012, DIMENS CRIT CARE NUR, V31, P159, DOI 10.1097/DCC.0b013e31824dffc6; Garza-Villarreal EA, 2014, FRONT PSYCHOL, P5; Green AC, 2008, NEUROREPORT, V19, P711, DOI 10.1097/WNR.0b013e3282fd0dd8; Hoshi Y, 2011, J NEUROIMAGING, V21, pe94, DOI 10.1111/j.1552-6569.2009.00454.x; Janata P, 2002, SCIENCE, V298, P2167, DOI 10.1126/science.1076262; Jiang J, 2013, ART PSYCHOTHER, V40, P201, DOI 10.1016/j.aip.2013.02.002; Katz MH, 2006, STUDY DESIGN STAT AN; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Koelsch S, 2010, TRENDS COGN SCI, V14, P131, DOI 10.1016/j.tics.2010.01.002; Korhonen MD, 2006, IEEE T SYST MAN CY B, V36, P588, DOI 10.1109/TSMCB.2005.862491; Minati L, 2009, NEUROREPORT, V20, P87, DOI 10.1097/WNR.0b013e32831af235; Moghimi S, 2012, NEUROSCI LETT, V525, P7, DOI 10.1016/j.neulet.2012.07.009; Morris JD, 1995, J ADVERTISING RES, V35, P63; Pereira CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027241; Power SD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/6/066004; Schudlo LC, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/046018; Schudlo LC., 2012, THESIS; Soto D, 2009, P NATL ACAD SCI USA, V106, P6011, DOI 10.1073/pnas.0811681106; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Tai K, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-39; Trappe H-J, 2012, MUSIC MED, V4, P100, DOI DOI 10.1177/1943862112438106; Vachiramon V, 2013, DERMATOL SURG, V39, P298, DOI 10.1111/dsu.12047; Van Den Bosch I, 2013, FRONT HUM NEUROSCI, P7; VanDrongelen W, 2010, SIGNAL PROCESSING FOR NEUROSCIENTISTS, A COMPANION VOLUME: ADVANCED TOPICS, NONLINEAR TECHNIQUES AND MULTI-CHANNEL ANALYSIS, P1; Warrier CM, 2004, BRAIN, V127, P1616, DOI 10.1093/brain/awh183; Zhu H, 2010, IET IMAGE PROCESS, V4, P335, DOI 10.1049/iet-ipr.2009.0195	39	2	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122148	10.1371/journal.pone.0122148	http://dx.doi.org/10.1371/journal.pone.0122148			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CE9BS	25837268	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000080
J	Tsao, HM; Sun, YC; Liou, DM				Tsao, Hsiao-Mei; Sun, Ying-Chou; Liou, Der-Ming			A Rational Approach to Estimating the Surgical Demand Elasticity Needed to Guide Manpower Reallocation during Contagious Outbreaks	PLOS ONE			English	Article							INFECTION-CONTROL; SARS OUTBREAK; EPIDEMIC; FEAR	Background Emerging infectious diseases continue to pose serious threats to global public health. So far, however, few published study has addressed the need for manpower reallocation needed in hospitals when such a serious contagious outbreak occurs. Aim To quantify the demand elasticity of the major surgery types in order to guide future manpower reallocation during contagious outbreaks. Materials and Methods Based on a nationwide research database in Taiwan, we extracted the monthly volumes of major surgery types for the period 1998-2003, which covered the SARS period, in order to carry out a time series analysis. The demand elasticity of each surgery type was then estimated by autoregressive integrated moving average (ARIMA) analysis. Results During the study period, the surgical volumes of most selected surgery types either increased or remained steady. We categorized these surgery types into low-, moderate- and high-elastic groups according to their demand elasticity. Appendectomy, 'open reduction of fracture with internal fixation' and 'free skin graft' were in the low demand elasticity group. Transurethral prostatectomy and extracorporeal shockwave lithotripsy (ESWL) were in the high demand elasticity group. The manpower of the departments carrying out the surgeries with low demand elasticity should be maintained during outbreaks. In contrast, departments in charge of surgeries mainly with high demand elasticity, like urology departments, may be in a position to have part of their staff reallocated. Conclusions Taking advantage of the demand variation during the SARS period in 2003, we adopted the concept of demand elasticity and used a time series approach to figure out an effective index of demand elasticity for various types of surgery that could be used as a rational reference to carry out manpower reallocation during contagious outbreak situations.	[Tsao, Hsiao-Mei; Sun, Ying-Chou; Liou, Der-Ming] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Sun, Ying-Chou] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Sun, Ying-Chou] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Liou, DM (corresponding author), Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan.	dmliou@ym.edu.tw			Taipei Veterans General Hospital, Taiwan [V103B-039]	Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This work is supported by Taipei Veterans General Hospital, Taiwan, grant number (V103B-039). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LONG HLTH INS DAT LH; Chang HJ, 2004, AM J PUBLIC HEALTH, V94, P562, DOI 10.2105/AJPH.94.4.562; Chen YC, 2004, EMERG INFECT DIS, V10, P895, DOI 10.3201/eid1005.030777; Cheng VCC, 2013, ANTIVIR RES, V100, P407, DOI 10.1016/j.antiviral.2013.08.016; Chow C B, 2004, Paediatr Respir Rev, V5, P289, DOI 10.1016/j.prrv.2004.07.006; Huang HH, 2006, J FORMOS MED ASSOC, V105, P31, DOI 10.1016/S0929-6646(09)60106-6; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Murphy GT, 2013, HEALTH POLICY PLANN, V28, P739, DOI 10.1093/heapol/czs115; Person B, 2004, EMERG INFECT DIS, V10, P358, DOI 10.3201/eid1002.030750; Taylor BL, 2010, INTENS CARE MED, V36, pS45, DOI 10.1007/s00134-010-1764-1; Wang KY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089405	11	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122625	10.1371/journal.pone.0122625	http://dx.doi.org/10.1371/journal.pone.0122625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837596	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000103
J	Leibowitch, J; Mathez, D; de Truchis, P; Ledu, D; Melchior, JC; Carcelain, G; Izopet, J; Perronne, C; David, JR				Leibowitch, Jacques; Mathez, Dominique; de Truchis, Pierre; Ledu, Damien; Melchior, Jean Claude; Carcelain, Guislaine; Izopet, Jacques; Perronne, Christian; David, John R.			Four days a week or less on appropriate anti-HIV drug combinations provided long-term optimal maintenance in 94 patients: the ICCARRE project	FASEB JOURNAL			English	Article						medical ethics; deontology; adjusted posology	ACTIVE ANTIRETROVIRAL THERAPY; CD4(+) T-CELLS; VIROLOGICAL FAILURE; HIV-1-INFECTED PATIENTS; INDUCTION THERAPY; INFECTED PATIENTS; LATENT RESERVOIR; INTERRUPTION; REPLICATION; ADHERENCE	Short, intraweekly cycles of anti-HIV combinations have provided intermittent, effective therapy (on 48 patients) (1). The concept is now extended to 94 patients on treatment, 4 days per week or less, over a median of 2.7 discontinuous treatment years per patient. On suppressive combinations, 94 patients volunteered to treatment, 5 and 4 days perweek, or reduced stepwise to 4, 3, 2, and 1 days per week in 94, 84, 66, and 12 patients, respectively, on various triple, standard, antiviral combinations, or nonregistered, quadruple, antiviral combinations. Ninety-four patients on treatment 4 days per week aggregated 165 intermittent treatment years; no viral breakthrough was observed over 87 average treatment weeks per patient, 63 of 94 having passed 2.5 intermittent treatment years on any of the antiviral combinations prescribed. On the hyperintermittent treatment of 3, 2, and 1 days per week, HIV RNA surged>50 copies, 4 weeks apart, in 18 instances (6.8 viral escapes/100 hyperdiscontinuous maintenance years). Viral escapes could have been a result of erratic adherence (EA) to regimen or follow-up (3 patients)-drug taken at half of the daily recommended dosage (8 patients) and/or overlooked archival-resistant HIVs from antecedent treatment failures (6 patients). Aside from the above circumstances, HIV unexpectedly rebounded in 3 patients on 2 days per week treatment and 1 patient on 1 day per week treatment, posting 2.2 intrinsic viral escapes/100 highly discontinuous treatment years. All 18 escapes were eventually reversed by 7 days per week salvage combinations, and 11 of 18 patients have been back for a second course of intermittent therapy, 4 days per week or less. Both cell-activation markers on the surface of T lymphocytes and cell-bound HIV DNA levels remained stable or declined. CD4/CD8 ratios rose to >= 1 in 35% of patients, whereas CD4 counts went >= 500/mu l in 75%. These values were previously 7 and 40%, respectively, on 7 days per week therapy. In our aging, long, HIV-enduring, multitreated patient cohort, treatment 4 days per week and less over 421 intermittent treatment years reduced prescription medicines by 60%-equivalent to 3 drug-free/3 virus-free remission year per patient-actually sparing (sic)3 million on just 94 patients at the cost of 2.2 intrinsic viral failure/100 hyperintermittent treatment years. At no risk of viral escape, maintenance therapy, 4 days per week, would quasiuniversally offer 40% cuts off of current over-prescriptions.	[Leibowitch, Jacques; Mathez, Dominique; de Truchis, Pierre; Ledu, Damien; Melchior, Jean Claude; Perronne, Christian] Hop Raymond Poincare, F-92380 Garches, France; [Carcelain, Guislaine] Hop La Pitie Salpetriere, Paris, France; [Izopet, Jacques] Purpan Hosp, Toulouse, France; [David, John R.] Harvard Univ, Sch Med, TH Chan Sch Pub Hlth, Boston, MA USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Harvard University; Harvard Medical School; Harvard T.H. Chan School of Public Health	Leibowitch, J (corresponding author), Hop Raymond Poincare, 104 Blvd Raymond Poincare, F-92380 Garches, France.	jacques.leibowitch@rpc.aphp.fr		IZOPET, JACQUES/0000-0002-8462-3234				American College of Physicians, 2012, ACP ETH MAN; Ananworanich J, 2003, AIDS, V17, pF33, DOI 10.1097/00002030-200310170-00001; [Anonymous], 2011, CLIN MAN TREATM HIV; Arribas JR, 2010, AIDS, V24, P223, DOI 10.1097/QAD.0b013e3283348944; Autran B, 1997, SCIENCE, V277, P112, DOI 10.1126/science.277.5322.112; Baril J, 2014, HIV MED, V15, P301, DOI 10.1111/hiv.12118; Bierman WFW, 2009, AIDS, V23, P279, DOI 10.1097/QAD.0b013e32831c54e5; Boulassel MR, 2012, J CLIN VIROL, V53, P29, DOI 10.1016/j.jcv.2011.09.018; Boyle A, 2012, J INT AIDS SOC, V15, P11, DOI 10.7448/IAS.15.6.18121; Charpentier C, 2012, J ANTIMICROB CHEMOTH, V67, P2231, DOI 10.1093/jac/dks191; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Cohen CJ, 2007, HIV CLIN TRIALS, V8, P19, DOI 10.1310/hct0801-19; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Descamps D, 2000, JAMA-J AM MED ASSOC, V283, P205, DOI 10.1001/jama.283.2.205; Devereux HL, 1999, AIDS, V13, pF123, DOI 10.1097/00002030-199912240-00001; Dybul M, 2004, J INFECT DIS, V189, P1974, DOI 10.1086/386344; Dybul M, 2002, ANN INTERN MED, V137, P381, DOI 10.7326/0003-4819-137-5_Part_2-200209031-00001; Dybul M, 2001, P NATL ACAD SCI USA, V98, P15161, DOI 10.1073/pnas.261568398; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Ferguson NM, 2005, J ROY SOC INTERFACE, V2, P349, DOI 10.1098/rsif.2005.0037; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fourati S, 2014, J ANTIMICROB CHEMOTH, V69, P753, DOI 10.1093/jac/dkt428; Gantner P, 2014, SCAND J INFECT DIS, V46, P838, DOI 10.3109/00365548.2014.947318; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Ghosn J, 2010, ANTIVIR THER, V15, P993, DOI 10.3851/IMP1666; Gianotti N, 2012, J ANTIMICROB CHEMOTH, V67, P213, DOI 10.1093/jac/dkr422; Giuntini R, 2010, HIV MED, V11, P40, DOI 10.1111/j.1468-1293.2009.00740.x; Glass TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029186; Guiguet M, 2012, AIDS, V26, P2345, DOI 10.1097/QAD.0b013e32835646e0; Havlir DV, 1998, NEW ENGL J MED, V339, P1261, DOI 10.1056/NEJM199810293391801; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Hocqueloux L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049289; Izopet J, 2002, VIROLOGY, V302, P393, DOI 10.1006/viro.2002.1621; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kaulich-Bartz J, 2013, AIDS, V27, P1641, DOI 10.1097/QAD.0b013e3283601199; Kent SJ, 2012, AIDS RES HUM RETROV, V28, P761, DOI [10.1089/aid.2012.0017, 10.1089/AID.2012.0017]; KESANIEMI YA, 1990, AM J CLIN NUTR, V51, P1007, DOI 10.1093/ajcn/51.6.1007; Lambert-Niclot S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041390; Ledergerber B, 2011, HIV MED, V12, P279, DOI 10.1111/j.1468-1293.2010.00880.x; Ledergerber B, 1999, LANCET, V353, P863, DOI 10.1016/S0140-6736(99)01122-8; Leibowitch J, 2010, FASEB J, V24, P1649, DOI 10.1096/fj.09-148676; Lucas GM, 1999, ANN INTERN MED, V131, P81, DOI 10.7326/0003-4819-131-2-199907200-00002; Mathis S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022003; Molina JM, 2014, HIV MED, V15, P57, DOI 10.1111/hiv.12071; Mugavero MJ, 2009, CLIN INFECT DIS, V48, P248, DOI 10.1086/595705; Neumann AU, 1999, AIDS, V13, P677, DOI 10.1097/00002030-199904160-00008; Pan XY, 2013, CELL RES, V23, P876, DOI 10.1038/cr.2013.74; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2014, GUID US ANT AG HIV 1; Parienti JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002783; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Pialoux G, 1998, NEW ENGL J MED, V339, P1269, DOI 10.1056/NEJM199810293391802; Piketty C, 2010, J MED VIROL, V82, P1819, DOI 10.1002/jmv.21907; Reijers MHE, 1998, LANCET, V352, P185, DOI 10.1016/S0140-6736(98)06193-5; Reynolds SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010307; Rokx C, 2015, CLIN INFECT DIS, V60, P143, DOI 10.1093/cid/ciu763; Rudy BJ, 2009, AIDS RES HUM RETROV, V25, P555, DOI 10.1089/aid.2008.0203; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Siliciano JD, 2013, CURR OPIN HIV AIDS, V8, P318, DOI 10.1097/COH.0b013e328361eaca; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Tseng A, 2012, AM J HEALTH-SYST PH, V69, P1284, DOI 10.2146/ajhp110721; Tseng AL, 2013, ANTIVIR THER, V18, P735, DOI 10.3851/IMP2685; Wilson IB, 2013, JAIDS-J ACQ IMM DEF, V64, P448, DOI 10.1097/QAI.0000000000000025; Yazdanpanah Y, 2009, CLIN INFECT DIS, V49, P1441, DOI 10.1086/630210; Zehnacker L, 2014, AIDS RES TREAT, V2014, DOI 10.1155/2014/724958; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101	68	12	12	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2015	29	6					2223	2234		10.1096/fj.14-260315	http://dx.doi.org/10.1096/fj.14-260315			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CJ0ZF	25833895				2022-12-26	WOS:000355209500002
J	Zhang, ZT; Elsayed, AK; Shi, QQ; Zhang, YN; Zuo, QS; Li, D; Lian, C; Tang, BB; Xiao, TR; Xu, Q; Chang, GB; Chen, GH; Zhang, L; Wang, KH; Wang, YJ; Jin, K; Wang, YL; Song, JZ; Cui, HM; Li, BC				Zhang, Zhentao; Elsayed, Ahmed Kamel; Shi, Qingqing; Zhang, Yani; Zuo, Qisheng; Li, Dong; Lian, Chao; Tang, Beibei; Xiao, Tianrong; Xu, Qi; Chang, Guobin; Chen, Guohong; Zhang, Lei; Wang, Kehua; Wang, Yingjie; Jin, Kai; Wang, Yilin; Song, Jiuzhou; Cui, Hengmi; Li, Bichun			Crucial Genes and Pathways in Chicken Germ Stem Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VIVO; FUNCTIONAL-CHARACTERIZATION; MOLECULAR EVOLUTION; SIGNAL-TRANSDUCTION; SELF-RENEWAL; EXPRESSION; PROTEIN; MOUSE; IDENTIFICATION; CHROMOSOME	Male germ cell differentiation is a subtle and complex regulatory process. Currently, its regulatory mechanism is still not fully understood. In our experiment, we performed the first comprehensive genome and transcriptome-wide analyses of the crucial genes and signaling pathways in three kinds of crucial cells (embryonic stem cells, primordial germ cell, and spermatogonial stem cells) that are associated with the male germ cell differentiation. We identified thousands of differentially expressed genes in this process, and from these we chose 173 candidate genes, of which 98 genes were involved in cell differentiation, 19 were involved in the metabolic process, and 56 were involved in the differentiation and metabolic processes, like GAL9, AMH, PLK1, and PSMD7 and so on. In addition, we found that 18 key signaling pathways were involved mainly in cell proliferation, differentiation, and signal transduction processes like TGF-beta, Notch, and Jak-STAT. Further exploration found that the candidate gene expression patterns were the same between in vitro induction experiments and transcriptome results. Our results yield clues to the mechanistic basis of male germ cell differentiation and provide an important reference for further studies.	[Zhang, Zhentao; Elsayed, Ahmed Kamel; Shi, Qingqing; Zhang, Yani; Zuo, Qisheng; Li, Dong; Lian, Chao; Tang, Beibei; Xiao, Tianrong; Xu, Qi; Chang, Guobin; Chen, Guohong; Zhang, Lei; Wang, Yingjie; Jin, Kai; Wang, Yilin; Cui, Hengmi; Li, Bichun] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Kehua] Chinese Acad Agr Sci, Poultry Inst, Yangzhou 225009, Jiangsu, Peoples R China; [Song, Jiuzhou] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20740 USA; [Elsayed, Ahmed Kamel] Suez Canal Univ, Coll Vet Med, Dept Anat & Embryol, Ismailia 41522, Egypt	Yangzhou University; Chinese Academy of Agricultural Sciences; University System of Maryland; University of Maryland College Park; Egyptian Knowledge Bank (EKB); Suez Canal University	Zhang, YN (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, 48 East Wenhui Rd, Yangzhou 225009, Jiangsu, Peoples R China.	ynzhang@yzu.edu.cn; yubcli@yzu.edu.cn	XU, Qi/AID-2262-2022; Elsayed, Ahmed/AAC-9689-2020; JIN, KAI/AAY-8565-2020; Song, Jiuzhou/AAD-6440-2020	JIN, KAI/0000-0003-2489-2173; Kamel, Ahmed/0000-0002-2519-1531				Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Arikawa T, 2009, BONE, V44, P849, DOI 10.1016/j.bone.2009.01.365; Ault BH, 2000, PEDIATR NEPHROL, V14, P1045, DOI 10.1007/s004670050069; Backstrom N, 2005, MOL BIOL EVOL, V22, P1992, DOI 10.1093/molbev/msi198; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; BEHRINGER RR, 1994, CURR TOP DEV BIOL, V29, P171, DOI 10.1016/S0070-2153(08)60550-5; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Breau MA, 2013, P NATL ACAD SCI USA, V110, P16892, DOI 10.1073/pnas.1306282110; Briggs MM, 2000, J EXP BIOL, V203, P2485; Butcher JT, 2007, DEV BIOL, V302, P256, DOI 10.1016/j.ydbio.2006.09.048; Camerino GM, 2006, CELL MOL BIOL, V52, P51, DOI 10.1170/T750; Ceplitis H, 2004, MOL BIOL EVOL, V21, P249, DOI 10.1093/molbev/msg239; CHAKRAVARTI S, 1995, MAMM GENOME, V6, P367, DOI 10.1007/BF00364803; Chen CH, 1997, J BIOL CHEM, V272, P8679, DOI 10.1074/jbc.272.13.8679; Chen CMA, 2000, MECH DEVELOP, V90, P293; Chia NY, 2010, NATURE, V468, P316, DOI 10.1038/nature09531; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Edelmann HML, 1999, BIOL CHEM, V380, P231, DOI 10.1515/BC.1999.031; Edgar AJ, 1996, J ANAT, V189, P451; Ellegren H, 2001, GENETICS, V158, P325; Ewen KA, 2010, MOL CELL ENDOCRINOL, V323, P76, DOI 10.1016/j.mce.2009.12.013; Fan XH, 2003, MOL CELL BIOL, V23, P4637, DOI 10.1128/MCB.23.13.4637-4648.2003; Foley HA, 2002, J BIOL CHEM, V277, P16211, DOI 10.1074/jbc.M106556200; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Garcez RC, 2014, CELL MOL LIFE SCI, V71, P2149, DOI 10.1007/s00018-013-1477-z; Grigoryev SA, 1999, J BIOL CHEM, V274, P5626, DOI 10.1074/jbc.274.9.5626; Grottoli S, 1996, J ENDOCRINOL INVEST, V19, P739, DOI 10.1007/BF03347877; Gupta-Rossi N, 2011, J BIOL CHEM, V286, P18720, DOI 10.1074/jbc.M110.190769; Haddad N, 2011, AM J PHYSIOL-RENAL, V301, pF1057, DOI 10.1152/ajprenal.00497.2010; Handel MA, 2006, MOL CELL ENDOCRINOL, V250, P201, DOI 10.1016/j.mce.2005.12.046; HARWIG SSL, 1994, FEBS LETT, V342, P281, DOI 10.1016/0014-5793(94)80517-2; Hattori S, 1996, YAKUGAKU ZASSHI, V116, P21, DOI 10.1248/yakushi1947.116.1_21; HIGGS DR, 1989, BLOOD, V73, P1081; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Hu JJ, 2010, J BIOL CHEM, V285, P33113, DOI 10.1074/jbc.M110.117044; Huber TB, 2003, HUM MOL GENET, V12, P3397, DOI 10.1093/hmg/ddg360; Irwin DM, 2003, J MOL EVOL, V56, P234, DOI 10.1007/s00239-002-2396-z; Johnson PA, 2008, BIOL REPROD, V78, P13, DOI 10.1095/biolreprod.107.061879; Kitadate Y, 2010, P NATL ACAD SCI USA, V107, P14241, DOI 10.1073/pnas.1003462107; KullakUblick GA, 1996, J HEPATOL, V25, P985, DOI 10.1016/S0168-8278(96)80307-2; KULLAKUBLICK GA, 1995, GASTROENTEROLOGY, V109, P1274, DOI 10.1016/0016-5085(95)90588-X; Kumar MS, 2003, CIRC RES, V92, P840, DOI 10.1161/01.RES.0000069031.55281.7C; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; LOPEZ FJ, 1991, P NATL ACAD SCI USA, V88, P4508, DOI 10.1073/pnas.88.10.4508; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; MAGUIRE J, 1994, SCIENCE, V265, P241, DOI 10.1126/science.7912851; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marx SO, 2000, CELL, V101, P365, DOI 10.1016/S0092-8674(00)80847-8; Miles DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054606; Milona P, 2007, BIOCHEM BIOPH RES CO, V356, P169, DOI 10.1016/j.bbrc.2007.02.098; Mu H, 2003, MECH DEVELOP, V120, P143, DOI 10.1016/S0925-4773(02)00423-9; MURAGAKI Y, 1991, EUR J BIOCHEM, V197, P615, DOI 10.1111/j.1432-1033.1991.tb15951.x; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pernaute B, 2010, DEV DYNAM, V239, P620, DOI 10.1002/dvdy.22176; Pommereit D, 2001, MECH DEVELOP, V102, P255, DOI 10.1016/S0925-4773(01)00305-7; Rao M, 2004, DEV BIOL, V275, P269, DOI 10.1016/j.ydbio.2004.08.013; Rastegar T, 2013, IRAN J BASIC MED SCI, V16, P134; Revenkova E, 2004, NAT CELL BIOL, V6, P555, DOI 10.1038/ncb1135; Sahlender DA, 2005, J CELL BIOL, V169, P285, DOI 10.1083/jcb.200501162; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2005, CELL CYCLE, V4, P1736, DOI 10.4161/cc.4.12.2209; SAJJADI FG, 1991, NEW BIOL, V3, P769; Salic AN, 1997, DEVELOPMENT, V124, P4739; Scaal M, 2001, ANAT EMBRYOL, V203, P1, DOI 10.1007/PL00008244; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI12849; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; SUMOY L, 1995, DEV BIOL, V170, P230, DOI 10.1006/dbio.1995.1210; SZALA S, 1990, P NATL ACAD SCI USA, V87, P6833, DOI 10.1073/pnas.87.17.6833; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Trbovich AM, 2004, J STEROID BIOCHEM, V92, P199, DOI 10.1016/j.jsbmb.2004.07.002; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Wahlberg K, 2009, BLOOD, V114, P1254, DOI 10.1182/blood-2009-03-210146; Wang B, 2006, NUTR NEUROSCI, V9, P147, DOI 10.1080/10284150600903594; WEISS J, 1987, BLOOD, V69, P652; Western PS, 1999, DEV DYNAM, V216, P411; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yu Z, 2009, J MOL CELL BIOL, V1, P93, DOI 10.1093/jmcb/mjp026; Zhang YG, 2008, J HYPERTENS, V26, P1119, DOI 10.1097/HJH.0b013e3282fa1412; Zhou JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065755; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	84	30	32	0	28	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13605	13621		10.1074/jbc.M114.601401	http://dx.doi.org/10.1074/jbc.M114.601401			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847247	Green Published, hybrid			2022-12-26	WOS:000354975700053
J	Ozcan, B; Negi, P; Laezza, F; Papadakis, M; Labate, D				Ozcan, Burcin; Negi, Pooran; Laezza, Fernanda; Papadakis, Manos; Labate, Demetrio			Automated Detection of Soma Location and Morphology in Neuronal Network Cultures	PLOS ONE			English	Article							IMAGE; ALGORITHM; GPU	Automated identification of the primary components of a neuron and extraction of its subcellular features are essential steps in many quantitative studies of neuronal networks. The focus of this paper is the development of an algorithm for the automated detection of the location and morphology of somas in confocal images of neuronal network cultures. This problem is motivated by applications in high-content screenings (HCS), where the extraction of multiple morphological features of neurons on large data sets is required. Existing algorithms are not very efficient when applied to the analysis of confocal image stacks of neuronal cultures. In addition to the usual difficulties associated with the processing of fluorescent images, these types of stacks contain a small number of images so that only a small number of pixels are available along the z-direction and it is challenging to apply conventional 3D filters. The algorithm we present in this paper applies a number of innovative ideas from the theory of directional multiscale representations and involves the following steps: (i) image segmentation based on support vector machines with specially designed multiscale filters; (ii) soma extraction and separation of contiguous somas, using a combination of level set method and directional multiscale filters. We also present an approach to extract the soma's surface morphology using the 3D shearlet transform. Extensive numerical experiments show that our algorithms are computationally efficient and highly accurate in segmenting the somas and separating contiguous ones. The algorithms presented in this paper will facilitate the development of a high-throughput quantitative platform for the study of neuronal networks for HCS applications.	[Ozcan, Burcin; Negi, Pooran; Papadakis, Manos; Labate, Demetrio] Univ Houston, Dept Math, Houston, TX 77204 USA; [Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Medical Branch Galveston	Labate, D (corresponding author), Univ Houston, Dept Math, Houston, TX 77204 USA.	dlabate@math.uh.edu	Laezza, Fernanda/X-4076-2019; Laezza, Fernanda/L-6019-2016; Negi, Pooran/O-2750-2019	Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; 	National Science Foundation [DMS 1320910, DMS 1008900]; National Institutes of Health [R01 MH095995]; Division Of Mathematical Sciences [1320910] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding provided by National Science Foundation (http://www.nsf.gov) GRANTS: DMS 1320910 (MP,DL) and DMS 1008900 (DL) and National Institutes of Health (http://www.nih.gov/) grant: R01 MH095995 (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOU IE, 1979, P IEEE, V67, P753, DOI 10.1109/PROC.1979.11325; Al-Kofahi KA, 2002, IEEE T INF TECHNOL B, V6, P171, DOI 10.1109/TITB.2002.1006304; Al-Kofahi Y, 2008, CYTOM PART A, V73A, P36, DOI 10.1002/cyto.a.20499; Al-Kofahi Y, 2010, IEEE T BIO-MED ENG, V57, P841, DOI 10.1109/TBME.2009.2035102; ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055037; Cates JE, 2004, MED IMAGE ANAL, V8, P217, DOI 10.1016/j.media.2004.06.022; Cornelissen F, 2013, J BIOMOL SCREEN, V18, P807, DOI 10.1177/1087057113486518; Dolmetsch R, 2011, CELL, V145, P831, DOI 10.1016/j.cell.2011.05.034; Easley G, 2008, APPL COMPUT HARMON A, V25, P25, DOI 10.1016/j.acha.2007.09.003; Easley GR, 2012, APPL NUMER HARMON AN, P283, DOI 10.1007/978-0-8176-8316-0_8; El-Laithy K, 2012, J NEUROSCI METH, V210, P206, DOI 10.1016/j.jneumeth.2012.07.007; Gibert X, 2014, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2014-64; Gonzalez R. C., 2013, DIGITAL IMAGE PROCES, V2nd; Gough AH, 2007, METH MOL B, V356, P41; Guo KH, 2012, J FOURIER ANAL APPL, V18, P488, DOI 10.1007/s00041-011-9209-y; Guo K, 2011, APPL COMPUT HARMON A, V30, P231, DOI 10.1016/j.acha.2010.08.004; Guo KH, 2009, SIAM J IMAGING SCI, V2, P959, DOI 10.1137/080741537; He W, 2003, MICROSC MICROANAL, V9, P296, DOI 10.1017/S143192760303040X; Huang Y, 2010, J NEUROSCI METH, V190, P299, DOI 10.1016/j.jneumeth.2010.05.012; Jimenez D, 2015, APPL COMPUT HARMON A, P1; Jimenez D, 2015, NEUROINFORMATICS, V13, P227, DOI 10.1007/s12021-014-9256-z; Jimenez D, 2013, I S BIOMED IMAGING, P1050; Kutyniok G, 2012, APPL NUMER HARMON AN, P1, DOI 10.1007/978-0-8176-8316-0; Labate D, 2014, MATH MODEL NAT PHENO, V9, P177, DOI 10.1051/mmnp/20149512; Lang P, 2006, NAT REV DRUG DISCOV, V5, P343, DOI 10.1038/nrd2008; Negi PS, 2012, IEEE T IMAGE PROCESS, V21, P2944, DOI 10.1109/TIP.2012.2183883; Nieland TJF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091744; Osher S., 2003, LEVEL SET METHODS DY, P17; Ozcan B, 2013, SPIE P, V8858, P1050; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Schug DA, 2011, PROC SPIE 8058, V8058; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Sharma K, 2013, CELL REP, V5, P1330, DOI 10.1016/j.celrep.2013.11.008; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Soille P., 2004, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Svoboda K, 2011, NEUROINFORMATICS, V9, P97, DOI 10.1007/s12021-011-9097-y; Vallotton P, 2007, CYTOM PART A, V71A, P889, DOI 10.1002/cyto.a.20462; Weaver CM, 2003, J NEUROSCI METH, V124, P197, DOI 10.1016/S0165-0270(03)00017-7; Yi S, 2009, IEEE T IMAGE PROCESS, V18, P929, DOI 10.1109/TIP.2009.2013082	42	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121886	10.1371/journal.pone.0121886	http://dx.doi.org/10.1371/journal.pone.0121886			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853656	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400053
J	Shen, T; Tang, LQ; Luo, DH; Chen, QY; Li, PJ; Mai, DM; Guo, SS; Liu, LT; Qian, CN; Guo, X; Zeng, MS; Mo, HY; Mai, HQ				Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mo, Hao-Yuan; Mai, Hai-Qiang			Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of F-18-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; QUANTITATIVE-ANALYSIS; EBV DNA; TUMOR VOLUME; FDG-PET; PREDICTION; RADIOTHERAPY; CANCER; MARKER; GLUT1	Purpose To evaluate and compare the prognostic value of Epstein-Barr virus (EBV) DNA and maximal standard uptake values (SUVmax) of F-18-fluoro-2-deoxy-D-glucose positron emission tomography (F-18-FDG-PET) in subgroups of nasopharyngeal carcinoma (NPC) patients with locoregional or distant recurrence. Patients and Methods A total of 194 patients with recurrent NPC (locoregional recurrence: 107, distant recurrence: 87) were enrolled. Patients took evidence of recurrence performed with F-18-FDG-PET and an EBV DNA test before salvage treatment. Clinical parameters, the status of EBV DNA and the value of SUVmax were used for survival analysis using the Kaplan-Meier method and the Cox proportional hazards regression model. Results In the subgroup of patients with locoregional recurrence, patients with SUVmax<8.65 had significantly better overall survival (OS) (P=0.005) compared with the patients with SUVmax >= 8.65. However, both elevated EBV DNA load (>= 21,100 copies/ml) and distant SUVmax (>= 13.55) were significantly associated with worse OS compared with the patients with EBV DNA < 21,100 copies/ml or distant SUVmax < 13.55 for the subgroup with distant recurrence (P=0.015 and P=0.006, respectively). The predictive ability of EBV DNA was superior to that of SUVmax (P=0.062). Multivariate analysis showed that SUVmax was only an independent prognostic factor for OS in patients with locoregional recurrence (P=0.042), whereas EBV DNA independently predicted OS for the patients with distant recurrence (P=0.007). For those patients with undetectable EBV DNA, SUVmax<8.65 was still an independent favorable prognostic factor (P=0.038). Conclusions SUVmax is a useful biomarker for predicting OS in nasopharyngeal carcinoma patients with locoregional recurrence or with undetectable EBV DNA. Both distant SUVmax and EBV DNA appear to be independent predictors of OS in patients with distant recurrence; however, the predictive ability of EBV DNA was superior to that of SUVmax.	[Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Zeng, Mu-Sheng; Mo, Hao-Yuan; Mai, Hai-Qiang] Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Shen, Ting; Tang, Lin-Quan; Luo, Dong-Hua; Chen, Qiu-Yan; Li, Pei-Jing; Mai, Dong-Mei; Guo, Shan-Shan; Liu, Li-Ting; Qian, Chao-Nan; Guo, Xiang; Mo, Hao-Yuan; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Mo, HY (corresponding author), Sun Yat Sen Univ Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	mohy@mail.sysu.edu.cn; maihq@mail.sysu.edu.cn	Li, Peijing/AAU-9696-2021		Ministry of Science and Technology of China [2011CB504300]; National Natural Science Foundation of China [81201629, 81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034, 2011B031800161, 2011B031800314]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Sun Yat-sen University Clinical Research 5010 Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was partially supported by the Ministry of Science and Technology of China (No. 2011CB504300), the National Natural Science Foundation of China (81201629 and 81072226), the 863 Project (No: 2012AA02A501), the National Key Basic Research Program of China (No: 2013CB910304), the Sci-Tech Project Foundation of Guangdong Province (No: 2011B080701034, 2011B031800161 and 2011B031800314), the Sci-Tech Project Foundation of Guangzhou City (No: 2011J4300100), the Sun Yat-sen University Clinical Research 5010 Program and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Allal AS, 2004, INT J RADIAT ONCOL, V59, P1295, DOI 10.1016/j.ijrobp.2003.12.039; An X, 2011, CANCER-AM CANCER SOC, V117, P3750, DOI 10.1002/cncr.25932; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chan JYW, 2014, LARYNGOSCOPE, V124, P126, DOI 10.1002/lary.24193; Chan JYW, 2012, HEAD NECK-J SCI SPEC, V34, P541, DOI 10.1002/hed.21768; Chan SC, 2013, ORAL ONCOL, V49, P71, DOI 10.1016/j.oraloncology.2012.07.016; Chan SC, 2009, ORAL ONCOL, V45, P52, DOI 10.1016/j.oraloncology.2008.03.010; Chang KP, 2012, J NUCL MED, V53, P21, DOI 10.2967/jnumed.111.090696; Delbeke D, 2006, J NUCL MED, V47, P885; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fleming ID, 1997, AJCC CANC STAGING MA, P31; Haber RS, 1998, CANCER, V83, P34, DOI 10.1002/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E; Higashi K, 2002, J NUCL MED, V43, P39; Ho J H, 1978, IARC Sci Publ, P99; Hua YJ, 2012, EUR J CANCER, V48, P3422, DOI 10.1016/j.ejca.2012.06.016; Kaira K, 2010, J CLIN ONCOL, V28, P3746, DOI 10.1200/JCO.2009.27.4662; Kam MKM, 2004, INT J RADIAT ONCOL, V60, P1440, DOI 10.1016/j.ijrobp.2004.05.022; Kitagawa Y, 2003, EUR J NUCL MED MOL I, V30, P63, DOI 10.1007/s00259-002-0978-z; Lee AWM, 2005, INT J RADIAT ONCOL, V61, P1107, DOI 10.1016/j.ijrobp.2004.07.702; Lee SW, 2008, RADIOTHER ONCOL, V87, P211, DOI 10.1016/j.radonc.2008.01.009; Leung SF, 2003, CLIN CANCER RES, V9, P3431; Leung SF, 2006, J CLIN ONCOL, V24, P5414, DOI 10.1200/JCO.2006.07.7982; Lin JC, 2007, INT J RADIAT ONCOL, V68, P1342, DOI 10.1016/j.ijrobp.2007.02.012; Liu SF, 2013, CARCINOGENESIS, V34, P627, DOI 10.1093/carcin/bgs364; Liu T, 2007, RADIOTHER ONCOL, V85, P327, DOI 10.1016/j.radonc.2007.11.002; Lo YMD, 1999, CANCER RES, V59, P1188; Lo YMD, 1999, CANCER RES, V59, P5452; MIN HQ, 1994, INT J RADIAT ONCOL, V30, P1037; Minn H, 1997, J NUCL MED, V38, P1907; Le QT, 2013, CLIN CANCER RES, V19, P2208, DOI 10.1158/1078-0432.CCR-12-3702; Raab-Traub N, 2002, SEMIN CANCER BIOL, V12, P431, DOI 10.1016/S1044579X0200086X; Ayala FRR, 2010, MOLECULES, V15, P2374, DOI 10.3390/molecules15042374; Seol YM, 2010, ACTA ONCOL, V49, P201, DOI 10.3109/02841860903440270; Shao JY, 2004, CANCER, V100, P1162, DOI 10.1002/cncr.20099; Shotelersuk K, 2000, CLIN CANCER RES, V6, P1046; Wang WY, 2010, CLIN CANCER RES, V16, P1016, DOI 10.1158/1078-0432.CCR-09-2796; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wei WI, 2005, LANCET, V365, P2041, DOI 10.1016/S0140-6736(05)66698-6; Wei WI, 2004, HEAD NECK-J SCI SPEC, V26, P878, DOI 10.1002/hed.20066; Wildeman MA, 2012, CLIN CANCER RES, V18, P5061, DOI 10.1158/1078-0432.CCR-12-0574; Yang XS, 2015, INT J CANCER, V136, pE127, DOI 10.1002/ijc.29192; Yen TC, 2006, INT J RADIAT ONCOL, V65, P1307, DOI 10.1016/j.ijrobp.2006.02.031; Yip TTC, 2014, ORAL ONCOL, V50, P527, DOI 10.1016/j.oraloncology.2013.12.011; Younes M, 1997, CANCER-AM CANCER SOC, V80, P1046, DOI 10.1002/(SICI)1097-0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7; Yu MC, 2002, SEMIN CANCER BIOL, V12, P421, DOI 10.1016/S1044579X02000858	46	25	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122756	10.1371/journal.pone.0122756	http://dx.doi.org/10.1371/journal.pone.0122756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853677	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400080
J	Aoun, SM; Grande, G; Howting, D; Deas, K; Toye, C; Troeung, L; Stajduhar, K; Ewing, G				Aoun, Samar M.; Grande, Gunn; Howting, Denise; Deas, Kathleen; Toye, Chris; Troeung, Lakkhina; Stajduhar, Kelli; Ewing, Gail			The Impact of the Carer Support Needs Assessment Tool (CSNAT) in Community Palliative Care Using a Stepped Wedge Cluster Trial	PLOS ONE			English	Article							OF-LIFE CARE; FAMILY CAREGIVERS; HOME; END; CANCER; VALIDATION; INTERVENTIONS; MORTALITY; OUTCOMES; BASE	Family caregiving towards the end-of-life entails considerable emotional, social, financial and physical costs for caregivers. Evidence suggests that good support can improve caregiver psychological outcomes. The primary aimof this study was to investigate the impact of using the carer support needs assessment tool (CSNAT), as an intervention to identify and address support needs in end of life home care, on family caregiver outcomes. A stepped wedge design was used to trial the CSNAT intervention in three bases of Silver Chain Hospice Care in Western Australia, 2012-14. The intervention consisted of at least two visits from nurses (2-3 weeks apart) to identify, review and address caregivers' needs. The outcome measures for the intervention and control groups were caregiver strain and distress as measured by the Family Appraisal of Caregiving Questionnaire (FACQ-PC), caregiver mental and physical health as measured by SF-12v2, and caregiver workload as measured by extent of caregiver assistance with activities of daily living, at baseline and follow up. Total recruitment was 620. There was 45% attrition for each group between baseline and follow-up mainly due to patient deaths resulting in 322 caregivers completing the study (233 in the intervention group and 89 in the control group). At follow-up, the intervention group showed significant reduction in caregiver strain relative to controls, p=0.018, d=0.348 (95% CI 0.25 to 0.41). Priority support needs identified by caregivers included knowing what to expect in the future, having time for yourself in the day and dealing with your feelings and worries. Despite the challenges at the clinician, organisational and trial levels, the CSNAT intervention led to an improvement in caregiver strain. Effective implementation of an evidence-informed and caregiver-led tool represents a necessary step towards helping palliative care providers better assess and address caregiver needs, ensuring adequate family caregiver support and reduction in caregiver strain.	[Aoun, Samar M.; Howting, Denise; Deas, Kathleen; Toye, Chris] Curtin Univ, Sch Nursing & Midwifery, Perth, WA 6845, Australia; [Grande, Gunn] Univ Manchester, Sch Nursing Midwifery & Social Work, Manchester, Lancs, England; [Troeung, Lakkhina] Univ Western Australia, Sch Populat Hlth, Crawley, WA, Australia; [Troeung, Lakkhina] Univ Notre Dame Australia, Sch Med, Fremantle, WA, Australia; [Stajduhar, Kelli] Univ Victoria, Sch Nursing, Victoria, BC, Canada; [Stajduhar, Kelli] Univ Victoria, Ctr Aging, Victoria, BC, Canada; [Ewing, Gail] Univ Cambridge, Ctr Family Res, Cambridge, England	Curtin University; University of Manchester; University of Western Australia; University of Notre Dame Australia; University of Victoria; University of Victoria; University of Cambridge	Aoun, SM (corresponding author), Curtin Univ, Sch Nursing & Midwifery, Perth, WA 6845, Australia.	s.aoun@curtin.edu.au	Grande, Gunn/A-6163-2011; Howting, Denise Ann/GWU-5045-2022; Toye, Christine M/I-4288-2012; Stajduhar, Kelli/AAJ-5914-2021	Grande, Gunn/0000-0003-2200-1680; Howting, Denise Ann/0000-0001-8753-5849; Toye, Christine M/0000-0003-4932-0016; Stajduhar, Kelli/0000-0003-2381-4712; Aoun, Samar/0000-0002-4073-4805	Australian Research Council linkage grant and Silver Chain [LP110100622]	Australian Research Council linkage grant and Silver Chain(Australian Research Council)	This research was financially supported by an Australian Research Council linkage grant and Silver Chain (LP110100622).	Aoun S, 2015, PALLIAT MED; Aoun S., 2004, 0975229508 PALL CAR; Aoun SM, 2014, J PAIN SYMPTOM MANAG, V48, P1222, DOI 10.1016/j.jpainsymman.2014.01.007; Bedini LA, 2002, FAMILY CAREGIVERS LE, P25; Briggs H, 2000, WARNING CARING HLTH; Candy B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007617.pub2; Carers Association of Australia, 1997, CAR EN BE POOR SURV; Carers UK, 2003, MISS OPPRT IMP NEW R; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Cooper B, 2006, PSYCHO-ONCOLOGY, V15, P613, DOI 10.1002/pon.1001; Currow DC, 2012, J PAIN SYMPTOM MANAG, V44, P595, DOI 10.1016/j.jpainsymman.2011.10.028; Ewing G, 2013, J PAIN SYMPTOM MANAG, V46, P395, DOI 10.1016/j.jpainsymman.2012.09.008; Ewing G, 2013, PALLIATIVE MED, V27, P244, DOI 10.1177/0269216312440607; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Grande G, 2009, PALLIATIVE MED, V23, P339, DOI 10.1177/0269216309104875; Grande G, 2014, PALLIATIVE MED, V28, P609; Grande GE, 2009, PALLIATIVE MED, V23, P248, DOI 10.1177/0269216309102620; Harding R, 2003, PALLIATIVE MED, V17, P63, DOI 10.1191/0269216303pm667oa; Harrop E, 2014, BMC PALLIAT CARE, V13, DOI 10.1186/1472-684X-13-22; Hawkins NG, 2007, AM J PREV MED, V33, P162, DOI 10.1016/j.amepre.2007.03.020; Henwood M, 1998, IGNORED INVISIBLE CA; Holden JE, 2008, AM J NEPHROL, V28, P792, DOI 10.1159/000131102; Hudson P., 2005, EUR J PALLAIT CARE, V12, P165; Hudson P, 2009, J PAIN SYMPTOM MANAG, V38, P299, DOI 10.1016/j.jpainsymman.2008.08.010; Hudson PL, 2011, J PALLIAT MED, V14, P397, DOI 10.1089/jpm.2010.0345; Hudson PL, 2010, PALLIATIVE MED, V24, P656, DOI 10.1177/0269216310373167; Kristjanson LJ, 2004, CAN J PSYCHIAT, V49, P359, DOI 10.1177/070674370404900604; Lee LA, 2010, ENCY RES DESIGN; McGough James J, 2009, Psychiatry (Edgmont), V6, P21; Nijboer C, 2001, CANCER, V91, P1029, DOI 10.1002/1097-0142(20010301)91:5<1029::AID-CNCR1094>3.3.CO;2-T; Northouse LL, 2010, CA-CANCER J CLIN, V60, P317, DOI 10.3322/caac.20081; Payne S, 2013, NURS STAND, V28, P57, DOI [10.7748/ns2013.09.28.3.57.s50, DOI 10.7748/NS2013.09.28.3.57.S50]; Peat J, 2002, HEALTH SCIENCE RESEA; Sanderson K, 2002, AUST NZ J PUBL HEAL, V26, P343, DOI 10.1111/j.1467-842X.2002.tb00182.x; Schulz R, 1999, JAMA-J AM MED ASSOC, V282, P2215, DOI 10.1001/jama.282.23.2215; Stajduhar KI, 2010, PALLIATIVE MED, V24, P573, DOI 10.1177/0269216310371412; Tan H, 2010, EXPLORE-NY, V6, P159, DOI 10.1016/j.explore.2010.03.008; Wagenaar AC, 2000, J STUD ALCOHOL, V61, P85, DOI 10.15288/jsa.2000.61.85	38	59	60	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123012	10.1371/journal.pone.0123012	http://dx.doi.org/10.1371/journal.pone.0123012			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF3VU	25849348	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800194
J	Che, SPY; DeLeonardis, C; Shuler, ML; Stokol, T				Che, Sara P. Y.; DeLeonardis, Christine; Shuler, Michael L.; Stokol, Tracy			Tissue Factor-Expressing Tumor Cells Can Bind to Immobilized Recombinant Tissue Factor Pathway Inhibitor under Static and Shear Conditions In Vitro	PLOS ONE			English	Article							CANCER-CELLS; COAGULATION; ADHESION; ENDOTHELIUM; INVASION; COMPLEX; DISSEMINATION; METASTASIS; MDA-MB-231; MIGRATION	Mammary tumors and malignant breast cancer cell lines over-express the coagulation factor, tissue factor (TF). High expression of TF is associated with a poor prognosis in breast cancer. Tissue factor pathway inhibitor (TFPI), the endogenous inhibitor of TF, is constitutively expressed on the endothelium. We hypothesized that TF-expressing tumor cells can bind to immobilized recombinant TFPI, leading to arrest of the tumor cells under shear in vitro. We evaluated the adhesion of breast cancer cells to immobilized TFPI under static and shear conditions (0.35 - 1.3 dyn/cm(2)). We found that high-TF-expressing breast cancer cells, MDA-MB-231 (with a TF density of 460,000/cell), but not low TF-expressing MCF-7 (with a TF density of 1,400/cell), adhered to recombinant TFPI, under static and shear conditions. Adhesion of MDA-MB-231 cells to TFPI required activated factor VII (FVIIa), but not FX, and was inhibited by a factor VIIa-blocking anti-TF antibody. Under shear, adhesion to TFPI was dependent on the TFPI-coating concentration, FVIIa concentration and shear stress, with no observed adhesion at shear stresses greater than 1.0 dyn/cm(2). This is the first study showing that TF-expressing tumor cells can be captured by immobilized TFPI, a ligand constitutively expressed on the endothelium, under low shear in vitro. Based on our results, we hypothesize that TFPI could be a novel ligand mediating the arrest of TF-expressing tumor cells in high TFPI-expressing vessels under conditions of low shear during metastasis.	[Che, Sara P. Y.; Shuler, Michael L.] Cornell Univ, Dept Biomed Engn, Coll Engn, Ithaca, NY USA; [DeLeonardis, Christine; Stokol, Tracy] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Stokol, T (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	tracy.stokol@cornell.edu			Natural Sciences and Engineering Research Council of Canada; Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute [U54CA143876]; National Science Foundation [ECCS-0335765]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Cornell Center on the Microenvironment & Metastasis from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF))	S.C. is funded by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/). The work described was supported by the Cornell Center on the Microenvironment & Metastasis through Award Number U54CA143876 from the National Cancer Institute (http://physics.cancer.gov/). This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Infrastructure Network, which is supported by the National Science Foundation (Grant ECCS-0335765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMERI A, 1992, BLOOD, V79, P3219; Andreasson-Ochsner M, 2011, LAB CHIP, V11, P2876, DOI 10.1039/c1lc20067d; Bacac M, 2008, ANNU REV PATHOL-MECH, V3, P221, DOI 10.1146/annurev.pathmechdis.3.121806.151523; Bahrami M, 2005, ICMM 2005, PROCEEDINGS OF THE 3RD INTERNATIONAL CONFERENCE ON MICROCHANNELS AND MINICHANNELS, PT A, P269; Bajaj MS, 1999, THROMB HAEMOSTASIS, V82, P1047; BAJAJ MS, 1990, P NATL ACAD SCI USA, V87, P8869, DOI 10.1073/pnas.87.22.8869; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bluff JE, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1871; Burdick MM, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00103; CALLANDER NS, 1992, J BIOL CHEM, V267, P876; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Chu AJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/367284; Cole M, 2013, ONCOLOGIST, V18, P14, DOI 10.1634/theoncologist.2012-0322; Fischer EG, 1999, J CLIN INVEST, V104, P1213, DOI 10.1172/JCI7750; GIAVAZZI R, 1993, J CLIN INVEST, V92, P3038, DOI 10.1172/JCI116928; Gil-Bernabe AM, 2012, BLOOD, V119, P3164, DOI 10.1182/blood-2011-08-376426; Gleghorn JP, 2010, LAB CHIP, V10, P27, DOI 10.1039/b917959c; Glinskii OV, 2003, CLIN EXP METASTAS, V20, P451, DOI 10.1023/A:1025449031136; Green JV, 2009, LAB CHIP, V9, P677, DOI 10.1039/b813516a; Haier R, 2003, J GASTROINTEST SURG, V7, P507, DOI 10.1016/S1091-255X(03)00023-4; Hjortoe GM, 2004, BLOOD, V103, P3029, DOI 10.1182/blood-2003-10-3417; Hook F, 2005, REV BTI MOL BIOL FEB, P8; Iversen N, 1998, BRIT J HAEMATOL, V102, P889, DOI 10.1046/j.1365-2141.1998.00875.x; Kakkar AK, 1999, BRIT J SURG, V86, P890, DOI 10.1046/j.1365-2168.1999.01153.x; Kato Hisao, 2008, P147, DOI 10.1007/978-4-431-78847-8_8; Kirby B., 2010, MICRO NANOSCALE FLUI; Koizume S, 2010, BREAST CANC CURRENT, P197; Koizume S, 2006, CANCER RES, V66, P9453, DOI 10.1158/0008-5472.CAN-06-1803; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; LAWRENCE MB, 1990, BLOOD, V75, P227; Liu Z, 2010, STUDIES BIOMACROMOLE; Ma ZW, 2011, INT J GYNECOL CANCER, V21, P616, DOI 10.1097/IGC.0b013e3182150e98; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Maity G, 2011, TUMOR BIOL, V32, P129, DOI 10.1007/s13277-010-0106-9; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; Milsom C, 2009, ARTERIOSCL THROM VAS, V29, P2005, DOI 10.1161/ATVBAHA.108.177444; MORRISSEY JH, 1988, THROMB RES, V52, P247, DOI 10.1016/0049-3848(88)90084-9; Myung JH, 2010, LANGMUIR, V26, P8589, DOI 10.1021/la904678p; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Nista A, 1997, INT J CANCER, V72, P133, DOI 10.1002/(SICI)1097-0215(19970703)72:1<133::AID-IJC19>3.0.CO;2-K; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; OSTERUD B, 1995, THROMB HAEMOSTASIS, V73, P873; Otero LL, 2011, BIOMARKERS, V16, P58, DOI 10.3109/1354750X.2010.533282; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Rak J, 2009, BEST PRACT RES CL HA, V22, P71, DOI 10.1016/j.beha.2008.12.008; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; Rickles FR, 2003, CHEST, V124, p58S, DOI 10.1378/chest.124.3_suppl.58S; Santana SM, 2012, BIOMED MICRODEVICES, V14, P401, DOI 10.1007/s10544-011-9616-5; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; St Hill CA, 2011, FRONT BIOSCI-LANDMRK, V16, P3233, DOI 10.2741/3909; Stott SL, 2010, P NATL ACAD SCI USA, V107, P18392, DOI 10.1073/pnas.1012539107; Stott SL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000403; Thangawng AL, 2007, SMALL, V3, P132, DOI 10.1002/smll.200500418; Thierry B, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3480573; van den Berg YW, 2012, BLOOD, V119, P924, DOI 10.1182/blood-2011-06-317685; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Wirtz D, 2011, NAT REV CANCER, V11, P512, DOI 10.1038/nrc3080; Yokota N, 2009, BRIT J CANCER, V101, P2023, DOI 10.1038/sj.bjc.6605406; Zhang XX, 2011, J BIOL CHEM, V286, P1429, DOI 10.1074/jbc.M110.146530; Zheng XJ, 2011, LAB CHIP, V11, P3431, DOI 10.1039/c1lc20455f	60	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123717	10.1371/journal.pone.0123717	http://dx.doi.org/10.1371/journal.pone.0123717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849335	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800254
J	Cinget, B; Gerardi, S; Beaulieu, J; Bousquet, J				Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean			Less Pollen-Mediated Gene Flow for More Signatures of Glacial Lineages: Congruent Evidence from Balsam Fir cpDNA and mtDNA for Multiple Refugia in Eastern and Central North America	PLOS ONE			English	Article							MITOCHONDRIAL-DNA MINISATELLITE; PINE PINUS-BANKSIANA; TAGGED-SITE MARKERS; SPRUCE BUDWORM; ABIES PINACEAE; CHLOROPLAST MICROSATELLITES; BLACK SPRUCE; WHITE SPRUCE; PHYLOGEOGRAPHIC STRUCTURE; POSTGLACIAL COLONIZATION	The phylogeographic structure and postglacial history of balsam fir (Abies balsamea), a transcontinental North American boreal conifer, was inferred using mitochondrial DNA (mtDNA) and chloroplast DNA (cpDNA) markers. Genetic structure among 107 populations (mtDNA data) and 75 populations (cpDNA data) was analyzed using Bayesian and genetic distance approaches. Population differentiation was high for mtDNA (dispersed by seeds only), but also for cpDNA (dispersed by seeds and pollen), indicating that pollen gene flow is more restricted in balsam fir than in other boreal conifers. Low cpDNA gene flow in balsam fir may relate to low pollen production due to the inherent biology of the species and populations being decimated by recurrent spruce budworm epidemics, and/or to low dispersal of pollen grains due to their peculiar structural properties. Accordingly, a phylogeographic structure was detected using both mtDNA and cpDNA markers and population structure analyses supported the existence of at least five genetically distinct glacial lineages in central and eastern North America. Four of these would originate from glacial refugia located south of the Laurentide ice sheet, while the last one would have persisted in the northern Labrador region. As expected due to reduced pollen-mediated gene flow, congruence between the geographic distribution of mtDNA and cpDNA lineages was higher than in other North American conifers. However, concordance was not complete, reflecting that restricted but nonetheless detectable cpDNA gene flow among glacial lineages occurred during the Holocene. As a result, new cpDNA and mtDNA genome combinations indicative of cytoplasmic genome capture were observed.	[Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean] Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ, Canada; [Cinget, Benjamin; Gerardi, Sebastien; Beaulieu, Jean; Bousquet, Jean] Univ Laval, Inst Syst & Integrat Biol, Quebec City, PQ, Canada; [Beaulieu, Jean] Nat Resources Canada, Canadian Wood Fibre Ctr, Quebec City, PQ, Canada	Laval University; Laval University; Natural Resources Canada	Bousquet, J (corresponding author), Univ Laval, Canada Res Chair Forest & Environm Genom, Ctr Forest Res, Quebec City, PQ, Canada.	jean.bousquet@sbf.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [46273]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding was provided by Natural Sciences and Engineering Research Council of Canada, grant number 46273, http://www.nserc-crsng.gc.ca/index_eng.asp, to J. Bousquet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre-Planter E, 2012, MOL PHYLOGENET EVOL, V62, P263, DOI 10.1016/j.ympev.2011.09.021; [Anonymous], 1971, ATLAS US TREES; BAGNELL CR, 1975, REV PALAEOBOT PALYNO, V19, P203, DOI 10.1016/0034-6667(75)90041-X; Bagnell CRJ, 1974, POLLEN MORPHOLOGY AB; Bagnoli F., 2011, Genetics, genomics and breeding of conifers, P141; BAKUZIS EV, 1965, BALSAM FIR MONOGRAPH; Bartlein PJ, 1998, QUATERNARY SCI REV, V17, P549, DOI 10.1016/S0277-3791(98)00012-2; Baskerville GL, 1979, DEP ENV CAN FOR SERV; BENNETT KD, 1985, J BIOGEOGR, V12, P147, DOI 10.2307/2844838; BIRKS HJB, 1981, QUATERNARY RES, V16, P322, DOI 10.1016/0033-5894(81)90015-6; Blais J.R., 1985, P49; BLAIS J. R., 1952, CANADIAN JOUR ZOOL, V30, P1, DOI 10.1139/z52-001; BLAIS JR, 1981, CAN J FOREST RES, V11, P620, DOI 10.1139/x81-085; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chapco W, 2002, GENOME, V45, P313, DOI 10.1139/G01-156; Charlesworth B, 1998, MOL BIOL EVOL, V15, P538, DOI 10.1093/oxfordjournals.molbev.a025953; Clark CM, 2000, AM J BOT, V87, P774, DOI 10.2307/2656885; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Colbeck GJ, 2008, J HERED, V99, P453, DOI 10.1093/jhered/esn025; Corander J., 2009, BAPS BAYESIAN ANAL P; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Cutler PI, 2001, GEOLOGY, V29, P1039, DOI 10.1130/0091-7613(2001)029<1039:IOTGLO>2.0.CO;2; de Lafontaine G, 2010, ECOSYSTEMS, V13, P932, DOI 10.1007/s10021-010-9366-x; de Lafontaine G, 2010, J BIOGEOGR, V37, P741, DOI 10.1111/j.1365-2699.2009.02241.x; DiGiovanni F, 1996, FOREST ECOL MANAG, V83, P87, DOI 10.1016/0378-1127(95)03691-1; Du FK, 2009, MOL ECOL, V18, P1396, DOI 10.1111/j.1365-294X.2009.04107.x; DUPONT A, 1991, CAN J FOREST RES, V21, P1752, DOI 10.1139/x91-242; Dyke AS, 2002, QUATERNARY SCI REV, V21, P9, DOI 10.1016/S0277-3791(01)00095-6; Eisenhut G, 1961, UNTERSUCHUNGEN MORPH; Ennos RA, 1999, SYST ASSOC SPEC VOL, V57, P1; Excoffier L, 2006, ANNU REV ECOL EVOL S, V40, P481; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farrar J, 1996, NATURAL RESOURCES; Frank R.M., 1990, ABIES BALSAMEA, VVolume 1; Frank RM, 1973, SILVICULTURAL GUIDE; Gerardi S, 2010, MOL ECOL, V19, P5265, DOI 10.1111/j.1365-294X.2010.04881.x; Godbout J, 2005, MOL ECOL, V14, P3497, DOI 10.1111/j.1365-294X.2005.02674.x; Godbout J, 2008, MOL ECOL, V17, P2463, DOI 10.1111/j.1365-294X.2008.03761.x; Godbout J, 2012, ECOL EVOL, V2, P1853, DOI 10.1002/ece3.294; Godbout J, 2010, AM J BOT, V97, P1903, DOI 10.3732/ajb.1000148; Gugger PF, 2008, J BIOGEOGR, V35, P1665, DOI 10.1111/j.1365-2699.2008.01915.x; Hansen OK, 2005, TREE GENET GENOMES, V1, P116, DOI 10.1007/s11295-005-0016-y; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Heilveil JS, 2006, MOL ECOL, V15, P1627, DOI 10.1111/j.1365-294X.2006.02876.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Isoda K, 2000, SILVAE GENET, V49, P161; Ives W.G.H., 1995, FOREST INSECT PESTS, P95; Jackson ST, 2000, QUATERNARY SCI REV, V19, P489, DOI 10.1016/S0277-3791(99)00093-1; Jackson ST, 1997, QUATERNARY SCI REV, V16, P1, DOI 10.1016/S0277-3791(96)00047-9; Jaramillo-Correa JP, 2003, THEOR APPL GENET, V106, P1353, DOI 10.1007/s00122-002-1174-z; Jaramillo-Correa JP, 2004, MOL ECOL, V13, P2735, DOI 10.1111/j.1365-294X.2004.02258.x; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Jaramillo-Correa JP, 2009, CAN J FOREST RES, V39, P286, DOI 10.1139/X08-181; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Kleman J, 1999, NATURE, V402, P63, DOI 10.1038/47005; Klopfstein S, 2006, MOL BIOL EVOL, V23, P482, DOI 10.1093/molbev/msj057; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; Lemieux MJ, 2008, CAN J FOREST RES, V41, P1047; MACLEAN DA, 1984, FOREST CHRON, V60, P273, DOI 10.5558/tfc60273-5; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Nagylaki T, 1998, GENETICS, V148, P1325; Neale D, 1998, GENETIC MANIPULATION, P251; NIKLAS KJ, 1984, AM J BOT, V71, P356, DOI 10.2307/2443495; Oetting WS, 1995, GENOMICS, V30, P450, DOI 10.1006/geno.1995.1264; Parducci L, 2001, THEOR APPL GENET, V102, P733, DOI 10.1007/s001220051704; Perron M, 2000, P NATL ACAD SCI USA, V97, P11331, DOI 10.1073/pnas.200417097; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Potter KM, 2008, CAN J FOREST RES, V38, P2128, DOI 10.1139/X08-064; Potter KM, 2010, CONSERV GENET, V11, P1499, DOI 10.1007/s10592-009-9980-3; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Prunier J, 2012, MOL ECOL, V21, P4270, DOI 10.1111/j.1365-294X.2012.05691.x; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Searcy J.L., 1984, AGR HDB USDA, V620, P83; Semerikova SA, 2011, J BIOGEOGR, V38, P326, DOI 10.1111/j.1365-2699.2010.02394.x; Shafer ABA, 2010, MOL ECOL, V19, P4589, DOI 10.1111/j.1365-294X.2010.04828.x; Shaw J, 2006, QUATERNARY SCI REV, V25, P2059, DOI 10.1016/j.quascirev.2006.03.002; Simard I, 2006, HOLOCENE, V16, P31, DOI 10.1191/0959683606hl904rp; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Su Q, 1996, CAN J FOREST RES, V26, P1620, DOI 10.1139/x26-182; TAKAHATA N, 1985, GENETICS, V109, P441; Tremblay NO, 1999, MOL ECOL, V8, P1187, DOI 10.1046/j.1365-294x.1999.00680.x; Tsumura Y, 1998, EVOLUTION, V52, P1031, DOI [10.1111/j.1558-5646.1998.tb01831.x, 10.2307/2411234]; VANZANT K, 1979, QUATERNARY RES, V12, P358, DOI 10.1016/0033-5894(79)90034-6; Vendramin GG, 1997, GENOME, V40, P857, DOI 10.1139/g97-811; Vendramin GG, 1999, MOL ECOL, V8, P1117, DOI 10.1046/j.1365-294x.1999.00666.x; Vendramin GG, 1996, MOL ECOL, V5, P595, DOI 10.1111/j.1365-294X.1996.tb00353.x; Verity R, 2014, MOL ECOL, V23, P4216, DOI 10.1111/mec.12856; Walter R, 2001, MOL ECOL, V10, P103, DOI 10.1046/j.1365-294X.2001.01177.x; Wei XX, 2011, TREE GENET GENOMES, V7, P1025, DOI 10.1007/s11295-011-0392-4; Weir B. S., 1996, GENETIC DATA ANAL; Weir G.H., 1977, PALYNOL, V1, P157; Williams CG, 2009, CONIFER REPRODUCTIVE BIOLOGY, P3; Williams JW, 2004, ECOL MONOGR, V74, P309, DOI 10.1890/02-4045; WINKLER MG, 1986, QUATERNARY RES, V25, P235, DOI 10.1016/0033-5894(86)90060-8; Wu JY, 1998, GENETICS, V150, P1605; Xiang QP, 2009, TAXON, V58, P141, DOI 10.1002/tax.581015	104	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122815	10.1371/journal.pone.0122815	http://dx.doi.org/10.1371/journal.pone.0122815			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849816	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800163
J	Maguire, CP; Lize, A; Price, TAR				Maguire, Chris P.; Lize, Anne; Price, Tom A. R.			Assessment of Rival Males through the Use of Multiple Sensory Cues in the Fruitfly Drosophila pseudoobscura	PLOS ONE			English	Article							MATING RIVALS; COPULATION; PERCEPTION; EVOLUTION; COURTSHIP; RESPONSES; SYSTEMS	Environments vary stochastically, and animals need to behave in ways that best fit the conditions in which they find themselves. The social environment is particularly variable, and responding appropriately to it can be vital for an animal's success. However, cues of social environment are not always reliable, and animals may need to balance accuracy against the risk of failing to respond if local conditions or interfering signals prevent them detecting a cue. Recent work has shown that many male Drosophila fruit flies respond to the presence of rival males, and that these responses increase their success in acquiring mates and fathering offspring. In Drosophila melanogaster males detect rivals using auditory, tactile and olfactory cues. However, males fail to respond to rivals if any two of these senses are not functioning: a single cue is not enough to produce a response. Here we examined cue use in the detection of rival males in a distantly related Drosophila species, D. pseudoobscura, where auditory, olfactory, tactile and visual cues were manipulated to assess the importance of each sensory cue singly and in combination. In contrast to D. melanogaster, male D. pseudoobscura require intact olfactory and tactile cues to respond to rivals. Visual cues were not important for detecting rival D. pseudoobscura, while results on auditory cues appeared puzzling. This difference in cue use in two species in the same genus suggests that cue use is evolutionarily labile, and may evolve in response to ecological or life history differences between species.	[Maguire, Chris P.; Price, Tom A. R.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Lize, Anne] Univ Rennes 1, UMR ECOBIO 6553, Rennes, France	University of Liverpool; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes	Price, TAR (corresponding author), Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England.	Tom.Price@liverpool.ac.uk	Lizé, Anne/B-9897-2011	Lizé, Anne/0000-0002-7289-4205; Price, Thomas/0000-0002-4394-6301	Natural Environment Research Council [NE/H015604/1]; NERC [NE/H015604/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the Natural Environment Research Council (www.nerc.ac.uk), which was not directly involved in the work in any way (grant NE/H015604/1 to TP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RD, 1990, ETHOL SOCIOBIOL, V11, P241, DOI 10.1016/0162-3095(90)90012-U; Andersson Malte, 1994; ARMSTRONG DP, 1991, BEHAV ECOL SOCIOBIOL, V29, P103, DOI 10.1007/BF00166484; Billeter JC, 2013, CURR OPIN NEUROBIOL, V23, P17, DOI 10.1016/j.conb.2012.08.009; Bourdeau PE, 2013, ECOLOGY, V94, P1449, DOI 10.1890/12-2116.1; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bretman A, 2013, EVOLUTION, V67, P2413, DOI 10.1111/evo.12125; Bretman A, 2011, TRENDS ECOL EVOL, V26, P467, DOI 10.1016/j.tree.2011.05.002; Bretman A, 2011, CURR BIOL, V21, P617, DOI 10.1016/j.cub.2011.03.008; Bretman A, 2009, P ROY SOC B-BIOL SCI, V276, P1705, DOI 10.1098/rspb.2008.1878; Candolin U, 2003, BIOL REV, V78, P575, DOI 10.1017/S1464793103006158; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; David JR, 2005, HEREDITY, V94, P3, DOI 10.1038/sj.hdy.6800562; delBarco-Trillo J, 2004, NATURE, V431, P446, DOI 10.1038/nature02845; Fernandez MP, 2013, J COMP PHYSIOL A, V199, P1065, DOI 10.1007/s00359-013-0851-5; Garbaczewska M, 2012, J INSECT PHYSIOL, V59, P306; Gray SJ, 2002, ANIM BEHAV, V63, P531, DOI 10.1006/anbe.2001.1932; Grether GF, 2011, INTEGR COMP BIOL, V51, P807, DOI 10.1093/icb/icr060; Huijbers CM, 2012, ECOLOGY, V93, P46, DOI 10.1890/10-2236.1; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jukema J, 2006, BIOL LETTERS, V2, P161, DOI 10.1098/rsbl.2005.0416; Karlsson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012755; Kim WJ, 2012, NAT NEUROSCI, V15, P876, DOI 10.1038/nn.3104; Lize A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0631; Lize A, 2012, PHYSIOL ENTOMOL, V37, P227, DOI 10.1111/j.1365-3032.2012.00836.x; Lize A, 2012, BIOL LETTERS, V8, P35, DOI 10.1098/rsbl.2011.0544; Markow T.A., 2005, DROSOPHILA GUIDE SPE; Mateo JM, 2004, ANN ZOOL FENN, V41, P729; Paaby AB, 2009, FLY, V3, P29, DOI 10.4161/fly.3.1.7771; Panhuis TM, 1999, BEHAV ECOL SOCIOBIOL, V46, P221, DOI 10.1007/s002650050613; Pitnick S, 1997, EVOLUTION, V51, P833, DOI [10.2307/2411158, 10.1111/j.1558-5646.1997.tb03665.x]; Popov A V, 2004, Zh Evol Biokhim Fiziol, V40, P521; Price TAR, 2012, BEHAV ECOL SOCIOBIOL, V66, P561, DOI 10.1007/s00265-011-1304-1; Price TAR, 2012, J INSECT PHYSIOL, V58, P1669, DOI 10.1016/j.jinsphys.2012.10.008; Rypstra AL, 2009, ANIM BEHAV, V77, P937, DOI 10.1016/j.anbehav.2008.12.026; Santangelo N, 2002, BEHAV ECOL, V13, P676, DOI 10.1093/beheco/13.5.676; Seetharam AS, 2013, PEERJ, V1, DOI 10.7717/peerj.226; Sinervo B, 1996, NATURE, V380, P240, DOI 10.1038/380240a0; Spottiswoode CN, 2012, AM NAT, V179, P633, DOI 10.1086/665031; Spottiswoode CN, 2010, P NATL ACAD SCI USA, V107, P8672, DOI 10.1073/pnas.0910486107; Thibert-Plante X, 2013, ECOL LETT, V16, P1004, DOI 10.1111/ele.12131; Turner TL, 2012, GENETICS, V191, P633, DOI 10.1534/genetics.112.139337; WALDMAN B, 1987, J THEOR BIOL, V128, P159, DOI 10.1016/S0022-5193(87)80167-4; Wigby S, 2009, CURR BIOL, V19, P751, DOI 10.1016/j.cub.2009.03.036; Zuk M, 2014, ANNU REV ENTOMOL, V59, P321, DOI 10.1146/annurev-ento-011613-162014	45	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0123058	10.1371/journal.pone.0123058	http://dx.doi.org/10.1371/journal.pone.0123058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849643	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800199
J	Mi, G; Di, YM				Mi, Gu; Di, Yanming			The Level of Residual Dispersion Variation and the Power of Differential Expression Tests for RNA-Seq Data	PLOS ONE			English	Article							BIOCONDUCTOR	RNA-Sequencing (RNA-Seq) has been widely adopted for quantifying gene expression changes in comparative transcriptome analysis. For detecting differentially expressed genes, a variety of statistical methods based on the negative binomial (NB) distribution have been proposed. These methods differ in the ways they handle the NB nuisance parameters (i.e., the dispersion parameters associated with each gene) to save power, such as by using a dispersion model to exploit an apparent relationship between the dispersion parameter and the NB mean. Presumably, dispersion models with fewer parameters will result in greater power if the models are correct, but will produce misleading conclusions if not. This paper investigates this power and robustness trade-off by assessing rates of identifying true differential expression using the various methods under realistic assumptions about NB dispersion parameters. Our results indicate that the relative performances of the different methods are closely related to the level of dispersion variation unexplained by the dispersion model. We propose a simple statistic to quantify the level of residual dispersion variation from a fitted dispersion model and show that the magnitude of this statistic gives hints about whether and how much we can gain statistical power by a dispersion-modeling approach.	[Mi, Gu; Di, Yanming] Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA; [Di, Yanming] Oregon State Univ, Mol & Cellular Biol Program, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Mi, G (corresponding author), Oregon State Univ, Dept Stat, Corvallis, OR 97331 USA.	neo.migu@gmail.com	Mi, Gu/M-6559-2015	Mi, Gu/0000-0001-8778-954X	National Institute of General Medical Sciences of the National Institutes of Health [R01GM104977]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104977] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	YD and GM were supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R01GM104977. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; [Anonymous], 2014, R LANG ENV STAT COMP; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brooks AN, 2011, GENOME RES, V21, P193, DOI 10.1101/gr.108662.110; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Chen YS, 2014, FRONT PROBAB STAT SC, P51, DOI 10.1007/978-3-319-07212-8_3; Di Y, 2014, STAT ITS IN IN PRESS; Di YM, 2013, STAT APPL GENET MOL, V12, DOI 10.1515/sagmb-2012-0071; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hsu PY, 2013, ELIFE, V2, DOI 10.7554/eLife.00473; Huber W, 2011, GENOME RES; Landau WM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081415; Laplace PS, 1986, STAT SCI, V1, P621, DOI DOI 10.1214/SS/1177013621; Li SYS, 2005, STAT MED, V24, P2267, DOI 10.1002/sim.2119; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCullagh P, 1989, GEN LINEAR MODELS; Mi G, 2015, PLOS ONE, V10; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Ramsey F., 2012, STAT SLEUTH COURSE M; Risso D, 2014, FRONT PROBAB STAT SC, P169, DOI 10.1007/978-3-319-07212-8_9; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Veneman WJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-255; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wu H, 2013, BIOSTATISTICS, V14, P232, DOI 10.1093/biostatistics/kxs033; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310	38	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120117	10.1371/journal.pone.0120117	http://dx.doi.org/10.1371/journal.pone.0120117			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849826	gold, Green Published, Green Submitted			2022-12-26	WOS:000352477800020
J	Wang, YP; Wang, MC; Lin, HC; Lee, KS; Chou, P				Wang, Ying-Piao; Wang, Mao-Che; Lin, Hung-Ching; Lee, Kuo-Sheng; Chou, Pesus			Tonsillectomy and the Risk for Deep Neck Infection-A Nationwide Cohort Study	PLOS ONE			English	Article							IMMUNE FUNCTIONS; IMMUNOLOGICAL RESPONSE; INTRANASAL INFECTION; PROPENSITY SCORE; IMMUNOGLOBULIN-A; EARLY-STAGE; CHILDREN; TONSILS; SERUM; ADENOTONSILLECTOMY	Background Although the tonsils contribute to first line immunity against foreign pathogens in the upper aero-digestive tract, the association of tonsillectomy with the risk of deep neck infection remains unclear. The aim of this study was to assess the incidence rate and risk of deep neck infection among patients who had undergone a tonsillectomy. Methods This retrospective cohort study evaluated all patients who had undergone tonsillectomy between 2001 and 2009 as identified from the Taiwan National Health Insurance Research Database. For each post-tonsillectomy patient, 10 age-, sex-, and index date-matched controls without a history of tonsillectomy were randomly selected. Cox Proportional hazard model and propensity score model were performed to evaluate the association between tonsillectomy and deep neck infection after adjusting for demographic and clinical data. Results There were 34 (71.6 cases per 100,000 person-years) and 174 (36.6 cases per 100,000 person-years) patients that developed deep neck infection in the tonsillectomized and comparison cohorts, respectively. After adjusting for covariates, patients who had undergone a tonsillectomy had a 1.71-fold greater risk of deep neck infection by both Cox proportional hazard model (95% confidence interval, 1.13-2.59) and propensity score model (95% confidence interval, 1.10-2.66). This association was not altered regardless of the indication for tonsillectomy (i.e. chronic/recurrent tonsillitis or sleep apnea/hypertrophy of tonsil) (p = 0.9797).Conclusions Based on our review of a nationwide cohort study we identified that the risk of deep neck infection is significantly increased among patients who have undergone a tonsillectomy. Additional research is needed to explore the possible mechanisms behind these findings. Conclusions Based on our review of a nationwide cohort study we identified that the risk of deep neck infection is significantly increased among patients who have undergone a tonsillectomy. Additional research is needed to explore the possible mechanisms behind these findings.	[Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Mem Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 104, Taiwan; [Wang, Ying-Piao; Wang, Mao-Che; Chou, Pesus] Natl Yang Ming Univ, Med Res Ctr, Inst Publ Hlth & Community, Taipei 112, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Med Coll, Dept Audiol & Speech Language Pathol, New Taipei City 252, Taiwan; [Wang, Ying-Piao; Lin, Hung-Ching; Lee, Kuo-Sheng] Mackay Med Coll, Sch Med, New Taipei City 252, Taiwan; [Wang, Mao-Che] Taipei Vet Gen Hosp, Dept Otolaryngol Head & Neck Surg, Taipei 112, Taiwan; [Wang, Mao-Che] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan	Mackay Memorial Hospital; National Yang Ming Chiao Tung University; Mackay Medical College; Mackay Medical College; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University	Chou, P (corresponding author), Natl Yang Ming Univ, Med Res Ctr, Inst Publ Hlth & Community, Taipei 112, Taiwan.	pschou@ym.edu.tw						Andreu-Ballester JC, 2003, AM J GASTROENTEROL, V98, P2806; Andreu-Ballester JC, 2007, CLIN IMMUNOL, V123, P289, DOI 10.1016/j.clim.2007.02.004; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P399, DOI 10.1080/00273171.2011.568786; Baugh RF, 2011, OTOLARYNG HEAD NECK, V144, pS1, DOI 10.1177/0194599810389949; Begg CB, 1998, JAMA-J AM MED ASSOC, V280, P1747, DOI 10.1001/jama.280.20.1747; Bell S, 2012, MOL ORAL MICROBIOL, V27, P160, DOI 10.1111/j.2041-1014.2012.640.x; Bhattacharyya N, 2010, OTOLARYNG HEAD NECK, V143, P680, DOI 10.1016/j.otohns.2010.06.918; BOCK A, 1994, EUR ARCH OTO-RHINO-L, V251, P423; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Brandtzaeg P, 2003, INT J PEDIATR OTORHI, V67, pS69, DOI 10.1016/j.ijporl.2003.08.018; Brandtzaeg P, 2011, ADV OTO-RHINO-LARYNG, V72, P20, DOI 10.1159/000324588; Brasky TM, 2009, CANCER CAUSE CONTROL, V20, P369, DOI 10.1007/s10552-008-9251-5; CANTANI A, 1986, ANN ALLERGY, V57, P413; Chen CY, 2007, PEDIATRICS, V119, pE435, DOI 10.1542/peds.2006-1477; Chen YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036332; Chiu HF, 2011, AM J GASTROENTEROL, V106, P894, DOI 10.1038/ajg.2010.475; Choi KY, 2012, J INNATE IMMUN, V4, P361, DOI 10.1159/000336630; Dai ZY, 2014, GENET MOL RES, V13, P3895, DOI 10.4238/2014.January.24.15; Duval M, 2008, INT J PEDIATR OTORHI, V72, P1765, DOI 10.1016/j.ijporl.2008.07.007; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Hoddeson EK, 2009, OTOLARYNG HEAD NECK, V140, P19, DOI 10.1016/j.otohns.2008.09.023; Janszky I, 2011, EUR HEART J, V32, P2290, DOI 10.1093/eurheartj/ehr137; Kaygusuz I, 2003, INT J PEDIATR OTORHI, V67, P1311, DOI 10.1016/j.ijporl.2003.07.017; Kaygusuz I, 2009, INT J PEDIATR OTORHI, V73, P445, DOI 10.1016/j.ijporl.2008.11.014; MORENO PM, 1992, CLIN OTOLARYNGOL, V17, P380, DOI 10.1111/j.1365-2273.1992.tb01678.x; Nasrin M, 2012, Bangladesh Med Res Counc Bull, V38, P59; National Center for Health Statistics, 1998, VIT HLTH STAT 13, V13; Nave H, 2001, ANAT EMBRYOL, V204, P367, DOI 10.1007/s004290100210; OGRA PL, 1971, NEW ENGL J MED, V284, P59, DOI 10.1056/NEJM197101142840201; Parker NP, 2011, INT J PEDIATR OTORHI, V75, P282, DOI 10.1016/j.ijporl.2010.11.019; Randel A, 2011, AM FAM PHYSICIAN, V84, P566; Rodriguez A, 2006, SCAND J IMMUNOL, V63, P177, DOI 10.1111/j.1365-3083.2006.01725.x; Rodriguez A, 2005, VACCINE, V23, P2565, DOI 10.1016/j.vaccine.2004.11.032; RUBIN DB, 1993, MED CARE, V31, pYS103, DOI 10.1097/00005650-199305001-00017; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; SAINZ M, 1992, CLIN OTOLARYNGOL, V17, P376, DOI 10.1111/j.1365-2273.1992.tb01677.x; Sigurdardottir SL, 2012, CLIN IMMUNOL, V142, P139, DOI 10.1016/j.clim.2011.09.013; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Suzumoto M, 2006, ACTA OTO-LARYNGOL, V126, P1164, DOI 10.1080/00016480600681593; van den Akker EH, 2004, CLIN OTOLARYNGOL, V29, P161, DOI 10.1111/j.0307-7772.2004.00771.x; van den Akker EH, 2006, ANN ALLERG ASTHMA IM, V97, P251, DOI 10.1016/S1081-1206(10)60022-1; van Kempen MJP, 2000, INT ARCH ALLERGY IMM, V122, P8, DOI 10.1159/000024354; Vestergaard H, 2010, INT J CANCER, V127, P633, DOI 10.1002/ijc.24973; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Zielnik-Jurkiewicz B, 2002, INT J PEDIATR OTORHI, V64, P127, DOI 10.1016/S0165-5876(02)00042-3	45	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0117535	10.1371/journal.pone.0117535	http://dx.doi.org/10.1371/journal.pone.0117535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849535	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800004
J	Crucello, A; Sforca, DA; Horta, MAC; dos Santos, CA; Viana, AJC; Beloti, LL; de Toledo, MAS; Vincentz, M; Kuroshu, RM; de Souza, AP				Crucello, Aline; Sforca, Danilo Augusto; Crivelente Horta, Maria Augusta; dos Santos, Clelton Aparecido; Carvalho Viana, Americo Jose; Beloti, Lilian Luzia; Szymanski de Toledo, Marcelo Augusto; Vincentz, Michel; Kuroshu, Reginaldo Massanobu; de Souza, Anete Pereira			Analysis of Genomic Regions of Trichoderma harzianum IOC-3844 Related to Biomass Degradation	PLOS ONE			English	Article							REAL-TIME PCR; ENDOGLUCANASE III; SUGARCANE BAGASSE; GENE-EXPRESSION; O-GLYCOSYLATION; REESEI; CELLULASE; PROTEIN; SWOLLENIN; CEL12A	Trichoderma harzianum IOC-3844 secretes high levels of cellulolytic-active enzymes and is therefore a promising strain for use in biotechnological applications in second-generation bioethanol production. However, the T. harzianum biomass degradation mechanism has not been well explored at the genetic level. The present work investigates six genomic regions (similar to 150 kbp each) in this fungus that are enriched with genes related to biomass conversion. A BAC library consisting of 5,760 clones was constructed, with an average insert length of 90 kbp. The assembled BAC sequences revealed 232 predicted genes, 31.5% of which were related to catabolic pathways, including those involved in biomass degradation. An expression profile analysis based on RNA-Seq data demonstrated that putative regulatory elements, such as membrane transport proteins and transcription factors, are located in the same genomic regions as genes related to carbohydrate metabolism and exhibit similar expression profiles. Thus, we demonstrate a rapid and efficient tool that focuses on specific genomic regions by combining a BAC library with transcriptomic data. This is the first BAC-based structural genomic study of the cellulolytic fungus T. harzianum, and its findings provide new perspectives regarding the use of this species in biomass degradation processes.	[Crucello, Aline; Sforca, Danilo Augusto; Crivelente Horta, Maria Augusta; dos Santos, Clelton Aparecido; Carvalho Viana, Americo Jose; Beloti, Lilian Luzia; Szymanski de Toledo, Marcelo Augusto; Vincentz, Michel; de Souza, Anete Pereira] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil; [Vincentz, Michel; de Souza, Anete Pereira] Univ Estadual Campinas, Dept Biol Vegetal, Inst Biol, Sao Paulo, Brazil; [Kuroshu, Reginaldo Massanobu] Univ Fed Sao Paulo, Inst Ciencia & Tecnol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP)	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, Sao Paulo, Brazil.	anete@unicamp.br	Crucello, Aline/AHD-3584-2022; Horta, Maria/N-5051-2016; DE SOUZA, ANETE PEREIRA/B-8663-2012; Viana, Américo/AAB-6593-2019; Horta, Maria/Q-6194-2019; Sforça, Danilo A/I-1551-2014; Sforça, Danilo/AAQ-1129-2020; Santos, Clelton A/I-2202-2012	Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Viana, Américo/0000-0001-9509-0093; Horta, Maria/0000-0003-2159-5296; Sforça, Danilo A/0000-0003-2304-8712; Sforça, Danilo/0000-0003-2304-8712; Santos, Clelton A/0000-0002-6725-8925	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); FAPESP [proc. 2009/13185-3]; CNPQ	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Nivel Superior (CAPES, Proj Bio-Computacional) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). AJCV, CAS, DAS, LB, MACH and MAST were recipients of PhD fellowships from FAPESP, and AC was a recipient of graduate fellowships from CNPQ (PhD degree) and FAPESP (MSc. Degree, proc. 2009/13185-3). APS and MV were recipients of research fellowships from CNPq.	Amore A, 2013, CURR GENOMICS, V14, P230, DOI 10.2174/1389202911314040002; Arantes V, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-4; Aro N, 2003, APPL ENVIRON MICROB, V69, P56, DOI 10.1128/AEM.69.1.56-65.2003; Asakawa S, 1997, GENE, V191, P69, DOI 10.1016/S0378-1119(97)00044-9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Balasubramanian N, 2008, AFR J BIOTECHNOL, V7; Brotman Y, 2008, PLANT PHYSIOL, V147, P779, DOI 10.1104/pp.108.116293; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Carpita NC, 2001, PLANT PHYSIOL, V127, P551, DOI 10.1104/pp.010146; Chaverri P, 2003, MOL PHYLOGENET EVOL, V27, P302, DOI 10.1016/S1055-7903(02)00400-1; Colussi F, 2011, J MICROBIOL BIOTECHN, V21, P808, DOI 10.4014/jmb.1010.10037; CONAB, 2013, AC SAFR BRAS CAN DE; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Horta MAC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088689; Dantas GA, 2013, RENEW SUST ENERG REV, V21, P356, DOI 10.1016/j.rser.2012.11.080; de Castro AM, 2010, APPL BIOCHEM BIOTECH, V162, P1612, DOI 10.1007/s12010-010-8942-z; Dean FB, 2001, GENOME RES, V11, P1095, DOI 10.1101/gr.180501; Diener SE, 2004, FUNGAL GENET BIOL, V41, P1077, DOI 10.1016/j.fgb.2004.08.007; Eisentraut A., 2010, IEA ENERGY PAPERS; Generoso WC, 2012, GENET MOL RES, V11, P1544, DOI 10.4238/2012.May.21.11; Gentzsch M, 1995, FEBS LETT, V377, P128, DOI 10.1016/0014-5793(95)01324-5; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Gourlay K, 2013, BIORESOURCE TECHNOL, V142, P498, DOI 10.1016/j.biortech.2013.05.053; Hakkinen M, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-14; Hakulinen N, 2000, J STRUCT BIOL, V132, P180, DOI 10.1006/jsbi.2000.4318; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Karimi-Aghcheh R, 2013, G3-GENES GENOM GENET, V3, P369, DOI 10.1534/g3.112.005140; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Karp SG, 2013, BRAZ ARCH BIOL TECHN, V56, P679, DOI 10.1590/S1516-89132013000400019; KUBICEK CP, 1981, EUR J APPL MICROBIOL, V13, P226, DOI 10.1007/BF00500103; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Liberato MV, 2012, ACTA CRYSTALLOGR F, V68, P306, DOI 10.1107/S1744309112000838; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Nakazawa H, 2008, APPL MICROBIOL BIOT, V81, P681, DOI 10.1007/s00253-008-1667-z; Ozbay N, 2004, ACTA HORTIC, P131, DOI 10.17660/ActaHortic.2004.635.16; Patil RS, 2000, ENZYME MICROB TECH, V26, P473, DOI 10.1016/S0141-0229(00)00134-4; Peterson D. G., 2000, Journal of Agricultural Genomics, V5, P1; Rayner JC, 1998, J BIOL CHEM, V273, P26836, DOI 10.1074/jbc.273.41.26836; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SADDLER JN, 1985, APPL MICROBIOL BIOT, V22, P139; Sadhasivam S, 2009, WORLD J MICROB BIOT, V25, P1733, DOI 10.1007/s11274-009-0069-4; Salamov A, 1998, FGENESH MULTIPLE GEN; Saloheimo M, 2002, EUR J BIOCHEM, V269, P4202, DOI 10.1046/j.1432-1033.2002.03095.x; Sandgren M, 2001, J MOL BIOL, V308, P295, DOI 10.1006/jmbi.2001.4583; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Soccol CR, 2010, BIORESOURCE TECHNOL, V101, P4820, DOI 10.1016/j.biortech.2009.11.067; Stals I, 2004, GLYCOBIOLOGY, V14, P713, DOI 10.1093/glycob/cwh080; Stanke M, 2004, NUCLEIC ACIDS RES, V32, pW309, DOI 10.1093/nar/gkh379; SUOMINEN PL, 1993, MOL GEN GENET, V241, P523, DOI 10.1007/BF00279894; THEVELEIN JM, 1984, MICROBIOL REV, V48, P42, DOI 10.1128/MMBR.48.1.42-59.1984; Valjamae P, 1998, EUR J BIOCHEM, V253, P469, DOI 10.1046/j.1432-1327.1998.2530469.x; Wagener J, 2008, EUKARYOT CELL, V7, P1661, DOI 10.1128/EC.00221-08; Wang LS, 2003, J MOL CATAL B-ENZYM, V24-5, P27, DOI 10.1016/S1381-1177(03)00070-5; Wang YG, 2011, APPL MICROBIOL BIOT, V91, P1353, DOI 10.1007/s00253-011-3421-1; WOOD TM, 1992, BIOCHEM SOC T, V20, P46, DOI 10.1042/bst0200046; Xia ZJ, 2014, ANAL BIOCHEM, V444, P38, DOI 10.1016/j.ab.2013.09.026	59	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122122	10.1371/journal.pone.0122122	http://dx.doi.org/10.1371/journal.pone.0122122			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836973	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000079
J	Fedy, BC; Kirol, CP; Sutphin, AL; Maechtle, TL				Fedy, Bradley C.; Kirol, Christopher P.; Sutphin, Andrew L.; Maechtle, Thomas L.			The Influence of Mitigation on Sage-Grouse Habitat Selection within an Energy Development Field	PLOS ONE			English	Article							RESOURCE SELECTION; NESTING HABITAT; IMPACTS; WINTER; POPULATIONS; ABUNDANCE; ECOLOGY; OFFSETS; SCALE	Growing global energy demands ensure the continued growth of energy development. Energy development in wildlife areas can significantly impact wildlife populations. Efforts to mitigate development impacts to wildlife are on-going, but the effectiveness of such efforts is seldom monitored or assessed. Greater sage-grouse (Centrocercus urophasianus) are sensitive to energy development and likely serve as an effective umbrella species for other sagebrush-steppe obligate wildlife. We assessed the response of birds within an energy development area before and after the implementation of mitigation action. Additionally, we quantified changes in habitat distribution and abundance in pre-and post-mitigation landscapes. Sage-grouse avoidance of energy development at large spatial scales is well documented. We limited our research to directly within an energy development field in order to assess the influence of mitigation in close proximity to energy infrastructure. We used nestlocation data (n = 488) within an energy development field to develop habitat selection models using logistic regression on data from 4 years of research prior to mitigation and for 4 years following the implementation of extensive mitigation efforts (e.g., decreased activity, buried powerlines). The post-mitigation habitat selection models indicated less avoidance of wells (well density beta = 0.18 +/- 0.08) than the pre-mitigation models (well density beta = -0.09 +/- 0.11). However, birds still avoided areas of high well density and nests were not found in areas with greater than 4 wells per km(2) and the majority of nests (63%) were located in areas with <= 1 well per km(2). Several other model coefficients differed between the two time periods and indicated stronger selection for sagebrush (pre-mitigation beta = 0.30 +/- 0.09; postmitigation beta = 0.82 +/- 0.08) and less avoidance of rugged terrain (pre-mitigation beta = -0.35 +/- 0.12; post-mitigation beta = -0.05 +/- 0.09). Mitigation efforts implemented may be responsible for the measurable improvement in sage-grouse nesting habitats within the development area. However, we cannot reject alternative hypotheses concerning the influence of population density and intraspecific competition. Additionally, we were unable to assess the actual fitness consequences of mitigation or the source-sink dynamics of the habitats. We compared the pre-mitigation and post-mitigation models predicted as maps with habitats ranked from low to high relative probability of use (equal-area bins: 1 -5). We found more improvement in habitat rank between the two time periods around mitigated wells compared to non-mitigated wells. Informed mitigation within energy development fields could help improve habitats within the field. We recommend that any mitigation effort include well-informed plans to monitor the effectiveness of the implemented mitigation actions that assess both habitat use and relevant fitness parameters.	[Fedy, Bradley C.] Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada; [Kirol, Christopher P.; Sutphin, Andrew L.; Maechtle, Thomas L.] Big Horn Environm Consultants, Sheridan, WY USA	University of Waterloo	Fedy, BC (corresponding author), Univ Waterloo, Dept Environm & Resource Studies, Waterloo, ON N2L 3G1, Canada.	bfedy@uwaterloo.ca	Fedy, Bradley C/A-6017-2015	Fedy, Bradley/0000-0003-3933-4043	Anadarko Petroleum Corporation	Anadarko Petroleum Corporation	The research presented here was supported in part by Anadarko Petroleum Corporation in addition to many non-commercial entities. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. The nest location data presented in this manuscript were submitted annually to the Wyoming Game and Fish Department as required. All other data (e.g., GIS layers) are publicly available through the relevant sources.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2012, J WILDLIFE MANAGE, V76, P391, DOI 10.1002/jwmg.268; Beyer HL, 2011, GEOSPATIAL MODELLING; Blickley JL, 2012, CONSERV BIOL, V26, P461, DOI 10.1111/j.1523-1739.2012.01840.x; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2011, ENERGY DEV WILDLIFE, pix; Braun CE, 2002, TRANS N AM WILDL NAT, V67, P337; Buchanan CB, 2014, RANGELAND ECOL MANAG, V67, P369, DOI 10.2111/REM-D-13-00136.1; Carpenter J, 2010, J WILDLIFE MANAGE, V74, P1806, DOI 10.2193/2009-368; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 2011, STUD AVIAN BIOL, P69; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Dalke P. D., 1963, Journal of Wildlife Management, V27, P811; DeCesare NJ, 2012, ECOL APPL, V22, P1068, DOI 10.1890/11-1610.1; Doesburg SM, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006142, 10.1371/journal.pone.0006802]; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; Dzialak MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026273; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; ENG ROBERT L., 1955, JOUR WILDLIFE MANAGEMENT, V19, P267, DOI 10.2307/3796862; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; Fedy BC, 2011, J WILDLIFE MANAGE, V75, P1022, DOI 10.1002/jwmg.155; Fedy BC, 2011, OECOLOGIA, V165, P915, DOI 10.1007/s00442-010-1768-0; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gibbons Philip, 2007, Ecological Management & Restoration, V8, P26, DOI 10.1111/j.1442-8903.2007.00328.x; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; Gilbert MM, 2011, J WILDLIFE MANAGE, V75, P816, DOI 10.1002/jwmg.123; Hanser SE, 2011, STUD AVIAN BIOL, P475; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Holloran MJ, J WILDL MAN IN PRESS; Homer CG, 2012, INT J APPL EARTH OBS, V14, P233, DOI 10.1016/j.jag.2011.09.012; Jones J, 2001, AUK, V118, P557, DOI 10.1642/0004-8038(2001)118[0557:HSSIAE]2.0.CO;2; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Kirol CP, WILDLIFE BI IN PRESS; Lyon AG, 2003, WILDLIFE SOC B, V31, P486; Manly B.F.J., 2002, RESOURCE SELECTION A; Patterson R.L., 1952, SAGE GROUSE WYOMING; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Sappington JM, 2007, J WILDLIFE MANAGE, V71, P1419, DOI 10.2193/2005-723; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Schroeder MA, 1999, BIRDS N AM, V425; Smith KT, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00238; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Theobald DM, 2007, LCAP V1 0 LANSCAPE C; U.S. Fish and Wildlife Service, 2010, FED REGISTER, V75, P13909; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walker B.L., 2008, GREATER SAGE GROUSE; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; Walker BL, 2011, STUD AVIAN BIOL, P127; Wisdom MJ, 2011, STUD AVIAN BIOL, P451	55	19	19	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121603	10.1371/journal.pone.0121603	http://dx.doi.org/10.1371/journal.pone.0121603			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835296	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000050
J	Ma, XX; Wang, LC; Wu, H; Li, N; Ma, L; Zeng, CF; Zhou, Y; Yang, J				Ma, Xiaoxue; Wang, Lachun; Wu, Hao; Li, Na; Ma, Lei; Zeng, Chunfen; Zhou, Yi; Yang, Jun			Impact of Yangtze River Water Transfer on the Water Quality of the Lixia River Watershed, China	PLOS ONE			English	Article							MULTIVARIATE STATISTICAL TECHNIQUES; INDEX METHOD; LAKE TAIHU; POLLUTION; RESTORATION; RESERVOIR; PROVINCE; REGIME	To improve water quality and reduce the negative impacts of sudden inputs of water pollution in the Lixia River watershed, China, a series of experimental water transfers from the Yangtze River to the Lixia River were conducted from 2 December 2006 to 7 January 2007. Water samples were collected every six days at 55 monitoring sites during this period. Eight water parameters (water temperature, pH, dissolved oxygen (DO), chemical oxygen demand (COD), potassium permanganate index (CODMn), ammonia nitrogen (NH4+-N), electrical conductivity (EC), and water transparency (WT)) were analyzed to determine changes in nutrient concentrations during water transfers. The comprehensive pollution index (Pi) and single-factor (Si) evaluation methods were applied to evaluate spatio-temporal patterns of water quality during water transfers. Water quality parameters displayed different spatial and temporal distribution patterns within the watershed. Water quality was improved significantly by the water transfers, especially for sites closer to water intake points. The degree of improvement is positively related to rates of transfer inflow and drainage outflow. The effects differed for different water quality parameters at each site and at different water transfer times. There were notable decreases in NH4+-N, DO, COD, and CODMn across the entire watershed. However, positive effects on EC and pH were not observed. It is concluded that freshwater transfers from the Yangtze River can be used as an emergency measure to flush pollutants from the Lixia River watershed. Improved understanding of the effects of water transfers on water quality can help the development and implementation of effective strategies to improve water quality within this watershed.	[Ma, Xiaoxue; Wang, Lachun; Wu, Hao; Li, Na; Ma, Lei; Zeng, Chunfen] Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing 210008, Jiangsu, Peoples R China; [Zhou, Yi] Hydrol & Water Resources Invest Bur Jiang Su Prov, Nanjing, Jiangsu, Peoples R China; [Yang, Jun] Flood Control & Drought Relief Command Ctr Jiangs, Nanjing, Jiangsu, Peoples R China	Nanjing University	Wang, LC (corresponding author), Nanjing Univ, Sch Geog & Oceanog Sci, Nanjing 210008, Jiangsu, Peoples R China.	wang6312@263.net.cn; zengchunfen@nju.edu.cn	Wu, Hao/J-2570-2017	Wu, Hao/0000-0003-3323-464X	Science and Technology Foundation of Department of Water Resources of Jiangsu Province [2014050]; Natural Science Foundation of Jiangsu Province [BK20130567]; National Science and Technology Pillar Program [2013BAB05B01-3]	Science and Technology Foundation of Department of Water Resources of Jiangsu Province; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science and Technology Pillar Program	This work was supported by the Science and Technology Foundation of Department of Water Resources of Jiangsu Province (No. 2014050), Natural Science Foundation of Jiangsu Province (No. BK20130567), National Science and Technology Pillar Program (No. 2013BAB05B01-3). The funders of National Science and Technology Pillar Program (No. 2013BAB05B01-3) and Natural Science Foundation of Jiangsu Province (No. BK20130567) had the role in data collection and analysis. The funders of National Science and Technology Pillar Program (No. 2013BAB05B01-3) had the role in study design.	[Anonymous], 2002, ENV QUALITY STANDARD; [Anonymous], 2006, REP STAT CHIN ENV; Chen D, 2013, APPL GEOGR, V45, P303, DOI 10.1016/j.apgeog.2013.09.025; Fornarelli R, 2011, WATER RES, V45, P5873, DOI 10.1016/j.watres.2011.08.048; Ganoulis J, 2008, ENG RISK ANAL WATER, P6; Gibbins CN, 2001, FISHERIES MANAG ECOL, V8, P463, DOI 10.1046/j.1365-2400.2001.00274.x; He T, 2012, PROCED EARTH PLAN SC, V5, P314, DOI 10.1016/j.proeps.2012.01.053; Hilt S, 2011, OIKOS, V120, P766, DOI 10.1111/j.1600-0706.2010.18553.x; Hu LM, 2010, ECOL ENG, V36, P471, DOI 10.1016/j.ecoleng.2009.11.016; Hu WP, 2008, ECOL ENG, V34, P30, DOI 10.1016/j.ecoleng.2008.05.018; Li YP, 2013, ECOL ENG, V60, P399, DOI 10.1016/j.ecoleng.2013.09.067; Li YP, 2011, ECOL ENG, V37, P325, DOI 10.1016/j.ecoleng.2010.11.024; Liu SG, 2011, MAR POLLUT BULL, V62, P2220, DOI 10.1016/j.marpolbul.2011.06.021; Ma XX, 2014, DESALIN WATER TREAT, P1; Su SL, 2011, WATER RES, V45, P1781, DOI 10.1016/j.watres.2010.11.030; Varol M, 2011, J HAZARD MATER, V195, P355, DOI 10.1016/j.jhazmat.2011.08.051; Voutsa D, 2001, WATER AIR SOIL POLL, V129, P13, DOI 10.1023/A:1010315608905; WELCH EB, 1980, WATER RES, V14, P1317, DOI 10.1016/0043-1354(80)90192-X; WELCH EB, 1981, J AM WATER RESOUR AS, V17, P558; Welch EB, 1992, ECOL ENG, V1, P173, DOI DOI 10.1016/0925-8574(92)90001-I; [谢兴勇 XIE Xing-yong], 2009, [环境科学研究, Research of Environmental Sciences], V22, P897; Yang LP, 2013, ENVIRON SCI POLLUT R, V20, P5341, DOI 10.1007/s11356-013-1536-x; Yao Qing-zheng, 2009, Huanjing Kexue, V30, P3534; Zhai SJ, 2010, ECOL ENG, V36, P406, DOI 10.1016/j.ecoleng.2009.11.007; Zhao Y, 2012, PROCEDIA ENVIRON SCI, V13, P1213, DOI 10.1016/j.proenv.2012.01.115	25	12	13	5	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119720	10.1371/journal.pone.0119720	http://dx.doi.org/10.1371/journal.pone.0119720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835525	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000013
J	Makumire, S; Revaprasadu, N; Shonhai, A				Makumire, Stanley; Revaprasadu, Neerish; Shonhai, Addmore			DnaK Protein Alleviates Toxicity Induced by Citrate-Coated Gold Nanoparticles in Escherichia coli	PLOS ONE			English	Article							OXIDE NANOPARTICLES; OVERPRODUCTION; AGGREGATION; CHAPERONES; SUPPRESS; GROWTH; IRON	A number of previously reported studies suggest that synthetic gold nanoparticles (AuNPs) are capable of stabilising proteins against heat stress in vitro. However, it remains to be understood if AuNPs confer stability to proteins against cellular stress in vivo. Heat shock proteins (Hsps) are conserved molecules whose main role is to facilitate folding of other proteins (chaperone function). Hsp70 (called DnaK in prokaryotes) is one of the most prominent molecular chaperones. Since gold nanoparticles exhibit chaperone-like function in vitro, we investigated the effect of citrate-coated gold nanoparticles on the growth of E. coli BB1553 cells that possess a deleted dnaK gene. We further investigated the effects of the AuNPs on the solubility of the E. coli BB1553 proteome. E. coli BB1553 cells exposed to AuNPs exhibited cellular defects such as filamentation and plasma membranes pulled off the cell wall. The toxic effects of the AuNPs were alleviated by transforming the E. coli BB1553 cells with a construct expressing DnaK. We also noted that cells in which DnaK was restored exhibited distinct zones to which the nanoparticles were restricted. Our study suggests a role for DnaK in alleviating nanoparticle induced stress in E. coli.	[Makumire, Stanley; Shonhai, Addmore] Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa; [Revaprasadu, Neerish] Univ Zululand, Dept Chem, ZA-3886 Kwa Dlangezwa, South Africa; [Makumire, Stanley; Shonhai, Addmore] Univ Zululand, Dept Biochem & Microbiol, ZA-3886 Kwa Dlangezwa, South Africa	University of Venda; University of Zululand; University of Zululand	Shonhai, A (corresponding author), Univ Venda, Sch Math & Nat Sci, Dept Biochem, Thohoyandou, South Africa.	adshon@gmail.com	Shonhai, Addmore/AAS-4506-2021	Revaprasadu, Neerish/0000-0001-5730-1232; Makumire, Stanley/0000-0003-4355-1382	National Research Foundation (ZA)	National Research Foundation (ZA)	This work was supported by the National Research Foundation (ZA) grant number, UID, awarded to AS and the National Research Foundation (ZA) grant awarded to NR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUKAU B, 1989, J BACTERIOL, V171, P2337, DOI 10.1128/jb.171.5.2337-2346.1989; Chatterjee S, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-34; Chatterjee T, 2010, FEBS J, V277, P4184, DOI 10.1111/j.1742-4658.2010.07807.x; Cui WJ, 2012, NANOMED-NANOTECHNOL, V8, P46, DOI 10.1016/j.nano.2011.05.005; De M, 2008, CHEM COMMUN, P3504, DOI 10.1039/b805242e; Doyen M, 2013, J COLLOID INTERF SCI, V399, P1, DOI 10.1016/j.jcis.2013.02.040; Dunpall R, 2012, IUBMB LIFE, V64, P995, DOI 10.1002/iub.1100; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; Gagner JE, 2012, BIOMATERIALS, V33, P8503, DOI 10.1016/j.biomaterials.2012.07.009; Gagner JE, 2011, BIOMATERIALS, V32, P7241, DOI 10.1016/j.biomaterials.2011.05.091; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Kang B, 2010, J AM CHEM SOC, V132, P1517, DOI 10.1021/ja9102698; Klaper R, 2014, ANALYST, V139, P882, DOI 10.1039/c3an01644g; Klein J, 2007, P NATL ACAD SCI USA, V104, P2029, DOI 10.1073/pnas.0611610104; Liebscher M, 2007, J BIOL CHEM, V282, P4437, DOI 10.1074/jbc.M607667200; Luthuli SD, 2013, IUBMB LIFE, V65, P454, DOI 10.1002/iub.1146; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; Makumire S, 2014, TOXICOL LETT, V227, P56, DOI 10.1016/j.toxlet.2014.02.027; Matambo TS, 2004, PROTEIN EXPRES PURIF, V33, P214, DOI 10.1016/j.pep.2003.09.010; Mayer MP, 2000, BIOL CHEM, V381, P877, DOI 10.1515/BC.2000.109; Mogk A, 1999, J BACTERIOL, V181, P1320; PAEK KH, 1987, J BACTERIOL, V169, P283, DOI 10.1128/jb.169.1.283-290.1987; Patil S, 2007, BIOMATERIALS, V28, P4600, DOI 10.1016/j.biomaterials.2007.07.029; Prema P., 2013, INT J PHARM PHARM SC, V5, p310?314, DOI DOI 10.1016/J.EURP0LYMJ.2007.01.012; Rocha S, 2008, BIOPHYS CHEM, V137, P35, DOI 10.1016/j.bpc.2008.06.010; Selvaraj V, 2007, INT J PHARMACEUT, V337, P275, DOI 10.1016/j.ijpharm.2006.12.027; Shonhai A, 2005, MOL GENET GENOMICS, V274, P70, DOI 10.1007/s00438-005-1150-9; Shonhai A., 2014, HEAT SHOCK PROTEINS, P47, DOI [10.1007/978-94-007-7438-4_3, DOI 10.1007/978-94-007-7438-4_3]; Shonhai A, 2008, PROTEIN PEPTIDE LETT, V15, P1117, DOI 10.2174/092986608786071067; Shonhai A, 2007, PROTEIN SCI, V16, P1803, DOI 10.1110/ps.072918107; Sobczak-Kupiec A, 2011, DIG J NANOMATER BIOS, V6, P803; Suppini JP, 2004, J BACTERIOL, V186, P6248, DOI 10.1128/JB.186.18.6248-6253.2004; Thi Ha Lien Nghiem, 2010, Advances in Natural Sciences: Nanoscience & Nanotechnology, V1, DOI 10.1088/2043-6254/1/2/025009; Triulzi RC, 2008, COLLOID SURFACE B, V63, P200, DOI 10.1016/j.colsurfb.2007.12.006; Vorderwulbecke S, 2004, FEBS LETT, V559, P181, DOI 10.1016/S0014-5793(04)00052-3; Xie YP, 2011, APPL ENVIRON MICROB, V77, P2325, DOI 10.1128/AEM.02149-10; ZEILSTRARYALLS J, 1991, ANNU REV MICROBIOL, V45, P301, DOI 10.1146/annurev.mi.45.100191.001505; Zhang DM, 2009, NANO LETT, V9, P666, DOI 10.1021/nl803054h; Zhou Y, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-19	39	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121243	10.1371/journal.pone.0121243	http://dx.doi.org/10.1371/journal.pone.0121243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837593	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000042
J	Van Landeghem, L; Santoro, MA; Mah, AT; Krebs, AE; Dehmer, JJ; McNaughton, KK; Helmrath, MA; Magness, ST; Lund, PK				Van Landeghem, Laurianne; Santoro, M. Agostina; Mah, Amanda T.; Krebs, Adrienne E.; Dehmer, Jeffrey J.; McNaughton, Kirk K.; Helmrath, Michael A.; Magness, Scott T.; Lund, P. Kay			IGF1 stimulates crypt expansion via differential activation of 2 intestinal stem cell populations	FASEB JOURNAL			English	Article						irradiation; tissue regeneration; actively cycling ISCs; facultative/reserve ISCs	GLUCAGON-LIKE PEPTIDE-2; SHORT-BOWEL SYNDROME; PROGENITOR CELLS; DNA-DAMAGE; IN-VITRO; EXPRESSION MARKS; EPITHELIAL-CELLS; TRANSGENIC MICE; GROWTH-FACTORS; CANCER CELLS	Insulin-like growth factor 1 (IGF1) has potent trophic effects on normal or injured intestinal epithelium, but specific effects on intestinal stem cells (ISCs) are undefined. We used Sox9-enhanced green fluorescent protein (EGFP) reportermice that permit analyses of both actively cycling ISCs (Sox9-EGFP(Low)) and reserve/facultative ISCs (Sox9-EGFP(High)) to study IGF1 action on ISCs in normal intestine or during crypt regeneration after high-dose radiation-induced injury. We hypothesized that IGF1 differentially regulates proliferation and gene expression in actively cycling and reserve/facultative ISCs. IGF1 was delivered for 5 days using subcutaneously implanted mini-pumps in uninjured mice or after 14 Gy abdominal radiation. ISC numbers, proliferation, and transcriptome were assessed. IGF1 increased epithelial growth in nonirradiated mice and enhanced crypt regeneration after radiation. In uninjured and regenerating intestines, IGF1 increased total numbers of Sox9-EGFP(Low) ISCs and percentage of these cells in M-phase. IGF1 increased percentages of Sox9-EGFP(High) ISCs in S-phase but did not expand this population. Microarray revealed that IGF1 activated distinct gene expression signatures in the 2 Sox9-EGFP ISC populations. In vitro IGF1 enhanced enteroid formation by Sox9-EGFP(High) facultative ISCs but not Sox9-EGFP(Low) actively cycling ISCs. Our data provide new evidence that IGF1 activates 2 ISC populations via distinct regulatory pathways to promote growth of normal intestinal epithelium and crypt regeneration after irradiation.	[Van Landeghem, Laurianne; Santoro, M. Agostina; Krebs, Adrienne E.; McNaughton, Kirk K.; Magness, Scott T.; Lund, P. Kay] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Mah, Amanda T.; Lund, P. Kay] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Dehmer, Jeffrey J.] Univ N Carolina, Dept Surg, Chapel Hill, NC USA; [Magness, Scott T.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Helmrath, Michael A.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Magness, Scott T.] Univ N Carolina, North Carolina State Biomed Engn, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University System of Ohio; University of Cincinnati; University of North Carolina; University of North Carolina Chapel Hill	Lund, PK (corresponding author), 6336 MBRB CB 7545,111 Mason Farm Rd, Chapel Hill, NC 27599 USA.	empk@med.unc.edu	, Histology Research Core Facility/ABF-6317-2021; Van+Landeghem, Laurianne/AAG-7334-2019; Van Landeghem, Laurianne/K-2430-2015; , UNC Flow Cytometry Core/AGU-9839-2022	Van+Landeghem, Laurianne/0000-0001-7408-3521; Magness, Scott/0000-0002-2746-1224	University of North Carolina (UNC) Flow Cytometry core facility [P30-CA06086]; Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease [P30-DK034987]; North Carolina Biotechnology Center; National Cancer Center; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK040247-19, R01-DK091427, R03-DK089126]; NIH National Institute on Aging Grant [R01-AG041198-01]; SanteDige Foundation; Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center; Michael Hooker Microscopy Facility; Department of Cell Biology and Physiology (UNC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089126, P30DK034987, K01DK080181, R01DK091427, R01DK040247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041198] Funding Source: NIH RePORTER	University of North Carolina (UNC) Flow Cytometry core facility; Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease; North Carolina Biotechnology Center; National Cancer Center; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging Grant; SanteDige Foundation; Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center; Michael Hooker Microscopy Facility; Department of Cell Biology and Physiology (UNC); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Barry Udis, Michael Chua, Neil Kramarcy, Ashley Ezzell, Adam Gracz, Josh Robbs, and Eric Blue for technical assistance. This work was assisted by services from the University of North Carolina (UNC) Flow Cytometry core facility (Grant P30-CA06086), the Genomics and Bioinformatics core of the UNC Lineberger Comprehensive Cancer Center, the Michael Hooker Microscopy Facility, the Histology Research Core Facilities of the Center for Gastrointestinal Biology and Disease (Grant P30-DK034987), and the Department of Cell Biology and Physiology (UNC). This work was supported by grants from the North Carolina Biotechnology Center and the National Cancer Center (to L.V.L.), U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK040247-19 (to P.K.L.), and R01-DK091427 and R03-DK089126 (to S.T.M.), NIH National Institute on Aging Grant R01-AG041198-01 (to P.K.L.), and funding from the SanteDige Foundation (to L.V.L.). The authors declare no conflicts of interest.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Booth D, 2000, INT J CANCER, V86, P53, DOI 10.1002/(SICI)1097-0215(20000401)86:1<53::AID-IJC8>3.0.CO;2-Z; Bortvedt SF, 2012, CURR OPIN GASTROEN, V28, P89, DOI 10.1097/MOG.0b013e32835004c6; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; Buczacki SJA, 2013, NATURE, V495, P65, DOI 10.1038/nature11965; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Cobaleda C, 2007, ANNU REV GENET, V41, P41, DOI 10.1146/annurev.genet.41.110306.130146; Coutts AS, 2009, P NATL ACAD SCI USA, V106, P19872, DOI 10.1073/pnas.0906785106; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dube PE, 2007, AM J PHYSIOL-ENDOC M, V293, pE460, DOI 10.1152/ajpendo.00149.2007; Farrell CL, 1998, CANCER RES, V58, P933; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Garrison AP, 2009, AM J PHYSIOL-GASTR L, V296, pG643, DOI 10.1152/ajpgi.90588.2008; Ge RT, 2015, SCI REP-UK, V5, DOI 10.1038/srep07735; Gillingham MB, 2003, AM J PHYSIOL-REG I, V284, pR363, DOI 10.1152/ajpregu.00247.2002; Goetz EM, 2011, ONCOGENE, V30, P3745, DOI 10.1038/onc.2011.92; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Howarth GS, 1997, SCAND J GASTROENTERO, V32, P1118, DOI 10.3109/00365529709002990; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; Hua GQ, 2012, GASTROENTEROLOGY, V143, P1266, DOI 10.1053/j.gastro.2012.07.106; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Karrich JJ, 2012, BLOOD, V119, P5191, DOI 10.1182/blood-2011-07-370239; Katoh M, 2002, INT J MOL MED, V10, P683; Kosinski C, 2010, GASTROENTEROLOGY, V139, P893, DOI 10.1053/j.gastro.2010.06.014; Kuemmerle JF, 2006, AM J PHYSIOL-GASTR L, V290, pG1194, DOI 10.1152/ajpgi.00345.2005; Lakshmikuttyamma A, 2008, ONCOGENE, V27, P3831, DOI 10.1038/onc.2008.8; Lau MT, 2012, CANCER LETT, V326, P191, DOI 10.1016/j.canlet.2012.08.016; LEMMEY AB, 1994, GROWTH FACTORS, V10, P243, DOI 10.3109/08977199409010990; Leri A, 1999, CIRC RES, V84, P752; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lund PK, 2012, GASTROENTEROLOGY, V143, P1144, DOI 10.1053/j.gastro.2012.09.021; Massague J, 2012, FEBS LETT, V586, P1953, DOI 10.1016/j.febslet.2012.03.023; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; McConnell BB, 2011, GASTROENTEROLOGY, V140, P540, DOI 10.1053/j.gastro.2010.10.061; McMellen ME, 2010, SEMIN PEDIATR SURG, V19, P35, DOI 10.1053/j.sempedsurg.2009.11.010; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Munoz J, 2012, EMBO J, V31, P3079, DOI 10.1038/emboj.2012.166; Nagashima M, 2003, ONCOGENE, V22, P343, DOI 10.1038/sj.onc.1206115; Nandan MO, 2005, FEBS LETT, V579, P4757, DOI 10.1016/j.febslet.2005.07.053; Nitzsche A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019470; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Powell AE, 2012, CELL, V149, P146, DOI 10.1016/j.cell.2012.02.042; Qiu W, 2010, ONCOGENE, V29, P1622, DOI 10.1038/onc.2009.451; Rehman J, 2010, J MOL MED, V88, P981, DOI 10.1007/s00109-010-0678-2; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; STEEB CB, 1995, GUT, V37, P630, DOI 10.1136/gut.37.5.630; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Thelen K, 2009, J PHARM PHARMACOL, V61, P541, DOI [10.1211/jpp.61.05.0002, 10.1211/jpp/61.05.0002]; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Van Landeghem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051310; Van Landeghem L, 2012, AM J PHYSIOL-GASTR L, V302, pG1111, DOI 10.1152/ajpgi.00519.2011; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Wilkins HR, 2002, AM J PHYSIOL-GASTR L, V283, pG457, DOI 10.1152/ajpgi.00019.2002; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Xu HL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012112; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109	76	50	50	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2015	29	7					2828	2842		10.1096/fj.14-264010	http://dx.doi.org/10.1096/fj.14-264010			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CL3OI	25837582	Green Published			2022-12-26	WOS:000356859100014
J	Avasarala, S; Van Scoyk, M; Rathinam, MKK; Zerayesus, S; Zhao, XM; Zhang, W; Pergande, MR; Borgia, JA; DeGregori, J; Port, JD; Winn, RA; Bikkavilli, RK				Avasarala, Sreedevi; Van Scoyk, Michelle; Rathinam, Manoj Kumar Karuppusamy; Zerayesus, Sereke; Zhao, Xiangmin; Zhang, Wei; Pergande, Melissa R.; Borgia, Jeffrey A.; DeGregori, James; Port, J. David; Winn, Robert A.; Bikkavilli, Rama Kamesh			PRMT1 Is a Novel Regulator of Epithelial-Mesenchymal-Transition in Non-small Cell Lung Cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ARGININE METHYLTRANSFERASES; E-CADHERIN; UP-REGULATION; TWIST; METHYLATION; EXPRESSION; PHOSPHORYLATION; BREAST; TRANSCRIPTION; SURVIVAL	Protein arginine methyl transferase 1 (PRMT1) was shown to be up-regulated in cancers and important for cancer cell proliferation. However, the role of PRMT1 in lung cancer progression and metastasis remains incompletely understood. In the present study, we show that PRMT1 is an important regulator of epithelial-mesenchymal transition (EMT), cancer cell migration, and invasion, which are essential processes during cancer progression, and metastasis. Additionally, we have identified Twist1, a basic helix-loop-helix transcription factor and a well-known E-cadherin repressor, as a novel PRMT1 substrate. Taken together, we show that PRMT1 is a novel regulator of EMT and arginine 34 (Arg-34) methylation of Twist1 as a unique "methyl arginine mark" for active E-cadherin repression. Therefore, targeting PRMT1-mediated Twist1 methylation might represent a novel strategy for developing new anti-invasive/anti-metastatic drugs. Moreover, methylated Twist1 (Arg-34), as such, could also emerge as a potential important biomarker for lung cancer.	[Avasarala, Sreedevi; Van Scoyk, Michelle; Rathinam, Manoj Kumar Karuppusamy; Zerayesus, Sereke; Zhao, Xiangmin; Winn, Robert A.; Bikkavilli, Rama Kamesh] Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Chicago, IL 60612 USA; [Zhang, Wei] Univ Illinois, Dept Pediat, Chicago, IL 60612 USA; [Pergande, Melissa R.; Borgia, Jeffrey A.] Rush Univ, Med Ctr, Dept Pathol, Chicago, IL 60612 USA; [Pergande, Melissa R.; Borgia, Jeffrey A.] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [DeGregori, James] Univ Colorado, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Port, J. David] Univ Colorado, Dept Med Cardiol & Pharmacol, Aurora, CO 80045 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Bikkavilli, RK (corresponding author), Univ Illinois, Div Pulm Crit Care Sleep & Allergy, Dept Med, Coll Med, Rm 3091,Res Bldg,909 S Wolcott Ave, Chicago, IL 60612 USA.	kamesh@uic.edu	Regan, Clinton/E-6250-2012	DeGregori, James/0000-0002-1287-1976; Pergande, Melissa/0000-0003-1197-4057; Port, Jonathan D./0000-0001-7048-3544	National Institutes of Health [R01CA138528]; Merit Award from the U.S. Dept. of Veterans Affairs	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merit Award from the U.S. Dept. of Veterans Affairs(US Department of Veterans Affairs)	This study was supported, in whole or in part, by National Institutes of Health Grant R01CA138528 (to R. W.) and a Merit Award from the U.S. Dept. of Veterans Affairs.	Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Bikkavilli RK, 2012, SCI REP-UK, V2, DOI 10.1038/srep00805; Bikkavilli RK, 2012, J CELL SCI, V125, P2446, DOI 10.1242/jcs.100933; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; BOFFA LC, 1977, BIOCHEM BIOPH RES CO, V74, P969, DOI 10.1016/0006-291X(77)91613-8; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Cha B, 2012, EXPERT OPIN THER TAR, V16, P651, DOI 10.1517/14728222.2012.688030; Silva BSD, 2014, J ORAL PATHOL MED, V43, P125, DOI 10.1111/jop.12096; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Devine DJ, 2014, ONCOGENE, V33, P2620, DOI 10.1038/onc.2013.215; Dhar S, 2013, SCI REP-UK, V3, DOI 10.1038/srep01311; Elakoum R, 2014, BIOCHIMIE, V97, P210, DOI 10.1016/j.biochi.2013.10.021; Feng ZZ, 2013, JPN J CLIN ONCOL, V43, P396, DOI 10.1093/jjco/hys237; Han SU, 2005, ANN SURG, V242, P676, DOI 10.1097/01.sla.0000186171.85804.fe; Hong J, 2011, CANCER RES, V71, P3980, DOI 10.1158/0008-5472.CAN-10-2914; Hosono S, 2007, BRIT J CANCER, V96, P314, DOI 10.1038/sj.bjc.6603533; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Kyo S, 2006, HUM PATHOL, V37, P431, DOI 10.1016/j.humpath.2005.12.021; Lander R, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2543; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee YH, 2009, MOL ENDOCRINOL, V23, P425, DOI 10.1210/me.2008-0380; Limm K, 2013, EUR J CANCER, V49, P1305, DOI 10.1016/j.ejca.2012.11.026; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Montserrat N, 2011, HUM PATHOL, V42, P103, DOI 10.1016/j.humpath.2010.05.019; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Otto EA, 2010, NAT GENET, V42, P840, DOI 10.1038/ng.662; PAIK WK, 1968, J BIOL CHEM, V243, P2108; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Shaw KRM, 2004, J MAMMARY GLAND BIOL, V9, P297, DOI 10.1007/s10911-004-1402-z; Singh S, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-47; Tadesse H, 2008, HUM MOL GENET, V17, P506, DOI 10.1093/hmg/ddm327; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vichalkovski A, 2010, ONCOGENE, V29, P3554, DOI 10.1038/onc.2010.115; Wang WS, 2013, ASIAN PAC J CANCER P, V14, P669, DOI 10.7314/APJCP.2013.14.2.669; Wilson-Rawls J, 2004, J BIOL CHEM, V279, P37685, DOI 10.1074/jbc.M401319200; Winn RA, 2005, J BIOL CHEM, V280, P19625, DOI 10.1074/jbc.M409392200; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yoshimatsu M, 2011, INT J CANCER, V128, P562, DOI 10.1002/ijc.25366; Yuen HF, 2007, J CLIN PATHOL, V60, P510, DOI 10.1136/jcp.2006.039099	47	72	83	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13479	13489		10.1074/jbc.M114.636050	http://dx.doi.org/10.1074/jbc.M114.636050			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847239	Green Published, hybrid			2022-12-26	WOS:000354975700042
J	Yan, JP; Hao, CL; DeLucia, M; Swanson, S; Florens, L; Washburn, MP; Ahn, J; Skowronski, J				Yan, Junpeng; Hao, Caili; DeLucia, Maria; Swanson, Selene; Florens, Laurence; Washburn, Michael P.; Ahn, Jinwoo; Skowronski, Jacek			CyclinA2-Cyclin-dependent Kinase Regulates SAMHD1 Protein Phosphohydrolase Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTRICTION FACTOR SAMHD1; AICARDI-GOUTIERES SYNDROME; E3 UBIQUITIN LIGASE; ALLOSTERIC ACTIVATION; RECOGNITION MOTIF; STRUCTURAL BASIS; HIV-1 INFECTION; DNA-DAMAGE; CELL; PHOSPHORYLATION	SAMHD1 is a nuclear deoxyribonucleoside triphosphate triphosphohydrolase that contributes to the control of cellular deoxyribonucleoside triphosphate (dNTP) pool sizes through dNTP hydrolysis and modulates the innate immune response to viruses. CyclinA2-CDK1/2 phosphorylates SAMHD1 at Thr-592, but how this modification controls SAMHD1 functions in proliferating cells is not known. Here, we show that SAMHD1 levels remain relatively unchanged during the cell division cycle in primary human T lymphocytes and in monocytic cell lines. Inactivation of the bipartite cyclinA2-CDK-binding site in the SAMHD1 C terminus described herein abolished SAMHD1 phosphorylation on Thr-592 during S and G(2) phases thus interfering with DNA replication and progression of cells through S phase. The effects exerted by Thr-592 phosphorylation-defective SAMHD1 mutants were associated with activation of DNA damage checkpoint and depletion of dNTP concentrations to levels lower than those seen upon expression of wild type SAMHD1 protein. These disruptive effects were relieved by either mutation of the catalytic residues of the SAMHD1 phosphohydrolase domain or by a Thr-592 phosphomimetic mutation, thus linking the Thr-592 phosphorylation state to the control of SAMHD1 dNTPase activity. Our findings support a model in which phosphorylation of Thr-592 by cyclinA2-CDK down-modulates, but does not inactivate, SAMHD1 dNTPase in S phase, thereby fine-tuning SAMHD1 control of dNTP levels during DNA replication.	[Yan, Junpeng; Hao, Caili; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [DeLucia, Maria; Ahn, Jinwoo] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA; [Ahn, Jinwoo; Skowronski, Jacek] Univ Pittsburgh, Sch Med, Pittsburgh Ctr HIV Prot Interact, Pittsburgh, PA 15260 USA; [Swanson, Selene; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA	Case Western Reserve University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu	Regan, Clinton/E-6250-2012	Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	National Institutes of Health [AI077459, AI100673, P50GM082251]; CFAR [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219, R01AI100673, R01AI077459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI077459 and AI100673 (to J. S.), P50GM082251 (to J. A.), and CFAR Grant P30 AI036219.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Amie SM, 2013, J BIOL CHEM, V288, P25001, DOI 10.1074/jbc.C113.493619; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6; Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Behrendt R, 2013, CELL REP, V4, P689, DOI 10.1016/j.celrep.2013.07.037; Beloglazova N, 2013, J BIOL CHEM, V288, P8101, DOI 10.1074/jbc.M112.431148; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Cribier A, 2013, CELL REP, V3, P1036, DOI 10.1016/j.celrep.2013.03.017; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Descours B, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-87; Diamond TL, 2004, J BIOL CHEM, V279, P51545, DOI 10.1074/jbc.M408573200; Franzolin E, 2013, P NATL ACAD SCI USA, V110, P14272, DOI 10.1073/pnas.1312033110; Goldstone DC, 2011, NATURE, V480, P379, DOI 10.1038/nature10623; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Gramberg T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-26; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hansen EC, 2014, P NATL ACAD SCI USA, V111, pE1843, DOI 10.1073/pnas.1401706111; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; Hollenbaugh JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003481; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Janardhan A, 2004, PLOS BIOL, V2, P65, DOI 10.1371/journal.pbio.0020006; Ji XY, 2014, P NATL ACAD SCI USA, V111, pE4305, DOI 10.1073/pnas.1412289111; Ji XY, 2013, NAT STRUCT MOL BIOL, V20, P1304, DOI 10.1038/nsmb.2692; Kim B, 2012, J BIOL CHEM, V287, P21570, DOI 10.1074/jbc.C112.374843; Koharudin LMI, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.591958; Kretschmer S, 2015, ANN RHEUM DIS, V74, DOI 10.1136/annrheumdis-2013-204845; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Pauls E, 2014, J IMMUNOL, V193, P1988, DOI 10.4049/jimmunol.1400873; Powell RD, 2011, J BIOL CHEM, V286, P43596, DOI 10.1074/jbc.C111.317628; Rehwinkel J, 2013, EMBO J, V32, P2454, DOI 10.1038/emboj.2013.163; Ryoo J, 2014, NAT MED, V20, P936, DOI 10.1038/nm.3626; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Stillman B, 2013, P NATL ACAD SCI USA, V110, P14120, DOI 10.1073/pnas.1312901110; Takeda DY, 2001, J BIOL CHEM, V276, P1993, DOI 10.1074/jbc.M005719200; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Welbourn S, 2013, J VIROL, V87, P11516, DOI 10.1128/JVI.01642-13; White TE, 2013, CELL HOST MICROBE, V13, P441, DOI 10.1016/j.chom.2013.03.005; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhu CF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3722	50	70	71	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13279	13292		10.1074/jbc.M115.646588	http://dx.doi.org/10.1074/jbc.M115.646588			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25847232	Green Published, hybrid			2022-12-26	WOS:000354975700028
J	Alam, MT; Weppelmann, TA; Longini, I; De Rochars, VMB; Morris, JG; Ali, A				Alam, Meer T.; Weppelmann, Thomas A.; Longini, Ira; De Rochars, Valery Madsen Beau; Morris, John Glenn, Jr.; Ali, Afsar			Increased Isolation Frequency of Toxigenic Vibrio cholerae O1 from Environmental Monitoring Sites in Haiti	PLOS ONE			English	Article								Since the identification of the first cholera case in 2010, the disease has spread in epidemic form throughout the island nation of Haiti; as of 2014, about 700,000 cholera cases have been reported, with over 8,000 deaths. While case numbers have declined, the more fundamental question of whether the causative bacterium, Vibrio cholerae has established an environmental reservoir in the surface waters of Haiti remains to be elucidated. In a previous study conducted between April 2012 and March 2013, we reported the isolation of toxigenic V. cholerae O1 from surface waters in the Ouest Department. After a second year of surveillance (April 2013 to March 2014) using identical methodology, we observed a more than five-fold increase in the number of water samples containing culturable V. cholerae O1 compared to the previous year (1.7% vs 8.6%), with double the number of sites having at least one positive sample (58% vs 20%). Both seasonal water temperatures and precipitation were significantly related to the frequency of isolation. Our data suggest that toxigenic V. cholerae O1 are becoming more common in surface waters in Haiti; while the basis for this increase is uncertain, our findings raise concerns that environmental reservoirs are being established.	[Alam, Meer T.; Weppelmann, Thomas A.; Ali, Afsar] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA; [Alam, Meer T.; Weppelmann, Thomas A.; De Rochars, Valery Madsen Beau; Morris, John Glenn, Jr.; Ali, Afsar] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA; [Longini, Ira] Univ Florida, Coll Med, Dept Biostat, Gainesville, FL USA; [Longini, Ira] Univ Florida, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA; [De Rochars, Valery Madsen Beau] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Hlth Serv Res Management & Policy, Gainesville, FL USA; [Morris, John Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ali, A (corresponding author), Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL 32611 USA.	aali@epi.ufl.edu	alam, Meer Taifur/AAQ-1435-2020	alam, Meer Taifur/0000-0002-0703-740X	National Institute of Health (NIH) [RO1 AI097405]; Department of Defense grant [C0654_12_UN]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097405] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense grant(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by a National Institute of Health (NIH) grant RO1 AI097405 awarded to J. G. M, and a Department of Defense grant (C0654_12_UN) awarded to A. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoachere JF, 2013, BMC INFECT DIS, V13, P1471; Alam M, 2006, APPL ENVIRON MICROB, V72, P2849, DOI 10.1128/AEM.72.4.2849-2855.2006; Alam MT, 2014, EMERG INFECT DIS, V20, P356, DOI 10.3201/eid2003.131293; Ali A, 2011, EMERG INFECT DIS, V17, P699, DOI 10.3201/eid1704.101973; Aliabad NH, 2012, LETT APPL MICROBIOL, V55, P27, DOI 10.1111/j.1472-765X.2012.03253.x; Barzilay EJ, 2013, NEW ENGL J MED, V368, P599, DOI 10.1056/NEJMoa1204927; Clesceri LS, 1998, STANDARD METHODS FOR; Colwell RR, 1994, VIBRIO CHOLERAE AND; Franco AA, 1997, AM J EPIDEMIOL, V146, P1067, DOI 10.1093/oxfordjournals.aje.a009235; Haitian Ministry of Public Health and Population (MSPP), 2014, DAILY REPORTS OF CHO; Haitian Misintry of Public Health and Population (MSPP), 2014, NATIONAL PLAN FOR TH; Huq A, 2005, APPL ENVIRON MICROB, V71, P4645, DOI 10.1128/AEM.71.8.4645-4654.2005; Huq Anwar, 2012, Curr Protoc Microbiol, VChapter 6, DOI 10.1002/9780471729259.mc06a05s26; Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x; Morris JG, 2011, EMERG INFECT DIS, V17, P2099, DOI 10.3201/eid1711.111109; NASA, 2014, NASA EARTH DATA DAIL; Pan American Health Organization, 2014, INTERACTIVE ATLAS OF; Rinaldo A, 2012, P NATL ACAD SCI USA, V109, P6602, DOI 10.1073/pnas.1203333109; Sjolund-Karlsson M, 2011, EMERG INFECT DIS, V17, P2151, DOI 10.3201/eid1711.110720	19	31	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0124098	10.1371/journal.pone.0124098	http://dx.doi.org/10.1371/journal.pone.0124098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853552	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400133
J	Hughes, JM; Schmidt, DJ; Huey, JA; Real, KM; Espinoza, T; McDougall, A; Kind, PK; Brooks, S; Roberts, DT				Hughes, Jane M.; Schmidt, Daniel J.; Huey, Joel A.; Real, Kathryn M.; Espinoza, Thomas; McDougall, Andrew; Kind, Peter K.; Brooks, Steven; Roberts, David T.			Extremely Low Microsatellite Diversity but Distinct Population Structure in a Long-Lived Threatened Species, the Australian Lungfish Neoceratodus forsteri (Dipnoi)	PLOS ONE			English	Article							LOW GENETIC-VARIATION; COMPUTER-PROGRAM; SIZE; BOTTLENECK; SOFTWARE; TESTS; LOCI; COD	The Australian lungfish is a unique living representative of an ancient dipnoan lineage, listed as 'vulnerable' to extinction under Australia's Environment Protection and Biodiversity Conservation Act 1999. Historical accounts indicate this species occurred naturally in two adjacent river systems in Australia, the Burnett and Mary. Current day populations in other rivers are thought to have arisen by translocation from these source populations. Early genetic work detected very little variation and so had limited power to answer questions relevant for management including how genetic variation is partitioned within and among sub-populations. In this study, we use newly developed microsatellite markers to examine samples from the Burnett and Mary Rivers, as well as from two populations thought to be of translocated origin, Brisbane and North Pine. We test whether there is significant genetic structure among and within river drainages; assign putatively translocated populations to potential source populations; and estimate effective population sizes. Eleven polymorphic microsatellite loci genotyped in 218 individuals gave an average within-population heterozygosity of 0.39 which is low relative to other threatened taxa and for freshwater fishes in general. Based on F-ST values (average over loci = 0.11) and STRUCTURE analyses, we identify three distinct populations in the natural range, one in the Burnett and two distinct populations in the Mary. These analyses also support the hypothesis that the Mary River is the likely source of translocated populations in the Brisbane and North Pine rivers, which agrees with historical published records of a translocation event giving rise to these populations. We were unable to obtain bounded estimates of effective population size, as we have too few genotype combinations, although point estimates were low, ranging from 29 - 129. We recommend that, in order to preserve any local adaptation in the three distinct populations that they be managed separately.	[Hughes, Jane M.; Schmidt, Daniel J.; Huey, Joel A.; Real, Kathryn M.] Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia; [Huey, Joel A.] Western Australian Museum, Terr Zool & Mol Systemat Unit, Welshpool, WA, Australia; [Espinoza, Thomas; McDougall, Andrew] Dept Nat Resources & Mines, Bundaberg, Qld, Australia; [Kind, Peter K.; Brooks, Steven] Queensland Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia; [Roberts, David T.] Seqwater, Ipswich, Qld, Australia	Griffith University; Western Australian Museum; Queensland Department of Agriculture & Fisheries	Hughes, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Brisbane, Qld 4111, Australia.	Jane.hughes@griffith.edu.au	Roberts, David/W-3004-2019; Roberts, David/AGK-0029-2022; hughes, jane m/C-5321-2008; McDougall, Andrew/AAA-8657-2019	Roberts, David/0000-0002-9768-6314; McDougall, Andrew/0000-0003-3304-984X; Huey, Joel/0000-0001-7108-0552	Australian Research Council Linkage grant [LP13010018]; South East Queensland Water; Queensland Department of Natural Resources and Mines; Queensland Department of Agriculture, Fisheries and Forestry	Australian Research Council Linkage grant(Australian Research Council); South East Queensland Water; Queensland Department of Natural Resources and Mines; Queensland Department of Agriculture, Fisheries and Forestry	Funding for this study was provided by an Australian Research Council Linkage grant LP13010018 to JMH with the support of South East Queensland Water, Queensland Department of Natural Resources and Mines, Queensland Department of Agriculture, Fisheries and Forestry.	Allendorf F. W., 2012, CONSERV GENET; Araripe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054470; Arthington AH, 2009, ENVIRON BIOL FISH, V84, P211, DOI 10.1007/s10641-008-9414-y; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bentley AI, 2010, FRESHWATER BIOL, V55, P1861, DOI 10.1111/j.1365-2427.2010.02420.x; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Carvalho GR, 1996, BIOL J LINN SOC, V57, P219, DOI 10.1111/j.1095-8312.1996.tb00310.x; Cornuet JM, 1996, GENETICS, V144, P2001; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dudu A., 2014, Scientific Papers: Animal Science and Biotechnologies, V47, P64; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frentiu FD, 2001, CONSERV GENET, V2, P63, DOI 10.1023/A:1011576116472; Gardner MG, 2011, MOL ECOL RESOUR, V11, P1093, DOI 10.1111/j.1755-0998.2011.03037.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Hawley DM, 2005, BIOL LETTERS, V1, P326, DOI 10.1098/rsbl.2005.0303; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Huey JA, 2013, CONSERV GENET, V14, P997, DOI 10.1007/s10592-013-0490-y; Huey JA, 2013, CONSERV GENET RESOUR, V5, P737, DOI 10.1007/s12686-013-9894-8; Illidge T, 1893, P ROYAL SOC QUEENSLA, V10, P40; Ingvarsson PK, 2001, TRENDS ECOL EVOL, V16, P62, DOI 10.1016/S0169-5347(00)02065-6; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; James KM, 2010, RADIOCARBON, V52, P1084, DOI 10.1017/S0033822200046166; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; KEMP A, 1986, J MORPHOL, P181; Kemp A, 1997, J PALEONTOL, V71, P713, DOI 10.1017/S0022336000040166; KEMP A, 1981, J PALEONTOL, V55, P211; Kemp A, 2012, WORLD LUNGFISH PERSO; Kemp A, 2014, J ARCHAEOL SCI, V52, P184, DOI 10.1016/j.jas.2014.08.021; Kemp A, 2014, AUST J ZOOL, V62, P63, DOI 10.1071/ZO13038; Kuo CH, 2004, CONSERV GENET, V5, P425, DOI 10.1023/B:COGE.0000041020.54140.45; Lee L, 2013, MULTISCALE GENETIC S; Lippe C, 2006, MOL ECOL, V15, P1769, DOI 10.1111/j.1365-294X.2006.02902.x; Lissone I, 2003, THESIS U SUNSHINE CO; McCusker MR, 2010, MOL ECOL, V19, P4852, DOI 10.1111/j.1365-294X.2010.04822.x; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; O'CONNOR D., 1897, P Soc Queensland, Vxii, P102; Peery MZ, 2012, MOL ECOL, V21, P3403, DOI 10.1111/j.1365-294X.2012.05635.x; Perez T, 1998, MOL ECOL, V7, P1347, DOI 10.1046/j.1365-294x.1998.00484.x; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard JK, 2010, DOCUMENTATION STRUCT; Pujolar JM, 2011, PLOS ONE, V6; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Real KM, 2009, CONSERV GENET RESOUR, V1, P411, DOI 10.1007/s12686-009-9095-7; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rourke ML, 2010, MAR FRESHWATER RES, V61, P918, DOI 10.1071/MF10037; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schoebel CN, 2013, J EVOLUTION BIOL, V26, P600, DOI 10.1111/jeb.12077; Schultz JK, 2009, J HERED, V100, P25, DOI 10.1093/jhered/esn077; Tallmon DA, 2004, TRENDS ECOL EVOL, V19, P489, DOI 10.1016/j.tree.2004.07.003; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x	56	15	16	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0121858	10.1371/journal.pone.0121858	http://dx.doi.org/10.1371/journal.pone.0121858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853492	gold, Green Submitted, Green Published			2022-12-26	WOS:000352478400051
J	Park, YH; Shin, JA; Han, JH; Park, YM; Yim, HW				Park, Young-Hoon; Shin, Jeong Ah; Han, Jae-Hyung; Park, Yong-Moon; Yim, Hyeon Woo			The Association between Chronic Kidney Disease and Diabetic Retinopathy: The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							RISK-FACTORS; PREVALENCE; POPULATION; EYE; TRENDS; ADULTS	Purpose To explore the relationship between chronic kidney disease and diabetic retinopathy in a representative population of Korean diabetic adults. Methods We analyzed data from the Korea National Health and Nutrition Examination Surveys (2008-2010). A total of 15,409 individuals (weighted frequency, 32,168,636) aged 19 and over who completed ophthalmologic and renal functional examinations were evaluated. Chronic kidney disease (CKD) was defined as an estimated glomerular filtration rate of < 60 ml/min/1.73 m(2) or proteinuria greater than 1+. Seven standard photographs from the Early Treatment for Diabetic Retinopathy Study were obtained from each eye after pharmacological pupil dilatation. Diabetic retinopathy (DR) was defined as the presence of 1 or more retinal microaneurysms or retinal blot hemorrhages with or without more severe lesions. Vision-threatening diabetic retinopathy (VTDR) was defined as the presence of a clinically significant macular edema (CSME) or proliferative diabetic retinopathy. Results CKD was significantly associated with DR and VTDR (odds ratio (OR), 95% confidence interval (CI); 2.49(1.43-4.35) and 3.74(1.56-8.95), respectively) in the diabetic population. After controlling for confounders, however, CKD was significantly associated only with DR [adjusted OR (aOR), 95% CI; 2.34(1.04-5.28)]. In the subgroup analysis for CKD, only proteinuria was significantly associated with DR and VTDR (aOR, 95% CI; 4.56(1.51-13.77) and 5.61(1.06-29.87), respectively) in this population. Conclusions Our results show that CKD appears to be associated with DR and VTDR in a Korean diabetic population. In particular, proteinuria, not decreased eGFR, is more significantly associated with DR or VTDR.	[Park, Young-Hoon; Shin, Jeong Ah; Han, Jae-Hyung] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Park, Yong-Moon; Yim, Hyeon Woo] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Park, Yong-Moon] Univ S Carolina, Dept Epidemiol & Biostat, Arnold Sch Publ Hlth, Columbia, SC 29208 USA	Catholic University of Korea; Catholic University of Korea; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Yim, HW (corresponding author), Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea.	y1693@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879				Agarwal DP, 2002, ALCOHOL ALCOHOLISM, V37, P409, DOI 10.1093/alcalc/37.5.409; Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Barri Yousri M, 2006, Curr Cardiol Rep, V8, P411, DOI 10.1007/s11886-006-0098-7; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CRUICKSHANKS KJ, 1993, OPHTHALMOLOGY, V100, P862; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Girach A, 2006, J DIABETES COMPLICAT, V20, P228, DOI 10.1016/j.jdiacomp.2006.03.001; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Kang HT, 2013, NEPHROL DIAL TRANSPL, V28, P927, DOI 10.1093/ndt/gfs535; Klein BEK, 2007, OPHTHAL EPIDEMIOL, V14, P179, DOI 10.1080/09286580701396720; Ko SH, 2011, DIABETES METAB J, V35, P431, DOI 10.4093/dmj.2011.35.5.431; Lee SW, 2011, NEPHROL DIAL TRANSPL, V26, P3975, DOI 10.1093/ndt/gfr154; Liew G, 2012, KIDNEY BLOOD PRESS R, V35, P589, DOI 10.1159/000339173; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mottl AK, 2012, DIABETES RES CLIN PR, V98, P487, DOI 10.1016/j.diabres.2012.09.041; Nagata M, 2010, NEPHROL DIAL TRANSPL, V25, P2557, DOI 10.1093/ndt/gfq062; Ohta M, 2010, DIABETIC MED, V27, P1017, DOI 10.1111/j.1464-5491.2010.03049.x; Park YM, 2014, DIABETES RES CLIN PR, V104, P435, DOI 10.1016/j.diabres.2014.04.003; Penno G, 2012, DIABETES CARE, V35, P2317, DOI 10.2337/dc12-0628; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Rodriguez-Poncelas A, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-46; Shankar A, 2008, NEPHROL DIAL TRANSPL, V23, P1910, DOI 10.1093/ndt/gfm878; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sivaprasad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032182; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wong CW, 2014, KIDNEY INT, V85, P1290, DOI 10.1038/ki.2013.491; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009	33	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0125338	10.1371/journal.pone.0125338	http://dx.doi.org/10.1371/journal.pone.0125338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849364	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800278
J	Sinha, P; Singh, VK; Suryanarayana, V; Krishnamurthy, L; Saxena, RK; Varshney, RK				Sinha, Pallavi; Singh, Vikas K.; Suryanarayana, V.; Krishnamurthy, L.; Saxena, Rachit K.; Varshney, Rajeev K.			Evaluation and Validation of Housekeeping Genes as Reference for Gene Expression Studies in Pigeonpea (Cajanus cajan) Under Drought Stress Conditions	PLOS ONE			English	Article							REAL-TIME PCR; INTERNAL CONTROL; QRT-PCR; NORMALIZATION; SELECTION; POTATO	Gene expression analysis using quantitative real-time PCR (qRT-PCR) is a very sensitive technique and its sensitivity depends on the stable performance of reference gene(s) used in the study. A number of housekeeping genes have been used in various expression studies in many crops however, their expression were found to be inconsistent under different stress conditions. As a result, species specific housekeeping genes have been recommended for different expression studies in several crop species. However, such specific housekeeping genes have not been reported in the case of pigeonpea (Cajanus cajan) despite the fact that genome sequence has become available for the crop. To identify the stable housekeeping genes in pigeonpea for expression analysis under drought stress conditions, the relative expression variations of 10 commonly used housekeeping genes (EF1 alpha, UBQ10, GAPDH, 18SrRNA, 25SrRNA, TUB6, ACT1, IF4 alpha, UBC and HSP90) were studied on root, stem and leaves tissues of Asha (ICPL 87119). Three statistical algorithms geNorm, NormFinder and BestKeeper were used to define the stability of candidate genes. geNorm analysis identified IF4 alpha and TUB6 as the most stable housekeeping genes however, NormFinder analysis determined IF4 alpha and HSP90 as the most stable housekeeping genes under drought stress conditions. Subsequently validation of the identified candidate genes was undertaken in qRT-PCR based gene expression analysis of uspA gene which plays an important role for drought stress conditions in pigeonpea. The relative quantification of the uspA gene varied according to the internal controls (stable and least stable genes), thus highlighting the importance of the choice of as well as validation of internal controls in such experiments. The identified stable and validated housekeeping genes will facilitate gene expression studies in pigeonpea especially under drought stress conditions.	[Sinha, Pallavi; Singh, Vikas K.; Suryanarayana, V.; Krishnamurthy, L.; Saxena, Rachit K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad 502324, Andhra Pradesh, India; [Varshney, Rajeev K.] Univ Western Australia, Sch Plant Biol, Crawley, WA 6009, Australia; [Varshney, Rajeev K.] Univ Western Australia, Inst Agr, Crawley, WA 6009, Australia	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University of Western Australia; University of Western Australia	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad 502324, Andhra Pradesh, India.	r.k.varshney@cgiar.org	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; sinha, Pallavi/0000-0003-0810-0711; Singh, Vikas Kumar/0000-0002-1560-1648	CGIAR Generation Challenge Programme (GCP); United States Agency for International Development (USAID)	CGIAR Generation Challenge Programme (GCP); United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The authors thank the CGIAR Generation Challenge Programme (GCP) and United States Agency for International Development (USAID) for financial support for the research work. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bohra A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-56; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Butte AJ, 2001, PHYSIOL GENOMICS, V7, P95, DOI 10.1152/physiolgenomics.2001.7.2.95; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Dubey A, 2011, DNA RES, V18, P153, DOI 10.1093/dnares/dsr007; Duhoux A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063576; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Garg R, 2010, BIOCHEM BIOPH RES CO, V396, P283, DOI 10.1016/j.bbrc.2010.04.079; Gimeno J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091474; Gonzalez MC, 2002, PLANT SCI, V162, P233, DOI 10.1016/S0168-9452(01)00548-9; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Gutierrez N, 2011, MOL BREEDING, V28, P13, DOI 10.1007/s11032-010-9456-7; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Imai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086492; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Krishnamurthy L, 2012, J AGR SCI-CAMBRIDGE, V150, P357, DOI 10.1017/S0021859611000682; Kudapa H, 2012, MOL PLANT, V5, P1020, DOI 10.1093/mp/ssr111; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Liu CL, 2012, EXTREMOPHILES, V16, P419, DOI 10.1007/s00792-012-0441-4; Long XY, 2010, PLANT MOL BIOL, V74, P307, DOI 10.1007/s11103-010-9666-8; Lopez-Pardo R, 2013, MOL BREEDING, V31, P39, DOI 10.1007/s11032-012-9766-z; Ma SS, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003840; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Mallona I, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-4; Manoli A, 2012, J PLANT PHYSIOL, V169, P807, DOI 10.1016/j.jplph.2012.01.019; MERRICK WC, 1992, MICROBIOL REV, V56, P291, DOI 10.1128/MMBR.56.2.291-315.1992; Nagaraja Deeplanaik, 2013, Journal of Crop Science and Biotechnology, V16, P243, DOI 10.1007/s12892-013-0069-7; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Priyanka B, 2010, MOL GENET GENOMICS, V283, P273, DOI 10.1007/s00438-010-0516-9; Raju NL, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-45; Reddy DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078555; Saxena K. B., 2008, Tropical Plant Biology, V1, P159, DOI 10.1007/s12042-008-9014-1; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Varshney RK, 2010, MOL BREEDING, V26, P393, DOI 10.1007/s11032-009-9327-2; Varshney RK, 2012, NAT BIOTECHNOL, V30, P83, DOI 10.1038/nbt.2022; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Yang Q, 2014, MOL BIOL REP, V41, P2325, DOI 10.1007/s11033-014-3086-9; Zhu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054411, 10.1371/journal.pone.0053196]	49	59	60	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122847	10.1371/journal.pone.0122847	http://dx.doi.org/10.1371/journal.pone.0122847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849964	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000352477800164
J	Zhang, Y; Wang, H; Cui, LJ; Zhang, YY; Liu, Y; Chu, X; Liu, ZY; Zhang, JP; Chu, L				Zhang, Ying; Wang, Hao; Cui, Lijing; Zhang, Yuanyuan; Liu, Yang; Chu, Xi; Liu, Zhenyi; Zhang, Jianping; Chu, Li			Continuing Treatment with Salvia miltiorrhiza Injection Attenuates Myocardial Fibrosis in Chronic Iron-Overloaded Mice	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKER; THALASSEMIA MAJOR; OXIDATIVE STRESS; COMPOUND ASTRAGALUS; COLLAGEN-SYNTHESIS; DANSHEN INJECTION; HEPATIC-FIBROSIS; CARDIAC FIBROSIS; CA2+ CHANNELS; EXTRACT	Iron overload cardiomyopathy results from iron accumulation in the myocardium that is closely linked to iron-mediated myocardial fibrosis. Salvia miltiorrhiza (SM, also known as Danshen), a traditional Chinese medicinal herb, has been widely used for hundreds of years to treat cardiovascular diseases. Here, we investigated the effect and potential mechanism of SM on myocardial fibrosis induced by chronic iron overload (CIO) in mice. Kunming male mice (8 weeks old) were randomized to six groups of 10 animals each: control (CONT), CIO, low-dose SM (L-SM), high-dose SM (H-SM), verapamil (VRP) and deferoxamine (DFO) groups. Normal saline was injected in the CONT group. Mice in the other five groups were treated with iron dextran at 50 mg/kg per day intraperitoneally for 7 weeks, and those in the latter four groups also received corresponding daily treatments, including 3 g/kg or 6 g/kg of SM, 100 mg/kg of VRP, or 100 mg/kg of DFO. The iron deposition was estimated histologically using Prussian blue staining. Myocardial fibrosis was determined by Masson's trichrome staining and hydroxyproline (Hyp) quantitative assay. Superoxide dismutase (SOD) activity, malondialdehyde (MDA) content and protein expression levels of type I collagen (COL I), type I collagen (COL III), transforming growth factor-beta(1) (TGF-beta(1)) and matrix metalloproteinase-9 (MMP-9) were analyzed to investigate the mechanisms underlying the effects of SM against iron-overloaded fibrosis. Treatment of chronic iron-overloaded mice with SM dose-dependently reduced iron deposition levels, fibrotic area percentage, Hyp content, expression levels of COL I and COL III, as well as upregulated the expression of TGF-beta(1) and MMP-9 proteins in the heart. Moreover, SM treatment decreased MDA content and increased SOD activity. In conclusion, SM exerted activities against cardiac fibrosis induced by CIO, which may be attributed to its inhibition of iron deposition, as well as collagen metabolism and oxidative stress.	[Zhang, Ying; Cui, Lijing; Liu, Yang; Zhang, Jianping; Chu, Li] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China; [Wang, Hao] Hebei Med Univ, Dept Chinese Mat Med, Shijiazhuang, Peoples R China; [Zhang, Yuanyuan; Liu, Zhenyi] Hebei Univ Chinese Med, Dept Pharmaceut, Shijiazhuang, Peoples R China; [Chu, Xi] Hebei Med Univ, Hosp 4, Shijiazhuang, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei University of Chinese Medicine; Hebei Medical University	Chu, L (corresponding author), Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Peoples R China.	chuli0614@126.com	zhang, yuanyuan/GYA-4428-2022		Nature Fund of Hebei Province, China [C2011206025, H2014206244]; Fund of Hebei Science and Technology Bureau [10276105D-2]	Nature Fund of Hebei Province, China; Fund of Hebei Science and Technology Bureau	This study was supported by the Nature Fund of Hebei Province, China http://hensf.hebstd.gov.cn/(No. C2011206025 and H2014206244) and the Fund of Hebei Science and Technology Bureau http://www.hebstd.gov.cn/(No. 10276105D-2). In this study, the funder conceived and designed the experiments, and wrote the paper.	Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Arezzini B, 2003, INT J BIOCHEM CELL B, V35, P486, DOI 10.1016/S1357-2725(02)00298-4; Barton JC, 1996, NAT MED, V2, P394, DOI 10.1038/nm0496-394; Berdoukas V, 2012, J BLOOD MED, V3, P119, DOI 10.2147/JBM.S27400; Boin F, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0123-7; Borgna-Pignatti C, 2005, ANN NY ACAD SCI, V1054, P40, DOI 10.1196/annals.1345.006; Borgna-Pignatti C, 2006, BLOOD, V107, P3733, DOI 10.1182/blood-2005-07-2933; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Cao CM, 2003, LIFE SCI, V72, P2451, DOI 10.1016/S0024-3205(03)00142-5; Cappellini Maria D, 2009, Hemoglobin, V33 Suppl 1, pS58, DOI 10.3109/03630260903346924; Chang WT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097455; Chen L, 2009, PLANTA MED, V75, P1573, DOI 10.1055/s-0029-1185905; Chern JPS, 2007, PEDIATR BLOOD CANCER, V48, P550, DOI 10.1002/pbc.21028; Ding M, 2006, J ALTERN COMPLEM MED, V12, P5, DOI 10.1089/acm.2006.12.5; Fernandes JL, 2013, AM J MED, V126, P834, DOI 10.1016/j.amjmed.2013.05.002; Fraga CG, 2002, TOXICOLOGY, V180, P23, DOI 10.1016/S0300-483X(02)00379-7; Franchini M, 2004, HEMATOL J, V5, P287, DOI 10.1038/sj.thj.6200407; FRIDOVICH I, 1989, FREE RADICAL BIO MED, V7, P557, DOI 10.1016/0891-5849(89)90032-4; Galey JB, 2000, J MED CHEM, V43, P1418, DOI 10.1021/jm9911635; Gao YG, 2014, J ETHNOPHARMACOL, V158, P397, DOI 10.1016/j.jep.2014.10.049; Gao YG, 2013, J ETHNOPHARMACOL, V145, P254, DOI 10.1016/j.jep.2012.10.060; Ge GH, 2014, GENE, V546, P97, DOI 10.1016/j.gene.2014.05.021; Guan SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074318; Gujja P, 2010, J AM COLL CARDIOL, V56, P1001, DOI 10.1016/j.jacc.2010.03.083; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; He S, 2012, BRIT J DERMATOL, V166, P564, DOI 10.1111/j.1365-2133.2011.10674.x; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HOU J, 1999, CHINESE J TUBERCULOS, V22, P43; Hsu YC, 2005, J BIOMED SCI, V12, P185, DOI 10.1007/s11373-004-8167-7; IKEDA H, 1992, HEPATOLOGY, V15, P282, DOI 10.1002/hep.1840150218; Jesmin S, 2002, DIABETOLOGIA, V45, P402, DOI 10.1007/s00125-001-0765-6; Karwinski W, 1996, J SURG RES, V64, P150, DOI 10.1006/jsre.1996.0321; Kudo H, 2008, TOXICOLOGY, V246, P143, DOI 10.1016/j.tox.2008.01.004; Kumfu S, 2011, EUR J HAEMATOL, V86, P156, DOI 10.1111/j.1600-0609.2010.01549.x; Lam FFY, 2006, EUR J PHARMACOL, V553, P240, DOI 10.1016/j.ejphar.2006.09.030; Lee SH, 2011, J ETHNOPHARMACOL, V137, P1409, DOI 10.1016/j.jep.2011.08.007; Lee TY, 2006, J PHARM PHARMACOL, V58, P659, DOI 10.1211/jpp.58.5.0011; Lian WS, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-26; Lin H, 2013, MOL PHARMACOL, V84, P275, DOI 10.1124/mol.112.083964; Liu L, 2012, MOL MED REP, V6, P1231, DOI 10.3892/mmr.2012.1076; Lu HY, 2014, BIOL PHARM BULL, V37, P961, DOI 10.1248/bpb.b13-00921; Matsui T, 2010, BIOCHEM BIOPH RES CO, V396, P566, DOI 10.1016/j.bbrc.2010.04.149; Murphy CJ, 2010, J CARD FAIL, V16, P888, DOI 10.1016/j.cardfail.2010.05.009; Nan JX, 2001, J PHARM PHARMACOL, V53, P197, DOI 10.1211/0022357011775406; Oudit GY, 2006, J MOL MED, V84, P349, DOI 10.1007/s00109-005-0029-x; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Patel R, 2006, J VASC SURG, V43, P364, DOI 10.1016/j.jvs.2005.10.032; Pepe A, 2009, HEART, V95, P1688, DOI 10.1136/hrt.2008.156497; Poggiali E, 2012, BLOOD TRANSFUS-ITALY, V10, P411, DOI 10.2450/2012.0008-12; Psaltis PJ, 2011, INT J CARDIOVAS IMAG, V27, P25, DOI 10.1007/s10554-010-9657-5; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reed AL, 2011, AM J PHYSIOL-HEART C, V301, pH824, DOI 10.1152/ajpheart.00407.2010; Reeder BJ, 2008, FREE RADICAL BIO MED, V44, P264, DOI 10.1016/j.freeradbiomed.2007.08.006; Rui WJ, 2014, J ETHNOPHARMACOL, V151, P198, DOI 10.1016/j.jep.2013.10.022; Saewong T, 2010, MED CHEM, V6, P57, DOI 10.2174/157340610791321479; Santos MM, 2000, AM J PATHOL, V157, P1883, DOI 10.1016/S0002-9440(10)64827-4; Selim M, 2010, TRANSL STROKE RES, V1, P35, DOI 10.1007/s12975-009-0001-0; Sugishita K, 2009, INT HEART J, V50, P829, DOI 10.1536/ihj.50.829; Tian Xiao-hui, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P404; Usunier B, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/340257; Verrecchia F, 2001, J BIOL CHEM, V276, P17058, DOI 10.1074/jbc.M100754200; Wang M, 2012, J ETHNOPHARMACOL, V141, P96, DOI 10.1016/j.jep.2012.02.005; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wasser S, 1998, J HEPATOL, V29, P760, DOI 10.1016/S0168-8278(98)80257-2; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; Wu WY, 2012, ACTA PHARMACOL SIN, V33, P1119, DOI 10.1038/aps.2012.126; Yang Y, 2008, J ETHNOPHARMACOL, V118, P264, DOI 10.1016/j.jep.2008.04.012; Yu QL, 2014, MYCOPATHOLOGIA, V177, P167, DOI 10.1007/s11046-014-9735-7; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhang JP, 2013, PLANTA MED, V79, P744, DOI 10.1055/s-0032-1328588; Zhang Y, 2012, EUR J PHARMACOL, V680, P95, DOI 10.1016/j.ejphar.2012.01.010; Zhang Y, 2013, J ETHNOPHARMACOL, V148, P671, DOI 10.1016/j.jep.2013.05.028; Zhou XL, 2012, PHYTOMEDICINE, V19, P1263, DOI 10.1016/j.phymed.2012.08.011; Zou CB, 2013, ENDOCRINE, V44, P666, DOI 10.1007/s12020-013-9907-0	74	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0124061	10.1371/journal.pone.0124061	http://dx.doi.org/10.1371/journal.pone.0124061			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25850001	Green Submitted, Green Published, gold			2022-12-26	WOS:000352477800261
J	Zhao, CQ; Fan, XF; Hou, XC; Zhu, Y; Yue, YS; Zhang, S; Wu, JY				Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Zhang, Shuang; Wu, Juying			Tassel Removal Positively Affects Biomass Production Coupled with Significantly Increasing Stem Digestibility in Switchgrass	PLOS ONE			English	Article							DILUTE-ACID PRETREATMENT; ENZYMATIC DIGESTIBILITY; CHEMICAL-COMPOSITION; TRADE-OFFS; CELL-WALLS; FORAGE; QUALITY; YIELD; FEATURES; BIOFUEL	In this study, tassels of Cave-in-Rock (upland) and Alamo (lowland) were removed at or near tassel emergence to explore its effects on biomass production and quality. Tassel-removed (TR) Cave-in-Rock and Alamo both exhibited a significant (P<0.05) increase in plant heights (not including tassel length), tiller number, and aboveground biomass dry weight (10% and 12%, 30% and 13%, 13% and 18%, respectively by variety) compared to a control (CK) treatment. Notably, total sugar yields of TR Cave-in-Rock and Alamo stems increased significantly (P<0.05 or 0.01) by 19% and 19%, 21% and 14%, 52% and 18%, respectively by variety, compared to those of control switchgrass under 3 treatments by direct enzymatic hydrolysis (DEH), enzymatic hydrolysis after 1% NaOH pretreatment (EHAL) and enzymatic hydrolysis after 1% H2SO4 pretreatment (EHAC). These differences were mainly due to significantly (P<0.05 or 0.01) higher cellulose content, lower cellulose crystallinity indexes (CrI) caused by higher arabinose (Ara) substitution in xylans, and lower S/G ratio in lignin. However, the increases of nitrogen (N) and sulphur (S) concentration negatively affects the combustion quality of switchgrass aboveground biomass. This work provides information for increasing biomass production and quality in switchgrass and also facilitates the inhibition of gene dispersal of switchgrass in China.	[Zhao, Chunqiao; Fan, Xifeng; Hou, Xincun; Zhu, Yi; Yue, Yuesen; Zhang, Shuang; Wu, Juying] Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China; [Zhao, Chunqiao] China Agr Univ, Coll Agr & Biotechnol, Beijing 100094, Peoples R China	Beijing Academy of Agriculture & Forestry; China Agricultural University	Fan, XF (corresponding author), Beijing Acad Agr & Forestry Sci, Beijing Res & Dev Ctr Grass & Environm, Beijing, Peoples R China.	fanxifengcau@163.com			Beijing Nova Program [Z131105000413020]; youth scientific research funds of Beijing Academy of Agriculture and Forestry [QNJJ201219, QNJJ201316]	Beijing Nova Program(Beijing Municipal Science & Technology Commission); youth scientific research funds of Beijing Academy of Agriculture and Forestry	This work was supported in part by grants from Beijing Nova Program (Z131105000413020), youth scientific research funds of Beijing Academy of Agriculture and Forestry (QNJJ201219), and youth scientific research funds of Beijing Academy of Agriculture and Forestry (QNJJ201316). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PR, 2006, AGRON J, V98, P1518, DOI 10.2134/agronj2005.0351; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Baxter HL, 2014, PLANT BIOTECHNOL J, V12, P914, DOI 10.1111/pbi.12195; Bell G., 1986, Oxford Surveys in Evolutionary Biology, V3, P83; Bilgin A, 2009, POL J ECOL, V57, P261; Boe A, 2003, CROP SCI, V43, P63, DOI 10.2135/cropsci2003.0063; Boe A, 2007, CROP SCI, V47, P636, DOI 10.2135/cropsci2006.04.0260; BREJDA JJ, 1994, J RANGE MANAGE, V47, P22, DOI 10.2307/4002835; Chen L, 2002, J AGR FOOD CHEM, V50, P5558, DOI 10.1021/jf020516x; Cruz A, 2001, ACTA OECOL, V22, P121, DOI 10.1016/S1146-609X(01)01107-9; Dien BS, 2006, BIOMASS BIOENERG, V30, P880, DOI 10.1016/j.biombioe.2006.02.004; Dische Z., 1962, METHODS CARBOHYDRATE, V1, P477; Dixon RA, 2013, NATURE, V493, P36, DOI 10.1038/493036a; Fry S. C., 1988, The growing plant cell wall: chemical and metabolic analysis.; Girio FM, 2010, BIORESOURCE TECHNOL, V101, P4775, DOI 10.1016/j.biortech.2010.01.088; Hendriks ATWM, 2009, BIORESOURCE TECHNOL, V100, P10, DOI 10.1016/j.biortech.2008.05.027; Holou RAY, 2013, BIOFUELS-UK, V4, P169, DOI [10.4155/bfs.12.79, 10.4155/BFS.12.79]; Hsu TC, 2010, BIORESOURCE TECHNOL, V101, P4907, DOI 10.1016/j.biortech.2009.10.009; Iiyama K, 2001, ASIAN AUSTRAL J ANIM, V14, P862, DOI 10.5713/ajas.2001.862; Jordan DB, 2012, BIOCHEM J, V442, P241, DOI 10.1042/BJ20111922; Jorgensen U, 1997, BIOMASS BIOENERG, V12, P155, DOI 10.1016/S0961-9534(97)00002-0; Kering MK, 2013, CROP SCI, V53, P1809, DOI 10.2135/cropsci2012.10.0568; Kumar V, 1999, INT J PHARM, V177, P173, DOI 10.1016/S0378-5173(98)00340-8; Lemus R, 2002, BIOMASS BIOENERG, V23, P433, DOI 10.1016/S0961-9534(02)00073-9; Lewandowski I, 1997, EUR J AGRON, V6, P163, DOI 10.1016/S1161-0301(96)02044-8; Li FC, 2013, BIORESOURCE TECHNOL, V130, P629, DOI 10.1016/j.biortech.2012.12.107; Li M, 2014, BIORESOURCE TECHNOL, V169, P447, DOI 10.1016/j.biortech.2014.07.017; Li ZR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105115; LUNDVALL JP, 1994, CROP SCI, V34, P1672, DOI 10.2135/cropsci1994.0011183X003400060046x; Madakadze IC, 1999, AGRON J, V91, P696, DOI 10.2134/agronj1999.914696x; Mclaughlin S., 1999, PERSPECTIVES NEW CRO, P282, DOI DOI 10.1081/E-EPCS; Miles TR, 1996, BIOMASS BIOENERG, V10, P125, DOI 10.1016/0961-9534(95)00067-4; Mitchell R, 2014, COMPEND BIOENERG PLA, P1; Mittal A, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-41; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; PAKONEN T, 1991, ACTA OECOL, V12, P249; Peng LC, 2000, PLANTA, V211, P406, DOI 10.1007/s004250000301; Rajendran C, 2000, J AGRON CROP SCI, V185, P23, DOI 10.1046/j.1439-037X.2000.00386.x; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Rinehart L, 2006, SWITCHGRASS BIOENERG; Roff Derek A., 1992; Sanderson MA, 1999, AGRON J, V91, P5, DOI 10.2134/agronj1999.00021962009100010002x; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Sluiter A, 2007, DETERMINATION STRUCT; Stearns S.C., 1992, pi; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Studer MH, 2011, P NATL ACAD SCI USA, V108, P6300, DOI 10.1073/pnas.1009252108; Tang Y, 2010, J INTEGR PLANT BIOL, V52, P112, DOI 10.1111/j.1744-7909.2010.00903.x; WESTLEY LC, 1993, ECOLOGY, V74, P2136, DOI 10.2307/1940858; Wu ZL, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-183; Xie GS, 2011, J INTEGR PLANT BIOL, V53, P143, DOI 10.1111/j.1744-7909.2010.01022.x; Xu N, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-58; Yi Zheng, 2009, International Journal of Agricultural and Biological Engineering, V2, P51, DOI 10.3965/j.issn.1934-6344.2009.03.051-068; Zhang W, 2013, BIORESOURCE TECHNOL, V130, P30, DOI 10.1016/j.biortech.2012.12.029	56	13	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120845	10.1371/journal.pone.0120845	http://dx.doi.org/10.1371/journal.pone.0120845			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849123	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800036
J	Hellrung, L; Hollmann, M; Zscheyge, O; Schlumm, T; Kalberlah, C; Roggenhofer, E; Okon-Singer, H; Villringer, A; Horstmann, A				Hellrung, Lydia; Hollmann, Maurice; Zscheyge, Oliver; Schlumm, Torsten; Kalberlah, Christian; Roggenhofer, Elisabeth; Okon-Singer, Hadas; Villringer, Arno; Horstmann, Annette			Flexible Adaptive Paradigms for fMRI Using a Novel Software Package 'Brain Analysis in Real-Time' (BART)	PLOS ONE			English	Article							EMOTION; FLUCTUATIONS; AMYGDALA	In this work we present a new open source software package offering a unified framework for the real-time adaptation of fMRI stimulation procedures. The software provides a straightforward setup and highly flexible approach to adapt fMRI paradigms while the experiment is running. The general framework comprises the inclusion of parameters from subject's compliance, such as directing gaze to visually presented stimuli and physiological fluctuations, like blood pressure or pulse. Additionally, this approach yields possibilities to investigate complex scientific questions, for example the influence of EEG rhythms or fMRI signals results themselves. To prove the concept of this approach, we used our software in a usability example for an fMRI experiment where the presentation of emotional pictures was dependent on the subject's gaze position. This can have a significant impact on the results. So far, if this is taken into account during fMRI data analysis, it is commonly done by the post-hoc removal of erroneous trials. Here, we propose an a priori adaptation of the paradigm during the experiment's runtime. Our fMRI findings clearly show the benefits of an adapted paradigm in terms of statistical power and higher effect sizes in emotion-related brain regions. This can be of special interest for all experiments with low statistical power due to a limited number of subjects, a limited amount of time, costs or available data to analyze, as is the case with real-time fMRI.	[Hellrung, Lydia; Hollmann, Maurice; Zscheyge, Oliver; Kalberlah, Christian; Roggenhofer, Elisabeth; Villringer, Arno; Horstmann, Annette] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany; [Hellrung, Lydia; Kalberlah, Christian; Horstmann, Annette] Univ Leipzig, Med Ctr, D-04109 Leipzig, Germany; [Schlumm, Torsten] Max Planck Inst Human Cognit & Brain Sci, NMR Unit, Leipzig, Germany; [Roggenhofer, Elisabeth; Villringer, Arno; Horstmann, Annette] Univ Leipzig, Med Ctr, IFB Adipos Dis, D-04109 Leipzig, Germany; [Roggenhofer, Elisabeth; Villringer, Arno] Univ Hosp, Clin Cognit Neurol, Leipzig, Germany; [Okon-Singer, Hadas] Univ Haifa, Dept Psychol, IL-31999 Haifa, Israel; [Villringer, Arno] Humboldt Univ & Charite, Berlin Sch Mind & Brain, Mind & Brain Inst, Berlin, Germany	Max Planck Society; Leipzig University; Max Planck Society; Leipzig University; Leipzig University; University of Haifa; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hellrung, L (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany.	hellrung@cbs.mpg.de	Horstmann, Annette/C-9083-2011; Hellrung, Lydia/AAC-3062-2019	Horstmann, Annette/0000-0001-6184-8484; Hellrung, Lydia/0000-0003-0317-4770; Villringer, Arno/0000-0003-2604-2404	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01E01001]; German Research Foundation (DFG), within the framework of the CRC 1052 'Obesity Mechanisms'; BMBF (Bernstein Focus, State Dependencies of Learning) [01GQ0975, 18GL4DW4]	IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG), within the framework of the CRC 1052 'Obesity Mechanisms'(German Research Foundation (DFG)); BMBF (Bernstein Focus, State Dependencies of Learning)(Federal Ministry of Education & Research (BMBF))	The work of AH and AV is supported by the IFB Adiposity Diseases, Federal Ministry of Education and Research (BMBF), Germany, FKZ: 01E01001 (http://www.bmbf.de). The work of AH, AV, CK and LH is funded by the German Research Foundation (DFG) (http://www.dfg.de), within the framework of the CRC 1052 'Obesity Mechanisms'. The work of MH is supported the BMBF (Bernstein Focus, State Dependencies of Learning 01GQ0975; Project 18GL4DW4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2008, BRAIN, V131, P2140, DOI 10.1093/brain/awn135; Becker R, 2011, J NEUROSCI, V31, P11016, DOI 10.1523/JNEUROSCI.0210-11.2011; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brosch T, 2013, SWISS MED WKLY, V143, DOI 10.4414/smw.2013.13786; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Glascher J, 2009, NEUROINFORMATICS, V7, P73, DOI 10.1007/s12021-008-9042-x; Hinds O, 2011, NEUROIMAGE, V54, P361, DOI 10.1016/j.neuroimage.2010.07.060; Hollmann M, 2008, J NEUROSCI METH, V175, P154, DOI 10.1016/j.jneumeth.2008.08.013; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lang PJ, 2008, INT AFFECTIVE PICTUR; Leopold DA, 2012, NEUROIMAGE, V62, P2190, DOI 10.1016/j.neuroimage.2011.10.059; Lim SL, 2009, P NATL ACAD SCI USA, V106, P16841, DOI 10.1073/pnas.0904551106; Linkenkaer-Hansen K, 2004, J NEUROSCI, V24, P10186, DOI 10.1523/JNEUROSCI.2584-04.2004; Padmala S, 2010, COGN AFFECT BEHAV NE, V10, P279, DOI 10.3758/CABN.10.2.279; Pessoa L, 2002, COGNITIVE BRAIN RES, V15, P31, DOI 10.1016/S0926-6410(02)00214-8; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Reynolds JH, 2004, ANNU REV NEUROSCI, V27, P611, DOI 10.1146/annurev.neuro.26.041002.131039; Robinson S, 2004, NEUROIMAGE, V22, P203, DOI 10.1016/j.neuroimage.2003.12.048; Rotshtein P, 2011, NEUROPSYCHOLOGIA, V49, P1544, DOI 10.1016/j.neuropsychologia.2010.12.002; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Smyser C, 2001, MAGN RESON MED, V45, P289, DOI 10.1002/1522-2594(200102)45:2<289::AID-MRM1038>3.0.CO;2-U; Voyvodic James T, 2011, Front Neuroinform, V5, P27, DOI 10.3389/fninf.2011.00027; Voyvodic JT, 1999, NEUROIMAGE, V10, P91, DOI 10.1006/nimg.1999.0457; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Ward R, 2007, NEUROPSYCHOLOGIA, V45, P1973, DOI 10.1016/j.neuropsychologia.2006.09.017; Weiskopf N, 2012, NEUROIMAGE, V62, P682, DOI 10.1016/j.neuroimage.2011.10.009; Wilms M, 2010, SOC COGN AFFECT NEUR, V5, P98, DOI 10.1093/scan/nsq024; Yoo JJ, 2012, NEUROIMAGE, V59, P846, DOI 10.1016/j.neuroimage.2011.07.063; Zscheyge O, 2010, DEV PLATFORM INDEPEN	34	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0118890	10.1371/journal.pone.0118890	http://dx.doi.org/10.1371/journal.pone.0118890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837719	Green Published, gold, Green Submitted			2022-12-26	WOS:000352139000006
J	Sen, R; Raychoudhury, R; Cai, YP; Sun, YJ; Lietze, VU; Peterson, BF; Scharf, ME; Boucias, DG				Sen, Ruchira; Raychoudhury, Rhitoban; Cai, Yunpeng; Sun, Yijun; Lietze, Verena-Ulrike; Peterson, Brittany F.; Scharf, Michael E.; Boucias, Drion G.			Molecular Signatures of Nicotinoid-Pathogen Synergy in the Termite Gut	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES ISOPTERA; INSECT IMMUNITY; LIGNOCELLULOSE; RHINOTERMITIDAE; BACTERIAL; ANTIFUNGAL; EXPRESSION; COMMUNITY; RESPONSES; SELECTION	Previous studies in lower termites revealed unexpected synergies between nicotinoid insecticides and fungal entomopathogens. The present study investigated molecular mechanisms of nicotinoid-pathogen synergy in the lower termite Reticulitermes flavipes, using the nicotinoid, imidacloprid, in combination with fungal and bacterial entomopathogens. Particular focus was placed on metatranscriptome composition and microbial dynamics in the symbiont- rich termite gut, which houses diverse mixes of protists and bacteria. cDNA microarrays containing a mix of host and protist symbiont oligonucleotides were used to simultaneously assess termite and protist gene expression. Five treatments were compared that included single challenges with sublethal doses of fungi (Metharizium anisopliae), bacteria (Serratia marcescens) or imidacloprid, and dual challenges with fungi + imidacloprid or bacteria + imidacloprid. Our findings point towards protist dysbiosis and compromised social behavior, rather than suppression of stereotypical immune defense mechanisms, as the dominant factors underlying nicotinoid-pathogen synergy in termites. Also, greater impacts observed for the fungal pathogen than for the bacterial pathogen suggest that the rich bacterial symbiont community in the R. flavipes gut (>5000 species-level phylotypes) exists in an ecological balance that effectively excludes exogenous bacterial pathogens. These findings significantly advance our understanding of antimicrobial defenses in this important eusocial insect group, as well as provide novel insights into how nicotinoids can exert deleterious effects on social insect colonies.	[Sen, Ruchira; Raychoudhury, Rhitoban; Peterson, Brittany F.; Scharf, Michael E.] Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA; [Cai, Yunpeng; Sun, Yijun] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Lietze, Verena-Ulrike; Boucias, Drion G.] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Scharf, ME (corresponding author), Purdue Univ, Dept Entomol, W Lafayette, IN 47907 USA.	mscharf@purdue.edu	Cai, Yunpeng/O-8823-2018; Sen, Ruchira/AAJ-4776-2021	Sen, Ruchira/0000-0001-7794-4315; Raychoudhury, Rhitoban/0000-0001-6835-1008	USDA-NIFA-AFRI [2009-05245, 2010-65106-30727]; O.W. Rollins/Orkin Endowment at Purdue University	USDA-NIFA-AFRI(United States Department of Agriculture (USDA)); O.W. Rollins/Orkin Endowment at Purdue University	This study was funding by USDA-NIFA-AFRI (http://www.nifa.usda.gov/) grants 2009-05245 and 2010-65106-30727 to MES and DGB and by the O.W. Rollins/Orkin Endowment (http://www.orkin.net/community/social-responsibility/rollins-philanthropic-foundations) at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Boucias D. G., 1996, Pflanzenschutz-Nachrichten Bayer (English ed.), V49, P103; Boucias DG, 2013, MOL ECOL, V22, P1836, DOI 10.1111/mec.12230; Brune A, 2014, NAT REV MICROBIOL, V12, P168, DOI 10.1038/nrmicro3182; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; Connick WJ, 2001, ENVIRON ENTOMOL, V30, P449, DOI 10.1603/0046-225X-30.2.449; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Elliott KL, 2009, PEPTIDES, V30, P855, DOI 10.1016/j.peptides.2009.01.009; Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56; Gibson G., 2002, PRIMER GENOME SCI; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grimont F, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P219, DOI 10.1007/0-387-30746-x_11; Hussain A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069543; Husseneder C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105582; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kang D, 2002, DEV COMP IMMUNOL, V26, P495, DOI 10.1016/S0145-305X(02)00009-5; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; Matsuura K, 2009, CURR BIOL, V19, P30, DOI 10.1016/j.cub.2008.11.030; Mikonranta L, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-23; Nuss AB, 2010, PEPTIDES, V31, P419, DOI 10.1016/j.peptides.2009.09.001; Osbrink WLA, 2001, ENVIRON ENTOMOL, V30, P443, DOI 10.1603/0046-225X-30.2.443; Parman V, 2010, J ECON ENTOMOL, V103, P791, DOI 10.1603/EC09386; Pavia CS, 2000, J MED MICROBIOL, V49, P675, DOI 10.1099/0022-1317-49-7-675; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Ramakrishnan R, 1999, J ECON ENTOMOL, V92, P1125, DOI 10.1093/jee/92.5.1125; Raychoudhury R, 2013, INSECT MOL BIOL, V22, P155, DOI 10.1111/imb.12011; Rosengaus RB, 1999, NATURWISSENSCHAFTEN, V86, P544, DOI 10.1007/s001140050672; Rosengaus RB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00607; Rosengaus RB, 2011, BIOLOGY OF TERMITES: A MODERN SYNTHESIS, P165, DOI 10.1007/978-90-481-3977-4_7; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Rubin BER, 2014, MICROBIOLOGYOPEN, V3, P910, DOI 10.1002/mbo3.216; Ryu JH, 2010, DEV COMP IMMUNOL, V34, P369, DOI 10.1016/j.dci.2009.11.010; Schwinghammer MA, 2011, GENE, V474, P12, DOI 10.1016/j.gene.2010.11.012; Sen R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-491; Sethi A, 2013, ARCH INSECT BIOCHEM, V84, P175, DOI 10.1002/arch.21135; Sethi A, 2013, INSECT BIOCHEM MOLEC, V43, P91, DOI 10.1016/j.ibmb.2012.10.001; Stathopoulos S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003897; Stokstad E, 2013, SCIENCE, V340, P674, DOI [10.1126/science.340.6133.674, 10.1126/science.340.6133.675]; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Szalanski AL, 2003, J ECON ENTOMOL, V96, P1514, DOI 10.1603/0022-0493-96.5.1514; Tai V, 2015, APPL ENVIRON MICROB, V81, P1059, DOI 10.1128/AEM.02945-14; Tartar A, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-25; Tarver MR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-28; Tomalski M, 2010, ANN ENTOMOL SOC AM, V103, P84, DOI 10.1603/008.103.0111; Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930; Traniello JFA, 2002, P NATL ACAD SCI USA, V99, P6838, DOI 10.1073/pnas.102176599; Wheeler MM, 2007, INSECT BIOCHEM MOLEC, V37, P1366, DOI 10.1016/j.ibmb.2007.09.010; Yanagawa A, 2008, J INVERTEBR PATHOL, V97, P165, DOI 10.1016/j.jip.2007.09.005	53	11	12	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0123391	10.1371/journal.pone.0123391	http://dx.doi.org/10.1371/journal.pone.0123391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837376	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000141
J	Shoji, JY; Charlton, ND; Yi, MH; Young, CA; Craven, KD				Shoji, Jun-Ya; Charlton, Nikki D.; Yi, Mihwa; Young, Carolyn A.; Craven, Kelly D.			Vegetative Hyphal Fusion and Subsequent Nuclear Behavior in Epichloe Grass Endophytes	PLOS ONE			English	Article							CONIDIAL ANASTOMOSIS TUBES; HORIZONTAL GENE-TRANSFER; TALL FESCUE; INTERSPECIFIC HYBRIDIZATION; FUNGAL ENDOPHYTES; ASPERGILLUS-NIDULANS; PROTOPLAST FUSION; COMPATIBILITY; DYNAMICS; GROWTH	Epichloe species (including the former genus Neotyphodium) are fungal symbionts of many agronomically important forage grasses, and provide their grass hosts with protection from a wide range of biotic and abiotic stresses. Epichloe species include many interspecific hybrids with allodiploid-like genomes, which may provide the potential for combined traits or recombination to generate new traits. Though circumstantial evidence suggests that such interspecific hybrids might have arisen from nuclear fusion events following vegetative hyphal fusion between different Epichloe strains, this hypothesis has not been addressed empirically. Here, we investigated vegetative hyphal fusion and subsequent nuclear behavior in Epichloe species. A majority of Epichloe strains, especially those having a sexual stage, underwent self vegetative hyphal fusion. Vegetative fusion also occurred between two hyphae from different Epichloe strains. Though Epichloe spp. are uninucleate fungi, hyphal fusion resulted in two nuclei stably sharing the same cytoplasm, which might ultimately lead to nuclear fusion. In addition, protoplast fusion experiments gave rise to uninucleate putative hybrids, which apparently had two markers, one from each parent within the same nucleus. These results are consistent with the notion that interspecific hybrids arise from vegetative hyphal fusion. However, we also discuss additional factors, such as post-hybridization selection, that may be important to explain the recognized prevalence of hybrids in Epichloe species.	[Shoji, Jun-Ya; Craven, Kelly D.] Samuel Roberts Noble Fdn Inc, Div Plant Biol, Ardmore, OK 73401 USA; [Charlton, Nikki D.; Yi, Mihwa; Young, Carolyn A.] Samuel Roberts Noble Fdn Inc, Forage Improvement Div, Ardmore, OK 73401 USA	Noble Research Institute; Noble Research Institute	Craven, KD (corresponding author), Samuel Roberts Noble Fdn Inc, Div Plant Biol, 2510 Sam Noble Pkwy, Ardmore, OK 73401 USA.	kdcraven@noble.org	Young, Carolyn Anne/Q-2963-2019	Young, Carolyn Anne/0000-0003-0406-8398; Craven, Kelly/0000-0002-1597-9413; Charlton, Nikki/0000-0001-9580-5466	Samuel Roberts Noble Foundation; NSF [DBI 0400580]	Samuel Roberts Noble Foundation; NSF(National Science Foundation (NSF))	This study was financially supported by The Samuel Roberts Noble Foundation (internal grant) and the NSF (equipment grant DBI 0400580).	Aanen DK, 2008, BIOESSAYS, V30, P1193, DOI 10.1002/bies.20840; ARACHEVALETA M, 1989, AGRON J, V81, P83, DOI 10.2134/agronj1989.00021962008100010015x; BACON CW, 1986, AGRON J, V78, P106, DOI 10.2134/agronj1986.00021962007800010023x; Becker Y, 2015, MOL PLANT MICROBE IN, V28, P69, DOI 10.1094/MPMI-06-14-0183-R; Bloemendal S, 2010, EUKARYOT CELL, V9, P1856, DOI 10.1128/EC.00186-10; Boddy L, 1999, MYCOLOGIA, V91, P13, DOI 10.2307/3761190; BRAUER KL, 1987, APPL ENVIRON MICROB, V53, P70, DOI 10.1128/AEM.53.1.70-73.1987; Ruiz-Roldan MC, 2010, EUKARYOT CELL, V9, P1216, DOI 10.1128/EC.00040-10; Charlton ND, 2014, FEMS MICROBIOL ECOL, V90, P276, DOI 10.1111/1574-6941.12393; Charlton ND, 2012, EUKARYOT CELL, V11, P1463, DOI 10.1128/EC.00191-12; Charlton ND, 2012, MYCOLOGIA, V104, P1187, DOI 10.3852/11-403; Christensen MJ, 2000, MYCOL RES, V104, P974, DOI 10.1017/S0953756299002300; Christensen MJ, 2002, MYCOL RES, V106, P93, DOI 10.1017/S095375620100510X; Chung KR, 1997, MYCOLOGIA, V89, P558, DOI 10.2307/3760992; Chung KR, 1997, MYCOL RES, V101, P295, DOI 10.1017/S0953756296002602; CLAY K, 1985, OECOLOGIA, V66, P1, DOI 10.1007/BF00378545; Clewes E, 2008, NEW PHYTOL, V177, P583, DOI 10.1111/j.1469-8137.2007.02327.x; Clutterbuck AJ, 1996, J GENET, V75, P281, DOI 10.1007/BF02966308; Cox MP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004180; Craven KD, 2001, ANN MO BOT GARD, V88, P14, DOI 10.2307/2666129; Croll D, 2009, NEW PHYTOL, V181, P924, DOI 10.1111/j.1469-8137.2008.02726.x; DALES RBG, 1983, J GEN MICROBIOL, V129, P3643; de Barros Lopes Miguel, 2002, FEMS Yeast Res, V1, P323, DOI 10.1016/S1567-1356(01)00051-4; Dettman JR, 2003, EVOLUTION, V57, P2703, DOI 10.1554/03-073; Fischer-Harman V, 2012, FUNGAL GENET BIOL, V49, P896, DOI 10.1016/j.fgb.2012.08.004; Fitzpatrick DA, 2012, FEMS MICROBIOL LETT, V329, P1, DOI 10.1111/j.1574-6968.2011.02465.x; Friesen TL, 2006, NAT GENET, V38, P953, DOI 10.1038/ng1839; Gentile A, 2005, MOL PHYLOGENET EVOL, V35, P196, DOI 10.1016/j.ympev.2005.01.008; Gibson AK, 2012, EVOLUTION, V66, P1917, DOI 10.1111/j.1558-5646.2011.01563.x; Glass NL, 2000, ANNU REV GENET, V34, P165, DOI 10.1146/annurev.genet.34.1.165; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hyde GJ, 1999, CELL MOTIL CYTOSKEL, V42, P114; Ishikawa FH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031175; Kayano Y, 2013, FUNGAL GENET BIOL, V56, P87, DOI 10.1016/j.fgb.2013.05.001; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; KEVEI F, 1977, J GEN MICROBIOL, V102, P255, DOI 10.1099/00221287-102-2-255; KEVEI F, 1984, J GEN MICROBIOL, V130, P2229; Kucsera J, 1998, CAN J MICROBIOL, V44, P959; Kuldau GA, 1999, MYCOLOGIA, V91, P776, DOI 10.2307/3761531; LEUCHTMANN A, 1994, MYCOLOGIA, V86, P802, DOI 10.2307/3760595; Leuchtmann A, 1998, MYCOL RES, V102, P1169, DOI 10.1017/S0953756298006236; Leuchtmann A, 2014, MYCOLOGIA, V106, P202, DOI 10.3852/106.2.202; Lichius A., 2010, FUNGAL GENET, V57, P8, DOI [10.4148/1941-4765.1070, DOI 10.4148/1941-4765.1070]; Lichius A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042565; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Mabashi Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1882, DOI 10.1271/bbb.60052; Malinowski DP, 2000, CROP SCI, V40, P923, DOI 10.2135/cropsci2000.404923x; Mehrabi R, 2011, FEMS MICROBIOL REV, V35, P542, DOI 10.1111/j.1574-6976.2010.00263.x; Moon CD, 2004, MOL ECOL, V13, P1455, DOI 10.1111/j.1365-294X.2004.02138.x; Namiki F, 2001, MOL PLANT MICROBE IN, V14, P580, DOI 10.1094/MPMI.2001.14.4.580; Oliver R, 2012, NEW PHYTOL, V196, P1015, DOI 10.1111/j.1469-8137.2012.04330.x; Olson A, 2002, MICROBES INFECT, V4, P1353, DOI 10.1016/S1286-4579(02)00005-9; Palma-Guerrero J, 2009, FUNGAL GENET BIOL, V46, P585, DOI 10.1016/j.fgb.2009.02.010; Querol A, 2009, FEMS MICROBIOL LETT, V293, P1, DOI 10.1111/j.1574-6968.2008.01480.x; Read ND, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P260; Read ND, 2009, CURR OPIN MICROBIOL, V12, P608, DOI 10.1016/j.mib.2009.09.008; Rech C, 2007, CURR GENET, V52, P259, DOI 10.1007/s00294-007-0158-6; RICE GC, 1989, CYTOMETRY, V10, P103, DOI 10.1002/cyto.990100119; Richards Thomas A., 2011, Fungal Biology Reviews, V25, P98, DOI 10.1016/j.fbr.2011.04.003; Roca MG, 2010, EUKARYOT CELL, V9, P1171, DOI 10.1128/EC.00329-09; Roca MG, 2005, FEMS MICROBIOL LETT, V249, P191, DOI 10.1016/j.femsle.2005.06.048; Roca MG, 2003, FUNGAL GENET BIOL, V40, P138, DOI 10.1016/S1087-1845(03)00088-4; Roper M, 2013, P NATL ACAD SCI USA, V110, P12875, DOI 10.1073/pnas.1220842110; Saari S, 2012, NEW PHYTOL, V195, P231, DOI 10.1111/j.1469-8137.2012.04140.x; Schardl CL, 2013, TOXINS, V5, P1064, DOI 10.3390/toxins5061064; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schardl CL, 2010, ANN MO BOT GARD, V97, P646, DOI 10.3417/2009144; Schardl CL, 1999, MYCOLOGIA, V91, P95, DOI 10.2307/3761196; Schardl CL, 2003, MOL ECOL, V12, P2861, DOI 10.1046/j.1365-294X.2003.01965.x; Schardl CL, 1997, MOL BIOL EVOL, V14, P133, DOI 10.1093/oxfordjournals.molbev.a025746; Schardl CL, 2004, ANNU REV PLANT BIOL, V55, P315, DOI 10.1146/annurev.arplant.55.031903.141735; Schmid J, 2000, BOOK SOIL P, P295; Scott B., 2012, TOPICS CURRENT GENET, P243, DOI DOI 10.1007/978-3-642-22916-9_12; Selosse MA, 2007, NEW PHYTOL, V173, P452, DOI 10.1111/j.1469-8137.2007.01978.x; Shoji JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015650; Shoji JY, 2006, EUKARYOT CELL, V5, P411, DOI 10.1128/EC.5.2.411-421.2006; Simonin A, 2012, EUKARYOT CELL, V11, P1345, DOI 10.1128/EC.00213-12; Sipiczki M, 2008, FEMS YEAST RES, V8, P996, DOI 10.1111/j.1567-1364.2008.00369.x; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tadych M, 2007, MYCOL RES, V111, P466, DOI 10.1016/j.mycres.2007.02.002; Tadych M, 2012, FUNGAL DIVERS, V54, P117, DOI 10.1007/s13225-012-0170-0; Takach JE, 2014, CROP SCI, V54, P667, DOI 10.2135/cropsci2013.06.0423; Takach JE, 2012, APPL ENVIRON MICROB, V78, P5501, DOI 10.1128/AEM.01084-12; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tan YY, 2001, APPL ENVIRON MICROB, V67, P5377, DOI 10.1128/AEM.67.12.5377-5383.2001; Tanaka A, 2013, MOL MICROBIOL, V90, P551, DOI 10.1111/mmi.12385; TSAI HF, 1994, P NATL ACAD SCI USA, V91, P2542, DOI 10.1073/pnas.91.7.2542; TSAI HF, 1992, CURR GENET, V22, P399, DOI 10.1007/BF00352441; WEST CP, 1993, AGRON J, V85, P264, DOI 10.2134/agronj1993.00021962008500020019x; Westermann B, 2002, FUNGAL GENET BIOL, V36, P91, DOI 10.1016/S1087-1845(02)00019-1; WHITE JF, 1993, MYCOLOGIA, V85, P444, DOI 10.2307/3760705; Wille PA, 1999, PLANT J, V18, P349, DOI 10.1046/j.1365-313X.1999.00462.x; Young C, 1998, CURR GENET, V33, P368, DOI 10.1007/s002940050349	93	13	14	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0121875	10.1371/journal.pone.0121875	http://dx.doi.org/10.1371/journal.pone.0121875			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25837972	Green Submitted, Green Published, gold			2022-12-26	WOS:000352139000066
J	Zhang, Y; Grosse-Honebrink, A; Minton, NP				Zhang, Ying; Grosse-Honebrink, Alexander; Minton, Nigel P.			A Universal Mariner Transposon System for Forward Genetic Studies in the Genus Clostridium	PLOS ONE			English	Article							BACILLUS-SUBTILIS; IN-VIVO; DIPICOLINIC ACID; ACETOBUTYLICUM; MUTAGENESIS; PERFRINGENS; DIFFICILE; SPORES; METABOLISM; EXPRESSION	DNA transposons represent an essential tool in the armoury of the molecular microbiologist. We previously developed a catP-based mini transposon system for Clostridium difficile in which the expression of the transposase gene was dependent on a sigma factor unique to C. difficile, TcdR. Here we have shown that the host range of the transposon is easily extended through the rapid chromosomal insertion of the tcdRgene at the pyrElocus of the intended clostridial target using Allele-Coupled Exchange (ACE). To increase the effectiveness of the system, a novel replicon conditional for plasmid maintenance was developed, which no longer supports the effective retention of the transposon delivery vehicle in the presence of the inducer isopropyl beta-D-1-thiogalactopyranoside (IPTG). As a consequence, those thiamphenicol resistant colonies that arise in clostridial recipients, following plating on agar medium supplemented with IPTG, are almost exclusively due to insertion of the mini transposon into the genome. The system has been exemplified in both Clostridium acetobutylicum and Clostridium sporogenes, where transposon insertion has been shown to be entirely random. Moreover, appropriate screening of both libraries resulted in the isolation of auxotrophic mutants as well as cells deficient in spore formation/germination. This strategy is capable of being implemented in any Clostridium species.	[Zhang, Ying; Grosse-Honebrink, Alexander; Minton, Nigel P.] Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Clostridia Res Grp, Nottingham NG7 2RD, England	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham	Zhang, Y (corresponding author), Univ Nottingham, Sch Life Sci, BBSRC EPSRC Synthet Biol Res Ctr SBRC, Clostridia Res Grp, Nottingham NG7 2RD, England.	ying.zhang@nottingham.ac.uk; nigel.minton@nottingham.ac.uk	zhang, ying/E-2718-2017	Minton, Nigel/0000-0002-9277-1261; Grosse-Honebrink, Alexander/0000-0003-3893-7483; Zhang, Ying/0000-0003-3074-9998	Biotechnology and Biological Sciences Research Council (BBSRC), UK; European Union [BB/I004475/1, BB/G016224/1, PEOPLE-ITN-2008-237942]; Biotechnology and Biological Sciences Research Council [BB/G016224/1, BB/I004475/1] Funding Source: researchfish; BBSRC [BB/G016224/1, BB/I004475/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC), UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC), UK and the European Union, through grant codes BB/I004475/1, BB/G016224/1 and PEOPLE-ITN-2008-237942. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2004, P NATL ACAD SCI USA, V101, P15172, DOI 10.1073/pnas.0406242101; Al-Hinai MA, 2012, APPL ENVIRON MICROB, V78, P8112, DOI 10.1128/AEM.02214-12; Amador-Noguez D, 2010, J BACTERIOL, V192, P4452, DOI 10.1128/JB.00490-10; BAER SH, 1987, APPL ENVIRON MICROB, V53, P2854, DOI 10.1128/AEM.53.12.2854-2861.1987; Brazier JS, 2008, BRIT J BIOMED SCI, V65, P39, DOI 10.1080/09674845.2008.11732796; Cao M, 2007, APPL ENVIRON MICROB, V73, P2758, DOI 10.1128/AEM.02844-06; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Cartman ST, 2010, APPL ENVIRON MICROB, V76, P1103, DOI 10.1128/AEM.02525-09; Chen Y, 2004, VIROLOGY, V329, P226, DOI 10.1016/j.virol.2004.08.018; Crown SB, 2011, BIOTECHNOL J, V6, P300, DOI 10.1002/biot.201000282; Durre P., 2005, HDB CLOSTRIDIA; Fagan RP, 2011, J BIOL CHEM, V286, P27483, DOI 10.1074/jbc.M111.263889; Feustel L, 2004, APPL ENVIRON MICROB, V70, P798, DOI 10.1128/AEM.70.2.798-803.2004; Fox ME, 1996, GENE THER, V3, P173; Gao LY, 2003, INFECT IMMUN, V71, P922, DOI 10.1128/IAI.71.2.922-929.2003; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Hartman AH, 2011, APPL ENVIRON MICROB, V77, P471, DOI 10.1128/AEM.01536-10; HARTMANIS MGN, 1984, APPL ENVIRON MICROB, V47, P1277, DOI 10.1128/AEM.47.6.1277-1283.1984; HATHEWAY CL, 1990, CLIN MICROBIOL REV, V3, P66, DOI 10.1128/CMR.3.1.66-98.1990; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2014, ONCOTARGET, V5, P1761, DOI 10.18632/oncotarget.1761; Heap JT, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1321; Heap JT, 2010, METHODS MOL BIOL, V646, P165, DOI 10.1007/978-1-60327-365-7_11; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hillmann F, 2009, J BACTERIOL, V191, P6082, DOI 10.1128/JB.00351-09; Kodama T, 2000, J BIOCHEM, V128, P655, DOI 10.1093/oxfordjournals.jbchem.a022798; Le Breton Y, 2006, APPL ENVIRON MICROB, V72, P327, DOI 10.1128/AEM.72.1.327-333.2006; Leang C, 2013, APPL ENVIRON MICROB, V79, P1102, DOI 10.1128/AEM.02891-12; Lehmann Y, 1996, J BACTERIOL, V178, P7152, DOI 10.1128/jb.178.24.7152-7158.1996; Liu HL, 2013, J BACTERIOL, V195, P629, DOI 10.1128/JB.01288-12; LOVITT RW, 1987, J APPL BACTERIOL, V62, P71, DOI 10.1111/j.1365-2672.1987.tb02382.x; Maier TM, 2006, APPL ENVIRON MICROB, V72, P1878, DOI 10.1128/AEM.72.3.1878-1885.2006; MERMELSTEIN LD, 1992, BIO-TECHNOL, V10, P190, DOI 10.1038/nbt0292-190; MINTON N, 1981, J GEN MICROBIOL, V127, P325; Munoz-Lopez M, 2010, CURR GENOMICS, V11, P115, DOI 10.2174/138920210790886871; Nariya H, 2011, APPL ENVIRON MICROB, V77, P1375, DOI 10.1128/AEM.01572-10; Ng YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056051; Nolling J, 2001, J BACTERIOL, V183, P4823, DOI 10.1128/JB.183.16.4823-4838.2001; OBRIEN RW, 1971, J GEN MICROBIOL, V68, P307, DOI 10.1099/00221287-68-3-307; Papoutsakis ET, 2008, CURR OPIN BIOTECH, V19, P420, DOI 10.1016/j.copbio.2008.08.003; Purdy D, 2002, MOL MICROBIOL, V46, P439, DOI 10.1046/j.1365-2958.2002.03134.x; Riebe O, 2009, MICROBIOL-SGM, V155, P16, DOI 10.1099/mic.0.022756-0; Shaw W V, 1975, Methods Enzymol, V43, P737; Tovar-Rojo F, 2002, J BACTERIOL, V184, P584, DOI 10.1128/JB.184.2.584-587.2002; Vepachedu VR, 2007, J BACTERIOL, V189, P1565, DOI 10.1128/JB.01613-06; Wilson AC, 2007, J MICROBIOL METH, V71, P332, DOI 10.1016/j.mimet.2007.09.006	46	24	24	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122411	10.1371/journal.pone.0122411	http://dx.doi.org/10.1371/journal.pone.0122411			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25836262	Green Submitted, gold, Green Published			2022-12-26	WOS:000352139000096
J	Repnik, U; Starr, AE; Overall, CM; Turk, B				Repnik, Urska; Starr, Amanda E.; Overall, Christopher M.; Turk, Boris			Cysteine Cathepsins Activate ELR Chemokines and Inactivate Non-ELR Chemokines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARIN-LIKE GLYCOSAMINOGLYCANS; CXC CHEMOKINES; GRO-ALPHA; IN-VIVO; CELL-MIGRATION; PROCATHEPSIN-B; CUTTING EDGE; BINDING; CANCER; CHEMOATTRACTANT	Cysteine cathepsins are primarily lysosomal proteases involved in general protein turnover, but they also have specific proteolytic functions in antigen presentation and bone remodeling. Cathepsins are most stable at acidic pH, although growing evidence indicates that they have physiologically relevant activity also at neutral pH. Post-translational proteolytic processing of mature chemokines is a key, yet underappreciated, level of chemokine regulation. Although the role of selected serine proteases and matrix metalloproteases in chemokine processing has long been known, little has been reported about the role of cysteine cathepsins. Here we evaluated cleavage of CXC ELR (CXCL1, -2, -3, -5, and -8) and non-ELR (CXCL9-12) chemokines by cysteine cathepsins B, K, L, and S at neutral pH by high resolution Tris-Tricine SDS-PAGE and matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Whereas cathepsin B cleaved chemokines especially in the C-terminal region, cathepsins K, L, and S cleaved chemokines at the N terminus with glycosaminoglycans modulating cathepsin processing of chemokines. The functional consequences of the cleavages were determined by Ca2+ mobilization and chemotaxis assays. We show that cysteine cathepsins inactivate and in some cases degrade non-ELR CXC chemokines CXCL9-12. In contrast, cathepsins specifically process ELR CXC chemokines CXCL1, -2, -3, -5, and -8 N-terminally to the ELR motif, thereby generating agonist forms. This study suggests that cysteine cathepsins regulate chemokine activity and thereby leukocyte recruitment during protective or pathological inflammation.	[Repnik, Urska; Turk, Boris] Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, SI-1000 Ljubljana, Slovenia; [Starr, Amanda E.; Overall, Christopher M.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Overall, Christopher M.] Univ British Columbia, Dept Oral Biol & Med Sci, Vancouver, BC V6T 1Z3, Canada; [Turk, Boris] Ctr Excellence Integrated Approaches Chem & Biol, SI-1000 Ljubljana, Slovenia; [Turk, Boris] Univ Ljubljana, Fac Chem & Chem Technol, SI-1000 Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of British Columbia; University of British Columbia; University of Ljubljana	Turk, B (corresponding author), Jozef Stefan Inst, Dept Biochem & Mol & Struct Biol, Jamova 39, SI-1000 Ljubljana, Slovenia.	chris.overall@ubc.ca; boris.turk@ijs.si		Turk, Boris/0000-0002-9007-5764	Slovene Research Agency [P1-0140, J1-6739, N1-0022]; Canadian Institutes of Health Research (CIHR); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada; Michael Smith Foundation for Health Research; CIHR [STP-53877]	Slovene Research Agency(Slovenian Research Agency - Slovenia); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Michael Smith Research Foundation (University of British Columbia Centre for Blood Research); British Columbia Proteomics Network; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Grants P1-0140, J1-6739, and N1-0022 from the Slovene Research Agency (to B. T.). This research was also supported by a Canadian Institutes of Health Research (CIHR) grant and an Infrastructure Grant from the Michael Smith Research Foundation (University of British Columbia Centre for Blood Research) and the British Columbia Proteomics Network.; Supported by the Natural Sciences and Engineering Research Council of Canada, the Michael Smith Foundation for Health Research, and CIHR Strategic Training Program STP-53877.	Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Almeida PC, 2001, J BIOL CHEM, V276, P944, DOI 10.1074/jbc.M003820200; Almeida PC, 1999, J BIOL CHEM, V274, P30433, DOI 10.1074/jbc.274.43.30433; Bellac CL, 2014, CELL REP, V9, P618, DOI 10.1016/j.celrep.2014.09.006; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bromme D, 2011, BIOL EXTRACELL MATR, P23, DOI 10.1007/978-3-642-16861-1_2; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Caglic D, 2013, BIOL CHEM, V394, P307, DOI 10.1515/hsz-2012-0283; Caglic D, 2011, BIOORGAN MED CHEM, V19, P1055, DOI 10.1016/j.bmc.2010.10.028; Clark AK, 2012, ARTHRITIS RHEUM-US, V64, P2038, DOI 10.1002/art.34351; Clark AK, 2009, J NEUROSCI, V29, P6945, DOI 10.1523/JNEUROSCI.0828-09.2009; ClarkLewis I, 1997, METHOD ENZYMOL, V287, P233; Cox JH, 2008, J BIOL CHEM, V283, P19389, DOI 10.1074/jbc.M800266200; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Dean RA, 2007, MOL CELL PROTEOMICS, V6, P611, DOI 10.1074/mcp.M600341-MCP200; Fonovic M, 2014, BBA-GEN SUBJECTS, V1840, P2560, DOI 10.1016/j.bbagen.2014.03.017; Fortelny N, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001869; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gocheva V, 2010, GENE DEV, V24, P241, DOI 10.1101/gad.1874010; Hasan L, 2006, J IMMUNOL, V176, P6512, DOI 10.4049/jimmunol.176.11.6512; Hou WS, 2002, ARTHRITIS RHEUM, V46, P663, DOI 10.1002/art.10114; Illy C, 1997, J BIOL CHEM, V272, P1197, DOI 10.1074/jbc.272.2.1197; Ishidoh K, 1995, BIOCHEM BIOPH RES CO, V217, P624, DOI 10.1006/bbrc.1995.2820; Jones BA, 2013, ARTHRITIS RHEUM-US, V65, P2814, DOI 10.1002/art.38095; King AG, 2000, J IMMUNOL, V164, P3774, DOI 10.4049/jimmunol.164.7.3774; KIRSCHKE H, 1989, BIOCHEM J, V264, P467, DOI 10.1042/bj2640467; Lemaire R, 1997, BRIT J RHEUMATOL, V36, P735; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Ludwig A, 2002, J LEUKOCYTE BIOL, V72, P183; McQuibban GA, 2000, SCIENCE, V289, P1202, DOI 10.1126/science.289.5482.1202; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Mihelic M, 2008, J BIOL CHEM, V283, P14453, DOI 10.1074/jbc.M801283200; Mohamed MM, 2006, NAT REV CANCER, V6, P764, DOI 10.1038/nrc1949; Mohamed MM, 2010, CELL PHYSIOL BIOCHEM, V25, P315, DOI 10.1159/000276564; Mortier A, 2011, EXP CELL RES, V317, P642, DOI 10.1016/j.yexcr.2010.11.016; Mortier A, 2008, PHARMACOL THERAPEUT, V120, P197, DOI 10.1016/j.pharmthera.2008.08.006; Nufer O, 1999, BIOCHEMISTRY-US, V38, P636, DOI 10.1021/bi981294s; Ohashi K, 2003, BBA-PROTEINS PROTEOM, V1649, P30, DOI 10.1016/S1570-9639(03)00152-3; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Proost P, 2001, BLOOD, V98, P3554, DOI 10.1182/blood.V98.13.3554; Proost P, 2007, BLOOD, V110, P37, DOI 10.1182/blood-2006-10-049072; Proudfoot AEI, 2006, BIOCHEM SOC T, V34, P422, DOI 10.1042/BST0340422; Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100; Rajagopalan L, 2006, BIOSCIENCE REP, V26, P325, DOI 10.1007/s10540-006-9025-9; Rozman J, 1999, FEBS LETT, V459, P358, DOI 10.1016/S0014-5793(99)01302-2; Salanga CL, 2011, EXP CELL RES, V317, P590, DOI 10.1016/j.yexcr.2011.01.004; Starr AE, 2012, J BIOL CHEM, V287, P13382, DOI 10.1074/jbc.M111.314179; Starr AE, 2012, J BIOL CHEM, V287, P5848, DOI 10.1074/jbc.M111.314609; Starr AE, 2009, METHOD ENZYMOL, V461, P281, DOI 10.1016/S0076-6879(09)05413-5; Staudt ND, 2012, STEM CELLS DEV, V21, P1924, DOI 10.1089/scd.2011.0307; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Turk B, 1999, EUR J BIOCHEM, V259, P926, DOI 10.1046/j.1432-1327.1999.00145.x; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Turk D, 1998, BIOL CHEM, V379, P137, DOI 10.1515/bchm.1998.379.2.137; Turk V, 2012, BBA-PROTEINS PROTEOM, V1824, P68, DOI 10.1016/j.bbapap.2011.10.002; Van den Steen PE, 2000, BLOOD, V96, P2673, DOI 10.1182/blood.V96.8.2673.h8002673_2673_2681; Vandercappellen J, 2008, CANCER LETT, V267, P226, DOI 10.1016/j.canlet.2008.04.050; Vasiljeva O, 2005, FEBS LETT, V579, P1285, DOI 10.1016/j.febslet.2004.12.093; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WALZ A, 1989, J EXP MED, V170, P1745, DOI 10.1084/jem.170.5.1745; Wuyts A, 1999, EUR J BIOCHEM, V260, P421, DOI 10.1046/j.1432-1327.1999.00166.x; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	69	54	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2015	290	22					13800	13811		10.1074/jbc.M115.638395	http://dx.doi.org/10.1074/jbc.M115.638395			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CJ2KK	25833952	Green Published, hybrid			2022-12-26	WOS:000355313000015
J	Lee, J; Ding, SJ; Walpole, TB; Holding, AN; Montgomery, MG; Fearnley, IM; Walker, JE				Lee, Jennifer; Ding, ShuJing; Walpole, Thomas B.; Holding, Andrew N.; Montgomery, Martin G.; Fearnley, Ian M.; Walker, John E.			Organization of Subunits in the Membrane Domain of the Bovine F-ATPase Revealed by Covalent Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-MITOCHONDRIA; YEAST MITOCHONDRIA; MASS-SPECTROMETRY; PERIPHERAL STALK; GXXXG MOTIF; SYNTHASE; PROTEIN; IDENTIFICATION; SEQUENCE; DISRUPTION	The F-ATPase in bovine mitochondria is a membrane-bound complex of about 30 subunits of 18 different kinds. Currently, similar to 85% of its structure is known. The enzyme has a membrane extrinsic catalytic domain, and a membrane intrinsic domain where the turning of the enzyme's rotor is generated from the transmembrane proton-motive force. The domains are linked by central and peripheral stalks. The central stalk and a hydrophobic ring of c-subunits in the membrane domain constitute the enzyme's rotor. The external surface of the catalytic domain and membrane subunit a are linked by the peripheral stalk, holding them static relative to the rotor. The membrane domain contains six additional subunits named ATP8, e, f, g, DAPIT(diabetes-associated protein in insulin-sensitive tissues), and 6.8PL (6.8-kDa proteolipid), each with a single predicted transmembrane alpha-helix, but their orientation and topography are unknown. Mutations in ATP8 uncouple the enzyme and interfere with its assembly, but its roles and the roles of the other five subunits are largely unknown. We have reacted accessible amino groups in the enzyme with bifunctional cross-linking agents and identified the linked residues. Cross-links involving the supernumerary subunits, where the structures are not known, show that the C terminus of ATP8 extends similar to 70 angstrom from the membrance into the peripheral stalk and that the N termini of the other supernumerary subunits are on the same side of the membrane, probably in the mitochondirail matrix. These experiments contribute significantly toward building up a complete structural picture of the F-ATPase.	[Lee, Jennifer; Ding, ShuJing; Walpole, Thomas B.; Montgomery, Martin G.; Fearnley, Ian M.; Walker, John E.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Holding, Andrew N.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Walker, JE (corresponding author), MRC, Mitochondrial Biol Unit, Cambridge Biomed Campus,Hills Rd, Cambridge CB2 0XY, England.	walker@mrc-mbu.cam.ac.uk	Holding, Andrew/I-1069-2019	Holding, Andrew/0000-0002-8459-7048; Walker, John/0000-0001-7929-2162; Walpole, Thomas Benjamin/0000-0001-5483-5650	Medical Research Council (MRC) [U105663150]; MRC [MC_U105663150] Funding Source: UKRI; Medical Research Council [MC_U105663150] Funding Source: researchfish	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the intramural program of the Medical Research Council (MRC Grant U105663150 (to J. E. W.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Allegretti M, 2015, NATURE, V521, P237, DOI 10.1038/nature14185; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Arnold I, 1998, EMBO J, V17, P7170, DOI 10.1093/emboj/17.24.7170; Arnold I, 1999, J BIOL CHEM, V274, P36, DOI 10.1074/jbc.274.1.36; Arselin G, 2004, J BIOL CHEM, V279, P40392, DOI 10.1074/jbc.M404316200; Arselin G, 2003, EUR J BIOCHEM, V270, P1875, DOI 10.1046/j.1432-1033.2003.03557.x; Baker LA, 2012, P NATL ACAD SCI USA, V109, P11675, DOI 10.1073/pnas.1204935109; Belogrudov GI, 1996, J BIOL CHEM, V271, P20340, DOI 10.1074/jbc.271.34.20340; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Bustos DM, 2005, J BIOL CHEM, V280, P29004, DOI 10.1074/jbc.M502140200; Carbajo RJ, 2007, J MOL BIOL, V368, P310, DOI 10.1016/j.jmb.2007.02.059; Chen RM, 2007, FEBS LETT, V581, P3145, DOI 10.1016/j.febslet.2007.05.079; Cherepanov DA, 1999, FEBS LETT, V449, P1, DOI 10.1016/S0014-5793(99)00386-5; COLLINSON IR, 1994, J MOL BIOL, V242, P408; COLLINSON IR, 1994, BIOCHEM J, V303, P639, DOI 10.1042/bj3030639; COLLINSON IR, 1994, BIOCHEMISTRY-US, V33, P7971, DOI 10.1021/bi00191a026; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEARNLEY IM, 1986, EMBO J, V5, P2003, DOI 10.1002/j.1460-2075.1986.tb04456.x; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; GRASSO DG, 1991, EUR J BIOCHEM, V199, P203, DOI 10.1111/j.1432-1033.1991.tb16110.x; Holding AN, 2013, J PROTEOME RES, V12, P5923, DOI 10.1021/pr4003867; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu SD, 2015, BIOCHEM J, V468, P167, DOI 10.1042/BJ20150197; MACREADIE IG, 1983, NUCLEIC ACIDS RES, V11, P4435, DOI 10.1093/nar/11.13.4435; Meyer B, 2007, MOL CELL PROTEOMICS, V6, P1690, DOI 10.1074/mcp.M700097-MCP200; Miranda-Astudillo H, 2014, BBA-BIOENERGETICS, V1837, P1, DOI 10.1016/j.bbabio.2013.08.001; NAGLEY P, 1988, P NATL ACAD SCI USA, V85, P2091, DOI 10.1073/pnas.85.7.2091; Ohsakaya S, 2011, J BIOL CHEM, V286, P20292, DOI 10.1074/jbc.M110.198523; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rees DM, 2009, P NATL ACAD SCI USA, V106, P21597, DOI 10.1073/pnas.0910365106; Rinner O, 2008, NAT METHODS, V5, P315, DOI [10.1038/nmeth.1192, 10.1038/NMETH.1192]; Roudeau S, 1999, J BIOENERG BIOMEMBR, V31, P85, DOI 10.1023/A:1005407525915; Runswick MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120160; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Seebacher J, 2006, J PROTEOME RES, V5, P2270, DOI 10.1021/pr060154z; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spannagel C, 1997, EUR J BIOCHEM, V247, P1111, DOI 10.1111/j.1432-1033.1997.01111.x; Stephens AN, 2000, EUR J BIOCHEM, V267, P6443, DOI 10.1046/j.1432-1327.2000.01733.x; Stephens AN, 2003, J BIOL CHEM, V278, P17867, DOI 10.1074/jbc.M300967200; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Vaillier J, 1999, J BIOL CHEM, V274, P543, DOI 10.1074/jbc.274.1.543; van Lis R, 2007, PLANT PHYSIOL, V144, P1190, DOI 10.1104/pp.106.094060; Vazquez-Acevedo M, 2006, J BIOENERG BIOMEMBR, V38, P271, DOI 10.1007/s10863-006-9046-x; Velours J, 1998, BIOCHIMIE, V80, P793, DOI 10.1016/S0300-9084(00)88873-2; VELOURS J, 1984, EMBO J, V3, P207, DOI 10.1002/j.1460-2075.1984.tb01785.x; WALKER JE, 1991, BIOCHEMISTRY-US, V30, P5369, DOI 10.1021/bi00236a007; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107	58	31	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2015	290	21					13308	13320		10.1074/jbc.M115.645283	http://dx.doi.org/10.1074/jbc.M115.645283			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CI7WL	25851905	Green Published, hybrid			2022-12-26	WOS:000354975700030
J	Mayer, J; Reichart, G; Tokay, T; Lange, F; Baltrusch, S; Junghanss, C; Wolkenhauer, O; Jaster, R; Kunz, M; Tiedge, M; Ibrahim, S; Fuellen, G; Kohling, R				Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Baltrusch, Simone; Junghanss, Christian; Wolkenhauer, Olaf; Jaster, Robert; Kunz, Manfred; Tiedge, Markus; Ibrahim, Saleh; Fuellen, Georg; Koehling, Ruediger			Reduced Adolescent-Age Spatial Learning Ability Associated with Elevated Juvenile-Age Superoxide Levels in Complex I Mouse Mutants	PLOS ONE			English	Article							LONG-TERM POTENTIATION; MITOCHONDRIAL-DNA MUTATIONS; OXIDATIVE STRESS; SYNAPTIC PLASTICITY; NADH-DEHYDROGENASE; FREE-RADICALS; MEMORY; DISEASE; MICE; HIPPOCAMPUS	Large-scale, heteroplasmic and generally pathogenic mtDNA defects (as induced by defective mitochondrial DNA polymerase, clonal mutations or DNA deletions) are known to negatively impact on life span and can result in apoptosis and tissue loss in, e.g., skeletal muscle or reduce learning abilities. The functional impact of homoplasmic specific mtDNA point mutations, e.g., in genes coding for the electron transport chain, however, remains a matter of debate. The present study contributes to this discussion and provides evidence that a single point mutation in complex I of the respiratory chain is associated with impairment of spatial navigation in adolescent (6-month-old) mice, i.e., reduced performance in the Morris Water Maze, which goes along with increased production of reactive oxygen species (ROS) in juvenile mice (3 months) but not at the age of phenotype expression. A point mutation in complex III goes along with only a mild and non-significant negative effect on cognitive performance and no significant changes in ROS production. These findings suggest to also consider the ontogenetic development of phenotypes when studying mtDNA mutations and highlights a possible impact of complex I dysfunction on the emergence of neurological deficits.	[Mayer, Johannes; Reichart, Gesine; Tokay, Tursonjan; Lange, Falko; Koehling, Ruediger] Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany; [Baltrusch, Simone; Tiedge, Markus] Univ Rostock, Med Ctr, Inst Med Biochem & Mol Biol, D-18055 Rostock, Germany; [Junghanss, Christian] Univ Rostock, Med Ctr, Dept Hematol Oncol Palliat Med, D-18055 Rostock, Germany; [Wolkenhauer, Olaf] Univ Rostock, Dept Syst Biol & Bioinformat, D-18055 Rostock, Germany; [Jaster, Robert] Univ Rostock, Med Ctr, Dept Med 2, Div Gastroenterol, D-18055 Rostock, Germany; [Kunz, Manfred] Univ Leipzig, Dept Dermatol Venereol & Allergol, D-04109 Leipzig, Germany; [Ibrahim, Saleh] Lubeck Univ, Med Ctr, Dept Dermatol, Lubeck, Germany; [Fuellen, Georg] Inst Biostat & Informat Med & Ageing Res, Rostock, Germany; [Fuellen, Georg; Koehling, Ruediger] Univ Rostock, Interdisciplinary Fac, D-18055 Rostock, Germany; [Tokay, Tursonjan] Nazarbayev Univ, Ctr Life Sci, Astana, Kazakhstan	University of Rostock; University of Rostock; University of Rostock; University of Rostock; University of Rostock; Leipzig University; University of Lubeck; University of Rostock; Nazarbayev University	Mayer, J (corresponding author), Univ Rostock, Med Ctr, Oscar Langendorff Inst Physiol, D-18055 Rostock, Germany.	johannes.mayer@uni-rostock.de; ruediger.koehling@uni-rostock.de	Köhling, Rüdiger/K-8647-2013; Ibrahim, Saleh/AAO-9541-2020; tokay, tursonjan/D-2457-2016	Köhling, Rüdiger/0000-0003-3330-4898; Ibrahim, Saleh/0000-0001-7827-2290; Lange, Falko/0000-0001-8782-5205	Bundesministerium fur Bildung und Forschung (BMBF) [ROSAge 31P6662]; Rostock University Medical Center FORUN programme [889062]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Rostock University Medical Center FORUN programme	This work was supported by Bundesministerium fur Bildung und Forschung (BMBF) grant ROSAge 31P6662, http://www.bmbf.de/, and Rostock University Medical Center FORUN programme funding no. 889062, https://www.med.uni-rostock.de/. The funders had no role in study design,	ARNHEIM N, 1992, MUTAT RES, V275, P157, DOI 10.1016/0921-8734(92)90020-P; Bleier L, 2013, BBA-BIOENERGETICS, V1827, P1320, DOI 10.1016/j.bbabio.2012.12.002; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; CORRALDEBRINSKI M, 1994, GENOMICS, V23, P471, DOI 10.1006/geno.1994.1525; CORRALDEBRINSKI M, 1992, NAT GENET, V2, P324, DOI 10.1038/ng1292-324; CORTOPASSI GA, 1990, NUCLEIC ACIDS RES, V18, P6927, DOI 10.1093/nar/18.23.6927; Dimauro S, 2001, AM J MED GENET, V106, P18, DOI 10.1002/ajmg.1392; Fukui K, 2001, ANN NY ACAD SCI, V928, P168; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Hiona A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011468; HRUSZKEWYCZ AM, 1992, MUTAT RES, V275, P243, DOI 10.1016/0921-8734(92)90028-N; Hu DY, 2007, NEUROBIOL LEARN MEM, V87, P372, DOI 10.1016/j.nlm.2006.10.003; Huang H, 2004, FRONT BIOSCI-LANDMRK, V9, P1100, DOI 10.2741/1298; Huang Y, 2013, NEUROSCIENCE, V231, P432, DOI 10.1016/j.neuroscience.2012.11.010; Ishihara K, 1997, BEHAV BRAIN RES, V83, P235, DOI 10.1016/S0166-4328(97)86077-9; Ishikawa K, 2008, SCIENCE, V320, P661, DOI 10.1126/science.1156906; Kamsler A, 2003, J NEUROSCI, V23, P269; Khrapko K, 2007, NAT GENET, V39, P445, DOI 10.1038/ng0407-445; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Lagouge M, 2013, J INTERN MED, V273, P529, DOI 10.1111/joim.12055; Lauritzen KH, 2010, MOL CELL BIOL, V30, P1357, DOI 10.1128/MCB.01149-09; Levy M, 2003, J BIOL CHEM, V278, P17727, DOI 10.1074/jbc.M212878200; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; LOMO T, 1966, ACTA PHYSIOL SCAND, VS 68, P128; Lynch MA, 2004, PHYSIOL REV, V84, P87, DOI 10.1152/physrev.00014.2003; Maharjan S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05896; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nicolle MM, 2001, NEUROSCIENCE, V107, P415, DOI 10.1016/S0306-4522(01)00374-8; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsen RHJ, 2013, J NEUROCHEM, V125, P303, DOI 10.1111/jnc.12187; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Schauer M, 2014, EXP DERMATOL, V23, pE6; Serrano F, 2004, AGEING RES REV, V3, P431, DOI 10.1016/j.arr.2004.05.002; SHOFFNER JM, 1993, GENOMICS, V17, P171, DOI 10.1006/geno.1993.1299; SIMONETTI S, 1992, BIOCHIM BIOPHYS ACTA, V1180, P113, DOI 10.1016/0925-4439(92)90059-V; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Tanaka D., 2008, MOL BRAIN, V16, P1, DOI DOI 10.1186/1756-6606-1-21; Trifunovic A, 2005, P NATL ACAD SCI USA, V102, P17993, DOI 10.1073/pnas.0508886102; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Vermulst M, 2008, NAT GENET, V40, P392, DOI 10.1038/ng.95; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988; Wei Yau-Huei, 2009, Chang Gung Med J, V32, P113; Weiss H, 2013, DIABETOLOGIA, V56, pS87; Yu X, 2009, GENOME RES, V19, P159, DOI 10.1101/gr.078865.108	55	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0123863	10.1371/journal.pone.0123863	http://dx.doi.org/10.1371/journal.pone.0123863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853418	gold, Green Published, Green Submitted			2022-12-26	WOS:000352478400122
J	Palta, P; Kaplinski, L; Nagirnaja, L; Veidenberg, A; Mols, M; Nelis, M; Esko, T; Metspalu, A; Laan, M; Remm, M				Palta, Priit; Kaplinski, Lauris; Nagirnaja, Liina; Veidenberg, Andres; Moels, Maert; Nelis, Mari; Esko, Tonu; Metspalu, Andres; Laan, Maris; Remm, Maido			Haplotype Phasing and Inheritance of Copy Number Variants in Nuclear Families	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HIDDEN-MARKOV MODEL; LINKAGE DISEQUILIBRIUM; POPULATION-GENETICS; GENOTYPE; POLYMORPHISM; INFERENCE; EVOLUTION; MAP; REARRANGEMENTS	DNA copy number variants (CNVs) that alter the copy number of a particular DNA segment in the genome play an important role in human phenotypic variability and disease susceptibility. A number of CNVs overlapping with genes have been shown to confer risk to a variety of human diseases thus highlighting the relevance of addressing the variability of CNVs at a higher resolution. So far, it has not been possible to deterministically infer the allelic composition of different haplotypes present within the CNV regions. We have developed a novel computational method, called PiCNV, which enables to resolve the haplotype sequence composition within CNV regions in nuclear families based on SNP genotyping microarray data. The algorithm allows to i) phase normal and CNV-carrying haplotypes in the copy number variable regions, ii) resolve the allelic copies of rearranged DNA sequence within the haplotypes and iii) infer the heritability of identified haplotypes in trios or larger nuclear families. To our knowledge this is the first program available that can deterministically phase null, mono-, di-, tri- and tetraploid genotypes in CNV loci. We applied our method to study the composition and inheritance of haplotypes in CNV regions of 30 HapMap Yoruban trios and 34 Estonian families. For 93.6% of the CNV loci, PiCNV enabled to unambiguously phase normal and CNV-carrying haplotypes and follow their transmission in the corresponding families. Furthermore, allelic composition analysis identified the co-occurrence of alternative allelic copies within 66.7% of haplotypes carrying copy number gains. We also observed less frequent transmission of CNV-carrying haplotypes from parents to children compared to normal haplotypes and identified an emergence of several de novo deletions and duplications in the offspring.	[Palta, Priit; Kaplinski, Lauris; Remm, Maido] Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, EE-50090 Tartu, Estonia; [Palta, Priit] Univ Helsinki, FIMM, Helsinki, Finland; [Kaplinski, Lauris; Moels, Maert; Metspalu, Andres; Remm, Maido] Estonian Bioctr, Tartu, Estonia; [Nagirnaja, Liina; Laan, Maris] Univ Tartu, Inst Mol & Cell Biol, Human Mol Genet Res Grp, EE-50090 Tartu, Estonia; [Veidenberg, Andres] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Moels, Maert] Univ Tartu, Inst Stat Math, Chair Math Stat, EE-50090 Tartu, Estonia; [Nelis, Mari; Esko, Tonu; Metspalu, Andres] Univ Tartu, Estonian Genome Ctr, EE-50090 Tartu, Estonia; [Esko, Tonu; Metspalu, Andres] Univ Tartu, Inst Mol & Cell Biol, Dept Biotechnol, EE-50090 Tartu, Estonia; [Esko, Tonu] Boston Childrens Hosp, Div Endocrinol, Boston, MA USA; [Esko, Tonu] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Esko, Tonu] Broad Inst, Cambridge, MA USA	University of Tartu; University of Helsinki; Estonian Biocentre; University of Tartu; University of Helsinki; University of Tartu; University of Tartu; University of Tartu; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Palta, P (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Dept Bioinformat, Ulikooli 18, EE-50090 Tartu, Estonia.	priit.palta@gmail.com	Nelis, Mari/ABG-7775-2020; Laan, Maris/A-4100-2011; Remm, Maido/L-9072-2019; Palta, Priit/W-2477-2019	Nelis, Mari/0000-0001-9748-1020; Laan, Maris/0000-0002-8519-243X; Remm, Maido/0000-0003-3966-8422; Palta, Priit/0000-0001-9320-7008; Nagirnaja, Liina/0000-0003-1948-2495; Esko, Tonu/0000-0003-1982-6569; Veidenberg, Andres/0000-0001-7451-0626	Estonian Ministry of Education and Research [SF0180026s09]; European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Finnish Cultural Foundation; Estonian Ministry of Education and Research Core Grants [SF0180022s12]; European Union through the European Regional Development Fund (project HAPPY PREGNANCY) [3.2.0701.12-0047]; Estonian Science Foundation Grant [ETF9030]; FP7 program (ENGAGE); FP7 program (OPENGENE); Estonian Government [SF0180142s08]; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu [SP1GVARENG]; Estonian Research Council [IUT2-2]; European Regional Development Fund	Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Estonian Ministry of Education and Research Core Grants; European Union through the European Regional Development Fund (project HAPPY PREGNANCY); Estonian Science Foundation Grant; FP7 program (ENGAGE); FP7 program (OPENGENE); Estonian Government; Estonian Research Roadmap through Estonian Ministry of Education and Research; Center of Excellence in Genomics (EXCEGEN); University of Tartu; Estonian Research Council(Estonian Research Council); European Regional Development Fund(European Commission)	This work was funded by workgroup grant SF0180026s09 from the Estonian Ministry of Education and Research and by the European Union grant through the European Regional Development Fund through the Estonian Centre of Excellence in Genomics (to MR). PP was also supported by personal research grant from the Finnish Cultural Foundation. Human Molecular Genetics Research Group was supported from the Estonian Ministry of Education and Research Core Grants (SF0180022s12); European Union through the European Regional Development Fund (project HAPPY PREGNANCY, 3.2.0701.12-0047) and Estonian Science Foundation Grant ETF9030 (to ML). The Estonian Genome Center of University of Tartu received financing from FP7 programs (ENGAGE, OPENGENE), targeted financing from Estonian Government (SF0180142s08), and also from Estonian Research Roadmap through Estonian Ministry of Education and Research, Center of Excellence in Genomics (EXCEGEN) and University of Tartu (SP1GVARENG), Estonian Research Council IUT2-2 and European Regional Development Fund (to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Barnes C, 2008, NAT GENET, V40, P1245, DOI 10.1038/ng.206; Boettger LM, 2012, NAT GENET, V44, P881, DOI 10.1038/ng.2334; Brahmachary M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004418; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Clark AG, 2004, LECT N BIOINFORMAT, V2983, P1; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cooper DN, 2013, HUM GENET, V132, P1077, DOI 10.1007/s00439-013-1331-2; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Eleftherohorinou H, 2011, BIOINFORMATICS, V27, P1873, DOI 10.1093/bioinformatics/btr264; Ezawa K, 2013, HEREDITY, V111, P364, DOI 10.1038/hdy.2013.59; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gamazon ER, 2014, AM J HUM GENET; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hannibal RL, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004290; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Iliadis A, 2014, EURASIP J BIOINFORM, DOI 10.1186/1687-4153-2014-7; Ionita-Laza I, 2008, GENET EPIDEMIOL, V32, P273, DOI 10.1002/gepi.20302; Itsara A, 2010, GENOME RES, V20, P1469, DOI 10.1101/gr.107680.110; Kato M, 2008, AM J HUM GENET, V83, P157, DOI 10.1016/j.ajhg.2008.06.021; Kato M, 2008, BIOINFORMATICS, V24, P1645, DOI 10.1093/bioinformatics/btn242; Kato M, 2011, G3-GENES GENOM GENET, V1, P35, DOI 10.1534/g3.111.000174; Kato M, 2010, HUM MOL GENET, V19, P761, DOI 10.1093/hmg/ddp541; Kim Soon-Young, 2012, Genomics & Informatics, V10, P194, DOI 10.5808/GI.2012.10.3.194; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kirov G, 2014, BIOL PSYCHIAT, V75, P378, DOI 10.1016/j.biopsych.2013.07.022; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Lin YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096841; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MacConaill LE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-211; Matsuzaki H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r125; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mefford HC, 2008, NEW ENGL J MED, V359, P1685, DOI 10.1056/NEJMoa0805384; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; O'Connell J, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004234; Perreault LPL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-226; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Pinto D, 2014, AM J HUM GENET, V94, P677, DOI 10.1016/j.ajhg.2014.03.018; Pinto D, 2011, NAT BIOTECHNOL, V29, P512, DOI 10.1038/nbt.1852; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Schaaf CP, 2011, ANNU REV GENOM HUM G, V12, P25, DOI 10.1146/annurev-genom-092010-110715; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Su SY, 2010, BIOINFORMATICS, V26, P1437, DOI 10.1093/bioinformatics/btq157; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Williams AL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r108; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhang F, 2009, NAT GENET, V41, P849, DOI 10.1038/ng.399	79	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122713	10.1371/journal.pone.0122713	http://dx.doi.org/10.1371/journal.pone.0122713			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853576	Green Published, gold, Green Submitted			2022-12-26	WOS:000352478400079
J	Rego, FD; Rugani, JMN; Shimabukuro, PHF; Tonelli, GB; Quaresma, PF; Gontijo, CMF				Rego, Felipe Dutra; Nunes Rugani, Jeronimo Marteleto; Fernandes Shimabukuro, Paloma Helena; Tonelli, Gabriel Barbosa; Quaresma, Patricia Flavia; Ferreira Gontijo, Celia Maria			Molecular Detection of Leishmania in Phlebotomine Sand Flies (Diptera: Psychodidae) from a Cutaneous Leishmaniasis Focus at Xakriaba Indigenous Reserve, Brazil	PLOS ONE			English	Article							LUTZOMYIA-LONGIPALPIS LUTZ; RIO-DOCE VALLEY; MINAS-GERAIS; VISCERAL LEISHMANIASIS; ENDEMIC AREA; FLAGELLATE INFECTIONS; SANDFLIES DIPTERA; MATO-GROSSO; SUL STATE; IDENTIFICATION	Autochthonous cases of American cutaneous leishmaniasis (ACL) have been reported since 2001 in the Xakriaba Indigenous Reserve located in the municipality of Sao Joao das Missoes in northern Minas Gerais state, Brazil. In order to study the presence of Leishmania DNA in phlebotomine sand flies, six entomological collections were carried out from July 2008 through July 2009, using 40 light traps placed in peridomicile areas of 20 randomly selected houses. From October 2011 through August 2012, another six collections were carried out with 20 light traps distributed among four trails (five traps per trail) selected for a previous study of wild and synanthropic hosts of Leishmania. A total of 4,760 phlebotomine specimens were collected belonging to ten genera and twenty-three species. Single female specimens or pools with up to ten specimens of the same locality, species and date, for Leishmania detection by molecular methods. Species identification of parasites was performed with ITS1 PCR-RFLP using HaeIII enzyme and genetic sequencing for SSU rRNA target. The presence of Leishmania DNA was detected in eleven samples from peridomicile areas: Lu. longipalpis (two), Nyssomyia intermedia (four), Lu. renei (two), Lu. ischnacantha, Micropygomyia goiana and Evandromyia lenti (one pool of each specie). The presence of Leishmania DNA was detected in twelve samples from among the trails: Martinsmyia minasensis (six), Ny. intermedia (three), Mi. peresi (two) and Ev. lenti (one). The presence of Leishmania infantum DNA in Lu. longipalpis and Leishmania braziliensis DNA in Ny. inter-mediasupport the epidemiological importance of these species of sand flies in the cycle of visceral and cutaneous leishmaniasis, respectively. The results also found other species associated with Leishmania DNA, such as Mt. minasensis and Ev. lenti, which may participate in a wild and/or synanthropic cycle of Leishmania transmission in the studied area.	[Rego, Felipe Dutra; Nunes Rugani, Jeronimo Marteleto; Fernandes Shimabukuro, Paloma Helena; Tonelli, Gabriel Barbosa; Quaresma, Patricia Flavia; Ferreira Gontijo, Celia Maria] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, BR-30190002 Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz	Rego, FD (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Grp Estudos Leishmanioses, Av Augusto Lima,1715 Barro Preto, BR-30190002 Belo Horizonte, MG, Brazil.	felipedutra@cpqrr.fiocruz.br	Gontijo, Célia/K-6120-2016; Rego, Felipe Dutra/V-4646-2019; Rêgo, Felipe Dutra/S-6013-2017; Shimabukuro, Paloma Helena Fernandes/AAC-8695-2022; Gontijo, Celia MF/AAU-7736-2020; Rugani, Jeronimo/ABE-4235-2020; Quaresma, Patricia/W-3876-2019	Rego, Felipe Dutra/0000-0002-2799-8267; Rêgo, Felipe Dutra/0000-0002-2799-8267; Shimabukuro, Paloma Helena Fernandes/0000-0002-5114-953X; Gontijo, Celia MF/0000-0002-7034-535X; Quaresma, Patricia Flavia/0000-0001-8274-4166; Barbosa Tonelli, Gabriel/0000-0002-8415-3199	National Council for Scientific and Technological Development; Minas Gerais Research Foundation; Oswaldo Cruz Foundation	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Minas Gerais Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Oswaldo Cruz Foundation	This study was funded by the National Council for Scientific and Technological Development, Minas Gerais Research Foundation, and Oswaldo Cruz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; Andrade JD, 2009, NEOTROP ENTOMOL, V38, P688, DOI 10.1590/S1519-566X2009000500022; Andrade JD, 2007, MEM I OSWALDO CRUZ, V102, P481, DOI 10.1590/S0074-02762007005000035; ANEZ N, 1994, ANN TROP MED PARASIT, V88, P279, DOI 10.1080/00034983.1994.11812868; Aransay AM, 2000, APPL ENVIRON MICROB, V66, P1933, DOI 10.1128/AEM.66.5.1933-1938.2000; ARIAS JR, 1985, AM J TROP MED HYG, V34, P1098, DOI 10.4269/ajtmh.1985.34.1098; Ashford RW, 2000, INT J PARASITOL, V30, P1269, DOI 10.1016/S0020-7519(00)00136-3; Barbosa AF, 2006, MEM I OSWALDO CRUZ, V101, P851, DOI 10.1590/S0074-02762006000800005; Brazil Reginaldo P., 1997, Anais da Sociedade Entomologica do Brasil, V26, P191, DOI 10.1590/S0301-80591997000100026; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; CHAGAS A. W., 1940, Memorias do Instituto Oswaldo Cruz, V35, P327, DOI 10.1590/S0074-02761940000200005; Coelho M V, 1965, Rev Bras Malariol Doencas Trop, V17, P143; CRONIN T M, 1987, Paleontological Society Memoir, P1; Cruz I., 2002, T R SOC TROP MED HYG, V96, pS185, DOI DOI 10.1016/S0035-9203(02)90074-X; Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05; da Silva OS, 1999, MEM I OSWALDO CRUZ, V94, P579, DOI 10.1590/S0074-02761999000500002; DASILVA ALFF, 1990, MEM I OSWALDO CRUZ, V85, P453, DOI 10.1590/S0074-02761990000400010; de Oliveira Alessandra Gutierrez, 2003, Cad Saude Publica, V19, P933; de Paiva BR, 2007, CAD SAUDE PUBLICA, V23, P87, DOI 10.1590/S0102-311X2007000100010; de Pita-Pereira D, 2008, ACTA TROP, V107, P66, DOI 10.1016/j.actatropica.2008.04.015; DEANE L. M., 1957, REV BRASIL MALARIOL E DOENCAS TROP, V9, P225; Deane L.M., 1978, Boletin de la Direccion de Malariologia y Saneamiento Ambiental, V18, P231; Deane LM, 1956, THESIS U SAO PAULO; Dias ES, 2007, REV SOC BRAS MED TRO, V40, P49, DOI 10.1590/S0037-86822007000100009; Nascimento João Cezar do, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P119, DOI 10.1590/S0036-46652007000200011; Dorval MEMC, 2006, REV SOC BRAS MED TRO, V39, P43, DOI 10.1590/S0037-86822006000100008; El Tai NO, 2000, T R SOC TROP MED HYG, V94, P1; Perez JE, 2007, MEM I OSWALDO CRUZ, V102, P655, DOI 10.1590/S0074-02762007005000077; FELICIANGELI M D, 1987, Memorias do Instituto Oswaldo Cruz, V82, P167, DOI 10.1590/S0074-02761987000200003; Freitas RA, 2002, MEM I OSWALDO CRUZ, V97, P53, DOI 10.1590/S0074-02762002000100008; Galati E. A. B., 2003, FLEBOTOMINEOS BRASIL, P23; Galati EAB, 1996, REV SAUDE PUBL, V30, P115, DOI 10.1590/S0034-89101996000200002; Gontijo CMF, 2002, ACTA TROP, V81, P143, DOI 10.1016/S0001-706X(01)00205-4; GONTIJO CMF, 1995, MEM I OSWALDO CRUZ, V90, P367, DOI 10.1590/S0074-02761995000300011; GRIMALDI G, 1993, CLIN MICROBIOL REV, V6, P230, DOI 10.1128/CMR.6.3.230-250.1993; GRIMALDI G, 1989, AM J TROP MED HYG, V41, P687, DOI 10.4269/ajtmh.1989.41.687; Grisard EC, 2000, ACTA TROP, V74, P89, DOI 10.1016/S0001-706X(99)00054-6; HERMETO MV, 1994, MEM I OSWALDO CRUZ, V89, P519, DOI 10.1590/S0074-02761994000400005; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; KILLICKKENDRICK R, 1981, PARASITOLOGY, V82, P143; LAINSON R, 1968, T ROY SOC TROP MED H, V62, P385, DOI 10.1016/0035-9203(68)90090-4; Lainson R., 1998, Topley & Wilson's microbiology & microbial infections Volume 5: Parasitology., P241; Lainson R., 1979, P1; LAINSON R, 1985, T ROY SOC TROP MED H, V79, P223, DOI 10.1016/0035-9203(85)90340-2; Luz ZMP, 2001, REV SOC BRAS MED TRO, V34, P249, DOI DOI 10.1590/S0037-86822001000300004; Margonari C, 2010, J MED ENTOMOL, V47, P1212, DOI 10.1603/ME09248; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; Martins Flavia, 2002, Revista de Patologia Tropical, V31, P211; Marzochi M C, 1994, Cad Saude Publica, V10 Suppl 2, P359, DOI 10.1590/S0102-311X1994000800014; MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239; Michalsky Érika Monteiro, 2011, Rev. Soc. Bras. Med. Trop., V44, P58, DOI 10.1590/S0037-86822011000100014; Miranda JC, 2002, MEM I OSWALDO CRUZ, V97, P185, DOI 10.1590/S0074-02762002000200006; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; Monteiro EM, 2005, REV SOC BRAS MED TRO, V38, P147, DOI 10.1590/S0037-86822005000200004; OLIVEIRA AC, 1959, HOSPITAL-RIO DE JAN, V56, P625; Paiva BR, 2010, ACTA TROP, V115, P126, DOI 10.1016/j.actatropica.2010.02.013; Paraense L., 1940, Brasil-Medico, V54, P179; PASSOS VMA, 1993, MEM I OSWALDO CRUZ, V88, P103, DOI 10.1590/S0074-02761993000100016; Passos VMA, 1999, ACTA TROP, V72, P251, DOI 10.1016/S0001-706X(98)00100-4; PEREZ JE, 1994, T ROY SOC TROP MED H, V88, P161, DOI 10.1016/0035-9203(94)90276-3; Pinto ID, 2012, J VECTOR ECOL, V37, P90, DOI 10.1111/j.1948-7134.2012.00204.x; Pita-Pereira D, 2005, ACTA TROP, V99, P905; Quaresma PF, 2011, T ROY SOC TROP MED H, V105, P579, DOI 10.1016/j.trstmh.2011.07.005; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; RANGEL E F, 1985, Memorias do Instituto Oswaldo Cruz, V80, P373, DOI 10.1590/S0074-02761985000300017; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Rego FD, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-220; Rocha LS, 2010, T ROY SOC TROP MED H, V104, P461, DOI 10.1016/j.trstmh.2010.02.005; Ryan L, 1984, Mem Inst Oswaldo Cruz, V79, P383, DOI 10.1590/S0074-02761984000300016; Ryan L, 1987, I EVANDRO CHAGAS 50, V1, P307; Saraiva L, 2006, REV SOC BRAS MED TRO, V39, P56, DOI 10.1590/S0037-86822006000100011; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Saraiva L, 2008, MEM I OSWALDO CRUZ, V103, P843, DOI 10.1590/S0074-02762008000800018; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; SHERLOCK I. A., 1957, REV BRASIL BIOL, V17, P77; Sherlock IA, 1992, LEISHMANIASIS CONTRO, p[54, 54]; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VANEYS GJJM, 1992, MOL BIOCHEM PARASIT, V51, P133, DOI 10.1016/0166-6851(92)90208-2; WARD RD, 1973, T ROY SOC TROP MED H, V67, P174, DOI 10.1016/0035-9203(73)90142-9; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	80	42	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 8	2015	10	4							e0122038	10.1371/journal.pone.0122038	http://dx.doi.org/10.1371/journal.pone.0122038			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3WA	25853254	Green Submitted, Green Published, gold			2022-12-26	WOS:000352478400058
J	Jin, SY; Merchant, ML; Ritzenthaler, JD; McLeish, KR; Lederer, ED; Torres-Gonzalez, E; Fraig, M; Barati, MT; Lentsch, AB; Roman, J; Klein, JB; Rane, MJ				Jin, Shunying; Merchant, Michael L.; Ritzenthaler, Jeffrey D.; McLeish, Kenneth R.; Lederer, Eleanor D.; Torres-Gonzalez, Edilson; Fraig, Mostafa; Barati, Michelle T.; Lentsch, Alex B.; Roman, Jesse; Klein, Jon B.; Rane, Madhavi J.			Baclofen, a GABA(B)R Agonist, Ameliorates Immune-Complex Mediated Acute Lung Injury by Modulating Pro-Inflammatory Mediators	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; NF-KAPPA-B; CELL-SURFACE EXPRESSION; MOUSE MODEL; RECEPTOR; ACTIVATION; PROTEIN; INHIBITION; RESPONSES; LIPOPOLYSACCHARIDE	Immune-complexes play an important role in the inflammatory diseases of the lung. Neutrophil activation mediates immune-complex (IC) deposition-induced acute lung injury (ALI). Components of gamma amino butyric acid (GABA) signaling, including GABA B receptor 2 (GABA(B)R2), GAD65/67 and the GABA transporter, are present in the lungs and in the neutrophils. However, the role of pulmonary GABA(B)R activation in the context of neutrophilmediated ALI has not been determined. Thus, the objective of the current study was to determine whether administration of a GABA(B)R agonist, baclofen would ameliorate or exacerbate ALI. We hypothesized that baclofen would regulate IC-induced ALI by preserving pulmonary GABA(B)R expression. Rats were subjected to sham injury or IC-induced ALI and two hours later rats were treated intratracheally with saline or 1 mg/kg baclofen for 2 additional hours and sacrificed. ALI was assessed by vascular leakage, histology, TUNEL, and lung caspase-3 cleavage. ALI increased total protein, tumor necrosis factor a (TNF-alpha and interleukin-1 receptor associated protein (IL-1R AcP), in the bronchoalveolar lavage fluid (BALF). Moreover, ALI decreased lung GABA(B)R2 expression, increased phospho-p38 MAPK, promoted I kappa B degradation and increased neutrophil influx in the lung. Administration of baclofen, after initiation of ALI, restored GABA(B)R expression, which was inhibited in the presence of a GABA(B)R antagonist, CGP52432. Baclofen administration activated pulmonary phospho-ERK and inhibited p38 MAPK phosphorylation and I kappa B degradation. Additionally, baclofen significantly inhibited pro-inflammatory TNF-alpha and IL-1 beta AcP release and promoted BAL neutrophil apoptosis. Protective effects of baclofen treatment on ALI were possibly mediated by inhibition of TNF-alpha-and IL-1 beta-mediated inflammatory signaling. Interestingly, GABA(B)R2 expression was regulated in the type II pneumocytes in lung tissue sections from lung injured patients, further suggesting a physiological role for GABA(B)R2 in the repair process of lung damage. GABA(B)R2 agonists may play a potential therapeutic role in ALI.	[Jin, Shunying; Merchant, Michael L.; Ritzenthaler, Jeffrey D.; McLeish, Kenneth R.; Lederer, Eleanor D.; Torres-Gonzalez, Edilson; Barati, Michelle T.; Roman, Jesse; Klein, Jon B.; Rane, Madhavi J.] Univ Louisville, Dept Med, Louisville, KY 40292 USA; [McLeish, Kenneth R.; Klein, Jon B.; Rane, Madhavi J.] Univ Louisville, Dept Biochem & Mol Biol, Louisville, KY 40292 USA; [McLeish, Kenneth R.; Lederer, Eleanor D.; Roman, Jesse; Klein, Jon B.] Robley Rex VA Med Ctr, Louisville, KY USA; [Lederer, Eleanor D.] Univ Louisville, Dept Physiol, Louisville, KY 40292 USA; [Fraig, Mostafa] Univ Louisville, Dept Pathol, Louisville, KY 40292 USA; [Lentsch, Alex B.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville; University System of Ohio; University of Cincinnati	Rane, MJ (corresponding author), Univ Louisville, Dept Med, Louisville, KY 40292 USA.	mjrane01@louisville.edu	Klein, Jon/B-9833-2013; McLeish, Kenneth R./B-9819-2013; Merchant, Michael/F-7109-2013; Fraig, Mostafa M/I-1670-2016; Merchant, Michael/N-7444-2013	McLeish, Kenneth R./0000-0002-7816-3286; Fraig, Mostafa M/0000-0003-1119-3672; Merchant, Michael/0000-0003-4128-4057	NIH NIAID [R01-AI075212]; VA merit; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075212] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001838] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); VA merit(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NIH NIAID R01-AI075212 to MJR (http://www.niaid.nih.gov/researchfunding/contract/Pages/default.aspx), and VA merit to KRM, JR, and JBK (http://www.research.va.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benke D, 2013, BIOCHEM PHARMACOL, V86, P1525, DOI 10.1016/j.bcp.2013.09.016; Bhat R, 2010, P NATL ACAD SCI USA, V107, P2580, DOI 10.1073/pnas.0915139107; Bless NM, 1998, AM J PATHOL, V153, P1113, DOI 10.1016/S0002-9440(10)65655-6; CHAPMAN RW, 1993, TRENDS PHARMACOL SCI, V14, P26, DOI 10.1016/0165-6147(93)90110-6; Chen QH, 2013, MOL MED REP, V8, P565, DOI 10.3892/mmr.2013.1537; Cheng CY, 2010, ACTA PHARMACOL SIN, V31, P889, DOI 10.1038/aps.2010.66; Chi GF, 2013, INFLAMMATION, V36, P501, DOI 10.1007/s10753-012-9571-1; Chintagari NR, 2012, CRIT CARE, V16, DOI 10.1186/cc11298; Chintagari NR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014171; Cullinan EB, 1998, J IMMUNOL, V161, P5614; Denora N, 2007, PHARM RES-DORDR, V24, P1309, DOI 10.1007/s11095-007-9255-y; DICPINIGAITIS PV, 1994, CHEST, V106, P758, DOI 10.1378/chest.106.3.758; Dowdy DW, 2006, INTENS CARE MED, V32, P1115, DOI 10.1007/s00134-006-0217-3; Duthey B, 2010, EXP DERMATOL, V19, P661, DOI 10.1111/j.1600-0625.2010.01076.x; Fan WM, 2013, DIGEST DIS SCI, V58, P1909, DOI 10.1007/s10620-013-2623-z; Fortis S, 2012, INTENS CARE MED, V38, P1548, DOI 10.1007/s00134-012-2610-4; Fu XW, 2011, AM J RESP CELL MOL, V44, P222, DOI 10.1165/rcmb.2010-0109OC; Gaiarsa JL, 2011, PHARMACOL THERAPEUT, V132, P170, DOI 10.1016/j.pharmthera.2011.06.004; Gao HW, 2006, J IMMUNOL, V177, P612, DOI 10.4049/jimmunol.177.1.612; Gao MY, 2013, INT IMMUNOPHARMACOL, V15, P240, DOI 10.1016/j.intimp.2012.11.019; Guo RF, 2002, FREE RADICAL BIO MED, V33, P303, DOI 10.1016/S0891-5849(02)00823-7; Howland RH, 2012, J PSYCHOSOC NURS MEN, V50, P11, DOI 10.3928/02793695-20120906-92; Im BH, 2012, NEUROSCI LETT, V513, P89, DOI 10.1016/j.neulet.2012.02.014; JOHNSON KJ, 1974, J CLIN INVEST, V54, P349, DOI 10.1172/JCI107770; Kilpatrick LE, 2006, J LEUKOCYTE BIOL, V80, P1512, DOI 10.1189/jlb.0406284; Laffray S, 2012, EMBO J, V31, P3239, DOI 10.1038/emboj.2012.161; Lentsch AB, 1999, CLIN CHEM LAB MED, V37, P205, DOI 10.1515/CCLM.1999.038; Lentsch AB, 1998, AM J PATHOL, V152, P1327; Lentsch AB, 1999, J IMMUNOL, V162, P1071; Lentsch AB, 2001, RESP PHYSIOL, V128, P17, DOI 10.1016/S0034-5687(01)00260-2; Lentsch Alex B., 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P59; Liu S, 2008, EUR J PHARMACOL, V584, P159, DOI 10.1016/j.ejphar.2008.02.009; Lu WY, 2009, CLIN EXP ALLERGY, V39, P956, DOI 10.1111/j.1365-2222.2009.03265.x; Lu Y, 2001, BRAIN RES, V889, P118, DOI 10.1016/S0006-8993(00)03124-3; Luerman GC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001552; Lujan R, 2012, CURR DRUG TARGETS, V13, P129, DOI 10.2174/138945012798868425; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Merchant ML, 2010, PROTEOM CLIN APPL, V4, P84, DOI 10.1002/prca.200800093; Merlo D, 2007, NEUROBIOL DIS, V25, P631, DOI 10.1016/j.nbd.2006.11.005; Mizukami K, 2002, PROG NEURO-PSYCHOPH, V26, P393, DOI 10.1016/S0278-5846(01)00247-0; Mizuta K, 2008, AM J PHYSIOL-LUNG C, V294, pL1206, DOI 10.1152/ajplung.00287.2007; Mulligan MS, 1996, P ASSOC AM PHYSICIAN, V108, P198; Osawa Y, 2006, AM J PHYSIOL-LUNG C, V291, pL923, DOI 10.1152/ajplung.00185.2006; Rane MJ, 2005, J IMMUNOL, V174, P7242, DOI 10.4049/jimmunol.174.11.7242; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Sasaki S, 2007, BIOL PHARM BULL, V30, P687, DOI 10.1248/bpb.30.687; Sauter K, 2005, J BIOL CHEM, V280, P33566, DOI 10.1074/jbc.M503482200; Straessle A, 2003, EUR J NEUROSCI, V18, P2213, DOI 10.1046/j.1460-9568.2003.02964.x; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tian JD, 2011, AUTOIMMUNITY, V44, P465, DOI 10.3109/08916934.2011.571223; Tu HJ, 2007, CELL SIGNAL, V19, P1996, DOI 10.1016/j.cellsig.2007.05.004; Uriarte SM, 2008, J IMMUNOL, V180, P5575, DOI 10.4049/jimmunol.180.8.5575; Uriarte SM, 2013, SHOCK, V39, P286, DOI 10.1097/SHK.0b013e318282c9a1; Vanhoose AM, 2002, J BIOL CHEM, V277, P9049, DOI 10.1074/jbc.M108309200; Wang XL, 2011, NEUROSCI LETT, V490, P112, DOI 10.1016/j.neulet.2010.12.038; Ward AB, 2002, DISABIL REHABIL, V24, P443, DOI 10.1080/09638280110108878; Ward PA, 1997, J LAB CLIN MED, V129, P400, DOI 10.1016/S0022-2143(97)90072-X; Ward PA, 2002, MOL CELL BIOCHEM, V234, P225, DOI 10.1023/A:1015944709177; WARD PA, 1979, AM J PATHOL, V97, P85; William R, 1998, J IMMUNOL, V161, P957; WOOD JD, 1965, CAN J PHYSIOL PHARM, V43, P405, DOI 10.1139/y65-040; Wu JZ, 2011, NEUROIMMUNOMODULAT, V18, P150, DOI 10.1159/000323141; Xiang YY, 2013, ANESTHESIOLOGY, V118, P1065, DOI 10.1097/ALN.0b013e31828e180e; Zemoura K, 2013, J BIOL CHEM, V288, P34897, DOI 10.1074/jbc.M113.514745	65	9	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121637	10.1371/journal.pone.0121637	http://dx.doi.org/10.1371/journal.pone.0121637			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848767	Green Published, gold, Green Submitted			2022-12-26	WOS:000352477800070
J	Schuster, A; Paul, M; Bettencourt, N; Hussain, ST; Morton, G; Kutty, S; Bigalke, B; Chiribiri, A; Perera, D; Nagel, E; Beerbaum, P				Schuster, Andreas; Paul, Matthias; Bettencourt, Nuno; Hussain, Shazia T.; Morton, Geraint; Kutty, Shelby; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp			Myocardial Feature Tracking Reduces Observer-Dependence in Low-Dose Dobutamine Stress Cardiovascular Magnetic Resonance	PLOS ONE			English	Article							WALL-MOTION; STRAIN; REPRODUCIBILITY; QUANTIFICATION; PREDICTION; VIABILITY; HEART	Objectives To determine whether quantitative wall motion assessment by CMR myocardial feature tracking (CMR-FT) would reduce the impact of observer experience as compared to visual analysis in patients with ischemic cardiomyopathy (ICM). Methods 15 consecutive patients with ICM referred for assessment of hibernating myocardium were studied at 3 Tesla using SSFP cine images at rest and during low dose dobutamine stress (5 and 10 mu g/kg/min of dobutamine). Conventional visual, qualitative analysis was performed independently and blinded by an experienced and an inexperienced reader, followed by post-processing of the same images by CMR-FT to quantify subendocardial and subepicardial circumferential (Ecc(endo) and Ecc(epi)) and radial (Err) strain. Receiver operator characteristics (ROC) were assessed for each strain parameter and operator to detect the presence of inotropic reserve as visually defined by the experienced observer. Results 141 segments with wall motion abnormalities at rest were eligible for the analysis. Visual scoring of wall motion at rest and during dobutamine was significantly different between the experienced and the inexperienced observer (p<0.001). All strain values (Ecc(endo), Ecc(epi) and Err) derived during dobutamine stress (5 and 10 mu g/kg/min) showed similar diagnostic accuracy for the detection of contractile reserve for both operators with no differences in ROC (p>0.05). Eccendo was the most accurate (AUC of 0.76, 10 mu g/kg/min of dobutamine) parameter. Diagnostic accuracy was worse for resting strain with differences between operators for Eccendo and Eccepi (p<0.05) but not Err (p>0.05). Conclusion Whilst visual analysis remains highly dependent on operator experience, quantitative CMR-FT analysis of myocardial wall mechanics during DS-CMR provides diagnostic accuracy for the detection of inotropic reserve regardless of operator experience and hence may improve diagnostic robustness of low-dose DS-CMR in clinical practice.	[Schuster, Andreas] Univ Gottingen, Dept Cardiol & Pulmonol, D-37073 Gottingen, Germany; [Schuster, Andreas] DZHK, German Ctr Cardiovasc Res, Gottingen, Germany; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Kings Coll London, British Heart Fdn, Ctr Excellence, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Guys & St Thomas NHS Fdn Trust, Natl Inst Hlth Res NIHR Biomed Res Ctr, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Wellcome Trust Res Labs, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] Engn & Phys Sci Res Council, Med Engn Ctr, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] St Thomas Hosp, Div Imaging Sci & Biomed Engn, London, England; [Schuster, Andreas; Paul, Matthias; Hussain, Shazia T.; Morton, Geraint; Bigalke, Boris; Chiribiri, Amedeo; Perera, Divaka; Nagel, Eike; Beerbaum, Philipp] St Thomas Hosp, Rayne Inst, London SE1 7EH, England; [Bettencourt, Nuno] Ctr Hosp Gaia Espinho, Dept Cardiol, Porto, Portugal; [Kutty, Shelby] Creighton Univ, Univ Nebraska, Childrens Hosp & Med Ctr, Joint Div Pediat Cardiol, Omaha, NE 68178 USA; [Bigalke, Boris] Charite, Campus Benjamin Franklin, Dept Cardiol, Berlin, Germany; [Perera, Divaka] Kings Coll London, BHF Ctr Excellence, NIHR Biomed Res Ctr, London, England; [Perera, Divaka] Guys & St Thomas NHS Fdn Trust, Dept Cardiol, London, England; [Beerbaum, Philipp] Hannover Med Sch, Dept Paediat Cardiol, Hannover, Germany	University of Gottingen; German Centre for Cardiovascular Research; University of London; King's College London; University College London; Guy's & St Thomas' NHS Foundation Trust; UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Creighton University; University of Nebraska System; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Hannover Medical School	Schuster, A (corresponding author), Univ Gottingen, Dept Cardiol & Pulmonol, D-37073 Gottingen, Germany.	andreas_schuster@gmx.net	Chiribiri, Amedeo/T-2771-2019; Nagel, Eike/C-6903-2008; Bettencourt, Nuno/AAX-1905-2020	Nagel, Eike/0000-0002-6044-950X; Bettencourt, Nuno/0000-0002-9582-7881; Chiribiri, Amedeo/0000-0003-3394-4289; Perera, Divaka/0000-0001-6362-1291	Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany; British Heart Foundation (BHF) [RE/08/003, FS/10/029/28253]; Biomedical Research Centre [BRC-CTF 196]; American College of Cardiology Foundation; Edna Ittner Pediatric Foundation; Children's Hospital and Medical Center Foundation; BHF [RE/08/003]; Wellcome Trust; Engineering and Physical Sciences Research Council (EPSRC) [WT 088641/Z/09/Z]; National Institute for Health Research (NIHR) via the comprehensive BRC award; St Thomas' NHS Foundation Trust; King's College London; British Heart Foundation [FS/10/029/28253] Funding Source: researchfish	Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany; British Heart Foundation (BHF)(British Heart Foundation); Biomedical Research Centre; American College of Cardiology Foundation(General Electric); Edna Ittner Pediatric Foundation; Children's Hospital and Medical Center Foundation; BHF(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research (NIHR) via the comprehensive BRC award(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London(General Electric); British Heart Foundation(British Heart Foundation)	AS receives grant support from the Research Program, Faculty of Medicine, Georg-August-University Gottingen, Germany, the British Heart Foundation (BHF) (RE/08/003 and FS/10/029/28253) and the Biomedical Research Centre (BRC-CTF 196). SK receives grant support from the American College of Cardiology Foundation, the Edna Ittner Pediatric Foundation, and the Children's Hospital and Medical Center Foundation. EN receives grant support from BHF (RE/08/003), the Wellcome Trust and Engineering and Physical Sciences Research Council (EPSRC, WT 088641/Z/09/Z) and the National Institute for Health Research (NIHR) via the comprehensive BRC award to Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Cardiology Foundation Task Force on Expert Consensus Documents, 2010, J Am Coll Cardiol, V55, P2614, DOI [10.1161/CIR.0b013e3181d44a8f, 10.1016/j.jacc.2009.11.011]; Bertini M, 2012, CIRC-CARDIOVASC IMAG, V5, P383, DOI 10.1161/CIRCIMAGING.111.970434; Bettencourt Nuno, 2009, Curr Heart Fail Rep, V6, P142; Bree D, 2006, CIRCULATION, V114, pI33, DOI 10.1161/CIRCULATIONAHA.105.000885; Buss SJ, 2015, EUR HEART J-CARD IMG, V16, P307, DOI 10.1093/ehjci/jeu181; Cerqueira MD, 2002, CIRCULATION, V105, P539, DOI 10.1161/hc0402.102975; Glaveckaite S, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-35; Hor KN, 2011, JOVE-J VIS EXP, DOI 10.3791/2356; Hor KN, 2010, JACC-CARDIOVASC IMAG, V3, P144, DOI 10.1016/j.jcmg.2009.11.006; Ibrahim ESH, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-36; Kim RJ, 2000, NEW ENGL J MED, V343, P1445, DOI 10.1056/NEJM200011163432003; Kirschbaum SW, 2012, INT J CARDIOL, V159, P192, DOI 10.1016/j.ijcard.2011.02.048; Kowallick JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109164; Kowallick JT, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0060-6; Kowallick JT, 2014, J CARDIOL THER, V1, P58, DOI DOI 10.6051/J; Maret E, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-53; Morton G, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-43; Morton G, 2010, EUR HEART J, V31, P2209, DOI 10.1093/eurheartj/ehq256; Nagel E, 2012, JACC-CARDIOVASC IMAG, V5, P509, DOI 10.1016/j.jcmg.2012.03.005; Nagel E, 2010, JACC-CARDIOVASC IMAG, V3, P731, DOI 10.1016/j.jcmg.2010.05.002; Padiyath A, 2013, ECHOCARDIOGR-J CARD, V30, P203, DOI 10.1111/echo.12016; Paetsch I, 2005, AM J PHYSIOL-HEART C, V288, pH2708, DOI 10.1152/ajpheart.01017.2003; Paetsch I, 2006, EUR HEART J, V27, P1459, DOI 10.1093/eurheartj/ehi883; Schuster A, 2013, EUR J RADIOL, V82, P296, DOI 10.1016/j.ejrad.2012.11.012; Schuster A, 2012, J AM COLL CARDIOL, V59, P359, DOI 10.1016/j.jacc.2011.08.076; Schuster A, 2013, INT J CARDIOL, V166, P413, DOI 10.1016/j.ijcard.2011.10.137; Schuster A, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-58; Schuster A, 2011, CURR CARDIOVASC IMAG, V4, P85, DOI 10.1007/s12410-011-9072-x; Shehata ML, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-55; Stanton T, 2009, CIRC-CARDIOVASC IMAG, V2, P356, DOI 10.1161/CIRCIMAGING.109.862334; Thiele H, 2002, J CARDIOV MAGN RESON, V4, P327, DOI 10.1081/JCMR-120013298; Thiele H, 2009, INT J CARDIOL, V135, P287, DOI 10.1016/j.ijcard.2008.03.055; Wellnhofer E, 2004, CIRCULATION, V109, P2172, DOI 10.1161/01.CIR.0000128862.34201.74	33	23	25	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0122858	10.1371/journal.pone.0122858	http://dx.doi.org/10.1371/journal.pone.0122858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25848764	Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800166
J	Tarr, SJ; Osborne, AR				Tarr, Sarah J.; Osborne, Andrew R.			Experimental Determination of the Membrane Topology of the Plasmodium Protease Plasmepsin V	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; INFECTED ERYTHROCYTE; MALARIA VIRULENCE; MAURERS CLEFTS; FALCIPARUM; PROTEINS; EXPORT; TRAFFICKING; SURFACE; TRANSFORMATION	The malaria parasite exports hundreds of proteins into its host cell. The majority of exported proteins contain a Host-Targeting motif (also known as a Plasmodium export element) that directs them for export. Prior to export, the Host-Targeting motif is cleaved by the endoplasmic reticulum-resident protease Plasmepsin V and the newly generated N-terminus is N-alpha-acetylated by an unidentified enzyme. The cleaved, N-a-acetylated protein is trafficked to the parasitophorous vacuole, where it is translocated across the vacuole membrane. It is clear that cleavage and N-alpha-acetylation of the Host-Targeting motif occur at the endoplasmic reticulum, and it has been proposed that Host-Targeting motif cleavage and N-alpha-acetylation occur either on the luminal or cytosolic side of the endoplasmic reticulum membrane. Here, we use self-associating 'split' fragments of GFP to determine the topology of Plasmepsin V in the endoplasmic reticulum membrane; we show that the catalytic protease domain of Plasmepsin V faces the endoplasmic reticulum lumen. These data support a model in which the Host-Targeting motif is cleaved and N-alpha-acetylated in the endoplasmic reticulum lumen. Furthermore, these findings suggest that cytosolic N-alpha-acetyltransferases are unlikely to be candidates for the N-alpha-acetyltransferase of Host-Targeting motif-containing exported proteins.	[Tarr, Sarah J.; Osborne, Andrew R.] Birkbeck & Univ Coll London, Inst Struct & Mol Biol, Div Biosci, London, England	University of London; Birkbeck University London	Osborne, AR (corresponding author), Birkbeck & Univ Coll London, Inst Struct & Mol Biol, Div Biosci, London, England.	a.osborne@ucl.ac.uk		Tarr, Sarah/0000-0003-0746-7319	Wellcome Trust [09095/Z/10/Z]; Institute of Structural and Molecular Biology	Wellcome Trust(Wellcome TrustEuropean Commission); Institute of Structural and Molecular Biology	This work was supported by a Wellcome Trust Grant to AO (Grant Number: 09095/Z/10/Z, www.wellcome.ac.uk), and by an Institute of Structural and Molecular Biology Start-up grant to AO (http://www.ismb.lon.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balu B, 2005, P NATL ACAD SCI USA, V102, P16391, DOI 10.1073/pnas.0504679102; Beck JR, 2014, NATURE, V511, P592, DOI 10.1038/nature13574; BENTING J, 1994, BIOCHEM J, V300, P821, DOI 10.1042/bj3000821; Bhattacharjee S, 2012, CELL, V148, P201, DOI 10.1016/j.cell.2011.10.051; Boddey JA, 2010, NATURE, V463, P627, DOI 10.1038/nature08728; Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044; Cabantous S, 2006, NAT METHODS, V3, P845, DOI 10.1038/nmeth932; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; ELMENDORF HG, 1992, MOL BIOCHEM PARASIT, V52, P215, DOI 10.1016/0166-6851(92)90054-N; Elsworth B, 2014, NATURE, V511, P587, DOI 10.1038/nature13555; Forte GMA, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001073; Gruring C, 2012, CELL HOST MICROBE, V12, P717, DOI 10.1016/j.chom.2012.09.010; Haase S, 2009, MOL MICROBIOL, V71, P1003, DOI 10.1111/j.1365-2958.2008.06582.x; Heiber A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003546; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Knuepfer E, 2005, MOL MICROBIOL, V58, P1039, DOI 10.1111/j.1365-2958.2005.04895.x; Knuepfer E, 2005, BLOOD, V105, P4078, DOI 10.1182/blood-2004-12-4666; Kulzer S, 2013, MOL BIOCHEM PARASIT, V187, P87, DOI 10.1016/j.molbiopara.2012.11.004; Kulzer S, 2009, PARASITOL RES, V104, P1535, DOI 10.1007/s00436-009-1397-x; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2007, BLOOD, V109, P1289, DOI 10.1182/blood-2006-08-043364; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Osborne AR, 2010, MOL BIOCHEM PARASIT, V171, P25, DOI 10.1016/j.molbiopara.2010.01.003; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Romisch K, 2012, F1000 RESEARCH, V1, DOI [10.3410/f1000research.1-12.v1, DOI 10.3410/F1000RESEARCH.1-12.V1]; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Saridaki T, 2009, TRAFFIC, V10, P137, DOI 10.1111/j.1600-0854.2008.00860.x; Soppa J, 2010, ARCHAEA, V2010, DOI 10.1155/2010/820681; Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x; Tarr SJ, 2013, MOL MICROBIOL, V87, P835, DOI 10.1111/mmi.12133; Toddo S, 2012, PROTEIN SCI, V21, P1571, DOI 10.1002/pro.2131; WHO, 2011, WORLD MALARIA REPORT 2011, P1	37	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0121786	10.1371/journal.pone.0121786	http://dx.doi.org/10.1371/journal.pone.0121786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849462	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000352477800076
J	Wang, ML; Khera, P; Pandey, MK; Wang, H; Qiao, LX; Feng, SP; Tonnis, B; Barkley, NA; Pinnow, D; Holbrook, CC; Culbreath, AK; Varshney, RK; Guo, BZ				Wang, Ming Li; Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Tonnis, Brandon; Barkley, Noelle A.; Pinnow, David; Holbrook, Corley C.; Culbreath, Albert K.; Varshney, Rajeev K.; Guo, Baozhu			Genetic Mapping of QTLs Controlling Fatty Acids Provided Insights into the Genetic Control of Fatty Acid Synthesis Pathway in Peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							LINOLENIC ACID; OLEIC-ACID; TRAIT; OIL; PHOTOSYNTHESIS; IDENTIFICATION; REGISTRATION; GENOMICS; CORE	Peanut, a high-oil crop with about 50% oil content, is either crushed for oil or used as edible products. Fatty acid composition determines the oil quality which has high relevance to consumer health, flavor, and shelf life of commercial products. In addition to the major fatty acids, oleic acid (C18:1) and linoleic acid (C18:2) accounting for about 80% of peanut oil, the six other fatty acids namely palmitic acid (C16:0), stearic acid (C18:0), arachidic acid (C20:0), gadoleic acid (C20:1), behenic acid (C22:0), and lignoceric acid (C24:0) are accounted for the rest 20%. To determine the genetic basis and to improve further understanding on effect of FAD2 genes on these fatty acids, two recombinant inbred line (RIL) populations namely S-population (high oleic line 'SunOleic 97R' x low oleic line 'NC94022') and T-population (normal oleic line 'Tifrunner' x low oleic line 'GT-C20') were developed. Genetic maps with 206 and 378 marker loci for the S-and the T-population, respectively were used for quantitative trait locus (QTL) analysis. As a result, a total of 164 main-effect (M-QTLs) and 27 epistatic (E-QTLs) QTLs associated with the minor fatty acids were identified with 0.16% to 40.56% phenotypic variation explained (PVE). Thirty four major QTLs (>10% of PVE) mapped on five linkage groups and 28 clusters containingmore than three QTLs were also identified. These results suggest that the major QTLs with large additive effects would play an important role in controlling composition of these minor fatty acids in addition to the oleic and linoleic acids in peanut oil. The interrelationship among these fatty acids should be considered while breeding for improved peanut genotypes with good oil quality and desired fatty acid composition.	[Wang, Ming Li; Tonnis, Brandon; Barkley, Noelle A.; Pinnow, David] USDA ARS, Plant Genet Resources Conservat Unit, Griffin, GA USA; [Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Guo, Baozhu] USDA ARS, Crop Protect & Management Res Unit, Tifton, GA 31793 USA; [Khera, Pawan; Pandey, Manish K.; Varshney, Rajeev K.] Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India; [Khera, Pawan; Pandey, Manish K.; Wang, Hui; Qiao, Lixian; Feng, Suping; Culbreath, Albert K.; Guo, Baozhu] Univ Georgia, Dept Plant Pathol, Tifton, GA 31793 USA; [Wang, Hui] Fujian Agr & Forestry Univ, Fuzhou, Fujian, Peoples R China; [Qiao, Lixian] Qingdao Agr Univ, Coll Life Sci, Qingdao, Shandong, Peoples R China; [Feng, Suping] Qiongzhou Univ, Coll Biosci & Biotechnol, Sanya, Hainan, Peoples R China; [Holbrook, Corley C.] USDA ARS, Crop Genet & Breeding Res Unit, Tifton, GA 31793 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); University System of Georgia; University of Georgia; Fujian Agriculture & Forestry University; Qingdao Agricultural University; Hainan Tropical Ocean University; United States Department of Agriculture (USDA)	Varshney, RK (corresponding author), Int Crops Res Inst Semi Arid Trop, Hyderabad, Telangana, India.	r.k.varshney@cgiar.org; baozhu.guo@ars.usda.gov	Varshney, Rajeev K/C-5295-2014	Varshney, Rajeev K/0000-0002-4562-9131; Pandey, Manish/0000-0002-4101-6530; Anglin, Noelle L./0000-0002-3454-1142	USDA Agricultural Research Service; Georgia Agricultural Commodity Commission for Peanuts; Peanut Foundation; National Peanut Board; ARS [ARS-0425281] Funding Source: Federal RePORTER	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Georgia Agricultural Commodity Commission for Peanuts; Peanut Foundation; National Peanut Board; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was partially supported by funds provided by the USDA Agricultural Research Service, the Georgia Agricultural Commodity Commission for Peanuts, Peanut Foundation and National Peanut Board. This work has been undertaken as part of the CGIAR Research Program on Grain Legumes. ICRISAT is a member of CGIAR Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker GC, 2007, PLANT PHYSIOL, V144, P1827, DOI 10.1104/pp.107.096172; Barkley NA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-62; Bobinski R, 2013, EUR J CLIN NUTR, V67, P966, DOI 10.1038/ejcn.2013.96; Cloutier S, 2011, MOL BREEDING, V28, P437, DOI 10.1007/s11032-010-9494-1; Crupkin M, 2008, COMPR REV FOOD SCI F, V7, P271, DOI 10.1111/j.1541-4337.2008.00045.x; Dean L. L., 2009, Peanut Science, V36, P104, DOI 10.3146/PS07-103.1; Fretts AM, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000889; Gautami B, 2012, MOL BREEDING, V30, P757, DOI 10.1007/s11032-011-9660-0; Gorbet DW, 2000, CROP SCI, V40, P1190, DOI 10.2135/cropsci2000.0032rcv; Guo Baozhu, 2013, Peanut Science, V40, P95, DOI 10.3146/PS13-03.1; Ha BK, 2014, THEOR APPL GENET, V127, P1501, DOI 10.1007/s00122-014-2314-y; Holbrook CC, 2007, J PLANT REGIST, V1, P124, DOI 10.3198/jpr2006.09.0575crc; HUGLY S, 1989, PLANT PHYSIOL, V90, P1134, DOI 10.1104/pp.90.3.1134; Johnson S, 2008, FATTY ACIDS PROFILE; Kavera B., 2008, THESIS U AGR SCI; Kratz M, 2002, EUR J CLIN NUTR, V56, P72, DOI 10.1038/sj.ejcn.1601288; Lopez Y, 2000, THEOR APPL GENET, V101, P1131, DOI 10.1007/s001220051589; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; McConn M, 1996, PLANT CELL, V8, P403, DOI 10.1105/tpc.8.3.403; Montoya C, 2013, TREE GENET GENOMES, V9, P1207, DOI 10.1007/s11295-013-0629-5; MOORE KM, 1989, J HERED, V80, P252, DOI 10.1093/oxfordjournals.jhered.a110845; NORDEN A J, 1987, Peanut Science, V14, P7, DOI 10.3146/i0095-3679-14-1-3; Pandey MK, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0133-4; Pandey MK, 2012, BIOTECHNOL ADV, V30, P639, DOI 10.1016/j.biotechadv.2011.11.001; Qin HD, 2012, THEOR APPL GENET, V124, P653, DOI 10.1007/s00122-011-1737-y; RIZZO WB, 1986, NEUROLOGY, V36, P357, DOI 10.1212/WNL.36.3.357; Sanyal A, 2012, THEOR APPL GENET, V124, P723, DOI 10.1007/s00122-011-1742-1; Sujay V, 2012, MOL BREEDING, V30, P773, DOI 10.1007/s11032-011-9661-z; Sultana R, 2012, J AM OIL CHEM SOC, V89, P1611, DOI 10.1007/s11746-012-2073-3; Varshney RK, 2014, THEOR APPL GENET, V127, P445, DOI 10.1007/s00122-013-2230-6; Varshney RK, 2013, BIOTECHNOL ADV, V31, P1120, DOI 10.1016/j.biotechadv.2013.01.001; Vassiliou EK, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-25; Wang H, 2013, PLANT GENOME, V6, P3; Wang ML, 2010, PLANT GENET RESOUR-C, V8, P71, DOI [10.1017/S1479262108048247, 10.1017/S1479262109990177]; Wang ML, 2013, J AGR FOOD CHEM, V61, P2875, DOI 10.1021/jf305208e; Wang S., 2011, WINDOWS QTL CARTOGRA; Wilson JN, 2013, J CROP IMPROV, V27, P430, DOI 10.1080/15427528.2013.790330; Yang J, 2005, QTL NETWORK 2 0; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1	39	43	53	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0119454	10.1371/journal.pone.0119454	http://dx.doi.org/10.1371/journal.pone.0119454			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849082	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000352477800012
J	Zeng, YL; Lan, JH; Ran, B; Wang, Q; Gao, J				Zeng, Yiliang; Lan, Jinhui; Ran, Bin; Wang, Qi; Gao, Jing			Restoration of Motion-Blurred Image Based on Border Deformation Detection: A Traffic Sign Restoration Model	PLOS ONE			English	Article							SEGMENTATION	Due to the rapid development of motor vehicle Driver Assistance Systems (DAS), the safety problems associated with automatic driving have become a hot issue in Intelligent Transportation. The traffic sign is one of the most important tools used to reinforce traffic rules. However, traffic sign image degradation based on computer vision is unavoidable during the vehicle movement process. In order to quickly and accurately recognize traffic signs in motion-blurred images in DAS, a new image restoration algorithm based on border deformation detection in the spatial domain is proposed in this paper. The border of a traffic sign is extracted using color information, and then the width of the border is measured in all directions. According to the width measured and the corresponding direction, both the motion direction and scale of the image can be confirmed, and this information can be used to restore the motion-blurred image. Finally, a gray mean grads (GMG) ratio is presented to evaluate the image restoration quality. Compared to the traditional restoration approach which is based on the blind deconvolution method and Lucy-Richardson method, our method can greatly restore motion blurred images and improve the correct recognition rate. Our experiments show that the proposed method is able to restore traffic sign information accurately and efficiently.	[Zeng, Yiliang; Lan, Jinhui; Wang, Qi; Gao, Jing] Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Dept Instrument Sci & Technol, Beijing 100083, Peoples R China; [Ran, Bin] Southeast Univ, Sch Transportat, Nanjing, Jiangsu, Peoples R China	University of Science & Technology Beijing; Southeast University - China	Zeng, YL (corresponding author), Univ Sci & Technol Beijing, Sch Automat & Elect Engn, Dept Instrument Sci & Technol, Beijing 100083, Peoples R China.	ustbzengyiliang@163.com; ustblanjinhui@gmail.com			National Natural Science Foundation of China [61174181]; Advanced Research Fund [9140A05030214QT02070]; National Basic Research Program of China (973 Program) [2012CB725405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Advanced Research Fund; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Grant No. 61174181), the Advanced Research Fund (Grant No. 9140A05030214QT02070), and the National Basic Research Program of China (973 Program, Project No. 2012CB725405). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JM, 2011, IEEE T INTELL TRANSP, V12, P184, DOI 10.1109/TITS.2010.2076349; Barnes N, 2008, IEEE T INTELL TRANSP, V9, P322, DOI 10.1109/TITS.2008.922935; de la Escalera A, 2004, IEEE T INTELL TRANSP, V5, P57, DOI 10.1109/TITS.2004.828173; Deshpande AM, 2014, OPTIK, V125, P3612, DOI 10.1016/j.ijleo.2014.01.126; Fang CY, 2003, PROC CVPR IEEE, P750; Fleyeh H, 2011, IET INTELL TRANSP SY, V5, P190, DOI 10.1049/iet-its.2010.0159; Franke U, 1998, IEEE INTELL SYST APP, V13, P40, DOI 10.1109/5254.736001; Gao Yue, 2010, P INT C MULT, P123; Gomez-Moreno H, 2010, IEEE T INTELL TRANSP, V11, P917, DOI 10.1109/TITS.2010.2054084; Gonzalez A, 2011, IEEE T INTELL TRANSP, V12, P485, DOI 10.1109/TITS.2010.2098029; Ji H, 2008, PROC CVPR IEEE, P1515; Ji RR, 2012, INT J COMPUT VISION, V96, P290, DOI 10.1007/s11263-011-0472-9; Jiang XY, MOTION DEBLURRING; Khan JF, 2011, IEEE T INTELL TRANSP, V12, P83, DOI 10.1109/TITS.2010.2073466; Ko J, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P1605; Kotera Jan, 2013, Computer Analysis of Images and Patterns. 15th International Conference, CAIP 2013. Proceedings: LNCS 8048, P59, DOI 10.1007/978-3-642-40246-3_8; Lin HT, 2011, IEEE T PATTERN ANAL, V33, P2329, DOI 10.1109/TPAMI.2011.93; LUCY LB, 1974, ASTRON J, V79, P745, DOI 10.1086/111605; Maldonado-Bascon S, 2007, IEEE T INTELL TRANSP, V8, P264, DOI 10.1109/TITS.2007.895311; Paclik P, 2006, IEEE T INTELL TRANSP, V7, P309, DOI 10.1109/TITS.2006.880627; RICHARDSON WH, 1972, J OPT SOC AM, V62, P55, DOI 10.1364/JOSA.62.000055; Singh MK., 2008, EURASIP J ADV SIG PR, V2008, P1; Stallkamp J, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P1453, DOI 10.1109/IJCNN.2011.6033395; Sun HW, 2009, IEEE IND ELEC, P1973, DOI 10.1109/IECON.2009.5415110; Wang W, 2011, 2011 8 INT C FUZZ SY, V4, P2158; Yang HL, 2014, SIGNAL PROCESS, V103, P399, DOI 10.1016/j.sigpro.2014.01.023; Zhang FQ, 2010, 2010 INT C INT COMP, P193	27	11	11	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2015	10	4							e0120885	10.1371/journal.pone.0120885	http://dx.doi.org/10.1371/journal.pone.0120885			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF3VU	25849350	Green Published, gold			2022-12-26	WOS:000352477800038
J	Yeh, ML; Peng, CY; Dai, CY; Lai, HC; Huang, CF; Hsieh, MY; Huang, JF; Chen, SC; Lin, ZY; Yu, ML; Chuang, WL				Yeh, Ming-Lun; Peng, Cheng-Yuan; Dai, Chia-Yen; Lai, Hsueh-Chou; Huang, Chung-Feng; Hsieh, Ming-Yen; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long			Pegylated-Interferon Alpha Therapy for Treatment-Experienced Chronic Hepatitis B Patients	PLOS ONE			English	Article							E-ANTIGEN SEROCONVERSION; HBEAG-NEGATIVE PATIENTS; PEGINTERFERON ALPHA-2A; SERUM HBSAG; HEPATOCELLULAR-CARCINOMA; SUSTAINED RESPONSE; STRONG PREDICTOR; VIRUS INFECTION; LAMIVUDINE; ENTECAVIR	Background Studies are limited on pegylated interferon (Peg-IFN) therapy for chronic hepatitis B (CHB) patients who failed or relapsed on previous antiviral therapy. Objectives We aimed to investigate the effect of Peg-IFN therapy in treatment-experienced CHB patients. Study Design A total of 57 treatment-experienced CHB patients at two medical centers were enrolled. All of the patients were treated with Peg-IFN alpha-2a at 180 mu g weekly for 24 or 48 weeks. The hepatitis B serological markers and viral loads were tested every 3 months until 1 year after stopping Peg-IFN therapy. The endpoints were HBV DNA <2000IU/mL, hepatitis B e antigen (HBeAg) seroconversion, and a hepatitis B surface antigen (HBsAg) loss at 12 months post-treatment. Results In HBeAg-positive patients, 25.0%, 29.2%, and 12.5% of the patients achieved HBeAg seroconversion, HBV DNA < 2000 IU/mL and a combined response, respectively, at 12 months post-treatment. Prior IFN therapy, a high baseline ALT level, a low creatinine level, undetectable HBV DNA at 12 weeks and a decline in HBV DNA >2 log(10) IU/mL at 12 weeks of therapy were factors associated with treatment response. In HBeAg-negative patients, 9.1%, 15.2%, and 6.1% of the patients achieved undetectable HBV DNA, HBV DNA <2000 IU/mL, and an HBsAg loss, respectively, at 12 months post-treatment. No factor was significantly associated with the treatment response in the HBeAg-negative patients. The median HBsAg level declined from 3.4 to 2.6 log(10) IU/mL in all the patients, and the 5-year cumulative rate of the HBsAg loss was 9.8% in the HBeAg-negative patients. Overall, none of the patients prematurely discontinued the Peg-IFN therapy. Conclusions Peg-IFN re-treatment is effective for a proportion of HBeAg-positive treatment-experienced patients; it has limited efficacy for HBeAg-negative treatment-experienced patients. PegIFN might facilitate HBsAg loss in HBeAg-negative treatment-experienced patients.	[Yeh, Ming-Lun; Dai, Chia-Yen; Huang, Chung-Feng; Hsieh, Ming-Yen; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan; [Peng, Cheng-Yuan; Lai, Hsueh-Chou] China Med Univ Hosp, Dept Internal Med, Div Hepatogastroenterol, Taichung, Taiwan; [Yeh, Ming-Lun; Dai, Chia-Yen] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Dai, Chia-Yen; Huang, Chung-Feng; Huang, Jee-Fu; Chen, Shinn-Cherng; Lin, Zu-Yau; Yu, Ming-Lung; Chuang, Wan-Long] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan; [Huang, Chung-Feng] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Occupat Med, Kaohsiung, Taiwan; [Huang, Jee-Fu] Kaohsiung Med Univ, Kaohsiung Municipal Hsiao Kang Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Hsieh, Ming-Yen] Kaohsiung Med Univ, Kaohsiung Municipal Ta Tung Hosp, Dept Internal Med, Kaohsiung, Taiwan; [Huang, Chung-Feng; Yu, Ming-Lung] Kaohsiung Med Univ, Grad Inst Clin Med, Coll Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Municipal Ta-Tung Hospital; Kaohsiung Medical University	Yu, ML (corresponding author), Kaohsiung Med Univ Hosp, Dept Internal Med, Div Hepatobiliary, Kaohsiung, Taiwan.	fish6069@gmail.com; waloch@kmu.edu.tw	Yu, Ming-Lung/AAZ-4306-2020; Huang, Jee-Fu/AAX-4622-2020; Chuang, Wan-Long/ABF-7427-2021	Yu, Ming-Lung/0000-0001-8145-1900; Huang, Jee-Fu/0000-0002-2752-7051; Chuang, Wan-Long/0000-0002-2376-421X				Brunetto MR, 2013, J HEPATOL, V59, P1153, DOI 10.1016/j.jhep.2013.07.017; Brunetto MR, 2009, HEPATOLOGY, V49, P1141, DOI 10.1002/hep.22760; Chan HLY, 2010, ALIMENT PHARM THER, V32, P1323, DOI 10.1111/j.1365-2036.2010.04474.x; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Jeng WJ, 2013, HEPATOLOGY, V58, P1888, DOI 10.1002/hep.26549; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Liaw YF, 2011, HEPATOLOGY, V54, P1591, DOI 10.1002/hep.24555; Lin SM, 2007, J HEPATOL, V46, P45, DOI 10.1016/j.jhep.2006.08.021; Liu F, 2011, J GASTROEN HEPATOL, V26, P456, DOI 10.1111/j.1440-1746.2010.06492.x; Ma H, 2010, J GASTROEN HEPATOL, V25, P1498, DOI 10.1111/j.1440-1746.2010.06282.x; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2013, HEPATOL INT, V7, P88, DOI 10.1007/s12072-012-9343-x; Mizokami M, 1999, FEBS LETT, V450, P66, DOI 10.1016/S0014-5793(99)00471-8; Moucari R, 2009, HEPATOLOGY, V49, P1151, DOI 10.1002/hep.22744; Peng CY, 2012, ALIMENT PHARM THER, V35, P458, DOI 10.1111/j.1365-2036.2011.04973.x; Piratvisuth T, 2013, HEPATOL INT, V7, P429, DOI 10.1007/s12072-011-9280-0; Reijnders JGP, 2010, GASTROENTEROLOGY, V139, P491, DOI 10.1053/j.gastro.2010.03.059; Rijckborst V, 2012, J HEPATOL, V56, P1006, DOI 10.1016/j.jhep.2011.12.007; Singal AK, 2013, ALIMENT PHARM THER, V38, P98, DOI 10.1111/apt.12344; Sonneveld MJ, 2010, HEPATOLOGY, V52, P1251, DOI 10.1002/hep.23844; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301	24	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0122259	10.1371/journal.pone.0122259	http://dx.doi.org/10.1371/journal.pone.0122259			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835020	gold, Green Submitted, Green Published			2022-12-26	WOS:000352139000089
J	Ding, CJ; Lu, J; Song, ZQ				Ding, Changjiang; Lu, Jun; Song, Zhiqing			Electrohydrodynamic Drying of Carrot Slices	PLOS ONE			English	Article							EHD; AIR; KINETICS; APPLE; RICE	Carrots have one of the highest levels of carotene, and they are rich in vitamins, fiber and minerals. However, since fresh carrots wilt rapidly after harvest under inappropriate storage conditions, drying has been used to improve their shelf life and retain nutritional quality. Therefore, to further investigate the potential of this method, carrot slices were dried in an EHD system in order to study the effect of different voltages on drying rate. As measures of quality, carotene content and rehydration ratio were, respectively, compared against the conventional oven drying regime. Carotene, the main component of the dried carrot, and rehydration characteristics of the dried product can both indicate quality by physical and chemical changes during the drying process. Mathematical modeling and simulation of drying curves were also performed, using root mean square error, reduced mean square of the deviation and modeling efficiency as the primary criteria to select the equation that best accounts for the variation in the drying curves of the dried samples. Theoretically, the Page model was best suited for describing the drying rate curve of carrot slices at 10kV to 30kV. Experimentally, the drying rate of carrots was notably greater in the EHD system when compared to control, and quality, as determined by carotene content and rehydration ratio, was also improved when compared to oven drying. Therefore, this work presents a facile and effective strategy for experimentally and theoretically determining the drying properties of carrots, and, as a result, it provides deeper insight into the industrial potential of the EHD drying technique.	[Ding, Changjiang; Lu, Jun; Song, Zhiqing] Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China	Inner Mongolia University of Technology	Ding, CJ (corresponding author), Inner Mongolia Univ Technol, Coll Sci, Phys Expt Ctr, Hohhot, Peoples R China.	ding9713@163.com	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	National Natural Science Foundations of China [51467015]; Natural Science Foundation of Inner Mongolia Autonomous Region of china [2013MS0106]; Science Foundation of Inner Mongolia of Technology [ZD201311]	National Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Inner Mongolia Autonomous Region of china; Science Foundation of Inner Mongolia of Technology	This work was Supported by National Natural Science Foundations of China(No. 51467015), Natural Science Foundation of Inner Mongolia Autonomous Region of china (No. 2013MS0106) and Science Foundation of Inner Mongolia of Technology (No. ZD201311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemrajabi AA, 2012, DRY TECHNOL, V30, P88, DOI 10.1080/07373937.2011.608913; Bai YX, 2012, J AQUAT FOOD PROD T, V21, P238, DOI 10.1080/10498850.2011.590271; Bai YX, 2011, J FOOD PROCESS PRES, V35, P891, DOI 10.1111/j.1745-4549.2011.00542.x; Bai YX, 2013, LWT-FOOD SCI TECHNOL, V54, P570, DOI 10.1016/j.lwt.2013.06.026; Bai YX, 2011, INT J APPL ELECTROM, V36, P217, DOI 10.3233/JAE-2011-1361; Balcer BE, 2004, DRY TECHNOL, V22, P821, DOI 10.1081/DRT-120034265; Basiry M, 2010, J ELECTROSTAT, V68, P360, DOI 10.1016/j.elstat.2010.05.002; Cao W, 2004, BIOSYST ENG, V87, P445, DOI 10.1016/j.biosystemseng.2003.12.007; Celma AR, 2008, CHEM ENG PROCESS, V47, P1810, DOI 10.1016/j.cep.2007.10.003; Demir V, 2007, BIOSYST ENG, V98, P47, DOI 10.1016/j.biosystemseng.2007.06.011; Dinani ST, 2014, ENERG CONVERS MANAGE, V86, P70, DOI 10.1016/j.enconman.2014.05.010; Dinani ST, 2014, DRY TECHNOL, V32, P597, DOI 10.1080/07373937.2013.851086; Ding CJ, 2014, INT J APPL ELECTROM, V46, P455, DOI 10.3233/JAE-141781; Esehaghbeygi A, 2012, DRY TECHNOL, V30, P1644, DOI 10.1080/07373937.2012.701262; Esehaghbeygi A, 2011, J FOOD ENG, V104, P628, DOI 10.1016/j.jfoodeng.2011.01.032; Hashinaga F, 1999, DRY TECHNOL, V17, P479, DOI 10.1080/07373939908917547; Lai FC, 2002, DRY TECHNOL, V20, P1393, DOI 10.1081/DRT-120005858; Li FD, 2006, J FOOD ENG, V77, P275, DOI 10.1016/j.jfoodeng.2005.06.028; Li FD, 2005, DRY TECHNOL, V23, P565, DOI 10.1081/DRT-200054133; Li ZF, 2010, LWT-FOOD SCI TECHNOL, V43, P291, DOI 10.1016/j.lwt.2009.08.002; Meisami-asl E., 2009, Pakistan Journal of Nutrition, V8, P804; Menges HO, 2006, J FOOD ENG, V77, P119, DOI 10.1016/j.jfoodeng.2005.06.049; Pardeshi IL, 2010, FOOD BIOPROCESS TECH, V3, P415, DOI 10.1007/s11947-008-0100-z; Romano G, 2009, DRY TECHNOL, V27, P574, DOI 10.1080/00304940802716233; Senadeera W, 2003, J FOOD ENG, V58, P277, DOI 10.1016/S0260-8774(02)00386-2; Singh A, 2012, DRY TECHNOL, V30, P1812, DOI 10.1080/07373937.2012.708912; Srikiatden J, 2008, J FOOD ENG, V84, P516, DOI 10.1016/j.jfoodeng.2007.06.009; Wu BG, 2014, J FOOD PROCESS ENG, V37, P111, DOI 10.1111/jfpe.12066; Zhang J, 2000, J INNER MONGOLIA AGR, V21, P121; Zhang Y, 2014, J ELECTROSTAT, V72, P76, DOI 10.1016/j.elstat.2013.11.010	30	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124077	10.1371/journal.pone.0124077	http://dx.doi.org/10.1371/journal.pone.0124077			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25835017	Green Published, gold, Green Submitted			2022-12-26	WOS:000353015800131
J	Zhao, SY; Ding, C; He, JZ				Zhao, Siyan; Ding, Chang; He, Jianzhong			Detoxification of 1,1,2-Trichloroethane to Ethene by Desulfitobacterium and Identification of Its Functional Reductase Gene	PLOS ONE			English	Article							DEHALOCOCCOIDES-ETHENOGENES; SP NOV.; DEHALOGENASE; GROWTH; 1,1,2,2-TETRACHLOROETHANE; DECHLORINATION; SPP.	1,1,2-trichloroethane (1,1,2-TCA) has become a common groundwater pollutant due to historically extensive utilization, improper disposal, as well as from incomplete dechlorination of 1,1,2,2-tetrachloroethane. Currently, limited information is available on microbial detoxification of 1,1,2-TCA. Desulfitobacterium sp. strain PR, which was isolated from an anaerobic bioreactor maintained to dechlorinate chloroethenes/ethanes, exhibited the capacity to dechlorinate 1,1,1-trichloroethane and chloroform. In this study, the dechlorinating ability of strain PR was further explored. Strain PR showed the capability to dechlorinate 1,1,2-TCA (similar to 1.12 mM) predominantly to 1,2-dichloroethane (1,2-DCA) and chloroethane, and to trace amounts of vinyl chloride and ethene within 20 days. Strain PR coupled growth with dechlorination of 1,1,2-TCA to 1,2-DCA, while no cell growth was observed with dechlorination of 1,2-DCA to chloroethane. Later, through transcriptomic and enzymatic analysis, the reductive dehalogenase CtrA, which was previously reported to be responsible for 1,1,1-trichloroethane and chloroform dechlorination, was identified as the 1,1,2-TCA reductive dehalogenase. Since trichloroethene (TCE) is usually co-contaminated with 1,1,2-TCA, a co-culture containing Dehalococcoides mccartyi strain 11a capable of detoxifying TCE and 1,2-DCA and strain PR was established. Interestingly, this co-culture dechlorinated 1,1,2-TCA and TCE to the non-toxic end-product ethene within 48 days without chloroethane production. This novel pathway avoids production of the carcinogenic intermediate dechlorination product vinyl chloride, providing a more environmentally friendly strategy to treat 1,1,2-TCA.	[Zhao, Siyan; Ding, Chang; He, Jianzhong] Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore	National University of Singapore	He, JZ (corresponding author), Natl Univ Singapore, Dept Civil & Environm Engn, Singapore 117576, Singapore.	jianzhong.he@nus.edu.sg	Ding, Chang/K-6663-2013; He, Jianzhong/J-2704-2018; ZHAO, SIYAN/AAF-1441-2020; Zhao, Siyan/L-1670-2018	Ding, Chang/0000-0001-5550-4685; He, Jianzhong/0000-0003-1895-6628; Zhao, Siyan/0000-0002-5282-3194	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council [102 101 0025]; National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme [NRF-CRP5-2009-05]	Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council(Agency for Science Technology & Research (A*STAR)); National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme(National Research Foundation, Singapore)	This study was supported by Singapore Agency for Science, Technology and Research (A*STAR) of the Science and Engineering Research Council under project no.: 102 101 0025 and the National Research Foundation, Prime Minister's Office, Singapore under the Competitive Research Programme with a project no.: NRF-CRP5-2009-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian L, 2007, APPL ENVIRON MICROB, V73, P7717, DOI 10.1128/AEM.01649-07; ATSDR, 2006, TOX PROF VIN CHLOR; ATSDR, 2010, TOX PROF 1 1 2 TRICH; Aulenta F, 2006, BIODEGRADATION, V17, P193, DOI 10.1007/s10532-005-4218-7; Bowman KS, 2013, INT J SYST EVOL MICR, V63, P1492, DOI 10.1099/ijs.0.045054-0; CASTRO CE, 1994, ENVIRON TOXICOL CHEM, V13, P429, DOI [10.1897/1552-8618(1994)13[429:BRDBMT]2.0.CO;2, 10.1002/etc.5620130310]; Chen C, 1996, ENVIRON SCI TECHNOL, V30, P542, DOI 10.1021/es9502987; Chow WL, 2010, ISME J, V4, P1020, DOI 10.1038/ismej.2010.27; Coons DE, 2000, CHEMICAL OXIDATION AND REACTIVE BARRIERS, P161; De Wildeman S, 2003, APPL ENVIRON MICROB, V69, P5643, DOI 10.1128/AEM.69.9.5643-5647.2003; Ding C, 2014, ENVIRON MICROBIOL, V15, P1462; FATHEPURE BZ, 1994, ENVIRON SCI TECHNOL, V28, P746, DOI 10.1021/es00053a031; Grostern A, 2006, APPL ENVIRON MICROB, V72, P428, DOI 10.1128/AEM.72.1.428-436.2006; He JZ, 2007, APPL ENVIRON MICROB, V73, P2847, DOI 10.1128/AEM.02574-06; He JZ, 2003, NATURE, V424, P62, DOI 10.1038/nature01717; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee LK, 2010, APPL ENVIRON MICROB, V76, P794, DOI 10.1128/AEM.01872-09; Lee PKH, 2013, ENVIRON MICROBIOL, V15, P2293, DOI 10.1111/1462-2920.12099; Magnuson JK, 2000, APPL ENVIRON MICROB, V66, P5141, DOI 10.1128/AEM.66.12.5141-5147.2000; Maness AD, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-54; Moe WM, 2009, INT J SYST EVOL MICR, V59, P2692, DOI 10.1099/ijs.0.011502-0; Plagentz V, 2006, ENVIRON GEOL, V49, P684, DOI 10.1007/s00254-005-0106-z; Regeard C, 2005, APPL ENVIRON MICROB, V71, P2955, DOI 10.1128/AEM.71.6.2955-2961.2005; Schiffmann CL, 2014, J PROTEOMICS, V98, P59, DOI 10.1016/j.jprot.2013.12.009	24	58	61	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 2	2015	10	4							e0119507	10.1371/journal.pone.0119507	http://dx.doi.org/10.1371/journal.pone.0119507			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CE9BS	25835017	Green Published, Green Submitted, gold			2022-12-26	WOS:000352139000009
